<SEC-DOCUMENT>0000950170-24-090770.txt : 20240805
<SEC-HEADER>0000950170-24-090770.hdr.sgml : 20240805
<ACCEPTANCE-DATETIME>20240805161529
ACCESSION NUMBER:		0000950170-24-090770
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		84
CONFORMED PERIOD OF REPORT:	20240630
FILED AS OF DATE:		20240805
DATE AS OF CHANGE:		20240805

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RxSight, Inc.
		CENTRAL INDEX KEY:			0001111485
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				943268801
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40690
		FILM NUMBER:		241174963

	BUSINESS ADDRESS:	
		STREET 1:		100 COLUMBIA STREET
		STREET 2:		SUITE 120
		CITY:			ALISO VIEJO
		STATE:			CA
		ZIP:			92656
		BUSINESS PHONE:		949-521-7822

	MAIL ADDRESS:	
		STREET 1:		100 COLUMBIA STREET
		STREET 2:		SUITE 120
		CITY:			ALISO VIEJO
		STATE:			CA
		ZIP:			92656

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CALHOUN VISION INC
		DATE OF NAME CHANGE:	20000410
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>rxst-20240630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-08-05T11:08:14.2466+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:rxst="http://rxsight.com/20240630" xmlns:calc="https://xbrl.org/2023/calculation-1.1" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>10-Q</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_bb88959c-f356-4068-b027-b3dc5285c04b" name="dei:AmendmentFlag" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b">false</ix:nonNumeric><ix:nonNumeric id="F_2f6eecc9-9f4f-40be-a663-c1c2c4ab2fd5" name="ecd:TrdArrDuration" contextRef="C_3da2657a-3194-4635-a909-ab3fd0a1dd6a" format="ixt-sec:durday">364</ix:nonNumeric><ix:nonNumeric id="F_23fea469-98dd-41bb-9305-d3fa52a2a388" name="ecd:TrdArrDuration" contextRef="C_9161bac0-099b-4ec0-be0c-82d298abeca3" format="ixt-sec:durday">360</ix:nonNumeric><ix:nonNumeric id="F_570d48e1-9972-46b1-b30e-66ec7ba6108a" name="dei:EntityCentralIndexKey" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b">0001111485</ix:nonNumeric><ix:nonNumeric id="F_a8d8ba7a-c559-43d9-b3de-4656978882f1" name="dei:DocumentFiscalPeriodFocus" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b">Q2</ix:nonNumeric><ix:nonNumeric id="F_d8dc038a-1947-4b2c-a8ff-a7f396403c89" name="ecd:TrdArrDuration" contextRef="C_e17b2aa6-cab6-4346-b87c-a405a33a2764" format="ixt-sec:durday">365</ix:nonNumeric><ix:nonNumeric id="F_f0a67186-5427-4468-82c4-65fa1c61c56c" name="dei:CurrentFiscalYearEndDate" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b">--12-31</ix:nonNumeric><ix:nonNumeric id="F_7259b73d-46cd-455b-aa27-086f0efec3bc" name="ecd:TrdArrDuration" contextRef="C_e16a6e57-fa09-4b23-9d5a-b5b69cb75e2d" format="ixt-sec:durday">274</ix:nonNumeric><ix:nonNumeric id="F_48ef4de0-fded-40e6-8c90-fd15c86c12d1" name="ecd:TrdArrDuration" contextRef="C_897a6866-6f1b-4fb5-a915-4273bf3c2aee" format="ixt-sec:durday">279</ix:nonNumeric><ix:nonFraction id="F_33c93a11-4585-4640-99ad-44e5cef73f19" name="us-gaap:CommitmentsAndContingencies" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" unitRef="U_USD" xsi:nil="true"/><ix:nonFraction id="F_f659414f-436d-4bae-b738-d7b407266e59" name="us-gaap:CommitmentsAndContingencies" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" unitRef="U_USD" xsi:nil="true"/><ix:nonNumeric id="F_3e517117-8319-4cc0-8225-94336556f3a7" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245">http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet</ix:nonNumeric><ix:nonNumeric id="F_00e18cde-e7c6-4077-9799-7012c3ad64fb" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a">http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet</ix:nonNumeric><ix:nonNumeric id="F_0bfe1017-2ed2-4326-a247-db41c8cf4d2b" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245">http://rxsight.com/20240630#LeaseLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric id="F_78fd0571-9a99-465d-8968-e56cfa5898f0" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a">http://rxsight.com/20240630#LeaseLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric id="F_0f7fb7b9-c9ea-4648-8251-fd72d360c669" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245">http://rxsight.com/20240630#LeaseLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric id="F_a8615e7e-3a3b-4497-9d55-86ea65153fd0" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a">http://rxsight.com/20240630#LeaseLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric id="F_502cbe2a-5432-41d0-85b4-23a20a165bac" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245">http://rxsight.com/20240630#LeaseLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric id="F_8be0e6d4-5a47-411b-9144-c408d3934f9a" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a">http://rxsight.com/20240630#LeaseLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric id="F_a8cedab2-1fe0-482a-a6c2-28f0caa7a48f" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245">http://rxsight.com/20240630#LeaseLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric id="F_21a43b30-4a3d-4632-a584-149b79b2db2c" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a">http://rxsight.com/20240630#LeaseLiabilitiesNoncurrent</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="rxst-20240630.xsd"/></ix:references><ix:resources><xbrli:context id="C_8075f4fa-a67c-485b-862f-ee66abf092dc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_83a98163-4754-4205-8811-d48d703e7dce"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_848743db-b358-4cf3-abd3-f3016e7703de"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_859e1bb0-35f3-40e8-afc9-6b5a07eec379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8658457e-b5f0-4fd7-bb30-dac4f9d122bf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_870c219c-a4a7-4462-846d-85d7110b3380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8711b3ad-aa2f-4b24-ab3c-bee15606d03d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021EsppPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_872467f9-67fd-4871-b993-41838a2b5113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8869c8c5-5883-4a92-b4bf-6238296536a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-08</xbrli:startDate><xbrli:endDate>2024-05-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_88b8255e-f275-4b86-96c2-52ba7228dcd4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_897a6866-6f1b-4fb5-a915-4273bf3c2aee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:JulieAndrewsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_89a390bf-cf3f-4d6e-9839-74e86626c8d9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8b1f96bb-fff2-49be-8819-b62edbf4e6d1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8c085cd2-f882-483a-9365-9c156f7d6bb4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8de5eb07-df34-4d9b-8ee7-1a3ce4214e1a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8f9792cd-5e2e-44bd-b8e7-5ba5d2e31334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9161bac0-099b-4ec0-be0c-82d298abeca3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:RonKurtzMDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_924b61de-5beb-4902-a3d1-1540e5a5473b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_92773448-1606-437d-912e-2e2bd0f53565"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_92a77da4-deaa-41ad-80d7-531024609f4d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_93f8bf54-9e45-4c16-9967-dfadb4c026ed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_94635311-ec03-402f-a7d8-37123b9f3f6c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9570a28c-b316-4e10-b753-972c9bfbc435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxst:ShelfRegistrationStatementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-08</xbrli:startDate><xbrli:endDate>2024-05-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_95eb6bb1-f341-4f69-9031-18165fd37316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_996a376f-b733-4535-8dce-1a21486a132a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9b623e0d-4f1d-4db1-ae4c-f10eeef88de2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9c844e79-68e3-4292-baac-af1e749bfefa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9dff912c-7bb1-4372-9d7e-a40dfcd38d40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9ea266a9-965b-4b22-8258-e30e3b49e49b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxst:The2021EsppPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a248ded6-40d4-40c0-89fd-1e7502f8ac3f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a5ac65aa-cc43-4c9f-a44e-01e67eb807a2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:LDDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a73767b4-7596-4747-a31a-9abee5f0e1c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:CliffordDDownsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a9fe9645-a679-4c9e-910d-64434fc0d770"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aa2973b8-fc17-4fe1-b3e1-f27dd4a7007f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ab888ba9-e469-447e-bb28-93d500a06c72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b0b9ecf4-f70c-49f1-9f26-10517280835d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:ServiceWarrantyServiceContractsAndAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b0cbb535-d10a-43e6-a2b0-bb698413d1e0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b23a28e2-f54d-421e-a468-87056efde586"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b2763b9c-65fc-4b20-9afe-65016b69e297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b7832ab7-5ac7-48b8-b36a-eeaa642bb7fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b88f6739-08be-4673-af5e-386409d97e2e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ba9d48f2-149a-4fc5-9666-638ff32e1c8d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bc685971-8f0a-4ea4-8c64-9c188aeabf26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:RxlalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bc923b7c-f61f-4557-a54a-e7a984c590a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rxst:NoCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bdb7c2a6-1dd2-4f29-924b-0d330d5760a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bf0d539d-f732-43b5-bfee-00d8e0a9765f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c1f69193-9ca1-46d8-825e-767d784caa8b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:RonKurtzMDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c25f11d6-dc7c-4161-b92c-872ba3474149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c3849e78-84e7-468a-b497-8a3fed88ad2d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rxst:NoCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c3b8c0f8-26a4-4d47-91da-6c055e856dac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c40bec78-b687-45c4-ad3c-00a3ff05916e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c4552e7a-d149-444f-86ed-06df03b923bb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:LDDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c4fcf8f2-fb38-42b9-adcb-eb6d516b8469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c6550ecc-1f2d-48a5-b93f-4051f05eeb19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c97db89c-4001-4cdb-bd4d-a54689c81080"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ca32f3ef-6b1d-45b4-9e16-40beee1bb09f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cbd133ad-eca3-4208-8941-8bfd8e1c173b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rxst:OfficeManufacturingAndWarehouseFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cc013c64-8342-45ef-9d49-af4eb130d7ea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cc563601-0f12-4cea-9637-53f1f309f9f1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:LDDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ce17e0b5-a12f-49d2-881e-1ca12b318794"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cffab339-4046-4bfa-b82a-1b1694720712"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d0985361-3665-4b26-8732-c0bc94e9d51c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d31c11d4-0dd3-4c7f-afa5-cc439fc19ddc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:LDDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d8974959-d59e-44c2-b138-8241de80e80a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d98bbae7-20c2-4ccd-9db3-beaa1215b76d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dac5e1bd-acd6-4c7d-aacf-a30a4e26a25c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rxst:IndustrialCommercialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:AccurideInternationalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dbf9a77d-f552-43c7-b738-3e4043920c2b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:ServiceWarrantyServiceContractsAndAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ddfd1e3b-9d8b-446b-abd3-a22e0ca0bfa2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_df8cf6d9-9e68-4550-b7d7-3f23bb4e4d54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e06ef83e-8ff7-41dd-94cc-bc2af4dde419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxst:StockOptionsIssuedAndOutstandingUnderPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e16a6e57-fa09-4b23-9d5a-b5b69cb75e2d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:JAndyCorleyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e17b2aa6-cab6-4346-b87c-a405a33a2764"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:EricWeinbergMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e18f6da3-90c2-4d9b-8b4e-269b15d12144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e2c20804-0137-4f36-8ede-788b3dd3695e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e3efc9bd-860f-444e-a889-ebfd9d131560"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e4a673c7-eaa6-4857-856c-50b98038b762"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e56c75b3-caad-43f6-8432-5c6f54278fe0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021EsppPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e648d52d-9f33-406d-b707-f0d436342566"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rxst:OfficeManufacturingAndWarehouseFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e7d6d427-25c9-4896-bb46-4266c78ddbb2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:ServiceWarrantyServiceContractsAndAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e95a0f17-9a53-4675-91e9-06e88ee7f46d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:AccurideInternationalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e969fc23-8eb5-4d5d-ace5-3eb8042365bb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxst:StockOptionsIssuedAndOutstandingUnderPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e9ed04cb-b0ee-40da-929b-a0f166a7eea4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ebf267e3-249d-4c66-a032-0ae76ee1e173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ecbfe3e0-15a9-4d92-ac2a-89dac13644c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eddb3485-0e74-4545-b102-ed16c7ec0a2c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:RxlalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ef35aeef-393e-488b-85fd-95ffed2e764e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f1b15466-ecb1-46a7-a2a9-b73c5a09ae08"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f2e112f5-12f8-406a-a985-9a26dca174bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f4720bce-2db3-4982-a9fd-2cefd4a958ca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f5781e6f-1600-45ee-a829-0c9af9692565"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f8984806-8a2c-407e-87a3-79fd81817c95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f9980517-1437-4032-bfd8-e4a47703b439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f9e9e639-bb5c-4c5b-bef2-2b16f5ee280c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fd5d1c6b-a916-4a4b-8a21-c86da5a58d96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:CliffordDDownsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-18</xbrli:startDate><xbrli:endDate>2024-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_05587aab-7a1f-40a3-9a56-c925bb5331b9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_080ee223-a04a-45a8-98a5-9eab7d1606a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0996adb5-0bb8-42c5-98aa-9a62af36677e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_09b691ca-838d-431d-8501-a873d038e2bf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_09e7c479-5280-4bf3-a282-cb28f4483242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0a0a72f6-5a6d-41e6-92e8-4b90cf7843c6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0abad422-2500-4d9e-b9d3-8c167c8ee9ab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0bd63812-92ba-4572-9a40-8db99e7f608b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0c499457-67d8-4be1-bbac-93b1615afe77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:EricWeinbergMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0f2db67e-f20d-4666-a388-00d0b1a6b9f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_101ce506-9642-467b-b38c-f2c003a92905"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_107d2d34-29e5-4238-80a7-75906a0160b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:CliffordDDownsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rxst:IndustrialCommercialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1223a5cf-5ff9-4abd-b52d-c7eebdeb8212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_15d45034-58a3-4d42-bc68-b3740b5e0b2a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1b3a5e20-5e60-40d8-ac83-f2c584e1b842"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1cc1ee8b-02ae-4c94-beaa-b81200fcda42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:JulieAndrewsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1e158749-5a3a-428a-9c8c-71d3347c8329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_204a0bf3-73bf-4334-8ffd-365bddaf6a28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_23476103-2290-488c-b788-5f19565bb756"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_236410b5-5576-4fb5-8213-e1ee25595cc3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:RxlalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_26af5d92-2265-4e0b-b68d-a926ef38258d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_27166295-b86b-480b-8ace-2e05125185d6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2790d20b-5e9b-4fbb-aab0-0988eacc2119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2a070290-4230-4337-a657-3d109387c5bf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2bacb43d-9328-45cb-9df2-94d7e8766fe6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2cc166d9-2e7c-4d1e-b33d-918c247c655d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:AccurideInternationalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-18</xbrli:startDate><xbrli:endDate>2024-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2d3d3cc5-4096-4048-9e86-726c8e7126ef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_306d346a-380e-4f34-a95e-850689d48e3f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_32b78179-ee95-441f-9a0f-c5d71aff0dbb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_32b79176-7c08-4e2f-8dd4-4a8b2a419726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:IlyaGoldshlegerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_33a5d823-d771-4f16-9c29-15bf632fdbb6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_35ccf33e-5721-47b9-9631-6b62ea10a50a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3713ac89-35d4-43e3-9168-1283294925cf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3861c8c4-bc18-464d-8af7-febf616f8757"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_39cfd17b-899f-40c4-845a-6fdae94d9625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3b6572ea-8779-41d7-9699-5abd96466e88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3c557978-5173-4887-9475-3c1de75ad09d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3ccf0dc7-e2f1-4cd5-97cc-45c2be8de24d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3ce1a97a-19b2-4c6c-aa54-c82451d2825f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3d547736-7d2f-4ab1-ba32-5440721ad534"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:BmlManagementLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rxst:IndustrialCommercialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">rxst:OneTwentyFiveColumbiaLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3da2657a-3194-4635-a909-ab3fd0a1dd6a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:IlyaGoldshlegerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3e89f686-064a-4ed5-8601-3e8782699162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3fde5492-dc3e-412c-b180-b37e6ed47396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_426cc0de-05ef-4df6-9f8f-d9cfc2eca447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_428789be-eb44-4bee-8e7d-43887c59ba81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_43a01723-f1d7-414d-a915-41d499a7b20c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:RxlalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_443df5e3-56fa-4ac9-ae8d-93e0566a45d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-04</xbrli:startDate><xbrli:endDate>2022-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_44a8675d-687c-4d77-b5fb-c997d6d277a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_46ae809e-f67b-4a77-b4c5-50a424b655df"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_46db9299-0314-43f1-84b8-70e7b2fcce61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4b3ce656-4281-4287-90bf-5e25822bf054"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4c8e9ae1-1e9e-45b8-982a-f941b1e59b4d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:ServiceWarrantyServiceContractsAndAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4cac1f56-50f3-44b0-afcc-1b3e03ff9aad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4d46893f-4145-428e-8ad7-90506451e341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021EsppPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4f93e213-8803-490d-b3f5-c935ceb12ab4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_51a8f883-c93e-441e-8b3a-10e80e0d9a20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_53193d0d-eccf-4650-b5ff-2f01e68f7024"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:CliffordDDownsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-18</xbrli:startDate><xbrli:endDate>2024-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5501518b-7c81-4968-a973-df58e4381f69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5517632f-b947-4c40-8db1-42c309a847d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rxst:NoCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_55616c71-0dc0-4231-8880-c2204423fe8a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_55f52d8a-909f-44fb-865e-6571cbcee723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_55feb510-96cb-4d20-af10-c695f8e02985"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_59908af3-c3c5-49c1-9bb8-171ba60eb5f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5aacfb5c-bd2e-4b8f-915c-d1f78db2a9d7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5f4a79f9-a984-4624-83b4-b702658dbd28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5f629c9c-346d-4df1-9e88-b538f5affce5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5ff8a19a-ef8a-4d06-aaa2-5caaf0edeb10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_628a0a40-4c51-46a8-ae7c-d6e7b44797d1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:JAndyCorleyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6702e775-6fe0-4e23-b7e7-44e40075c069"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxst:StockOptionsIssuedAndOutstandingUnderPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_67e0d5d6-5fee-4a17-ba10-34c977d6903a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6ade43c7-7714-458d-a02a-e56ad23d0eec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6e1c7f83-49b9-4025-a3c3-dc623355c0cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6f6583f5-ec7a-4082-9b35-96788b1aca0c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_70dadb47-1500-4a1d-8f19-f29b9940b04f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_714e2128-63aa-4240-8ef9-520e2ff63b1a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_71726fb1-fc7b-4769-9509-bbabcda3b877"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7186a63a-2ded-414c-b053-cba2402cd973"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxst:StockOptionsIssuedAndOutstandingUnderPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_72207dc6-8a88-4a0a-988b-d8bca47ecaaa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_72d61c44-49fd-41dd-ad51-35f48ea85916"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7391a03e-f048-45b1-8c90-50f3375336d3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7424c8a5-89f5-43f8-895f-fd84c2c2a996"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021EsppPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_748782be-b4c1-440b-81fc-508b52d9ef24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_754f24b7-506d-4d0e-80c0-6352678c3425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rxst:NoCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_755fa8c1-f901-448e-a391-c05a19ebe37b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:AccurideInternationalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-18</xbrli:startDate><xbrli:endDate>2024-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7634a85b-9ef7-4095-a9b2-36e304f09a7e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxst:The2021EsppPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_78dfb1d2-f1e6-40bf-aa34-8f63a8bccd9f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_79f66c27-e4ac-416a-b575-59bf974253cf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:BmlManagementLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rxst:IndustrialCommercialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">rxst:OneTwentyFiveColumbiaLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-18</xbrli:startDate><xbrli:endDate>2024-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7e061ea2-e4c5-4f24-a010-06a54d38af8e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7e492a7e-2688-44a6-8a92-202d81383908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7fd1d14f-2011-4d83-8445-f16b305c1b27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001111485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Subsidiary"><xbrli:measure>rxst:Subsidiary</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U_Segment"><xbrli:measure>rxst:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U_Item"><xbrli:measure>rxst:Item</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div><p style="border-top:2.25pt double;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WASHINGTON, DC 20549</span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:6pt;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_468542ba-c480-4c3c-8cc4-80ab0b4a2573" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">10-Q</span></ix:nonNumeric></span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:6pt;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:4.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(Mark One)</span></p>
   <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:4%;"/>
     <td style="width:96%;"/>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><ix:nonNumeric id="F_386fe7b3-7915-4370-8df3-ef5907c40db5" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
     <td style="padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the quarterly period ended </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0add0e3b-350c-40d7-b113-da81dfb85079" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c0a03e40-1c6e-4412-992e-799d455ceeed" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:DocumentFiscalYearFocus"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2024</span></ix:nonNumeric></span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">OR</span></p>
   <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:4%;"/>
     <td style="width:96%;"/>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><ix:nonNumeric id="F_d481d750-11c3-4535-a240-3734d47b708b" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the transition period from     to</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Commission File Number: </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3ac66bfb-16d8-4e4d-901a-0cf337e03c04" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">001-40690</span></ix:nonNumeric></span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:6pt;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:22pt;font-family:Times New Roman;"><ix:nonNumeric id="F_18baac1f-d84f-44a2-83ae-9e0e724de4b2" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:22pt;font-family:Times New Roman;min-width:fit-content;">RxSIGHT, INC.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Exact Name of Registrant as Specified in its Charter)</span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50%;"/>
     <td style="width:50%;"/>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_d7334ef2-581c-4ada-b3de-53d3622bf146" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_4c2fa7db-7059-4460-bfac-8675a5686126" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">94-3268801</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(State or other jurisdiction of</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">incorporation or organization)</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(I.R.S. Employer<br/>Identification No.)</span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_76640bd1-a7ec-493d-9027-c0708da8cc3a" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">100 Columbia</span></ix:nonNumeric></span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_ec94b197-26f1-44ea-a488-e2a3fac8e085" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aliso Viejo</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_308e14e4-039b-4e66-9f50-6c3835852366" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">CA</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_2c6054ce-1b2c-4770-ad30-25a4b207e36f" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">92656</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Zip Code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registrant&#8217;s telephone number, including area code: (</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_78e6fee1-98db-49f3-b9e6-6f9f2af74fd0" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">949</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b1e33beb-f9a9-40d0-997d-9c5f5896c33f" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">521-7830</span></ix:nonNumeric></span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:40%;"/>
     <td style="width:1%;"/>
     <td style="width:18%;"/>
     <td style="width:1%;"/>
     <td style="width:40%;"/>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Title of each class</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Trading</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Symbol(s)</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_1567118b-79fa-4d1a-ad2b-a2fe58930340" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common Stock, par value $0.001 per share</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;"> </span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_b4182d6c-b792-4461-9172-3b4baf82fcbf" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">RXST</span></ix:nonNumeric></span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_067ebab5-5fc4-4caa-8bea-4630dd5e363f" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a6ecfd6a-ccde-4490-8e30-9f9493edd5ed" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:EntityCurrentReportingStatus"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> &#9746;    No   &#9744;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_646a91fd-5abc-4dd0-9e83-ad276d07a4fe" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:EntityInteractiveDataCurrent"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">  &#9746;    No  &#9744;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:18.9%;"/>
     <td style="width:1%;"/>
     <td style="width:55.84%;"/>
     <td style="width:1.06%;"/>
     <td style="width:20.1%;"/>
     <td style="width:1%;"/>
     <td style="width:2.1%;"/>
    </tr>
    <tr style="height:10.8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_e9b9a1bd-142c-4365-bfad-db96bcac4979" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Large accelerated filer</span></ix:nonNumeric></span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#9746;</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accelerated filer</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#9744;</span></p></td>
    </tr>
    <tr style="height:3.6pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:top;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:top;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:top;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Non-accelerated filer</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#9744;</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Smaller reporting company</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_8c7ef7c5-f79c-4fd0-afdd-c4ff8c108d2c" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:EntitySmallBusiness" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Emerging growth company</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_fd6839ae-902c-4461-8f60-43d9cb5ab9d8" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  &#9744;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes    &#9744;  No  </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e9ae6319-7a8c-46e0-967b-c2e5c2e0c632" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="dei:EntityShellCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">As of July 31, 2024, the registrant had </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_26a17a7a-6a17-4955-8d17-5d6058ff5a4c" contextRef="C_8075f4fa-a67c-485b-862f-ee66abf092dc" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">39,682,804</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock, $0.001 par value per share, outstanding.</span></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:10.1%;"/>
     <td style="width:82.82%;"/>
     <td style="width:7.08%;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Page</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">PART I.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">FINANCIAL INFORMATION</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Item 1.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1_fs"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Financial Statements (Unaudited)</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_balance_sheets"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Condensed Consolidated Balance Sheets</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_statements_operations"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Condensed Consolidated Statements of Operations and Comprehensive Loss</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#equity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Condensed Consolidated Statements of Equity</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_statements_cash_flows"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Condensed Consolidated Statements of Cash Flows</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#notes_to_condensed_financial_statements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Notes to Unaudited Condensed Consolidated Financial Statements</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Item 2.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_2_mda"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Item 3.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_3_quantitative_qualitative_disclosu"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Item 4.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_4_controls_procedures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Controls and Procedures</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">PART II.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">OTHER INFORMATION</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Item 1.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1_legal_proceedings"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Legal Proceedings</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Item 1A.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="toc_page"><a href="#risk_factors"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Risk Factors</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Item 2.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_2_unregistered_sales_equity_securit"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">94</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Item 3.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item3_defaults"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Defaults Upon Senior Securities</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">94</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Item 4.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">94</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Item 5.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item5otherinformation"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Other Information</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">95</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Item 6.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_6_exhibits"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Exhibits</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">96</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#signatures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Signatures</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">98</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10.5pt;font-family:Times New Roman;min-width:fit-content;">	</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following discussion and analysis should be read together with our condensed consolidated financial statements and the condensed notes to those statements included elsewhere in this report. This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are based on our management&#8217;s beliefs and assumptions and on information currently available to our management. In this report, &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to RxSight, Inc., a Delaware corporation, and its consolidated subsidiaries.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Forward-looking statements include, but are not limited to, statements concerning the following:</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the sufficiency of our existing capital resources to fund our future operating expenses and capital expenditure requirements, including our expectation that we do not anticipate the need to raise additional capital or incur additional debt in order to reach profit from operations, as disclosed in the Company&#8217;s future Annual Reports on Form 10-K or Quarterly Reports on Form 10-Q as filed with the Securities and Exchange Commission (&#8220;SEC&#8221;), provided that we may opportunistically seek to raise capital under advantageous circumstances from time to time in order to support the expansion of our sales and operations in the U.S. and internationally and to pursue other business opportunities;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the expected acceptance and use of our products by doctors;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to expand our business into new geographic markets;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the expected growth of our business and our organization;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our intentions regarding investment in our business as we pursue growth;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our plans and expected timelines related to our products, or developing new products, to address additional indications or otherwise;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to obtain, maintain and expand regulatory clearances for our products and any new products we create;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our expected uses of our existing resources;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our expectations regarding government and third-party payer coverage and reimbursement;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to recruit and retain key personnel, including the continued development of a sales and marketing infrastructure;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to obtain an adequate supply of materials and components for our products from our third-party suppliers, including single and sole source suppliers;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to manufacture sufficient quantities of our products with appropriate quality;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to obtain, maintain and enforce intellectual property protection for our products and protect our intellectual property rights;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our plans to conduct further clinical trials and any expectations related to the timing or outcomes of such trials;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to comply with applicable SEC rules and Nasdaq continued listing requirements;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to comply with existing and future government laws, rules and regulations both in the United States and internationally;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our expectations regarding the allocation of resources toward expenses associated with being a public company;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our estimates of our expenses, ongoing losses, future revenue, capital requirements and our need for, or ability to obtain, additional financing;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the volatility of the trading price of our common stock;</span></div></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to identify and develop new and planned products and/or acquire new products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">development and projections relating to our competitors or our industry, including anticipated growth rates for the conventional and premium intraocular lens (&#8220;IOL&#8221;) markets;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the impact of local, regional, national or political conditions and events; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the impact of worldwide political and economic conditions and unknown future events on our business, financial condition and results of operations.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Forward-looking statements include statements that are not historical facts and can be identified by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;intends,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;potential,&#8221; or &#8220;continue,&#8221; or the negative of such terms and other same terminology.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in Part II, Item 1A, &#8220;Risk Factors&#8221;, elsewhere in this report. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for us to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The forward-looking statements made in this report relate only to events as of the date on which the statements are made. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">INDUSTRY, BUSINESS AND MARKET DATA</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">This report also contains estimates, projections and other information concerning our industry, our business, and market opportunity, including data regarding the estimated size of the market. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data and similar sources.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TRADEMARKS, SERVICE MARKS AND TRADE NAMES</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">This report contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this report may appear without the &#174; or TM symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies&#8217; trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of it by, any other companies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;" id="item_1_fs"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Item 1: </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Financial Statements (Unaudited)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RxSIGHT, INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_balance_sheets"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CONDENSED CONSOLIDATED BA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">LANCE SHEETS</span></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt solid;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">(In thousands, except share and per share amounts)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:67.726%;"/>
     <td style="width:2.38%;"/>
     <td style="width:1%;"/>
     <td style="width:11.118%;"/>
     <td style="width:1%;"/>
     <td style="width:1.58%;"/>
     <td style="width:1%;"/>
     <td style="width:13.197%;"/>
     <td style="width:1%;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30,</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
     <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:middle;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
     <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(Unaudited)</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current assets:</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash and cash equivalents</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7afbff37-8b25-48a5-9f1d-a1b5034c0fbe" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,445</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_84f5626f-b97c-42c1-9a5d-239f750bdfad" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,692</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Short-term investments</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d0a44074-af77-41cf-99a3-1e4e5469bd96" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">208,839</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9d1f0e72-e9f0-4d4a-ab76-c5d82a22e81e" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">117,490</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accounts receivable</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_cfadd42f-e313-41a1-a006-f77a9bb1909d" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,723</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1d8675d1-c618-42c0-a8fd-836fe43c8210" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,281</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Inventories, net</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ec5f9a99-b9d7-4bf0-ae5a-1ff80a575786" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:InventoryNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,443</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_aa4f1490-270a-4cdd-bd98-3c0cf593617a" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:InventoryNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,421</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Prepaid and other current assets</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a74576a5-0899-4de4-bf9a-0f2d60e2d4f6" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,773</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f76ccd57-9647-424f-9d51-4b004bf4b7c0" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,523</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total current assets</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_016f2178-8bc8-4634-9837-f99801b1eb63" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">281,223</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_cccfe43e-f80c-44a9-a128-9869191d7e1a" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">168,407</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Property and equipment, net</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_06d64d46-e685-479e-9cdb-695281b5d4ad" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,444</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ff95ca1e-cab8-4dad-ba6f-563fe6d13f35" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,841</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating leases right-of-use assets</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_87e49d85-8637-4a11-bd19-955476a9049a" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,818</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1a544e37-8184-4d5d-96fc-3847504fc504" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,444</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Restricted cash</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a2b9608e-fcab-4367-9577-6da40bdbb411" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">711</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c5c50abc-3cee-452a-88fe-3c74f4d00128" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">711</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_34f420b5-794e-406c-bf62-fe373b58b1c9" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">303</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_88c3aa53-6b99-49ac-b1f6-26de4ff0ac2d" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">147</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total assets</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e9c5c915-df58-46c2-9153-2e22c791d45c" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">305,499</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_937a20b8-64f4-4b8b-a2df-ee9055499475" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">182,550</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Liabilities and stockholders' equity</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current liabilities:</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accounts payable</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6e41e23b-db67-4455-8010-c2a56cce1fee" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,095</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9801e629-57bd-4958-828c-e814c4c3fcf2" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,863</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0cc236bd-6e61-46db-9189-70ceae37253a" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,787</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_514d1a26-7c63-4226-8c66-e1195f3e2226" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,239</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lease liabilities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_36a15cde-27d5-4f3c-a662-c92b990a298b" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="rxst:LeaseLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">736</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_10256429-af59-4315-b608-515eb4b4cc10" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="rxst:LeaseLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,801</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total current liabilities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2e15577e-3c05-45ee-8f9f-4c11d52233de" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,618</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d43df426-595b-4b37-951b-79d9279f2e01" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,903</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term lease liabilities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8703eeae-a557-4607-a8d5-1d3175708b69" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="rxst:LeaseLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,674</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f6dbe58b-45d0-4fc8-a5e0-c396c03d9c12" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="rxst:LeaseLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,211</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other long-term liabilities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_602b90df-cbe5-4780-a8b4-3746ed4dec14" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f0a73557-3e43-4001-95f6-edee45eb0446" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total liabilities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_309b292a-3d40-402b-aa74-6194382e8164" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,292</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_00211713-fc90-44bb-b68f-ffebf5b39eeb" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,188</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><span style="-sec-ix-hidden:F_33c93a11-4585-4640-99ad-44e5cef73f19;"><span style="-sec-ix-hidden:F_f659414f-436d-4bae-b738-d7b407266e59;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Commitments and contingencies (Note 8)</span></span></span></span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stockholders' equity:</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">Common stock, $</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d7c4b66b-b924-4daa-993c-beb4ef1384e4" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_331448c0-92b3-4567-9f3c-5ae439eb3c11" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">&#160;par value, </span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9b8ccba8-b3ab-4ce8-87dc-e2f5c40ddafa" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_01b7c800-34b0-4a2b-9a16-8e4a270f2e50" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">900,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">&#160;shares authorized,<br/>&#160;&#160;</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0d52a8cf-e87b-47bb-9e53-9b10ea54c355" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4f94b57e-175f-453e-a04c-46665185903a" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">39,617,334</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">&#160;shares issued and outstanding as of June 30, 2024 and<br/>&#160;&#160;</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c607fb56-8a8d-4ad0-b90f-7e537518b78a" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_304cb782-34ad-4a9e-bd48-a0db9fc52695" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">36,139,513</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">&#160;shares issued and outstanding as of December 31, 2023</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_78895e80-6123-46a4-baae-3967b7982b21" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_740b5e99-f532-47ca-b6de-369e900fdcd0" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">Preferred stock, $</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d7c18882-058e-429b-975b-5fd7702b0b88" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4121e940-8bf1-4543-bf8d-baad432a2696" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">&#160;par value, </span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d8d65060-6308-4335-9f07-3a178c71e3a3" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_33b97761-536f-4186-ad18-e1e04798baf3" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">100,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">&#160;shares authorized,<br/>&#160;</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_bb7c1543-c2c5-4588-b6fc-62f414cd1151" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_f6108473-1f78-4809-b9dd-7da8b078f3a5" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_957abbda-5e8e-432b-843f-cb5598dea11e" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_b0200075-eda4-4890-9867-5ab6e331e065" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">&#160;shares issued and outstanding</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0ad5ccda-ba3f-4339-915e-89f4a716bd17" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_dfae5745-e227-4f3e-8388-dd9636cc2170" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Additional paid-in capital</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0fa8423e-b505-43bf-940b-1a8b0433d94f" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">885,104</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c3389bf5-4e78-45bc-8873-937ef901f23b" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">754,971</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accumulated other comprehensive loss</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_21703fc1-b869-4619-b65f-610033efa25a" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">118</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f56d0f42-d7ae-4c9e-9da5-ace4c8386529" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accumulated deficit</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_31d9b910-0136-432c-bd17-6a85bce1d58e" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">609,819</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e5ad90fa-1d2e-44d5-9575-99ed55a82789" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">594,640</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total stockholders' equity</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_628c3352-f0cc-4d69-8e62-9474023f6fb2" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">275,207</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e58166b8-853d-4719-85d6-feafe1b9bacb" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">160,362</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total liabilities and stockholders' equity</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f565793c-0cd9-46e8-9b40-f953b51ec511" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">305,499</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4a36e66d-f649-4995-ad8b-dd184045bca9" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">182,550</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">See accompanying notes to unaudited condensed consolidated financial statements.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RxSIGHT, INC.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_statements_operations"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CONDENSED CONSOLIDATED STATEMEN</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TS OF OPERATIONS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">AND COMPREHENSIVE LOSS (UNAUDITED)</span></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt solid;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">(In thousands, except share and per share amounts)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:33.287%;"/>
     <td style="width:1.92%;"/>
     <td style="width:1%;"/>
     <td style="width:15.583%;"/>
     <td style="width:1%;"/>
     <td style="width:1.92%;"/>
     <td style="width:1%;"/>
     <td style="width:12.763%;"/>
     <td style="width:1%;"/>
     <td style="width:1.92%;"/>
     <td style="width:1%;"/>
     <td style="width:11.342%;"/>
     <td style="width:1%;"/>
     <td style="width:1.92%;"/>
     <td style="width:1%;"/>
     <td style="width:11.342%;"/>
     <td style="width:1%;"/>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
     <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:middle;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
     <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:middle;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
     <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:middle;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
     <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sales</span></p></td>
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c62e5fe9-2f12-4fd8-a7a9-ae07631c0108" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,887</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7e014ed8-5df7-4039-817c-37fe27ba5524" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,810</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_81799486-d33d-4224-bc86-59f440d6ca2f" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,399</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d6aa82b7-6c88-4fa7-9655-c79903ee53a1" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,299</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of sales</span></p></td>
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c22ab69b-7cfc-46dc-931e-2cd220dd2b36" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,637</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_86e60b33-4ce9-410d-906b-8b3b5aebfa2a" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,795</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_60fc0848-8e8b-4f72-8c66-f75ff16df2ea" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,464</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_73030a95-cb4a-4386-97e5-3489f5892e5d" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,919</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Gross profit</span></p></td>
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5192f2d7-bedd-4055-a042-d707269382e8" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:GrossProfit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,250</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9cf88bbf-d450-479f-8ead-2cdc381c7aa8" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:GrossProfit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,015</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1606953b-b711-48e5-ad73-7812f147ceb0" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:GrossProfit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,935</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_03824927-ae8c-4ada-aef7-213718b5e752" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:GrossProfit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,380</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:10pt;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating expenses:</span></p></td>
     <td style="text-indent:10pt;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative</span></p></td>
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0e5f313f-2c63-4b8e-bea1-e153643d1e5c" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:SellingGeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,292</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_53f6e99e-2458-459c-9694-57b6abcc71b1" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:SellingGeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,239</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9d1a37c5-619e-4886-93fb-cf317c092a9e" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:SellingGeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,616</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e77a7afc-1bf7-4fba-aec9-6ce9f89cb56c" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:SellingGeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,492</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development</span></p></td>
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a56ef974-f9e7-4cc5-bdb8-cb787b5fb1e8" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,291</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_23df147b-b39e-45c9-ac6c-4dcf01b936ab" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,401</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_31731d5f-28ad-46c0-8f61-d55ea37afd29" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,322</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8b69965d-0ce1-4eb3-ac05-f9bde94baa03" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,608</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:30pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:30pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total operating expenses</span></p></td>
     <td style="text-indent:30pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:30pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8eb76c45-bc65-4e8e-8edf-b002697551b2" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,583</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a5b731d3-b1c7-484a-897f-926023fe2b63" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,640</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2e79dd5b-edac-43fb-a49b-9273a3afabcd" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,938</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_fdb7308c-2075-429b-9eea-6163dbf76003" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49,100</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:30pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:30pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Loss from operations</span></p></td>
     <td style="text-indent:30pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:30pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4b490e84-8787-43c5-ad06-ea2a3730c87e" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">8,333</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0df53456-15a0-4979-89fc-666f53a52527" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,625</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4d2a17c7-9495-4c7d-9b87-3c758ab6da0e" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">19,003</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_63414d11-8a85-443d-b2bc-8a84349ed4ce" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">26,720</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:10pt;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other income (expense), net:</span></p></td>
     <td style="text-indent:10pt;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest expense</span></p></td>
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b86d9dc6-bf4b-4b2b-8615-850383be745f" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_cea92882-671a-445f-bd3b-ebd86e3a5038" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,568</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ec13e22a-c8b8-4134-a76b-520f002c8240" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_79e67358-73d0-482b-a697-8719de27f919" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,075</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest and other income</span></p></td>
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_82ec3fdf-5347-47c6-9fe8-2275a25a5ae2" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:InterestAndOtherIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,276</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_61a10fa0-b23b-44f8-ad8f-99e62e44687b" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:InterestAndOtherIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,777</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4ee2f604-5d26-429f-81fc-84caecc416c9" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:InterestAndOtherIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,860</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ba209629-2d2b-49d3-8a35-5d9e31cdba54" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:InterestAndOtherIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,168</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Loss on extinguishment of term loan</span></p></td>
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_09515eff-0177-492b-9958-ed0dedf352f4" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_68b69129-4889-4ebf-b404-f85806c0b7f5" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">362</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c2915fc4-10f2-401d-9ec0-0a0d7f02e568" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0f509bb7-6118-4c81-b14c-9d6e78255beb" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">362</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Loss before income taxes</span></p></td>
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_fa138c1b-bf27-4a20-a3d5-2dccc3147672" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">6,063</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e1e77f02-c78d-4dcc-ba73-0eee56f19f9f" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,778</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1fcd902d-66ea-4b1e-abd6-012ee3bc6e01" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15,154</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0089612e-0f23-476f-8176-dca382fe7480" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">26,989</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Income tax expense</span></p></td>
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1c65869d-022d-4dd1-bdf7-42477d04c6be" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_76dacad5-ed6c-411f-b9ca-3842a5744b35" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9f693330-6a45-4c0a-bfd3-0fc7d9611200" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9c229c43-ae43-4389-a885-7356bcf8f970" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:30pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:30pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss</span></p></td>
     <td style="text-indent:30pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:30pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_239a8137-bfe8-4ee3-9e1e-75c593208eef" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">6,079</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d35f1401-82d4-43db-9323-3fbf316350fe" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,804</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_23f68c84-d999-4634-ab5d-05730ebb660f" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15,179</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c40e0a36-34d6-486b-9c4a-64a8d04d26ed" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">27,016</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:10pt;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other comprehensive (loss) income</span></p></td>
     <td style="text-indent:10pt;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unrealized (loss) gain on short-term investments</span></p></td>
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ba9964d3-8255-4d6a-ace2-bdd0882db550" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">64</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2c75811a-601e-475e-8404-308bd9d19ea5" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">65</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0291a537-163d-4bba-acbf-3921b5fa684e" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">109</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_cf433510-82cb-4149-a5d0-0f103f028bbb" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency translation (loss) gain</span></p></td>
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_666106a8-f0a2-4ee7-a406-7c251797014c" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_3bdea725-a498-4d58-bcb9-b2417ae1fad5" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_65b7ec32-3b55-435b-82a5-04e62f9e7a7c" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c715ddb6-2d74-47d7-9e25-2d6182f716f0" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total other comprehensive (loss) income</span></p></td>
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ce94f259-ad6c-4d07-8038-284df37454ba" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">65</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c467f7cf-29fe-4ecd-9f17-4f054c175c50" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">64</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e542abc4-2546-4ab1-ba51-640475df6964" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">113</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_3ea6e706-a1f9-4b18-bfe7-7d7b1e8fb77f" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Comprehensive loss</span></p></td>
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_66b6bef2-7d2a-431c-8045-043685e23180" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">6,144</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9a4aa7e9-df93-4765-8170-47b47e3ab129" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,868</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4863e397-7f73-4d1b-bd0c-33a39c7a462d" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15,292</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_38dfab1f-fd70-44d7-88d3-8cd70d34115f" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">26,994</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:10pt;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss per share:</span></p></td>
     <td style="text-indent:10pt;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Basic &amp; diluted</span></p></td>
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6b82eb60-9721-491c-81a4-89d99fe3cf54" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a8572260-f3e3-4233-968e-d501cf930327" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.16</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5e9e0785-a9f0-41d3-831c-8ac1753a50e6" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_1a2e4a59-5f96-4bc9-b21f-5426bd090a97" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.40</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_edd8b778-2783-45d9-af13-6a6dc3707300" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_94623031-f063-48ed-b115-9b55ff664549" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.40</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_dfc59f4c-c93e-422c-bfce-de421cba9700" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4d1143ac-f4a0-48a5-b9dc-62252bb4944e" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.82</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:10pt;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted-average shares used in computing net loss per share:</span></p></td>
     <td style="text-indent:10pt;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Attributable to common stock, basic &amp; diluted</span></p></td>
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f3aff8aa-5eba-40fa-ba5f-c2913f19b880" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_72814266-864f-4ef1-af51-85be5fc763b1" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">38,455,955</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_575df07c-da96-478e-ab82-d55337d84681" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_86f847aa-5732-4f18-abb9-dbc7df74a3be" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">34,498,265</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0977c0ca-8aeb-4711-b55f-affc1943654d" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_6a65eacd-4950-4c31-90ba-69b4ce3259e1" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">37,649,521</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_00826041-3635-4146-a1e7-04a64b385862" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_691d1c76-3a1a-43c5-8960-d62efb90679c" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">33,075,585</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">See accompanying notes to unaudited condensed consolidated financial statements.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:10in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">RxSIGHT, INC.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="equity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">CONDENSED CONSOLIDATED STATEMENTS OF </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">STOCKHOLDERS&#8217; EQUITY</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> (UNAUDITED)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt solid;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(In thousands, except number of shares)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:27.429%;"/>
     <td style="width:1%;"/>
     <td style="width:1%;"/>
     <td style="width:9.016%;"/>
     <td style="width:1%;"/>
     <td style="width:1.02%;"/>
     <td style="width:1%;"/>
     <td style="width:6.757%;"/>
     <td style="width:1%;"/>
     <td style="width:1.02%;"/>
     <td style="width:1%;"/>
     <td style="width:9.456%;"/>
     <td style="width:1%;"/>
     <td style="width:1.02%;"/>
     <td style="width:1%;"/>
     <td style="width:10.236%;"/>
     <td style="width:1%;"/>
     <td style="width:1.02%;"/>
     <td style="width:1%;"/>
     <td style="width:10.236%;"/>
     <td style="width:1%;"/>
     <td style="width:1.02%;"/>
     <td style="width:1%;"/>
     <td style="width:8.776%;"/>
     <td style="width:1%;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="22" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30, 2024</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Common stock</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Additional paid-in</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accumulated other</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accumulated</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total stockholders'</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Shares</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amount</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">capital</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">comprehensive loss</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">deficit</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">equity</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_54f62da2-6278-417b-8ad5-72244e16fef4" contextRef="C_f4720bce-2db3-4982-a9fd-2cefd4a958ca" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">36,139,513</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a90e8f8e-e7ff-4338-ba61-4533020cede1" contextRef="C_f4720bce-2db3-4982-a9fd-2cefd4a958ca" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_12dbdd65-cd5c-4629-82b9-15d9edea56ad" contextRef="C_7e492a7e-2688-44a6-8a92-202d81383908" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">754,971</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_342cf532-c0e8-4208-b223-a8b5d586b052" contextRef="C_cc013c64-8342-45ef-9d49-af4eb130d7ea" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9e283dc9-3992-44bd-a199-023fd7c08b7f" contextRef="C_9c844e79-68e3-4292-baac-af1e749bfefa" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">594,640</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9fe76340-4747-427a-b85f-121e2effac2e" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">160,362</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares issued for the exercise of stock options<br/>&#160;and vesting of restricted stock units</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_31145d93-e120-4388-bb48-cd20751d5fb8" contextRef="C_83a98163-4754-4205-8811-d48d703e7dce" name="rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,061,336</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_055850c1-b271-4c51-a315-99048e45b2e4" contextRef="C_83a98163-4754-4205-8811-d48d703e7dce" name="rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_10ff395a-e231-4dc4-b553-bdf93bfcacbb" contextRef="C_ddfd1e3b-9d8b-446b-abd3-a22e0ca0bfa2" name="rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,152</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_24b644ff-55e7-486d-b929-ac5b67c0359e" contextRef="C_27166295-b86b-480b-8ace-2e05125185d6" name="rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,153</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares redeemed for employee tax withholdings</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ef1db93a-e9ee-403d-9237-34ddd95b577a" contextRef="C_83a98163-4754-4205-8811-d48d703e7dce" name="rxst:SharesRedeemedForEmployeeTaxWithholdings" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">39,096</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_64369299-da42-4c2b-8bbe-5e95849ddb80" contextRef="C_ddfd1e3b-9d8b-446b-abd3-a22e0ca0bfa2" name="rxst:SharesRedeemedForEmployeeTaxWithHoldingsAmount" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,134</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ec4abf04-407d-4b32-b90c-1ecc006df166" contextRef="C_27166295-b86b-480b-8ace-2e05125185d6" name="rxst:SharesRedeemedForEmployeeTaxWithHoldingsAmount" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,134</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock-based compensation expense</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ec66b23f-ce77-4bfa-9386-3ea8922cdbc9" contextRef="C_ddfd1e3b-9d8b-446b-abd3-a22e0ca0bfa2" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,696</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b9980b40-ae50-4625-8b02-a937b2adfa61" contextRef="C_27166295-b86b-480b-8ace-2e05125185d6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,696</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unrealized loss on short-term investments <br/>&#160;and cash equivalents, net of tax</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8c265bcc-5a08-43d6-b928-cdce5f9b36df" contextRef="C_c3b8c0f8-26a4-4d47-91da-6c055e856dac" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">45</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2480a7b2-dee9-4ea9-8f00-4462c0bb3e59" contextRef="C_27166295-b86b-480b-8ace-2e05125185d6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">45</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency translation adjustment</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9b735bb9-54c2-4066-8665-5576a5576714" contextRef="C_c3b8c0f8-26a4-4d47-91da-6c055e856dac" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_caa9e3e0-c0a1-412d-96a0-ba86326ee3d3" contextRef="C_27166295-b86b-480b-8ace-2e05125185d6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_98b68504-b75a-4e49-818e-af0bd29bc5a9" contextRef="C_3ce1a97a-19b2-4c6c-aa54-c82451d2825f" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">9,100</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_cc67c202-9edb-412d-80b6-2096d603a951" contextRef="C_27166295-b86b-480b-8ace-2e05125185d6" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">9,100</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at March 31, 2024</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b0b51fac-0a57-43c1-8759-43c0d23bfba8" contextRef="C_ecbfe3e0-15a9-4d92-ac2a-89dac13644c1" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">37,161,753</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2c12293e-3d3e-455f-9917-3ebd56ada892" contextRef="C_ecbfe3e0-15a9-4d92-ac2a-89dac13644c1" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_168e20cc-ba02-4235-89fd-dbc4443b5d44" contextRef="C_bf0d539d-f732-43b5-bfee-00d8e0a9765f" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">767,685</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2046cb93-00d2-44d8-9853-54f378bde265" contextRef="C_32b78179-ee95-441f-9a0f-c5d71aff0dbb" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_473dbabe-ea6e-467b-bb74-b100587f4701" contextRef="C_4f93e213-8803-490d-b3f5-c935ceb12ab4" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">603,740</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_35abb905-0df7-424f-996b-068f3892baf0" contextRef="C_996a376f-b733-4535-8dce-1a21486a132a" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">163,929</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares issued for the exercise of stock options<br/>&#160;and vesting of restricted stock units</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ba070524-30ed-407f-9243-852e07cb5bec" contextRef="C_55feb510-96cb-4d20-af10-c695f8e02985" name="rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">363,105</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a9b6b8e1-e074-4cee-86d1-549ca66bbdae" contextRef="C_55feb510-96cb-4d20-af10-c695f8e02985" name="rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4ab06c43-44bf-452d-916e-42c713ce5de6" contextRef="C_3713ac89-35d4-43e3-9168-1283294925cf" name="rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,102</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a5da59d1-767f-46bb-bcc6-78174e16c183" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,103</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock-based compensation expense</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_145e8d2d-1b54-4e1e-8b4b-186feba05ccd" contextRef="C_3713ac89-35d4-43e3-9168-1283294925cf" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,105</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d99d018a-3c1e-44b5-8eda-20532beda6a0" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,105</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares issued for the employee stock purchase plan</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_356a4e16-f6f4-428b-995b-aa7618cb7738" contextRef="C_55feb510-96cb-4d20-af10-c695f8e02985" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">38,905</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b1a8339d-60ce-4701-b490-64301db3a39d" contextRef="C_3713ac89-35d4-43e3-9168-1283294925cf" name="rxst:SharesIssuedForTheEmployeeStockPurchasePlanAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">737</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4dfbf5ad-9149-4834-9726-ced7f5d8fc9d" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="rxst:SharesIssuedForTheEmployeeStockPurchasePlanAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">737</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e932f97c-5968-4fca-a3dc-00fc07ed4dfd" contextRef="C_55feb510-96cb-4d20-af10-c695f8e02985" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,053,571</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e7ad19b7-0d78-47e6-862b-d854ee7d2247" contextRef="C_55feb510-96cb-4d20-af10-c695f8e02985" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5debb525-fb7f-4b6c-b0ff-21d72a1e4614" contextRef="C_3713ac89-35d4-43e3-9168-1283294925cf" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">107,475</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_3d6dfbdf-fe2f-4d15-8623-f4a551b56cc4" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">107,477</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unrealized loss on short-term investments <br/>&#160;and cash equivalents, net of tax</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9fd1d043-28b1-4490-84d0-2d76fd10d6b2" contextRef="C_2bacb43d-9328-45cb-9df2-94d7e8766fe6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">64</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_cc8a6410-f405-4fc5-a4f3-226502df068b" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">64</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency translation adjustment</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_052bc92c-8bfc-4d10-9cc6-46066612580d" contextRef="C_2bacb43d-9328-45cb-9df2-94d7e8766fe6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_eddd5857-793d-41cd-a4a0-f272f89e35f4" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0e957810-2b45-46cd-86f1-f4e73474d3d3" contextRef="C_09b691ca-838d-431d-8501-a873d038e2bf" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">6,079</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c622e94c-c71e-40f9-8d86-3e233ba0b4d7" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">6,079</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at June 30, 2024</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c77204a1-283e-4750-9702-474903cdc942" contextRef="C_92a77da4-deaa-41ad-80d7-531024609f4d" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">39,617,334</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a00df9e8-6e6e-4a4f-acf5-b549f96f72d2" contextRef="C_92a77da4-deaa-41ad-80d7-531024609f4d" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7a125844-0a70-4b63-b58c-da6ed6a748f4" contextRef="C_0996adb5-0bb8-42c5-98aa-9a62af36677e" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">885,104</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_85b141d4-9c65-4538-b697-3946f27fb34a" contextRef="C_78dfb1d2-f1e6-40bf-aa34-8f63a8bccd9f" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">118</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7d7fad4e-fff1-493c-a7bf-145166b97eb3" contextRef="C_1b3a5e20-5e60-40d8-ac83-f2c584e1b842" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">609,819</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e3bd2b9e-4795-4dab-948e-1b9439c6d998" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">275,207</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">See accompanying notes to unaudited condensed consolidated financial statements</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:10in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:10in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">RxSIGHT, INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(UNAUDITED)</span></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt solid;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(In thousands, except number of shares)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:27.429%;"/>
     <td style="width:1%;"/>
     <td style="width:1%;"/>
     <td style="width:9.016%;"/>
     <td style="width:1%;"/>
     <td style="width:1.02%;"/>
     <td style="width:1%;"/>
     <td style="width:6.757%;"/>
     <td style="width:1%;"/>
     <td style="width:1.02%;"/>
     <td style="width:1%;"/>
     <td style="width:9.456%;"/>
     <td style="width:1%;"/>
     <td style="width:1.02%;"/>
     <td style="width:1%;"/>
     <td style="width:10.236%;"/>
     <td style="width:1%;"/>
     <td style="width:1.02%;"/>
     <td style="width:1%;"/>
     <td style="width:10.236%;"/>
     <td style="width:1%;"/>
     <td style="width:1.02%;"/>
     <td style="width:1%;"/>
     <td style="width:8.776%;"/>
     <td style="width:1%;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="22" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30, 2023</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Common stock</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Additional paid-in</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accumulated other</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accumulated</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total stockholders'</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Shares</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amount</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">capital</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">comprehensive loss</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">deficit</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">equity</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_62248cea-5dbb-4041-ab21-e2ce9b67a40c" contextRef="C_70dadb47-1500-4a1d-8f19-f29b9940b04f" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">28,268,389</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6ccde3fa-7953-4027-a7f3-9ec7ab4525e9" contextRef="C_70dadb47-1500-4a1d-8f19-f29b9940b04f" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b10311b5-7821-4515-944b-4421ba9360c8" contextRef="C_924b61de-5beb-4902-a3d1-1540e5a5473b" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">636,001</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_88ce2ae3-d695-4ca6-89a4-87e75b045b22" contextRef="C_a248ded6-40d4-40c0-89fd-1e7502f8ac3f" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">95</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b9942c63-10e9-47ef-ae68-0388ef144991" contextRef="C_e9ed04cb-b0ee-40da-929b-a0f166a7eea4" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">546,032</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0b3988d3-1fd9-4ef3-a39f-d5f16909dd78" contextRef="C_ef35aeef-393e-488b-85fd-95ffed2e764e" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89,902</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares issued for the exercise of stock options<br/>&#160;and vesting of restricted stock units</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b191f6b2-95aa-4bd3-a9b1-f630f10c1a6e" contextRef="C_f2e112f5-12f8-406a-a985-9a26dca174bc" name="rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">243,598</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_837abe1d-841b-4f97-8c48-cb3ba05a74b8" contextRef="C_44a8675d-687c-4d77-b5fb-c997d6d277a5" name="rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">761</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_79a1d5fb-63dc-413c-b15a-e0e8abb9641f" contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c" name="rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">761</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares redeemed for employee tax withholdings</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6f5200da-e435-4b3c-ad29-a6017c751372" contextRef="C_f2e112f5-12f8-406a-a985-9a26dca174bc" name="rxst:SharesRedeemedForEmployeeTaxWithholdings" unitRef="U_shares" decimals="0" sign="-" format="ixt:num-dot-decimal">24,631</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_22d57b2b-d0b0-4f0e-9ef4-a17d7aac86a9" contextRef="C_44a8675d-687c-4d77-b5fb-c997d6d277a5" name="rxst:SharesRedeemedForEmployeeTaxWithHoldingsAmount" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">337</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9ecc8b4f-ba64-485d-a338-175476630945" contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c" name="rxst:SharesRedeemedForEmployeeTaxWithHoldingsAmount" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">337</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock-based compensation expense</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_85f8b86f-3a10-42a5-bd0b-8475b1e54e21" contextRef="C_44a8675d-687c-4d77-b5fb-c997d6d277a5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,295</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_3a132a5a-06d8-47e1-bb31-53d719d9bd34" contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,295</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a28ab615-19fc-490c-afc7-e8dbe43d014f" contextRef="C_f2e112f5-12f8-406a-a985-9a26dca174bc" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">4,600,000</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e381f2d7-9f94-44ba-ab2a-bebba582c14a" contextRef="C_f2e112f5-12f8-406a-a985-9a26dca174bc" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8ce15e09-9b58-415a-87d0-0f816903cd61" contextRef="C_44a8675d-687c-4d77-b5fb-c997d6d277a5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,595</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7de2feeb-ea3b-439f-9ca7-473a28ba96c7" contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,600</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Issuance of common stock for at-the-market offerings, <br/>net of issuance costs</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a2927b76-b546-4250-857d-6075a16cc8b6" contextRef="C_f2e112f5-12f8-406a-a985-9a26dca174bc" name="rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:num-dot-decimal">879,341</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b1c775c6-c1ce-41f1-b3ae-0346b0262a39" contextRef="C_f2e112f5-12f8-406a-a985-9a26dca174bc" name="rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_23fe1017-1cbb-406b-a200-77562d7dab7c" contextRef="C_44a8675d-687c-4d77-b5fb-c997d6d277a5" name="rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,913</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7ec831d8-4960-4391-8270-c57ec70ab5ab" contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c" name="rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,914</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unrealized gain on short-term investments <br/>&#160;and cash equivalents, net of tax</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_58717169-bc14-4f04-baee-dec1fc357a12" contextRef="C_e2c20804-0137-4f36-8ede-788b3dd3695e" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6c8f1dd4-629a-42bf-8590-ddaeb8d50b0b" contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency translation adjustment</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9344ccfc-96a6-4282-bda2-494c41289d83" contextRef="C_e2c20804-0137-4f36-8ede-788b3dd3695e" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5d5b61cb-a3b0-4753-af1e-ca0740b7297f" contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f18329b8-7e63-44a0-abed-648c82555897" contextRef="C_b23a28e2-f54d-421e-a468-87056efde586" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,212</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9ad7d6d5-e5f4-4e9b-83a4-7310ed0e60c5" contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,212</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at March 31, 2023</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_608dacfa-1b50-4b1c-b36d-a9db6a853be4" contextRef="C_859e1bb0-35f3-40e8-afc9-6b5a07eec379" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">33,966,697</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ac060396-3928-49b7-a3f0-3c4cca2f5eed" contextRef="C_859e1bb0-35f3-40e8-afc9-6b5a07eec379" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_72f4f698-426f-4ad4-ade3-0e067b53bd8e" contextRef="C_46db9299-0314-43f1-84b8-70e7b2fcce61" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">704,228</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_902a6a1c-9b48-4364-be42-8bf9268e1e55" contextRef="C_8de5eb07-df34-4d9b-8ee7-1a3ce4214e1a" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">9</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1f1ec47a-2e88-44e3-807d-b6914ec259fb" contextRef="C_3861c8c4-bc18-464d-8af7-febf616f8757" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">559,244</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b5cc02b4-e602-48b3-9382-3e74645d41a7" contextRef="C_d8974959-d59e-44c2-b138-8241de80e80a" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">145,009</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares issued for the exercise of stock options<br/>&#160;and vesting of restricted stock units</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b9a2c8bc-12a0-4d61-9b22-a198307cd20e" contextRef="C_aa2973b8-fc17-4fe1-b3e1-f27dd4a7007f" name="rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">316,092</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0c1fe43f-6da3-4e9d-8a37-2b76fa1cd8e0" contextRef="C_51a8f883-c93e-441e-8b3a-10e80e0d9a20" name="rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,599</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_695803c0-0fcf-4f90-99e6-894672b243ea" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,599</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock-based compensation expense</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_da039c26-2578-4510-8c8d-f293631e7237" contextRef="C_51a8f883-c93e-441e-8b3a-10e80e0d9a20" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,955</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b7631a0d-37b7-4bf4-b805-59320fe53358" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,955</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares issued for the employee stock purchase plan</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4aba49dd-f442-4a8a-b503-cb92941533e3" contextRef="C_aa2973b8-fc17-4fe1-b3e1-f27dd4a7007f" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">50,504</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_927cce34-c9c8-4198-b0ab-4de8f99966f4" contextRef="C_51a8f883-c93e-441e-8b3a-10e80e0d9a20" name="rxst:SharesIssuedForTheEmployeeStockPurchasePlanAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">536</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6c4c6782-421d-47d5-84b6-cbebd4c2c38f" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="rxst:SharesIssuedForTheEmployeeStockPurchasePlanAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">536</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Issuance of common stock for at-the-market offerings, <br/>net of issuance costs</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8c0a49bb-f317-4eea-84a8-54a320fef64a" contextRef="C_aa2973b8-fc17-4fe1-b3e1-f27dd4a7007f" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">834,748</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_36491e35-2fd7-4b56-8da4-de6486c6a27d" contextRef="C_aa2973b8-fc17-4fe1-b3e1-f27dd4a7007f" name="rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9a57b6c5-afbc-46a0-b1a7-c393741fc949" contextRef="C_51a8f883-c93e-441e-8b3a-10e80e0d9a20" name="rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,956</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6762c99b-0cba-4e2a-9019-9c149bc0ca69" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,957</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unrealized loss on short-term investments <br/>&#160;and cash equivalents, net of tax</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_cc4a5eb1-ab4b-4140-8368-33c5b65af421" contextRef="C_f9e9e639-bb5c-4c5b-bef2-2b16f5ee280c" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">65</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5372c1bf-fd19-4fff-8142-222563389818" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">65</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency translation adjustment</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7b68616c-efb1-4607-bc3a-0b170ec738f5" contextRef="C_f9e9e639-bb5c-4c5b-bef2-2b16f5ee280c" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_75035192-8b58-4ad2-bd77-6534384304c4" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e78d845d-b3ea-48a1-b0ed-a0f689e6ea8b" contextRef="C_d98bbae7-20c2-4ccd-9db3-beaa1215b76d" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,804</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_175539eb-0c73-477b-a0e4-fcd12340f612" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,804</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at June 30, 2023</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_08a31b96-699b-407f-8552-67a4e1025aab" contextRef="C_88b8255e-f275-4b86-96c2-52ba7228dcd4" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">35,168,041</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_fd1dff6d-ba99-4770-92c3-baabe433a123" contextRef="C_88b8255e-f275-4b86-96c2-52ba7228dcd4" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_34217056-8c79-4896-afe0-aa72cbaa104f" contextRef="C_080ee223-a04a-45a8-98a5-9eab7d1606a5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">730,274</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9a5f36bc-7da7-424c-a53d-e97efa859e9d" contextRef="C_93f8bf54-9e45-4c16-9967-dfadb4c026ed" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">73</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6ca7c851-428d-4786-805a-20b5a3285507" contextRef="C_5aacfb5c-bd2e-4b8f-915c-d1f78db2a9d7" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">573,048</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_88bb0e1f-e833-45da-87c8-474fceb6aab5" contextRef="C_4cac1f56-50f3-44b0-afcc-1b3e03ff9aad" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">157,188</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">See accompanying notes to unaudited condensed consolidated financial statements</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:10in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RxSIGHT, INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_statements_cash_flows"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;min-width:fit-content;">CONDENSED CONSOLIDATED STATEMEN</span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;min-width:fit-content;">TS OF CASH FLOWS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;min-width:fit-content;">(UNAUDITED)</span></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt solid;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;min-width:fit-content;">(In thousands)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:66.993%;"/>
     <td style="width:1.42%;"/>
     <td style="width:1%;"/>
     <td style="width:13.083%;"/>
     <td style="width:1%;"/>
     <td style="width:1.42%;"/>
     <td style="width:1%;"/>
     <td style="width:13.083%;"/>
     <td style="width:1%;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Operating Activities:</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2f616cc2-e9e1-454b-89f5-9242e580fc01" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15,179</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_38026887-85cf-4f08-850c-cdb270437cb1" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">27,016</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Depreciation and amortization</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6ad755b5-7f7b-44cb-980c-3ee5ce89a4fe" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,927</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4e7fa969-d285-409e-8cf4-01deaa7b78d2" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,944</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amortization of right-of-use lease assets</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_70b9436c-f092-46ed-9450-ab4b9d52d824" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_957ed513-bf81-4333-b652-4564656e8cf5" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">85</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amortization of debt issuance costs and premium</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a5e500ee-e128-4e83-bf07-68e5effd6edd" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_311b6dc3-53fd-4591-b21d-2eb8729c2665" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">283</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Loss on extinguishment of debt</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a3036dfb-b9f5-48a9-90ad-777f7c414acd" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_3bcc4784-c82b-4a50-9091-60af80452a4f" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">362</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amortization of discount on short-term investments</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ffbbcc09-980d-4426-847b-6bb881ac7076" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,578</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_75501ab5-9d8c-4371-a40e-12f4b1a775f4" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,953</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock-based compensation</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_14b818fc-6e6b-413b-a46d-17201e259183" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,801</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e4beea6e-9698-4d1e-ad8e-e60bcbb2682d" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,250</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Provision for excess and obsolete inventory</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_fd867550-5c7c-4f78-a7fc-7133d96beef5" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:InventoryWriteDown" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">167</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_57d02b08-8872-4a74-be4b-1f4751b2a4eb" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:InventoryWriteDown" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:10pt;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Change in operating assets and liabilities:</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accounts receivable</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8cb2a630-60eb-4657-8b30-fd56221fcdd5" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,441</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5fe3db23-67d8-46a4-894f-db6e2b93f9e9" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,338</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Inventories</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_05420c7c-bc94-4244-8fb8-3f6668cbadaf" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:IncreaseDecreaseInInventories" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,189</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ad1e7179-f425-4f00-b7f1-ab2f568c94e8" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:IncreaseDecreaseInInventories" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,124</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Prepaid and other assets</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7e3a4dc9-187d-4be2-9ffd-eca19b1c913e" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">673</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8d610d2d-07cb-4ad4-9110-a655138a74fa" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">868</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accounts payable</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4acd82ec-4fbc-4b14-93ce-30ca89e53e68" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">789</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2b266d42-c447-4df8-9a63-a88a5d3968e5" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,324</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accrued expenses and other liabilities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_3ade0a34-f5b0-4725-bca7-0228ef89937c" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,339</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_46f1707b-4fc3-48d6-9988-8bc4fbf5357f" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,009</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:30pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:30pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net cash used in operating activities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_96a7f645-1362-4711-8b0e-86a104d6971e" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,336</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e14990e2-30e8-4db2-ba8d-ee8a9e130191" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">25,310</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Investing Activities:</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Purchase of property and equipment</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_99c8b7a7-8940-4fe2-b3f0-7b0dbb620382" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,490</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0f1ecd23-7c89-4426-a85e-cad5b6bec1ae" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,570</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Maturity of short-term investments</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_282a7d69-5391-4e0c-8814-d91b85b4d52d" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,000</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_17220518-0441-46b1-bb6d-cff0ba35a784" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">115,000</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Purchases of short-term investments</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_384837fa-ccaa-4b5f-bd50-3fc5c4694511" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:PaymentsToAcquireShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">206,881</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_3b8a647f-7915-4f26-96f0-d0e86f9c6056" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:PaymentsToAcquireShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">156,400</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:30pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:30pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net cash used in investing activities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_bd319cd4-c923-4b47-8d26-c9b3f77fb148" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">91,371</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8dfffad1-602c-4248-bf6f-be82afc3884b" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">43,970</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Financing Activities:</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Proceeds from term loan</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6e7239b8-c359-4aa3-97e2-f773896f476e" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ProceedsFromNotesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_157c29e9-478b-44aa-8900-8c1d66700be0" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:ProceedsFromNotesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,000</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Repayment of term loan</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_88f033c7-476d-4011-9dfd-9f356a7325e6" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:RepaymentOfTermLoan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_10dd6bca-920d-4ff7-9baf-0af8fd961b12" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="rxst:RepaymentOfTermLoan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,000</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Proceeds from issuance of common stock from public offering</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c8653d95-2077-46d6-bd5f-d52df66780f7" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">108,100</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7bcaf0cc-6419-4d25-9788-6199d20bbd08" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">54,050</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Proceeds from issuance of common stock from at-the-market offerings</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1064cfd4-198d-443d-875a-864fad532c71" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_73b1cd4d-da43-4e9d-bf24-85a00be7f506" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="rxst:ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,496</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Proceeds from issuance of common stock</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e999b4f9-c9ca-4137-985d-8d3de89fadfd" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,993</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ac0f2caa-25b1-46f3-8343-43f798f4d371" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,896</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Payments for employee taxes related to stock compensation</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8746a4b1-2081-4773-8376-07cc5f00fea2" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:PaymentsForEmployeeTaxesRelatedToStockCompensation" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,133</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_71baa480-7695-4189-92ae-e875ed1ef59a" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="rxst:PaymentsForEmployeeTaxesRelatedToStockCompensation" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">337</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Principal payments on finance lease liabilities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_72f8fdf4-f1f5-4bc1-a3b5-ed5aa74b2a33" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:FinanceLeasePrincipalPayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_47f49fd8-8466-40d9-a930-7fc4723681d9" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:FinanceLeasePrincipalPayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Payments of deferred offering costs</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c00373e0-e31b-4ac1-836b-c1a0e543e73a" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">377</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a5315514-a60b-4d4a-ab2a-c273d1ae06f9" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">602</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Payments of debt issuance costs</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f8e66263-1630-4f93-8c8b-6245030cc726" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:PaymentsOfDebtIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">80</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_bb63392c-0314-4c98-aa39-ad36642f69e3" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:PaymentsOfDebtIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,225</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:30pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:30pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d23852d7-4b82-46aa-a5b2-9cf3482d0e40" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,465</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b430c663-878d-4592-9083-6e28d7376cdc" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,196</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Effect of foreign exchange rate on cash, cash equivalents and restricted cash</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6b040cfd-abdd-4c15-8655-33a8bbaaa711" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a1c776dd-d6b7-4953-beac-0c5d0e4845f7" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net increase (decrease) in cash, cash equivalents and restricted cash</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a2bc7f69-ab3e-4b2a-be64-c8238252689b" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,754</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_21c8eeda-5547-4e95-b3b8-06635e003425" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,081</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cash, cash equivalents and restricted cash - beginning of period</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_76b1f6b6-e86a-4ad5-a1a3-8c2fc50cd210" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,402</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6c4ed82d-4782-472c-b592-df3ad1779e05" contextRef="C_ef35aeef-393e-488b-85fd-95ffed2e764e" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,595</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cash, cash equivalents and restricted cash - end of period</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b0d6c42d-efde-4333-bef3-17884bc08731" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,156</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ed8c2e8a-4f94-4603-85ca-b340346aa6a6" contextRef="C_4cac1f56-50f3-44b0-afcc-1b3e03ff9aad" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,514</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Supplemental disclosure of cash flow information:</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_77cfacdc-9852-401e-8477-acdd4a492ee9" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,128</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6b6ef941-ce18-40a3-aeb4-e5fb7996f781" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,107</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash paid for income taxes</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_71a7bc7d-3ed4-4cf1-bb59-b9ad91227602" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:IncomeTaxesPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b4ee8f74-2f9d-4b6f-b100-da35b50efd54" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:IncomeTaxesPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash paid for interest on financing leases</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d833f75e-36f5-44c3-8fbd-f90b1a2a7d92" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:InterestPaidOnFinancingLeases" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6fcd3194-6fc7-4d39-bd35-52613b297dd2" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="rxst:InterestPaidOnFinancingLeases" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash paid for interest on term loan</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_64e746ee-9971-4ac8-990b-ba3d27530a0b" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:InterestPaidOnTermLoan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e5b894e3-a65f-4d68-8506-201194151dd0" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="rxst:InterestPaidOnTermLoan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,240</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Non-cash investing and financing activities:</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:10pt;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Right-of-use assets obtained in exchange for lease obligations:</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating lease</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d9982fe6-da74-438d-9c0b-347c9a5f5026" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,060</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4fa2f9b2-88fc-498e-8247-f888012566f1" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance lease</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ee243091-da9c-4429-88aa-53091edc5176" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_bd032f52-4829-4c07-b450-0d8dd0fde630" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:10pt;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lease obligations recorded for right-of-use assets:</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating lease</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5de748dd-8af1-423c-ac24-10bb35498408" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:OperatingLeaseObligationsIncurred" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,060</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d4a69e3a-8c9a-4399-abe5-de2b10671df4" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="rxst:OperatingLeaseObligationsIncurred" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance lease</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2b7da1b4-0e0d-4461-9f96-9432c53df499" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:FinanceLeaseObligationsIncurred" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_20fcb84f-48e5-450a-92e4-156d17c4030f" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="rxst:FinanceLeaseObligationsIncurred" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Acquisition of property and equipment included in accounts payable and accrued expenses <br/>&#160;&#160;and other current liabilities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_728cce9f-d4db-4d3f-91ec-6b43adeb973a" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">229</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8695dea1-0cd6-44f1-b2eb-2b95b2dcb51d" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">408</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred offering and financing costs included in accounts payable and accrued liabilities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_05f5265d-950b-4fec-9f68-e76ab990192c" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:DeferredOfferingCostsIncludedInAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">392</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_12d2dc80-526c-4975-a488-8c2177ed4e35" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="rxst:DeferredOfferingCostsIncludedInAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">187</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Reclassification of deferred financing costs</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d26d13de-f89b-4bd6-80eb-2de4f28ab475" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:ReclassificationOfDeferredCost" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">768</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;min-width:fit-content;">(</span><span style="font-size:7.5pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ebd1f684-0d02-4346-9d07-b5b80c9d8a27" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="rxst:ReclassificationOfDeferredCost" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,075</ix:nonFraction></span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">See accompanying notes to unaudited condensed consolidated financial statements.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RxSIGHT, INC.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="notes_to_condensed_financial_statements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NOTES TO UNAUDITED CONDENSED CONSOLIDATED F</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">INANCIAL STATEMENTS</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c6e64300-be56-4750-8495-4ca30021a813" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 1 - Organization and Basis of Presentation</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Description of Business</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RxSight&#174;, Inc. (the &#8220;Company&#8221;) is a Delaware corporation headquartered in Aliso Viejo, California with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_72ca3af0-d321-47b4-a89f-2f9b0ff2afa6" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:NumberOfWhollyOwnedSubsidiaries" unitRef="U_Subsidiary" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> wholly owned subsidiary located in Amsterdam, Netherlands (&#8220;RxSight, B.V.&#8221;).  RxSight, B.V. has a registered branch in the United Kingdom and a wholly owned subsidiary located in Germany (&#8220;RxSight GmbH&#8221;).  The Company is engaged in the research and development, manufacture and sale of light adjustable intraocular lenses used in cataract surgery along with capital equipment used with the lenses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s products, which include the light adjustable lens&#174; (&#8220;LAL&#153;&#8221; and &#8220;LAL+&#153;&#8221;, and collectively the &#8220;LAL&#8221;) and a specially designed machine for delivering light to the eye, the Light Delivery Device (&#8220;LDD&#153;&#8221;), are approved by the United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) primarily for sale in the U.S. and have regulatory approval in the U.S., Europe, Canada and Mexico. The Company began marketing its products in 2019. The LAL is a premium intraocular lens (&#8220;IOL&#8221;) which is partially reimbursable under Medicare. The Company competes with other IOLs in the premium market.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying unaudited condensed consolidated financial statements include the accounts of RxSight, Inc. and its wholly owned subsidiaries, RxSight, B.V. and RxSight GmbH. All significant inter-company balances and transactions have been eliminated in consolidation.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_443141ee-b4d3-403c-a472-d4780c1f40bc" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and pursuant to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements. The unaudited interim financial statements reflect all adjustments which, in the opinion of management, are necessary for a fair statement of the results for the periods presented. All such adjustments are of a normal and recurring nature.  The December 31, 2023 balance sheet data was derived from audited financial statements; however, the accompanying notes to the condensed consolidated financial statements do not include all of the annual disclosures required under GAAP and should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2023 Annual Report on Form 10-K filed with the SEC on February 28, 2024. The operating results presented in these unaudited condensed consolidated financial statements are not necessarily indicative of the results that may be expected for any future periods.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Operating Segments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company determined its operating segment on the same basis that it uses to evaluate its performance internally. The Company&#8217;s chief operating decision-maker (&#8220;CODM&#8221;), its Chief Executive Officer, reviews its consolidated operating results for the purpose of allocating resources and evaluating financial performance.  The Company determined that it operates and manages its business (including its non-U.S. subsidiaries) in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_44643835-4d9e-472c-a02b-34a8ef834845" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:NumberOfReportableSegments" unitRef="U_Segment" decimals="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> reportable segment: the research and development, manufacture and sale of light adjustable lenses and related capital equipment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_9b1ed617-c6e8-46d2-9620-4ed0d10903f7" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:LiquidityAndFinancialPositionPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Liquidity</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Shelf Registration Statement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On May 8, 2024, the Company filed an automatic shelf registration statement on Form S-3 (&#8220;shelf registration statement&#8221;). The shelf registration statement is effective for three years and permits the Company to sell, from time to time, common stock, preferred stock, debt securities, warrants, and/or units. The shelf registration statement is intended to provide the Company with flexibility to access additional capital.  At the time of filing the shelf registration statement, the Company also filed a prospectus supplement to sell up to an aggregate value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_292e23cb-1873-462a-b78d-331e8102a579" contextRef="C_9570a28c-b316-4e10-b753-972c9bfbc435" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">115.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million dollars of common stock through a public offering (&#8220;Public Offering&#8221;).</span></p><ix:exclude><div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
          <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
           <tr style="visibility:collapse;">
            <td style="width:33.447%;"/>
            <td style="width:33.447%;"/>
            <td style="width:33.106%;"/>
           </tr>
           <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           </tr>
          </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div></ix:exclude><ix:exclude>
        <hr style="page-break-after:always;"/><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div></ix:exclude><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Public Offering</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1e6016d2-619a-476e-b3b8-4619af7dad0b" contextRef="C_8869c8c5-5883-4a92-b4bf-6238296536a0" name="us-gaap:SaleOfStockTransactionDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">May 8, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company entered into an underwriting agreement with BofA Securities, Inc., in which the Company agreed to issue and sell </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_74c013f7-323f-49af-85e5-da708b523c6c" contextRef="C_8869c8c5-5883-4a92-b4bf-6238296536a0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,785,714</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company's common stock in a public offering, pursuant to the shelf registration statement. The shares of common stock were sold at a price to the public of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4d489139-7c0f-4c1f-b565-b750b5438f8c" contextRef="C_7fd1d14f-2011-4d83-8445-f16b305c1b27" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">56.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share. Under the terms of the underwriting agreement, the Company also granted the underwriters an option exercisable for 30 days from the date of the underwriting agreement to purchase up to an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_39ba392b-8732-4886-a9c4-b12911887316" contextRef="C_8869c8c5-5883-4a92-b4bf-6238296536a0" name="rxst:AdditionalNumberOfCommonSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">267,857</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock on the same terms and conditions.  The underwriters' option was exercised in full on May 10, 2024 and the Public Offering (inclusive of the underwriters' option shares) closed on May 13, 2024.  The Company received net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e79860f0-4d0b-40d9-90e1-1fdd57cfc91e" contextRef="C_8869c8c5-5883-4a92-b4bf-6238296536a0" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">107.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million from the Public Offering, after deducting underwriters' discounts and commissions of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5fe7c5a6-7064-40f9-9d5a-63d09fe9be52" contextRef="C_7fd1d14f-2011-4d83-8445-f16b305c1b27" name="rxst:CommonStockSaleUnderwritingDiscountsAndCommissionDeducted" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and other offering expenses of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_234d28fe-6e11-4094-b48a-5b198af6f82d" contextRef="C_7fd1d14f-2011-4d83-8445-f16b305c1b27" name="rxst:CommonStockOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024 and December 31, 2023 the Company had cash, cash equivalents and short-term investments of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_00000bf3-b7c5-4cd3-84ad-9319a0274d5e" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">233.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ebe4a9c6-22a9-4f53-bf2e-156f9269fbc0" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">127.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company began generating revenue from its principal operations in 2019. The Company has a limited operating history, and the revenue and income potential of the Company&#8217;s business and market are unproven. The Company has experienced recurring net losses and negative cash flows from operating activities since its inception. For the three months ended June 30, 2024 and 2023, the Company incurred losses from operations of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_100f889c-92b3-43fa-bfb2-eeffd2f3900c" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="rxst:OperatingIncomeLoss1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a81c5816-f18a-4519-854d-bbc788b8c290" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="rxst:OperatingIncomeLoss1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. For the six months ended June 30, 2024 and 2023, the Company incurred losses from operations of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_11ab7eff-ef03-45dd-9eb7-f97b24541e0f" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:OperatingIncomeLoss1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">19.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_0721bae3-56a9-4344-9687-f4f379bd0640" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="rxst:OperatingIncomeLoss1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">26.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.  Based on the Company&#8217;s anticipated sales growth in relation to the anticipated costs associated with, among other things, its continuing research and development activities and the expansion of its sales and marketing activities, the Company expects to continue to incur net operating losses into the foreseeable future. Successful transition to attaining profitable operations is dependent upon gaining market acceptance of the Company&#8217;s products and achieving a level of revenues adequate to support the Company&#8217;s cost structure.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company believes that existing cash resources will be sufficient to meet projected operating requirements for at least 12 months from the date of issuance of the accompanying condensed consolidated financial statements, however for the near future, the Company expects to continue to incur operating losses and negative cash flows. The Company plans to continue to fund its losses from operations using its cash, cash equivalents and short-term investments as of June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and meet its future capital funding needs through equity or debt financings, other third-party funding, collaborations, strategic alliances and licensing arrangements or a combination of these. If the Company raises additional funds by issuing equity securities, its stockholders may experience dilution. Any future debt financing into which the Company enters may impose additional covenants that restrict operations, including limitations on its ability to incur liens or additional debt, pay dividends, repurchase common stock, make certain investments or engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity raise may contain terms that are not favorable to the Company or its stockholders. If the Company is required to enter into collaborations and other arrangements to address its liquidity needs, it may have to give up certain rights that limit its ability to develop and commercialize product candidates or may have other terms that are not favorable to the Company or its stockholders, which could materially and adversely affect its business and financial prospects. There can be no assurance that the Company will be able to obtain additional financing on acceptable terms, or at all. If the Company is not able to secure adequate additional funding, the Company may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible and/or suspend or curtail planned programs. Any of these actions could materially harm the Company&#8217;s business, results of operations and future prospects.</span></p></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0c273bdd-6e84-4d5e-b6e8-6d6e4d329411" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true" continuedAt="F_0c273bdd-6e84-4d5e-b6e8-6d6e4d329411_1"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 2 - Summary of Accounting Policies</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_0f12b5db-257b-46ca-8c29-454af0a93cb2" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:UseOfEstimates" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">preparation of consolidated financial statements in conformity with GAAP requires management to make informed estimates, judgments and assumptions that affect the reported amounts in the condensed consolidated financial statements and disclosures in the accompanying notes as of the date of the accompanying condensed consolidated financial statements. On an on-going basis, management evaluates the most critical estimates and assumptions for continued reasonableness. Actual results may differ materially from the estimates used in the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><ix:exclude><div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
          <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
           <tr style="visibility:collapse;">
            <td style="width:33.447%;"/>
            <td style="width:33.447%;"/>
            <td style="width:33.106%;"/>
           </tr>
           <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           </tr>
          </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div></ix:exclude><ix:exclude>
        <hr style="page-break-after:always;"/><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div></ix:exclude><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">preparation </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of the accompanying condensed consolidated financial statements under different assumptions or conditions.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4a8f0693-6a3a-4926-b348-cbac73ad40e4" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:SignificantAccountingPoliciesPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Significant Accounting Policies</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There have been no significant changes to the accounting policies during the three months ended June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, as compared to the significant accounting policies described in Note 2 of the &#8220;Notes to Consolidated Financial Statements&#8221; in the Company&#8217;s audited consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on February 28, 2024.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7b76a851-b1e4-4415-8b45-968cb87a21ad" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents consist of investments in money market accounts. The Company considers all highly liquid investments with original maturities of three months or less at the date of purchase that can be liquidated without prior notice or penalty to be cash equivalents.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_93dce737-a2a9-4380-9aaa-f910cf770991" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:ShortTermInvestmentsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Short-term Investments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Short-term investments are classified based on the maturity date of the related securities. Based on the nature of the assets, the Company&#8217;s short-term investments, which are government securities, are classified as available-for-sale and are recorded at their estimated fair value as determined by prices for identical or similar securities at the balance sheet date. The Company&#8217;s short-term investments consist of Level 2 financial instruments in the fair value hierarchy. Unrealized gains and losses are recorded as a component of Other Comprehensive Loss within Stockholders&#8217; Equity on the condensed consolidated balance sheets. Realized gains and losses are included as other income (expense) in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss. The cost basis for realized gains and losses on available-for-sale securities is determined on a specific identification basis. Management determines the appropriate classification of its investments at the time of purchase and reevaluates such determination at each balance sheet date. The Company periodically reviews its investments for unrealized losses other than credit losses and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In determining whether the carrying value is recoverable, management considers the following factors:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">whether the investment has been in a continuous loss position for over 12 months; </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the duration to maturity of investments; </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">intention and ability to hold the investment to maturity and if it is not more likely than not that the Company will be required to sell the investment before recovery of the amortized cost basis; </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the credit rating, financial condition and near-term prospects of the issuer; and </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the type of investments made. </span></div></div><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company had an unrealized loss of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_3337b1c7-0bab-4bfb-a537-eb3ceefeb0d9" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:UnrealizedGainLossOnInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">99,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_176bbb39-02e0-4375-ad15-ab46a5cb9822" contextRef="C_1223a5cf-5ff9-4abd-b52d-c7eebdeb8212" name="us-gaap:UnrealizedGainLossOnInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of net unrealized gains related to short-term investments as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_1f0a3125-8c5b-4120-a915-8d2559e68a88" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk and Other Risks and Uncertainties</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, short-term investments and accounts receivable. The Company&#8217;s policy is to invest cash in institutional money market funds and marketable securities of the U.S. government to limit the amount of credit exposure. The Company currently maintains a portfolio of cash equivalents and short-term investments in money market funds and U.S. treasury bills. A portion of the Company's operating cash is held in accounts in excess of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance limits; however, the Company has established guidelines regarding diversification of its investments and their maturities, which are designed to maintain principal and maximize liquidity. The Company has not experienced material losses on cash equivalents and short-term investments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s products require approval from the FDA and foreign regulatory agencies before commercial sales can commence. There can be no assurance that the Company&#8217;s products will receive any of these required</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><ix:exclude><div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
          <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
           <tr style="visibility:collapse;">
            <td style="width:33.447%;"/>
            <td style="width:33.447%;"/>
            <td style="width:33.106%;"/>
           </tr>
           <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           </tr>
          </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div></ix:exclude><ix:exclude>
        <hr style="page-break-after:always;"/><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div></ix:exclude><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">approvals. The denial or delay of such approvals may have a material adverse impact on the Company&#8217;s business and may impact business in the future. In addition, after approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the device approval process.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is subject to risks common to companies in the medical device industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of the Company's products, product liability and the need to obtain additional financing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is subject to the risks related to global lead times, particularly in Europe and Asia, leading to a supply interruption from the Company's suppliers. In addition, the Company is currently experiencing inflation and longer lead times and limited availability in its supply chain for certain components and has continued exposure to price and supply risk related to anticipated purchases of certain commodities, materials and products used in its business.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7d66201c-dc7b-46a7-831e-bff880b806d0" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ReceivablesPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounts Receivable</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has a diverse customer base and as of June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the Company did not have any customers who individually accounted for greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ee1a033b-5318-47f5-a822-c07619c40d97" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:AccountsReceivablePercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fa0389be-b9b1-4a20-983b-00696915d165" contextRef="C_1223a5cf-5ff9-4abd-b52d-c7eebdeb8212" name="rxst:AccountsReceivablePercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of accounts receivable. The Company maintains an allowance for credit losses resulting from the inability of its customers, including ambulatory surgery centers, to make required payments. After evaluation of the collectability of accounts receivable, the Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e4c276de-923d-44bb-a755-cdc7ef506c69" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ProvisionForDoubtfulAccounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_dd215395-ce15-45eb-a695-1b902eea0bad" contextRef="C_1223a5cf-5ff9-4abd-b52d-c7eebdeb8212" name="us-gaap:ProvisionForDoubtfulAccounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">t record any significant allowance for credit losses as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 or December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p></ix:nonNumeric></div><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_255d278e-286f-4645-b3b4-fe10b60f6184" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" escape="true"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value of Financial Instruments</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company uses fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures.  Fair value is measured as the price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques that are consistent with the market, income or cost approach are used to measure fair value. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three levels:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 1&#8212;Observable inputs such as unadjusted quoted prices in active markets that are accessible at the measurement date for identical unrestricted assets or liabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 2&#8212;Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability, for substantially the full term of the asset or liability, through correlation with market data. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 3&#8212;One or more significant inputs that are unobservable and supported by little or no market activity and reflect the use of significant management judgment and assumptions. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques and significant management judgment or estimation. These include the Black-Scholes option-pricing model which uses inputs such as expected volatility, risk-free interest rate and expected term to determine fair market valuation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification at each reporting date. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the years presented.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s financial instruments consist principally of cash, cash equivalents, short-term investments, accounts receivable, accounts payable and operating lease liabilities. Cash, cash equivalents, accounts receivable and accounts payable are carried at their estimated fair value because of the short-term nature of these assets and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><ix:exclude><div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
          <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
           <tr style="visibility:collapse;">
            <td style="width:33.447%;"/>
            <td style="width:33.447%;"/>
            <td style="width:33.106%;"/>
           </tr>
           <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           </tr>
          </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div></ix:exclude><ix:exclude>
        <hr style="page-break-after:always;"/><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div></ix:exclude><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">liabilities. The Company&#8217;s short-term investments in government securities are carried at fair value, determined based on publicly available quoted market prices for identical securities at the measurement date. The Company believes the fair values of its operating lease liabilities at June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, approximated their carrying values, based on the borrowing rates that were available for loans with similar terms as of such date.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cbb9f2ec-8558-4ba0-bf9b-bd646d0891fb" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:InventoryPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Inventories</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inventories consist of raw materials, work-in-process and finished goods. Raw materials are comprised of chemicals and parts used in the production of the Company's lenses, cartridges, and LDDs. Finished goods are comprised of lenses, cartridges, accessories and LDDs. Inventories are valued at the lower of cost or net realizable value. Cost is computed using standard cost, which approximates actual cost on a first-in, first-out basis. The carrying value of inventories is reviewed for potential impairment whenever indicators suggest that the cost of inventories exceeds the carrying value and management adjusts the inventories to its net realizable value. The cost of finished goods and work-in-process is comprised of raw materials, direct labor, other direct costs and related production overhead to the extent that these costs do not exceed the net realizable value of the goods produced. The Company periodically reviews inventories for potential impairment, estimated losses from obsolescence, material expirations or unmarketable inventories or excess inventories and writes down the cost of inventories to net realizable value at the time such determinations are made. Net realizable value is determined using the estimated selling price, in the ordinary course of business, less estimated costs to complete and dispose.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0f42d387-58e9-4805-b03e-338553aa3e3b" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Leases</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lease right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term, and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized when the Company takes possession of the leased property (&#8220;Commencement Date&#8221;) based on the present value of lease payments over the lease term. The Company estimates the incremental borrowing rate based upon the cost of its own debt financing, current market interest rates and quoted offerings or the rate implicit in the lease. Operating lease right-of-use assets also include any lease payments made at or before lease commencement and exclude any lease incentives received. The lease terms used to calculate the right-of-use asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Rent expense on noncancelable leases containing known future scheduled rent increases is recorded on a straight-line basis over the term of the respective leases beginning on the Commencement Date. The difference between rent expense and rent paid is accounted for as a component of operating lease right-of-use assets on the accompanying condensed consolidated balance sheets. Landlord improvement allowances and other such lease incentives are recorded as property and equipment and as reduction of the right-of-use leased assets and are amortized on a straight-line basis as a reduction to operating lease costs. Leases with an initial term of 12 months or less are expensed as incurred and are not recorded as right-of-use assets on the condensed consolidated balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_e987f6e8-2ae5-40c0-be12-afc5431af5b3" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Net Loss per Share</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average shares of common stock outstanding for the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average shares of common stock and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock and potential dilutive securities outstanding during the period.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><ix:exclude><div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
          <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
           <tr style="visibility:collapse;">
            <td style="width:33.447%;"/>
            <td style="width:33.447%;"/>
            <td style="width:33.106%;"/>
           </tr>
           <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           </tr>
          </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div></ix:exclude><ix:exclude>
        <hr style="page-break-after:always;"/><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div></ix:exclude><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fc8944f6-d505-46cc-bfae-f61ff857f758" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common stockholders because their impact under the treasury stock method was anti-dilutive for the periods presented:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:41.74%;"/>
           <td style="width:1%;"/>
           <td style="width:12.36%;"/>
           <td style="width:1%;"/>
           <td style="width:1%;"/>
           <td style="width:1%;"/>
           <td style="width:11.26%;"/>
           <td style="width:1%;"/>
           <td style="width:1%;"/>
           <td style="width:1%;"/>
           <td style="width:11.48%;"/>
           <td style="width:1%;"/>
           <td style="width:1%;"/>
           <td style="width:1%;"/>
           <td style="width:12.16%;"/>
           <td style="width:1%;"/>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock options issued and outstanding under the Calhoun Vision, Inc. 2006 Stock Plan, Calhoun Vision, Inc. 2015 Equity Incentive Plan and the 2021 Equity Incentive Plan</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_072d9ada-2a1c-4622-8528-00f20f45fcc1" contextRef="C_e969fc23-8eb5-4d5d-ace5-3eb8042365bb" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,618,186</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d107ccc4-e67e-4bd9-9901-5a9025867b2b" contextRef="C_6702e775-6fe0-4e23-b7e7-44e40075c069" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,821,076</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d3bec5b3-9e73-4696-ac90-f1bb3bb400a4" contextRef="C_e06ef83e-8ff7-41dd-94cc-bc2af4dde419" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,843,009</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_62314761-3e44-4d4e-acb4-be8cb2615beb" contextRef="C_7186a63a-2ded-414c-b053-cba2402cd973" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,409,842</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Restricted stock units issued under the 2021 Equity Incentive Plan</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1201ef1e-b2b2-4883-89c6-b876e093997a" contextRef="C_5f4a79f9-a984-4624-83b4-b702658dbd28" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">666,573</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7eead190-8f3d-496f-969a-440d07ec0ab4" contextRef="C_8658457e-b5f0-4fd7-bb30-dac4f9d122bf" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">773,940</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_afaaf286-3cef-45f2-aa42-dab001d94b89" contextRef="C_05587aab-7a1f-40a3-9a56-c925bb5331b9" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">544,320</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_78d43b01-1750-4724-a3a5-1d11ef2c4705" contextRef="C_ab888ba9-e469-447e-bb28-93d500a06c72" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">671,956</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock issuable in offering period under the 2021 Employee Stock Purchase Plan</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4eafd2cc-91c5-440d-a6cc-b84975de41ac" contextRef="C_95eb6bb1-f341-4f69-9031-18165fd37316" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">59,149</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_28ff6d44-0661-4d04-8f14-38bf69b26b36" contextRef="C_714e2128-63aa-4240-8ef9-520e2ff63b1a" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">39,568</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_eb66c1a2-5d12-429c-b075-4a4ee36d8833" contextRef="C_426cc0de-05ef-4df6-9f8f-d9cfc2eca447" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">61,085</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2e1f17cb-97cc-4a6e-b893-28631c984c55" contextRef="C_6ade43c7-7714-458d-a02a-e56ad23d0eec" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">45,191</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></ix:nonNumeric></div></ix:nonNumeric></div><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_938a8e55-0085-4138-bccf-aad8c1037f41" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s revenue is generated from the sale of LALs used in cataract surgery along with a specifically designed machine for delivering light to the eye, the LDD, to adjust the lens post-surgery, as needed. Revenue is recognized from sales of products in the U.S., Canada and Europe. Customers are primarily comprised of ambulatory surgery centers, hospitals, and physician private practices.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company recognizes revenues when promised goods or services are transferred to customers at a transaction price that reflects the consideration to which the Company expects to be entitled in exchange for those goods and services. Specifically, the Company applies the following five steps to recognize revenue: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when, or as, the Company satisfies a performance obligation. The Company applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. At contract inception, the Company assesses the goods promised within each customer contract to determine the individual deliverables in its product offerings as separate performance obligations and assesses whether each promised good or service is distinct. The transaction price is determined based on the consideration expected to be received, based either on the stated value in contractual arrangements or the estimated cash to be collected in non-contracted arrangements. The Company recognizes revenue as the amount of the transaction price that is allocated to the respective performance obligation when, or as, the performance obligation is satisfied, considering whether or not this occurs at a point in time or over time. The Company elected to account for shipping costs as fulfillment costs rather than a promised service and excludes from revenue any taxes collected from customers that are remitted to government authorities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s LDD contracts contain multiple performance obligations bundled for one transaction price, with all obligations generally satisfied within one year. For these bundled arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct, that is, if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company&#8217;s LDD contracts include a combination of the following performance obligations: (i) LDD capital asset and related components, (ii) training and (iii) device service (initial year). Each of these three performance obligations are considered distinct. The LDD capital asset is distinct because the customer can benefit from it together with other resources that are readily available to the customer.  Training on the use of the machine is offered as a distinct activity after installation of the LDD to enhance the customer&#8217;s ability to utilize the machine by having an industry professional provide best practices and customize training to the specific needs of the customer. Each LDD comes with a twelve-month manufacturer&#8217;s warranty (service-type) that includes preventative maintenance, unscheduled service (labor and parts) and software updates. After the first year, service contracts can be purchased separately on a standalone basis. The Company recognizes revenue as performance obligations are satisfied by transferring control of the product or service to a customer. Specifically, revenue for the LDD capital asset is recognized at a point in time at installation.  Revenue for training is also recorded at a point in time, generally 60 days after installation.  Revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><ix:exclude><div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
          <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
           <tr style="visibility:collapse;">
            <td style="width:33.447%;"/>
            <td style="width:33.447%;"/>
            <td style="width:33.106%;"/>
           </tr>
           <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           </tr>
          </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div></ix:exclude><ix:exclude>
        <hr style="page-break-after:always;"/><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div></ix:exclude><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">for the device service is recognized ratably over time after installation, generally 12 months. The Company has determined that the transaction price is the invoice price, net of adjustments, if any. The allocation to the separate performance obligations is based upon the relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. The Company estimates the standalone selling price using the market assessment approach considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services, geographies, type of customer and market conditions. The Company regularly reviews and updates standalone selling prices as necessary.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">LALs are generally held at customer sites on consignment. The single performance obligation is satisfied, and revenue from sales is recognized for LALs upon customer notification that the LALs have been implanted in a patient. For the three and six months ended June 30, 2024 and 2023, credits related to returns and rebates on list prices were not significant.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has adopted the practical expedient permitting the direct expensing of costs incurred to obtain contracts where the amortization of such costs would occur over one year or less, and it applied to substantially all the Company&#8217;s contracts. Revenue for service agreements is recognized ratably over the term of each contract.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_353ab134-d1e9-4193-bc4d-4daa1ccb2a77" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" escape="true"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2024 and 2023, revenue from contracts with customers consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:32.867%;"/>
           <td style="width:1.259%;"/>
           <td style="width:1%;"/>
           <td style="width:16.054%;"/>
           <td style="width:1%;"/>
           <td style="width:1.259%;"/>
           <td style="width:1%;"/>
           <td style="width:11.775%;"/>
           <td style="width:1%;"/>
           <td style="width:1.259%;"/>
           <td style="width:1%;"/>
           <td style="width:13.135%;"/>
           <td style="width:1%;"/>
           <td style="width:1.259%;"/>
           <td style="width:1%;"/>
           <td style="width:13.135%;"/>
           <td style="width:1%;"/>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">LDD (including training)</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c21a877a-fca5-4be2-a358-ac8ddee8dbd1" contextRef="C_a5ac65aa-cc43-4c9f-a44e-01e67eb807a2" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,189</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_fd3a0136-46e0-4350-9be6-e5cb4807f36c" contextRef="C_c4552e7a-d149-444f-86ed-06df03b923bb" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,720</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_fe2326e1-0f89-46cb-9ef4-e57caea5adbc" contextRef="C_d31c11d4-0dd3-4c7f-afa5-cc439fc19ddc" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,902</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9bb4229d-8ae0-4005-a8c2-81c57c9dcab0" contextRef="C_cc563601-0f12-4cea-9637-53f1f309f9f1" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,195</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">LAL</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c2d63a44-e147-45d5-a3e0-3b24ae97ab52" contextRef="C_43a01723-f1d7-414d-a915-41d499a7b20c" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,828</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ef3d01b1-9738-4f38-87b4-a0d997fdf03e" contextRef="C_236410b5-5576-4fb5-8213-e1ee25595cc3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,411</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c566960d-9118-4198-9afc-fcfa59137c65" contextRef="C_bc685971-8f0a-4ea4-8c64-9c188aeabf26" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,745</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4e7b309c-6c3f-4ac0-b41f-7b7ab88751b9" contextRef="C_eddb3485-0e74-4545-b102-ed16c7ec0a2c" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,806</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Service warranty, service contracts, and accessories</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_92f33a83-6028-480d-99ce-342a7256688d" contextRef="C_e7d6d427-25c9-4896-bb46-4266c78ddbb2" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">870</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_177db21f-c9a4-47fe-97f1-6018983c09b0" contextRef="C_4c8e9ae1-1e9e-45b8-982a-f941b1e59b4d" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">679</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f32495e9-33d3-4c8b-83dc-ccdc741bcebe" contextRef="C_dbf9a77d-f552-43c7-b738-3e4043920c2b" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,752</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_75d09100-e594-4e45-8e46-13ebdee43d34" contextRef="C_b0b9ecf4-f70c-49f1-9f26-10517280835d" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,298</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7b50649f-db0b-4b93-bec5-d51483c006f9" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,887</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9f69913a-75ac-4dad-8639-98bc5c679e18" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,810</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a7ca2479-4933-4bb1-9d7a-ace2eb92df6e" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,399</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_574c37c3-5d6f-4409-900a-e2df24533864" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,299</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the three and six months ended June 30, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company did not have any customers who individually accounted for greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1386d4b6-1ef0-4f3c-b0da-e970a6cd95fd" contextRef="C_754f24b7-506d-4d0e-80c0-6352678c3425" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f8c9b176-abb1-401a-957e-e458a69d57e9" contextRef="C_bc923b7c-f61f-4557-a54a-e7a984c590a4" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="F_7d083e65-289b-404e-ad8c-5b5dcadc56c0" contextRef="C_c3849e78-84e7-468a-b497-8a3fed88ad2d" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="F_2642d07d-17ae-4116-b08c-522830fff095" contextRef="C_5517632f-b947-4c40-8db1-42c309a847d8" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of revenue.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bb7c7950-a0fb-4b1f-8da7-937f399f05d5" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:DeferredRevenueByArrangementDisclosureTextBlock" escape="true"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table represents the contract liabilities from sales activity for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">six months ended June 30, 2024 and 2023, respectively (in thousands):</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:51.661%;"/>
           <td style="width:1.961%;"/>
           <td style="width:1%;"/>
           <td style="width:21.769%;"/>
           <td style="width:1%;"/>
           <td style="width:1.961%;"/>
           <td style="width:1%;"/>
           <td style="width:16.686999999999998%;"/>
           <td style="width:1%;"/>
           <td style="width:1.961%;"/>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="text-indent:40pt;vertical-align:bottom;"><p style="margin-left:40pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at beginning of period</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_dc04029f-f879-4864-ada0-bda2f1012156" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="rxst:DeferredRevenue1" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,888</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4945a2f2-c98d-4808-a2c2-39256e20d4d1" contextRef="C_ef35aeef-393e-488b-85fd-95ffed2e764e" name="rxst:DeferredRevenue1" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,193</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;word-break:break-word;">
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Additions during the period</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9e3a436a-cdab-483c-a3ba-cee6a01eb8de" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:DeferredRevenueAdditions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,949</ix:nonFraction></span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6b909d52-267d-4b7b-8504-4ac3dace455e" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:DeferredRevenueAdditions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,391</ix:nonFraction></span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Revenue recognized during the period</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e6e6af70-8488-4f0d-95ee-ca0618584ccf" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:DeferredRevenueRevenueRecognized1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,707</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4722011c-2491-4b97-8df3-53effbdea67a" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:DeferredRevenueRevenueRecognized1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,233</ix:nonFraction></span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;word-break:break-word;">
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at end of period</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4d7bba67-1baf-4398-aaee-c09e5db3d134" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="rxst:DeferredRevenue1" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,130</ix:nonFraction></span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a158ae8e-47ba-4d98-844b-b99970ccb585" contextRef="C_4cac1f56-50f3-44b0-afcc-1b3e03ff9aad" name="rxst:DeferredRevenue1" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,351</ix:nonFraction></span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></ix:nonNumeric></div></ix:nonNumeric></div><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_ee3978c3-d8e6-46ba-a4f3-7fb63e68f5e3" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has three equity incentive compensation plans: the Calhoun Vision, Inc. 2006 Stock Plan (&#8220;2006 Plan&#8221;); the Calhoun Vision, Inc. 2015 Equity Incentive Plan (&#8220;2015 Plan&#8221;); and the 2021 Equity Incentive Plan (&#8220;2021 Plan&#8221;), which are collectively referred to as the &#8220;Equity Plans.&#8221; The Company also has an employee stock purchase plan, the 2021 Employee Stock Purchase Plan (&#8220;2021 ESPP&#8221;).</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company recognizes compensation expense for equity-based awards on the date of grant to employees, board of directors and consultants based on the estimated grant date fair value of the award's Equity-based payments including stock options, restricted stock units and employee stock plan purchases. The fair value of the option awards are estimated using the Black-Scholes option-pricing model and recognized as an expense in the condensed consolidated statements of operations and comprehensive loss over the requisite service period, which is generally four years. The Company amortizes the stock-based compensation for equity awards with service conditions on a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><ix:exclude><div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
          <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
           <tr style="visibility:collapse;">
            <td style="width:33.447%;"/>
            <td style="width:33.447%;"/>
            <td style="width:33.106%;"/>
           </tr>
           <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           </tr>
          </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div></ix:exclude><ix:exclude>
        <hr style="page-break-after:always;"/><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div></ix:exclude><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">straight-line basis over the vesting period of the awards. Forfeitures of unvested stock option awards are recognized as reductions of expense as they occur.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Black-Scholes option-pricing model requires the use of assumptions about a number of variables, such as the fair market value of the Company&#8217;s common stock, expected volatility, expected term, risk-free interest rate, and dividend yield as discussed below:</span></p><p style="margin-left:30.95pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair market value</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;The fair value of common stock is determined by using the closing price per share of common stock as reported on the Nasdaq Global Market.</span></p><p style="margin-left:30.95pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Expected volatility</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;Effective January 1, 2024, the Company based the expected volatility on the historic volatility of its common stock. During the year ended December 31, 2023, the expected volatility was estimated based on the average historical volatilities for comparable publicly traded medical device companies over a period equal to the expected term of the stock option grants. Comparable companies were chosen based on their similar size, stage in the life cycle and area of specialty.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:30.95pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Expected term</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;The Company&#8217;s expected term represents the period that the Company&#8217;s stock-based awards are expected to be outstanding. The Company used the simplified method (based on the mid-point between the vesting date and the end of the contractual term) to determine the expected term.</span></p><p style="margin-left:30.6pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Risk-free interest rate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;The risk-free interest rate used is based on the published U.S. Department of Treasury interest rates in effect at the time of stock option grant for zero coupon U.S. Treasury notes with maturities approximating each grant&#8217;s expected term.</span></p><p style="margin-left:30.6pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Dividend yield</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of zero.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_942eeccf-5a89-4bd0-9209-6406cd30484d" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true" continuedAt="F_942eeccf-5a89-4bd0-9209-6406cd30484d_1"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements</span></p></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><p style="text-indent:3.846%;font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:continuation id="F_0c273bdd-6e84-4d5e-b6e8-6d6e4d329411_1"><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_942eeccf-5a89-4bd0-9209-6406cd30484d_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Changes to GAAP are established by the Financial Accounting Standards Board (&#8220;FASB&#8221;) in the form of accounting standards updates (&#8220;ASU&#8221;). There have been no recent accounting pronouncements, changes in accounting pronouncements or recently adopted accounting guidance during the three months ended June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> that are of significance or potential significance to the Company.</span></ix:continuation></span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">
</span></p><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e9a4c6b5-0e38-4cd4-af0b-89ab59509e7a" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 3 &#8211; Short-Term Investments</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Short-term investments, principally U.S. Treasury bills, are available-for-sale and consisted of the following (in thousands):</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2fa48cc5-9ab5-48d8-892d-38deeb2b720a" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" escape="true">
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.94%;"/>
         <td style="width:2.24%;"/>
         <td style="width:1%;"/>
         <td style="width:16.459999999999997%;"/>
         <td style="width:1%;"/>
         <td style="width:2.24%;"/>
         <td style="width:1%;"/>
         <td style="width:22.259999999999998%;"/>
         <td style="width:1%;"/>
         <td style="width:2.24%;"/>
         <td style="width:1%;"/>
         <td style="width:22.619999999999997%;"/>
         <td style="width:1%;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of June 30, 2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amortized Cost</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unrealized Loss, Net</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Estimated Fair Value</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Treasury securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_3823c18f-a634-4945-9e8b-a40251bd3590" contextRef="C_6e1c7f83-49b9-4025-a3c3-dc623355c0cc" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">208,938</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_3861f418-502e-49d2-840f-5258ab1a88fd" contextRef="C_6e1c7f83-49b9-4025-a3c3-dc623355c0cc" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">99</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_93a9565c-34e6-446d-9fc6-87a405715277" contextRef="C_6e1c7f83-49b9-4025-a3c3-dc623355c0cc" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">208,839</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.835%;"/>
         <td style="width:2.24%;"/>
         <td style="width:1%;"/>
         <td style="width:16.397%;"/>
         <td style="width:1%;"/>
         <td style="width:2.599%;"/>
         <td style="width:1%;"/>
         <td style="width:22.156%;"/>
         <td style="width:1%;"/>
         <td style="width:2.24%;"/>
         <td style="width:1%;"/>
         <td style="width:22.535999999999998%;"/>
         <td style="width:1%;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of December 31, 2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amortized Cost</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unrealized Gain, Net</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Estimated Fair Value</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Treasury securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c2206204-1172-45b1-b6d8-fa55cce8a36a" contextRef="C_5ff8a19a-ef8a-4d06-aaa2-5caaf0edeb10" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">117,480</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_98f3cf4e-74fa-4619-b980-4b3de59ebb67" contextRef="C_5ff8a19a-ef8a-4d06-aaa2-5caaf0edeb10" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">10</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ea89dc15-e19b-409a-bba2-3a8ecf201aa4" contextRef="C_5ff8a19a-ef8a-4d06-aaa2-5caaf0edeb10" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">117,490</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All available-for-sale securities held as of June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> had a maturity of less than </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ae7e114b-b437-4b9d-a3a1-8afccfb13f60" contextRef="C_f5781e6f-1600-45ee-a829-0c9af9692565" name="rxst:InvestmentMaturityPeriod" format="ixt-sec:durwordsen"><ix:nonNumeric id="F_222b099c-ba65-4afc-8ec1-1cd8bbee4228" contextRef="C_e18f6da3-90c2-4d9b-8b4e-269b15d12144" name="rxst:InvestmentMaturityPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">one year</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company has classified all marketable securities, regardless of maturity, as short-term investments based upon the Company&#8217;s ability and intent to use any and all of those marketable securities to satisfy the Company&#8217;s liquidity requirements.</span></p></ix:nonNumeric></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2ea52163-c108-4bd4-85f4-b3e0e51eea92" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:InventoryDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 4 &#8211; Inventories</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d9acc590-294a-4baa-a4f0-71ba41199b6e" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" escape="true"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inventories consisted of the following (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:57.74%;"/>
         <td style="width:1.76%;"/>
         <td style="width:1%;"/>
         <td style="width:14.200000000000001%;"/>
         <td style="width:1%;"/>
         <td style="width:5.16%;"/>
         <td style="width:1%;"/>
         <td style="width:14.200000000000001%;"/>
         <td style="width:1%;"/>
         <td style="width:2.94%;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30,</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finished goods</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ab878ee3-213f-4b20-bfb0-c52b7bc1da4c" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:InventoryFinishedGoods" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,327</ix:nonFraction></span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b44cdd50-97bb-4b0c-96d4-bad3e07f01c8" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:InventoryFinishedGoods" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,092</ix:nonFraction></span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Raw materials</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e554a837-34b8-489d-a174-b974a8ca113c" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:InventoryRawMaterials" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,313</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_88a85398-ad9d-494c-98bd-3d64cab5b354" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:InventoryRawMaterials" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,680</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Work-in-process</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c3f09305-651d-4c31-bbb6-6ceb3e7c8502" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:InventoryWorkInProcess" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,371</ix:nonFraction></span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_dc767048-7f92-4a76-a9ae-fe553928af5a" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:InventoryWorkInProcess" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,145</ix:nonFraction></span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_61b8e6de-424f-4353-b7f0-ca7698f2181e" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:InventoryGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,011</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c2dc2926-4621-45dd-b405-aadc58decfbd" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:InventoryGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,917</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less: reserve for excess and obsolete inventory</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_35222aa6-a456-4bc8-8866-416d0c363d97" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:InventoryValuationReserves" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">568</ix:nonFraction></span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_bac62254-75ee-40de-ac51-c62f2ae3d9bf" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:InventoryValuationReserves" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">496</ix:nonFraction></span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_85ed387c-9d7c-449e-bb94-a51fd4520761" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:InventoryNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,443</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_388d6108-0506-4638-8852-315ed8afdfe3" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:InventoryNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,421</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At June 30, 2024 and December 31, 2023, finished goods included </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e8998300-3aa6-4467-8b2a-7ce130f2ee77" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c1f1c287-917d-4d83-954c-912260ef954e" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of inventory held on consignment at customer sites, respectively.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_108a559c-0301-411d-bf0b-10e0fad40438" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:FairValueDisclosuresTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 5 &#8211; Fair Value Measurements</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_636f2d6a-02ed-4757-962d-c471625a56fd" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" escape="true"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The table and disclosures for the periods presented below (in thousands) present the Company&#8217;s assets and liabilities measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value. The Company did not have any assets or liabilities measured at fair value on a recurring basis within Level 3 fair value measurements.</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:33.22%;"/>
         <td style="width:2.18%;"/>
         <td style="width:1%;"/>
         <td style="width:18.08%;"/>
         <td style="width:1%;"/>
         <td style="width:2.18%;"/>
         <td style="width:1%;"/>
         <td style="width:18.08%;"/>
         <td style="width:1%;"/>
         <td style="width:2.18%;"/>
         <td style="width:1%;"/>
         <td style="width:18.08%;"/>
         <td style="width:1%;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of June 30, 2024</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level I</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level II</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets:</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Money market securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_061e8095-a3c9-4fc2-bfef-92e398a06523" contextRef="C_2a070290-4230-4337-a657-3d109387c5bf" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,986</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b32b32e8-a6f4-404d-bf6d-4cf5c5441cad" contextRef="C_c25f11d6-dc7c-4161-b92c-872ba3474149" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,986</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Treasury securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c6f82bea-46e1-46fd-b1a4-f257e5ec82b4" contextRef="C_c97db89c-4001-4cdb-bd4d-a54689c81080" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b6511721-cf2d-49f1-adad-8032a879a3ec" contextRef="C_b0cbb535-d10a-43e6-a2b0-bb698413d1e0" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">208,839</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_483946be-9e50-40ba-9aa2-9d6df1972167" contextRef="C_8c085cd2-f882-483a-9365-9c156f7d6bb4" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">208,839</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total assets at fair value</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e1cbadcd-37ca-48a1-b130-a2a65dbbe0c3" contextRef="C_b88f6739-08be-4673-af5e-386409d97e2e" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,986</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_344b6d0f-2e4f-4c2c-ba56-1bc5719bd651" contextRef="C_7391a03e-f048-45b1-8c90-50f3375336d3" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">208,839</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4b3269c5-712a-484a-9037-c364da299251" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">227,825</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:33.22%;"/>
         <td style="width:2.18%;"/>
         <td style="width:1%;"/>
         <td style="width:18.08%;"/>
         <td style="width:1%;"/>
         <td style="width:2.18%;"/>
         <td style="width:1%;"/>
         <td style="width:18.08%;"/>
         <td style="width:1%;"/>
         <td style="width:2.18%;"/>
         <td style="width:1%;"/>
         <td style="width:18.08%;"/>
         <td style="width:1%;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of December 31, 2023</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level I</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level II</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets:</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Money market securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4d3fc422-bdc1-498b-b26b-6ac976fbe303" contextRef="C_39cfd17b-899f-40c4-845a-6fdae94d9625" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,475</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_01f5e8b6-f218-4530-833a-5cf5a5309a3e" contextRef="C_71726fb1-fc7b-4769-9509-bbabcda3b877" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,475</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Treasury securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c333f4e8-68a8-4032-8d13-919e28ffb9ec" contextRef="C_a9fe9645-a679-4c9e-910d-64434fc0d770" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_bf25cf92-9f24-44cb-9266-59ca47f40640" contextRef="C_33a5d823-d771-4f16-9c29-15bf632fdbb6" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">117,490</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_399113be-75b4-4f71-a2ca-511afe2ba513" contextRef="C_848743db-b358-4cf3-abd3-f3016e7703de" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">117,490</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total assets at fair value</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8c5d2853-fa5d-4dd9-b482-81bed611a147" contextRef="C_5f629c9c-346d-4df1-9e88-b538f5affce5" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,475</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c0b8d072-a49e-44eb-81ad-e82bd9a636c0" contextRef="C_0a0a72f6-5a6d-41e6-92e8-4b90cf7843c6" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">117,490</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_73a00ab9-5307-403c-9069-26055dcdbc98" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">121,965</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_20918c9c-c73f-4b8d-bfcd-3b6d3be11a09" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 6 &#8211; Stock-Based Compensation Expense</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has three equity incentive compensation plans: the 2006 Plan, the 2015 Plan and the 2021 Plan.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">2006 Plan</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The 2006 Plan was originally adopted by the Board and approved by the Company&#8217;s stockholders in 2006. The 2006 Plan was terminated in 2015 in connection with the adoption of the 2015 Plan and as a result no new awards may be issued under the 2006 Plan. However, the 2006 Plan will continue to govern the terms and conditions of the outstanding awards previously granted under the 2006 Plan.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">2015 Plan</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The 2015 Plan was originally adopted by the Board and approved by the Company&#8217;s stockholders in 2015. In July 2021, the 2015 Plan terminated immediately prior to effectiveness of the 2021 Plan with respect to the grant of future awards. However, the 2015 Plan will continue to govern the terms and conditions of the outstanding awards previously granted under the 2015 Plan.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">2021 Plan</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">July 28, 2021, the 2021 Plan was adopted and approved by the Board and stockholders prior to the IPO and became effective on the business day immediately prior to the effective date of the Company&#8217;s IPO registration</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><ix:exclude><div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:33.447%;"/>
          <td style="width:33.447%;"/>
          <td style="width:33.106%;"/>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div></ix:exclude><ix:exclude>
      <hr style="page-break-after:always;"/><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div></ix:exclude><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">statement.  </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The 2021 Plan provides for the grant of incentive stock options to employees and any subsidiary corporations&#8217; employees, and for the grant of nonstatutory stock options, stock appreciation rights, restricted stock, restricted stock units (&#8220;RSUs&#8221;), and performance awards to employees, directors, and consultants and subsidiary corporations&#8217; employees and consultants.  The number of shares of the Company&#8217;s common stock originally available for issuance under the 2021 Plan was equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_fae178ae-95b0-45f1-85dd-5e809b20e4f3" contextRef="C_09e7c479-5280-4bf3-a282-cb28f4483242" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,420,135</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock plus any shares subject to awards granted under the 2015 Plan and the 2006 Plan that, after the effectiveness of the 2021 Plan, expire or otherwise terminate without having been exercised in full, are tendered to or withheld by the Company for payment of an exercise price or for tax withholding obligations, or are forfeited to or repurchased by the Company due to failure to vest, with the maximum number of shares to be added to the 2021 Plan from the 2015 Plan and 2006 Plan equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_dda4aa8f-b0ee-47bb-aa61-1d22624e1978" contextRef="C_7e061ea2-e4c5-4f24-a010-06a54d38af8e" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,569,530</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Evergreen provision</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The number of common shares reserved for issuance under the 2021 Plan will be increased automatically on the first day of each fiscal year beginning with the 2022 fiscal year and ending on the ten year anniversary of the date the Board approved the 2021 Plan, by a number equal to the least of: (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b08d5327-42a6-450d-8965-783aeb0dbebc" contextRef="C_09e7c479-5280-4bf3-a282-cb28f4483242" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,260,406</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of our common stock; (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_82b8d2a6-284e-46e2-8808-969a0c7d7b9a" contextRef="C_3b6572ea-8779-41d7-9699-5abd96466e88" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the outstanding shares of our common stock on the last day of the immediately preceding fiscal year; or (iii) such lesser number of shares of our common stock as the administrator may determine. The 2021 Plan is administered by the Board. On January 1, 2024 and 2023, the number of shares available under the 2021 Plan increased by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_06dc6fe9-49ba-440b-bc17-4b8f5ae2a106" contextRef="C_ce17e0b5-a12f-49d2-881e-1ca12b318794" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,445,580</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9ff33db1-be0b-48ef-bf5d-c4671ddd39dc" contextRef="C_5501518b-7c81-4968-a973-df58e4381f69" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,130,735</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock, respectively pursuant to this feature.  As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024, the number of shares of the Company&#8217;s common stock available for future issuance under the 2021 Plan was equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_55f72d8b-9b4f-4af7-bf22-f7e9ed8de611" contextRef="C_f1b15466-ecb1-46a7-a2a9-b73c5a09ae08" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">951,817</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">2021 ESPP</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On July 28, 2021, the Board and stockholders adopted and approved the 2021 ESPP. As of June 30, 2024, the number of shares of the Company&#8217;s common stock available for future issuance under the 2021 ESPP was equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1bba3837-5e26-428f-b1ec-381f69289812" contextRef="C_4d46893f-4145-428e-8ad7-90506451e341" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">538,942</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The 2021 ESPP provides eligible employees of the Company and its subsidiaries with the opportunity to purchase shares of the Company&#8217;s common stock at a purchase price equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a8d5d99d-5847-4488-989c-0a90a158cdab" contextRef="C_7424c8a5-89f5-43f8-895f-fd84c2c2a996" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">85</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the common stock&#8217;s fair market value on the first trading day or last trading day of each purchase period, whichever is lower. The 2021 ESPP  provides for two six-month purchase periods every twelve months: May 1 through October 31 and November 1 through April 30. The initial purchase period began on November 1, 2021.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Evergreen provision</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The number of common shares reserved for issuance under the 2021 ESPP will be increased automatically on the first day of each fiscal year beginning with the 2022 fiscal year, by a number equal to the least of: (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_3ee18b52-b44f-485a-97e1-7d99facd3951" contextRef="C_8711b3ad-aa2f-4b24-ab3c-bee15606d03d" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,452,081</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares; (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_82ccee98-891d-4929-b0e2-28cf7cd5e1d8" contextRef="C_e56c75b3-caad-43f6-8432-5c6f54278fe0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the outstanding shares of our common stock on the last day of the immediately preceding fiscal year; or (iii) such other amount as the administrator may determine. The 2021 ESPP is administered by the Board.  No additional shares were reserved for issuance on January 1, 2024 and 2023 pursuant to this feature.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock-Based Compensation Expense</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The purpose of the 2021 Plan and 2021 ESPP is to provide a means by which eligible recipients of stock awards may be given an opportunity to benefit from increases in the value of the common stock in order to retain or procure the services of the employees, members of the Board and consultants and provide them with an incentive to promote the Company&#8217;s success and accomplish corporate goals.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_53dc87ca-e2a8-4348-bc26-804871cd3eca" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Stock option awards are granted with an exercise price of no less than 100% of estimated fair market value on the date of grant. Time based awards generally vest over </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_df3f5a60-1989-4793-b249-21042edba366" contextRef="C_59908af3-c3c5-49c1-9bb8-171ba60eb5f6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">four years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> as follows, subject to the optionee&#8217;s continuing service: (i) one fourth of the total number of shares vest and become exercisable on the one-year anniversary and then 1/48th of the total number of shares subject to the option vest and become exercisable on each monthly anniversary thereafter for the remaining three years, or (ii) 1/48th of the total number of shares subject to the option vest and become exercisable each month over four years.</span></ix:nonNumeric></span></p><ix:exclude><div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:33.447%;"/>
          <td style="width:33.447%;"/>
          <td style="width:33.106%;"/>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div></ix:exclude><ix:exclude>
      <hr style="page-break-after:always;"/><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div></ix:exclude><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4ba8a6a9-13e7-40ed-81fd-c085f75c7ba5" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A summary of the stock option activities related to the Equity Plans for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">six months ended June 30, 2024 is presented below:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:51.15%;"/>
         <td style="width:1.36%;"/>
         <td style="width:1%;"/>
         <td style="width:1%;"/>
         <td style="width:12.603%;"/>
         <td style="width:1%;"/>
         <td style="width:1.4%;"/>
         <td style="width:1%;"/>
         <td style="width:12.042%;"/>
         <td style="width:1%;"/>
         <td style="width:1%;"/>
         <td style="width:1%;"/>
         <td style="width:13.443%;"/>
         <td style="width:1%;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of Options</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted<br/>Average<br/>Exercise<br/>Price</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Avg<br/>Remaining<br/>Contractual Life<br/>(Years)</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Options outstanding as of December 31, 2023</span></p></td>
         <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_603ab7fc-5182-4d8e-afa9-d51c904860cf" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">6,777,404</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7077f26d-7fa6-49a8-b123-d1c14761ae54" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.02</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;"><ix:nonNumeric id="F_579c2493-c4f9-4cfe-8636-20289d86e9d1" contextRef="C_1223a5cf-5ff9-4abd-b52d-c7eebdeb8212" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.51</span></ix:nonNumeric></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Granted</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c3547d56-9170-4eea-a216-fdc9ef29ce13" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">799,502</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ed2227ad-eb64-476f-94e3-e427f3e3f00e" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">55.89</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Exercised</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f2f91804-23b8-43c4-b3f1-f46448ac92f7" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,258,874</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7885a376-73e7-4c03-ae6b-c06b518e10f8" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">10.53</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forfeited</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a5e70c63-b77b-42ba-a46b-89a9d74cff5c" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">62,995</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_dc80197c-356e-4d3e-a58e-f8f283de5b1e" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">16.05</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expired</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4372ed40-46a5-45d3-8f0c-7c5ba3cedc2b" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">10,236</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_58f80331-52dc-4348-a3b6-2d25ae5def1e" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.57</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Options outstanding as of June 30, 2024</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_837a7631-ec41-4dd6-b832-fca39b3fcf36" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">6,244,801</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2fcfc02d-3a93-4b13-8fd3-63f280622db0" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">18.99</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;"><ix:nonNumeric id="F_38d67ac8-d722-4e56-9120-51be024be880" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.78</span></ix:nonNumeric></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Exercisable as of June 30, 2024</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2fc46ae0-b6ad-4b08-a1ab-ab7060989ad4" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">3,623,940</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b56ffbc6-6bbc-422d-bad6-4eb21eb26910" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">13.23</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;"><ix:nonNumeric id="F_e08c48e2-2636-4532-81ba-c9c38bd4476b" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.45</span></ix:nonNumeric></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:18pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the intrinsic value of options vested was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_423f1e75-c0f3-4938-8f15-fd26ccb3a45f" contextRef="C_cffab339-4046-4bfa-b82a-1b1694720712" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">170.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1752a5f3-c1c2-4107-a19d-41f53cea2c91" contextRef="C_1e158749-5a3a-428a-9c8c-71d3347c8329" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">121.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, and of all options outstanding was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_13081e48-d44f-49e4-91a9-18f1703bacf1" contextRef="C_cffab339-4046-4bfa-b82a-1b1694720712" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">257.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7908a9c7-4792-4f5d-9c8d-6bf97c784281" contextRef="C_1e158749-5a3a-428a-9c8c-71d3347c8329" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">185.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. During the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">six months ended June 30, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the total cash received from the exercise of stock options was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_65aed650-2e8d-450c-b0e8-1a8d0ee972eb" contextRef="C_f9980517-1437-4032-bfd8-e4a47703b439" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7e8caaa4-a356-4a85-a56b-42ce6c28a328" contextRef="C_b2763b9c-65fc-4b20-9afe-65016b69e297" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. The total fair value less strike price of these options was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_3bb023dc-7e58-4c9a-b8e4-0d43bc30d477" contextRef="C_f9980517-1437-4032-bfd8-e4a47703b439" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">50.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1e63f5e9-046e-4f93-b2a0-7bfdf436b313" contextRef="C_b2763b9c-65fc-4b20-9afe-65016b69e297" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.</span></p><div style="font-size:10.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b5ea7f37-76ab-4ae3-8648-cf28ef25366e" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" escape="true"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A summary of non-vested restricted stock unit activities for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">six months ended June 30, 2024 is as follows:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:61.16%;"/>
         <td style="width:1.72%;"/>
         <td style="width:1.2%;"/>
         <td style="width:1%;"/>
         <td style="width:15.36%;"/>
         <td style="width:1%;"/>
         <td style="width:1.68%;"/>
         <td style="width:1%;"/>
         <td style="width:14.88%;"/>
         <td style="width:1%;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Average</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Grant Date</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Shares</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair Value</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested at December 31, 2023</span></p></td>
         <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_00f23ad4-402a-4d19-ae64-a6181806e676" contextRef="C_6f6583f5-ec7a-4082-9b35-96788b1aca0c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">650,357</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_953df739-3cbf-477d-a9ed-10eb0dba2a76" contextRef="C_6f6583f5-ec7a-4082-9b35-96788b1aca0c" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.80</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Granted</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_315e50f7-c370-4552-b292-c47609f067a0" contextRef="C_72d61c44-49fd-41dd-ad51-35f48ea85916" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">183,231</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f84168c9-7d94-4924-9ce6-557ec033c4dd" contextRef="C_72d61c44-49fd-41dd-ad51-35f48ea85916" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">56.36</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Vested</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_79dd5519-0e71-4f48-a040-b7c0cc8e38b5" contextRef="C_72d61c44-49fd-41dd-ad51-35f48ea85916" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">165,567</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_05f7735b-67d7-4341-9a3c-bd12cf896d28" contextRef="C_72d61c44-49fd-41dd-ad51-35f48ea85916" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">17.99</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forfeited</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1e76c25c-c5b8-4ac9-98fc-2112f06f63ef" contextRef="C_72d61c44-49fd-41dd-ad51-35f48ea85916" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">18,033</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_25a24024-f6fe-4378-9087-de222a175657" contextRef="C_72d61c44-49fd-41dd-ad51-35f48ea85916" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.71</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested at June 30, 2024</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_0e24f73e-34af-4266-96ae-7878e745712d" contextRef="C_0abad422-2500-4d9e-b9d3-8c167c8ee9ab" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">649,988</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_bc0c7109-b6c8-4713-8621-5085abdef2ac" contextRef="C_0abad422-2500-4d9e-b9d3-8c167c8ee9ab" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">26.68</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bde16b79-d09a-44bb-b43a-55243514d2b2" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Stock-based compensation expense was classified in the accompanying condensed consolidated statements of operations and comprehensive income (loss) as follows (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:37.792%;"/>
         <td style="width:1.44%;"/>
         <td style="width:1%;"/>
         <td style="width:15.697000000000001%;"/>
         <td style="width:1%;"/>
         <td style="width:1.44%;"/>
         <td style="width:1%;"/>
         <td style="width:9.958%;"/>
         <td style="width:1%;"/>
         <td style="width:1.44%;"/>
         <td style="width:1%;"/>
         <td style="width:11.158000000000001%;"/>
         <td style="width:1%;"/>
         <td style="width:1.44%;"/>
         <td style="width:1%;"/>
         <td style="width:11.638%;"/>
         <td style="width:1%;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_70856c81-5348-4bd5-a549-d6f31a8028b3" contextRef="C_8f9792cd-5e2e-44bd-b8e7-5ba5d2e31334" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,395</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4f476979-6e97-4a17-9ed1-9f173693041c" contextRef="C_15d45034-58a3-4d42-bc68-b3740b5e0b2a" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,021</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_60f2af53-94de-48dd-b347-03c86d075596" contextRef="C_2d3d3cc5-4096-4048-9e86-726c8e7126ef" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,501</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_fb759cd6-7be1-4f3a-ab6b-37f1e51c99ca" contextRef="C_c40bec78-b687-45c4-ad3c-00a3ff05916e" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,823</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7670973c-f1c5-40cc-b587-aba2446c8b58" contextRef="C_ca32f3ef-6b1d-45b4-9e16-40beee1bb09f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,210</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c5c94d85-4b39-4641-94a6-65168f9c31a0" contextRef="C_306d346a-380e-4f34-a95e-850689d48e3f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,639</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_970d35d1-8183-40f0-8c40-81950db69452" contextRef="C_9b623e0d-4f1d-4db1-ae4c-f10eeef88de2" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,410</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f4c06bde-b5da-4bfe-b981-ccc0d18b07e9" contextRef="C_55f52d8a-909f-44fb-865e-6571cbcee723" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,910</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of sales</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7bbfb565-da03-4be7-8311-d3daf84c2eed" contextRef="C_ebf267e3-249d-4c66-a032-0ae76ee1e173" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">500</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_65afef93-9708-45d2-a765-e2ec7c292cbb" contextRef="C_35ccf33e-5721-47b9-9631-6b62ea10a50a" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">295</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f6a2a938-2a06-4c92-8605-d6cdcb6fdb0f" contextRef="C_9dff912c-7bb1-4372-9d7e-a40dfcd38d40" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">890</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5939e50a-0b39-462e-9e51-2df4188079e2" contextRef="C_872467f9-67fd-4871-b993-41838a2b5113" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">517</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_59ea0e4a-1868-4721-9dd7-6077471299af" contextRef="C_748782be-b4c1-440b-81fc-508b52d9ef24" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,105</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f2388649-c360-4d17-a59f-c17488381b21" contextRef="C_bdb7c2a6-1dd2-4f29-924b-0d330d5760a5" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,955</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_80583c23-e3d9-4472-834e-45fde6f44f30" contextRef="C_f9980517-1437-4032-bfd8-e4a47703b439" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,801</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d4998a01-1586-4e3e-8ccb-16a1c1db8968" contextRef="C_b2763b9c-65fc-4b20-9afe-65016b69e297" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,250</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_26a12a0b-affc-42b4-8ab4-91b62a936d55" contextRef="C_cffab339-4046-4bfa-b82a-1b1694720712" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,620,861</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b098af18-da35-42ab-ad75-c9ed87bdb790" contextRef="C_1e158749-5a3a-428a-9c8c-71d3347c8329" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,539,445</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> unvested options, respectively.  As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, total unrecognized expense related to unvested stock options was approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_717bf915-1723-47e3-bdf6-4aa080312c44" contextRef="C_cffab339-4046-4bfa-b82a-1b1694720712" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">44.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b1dd1776-cc0a-4d19-876f-5ae5298c6f5a" contextRef="C_1e158749-5a3a-428a-9c8c-71d3347c8329" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">22.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. Both amounts are expected to be recognized over a weighted average period of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_65bbe0df-4761-4664-9384-4680e01292bb" contextRef="C_f9980517-1437-4032-bfd8-e4a47703b439" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.5</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_18560374-11c6-467e-a0cf-963168ef3751" contextRef="C_4b3ce656-4281-4287-90bf-5e25822bf054" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.4</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years, respectively.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024, and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, total unrecognized expense related to non-vested restricted stock units was approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c1cd00a2-42b6-4c17-b059-9823e0243f2f" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_da6a1132-32c1-4c6f-9a1a-d23281b8f691" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. The unrecognized compensation cost is expected to be recognized over a weighted average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4a53baad-2264-4e75-999c-b2a60dd8cb14" contextRef="C_72207dc6-8a88-4a0a-988b-d8bca47ecaaa" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.4</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years and </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b43776b9-dc6b-4713-869f-daf80e48e8ac" contextRef="C_26af5d92-2265-4e0b-b68d-a926ef38258d" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.3</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years, respectively.</span></p><ix:exclude><div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:33.447%;"/>
          <td style="width:33.447%;"/>
          <td style="width:33.106%;"/>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div></ix:exclude><ix:exclude>
      <hr style="page-break-after:always;"/><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div></ix:exclude><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ed1ee47f-b966-4439-9ed6-c20b6ae3f0ed" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the range and weighted-average assumptions, used in the Black-Scholes option pricing model to determine the fair value of stock options:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:23.81%;"/>
         <td style="width:1.581%;"/>
         <td style="width:17.467%;"/>
         <td style="width:1.581%;"/>
         <td style="width:17.467%;"/>
         <td style="width:1.581%;"/>
         <td style="width:17.467%;"/>
         <td style="width:1.581%;"/>
         <td style="width:17.467%;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="7" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Range</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Range</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected volatility</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ca767714-5335-427c-a4fc-43d9604d7aaf" contextRef="C_ba9d48f2-149a-4fc5-9666-638ff32e1c8d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">69.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% to </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1bc02982-949a-4a15-b8f4-2c9b28d0bb87" contextRef="C_f5781e6f-1600-45ee-a829-0c9af9692565" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">72.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_3e77aeed-0f1f-43be-a8a6-cd7727a2036b" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">71.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_145d944c-bb9e-4923-855f-d6c7d808ca4c" contextRef="C_55616c71-0dc0-4231-8880-c2204423fe8a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">64.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% to </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4cdfbfd6-9cf9-4709-b6d2-350c91f17c74" contextRef="C_3ccf0dc7-e2f1-4cd5-97cc-45c2be8de24d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">65.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_cbec10fc-540f-4d1f-9f9c-0148a1b5e8f4" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">65.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Risk-free interest rate</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b0b9d79d-db7a-4799-a130-e04cafd3ab16" contextRef="C_ba9d48f2-149a-4fc5-9666-638ff32e1c8d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% to </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f5d4dade-b57d-4f18-b7b5-5e8afef4b55a" contextRef="C_f5781e6f-1600-45ee-a829-0c9af9692565" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e1eea515-436d-46f5-8edb-cd1f7be10274" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_cb8c5e7b-37c6-4958-aaef-c217e3ddbd0f" contextRef="C_55616c71-0dc0-4231-8880-c2204423fe8a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% to </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_38817c6b-0016-4b9e-8265-c5ec1dbf94aa" contextRef="C_3ccf0dc7-e2f1-4cd5-97cc-45c2be8de24d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a510e126-0622-498a-af85-db85269d5deb" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected life (in years)</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_28e1b1db-dbc3-4d98-8f75-42da72cc6273" contextRef="C_ba9d48f2-149a-4fc5-9666-638ff32e1c8d" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.0</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;years</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_51e98ba1-017a-47bf-ae73-98a2ed82ebb6" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.0</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;years</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_6fa5202a-c136-40c3-aa98-761f8fe43e79" contextRef="C_55616c71-0dc0-4231-8880-c2204423fe8a" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.0</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;to </span><span><ix:nonNumeric id="F_5c65fb28-733a-469c-bb6e-36deab46c24c" contextRef="C_3ccf0dc7-e2f1-4cd5-97cc-45c2be8de24d" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.0</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;years</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_ca7256af-2162-4902-a41e-c2137bac59f2" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.0</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;years</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected dividend yield</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_850ccd58-d9ce-4d59-b8ff-b914344ced17" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c9bec6ad-ab76-4e6d-b9e7-3011f35855fe" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9260f4ed-cfb2-4671-a7ee-fac3fd238f7c" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ae5d8ac8-4f84-4ec9-946d-d0f1b28dfe33" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Grant date fair value</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b048b075-435f-44ba-96fe-57c470dc357a" contextRef="C_ba9d48f2-149a-4fc5-9666-638ff32e1c8d" name="rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">36.89</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;to $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_de23e424-75e5-45e9-81a4-9c4fef2a5dc3" contextRef="C_f5781e6f-1600-45ee-a829-0c9af9692565" name="rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">60.65</ix:nonFraction></span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_71fb0542-0c56-491c-81e3-b5545f836102" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">55.93</ix:nonFraction></span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9e5dc522-3833-40a8-ae7c-35d1fd75c166" contextRef="C_55616c71-0dc0-4231-8880-c2204423fe8a" name="rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.91</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;to $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_dffdd35f-72a6-43e0-996f-77c283ac1b82" contextRef="C_3ccf0dc7-e2f1-4cd5-97cc-45c2be8de24d" name="rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">28.80</ix:nonFraction></span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c996e710-cff6-445a-bdc1-fc5e9622dabc" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.26</ix:nonFraction></span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:-18pt;padding-left:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Common Stock</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a5142fd3-f670-4721-b644-e9c568f5f0bb" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" escape="true"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Each share of common stock is entitled to one vote. Common stock reserved for future issuance consisted of the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.967%;"/>
         <td style="width:1.16%;"/>
         <td style="width:1%;"/>
         <td style="width:13.357%;"/>
         <td style="width:1%;"/>
         <td style="width:1.16%;"/>
         <td style="width:1%;"/>
         <td style="width:13.357%;"/>
         <td style="width:1%;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30, 2024</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock options issued and outstanding under the Equity Plans</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_869b30f7-cfe3-4468-b26d-04a2548ca898" contextRef="C_e4a673c7-eaa6-4857-856c-50b98038b762" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">6,244,801</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_bad76b78-4350-4ce5-8dc3-e8124d724ce2" contextRef="C_0f2db67e-f20d-4666-a388-00d0b1a6b9f6" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">6,777,404</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares available for future issuance under the 2021 Plan</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ee6bdd7e-9c69-45ad-a2a1-86eecf202bb9" contextRef="C_23476103-2290-488c-b788-5f19565bb756" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">951,817</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_cf5ed909-383a-41e7-b4e9-7baab78be153" contextRef="C_3fde5492-dc3e-412c-b180-b37e6ed47396" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">358,610</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Restricted stock units issued under the 2021 Plan</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_08263fec-43a2-4e02-a7cb-392b954bf09e" contextRef="C_0abad422-2500-4d9e-b9d3-8c167c8ee9ab" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">649,988</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4712b9ec-07ff-4dfb-8612-d4f06da97441" contextRef="C_6f6583f5-ec7a-4082-9b35-96788b1aca0c" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">650,357</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares available for future issuance under 2021 ESPP</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5f0aab4f-3087-4907-b9a9-087e8c614b1a" contextRef="C_9ea266a9-965b-4b22-8258-e30e3b49e49b" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">538,942</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f3f968a3-9b9e-40d3-a319-d7ef66b7ee09" contextRef="C_7634a85b-9ef7-4095-a9b2-36e304f09a7e" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">577,847</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total shares of common stock reserved</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5f1a8d7e-817a-4290-b2ca-1934c6059f9a" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">8,385,548</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1560a4de-2c55-468d-94a8-7f6975d108bb" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">8,364,218</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_ca8ea59f-9b3a-40d6-a50e-612fb5793b93" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:LesseeOperatingLeasesTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 7 &#8211; Leases</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has operating and finance leases for facilities and certain equipment. Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheets. Lease expense for operating leases is recognized on a straight-line basis over the lease term.  The Company does not combine lease and non-lease components in the recognition of lease expense.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the Company held </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4b3b35f1-6705-4a6d-8c9e-a56fbf79654e" contextRef="C_e648d52d-9f33-406d-b707-f0d436342566" name="rxst:NumberOfLeases" unitRef="U_Item" decimals="INF" format="ixt-sec:numwordsen">four</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> leases for office, manufacturing and warehouse facilities in Aliso Viejo, California. The four leases are for approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9ec26b75-0ae1-446d-84d2-f111751739f4" contextRef="C_e648d52d-9f33-406d-b707-f0d436342566" name="us-gaap:AreaOfRealEstateProperty" unitRef="U_sqft" decimals="0" format="ixt:num-dot-decimal">137,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> square feet in the aggregate. For one such operating lease, the lessor provided $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e77fb000-b47f-4474-9a8d-dc846cd46ac9" contextRef="C_cbd133ad-eca3-4208-8941-8bfd8e1c173b" name="us-gaap:PaymentsForProceedsFromTenantAllowance" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">900,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> in tenant allowances.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 4, 2022, the Company entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b4691cd3-a6f6-44a0-9d0d-dcc38941e143" contextRef="C_c4fcf8f2-fb38-42b9-adcb-eb6d516b8469" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">thirty-four-month</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> sublease agreement for a portion of the 5 Columbia Building, in Aliso Viejo, CA. The sublease commencement date was June 13, 2022 and was to expire on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_36a8f29f-818a-44a1-a188-f96ff73b9d2d" contextRef="C_443df5e3-56fa-4ac9-ae8d-93e0566a45d5" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The base rent receivable was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6aa21ba2-89d9-4bd3-8eca-8d09dc9c6765" contextRef="C_443df5e3-56fa-4ac9-ae8d-93e0566a45d5" name="us-gaap:LeaseAndRentalExpense" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">11,410</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per month. On January 4, 2023 the Company entered into a second amendment to the sublease agreement adjusting the base rent receivable to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b7716a45-d767-4ec1-86f9-d40a8ba304be" contextRef="C_204a0bf3-73bf-4334-8ffd-365bddaf6a28" name="us-gaap:OperatingLeasesRentExpenseSubleaseRentals1" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">5,319</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per month. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_033c3dc5-2f90-473c-8dbf-a307d9352d2c" contextRef="C_204a0bf3-73bf-4334-8ffd-365bddaf6a28" name="us-gaap:LesseeOperatingSubleaseOptionToTerminate"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 1, 2024 the sublease was cancelled.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">New lease and lease amendments</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 18, 2024, the Company entered into a new lease, and amendments to two existing leases, for three of its facilities comprising the Company&#8217;s headquarters, manufacturing, research and development and administrative offices in Aliso Viejo, California, as described in further detail below.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">125 Columbia</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 18, 2024, the Company entered into a Standard Industrial/Commercial Single-Tenant Lease &#8211; Net (the &#8220;125 Columbia Lease&#8221;) with BML Management, LLC, for an approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_12ca8718-2263-419b-b2ea-9aca7120a35b" contextRef="C_3d547736-7d2f-4ab1-ba32-5440721ad534" name="us-gaap:AreaOfRealEstateProperty" unitRef="U_sqft" decimals="0" format="ixt:num-dot-decimal">26,825</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> square foot industrial and research and development facility in Aliso Viejo, California.   The 125 Columbia Lease commences on</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_946655ab-e440-4abe-9ece-bea69acfca9f" contextRef="C_79f66c27-e4ac-416a-b575-59bf974253cf" name="us-gaap:OperationsCommencedDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> June 1, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and will end on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7cf4db5f-c62d-4cea-af3d-5602585324f8" contextRef="C_79f66c27-e4ac-416a-b575-59bf974253cf" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 31, 2031</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company has two options to extend the term of the 125 Columbia Lease, with each option to extend being for a term of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2cd73cff-0926-41af-8d11-f8dffb550d6b" contextRef="C_3d547736-7d2f-4ab1-ba32-5440721ad534" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">60</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> months, commencing when the prior term expires. The base rent is initially $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c9d74e40-b3f9-4e53-ac23-e88ce5f70013" contextRef="C_79f66c27-e4ac-416a-b575-59bf974253cf" name="us-gaap:LeaseAndRentalExpense" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">41,579</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per month, payable on the first day of each month commencing on June 1, 2024, subject to adjustment as set forth in the 125 Columbia Lease.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><ix:exclude><div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:33.447%;"/>
          <td style="width:33.447%;"/>
          <td style="width:33.106%;"/>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div></ix:exclude><ix:exclude>
      <hr style="page-break-after:always;"/><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div></ix:exclude><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">5 Columbia</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 18, 2024 and June 3, 2024, the Company entered into Lease Amendment #2 and Lease Amendment #3, respectively to that certain Lease Agreement dated January 10, 2018, as amended on April 5, 2022, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">with Clifford D. Downs, for an approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_47c9cad1-e450-45bd-a93b-905936e4c2f9" contextRef="C_107d2d34-29e5-4238-80a7-75906a0160b4" name="us-gaap:AreaOfRealEstateProperty" unitRef="U_sqft" decimals="0" format="ixt:num-dot-decimal">19,680</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> square foot industrial facility located at 5 Columbia in Aliso Viejo, California (collectively the &#8220;5 Columbia Amendments&#8221;). Pursuant to the 5 Columbia Amendments, the term of the lease was extended </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a2b0fec5-21c2-45e5-893a-c5fc0c5ec6ca" contextRef="C_a73767b4-7596-4747-a31a-9abee5f0e1c3" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">70 </span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">months, beginning on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cf841917-3cc6-4b9c-85e1-86a8cbd96e75" contextRef="C_fd5d1c6b-a916-4a4b-8a21-c86da5a58d96" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">April 1, 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and ending on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_369d5770-9813-41d2-b2f5-5cbdfc5295e5" contextRef="C_53193d0d-eccf-4650-b5ff-2f01e68f7024" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 31, 2031</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The parties agreed to the base rent rate payable over the </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_360188f9-9a77-4df3-8813-67a419eb9b4e" contextRef="C_a73767b4-7596-4747-a31a-9abee5f0e1c3" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">70</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> month term as set forth in the 5 Columbia Amendments. The base rent is initially $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2ca6c720-0f3b-4dbe-ba6e-74dcf125bc92" contextRef="C_fd5d1c6b-a916-4a4b-8a21-c86da5a58d96" name="us-gaap:LeaseAndRentalExpense" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">30,701</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per month and includes fixed rent escalations beginning on April 1, 2027. The Company has two options to extend the term of the lease, with each option to extend being for a term of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0c69d2b4-d4ef-4505-88e5-a68063dd9386" contextRef="C_a73767b4-7596-4747-a31a-9abee5f0e1c3" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">60</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> months, commencing when the prior term expires.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">100 Columbia</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 18, 2024, the Company entered into a Fifth Amendment to that certain Commercial Lease Agreement, dated August 31, 2015, as amended November 23, 2015, December 22, 2015, January 18, 2016, and November 12, 2016, with Accuride International Inc., for an approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2877d9b1-00ef-4f30-ac5d-eb8c4c76bc27" contextRef="C_dac5e1bd-acd6-4c7d-aacf-a30a4e26a25c" name="us-gaap:AreaOfRealEstateProperty" unitRef="U_sqft" decimals="0" format="ixt:num-dot-decimal">42,106</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> square foot industrial facility located at 100 Columbia in Aliso Viejo, California (the &#8220;April 2024 100 Columbia Amendment&#8221;). Pursuant to the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">April 2024 100 Columbia Amendment, the term of the lease was extended </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c064a79e-5f9e-492b-975b-1cfad4548aa8" contextRef="C_e95a0f17-9a53-4675-91e9-06e88ee7f46d" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">76</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> months, beginning on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dc435c9a-31f3-4768-8f29-353467772427" contextRef="C_755fa8c1-f901-448e-a391-c05a19ebe37b" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">October 1, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and ending on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e620243c-3029-4ec3-9784-d696470c7182" contextRef="C_2cc166d9-2e7c-4d1e-b33d-918c247c655d" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 31, 2031</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The parties agreed to the base rent rate payable over the </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9c8bba11-10dd-4b7b-95ac-6659f25dbc41" contextRef="C_e95a0f17-9a53-4675-91e9-06e88ee7f46d" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">76</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> month term as set forth in the April 2024 100 Columbia Amendment. The base rent is initially $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_44668959-966b-4bdb-bdab-a937d101a326" contextRef="C_755fa8c1-f901-448e-a391-c05a19ebe37b" name="us-gaap:LeaseAndRentalExpense" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">64,843</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per month and includes fixed rent escalations beginning on October 1, 2025.</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bbf74d80-ae48-4fe3-9414-d478990f9aab" contextRef="C_755fa8c1-f901-448e-a391-c05a19ebe37b" name="us-gaap:LesseeOperatingLeaseOptionToExtend"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The Company has two options to extend the term of the lease at the end of the current term, with each option to extend being for a 5 year term.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The lessor provided $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6530a97b-5866-452e-a8ab-b7e278522ccf" contextRef="C_755fa8c1-f901-448e-a391-c05a19ebe37b" name="us-gaap:PaymentsForProceedsFromTenantAllowance" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">50,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> in tenant allowances.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On June 3, 2024, the Company entered into a Sixth Amendment to that certain Commercial Lease Agreement, dated August 31, 2015, as amended April 18, 2024 as amended November 23, 2015, December 22, 2015, January 18, 2016, and November 12, 2016, with Accuride International Inc., for the property located at 100 Columbia in Aliso Viejo, California (the &#8220;June 2024 100 Columbia Amendment&#8221;). The June 2024 100 Columbia Amendment updated certain notification requirements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under these lease agreements, the Company is required to pay approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6b0df3c0-f6d8-4616-a14a-70173d9ea874" contextRef="C_d0985361-3665-4b26-8732-c0bc94e9d51c" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in future minimum lease payments of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c8ad058b-11e1-42f2-87e1-728019f4c8ae" contextRef="C_d0985361-3665-4b26-8732-c0bc94e9d51c" name="us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million will be paid in 2024, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2de54286-3016-4c79-83b5-6bc6b03519b1" contextRef="C_d0985361-3665-4b26-8732-c0bc94e9d51c" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million will be paid in 2025, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5c0c3d0f-0cbb-481d-b689-7b807803fec6" contextRef="C_d0985361-3665-4b26-8732-c0bc94e9d51c" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million will be paid in 2026, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f1d79f31-f00f-4165-99f6-fc4fd014a8a5" contextRef="C_d0985361-3665-4b26-8732-c0bc94e9d51c" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a6eb7584-c690-4c2a-8575-b62cc95c8ecb" contextRef="C_d0985361-3665-4b26-8732-c0bc94e9d51c" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.8</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million will be paid in both 2027 and 2028, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_817bec39-87b5-48fe-9081-1a8f089b0ad0" contextRef="C_d0985361-3665-4b26-8732-c0bc94e9d51c" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million will be paid thereafter.</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_8efd21fe-95de-4c3a-a1e8-cf70fe964980" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:SummaryOfLeaseBalancesTableTextBlock" escape="true"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the lease balances within the Condensed Consolidated Balance Sheets as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 and December 31, 2023 (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:29.294%;"/>
         <td style="width:1.64%;"/>
         <td style="width:35.833%;"/>
         <td style="width:1.64%;"/>
         <td style="width:1%;"/>
         <td style="width:12.977%;"/>
         <td style="width:1%;"/>
         <td style="width:1.64%;"/>
         <td style="width:1%;"/>
         <td style="width:12.977%;"/>
         <td style="width:1%;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30,</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Leases</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Classification</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating leases right-of-use assets</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8d12057b-b2aa-4f0c-8cc3-ded2eab775d9" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,818</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_aaeb33aa-d17e-43b5-b304-45f4e6135c33" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,444</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_3e517117-8319-4cc0-8225-94336556f3a7;"><span style="-sec-ix-hidden:F_00e18cde-e7c6-4077-9799-7012c3ad64fb;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Property and equipment, net</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ee0da4b3-8421-4392-82a3-dfca4d739aaa" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">142</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_bcf06078-d158-441b-af9a-9798fb5e0564" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:FinanceLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">156</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease assets</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_608f8d67-fc2e-4ee0-96ae-cc40c9cdc2a3" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="rxst:TotalLeaseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,960</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_70788c75-a57b-46d1-979c-cf5f45cc389c" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="rxst:TotalLeaseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,600</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Liabilities</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_0bfe1017-2ed2-4326-a247-db41c8cf4d2b;"><span style="-sec-ix-hidden:F_78fd0571-9a99-465d-8968-e56cfa5898f0;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lease liabilities</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b0443a72-fc70-4650-9ccb-de68f51e3d99" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">710</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1acbdfe9-eb6b-4731-94ae-999b1f4fc269" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,764</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_0f7fb7b9-c9ea-4648-8251-fd72d360c669;"><span style="-sec-ix-hidden:F_a8615e7e-3a3b-4497-9d55-86ea65153fd0;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lease liabilities</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_cf1e7a1c-8add-41ef-8ccf-c0b1b1677db9" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7f29b44e-feb4-4f8c-9602-82675b120f51" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Noncurrent</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_502cbe2a-5432-41d0-85b4-23a20a165bac;"><span style="-sec-ix-hidden:F_8be0e6d4-5a47-411b-9144-c408d3934f9a;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term lease liabilities</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_df73bb11-6f32-4037-9268-8ad4849adbde" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,553</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b1754a26-2287-4973-a9ec-4e6b93f3e0b1" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,093</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_a8cedab2-1fe0-482a-a6c2-28f0caa7a48f;"><span style="-sec-ix-hidden:F_21a43b30-4a3d-4632-a584-149b79b2db2c;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term lease liabilities</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_70bea841-4f1f-4f19-8bd7-c59ec67284ff" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">121</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_a3b26af9-a799-49e5-ae07-892010bf8df8" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">118</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease liabilities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5557ee2f-80a9-4ffd-8565-a1eb412e17ac" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="rxst:TotalLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,410</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b2ef5658-841d-46c2-89d2-fb995dcc7213" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="rxst:TotalLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,012</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><ix:exclude><div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
          <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
           <tr style="visibility:collapse;">
            <td style="width:33.447%;"/>
            <td style="width:33.447%;"/>
            <td style="width:33.106%;"/>
           </tr>
           <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
            <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           </tr>
          </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div></ix:exclude><ix:exclude>
        <hr style="page-break-after:always;"/><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div></ix:exclude></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_092b48c8-9b59-4b4b-9feb-e4bd064dcdb9" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:LeaseCostTableTextBlock" escape="true"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> For the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2024 and 2023, the components of operating and finance lease expenses were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.965%;"/>
         <td style="width:1.4%;"/>
         <td style="width:30.546%;"/>
         <td style="width:1.52%;"/>
         <td style="width:1%;"/>
         <td style="width:6.901%;"/>
         <td style="width:1%;"/>
         <td style="width:2.3%;"/>
         <td style="width:1%;"/>
         <td style="width:7.662000000000001%;"/>
         <td style="width:1%;"/>
         <td style="width:1.4%;"/>
         <td style="width:1%;"/>
         <td style="width:4.481%;"/>
         <td style="width:1%;"/>
         <td style="width:2.921%;"/>
         <td style="width:1%;"/>
         <td style="width:6.901%;"/>
         <td style="width:1%;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Lease Cost</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Classification</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating lease cost</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of sales</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_fda7a48b-8138-445e-94bc-00b7b7fef87d" contextRef="C_f8984806-8a2c-407e-87a3-79fd81817c95" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9bd164d8-1214-4ae3-87bd-b2f2d03cdff2" contextRef="C_428789be-eb44-4bee-8e7d-43887c59ba81" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_be4ff0d2-9c95-4af9-98a8-23631a2419d4" contextRef="C_870c219c-a4a7-4462-846d-85d7110b3380" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ecc0ea2f-3e90-4a75-b476-ac59f2e6c2b7" contextRef="C_46ae809e-f67b-4a77-b4c5-50a424b655df" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_08bb3bae-5ba7-4042-b61a-18c2508424e5" contextRef="C_89a390bf-cf3f-4d6e-9839-74e86626c8d9" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_6b8835b0-4c36-4949-8414-c0097d69fbca" contextRef="C_8b1f96bb-fff2-49be-8819-b62edbf4e6d1" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e754d8b4-5ea4-417a-8a1d-003c45ba4e6b" contextRef="C_3e89f686-064a-4ed5-8601-3e8782699162" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c089284b-c404-4273-895a-1b2360e715c6" contextRef="C_101ce506-9642-467b-b38c-f2c003a92905" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_86473ee7-2021-43e8-8270-7cbcfc3ed22d" contextRef="C_c6550ecc-1f2d-48a5-b93f-4051f05eeb19" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">588</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5b5e0900-d0f1-4a01-975b-f3e4661ea73d" contextRef="C_67e0d5d6-5fee-4a17-ba10-34c977d6903a" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">438</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_61cd8750-45c1-4d02-92df-e02f8300289f" contextRef="C_2790d20b-5e9b-4fbb-aab0-0988eacc2119" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,027</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2e1d2796-f115-4dbb-bb89-b936120cd067" contextRef="C_e3efc9bd-860f-444e-a889-ebfd9d131560" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">887</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance lease cost</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_44da6cd4-6727-458c-97f2-6715487ee7b4" contextRef="C_89a390bf-cf3f-4d6e-9839-74e86626c8d9" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_453d9155-d1a0-49e3-8f05-0a1a7574de8a" contextRef="C_8b1f96bb-fff2-49be-8819-b62edbf4e6d1" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d571789a-f2ba-442d-a8db-179a4c2d589f" contextRef="C_3e89f686-064a-4ed5-8601-3e8782699162" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f9e3fa9e-752f-4c95-aeec-b2a301d747a4" contextRef="C_101ce506-9642-467b-b38c-f2c003a92905" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_95a863db-394d-4913-8b39-0773dd511da6" contextRef="C_c6550ecc-1f2d-48a5-b93f-4051f05eeb19" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f3d988c2-5743-4070-8381-6db06e02a103" contextRef="C_67e0d5d6-5fee-4a17-ba10-34c977d6903a" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_63949c2e-e58a-40a4-8bae-d53281d61e3c" contextRef="C_2790d20b-5e9b-4fbb-aab0-0988eacc2119" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_adf5c4a4-590b-419b-9df2-544345841c4e" contextRef="C_e3efc9bd-860f-444e-a889-ebfd9d131560" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance lease cost</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest expense</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_85c28938-4cf3-4313-9ca2-1bdd72b81a11" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="us-gaap:FinanceLeaseInterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_06ed1df9-1511-4722-b744-d026af433df5" contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223" name="us-gaap:FinanceLeaseInterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d689edc2-3b76-4e80-b568-ffb2224e963a" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:FinanceLeaseInterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7db8df52-a87a-4046-b107-42d670ceff06" contextRef="C_92773448-1606-437d-912e-2e2bd0f53565" name="us-gaap:FinanceLeaseInterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_44e37b99-ecb9-4fdf-8d50-1e2afa478388" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" escape="true"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Maturities of the Company&#8217;s operating and finance lease liabilities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:42.989%;"/>
         <td style="width:8.242%;"/>
         <td style="width:1%;"/>
         <td style="width:15.143%;"/>
         <td style="width:1%;"/>
         <td style="width:11.362%;"/>
         <td style="width:1%;"/>
         <td style="width:18.264%;"/>
         <td style="width:1%;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Operating</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Finance</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Leases</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Leases</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2024 (remainder)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_96973771-ee4d-441f-8749-eb09b69ac931" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,004</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f388b213-d674-45f8-ba10-ed7d41828894" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2025</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_86f629fe-e784-4c50-9480-c44c8744e221" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,434</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_4b7885a8-4c73-4c0a-894a-9fced682b938" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2026</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1b9f00fa-529c-4409-807d-d8ac997d7144" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,637</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1a50fd99-8333-4e36-98ff-57dcabea86df" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2027</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b17f1c2f-05bd-46f0-ad06-47457a5e4348" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,782</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ccfb3a18-3496-40b6-85b6-c651dfb434d8" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2028</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_756d5af6-e314-4fa1-8c5c-af61f3815f8e" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,871</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_1ab440de-1962-4355-8d5c-68fd1ffb7549" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2029</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f0c2d27b-b734-4f8f-84b0-04f9b3a78fdc" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,954</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d0098ea8-b571-4e13-b98b-98488a3b01ef" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Thereafter</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_3c0d461b-1726-4328-9c94-a4df31f528c1" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,308</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_86112392-a54b-4ab8-a74c-05747c90e529" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease payments</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_2f99babd-2860-46d6-86b5-ee7d1b0620cd" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,990</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8f9189eb-edab-4fb3-a50a-61e9e3c1f46a" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">199</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less: imputed interest</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_f699cdc1-e153-4bc2-8a91-6ce2acf8f1c4" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,727</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_d8b9ea1e-c20e-40cf-ab73-70dd340ce064" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease liabilities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9fa71cbf-c377-4134-809e-ea015ca32587" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,263</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_252f4061-f8ad-439b-9599-287c39c27a54" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">147</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;">&#160;</p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d402a400-8edd-42b4-8523-a5144f6dc7b0" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="rxst:SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" escape="true"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The weighted average remaining lease term and weighted average discount rate used to determine lease liabilities related to the Company&#8217;s operating and finance leases as of June 30, 2024 and December 31, 2023 were:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.311%;"/>
         <td style="width:1.08%;"/>
         <td style="width:1%;"/>
         <td style="width:18.484%;"/>
         <td style="width:1%;"/>
         <td style="width:1.08%;"/>
         <td style="width:1%;"/>
         <td style="width:20.044%;"/>
         <td style="width:1%;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30,</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Lease Term and Discount Rate</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average remaining lease term (years)</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating leases</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_81baf750-5d4d-44bb-bab2-e0731a102a25" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.58</span></ix:nonNumeric></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_0179a7c6-cb8a-486a-935d-b4d89777ca88" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.69</span></ix:nonNumeric></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance leases</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_bfddf7dc-30af-4964-94d2-a2c1b4b25447" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.35</span></ix:nonNumeric></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_f5d5bd84-06aa-4ca3-a1b6-44f0203e3997" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.37</span></ix:nonNumeric></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average discount rate</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating leases</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_9949c7aa-c2fd-4c48-aa40-82fc6763ed5f" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">14.4</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ed5d6b94-e089-44cd-a62e-0b530eeb56d9" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">10.4</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance leases</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_5a3769e3-4785-4ece-a3e1-e71e04c66c05" contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">14.4</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_8eaa47e2-f092-4fa5-a9e3-2dfe54c2cdc4" contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">14.0</ix:nonFraction></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
        </tr>
       </table></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_41c00b32-9cba-4c06-b050-8f3581a6f689" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 8 &#8211; Commitments and Contingencies</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Letter of credit</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has a standby letter of credit, expiring September 30, 2024, issued by a financial institution as required security for one operating lease. The aggregate amount of the letter of credit was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_c258bd01-5adc-45e6-9037-41371df259de" contextRef="C_b7832ab7-5ac7-48b8-b36a-eeaa642bb7fb" name="us-gaap:LinesOfCreditCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a8b230d9-12fc-4e58-acdb-dbaa48cb8dd1" contextRef="C_df8cf6d9-9e68-4550-b7d7-3f23bb4e4d54" name="us-gaap:LinesOfCreditCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 and December 31, 2023.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Legal Matters</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">From time-to-time, the Company may be involved in certain legal proceedings or regulatory matters arising in the ordinary course of business, including without limitation, actions with respect to intellectual property, employment, regulatory, product liability and contractual matters. In connection with these proceedings or matters,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><ix:exclude><div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:33.447%;"/>
          <td style="width:33.447%;"/>
          <td style="width:33.106%;"/>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div></ix:exclude><ix:exclude>
      <hr style="page-break-after:always;"/><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div></ix:exclude><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the Company regularly assesses the probability and amount (or range) of possible issues based on the developments in these proceedings or matters. A liability is recorded in the consolidated financial statements if it is determined that it is probable that a loss has been incurred, and that the amount (or range) of the loss can be reasonably estimated. Because of the uncertainties related to any pending proceedings or matters, the Company is currently unable to predict their ultimate outcome and, with respect to any legal proceeding or regulatory matter where no liability has been accrued, to make a reasonable estimate of the possible loss (or range of loss) that could result from an adverse outcome. At June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_7faecc7e-0a97-4777-87d4-1d8749b97a12" contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b" name="us-gaap:LegalFees" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_8eac3d8b-6072-4388-8fbc-44880cbc7a41" contextRef="C_1223a5cf-5ff9-4abd-b52d-c7eebdeb8212" name="us-gaap:LegalFees" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> legal proceedings, regulatory matters, or other disputes or claims for which a material loss was considered probable or for which the amount (or range) of loss was reasonably estimable. However, regardless of the outcome, legal proceedings, regulatory matters, and other disputes and claims can have an adverse impact on the Company because of legal costs, diversion of management time and resources, and other factors.</span></p></ix:nonNumeric></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_2_mda"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 2: M</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes to those statements included elsewhere in this report and our audited consolidated financial statements and related notes thereto for the year ended December 31, 2023, included in our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on February 28, 2024. In addition to historical financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those discussed under Part II, Item 1A &#8220;Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">, and elsewhere in, this report. See &#8220;Special Note Regarding Forward-Looking Statements.&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are a commercial-stage medical technology company dedicated to providing high quality customized vision to patients following cataract surgery. Our proprietary RxSight&#174; Light Adjustable Lens system (&#8220;RxSight system&#8221;) is the first and only commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system is comprised of our RxSight Light Adjustable Lens&#174; (&#8220;LAL&#153;&#8221; and &#8220;LAL+&#153;&#8221;, collectively the &#8220;LAL&#8221;), RxSight Light Delivery Device (&#8220;LDD&#153;&#8221;), and accessories. Our LAL is a premium intraocular lens (&#8220;IOL&#8221;) made of proprietary photosensitive material that changes shape in response to specific patterns of ultraviolet (&#8220;UV&#8221;) light generated by our LDD.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We designed our RxSight system to address the shortcomings of competitive premium IOL technologies and provide a solution that doctors can trust to improve visual outcomes and achieve high levels of patient satisfaction. Competitive premium IOLs require patients to specify their visual priorities before surgery and be willing to accept various optical trade-offs associated with those choices. Once a patient has selected a competitive premium IOL, the surgeon must rely on a series of preoperative diagnostic tests and predictive formulae to choose the appropriate lens power. If the doctor&#8217;s prediction isn&#8217;t exact, the patient may experience suboptimal results that could necessitate a subsequent corneal refractive procedure or certain other compromises in order to reach vision targets.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient&#8217;s desired vision outcomes. We believe our RxSight system provides doctors and patients increased confidence and peace of mind by eliminating the high-stakes preoperative guesswork common to competitive premium IOLs and allowing patients to iterate their final vision characteristics with customized post-surgical adjustments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We compete primarily in the IOL market in the U.S. The LAL is a premium IOL which is partially reimbursable under Medicare, and in some cases by private payors. Premium IOLs are sold at a higher price point than conventional IOLs, as they provide refractive correction of vision unlike a conventional IOL that only replaces the natural lens with a clear lens (which is the standard for Medicare reimbursement). Our RxSight system is approved in the U.S., Europe, Canada and Mexico for improving uncorrected visual acuity by adjusting the LAL power to correct residual postoperative refractive error. We may selectively pursue commercial expansion in these or other geographies that accept these approvals in the future, with a priority on markets where we see significant potential opportunities. New approvals may also be sought in large foreign cataract markets with more complex regulatory processes such as Asia and Europe.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are a Delaware corporation headquartered in Aliso Viejo, California with one wholly owned subsidiary located in Amsterdam, Netherlands.  The wholly owned subsidiary has a registered branch in the United Kingdom and a wholly owned subsidiary located in Germany.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our commercial efforts began in 2019 and have been primarily focused in the United States, where we are building a &#8220;razor and razor blade&#8221; business model to drive new customer adoption and ongoing LAL volume growth. Our United States commercial organization includes a direct sales team of LDD sales personnel and LAL account managers, as well as clinical specialists, field service engineers and marketing personnel. Our sales efforts are concentrated on the roughly 4,000 U.S. cataract surgeons that perform 70%-80% of all premium IOL procedures. As of June 30, 2024, we had established an installed base of 810 LDDs in ophthalmology practices and, since our inception through June 30, 2024, surgeons have implanted over 141,000 LALs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We believe this business model provides an attractive and concentrated market opportunity addressable with a focused sales force. We intend to continue to make significant investments in our sales and marketing organization. We believe selectively increasing the number of sales representatives, practice development personnel and clinical trainers will help facilitate further adoption of our products among existing customer accounts as well as broaden awareness of our products to new accounts. We plan to grow our business primarily by expanding the size of our LDD installed base and driving increased utilization of our LAL through heightened awareness of the superior clinical outcomes that our RxSight system provides patients. To continue to strengthen our competitive position in the premium IOL market, our research and development activities are focused primarily on programs that improve clinical outcomes, improve customer experience, expand our indications for use, reduce manufacturing costs and lifecycle management.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our near-term research and development activities are focused on enhancements to the RxSight system to improve the patient and doctor experience, expand the range of patients that can be treated, as well as expand the RxSight system indications and drive adoption. We believe that over time, our adjustable lens solution can be used to address a broad range of cataract surgery patients, including those that would otherwise elect for a conventional cataract procedure today. Additional development and clinical studies that are designed to provide clinical evidence of the safety and effectiveness of our existing and future generations of products are also anticipated. Finally, we may in the future seek to acquire or invest in additional businesses, products or technologies that we believe could complement or expand our portfolio, enhance our technical capabilities or otherwise offer growth opportunities.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We intend to continue to make investments in our sales and marketing organization, primarily sales representatives, clinical applications specialists and technical service personnel to support new customers and upgrades and LAL account managers to facilitate adoption of use of our LALs among existing accounts. We will expand our marketing efforts with additional print and digital, social media and other customer tools to expand their local advertising. We will also continue to make significant investments in research and development and clinical expenses to make enhancements in our current products. Additionally, as a public company, we have incurred and expect to continue to incur increased costs for employee-related expenses, director and officer insurance premiums, audit fees, (including costs for compliance with Section 404(b) of the Sarbanes-Oxley Act), legal fees, investor relations fees, fees to members of our Board of directors, and expenses for compliance with public-company reporting requirements. Because of these and other factors, we expect to continue to incur net losses and negative cash flows from operations in the near future.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Key business metrics</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We regularly review several operating and financial metrics to evaluate our business, measure our performance, identify trends affecting our business, formulate our business plan and make strategic decisions. We believe the number of LDDs installed and, LALs implanted are indicators of our ability to drive adoption and generate revenue. We believe these are important metrics for our business.  We may not yet be able to accurately assess seasonality and other trends, and we will continue to evaluate our business in the future using these and other financial metrics as we observe trends in our business. Our quarterly and annual financial results may fluctuate as a result of a variety of factors many of which are outside our control.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We believe the number of LDDs sold in each quarter and our LDD installed base at the end of each period are important metrics as they represent an installed base into which we can sell our LALs. We also believe the number of LALs sold (reported as implanted in a patient) in each quarter is an important metric indicative of adoption and utilization of our RxSight system.<br/></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:32.494%;"/>
     <td style="width:1.68%;"/>
     <td style="width:1.06%;"/>
     <td style="width:1%;"/>
     <td style="width:7.259%;"/>
     <td style="width:1%;"/>
     <td style="width:1.2%;"/>
     <td style="width:1%;"/>
     <td style="width:7.958%;"/>
     <td style="width:1%;"/>
     <td style="width:1.34%;"/>
     <td style="width:1%;"/>
     <td style="width:7.259%;"/>
     <td style="width:1%;"/>
     <td style="width:1.2%;"/>
     <td style="width:1%;"/>
     <td style="width:7.958%;"/>
     <td style="width:1%;"/>
     <td style="width:1.2%;"/>
     <td style="width:1%;"/>
     <td style="width:7.958%;"/>
     <td style="width:1%;"/>
     <td style="width:1.06%;"/>
     <td style="width:1%;"/>
     <td style="width:6.699%;"/>
     <td style="width:1%;"/>
     <td style="width:1.68%;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Q1</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Q2</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Q1</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Q2</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Q3</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Q4</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">LDDs Sold</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">66</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">78</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">56</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">67</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">66</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">77</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Installed Base at End of Period</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">732</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">810</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">456</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">523</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">589</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">666</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:32.607%;"/>
     <td style="width:1.219%;"/>
     <td style="width:1%;"/>
     <td style="width:7.8500000000000005%;"/>
     <td style="width:1%;"/>
     <td style="width:1.219%;"/>
     <td style="width:1%;"/>
     <td style="width:7.8500000000000005%;"/>
     <td style="width:1%;"/>
     <td style="width:1.219%;"/>
     <td style="width:1%;"/>
     <td style="width:7.57%;"/>
     <td style="width:1%;"/>
     <td style="width:1.219%;"/>
     <td style="width:1%;"/>
     <td style="width:8.549%;"/>
     <td style="width:1%;"/>
     <td style="width:1.219%;"/>
     <td style="width:1%;"/>
     <td style="width:7.151%;"/>
     <td style="width:1%;"/>
     <td style="width:1.219%;"/>
     <td style="width:1%;"/>
     <td style="width:7.431%;"/>
     <td style="width:1%;"/>
     <td style="width:1.678%;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Q1</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Q2</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Q1</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Q2</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Q3</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Q4</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">LALs Sold</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,218</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24,214</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,523</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,622</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,657</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,071</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the quarter ended June 30, 2024, we had increased LDD sales of 11 and increased LAL sales of 11,592 when compared to the quarter ended June 30, 2023 from strong adoption of our RxSight technology by practices and doctors combined with an increased LDD installed base.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Components of results of operations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Sales</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our sales consist of the sale of LALs used in cataract surgeries, the LDDs for delivering light to the LALs to adjust the lens post-surgery, as needed, and service and accessories. Revenue is derived from sales of products primarily in the United States. Customers are primarily comprised of ophthalmic practices (LDD sales) and ambulatory surgery centers (LAL sales). We expect revenue to increase in absolute dollars as we expand our sales organization and sales territories, add customers, expand the base of doctors that are trained to use our products, and expand awareness of our products with new and existing customers and as doctors perform more procedures using our products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">LALs are held at customer sites on consignment. Revenue is recognized for LALs upon customer notification that the LALs have been implanted in a patient.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our LDD contracts contain multiple performance obligations bundled into one transaction price, with all obligations generally satisfied within one year. The LDD capital asset and related components revenue is recognized upon installation and customer acceptance, training revenue is recognized upon completion of training by at least one doctor and the initial warranty and service agreement are recognized ratably over the service period. After the first year, service contracts can be purchased separately on a standalone basis.  Revenue for such service agreements will be recognized over the term of each contract.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the three and six months ended June 30, 2024 and 2023, revenue from contracts with customers consisted of the following (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:32.867%;"/>
     <td style="width:1.259%;"/>
     <td style="width:1%;"/>
     <td style="width:16.054%;"/>
     <td style="width:1%;"/>
     <td style="width:1.259%;"/>
     <td style="width:1%;"/>
     <td style="width:11.775%;"/>
     <td style="width:1%;"/>
     <td style="width:1.259%;"/>
     <td style="width:1%;"/>
     <td style="width:13.135%;"/>
     <td style="width:1%;"/>
     <td style="width:1.259%;"/>
     <td style="width:1%;"/>
     <td style="width:13.135%;"/>
     <td style="width:1%;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">LDD (including training)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,189</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,720</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,902</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,195</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">LAL</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23,828</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,411</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43,745</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,806</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Service warranty, service contracts, and accessories</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">870</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">679</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,752</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,298</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34,887</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,810</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">64,399</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,299</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the three and six months ended June 30, 2024 and 2023 we did not have any one customer who individually accounted for more than 10% of revenue.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cost of sales</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cost of sales consist of materials, labor and manufacturing overhead internally to produce our products as well as the cost of shipping and handling. Overhead costs include the cost of quality assurance, material procurement, inventory control, facilities, equipment and operations supervision and management and stock-based compensation. Cost of sales also includes depreciation expense for production equipment and certain direct costs such as shipping costs and royalty and license fee expense. Shipping costs billed to customers are included in sales. We expect cost of sales to increase in absolute dollars as our revenue grows and more of our products are sold.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We calculate gross margin as gross profit/(loss) divided by sales. Our gross margin has been and will continue to be affected by a variety of factors, including average selling prices, product sales mix, production and ordering volumes, manufacturing costs, product yields, headcount and cost-reduction strategies. Our gross margin could fluctuate from quarter to quarter as we introduce new products, and as we adopt new manufacturing processes and technologies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our LDD, as is typical of many medical device capital equipment products, has a low gross margin, as the material cost of the LDD is significant, representing greater than 50% of the total cost to manufacture. In addition, we do not mark up our LDD substantially because LDDs, once sold, generate LAL procedures. Our LAL gross margin is higher, with low material cost but high fixed overhead costs. As our manufacturing volume of the LAL increases, we expect gross margin may improve significantly.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Selling, general and administrative expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Selling, general and administrative (&#8220;SG&amp;A&#8221;), expenses consist primarily of personnel-related expenses, including wages, incentive bonuses, stock-based compensation and benefits related to administrative, selling and marketing functions, education programs for doctors, commercial operations and analytics, finance, information technology and human resource functions. Other SG&amp;A expenses include sales commissions, travel expenses, promotional activities, marketing initiatives, market research and analysis, conferences and trade shows, training for doctors, professional services fees such as legal, patent registration costs, accounting, audit fees (including costs for compliance with Section 404(b) of the Sarbanes-Oxley Act), tax fees, board of directors&#8217; expenses, insurance costs, general corporate expenses and facilities-related expenses. We expect SG&amp;A expenses to continue to increase in absolute dollars as we expand our sales and marketing organization and infrastructure to both drive and support the anticipated growth in revenue and due to additional legal, accounting audit and tax fees, insurance and other expenses associated with being a public company.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Research and development expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development expenses consist of expenses incurred in performing research and development and engineering activities for new products and technology, clinical studies and regulatory submissions and compliance. The expenses include personnel-related expenses, including wages, incentive bonuses, stock-based compensation and benefits, costs incurred at clinical trial sites, regulatory and manufacturing engineering costs, including those related to various laboratory and research equipment and supplies, expense of pre-approved inventory utilized for clinical trial and research purposes, costs incurred in the development of manufacturing processes in excess of capitalizable value, fees paid to consultants and contract clinical organizations and direct FDA related costs and costs related to FDA premarket approval submission preparation. Research and development expenses are expensed as incurred. We expect research and development expenses as a percentage of revenue to vary over time depending on the level and timing of our new product development efforts, as well as our clinical development, clinical trials and registries and other related activities.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Interest expense</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest expense consist primarily of interest incurred on our outstanding indebtedness and non-cash interest related to the amortization of debt discount and issuance costs associated with our indebtedness and interest on leases.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Interest and other income, net</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest and other income, net consist primarily of interest income earned on our short-term investments and cash equivalents.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Comprehensive loss</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All components of comprehensive loss, including net loss, are reported in the consolidated financial statements in the period in which they are recognized. Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources, including unrealized gains and losses on short-term investments and foreign currency translation adjustments.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Results of operations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Comparison of the three months ended June 30, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">  </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes our results of operations for the three months ended June 30, 2024 and 2023 together with the dollar increase or decrease and percentage change in those items.</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:42.72%;"/>
     <td style="width:1%;"/>
     <td style="width:11.24%;"/>
     <td style="width:1%;"/>
     <td style="width:1.44%;"/>
     <td style="width:1%;"/>
     <td style="width:11.24%;"/>
     <td style="width:1%;"/>
     <td style="width:1.44%;"/>
     <td style="width:1%;"/>
     <td style="width:11.22%;"/>
     <td style="width:1%;"/>
     <td style="width:1%;"/>
     <td style="width:1%;"/>
     <td style="width:11.700000000000001%;"/>
     <td style="width:1%;"/>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Change</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(in thousands, except percentages)</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">($)</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(%)</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sales</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34,887</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,810</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,077</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">67.6</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of sales</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,637</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,795</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,842</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20.9</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Gross profit</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24,250</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,015</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,235</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">101.8</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating expenses:</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24,292</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,239</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,053</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">33.2</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,291</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,401</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">890</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12.0</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total operating expenses</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">32,583</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25,640</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,943</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.1</span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Loss from operations</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(8,333</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(13,625</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,292</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(38.8</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other income (expense), net:</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest expense</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(6</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(1,568</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,562</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(99.6</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest and other income</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,276</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,777</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">499</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">28.1</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Loss on extinguishment of term loan</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(362</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total other (expense) income, net:</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,270</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(153</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,423</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(1585.2</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Loss before income taxes</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(6,063</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(13,778</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,715</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(56.0</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Income tax expense</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(10</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(38.1</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(6,079</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(13,804</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,725</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(56.0</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other comprehensive loss</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unrealized loss on short-term investments</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(64</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(65</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(1.8</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency translation (loss) gain</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(1</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(2</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(163.4</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total other comprehensive loss</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(65</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(64</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(1</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Comprehensive loss</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(6,144</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(13,868</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,724</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(55.7</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Sales</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Sales increased by $14.1 million, or 67.6%, to $34.9 million for the three months ended June 30, 2024, from $20.8 million for the three months ended June 30, 2023. The increase in total sales was primarily due to the incremental sales of 11,592 LALs and 11 LDDs from strong adoption of our RxSight system by practices and doctors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cost of sales</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cost of sales increased by $1.8 million, or 20.9%, to $10.6 million for the three months ended June 30, 2024, from $8.8 million for the three months ended June 30, 2023, primarily due to the increase in the number of LALs and LDDs sold during the period.  Gross margin increased to 69.5% in the three months ended June 30, 2024, from 57.8% for the three months ended June 30, 2023 primarily due to improved operating leverage, favorable product mix from a greater percentage of revenue from LAL sales, and increased margins on our LDD due to lower material costs.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Selling, general and administrative expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SG&amp;A expenses increased by $6.1 million, or 33.2%, to $24.3 million for the three months ended June 30, 2024, from $18.2 million for the three months ended June 30, 2023. This increase was primarily attributable to an increase in selling and marketing costs of $4.0 million mainly due to increased salaries from increased headcount of 37, increased sales commissions, incentive bonuses and employee benefits of $2.1 million, $0.8 million of increased stock-based compensation expense, $0.3 million in additional post market study costs, and new customer acquisition costs, in each case when compared to the three months ended June 30, 2023. General and administrative expenses increased $2.0 million due to increased personnel expenses of $0.6 million, $0.2 million of increased costs related to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">28</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">operating as a public company for Sarbanes-Oxley compliance and increased stock-based compensation of $0.8 million, in each case when compared to the three months ended June 30, 2023.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Research and development expenses</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development expenses increased by $0.9 million, or 12.0%, to $8.3 million for the three months ended June 30, 2024, from $7.4 million for the three months ended June 30, 2023. This increase was primarily attributable to $0.8 million due to increased facility costs and $0.3 million from increased stock-based compensation.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Other income (expense), net</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other income (expense), net, was income of $2.3 million for the three months ended June 30, 2024, compared to expense of $0.2 million for the three months ended June 30, 2023. The increase was primarily due to (i) decreased interest expense of $1.6 million due to the repayment of the Oxford term loan, as compared to the prior year period which also included a $0.3 million loss from the extinguishment of such term loan and (ii) increased interest income of $0.5 million, as compared to the prior year period, from higher interest rates earned on higher short term investment balances.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> Comparison of the six months ended June 30, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes our results of operations for the six months ended June 30, 2024 and 2023 together with the dollar increase or decrease and percentage change in those items:</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:42.72%;"/>
     <td style="width:1%;"/>
     <td style="width:11.24%;"/>
     <td style="width:1%;"/>
     <td style="width:1.44%;"/>
     <td style="width:1%;"/>
     <td style="width:11.24%;"/>
     <td style="width:1%;"/>
     <td style="width:1.44%;"/>
     <td style="width:1%;"/>
     <td style="width:11.22%;"/>
     <td style="width:1%;"/>
     <td style="width:1%;"/>
     <td style="width:1%;"/>
     <td style="width:11.700000000000001%;"/>
     <td style="width:1%;"/>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Change</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(in thousands, except percentages)</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">($)</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(%)</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sales</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">64,399</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,299</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26,100</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">68.1</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of sales</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19,464</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,919</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,545</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22.3</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Gross profit</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">44,935</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,380</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,555</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">100.8</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating expenses:</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47,616</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34,492</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,124</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38.0</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16,322</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,608</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,714</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.7</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total operating expenses</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">63,938</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">49,100</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,838</span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">30.2</span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Loss from operations</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(19,003</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(26,720</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,717</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(28.9</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other income (expense), net:</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest expense</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(11</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(3,075</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,064</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(99.6</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest and other income</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,860</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,168</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">692</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.9</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Loss on extinguishment of term loan</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(362</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total other income (expense), net:</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,849</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(269</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,118</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(1531.6</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Loss before income taxes</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(15,154</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(26,989</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,835</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(43.9</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Income tax expense</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(2</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(7.5</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(15,179</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(27,016</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,833</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(43.8</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other comprehensive loss (income)</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unrealized (loss) gain on short-term investments</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(109</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(128</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(682.7</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign currency translation (loss) gain</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(4</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(7</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(216.9</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total other comprehensive (loss) income</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(113</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(135</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(618.5</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Comprehensive loss</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(15,292</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(26,994</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,698</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(43.3</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td>
    </tr>
   </table><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Sales</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Sales increased by $26.1 million, or 68.1%, to $64.4 million for the six months ended June 30, 2024, from $38.3 million for the six months ended June 30, 2023. The increase was due to incremental sales of 21,287 LALs primarily due to an increased LDD installed base and incremental sales of 21 LDDs from strong adoption of our RxSight technology by practices and doctors combined with an increased LDD installed base.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cost of sales</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cost of sales increased by $3.6 million, or 22.3%, to $19.5 million for the six months ended June 30, 2024 from $15.9 million for the six months ended June 30, 2023, primarily due to the increase in the number of LALs and LDDs sold during the period.  Gross margin increased to 69.8% for the six months ended June 30, 2024 from 58.4% for the six months ended June 30, 2023 primarily due to favorable product mix from a greater percentage of revenue from LAL sales and increased margins on our LDD due to lower material costs from the introduction of our compact LDD during the third quarter of 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">SG&amp;A expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SG&amp;A expenses increased by $13.1 million, or 38.0%, to $47.6 million for the six months ended June 30, 2024, from $34.5 million for the six months ended June 30, 2023. This increase was primarily attributable to an increase in selling and marketing costs of $8.8 million mainly due to increased salaries from increased headcount of 37, increased sales commissions, incentive bonuses and employee benefits of $4.5 million, $1.4 million of increased stock-based compensation expense, $1.5 million in additional post market study costs, and new customer acquisition costs and increased travel costs of $0.6 million from increased LDD sales, in each case when compared to the six months ended June 30, 2023.  General and administrative expenses increased $4.2 million due to increased personnel expenses of $1.3 million, $0.6 million of increased costs related to operating as a public company and increased stock-based compensation of $1.1 million.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Research and development expenses</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development expenses increased by $1.7 million, or 11.7%, to $16.3 million for the six months ended June 30, 2024, from $14.6 million for the six months ended June 30, 2023. This increase was primarily attributable to $1.0 million in increased personnel costs primarily from increased headcount and $0.8 million in increased clinical study costs and $0.6 million from increased stock-based compensation.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Other income (expense), net</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other income (expense), net, was income of $3.8 million for the six months ended June 30, 2024, as compared to expense of $0.3 million for the six months ended June 30, 2023,  The increase was primarily due to decreased interest expense of $3.1 million and $0.3 million loss from extinguishment of term loan due to the repayment of the Oxford term loan in 2023 and increased interest income of $0.7 million from higher interest rates earned on higher short-term investment balances.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Liquidity and capital resources</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Sources of liquidity</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have incurred significant operating losses and negative cash flows from operations since our inception, and we anticipate that we will incur significant losses in the future.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024, we had cash, cash equivalents and short-term investments of $233.2 million. For the six months ended June 30, 2024, and 2023, our loss from operations were $19.0 million and $26.7 million, respectively. We had an accumulated deficit of $609.8 million as of June 30, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Recent Developments</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Shelf Registration Statement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On May 8, 2024, we filed an automatic shelf registration statement on Form S-3 (&#8220;shelf registration statement&#8221;). The shelf registration statement is effective for three years and permits us to sell, from time to time, common stock, preferred stock, debt securities, warrants, and/or units. The shelf registration statement is intended to provide us with the flexibility to access additional capital.  At the time of filing the shelf registration statement, we also filed a prospectus supplement to sell up to an aggregate value of $115.0 million dollars of common stock through a public offering (&#8220;Public Offering&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Public Offering</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On May 8, 2024, we entered into an underwriting agreement with BofA Securities, Inc., in which we agreed to issue and sell 1,785,714 shares of our common stock in a Public Offering, pursuant to the shelf registration statement. The shares of common stock were sold at a price to the public of $56.00 per share. Under the terms of the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">30</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">underwriting agreement, we also granted the underwriters an option exercisable for 30 days from the date of the underwriting agreement to purchase up to an additional 267,857 shares of common stock on the same terms and conditions.  The underwriters' option was exercised in full on May 10, 2024 and the Public Offering (inclusive of the underwriters' option shares) closed on May 13, 2024.  We received net proceeds of approximately $107.5 million from the Public Offering, after deducting underwriters' discounts and commissions of $6.9 million and other offering expenses of $0.6 million.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Contractual obligations and commitments</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">April 2024 lease activity</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 18, 2024, we entered into a new lease, and amendments to two existing leases, for three of our four facilities comprising our headquarters, manufacturing, research and development and administrative offices in Aliso Viejo, California. We entered into the new lease and amended two existing leases to extend the rental terms and options, ensure continued long-term access to our facilities, acquire additional square footage to expand manufacturing, and align the lease end dates for each of our four facilities. See Note 7 &#8211; Leases in the Notes to the condensed consolidated financial statements included in this report.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Standby letter of credit</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We also have a standby letter of credit, expiring September 30, 2024, issued by a financial institution as a required security for one operating lease. The aggregate amount of the letter of credit was $0.2 million as of June 30, 2024 and December 31, 2023.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Funding requirements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our future liquidity and capital funding requirements will depend on numerous factors, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our sales growth, including potential international expansion;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our research and development efforts; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our sales and marketing activities; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">working capital investments, primarily in inventories and accounts receivable;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to raise additional funds or borrow to finance our operations; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the outcome, costs and timing of any clinical trial results for our current or future products; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the emergence and effect of competing or complementary products; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to maintain, expand, enforce and defend our intellectual property portfolio, including the amount and timing of any payments we may be required to make, or that we may receive, in connection with the licensing, filing, prosecution, maintenance, defense and enforcement of any patents or other intellectual property rights; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to retain our current employees and the need and ability to hire additional management, sales, research and development, scientific and customer support personnel; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the terms and timing of any collaborative, licensing or other arrangements that we have or may establish; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">operating and finance lease payments for our facilities; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the extent to which we acquire or invest in businesses, products or technologies.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We believe that our current cash, cash equivalents and short-term investments through the date of filing of this report will be sufficient to fund our operations for at least the next 12 months. Although, based on our current planned operations, we do not anticipate the need to raise additional capital or incur additional debt in order to reach profit from operations, as the same may be disclosed in the Company&#8217;s future Annual Reports on Form 10-K or Quarterly Reports on Form 10-Q filed with the SEC, we may be required to raise additional capital through public or private equity offerings or debt financings, credit or loan facilities or by entering into partnerships or a combination of one or more of these funding sources in order to meet our liquidity requirements.  We may also opportunistically</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">raise capital under advantageous circumstances from time to time, such as the Public Offering, in order to support the expansion of our sales and operations in the U.S. and internationally and to pursue other business opportunities.  If we determine that we need to raise additional funds, which may not be available to us when needed or on terms that we deem to be favorable. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interests of our stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of common stockholders. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends. If we are unable to maintain sufficient financial resources, our business, financial condition and results of operations will be materially and adversely affected, including potentially requiring us to delay, limit, reduce or terminate certain of our product discovery and development activities or future commercialization efforts. If we raise additional funds by issuing equity securities, our stockholders may experience dilution.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">See Part II, Item 1A (&#8220;Risk Factors&#8221;) of this report for additional risks associated with our substantial capital requirements.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Summary statement of cash flows</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table sets forth the primary sources and uses of cash, cash equivalents, and restricted cash for each of the periods presented below (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:66.993%;"/>
     <td style="width:1.62%;"/>
     <td style="width:1%;"/>
     <td style="width:12.883000000000001%;"/>
     <td style="width:1%;"/>
     <td style="width:1.62%;"/>
     <td style="width:1%;"/>
     <td style="width:12.883000000000001%;"/>
     <td style="width:1%;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">For the Six Months Ended June 30,</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(unaudited)</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net cash (used in) provided by:</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating activities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(13,336</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(25,310</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Investing activities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(91,371</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(43,970</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Financing activities</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">119,465</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">66,196</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Effect of foreign exchange rate on cash, cash equivalents<br/>&#160;&#160;&#160;and restricted cash</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(4</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net increase (decrease) in cash, cash equivalents and restricted cash</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,754</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(3,081</span></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash used in operating activities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net cash used in operating activities for the six months ended June 30, 2024, was $13.3 million, consisting primarily of a net loss of $15.2 million and a change in operating assets and liabilities of $7.5 million, partially offset by non-cash stock-based compensation of $10.8 million and depreciation and amortization of $1.9 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net cash used in operating activities for the six months ended June 30, 2023, was $25.3 million, consisting primarily of a net loss of $27.0 million and a change in operating assets and liabilities of $5.3 million, partially offset by non-cash stock-based compensation of $7.3 million and depreciation and amortization of $1.9 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash used in investing activities</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net cash used in investing activities for the six months ended June 30, 2024, was $91.4 million, consisting of net purchase of short-term investments of $87.9 million and purchases of property and equipment of $3.5 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net cash used in investing activities for the six months ended June 30, 2023, was $44.0 million, consisting of net purchases of short-term investments of $41.4 million and purchases of property and equipment of $2.6 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash provided by financing activities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net cash provided by financing activities for the six months ended June 30, 2024, was $119.5 million consisting primarily of proceeds from issuances of common stock from the Public Offering of $108.1 million, proceeds from issuance of common stock from stock option exercises of $14.0 million partially offset by tax payments for employee stock compensation of $2.1 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net cash provided by financing activities for the six months ended June 30, 2023, was $66.2 million consisting primarily of proceeds from issuances of common stock from the Public Offering of $54.1 million, proceeds from issuance of common stock from at-the-market offerings of $30.5 million and proceeds from issuance of common</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">32</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">stock from stock option exercises of $3.9 million partially offset by a net paydown of the Oxford term loan of $20.0 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Critical accounting policies, significant judgments and use of estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our management&#8217;s discussion and analysis of financial condition and results of operations is based on our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions, which may affect our future financial statement presentation, financial condition, results of operations and cash flows. Our significant accounting policies are more fully described in the notes to our financial statements included in our Annual Report on Form 10-K filed with the SEC on February 28, 2024. We believe that the accounting policies we use are critical to the process of making significant judgments and estimates in the preparation of our financial statements and understanding and evaluating our reported financial results.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We believe that accounting policies we have identified as critical involve a greater degree of judgment and complexity than our other accounting policies. Accordingly, those are the policies we believe are the most critical to understanding and evaluating our consolidated financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For a summary of our critical accounting policies and estimates, refer to &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our Annual Report on Form 10-K filed with the SEC on February 28, 2024. There have been no material changes to our critical accounting policies and estimates during the three months ended June 30, 2024.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indemnification agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We enter into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, we indemnify, hold harmless and agree to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement, misappropriation or other violation claim by any third party with respect to its technology. The term of these indemnification agreements is generally perpetual any time after the execution of the agreement. The maximum potential amount of future payments we could be required to make under these arrangements is not determinable. We have never incurred costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, we believe the fair value of these agreements is minimal.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Recent accounting pronouncements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">See the section titled &#8220;Summary of Significant Accounting Policies&#8212;Recent Accounting Pronouncements&#8221; in Note 2 to our financial statements included elsewhere in this report for additional information.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Supply chain constraints and inflation</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We rely on third parties, including single and sole source suppliers, to manufacture certain components and subcomponents of our products and to provide raw materials, primarily chemicals for our LAL. We do not have long-term supply agreements with, or guaranteed commitments from our suppliers, including single and sole source suppliers. We utilize purchase orders or blanket orders covering the medium term of 18&#8211;24 months for the majority of our supplier base. While we depend on our suppliers to provide us and our customers with materials in a timely manner that meet our and their quality, quantity and cost requirements, vendors will miss delivery dates, extend delivery dates or in some circumstances cancel purchase orders because these suppliers may encounter problems during manufacturing for a variety of reasons, any of which could delay or impede their ability to meet our demand. The expansion of global lead times has resulted in the lack of availability of raw materials, including semiconductors, computers, monitors electronic parts, metals, packaging, adhesives, chemicals, resins and subcontract painted components. Certain suppliers have passed on higher prices, surcharges and expedited shipping fees to defray the higher commodity prices they are paying due to short supply and pushed out delivery dates. Additionally, we identify and qualify new suppliers to mitigate risk due to single and sole source suppliers and to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">33</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">alleviate supply chain constraints we will identify and qualify new vendors or substitute components which requires testing, validations and documentation adding to internal costs and diverting engineering resources from other projects.  While we have taken measures to mitigate business continuity risk, including increasing standard lead times, payment of expedite fees, issuance of a limited number of non-cancelable purchase orders, advance delivery of critical components ahead of normal delivery dates and second sourcing, our suppliers may cease producing the components we purchase from them or otherwise decide to cease doing business with us. Any supply interruption from our suppliers or failure to obtain additional suppliers for any of the components or subcomponents used in our products would limit our ability to manufacture our current and new products and could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Uncertain macroeconomic conditions including recent inflationary pressures and the rise in interest rates have created significant uncertainty in the U.S. economy and capital markets, which is expected to continue through the remainder of 2024 and beyond and could negatively impact our financial results and liquidity.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_3_quantitative_qualitative_disclosu"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">
<br/>ITEM 3.</span><span style="color:#222222;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">QUANTITATIVE AND QUALITAT</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">IVE DISCLOSURES ABOUT MARKET RISK</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are exposed to market risks in the ordinary course of our business. Market risk is the potential loss arising from the adverse changes in market rates and prices.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest Fluctuation Rate Risk</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We had cash and cash equivalents and short-term investments of $233.2 million as of June 30, 2024, which consisted of $208.8 million in highly liquid money market and U.S. Treasury securities with maturities of twelve months or less. The primary goals of our investment policy are liquidity and capital preservation. We do not enter into investments for trading or speculative purposes. We believe that we do not have any material exposure to changes in the fair value of these assets as a result of changes in interest rates due to the short-term nature of our cash and cash equivalents and short-term investments. Declines in interest rates, however, would reduce future investment income. We considered the historical volatility of short-term interest rates and determined that it was reasonably possible that an adverse change of 100 basis points could be experienced in the near term. A hypothetical 1.00% (100 basis points) change in interest rates would not have materially impacted the fair value of our marketable securities as of June 30, 2024 and December 31, 2023.  If overall interest rates had increased or decreased by 1.00% (100 basis points), our interest income would not have been materially affected during the quarter ended June 30, 2024 or June 30, 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Foreign Currency Exchange Risk</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024, we have de minimis amounts of revenue and expenses that are denominated in currencies other than U.S. dollars.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_4_controls_procedures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ITEM 4.</span><span style="color:#222222;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CONTROLS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> AND PROCEDURES</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024, our management, with the participation and supervision of our principal executive officer and our principal financial officer, evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act).  Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2024. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of achieving their objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Changes in Internal Control over Financial Reporting</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended  June 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Limitations on the Effectiveness of Controls</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Control systems, no matter how well conceived and operated, are designed to provide a reasonable, but not an absolute, level of assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Because of the inherent limitations in any control system, misstatements due to error or fraud may occur and not be detected.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_ii_or_information"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Part II. OTHER</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> INFORMATION</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1_legal_proceedings"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 1: Legal </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Proceedings</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">From time to time, we may become involved in various claims and legal proceedings. Regardless of outcome, litigation and other legal and administrative proceedings can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. We are currently not a party to any legal proceedings the outcome of which, if determined adversely to us, would individually or in the aggregate have a material adverse effect on our business, financial condition, and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;" id="risk_factors"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 1A:  Risk Factors</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We operate in a rapidly changing environment that involves numerous uncertainties and risks. In addition to the other information included in this report, the following risks and uncertainties may have a material and adverse effect on our business, financial condition, results of operations, or stock price. You should consider these risks and uncertainties carefully, together with all of the other information included or incorporated by reference in this report. The risks and uncertainties described below may not be the only ones we face. If any of the risks or uncertainties we face were to occur, the trading price of our securities could decline, and you may lose all or part of your investment. This report also contains forward-looking statements that involve risks and uncertainties. See the section titled &#8220;Special Note Regarding Forward-Looking Statements&#8221; appearing elsewhere in this report. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of factors that are described below and elsewhere in this report.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Summary Risk Factors</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our following risks and uncertainties are among the most significant we face, however, the risks and uncertainties identified in this subsection are not the only ones we face and are qualified in their entirety by reference to all of the risk factors described herein:</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks related to our business and products:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have a limited operating history, and if we fail to effectively train our sales force, increase our sales and marketing capabilities, or develop broad brand awareness in a cost-effective manner, our growth will be impeded, and our business will suffer. </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have a history of net operating losses, and we expect to continue to incur losses in the future. If we ever achieve profitability, we may not be able to sustain it.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our success depends in large part on our RxSight system. If we are unable to successfully market and sell our RxSight system, our business prospects will be significantly harmed, and we may be unable to achieve revenue growth.</span></div></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We face significant competition, and if we are unable to compete effectively, we may not be able to achieve or maintain significant market penetration or improve our results of operations.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Global economic, political and market conditions, including downgrades of the U.S. credit rating, may adversely affect our business, results of operations and financial condition, including our revenue growth and profitability.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We currently maintain all of our cash, cash equivalents and short-term investments in one financial institution and, therefore, our cash, cash equivalents and short-term investments could be adversely affected if the financial institution in which we hold our cash, cash equivalents and short-term investments fails.</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks related to intellectual property:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we are unable to obtain, maintain, protect and enforce patent and other intellectual property protection for our technology and products, or if the scope of the patent and other intellectual property protection obtained is not sufficiently broad, we may not be able to compete effectively in our markets.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we are unable to protect the confidentiality of our trade secrets and other proprietary information, our business and competitive position may be harmed.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We may not be able to protect our intellectual property rights throughout the world, which could impair our business.</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks related to government regulation:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we fail to obtain and maintain necessary regulatory clearances or approvals for our products, or if clearances or approvals for future products and indications are delayed or not issued, our commercial operations may be harmed.</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks related to reliance on third parties:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We depend upon third parties, including single and sole source suppliers, to manufacture certain components and subcomponents of the RxSight system, making us vulnerable to supply disruptions and price fluctuations.</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks related to our common stock:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The price of our stock may be volatile, and you could lose all or part of your investment.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We do not know whether an active, liquid and orderly trading market will exist for our common stock or what the market price of our common stock will be and as a result it may be difficult for you to sell your shares of our common stock.</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">General risk factors:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We must recruit, retain, manage and motivate qualified executives as we build out the management team, and we are highly dependent on our management team.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Future litigation proceedings could adversely affect our business. </span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks related to our business and products</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We have a limited operating history and if we fail to effectively train our sales force, increase our sales and marketing capabilities or develop broad brand awareness in a cost-effective manner, our growth will be impeded, and our business will suffer.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We were incorporated in March 1997 and began commercializing our products in the second half of 2019, when we initiated a full launch of our LAL and LDD. Accordingly, our limited commercialization experience and limited number of approved or cleared products make it difficult to evaluate our current business and assess our prospects. We also currently have limited sales and marketing experience. If we are unable to establish or scale effective sales and marketing capabilities, or if we are unable to commercialize any of our products, we may not be able to generate sufficient product revenue, sustain revenue growth and compete effectively. In order to generate future growth, we</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">plan to continue to expand and leverage our sales and marketing infrastructure to increase our customer base and grow our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Identifying and recruiting qualified sales and marketing personnel and training them on our products, applicable federal and state laws and regulations, and on our internal policies and procedures requires significant time, expense and attention. It often takes several months or more before a sales representative is fully trained and productive. Our business may be harmed if our efforts to expand and train our sales force do not generate a corresponding increase in revenue, or in the event we are unable to reduce costs in the face of an unexpected decline in demand for our products. Any failure to hire, develop and retain talented sales and marketing personnel, to achieve desired productivity levels in a reasonable timeframe or timely leverage our fixed costs could have a material adverse effect on our business, financial condition and results of operations. Moreover, the members of our direct sales force are at-will employees. The loss of these personnel to competitors or otherwise could materially harm our business. If we are unable to retain our direct sales force personnel or replace them with individuals of equivalent technical expertise and qualifications, or if we are unable to successfully instill technical expertise in replacement personnel, our revenue and results of operations could be materially harmed.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our ability to increase our customer base and achieve broader market acceptance of our products will also depend to a significant extent on our ability to expand our marketing efforts. Our business may be harmed if our marketing efforts and expenditures do not generate a corresponding increase in revenue. In addition, we believe that developing and maintaining broad awareness of our brand in a cost-effective manner is critical to achieving broad acceptance of our products and penetrating new customer accounts. Brand promotion activities may not generate patient or doctor awareness or increased revenue, and even if they do, any increase in revenue may not offset the costs and expenses we incur in building our brand. If we fail to successfully promote, maintain and protect our brand, we may fail to attract or retain the doctor acceptance necessary to realize a sufficient return on our brand building efforts, or to achieve the level of brand awareness that is critical for broad adoption of our products.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">These factors also make it difficult for us to forecast our financial performance and growth, and such forecasts are subject to a number of uncertainties, including our ability to successfully develop additional products that add functionality, reduce the cost of products sold, and broaden our commercial portfolio offerings and our ability to obtain the required regulatory approvals and clearances under applicable law both domestically and internationally, including FDA 510(k) clearance or pre-market approval, or PMA, for, and successfully commercialize, market and sell, our planned or future products in the United States or in international markets. If our assumptions regarding the risks and uncertainties we face, which we use to plan our business, are incorrect or change due to circumstances in our business or our markets, or if we do not address these risks successfully, our operating and financial results could differ materially from our expectations and our business could suffer.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We have a history of net losses, and we expect to continue to incur losses in the future. If we ever achieve profitability, we may not be able to sustain it.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have incurred losses from operations since our inception and expect to continue to incur losses from operations in the future. We reported losses from operations of $50.1 million and $63.3 million for the years ended December 31, 2023 and 2022, respectively, and $8.3 million for the three months ended June 30, 2024. As a result of these losses, as of June 30, 2024, we had an accumulated deficit of $609.8 million. We expect to continue to incur significant sales and marketing, research and development, regulatory and other expenses as we expand our marketing efforts to increase adoption of our products, expand existing relationships with our customers, obtain regulatory clearances or approvals for our planned or future products, conduct clinical trials on our existing and planned or future products and develop new products or add new features to our existing products. In addition, we expect our general and administrative expenses to increase due to the costs associated with being a public company.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The net losses that we incur may fluctuate from period to period. We will need to generate significant additional revenue in order to achieve and sustain profitability. Even if we achieve profitability, we cannot be sure that we will remain profitable for any substantial period of time.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">In order to support our continued operations and the growth of our business, we may seek to raise additional capital, which may not be available to us on acceptable terms, or at all.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We expect capital expenditures and operating expenses to increase over the next several years as we continue to operate our business and expand our infrastructure, commercial operations and research and development activities. Our primary uses of capital are, and we expect will continue to be, investment in our commercial organization and related expenses, clinical research and development services, laboratory and related supplies, legal and other</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">37</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">regulatory expenses, general administrative costs and working capital. In addition, we may in the future seek to acquire or invest in additional businesses, products, services or technologies that we believe could complement or expand our product portfolio, enhance our technical capabilities or otherwise offer growth opportunities.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Because of these and other factors, we expect to continue to incur net losses and negative cash flows from operations in the future. Our future liquidity and capital funding requirements will depend on numerous factors, including:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our sales growth; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our research and development efforts; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our sales and marketing activities; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our success in leveraging future strategic partnerships;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">working capital investments, primarily in inventories and accounts receivable;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to borrow or raise additional funds through future debt or equity offerings to finance our operations; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the outcome, costs and timing of any clinical trial results for our current or future products; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the emergence and effect of competing or complementary products; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the availability and amount of reimbursement for procedures using our products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to maintain, expand, enforce and defend our intellectual property portfolio, including the amount and timing of any payments we may be required to make, or that we may receive, in connection with the licensing, filing, prosecution, maintenance, defense and enforcement of any patents or other intellectual property rights; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to retain our current employees and the need and ability to hire additional management, sales, research and development, scientific and customer support personnel; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the terms and timing of any collaborative, licensing or other arrangements that we have or may establish; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">operating and finance lease payments for our facilities; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the extent to which we acquire or invest in businesses, products or technologies.</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we determine that we need to raise additional funds, we may do so through equity or debt financings, which may not be available to us when needed or on terms that we deem to be favorable. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interests of our stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of common stockholders. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends. If we are unable to maintain sufficient financial resources, our business, financial condition and results of operations will be materially and adversely affected, including potentially requiring us to delay, limit, reduce or terminate certain of our product discovery and development activities or future commercialization efforts.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Moreover, in the event that we enter into collaborations or licensing arrangements to raise capital, we may be required to accept unfavorable terms. These agreements may require that we relinquish or license to a third party on unfavorable terms our rights to products or technologies we otherwise would seek to develop or commercialize ourselves, or reserve certain opportunities for future potential arrangements when we might be able to achieve more favorable terms. We may be unable to raise additional funds or to enter into such agreements or arrangements on favorable terms, or at all. Our ability to raise additional funds may be adversely impacted by potential worsening global economic conditions and the recent disruptions to, and volatility in, the credit and financial markets in the United States and worldwide resulting from the conflicts in Eastern Europe, the Middle East and otherwise.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024 and December 31, 2023, we had $233.2 million and $127.2 million, respectively, in cash, cash equivalents and short-term investments. While we believe that our existing cash, cash equivalents and short-term investments and anticipated cash generated from sales of our products will be sufficient to meet our anticipated cash needs for at least 12 months following the date of this report, we cannot assure you that we will be able to generate sufficient liquidity as and when needed. Further, although we do not anticipate the need to raise additional capital or incur additional debt in order to reach profit from operations, as such metric may be disclosed in the Company&#8217;s future Annual Reports on Form 10-K or Quarterly Reports on Form 10-Q filed with the SEC, though we may opportunistically seek to raise capital under advantageous circumstances from time to time in order to support the expansion of our sales and operations in the U.S. and internationally and to pursue other business opportunities. We have based this estimate on assumptions that may prove to be wrong, and we could use our capital resources sooner than we currently expect. Changing circumstances, some of which may be beyond our control, could cause us to consume capital significantly faster than we currently anticipate, and we may need to seek additional funds sooner than planned.  We cannot assure you that we will be able to generate sufficient liquidity as and when needed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Global economic, political and market conditions, including downgrades of the U.S. credit rating, may adversely affect our business, results of operations and financial condition, including our revenue growth and profitability.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The current worldwide economic and financial environment, as well as various social and political tensions in the U.S. and around the world, may contribute to increased market volatility, may have long-term effects on the U.S. and worldwide financial markets and may cause economic uncertainties or deterioration in the U.S. and worldwide. The impact of downgrades by rating agencies to the U.S. government&#8217;s sovereign credit rating or its perceived creditworthiness as well as potential government shutdowns could adversely affect the U.S. and global financial markets and economic conditions. U.S. debt ceiling and budget deficit concerns have increased the possibility of additional credit-rating downgrades and economic slowdowns, or a recession in the U.S. In addition, disagreement over the federal budget has caused the U.S. federal government to shut down for periods of time. Continued adverse political and economic conditions could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Deterioration in the economic conditions globally resulting in instability in global financial markets, including the following, may pose a risk to our business: inflation and rising interest rates, large sovereign debts and fiscal deficits of several countries in Europe and in emerging markets&#8217; jurisdictions, levels of non-performing loans on the balance sheets of European banks, the effect of the United Kingdom leaving the European Union, and instability in the capital markets.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics) may also contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide and have a material adverse effect on our business, financial conditions, results of operations and prospects.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We currently maintain all of our cash, cash equivalents and short-term investments in one financial institution and, therefore, our cash, cash equivalents and short-term investments could be adversely affected if the financial institution in which we hold our cash, cash equivalents and short-term investments fails.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We currently maintain all of our cash, cash equivalents and short-term investments with one financial institution.  At the current time, our cash, cash equivalents and short-term investment balances with such financial institution are held primarily in U.S. treasury bills with a duration of less than 12 months. A portion of our operating cash is held in accounts in excess of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance limits. The failure of the financial institution in which our cash, cash equivalents and short-term-investments are held, the resulting inability for us to obtain the return of our funds from that financial institution, or any other adverse condition suffered by the financial institution, could impact access to our operating cash and a temporary inability to access our short-term investments in U.S. treasury bills which could have an adverse effect on our business, financial condition and results of operations.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our success depends in large part on our RxSight system. If we are unable to successfully market and sell our RxSight system, our business prospects will be significantly harmed, and we may be unable to achieve revenue growth.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our future financial success will depend substantially on our ability to effectively and profitably market and sell our RxSight system to ophthalmic practices. The commercial success of our RxSight system and any of our planned or future products will depend on a number of factors, including the following:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the actual and perceived effectiveness and reliability of our RxSight system, especially relative to alternative products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the prevalence and severity of any adverse patient events involving our RxSight system;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the results of clinical studies and trials relating to our RxSight system;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to sustain meaningful clinical benefits for our patients;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to obtain regulatory approval to market our planned or future products for use in the United States or internationally;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the availability, relative cost and perceived advantages and disadvantages of alternative technologies or treatment methods for conditions treated by our products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the degree of patient willingness to pay for the additional costs associated with our premium intraocular lens out of pocket;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the degree to which doctors adopt our RxSight system;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the fact that governmental and private health care providers and payors around the world are increasingly utilizing managed care for the delivery of health care services, centralizing purchasing, limiting the number of vendors that may participate in purchasing programs, forming group purchasing organizations and integrated health delivery networks and pursuing consolidation to improve their purchasing leverage and using competitive bid processes to procure health care products and services;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to obtain, maintain, protect and enforce our intellectual property rights in and to our RxSight system;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the degree to which patients value the customized vision delivered by the RxSight system and are satisfied with their results;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">achieving and maintaining compliance with regulatory requirements applicable to our products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the extent to which we are successful in educating doctors about IOLs in general, and the benefits of our RxSight system;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our reputation among doctors;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the strength of our marketing and commercial organization;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the effectiveness of our marketing and sales efforts in the United States, including our efforts to build out our sales team;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to expand the commercialization of our products into international markets;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to continue to develop, validate and maintain a commercially viable manufacturing process that is compliant with the Quality Systems Regulations (&#8220;QSR&#8221;), or QSMR when it goes into effect in February 2026, and other applicable foreign, federal and state regulatory requirements;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the success of our ongoing or future clinical trials; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">whether we are required by the FDA or comparable non-U.S. regulatory authorities to conduct additional clinical trials for current or future indications.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we fail to successfully market and sell our products, we will not be able to grow our revenue or achieve profitability, which will have a material adverse effect on our business, financial condition and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our ability to grow our revenue in future periods will depend on our ability to successfully penetrate our target markets and increase sales of our RxSight system and any new product or product indications that we introduce, which will, in turn, depend in part on our success in growing our user base and driving increased use of our products. New products or product indications will also need to be approved or cleared by the FDA and comparable non-U.S. regulatory agencies in any international markets we target in order to commercialize them. If we cannot achieve revenue growth or achieve or sustain profitability, it could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Adoption of our products depends upon appropriate training for doctors, and inadequate training may lead to negative patient outcomes, affect adoption of our products and adversely affect our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The success of our products depends in part on our customers&#8217; adherence to appropriate patient selection and proper techniques provided in training sessions conducted by our training faculty. For example, we train our customers to ensure correct use of our RxSight system. However, doctors rely on their previous medical training and experience, and we cannot guarantee that all such doctors will have the necessary skills or training to effectively utilize our products. We do not control which doctors use our products or how much training they receive, and doctors who have not completed our training sessions may nonetheless attempt to use our products. In addition, doctors may use our products in a manner that is not consistent with their labeled indications for which no training is available. If doctors use our products in a manner that is inconsistent with their labeled indications, with components that are not compatible with our products or otherwise without adhering to or completing our training sessions, their patient outcomes may not be consistent with the outcomes achieved by other doctors or in our clinical trials. This result may negatively impact the perception of patient benefit and safety and limit adoption of our products, which would have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We currently require limited training in the use of our products because we market primarily to doctors who are experienced in the specific techniques required to use our devices. If demand for our products continues to grow, less experienced doctors will likely use our products, potentially leading to more injury and an increased risk of product liability claims. The use or misuse of our products may in the future result in complications and potentially lead to product liability claims.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The commercial success of our RxSight system will depend upon attaining significant market acceptance of these products among patients and doctors.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our success will depend, in part, on the acceptance of our RxSight system as safe, effective and, with respect to doctors, cost-effective. We cannot predict how quickly, if at all, patients, doctors, or payors will accept our RxSight system or, if accepted, how frequently it will be used. Our RxSight system and planned or future products we may develop or market may never gain broad market acceptance for some or all of our targeted indications. Patients and doctors must believe that our products offer benefits over alternative treatment methods. To date, a substantial majority of our product sales and revenue have been derived from a limited number of customers who have adopted our RxSight system. Our future growth and profitability largely depend on our ability to increase doctors&#8217; awareness of our RxSight system and our products and on the willingness of patients and doctors to adopt them. These parties may not adopt our products unless they are able to determine, based on experience, clinical data, medical society recommendations and other analyses, that our products are safe, effective and, with respect to providers, cost-effective, on a stand-alone basis and relative to competitors&#8217; products. Patients and doctors must believe that our products offer benefits over alternative treatment methods. Even if we are able to raise awareness, doctors tend to be slow in changing their medical treatment practices and may be hesitant to select our products for recommendation to their patients for a variety of reasons, including:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">long-standing relationships with competing companies and distributors that sell other products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">competitive response and negative selling efforts from providers of alternative products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">lack of experience with our products and concerns that we are relatively new to market;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">lack or perceived lack of sufficient clinical evidence, including long-term data, supporting safety or clinical benefits;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">time commitment and skill development that may be required to gain familiarity and proficiency with our products;</span></div></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">41</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">patient confusion regarding the wide range of commercially available premium IOL offerings and their ability to deliver promised results at near, middle and far distances without reliance on glasses;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">patient reticence to select a premium IOL due to nonperformance and adverse side effects associated with competing products in the market;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">patient non-compliance with the RxSight system requirement to wear protective glasses following surgery until the LAL is locked to avoid UV exposure and an unintended change to the LAL, resulting in patient dissatisfaction with the results and possible need to remove the LAL; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">an inability to generate patient referral due to dissatisfaction with results obtained through treatment with our products, the out-of-pocket cost of treatments using our products or otherwise.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In order for doctors to use our RxSight system, they must make a significant up-front investment to purchase the LDD. This can result in a lengthy sales cycle and require extensive negotiations and management time. If we are unsuccessful in placing LDDs with providers, our sales may decrease, and our operating results may be harmed.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Doctors play a significant role in determining the course of a patient&#8217;s treatment, and, as a result, the type of treatment that will be utilized and provided to a patient. We focus our sales, marketing and education efforts primarily on doctors, and aim to educate referring doctors on the patient population that would benefit from our products. However, we cannot assure you that we will achieve broad market acceptance among doctors.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For example, some doctors may choose to utilize our RxSight system on only a subset of their total patient population or may not adopt our RxSight system at all. If we are not able to effectively demonstrate that the use of our RxSight system is beneficial in a broad range of patients, adoption of our product will be limited and may not occur as rapidly as we anticipate or at all, which would have a material adverse effect on our business, financial condition and results of operations. We cannot assure you that our products will achieve broad market acceptance among doctors. Additionally, even if our products achieve market acceptance, they may not maintain that market acceptance over time if competing products, procedures or technologies are considered safer or more cost-effective or otherwise superior. Any failure of our products to generate sufficient demand or to achieve meaningful market acceptance and penetration will harm our future prospects and have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our reputation among our current or potential customers, as well as among doctors, could also be negatively affected by safety or customer satisfaction issues involving us or our products, including product recalls. Future product recalls or other safety or customer satisfaction issues relating to our reputation could negatively affect our ability to establish or maintain broad adoption of our products, which would harm our future prospects and have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our RxSight system involves surgical risks and is contraindicated in certain patients, which may limit adoption.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks of using our products include those associated with cataract surgery and IOL implantation. There are also possible, but rare, complications due to the use of UV light from the LDD, including a temporary or long-lasting change to vision. We are aware of certain characteristics and features of our RxSight system that may prevent widespread market adoption, including the fact that doctors would need to adopt a new procedure, and training for doctors will be required to enable them to effectively operate our products.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We face significant competition, and if we are unable to compete effectively, we may not be able to achieve or maintain significant market penetration or improve our results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The medical device industry is intensely competitive, subject to rapid change and significantly affected by new product introductions and other market activities of industry participants. We compete with manufacturers and distributors of premium and conventional IOLs. Our most significant competitors in the IOL field include Alcon, Johnson &amp; Johnson Vision and Bausch + Lomb. Many of our competitors are large, well-capitalized companies with significantly greater market share and resources than we have. Therefore, they can spend more on product development, marketing, sales and other product initiatives than we can. We also compete with smaller medical device companies that have a single product or a limited range of products. In addition, patients who receive an LAL will be required to wear UV protective glasses until final lock-in which is approximately four to five weeks after surgery. They will also be required to return for an additional two to three clinic visits compared to traditional monofocal cataract surgery. The additional clinic visits are non-surgical but do require the patient&#8217;s eyes to be</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">dilated. Due to these additional requirements, market acceptance of the LAL may be impacted. We believe the principal competitive factors in our markets include:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The quality of patient outcomes, oftentimes measured by visual acuity, and adverse event rates;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Patient experience, including patient recovery time and level of discomfort;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Acceptance by treating doctors and referral sources;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Doctor learning curves and willingness to adopt new technologies;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Ease-of-use and reliability;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Economic benefits and cost savings;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Strength of clinical evidence;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Effective distribution and marketing to surgeons and potential patients; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Product price and qualification for coverage and reimbursement.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We compete primarily on the basis that our products are designed to enable more doctors to treat more patients more efficiently and effectively. Our continued success depends on our ability to:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">continue to develop innovative, proprietary products that address significant clinical needs in a manner that is safe and effective for patients and easy-to-use for doctors;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">obtain and maintain regulatory clearances or approvals;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">demonstrate safety and effectiveness in our sponsored and third-party clinical trials;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">expand our sales force across key markets to increase doctors&#8217; awareness;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">obtain and maintain coverage and adequate reimbursement for procedures using our products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">attract and retain skilled research, development, sales and clinical personnel;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">cost-effectively manufacture, market and sell our products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provide doctors with a sufficient return on investment as compared to alternative premium IOL procedures that justifies the upfront cost of our LDD; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">obtain, maintain, enforce and defend our intellectual property rights and operate our business without infringing, misappropriating or otherwise violating the intellectual property rights of others.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We can provide no assurance that we will be successful in developing new products or commercializing them in ways that achieve market acceptance. If we develop new products, sales of those products may reduce revenue generated from our existing products. Moreover, any significant delays in our product launches may significantly impede our ability to enter or compete in a given market and may reduce the sales that we are able to generate from these products. We may experience delays in any phase of a product development, including during research and development, clinical trials, regulatory review, manufacturing and marketing. Delays in product introductions could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, many medical device companies are consolidating to create new companies with greater market power. As the medical device industry consolidates, competition to provide goods and services to industry participants will become more intense. These industry participants may try to use their market power to negotiate price concessions or reductions for our products. If we reduce our prices because of consolidation in the healthcare industry, our revenue may decrease, which could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">If our facilities become damaged or inoperable, or if we are required to vacate a facility, we may be unable to manufacture our products or we may experience delays in production or an increase in costs, which could adversely affect our results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We currently maintain our research and development, manufacturing and administrative operations in Aliso Viejo, California, and we do not have redundant facilities. We operate in four separate facilities, designated as a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">single manufacturing facility, and should any one of these facilities be significantly damaged or destroyed by natural or man-made disasters, such as earthquakes, fires (both of which are prevalent in California) or other events, it could take months to relocate or rebuild, during which time our employees may seek other positions, our research, development and manufacturing would cease or be delayed and our products may be unavailable. A major interruption in the manufacturing operations at this facility would materially impact our ability to operate. Because of the time required to authorize manufacturing in a new facility under federal, state and non-U.S. regulatory requirements, we may not be able to resume production on a timely basis even if we are able to replace production capacity. While we maintain property and business interruption insurance, such insurance has limits and would not cover all damages, including losses caused by earthquakes or losses we may suffer due to our products being replaced by competitors&#8217; products. The inability to perform our research, development and manufacturing activities if our facilities become inoperable, combined with our limited inventory of materials and components and manufactured products, may cause doctors to discontinue using our products or harm our reputation, and we may be unable to re-establish relationships with such doctors in the future. Consequently, a catastrophic event at our current facility or any future facilities could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Furthermore, the current leases on our four facilities expire or have options to extend until January 31, 2031, with two options to extend for five years each. We may be unable to renew our leases or find a new facility on commercially reasonable terms, or at all. If we were unable or unwilling to renew at the proposed rates, relocating our manufacturing facility would involve significant expense in connection with the movement and installation of key manufacturing equipment and any necessary recertification with regulatory bodies, and we cannot assure you that such a move would not delay or otherwise adversely affect our manufacturing activities or operating results. If our manufacturing capabilities were impaired by any such move, we may not be able to manufacture and ship our products in a timely manner, which would adversely impact our business.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Technological change may adversely affect sales of our products and may cause our products to become obsolete.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The medical device market is characterized by extensive research and development and rapid technological change. There can be no assurance that other companies, including current competitors or new entrants, will not succeed in developing or marketing products that are more effective than our products or that would render our products obsolete or noncompetitive. Additionally, new surgical procedures, medications and other therapies could be developed that replace or reduce the importance of our products. If we are unable to innovate successfully, our products could become obsolete and our revenue would decline as our customers purchase our competitors&#8217; products. Our failure to develop new products, applications or features could result from insufficient cash resources, high employee turnover, inability to hire personnel with sufficient technical skills, a lack of other research and development resources or other constraints. Our failure or inability to devote adequate research and development resources or compete effectively with the research and development programs of our current or future competitors could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We have limited data and experience regarding the safety and efficacy of our RxSight system. Results of earlier studies may not be predictive of future clinical trial results, and planned studies may not establish an adequate safety or efficacy profile for our RxSight system and other planned or future products, which would affect market acceptance of our RxSight system.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Because our RxSight system technology is a relatively new treatment to optimize vision after cataract surgery, we have performed clinical trials only with limited patient populations. The long-term effects of using our products in a large number of patients have not been studied and the results of short-term clinical use of such products do not necessarily predict long-term clinical benefits or reveal long-term adverse effects. The results of preclinical studies and clinical trials of our products conducted to date and ongoing or future studies and trials of our current, planned or future products may not be predictive of the results of later clinical trials, and interim results of a clinical trial do not necessarily predict final results. Our interpretation of data and results from our clinical trials do not ensure that we will achieve similar results in future clinical trials in other patient populations. In addition, preclinical and clinical data are often susceptible to various interpretations and analyses, and many companies that have believed their products performed satisfactorily in preclinical studies and earlier clinical trials have nonetheless failed to replicate results in later clinical trials and subsequently failed to obtain marketing approval. Products in later stages of clinical trials may fail to show the desired safety and efficacy despite having progressed through nonclinical studies and earlier clinical trials.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">44</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">If our clinical trials are unsuccessful or significantly delayed, or if we do not complete our clinical trials, our business may be harmed.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Clinical development is a long, expensive and uncertain process and is subject to delays and the risk that products may ultimately prove unsafe or ineffective in treating the indications for which they are designed. We are currently engaged in post-market clinical trials of our RxSight system. Completion of clinical trials may take several years or more. Clinical trials can be delayed for a variety of reasons, including delays in obtaining regulatory approval to commence a trial, in reaching an agreement on acceptable clinical trial terms with prospective sites, in obtaining institutional review board approval at each site, in recruiting patients to participate in a trial or in obtaining sufficient supplies of clinical trial materials. We cannot provide any assurance that we will successfully, or in a timely manner, enroll our clinical trials, that our clinical trials will meet their primary endpoints or that such trials or their results will be accepted by the FDA or foreign regulatory authorities.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We may experience numerous unforeseen events during, or because of, the clinical trial process that could delay or prevent us from receiving regulatory clearance or approval for new products, modifications of existing products, or new indications for existing products, including:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">successful and timely completion of nonclinical studies or clinical development of our products, as well as the associated costs, including any unforeseen costs we may incur as a result of clinical trial delays;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enrollment in our clinical trials may be slower than we anticipate, or we may experience high screen failure rates in our clinical trials, resulting in significant delays;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our clinical trials may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical and/or preclinical testing which may be expensive and time-consuming;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">trial results may not meet the level of statistical significance required by the FDA or other regulatory authorities;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the FDA or similar foreign regulatory authorities may find that one or more of our products is not sufficiently safe for investigational use in humans;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the FDA or similar foreign regulatory authorities may interpret data from preclinical testing and clinical trials in different ways than we do;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">there may be delays or failure in obtaining approval of our clinical trial protocols from the FDA or other regulatory authorities;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">there may be delays in obtaining institutional review board approvals or governmental approvals to conduct clinical trials at prospective sites;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the FDA or similar foreign regulatory authorities may find our or our suppliers&#8217; manufacturing processes or facilities unsatisfactory;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the FDA or similar foreign regulatory authorities may change their review policies or adopt new regulations that may negatively affect or delay our ability to bring a product to market or receive approvals or clearances to treat new indications;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">we may have trouble in managing multiple clinical sites;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">we may have trouble finding patients to enroll in our trials;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">we may experience delays in agreeing on acceptable terms with third-party research organizations and trial sites that may help us conduct the clinical trials; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">we, or regulators, may suspend or terminate our clinical trials because the participating patients are being exposed to unacceptable health risks.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Failures or perceived failures in our clinical trials will delay and may prevent our product development and regulatory approval process, damage our business prospects and negatively affect our reputation and competitive position.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Unauthorized third parties may seek to access our devices or other products and services, or related devices, products, and services, and modify or use them in a way inconsistent with our FDA clearances and approvals, which may create risks to users.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Medical devices are increasingly connected to the internet, hospital networks, and other medical devices to provide features that improve healthcare and increase the ability of healthcare providers to treat patients and patients to manage their conditions. While currently bidirectional connectivity and interoperability of our RxSight system with other devices, local networks and the internet is not enabled, this may change in the future. Enablement of such features may increase cybersecurity risks and the risks of unauthorized access and use by third parties. For example, unauthorized third parties may seek to access our devices or other products and services, or related devices, products, and services, and modify or use them in a way inconsistent with our FDA clearances and approvals, which may create risks to users and potential exposure to the company.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We may experience a significant disruption in our information technology systems or breaches of data security.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We rely upon the capacity, reliability and security of our information technology infrastructure and our ability to expand and continually update this infrastructure in response to our business needs. In some cases, we rely upon third-party hosting and support services to meet these needs. The internet has experienced increasingly sophisticated and damaging threats in the form of phishing emails, malware, malicious websites, ransomware, exploitation of application vulnerabilities, and nation-state attacks. It is also becoming more common for these attacks to leverage previously unknown vulnerabilities. The growing and evolving cyber-risk environment means that individuals, companies, and organizations of all sizes, including ourselves, our customers, suppliers and our hosting and support partners, are increasingly vulnerable to attacks and disruptions on their networks and systems by a wide range of actors on an ongoing and regular basis.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For example, as previously disclosed, on May 2, 2024, an unauthorized actor targeted the personal cell phone number of an RxSight employee. On May 3, 2024, the unauthorized actor obtained unauthorized access to the employee&#8217;s cloud-based work account and to e-mails and files that were accessible from that account. We discovered the incident on the same day, May 3, 2024, promptly disabled the employee&#8217;s account, initiated response and investigation procedures, contacted our insurance provider, and retained external cybersecurity experts to assist in our response and investigation.  While the unauthorized actor accessed and acquired copies of e-mail messages and other materials that were accessible from the employee&#8217;s cloud-based work account, our information systems were never interrupted and remained operational during this unauthorized access, and we have not observed any aspect of this incident will have a material impact on our operations, financial systems, or financial condition. However, there can be no assurance as to whether the incident will have a future material impact on our operations, financial systems, or financial condition and we remain subject to various risks due to the incident.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We maintain information security tools and technologies, staff, policies and procedures for managing risk to our networks and information systems, and conduct employee training on cybersecurity designed to mitigate persistent and continuously evolving cybersecurity threats. Our network security controls are comprised of administrative, physical and technical controls, which include, but are not limited to, the implementation of firewalls, anti-virus protection, patches, log monitors, routine backups, off-site storage, network audits and other routine updates and modifications. We also routinely monitor and develop our internal information technology systems to address risks to our information systems. Any system failure, accident or security breach could result in disruptions to our business processes, network degradation, and system down time, along with the potential that a third-party will gain unauthorized access to, or acquire intellectual property, proprietary business information, and data related to our employees, customers, suppliers, and business partners, including personal data. To the extent that any disruption, degradation, downtime or other security event results in a loss or damage to our data or systems, or in inappropriate disclosure of confidential or personal data, it could adversely impact us and our customers, potentially resulting in, among other things, financial losses, loss of customers or business, our inability to transact business, adverse impact on our reputation, violations of applicable privacy, data protection, security and other laws, regulatory fines, penalties, litigation, reputational damage, reimbursement, or additional compliance and regulatory costs. We may also incur additional costs related to cybersecurity risk management and remediation. There can be no assurance that we or our service providers, if applicable, will not suffer losses relating to cyber-attacks or security breaches or incidents in the future or that our insurance coverage will be adequate to cover all the costs resulting from such events. No assurances can be given that our efforts to reduce the risk of such attacks or to detect attacks that occur will be successful and our failure to do so could have a material adverse effect on our business, financial condition and results of operations.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We may expend our limited resources to pursue a particular product or indication and fail to capitalize on products or indications that may be more profitable or for which there is a greater likelihood of success.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Because we have limited financial and managerial resources, we focus on specific products and indications. As a result, we may forgo or delay pursuit of other opportunities with others that could have had greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs for specific indications or enhancements may not yield any commercially viable products. If we do not accurately evaluate the commercial potential or target market for a particular potential product, we may relinquish valuable rights to that potential product through future collaborations, licenses and other similar arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such potential product.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We may not be able to develop, license or acquire new products, enhance the capabilities of our existing products to keep pace with rapidly changing technology and customer requirements or successfully manage the transition to new product offerings, any of which could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our success depends on our ability to develop, license or acquire and commercialize additional products and to develop new applications for our technologies in existing and new markets, while improving the performance and cost-effectiveness of our existing products, in each case in ways that address current and anticipated customer requirements. We intend to develop and commercialize additional products through our research and development program and by licensing or acquiring additional products and technologies from third parties. Our success is dependent upon several factors, including functionality, competitive pricing, ease of use, the safety and efficacy of our products and our ability to identify, select and acquire the rights to products and technologies on terms that are acceptable to us.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The medical device industry is characterized by rapid technological change and innovation. New technologies, techniques or products could emerge that might offer better combinations of price and performance or better address customer requirements as compared to our current or future products. Competitors, who may have greater financial, marketing and sales resources than we do, may be able to respond more quickly and effectively than we can to new or changing opportunities, technologies, standards or customer requirements. Any new product we identify for internal development, licensing or acquisition may require additional development efforts prior to commercial sale, including extensive clinical testing and approval or clearance by the FDA and applicable foreign regulatory authorities. Due to the significant lead time and complexity involved in bringing a new product to market, we are required to make a number of assumptions and estimates regarding the commercial feasibility of a new product. These assumptions and estimates may prove incorrect, resulting in our introduction of a product that is not competitive at the time of launch. We anticipate that we will face increased competition in the future as existing companies and competitors develop new or improved products and as new companies enter the market with new technologies. Our ability to mitigate downward pressure on our selling prices will be dependent upon our ability to maintain or increase the value we offer to doctors as well as payors. All new products are prone to the risks of failure inherent in medical device product development, including the possibility that the product will not be shown to be sufficiently safe and effective for approval or clearance by regulatory authorities. In addition, we cannot assure you that any such products that are approved or cleared will be manufactured or produced economically, successfully commercialized or widely accepted in the marketplace. The expenses or losses associated with unsuccessful product development or launch activities, or a lack of market acceptance of our new products, could adversely affect our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our ability to attract new customer accounts depends in large part on our ability to enhance and improve our existing products and to introduce compelling new products. The success of any enhancement to our products depends on several factors, including adoption and continued use by doctors, competitive pricing and overall market acceptance. Any new product that we develop may not be introduced in a timely or cost-effective manner, may contain defects or may not achieve the market acceptance necessary to generate significant revenue. If we are unable to successfully develop, license or acquire new products, enhance our existing products to meet customer requirements or otherwise gain market acceptance, our business, financial condition and results of operations would be harmed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The typical development cycle of new medical device products can be lengthy and complicated and may require complex technology and engineering. Such developments may involve external suppliers and service providers,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">making the management of development projects complex and subject to risks and uncertainties regarding timing, timely delivery of required components or services and satisfactory technical performance of such components or assembled products. If we do not achieve the required technical specifications or successfully manage new product development processes, or if development work is not performed according to schedule, then such new technologies or products may be adversely impacted, and our business and operating results may be harmed.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we fail to identify, acquire and develop other products, we may be unable to grow our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As a significant part of our growth strategy, we intend to develop and commercialize additional products through our research and development program or by licensing or acquiring additional products and technologies from third parties. The success of this strategy depends upon our ability to identify, select and acquire the right to products and technologies on terms that are acceptable to us.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Any product we identify, license or acquire may require additional development efforts prior to commercial sale, including extensive clinical testing and approval or clearance by the FDA and applicable foreign regulatory authorities. All products are prone to the risks of failure inherent in medical device product development, including the possibility that the product will not be shown to be sufficiently safe and effective for approval or clearance by regulatory authorities. In addition, we cannot assure you that any such products that are approved or cleared will be manufactured or produced economically, successfully commercialized or widely accepted in the marketplace.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Proposing, negotiating and implementing an economically viable product or technology acquisition or license is a lengthy and complex process. Other companies, including those with substantially greater financial, marketing and sales resources, may compete with us for the acquisition or license of approved or cleared products. We may not be able to acquire or license the rights to additional approved or cleared products on terms that we find acceptable, or at all.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we are unable to develop suitable potential products through internal research programs or by obtaining rights from third parties, it could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We may acquire other companies or technologies, which could fail to result in a commercial product or increased revenue, divert our management&#8217;s attention, result in additional dilution to our stockholders and otherwise disrupt our operations and harm our operating results.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Although we currently have no agreements or commitments to complete any such transactions, we may in the future seek to acquire or invest in businesses, applications or technologies that we believe could complement or expand our portfolio, enhance our technical capabilities or otherwise offer growth opportunities. However, we cannot assure you that we would be able to successfully complete any acquisition we choose to pursue, or that we would be able to successfully integrate any acquired business, product or technology in a cost-effective and non-disruptive manner. The pursuit of potential acquisitions may divert the attention of management and cause us to incur various costs and expenses in identifying, investigating and pursuing suitable acquisitions, whether or not they are consummated. We may not be able to identify desirable acquisition targets or be successful in entering into an agreement with any particular target or obtain the expected benefits of any acquisition or investment.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To date, the growth of our operations has been largely organic, and we have limited experience in acquiring other businesses or technologies. We may not be able to successfully integrate any acquired personnel, operations and technologies, or effectively manage the combined business following an acquisition. Acquisitions could also result in dilutive issuances of equity securities, the use of our available cash, or the incurrence of debt, which could harm our operating results. In addition, if an acquired business fails to meet our expectations, our operating results, business and financial condition may suffer.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Coverage and adequate reimbursement and/or the ability of patients to pay for the difference between the price charged by practices and the reimbursement amount may not be available for our products in sufficient markets, which could diminish our sales or affect our ability to sell our products.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In both U.S. and non-U.S. markets, our ability to successfully commercialize and achieve market acceptance of our products depends, in significant part, on the availability of adequate financial remuneration to doctor practices and surgical centers. This remuneration can come from a combination of sources, including third-party payors, such as Medicare and Medicaid programs in the United States, managed care organizations and private health insurers. Third-party payors decide which treatments they will cover and establish reimbursement rates for those treatments. They also can preclude patients from paying extra to receive additional services, such as those associated with</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">48</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">placement of premium IOLs. Our products are purchased by doctors who will then seek reimbursement from third-party payors and patients for the procedures performed using our products. Reimbursement systems and patient billing rules in international markets vary significantly by country and by region within some countries, and reimbursement and/or non-reimbursement approvals must be obtained on a country-by-country basis. In certain international markets, a product must be approved for reimbursement before it can be approved for sale in that country. Furthermore, many international markets have government-managed healthcare systems that control reimbursement for new devices and procedures, as well as the ability to charge patients directly for non-reimbursed devices and procedures. In most markets there are private insurance systems as well as government-managed systems.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">While third-party payors currently cover and provide reimbursement for a portion of the cost of the procedures performed using our currently cleared or approved products, we can give no assurance that these third-party payors will continue to provide coverage and adequate reimbursement or permit patient payment for the non-reimbursed portion sufficient to permit doctors to offer procedures using our products to patients requiring treatment. If sufficient coverage and reimbursement or flexibility to enable patient payment is not available for the procedures performed using our products, in either the United States or any international markets we enter, the demand for our products and our revenue will be adversely affected.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Furthermore, the overall amount of reimbursement available for products and procedures intended to treat cataract and refractive conditions of the eye could remain at current levels or decrease in the future. Failure by doctors to obtain and maintain coverage and adequate reimbursement as well as patient charges for the procedures performed using our products would materially adversely affect our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Third-party payors are also increasingly examining the cost effectiveness of products, in addition to their safety and efficacy, when making coverage and payment decisions. Third-party payors have also instituted initiatives to limit the growth of healthcare costs using, for example, price regulation or controls and competitive pricing programs. Some third-party payors also require demonstrated superiority, on the basis of randomized clinical trials, or pre-approval of coverage, for new or innovative devices or procedures before they will reimburse healthcare providers who use such devices or procedures. Additionally, no uniform policy for coverage and reimbursement exists in the United States, and coverage and reimbursement can differ significantly from payor to payor. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement rates, but also have their own methods and approval process apart from Medicare determinations. It is uncertain whether our current products or any planned or future products will be viewed (or continue to be viewed) as sufficiently cost effective to warrant coverage and adequate reimbursement levels for procedures using such products in any given jurisdiction.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">If product liability lawsuits are brought against us, we may incur substantial liabilities and may be required to limit or halt the marketing and sale of our products. The expense and potential unavailability of insurance coverage for liabilities resulting from our products could harm us and our ability to sell our products.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We face an inherent risk of product liability as a result of the marketing and sale of our products. For example, we may be sued if our products cause or are perceived to cause injury or are found to be otherwise unsuitable during manufacturing, marketing or sale. Any such product liability claim may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability or a breach of warranties. In addition, we may be subject to claims against us even if the apparent injury is due to the actions of others or the pre-existing health of the patient. For example, we rely on doctors in connection with the use of our products on patients. If these doctors are not properly trained or are negligent, the capabilities of our products may be diminished, or the patient may suffer critical injury. We may also be subject to claims that are caused by the activities of our suppliers, such as those who provide us with components and sub-assemblies.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit or halt commercialization of our products. Even successful defense would require significant financial and management resources. Regardless of the merits or eventual outcome, liability claims may result in:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">decreased demand for our products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">injury to our reputation;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">initiation of investigations by regulators;</span></div></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">49</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">costs to defend the related litigation;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a diversion of management&#8217;s time and our resources;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">substantial monetary awards to trial participants or patients;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">product recalls, withdrawals or labeling, marketing or promotional restrictions;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">loss of revenue;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">exhaustion of any available insurance and our capital resources; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the inability to market and sell our products.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We believe we have adequate product liability insurance, but it may not prove to be adequate to cover all liabilities that we may incur. Insurance coverage is increasingly expensive. We may not be able to maintain or obtain insurance at a reasonable cost or in an amount adequate to satisfy any liability that may arise. Our insurance policy contains various exclusions, and we may be subject to a product liability claim for which we have no coverage. The potential inability to obtain sufficient product liability insurance at an acceptable cost to protect against product liability claims could prevent or inhibit the marketing and sale of products we develop. We may have to pay any amounts awarded by a court or negotiated in a settlement that exceed our coverage limitations or that are not covered by our insurance, and we may not have, or be able to obtain, sufficient capital to pay such amounts, which would have a material adverse effect on our business, financial condition and results of operations. In addition, any product liability claims brought against us, with or without merit, could increase our product liability insurance rates or prevent us from securing continuing coverage, harm our reputation in the industry, significantly increase our expenses and reduce product sales.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Some of our customers and prospective customers may also have difficulty in procuring or maintaining liability insurance to cover their operations and use of our products. Medical malpractice carriers are withdrawing coverage in certain states or substantially increasing premiums. If this trend continues or worsens, our customers may discontinue using our products and potential customers may opt against purchasing our products due to the cost or inability to procure insurance coverage.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We intend to expand sales of our products internationally in the future, but we may experience difficulties in obtaining regulatory clearance or approval or in successfully marketing our products internationally even if approved. A variety of risks associated with marketing our products internationally could materially adversely affect our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Sales of our products outside of the United States would be subject to foreign regulatory requirements governing clinical trials and marketing approval. We will incur substantial expenses in connection with our international expansion. Additional risks related to operating in foreign countries include:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">differing regulatory requirements and reimbursement regimes in foreign countries, including changes to regulatory requirements and implementation of new regulations in foreign countries;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">difficulties in compliance with non-U.S. laws and regulations;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">unexpected changes in tariffs, trade barriers, price and exchange controls and other regulatory requirements;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">trade protection measures, import or export licensing requirements, or other restrictive actions by U.S. or non-U.S. governments;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">economic weakness, including inflation, or political instability in particular foreign economies and markets;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">foreign taxes, including withholding of payroll taxes;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business in another country;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">difficulties staffing and managing foreign operations;</span></div></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">workforce uncertainty in countries where labor unrest is more common than in the United States;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">potential liability under the FCPA or comparable foreign regulations;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">challenges enforcing our contractual and intellectual property rights, especially in those foreign countries that do not respect and protect intellectual property rights to the same extent as the United States;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">business interruptions resulting from geo-political actions, including war and terrorism.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">These and other risks associated with international operations may materially adversely affect our ability to attain or maintain profitable operations in international markets, which would have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Further, our products may be subject to U.S. and foreign export controls, trade sanctions and import laws and regulations. Governmental regulation of the import or export of our products, or our failure to obtain any required import or export authorization for our products, where applicable, could harm our international sales and adversely affect our revenue. Compliance with applicable regulatory requirements regarding the export of our products may create delays in the introduction of our products in international markets or, in some cases, prevent the export of our products to some countries altogether. Furthermore, U.S. export control laws and economic sanctions prohibit the shipment of certain products and services to countries, governments, and persons targeted by U.S. sanctions. If we fail to comply with export and import regulations and such economic sanctions, penalties could be imposed, including fines and/or denial of certain export privileges. Moreover, any new export or import restrictions, new legislation or shifting approaches in the enforcement or scope of existing regulations, or in the countries, persons, or products targeted by such regulations, could result in decreased use of our products by, or in our decreased ability to export our products to, existing or potential customers with international operations. Any decreased use of our products or limitation on our ability to export or sell our products would likely adversely affect our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In particular, there is currently significant uncertainty about the future relationship between the United States and various other countries, most significantly China, with respect to trade policies, treaties, tariffs, taxes, and other limitations on cross-border operations. The U.S. government has made and continues to make significant additional changes in U.S. trade policy and may continue to take future actions that could negatively impact U.S. trade.  For example, legislation has been introduced in Congress to limit certain U.S. biotechnology companies from using equipment or services produced or provided by select Chinese biotechnology companies, and others in Congress have advocated for the use of existing executive branch authorities to limit those Chinese service providers&#8217; ability to engage in business in the U.S. We cannot predict what actions may ultimately be taken with respect to trade relations between the United States and China or other countries, what products and services may be subject to such actions or what actions may be taken by the other countries in retaliation. If we are unable to obtain or use services from existing service providers or become unable to export or sell our products to any of our customers or service providers, our business, liquidity, financial condition, and/or results of operations would be materially and adversely affected.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, there can be no guarantee that we will receive approval to sell our products in the international markets we target, nor can there be any guarantee that any sales would result even if such approval is received. Even if the FDA grants marketing approval for a product, comparable regulatory authorities of foreign countries must also approve the manufacturing or marketing of the product in those countries. Approval in the United States, or in any other jurisdiction, does not ensure approval in other jurisdictions. Obtaining foreign approvals could result in significant delays, difficulties and costs for us and require additional trials and additional expenses. Regulatory requirements can vary widely from country to country and could delay the introduction of our products in those countries. Clinical trials conducted in one country may not be accepted by other countries, and regulatory approval in one country does not mean that regulatory approval will be obtained in any other country. If we fail to comply with these regulatory requirements or to obtain and maintain required approvals, our target market will be reduced and our ability to generate revenue will be diminished. Our inability to successfully enter all our desired international markets and manage business on a global scale could negatively affect our business, financial results and results of operations.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">51</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We may not be able to achieve or maintain satisfactory pricing and margins for our products.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Manufacturers of medical devices have a history of price competition, and we can give no assurance that we will be able to achieve satisfactory prices for our products or maintain prices at the levels we have historically achieved. Any decline in the amount that payors reimburse doctors performing cataract procedures, or any reduction in the flexibility to charge patients for non-reimbursed procedures could make it difficult for us to convince our customers to make the up-front investment in our LDD and could create additional pricing pressure with respect to the patient&#8217;s decision to pay the additional cost associated with our LALs and potentially a reduction in the number of procedures performed using the RxSight system and corresponding sales of LDDs, LALs, accessories and services. If we are forced to lower the price we charge for our products, our revenue and gross margins will decrease, which will adversely affect our ability to invest in and grow our business. If we are unable to maintain our prices, or if our costs increase and we are unable to offset such increase with an increase in our prices, our margins could erode. We will continue to be subject to significant pricing pressure, which could harm our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">The sizes of the markets for our current and future products have not been established with precision and may be smaller than we estimate.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our estimates of the annual total addressable markets for our current products and products under development are based on a number of internal and third-party estimates, including, without limitation, the number of patients who have undergone cataract surgery, and the assumed prices at which we can sell our RxSight system. While we believe our assumptions and the data underlying our estimates are reasonable, these assumptions and estimates may not be correct and the conditions supporting our assumptions or estimates may change at any time, thereby reducing the predictive accuracy of these underlying factors. In addition, our estimates of the sizes of the cataract surgery patient population include patients who might never be likely candidates for treatment with our products. As a result, our estimates of the annual total addressable market for our current or future products may prove to be incorrect. If the actual number of patients who would benefit from our products, the price at which we can sell future products, or the annual total addressable market for our products is smaller than we have estimated, it may impair our sales growth and have an adverse impact on our business.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">To the extent changes to state regulations and interpretation of the practice of optometry, changes to insurance coverage and government reimbursement rates for our products and related procedures and/or changes in medical or professional malpractice insurance coverage for doctors who perform procedures using our products are implemented, such changes could affect the adoption of our products and our future revenue.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">States regulate the practice of optometry, including the types of procedures optometrists are authorized to perform in each state.  To the extent states change the scope of optometry with respect to those who are qualified to perform LDD procedures involving our RxSight system, such state regulation or policy can have a material impact on our business. Additionally, payor restrictions on the coverage and/or reimbursement levels for procedures using our RxSight system can negatively impact our business. Changes to medical or professional malpractice insurance coverage policies for doctors who perform procedures using our products, can also impact the adoption of our products and our business operations. We can provide no assurance on the impact of current and future federal and state legislative, executive, and administrative actions, including measures implemented by state boards of examiners in optometry, as well as policies of malpractice insurance carriers and payors on us, our business operations, and the business of our customers. The implementation of cost containment measures or other policy and regulatory changes may prevent us from being able to generate revenue, attain profitability, or commercialize our products.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The federal government is considering ways to change, and has changed, the manner in which healthcare services are paid for in the United States. Individual states may also enact legislation that impacts Medicaid payments to doctors. In addition, CMS establishes Medicare payment levels for doctors on an annual basis, which can increase or decrease payment to such entities. Internationally, medical reimbursement systems vary significantly from country to country, with some countries limiting medical centers&#8217; spending through fixed budgets, regardless of levels of patient treatment, and other countries requiring application for, and approval of, government or third-party reimbursement. In addition, the ability to charge patients directly for premium IOLs and associated services also varies widely across different countries and could become more restricted. Even if we succeed in bringing our products to market internationally, uncertainties regarding future healthcare policy, legislation and regulation, as well as private market practices, could affect our ability to sell our products in commercially acceptable quantities at acceptable prices.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our quarterly and annual results may fluctuate significantly and may not fully reflect the underlying performance of our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our quarterly and annual results of operations, including our revenue, profitability and cash flow, may vary significantly in the future, and period-to-period comparisons of our operating results may not be meaningful. Accordingly, the results of any one quarter or period should not be relied upon as an indication of future performance. Our quarterly and annual financial results may fluctuate as a result of a variety of factors, many of which are outside our control and, as a result, may not fully reflect the underlying performance of our business. Fluctuations in quarterly and annual results may decrease the value of our common stock. Because our quarterly results may fluctuate, period-to-period comparisons may not be the best indication of the underlying results of our business and should only be relied upon as one factor in determining how our business is performing.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We have expanded, and expect to continue to expand, our organization, including expanding our sales and marketing capability and creating additional infrastructure to support our operations as a public company, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have and expect to experience significant growth in the number of our employees and the scope of our operations, particularly in the areas of sales and marketing and finance and accounting. To manage our anticipated future growth, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities and continue to recruit and train additional qualified personnel. Due to our limited financial resources and our limited experience in managing such anticipated growth, we may not be able to effectively manage the expansion of our operations or recruit and train additional qualified personnel. The expansion of our operations may lead to significant costs and may divert or stretch our management and business development resources in a way that we may not anticipate. Any inability to manage growth could delay the execution of our business plans or disrupt our operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Certain of our operating results and financial metrics may be difficult to predict as a result of seasonality.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">It is not uncommon in our industry to experience seasonally weaker revenue during the summer months and end-of-year holiday season. We may be affected by other seasonal trends in the future, including severe weather (which can impact the number of elective procedures performed), particularly as our business matures. Additionally, this seasonality may be reflected to a much lesser extent, and sometimes may not be immediately apparent, in our revenue. To the extent we experience this seasonality, it may cause fluctuations in our operating results and financial metrics and make forecasting our future operating results and financial metrics more difficult.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our ability to use our net operating loss carryforwards and certain other tax attributes to offset future taxable income may be subject to certain limitations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of December 31, 2023, we had federal net operating loss carryforwards (&#8220;NOLs&#8221;) of approximately $311.2 million, some of which will begin to expire in various years ranging from 2024 to 2037. Our NOLs could expire unused and be unavailable to offset future income tax liabilities because of their limited duration or because of restrictions under U.S. tax law. Under the Tax Cuts and Jobs Act (&#8220;Tax Act&#8221;), as modified by the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, our federal NOLs generated in tax years ending after December 31, 2017 may be carried forward indefinitely, but the deductibility of such federal NOLs in tax years beginning after December 31, 2020 is limited to 80% of taxable income. It is uncertain if and to what extent various states will conform to the Tax Act, as modified by the CARES Act.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), if a corporation undergoes an &#8220;ownership change&#8221; (generally defined as a cumulative change in our ownership by &#8220;5-percent shareholders&#8221; that exceeds 50 percentage points over a rolling three-year period), the corporation&#8217;s ability to use its pre-change NOLs and certain other pre-change tax attributes to offset its post-change income and taxes may be limited. Similar rules may apply under state tax laws. We may have experienced such ownership changes in the past, and we may experience an ownership change in the future as a result of subsequent shifts in our stock ownership, some of which are outside our control. We have not conducted any studies to determine annual limitations, if any, that could result from such changes in our stock ownership. Our ability to utilize those NOLs and certain other tax attributes could be limited by an &#8220;ownership change&#8221; as described above and consequently, we may not be able to utilize a material portion of our NOLs and certain other tax attributes, which could have a material adverse effect on our cash flows and results of operations.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">53</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks related to intellectual property</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">If we are unable to obtain, maintain, protect and enforce patent and other intellectual property protection for our technology and products, or if the scope of the patent and other intellectual property protection obtained is not sufficiently broad, we may not be able to compete effectively in our markets.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our success depends in large part on our ability to obtain, maintain, protect and enforce patent and other intellectual property protection in the United States and other countries with respect to our products and technology we develop. If we fail to obtain, maintain, protect and enforce our intellectual property, third parties may be able to compete more effectively against us, we may lose our technological or competitive advantage, or we may incur substantial litigation costs in our attempts to recover or restrict use of our intellectual property.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We seek to protect our position by in-licensing intellectual property relating to our products and filing patent applications in the United States and abroad related to our technologies and products that are important to our business. We also rely on a combination of contractual provisions, confidentiality procedures and copyright, trademark, trade secret and other intellectual property rights to protect the proprietary aspects of our brands, products, technologies and data. These legal measures afford only limited protection, and competitors or others may gain access to or use our intellectual property and proprietary information. Our success will depend, in part, on obtaining and maintaining patents, copyrights, trademarks, trade secrets, data and know-how and other intellectual property rights.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We may not be able to obtain and maintain intellectual property or other proprietary rights necessary to our business or in a form that provides us with a competitive advantage. For example, our trade secrets, data and know-how could be subject to unauthorized use, misappropriation or disclosure to unauthorized parties, despite our efforts to enter into confidentiality agreements with our employees, consultants, contractors, clients and other vendors who have access to such information, and could otherwise become known or be independently discovered by third parties. In addition, the patent prosecution process is expensive, time-consuming and complex, and we may not be able to file, prosecute, maintain, enforce or license all necessary or desirable patent applications at a reasonable cost, in a timely manner, or in all jurisdictions where protection may be commercially advantageous, or we may not be able to protect our intellectual property at all. Despite our efforts to protect our intellectual property, unauthorized parties may be able to obtain and use information that we regard as proprietary.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability and our owned and in-licensed issued patents may be challenged in courts or patent offices in the United States and abroad. For example, we may be subject to a third-party submission of prior art to the USPTO, challenging the validity of one or more claims of our owned or in-licensed issued patents. Such submissions may also be made prior to a patent&#8217;s issuance, precluding the granting of a patent based on one of our owned or in-licensed pending patent applications.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">It is also possible that we will fail to identify patentable aspects of our research and development output in time to obtain patent protection. Although we enter into non-disclosure and confidentiality agreements with parties who have access to confidential or patentable aspects of our research and development output, such as our employees, consultants, contractors, collaborators, vendors and other third parties, any of these parties may breach the agreements and disclose such output before a patent application is filed, thereby jeopardizing our ability to seek patent protection. We may not be able to obtain or maintain patent applications and issued patents due to the subject matter claimed in such patent applications and issued patents being in disclosures in the public domain, and we may not be able to prevent any third party from using any of our technology that is in the public domain to compete with our technologies. In addition, publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, or in some cases not at all. Therefore, we cannot be certain that we were the first to make the inventions claimed in our owned or in-licensed issued patents or pending patent applications, or that we were the first to file for patent protection of such inventions. If a third party can establish that we or our licensors were not the first to make or the first to file for patent protection of such inventions, our owned or in-licensed patent applications may not issue as patents and even if issued, may be challenged and invalidated or rendered unenforceable.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The patent position of medical device companies generally is highly uncertain, involves complex legal and factual questions, and has been the subject of much litigation in recent years. Changes in either the patent laws or their interpretation in the United States and other countries may diminish our ability to protect our inventions, obtain, maintain, and enforce our intellectual property rights and, more generally, could affect the value of our intellectual property or narrow the scope of our owned and in-licensed patents. With respect to both in-licensed and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">owned intellectual property, we cannot predict whether the patent applications we and our licensors are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient protection from competitors. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Moreover, the coverage claimed in a patent application can be significantly reduced before a patent is issued, and its scope can be reinterpreted after issuance. Even if patent applications we license or own currently or in the future issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors or other third parties from competing with us, or otherwise provide us with any competitive advantage. Any patents that we hold or in-license may be challenged, narrowed or invalidated by third parties. Additionally, our competitors or other third parties may be able to circumvent our patents by developing similar or alternative technologies or products in a non-infringing manner. Third parties may also have blocking patents that could prevent us from marketing our own products and practicing our own technology. Alternatively, third parties may seek approval to market their own products similar to or otherwise compete with our products. In these circumstances, we may need to defend and/or assert our patents, including by filing lawsuits alleging patent infringement. In any of these types of proceedings, a court or agency with jurisdiction may find our patents invalid, unenforceable or not infringed, in which case, our competitors and other third parties may then be able to market products and use manufacturing and analytical processes that are substantially similar to ours. Even if we have valid and enforceable patents, these patents still may not provide protection against competing products or processes sufficient to achieve our business objectives.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Given that patent applications are confidential for a period of time after filing, we cannot be certain that we were the first to file any patent application related to our products. Competitors may also contest our patents, if issued, by showing the USPTO, or the applicable other foreign patent agency that the invention was not original, was not novel or was obvious. In litigation, a competitor could claim that our patents, if issued, are not valid for a number of reasons. If a court agrees, we would lose our rights to those challenged patents.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, given the amount of time required for the development, testing and regulatory review of new products, patents protecting such products might expire before or shortly after such products are commercialized. As a result, our intellectual property may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. Moreover, some of our owned and in-licensed patents and patent applications may in the future be co-owned with third parties. If we are unable to obtain an exclusive license to any such third-party co-owners&#8217; interest in such patents or patent applications, such co-owners may be able to license their rights to other third parties, including our competitors, and our competitors could market competing products and technology. In addition, we may need the cooperation of any such co-owners of our patents in order to enforce such patents against third parties, and such cooperation may not be provided to us.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our other intellectual property, including our trademarks, could also be challenged, invalidated, infringed and circumvented by third parties, and our trademarks could also be diluted, declared generic or found to be infringing on other marks, in which case we could be forced to re-brand our products, resulting in loss of brand recognition and requiring us to devote resources to advertising and marketing new brands, and suffer other competitive harm. Third parties may also adopt trademarks similar to ours, which could harm our brand identity and lead to market confusion.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We may in the future also be subject to claims by our former employees, consultants or contractors asserting an ownership right in our patents or patent applications, as a result of the work they performed on our behalf. Although we generally require all of our employees, consultants, contractors and any other partners or collaborators who have access to our proprietary know-how, information or technology to assign or grant similar rights to their inventions to us, we cannot be certain that we have executed such agreements with all parties who may have contributed to our intellectual property, nor can we be certain that our agreements with such parties will be upheld in the face of a potential challenge, or that they will not be breached, for which we may not have an adequate remedy.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Failure to obtain and maintain patents, trademarks and other intellectual property rights necessary to our business and failure to protect, monitor and control the use of our intellectual property rights could negatively impact our ability to compete and cause us to incur significant expenses. The intellectual property laws and other statutory and contractual arrangements in the United States and other jurisdictions we depend upon may not provide sufficient protection in the future to prevent the infringement, use, violation or misappropriation of our patents, trademarks, data, technology and other intellectual property, and may not provide an adequate remedy if our intellectual property rights are infringed, misappropriated or otherwise violated. Any of the foregoing could have a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">55</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">material adverse effect on our competitive position, business, financial conditions, results of operations and prospects.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Furthermore, our owned and in-licensed patents may be subject to a reservation of rights by one or more third parties. For example, this could arise if the research resulting in certain of our owned or in-licensed patent rights and technology was funded in part by the United States government. As a result, the government may have certain rights, or march-in rights, to such patent rights and technology. When new technologies are developed with government funding, the government generally obtains certain rights in any resulting patents, including a non-exclusive license authorizing the government to use the invention for non-commercial purposes. These rights may permit the government to disclose our confidential information to third parties and to exercise march-in rights to use or allow third parties to use our licensed technology. The government can exercise its march-in rights if it determines that action is necessary because we fail to achieve practical application of the government-funded technology, because action is necessary to alleviate health or safety needs, to meet requirements of federal regulations, or to give preference to United States industry. In addition, our rights in such inventions may be subject to certain requirements to manufacture products embodying such inventions in the United States. Recently, the government released a draft framework that may be used by an agency when deciding to exercise its march-in rights for public comments, and as such, the framework for deciding when march-in rights are exercised may change.  Any exercise by the government of such rights could harm our competitive position, business, financial condition, results of operations and prospects.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Moreover, a portion of our intellectual property has been acquired from one or more third parties. While we have conducted diligence with respect to such acquisitions, because we did not participate in the development or prosecution of much of the acquired intellectual property, we cannot guarantee that our diligence efforts identified and/or remedied all issues related to such intellectual property, including potential ownership errors, potential errors during prosecution of such intellectual property, and potential encumbrances that could limit our ability to enforce such intellectual property rights.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Patent terms may be inadequate to protect our competitive position on technology for an adequate amount of time.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest claimed U.S. non-provisional or Patent Cooperation Treaty application filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our products are obtained, once the patent life has expired for a product, we may be open to competition. Given the amount of time required for the development, testing and regulatory review of new products, patents protecting such products might expire before or shortly after such products are commercialized. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours for a meaningful amount of time, or at all.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment, and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for noncompliance with these requirements.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Periodic maintenance fees, renewal fees, annuity fees and various other government fees on any issued patents and patent applications are due to be paid to the USPTO and other foreign patent agencies in several stages over the lifetime of such issued patents and patent applications. The USPTO and various foreign national or international patent agencies require compliance with a number of procedural, documentary, fee payment, and other similar provisions during the patent application process. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Noncompliance events that could result in abandonment or lapse of patent rights include, but are not limited to, failure to timely file national and regional stage patent applications based on our international patent application, failure to respond to official actions within prescribed time limits, non-payment of fees, and failure to properly legalize and submit formal documents. We are dependent on our licensors to take the necessary action to comply with these requirements with respect to certain of our in-licensed intellectual property, and if we or any of our current or future licensors fail to maintain the patents and patent applications covering our RxSight system or any future products, our competitors may be able to enter the market, which would have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">56</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We may not identify relevant third-party patents or may incorrectly interpret the relevance, scope or expiration of a third-party patent, which might adversely affect our ability to develop and market our products.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We cannot guarantee that any of our patent searches or analyses, including the identification of relevant patents, the scope of patent claims or the expiration of relevant patents, are complete or thorough, nor can we be certain that we have identified each and every third-party patent and pending application in the United States and abroad that is relevant to or necessary for the commercialization of our current and future products in any jurisdiction.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent&#8217;s prosecution history. Our interpretation of the relevance or the scope of a patent or a pending application may be incorrect, which may negatively impact our ability to market our products. We may incorrectly determine that our products are not covered by a third-party patent or may incorrectly predict whether a third party&#8217;s pending application will issue with claims of relevant scope. Our determination of the expiration date of any patent in the United States or abroad that we consider relevant may be incorrect, and our failure to identify and correctly interpret relevant patents may negatively impact our ability to develop and market our products.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our future reliance on third parties may require us to share our trade secrets, which increases the possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Because we expect to rely on a third party to manufacture our RxSight system, and any future products, and we expect to collaborate with third parties on the continuing development of our RxSight system, and any future products, we must, at times, share trade secrets with them. We also expect to conduct R&amp;D programs that may require us to share trade secrets under the terms of our partnerships or agreements with CROs. We seek to protect our proprietary technology in part by entering into agreements containing confidentiality and use restrictions and obligations with our advisors, employees, contractors, CMOs, CROs, other service providers and consultants prior to disclosing proprietary information. These agreements typically limit the rights of the third parties to use or disclose our confidential information, including our trade secrets. Despite the contractual provisions employed when working with third parties, the need to share trade secrets and other confidential information increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. Given that our proprietary position is based, in part, on our know-how and trade secrets, a competitor&#8217;s discovery of our trade secrets or other unauthorized use or disclosure would impair our competitive position and may have an adverse effect on our business and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, these agreements typically restrict the ability of our advisors, employees, third-party contractors, CMOs, CROs, other service providers and consultants to publish data potentially relating to our trade secrets, although our agreements may contain certain limited publication rights. Despite our efforts to protect our trade secrets, our competitors may discover our trade secrets, either through breach of our agreements with third parties, independent development or publication of information by any of our third-party collaborators. A competitor&#8217;s discovery of our trade secrets would impair our competitive position and have an adverse impact on our business.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We may be subject to claims that we or our employees have misappropriated the intellectual property of a third party, including trade secrets or know-how, or are in breach of non-competition or non-solicitation agreements with our competitors and third parties may claim an ownership interest in intellectual property we regard as our own.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Many of our employees and consultants were previously employed at or engaged by other medical device, biotechnology or pharmaceutical companies, including our competitors or potential competitors. Some of these employees, consultants and contractors, may have executed proprietary rights, non-disclosure and non-competition agreements in connection with such previous employment. Although we try to ensure that our employees and consultants do not use the intellectual property, proprietary information, know-how or trade secrets of others in their work for us, we may be subject to claims that we or these individuals have, inadvertently or otherwise, misappropriated the intellectual property or disclosed the alleged trade secrets or other proprietary information, of these former employers or competitors. Litigation may be necessary to defend against these claims, and if we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights. In addition, we may lose personnel as a result of such claims. Any such litigation, or the threat thereof, may adversely affect our ability to hire employees or contract with independent contractors. A loss of key personnel or</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">57</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">their work product could hamper or prevent our ability to commercialize our products, which would have a material adverse effect on our business, results of operations, financial condition and prospects.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Additionally, we may be subject to claims from third parties challenging our ownership interest in intellectual property we regard as our own, based on claims that our employees or consultants have breached an obligation to assign inventions to another employer, to a former employer, or to another person or entity. Litigation may be necessary to defend against any other claims, and it may be necessary or we may desire to enter into a license to settle any such claim; however, there can be no assurance that we would be able to obtain a license on commercially reasonable terms, if at all. If our defense to those claims fails, in addition to paying monetary damages, a court could prohibit us from using technologies or features that are essential to our products, if such technologies or features are found to incorporate or be derived from the trade secrets or other proprietary information of the former employers.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, we or our licensors may in the future be subject to claims by former employees, consultants or other third parties asserting an ownership right in our owned or in-licensed issued patents or patent applications. An adverse determination in any such submission or proceeding may result in loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar technology and therapeutics, without payment to us, or could limit the duration of the patent protection covering our technology. Such challenges may also result in our inability to develop, manufacture or commercialize our technology without infringing third-party patent rights. In addition, if the breadth or strength of protection provided by our owned or in-licensed issued patents and patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future products. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">An inability to incorporate technologies or features that are important or essential to our products could have a material adverse effect on our business, financial condition and results of operations, and may prevent us from selling our products. In addition, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against these claims, litigation could result in substantial costs and could be a distraction to management. Any litigation or the threat thereof may adversely affect our ability to hire employees or contract with independent sales representatives. A loss of key personnel or their work product could hamper or prevent our ability to commercialize our products, which could have an adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We may become a party to intellectual property litigation or administrative proceedings that could be costly and could interfere with our ability to sell and market our products.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The medical device industry has been characterized by extensive litigation regarding patents, trademarks, trade secrets and other intellectual property rights, and companies in the industry have used intellectual property litigation to gain a competitive advantage. It is possible that U.S. and foreign patents and pending patent applications, copyrights, or trademarks controlled by third parties may be alleged to cover our products, or that we may be accused of misappropriating third parties&#8217; trade secrets. Additionally, our products include components that we purchase from vendors, and may include design components that are outside of our direct control. Our competitors, many of which have substantially greater resources and have made substantial investments in patent portfolios, trade secrets, copyrights, trademarks and competing technologies, may have applied for or obtained, or may in the future apply for or obtain, patents, copyrights, or trademarks that will prevent, limit or otherwise interfere with our ability to make, use, sell and/or export our products or to use product names. Because patent applications can take years to issue and are often afforded confidentiality for some period of time, there may currently be pending applications, unknown to us, that later result in issued patents that could cover one or more of our products. Moreover, in recent years, individuals and groups that are non-practicing entities, commonly referred to as &#8220;patent trolls,&#8221; have purchased patents and other intellectual property assets for the purpose of making claims of infringement in order to extract settlements. From time to time, we may receive threatening letters, notices or &#8220;invitations to license,&#8221; or may be the subject of claims that our products and business operations infringe or violate the intellectual property rights of others. We may face patent infringement claims from non-practicing entities that have no relevant product revenue and against whom our owned or in-licensed patent portfolio may therefore have no deterrent effect. We may in the future become party to adversarial proceedings or litigation where our competitors or other third parties may assert claims against us, alleging that our products or services infringe, misappropriate or otherwise violate their intellectual property rights, including patents and trade secrets. The defense of these matters can be time consuming, be costly, divert management&#8217;s attention and resources, damage our reputation and brand and cause us to incur</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">58</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">significant expenses or make substantial payments. Vendors from whom we purchase hardware or software may not indemnify us in the event that such hardware or software is accused of infringing a third party&#8217;s patent or trademark or of misappropriating a third party&#8217;s trade secret, or any indemnification granted by such vendors may not be sufficient to address any liability and costs we incur as a result of such claims. Additionally, we may be obligated to indemnify our customers or business partners in connection with litigation and to obtain licenses or refund subscription fees, which could further exhaust our resources.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Even if we believe a third party&#8217;s intellectual property claims are without merit, there is no assurance that a court would find in our favor, including on questions of infringement, validity, enforceability or priority of patents. The strength of our defenses will depend on the patents asserted, the interpretation of these patents, and our ability to invalidate the asserted patents. A court of competent jurisdiction could hold that these third-party patents are valid, enforceable and infringed, which could materially and adversely affect our ability to commercialize any products or technology we may develop, and any other products or technologies covered by the asserted third-party patents. In order to successfully challenge the validity of any such United States patent in federal court, we would need to overcome a presumption of validity. As this burden is a high one requiring us to present clear and convincing evidence as to the invalidity of any such United States patent claim, there is no assurance that a court of competent jurisdiction would invalidate the claims of any such United States patent. Conversely, the patent owner need only prove infringement by a preponderance of the evidence, which is a lower burden of proof.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Further, if patents, trademarks, copyrights, or trade secrets are successfully asserted against us, this may harm our business and result in injunctions preventing us from developing, manufacturing, marketing or selling our products, or result in obligations to pay license fees, damages, attorney fees and court costs, which could be significant. In addition, if we are found to willfully infringe third-party patents or trademarks or to have misappropriated trade secrets, we could be required to pay treble damages in addition to other penalties.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Although patent, copyright, trademark, trade secret and other intellectual property disputes in the medical device area have often been settled through licensing or similar arrangements, costs associated with such arrangements may be substantial and could include ongoing royalties. We may be unable to obtain necessary licenses on satisfactory terms, if at all. In addition, if any license we obtain is non-exclusive, we may not be able to prevent our competitors and other third parties from using the intellectual property or technology covered by such license to compete with us. If we do not obtain necessary licenses, we may not be able to redesign our products to avoid infringement. Any of these events could materially and adversely affect our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Similarly, interference or derivation proceedings provoked by third parties or brought by the USPTO, may be necessary to determine priority with respect to our patents, patent applications, trademarks or trademark applications. We may also become involved in other proceedings, such as reexamination, inter partes review, derivation or opposition proceedings before the USPTO or other jurisdictional body relating to our intellectual property rights or the intellectual property rights of others. Adverse determinations in a judicial or administrative proceeding or failure to obtain necessary licenses could prevent us from manufacturing our products or using product names, which would have a significant adverse impact on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Additionally, we may file lawsuits or initiate other proceedings to protect or enforce our patents or other intellectual property rights, which could be expensive, time consuming and unsuccessful. Competitors may infringe our issued patents or other intellectual property, which we may not always be able to detect. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. Any claims we assert against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their intellectual property or alleging that our intellectual property is invalid or unenforceable. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO, or made a misleading statement, during prosecution. Third parties may raise challenges to the validity of certain of our owned or in-licensed patent claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include re-examination, post-grant review, inter partes review, interference proceedings, derivation proceedings and equivalent proceedings in foreign jurisdictions (e.g., opposition proceedings). In any such</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">lawsuit or other proceedings, a court or other administrative body may decide that a patent of ours is invalid or unenforceable, in whole or in part, construe the patent&#8217;s claims narrowly or refuse to stop the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">59</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">other party from using the technology at issue on the grounds that our patents do not cover the technology in question.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The outcome following legal assertions of invalidity and unenforceability is unpredictable. If a third party were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on our products or products that we may develop. If our patents are found to be valid and infringed, a court may refuse to grant injunctive relief against the infringer and instead grant us monetary damages and/or ongoing royalties. Such monetary compensation may be insufficient to adequately offset the damage to our business caused by the infringer&#8217;s competition in the market. An adverse result in any litigation or other proceeding could put one or more of our patents at risk of being invalidated or interpreted narrowly. Any of these events could materially and adversely affect our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Even if resolved in our favor, litigation or other proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential or sensitive information could be compromised by disclosure in the event of litigation. Uncertainties resulting from the initiation and continuation of patent and other intellectual property litigation or other proceedings could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Because of the expense and uncertainty of litigation, we may not be in a position to enforce our intellectual property rights against third parties.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Because of the expense and uncertainty of litigation, we may conclude that even if a third party is infringing, misappropriating or otherwise violating our owned or in-licensed patents, any patents that may be issued as a result of our future patent applications, or other intellectual property rights, the risk-adjusted cost of bringing and enforcing such a claim or action may be too high or not in the best interest of our company or our shareholders. In such cases, we may decide that the more prudent course of action is to simply monitor the situation or initiate or seek some other non-litigious action or solution.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our rights to develop and commercialize our products are subject, in part, to the terms and conditions of licenses granted to us by others.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Although we do not currently rely upon any material licenses to any patent rights, proprietary technology, or other intellectual property from any third parties for the development of our products and technology, we may in the future rely, in part, upon licenses to certain patent rights, proprietary technology and other intellectual property from third parties that are important or necessary to the development of our products and technology, including future products and technology. Further development and commercialization of our current products, and development of any future products, may require us to enter into license or collaboration agreements. These and other licenses may not provide exclusive rights to use such intellectual property and technology in all relevant fields of use and in all territories in which we may wish to develop or commercialize our technology and products in the future. As a result, we may not be able to prevent competitors from developing and commercializing competitive products in territories included in all of our licenses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, and as such, in the future we may not have the right to control the preparation, filing, prosecution, maintenance, enforcement and defense of patents and patent applications covering the technology that we license from third parties. Therefore, we cannot be certain that these patents and patent applications will be prepared, filed, prosecuted, maintained, enforced and defended in a manner consistent with the best interests of our business. Additionally, patents that may be licensed to us could be put at risk of being invalidated or interpreted narrowly in litigation filed by or against our licensors or another licensee or in administrative proceedings brought by or against our licensors or another licensee in response to such litigation or for other reasons. If our potential licensors fail to prosecute, maintain, enforce and defend such patents, or lose rights to those patents or patent applications, the rights</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">we have licensed may be reduced or eliminated, and our right to develop and commercialize any of our products that are subject of such licensed rights could be adversely affected.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our potential licensors may have relied on third-party consultants or collaborators or on funds from third parties such that our licensors are not the sole and exclusive owners of the patents we in-license. This could materially and adversely affect our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The agreements under which we currently license intellectual property or technology from third parties are complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology or increase what we believe to be our financial or other obligations under the relevant agreement. In spite of our best efforts, our licensors might also conclude that we have materially breached our license agreements and terminate the license agreements, thereby removing our ability to develop and commercialize products and technology covered by these license agreements. If these in-licenses are terminated, or if the underlying patents fail to provide the intended exclusivity, competitors would have the freedom to seek regulatory approval of, and to market, products identical to ours. In addition, we may seek to obtain additional licenses from our licensors and, in connection with obtaining such licenses, we may agree to amend our existing licenses in a manner that may be more favorable to the licensors, including by agreeing to terms that could enable third parties (potentially including our competitors) to receive licenses to a portion of the intellectual property that is subject to our existing licenses. Moreover, if disputes over intellectual property that we license prevent or impair our ability to maintain other licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize the affected products. Any of these events could materially and adversely affect our business, financial condition and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">In the future, we may enter agreements involving licenses or collaborations that provide for access or sharing of intellectual property. If we fail to comply with our obligations under any license, collaboration or other agreements, we may be required to pay damages and could lose intellectual property rights that are necessary for developing and protecting our current and future products.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We currently, and in the future may continue to, license from third parties certain intellectual property relating to our current and future products. In the event we do so, we may have certain obligations to such licensors. If we breach any material obligations, or use the intellectual property licensed to us in an unauthorized manner, we may be required to pay damages and the licensor may have the right to terminate the license, which could result in us being unable to develop, manufacture, and sell products that are covered by the licensed technology or enable a competitor to gain access to the licensed technology.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Disputes may arise between us and our future licensors regarding intellectual property subject to a license agreement, including:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the scope of rights granted under the license agreement and other interpretation-related issues;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">whether and the extent to which our technology and processes infringe on intellectual property of the licensor that is not subject to the licensing agreement;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our right to sublicense patents and other rights to third parties;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our diligence obligations with respect to the use of the licensed technology in relation to our development and commercialization of our products, and what activities satisfy those diligence obligations;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our right to transfer or assign the license; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the ownership of inventions and know-how resulting from the joint creation or use of intellectual property by any of our future licensors and us and our partners.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If disputes over intellectual property that we license in the future prevent or impair our ability to maintain our licensing arrangements on acceptable terms, we may not be able to successfully develop and commercialize the affected products, which would have a material adverse effect on our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, certain of our future agreements with third parties may limit or delay our ability to consummate certain transactions, may impact the value of those transactions, or may limit our ability to pursue certain activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">61</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For example, we may in the future enter into license agreements that are not assignable or transferable, or that require the licensor&#8217;s express consent in order for an assignment or transfer to take place.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Further, we or our future licensors, if any, may fail to identify patentable aspects of inventions made in the course of development and commercialization activities before it is too late to obtain patent protection on them. Therefore, we may miss potential opportunities to strengthen our patent position. It is possible that defects of form in the preparation or filing of our patents or patent applications may exist, or may arise in the future, for example with respect to proper priority claims, inventorship, claim scope, or requests for patent term adjustments. If we or our future licensors fail to establish, maintain or protect such patents and other intellectual property rights, such rights may be reduced or eliminated. If our future licensors are not fully cooperative or disagree with us as to the prosecution, maintenance or enforcement of any patent rights, such patent rights could be compromised. If there are material defects in the form, preparation, prosecution, or enforcement of our patents or patent applications, such patents may be invalid and/or unenforceable, and such applications may never result in valid, enforceable patents. Any of these outcomes could impair our ability to prevent competition from third parties, which may have an adverse impact on our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, even where we have the right to control patent prosecution of patents and patent applications under future license from third parties, we may still be adversely affected or prejudiced by actions or inactions of our predecessors or licensors and their counsel that took place prior to us assuming control over patent prosecution.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our technology acquired or licensed in the future from various third parties may be subject to retained rights. Our predecessors or licensors may retain certain rights under their agreements with us, including the right to use the underlying technology for noncommercial academic and research use, to publish general scientific findings from research related to the technology, and to make customary scientific and scholarly disclosures of information relating to the technology. It is difficult to monitor whether our predecessors or future licensors limit their use of the technology to these uses, and we could incur substantial expenses to enforce our rights to our licensed technology in the event of misuse.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we are limited in our ability to utilize acquired or future licensed technologies, or if we lose our rights to critical future in-licensed technology, we may be unable to successfully develop, out-license, market and sell our products, which could prevent or delay new product introductions. Our business strategy depends on the successful development of acquired technologies, and possibly in the future licensed technology, into commercial products. Therefore, any limitations on our ability to utilize these technologies may impair our ability to develop, out-license or market and sell our products.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We may not be successful in obtaining necessary rights to any products we may develop through acquisitions and in-licenses.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We may need to obtain additional licenses from our existing licensors or otherwise acquire or in-license any intellectual property rights from third parties that we identify as necessary for our products. It is possible that we may be unable to obtain any additional licenses or acquire such intellectual property rights at a reasonable cost or on reasonable terms, if at all. The licensing or acquisition of third-party intellectual property rights is a competitive area, and several more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment or at all. In that event, we may be required to expend significant time and resources to redesign our technology, products, or the methods for manufacturing them or to develop or license replacement technology, all of which may not be feasible on a technical or commercial basis. If we are unable to do so, we may be unable to develop or commercialize the affected products, which could materially and adversely affect our business, financial condition and results of operations.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">62</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Any collaboration or partnership arrangements that we may enter into in the future may not be successful, which could adversely affect our ability to develop and commercialize our products.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Any future collaborations that we enter into may not be successful. The success of our collaboration arrangements will depend heavily on the efforts and activities of our collaborators. Collaborations are subject to numerous risks, which may include that:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">collaborators have significant discretion in determining the efforts and resources that they will apply to collaborations;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">collaborators may not pursue development and commercialization of our products or may elect not to continue or renew development or commercialization programs based on trial or test results, changes in their strategic focus due to the acquisition of competitive products, availability of funding or other external factors, such as a business combination that diverts resources or creates competing priorities;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our current and future products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a collaborator with marketing, manufacturing and distribution rights to one or more products may not commit sufficient resources to or otherwise not perform satisfactorily in carrying out these activities;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">we could grant exclusive rights to our collaborators that would prevent us from collaborating with others;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">collaborators may not properly maintain or defend our intellectual property rights or may use our intellectual property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">disputes may arise between us and a collaborator that causes the delay or termination of the research, development or commercialization of our current or future products or that results in costly litigation or arbitration that diverts management attention and resources;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">collaborations may be terminated, and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable current or future products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">collaborators may own or co-own intellectual property covering our products that results from our collaborating with them, and in such cases, we would not have the exclusive right to develop or commercialize such intellectual property; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a collaborator&#8217;s sales and marketing activities or other operations may not be in compliance with applicable laws resulting in civil or criminal proceedings.</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We may be subject to claims challenging the inventorship of our patents and other intellectual property.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We or our licensors may be subject to claims that former consultants, contractors or other third parties have an interest in our owned or in-licensed patents, trade secrets or other intellectual property as an inventor or co-inventor. While it is our policy to require our employees, consultants and contractors who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. The assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. If we or our licensors fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our products. Furthermore, individuals executing invention assignment agreements with us may have preexisting or competing obligations to a third party, such as an academic institution, and thus an agreement with us may be ineffective in perfecting ownership of inventions developed by that individual. Any such events could have a material adverse effect on our business, financial condition and results of operations.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">63</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">If we are unable to protect the confidentiality of our trade secrets and other proprietary information, our business and competitive position may be harmed.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition to patent protection, we also rely on other proprietary rights, including protection of trade secrets, and other proprietary information that is not patentable or that we elect not to patent. However, trade secrets can be difficult to protect and some courts inside and outside the United States are less willing or unwilling to protect trade secrets. To maintain the confidentiality of our trade secrets and proprietary information, we rely heavily on confidentiality provisions that we have in contracts with our employees, consultants, collaborators and others upon the commencement of their relationship with us. We cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or proprietary technology and processes. We may not be able to prevent the unauthorized disclosure or use of our technical knowledge or other trade secrets by such third parties, despite the existence generally of these confidentiality restrictions. These contracts may not provide meaningful protection for our trade secrets, know-how, or other proprietary information in the event of any unauthorized use, misappropriation, or disclosure of such trade secrets, know-how, or other proprietary information. There can be no assurance that such third parties will not breach their agreements with us, that we will have adequate remedies for any breach, or that our trade secrets will not otherwise become known or independently developed by competitors. Despite the protections we do place on our intellectual property or other proprietary rights, monitoring unauthorized use and disclosure of our intellectual property is difficult, and we do not know whether the steps we have taken to protect our intellectual property or other proprietary rights will be adequate. In addition, the laws of many foreign countries will not protect our intellectual property or other proprietary rights to the same extent as the laws of the United States. Consequently, we may be unable to prevent our proprietary technology from being exploited abroad, which could affect our ability to expand to international markets or require costly efforts to protect our technology.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To the extent our intellectual property or other proprietary information protection is incomplete, we are exposed to a greater risk of direct competition. A third party could, without authorization, copy or otherwise obtain and use our products or technology, or develop similar technology. Our competitors could purchase our products and attempt to replicate some or all of the competitive advantages we derive from our development efforts or design around our protected technology. Our failure to secure, protect and enforce our intellectual property rights could substantially harm the value of our products, brand and business. The theft or unauthorized use or publication of our trade secrets and other confidential business information could reduce the differentiation of our products and harm our business, the value of our investment in development or business acquisitions could be reduced and third parties might make claims against us related to losses of their confidential or proprietary information. Any of the foregoing could materially and adversely affect our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Further, it is possible that others will independently develop the same or similar technology or otherwise obtain access to our unpatented technology, and in such cases we could not assert any trade secret rights against such parties or those to whom they communicate such trade secrets. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our trade secret rights and related confidentiality and nondisclosure provisions. If we fail to obtain or maintain trade secret protection, or if our competitors obtain our trade secrets or independently develop technology similar to ours or competing technologies, our competitive market position could be materially and adversely affected. In addition, some courts are less willing or unwilling to protect trade secrets and agreement terms that address non-competition are difficult to enforce in many jurisdictions and might not be enforceable in certain cases.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We also seek to preserve the integrity and confidentiality of our data and other confidential information by maintaining physical security of our premises and physical and electronic security of our information technology systems. While we have confidence in these individuals, organizations and systems, agreements or security measures may be breached and detecting the disclosure or misappropriation of confidential information and enforcing a claim that a party illegally disclosed or misappropriated confidential information is difficult, expensive and time-consuming, and the outcome is unpredictable. Further, we may not be able to obtain adequate remedies for any breach.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Changes in United States patent law or the patent law of other countries or jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our products.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Changes in either the patent laws or interpretation of the patent laws in the United States could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. The United States has enacted and implemented wide-ranging patent reform legislation. Assuming that</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">64</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">other requirements for patentability are met, prior to March 2013, in the United States, the first to invent the claimed invention was entitled to the patent, while outside the United States, the first to file a patent application was entitled to the patent. After March 2013, under the Leahy-Smith America Invents Act, or the America Invents Act, enacted in September 2011, the United States transitioned to a first inventor to file system in which, assuming that other requirements for patentability are met, the first inventor to file a patent application will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. The America Invents Act also includes a number of significant changes that affect the way patent applications are prosecuted and also may affect patent litigation. These include allowing third-party submission of prior art to the USPTO during patent prosecution and additional procedures to challenge the validity of a patent by USPTO administered post-grant proceedings, including post-grant review, inter partes review and derivation proceedings. The America Invents Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, the U.S. Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. We cannot predict how decisions or actions by the courts, the U.S. Congress or the USPTO may impact the value of our patents. Depending on actions by Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce patents that we have licensed or that we might obtain in the future. Similarly, changes in patent law and regulations in other countries or jurisdictions or changes in the governmental bodies that enforce them or changes in how the relevant governmental authority enforces patent laws or regulations may weaken our ability to obtain new patents or to enforce patents that we have licensed or that we may obtain in the future. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We may not be able to protect our intellectual property rights throughout the world, which could impair our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Filing, prosecuting, and defending patents covering our RxSight system, and any of our future products throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States are less extensive than those in the United States. In some cases, we or our licensors may not be able to obtain patent protection for certain technology outside the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our or our licensors&#8217; inventions in all countries outside the United States, even in jurisdictions where we or our licensors do pursue patent protection, or from selling or importing products made using our or our licensors&#8217; inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we or our licensors have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we may have or obtain patent protection, but where patent enforcement is not as strong as that in the United States. These unauthorized products may compete with our products in such jurisdictions and take away our market share where we do not have any issued or in-licensed patents and any future patent claims or other intellectual property rights may not be effective or sufficient to prevent them from so competing.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Many companies have encountered significant problems in enforcing and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, which could make it difficult for us to stop the infringement of our patents, if pursued and obtained, or marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce our or our licensors&#8217; patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We or our licensors may not prevail in any lawsuits that we or our licensors initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">65</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Many countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we or any of our licensors is forced to grant a license to third parties with respect to any patents relevant to our business, our business, financial condition, results of operations and prospects could be materially and adversely affected.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Since June 1, 2023, European applications have the option, upon grant of a patent, of becoming a Unitary Patent which will be subject to the jurisdiction of the Unitary Patent Court (&#8220;UPC&#8221;). This is a significant change in European patent practice. As the UPC is a new court system, there is no precedent for the court, increasing the uncertainty of any litigation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Intellectual property rights do not necessarily address all potential threats to our competitive advantage.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations, and may not adequately protect our business, or permit us to maintain our competitive advantage. The following examples are illustrative:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">others may be able to make a product that is similar to our current products and future products we intend to commercialize and that is not covered by the patents that we own or exclusively in-license and have the right to enforce;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">we and any of our current or future licensors or collaborators might not have been the first to make the inventions covered by the issued patents or pending patent applications that we own, license or may own or license in the future;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">we or any of our current or future licensors or collaborators might not have been the first to file patent applications covering certain of our inventions;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing, misappropriating or otherwise violating our intellectual property rights;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">it is possible that our current or future owned or in-licensed patent applications will not lead to issued patents;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">issued patents that we own or in-license may not provide us with any competitive advantages, or may be held invalid or unenforceable as a result of legal challenges, including as a result of legal challenges by our competitors;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our competitors might conduct research and development activities in the United States and other countries that provide a safe harbor from patent infringement claims for certain research and development activities, as well as in countries where we do not have patent rights, and then use the information learned from such activities to develop competitive products for sale in our major commercial markets;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">we may not develop additional proprietary technologies that are patentable; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">we may choose not to file a patent for certain trade secrets or know-how, and a third party may subsequently file a patent covering such intellectual property.</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our future use of &#8220;open source&#8221; software could subject our proprietary software to general release, adversely affect our ability to sell our products and subject us to possible litigation.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We intend to incorporate open source software in future products or technologies licensed, developed and/or distributed by us. Open source software is generally licensed by its authors or other third parties under open source licenses. Some open source licenses contain requirements that we disclose source code for modifications we make to the open source software and that we license such modifications to third parties at no cost. In some circumstances, distribution of our software in connection with open source software could require that we disclose and license some or all of our proprietary source code in that software, as well as distribute our products that use particular open source software at no cost to the user. We intend to monitor our use of open source software in an effort to avoid uses in a manner that would require us to disclose or grant licenses under our proprietary source code; however, there can be no assurance that such efforts will be successful. Open source license terms are often ambiguous and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">66</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">such use could inadvertently occur. There is little legal precedent governing the interpretation of many of the terms of these licenses, and the potential impact of these terms on our business may result in unanticipated obligations regarding our products and technologies. Companies that incorporate open source software into their products have, in the past, faced claims seeking enforcement of open source license provisions and claims asserting ownership of open source software incorporated into their product. If an author or other third party that distributes such open source software were to allege that we had not complied with the conditions of an open source license, we could incur significant legal costs defending ourselves against such allegations. In the event such claims were successful, we could be subject to significant damages or be enjoined from the distribution of our products. In addition, if we combine our proprietary software with open source software in certain ways, under some open source licenses, we could be required to release the source code of our proprietary software, which could substantially help our competitors develop products that are similar to or better than ours and otherwise adversely affect our business. These risks could be difficult to eliminate or manage, and, if not addressed, could harm our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">If our trademarks, service marks and tradenames are not adequately protected, then we may not be able to build name recognition in our markets and our business may be adversely affected.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We rely on trademarks, service marks, tradenames and brand names to distinguish our products from the products of our competitors and have registered or applied to register these trademarks. We cannot assure you that our trademark and service mark applications will be approved. During trademark and service mark registration proceedings, we may receive rejections. Although we are given an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, in proceedings before the USPTO and comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark and service mark applications and to seek to cancel registered trademarks and service marks. Opposition or cancellation proceedings may be filed against our trademarks and service marks, and our trademarks and service marks may not survive such proceedings. In the event that our trademarks and service marks are successfully challenged, we could be forced to rebrand our products, which could result in loss of brand recognition and could require us to devote resources towards advertising and marketing new brands. At times, competitors may adopt trade names, trademarks or service marks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. As a means to enforce our trademark and service mark rights and prevent infringement and other violations, we may be required to file claims against third parties or initiate opposition proceedings. This can be expensive and time-consuming. In addition, there could be potential trademark or service mark infringement claims brought by owners of other registered trademarks, service marks, or trademarks or service marks that incorporate variations of our registered or unregistered trademarks or service marks. Certain of our current or future trademarks or service marks may become so well known by the public that their use becomes generic and they lose trademark or service mark protection. Over the long term, if we are unable to establish name recognition based on our trademarks, service marks and trade names, then we may not be able to compete effectively and our business, financial condition and results of operations may be adversely affected.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks related to government regulation</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">If we fail to obtain and maintain necessary regulatory clearances or approvals for our products, or if clearances or approvals for future products and indications are delayed or not issued, our commercial operations would be harmed.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our products are subject to extensive regulation by the FDA in the United States and by regulatory agencies in other countries where we may choose to do business. Government regulations specific to medical devices are wide ranging and govern, among other things:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">product design, development and manufacture;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">laboratory, preclinical and clinical testing, labeling, packaging, storage and distribution;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">premarketing clearance or approval;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">record keeping;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">product safety and effective;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">product changes;</span></div></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">67</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">product marketing, promotion and advertising, sales and distribution; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">post marketing surveillance, including reporting of deaths or serious injuries and recalls and correction and removals.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Before a new medical device, or a new intended use for an existing product, can be marketed in the United States, a company must first submit and receive either 510(k) clearance pursuant to Section 510(k) of the FDCA, or approval of a premarket approval, or PMA, application from the FDA, unless an exemption applies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In many cases, the process of obtaining PMA approval is much more rigorous, costly, lengthy and uncertain than the 510(k) clearance process. In the 510(k) clearance process, the FDA must determine that a proposed device is &#8220;substantially equivalent&#8221; to a device legally on the market, known as a &#8220;predicate&#8221; device, in order to clear the proposed device for marketing. To be &#8220;substantially equivalent,&#8221; the proposed device must have the same intended use as the predicate device, and either have the same technological characteristics as the predicate device or have different technological characteristics and not raise different questions of safety or effectiveness than the predicate device. Clinical data is sometimes required to support substantial equivalence. In the PMA approval process, the FDA must determine that a proposed device is safe and effective for its intended use based on extensive data, including technical, pre-clinical, clinical trial, manufacturing and labeling data. The PMA process is typically required for devices for which the 510(k) process cannot be used and that are deemed to pose the greatest risk. Modifications to products that are approved through a PMA application generally need prior FDA approval of a PMA supplement. Similarly, some modifications made to products cleared through a 510(k) may require a new 510(k), or such modification may put the device into class III and require PMA approval. The FDA&#8217;s 510(k) clearance process usually takes from three to 12 months but may last longer. The process of obtaining a PMA generally takes from one to three years, or even longer, from the time the PMA is submitted to the FDA until an approval is obtained. Any delay or failure to obtain necessary regulatory approvals or clearances would have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The FDA can delay, limit or deny clearance or approval of a device for many reasons, including:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our inability to demonstrate to the satisfaction of the FDA or the applicable regulatory entity or notified body that our products are safe or effective for their intended uses;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the disagreement of the FDA or the applicable foreign regulatory body with the design, conduct or implementation of our clinical trials or the analyses or interpretation of data from pre-clinical studies or clinical trials;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">serious and unexpected adverse device effects experienced by participants in our clinical trials;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the data from our pre-clinical studies and clinical trials may be insufficient to support clearance or approval, where required;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our inability to demonstrate that the clinical and other benefits of the device outweigh the risks;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">an advisory committee, if convened by the applicable regulatory authority, may recommend against approval of our application or may recommend that the applicable regulatory authority require, as a condition of approval, additional preclinical studies or clinical trials, limitations on approved labeling or distribution and use restrictions, or even if an advisory committee, if convened, makes a favorable recommendation, the respective regulatory authority may still not approve the product;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the applicable regulatory authority may identify significant deficiencies in our manufacturing processes, facilities or analytical methods or those of our third-party contract manufacturers;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the potential for approval policies or regulations of the FDA or applicable foreign regulatory bodies to change significantly in a manner rendering our clinical data or regulatory filings insufficient for clearance or approval; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the FDA or foreign regulatory authorities may audit our clinical trial data and conclude that the data is not sufficiently reliable to support approval or clearance.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Similarly, regulators may determine that our financial relationships with our principal investigators resulted in a perceived or actual conflict of interest that may have affected the interpretation of a study, the integrity of the data generated at the applicable clinical trial site or the utility of the clinical trial itself. Even if we are granted regulatory</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">68</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">clearances or approvals, they may include significant limitations on the indicated uses for the product, which may limit the market for the product. Moreover, the FDA and European Union regulatory authorities strictly regulate the labeling, promotion and advertising of medical devices, including comparative and superiority claims vis a vis competitors&#8217; products, that may be made about products.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As a condition of approving a PMA application, the FDA may also require some form of post-approval study or post-market surveillance, whereby the applicant conducts a follow-up study or follows certain patient groups for a number of years and makes periodic reports to the FDA on the clinical status of those patients when necessary to protect the public health or to provide additional safety and effectiveness data for the device. Failure to conduct the post-approval study in compliance with applicable regulations or to timely complete required post-approval studies or comply with other post-approval requirements could result in withdrawal of approval of the PMA, which would harm our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, we are required to timely file various reports with the FDA, including, Medical Device Reporting (&#8220;MDR&#8221;), that requires that we report to the regulatory authorities if our products may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction were to recur. If these reports are not filed in a timely manner, regulators may impose sanctions and we may be subject to product liability or regulatory enforcement actions, all of which could harm our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we initiate a correction or removal action for our products to reduce a significant risk to health posed by our products, we would be required to submit a publicly available correction and removal report to the FDA and, in many cases, similar reports to other regulatory agencies. This report could be classified by the FDA as a device recall which could lead to increased scrutiny by the FDA, other international regulatory agencies and our customers regarding the quality and safety of our products. Furthermore, the submission of these reports could be used by competitors against us and cause doctors to delay or cancel procedures, which could harm our reputation.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The FDA and the Federal Trade Commission, or FTC, also regulate the advertising, promotion and labeling of our products to ensure that the claims we make are consistent with our regulatory clearances and approvals, that there is adequate and reasonable scientific data to substantiate the claims and that our promotional labeling and advertising is neither false nor misleading in any respect. If the FDA or FTC determines that any of our advertising or promotional claims are misleading, not substantiated or not permissible, we may be subject to enforcement actions, including adverse publicity and warning letters, and we may be required to revise our promotional claims and make other corrections or restitutions.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The FDA and state authorities have broad enforcement powers. Our failure to comply with applicable regulatory requirements could result in enforcement action by the FDA or state agencies, which may include any of the following sanctions:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">adverse publicity, warning letters, fines, injunctions, consent decrees and civil penalties;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">repair, replacement, refunds, recalls, termination of distribution, administrative detention or seizure of our products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">operating restrictions, partial suspension or total shutdown of production;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">denial of our requests for 510(k) clearance or PMA of new products, new intended uses or modifications to existing products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">withdrawal of 510(k) clearance or PMAs that have already been granted; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">criminal prosecution.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If any of these events were to occur, our business and financial condition could be harmed. In addition, the FDA&#8217;s and other regulatory authorities&#8217; policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our products. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability, which would adversely affect our business, financial condition and results of operations.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">69</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our products and operations are subject to extensive government regulation and oversight in the United States.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Medical devices regulated by the FDA are subject to &#8220;general controls&#8221; which include: registration with the FDA; listing commercially distributed products with the FDA; complying with all applicable requirements under the QSR, or QSMR when its goes into effect in February 2026; filing reports with the FDA of and keeping records relative to certain types of adverse events associated with devices under the medical device reporting regulation; assuring that device labeling complies with device labeling requirements; reporting certain device field removals and corrections to the FDA; and obtaining pre-market notification 510(k) clearance for devices prior to marketing. Some devices known as &#8220;510(k)-exempt&#8221; devices can be marketed without prior marketing-clearance or approval from the FDA. In addition to the &#8220;general controls,&#8221; some Class II medical devices are also subject to &#8220;special controls,&#8221; including adherence to a particular guidance document and compliance with the performance standard. Instead of obtaining 510(k) clearance, most Class III devices are subject to PMA.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Although our products have received regulatory approval or clearance from FDA in the United States for a particular patient population, they will be subject to ongoing regulatory requirements for manufacturing, labeling, packaging, storage, advertising, promotion, sampling, record-keeping, conduct of post-marketing studies and submission of safety, effectiveness and other post-market information, including both federal and state requirements in the United States and requirements of comparable non-U.S. regulatory authorities in any international markets we choose to enter.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Any regulatory clearances or approvals that we have received for our products will be subject to limitations on the cleared or approved indicated uses for which the product may be marketed and promoted, will be subject to the conditions of approval, or will contain requirements for potentially costly post-marketing testing. We are required to report certain adverse events and production problems, if any, to the FDA and comparable foreign regulatory authorities. Any new legislation addressing product safety issues could result in increased costs to assure compliance. The FDA and other agencies, including the DOJ, closely regulate and monitor the post-clearance or approval marketing and promotion of products to ensure that they are marketed and distributed only for the cleared or approved indications and in accordance with the provisions of the cleared or approved labeling. We have to comply with requirements concerning advertising and promotion for our products.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Promotional communications with respect to devices are subject to a variety of legal and regulatory restrictions and must be consistent with the information in the products&#8217; cleared or approved labeling. As such, we may not promote our products for indications or uses for which they do not have clearance or approval. We received a PMA for the LAL and LDD, which is indicated for the reduction of residual astigmatism to improve uncorrected visual acuity after removal of the cataractous natural lens by phacoemulsification and implantation of the intraocular lens in the capsular bag, in adult patients with pre-existing corneal astigmatism of &gt; 0.75 diopters and without pre-existing macular disease. We also received a 510(k) clearance for our contact lens, which is indicated for visualization and treatment in the anterior segment of the eye. We train our marketing and sales force against promoting our products for uses outside of the cleared or approved indications for use, known as &#8220;off-label uses.&#8221; However, doctors may use our products for off-label purposes and are allowed to do so when in the doctor&#8217;s independent professional medical judgment he or she deems it appropriate. If the FDA determines that our promotional materials or training constitute promotion of an off-label or other improper use, or that our internal policies and procedures are inadequate to prevent such off-label uses, it could subject us to regulatory or enforcement actions as discussed below.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, we cannot make comparative claims regarding the use of our products against any alternative treatments without conducting head-to-head comparative clinical studies, which would be expensive and time-consuming. If the FDA determines that our promotional, reimbursement or training materials for sales representatives or doctors constitute promotion of an off-label use, the FDA could request that we modify our training, promotional or reimbursement materials and/or subject us to regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, injunction, seizure, disgorgement of profits, significant penalties, including civil fines and criminal penalties. Other federal, state or foreign governmental authorities also might take action if they consider our promotion, reimbursement or training materials to constitute promotion of an off-label use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement. Although we train our sales force not to promote our products for off-label uses, and our instructions for use in all markets specify that our products are not intended for use outside of those indications cleared or approved for use, the FDA or another regulatory agency could conclude that we have engaged in off-label promotion. For example, the government may take the position that off-label promotion resulted in inappropriate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">70</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reimbursement for an off-label use in violation of the federal civil False Claims Act for which it might impose significant civil fines and even pursue criminal action. In those possible events, our reputation could be damaged, and adoption of the products would be impaired.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If a regulatory agency discovers previously unknown problems with a product, such as adverse events of unanticipated severity or frequency, or problems with our facility where the product is manufactured or disagrees with the promotion, marketing or labeling of a product, such regulatory agency may impose restrictions on that product or us, including requiring withdrawal of the product from the market.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we fail to comply with applicable regulatory requirements, a regulatory agency or enforcement authority may, among other things:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">subject our facility to an adverse inspectional finding or Form 483, or other compliance or enforcement notice, communication or correspondence;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">issue warning or untitled letters that would result in adverse publicity or may require corrective advertising;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">impose civil or criminal penalties;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">suspend or withdraw regulatory clearances or approvals;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">refuse to clear or approve pending applications or supplements to approved applications submitted by us;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">impose restrictions on our operations, including closing our sub-assembly suppliers&#8217; facilities;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">seize or detain products; or</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">require a product recall.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, violations of the FDCA relating to the promotion of approved products may lead to investigations alleging violations of federal and state healthcare fraud and abuse and other laws, as well as state consumer protection laws.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Any government investigation of alleged violations of law could require us to expend significant time and resources in response and could generate negative publicity. Any failure to comply with ongoing regulatory requirements may significantly and adversely affect our ability to commercialize and generate revenue from our products. If regulatory sanctions are applied or if regulatory clearance or approval is withdrawn, it would have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, the policies of the FDA and of comparable foreign regulatory authorities may change and additional laws, regulations and government actions may be enacted that could prevent, limit, or delay regulatory approval of our product candidates. We cannot predict the likelihood, nature, or extent of government regulation that may arise from future legislation or administrative or executive action, either in the United States or abroad.  Recently, the U.S. Supreme Court overruled the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Chevron</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> doctrine, which gives deference to regulatory agencies&#8217; statutory interpretations in litigation against federal government agencies, such as the FDA, where the law is ambiguous. This landmark Supreme Court decision may invite more companies and other stakeholders to bring lawsuits against the FDA to challenge longstanding decisions and policies of the FDA, which could undermine the FDA&#8217;s authority, lead to uncertainties in the industry, and disrupt the FDA&#8217;s normal operations, any of which could delay the FDA&#8217;s review of our regulatory submissions. We cannot predict the full impact of this decision, future judicial challenges brought against the FDA, or the nature or extent of government regulation that may arise from future legislation or administrative action.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Material modifications to our products may require new 510(k) clearances or pre-market approvals or may require us to recall or cease marketing our products until clearances or approvals are obtained.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Modifications that could significantly affect the safety and effectiveness of our approved or cleared products, such as changes to the intended use or technological characteristics of our products, will require new 510(k) clearances or PMAs or require us to recall or cease marketing the modified devices until these clearances or approvals are obtained. Based on FDA published guidelines, the FDA requires device manufacturers to initially make and document a determination of whether or not a modification requires a new approval, supplemental approval or clearance; however, the FDA can review a manufacturer&#8217;s decision. Any modification to an</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">71</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FDA-cleared device that could significantly affect its safety or efficacy or that would constitute a major change in its intended use would require a new 510(k) clearance or possibly a PMA. We may not be able to obtain the required 510(k) clearances or PMAs, or PMA supplements, or similar marketing authorization in applicable foreign jurisdictions, for new products or for modifications to, or additional indications for, our products in a timely fashion, or at all. Delays in obtaining required future clearances or approvals would adversely affect our ability to introduce new or enhanced products in a timely manner, which in turn would harm our future growth. We have made modifications to our products in the past and expect to make additional modifications in the future that we believe do not or will not require additional clearances or approvals. If the FDA or a comparable foreign regulatory authority disagrees and requires new clearances or approvals for these modifications, we may be required to recall and to stop selling or marketing such products as modified, which could harm our operating results and require us to redesign such products. In these circumstances, we may be subject to significant enforcement actions.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Obtaining and maintaining regulatory approval of our current and future products in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of our current and future products in other jurisdictions. The FDA and other comparable foreign regulatory authorities may not accept data from trials conducted in locations outside of their jurisdiction.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Obtaining and maintaining regulatory approvals or clearances of our current and future products in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory approval in any other jurisdiction. For example, even if the FDA grants marketing approval or clearance of a current or future product, comparable regulatory authorities in foreign jurisdictions must also approve or clear the manufacturing, marketing and promotion and reimbursement of a current or future product in those countries. However, a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory approval process in others. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from those in the United States, including additional preclinical studies or clinical trials as clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the United States, a product must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we intend to charge for our products is also subject to approval.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The RxSight system is approved for improving uncorrected visual acuity by adjusting the LAL power to correct residual postoperative refractive error, including for -2.0 to + 2.0 diopters of sphere and -3.0 to -0.50 diopters of cylinder and by changing lens curvature to introduce controlled amounts of spherical aberration (+/- 1 micron) and center near add (up to 2.0 diopters) which is also registered with the MHRA in the United Kingdom, in Canada and in Mexico. Obtaining additional foreign regulatory approvals and establishing and ensuring compliance with foreign regulatory requirements in jurisdictions where we conduct business currently or in the future, could be time-consuming and expensive, and could delay the introduction of our products in certain countries. If we or any future collaborator fail to comply with the regulatory requirements in international markets or fail to receive applicable marketing approvals or clearances, our target market will be reduced and our ability to realize the full market potential of our current and future products will be harmed.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, we have conducted clinical trials in Mexico and may choose to conduct further international clinical trials. The acceptance of study data by the FDA or other comparable foreign regulatory authority from clinical trials conducted outside of their respective jurisdictions may be subject to certain conditions. In cases where data from foreign clinical trials are intended to serve as the basis for marketing approval in the United States, the FDA will generally not approve the application on the basis of foreign data alone unless (1) the data are applicable to the U.S. population and U.S. medical practice; (2) the trials are performed by clinical investigators of recognized competence and pursuant to current good clinical practices regulations; and (3) audits by regulatory authorities of the clinical data do not identify significant data integrity issues. Additionally, the FDA&#8217;s clinical trial requirements, including the adequacy of the patient population studied and statistical powering, must be met. In addition, such foreign trials are subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA or any applicable foreign regulatory authority will accept data from trials conducted outside of its applicable jurisdiction. If the FDA or any applicable foreign regulatory authority does not accept such data, it would result in the need for additional trials, which would be costly and time-consuming and delay aspects of our business plan, and which may result in our products not receiving approval or clearance for commercialization in the applicable jurisdiction.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our products may be subject to recalls after receiving FDA or foreign approval or clearance, which could divert managerial and financial resources, harm our reputation and adversely affect our business.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">72</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The FDA and similar foreign governmental authorities have the authority to require the recall of our products because of any failure to comply with applicable laws and regulations, or defects in design or manufacture. A government mandated or voluntary product recall by us could occur because of, for example, component failures, device malfunctions or other adverse events, such as serious injuries or deaths, or quality-related issues, such as manufacturing errors or design or labeling defects. Any future recalls of our products could divert managerial and financial resources, harm our reputation and adversely affect our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we initiate a correction or removal for one of our devices to reduce a risk to health posed by the device, we would be required to submit a publicly available Correction and Removal report to the FDA and, in many cases, similar reports to other regulatory agencies. This report could be classified by the FDA as a device recall which could lead to increased scrutiny by the FDA, other international regulatory agencies and our customers regarding the quality and safety of our devices. Furthermore, the submission of these reports has been and could be used by competitors against us in competitive situations and cause customers to delay purchase decisions or cancel orders and would harm our reputation.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, we are subject to medical device reporting regulations that require us to report to the FDA or similar foreign governmental authorities if one of our products may have caused or contributed to a death or serious injury or if we become aware that it has malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction recurred. Failures to properly identify reportable events or to file timely reports, as well as failure to address each of the observations to the FDA&#8217;s satisfaction, can subject us to sanctions and penalties, including warning letters and recalls.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Doctors may make similar reports to regulatory authorities. Any such reports may trigger an investigation by the FDA or similar foreign regulatory bodies, which could divert managerial and financial resources, harm our reputation and have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">If we, or our suppliers, fail to comply with the FDA&#8217;s QSR or QSMR when it goes into effect in February 2026, or other applicable foreign regulations, our manufacturing or distribution operations could be delayed or shut down and our revenue could suffer.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our manufacturing and design processes and those of our third-party component suppliers are required to comply with the FDA&#8217;s QSR, which covers procedures and documentation of the design, testing, production, control, quality assurance, labeling, packaging, storage and shipping of our products in the United States. We are also subject to similar state requirements and licenses, and to ongoing ISO 13485 compliance in our operations, including design, manufacturing, and service, to maintain our CE Mark in Europe. In addition, we must engage in extensive recordkeeping and reporting and must make available our facilities and records for periodic unannounced inspections by governmental agencies, including the FDA, state authorities, EU Notified Bodies, and comparable agencies in other countries. Further, the FDA issued a final rule in February 2024 replacing the QSR with Quality Management System Regulation (&#8220;QMSR&#8221;), which incorporates by reference the quality management system requirements of ISO 13485:2016. The FDA has stated that the standards contained in ISO 13485:216 are substantially similar to those set forth in the existing QSR. The FDA will begin to enforce the QMSR requirements upon the effective date, February 2, 2026. If we or any of our suppliers or contractors fail to meet the regulatory requirements or a regulatory inspection, our operations could be disrupted and our manufacturing interrupted. Failure to take timely and adequate corrective action in response to an adverse regulatory inspection could result in, among other things, a shutdown of our manufacturing or product distribution operations, significant fines, suspension of marketing clearances and approvals, seizures or recalls of our device, operating restrictions and criminal prosecutions, any of which would cause our business to suffer. Furthermore, our key component suppliers may not currently be or may not continue to be in compliance with applicable regulatory requirements, which may result in manufacturing delays for our products and cause our revenue to decline.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The FDA has broad post-market and regulatory enforcement powers. We are subject to unannounced inspections by the FDA and the Food and Drug Branch of the California Department of Public Health (&#8220;CDPH&#8221;), and our Notified Body to determine our compliance with the QSR and other regulations at both our design and manufacturing facilities, and these inspections may include the manufacturing facilities of our suppliers.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We can provide no assurance that we will continue to remain in material compliance with the QSR, or QSMR when it goes into effect in February 2026. If the FDA, CDPH, or any applicable notified body in the European Union or United Kingdom inspects any of our facilities and discover compliance problems, we may have to cease manufacturing and product distribution until we can take the appropriate remedial steps to correct the audit findings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">73</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Taking corrective action may be expensive, time consuming and a distraction for management and if we experience a delay at our manufacturing facility, we may be unable to produce our products, which would harm our business.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Healthcare reform initiatives and other administrative and legislative proposals may adversely affect our business, financial condition, results of operations and cash flows in our key markets.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There have been and continue to be proposals by the federal government, state governments, regulators and third-party payors to control or manage the increased costs of healthcare and, more generally, to reform the U.S. healthcare system. Certain of these proposals could limit the prices we are able to charge for our products or the coverage and reimbursement available for our products and could limit the acceptance and availability of our products. The adoption of proposals to control costs could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For example, in the United States, in March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, together, the Affordable Care Act (&#8220;ACA&#8221;), was enacted. The ACA is a sweeping measure intended to expand healthcare coverage within the United States, primarily through the imposition of health insurance mandates on employers and individuals, the provision of subsidies to eligible individuals enrolled in plans offered on the health insurance exchanges and the expansion of the Medicaid program. The ACA has impacted existing government healthcare programs and has resulted in the development of new programs.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain provisions of the ACA have been subject to judicial and Congressional challenges. For example, various portions of the ACA have been the subject of legal and constitutional challenges, including legal proceedings in the Fifth Circuit Court of Appeals. In June 2021, the United States Supreme Court held that Texas and other challengers had no legal standing to challenge the ACA, dismissing the case on procedural grounds without specifically ruling on the constitutionality of the ACA. Thus, the ACA will remain in effect in its current form. It is unclear how this Supreme Court decision, future litigation, and healthcare measures promulgated by the Biden administration will impact the ACA, our business, financial condition and results of operations. Complying with any new legislation or reversing changes implemented under the ACA could be time-intensive and expensive, resulting in a material adverse effect on our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, other legislative changes have been proposed and adopted since the ACA was enacted. On August 2, 2011, the Budget Control Act of 2011 was signed into law, which, among other things, includes reductions to Medicare payments to providers of, on average, 2% per fiscal year, which went into effect on April 1, 2013, which, due to subsequent legislative amendments, will stay in effect through 2032, with the exception of a temporary suspension implemented under various COVID-19 relief legislation. In January 2013, President Obama signed into law the American Taxpayer Relief Act of 2012, which, among other things, reduced Medicare payments to several providers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. These new laws may result in additional reductions in Medicare and other healthcare funding, which could have a material adverse effect on customers for our products, if approved, and accordingly, our financial operations. We cannot assure you that the ACA, as currently enacted or as amended in the future, will not harm our business and financial results, and we cannot predict how future federal or state legislative or administrative changes relating to healthcare reform will affect our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There likely will continue to be legislative and regulatory proposals at the federal and state levels directed at containing or lowering the cost of healthcare. We cannot predict the initiatives that may be adopted in the future or their full impact. The continuing efforts of the government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare may harm:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to set a price that we believe is fair for our products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to generate revenue and achieve or maintain profitability; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the availability of capital.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Further, recently there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several United States Congressional inquiries and proposed and enacted federal legislation designed to bring transparency to product pricing and reduce the cost of products and services under government healthcare programs. While some of these measures may require additional authorization to become effective, Congress and the federal administration have each indicated that it will continue to seek new</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">74</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">legislative and/or administrative measures to control healthcare costs. Additionally, individual states in the United States have also increasingly passed legislation and implemented regulations designed to control product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures. Moreover, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what products to purchase and which suppliers will be included in their healthcare programs. Adoption of price controls and other cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures may prevent or limit our ability to generate revenue and attain profitability. Various new healthcare reform proposals are emerging at the federal and state level. Any new federal and state healthcare initiatives that may be adopted could limit the amounts that federal and state governments will pay for healthcare products and services and could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">If we fail to comply with United States federal and state fraud and abuse and other healthcare laws and regulations, we could face substantial penalties and our business operations and financial condition could be adversely affected.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Healthcare providers and third-party payors play a primary role in the distribution, recommendation, ordering and purchasing of any medical device for which we have or obtain marketing clearance or approval. Through our arrangements with principal investigators, healthcare professionals, third-party payors and customers, we are exposed to broadly applicable anti-fraud and abuse, anti-kickback, false claims and other healthcare laws and regulations that may constrain our business, our arrangements and relationships with customers, and how we market, sell and distribute our marketed medical devices. We have a compliance program, a Code of Conduct and associated policies and procedures, but it is not always possible to identify and deter misconduct by our employees and other third parties, and the precautions we take to detect and prevent noncompliance may not be effective in protecting us from governmental investigations for failure to comply with applicable fraud and abuse or other healthcare laws and regulations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the United States, we are subject to various state and federal anti-fraud and abuse laws, including, without limitation, the federal healthcare Anti-Kickback Statute and federal civil False Claims Act. There are similar laws in other countries. Our current and future arrangements with healthcare providers, third-party payors, customers, and others may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations, which may constrain the business or financial arrangements and relationships through which we research, as well as, sell, market, and distribute any products for which we obtain marketing approval. Healthcare fraud and abuse laws and related regulations are complex, and even minor irregularities can potentially give rise to claims that a statute or prohibition has been violated. The laws that may affect our ability to operate include:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the federal Anti-Kickback Statute, which makes it illegal for any person, including a prescription drug or medical device manufacturer (or a party acting on its behalf), to knowingly and willfully solicit, receive, offer or pay any remuneration that is intended to induce or reward referrals, including the purchase, recommendation, or order of, items or services for which payment may be made, in whole or in part, under a federal healthcare program, such as Medicare or Medicaid. Moreover, the ACA provides that the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the Federal False Claims Act, including its civil provisions that can be enforced by private citizens through civil whistleblower or qui tam actions, and civil monetary penalties prohibiting individuals or entities from, among other things, knowingly presenting, or causing to be presented, to the federal government, claims for payment that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government, and/or impose exclusions from federal health care programs and/or penalties for parties who engage in such prohibited conduct;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the Federal Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), which prohibits, among other things, executing or attempting to execute a scheme to defraud any healthcare benefit program or making false statements relating to healthcare matters;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, and their implementing regulations also impose obligations on covered entities such as health insurance plans, healthcare clearinghouses, and certain health care providers and their respective business </span></div></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">75</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">associates and their covered subcontractors, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the federal Physician Payments Sunshine Act, also referred to as the CMS Open Payments, which requires applicable manufacturers of covered drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program, with specific exceptions, to annually report to CMS information regarding certain payments and other transfers of value to covered recipients, including physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain non-physician healthcare professionals (such as physician assistants and nurse practitioners, among others) and teaching hospitals, as well as information regarding ownership and investment interests held by physicians and their immediate family members; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">analogous state and foreign laws and regulations, such as state anti-kickback and false claims laws which may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers, state laws that require biotechnology companies to comply with the biotechnology industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government; state and local laws that require medical device manufacturers to report information related to payments and other transfers of value to doctors or marketing expenditures and require the registration of their sales representatives; state laws that require medical device companies to report information on the pricing of certain medical device products; and state and foreign laws that govern the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">State and federal regulatory and enforcement agencies continue to actively investigate violations of healthcare laws and regulations, and the U.S. Congress continues to strengthen the arsenal of enforcement tools. Most recently, the Bipartisan Budget Act of 2018 (&#8220;BBA&#8221;), increased the criminal and civil penalties that can be imposed for violating certain federal health care laws, including the Anti-Kickback Statute. Enforcement agencies also continue to pursue novel theories of liability under these laws. In particular, government agencies recently have increased regulatory scrutiny and enforcement activity with respect to manufacturer reimbursement support activities and patient support programs, including bringing criminal charges or civil enforcement actions under the Anti-Kickback Statute, federal civil False Claims Act and HIPAA&#8217;s healthcare fraud and privacy provisions.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Because of the breadth of these laws and the narrowness of available statutory and regulatory exemptions or safe harbors, it is possible that some of our activities, such as stock-option compensation paid to doctors that have entered into consulting agreements with us, could be subject to challenge under one or more of such laws. Any action brought against us for violations of these laws or regulations, even successfully defended, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business. We may be subject to private &#8220;qui tam&#8221; actions brought by individual whistleblowers on behalf of the federal or state governments.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The growth of our business and sales organization and our expansion outside of the United States may increase the potential of violating these laws or our internal policies and procedures. The risk of our being found in violation of these or other laws and regulations is further increased by the fact that many have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Any action brought against us for violation of these or other laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business. If our operations are found to be in violation of any of the federal, state and foreign laws described above or any other current or future fraud and abuse or other healthcare laws and regulations that apply to us, we may be subject to penalties, including significant criminal, civil, and administrative penalties, damages, fines, imprisonment of individuals, exclusion from participation in government programs, such as Medicare and Medicaid, and we could be required to curtail or cease our operations. Any of the foregoing consequences could seriously harm our business and our financial results.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Achieving and sustaining compliance with applicable federal and state anti-fraud and abuse laws may prove costly. If we or our employees are found to have violated any of the above laws we may be subjected to substantial criminal, civil and administrative penalties, including imprisonment, exclusion from participation in federal healthcare programs, such as Medicare and Medicaid, and significant fines, monetary penalties, forfeiture,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">76</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">disgorgement and damages, contractual damages, reputational harm, administrative burdens, diminished profits and future earnings and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our financial results. Any action or investigation against us for the violation of these healthcare fraud and abuse laws, even if successfully defended, could result in significant legal expenses and could divert our management&#8217;s attention from the operation of our business. Companies settling federal civil False Claims Act, Anti-Kickback Statute or civil monetary penalties law cases also may be required to enter into a Corporate Integrity Agreement with the OIG in order to avoid exclusion from participation (i.e., loss of coverage for their products) in federal healthcare programs such as Medicare and Medicaid. Corporate Integrity Agreements typically impose substantial costs on companies to ensure compliance. Defending against any such actions can be costly, time-consuming and may require significant personnel resources, and may have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Changes in the CMS fee schedules may harm our revenue and operating results.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Government payers, such as CMS as well as insurers, have increased their efforts to control the cost, utilization and delivery of healthcare services. From time to time, the United States Congress has considered and implemented changes in the CMS fee schedules in conjunction with budgetary legislation. Reductions of reimbursement by Medicare or Medicaid for procedures that use our products or changes in policy regarding coverage of these procedures, such as adding requirements for payment, or prior authorizations, may be implemented from time to time. Reductions in the reimbursement rates and changes in payment policies of other third-party payers may occur as well. Similar changes in the past have resulted in reduced payments for procedures that use medical device products as well as added costs and have added more complex regulatory and administrative requirements. Further changes in federal, state, local and third-party payer regulations or policies may have a material adverse impact on the demand for our products and on our business. Actions by agencies regulating insurance or changes in other laws, regulations, or policies may also have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Legislative or regulatory reforms may make it more difficult and costly for us to obtain regulatory clearance or approval of our planned or future products and to manufacture, market and distribute our products after clearance or approval is obtained.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">From time to time, legislation is drafted and introduced in Congress that could significantly change the statutory provisions governing the regulatory approval, manufacture and marketing of regulated products or the reimbursement thereof. In addition, FDA regulations and guidance are often revised or reinterpreted by the FDA in ways that may significantly affect our business and our products. Any new regulations or revisions or reinterpretations of existing regulations may impose additional costs or lengthen review times of planned or future products. It is impossible to predict whether legislative changes will be enacted, or FDA regulations, guidance or interpretations changed, and what the impact of such changes, if any, may be.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Any change in the laws or regulations that govern the clearance and approval processes relating to our current, planned and future products could make it more difficult and costly to obtain clearance or approval for new products or to produce, market and distribute existing products. Significant delays in receiving clearance or approval or the failure to receive clearance or approval for our new products would have an adverse effect on our ability to expand our business.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Compliance with the EU Medical Device Regulation, applicable regulations in the United Kingdom, and other applicable foreign regulations, as well as any changes to existing regulations, may be costly and disruptive to our business, and expose us to increased liability.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In 2017, the European Union (&#8220;EU&#8221;) published the new EU Medical Device Regulation (&#8220;EU MDR&#8221;) (2017/745), the application of which was postponed until May 26, 2021 for class I devices (lowest risk) and May 26, 2024 for all other class devices (higher risk devices). In February 2023, EU Parliament voted to extend the EU MDR transition timelines, which postpones application until December 2027 for higher-risk Class III and implantable IIb devices and until December 2028 for lower-risk Class I and IIa devices. The new regulations replace predecessor directives and emphasize a global convergence of regulations. With the transition from the Medical Devices Directive (&#8220;MDD&#8221;), to the EU MDR, notified bodies are required to seek designation to operate as conformity assessment authorities under the new law. While we are currently in compliance with the EU MDR and in process of transferring certification from MDD to EU MDR, compliance with any new or changing regulations in the EU or other jurisdictions where we currently commercialize our products or intend to commercialize in the future is a time</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">77</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">consuming process that may require comprehensive quality system audits and new conformity assessment certifications for our products. Major changes include:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reclassification of some products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">greater emphasis on clinical data;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">data transparency, including publication of clinical trial data and safety summaries;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">defined content and structure for technical files to support registration;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">unique device identification system;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">greater burden on post-market surveillance and clinical follow-up;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reduction of adverse event reporting time from 30 to 15 days after the event; </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">delayed review times; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">more power to notified bodies.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Implementation of the Medical Device Regulations introduces substantial changes to the obligations with which medical device manufacturers must comply in the EU. High risk medical devices will be subject to additional scrutiny during the conformity assessment procedure. For any products that we may develop in the future, complying with these new regulations may result in Europe being less attractive as a &#8220;first market&#8221; destination. Marketing authorization timelines will become more protracted and the costs of operating in Europe will increase. A significantly more costly path to regulatory compliance is anticipated.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our clinical trials may fail to demonstrate competent and reliable evidence of the safety and effectiveness of our products, which would prevent or delay commercialization of our products in development.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We may be required to conduct clinical studies that demonstrate competent and reliable evidence that our products are safe and effective before we can commercialize our products. Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. We cannot be certain that our planned clinical trials or any other future clinical trials will be successful. In addition, even if such clinical trials are successfully completed, we cannot guarantee that the FDA or foreign regulatory authorities will interpret the results as we do, and more trials could be required before we submit our products for approval. To the extent that the results of the trials are not satisfactory to the FDA or foreign regulatory authorities for support of a marketing application, we may be required to expend significant resources, which may not be available to us, to conduct additional trials in support of potential approval of our products. Even if regulatory approval is secured for any of our products, the terms of such approval may limit the scope and use of our products, which may also limit their commercial potential.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Defects or failures associated with our products could lead to recalls, safety alerts or litigation, as well as significant costs and negative publicity.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our business is subject to significant risks associated with manufacture, distribution and use of medical devices that are placed inside the human body, including the risk that patients may be severely injured by or even die from the misuse or malfunction of our products caused by design flaws or manufacturing defects. In addition, component failures, design defects, off-label uses, or inadequate disclosure of product-related information could also result in an unsafe condition or the injury or death of a patient. These problems could lead to a recall or market withdrawal of, or issuance of a safety alert relating to, our products and result in significant costs, negative publicity and adverse competitive pressure. The circumstances giving rise to recalls are unpredictable, and any recalls of existing or future products could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We provide a limited warranty that our products are free of material defects and conform to specifications and offer to repair the LDD in the event of a defect and replace or refund the purchase price of a defective LAL. As a result, we bear the risk of potential warranty claims on our products. In the event that we attempt to recover some or all of the expenses associated with a warranty claim against us from our suppliers or vendors, we may not be successful in claiming such recovery, or any recovery from such vendor or supplier may be inadequate or unavailable.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The medical device industry has historically been subject to extensive litigation over product liability claims. We may be subject to product liability claims if our products cause, or merely appear to have caused, an injury or</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">78</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">death, even if due to doctor error. In addition, an injury or death that is caused by the activities of our suppliers, such as those that provide us with components and raw materials, or by an aspect of a treatment used in combination with our products, such as a complementary drug or anesthesia, may be the basis for a claim against us by patients, doctors or others purchasing or using our products, even if our products were not the actual cause of such injury or death. We may choose to settle any claims to avoid a determination of fault, even if we believe fault was not due to failure of our products. An adverse outcome involving one of our products could result in reduced market acceptance and demand for such products or any or all of our other products and could harm our brand and reputation and our ability to market our products in the future. In some circumstances, adverse events arising from or associated with the design, manufacture or marketing of our products could result in the suspension or delay of regulatory reviews of our premarket notifications or applications for marketing. Any of the foregoing problems could disrupt our business and have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Although we carry product liability insurance in the United States and in other countries in which we conduct business, including for clinical trials and product marketing, we can give no assurance that such coverage will be available or adequate to satisfy any claims. Product liability insurance is expensive, subject to significant deductibles and exclusions, and may not be available on acceptable terms, if at all. If we are unable to obtain or maintain insurance at an acceptable cost or on acceptable terms with adequate coverage or otherwise protect against potential product liability claims, we could be exposed to significant liabilities. A product liability claim recall or other claim with respect to uninsured liabilities or for amounts in excess of insured liabilities could have a material adverse effect on our business, financial condition and results of operations. Defending a suit, regardless of its merit or eventual outcome, could be costly, could divert management&#8217;s attention from our business and might result in adverse publicity, which could result in reduced acceptance of our products in the market, product recalls or market withdrawals.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are required to file adverse event reports under MDR, regulations with the FDA that are publicly available on the FDA&#8217;s website. We are required to file MDRs if our products may have caused or contributed to a serious injury or death or malfunctioned in a way that could likely cause or contribute to a serious injury or death if it were to recur. Any such MDR that reports a significant adverse event could result in negative publicity, which could harm our reputation and future sales. If we fail to report events required to be reported to the FDA within the required timeframes, or at all, the FDA could take enforcement action and impose sanctions against us. Any such adverse event involving our products also could result in future voluntary corrective actions, such as recalls or customer notifications, or agency action, such as inspection or enforcement action. Any corrective action, whether voluntary or involuntary, as well as defending ourselves in a lawsuit, would require our time and capital, distract management from operating our business and may harm our reputation and have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our employees, independent contractors, consultants, commercial partners, distributors and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are exposed to the risk that our employees, independent contractors, consultants, commercial partners, distributors and vendors may engage in fraudulent or illegal activity. Misconduct by these parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities to us that violates: (i) the laws of the FDA and other similar foreign regulatory bodies, including those laws requiring the reporting of true, complete and accurate information to such regulators; (ii) manufacturing standards; (iii) healthcare fraud and abuse laws in the United States and similar foreign fraudulent misconduct laws; or (iv) laws that require the true, complete and accurate reporting of financial information or data. These laws may impact, among other things, future sales, marketing and education programs. In particular, the promotion, sales and marketing of healthcare items and services, as well as certain business arrangements in the healthcare industry, are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, structuring and commissions, certain customer incentive programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course of patient recruitment for clinical trials.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have adopted a code of business conduct and ethics, but it is not always possible to identify and deter misconduct by our employees and other third parties, and the precautions we take to detect and prevent these activities may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">79</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are instituted against us and we are not successful in defending ourselves or asserting our rights, those actions could result in the imposition of significant fines or other sanctions, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, disgorgement, individual imprisonment, additional integrity reporting and oversight obligations, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings and curtailment of operations, any of which could adversely affect our ability to operate our business and our results of operations. Whether or not we are successful in defending against any such actions or investigations, we could incur substantial costs, including legal fees, and divert the attention of management in defending ourselves against any of these claims or investigations, which could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Environmental health and safety laws may result in liabilities, expenses and restrictions on our operations. Failure to comply with environmental laws and regulations could subject us to significant liability.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our research and development and manufacturing operations involve the use of hazardous substances and are subject to a variety of federal, state, local and foreign environmental laws and regulations relating to the storage, use, discharge, disposal, remediation of, and human exposure to, hazardous substances and the sale, labeling, collection, recycling, treatment and disposal of products containing hazardous substances. Liability under environmental laws and regulations can be joint and several and without regard to fault or negligence. Compliance with environmental laws and regulations may be expensive and noncompliance could result in substantial liabilities, fines and penalties, personal injury and third-party property damage claims and substantial investigation and remediation costs. Environmental laws and regulations could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations. We cannot assure you that violations of these laws and regulations will not occur in the future or have not occurred in the past as a result of human error, accidents, equipment failure or other causes. The expense associated with environmental regulation and remediation could harm our financial condition and operating results.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Federal, state, local and foreign laws regarding environmental protection, hazardous substances and human health and safety may adversely affect our business. Our research and development and manufacturing operations involve the use of hazardous substances and are subject to a variety of federal, state, local and foreign environmental laws and regulations relating to the storage, use, discharge, disposal and remediation of, as well as human exposure to, hazardous substances and the sale, labeling, collection, recycling, treatment and disposal of products containing hazardous substances. These operations are permitted by regulatory authorities, and the resultant waste materials are disposed of in material compliance with environmental laws and regulations. Using hazardous substances in our operations exposes us to the risk of accidental injury, contamination or other liability from the use, storage, importation, handling or disposal of hazardous materials. If our or our suppliers&#8217; operations result in the contamination of the environment or expose individuals to hazardous substances, we could be liable for damages and fines, and any liability could significantly exceed our insurance coverage and have a material adverse effect on our on our business, financial condition and results of operations. Liability under environmental laws and regulations can be joint and several and without regard to fault or negligence. Compliance with environmental laws and regulations may be expensive, and non-compliance could result in substantial liabilities, fines and penalties, personal injury and third-party property damage claims and substantial investigation and remediation costs. Environmental laws and regulations could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations. We cannot assure you that violations of these laws and regulations will not occur in the future or have not occurred in the past as a result of human error, accidents, equipment failure or other causes. The expense associated with environmental regulation and remediation could harm our business, financial condition and results of operation.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We face risks related to our collection and use of data, which could result in investigations, inquiries, litigation, fines, legislative and regulatory action and negative press about our privacy and data and security protection practices.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our business processes personal data, including some data related to health. When conducting clinical trials, we face risks associated with collecting trial participants&#8217; data, especially health data, in a manner consistent with applicable laws and regulations, such as the Common Rule (&#8220;GCP&#8221;) guidelines, or FDA human subject protection regulations. We also face risks inherent in handling large volumes of data and in protecting the security of such data. We have been and could again be subject to attacks on our systems by outside parties, or by fraudulent or</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">inappropriate behavior by our service providers or employees. Third parties may also gain access to users&#8217; accounts using stolen or inferred credentials, computer malware, viruses, spamming, sim-swap attacks, phishing attacks or other means, and may use such access to obtain users&#8217; personal data or prevent use of their accounts. Data breaches or other incidents could result in a violation of applicable United States and international privacy, data protection, security and other laws, and subject us to individual or consumer class action litigation and governmental investigations and proceedings by federal, state and local regulatory entities in the United States and by international regulatory entities, resulting in exposure to material civil and/or criminal liability. Further, our general liability insurance and corporate risk program may not cover all potential claims to which we are exposed and may not be adequate to indemnify us for all liability that may be imposed.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">This risk is enhanced in certain jurisdictions and, as we expand our operations domestically and internationally, we may be subject to additional laws in other jurisdictions. Any failure, or perceived failure, by us to comply with privacy, data protection or security laws, rules and regulations could result in proceedings or actions against us by governmental entities or others. These proceedings or actions may subject us to significant penalties and negative publicity, require us to change our business practices, increase our costs and severely disrupt our business. In the United States, various federal and state regulators, including governmental agencies like the Consumer Financial Protection Bureau and the Federal Trade Commission, have adopted, or are considering adopting, laws, regulations or rules concerning personal information and data security and have prioritized privacy and security violations for enforcement actions. Additionally, in the United States, California adopted the CCPA in January 2020, which requires certain companies that process information of California consumers to, among other things, provide new disclosures to California consumers and afford such consumers new abilities to exercise certain rights with respect to their personal information and opt out of certain sales of personal information, in addition to severely limiting our ability to use their information. The CCPA provides for civil penalties for violations, as well as a private right of action for certain data breaches that result in the unauthorized access and exfiltration, theft, or disclosure of personal information. Furthermore, in November 2020, California voters passed the CPRA, which became effective January 1, 2023. The CPRA imposes additional obligations on covered companies and significantly modifies the CCPA, including by expanding California residents&#8217; rights with respect to certain sensitive personal information. Other states have proposed or enacted privacy laws that are similar to the CCPA and CPRA, further complicating the legal landscape. Further, other states have enacted laws that cover certain aspects of the collection, use, disclosure, and/or other processing of health information, such as Washington&#8217;s My Health, My Data Act, which, among other things, provides for a private right of action. It remains unclear how various provisions of the CCPA and these other new and evolving state laws will be interpreted and enforced. In addition, laws in all 50 states require businesses to provide notice to consumers whose personal information has been accessed or acquired as a result of a data breach (and, in some cases, to regulators). The effects of the CCPA, CPRA and other such privacy laws are potentially significant, and may require us to modify our practices and policies and to incur substantial costs and expenses in an effort to comply.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, we are subject to international laws, regulations and standards in many jurisdictions, which apply broadly to the collection, use, retention, security, disclosure, transfer and other processing of personal information. For example, the GDPR, which was adopted by the EU and became effective in May 2018, applies extraterritorially and imposes several stringent requirements for controllers and processors of personal data, including, for example, higher standards for obtaining consent from individuals to process their personal data, more robust disclosures to individuals and a strengthened individual data rights regime, shortened timelines for data breach notifications, limitations on retention of information, increased requirements pertaining to special categories of personal data and pseudonymized (i.e., key-coded) data and additional obligations when we contract third-party processors in connection with the processing of the personal data.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The GDPR provides that EU member states may make their own laws and regulations limiting the (i) processing of personal data, including special categories of data (e.g., racial or ethnic origin, political opinions, religious or philosophical beliefs) and (ii) profiling and automated individual decision-making of individuals, which could limit our ability to use and share personal data or other data and could cause our costs to increase, harming our business and financial condition. Non-compliance with the GDPR is subject to significant penalties, including fines of up to &#8364;20 million or 4% of total worldwide revenue, whichever is greater. Interpretations of the GDPR by local data protection authorities in EU member states, along with the complexity of the regime itself, create uncertainty regarding the interpretation and enforcement of the law, with potential inconsistencies across EU member states. Other jurisdictions outside the EU are similarly introducing or enhancing laws and regulations relating to privacy, data protection or security, which enhances risks relating to compliance with such laws. Further, the United</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">81</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Kingdom has adopted the UK General Data Protection Regulation and UK Data Protection Act, which retain the GDPR in the United Kingdom&#8217;s national law and provide for a penalty structure similar to the GDPR. These recent developments have required us to review and modify the legal means by which we process personal data and may require us to make other modifications. The implementation and enforcement of the GDPR and other evolving legislation may subject us to enforcement risk and requirements to change certain of our data collection, processing and other policies and practices. We could incur significant costs investigating and defending such claims and, if we are found liable, significant damages. If any of these events were to occur, our business and financial results could be adversely affected.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Additionally, we are subject to laws and regulations regarding cross-border transfers of personal data, including laws relating to transfer of personal data outside of the European Economic Area (&#8220;EEA&#8221;), Switzerland, and the United Kingdom. We rely on transfer mechanisms permitted under these laws, including EU Standard Contractual Clauses (&#8220;SCCs&#8221;). Such mechanisms have received heightened regulatory and judicial scrutiny in recent years.  The Court of Justice of the European Union (&#8220;CJEU&#8221;) issued a decision in 2020 invalidating a transfer of personal data from the EEA and Switzerland to the U.S. and imposing additional obligations on companies using the SCCs. The European Commission has adopted new SCCs that are required to be implemented, and the United Kingdom has adopted new standard contractual clauses that also are required to be implemented.  In June 2021, the European Commission issued an adequacy decision in respect of the United Kingdom&#8217;s data protection framework, enabling data transfers from EU member states to the United Kingdom to continue without requiring contractual or other additional measures. While it is intended to last for at least four years, the European Commission may revoke the adequacy decision at any point, and if this occurs it could lead to additional costs and increase our overall risk exposure. These developments and other regulatory guidance or developments may impose additional obligations with respect to the transfer of personal data from the EEA, Switzerland, and the United Kingdom, all of which could restrict our activities in those jurisdictions, limit our ability to provide our products and services in those jurisdictions, require us to modify our policies and practices, and to engage in additional contractual negotiations, or increase our costs and obligations and impose limitations upon our ability to efficiently transfer personal data from the EEA, Switzerland, and the United Kingdom to the U.S. This could adversely affect the manner in which we provide our services and thus materially affect our operations and financial results.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Because the interpretation and application of laws, regulations, standards and other obligations relating to privacy, data protection and security are still uncertain, it is possible that these laws, regulations, standards and other obligations may be interpreted and applied in a manner that is inconsistent with our practices and policies. Any noncompliance, or perceived noncompliance, with laws, regulations, standards and other obligations or changes in interpretations or applications of existing laws, regulations, standards and other obligations, may subject us to fines, audits, inquiries, whistleblower complaints, adverse media coverage, investigations, lawsuits, loss of export privileges, severe criminal or civil sanction or other penalties. Additionally, although we endeavor to comply with our public statements and documentation, we may at times fail to do so or be alleged to have failed to do so. The publication of our privacy policies and other statements that provide notices and representations about privacy, data protection or security can subject us to potential government or legal action if they are found to be deceptive, unfair or misrepresentative of our actual practices. Any concerns about our privacy, data protection or security practices, even if unfounded, could damage the reputation of our businesses and discourage potential users from our products and services. Any of the foregoing could have an adverse effect on our business, financial condition, results of operations and prospects.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Inadequate funding for the FDA and other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Disruptions at the FDA and other agencies, including delays, travel restrictions, and staffing shortages, may also slow the time necessary for new medical devices to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, in 2018 and 2019, the U.S. government shut down several times and certain regulatory agencies such as the FDA had to furlough critical employees and stop critical activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">82</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2020, in response to the COVID-19 pandemic, foreign and domestic inspections of facilities were largely placed on hold, the FDA worked to resume routine surveillance, bioresearch monitoring and pre-approval inspections on a prioritized basis. During 2020 and 2021 a number of companies announced receipt of complete response letters due to the FDA&#8217;s inability to complete required inspections for their applications.  While the FDA has largely caught up with domestic preapproval inspections, it continues to work through its backlog of foreign inspections. However, the FDA may not be able to continue its current inspection pace or may be unable to complete required inspections during the review period, which can delay clinical development and result in a complete response letter. On May 11, 2023, the federal government ended the COVID-19 public health emergency, which ended a number of temporary changes made to federally funded programs while some continue to be in effect. The full impact of such policy changes and the wind-down of the public health emergency on the FDA and other regulatory policies and operations is unclear.  Disruptions at the FDA could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our global operations can expose us to numerous and sometimes conflicting legal and regulatory requirements, including to anti-bribery and anti-corruption laws, such as the FCPA and the U.K. Bribery Act, and violation of these requirements could result in substantial penalties and prosecution and harm our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have commercialized the RxSight system outside of the United States, and each component is registered with the MHRA in the United Kingdom. We are subject to numerous, and sometimes conflicting, legal regimes in the countries in which we operate, including on matters as diverse as health and safety standards, marketing and promotional activities, anticorruption, import/export controls, content requirements, trade restrictions, tariffs, taxation, sanctions, immigration, internal and disclosure control obligations, securities regulation, anti-competition, data protection privacy, security and labor relations. This includes in emerging markets where legal systems may be less familiar to us. We strive to abide by and maintain compliance with these laws and regulations. Compliance with diverse legal requirements is costly, time-consuming and requires significant resources. Violations of one or more of these regulations in the conduct of our business could result in significant fines, criminal sanctions against us or our officers, prohibitions on doing business and damage to our reputation. Violations of these regulations in connection with the performance of our obligations to our customers also could result in liability for significant monetary damages, fines and/or criminal prosecution, unfavorable publicity and other reputational damage, restrictions on our ability to process information and allegations by our customers or distributors that we have not performed our contractual obligations. Due to the varying degrees of development of the legal systems of the countries in which we operate, local laws might be insufficient to protect our rights.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our operations outside of the United States are subject to various heavily enforced anti-bribery and anti-corruption laws, such as the FCPA, U.K. Bribery Act and similar laws around the world. These laws generally prohibit U.S. companies and their employees and intermediaries from offering, promising, authorizing or making improper payments to foreign government officials for the purpose of obtaining or retaining business or gaining any advantage. We face significant risks if we, which includes our third-party business partners and intermediaries, fail to comply with the FCPA or other anti-corruption and anti-bribery laws. Responding to any enforcement action or related investigation may result in a materially significant diversion of management&#8217;s attention and resources and significant defense costs and other professional fees. Any violation of the FCPA or other applicable anti-bribery, anti-corruption or anti-money laundering laws could result in whistleblower complaints, adverse media coverage, investigations, loss of export privileges, severe criminal or civil sanctions and, in the case of the FCPA, suspension or debarment from U.S. government contracts, which could have a material and adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our international operations could be affected by changes in laws, trade regulations, labor and employment regulations, and procedures and actions affecting approval, products and solutions, pricing, reimbursement and marketing of our products and solutions, as well as by inter-governmental disputes. Any of these changes could adversely affect our business. The imposition of new laws or regulations, including potential trade barriers, may increase our operating costs, impose restrictions on our operations or require us to spend additional funds to gain compliance with the new rules, if possible, which could have an adverse impact on our financial condition and results of operations.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">83</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks related to reliance on third parties</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">From time to time, we engage outside parties to perform services related to certain of our clinical studies and trials. If these third parties do not successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain regulatory approval for or commercialize our products.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">From time to time, we engage consultants to help design, monitor and analyze the results of certain of our clinical studies and trials. The consultants we engage interact with clinical investigators to enroll patients in our clinical trials. We depend on these consultants and clinical investigators to conduct clinical studies and trials and monitor and analyze data from these studies and trials under the investigational plan and protocol for the study or trial and in compliance with applicable regulations and standards, such as GCP guidelines, the Common Rule, and FDA human subject protection regulations. We may face delays in our regulatory approval process if these parties do not perform their obligations in a timely, compliant or competent manner. If these third parties do not successfully carry out their duties or meet expected deadlines, or if the quality, completeness or accuracy of the data they obtain is compromised due to the failure to adhere to our clinical trial protocols or for other reasons, our clinical studies or trials may be extended, delayed or terminated or may otherwise prove to be unsuccessful, and we may have to conduct additional studies, which would significantly increase our costs, in order to obtain the regulatory clearances or approvals that we need to commercialize our products.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We and our component suppliers may not meet regulatory quality standards applicable to our manufacturing processes, which could have an adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As a medical device manufacturer, we must register with the FDA and non-U.S. regulatory agencies in jurisdictions where we commercialize our products, and we are subject to periodic inspection by the FDA and foreign regulatory agencies, for compliance with certain good manufacturing practices, including design controls, product validation and verification, in process testing, quality control and documentation procedures. Compliance with applicable regulatory requirements is subject to continual review and is rigorously monitored through periodic inspections by the FDA and foreign regulatory agencies. Our manufacturer, component, and sub-component suppliers are also required to meet certain standards applicable to their manufacturing processes.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We cannot assure you that we or our component suppliers comply or can continue to comply with all regulatory requirements. The failure by us or one of our component suppliers to achieve or maintain compliance with these requirements or quality standards may disrupt our ability to supply products sufficient to meet demand until compliance is achieved or, with a component supplier, until a new supplier has been identified and evaluated. Our or any of our component supplier&#8217;s failure to comply with applicable regulations could cause sanctions to be imposed on us, including warning letters, fines, injunctions, civil penalties, failure of regulatory authorities to grant marketing approval of our products, delays, suspension or withdrawal of approvals or clearances, license revocation, seizures or recalls of products, operating restrictions and criminal prosecutions, which could harm our business. We cannot assure you that if we need to engage new suppliers to satisfy our business requirements, we can locate new suppliers in compliance with regulatory requirements at a reasonable cost and in an acceptable timeframe. Our failure to do so could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For products that we currently distribute or market in the EU and the United Kingdom, as well as future products for which we obtain the applicable marketing authorization, we must maintain certain International Organization for Standardization (&#8220;ISO&#8221;), certifications to sell our products and must undergo periodic inspections by notified bodies, such as BSI, to obtain and maintain these certifications. If we fail these inspections or fail to meet these regulatory standards, it could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We depend upon third parties, including single and sole source suppliers, to manufacture certain components and subcomponents of the RxSight system making us vulnerable to supply disruptions and price fluctuations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We rely on third parties, including single and sole source suppliers, to manufacture certain components and subcomponents of our products and to provide raw materials, primarily chemicals for our LAL. We do not have long-term supply agreements with, or guaranteed commitments from our suppliers, including single and sole source suppliers. We utilize purchase orders or blanket orders covering the medium term of 18&#8211;24 months for the majority of our supplier base. While we depend on our suppliers to provide us and our customers with materials in a timely manner that meet our and their quality, quantity and cost requirements, vendors will miss delivery dates, extend delivery dates or in some circumstances cancel purchase orders because these suppliers may encounter problems during manufacturing for a variety of reasons, any of which could delay or impede their ability to meet our demand.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">84</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The expansion of global lead times has resulted in the lack of availability of raw materials, including semiconductors, computers, monitors electronic parts, metals, packaging, adhesives, chemicals, resins and subcontract painted components. Certain suppliers have passed on higher prices, surcharges and expedited shipping fees to defray the higher commodity prices they are paying due to short supply and pushed out delivery dates. Additionally, we identify and qualify new suppliers to mitigate risk due to single and sole source suppliers and to alleviate supply chain constraints we will identify and qualify new vendors or substitute components which requires testing, validations and documentation adding to internal costs and diverting engineering resources from other projects.  While we have taken measures to mitigate business continuity risk, including increasing standard lead times, payment of expedite fees, issuance of a limited number of non-cancelable purchase orders, advance delivery of critical components ahead of normal delivery dates and second sourcing, our suppliers may cease producing the components we purchase from them or otherwise decide to cease doing business with us. Any supply interruption from our suppliers or failure to obtain additional suppliers for any of the components or subcomponents used in our products would limit our ability to manufacture our current and new products and could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">The failure of third parties to meet their contractual, regulatory, and other obligations could adversely affect our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We rely on suppliers, vendors, outsourcing partners, consultants, and other third parties to research, develop, manufacture and commercialize our products. Using these third parties poses a number of risks, such as: (i) they may not perform to our standards or legal requirements; (ii) they may not produce reliable results; (iii) they may not perform in a timely manner; (iv) they may not maintain confidentiality of our proprietary information; (v) disputes may arise with respect to ownership of rights to technology developed with our partners; and (vi) disagreements could cause delays in, or termination of, the research, development or commercialization of our products or result in litigation or arbitration. Moreover, some third parties are located in markets subject to political and social risk, corruption, infrastructure problems and natural disasters, in addition to country-specific privacy, data protection and security risk given current legal and regulatory environments. Failure of third parties to meet their contractual, regulatory and other obligations may have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks related to our common stock</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">The price of our stock may be volatile, and you could lose all or part of your investment.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The trading price of our common stock has been and may continue to be highly volatile and could be subject to wide fluctuations in response to various factors, some of which we cannot control. From the date of our initial public offering through August 1, 2024, our common stock has traded at a low of $8.80 and a high of $66.54 on the Nasdaq Global Market.  The stock market in general has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating performance. In addition to the factors discussed in Part II, Item 1A, &#8220;Risk Factors,&#8221; and elsewhere in this report, these factors include:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">announcement of our results of operations and updates regarding our business;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the timing and results of preclinical studies and clinical trials of our current and future products or those of our competitors;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the success of competitive products or announcements by potential competitors of their product development efforts;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">regulatory actions with respect to our products or our competitors&#8217; products;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">actual or anticipated changes in our growth rate relative to our competitors;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">regulatory or legal developments in the United States and other countries;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">developments or disputes concerning patent applications, issued patents or other intellectual property or proprietary rights;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the recruitment or departure of key personnel;</span></div></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">announcements by us or our competitors of significant acquisitions, strategic collaborations, joint ventures, collaborations or capital commitments;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">actual or anticipated changes in estimates as to financial results, development timelines or recommendations by securities analysts;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">fluctuations in the valuation of companies perceived by investors to be comparable to us;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">market conditions in the medical device sector;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">changes in the structure of healthcare payment systems;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">share price and volume fluctuations attributable to inconsistent trading volume levels of our shares;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">announcement or expectation of additional financing efforts;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">sales of our common stock by us, our insiders or our other stockholders; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">general economic, industry and market conditions, including global and national events, such as the conflicts in Eastern Europe, and general economic downturns.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The realization of any of the above risks or any of a broad range of other risks, including those described in this Part II, Item 1A, &#8220;Risk Factors,&#8221; could have a dramatic and adverse impact on the market price of our common stock.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert our management&#8217;s attention from other business concerns, which could seriously harm our business.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">If securities or industry analysts do not publish research or publish unfavorable research about our business, our stock price and trading volume could decline.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The trading market for our common stock will rely in part on the research and reports that equity research analysts publish about us and our business. We will not have any control of the analysts or the content and opinions included in their reports. The price of our stock could decline if one or more equity research analysts downgrade our stock or issue other unfavorable commentary or research. If one or more equity research analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which in turn could cause our stock price or trading volume to decline.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We do not know whether an active, liquid and orderly trading market will exist for our common stock or what the market price of our common stock will be and as a result it may be difficult for you to sell your shares of our common stock.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our common stock is currently traded on Nasdaq Global Market, but we can provide no assurance that we will be able to maintain an active trading market on Nasdaq Global Market or any other exchange in the future. If an active trading market does not develop, or is not maintained, or if we fail to satisfy the continued listing standards of  the Nasdaq Global Market or applicable SEC rules for any reason and our securities are delisted, you may have difficulty selling any of our shares of common stock that you buy. The lack of an active trading market may impair your ability to sell your shares at the time you wish to sell them or at a price that you consider reasonable. The lack of an active trading market may also reduce the fair market value of your shares. Furthermore, an inactive trading market may also impair our ability to raise capital by selling shares of our common stock and may impair our ability to enter into strategic collaborations or acquire companies, technologies or other assets by using our shares of common stock as consideration.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Sales of a substantial number of shares of our common stock in the public market could cause our stock price to fall.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Sales of a substantial number of shares of our common stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">86</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024, we had 39,617,334 shares of common stock issued and outstanding. All of these shares are available for sale in the public market, subject to limitations under Rule 144 with respect to affiliates of our company.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have filed registration statements on Form S-8 under the Securities Act registering the offer and sale of up to an aggregate of 10,660,797 shares of common stock pursuant to our Equity Plans and an aggregate of 757,694 shares of common stock pursuant to our 2021 ESPP. Our 2021 Plan and 2021 ESPP each contain an evergreen provision that may increase the number of shares available for issuance pursuant to such plans on the first day of each fiscal year. See Note 6 &#8211; Stock-Based Compensation Expense in the Notes to the unaudited condensed consolidated financial statements included in this report.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 8, 2022, we filed a $200.0 million shelf registration statement which became effective on August 12, 2022. The shelf registration statement is effective for three years and permits us to sell, from time to time, up to $200.0 million in aggregate value of our common stock, preferred stock, debt securities, warrants, and/or units. The shelf registration statement is intended to provide us with flexibility to access additional capital when market conditions are appropriate.  At the time of filing of the shelf registration statement, we also filed a prospectus supplement to sell up to an aggregate value of $50.0 million dollars of our common stock through an &#8220;at-the-market&#8221; (the &#8220;ATM&#8221;) offering. The shares were offered through BofA Securities, Inc. as sales agent. As of December 31, 2023, the full $50 million authorized under the ATM offering was sold.  On February 10, 2023, we filed a prospectus supplement to sell $50.0 million dollars of our common stock in an underwritten public offering (the &#8220;Public Offering&#8221;). Pursuant to the Public Offering, we granted the underwriters an option to purchase up to an additional $7.5 million of our common stock. On February 10, 2023, we sold $50.0 million of our common stock and on February 14, 2023, the underwriters exercised their over-allotment option in full. As of June 30, 2024 $92.5 million remains available for issuance under the shelf registration statement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On February 28, 2024, we filed a registration statement on Form S-8 under the Securities Act to register the issuance of 1,445,580 shares of common stock subject to options or other equity awards reserved for future issuance under the 2021 Plan.  The number of shares registered represents the annual evergreen increase calculated as 4% of the outstanding shares of our common stock on the last day of fiscal year 2023 under our 2021 Plan.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On May 8, 2024, we filed an automatic shelf registration statement on Form S-3ASR with the SEC that enables us to offer for sale, from time to time and as the capital markets permit, an unspecified amount of common stock, preferred stock, debt securities, warrants and units. The shelf registration statement became automatically effective upon filing and is valid for three years. Each time we offer to sell securities under the registration statement, we will provide a prospectus supplement that will contain specific information about the terms of that offering and the securities being offered. For example, on May 9, 2024, we filed a prospectus supplement for the offer and sale of up to 1,785,714 shares of our common stock in an underwritten public offering (the &#8220;Public Offering&#8221;). On May 13, 2024, we issued 2,053,571 shares of our common stock at a price to the public of $56.00 per share, which included the full exercise by the underwriters of their option to purchase up to 267,857 additional shares. Our net proceeds from the offering were $107.5 million, after deducting $6.9 in underwriting discounts and commissions and $0.6 million in other offering costs. We cannot predict what effect, if any, sales of our shares in the public market or the availability of shares for sale will have on the market price of our common stock. However, future sales of substantial amounts of our common stock in the public market, or the perception that such sales may occur, could adversely affect the market price of our common stock.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the future, we may issue additional shares of common stock or other equity or debt securities convertible into common stock in connection with a financing, acquisition, litigation settlement, and employee arrangements or otherwise. Any such issuance could result in substantial dilution to our existing stockholders and could cause our stock price to decline.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We have incurred increased costs as a result of operating as a public company, and our management devotes substantial time to new compliance initiatives and corporate governance practices. Additionally, if we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements on a timely basis could be impaired.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As a public company we are incurring significant legal, accounting and other expenses and these expenses may increase since after December 31, 2023, we are no longer considered an &#8220;emerging growth company.&#8221; We are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Protection Act, as well as rules adopted, and to be adopted, by the SEC and Nasdaq. Our management</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">87</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and other personnel will need to devote a substantial amount of time and effort to these compliance initiatives. Moreover, we expect these rules and regulations to substantially increase our legal and financial compliance costs and to make some activities more time-consuming and costly, which will increase our operating expenses. For example, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to incur substantial costs to maintain sufficient coverage. We cannot accurately predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified employees and persons to serve on our Board of Directors, our board committees or as executive officers.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Because we no longer qualify as an &#8220;emerging growth company&#8221; we will incur additional expenses and management&#8217;s time may be diverted in an effort to comply with compliance-related activities to comply with the increased documentation and reporting requirements under Section 404(b) of the Sarbanes-Oxley Act of 2002. The Sarbanes-Oxley Act requires, among other things, that we assess the effectiveness of our internal control over financial reporting annually and the effectiveness of our disclosure controls and procedures quarterly.  In addition, our independent registered public accounting firm will have to attest to the effectiveness of our internal control over financial reporting under Section 404(b).  We have implemented improved processes for documenting and evaluating our system of internal controls required under Section 404(b) however, the rules governing the standards that must be met for management to assess our internal control over financial reporting are complex and require significant judgment, documentation, testing and possible remediation to meet the detailed standards. During the course of documenting, evaluating and testing our internal control over financial reporting, our management may identify significant deficiencies or material weaknesses which may not be remedied in time to meet the deadline imposed by the Sarbanes-Oxley Act.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud will be detected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we are unable to comply with the requirements of Section 404(b) of the Sarbanes-Oxley Act effectively and if management identifies one or more significant deficiencies or material weaknesses, or if our independent registered public accounting firm is unable to attest that our management&#8217;s report is fairly stated or if they are unable to express an opinion on the effectiveness of our internal controls or if we are unable to maintain proper and effective internal controls, we may not be able to produce timely and accurate financial statements any of which could result in a loss of investor confidence or negative investor perceptions. If any of the above were to happen, the market price of our stock could decline significantly and we could be subject to sanctions or investigations by Nasdaq, the SEC or other regulatory authorities.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">We do not intend to pay dividends on our common stock so any returns will be limited to the value of our stock.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have never declared or paid any cash dividends on our common stock. We currently anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. Any return to stockholders will therefore be limited to any appreciation in the value of their stock.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Provisions in our certificate of incorporation, bylaws and Delaware law might discourage, delay or prevent a change in control of our company or changes in our management and, therefore, depress the market price of our common stock.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our certificate of incorporation and bylaws contain provisions that could depress the market price of our common stock by acting to discourage, delay or prevent a change in control of our company or changes in our management that the stockholders of our company may deem advantageous. These provisions, among other things:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">establish a classified Board of Directors so that not all members of our board are elected at one time;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">permit only the Board of Directors to establish the number of directors and fill vacancies on the board;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provide that directors may only be removed &#8220;for cause&#8221; and only with the approval of two-thirds of our stockholders;</span></div></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">88</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">authorize the issuance of &#8220;blank check&#8221; preferred stock that our board could use to implement a stockholder rights plan (also known as a poison pill);</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">eliminate the ability of our stockholders to call special meetings of stockholders;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">prohibit stockholder action by written consent, which requires all stockholder actions to be taken at a meeting of our stockholders;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">prohibit cumulative voting;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">authorize our Board of Directors to amend the bylaws;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">establish advance notice requirements for nominations for election to our board or for proposing matters that can be acted upon by stockholders at annual stockholder meetings; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">require a super-majority vote of stockholders to amend some provisions described above.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, Section 203 of the General Corporation Law of the State of Delaware, (&#8220;DGCL&#8221;), prohibits a publicly-held Delaware corporation from engaging in a business combination with an interested stockholder, generally a person which together with its affiliates owns, or within the last three years has owned, 15% of our voting stock, for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Any provision of our amended and restated certificate of incorporation, amended and restated bylaws or Delaware law that has the effect of delaying or preventing a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our capital stock and could also affect the price that some investors are willing to pay for our common stock.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our bylaws provide that, unless the company consents in writing to an alternative forum, the Court of Chancery of the State of Delaware will be the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another State court in Delaware or the federal district court for the District of Delaware) is the exclusive forum for:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">any derivative action or proceeding brought on our behalf;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">any action asserting a claim of breach of fiduciary duty;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">any action asserting a claim against us arising under the DGCL, our amended and restated certificate of incorporation or our bylaws; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:5.5235502658900995%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">any action asserting a claim against us that is governed by the internal-affairs doctrine.</span></div></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">This Delaware forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that the stockholder finds favorable for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees. Any person or entity purchasing or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented to this provision. If a court were to find this Delaware forum provision to be inapplicable or unenforceable in an action, we may incur additional costs associated with litigating such disputes in multiple and/or other jurisdictions, which could seriously harm our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended against any person in connection with any offering of the Company&#8217;s securities, including but not limited to any auditor, underwriter, expert, control person, or other defendant. This federal forum provision may limit a stockholder&#8217;s ability to bring a Securities Act claim in a judicial forum that the stockholder finds favorable, which may discourage lawsuits against us and our directors, officers and other employees. Any person purchasing or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented to this provision. While the Delaware Supreme Court has held such provisions to be facially valid as a matter of Delaware law and several state trial courts have enforced such</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">89</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provisions and required that suits asserting Securities Act claims be filed in federal court, there is no guarantee that courts of appeal will affirm the enforceability of such provisions. If a court were to find this federal forum provision to be inapplicable or unenforceable in an action, we may incur additional costs associated with litigating Securities Act claims in state court, or both state and federal court, which could seriously harm our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">This Delaware forum provision does not apply to actions arising under the Securities Exchange Act of 1934 because the federal courts have exclusive jurisdiction over such claims.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Taxing authorities may successfully assert that we should have collected or in the future should collect sales and use, value added or similar taxes, and we could be subject to liability with respect to past or future sales, which could adversely affect our results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We rely on third party software for state and local tax rates, updated whenever tax rates change. We also rely on state exemptions, when applicable, for medical devices and services, which are determined by management&#8217;s review of each state&#8217;s sales tax laws and regulations concerning prescribed medical treatments. However, as laws and regulations change from time to time, these exemptions may or may not continue to apply to our products in the various taxing jurisdictions. Certain jurisdictions in which we do not collect such taxes on sales of our products may later assert that such taxes are applicable, which could result in tax assessments, penalties and interest, and we may be required to collect such taxes in the future. Such tax assessments, penalties and interest or future requirements may adversely affect the results of our operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our Board of Directors are authorized to issue and designate shares of our preferred stock in additional series without stockholder approval under our charter documents and Delaware law.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our certificate of incorporation authorizes our Board of Directors, without the approval of our stockholders, to issue shares of our preferred stock, subject to limitations prescribed by applicable law, rules and regulations and the provisions of our amended and restated certificate of incorporation, as shares of preferred stock in series, to establish from time to time the number of shares to be included in each such series and to fix the designation, powers, preferences and rights of the shares of each such series and the qualifications, limitations or restrictions thereof. The powers, preferences and rights of these additional series of preferred stock may be senior to or on parity with our common stock, which may reduce its value.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, financial condition or results of operations.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Tax Act enacted many significant changes to the U.S. tax laws, the consequences of which have not yet been fully determined. Changes in corporate tax rates, the realization of net deferred tax assets relating to our U.S. operations, the taxation of foreign earnings and the deductibility of expenses contained in the Tax Act or other tax reform legislation could have a material impact on the value of our deferred tax assets, could result in significant one-time charges in the current or future taxable years and could increase our future U.S. tax expense. As an example, for taxable years beginning during or after 2022, the Tax Act eliminated the option to immediately deduct research and development expenditures currently and required taxpayers to capitalize and amortize them over five or fifteen years pursuant to Section 174 of the Code, which may impact our effective tax rate and our cash tax liability.  However, recently proposed tax legislation, if enacted, would restore the ability to deduct currently domestic research and development expenditures through 2025 and would retroactively restore this benefit for 2022 and 2023. Regulatory or legislative developments may arise from the proposed U.S. tax reform under the Biden Administration, which has proposed several changes to the corporate income tax regime, which, if adopted, could result in increased taxation of our business operations. There is uncertainty regarding what changes, if any, will be enacted and the effect on our business and financial results. The foregoing items, as well as any future changes in tax laws, could have a material adverse effect on our business, cash flow, financial condition or results of operations.  We will also continue to monitor and assess the impact of international tax reform, including but not limited to the 15% global minimal tax proposed by the Organisation for Economic Co-operation and Development.  Finally, the Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;) was effective beginning in fiscal year 2023. We do not currently expect that the IRA will have a material impact on our income tax liability.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">General risk factors</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our success is highly dependent on our ability to attract and retain highly skilled executive officers and employees.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To succeed, we must recruit, retain, manage and motivate qualified executives as we build out the management team, and we face significant competition for experienced personnel. We are highly dependent on the principal members of our management and need to add executives with operational and commercialization experience as we plan for commercialization of our current and future products and build out a leadership team that can manage our operations as a public company. If we do not succeed in attracting and retaining qualified personnel, particularly at the management level, it could adversely affect our ability to execute our business plan and harm our operating results. In particular, the loss of one or more of our executive officers could be detrimental to us if we cannot recruit suitable replacements in a timely manner. The competition for qualified personnel in the medical device and ophthalmology field is intense and as a result, we may be unable to continue to attract and retain qualified personnel necessary for the future success of our business. We could in the future have difficulty attracting experienced personnel to our company and may be required to expend significant financial resources in our employee recruitment and retention efforts.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Many of the other medical device and biotechnology companies that we compete against for qualified personnel have greater financial and other resources, different risk profiles and a longer history in the industry than we do. They also may provide more diverse opportunities and better prospects for career advancement. Some of these characteristics may be more appealing to high-quality candidates than what we have to offer. If we are unable to continue to attract and retain high-quality personnel, the rate and success at which we can discover, develop and commercialize our current and future products will be limited and the potential for successfully growing our business will be harmed.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our business and operations would suffer in the event of system failures or security breaches or incidents.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our computer systems, as well as those of our contractors and other third parties with whom we do business, are vulnerable to damage from computer viruses, ransomware and other malicious code, unauthorized access, natural disasters (including hurricanes), terrorism, war and telecommunication and electrical failures. Any disruption or interruption in our systems, or those of our contractors or other third parties with whom we do business, whether from these or other causes,  could cause interruptions in our operations, result in a material disruption of the commercialization of our RxSight system and our future products, and result in significant legal and financial exposure and reputational damages that could potentially have an adverse effect on our business. For example, the loss, corruption, or unavailability of preclinical study or clinical trial data from completed, ongoing, or planned trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Any disruption or security breach or incident resulting in, or believed or perceived to have reported in, the loss or unavailability of or damage to our data or applications, or inappropriate disclosure or other processing of personal, confidential or proprietary information, could cause us to incur liability and cause the commercialization of our RxSight system and the further development of our current and future products to be delayed.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The secure processing, maintenance, and transmission of this information is critical to our operations. Despite our security measures, our information technology and infrastructure may be vulnerable to attacks by hackers, internal bad actors, or others, or breached due to technical vulnerabilities, employee error, malfeasance, or other disruptions. Although, to our knowledge, we have not experienced any such material security breach to date, any security breach or security incident could compromise our systems and networks and the information stored or otherwise processed on them could be accessed, publicly disclosed, lost, stolen, rendered unavailable, modified, or otherwise processed without authorization. Any such actual or perceived access, disclosure, or other security breach or incident, loss, or unauthorized processing of information (whether affecting us or one of our third-party service providers or other third parties with whom we do business) could result in legal claims and proceedings, regulatory investigations, and other proceedings and liability under laws that protect the privacy of personal information, significant regulatory penalties or other fines or remedies, and such an event could disrupt our operations, damage our reputation, and cause a loss of confidence in us and our ability to commercialize our products and conduct clinical trials, which could adversely affect our reputation and delay the commercialization of our RxSight system and clinical development of our current and future products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The techniques and sophistication used to conduct cyber-attacks and security breaches or other incidents, including of information technology systems, as well as the sources and targets of these attacks, may take many</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">91</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">forms (including phishing, social engineering, denial or degradation of service attacks, sim swaps, ransomware, malware or other malicious code), change frequently and are often not recognized until such attacks are launched or have been in place for a period of time. In addition, our employees, contractors, or third parties with whom we do business may attempt to circumvent our security measures in order to misappropriate information, including confidential, personal, or otherwise regulated or protected information, and may purposefully or inadvertently cause a breach or incident involving, or compromise of, such information. Third parties may have the technology or know-how to breach the security of the information collected, stored, or transmitted by us, our contractors, third-party service providers, or other third parties with whom we do business, and our respective security measures, as well as those of our respective third-party service providers, may not effectively prohibit others from obtaining improper access to this information. Advances in computer and software capabilities and encryption technology, new tools, and other developments may increase the risk of such a breach, incident, or compromise. There is no assurance that any security procedures or controls that we, our contractors, or our third-party service providers or other third parties with whom we do business have implemented will be sufficient to prevent data-security related incidents from occurring.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We may be required to expend significant capital and other resources to protect against, respond to, and recover from any potential, attempted or existing security breaches, incidents, or failures and their consequences. As data security-related threats continue to evolve, we may be required to expend significant additional resources to continue to modify or enhance our protective measures or to investigate and remediate any information security vulnerabilities. We could be forced to expend significant financial and operational resources in responding to a security breach or incident, including investigating and remediating any information security vulnerabilities, defending against and resolving legal and regulatory claims and complying with notification obligations, all of which could divert resources and the attention of our management and key personnel away from our business operations and adversely affect our business, financial condition and results of operations. In addition, our remediation efforts may not be successful, and we could be unable to implement, maintain and upgrade adequate safeguards.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our insurance policies may not be adequate to compensate us for the potential losses arising from any such disruption, failure, or security breach of, or security incident of or impacting, our systems or third-party systems where information important to our business operations or commercial development is stored or otherwise processed. In addition, such insurance may not be available to us in the future on economically reasonable terms, or at all. Further, our insurance may not cover all claims made against us and could have high deductibles in any event, and defending a suit, regardless of its merit, could be costly and divert management attention.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Economic conditions may adversely affect our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Global economic, political and market conditions, armed conflict, including in Eastern Europe and the Middle East, and general economic downturns, may negatively impact our business. Challenging or uncertain economic conditions including those related to global epidemics, pandemics, or contagious diseases, geopolitical turmoil, and macroeconomic conditions, inflation, fluctuations in foreign exchange rates, instability in the global banking system, disruptions in supply chains and interest rates, could make it difficult for our customers and potential customers to accurately forecast and plan future business activities and may cause our customers and potential customers to slow or reduce spending, or vary order frequency, on our products. Furthermore, during challenging or uncertain economic times, our customers may face difficulties gaining timely access to sufficient credit and experience decreasing cash flow, which could impact their willingness to make purchases and their ability to make timely payments to us. Global economic conditions could have an adverse effect on demand for our products, including on our ability to predict future operating results and on our financial condition and operating results. If global economic conditions remain uncertain or deteriorate, it may materially impact our business, operating results and financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For example, we and other key international economies are currently operating in a period of economic uncertainty and the United States has recently experienced historically high levels of inflation and rising interest rates, which has led to increased costs of labor, capital, employee compensation and other similar effects. If unfavorable conditions in the national and global economy persist, or worsen, our current and potential customers&#8217; operating costs will likely increase, which could result in reduced operating budgets. Our revenue may be disproportionately affected by delays or reductions in spending.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The present conditions and state of the U.S. and global economies make it difficult to predict whether, when and to what extent a recession has occurred or will occur in the near future. We cannot predict the timing, strength or</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">92</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">duration of any economic slowdown, instability or recovery, generally or within any particular industry. If the economic conditions of the general economy or markets in which we operate do not improve, or worsen from present levels, our business, results of operations, and financial condition could be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Additionally, adverse worldwide economic conditions may also adversely impact our suppliers&#8217; ability to provide us with materials and components, cause them to limit or place burdensome conditions upon future transactions with us, or affect their ability to fulfill their respective contractual obligations to us, which could have a material adverse effect on our business, financial condition and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Litigation and other legal proceedings may adversely affect our business.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">From time to time we may become involved in legal proceedings relating to patent and other intellectual property matters, product liability claims, employee claims, tort or contract claims, federal regulatory investigations, securities class action and other legal proceedings or investigations, which could have an adverse impact on our reputation, business and financial condition and divert the attention of our management from the operation of our business. Litigation is inherently unpredictable and can result in excessive or unanticipated verdicts and/or injunctive relief that affect how we operate our business. We could incur judgments or enter into settlements of claims for monetary damages or for agreements to change the way we operate our business, or both. There may be an increase in the scope of these matters or there may be additional lawsuits, claims, proceedings or investigations in the future, which could have a material adverse effect on our business, financial condition and results of operations. Adverse publicity about regulatory or legal action against us could damage our reputation and brand image, undermine our customers&#8217; confidence and reduce long-term demand for our products, even if the regulatory or legal action is unfounded or not material to our operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our operations could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, severe weather conditions, medical epidemics and other natural or man-made disasters or business interruptions, for which we are predominantly self-insured. We rely on third-party manufacturers to produce our products. Our ability to obtain clinical supplies of our products could be disrupted if the operations of these suppliers were affected by a man-made or natural disaster or other business interruption. In addition, our corporate headquarters is located in Aliso Viejo, California, near major earthquake faults and fire zones, and the ultimate impact on us for being located near major earthquake faults and fire zones and being consolidated in a certain geographical area is unknown. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our results of operations could be materially harmed if we are unable to accurately forecast customer demand for our products and manage our inventory.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We seek to maintain sufficient levels of inventory in order to protect ourselves from supply interruptions, but due to the expansion of global lead times, particularly in Europe and Asia, has resulted in the lack of availability of raw materials, including semiconductors, computers, monitors electronic parts, metals, packaging, adhesives, chemicals, resins and subcontract painted components, limiting our ability to maintain as much inventory of components, sub-assemblies, materials and finished products on hand as would be ideal under normal circumstances. To ensure adequate inventory supply and manage our operations with our third-party manufacturers and suppliers, we forecast anticipated materials requirements and demand for our products in order to predict inventory needs and then place orders with our suppliers based on these predictions. Our ability to accurately forecast demand for our products could be negatively affected by many factors, including our limited historical commercial experience, rapid growth, failure to accurately manage our expansion strategy, the expansion of global lead times, product introductions by competitors, an increase or decrease in customer demand for our products, our failure to accurately forecast customer acceptance of new products, unanticipated changes in general market conditions or regulatory matters and weakening of economic conditions or consumer confidence in future economic conditions.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inventory levels in excess of customer demand, including as a result of our introduction of product enhancements, may result in a portion of our inventory becoming obsolete or expiring, as well as inventory write-downs or write-offs, which could have a material adverse effect on our business, financial condition and results of operations. Conversely, if we underestimate customer demand for our products or our own requirements for components, subassemblies and materials, our third-party manufacturers and suppliers may not be able to deliver</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">93</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">components, sub-assemblies and materials to meet our requirements, which could result in inadequate inventory levels or interruptions, delays or cancellations of deliveries to our customers, any of which would damage our reputation, customer relationships and business. In addition, several components, sub-assemblies and materials incorporated into our products require lengthy order lead times, and additional supplies or materials may not be available when required on terms that are acceptable to us, or at all, and our third-party manufacturers and suppliers may not be able to allocate sufficient capacity in order to meet our increased requirements, any of which could have an adverse effect on our ability to meet customer demand for our products and our business, financial condition and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_2_unregistered_sales_equity_securit"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 2. Unregistered Sales of Equi</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ty Securities and Use of Proceeds</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(a) Recent Sales of Unregistered Securities</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">None</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(b) Use of Proceeds from Registered Securities</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">None</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(c) Issuer Purchases of Equity Securities</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">None</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item3_defaults"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 3. D</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">efaults Upon Senior Securities.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">None.</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_4_mine_safety_disclosures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 4. M</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ine Safety Disclosures.</span></p><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">None.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">94</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item5otherinformation"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 5. Other </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Information.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_38a565c1-b9b7-4d8c-9d86-ca2b89f36747" contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d" name="ecd:MtrlTermsOfTrdArrTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Rule 10b5-1 Trading Arrangements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8adbd0ff-0457-487d-8a3f-c087a060244d" contextRef="C_e16a6e57-fa09-4b23-9d5a-b5b69cb75e2d" name="ecd:TrdArrAdoptionDate"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">May 15, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1cf4e412-5d95-4d8a-b525-465e686c04a5" contextRef="C_e16a6e57-fa09-4b23-9d5a-b5b69cb75e2d" name="ecd:TrdArrIndName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">J. Andy Corley</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, a member of our </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6b3554c2-0df2-418f-a497-d997b1bd1842" contextRef="C_e16a6e57-fa09-4b23-9d5a-b5b69cb75e2d" name="ecd:TrdArrIndTitle"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Board of Directors</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">,  entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8f39efd9-7401-4741-9f3b-2095ab9ab26a" contextRef="C_e16a6e57-fa09-4b23-9d5a-b5b69cb75e2d" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rule 10b5-1</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> trading arrangement that is intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c) (a &#8220;Rule 10b5-1 Trading Plan&#8221;) for the sale of securities of our common stock. Mr. Corley&#8217;s Rule 10b5-1 Trading Plan, which has a term from August 19, 2024 to May 20, 2025, provides for the sale of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_b466ed0d-aa2f-4008-8113-bbc5b0a4935c" contextRef="C_628a0a40-4c51-46a8-ae7c-d6e7b44797d1" name="ecd:TrdArrSecuritiesAggAvailAmt" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">40,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock at a pre-determined limit price.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9b1c7452-966e-44ec-83f2-5608a312d0e2" contextRef="C_9161bac0-099b-4ec0-be0c-82d298abeca3" name="ecd:TrdArrAdoptionDate"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">May 21, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b18f7c28-a5c9-4bae-85d6-09c612e759b1" contextRef="C_9161bac0-099b-4ec0-be0c-82d298abeca3" name="ecd:TrdArrIndName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Ron Kurtz M.D</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">., </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f9c68b15-edd3-4806-9416-270a8fd55cd7" contextRef="C_9161bac0-099b-4ec0-be0c-82d298abeca3" name="ecd:TrdArrIndTitle"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Chief Executive Officer and President and a member of our Board of Directors</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4b65e25d-6912-47f3-8493-059715408ff0" contextRef="C_9161bac0-099b-4ec0-be0c-82d298abeca3" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rule 10b5-1</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Trading Plan for the sale of securities of our common stock. Dr. Kurtz&#8217;s Rule 10b5-1 Trading Plan, which has a term from August 20, 2024 to August 15, 2025, provides for the sale of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_82b12066-d0d2-4b7c-b76a-e90d6f496c96" contextRef="C_c1f69193-9ca1-46d8-825e-767d784caa8b" name="ecd:TrdArrSecuritiesAggAvailAmt" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">180,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock pursuant to a series of market orders at pre-determined limit prices.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2f1922cb-4e4f-4e75-8747-8a3f15fe5d0a" contextRef="C_3da2657a-3194-4635-a909-ab3fd0a1dd6a" name="ecd:TrdArrAdoptionDate"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 3, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fb3755a9-368f-4818-821b-c41b867ce1ff" contextRef="C_3da2657a-3194-4635-a909-ab3fd0a1dd6a" name="ecd:TrdArrIndName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Ilya Goldshleger</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, Ph.D., </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ec303f45-ac74-484a-b6cb-76ecac6a00f8" contextRef="C_3da2657a-3194-4635-a909-ab3fd0a1dd6a" name="ecd:TrdArrIndTitle"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Co-President and Chief Operating Officer</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5fa9a443-49b4-4fe5-abba-58d253a3d635" contextRef="C_3da2657a-3194-4635-a909-ab3fd0a1dd6a" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rule 10b5-1</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Trading Plan for the sale of securities of our common stock. Dr. Goldshleger&#8217;s Rule 10b5-1 Trading Plan, which has a term from September 16, 2024 to September 15, 2025, provides for the exercise and sale </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of options for</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_ef451c23-e726-4880-9f2a-253e6672603a" contextRef="C_32b79176-7c08-4e2f-8dd4-4a8b2a419726" name="ecd:TrdArrSecuritiesAggAvailAmt" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">295,529</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock pursuant to a series of market orders at pre-determined limit prices</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_20fa451a-69bf-4861-b6ce-6d63eeed4c13" contextRef="C_e17b2aa6-cab6-4346-b87c-a405a33a2764" name="ecd:TrdArrAdoptionDate"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 7, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9477c82b-6e3a-4bb2-bad6-16b2b796107a" contextRef="C_e17b2aa6-cab6-4346-b87c-a405a33a2764" name="ecd:TrdArrIndName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Eric Weinberg</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">., </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d61bb82d-5283-4785-9b9d-fc3c6b44bac6" contextRef="C_e17b2aa6-cab6-4346-b87c-a405a33a2764" name="ecd:TrdArrIndTitle"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Co-President and Chief Commercial Officer</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4d84148a-5c3a-4105-8c8f-b9e147f5b3aa" contextRef="C_e17b2aa6-cab6-4346-b87c-a405a33a2764" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rule 10b5-1</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Trading Plan for the sale of securities of our common stock. Mr. Weinberg&#8217;s Rule 10b5-1 Trading Plan, which has a term from September 9, 2024 to September 9, 2025, provides for the sale of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_371f2021-297a-43d5-ba8d-ca8895c33e66" contextRef="C_0c499457-67d8-4be1-bbac-93b1615afe77" name="ecd:TrdArrSecuritiesAggAvailAmt" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">100,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock pursuant to a series of market orders at pre-determined limit prices.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6bb97f57-21c8-4fc8-9355-e56145992f47" contextRef="C_897a6866-6f1b-4fb5-a915-4273bf3c2aee" name="ecd:TrdArrAdoptionDate"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 12, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">,  </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b695cb8b-1ffa-4124-816a-fac34a0b578f" contextRef="C_897a6866-6f1b-4fb5-a915-4273bf3c2aee" name="ecd:TrdArrIndName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Julie Andrews</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f55aead6-0da4-4225-813c-3da8b59ba535" contextRef="C_897a6866-6f1b-4fb5-a915-4273bf3c2aee" name="ecd:TrdArrIndTitle"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">member of our Board of Directors</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_035e4dd1-b415-44d7-b62e-0a1a6f4e7aef" contextRef="C_897a6866-6f1b-4fb5-a915-4273bf3c2aee" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rule 10b5-1</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Trading Plan for the sale of securities of our common stock. Ms. Andrews&#8217; Rule 10b5-1 Trading Plan, which has a term from June 14, 2024 to March 20, 2025, provides for the sale of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"><ix:nonFraction id="F_e3195463-1eaf-4b78-af4c-bae8696e1546" contextRef="C_1cc1ee8b-02ae-4c94-beaa-b81200fcda42" name="ecd:TrdArrSecuritiesAggAvailAmt" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">15,625</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock at a pre-determined limit price.</span></p></ix:nonNumeric></div><p style="text-indent:3.846%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;">
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.447%;"/>
      <td style="width:33.447%;"/>
      <td style="width:33.106%;"/>
     </tr>
     <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">95</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
      <td style="padding-top:0.01in;vertical-align:top;border-bottom:2pt solid;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_6_exhibits"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 6. E</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">xhibits.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following exhibits are filed as part of, or incorporated by reference into, this report unless otherwise stated.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">EXHIBIT INDEX</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:8.62%;"/>
     <td style="width:40.94%;"/>
     <td style="width:9.22%;"/>
     <td style="width:13.74%;"/>
     <td style="width:13.74%;"/>
     <td style="width:13.74%;"/>
    </tr>
    <tr style="height:15pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;min-width:fit-content;">Exhibit</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="4" style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;min-width:fit-content;">Incorporated by Reference</span></p></td>
    </tr>
    <tr style="height:15pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;min-width:fit-content;">Number</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;min-width:fit-content;">Description</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;min-width:fit-content;">Form</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;min-width:fit-content;">File No.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;min-width:fit-content;">Exhibit</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;min-width:fit-content;">Filing Date</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.1*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><a href="rxst-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Lease, dated as of April 18, 2024, by and between BML Management, LLC, and the Registrant, for premises located at 125 Columbia, Aliso Viejo, California 92656.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.2*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><a href="rxst-ex10_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Lease Amendment #2, dated as of April 18, 2024, by and between the Registrant and Clifford D. Downs for premises located at 5 Columbia, Aliso Viejo, California 92656.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.3*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><a href="rxst-ex10_3.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Lease Amendment #3, dated as of June 3, 2024, by and between the Registrant and Clifford D. Downs for premises located at 5 Columbia, Aliso Viejo, California 92656.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.4*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><a href="rxst-ex10_4.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Fifth Amendment (extension to the lease), dated as of April 18, 2024, by and between the Registrant and Accuride International Inc., for premises located at 100-200 Columbia, Suites, Aliso Viejo, California 92656.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.5*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><a href="rxst-ex10_5.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Sixth Amendment (extension to the lease), dated as of June 3, 2024, by and between the Registrant and Accuride International Inc., for premises located at 100-200 Columbia, Suites, Aliso Viejo, California 92656.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.6*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><a href="rxst-ex10_6.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Amendment #3 to Sublease, dated as of August 1, 2024, by and between the Registrant and Compass Bible Church for premises located at 5 Columbia, Aliso Viejo, California 92656.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31.1*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><a href="rxst-ex31_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span><span style="color:#0000ff;white-space:pre-wrap;min-width:fit-content;"> </span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31.2*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><a href="rxst-ex31_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span><span style="color:#0000ff;white-space:pre-wrap;min-width:fit-content;"> </span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">96</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:8.62%;"/>
     <td style="width:40.94%;"/>
     <td style="width:9.22%;"/>
     <td style="width:13.74%;"/>
     <td style="width:13.74%;"/>
     <td style="width:13.74%;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">32.1&#134;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><a href="rxst-ex32_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">32.2&#134;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><a href="rxst-ex32_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="5" style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:14.67%;"/>
     <td style="width:85.33%;"/>
    </tr>
    <tr style="height:27pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">101.INS</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.</span></p></td>
    </tr>
    <tr style="height:22.5pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">101.SCH</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema with embedded linkbase documents.</span></p></td>
    </tr>
    <tr style="height:40.5pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cover page Interactive Data File (embedded with the Inline XBRL document).</span></p></td>
    </tr>
   </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:84.615%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">* Filed herewith</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#134; The certifications attached as Exhibit 32.1 and 32.2 that accompany this report are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of RxSight Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this report, irrespective of any general incorporation language contained in such filing.</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">97</span></p></div>
   <hr style="page-break-after:always;"/></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="signatures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIG</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NATURES</span></p><p style="text-indent:5.231%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:49.627%;"/>
     <td style="width:5.037%;"/>
     <td style="width:3.022%;"/>
     <td style="width:42.313%;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">RxSight, Inc.</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date: August 5, 2024</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Ron Kurtz, M.D.</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Ron Kurtz, M.D.</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Executive Officer and President</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(Principal Executive Officer)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date: August 5, 2024</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Shelley Thunen</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shelley Thunen</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Co- President and Chief Financial Officer</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(Principal Financial and Accounting Officer)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">98</span></p></div>
   <hr style="page-break-after:always;"/></div>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>rxst-ex10_1.htm
<DESCRIPTION>125 COLUMBIA
<TEXT>
<html>
 <head>
  <title>EX-10.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Exhibit 10.1</font></p><p style="margin-left:5pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_0.jpg" alt="img74569629_0.jpg" style="width:152px;height:48px;">&#160;</p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:'Calibri',sans-serif;min-width:fit-content;">STANDARD INDUSTRIAL/COMMERCIAL SINGLE-TENANT LEASE - NET</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(DO NOT USE THIS FORM FOR MULTI-TENANT BUILDINGS)</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Basic Provisions (&#34;Basic Provisions&#34;).</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1.1</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Parties. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">This Lease (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lease</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;), dated for reference purposes only </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> April 5, 2024</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, is made by and between </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> BML Management, LLC </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) and </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> RxSight, Inc.</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;), (collectively the &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">,&#34; or individually a &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Party</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;).</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1.2</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Premises: </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">That certain real property, including all improvements therein or to be provided by Lessor under the terms of this Lease, commonly known as (street address, city, state, zip): </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> 125 Columbia, Aliso Viejo, CA 92656</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Premises</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;). The Premises are located in the County of </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Orange</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, and are generally described as (describe brie&#xfb02;y the nature of the property and , if applicable, the &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Project</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">,&#34; if the property is located within a Project): </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> An approximate</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">26,825 square foot Industrial/R&amp;D building</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. (See also Paragraph 2)</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1.3 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Term: </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> 6	</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">years and </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> 8	</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">months (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Original Term</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) commencing </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> June 1, 2024</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Commencement Date</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) and ending </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> January 31,</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2031</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Expiration Date</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;). (See also Paragraph 3)</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1.4 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Early Possession: </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">If the Premises are available Lessee may have non-exclusive possession of the Premises commencing </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Early Possession Date</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;). (See also Paragraphs 3.2 and 3.3)</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1.5 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Base Rent: </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> $41,578.75</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">per month (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Base Rent</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;), payable on the </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> first</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">day of each month commencing </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> June 1, 2024</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. (See also Paragraph 4)</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9745;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> If this box is checked, there are provisions in this Lease for the Base Rent to be adjusted. See Paragraph </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> 51	</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1.6 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Base Rent and Other Monies Paid Upon Execution:</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) Base Rent: </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> $41,578.75</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">for the period </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> June 1, 2024 - June 30, 2024</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) Security Deposit: </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> $34,281.00</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Security Deposit</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;). (See also Paragraph 5 </font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&amp; 60</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">)</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) Association Fees</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> for the period </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(d) Other: </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Operating Expenses: $11,534.75</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">for </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> the period of June 1, 2024 - June 30 , 2024.(See also Paragraph 54)</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(e) Total Due Upon Execution of this Lease: </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> $87,394.50</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1.7</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Agreed Use</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">: </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Office / Warehouse / Lab</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. (See also Paragraph 6)</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1.8</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Insuring Party. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor is the &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Insuring Party</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; unless otherwise stated herein. (See also Paragraph 8)</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1.9</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Real Estate Brokers. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(See also Paragraph 15 and 25)</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) Representation</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">: Each Party acknowledges receiving a Disclosure Regarding Real Estate Agency Relationship, con&#xfb01;rms and consents to the following agency relationships in this Lease with the following real estate brokers (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Broker(s)</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) and/or their agents (&#34;Agent(s)&#34;):</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor's Brokerage Firm </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> CBRE, Inc.</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">License No. </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> 00409987</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Is the broker of (check one): </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9745;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> the Lessor; or </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> both the Lessee and Lessor (dual agent).</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor's Agent </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Keith Black</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">License No. </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> 01266477</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">is (check one): </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9745;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> the Lessor's Agent (salesperson or broker associate); or </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> both the Lessee's Agent and the Lessor's Agent (dual agent).</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee's Brokerage Firm </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Lee &amp; Associates</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">License No. </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> 01044791</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Is the broker of (check one): </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9745;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> the Lessee; or </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> both the Lessee and Lessor (dual agent).</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee's Agent </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Guy Laferrara</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">License No. </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> 01012355</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">is (check one): </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9745;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> the Lessee's Agent (salesperson or broker associate); or </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> both the Lessee's Agent and the Lessor's Agent (dual agent).</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Payment to Brokers. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Upon execution and delivery of this Lease by both Parties, Lessor shall pay to the Brokers the brokerage fee agreed to in a separate written agreement (or if there is no such agreement, the sum of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> or </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> 5  </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">% of the total Base Rent) for the brokerage services rendered by the Brokers. </font><font style="color:#ff0000;white-space:pre-wrap;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;">(3% to Lee &amp; Associates - Guy LaFerrara and 2% to CBRE - Keith Black.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1.10 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Guarantor. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The obligations of the Lessee under this Lease are to be guaranteed by </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> N/A </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Guarantor</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;). (See also Paragraph 37)</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1.11</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Attachments. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Attached hereto are the following, all of which constitute a part of this Lease:</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="text-indent:18pt;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9745;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> an Addendum consisting of Paragraphs </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> 54	</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">through </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> 61	</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">;</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> a plot plan depicting the Premises;</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> a current set of the Rules and Regulations;</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> a Work Letter;</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9745;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> other (specify): </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Rent Adjustments (Paragraph 51), Option to Extend (Paragraph 52) Arbitration Agreement</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(Paragraph 53), Floor Plan (Exhibit A)</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2. Premises.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2.1 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Letting</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessor hereby leases to Lessee, and Lessee hereby leases from Lessor, the Premises, for the term, at the rental, and upon all of the terms, covenants and conditions set forth in this Lease. While the approximate square footage of the Premises may have been used in the marketing of the Premises for purposes of comparison, the Base Rent stated herein is NOT tied to square footage and is not subject to adjustment should the actual size be determined to be</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">different. </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">NOTE: Lessee is advised to verify the actual size prior to executing this Lease.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2.2 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Condition</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessor shall deliver the Premises to Lessee broom clean and free of debris on the Commencement Date or the Early Possession Date, whichever &#xfb01;rst occurs (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Start Date</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;), and, so long as the required service contracts described in Paragraph 7.1(b) below are obtained by Lessee and in e&#xfb00;ect within thirty days following the Start Date, warrants that the existing electrical, plumbing, &#xfb01;re sprinkler, lighting, heating, ventilating and air conditioning systems (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">HVAC</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;), loading</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">doors, sump pumps, if any, and all other such elements in the Premises, other than those constructed by Lessee, shall be in good operating condition on said date, that the structural elements of the roof, bearing walls and foundation of any buildings on the Premises (the &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Building</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) shall be free of material defects, and that the Premises do not contain hazardous levels of any mold or fungi de&#xfb01;ned as toxic under applicable state or federal law. If a non-compliance with said warranty exists as of the Start Date, or if one of such systems or elements should malfunction or fail within the appropriate warranty period, Lessor shall, as Lessor's sole obligation with respect to such matter, except as otherwise provided in this Lease, promptly after receipt of written notice from Lessee setting forth with speci&#xfb01;city the nature and extent of such non-compliance, malfunction or failure, rectify same at Lessor's expense. The warranty periods shall be as follows: (i) 6 months as to the HVAC systems, and (ii) 30 days as to the remaining systems and other elements of the Building. If Lessee does not give Lessor the required notice within the appropriate warranty period, correction of any such non-compliance, malfunction or failure shall be the obligation of Lessee at Lessee's sole cost and expense. Lessor also warrants, that unless otherwise speci&#xfb01;ed in writing, Lessor is unaware of (i) any recorded Notices of Default a&#xfb00;ecting the Premise; (ii) any delinquent amounts due under any loan secured by the Premises; and (iii) any bankruptcy proceeding a&#xfb00;ecting the Premises.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2.3 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Compliance</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessor warrants that to the best of its knowledge the improvements on the Premises comply with the building codes, applicable laws, covenants or restrictions of record, regulations, and ordinances (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Applicable Requirements</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) that were in e&#xfb00;ect at the time that each improvement, or portion thereof, was constructed. Said warranty does not apply to the use to which Lessee will put the Premises, modi&#xfb01;cations which may be required by the Americans with Disabilities Act or any similar laws as a result of Lessee's use (see Paragraph 50), or to any Alterations or Utility Installations (as de&#xfb01;ned in Paragraph 7.3(a)) made or to be made by Lessee. </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">NOTE: Lessee is responsible for determining whether or not the Applicable Requirements, and especially the zoning, are appropriate for Lessee's intended use, and acknowledges that past uses of the Premises may no longer be allowed. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">If the Premises do not comply with said warranty, Lessor shall, except as otherwise provided, promptly after receipt of written notice from Lessee setting forth with speci&#xfb01;city the nature and extent of such non-compliance, rectify the same at Lessor's expense. If Lessee does not give Lessor written notice of a non-compliance with this warranty within 6 months following the Start Date, correction of that non-compliance shall be the obligation of Lessee at Lessee's sole cost and expense. If the Applicable Requirements are hereafter changed so as to require during the term of this Lease the construction of an addition to or an alteration of the Premises and/or Building, the remediation of any Hazardous Substance, or the reinforcement or other physical modi&#xfb01;cation of the Unit, Premises and/or Building (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Capital Expenditure</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;), Lessor and Lessee shall allocate the cost of such work as follows:</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) Subject to Paragraph 2.3(c) below, if such Capital Expenditures are required as a result of the speci&#xfb01;c and unique use of the Premises by Lessee as compared with uses by tenants in general, Lessee shall be fully responsible for the cost thereof, provided, however, that if such Capital Expenditure is required during the last 2 years of this Lease and the cost thereof exceeds 6 months' Base Rent, Lessee may instead terminate this Lease unless Lessor noti&#xfb01;es Lessee, in writing, within 10 days after receipt of Lessee's termination notice that Lessor has elected to pay the difference between the actual cost thereof and an amount equal to 6 months' Base Rent. If Lessee elects termination, Lessee shall immediately cease the use of the Premises which requires such Capital Expenditure and deliver to Lessor written notice specifying a termination date at least 90 days thereafter. Such termination date shall, however, in no event be earlier than the last day that Lessee could legally utilize the Premises without commencing such Capital Expenditure.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) If such Capital Expenditure is not the result of the speci&#xfb01;c and unique use of the Premises by Lessee (such as, governmentally mandated seismic modi&#xfb01;cations), then Lessor shall pay for such Capital Expenditure and Lessee shall only be obligated to pay, each month during the remainder of the term of this Lease or any extension thereof, on the date that on which the Base Rent is due, an amount equal to 1/144th of the portion of such costs reasonably attributable to the Premises. Lessee shall pay Interest on the balance but may prepay its obligation at any time. If, however, such Capital Expenditure is required during the last 2 years of this Lease or if Lessor reasonably determines that it is not economically feasible to pay its share thereof, Lessor shall have the option to terminate this Lease upon 90 days prior written notice to Lessee unless Lessee noti&#xfb01;es Lessor, in writing, within 10 days after receipt of Lessor's termination notice that Lessee will pay for such Capital Expenditure. If Lessor does not elect to terminate, and fails to tender its share of any such Capital Expenditure, Lessee may advance such funds and deduct same, with Interest, from Rent until Lessor's share of such costs have been fully paid. If Lessee is unable to &#xfb01;nance Lessor's share, or if the balance of the Rent due and payable for the remainder of this Lease is not su&#xfb03;cient to fully reimburse Lessee on an o&#xfb00;set basis, Lessee shall have the right to terminate this Lease upon 30 days written notice to Lessor.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) Notwithstanding the above, the provisions concerning Capital Expenditures are intended to apply only to non-voluntary, unexpected, and new Applicable Requirements. If the Capital Expenditures are instead triggered by Lessee as a result of an actual or proposed change in use, change in intensity of use, or modi&#xfb01;cation to the Premises then, and in that event, Lessee shall either: (i) immediately cease such changed use or intensity of use and/or take such other steps as may be necessary to eliminate the requirement for such Capital Expenditure, or (ii) complete such Capital Expenditure at its own expense. Lessee shall not, however, have any right to terminate this Lease.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2.4 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Acknowledgements</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee acknowledges that: (a) it has been given an opportunity to inspect and measure the Premises, (b) it has been advised by Lessor and/or Brokers to satisfy itself with respect to the size and condition of the Premises (including but not limited to the electrical, HVAC and &#xfb01;re sprinkler systems, security, environmental aspects, and compliance with Applicable Requirements and the Americans with Disabilities Act), and their suitability for Lessee's intended use, (c) Lessee has made such investigation as it deems necessary with reference to such matters and assumes all responsibility therefor as the same relate to its occupancy of the Premises, (d) it is not relying on any representation as to the size of the Premises made by Brokers or Lessor, (e) the square footage of the Premises was not material to Lessee's decision to lease the Premises and pay the Rent stated herein, and (f) neither Lessor, Lessor's agents, nor Brokers have made any oral or written representations or warranties with respect to said matters other than as set forth in this Lease. In addition, Lessor acknowledges that: (i) Brokers have made no representations, promises or warranties concerning Lessee's ability to honor the Lease or suitability to occupy the Premises, and (ii) it is Lessor's sole responsibility to investigate the &#xfb01;nancial capability and/or suitability of all proposed tenants.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2.5 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee as Prior Owner/Occupant</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. The warranties made by Lessor in Paragraph 2 shall be of no force or e&#xfb00;ect if immediately prior to the Start Date Lessee was the owner or occupant of the Premises. In such event, Lessee shall be responsible for any necessary corrective work.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">3. Term.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">3.1 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Term</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. The Commencement Date, Expiration Date and Original Term of this Lease are as speci&#xfb01;ed in Paragraph 1.3.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">3.2 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Early Possession</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Any provision herein granting Lessee Early Possession of the Premises is subject to and conditioned upon the Premises being available for such possession prior to the Commencement Date. Any grant of Early Possession only conveys a non-exclusive right to occupy the Premises. If Lessee totally or partially occupies the Premises prior to the Commencement Date, the obligation to pay Base Rent shall be abated for the period of such Early Possession. All other terms of this Lease (including but not limited to the obligations to pay Real Property Taxes and insurance premiums and to maintain the Premises) shall be in e&#xfb00;ect during such period. Any such Early Possession shall not a&#xfb00;ect the Expiration Date.</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">2</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">3.3 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Delay In Possession</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessor agrees to use commercially reasonable e&#xfb00;orts to deliver exclusive possession of the Premises to Lessee by the Commencement Date. If, despite said efforts, Lessor is unable to deliver possession by such date, Lessor shall not be subject to any liability therefor, nor shall such failure affect the validity of this Lease or change the Expiration Date. Lessee shall not, however, be obligated to pay Rent or perform its other obligations until Lessor delivers possession of the Premises and any period of rent abatement that Lessee would otherwise have enjoyed shall run from the date of delivery of possession and continue for a period equal to what Lessee would otherwise have enjoyed under the terms hereof, but minus any days of delay caused by the acts or omissions of Lessee. If possession is not delivered within 60 days after the Commencement Date, as the same may be extended under the terms of any Work Letter executed by Parties, Lessee may, at its option, by notice in writing within 10 days after the end of such 60 day period, cancel this Lease, in which event the Parties shall be discharged from all obligations hereunder. If such written notice is not received by Lessor within said 10 day period, Lessee's right to cancel shall terminate. If possession of the Premises is not delivered within 120 days after the Commencement Date, this Lease shall terminate unless other agreements are reached between Lessor and Lessee, in writing.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">3.4 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee Compliance</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessor shall not be required to tender possession of the Premises to Lessee until Lessee complies with its obligation to provide evidence of insurance (Paragraph 8.5). Pending delivery of such evidence, Lessee shall be required to perform all of its obligations under this Lease from and after the Start Date, including the payment of Rent, notwithstanding Lessor's election to withhold possession pending receipt of such evidence of insurance. Further, if Lessee is required to perform any other conditions prior to or concurrent with the Start Date, the Start Date shall occur but Lessor may elect to withhold possession until such conditions are satisfied.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">4. Rent.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">4.1 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Rent De&#xfb01;ned</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. All monetary obligations of Lessee to Lessor under the terms of this Lease (except for the Security Deposit) are deemed to be rent (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Rent</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;).</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">4.2 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Payment</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall cause payment of Rent to be received by Lessor in lawful money of the United States, without o&#xfb00;set or deduction (except as speci&#xfb01;cally permitted in this Lease), on or before the day on which it is due. All monetary amounts shall be rounded to the nearest whole dollar. In the event that any invoice prepared by Lessor is inaccurate such inaccuracy shall not constitute a waiver and Lessee shall be obligated to pay the amount set forth in this Lease. Rent for any period during the term hereof which is for less than one full calendar month shall be prorated based upon the actual number of days of said month. Payment of Rent shall be made to Lessor at its address stated herein or to such other persons or place as Lessor may from time to time designate in writing. Acceptance of a payment which is less than the amount then due shall not be a waiver of Lessor's rights to the balance of such Rent, regardless of Lessor's endorsement of any check so stating. In the event that any check, draft, or other instrument of payment given by Lessee to Lessor is dishonored for any reason, Lessee agrees to pay to Lessor the sum of $25 in addition to any Late Charge and Lessor, at its option, may require all future Rent be paid by cashier's check. Payments will be applied &#xfb01;rst to accrued late charges and attorney's fees, second to accrued interest, then to Base Rent, Insurance and Real Property Taxes, and any remaining amount to any other outstanding charges or costs.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">4.3 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Association Fees</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. In addition to the Base Rent, Lessee shall pay to Lessor each month an amount equal to any owner's association or condominium fees levied or assessed against the Premises. Said monies shall be paid at the same time and in the same manner as the Base Rent.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">5. Security Deposit. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee shall deposit with Lessor upon execution hereof the Security Deposit as security for Lessee's faithful performance of its obligations under this Lease. If Lessee fails to pay Rent, or otherwise Defaults under this Lease, Lessor may use, apply or retain all or any portion of said Security Deposit for the payment of any amount already due Lessor, for Rents which will be due in the future, and/ or to reimburse or compensate Lessor for any liability, expense, loss or damage which Lessor may su&#xfb00;er or incur by reason thereof. If Lessor uses or applies all or any portion of the Security Deposit, Lessee shall within 10 days after written request therefor deposit monies with Lessor su&#xfb03;cient to restore said Security Deposit to the full amount required by this Lease. If the Base Rent increases during the term of this Lease, Lessee shall, upon written request from Lessor, deposit additional monies with Lessor so that the total amount of the Security Deposit shall at all times bear the same proportion to the increased Base Rent as the initial Security Deposit bore to the initial Base Rent. Should the Agreed Use be amended to accommodate a material change in the business of Lessee or to accommodate a sublessee or assignee, Lessor shall have the right to increase the Security Deposit to the extent necessary, in Lessor's reasonable judgment, to account for any increased wear and tear that the Premises may su&#xfb00;er as a result thereof. If a change in control of Lessee occurs during this Lease and following such change the &#xfb01;nancial condition of Lessee is, in Lessor's reasonable judgment, signi&#xfb01;cantly reduced, Lessee shall deposit such additional monies with Lessor as shall be su&#xfb03;cient to cause the Security Deposit to be at a commercially reasonable level based on such change in &#xfb01;nancial condition. Lessor shall not be required to keep the Security Deposit separate from its general accounts. Within 90 days after the expiration or termination of this Lease, Lessor shall return that portion of the Security Deposit not used or applied by Lessor. Lessor shall upon written request provide Lessee with an accounting showing how that portion of the Security Deposit that was not returned was applied. No part of the Security Deposit shall be considered to be held in trust, to bear interest or to be prepayment for any monies to be paid by Lessee under this Lease. THE SECURITY DEPOSIT SHALL NOT BE USED BY LESSEE IN LIEU OF PAYMENT OF THE LAST MONTH'S RENT.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">6. Use.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">6.1 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Use</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall use and occupy the Premises only for the Agreed Use, or any other legal use which is reasonably comparable thereto, and for no other purpose. Lessee shall not use or permit the use of the Premises in a manner that is unlawful, creates damage, waste or a nuisance, or that disturbs occupants of or causes damage to neighboring premises or properties. Other than guide, signal and seeing eye dogs, Lessee shall not keep or allow in the Premises any pets, animals, birds, &#xfb01;sh, or reptiles. Lessor shall not unreasonably withhold or delay its consent to any written request for a modi&#xfb01;cation of the Agreed Use, so long as the same will not impair the structural integrity of the improvements on the Premises or the mechanical or electrical systems therein, and/or is not signi&#xfb01;cantly more burdensome to the Premises. If Lessor elects to withhold consent, Lessor shall within 7 days after such request give written noti&#xfb01;cation of same, which notice shall include an explanation of Lessor's objections to the change in the Agreed Use.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">6.2 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Hazardous Substances</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Reportable Uses Require Consent</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. The term &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Hazardous Substance</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; as used in this Lease shall mean any product, substance, or waste whose presence, use, manufacture, disposal, transportation, or release, either by itself or in combination with other materials expected to be on the Premises, is either: (i) potentially injurious to the public health, safety or welfare, the environment or the Premises, (ii) regulated or monitored by any governmental authority, or (iii) a basis for potential liability of Lessor to any governmental agency or third party under any applicable statute or common law theory. Hazardous Substances shall include, but not be limited to, hydrocarbons, petroleum, gasoline, and/or crude oil or any products, byproducts or fractions thereof. Lessee shall not engage in any activity in or on the Premises which constitutes a Reportable Use of Hazardous Substances without the express prior written consent of Lessor and timely compliance (at Lessee's expense) with all Applicable Requirements. &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Reportable Use</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall mean (i) the installation or use of any above or below ground storage tank, (ii) the generation, possession, storage, use, transportation, or disposal of a Hazardous Substance that requires a permit from, or with respect to which a report, notice,</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">3</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">registration or business plan is required to be &#xfb01;led with, any governmental authority, and/or (iii) the presence at the Premises of a Hazardous Substance with respect to which any Applicable Requirements requires that a notice be given to persons entering or occupying the Premises or neighboring properties. Notwithstanding the foregoing, Lessee may use any ordinary and customary materials reasonably required to be used in the normal course of the Agreed Use, ordinary o&#xfb03;ce supplies (copier toner, liquid paper, glue, etc.) and common household cleaning materials, so long as such use is in compliance with all Applicable Requirements, is not a Reportable Use, and does not expose the Premises or neighboring property to any meaningful risk of contamination or damage or expose Lessor to any liability therefor. In addition, Lessor may condition its consent to any Reportable Use upon receiving such additional assurances as Lessor reasonably deems necessary to protect itself, the public, the Premises and/or the environment against damage, contamination, injury and/or liability, including, but not limited to, the installation (and removal on or before Lease expiration or termination) of protective modi&#xfb01;cations (such as concrete encasements) and/or increasing the Security Deposit.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Duty to Inform Lessor</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. If Lessee knows, or has reasonable cause to believe, that a Hazardous Substance has come to be located in, on, under or about the Premises, other than as previously consented to by Lessor, Lessee shall immediately give written notice of such fact to Lessor, and provide Lessor with a copy of any report, notice, claim or other documentation which it has concerning the presence of such Hazardous Substance.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee Remediation</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall not cause or permit any Hazardous Substance to be spilled or released in, on, under, or about the Premises (including through the plumbing or sanitary sewer system) and shall promptly, at Lessee's expense, comply with all Applicable Requirements and take all investigatory and/or remedial action reasonably recommended, whether or not formally ordered or required, for the cleanup of any contamination of, and for the maintenance, security and/or monitoring of the Premises or neighboring properties, that was caused or materially contributed to by Lessee, or pertaining to or involving any Hazardous Substance brought onto the Premises during the term of this Lease, by or for Lessee, or any third party.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(d) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee Indemni&#xfb01;cation</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall indemnify, defend and hold Lessor, its agents, employees, lenders and ground lessor, if any, harmless from and against any and all loss of rents and/or damages, liabilities, judgments, claims, expenses, penalties, and attorneys' and consultants' fees arising out of or involving any Hazardous Substance brought onto the Premises by or for Lessee, or any third party (provided, however, that Lessee shall have no liability under this Lease with respect to underground migration of any Hazardous Substance under the Premises from adjacent properties not caused or contributed to by Lessee). Lessee's obligations shall include, but not be limited to, the e&#xfb00;ects of any contamination or injury to person, property or the environment created or su&#xfb00;ered by Lessee, and the cost of investigation, removal, remediation, restoration and/or abatement, and shall survive the expiration or termination of this Lease. </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">No termination, cancellation or release agreement entered into by Lessor and Lessee shall release Lessee from its obligations under this Lease with respect to Hazardous Substances, unless speci&#xfb01;cally so agreed by Lessor in writing at the time of such agreement.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(e) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor Indemni&#xfb01;cation</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Except as otherwise provided in paragraph 8.7, Lessor and its successors and assigns shall indemnify, defend, reimburse and hold Lessee, its employees and lenders, harmless from and against any and all environmental damages, including the cost of remediation, which result from Hazardous Substances which existed on the Premises prior to Lessee's occupancy or which are caused by the gross negligence or willful misconduct of Lessor, its agents or employees. Lessor's obligations, as and when required by the Applicable Requirements, shall include, but not be limited to, the cost of investigation, removal, remediation, restoration and/or abatement, and shall survive the expiration or termination of this Lease.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(f) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Investigations and Remediations</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessor shall retain the responsibility and pay for any investigations or remediation measures required by governmental entities having jurisdiction with respect to the existence of Hazardous Substances on the Premises prior to Lessee's occupancy, unless such remediation measure is required as a result of Lessee's use (including &#34;Alterations&#34;, as de&#xfb01;ned in paragraph 7.3(a) below) of the Premises, in which event Lessee shall be responsible for such payment. Lessee shall cooperate fully in any such activities at the request of Lessor, including allowing Lessor and Lessor's agents to have reasonable access to the Premises at reasonable times in order to carry out Lessor's investigative and remedial responsibilities.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(g) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor Termination Option</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. If a Hazardous Substance Condition (see Paragraph 9.1(e)) occurs during the term of this Lease, unless Lessee is legally responsible therefor (in which case Lessee shall make the investigation and remediation thereof required by the Applicable Requirements and this Lease shall continue in full force and e&#xfb00;ect, but subject to Lessor's rights under Paragraph 6.2(d) and Paragraph 13), Lessor may, at Lessor's option, either (i) investigate and remediate such Hazardous Substance Condition, if required, as soon as reasonably possible at Lessor's expense, in which event this Lease shall continue in full force and e&#xfb00;ect, or (ii) if the estimated cost to remediate such condition exceeds 12 times the then monthly Base Rent or $100,000, whichever is greater, give written notice to Lessee, within 30 days after receipt by Lessor of knowledge of the occurrence of such Hazardous Substance Condition, of Lessor's desire to terminate this Lease as of the date 60 days following the date of such notice. In the event Lessor elects to give a termination notice, Lessee may, within 10 days thereafter, give written notice to Lessor of Lessee's commitment to pay the amount by which the cost of the remediation of such Hazardous Substance Condition exceeds an amount equal to 12 times the then monthly Base Rent or $100,000, whichever is greater. Lessee shall provide Lessor with said funds or satisfactory assurance thereof within 30 days following such commitment. In such event, this Lease shall continue in full force and e&#xfb00;ect, and Lessor shall proceed to make such remediation as soon as reasonably possible after the required funds are available. If Lessee does not give such notice and provide the required funds or assurance thereof within the time provided, this Lease shall terminate as of the date speci&#xfb01;ed in Lessor's notice of termination.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">6.3 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee's Compliance with Applicable Requirements</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Except as otherwise provided in this Lease, Lessee shall, at Lessee's sole expense, fully, diligently and in a timely manner, materially comply with all Applicable Requirements, the requirements of any applicable &#xfb01;re insurance underwriter or rating bureau, and the recommendations of Lessor's engineers and/or consultants which relate in any manner to the Premises, without regard to whether said Applicable Requirements are now in e&#xfb00;ect or become e&#xfb00;ective after the Start Date. Lessee shall, within 10 days after receipt of Lessor's written request, provide Lessor with copies of all permits and other documents, and other information evidencing Lessee's compliance with any Applicable Requirements speci&#xfb01;ed by Lessor, and shall immediately upon receipt, notify Lessor in writing (with copies of any documents involved) of any threatened or actual claim, notice, citation, warning, complaint or report pertaining to or involving the failure of Lessee or the Premises to comply with any Applicable Requirements. Likewise, Lessee shall immediately give written notice to Lessor of: (i) any water damage to the Premises and any suspected seepage, pooling, dampness or other condition conducive to the production of mold; or (ii) any mustiness or other odors that might indicate the presence of mold in the Premises. In addition, Lessee shall provide copies of all relevant material safety data sheets (</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">MSDS</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">) to Lessor within 10 days of the receipt of a written request therefor. In addition, Lessee shall provide Lessor with copies of its business license, certi&#xfb01;cate of occupancy and/or any similar document within 10 days of the receipt of a written request therefor.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">6.4 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Inspection; Compliance</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessor and Lessor's &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lender</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; (as de&#xfb01;ned in Paragraph 30) and consultants authorized by Lessor shall have the right to enter into Premises at any time in the case of an emergency, and otherwise at reasonable times after reasonable notice, for the purpose of inspecting and/or testing the condition of the Premises and/or for verifying compliance by Lessee with this Lease. The cost of any such inspections shall be paid by Lessor, unless a violation of Applicable Requirements, or a Hazardous Substance Condition (see paragraph 9.1(e)) is found to exist or be imminent, or the inspection is requested or ordered by a governmental authority. In such case, Lessee shall upon request reimburse Lessor for the cost of such inspection, so long as such inspection is reasonably related to the violation or contamination. In addition, Lessee shall provide copies of all relevant material safety data sheets (</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">MSDS</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">) to Lessor within 10 days of the receipt of a written request therefor. Lessee acknowledges that any failure on its part to allow such inspections or testing will expose Lessor to risks and potentially cause Lessor</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">4</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">to incur costs not contemplated by this Lease, the extent of which will be extremely di&#xfb03;cult to ascertain. Accordingly, should the Lessee fail to allow such inspections and/or testing in a timely fashion the Base Rent shall be automatically increased, without any requirement for notice to Lessee, by an amount equal to 10% of the then existing Base Rent or $100, whichever is greater for the remainder to the Lease. The Parties agree that such increase in Base Rent represents fair and reasonable compensation for the additional risk/costs that Lessor will incur by reason of Lessee's failure to allow such inspection and/or testing. Such increase in Base Rent shall in no event constitute a waiver of Lessee's Default or Breach with respect to such failure nor prevent the exercise of any of the other rights and remedies granted hereunder.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">7. Maintenance; Repairs; Utility Installations; Trade Fixtures and Alterations.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">7.1 Lessee's Obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">In General</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Subject to the provisions of Paragraph 2.2 (Condition), 2.3 (Compliance), 6.3 (Lessee's Compliance with Applicable Requirements), 7.2 (Lessor's Obligations), 9 (Damage or Destruction), and 14 (Condemnation), Lessee shall, at Lessee's sole expense, keep the Premises, Utility Installations (intended for Lessee's exclusive use, no matter where located), and Alterations in good order, condition and repair (whether or not the portion of the Premises requiring repairs, or the means of repairing the same, are reasonably or readily accessible to Lessee, and whether or not the need for such repairs occurs as a result of Lessee's use, any prior use, the elements or the age of such portion of the Premises), including, but not limited to, all equipment or facilities, such as plumbing, HVAC equipment, electrical, lighting facilities, boilers, pressure vessels, &#xfb01;re protection system, &#xfb01;xtures, walls (interior and exterior), foundations, ceilings, roofs, roof drainage systems, &#xfb02;oors, windows, doors, plate glass, skylights, landscaping, driveways, parking lots, fences, retaining walls, signs, sidewalks and parkways located in, on, or adjacent to the Premises. Lessee, in keeping the Premises in good order, condition and repair, shall exercise and perform good maintenance practices, speci&#xfb01;cally including the procurement and maintenance of the service contracts required by Paragraph 7.1(b) below. Lessee's obligations shall include restorations, replacements or renewals when necessary to keep the Premises and all improvements thereon or a part thereof in good order, condition and state of repair. Lessee shall, during the term of this Lease, keep the exterior appearance of the Building in a &#xfb01;rst-class condition (including, e.g. gra&#xfb03;ti removal) consistent with the exterior appearance of other similar facilities of comparable age and size in the vicinity, including, when necessary, the exterior repainting of the Building.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Service Contracts</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall, at Lessee's sole expense, procure and maintain contracts, with copies to Lessor, in customary form and substance for, and with contractors specializing and experienced in the maintenance of the following equipment and improvements, if any, if and when installed on the Premises: (i) HVAC equipment, (ii) boiler, and pressure vessels, (iii) &#xfb01;re extinguishing systems, including &#xfb01;re alarm and/or smoke detection, (iv) landscaping and irrigation systems, (v) roof covering and drains, and (vi) clari&#xfb01;ers. However, Lessor reserves the right, upon notice to Lessee, to procure and maintain any or all of such service contracts, and Lessee shall reimburse Lessor, upon demand, for the cost thereof.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Failure to Perform</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. If Lessee fails to perform Lessee's obligations under this Paragraph 7.1, Lessor may enter upon the Premises after 10 days' prior written notice to Lessee (except in the case of an emergency, in which case no notice shall be required), perform such obligations on Lessee's behalf, and put the Premises in good order, condition and repair, and Lessee shall promptly pay to Lessor a sum equal to 115% of the cost thereof.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(d) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Replacement</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Subject to Lessee's indemni&#xfb01;cation of Lessor as set forth in Paragraph 8.7 below, and without relieving Lessee of liability resulting from Lessee's failure to exercise and perform good maintenance practices, if an item described in Paragraph 7.1(b) cannot be repaired other than at a cost which is in excess of 50% of the cost of replacing such item, then such item shall be replaced by Lessor, and the cost thereof shall be prorated between the Parties and Lessee shall only be obligated to pay, each month during the remainder of the term of this Lease or any extension thereof, on the date on which Base Rent is due, an amount equal to the product of multiplying the cost of such replacement by a fraction, the numerator of which is one, and the denominator of which is 144 (i.e. 1/144th of the cost per month). Lessee shall pay Interest on the unamortized balance but may prepay its obligation at any time.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">7.2 Lessor's Obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Subject to the provisions of Paragraphs 2.2 (Condition), 2.3 (Compliance), 9 (Damage or Destruction) and 14 (Condemnation), it is intended by the Parties hereto that Lessor have no obligation, in any manner whatsoever, to repair and maintain the Premises, or the equipment therein, all of which obligations are intended to be that of the Lessee. It is the intention of the Parties that the terms of this Lease govern the respective obligations of the Parties as to maintenance and repair of the Premises.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">7.3 Utility Installations; Trade Fixtures; Alterations</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) De&#xfb01;nitions</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. The term &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Utility Installations</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; refers to all &#xfb02;oor and window coverings, air and/or vacuum lines, power panels, electrical distribution, security and &#xfb01;re protection systems, communication cabling, lighting &#xfb01;xtures, HVAC equipment, plumbing, and fencing in or on the Premises. The term &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Trade Fixtures</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall mean Lessee's machinery and equipment that can be removed without doing material damage to the Premises. The term &#34;Alterations&#34; shall mean any modi&#xfb01;cation of the improvements, other than Utility Installations or Trade Fixtures, whether by addition or deletion. &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee Owned Alterations and/or Utility Installations</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; are de&#xfb01;ned as Alterations and/or Utility Installations made by Lessee that are not yet owned by Lessor pursuant to Paragraph 7.4(a).</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) Consent</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall not make any Alterations or Utility Installations to the Premises without Lessor's prior written consent. Lessee may, however, make non-structural Alterations or Utility Installations to the interior of the Premises (excluding the roof) without such consent but upon notice to Lessor, as long as they are not visible from the outside, do not involve puncturing, relocating or removing the roof or any existing walls, will not a&#xfb00;ect the electrical, plumbing, HVAC, and/or life safety systems, do not trigger the requirement for additional modi&#xfb01;cations and/or improvements to the Premises resulting from Applicable Requirements, such as compliance with Title 24, and the cumulative cost thereof during this Lease as extended does not exceed a sum equal to 3 month's Base Rent in the aggregate or a sum equal to one month's Base Rent in any one year. Notwithstanding the foregoing, Lessee shall not make or permit any roof penetrations and/or install anything on the roof without the prior written approval of Lessor. Lessor may, as a precondition to granting such approval, require Lessee to utilize a contractor chosen and/or approved by Lessor. Any Alterations or Utility Installations that Lessee shall desire to make and which require the consent of the Lessor shall be presented to Lessor in written form with detailed plans. Consent shall be deemed conditioned upon Lessee's: (i) acquiring all applicable governmental permits, (ii) furnishing Lessor with copies of both the permits and the plans and speci&#xfb01;cations prior to commencement of the work, and (iii) compliance with all conditions of said permits and other Applicable Requirements in a prompt and expeditious manner. Any Alterations or Utility Installations shall be performed in a workmanlike manner with good and su&#xfb03;cient materials. Lessee shall promptly upon completion furnish Lessor with as-built plans and speci&#xfb01;cations. For work which costs an amount in excess of one month's Base Rent, Lessor may condition its consent upon Lessee providing a lien and completion bond in an amount equal to 150% of the estimated cost of such Alteration or Utility Installation and/or upon Lessee's posting an additional Security Deposit with Lessor.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) Liens; Bonds</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall pay, when due, all claims for labor or materials furnished or alleged to have been furnished to or for Lessee at or for use on the Premises, which claims are or may be secured by any mechanic's or materialmen's lien against the Premises or any interest therein. Lessee shall give Lessor not less than 10 days notice prior to the commencement of any work in, on or about the Premises, and Lessor shall have the right to post notices of non-responsibility. If Lessee shall contest the validity of any such lien, claim or demand, then Lessee shall, at its sole expense defend and protect itself, Lessor and the Premises against the same and shall pay and satisfy any such adverse judgment that may be rendered thereon before the enforcement thereof. If Lessor shall require, Lessee shall furnish</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">5</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">a surety bond in an amount equal to 150% of the amount of such contested lien, claim or demand, indemnifying Lessor against liability for the same. If Lessor elects to participate in any such action, Lessee shall pay Lessor's attorneys' fees and costs.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">7.4 Ownership; Removal; Surrender; and Restoration</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) Ownership</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Subject to Lessor's right to require removal or elect ownership as hereinafter provided, all Alterations and Utility Installations made by Lessee shall be the property of Lessee, but considered a part of the Premises. Lessor may, at any time, elect in writing to be the owner of all or any speci&#xfb01;ed part of the Lessee Owned Alterations and Utility Installations. Unless otherwise instructed per paragraph 7.4(b) hereof, all Lessee Owned Alterations and Utility Installations shall, at the expiration or termination of this Lease, become the property of Lessor and be surrendered by Lessee with the Premises.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) Removal</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. By delivery to Lessee of written notice from Lessor not earlier than 90 and not later than 30 days prior to the end of the term of this Lease, Lessor may require that any or all Lessee Owned Alterations or Utility Installations be removed by the expiration or termination of this Lease. Lessor may require the removal at any time of all or any part of any Lessee Owned Alterations or Utility Installations made without the required consent.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) Surrender; Restoration</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall surrender the Premises by the Expiration Date or any earlier termination date, with all of the improvements, parts and surfaces thereof broom clean and free of debris, and in good operating order, condition and state of repair, ordinary wear and tear excepted. &#34;Ordinary wear and tear&#34; shall not include any damage or deterioration that would have been prevented by good maintenance practice. Notwithstanding the foregoing and the provisions of Paragraph 7.1(a), if the Lessee occupies the Premises for 12 months or less, then Lessee shall surrender the Premises in the same condition as delivered to Lessee on the Start Date with NO allowance for ordinary wear and tear. Lessee shall repair any damage occasioned by the installation, maintenance or removal of Trade Fixtures, Lessee owned Alterations and/or Utility Installations, furnishings, and equipment as well as the removal of any storage tank installed by or for Lessee. Lessee shall also completely remove from the Premises any and all Hazardous Substances brought onto the Premises by or for Lessee, or any third party (except Hazardous Substances which were deposited via underground migration from areas outside of the Premises) to the level speci&#xfb01;ed in Applicable Requirements. Trade Fixtures shall remain the property of Lessee and shall be removed by Lessee. Any personal property of Lessee not removed on or before the Expiration Date or any earlier termination date shall be deemed to have been abandoned by Lessee and may be disposed of or retained by Lessor as Lessor may desire. The failure by Lessee to timely vacate the Premises pursuant to this Paragraph 7.4(c) without the express written consent of Lessor shall constitute a holdover under the provisions of Paragraph 26 below.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">8. Insurance; Indemnity.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">8.1 Payment For Insurance</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall pay for all insurance required under Paragraph 8 except to the extent of the cost attributable to liability insurance carried by Lessor under Paragraph 8.2(b) in excess of $2,000,000 per occurrence. Premiums for policy periods commencing prior to or extending beyond the Lease term shall be prorated to correspond to the Lease term. Payment shall be made by Lessee to Lessor within 10 days following receipt of an invoice.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">8.2 Liability Insurance</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) Carried by Lessee</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall obtain and keep in force a Commercial General Liability policy of insurance protecting Lessee and Lessor as an additional insured against claims for bodily injury, personal injury and property damage based upon or arising out of the ownership, use, occupancy or maintenance of the Premises and all areas appurtenant thereto. Such insurance shall be on an occurrence basis providing single limit coverage in an amount not less than $1,000,000 per occurrence with an annual aggregate of not less than </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$2,000,000</font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$1,000,000.00</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall add Lessor as an additional insured by means of an endorsement at least as broad as the Insurance Service Organization's &#34;Additional Insured-Managers or Lessors of Premises&#34; Endorsement. The policy shall not contain any intra-insured exclusions as between insured persons or organizations, but shall include coverage for liability assumed under this Lease as an &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">insured contract</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; for the performance of Lessee's indemnity obligations under this Lease. The limits of said insurance shall not, however, limit the liability of Lessee nor relieve Lessee of any obligation hereunder. Lessee shall provide an endorsement on its liability policy(ies) which provides that its insurance shall be primary to and not contributory with any similar insurance carried by Lessor, whose insurance shall be considered excess insurance only.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Carried by Lessor. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor shall maintain liability insurance as described in Paragraph 8.2(a), in addition to, and not in lieu of, the insurance required to be maintained by Lessee. Lessee shall not be named as an additional insured therein.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">8.3 Property Insurance - Building, Improvements and Rental Value</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) Building and Improvements</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. The Insuring Party shall obtain and keep in force a policy or policies in the name of Lessor, with loss payable to Lessor, any ground-lessor, and to any Lender insuring loss or damage to the Premises. The amount of such insurance shall be equal to the full insurable replacement cost of the Premises, as the same shall exist from time to time, or the amount required by any Lender, but in no event more than the commercially reasonable and available insurable value thereof. Lessee Owned Alterations and Utility Installations, Trade Fixtures, and Lessee's personal property shall be insured by Lessee not by Lessor. If the coverage is available and commercially appropriate, such policy or policies shall insure against all risks of direct physical loss or damage (except the perils of &#xfb02;ood and/or earthquake unless required by a Lender), including coverage for debris removal and the enforcement of any Applicable Requirements requiring the upgrading, demolition, reconstruction or replacement of any portion of the Premises as the result of a covered loss. Said policy or policies shall also contain an agreed valuation provision in lieu of any coinsurance clause, waiver of subrogation, and in&#xfb02;ation guard protection causing an increase in the annual property insurance coverage amount by a factor of not less than the adjusted U.S. Department of Labor Consumer Price Index for All Urban Consumers for the city nearest to where the Premises are located. If such insurance coverage has a deductible clause, the deductible amount shall not exceed $5,000 per occurrence, and Lessee shall be liable for such deductible amount in the event of an Insured Loss.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) Rental Value</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. The Insuring Party shall obtain and keep in force a policy or policies in the name of Lessor with loss payable to Lessor and any Lender, insuring the loss of the full Rent for one year with an extended period of indemnity for an additional 180 days (&#34;Rental Value insurance&#34;). Said insurance shall contain an agreed valuation provision in lieu of any coinsurance clause, and the amount of coverage shall be adjusted annually to re&#xfb02;ect the projected Rent otherwise payable by Lessee, for the next 12 month period. Lessee shall be liable for any deductible amount in the event of such loss.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) Adjacent Premises</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. If the Premises are part of a larger building, or of a group of buildings owned by Lessor which are adjacent to the Premises, the Lessee shall pay for any increase in the premiums for the property insurance of such building or buildings if said increase is caused by Lessee's acts, omissions, use or occupancy of the Premises.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">8.4 Lessee's Property; Business Interruption Insurance; Worker's Compensation Insurance</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) Property Damage</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall obtain and maintain insurance coverage on all of Lessee's personal property, Trade Fixtures, and Lessee Owned Alterations and Utility Installations. Such insurance shall be full replacement cost coverage with a deductible of not to exceed $1,000 per occurrence. The proceeds from any such insurance shall be used by Lessee for the replacement of personal property, Trade Fixtures and Lessee Owned Alterations and Utility Installations.</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">6</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) Business Interruption</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall obtain and maintain loss of income and extra expense insurance in amounts as will reimburse Lessee for direct or indirect loss of earnings attributable to all perils commonly insured against by prudent lessees in the business of Lessee or attributable to prevention of access to the Premises as a result of such perils.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) Worker's Compensation Insurance</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall obtain and maintain Worker's Compensation Insurance in such amount as may be required by Applicable Requirements. Such policy shall include a 'Waiver of Subrogation' endorsement. Lessee shall provide Lessor with a copy of such endorsement along with the certi&#xfb01;cate of insurance or copy of the policy required by paragraph 8.5.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(d) No Representation of Adequate Coverage</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessor makes no representation that the limits or forms of coverage of insurance speci&#xfb01;ed herein are adequate to cover Lessee's property, business operations or obligations under this Lease.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">8.5 Insurance Policies</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Insurance required herein shall be by companies maintaining during the policy term a &#34;General Policyholders Rating&#34; of at least A-, VII, as set forth in the most current issue of &#34;Best's Insurance Guide&#34;, or such other rating as may be required by a Lender. Lessee shall not do or permit to be done anything which invalidates the required insurance policies. Lessee shall, prior to the Start Date, deliver to Lessor certi&#xfb01;ed copies of policies of such insurance or certi&#xfb01;cates with copies of the required endorsements evidencing the existence and amounts of the required insurance. No such policy shall be cancelable or subject to modi&#xfb01;cation except after 30 days prior written notice to Lessor. Lessee shall, at least 10 days prior to the expiration of such policies, furnish Lessor with evidence of renewals or &#34;insurance binders&#34; evidencing renewal thereof, or Lessor may increase his liability insurance coverage and charge the cost thereof to Lessee, which amount shall be payable by Lessee to Lessor upon demand. Such policies shall be for a term of at least one year, or the length of the remaining term of this Lease, whichever is less. If either Party shall fail to procure and maintain the insurance required to be carried by it, the other Party may, but shall not be required to, procure and maintain the same.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">8.6 Waiver of Subrogation</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Without a&#xfb00;ecting any other rights or remedies, Lessee and Lessor each hereby release and relieve the other, and waive their entire right to recover damages against the other, for loss of or damage to its property arising out of or incident to the perils required to be insured against herein. The e&#xfb00;ect of such releases and waivers is not limited by the amount of insurance carried or required, or by any deductibles applicable hereto. The Parties agree to have their respective property damage insurance carriers waive any right to subrogation that such companies may have against Lessor or Lessee, as the case may be, so long as the insurance is not invalidated thereby.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">8.7 Indemnity</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Except for Lessor's gross negligence or willful misconduct, Lessee shall indemnify, protect, defend and hold harmless the Premises, Lessor and its agents, Lessor's master or ground lessor, partners and Lenders, from and against any and all claims, loss of rents and/or damages, liens, judgments, penalties, attorneys' and consultants' fees, expenses and/or liabilities arising out of, involving, or in connection with, a Breach of the Lease by Lessee and/or the use and/or occupancy of the Premises and/or Project by Lessee and/or by Lessee's employees, contractors or invitees. If any action or proceeding is brought against Lessor by reason of any of the foregoing matters, Lessee shall upon notice defend the same at Lessee's expense by counsel reasonably satisfactory to Lessor and Lessor shall cooperate with Lessee in such defense. Lessor need not have &#xfb01;rst paid any such claim in order to be defended or indemni&#xfb01;ed.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">8.8 Exemption of Lessor and its Agents from Liability</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Notwithstanding the negligence or breach of this Lease by Lessor or its agents, neither Lessor nor its agents shall be liable under any circumstances for: (i) injury or damage to the person or goods, wares, merchandise or other property of Lessee, Lessee's employees, contractors, invitees, customers, or any other person in or about the Premises, whether such damage or injury is caused by or results from &#xfb01;re, steam, electricity, gas, water or rain, indoor air quality, the presence of mold or from the breakage, leakage, obstruction or other defects of pipes, &#xfb01;re sprinklers, wires, appliances, plumbing, HVAC or lighting &#xfb01;xtures, or from any other cause, whether the said injury or damage results from conditions arising upon the Premises or upon other portions of the building of which the Premises are a part, or from other sources or places, (ii) any damages arising from any act or neglect of any other tenant of Lessor or from the failure of Lessor or its agents to enforce the provisions of any other lease in the Project, or (iii) injury to Lessee's business or for any loss of income or pro&#xfb01;t therefrom. Instead, it is intended that Lessee's sole recourse in the event of such damages or injury be to &#xfb01;le a claim on the insurance policy(ies) that Lessee is required to maintain pursuant to the provisions of paragraph 8.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">8.9 Failure to Provide Insurance</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee acknowledges that any failure on its part to obtain or maintain the insurance required herein will expose Lessor to risks and potentially cause Lessor to incur costs not contemplated by this Lease, the extent of which will be extremely di&#xfb03;cult to ascertain. Accordingly, for any month or portion thereof that Lessee does not maintain the required insurance and/or does not provide Lessor with the required binders or certi&#xfb01;cates evidencing the existence of the required insurance, the Base Rent shall be automatically increased, without any requirement for notice to Lessee, by an amount equal to 10% of the then existing Base Rent or $100, whichever is greater. The parties agree that such increase in Base Rent represents fair and reasonable compensation for the additional risk/costs that Lessor will incur by reason of Lessee's failure to maintain the required insurance. Such increase in Base Rent shall in no event constitute a waiver of Lessee's Default or Breach with respect to the failure to maintain such insurance, prevent the exercise of any of the other rights and remedies granted hereunder, nor relieve Lessee of its obligation to maintain the insurance speci&#xfb01;ed in this Lease.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">9. Damage or Destruction.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">9.1</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> De&#xfb01;nitions</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Premises Partial Damage</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall mean damage or destruction to the improvements on the Premises, other than Lessee Owned Alterations and Utility Installations, which can reasonably be repaired in 6 months or less from the date of the damage or destruction. Lessor shall notify Lessee in writing within 30 days from the date of the damage or destruction as to whether or not the damage is Partial or Total.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Premises Total Destruction</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall mean damage or destruction to the Premises, other than Lessee Owned Alterations and Utility Installations and Trade Fixtures, which cannot reasonably be repaired in 6 months or less from the date of the damage or destruction. Lessor shall notify Lessee in writing within 30 days from the date of the damage or destruction as to whether or not the damage is Partial or Total.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Insured Loss</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall mean damage or destruction to improvements on the Premises, other than Lessee Owned Alterations and Utility Installations and Trade Fixtures, which was caused by an event required to be covered by the insurance described in Paragraph 8.3(a), irrespective of any deductible amounts or coverage limits involved.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(d) &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Replacement Cost</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall mean the cost to repair or rebuild the improvements owned by Lessor at the time of the occurrence to their condition existing immediately prior thereto, including demolition, debris removal and upgrading required by the operation of Applicable Requirements, and without deduction for depreciation.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(e) &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Hazardous Substance Condition</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall mean the occurrence or discovery of a condition involving the presence of, or a contamination by, a Hazardous Substance, in, on, or under the Premises which requires restoration.</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">7</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">9.2</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Partial Damage - Insured Loss</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. If a Premises Partial Damage that is an Insured Loss occurs, then Lessor shall, at Lessor's expense, repair such damage (but not Lessee's Trade Fixtures or Lessee Owned Alterations and Utility Installations) as soon as reasonably possible and this Lease shall continue in full force and e&#xfb00;ect; provided, however, that Lessee shall, at Lessor's election, make the repair of any damage or destruction the total cost to repair of which is $10,000 or less, and, in such event, Lessor shall make any applicable insurance proceeds available to Lessee on a reasonable basis for that purpose. Notwithstanding the foregoing, if the required insurance was not in force or the insurance proceeds are not su&#xfb03;cient to e&#xfb00;ect such repair, the Insuring Party shall promptly contribute the shortage in proceeds (except as to the deductible which is Lessee's responsibility) as and when required to complete said repairs. In the event, however, such shortage was due to the fact that, by reason of the unique nature of the improvements, full replacement cost insurance coverage was not commercially reasonable and available, Lessor shall have no obligation to pay for the shortage in insurance proceeds or to fully restore the unique aspects of the Premises unless Lessee provides Lessor with the funds to cover same, or adequate assurance thereof, within 10 days following receipt of written notice of such shortage and request therefor. If Lessor receives said funds or adequate assurance thereof within said 10 day period, the party responsible for making the repairs shall complete them as soon as reasonably possible and this Lease shall remain in full force and e&#xfb00;ect. If such funds or assurance are not received, Lessor may nevertheless elect by written notice to Lessee within 10 days thereafter to: (i) make such restoration and repair as is commercially reasonable with Lessor paying any shortage in proceeds, in which case this Lease shall remain in full force and e&#xfb00;ect, or (ii) have this Lease terminate 30 days thereafter. Lessee shall not be entitled to reimbursement of any funds contributed by Lessee to repair any such damage or destruction. Premises Partial Damage due to &#xfb02;ood or earthquake shall be subject to Paragraph 9.3, notwithstanding that there may be some insurance coverage, but the net proceeds of any such insurance shall be made available for the repairs if made by either Party.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">9.3</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Partial Damage - Uninsured Loss</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. If a Premises Partial Damage that is not an Insured Loss occurs, unless caused by a negligent or willful act of Lessee (in which event Lessee shall make the repairs at Lessee's expense), Lessor may either: (i) repair such damage as soon as reasonably possible at Lessor's expense, in which event this Lease shall continue in full force and e&#xfb00;ect, or (ii) terminate this Lease by giving written notice to Lessee within 30 days after receipt by Lessor of knowledge of the occurrence of such damage. Such termination shall be e&#xfb00;ective 60 days following the date of such notice. In the event Lessor elects to terminate this Lease, Lessee shall have the right within 10 days after receipt of the termination notice to give written notice to Lessor of Lessee's commitment to pay for the repair of such damage without reimbursement from Lessor. Lessee shall provide Lessor with said funds or satisfactory assurance thereof within 30 days after making such commitment. In such event this Lease shall continue in full force and e&#xfb00;ect, and Lessor shall proceed to make such repairs as soon as reasonably possible after the required funds are available. If Lessee does not make the required commitment, this Lease shall terminate as of the date speci&#xfb01;ed in the termination notice.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">9.4</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Total Destruction</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Notwithstanding any other provision hereof, if a Premises Total Destruction occurs, this Lease shall terminate 60 days following such Destruction. If the damage or destruction was caused by the gross negligence or willful misconduct of Lessee, Lessor shall have the right to recover Lessor's damages from Lessee, except as provided in Paragraph 8.6.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">9.5</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Damage Near End of Term</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. If at any time during the last 6 months of this Lease there is damage for which the cost to repair exceeds one month's Base Rent, whether or not an Insured Loss, Lessor may terminate this Lease e&#xfb00;ective 60 days following the date of occurrence of such damage by giving a written termination notice to Lessee within 30 days after the date of occurrence of such damage. Notwithstanding the foregoing, if Lessee at that time has an exercisable option to extend this Lease or to purchase the Premises, then Lessee may preserve this Lease by, (a) exercising such option and (b) providing Lessor with any shortage in insurance proceeds (or adequate assurance thereof) needed to make the repairs on or before the earlier of (i) the date which is 10 days after Lessee's receipt of Lessor's written notice purporting to terminate this Lease, or (ii) the day prior to the date upon which such option expires. If Lessee duly exercises such option during such period and provides Lessor with funds (or adequate assurance thereof) to cover any shortage in insurance proceeds, Lessor shall, at Lessor's commercially reasonable expense, repair such damage as soon as reasonably possible and this Lease shall continue in full force and e&#xfb00;ect. If Lessee fails to exercise such option and provide such funds or assurance during such period, then this Lease shall terminate on the date speci&#xfb01;ed in the termination notice and Lessee's option shall be extinguished.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">9.6</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Abatement of Rent; Lessee's Remedies</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) Abatement</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. In the event of Premises Partial Damage or Premises Total Destruction or a Hazardous Substance Condition for which Lessee is not responsible under this Lease, the Rent payable by Lessee for the period required for the repair, remediation or restoration of such damage shall be abated in proportion to the degree to which Lessee's use of the Premises is impaired, but not to exceed the proceeds received from the Rental Value insurance. All other obligations of Lessee hereunder shall be performed by Lessee, and Lessor shall have no liability for any such damage, destruction, remediation, repair or restoration except as provided herein.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) Remedies</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. If Lessor is obligated to repair or restore the Premises and does not commence, in a substantial and meaningful way, such repair or restoration within 90 days after such obligation shall accrue, Lessee may, at any time prior to the commencement of such repair or restoration, give written notice to Lessor and to any Lenders of which Lessee has actual notice, of Lessee's election to terminate this Lease on a date not less than 60 days following the giving of such notice. If Lessee gives such notice and such repair or restoration is not commenced within 30 days thereafter, this Lease shall terminate as of the date speci&#xfb01;ed in said notice. If the repair or restoration is commenced within such 30 days, this Lease shall continue in full force and e&#xfb00;ect. &#34;Commence&#34; shall mean either the unconditional authorization of the preparation of the required plans, or the beginning of the actual work on the Premises, whichever &#xfb01;rst occurs.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">9.7</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Termination; Advance Payments</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Upon termination of this Lease pursuant to Paragraph 6.2(g) or Paragraph 9, an equitable adjustment shall be made concerning advance Base Rent and any other advance payments made by Lessee to Lessor. Lessor shall, in addition, return to Lessee so much of Lessee's Security Deposit as has not been, or is not then required to be, used by Lessor.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">10. Real Property Taxes.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">10.1</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> De&#xfb01;nition</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. As used herein, the term &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Real Property Taxes</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall include any form of assessment; real estate, general, special, ordinary or extraordinary, or rental levy or tax (other than inheritance, personal income or estate taxes); improvement bond; and/or license fee imposed upon or levied against any legal or equitable interest of Lessor in the Premises or the Project, Lessor's right to other income therefrom, and/or Lessor's business of leasing, by any authority having the direct or indirect power to tax and where the funds are generated with reference to the Building address. Real Property Taxes shall also include any tax, fee, levy, assessment or charge, or any increase therein: (i) imposed by reason of events occurring during the term of this Lease, including but not limited to, a change in the ownership of the Premises, and (ii) levied or assessed on machinery or equipment provided by Lessor to Lessee pursuant to this Lease.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">10.2</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Payment of Taxes</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. In addition to Base Rent, Lessee shall pay to Lessor an amount equal to the Real Property Tax installment due at least 20 days prior to the applicable delinquency date. If any such installment shall cover any period of time prior to or after the expiration or termination of this Lease, Lessee's share of such installment shall be prorated. In the event Lessee incurs a late charge on any Rent payment, Lessor may estimate the current Real Property Taxes, and require that such taxes be paid in advance to Lessor by Lessee monthly in advance with the payment of the Base Rent. Such monthly payments shall be an amount equal to the amount of the estimated installment of taxes divided by the number of months remaining before the month in which said installment becomes delinquent. When</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">8</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">the actual amount of the applicable tax bill is known, the amount of such equal monthly advance payments shall be adjusted as required to provide the funds needed to pay the applicable taxes. If the amount collected by Lessor is insu&#xfb03;cient to pay such Real Property Taxes when due, Lessee shall pay Lessor, upon demand, such additional sum as is necessary. Advance payments may be intermingled with other moneys of Lessor and shall not bear interest. In the event of a Breach by Lessee in the performance of its obligations under this Lease, then any such advance payments may be treated by Lessor as an additional Security Deposit.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">10.3</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Joint Assessment</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. If the Premises are not separately assessed, Lessee's liability shall be an equitable proportion of the Real Property Taxes for all of the land and improvements included within the tax parcel assessed, such proportion to be conclusively determined by Lessor from the respective valuations assigned in the assessor's work sheets or such other information as may be reasonably available.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">10.4</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Personal Property Taxes</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee shall pay, prior to delinquency, all taxes assessed against and levied upon Lessee Owned Alterations, Utility Installations, Trade Fixtures, furnishings, equipment and all personal property of Lessee. When possible, Lessee shall cause its Lessee Owned Alterations and Utility Installations, Trade Fixtures, furnishings, equipment and all other personal property to be assessed and billed separately from the real property of Lessor. If any of Lessee's said property shall be assessed with Lessor's real property, Lessee shall pay Lessor the taxes attributable to Lessee's property within 10 days after receipt of a written statement setting forth the taxes applicable to Lessee's property.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">11. Utilities and Services.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">11.1 Lessee shall pay for all water, gas, heat, light, power, telephone, trash disposal and other utilities and services supplied to the Premises, together with any taxes thereon. If any such services are not separately metered or billed to Lessee, Lessee shall pay a reasonable proportion, to be determined by Lessor, of all charges jointly metered or billed. There shall be no abatement of rent and Lessor shall not be liable in any respect whatsoever for the inadequacy, stoppage, interruption or discontinuance of any utility or service due to riot, strike, labor dispute, breakdown, accident, repair or other cause beyond Lessor's reasonable control or in cooperation with governmental request or directions.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">11.2 Within &#xfb01;fteen days of Lessor's written request, Lessee agrees to deliver to Lessor such information, documents and/or authorization as Lessor needs in order for Lessor to comply with new or existing Applicable Requirements relating to commercial building energy usage, ratings, and/or the reporting thereof.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">12. Assignment and Subletting.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">12.1 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor's Consent Required</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) Lessee shall not voluntarily or by operation of law assign, transfer, mortgage or encumber (collectively, &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">assign or assignment</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) or sublet all or any part of Lessee's interest in this Lease or in the Premises without Lessor's prior written consent.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) Unless Lessee is a corporation and its stock is publicly traded on a national stock exchange, a change in the control of Lessee shall constitute an assignment requiring consent. The transfer, on a cumulative basis, of 25% or more of the voting control of Lessee shall constitute a change in control for this purpose.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) The involvement of Lessee or its assets in any transaction, or series of transactions (by way of merger, sale, acquisition, &#xfb01;nancing, transfer, leveraged buyout or otherwise), whether or not a formal assignment or hypothecation of this Lease or Lessee's assets occurs, which results or will result in a reduction of the Net Worth of Lessee by an amount greater than 25% of such Net Worth as it was represented at the time of the execution of this Lease or at the time of the most recent assignment to which Lessor has consented, or as it exists immediately prior to said transaction or transactions constituting such reduction, whichever was or is greater, shall be considered an assignment of this Lease to which Lessor may withhold its consent. &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Net Worth of Lessee</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall mean the net worth of Lessee (excluding any guarantors) established under generally accepted accounting principles.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(d) An assignment or subletting without consent shall, at Lessor's option, be a Default curable after notice per Paragraph 13.1(d), or a non-curable Breach without the necessity of any notice and grace period. If Lessor elects to treat such unapproved assignment or subletting as a non-curable Breach, Lessor may either: (i) terminate this Lease, or (ii) upon 30 days written notice, increase the monthly Base Rent to 110% of the Base Rent then in effect. Further, in the event of such Breach and rental adjustment, (i) the purchase price of any option to purchase the Premises held by Lessee shall be subject to similar adjustment to 110% of the price previously in effect, and (ii) all &#xfb01;xed and non-&#xfb01;xed rental adjustments scheduled during the remainder of the Lease term shall be increased to 110% of the scheduled adjusted rent.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(e) Lessee's remedy for any breach of Paragraph 12.1 by Lessor shall be limited to compensatory damages and/or injunctive relief.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(f) Lessor may reasonably withhold consent to a proposed assignment or subletting if Lessee is in Default at the time consent is requested.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(g) Notwithstanding the foregoing, allowing a de minimis portion of the Premises, i.e. 20 square feet or less, to be used by a third party vendor in connection with the installation of a vending machine or payphone shall not constitute a subletting.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">12.2 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Terms and Conditions Applicable to Assignment and Subletting</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) Regardless of Lessor's consent, no assignment or subletting shall : (i) be e&#xfb00;ective without the express written assumption by such assignee or sublessee of the obligations of Lessee under this Lease, (ii) release Lessee of any obligations hereunder, or (iii) alter the primary liability of Lessee for the payment of Rent or for the performance of any other obligations to be performed by Lessee.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) Lessor may accept Rent or performance of Lessee's obligations from any person other than Lessee pending approval or disapproval of an assignment. Neither a delay in the approval or disapproval of such assignment nor the acceptance of Rent or performance shall constitute a waiver or estoppel of Lessor's right to exercise its remedies for Lessee's Default or Breach.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) Lessor's consent to any assignment or subletting shall not constitute a consent to any subsequent assignment or subletting.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(d) In the event of any Default or Breach by Lessee, Lessor may proceed directly against Lessee, any Guarantors or anyone else responsible for the performance of Lessee's obligations under this Lease, including any assignee or sublessee, without &#xfb01;rst exhausting Lessor's remedies against any other person or entity responsible therefor to Lessor, or any security held by Lessor.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(e) Each request for consent to an assignment or subletting shall be in writing, accompanied by information relevant to Lessor's determination as to the &#xfb01;nancial and operational responsibility and appropriateness of the proposed assignee or sublessee, including but not limited to the intended use and/or required modi&#xfb01;cation of the Premises, if any, together with a fee of $500 as consideration for Lessor's considering and processing said request. Lessee agrees to provide Lessor with such other or additional information and/or documentation as may be reasonably requested. (See also Paragraph 36)</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(f) Any assignee of, or sublessee under, this Lease shall, by reason of accepting such assignment, entering into such sublease, or entering into possession of the Premises or any portion thereof, be deemed to have assumed and agreed to conform and comply with each and every term, covenant, condition and obligation herein to be observed or performed by Lessee during the term of said assignment or sublease, other than such obligations as are contrary to or inconsistent with provisions of an assignment or sublease to which Lessor has speci&#xfb01;cally consented to in writing.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(g) Lessor's consent to any assignment or subletting shall not transfer to the assignee or sublessee any Option granted to the original Lessee by this Lease unless such transfer is speci&#xfb01;cally consented to by Lessor in writing. (See Paragraph 39.2)</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">9</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">12.3 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Additional Terms and Conditions Applicable to Subletting</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. The following terms and conditions shall apply to any subletting by Lessee of all or any part of the Premises and shall be deemed included in all subleases under this Lease whether or not expressly incorporated therein:</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) Lessee hereby assigns and transfers to Lessor all of Lessee's interest in all Rent payable on any sublease, and Lessor may collect such Rent and apply same toward Lessee's obligations under this Lease; provided, however, that until a Breach shall occur in the performance of Lessee's obligations, Lessee may collect said Rent. In the event that the amount collected by Lessor exceeds Lessee's then outstanding obligations any such excess shall be refunded to Lessee. Lessor shall not, by reason of the foregoing or any assignment of such sublease, nor by reason of the collection of Rent, be deemed liable to the sublessee for any failure of Lessee to perform and comply with any of Lessee's obligations to such sublessee. Lessee hereby irrevocably authorizes and directs any such sublessee, upon receipt of a written notice from Lessor stating that a Breach exists in the performance of Lessee's obligations under this Lease, to pay to Lessor all Rent due and to become due under the sublease. Sublessee shall rely upon any such notice from Lessor and shall pay all Rents to Lessor without any obligation or right to inquire as to whether such Breach exists, notwithstanding any claim from Lessee to the contrary.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) In the event of a Breach by Lessee, Lessor may, at its option, require sublessee to attorn to Lessor, in which event Lessor shall undertake the obligations of the sublessor under such sublease from the time of the exercise of said option to the expiration of such sublease; provided, however, Lessor shall not be liable for any prepaid rents or security deposit paid by such sublessee to such sublessor or for any prior Defaults or Breaches of such sublessor.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) Any matter requiring the consent of the sublessor under a sublease shall also require the consent of Lessor.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(d) No sublessee shall further assign or sublet all or any part of the Premises without Lessor's prior written consent.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(e) Lessor shall deliver a copy of any notice of Default or Breach by Lessee to the sublessee, who shall have the right to cure the Default of Lessee within the grace period, if any, speci&#xfb01;ed in such notice. The sublessee shall have a right of reimbursement and o&#xfb00;set from and against Lessee for any such Defaults cured by the sublessee.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">13. Default; Breach; Remedies.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">13.1 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Default; Breach</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. A &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Default</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; is de&#xfb01;ned as a failure by the Lessee to comply with or perform any of the terms, covenants, conditions or Rules and Regulations under this Lease. A &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Breach</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; is de&#xfb01;ned as the occurrence of one or more of the following Defaults, and the failure of Lessee to cure such Default within any applicable grace period:</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) The abandonment of the Premises; the vacating of the Premises prior to the expiration or termination of this Lease without providing a commercially reasonable level of security, or where the coverage of the property insurance described in Paragraph 8.3 is jeopardized as a result thereof, or without providing reasonable assurances to minimize potential vandalism; or failure to deliver to Lessor exclusive possession of the entire Premises in accordance herewith prior to the expiration or termination of this Lease.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) The failure of Lessee to make any payment of Rent or any Security Deposit required to be made by Lessee hereunder, whether to Lessor or to a third party, when due, to provide reasonable evidence of insurance or surety bond, or to ful&#xfb01;ll any obligation under this Lease which endangers or threatens life or property, where such failure continues for a period of 3 business days following written notice to Lessee. THE ACCEPTANCE BY LESSOR OF A PARTIAL PAYMENT OF RENT OR SECURITY DEPOSIT SHALL NOT CONSTITUTE A WAIVER OF ANY OF LESSOR'S RIGHTS, INCLUDING LESSOR'S RIGHT TO RECOVER POSSESSION OF THE PREMISES.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) The failure of Lessee to allow Lessor and/or its agents access to the Premises or the commission of waste, act or acts constituting public or private</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">nuisance, and/or an illegal activity on the Premises by Lessee, where such actions continue for a period of 3 business days following written notice to Lessee. In the event that Lessee commits waste, a nuisance or an illegal activity a second time then, the Lessor may elect to treat such conduct as a non-curable Breach rather than a Default.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(d) The failure by Lessee to provide (i) reasonable written evidence of compliance with Applicable Requirements, (ii) the service contracts, (iii) the rescission of an unauthorized assignment or subletting, (iv) an Estoppel Certi&#xfb01;cate or &#xfb01;nancial statements, (v) a requested subordination, (vi) evidence concerning any guaranty and/or Guarantor, (vii) any document requested under Paragraph 42, (viii) material safety data sheets (MSDS), or (ix) any other documentation or information which Lessor may reasonably require of Lessee under the terms of this Lease, where any such failure continues for a period of 10 days following written notice to Lessee.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(e) A Default by Lessee as to the terms, covenants, conditions or provisions of this Lease, or of the rules adopted under Paragraph 40 hereof, other than those described in subparagraphs 13.1(a), (b), (c) or (d), above, where such Default continues for a period of 30 days after written notice; provided, however, that if the nature of Lessee's Default is such that more than 30 days are reasonably required for its cure, then it shall not be deemed to be a Breach if Lessee commences such cure within said 30 day period and thereafter diligently prosecutes such cure to completion.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(f) The occurrence of any of the following events: (i) the making of any general arrangement or assignment for the bene&#xfb01;t of creditors; (ii) becoming a &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">debtor</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; as de&#xfb01;ned in 11 U.S.C. &#167; 101 or any successor statute thereto (unless, in the case of a petition &#xfb01;led against Lessee, the same is dismissed within 60 days); (iii) the appointment of a trustee or receiver to take possession of substantially all of Lessee's assets located at the Premises or of Lessee's interest in this Lease, where possession is not restored to Lessee within 30 days; or (iv) the attachment, execution or other judicial seizure of substantially all of Lessee's assets located at the Premises or of Lessee's interest in this Lease, where such seizure is not discharged within 30 days; provided, however, in the event that any provision of this subparagraph is contrary to any applicable law, such provision shall be of no force or e&#xfb00;ect, and not a&#xfb00;ect the validity of the remaining provisions.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(g) The discovery that any &#xfb01;nancial statement of Lessee or of any Guarantor given to Lessor was materially false.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(h) If the performance of Lessee's obligations under this Lease is guaranteed: (i) the death of a Guarantor, (ii) the termination of a Guarantor's liability with respect to this Lease other than in accordance with the terms of such guaranty, (iii) a Guarantor's becoming insolvent or the subject of a bankruptcy &#xfb01;ling, (iv) a Guarantor's refusal to honor the guaranty, or (v) a Guarantor's breach of its guaranty obligation on an anticipatory basis, and Lessee's failure, within 60 days following written notice of any such event, to provide written alternative assurance or security, which, when coupled with the then existing resources of Lessee, equals or exceeds the combined &#xfb01;nancial resources of Lessee and the Guarantors that existed at the time of execution of this Lease.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">13.2 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Remedies</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. If Lessee fails to perform any of its a&#xfb03;rmative duties or obligations, within 10 days after written notice (or in case of an emergency, without notice), Lessor may, at its option, perform such duty or obligation on Lessee's behalf, including but not limited to the obtaining of reasonably required bonds, insurance policies, or governmental licenses, permits or approvals. Lessee shall pay to Lessor an amount equal to 115% of the costs and expenses incurred by Lessor in such performance upon receipt of an invoice therefor. In the event of a Breach, Lessor may, with or without further notice or demand, and without limiting Lessor in the exercise of any right or remedy which Lessor may have by reason of such Breach:</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) Terminate Lessee's right to possession of the Premises by any lawful means, in which case this Lease shall terminate and Lessee shall immediately surrender possession to Lessor. In such event Lessor shall be entitled to recover from Lessee: (i) the unpaid Rent which had been earned at the time of termination;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">10</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(ii) the worth at the time of award of the amount by which the unpaid rent which would have been earned after termination until the time of award exceeds the amount of such rental loss that the Lessee proves could have been reasonably avoided; (iii) the worth at the time of award of the amount by which the unpaid rent for the balance of the term after the time of award exceeds the amount of such rental loss that the Lessee proves could be reasonably avoided; and (iv) any other amount necessary to compensate Lessor for all the detriment proximately caused by the Lessee's failure to perform its obligations under this Lease or which in the ordinary course of things would be likely to result therefrom, including but not limited to the cost of recovering possession of the Premises, expenses of reletting, including necessary renovation and alteration of the Premises, reasonable attorneys' fees, and that portion of any leasing commission paid by Lessor in connection with this Lease applicable to the unexpired term of this Lease. The worth at the time of award of the amount referred to in provision (iii) of the immediately preceding sentence shall be computed by discounting such amount at the discount rate of the Federal Reserve Bank of the District within which the Premises are located at the time of award plus one percent. E&#xfb00;orts by Lessor to mitigate damages caused by Lessee's Breach of this Lease shall not waive Lessor's right to recover any damages to which Lessor is otherwise entitled. If termination of this Lease is obtained through the provisional remedy of unlawful detainer, Lessor shall have the right to recover in such proceeding any unpaid Rent and damages as are recoverable therein, or Lessor may reserve the right to recover all or any part thereof in a separate suit. If a notice and grace period required under Paragraph 13.1 was not previously given, a notice to pay rent or quit, or to perform or quit given to Lessee under the unlawful detainer statute shall also constitute the notice required by Paragraph 13.1. In such case, the applicable grace period required by Paragraph 13.1 and the unlawful detainer statute shall run concurrently, and the failure of Lessee to cure the Default within the greater of the two such grace periods shall constitute both an unlawful detainer and a Breach of this Lease entitling Lessor to the remedies provided for in this Lease and/or by said statute.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) Continue the Lease and Lessee's right to possession and recover the Rent as it becomes due, in which event Lessee may sublet or assign, subject only to reasonable limitations. Acts of maintenance, e&#xfb00;orts to relet, and/or the appointment of a receiver to protect the Lessor's interests, shall not constitute a termination of the Lessee's right to possession.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) Pursue any other remedy now or hereafter available under the laws or judicial decisions of the state wherein the Premises are located. The expiration or termination of this Lease and/or the termination of Lessee's right to possession shall not relieve Lessee from liability under any indemnity provisions of this Lease</font></p><p style="margin-left:5pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">as to matters occurring or accruing during the term hereof or by reason of Lessee's occupancy of the Premises.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">13.3 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Inducement Recapture. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Any agreement for free or abated rent or other charges, the cost of tenant improvements for Lessee paid for or performed by Lessor, or for the giving or paying by Lessor to or for Lessee of any cash or other bonus, inducement or consideration for Lessee's entering into this Lease, all of which concessions are hereinafter referred to as &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Inducement Provisions</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">,&#34; shall be deemed conditioned upon Lessee's full and faithful performance of all of the terms, covenants and conditions of this Lease. Upon Breach of this Lease by Lessee, any such Inducement Provision shall automatically be deemed deleted from this Lease and of no further force or e&#xfb00;ect, and any rent, other charge, bonus, inducement or consideration theretofore abated, given or paid by Lessor under such an Inducement Provision shall be immediately due and payable by Lessee to Lessor, notwithstanding any subsequent cure of said Breach by Lessee. The acceptance by Lessor of rent or the cure of the Breach which initiated the operation of this paragraph shall not be deemed a waiver by Lessor of the provisions of this paragraph unless speci&#xfb01;cally so stated in writing by Lessor at the time of such acceptance.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">13.4 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Late Charges</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee hereby acknowledges that late payment by Lessee of Rent will cause Lessor to incur costs not contemplated by this Lease, the exact amount of which will be extremely di&#xfb03;cult to ascertain. Such costs include, but are not limited to, processing and accounting charges, and late charges which may be imposed upon Lessor by any Lender. Accordingly, if any Rent shall not be received by Lessor within 5 days after such amount shall be due, then, without any requirement for notice to Lessee, Lessee shall immediately pay to Lessor a one-time late charge equal to 10% of each such overdue amount or $100, whichever is greater. The Parties hereby agree that such late charge represents a fair and reasonable estimate of the costs Lessor will incur by reason of such late payment. Acceptance of such late charge by Lessor shall in no event constitute a waiver of Lessee's Default or Breach with respect to such overdue amount, nor prevent the exercise of any of the other rights and remedies granted hereunder. In the event that a late charge is payable hereunder, whether or not collected, for 3 consecutive installments of Base Rent, then notwithstanding any provision of this Lease to the contrary, Base Rent shall, at Lessor's option, become due and payable quarterly in advance.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">13.5 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Interest</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Any monetary payment due Lessor hereunder, other than late charges, not received by Lessor, when due shall bear interest from the 31st day after it was due. The interest (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Interest</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) charged shall be computed at the rate of 10% per annum but shall not exceed the maximum rate allowed by law. Interest is payable in addition to the potential late charge provided for in Paragraph 13.4.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">13.6 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Breach by Lessor</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Notice of Breach</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessor shall not be deemed in breach of this Lease unless Lessor fails within a reasonable time to perform an obligation required to be performed by Lessor. For purposes of this Paragraph, a reasonable time shall in no event be less than 30 days after receipt by Lessor, and any Lender whose name and address shall have been furnished to Lessee in writing for such purpose, of written notice specifying wherein such obligation of Lessor has not been performed; provided, however, that if the nature of Lessor's obligation is such that more than 30 days are reasonably required for its performance, then Lessor shall not be in breach if performance is commenced within such 30 day period and thereafter diligently pursued to completion.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Performance by Lessee on Behalf of Lessor</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. In the event that neither Lessor nor Lender cures said breach within 30 days after receipt of said notice, or if having commenced said cure they do not diligently pursue it to completion, then Lessee may elect to cure said breach at Lessee's expense and o&#xfb00;set from Rent the actual and reasonable cost to perform such cure, provided however, that such o&#xfb00;set shall not exceed an amount equal to the greater of one month's Base Rent or the Security Deposit, reserving Lessee's right to seek reimbursement from Lessor for any such expense in excess of such o&#xfb00;set. Lessee shall document the cost of said cure and supply said documentation to Lessor.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">14. Condemnation. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">If the Premises or any portion thereof are taken under the power of eminent domain or sold under the threat of the exercise of said power (collectively &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Condemnation</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;), this Lease shall terminate as to the part taken as of the date the condemning authority takes title or possession, whichever &#xfb01;rst occurs. If more than 10% of the Building, or more than 25% of that portion of the Premises not occupied by any building, is taken by Condemnation, Lessee may, at Lessee's option, to be exercised in writing within 10 days after Lessor shall have given Lessee written notice of such taking (or in the absence of such notice, within 10 days after the condemning authority shall have taken possession) terminate this Lease as of the date the condemning authority takes such possession. If Lessee does not terminate this Lease in accordance with the foregoing, this Lease shall remain in full force and e&#xfb00;ect as to the portion of the Premises remaining, except that the Base Rent shall be reduced in proportion to the reduction in utility of the Premises caused by such Condemnation. Condemnation awards and/or payments shall be the property of Lessor, whether such award shall be made as compensation for diminution in value of the leasehold, the value of the part taken, or for severance damages; provided, however, that Lessee shall be entitled to any compensation paid by the condemnor for Lessee's relocation expenses, loss of business goodwill and/or Trade Fixtures, without regard to whether or not this Lease is terminated pursuant to the provisions of this Paragraph. All Alterations and Utility Installations made to the Premises by Lessee, for purposes of Condemnation only, shall be considered the property of the Lessee and Lessee shall be entitled to any and all</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">11</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">compensation which is payable therefor. In the event that this Lease is not terminated by reason of the Condemnation, Lessor shall repair any damage to the Premises caused by such Condemnation.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">15. Brokerage Fees.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">15.1 Additional Commission</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. In addition to the payments owed pursuant to Paragraph 1.9 above, Lessor agrees that: (a) if Lessee exercises any Option, (b) if Lessee or anyone a&#xfb03;liated with Lessee acquires any rights to the Premises or other premises owned by Lessor and located within the same Project, if any, within which the Premises is located, (c) if Lessee remains in possession of the Premises, with the consent of Lessor, after the expiration of this Lease, or (d) if Base Rent is increased, whether by agreement or operation of an escalation clause herein, then, Lessor shall pay Brokers a fee in accordance with the fee schedule of the Brokers in e&#xfb00;ect at the time the Lease was executed. The provisions of this paragraph are intended to supersede the provisions of any earlier agreement to the contrary.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">15.2 Assumption of Obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Any buyer or transferee of Lessor's interest in this Lease shall be deemed to have assumed Lessor's obligation hereunder. Brokers shall be third party bene&#xfb01;ciaries of the provisions of Paragraphs 1.9, 15, 22 and 31. If Lessor fails to pay to Brokers any amounts due as and for brokerage fees pertaining to this Lease when due, then such amounts shall accrue Interest. In addition, if Lessor fails to pay any amounts to Lessee's Broker when due, Lessee's Broker may send written notice to Lessor and Lessee of such failure and if Lessor fails to pay such amounts within 10 days after said notice, Lessee shall pay said monies to its Broker and o&#xfb00;set such amounts against Rent. In addition, Lessee's Broker shall be deemed to be a third party bene&#xfb01;ciary of any commission agreement entered into by and/or between Lessor and Lessor's Broker for the limited purpose of collecting any brokerage fee owed.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">15.3 Representations and Indemnities of Broker Relationships</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee and Lessor each represent and warrant to the other that it has had no dealings with any person, &#xfb01;rm, broker, agent or &#xfb01;nder (other than the Brokers and Agents, if any) in connection with this Lease, and that no one other than said named Brokers and Agents is entitled to any commission or &#xfb01;nder's fee in connection herewith. Lessee and Lessor do each hereby agree to indemnify, protect, defend and hold the other harmless from and against liability for compensation or charges which may be claimed by any such unnamed broker, &#xfb01;nder or other similar party by reason of any dealings or actions of the indemnifying Party, including any costs, expenses, attorneys' fees reasonably incurred with respect thereto.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">16. Estoppel Certi&#xfb01;cates.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) Each Party (as &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Responding Party</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) shall within 10 days after written notice from the other Party (the &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Requesting Party</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) execute, acknowledge and deliver to the Requesting Party a statement in writing in form similar to the then most current &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Estoppel Certi&#xfb01;cate</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; form published by AIR CRE, plus such additional information, con&#xfb01;rmation and/or statements as may be reasonably requested by the Requesting Party.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) If the Responding Party shall fail to execute or deliver the Estoppel Certi&#xfb01;cate within such 10 day period, the Requesting Party may execute an Estoppel Certi&#xfb01;cate stating that: (i) the Lease is in full force and e&#xfb00;ect without modi&#xfb01;cation except as may be represented by the Requesting Party, (ii) there are no uncured defaults in the Requesting Party's performance, and (iii) if Lessor is the Requesting Party, not more than one month's rent has been paid in advance. Prospective purchasers and encumbrancers may rely upon the Requesting Party's Estoppel Certi&#xfb01;cate, and the Responding Party shall be estopped from denying the truth of the facts contained in said Certi&#xfb01;cate. In addition, Lessee acknowledges that any failure on its part to provide such an Estoppel Certi&#xfb01;cate will expose Lessor to risks and potentially cause Lessor to incur costs not contemplated by this Lease, the extent of which will be extremely di&#xfb03;cult to ascertain. Accordingly, should the Lessee fail to execute and/or deliver a requested Estoppel Certi&#xfb01;cate in a timely fashion the monthly Base Rent shall be automatically increased, without any requirement for notice to Lessee, by an amount equal to 10% of the then existing Base Rent or $100, whichever is greater for remainder of the Lease. The Parties agree that such increase in Base Rent represents fair and reasonable compensation for the additional risk/costs that Lessor will incur by reason of Lessee's failure to provide the Estoppel Certi&#xfb01;cate. Such increase in Base Rent shall in no event constitute a waiver of Lessee's Default or Breach with respect to the failure to provide the Estoppel Certi&#xfb01;cate nor prevent the exercise of any of the other rights and remedies granted hereunder.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) If Lessor desires to &#xfb01;nance, re&#xfb01;nance, or sell the Premises, or any part thereof, Lessee and all Guarantors shall within 10 days after written notice from Lessor deliver to any potential lender or purchaser designated by Lessor such &#xfb01;nancial statements as may be reasonably required by such lender or purchaser, including but not limited to Lessee's &#xfb01;nancial statements for the past 3 years. All such &#xfb01;nancial statements shall be received by Lessor and such lender or purchaser in </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">con&#xfb01;dence and shall be used only for the purposes herein set forth.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">17. De&#xfb01;nition of Lessor. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The term &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; as used herein shall mean the owner or owners at the time in question of the fee title to the Premises, or, if this is a sublease, of the Lessee's interest in the prior lease. In the event of a transfer of Lessor's title or interest in the Premises or this Lease, Lessor shall deliver to the transferee or assignee (in cash or by credit) any unused Security Deposit held by Lessor. Upon such transfer or assignment and delivery of the Security Deposit, as aforesaid, the prior Lessor shall be relieved of all liability with respect to the obligations and/or covenants under this Lease thereafter to be performed by the Lessor. Subject to the foregoing, the obligations and/or covenants in this Lease to be performed by the Lessor shall be binding only upon the Lessor as hereinabove de&#xfb01;ned.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">18. Severability. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The invalidity of any provision of this Lease, as determined by a court of competent jurisdiction, shall in no way a&#xfb00;ect the validity of any other provision hereof.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">19. Days. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Unless otherwise speci&#xfb01;cally indicated to the contrary, the word &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">days</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; as used in this Lease shall mean and refer to calendar days.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">20. Limitation on Liability. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The obligations of Lessor under this Lease shall not constitute personal obligations of Lessor, or its partners, members, directors, o&#xfb03;cers or shareholders, and Lessee shall look to the Premises, and to no other assets of Lessor, for the satisfaction of any liability of Lessor with respect to this Lease, and shall not seek recourse against Lessor's partners, members, directors, o&#xfb03;cers or shareholders, or any of their personal assets for such satisfaction.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">21. Time of Essence. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Time is of the essence with respect to the performance of all obligations to be performed or observed by the Parties under this Lease.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">22. No Prior or Other Agreements; Broker Disclaimer</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. This Lease contains all agreements between the Parties with respect to any matter mentioned herein, and no other prior or contemporaneous agreement or understanding shall be e&#xfb00;ective. Lessor and Lessee each represents and warrants to the Brokers that it has made, and is relying solely upon, its own investigation as to the nature, quality, character and &#xfb01;nancial responsibility of the other Party to this Lease and as to the use, nature, quality and character of the Premises. Brokers have no responsibility with respect thereto or with respect to any default or breach hereof by either Party.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">23. Notices.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">23.1 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Notice Requirements</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. All notices required or permitted by this Lease or applicable law shall be in writing and may be delivered in person (by hand or by courier) or may be sent by regular, certi&#xfb01;ed or registered mail or U.S. Postal Service Express Mail, with postage prepaid, or by facsimile transmission, or by email, and shall be deemed su&#xfb03;ciently given if served in a manner speci&#xfb01;ed in this Paragraph 23. The addresses noted adjacent to a Party's signature on this Lease shall be that Party's address for delivery or mailing of notices. Either Party may by written notice to the other specify a di&#xfb00;erent address for notice, except that upon Lessee's</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">12</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">taking possession of the Premises, the Premises shall constitute Lessee's address for notice. A copy of all notices to Lessor shall be concurrently transmitted to such party or parties at such addresses as Lessor may from time to time hereafter designate in writing.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">23.2 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Date of Notice</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Any notice sent by registered or certi&#xfb01;ed mail, return receipt requested, shall be deemed given on the date of delivery shown on the receipt card, or if no delivery date is shown, the postmark thereon. If sent by regular mail the notice shall be deemed given 72 hours after the same is addressed as required herein and mailed with postage prepaid. Notices delivered by United States Express Mail or overnight courier that guarantees next day delivery shall be deemed given 24 hours after delivery of the same to the Postal Service or courier. Notices delivered by hand, or transmitted by facsimile transmission or by email shall be deemed delivered upon actual receipt. If notice is received on a Saturday, Sunday or legal holiday, it shall be deemed received on the next business day.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">23.3 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Options. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Notwithstanding the foregoing, in order to exercise any Options (see paragraph 39), the Notice must be sent by Certi&#xfb01;ed Mail (return receipt requested), Express Mail (signature required), courier (signature required) or some other methodology that provides a receipt establishing the date the notice was received by the Lessor.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">24. Waivers.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) No waiver by Lessor of the Default or Breach of any term, covenant or condition hereof by Lessee, shall be deemed a waiver of any other term, covenant or condition hereof, or of any subsequent Default or Breach by Lessee of the same or of any other term, covenant or condition hereof. Lessor's consent to, or approval of, any act shall not be deemed to render unnecessary the obtaining of Lessor's consent to, or approval of, any subsequent or similar act by Lessee, or be construed as the basis of an estoppel to enforce the provision or provisions of this Lease requiring such consent.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) The acceptance of Rent by Lessor shall not be a waiver of any Default or Breach by Lessee. Any payment by Lessee may be accepted by Lessor on account of monies or damages due Lessor, notwithstanding any qualifying statements or conditions made by Lessee in connection therewith, which such statements and/or conditions shall be of no force or e&#xfb00;ect whatsoever unless speci&#xfb01;cally agreed to in writing by Lessor at or before the time of deposit of such payment.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) THE PARTIES AGREE THAT THE TERMS OF THIS LEASE SHALL GOVERN WITH REGARD TO ALL MATTERS RELATED THERETO AND HEREBY WAIVE THE PROVISIONS OF ANY PRESENT OR FUTURE STATUTE TO THE EXTENT THAT SUCH STATUTE IS INCONSISTENT WITH THIS LEASE.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">25. Disclosures Regarding The Nature of a Real Estate Agency Relationship.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) When entering into a discussion with a real estate agent regarding a real estate transaction, a Lessor or Lessee should from the outset understand what type of agency relationship or representation it has with the agent or agents in the transaction. Lessor and Lessee acknowledge being advised by the Brokers in this transaction, as follows:</font></p><p style="text-indent:24.5pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(i) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Lessor's Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. A Lessor's agent under a listing agreement with the Lessor acts as the agent for the Lessor only. A Lessor's agent or subagent has the following a&#xfb03;rmative obligations: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">To the Lessor</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">: A &#xfb01;duciary duty of utmost care, integrity, honesty, and loyalty in dealings with the Lessor. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">To the Lessee and</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">the Lessor</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">: (a) Diligent exercise of reasonable skills and care in performance of the agent's duties. (b) A duty of honest and fair dealing and good faith. (c) A duty to disclose all facts known to the agent materially a&#xfb00;ecting the value or desirability of the property that are not known to, or within the diligent attention and observation of, the Parties. An agent is not obligated to reveal to either Party any con&#xfb01;dential information obtained from the other Party which does not involve the a&#xfb03;rmative duties set forth above.</font></p><p style="text-indent:24.5pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(ii) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Lessee's Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. An agent can agree to act as agent for the Lessee only. In these situations, the agent is not the Lessor's agent, even if by agreement the agent may receive compensation for services rendered, either in full or in part from the Lessor. An agent acting only for a Lessee has the following a&#xfb03;rmative obligations. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">To the Lessee</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">: A &#xfb01;duciary duty of utmost care, integrity, honesty, and loyalty in dealings with the Lessee. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">To the Lessee and the Lessor</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">: (a) Diligent exercise of reasonable skills and care in performance of the agent's duties. (b) A duty of honest and fair dealing and good faith. (c) A duty to disclose all facts known to the agent materially a&#xfb00;ecting the value or desirability of the property that are not known to, or within the diligent attention and observation of, the Parties. An agent is not obligated to reveal to either Party any con&#xfb01;dential information obtained from the other Party which does not involve the a&#xfb03;rmative duties set forth above.</font></p><p style="text-indent:24.5pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(iii) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Agent Representing Both Lessor and Lessee</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. A real estate agent, either acting directly or through one or more associate licensees, can legally be the agent of both the Lessor and the Lessee in a transaction, but only with the knowledge and consent of both the Lessor and the Lessee. In a dual agency situation, the agent has the following a&#xfb03;rmative obligations to both the Lessor and the Lessee: (a) A &#xfb01;duciary duty of utmost care, integrity, honesty and loyalty in the dealings with either Lessor or the Lessee. (b) Other duties to the Lessor and the Lessee as stated above in subparagraphs (i) or (ii). In representing both Lessor and Lessee, the agent may not, without the express permission of the respective Party, disclose to the other Party con&#xfb01;dential information, including, but not limited to, facts relating to either Lessee's or Lessor's &#xfb01;nancial position, motivations, bargaining position, or other personal information that may impact rent, including Lessor's willingness to accept a rent less than the listing rent or Lessee's willingness to pay rent greater than the rent o&#xfb00;ered. The above duties of the agent in a real estate transaction do not relieve a Lessor or Lessee from the responsibility to protect their own interests. Lessor and Lessee should carefully read all agreements to assure that they adequately express their understanding of the transaction. A real estate agent is a person quali&#xfb01;ed to advise about real estate. If legal or tax advice is desired, consult a competent professional. Both Lessor and Lessee should strongly consider obtaining tax advice from a competent professional because the federal and state tax consequences of a transaction can be complex and subject to change.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) Brokers have no responsibility with respect to any default or breach hereof by either Party. The Parties agree that no lawsuit or other legal proceeding involving any breach of duty, error or omission relating to this Lease may be brought against Broker more than one year after the Start Date and that the liability (including court costs and attorneys' fees), of any Broker with respect to any such lawsuit and/or legal proceeding shall not exceed the fee received by such Broker pursuant to this Lease; provided, however, that the foregoing limitation on each Broker's liability shall not be applicable to any gross negligence or willful misconduct of such Broker.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) Lessor and Lessee agree to identify to Brokers as &#34;Con&#xfb01;dential&#34; any communication or information given Brokers that is considered by such Party to be con&#xfb01;dential.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">26. No Right To Holdover</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessee has no right to retain possession of the Premises or any part thereof beyond the expiration or termination of this Lease. At or prior to the expiration or termination of this Lease Lessee shall deliver exclusive possession of the Premises to Lessor. For purposes of this provision and Paragraph 13.1(a), exclusive possession shall mean that Lessee shall have vacated the Premises, removed all of its personal property therefrom and that the Premises have been returned in the condition speci&#xfb01;ed in this Lease. In the event that Lessee does not deliver exclusive possession to Lessor as speci&#xfb01;ed above, then Lessor's damages during any holdover period shall be computed at the amount of the Rent (as de&#xfb01;ned in Paragraph 4.1) due during the last full month before the expiration or termination of this Lease (disregarding any temporary abatement of Rent that may have been in e&#xfb00;ect), but with Base Rent being 150% of the Base Rent payable during such last full month. Nothing contained herein shall be construed as consent by Lessor to any holding over by Lessee.</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">13</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">27. Cumulative Remedies. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">No remedy or election hereunder shall be deemed exclusive but shall, wherever possible, be cumulative with all other remedies at law or in equity.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">28. Covenants and Conditions; Construction of Agreement. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">All provisions of this Lease to be observed or performed by Lessee are both covenants and conditions. In construing this Lease, all headings and titles are for the convenience of the Parties only and shall not be considered a part of this Lease. Whenever required by the context, the singular shall include the plural and vice versa. This Lease shall not be construed as if prepared by one of the Parties, but rather according to its fair meaning as a whole, as if both Parties had prepared it.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">29. Binding E&#xfb00;ect; Choice of Law. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">This Lease shall be binding upon the Parties, their personal representatives, successors and assigns and be governed by the laws of the State in which the Premises are located. Any litigation between the Parties hereto concerning this Lease shall be initiated in the county in which the Premises are located. Signatures to this Lease accomplished by means of electronic signature or similar technology shall be legal and binding.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">30. Subordination; Attornment; Non-Disturbance.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">30.1 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Subordination</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. This Lease and any Option granted hereby shall be subject and subordinate to any ground lease, mortgage, deed of trust, or other hypothecation or security device (collectively, &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Security Device</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;), now or hereafter placed upon the Premises, to any and all advances made on the security thereof, and to all renewals, modi&#xfb01;cations, and extensions thereof. Lessee agrees that the holders of any such Security Devices (in this Lease together referred to as &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lender</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) shall have no liability or obligation to perform any of the obligations of Lessor under this Lease. Any Lender may elect to have this Lease and/or any Option granted hereby superior to the lien of its Security Device by giving written notice thereof to Lessee, whereupon this Lease and such Options shall be deemed prior to such Security Device, notwithstanding the relative dates of the documentation or recordation thereof.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">30.2 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Attornment</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. In the event that Lessor transfers title to the Premises, or the Premises are acquired by another upon the foreclosure or termination of a Security Device to which this Lease is subordinated (i) Lessee shall, subject to the non-disturbance provisions of Paragraph 30.3, attorn to such new owner, and upon request, enter into a new lease, containing all of the terms and provisions of this Lease, with such new owner for the remainder of the term hereof, or, at the election of the new owner, this Lease will automatically become a new lease between Lessee and such new owner, and (ii) Lessor shall thereafter be relieved of any further obligations hereunder and such new owner shall assume all of Lessor's obligations, except that such new owner shall not: (a) be liable for any act or omission of any prior lessor or with respect to events occurring prior to acquisition of ownership; (b) be subject to any o&#xfb00;sets or defenses which Lessee might have against any prior lessor, (c) be bound by prepayment of more than one month's rent, or (d) be liable for the return of any security deposit paid to any prior lessor which was not paid or credited to such new owner.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">30.3 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Non-Disturbance</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. With respect to Security Devices entered into by Lessor after the execution of this Lease, Lessee's subordination of this Lease shall be subject to receiving a commercially reasonable non-disturbance agreement (a &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Non-Disturbance Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) from the Lender which Non-Disturbance Agreement provides that Lessee's possession of the Premises, and this Lease, including any options to extend the term hereof, will not be disturbed so long as Lessee is not in Breach hereof and attorns to the record owner of the Premises. Further, within 60 days after the execution of this Lease, Lessor shall, if requested by Lessee, use its commercially reasonable e&#xfb00;orts to obtain a Non-Disturbance Agreement from the holder of any pre-existing Security Device which is secured by the Premises. In the event that Lessor is unable to provide the Non-Disturbance Agreement within said 60 days, then Lessee may, at Lessee's option, directly contact Lender and attempt to negotiate for the execution and delivery of a Non-Disturbance Agreement.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">30.4 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Self-Executing</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. The agreements contained in this Paragraph 30 shall be e&#xfb00;ective without the execution of any further documents; provided, however, that, upon written request from Lessor or a Lender in connection with a sale, &#xfb01;nancing or re&#xfb01;nancing of the Premises, Lessee and Lessor shall execute such further writings as may be reasonably required to separately document any subordination, attornment and/or Non-Disturbance Agreement provided for herein.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">31. Attorneys' Fees. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">If any Party or Broker brings an action or proceeding involving the Premises whether founded in tort, contract or equity, or to declare rights hereunder, the Prevailing Party (as hereafter de&#xfb01;ned) in any such proceeding, action, or appeal thereon, shall be entitled to reasonable attorneys' fees. Such fees may be awarded in the same suit or recovered in a separate suit, whether or not such action or proceeding is pursued to decision or judgment. The term, &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Prevailing Party</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall include, without limitation, a Party or Broker who substantially obtains or defeats the relief sought, as the case may be, whether by compromise, settlement, judgment, or the abandonment by the other Party or Broker of its claim or defense. The attorneys' fees award shall not be computed in accordance with any court fee schedule, but shall be such as to fully reimburse all attorneys' fees reasonably incurred. In addition, Lessor shall be entitled to attorneys' fees, costs and expenses incurred in the preparation and service of notices of Default and consultations in connection therewith, whether or not a legal action is subsequently commenced in connection with such Default or resulting Breach ($200 is a reasonable minimum per occurrence for such services and consultation).</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">32. Lessor's Access; Showing Premises; Repairs. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor and Lessor's agents shall have the right to enter the Premises at any time, in the case of an emergency, and otherwise at reasonable times after reasonable prior notice for the purpose of showing the same to prospective purchasers, lenders, or tenants, and making such alterations, repairs, improvements or additions to the Premises as Lessor may deem necessary or desirable and the erecting, using and maintaining of utilities, services, pipes and conduits through the Premises and/or other premises as long as there is no material adverse e&#xfb00;ect on Lessee's use of the Premises. All such activities shall be without abatement of rent or liability to Lessee.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">33. Auctions. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee shall not conduct, nor permit to be conducted, any auction upon the Premises without Lessor's prior written consent. Lessor shall not be obligated to exercise any standard of reasonableness in determining whether to permit an auction.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">34. Signs. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor may place on the Premises ordinary &#34;For Sale&#34; signs at any time and ordinary &#34;For Lease&#34; signs during the last 6 months of the term hereof. Except for ordinary &#34;for sublease&#34; signs, Lessee shall not place any sign upon the Premises without Lessor's prior written consent. All signs must comply with all Applicable Requirements.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">35. Termination; Merger. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Unless speci&#xfb01;cally stated otherwise in writing by Lessor, the voluntary or other surrender of this Lease by Lessee, the mutual termination or cancellation hereof, or a termination hereof by Lessor for Breach by Lessee, shall automatically terminate any sublease or lesser estate in the Premises; provided, however, that Lessor may elect to continue any one or all existing subtenancies. Lessor's failure within 10 days following any such event to elect to the contrary by written notice to the holder of any such lesser interest, shall constitute Lessor's election to have such event constitute the termination of such interest.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">36. Consents. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">All requests for consent shall be in writing. Except as otherwise provided herein, wherever in this Lease the consent of a Party is required to an act by or for the other Party, such consent shall not be unreasonably withheld or delayed. Lessor's actual reasonable costs and expenses (including but not limited to architects', attorneys', engineers' and other consultants' fees) incurred in the consideration of, or response to, a request by Lessee for any Lessor consent, including</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">14</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">but not limited to consents to an assignment, a subletting or the presence or use of a Hazardous Substance, shall be paid by Lessee upon receipt of an invoice and supporting documentation therefor. Lessor's consent to any act, assignment or subletting shall not constitute an acknowledgment that no Default or Breach by Lessee of this Lease exists, nor shall such consent be deemed a waiver of any then existing Default or Breach, except as may be otherwise speci&#xfb01;cally stated in writing by Lessor at the time of such consent. The failure to specify herein any particular condition to Lessor's consent shall not preclude the imposition by Lessor at the time of consent of such further or other conditions as are then reasonable with reference to the particular matter for which consent is being given. In the event that either Party disagrees with any determination made by the other hereunder and reasonably requests the reasons for such determination, the determining party shall furnish its reasons in writing and in reasonable detail within 10 business days following such request.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">37. Guarantor.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">37.1 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Execution</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. The Guarantors, if any, shall each execute a guaranty in the form most recently published by AIR CRE, and each such Guarantor shall have the same obligations as Lessee under this Lease.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">37.2 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Default</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. It shall constitute a Default of the Lessee if any Guarantor fails or refuses, upon request to provide: (a) evidence of the execution of the guaranty, including the authority of the party signing on Guarantor's behalf to obligate Guarantor, and in the case of a corporate Guarantor, a certi&#xfb01;ed copy of a resolution of its board of directors authorizing the making of such guaranty, (b) current &#xfb01;nancial statements, (c) an Estoppel Certi&#xfb01;cate, or (d) written con&#xfb01;rmation that the guaranty is still in e&#xfb00;ect.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">38. Quiet Possession. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Subject to payment by Lessee of the Rent and performance of all of the covenants, conditions and provisions on Lessee's part to be observed and performed under this Lease, Lessee shall have quiet possession and quiet enjoyment of the Premises during the term hereof.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">39. Options. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">If Lessee is granted any Option, as de&#xfb01;ned below, then the following provisions shall apply.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">39.1 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">De&#xfb01;nition</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Option</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall mean: (a) the right to extend or reduce the term of or renew this Lease or to extend or reduce the term of or renew any lease that Lessee has on other property of Lessor; (b) the right of &#xfb01;rst refusal or &#xfb01;rst o&#xfb00;er to lease either the Premises or other property of Lessor; (c) the right to purchase, the right of &#xfb01;rst o&#xfb00;er to purchase or the right of &#xfb01;rst refusal to purchase the Premises or other property of Lessor.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">39.2 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Options Personal To Original Lessee</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Any Option granted to Lessee in this Lease is personal to the original Lessee, and cannot be assigned or exercised by anyone other than said original Lessee and only while the original Lessee is in full possession of the Premises and, if requested by Lessor, with Lessee certifying that Lessee has no intention of thereafter assigning or subletting.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">39.3 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Multiple Options</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. In the event that Lessee has any multiple Options to extend or renew this Lease, a later Option cannot be exercised unless the prior Options have been validly exercised.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">39.4 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">E&#xfb00;ect of Default on Options</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) Lessee shall have no right to exercise an Option: (i) during the period commencing with the giving of any notice of Default and continuing until said Default is cured, (ii) during the period of time any Rent is unpaid (without regard to whether notice thereof is given Lessee), (iii) during the time Lessee is in Breach of this Lease, or (iv) in the event that Lessee has been given 3 or more notices of separate Default, whether or not the Defaults are cured, during the 12 month period immediately preceding the exercise of the Option.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) The period of time within which an Option may be exercised shall not be extended or enlarged by reason of Lessee's inability to exercise an Option because of the provisions of Paragraph 39.4(a).</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) An Option shall terminate and be of no further force or e&#xfb00;ect, notwithstanding Lessee's due and timely exercise of the Option, if, after such exercise and prior to the commencement of the extended term or completion of the purchase, (i) Lessee fails to pay Rent for a period of 30 days after such Rent becomes due (without any necessity of Lessor to give notice thereof), or (ii) if Lessee commits a Breach of this Lease.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">40. Multiple Buildings. </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">If the Premises are a part of a group of buildings controlled by Lessor, Lessee agrees that it will abide by and conform to all reasonable rules and regulations which Lessor may make from time to time for the management, safety, and care of said properties, including the care and cleanliness of the grounds and including the parking, loading and unloading of vehicles, and to cause its employees, suppliers, shippers, customers, contractors and invitees to so abide and conform. Lessee also agrees to pay its fair share of common expenses incurred in connection with such rules and regulations.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">41. Security Measures. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee hereby acknowledges that the Rent payable to Lessor hereunder does not include the cost of guard service or other security measures, and that Lessor shall have no obligation whatsoever to provide same. Lessee assumes all responsibility for the protection of the Premises, Lessee, its agents and invitees and their property from the acts of third parties.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">42. Reservations</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Lessor reserves to itself the right, from time to time, to grant, without the consent or joinder of Lessee, such easements, rights and dedications that Lessor deems necessary, and to cause the recordation of parcel maps and restrictions, so long as such easements, rights, dedications, maps and restrictions do not unreasonably interfere with the use of the Premises by Lessee. Lessee agrees to sign any documents reasonably requested by Lessor to effectuate any such easement rights, dedication, map or restrictions.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">43. Performance Under Protest. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">If at any time a dispute shall arise as to any amount or sum of money to be paid by one Party to the other under the provisions hereof, the Party against whom the obligation to pay the money is asserted shall have the right to make payment &#34;under protest&#34; and such payment shall not be regarded as a voluntary payment and there shall survive the right on the part of said Party to institute suit for recovery of such sum. If it shall be adjudged that there was no legal obligation on the part of said Party to pay such sum or any part thereof, said Party shall be entitled to recover such sum or so much thereof as it was not legally required to pay. A Party who does not initiate suit for the recovery of sums paid &#34;under protest&#34; within 6 months shall be deemed to have waived its right to protest such payment.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">44. Authority; Multiple Parties; Execution.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) If either Party hereto is a corporation, trust, limited liability company, partnership, or similar entity, each individual executing this Lease on behalf of such entity represents and warrants that he or she is duly authorized to execute and deliver this Lease on its behalf. Each Party shall, within 30 days after request, deliver to the other Party satisfactory evidence of such authority.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) If this Lease is executed by more than one person or entity as &#34;Lessee&#34;, each such person or entity shall be jointly and severally liable hereunder. It is agreed that any one of the named Lessees shall be empowered to execute any amendment to this Lease, or other document ancillary thereto and bind all of the named Lessees, and Lessor may rely on the same as if all of the named Lessees had executed such document.</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">15</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) This Lease may be executed by the Parties in counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">45. Con&#xfb02;ict. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Any con&#xfb02;ict between the printed provisions of this Lease and the typewritten or handwritten provisions shall be controlled by the typewritten or handwritten provisions.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">46. O&#xfb00;er</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. Preparation of this Lease by either Party or their agent and submission of same to the other Party shall not be deemed an o&#xfb00;er to lease to the other Party. This Lease is not intended to be binding until executed and delivered by all Parties hereto.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">47. Amendments. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">This Lease may be modi&#xfb01;ed only in writing, signed by the Parties in interest at the time of the modi&#xfb01;cation. As long as they do not materially change Lessee's obligations hereunder, Lessee agrees to make such reasonable non-monetary modi&#xfb01;cations to this Lease as may be reasonably required by a Lender in connection with the obtaining of normal &#xfb01;nancing or re&#xfb01;nancing of the Premises.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">48. Waiver of Jury Trial. THE PARTIES HEREBY WAIVE THEIR RESPECTIVE RIGHTS TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING INVOLVING THE PROPERTY OR ARISING OUT OF THIS LEASE.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">49. Arbitration of Disputes. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">An Addendum requiring the Arbitration of all disputes between the Parties and/or Brokers arising out of this Lease </font><font style="color:#0000ff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9745;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> is </font><font style="color:#0000ff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> is not attached to this Lease.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">50. Accessibility; Americans with Disabilities Act.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) The Premises:</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9745;</font><font style="color:#0000ff;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">have not undergone an inspection by a Certi&#xfb01;ed Access Specialist (CASp). Note: A Certi&#xfb01;ed Access Specialist (CASp) can inspect the subject premises and determine whether the subject premises comply with all of the applicable construction-related accessibility standards under state law. Although state law does not require a CASp inspection of the subject premises, the commercial property owner or lessor may not prohibit the lessee or tenant from obtaining a CASp inspection of the subject premises for the occupancy or potential occupancy of the lessee or tenant, if requested by the lessee or tenant. The parties shall mutually agree on the arrangements for the time and manner of the CASp inspection, the payment of the fee for the CASp inspection, and the cost of making any repairs necessary to correct violations of construction-related accessibility standards within the premises.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#0000ff;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">have undergone an inspection by a Certi&#xfb01;ed Access Specialist (CASp) and it was determined that the Premises met all applicable construction-related accessibility standards pursuant to California Civil Code &#167;55.51 et seq. Lessee acknowledges that it received a copy of the inspection report at least 48 hours prior to executing this Lease and agrees to keep such report con&#xfb01;dential.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#0000ff;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">have undergone an inspection by a Certi&#xfb01;ed Access Specialist (CASp) and it was determined that the Premises did not meet all applicable construction-related accessibility standards pursuant to California Civil Code &#167;55.51 et seq. Lessee acknowledges that it received a copy of the inspection report at least 48 hours prior to executing this Lease and agrees to keep such report con&#xfb01;dential except as necessary to complete repairs and corrections of violations of construction related accessibility standards.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">In the event that the Premises have been issued an inspection report by a CASp the Lessor shall provide a copy of the disability access inspection certi&#xfb01;cate to Lessee within 7 days of the execution of this Lease.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) Since compliance with the Americans with Disabilities Act (ADA) and other state and local accessibility statutes are dependent upon Lessee's speci&#xfb01;c use of the Premises, Lessor makes no warranty or representation as to whether or not the Premises comply with ADA or any similar legislation. In the event that Lessee's use of the Premises requires modi&#xfb01;cations or additions to the Premises in order to be in compliance with ADA or other accessibility statutes, Lessee agrees to make any such necessary modi&#xfb01;cations and/or additions at Lessee's expense.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">LESSOR AND LESSEE HAVE CAREFULLY READ AND REVIEWED THIS LEASE AND EACH TERM AND PROVISION CONTAINED HEREIN, AND BY THE EXECUTION OF THIS LEASE SHOW THEIR INFORMED AND VOLUNTARY CONSENT THERETO. THE PARTIES HEREBY AGREE THAT, AT THE TIME THIS LEASE IS EXECUTED, THE TERMS OF THIS LEASE ARE COMMERCIALLY REASONABLE AND EFFECTUATE THE INTENT AND PURPOSE OF LESSOR AND LESSEE WITH RESPECT TO THE PREMISES.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">ATTENTION: NO REPRESENTATION OR RECOMMENDATION IS MADE BY AIR CRE OR BY ANY BROKER AS TO THE LEGAL SUFFICIENCY, LEGAL EFFECT, OR TAX CONSEQUENCES OF THIS LEASE OR THE TRANSACTION TO WHICH IT RELATES. THE PARTIES ARE URGED TO:</font></p><p style="font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1. SEEK ADVICE OF COUNSEL AS TO THE LEGAL AND TAX CONSEQUENCES OF THIS LEASE.</font></p><p style="font-size:10pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.19027777777777777in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2. RETAIN APPROPRIATE CONSULTANTS TO REVIEW AND INVESTIGATE THE CONDITION OF THE PREMISES. SAID INVESTIGATION SHOULD INCLUDE BUT NOT BE LIMITED TO: THE POSSIBLE PRESENCE OF HAZARDOUS SUBSTANCES, THE ZONING OF THE PREMISES, THE STRUCTURAL INTEGRITY, THE CONDITION OF THE ROOF AND OPERATING SYSTEMS, AND THE SUITABILITY OF THE PREMISES FOR LESSEE'S INTENDED USE.</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">16</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="min-height:0.5in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">WARNING: IF THE PREMISES ARE LOCATED IN A STATE OTHER THAN CALIFORNIA, CERTAIN PROVISIONS OF THE LEASE MAY NEED TO BE REVISED TO COMPLY WITH THE LAWS OF THE STATE IN WHICH THE PREMISES ARE LOCATED.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The parties hereto have executed this Lease at the place and on the dates speci&#xfb01;ed above their respective signatures.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:5%;"></td>
     <td style="width:43%;"></td>
     <td style="width:4%;"></td>
     <td style="width:5%;"></td>
     <td style="width:43%;"></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Executed at:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Executed at:</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">On:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">On:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">By LESSOR</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">By LESSEE</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">:</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="text-indent:7.2pt;vertical-align:top;"><p style="margin-left:7.2pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">BML Management, LLC</font></p></td>
     <td style="text-indent:7.2pt;vertical-align:top;"><p style="margin-left:7.2pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="text-indent:7.2pt;vertical-align:top;"><p style="margin-left:7.2pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">RxSight, Inc.</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:9%;"></td>
     <td style="width:39%;"></td>
     <td style="width:4%;"></td>
     <td style="width:9%;"></td>
     <td style="width:39%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">By:</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">/s/ Peter Lim</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">By:</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">/s/ Ron Kurtz</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Name Printed:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Peter Lim</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Name Printed:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Ron Kurtz</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Title:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Manager</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Title:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">President and CEO</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Phone:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Phone:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Fax:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Fax:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Email:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">peter.lim@bureauveritas.com</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Email:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">rkurtz@rxsight.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:9%;"></td>
     <td style="width:39%;"></td>
     <td style="width:4%;"></td>
     <td style="width:9%;"></td>
     <td style="width:39%;"></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">By:</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">By:</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Name Printed:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Name Printed:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Title:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Title:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Phone:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Phone:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Fax:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Fax:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Email:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Email:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Address:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Address:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Federal ID No.:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Federal ID No.:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:5%;"></td>
     <td style="width:43%;"></td>
     <td style="width:4%;"></td>
     <td style="width:5%;"></td>
     <td style="width:43%;"></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">BROKER</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">BROKER</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="text-indent:7.2pt;vertical-align:top;"><p style="margin-left:7.2pt;text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">CBRE, Inc.</font><font style="color:#0000ff;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="text-indent:7.2pt;vertical-align:top;"><p style="margin-left:7.2pt;text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="text-indent:7.2pt;vertical-align:top;"><p style="margin-left:7.2pt;text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">Lee &amp; Associates</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Attn:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">Keith Black</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Attn:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">Guy Laferrara</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Title:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Title:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:13%;"></td>
     <td style="width:35%;"></td>
     <td style="width:4%;"></td>
     <td style="width:13%;"></td>
     <td style="width:35%;"></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Address:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Address:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Phone:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Phone:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Fax:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Fax:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Email:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Email:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Federal ID No.:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Federal ID No.:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Broker DRE License #:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="text-indent:5pt;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">00409987</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Broker DRE License #:</font></p></td>
     <td style="text-indent:5pt;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">01044791</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Agent DRE License #:</font></p></td>
     <td style="text-indent:5pt;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">01266477</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Agent DRE License #:</font></p></td>
     <td style="text-indent:5pt;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">01012355</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">AIR CRE * https://</font><font><font style="white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">www.aircre.com</font></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> * 213-687-8777 * contracts@aircre.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">NOTICE: No part of these works may be reproduced in any form without permission in writing.</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2019 AIR CRE. All Rights Reserved.</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">STN-27.30, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">17</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 17</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="margin-left:5pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_3.jpg" alt="img74569629_3.jpg" style="width:152px;height:48px;">&#160;</p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:'Calibri',sans-serif;min-width:fit-content;">RENT ADJUSTMENT(S)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(ORIGINAL TERM)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">STANDARD LEASE ADDENDUM</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:17%;"></td>
     <td style="width:83%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Dated:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-family:Arial;min-width:fit-content;">April 5, 2024</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">By and Between</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:7.2pt;vertical-align:top;"><p style="margin-left:7.2pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-family:Arial;min-width:fit-content;">BML Management, LLC</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:7.2pt;vertical-align:top;"><p style="margin-left:7.2pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-family:Arial;min-width:fit-content;">RxSight, Inc.</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Property Address:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-family:Arial;min-width:fit-content;">125 Columbia, Aliso Viejo, CA 92656</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(street address, city, state, zip)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:5pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Paragraph: </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;"> 51</font><font style="color:#0000ff;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The monthly Base Rent during the Original Term of the Lease shall be increased by using the method(s) selected below (</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">check method(s) to be used and &#xfb01;ll in appropriately</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">):</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#9744; </font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">I.	Consumer Price Index.</font></p><div class="item-list-element-wrapper" style="text-indent:18pt;font-size:0;margin-top:6pt;justify-content:flex-start;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:Calibri;min-width:1.2%;text-indent:0;display:inline-flex;justify-content:flex-start;">a.</font><div style="width:100%;display:inline;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The monthly Base Rent shall be increased on</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">        </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">and every</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">          </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">months thereafter during the Original Term (&#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">CPI Increase Date(s)</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;)</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">commensurate with the increase in the CPI (as herein de&#xfb01;ned) determined as follows: the monthly Base Rent scheduled for the &#xfb01;rst month of the Original Term shall</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">be multiplied by a fraction the denominator of which is the Base CPI (as herein de&#xfb01;ned), and the numerator of which is the Comparison CPI (as herein de&#xfb01;ned). The</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">amount so calculated shall constitute the new Base Rent until the next CPI Increase Date, but in no event shall any such new Base Rent be less than the Base Rent for</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">the month immediately preceding the applicable CPI Increase Date.</font></div></div><div class="item-list-element-wrapper" style="text-indent:18pt;font-size:0;margin-top:6pt;justify-content:flex-start;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:Calibri;min-width:1.2%;text-indent:0;display:inline-flex;justify-content:flex-start;">b.</font><div style="width:100%;display:inline;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The term &#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">CPI</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall mean the Consumer Price Index of the Bureau of Labor Statistics of the U.S. Department of Labor for (</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">select one</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">):</font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> &#9744; </font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">CPI W (Urban Wage Earners and Clerical Workers) or</font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> &#9744; </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">CPI U (All Urban Consumers), for (</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">&#xfb01;ll in Urban Area</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">):</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">  </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">        </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">or</font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">the area in which the Premises is located, All</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Items (1982-1984 = 100). The term &#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Comparison CPI</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall mean the CPI of the calendar month which is 2 full months prior to the applicable Original Term CPI</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Increase Date. The term &#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Base CPI</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall mean the CPI of the calendar month which is 2 full months prior to the Commencement Date of the Original Term</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="text-indent:18pt;font-size:0;margin-top:6pt;justify-content:flex-start;margin-bottom:0;min-width:0.25in;text-align:justify;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:Calibri;min-width:1.2%;text-indent:0;display:inline-flex;justify-content:flex-start;">c.</font><div style="width:100%;display:inline;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">  If the compilation and/or publication of the CPI is transferred to another governmental department, bureau or agency or is discontinued, then instead</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">the index most nearly the same as the CPI shall be used to calculate the Base Rent increases hereunder. If the Parties cannot agree on such alternative index, then the</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">matter shall be submitted for decision to the American Arbitration Association in accordance with the then rules of said association and the decision of the arbitrators</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">shall be binding upon the parties, with the cost of such arbitration being paid equally by the Parties</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744; </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">  </font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">II.	Fixed Percentage. </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The monthly Base Rent shall be increased on</font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">      </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">and every</font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">           </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">months thereafter during the Original Term (&#34;Percentage Increase</font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Date(s)&#34;) by</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">       </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">percent (</font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">       </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">%) of the monthly Base Rent scheduled to be paid for the month immediately preceding the applicable Percentage Increase Date</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9745; </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">III.	Fixed Rental Adjustment(s) (&#34;FRA&#34;).</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The monthly Base Rent shall be increased to the following amounts on the dates set forth below:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:58.12%;"></td>
     <td style="width:41.88%;"></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">On (&#xfb01;ll in FRA Adjustment Date(s)):</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">The new Base Rent shall be:</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;June 1, 2024 - June 30, 2024</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;$41,578.75</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;July 1, 2024 - November 30, 2024</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;$0.00</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;December 1, 2024 - May 31, 2025</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;$41,578.75</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;June 1, 2025 - May 31, 2026</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;$43,034.01</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;June 1, 2026 - May 31, 2027</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;$44,540.20</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;June 1, 2027 - May 31, 2028</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;$46,099.10</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;June 1, 2028 - May 31, 2029</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;$47,712.57</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;June 1, 2029 - May 31, 2030</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;$49,382.51</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;June 1, 2030 - January 31, 2031</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;$51,110.90</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">BROKER'S FEE: </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">For each adjustment in Base Rent speci&#xfb01;ed above, the Brokers shall be paid a Brokerage Fee in accordance with paragraph 15 of the Lease or if applicable, paragraph 9 of the Sublease.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">AIR CRE * https://</font><font><font style="white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">www.aircre.com</font></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> * 213-687-8777 * contracts@aircre.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">NOTICE: No part of these works may be reproduced in any form without permission in writing.</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2017 AIR CRE. All Rights Reserved.</font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">RA-8.00, Revised 10-13-2022</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 1</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="min-height:0.5in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_4.jpg" alt="img74569629_4.jpg" style="width:152px;height:48px;">&#160;</p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:'Calibri',sans-serif;min-width:fit-content;">OPTION(S) TO EXTEND TERM</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">STANDARD LEASE ADDENDUM</font></p><p style="margin-left:49.85pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:93.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:13.978%;"></td>
     <td style="width:1.075%;"></td>
     <td style="width:84.946%;"></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Dated:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">April 5, 2024</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">By and Between</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:9.35pt;vertical-align:top;padding-right:0.01in;"><p style="margin-left:9.35pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">BML Management, LLC</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:9.35pt;vertical-align:top;padding-right:0.01in;"><p style="margin-left:9.35pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">RxSight, Inc.</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Property Address:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">125 Columbia, Aliso Viejo, CA 92656</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">(street address, city, state, zip)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Paragraph: </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">52</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">OPTION(S) TO EXTEND TERM. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Subject to the terms, conditions and provisions of Paragraph 39, Lessor grants Lessee</font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> two (2)</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">option(s) to extend the term of the Lease (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Extension Option(s)</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;), with each Extension Option being for a term of </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> sixty (60)</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">months, commencing when the prior term expires (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Option Term(s)</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;). In order to exercise an Extension Option, Lessee must give written notice of such election to Lessor and Lessor must receive such notice at least </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> nine (9) months</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">but not more than</font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">months prior to the date that the applicable Option Term would commence, time being of the essence. If timely and proper noti&#xfb01;cation of the exercise of an Extension Option is not given by Lessee and/or received by Lessor, such Extension Option shall automatically expire. Except as speci&#xfb01;cally modi&#xfb01;ed, the terms, conditions and provisions of the Lease shall apply during Option Terms but the amount of Rent during Option Terms shall be established by using the method(s) selected below </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">(check method(s) to be used and &#xfb01;ll in appropriately)</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">:</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744; </font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">I. Consumer Price Index.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a) </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">During the Option Term(s) which start(s) on </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, the monthly Base Rent shall be increased on </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">____ </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">and every </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">____ </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">months thereafter during such Option Term(s) (&#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Option Term CPI Increase Date(s)</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) commensurate with the increase in the Option Term CPI (as herein de&#xfb01;ned) determined as follows: the monthly Base Rent scheduled for the month immediately preceding the &#xfb01;rst occurring Option Term CPI Increase Date shall be multiplied by a fraction the denominator of which is the Option Term Base CPI (as herein de&#xfb01;ned), and the numerator of which is the Option Term Comparison CPI (as herein de&#xfb01;ned). The amount so calculated shall constitute the new Base Rent until the next Option Term CPI Increase Date during the applicable Option Term, but in no event shall any such new Base Rent be less than the Base Rent for the month immediately preceding the applicable Option Term CPI Increase Date.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b) The term &#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Option Term CPI</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall mean the Consumer Price Index of the Bureau of Labor Statistics of the U.S. Department of Labor for </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">(select one)</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">:</font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> CPI W (Urban Wage Earners and Clerical Workers) or</font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">CPI U (All Urban Consumers), for (</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">&#xfb01;ll in Urban Area</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">):</font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">____ </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">or </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">the area in which the Premises is located, All Items (1982-1984 = 100). The term &#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Option Term Comparison CPI</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34; shall mean the CPI of the calendar month which is 2 full months prior to the applicable Option Term CPI Increase Date. The term &#34;Option Term Base CPI&#34; shall mean the CPI of the calendar month which is 2 full months prior to (select one): </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Commencement Date of the Original Term, </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> start of the applicable Option Term, or </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> (&#xfb01;ll in month)</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">____.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">If compilation and/or publication of the CPI is transferred to another governmental department, bureau or agency or is discontinued, then instead the</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">index most nearly the same as the CPI shall be used to calculate the Base Rent increases hereunder. If the Parties cannot agree on such alternative index, then the matter shall be submitted for decision to the American Arbitration Association in accordance with the then rules of said association and the decision of the arbitrators shall be binding upon the parties, with the cost of such arbitration being paid equally by the Parties.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744; </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">II. Fixed Percentage. </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">During the Option Term(s) which start(s) on </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> February 1, 2031 and February 1, 2036</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, the monthly Base Rent shall be increased on </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> February 1, 2031</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">and every </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">12</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">months thereafter during such Option Term(s) (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Option Term Percentage Increase Date(s)&#34;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">) by </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> three</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">percent ( </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> 3</font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">%) of the monthly Base Rent scheduled to be paid for the month immediately preceding the applicable Option Term Percentage Increase Date.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744; </font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">III. Fair Market Value.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(a)  </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">During the Option Term(s) which start(s) on</font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, the amount of Rent shall be the amount forecasted to be the fair market rental value of the Premises during such Option Term established pursuant to the procedures, terms, assumptions and conditions set forth herein (&#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Fair Market Value</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;); provided, however, regardless of such Fair Market Value, Base Rent during an Option Term shall not be less than the Base Rent scheduled as of when the prior term expires. Starting as of Lessee's exercise of the applicable Extension Option (but not earlier than six (6) months before start of the applicable Option Term), the Parties shall for thirty (30) days (&#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Negotiation Period</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) attempt to agree upon the Fair Market Value. If during the Negotiation Period the Parties do not agree on the Fair Market Value, then the Fair Market Value shall be established pursuant to the procedures set forth herein, which shall be binding.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(b)  </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Each Party shall, within &#xfb01;fteen (15) days after the end of the Negotiation Period, in writing submit to the other Party such Party's determination of the Fair Market Value (&#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Submitted Value(s)</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;). If a Party fails to timely provide a Submitted Value, then the other Party's Submitted Value shall be the Fair Market Value. If both Parties timely provide Submitted Values, then each Party shall, within &#xfb01;fteen (15) days after both Parties have exchanged Submitted Values, in writing notify the other Party of such Party's selected valuator who shall meet the quali&#xfb01;cations set forth herein (&#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Advocate Valuator(s)</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;). Lessor and Lessee may select an Advocate Valuator who is favorable to such Party's position and may, prior to or after appointment of an Advocate Valuator, consult with such Party's Advocate Valuator. If a Party fails to timely and properly provide notice of such Party's chosen Advocate Valuator, then the other Party's Submitted Value shall be the Fair Market Value.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(c) </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">If both Parties timely and properly designate Advocate Valuators, then such Advocate Valuators shall, within &#xfb01;fteen (15) days after their selection, choose a third (3rd) neutral valuator who shall meet the quali&#xfb01;cations set forth herein (&#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Neutral Valuator</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;). The Neutral Valuator shall be engaged jointly by Lessor and Lessee. If Advocate Valuators fail to agree upon and timely appoint a Neutral Valuator, then the President of AIR CRE shall appoint such Neutral Valuator within &#xfb01;fteen (15)</font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:1.22in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2017 AIR CRE. All Rights Reserved.</font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">OE-7.02, Revised 01-13-2023</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 2</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="min-height:0.5in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">days after request by either Party. If the President of AIR CRE does not timely appoint the Neutral Valuator, then either Party may &#xfb01;le an appropriate legal action for a judge with competent jurisdiction over the Parties to appoint the Neutral Valuator.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(d) </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The Advocate Valuators and the Neutral Valuator (&#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Valuator(s)</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) shall be duly licensed real estate brokers or salespersons in good standing in the state in which the Premises is located, shall have been active over the &#xfb01;ve (5) year period before their appointment in the leasing of properties similar to the Premises within the general real estate market of the Premises. The Neutral Valuator shall additionally not be related to or a&#xfb03;liated with either Party or Advocate Valuator, and shall not have previously represented in a real estate transaction a Party or anyone related to or a&#xfb03;liated with a Party. All matters to be determined by the Valuators shall be decided by a majority vote of the Valuators, with each Valuator having one (1) vote. The Valuators may, as the Valuators determine, hold hearings and require briefs, including market data and additional information.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(e) </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Within thirty (30) days after selection of the Neutral Valuator, the Valuators shall &#xfb01;rst determine the Fair Market Value established by taking into account the terms, assumptions and conditions set forth herein (&#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Valuators' Market Value</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;), then decide which Party's Submitted Value is closer in monetary amount to the Valuators' Market Value (&#34;</font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Selected Market Value</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;), then provide the Parties a copy of the Valuators' Market Value and &#xfb01;nally notify the Parties of the Selected Market Value. The Selected Market Value shall be the Fair Market Value. The Valuators shall have no right to decide a Selected Market Value which is a compromise to (or modi&#xfb01;cation of) the Submitted Values. The decision of the Valuators shall be binding upon the Parties. The Party whose Submitted Value is not the Selected Market Value shall, within ten (10) days after the Valuators decide the Selected Market Value, pay the fees and costs of all three (3) Valuators.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(f) If the Fair Market Value has not been established before the start of the applicable Option Term, then Lessee shall continue to pay to Lessor rent in the amount payable for the month immediately preceding the start of such Option Term and Lessor's acceptance of such rent shall not waive, adversely a&#xfb00;ect or prejudice the Parties' right to complete establishment of the Fair Market Value or Lessor's right to collect the full amount of the Fair Market Value once the Fair Market Value is established. Lessee shall, within ten (10) days after establishment of the Fair Market Value, pay to Lessor any de&#xfb01;ciency in rent then due for the Option Term. Following establishment of Fair Market Value, the Parties shall, within ten (10) days after request by either Party, sign an amendment to this Lease to con&#xfb01;rm the Fair Market Value and the expiration date of this Lease, but the Parties' failure to request or to sign such an amendment shall not a&#xfb00;ect establishment of the Fair Market Value or extension of the Lease term.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(g)  </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The Valuators, in deciding the Valuators' Market Value, shall take into account rent rates, rent abatements, periodic rent increases, real property taxes, insurance premiums and other operating expenses, tenant improvement and other applicable allowances, building services, length of lease term and other factors professional real estate brokers and/or appraisers customarily consider in determining fair market rent of property in an arm's length transaction by ready, willing and able parties for space of comparable location, size, age, condition, quality, parking, visibility, view, signage and accessibility if the Premises were marketed in a normal and customary manner for a reasonable length of time on the open market to be leased to a tenant with &#xfb01;nancial strength and credit worthiness comparable to Lessee and guarantors (if any) of this Lease (as of Lessee's exercise of the Extension Option) for a term comparable to the length of the applicable Option Term and used for the Agreed Use (or other reasonably comparable uses). The Valuators, in deciding the Valuators' Market Value, shall not consider as a comparable transaction any of the following: a sublease, lease assignment, lease renewal or extension; lease with a tenant that has equity, is related to or a&#xfb03;liated with the landlord; or a lease of space that was subject to a right of &#xfb01;rst refusal, right of &#xfb01;rst o&#xfb00;er, expansion option or other encumbrances. The Valuators, in deciding the Valuators' Market Value, shall reduce the Fair Market Value on account of Alterations and improvements made by Lessee to the extent the cost thereof was paid solely by Lessee (in excess of any applicable improvement allowance, abated rent in lieu of improvement allowance or other consideration provided by Lessor for Lessee's improvement of the Premises), shall not reduce the Fair Market Value on account of any real estate brokerage commission savings by Lessor, and shall not reduce the Fair Market Value on account of deferred maintenance or repair of the Premises for which Lessee was responsible under the Lease but did not perform.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744; </font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">IV. Fixed Rental Adjustment(s) (&#34;FRA&#34;)</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The monthly Base Rent shall be increased to the following amounts on the dates set forth below:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50%;"></td>
     <td style="width:50%;"></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-family:'Calibri',sans-serif;min-width:fit-content;">On (&#xfb01;ll in FRA Adjustment Date(s)):</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-family:'Calibri',sans-serif;min-width:fit-content;">The new Base Rent shall be</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">:</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744; </font><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">V. Continuation of Original Term Adjustments.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The monthly Base Rent during the Option Term(s) which start(s) on</font><font style="color:#ff0000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">____</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">shall be increased in accordance with the same formula provided in the Lease to be used to calculate increases in the Base Rent during the Original Term of the Lease.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">BROKER'S FEE</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">: For each adjustment in Base Rent speci&#xfb01;ed above, the Brokers shall be paid a Brokerage Fee in accordance with paragraph 15 of the Lease or if applicable, paragraph 9 of the Sublease.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">AIR CRE * https://</font><font><font style="white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">www.aircre.com</font></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> * 213-687-8777 * contracts@aircre.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">NOTICE: No part of these works may be reproduced in any form without permission in writing.</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:1.22in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2017 AIR CRE. All Rights Reserved.</font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">OE-7.02, Revised 01-13-2023</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">2</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 2</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_5.jpg" alt="img74569629_5.jpg" style="width:152px;height:48px;">&#160;</p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:'Calibri',sans-serif;min-width:fit-content;">ARBITRATION AGREEMENT</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">STANDARD LEASE ADDENDUM</font></p><p style="margin-left:49.85pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:93.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:13.978%;"></td>
     <td style="width:1.075%;"></td>
     <td style="width:84.946%;"></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Dated:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">April 5, 2024</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">By and Between</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:9.35pt;vertical-align:top;padding-right:0.01in;"><p style="margin-left:9.35pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">BML Management, LLC</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:9.35pt;vertical-align:top;padding-right:0.01in;"><p style="margin-left:9.35pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;RxSight, Inc.</font></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Property Address:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">125 Columbia, Aliso Viejo, CA 92656</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">(street address, city, state, zip)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Paragraph: </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">53</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">A. ARBITRATION OF DISPUTES</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">:</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Except as provided in Paragraph B below, the Parties agree to resolve any and all claims, disputes or disagreements arising under this Lease, including, but not limited to any matter relating to Lessor's failure to approve an assignment, sublease or other transfer of Lessee's interest in the Lease under Paragraph 12 of this Lease, any other defaults by Lessor, or any defaults by Lessee by and through arbitration as provided below and irrevocably waive any and all rights to the contrary. The Parties agree to at all times conduct themselves in strict, full, complete and timely accordance with the terms hereof and that any attempt to circumvent the terms of this Arbitration Agreement shall be absolutely null and void and of no force or e&#xfb00;ect whatsoever.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">B.DISPUTES EXCLUDED FROM ARBITRATION</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">:</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The following claims, disputes or disagreements under this Lease are expressly excluded from the arbitration procedures set forth herein: 1. Disputes for which a di&#xfb00;erent resolution determination is speci&#xfb01;cally set forth in this Lease, 2. All claims by either party which (a) seek anything other than enforcement or determination of rights under this Lease, or (b) are primarily founded upon matters of fraud, willful misconduct, bad faith or any other allegations of tortious action, and seek the award of punitive or exemplary damages, 3. Claims relating to (a) Lessor's exercise of any unlawful detainer rights pursuant to applicable law or (b) rights or remedies used by Lessor to gain possession of the Premises or terminate Lessee's right of possession to the Premises, all of which disputes shall be resolved by suit &#xfb01;led in the applicable court of jurisdiction, the decision of which court shall be subject to appeal pursuant to applicable law 4. Any claim or dispute that is within the jurisdiction of the Small Claims Court and 5. All claims arising under Paragraph 39 of this Lease.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">C. APPOINTMENT OF AN ARBITRATOR</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">:</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">All disputes subject to this Arbitration Agreement, shall be determined by binding arbitration before: </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> a retired judge of the applicable court of jurisdiction (e.g., the Superior Court of the State of California) a&#xfb03;liated with Judicial Arbitration &amp; Mediation Services, Inc. (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">JAMS</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;), </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9745; </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">the American Arbitration Association (&#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">AAA</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) under its commercial arbitration rules, </font><font style="color:#0000ff;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#9744; ___</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, or as may be otherwise mutually agreed by Lessor and Lessee (the &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Arbitrator</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;). In the event that the parties elect to use an arbitrator other than one a&#xfb03;liated with JAMS or AAA then such arbitrator shall be obligated to comply with the Code of Ethics for Arbitrators in Commercial Disputes (see: </font><font><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">http://www.adr.org/aaa/ShowProperty?nodeId=/UCM/ADRSTG_003867).</font></font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Such arbitration shall be initiated by the Parties, or either of them, within ten (10) days after either party sends written notice (the &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Arbitration Notice</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#34;) of a demand to arbitrate by registered or certi&#xfb01;ed mail to the other party and to the Arbitrator. The Arbitration Notice shall contain a description of the subject matter of the arbitration, the dispute with respect thereto, the amount involved, if any, and the remedy or determination sought. If the Parties have agreed to use JAMS they may agree on a retired judge from the JAMS panel. If they are unable to agree within ten days, JAMS will provide a list of three available judges and each party may strike one. The remaining judge (or if there are two, the one selected by JAMS) will serve as the Arbitrator. If the Parties have elected to utilize AAA or some other organization, the Arbitrator shall be selected in accordance with said organization's rules. In the event the Arbitrator is not selected as provided for above for any reason, the party initiating arbitration shall apply to the appropriate Court for the appointment of a quali&#xfb01;ed retired judge to act as the Arbitrator.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">D. ARBITRATION PROCEDURE</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">:</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1. PRE-HEARING ACTIONS</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. The Arbitrator shall schedule a pre-hearing conference to resolve procedural matters, arrange for the exchange of information, obtain stipulations, and narrow the issues. The Parties will submit proposed discovery schedules to the Arbitrator at the pre-hearing conference. The scope and duration of discovery will be within the sole discretion of the Arbitrator. The Arbitrator shall have the discretion to order a pre-hearing exchange of information by the Parties, including, without limitation, production of requested documents, exchange of summaries of testimony of proposed witnesses, and examination by deposition of parties and third-party witnesses. This discretion shall be exercised in favor of discovery reasonable under the circumstances. The Arbitrator shall issue subpoenas and subpoenas duces tecum as provided for in the applicable statutory or case law (e.g., in California Code of Civil Procedure Section 1282.6).</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2. THE DECISION</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">. The arbitration shall be conducted in the city or county within which the Premises are located at a reasonably convenient site. Any Party may be represented by counsel or other authorized representative. In rendering a decision(s), the Arbitrator shall determine the rights and obligations of the Parties according to the substantive laws and the terms and provisions of this Lease. The Arbitrator's decision shall be based on the evidence introduced at the hearing, including all logical and reasonable inferences therefrom. The Arbitrator may make any determination and/or grant any remedy or relief that is just and equitable. The decision must be based on, and accompanied by, a written statement of decision explaining the factual and legal basis for the decision as to each of the principal controverted issues. The decision shall be conclusive and binding, and it may thereafter be con&#xfb01;rmed as a judgment by the court of applicable jurisdiction, subject only to challenge on the grounds set forth in the applicable statutory or case law (e.g., in California Code of Civil Procedure Section 1286.2). The validity and</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2017 AIR CRE. All Rights Reserved.</font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">ARB-3.03, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 2</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">enforceability of the Arbitrator's decision is to be determined exclusively by the court of appropriate jurisdiction pursuant to the provisions of this Lease. The Arbitrator may award costs, including without limitation, Arbitrator's fees and costs, attorneys' fees, and expert and witness costs, to the prevailing party, if any, as determined by the Arbitrator in his discretion.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Whenever a matter which has been submitted to arbitration involves a dispute as to whether or not a particular act or omission (other than a failure to pay money) constitutes a Default, the time to commence or cease such action shall be tolled from the date that the Notice of Arbitration is served through and until the date the Arbitrator renders his or her decision. Provided, however, that this provision shall NOT apply in the event that the Arbitrator determines that the Arbitration Notice was prepared in bad faith.</font></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Whenever a dispute arises between the Parties concerning whether or not the failure to make a payment of money constitutes a default, the service of an Arbitration Notice shall NOT toll the time period in which to pay the money. The Party allegedly obligated to pay the money may, however, elect to pay the money &#34;under protest&#34; by accompanying said payment with a written statement setting forth the reasons for such protest. If thereafter, the Arbitrator determines that the Party who received said money was not entitled to such payment, said money shall be promptly returned to the Party who paid such money under protest together with Interest thereon as de&#xfb01;ned in Paragraph 13.5. If a Party makes a payment &#34;under protest&#34; but no Notice of Arbitration is &#xfb01;led within thirty days, then such protest shall be deemed waived. (See also Paragraph 42 or 43)</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">AIR CRE * https://</font><font><font style="white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">www.aircre.com</font></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> * 213-687-8777 * contracts@aircre.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">NOTICE: No part of these works may be reproduced in any form without permission in writing.</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2017 AIR CRE. All Rights Reserved.</font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">ARB-3.03, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">2</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 2</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="margin-left:5pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_6.jpg" alt="img74569629_6.jpg" style="width:152px;height:48px;">&#160;</p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:'Calibri',sans-serif;min-width:fit-content;">ADDENDUM TO LEASE</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:19%;"></td>
     <td style="width:81%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Date:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">April 5, 2024</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">By and Between</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:7.2pt;vertical-align:top;"><p style="margin-left:7.2pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">BML Management, LLC</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:7.2pt;vertical-align:top;"><p style="margin-left:7.2pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">RxSight, Inc.</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Property Address:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-family:'Calibri',sans-serif;min-width:fit-content;">125 Columbia, Aliso Viejo, CA 92656</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">(street address, city, state, zip)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Paragraph: </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> 54 - 61</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">In the event of any con&#xfb02;ict between the provisions of this Addendum and the printed provisions of the Lease, this Addendum shall control.</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;">54. Operating Expenses:</font><font style="color:#ff0000;white-space:pre-wrap;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;"> In addition to the base rent, Tenant shall be responsible for the Operating Expenses each month of the term currently estimated to be $0.43/PSF. The Operating Expense shall also be paid during the abated months of July-November 2024.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;">55. Improvement Allowance :</font><font style="color:#ff0000;white-space:pre-wrap;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;"> Landlord shall provide a $30,000 Allowance for all mutually agreed upon building improvements.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;">56. Tenant Improvements :</font><font style="color:#ff0000;white-space:pre-wrap;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;"> Landlord approves the attached Tenant Improvement plan, (Exhibit A), but understands Tenant may perform minor changes to said plan prior to commencing construction. Tenant at Tenant&#x2019;s sole cost shall perform all interior improvements to include the following:</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;">1) Building out a Light Manufacturing Space of approximately 9,000 sq ft (including a clean room area of 6,000 sq ft)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;">2) Building out a conference/meeting area of approximately 6,000 sf.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;">3) Building out functional Office space of approximately 11,000 sf.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;">Landlord to provide Tenant architectural plans with dimensions so a specific improvement plan can be provided to Landlord for approval prior to lease execution. Upon Landlord&#x2019;s acceptance of Tenant&#x2019;s improvements and changes to the Premises, Tenant may leave the Premises in its current condition (layout, plan, setup, etc.) and shall not be obligated to restore the Premises back to its original condition at the end of Tenant&#x2019;s lease term. In addition to the above improvement items, Tenant shall paint, install flooring, and provide overall upgrades. (See Exhibit A).</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;">57. Condition of Premises :</font><font style="color:#ff0000;white-space:pre-wrap;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;"> Landlord shall warrant and deliver the building clean with all building systems in proper working condition including roof, electrical, fire sprinklers and plumbing. The HVAC systems, plumbing fixtures and truck doors shall be inspected by a service contractor and all recommended maintenance/repairs/ replacements shall be completed at Lessor&#x2019;s cost. Thereafter, all maintenance and replacements shall be in accordance with the AIR lease form.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;">58. Signage :</font><font style="color:#ff0000;white-space:pre-wrap;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;"> Tenant shall have the right at their sole cost and expense to install building signage. All signage shall be in compliance with the City of Aliso Viejo ordinances, Association and Landlord&#x2019;s approval.</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2017 AIR CRE. All Rights Reserved.</font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">ADD-1.03, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 2</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;">59. Parking :</font><font style="color:#ff0000;white-space:pre-wrap;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;"> Tenant shall receive exclusive parking for the building free and in common throughout the lease term and option periods</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;">60. Security Deposit:</font><font style="color:#ff0000;white-space:pre-wrap;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;"> Upon lease execution, Tenant shall pay the first month&#x2019;s Base Rent, expenses and a Security Deposit equal to the last month&#x2019;s rent ($51,111.90). The existing security deposit of Unit B ($16,829.90) shall be transferred over to the new lease and Tenant shall provide the difference of $34,281.00 to fulfill the security deposit amount.</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ff0000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;">61. Existing Lease Agreement:</font><font style="color:#ff0000;white-space:pre-wrap;font-size:12pt;font-family:'Georgia',serif;min-width:fit-content;"> The Lease Agreement with RxSight for 125 Columbia, Suite B, shall terminate on June 1, 2024, subject to mutual execution of this Lease Agreement and the monies due upon execution being delivered to Lessor.</font></p><p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">AIR CRE * https://</font><font><font style="white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">www.aircre.com</font></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> * 213-687-8777 * contracts@aircre.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">NOTICE: No part of these works may be reproduced in any form without permission in writing.</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:3pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
      <td style="width:33.333%;"></td>
     </tr>
     <tr style="white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img74569629_1.jpg" alt="img74569629_1.jpg" style="width:84px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_2.jpg" alt="img74569629_2.jpg" style="width:56px;height:43px;">&#160;</p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     </tr>
     <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#169; 2017 AIR CRE. All Rights Reserved.</font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">ADD-1.03, Revised 10-22-2020</font></p></td>
      <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">INITIALS</font></p></td>
      <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Last Edited: 4/10/2024 2:06 PM</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">2</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;of 2</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:10in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img74569629_7.jpg" alt="img74569629_7.jpg" style="width:959px;height:684px;">&#160;</p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:10in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>rxst-ex10_2.htm
<DESCRIPTION>5 COLUMBIA AMENDMENT #2
<TEXT>
<html>
 <head>
  <title>EX-10.2</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Exhibit 10.2</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">LEASE AMENDMENT #2</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(5 Columbia, Aliso Viejo, CA 92656)</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">This 2</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:'Calibri',sans-serif;min-width:fit-content;">nd</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Amendment to the Lease Agreement (hereinafter referred to as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;) is made and entered into by and between Clifford D. Downs (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;) and RxSight, Inc., a Delaware Corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;, and together with Lessor, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;) as the last date signed by the Parties (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Effective Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;).</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, the Parties entered into that certain Lease Agreement dated January 10, 2018, as amended on April 5, 2022, (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;) for the property located at 5 Columbia, Aliso Viejo, CA 92656, and</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, the Parties desire to amend the Agreement in the manner reflected herein, and</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, the Parties to the Agreement have approved the Amendment in the manner reflected herein.</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">NOW THEREFORE</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, in consideration of the premises and mutual covenants and conditions herein, the Parties, intending to be legally bound, hereby agree as follows:</font></p><div class="item-list-element-wrapper" style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The Parties agree to a 70-month lease extension beginning April 1, 2025, and ending January 31, 2031 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Extension</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;).  </font></div></div><div class="item-list-element-wrapper" style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The monthly lease rate shall continue as a Net Net Net (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">NNN</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;) lease per the Agreement terms with the Extension base rent rate payable as follows:</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:88.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:27.12%;"></td>
     <td style="width:21.76%;"></td>
     <td style="width:51.12%;"></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="border-top:0.5pt solid;border-right:0.5pt solid;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="border-top:0.5pt solid;border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">$ per Square Foot</font></p></td>
     <td style="border-top:0.5pt solid;border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Monthly Rent</font></p></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="border-right:0.5pt solid;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Month 1 (April 1, 2025)</font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$1.56</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$30,700.80 plus Lessee&#x2019;s NNN expenses.</font></p></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="border-right:0.5pt solid;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Month 2 - 5</font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$0.78</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$15,350.40 plus Lessee&#x2019;s NNN expenses.</font></p></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="border-right:0.5pt solid;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Months 6 - 13</font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$1.56</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$30,700.80 plus Lessee&#x2019;s NNN expenses.</font></p></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="border-right:0.5pt solid;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Months 14 - 17</font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$0.78</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$15,350.40 plus Lessee&#x2019;s NNN expenses.</font></p></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="border-right:0.5pt solid;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Months 18 - 24</font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$1.56</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$30,700.80 plus Lessee&#x2019;s NNN expenses.</font></p></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="border-right:0.5pt solid;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Months 25 - 36</font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$1.60</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$31,488.00 plus Lessee&#x2019;s NNN expenses.</font></p></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="border-right:0.5pt solid;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Months 37 - 48</font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$1.65</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$32,472.00 plus Lessee&#x2019;s NNN expenses.</font></p></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="border-right:0.5pt solid;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Months 49 - 60</font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$1.70</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$33,456.00 plus Lessee&#x2019;s NNN expenses.</font></p></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="border-right:0.5pt solid;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Months 61 - 70</font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$1.75</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
     <td style="border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">$34,440.00 plus Lessee&#x2019;s NNN expenses.</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:0.25in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Upon execution of this Amendment, Lessee shall pay $9,170.88 to Lessor as an additional security deposit (resulting in a total security deposit amount of $34,440.00).  </font></div></div><div class="item-list-element-wrapper" style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor hereby grants Lessee two (2) sixty (60)-month options to renew/extend the lease at the end of the then-current lease term (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Options</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;) by providing written notice to Lessor not less than six (6) months prior to the Option period commencing.  If proper notification is not received than the Option shall expire.  The base rent rate increase for the Options will reflect the proportionate cumulative increase in the Consumer Price Index (&#x201c;CPI&#x201d;) during the previous year. Notwithstanding the foregoing, the base rent increase shall never be less than 3% and never more than 6%. For purposes of this section, CPI means the United States Department of Labor, Bureau of Labor Statistics, All Cities Average Consumer Price Index, or if such index is no longer published, a successor or substitute index designated and mutually agreed to by the Parties. The Options supersedes any previously agreed to options to renew/extend.  </font></div></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><div class="item-list-element-wrapper" style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Provided Lessor has approved all and such Lessee improvements, Lessee&#x2019;s improvements and changes to the Premises do not need to be restored back to the original condition at the end of Lessee&#x2019;s lease term; Lessee may leave the Premises in its current condition (layout, plan, setup, etc.) and is not obligated to remove any improvements, additions, and alterations. Lessee&#x2019;s improvements to date have been previously approved by Lessor with additional proposed plans (attached as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">EXHIBIT A</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;). Lessor approves EXHIBIT A, and understands Lessee may perform minor changes to said plan prior to commencing construction. </font></div></div><div class="item-list-element-wrapper" style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">This Amendment may be executed in one or more facsimile, electronic, or original counterparts, each of which shall be deemed an original and both of which together shall constitute the same instrument.</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">All Terms and provisions of the Agreement not amended hereby, either expressly or by necessary implication, shall remain in full force and effect. From and after the date of this Amendment, all references to the term &#x201c;Agreement&#x201d; in this Amendment or the original Agreement shall include the terms contained in this Amendment.</font></div></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">AGREED &amp; ACCEPTED:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:5%;"></td>
     <td style="width:40%;"></td>
     <td style="width:2%;"></td>
     <td style="width:6%;"></td>
     <td style="width:47%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">LESSOR:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">LESSEE:</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">RxSight, Inc.</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td rowspan="3" style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">By:</font></p></td>
     <td rowspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img75493150_0.jpg" alt="img75493150_0.jpg" style="width:193px;height:44px;">&#160;</p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">/s/ Ron Kurtz</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Name:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Ron Kurtz</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Title:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Title:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">President &amp; CEO</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Date:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">4-17-24</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Date:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">4/18/2024</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;">EXHIBIT A</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:10in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:1pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img75493150_1.jpg" alt="img75493150_1.jpg" style="width:919px;height:684px;">&#160;</p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:10in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:10in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img75493150_2.jpg" alt="img75493150_2.jpg" style="width:919px;height:679px;">&#160;</p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:10in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>rxst-ex10_3.htm
<DESCRIPTION>5 COLUMBIA AMENDMENT #3
<TEXT>
<html>
 <head>
  <title>EX-10.3</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Exhibit 10.3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">LEASE AMENDMENT #3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(5 Columbia, Aliso Viejo, CA 92656)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">This 3</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:'Calibri',sans-serif;min-width:fit-content;">rd</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> Amendment to the Lease Agreement (hereinafter referred to as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;) is made and entered into by and between Clifford D. Downs (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessor</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;) and RxSight, Inc., a Delaware Corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Lessee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;, and together with Lessor, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;) as the last date signed by the Parties (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Effective Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;).</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, the Parties entered into that certain Lease Agreement dated January 10, 2018, as amended from time to time, (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;) for the property located at 5 Columbia, Aliso Viejo, CA 92656, and</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, the Parties desire to amend the Agreement in the manner reflected herein, and</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, the Parties to the Agreement have approved the Amendment in the manner reflected herein.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">NOW THEREFORE</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, in consideration of the premises and mutual covenants and conditions herein, the Parties, intending to be legally bound, hereby agree as follows:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:0.25in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Section 3. of Lease Amendment #2 is hereby amended and restated in its entirety as follows:</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.75in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:4.347629490628745%;display:inline-flex;justify-content:flex-start;">a.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Upon execution of this Amendment, Lessee shall pay $3,739.20 to Lessor as an additional security deposit resulting in a total security deposit amount of $34,440.00. (For reference, Lessee paid an initial security deposit when the original lease was executed of $25,269.12. Lessee then paid an additional security deposit of $5,431.68 per the Lease Addendum dated April 5, 2022.)</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:0.25in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">This Amendment may be executed in one or more facsimile, electronic, or original counterparts, each of which shall be deemed an original and both of which together shall constitute the same instrument.</font></div></div><p style="margin-left:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:0.25in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">All Terms and provisions of the Agreement not amended hereby, either expressly or by necessary implication, shall remain in full force and effect. From and after the date of this Amendment, all references to the term &#x201c;Agreement&#x201d; in this Amendment or the original Agreement shall include the terms contained in this Amendment.</font></div></div><p style="margin-left:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">AGREED &amp; ACCEPTED:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:5%;"></td>
     <td style="width:40%;"></td>
     <td style="width:2%;"></td>
     <td style="width:6%;"></td>
     <td style="width:47%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">LESSOR:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">LESSEE:</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Clifford D. Downs</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">RxSight, Inc.</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td rowspan="3" style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">By:</font></p></td>
     <td rowspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img76416671_0.jpg" alt="img76416671_0.jpg" style="width:169px;height:42px;">&#160;</p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">/s/ Shelley Thunen</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Title:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Owner</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Title:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Chief Financial Officer</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Date:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">5-26-24</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Date:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">6/3/2024</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">					</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>rxst-ex10_4.htm
<DESCRIPTION>100-150 COLUMBIA FIFTH AMENDMENT
<TEXT>
<html>
 <head>
  <title>EX-10.4</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="min-height:1in;"></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 10.4</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FIFTH AMENDMENT (EXTENSION TO THE LEASE)</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:11pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">THIS Amendment (hereinafter referred to as the &#x201c;Fifth Amendment&#x201d;), dated the 18th day of April 2024, is entered into by ACCURIDE INTERNATIONAL INC., a California corporation (hereinafter referred to as &#x201c;Landlord&#x201d;) and RXSIGHT, Inc., a Delaware corporation, (hereinafter referred to as &#x201c;Tenant&#x201d;).  The parties agree as follows:</font></p><div class="item-list-element-wrapper" style="margin-left:1in;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:6.544938840631094%;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Identification of Lease</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  Reference is made to that certain Commercial Lease</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Agreement dated August 31</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">st</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, 2015 (the &#x201c;Original Lease&#x201d;), as amended by that certain </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">First</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amendment </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">to the Lease dated November 23</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">rd</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, 2015, as amended by that certain </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Second</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to the Lease dated December 22</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">nd</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> , 2015 , as amended by that certain </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Third</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to the Lease dated January 18</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, 2016, as amended by that certain </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fourth Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to the Lease dated November 12</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, 2016,  (The Original Lease, as so amended, is herein collectively referred to as the &#x201c;Lease&#x201d;) for certain premises containing approximately 21,498 rentable square feet located at 100 Columbia Suite 200, Aliso Viejo, CA and 20,608 rentable square feet located at 100 Columbia Suite 100, Aliso Viejo Ca as more particularly described in the Lease as the Premises.</font></p><div class="item-list-element-wrapper" style="margin-left:1in;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:6.544938840631094%;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Context of Fifth Amendment.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  The parties have agreed to the following:</font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:7.692%;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Term/Premises.  </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Landlord and Tenant agree to extend the Lease for an additional 76 months for the total 42,106 square feet.</font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:7.692%;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Lease extension period</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  The Lease Extension Period shall be from October 1, 2024 and  January 31, 2031.</font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:7.692%;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Tenant Improvement Allowance.  </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Landlord shall provide a $50,000 allowance for all mutually agreed upon building improvements. Tenant agrees to allocate up to $10,000 of the allowance to upgrade the trash enclosure to match the enclosures located at 120/140 and 150 Columbia. Tenant shall provide a work letter defining what work will be covered under the Tenant Improvement Allowance. (See Attachment A) </font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:7.692%;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ISLC.  </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Any existing Irrevocable Standby Letter of Credit (ISLC) issued to Landlord shall be canceled and nullified as of September 30, 2024. As of the commencement of the Fifth Amendment, Tenant shall be required to:</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:8.332972223425923%;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Submit a copy or link of its 10-Q and 10-K to Landlord within ten (10) business days of public release.</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:8.332972223425923%;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the event Tenant&#x2019;s cash and equivalents fall below $40,000,000, Tenant shall notify Landlord within ten (10) business days.</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:8.332972223425923%;display:inline-flex;justify-content:flex-start;">iii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the event Tenant&#x2019;s cash equivalents fall below $30,000,000 for any five (5) business day period, Tenant shall notify Landlord within two (2) business days and provide Landlord with an Irrevocable Standby Letter of Credit (ISLC) in the amount of $773,661.81 within thirty (30 calendar days). Tenant shall conform to the format issued under the ISLC requirements (Attachment F, under the Original Lease)</font></div></div><p style="margin-left:126pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="margin-left:126pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="margin-left:126pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;This section left intentionally blank&#x201d;</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="min-height:1in;"></div><div class="item-list-element-wrapper" style="margin-left:1in;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:6.544938840631094%;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rent During Fifth Extension Period.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> During the Fifth Extension Period, the base rent payable shall be the amount called for by the following:</font></div></div><p style="margin-left:72pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:1in;border-spacing:0;table-layout:fixed;width:52.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:32.692%;"></td>
     <td style="width:28.846%;"></td>
     <td style="width:38.462%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Months</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Rate/SF</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Rate/Month</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">*01-12:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$1.540</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$64,843.24 Plus NNN</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13 &#x2013; 24:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$1.594</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$67,112.75 Plus NNN</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25 &#x2013; 36:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$1.650</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$69,461.70 Plus NNN</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">37 &#x2013; 48:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$1.707</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$71,892.86 Plus NNN</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">49 &#x2013; 60:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$1.767</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$74,409.11 Plus NNN</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">61 &#x2013; 72:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$1.829</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$77,013.43 Plus NNN</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">73 &#x2013; 76:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$1.893</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$79,708.90 Plus NNN</font></p></td>
    </tr>
   </table><p style="margin-left:72pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">*Abated Base rent in months 2,11 and 12</font></p><p style="margin-left:72pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">In addition to the base rent, Tenant shall be responsible for the Triple Net expenses as per the</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="margin-left:72pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">existing Lease.</font></p><div class="item-list-element-wrapper" style="margin-left:0.5in;text-indent:36pt;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:0.5in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.999480001733328%;">D.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Option to Renew. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Tenant shall receive two (2) five (5) year Options to Extend the Lease at the end of the Fourth Amendment term. All other Renewal options prior to this Fifth Amendment shall be null and void.  Tenant shall provide notice to renew with no less than nine (9) months prior written notice and no more than Twelve (12) months prior to the Lease Expiration date, of its intention to extend the lease. The base rent amounts for the option periods shall be at 95% of FMV and not less than the last month&#x2019;s rent paid. </font></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;text-indent:36pt;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:0.5in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.999480001733328%;">E.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Deposit.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Upon lease execution, Tenant shall pay a Security Deposit equal to the last month&#x2019;s rent ($79,708.90). The existing security deposit of the current lease is $52,905.71 and shall be increased by $26,803.19 at execution.</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;text-indent:36pt;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.999480001733328%;">F.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Commission</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  Neither Party was represented by a Broker in the matter.</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;text-indent:36pt;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.999480001733328%;">G.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Miscellaneous</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  Any term used in this Fifth Amendment, which is defined in the Lease, shall have the same meaning herein, unless the context indicates that another meaning is intended.  The Lease is intended to be and is supplemented and amended by the provisions of this Fifth Amendment, and hereafter the Lease shall be considered and construed together.  All of the terms, provisions, conditions, and covenants of the Lease, as modified by this Fifth Amendment, shall be and remain in full force and effect.</font></div></div><p style="text-indent:36pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">IN WITNESS WHEREOF, the parties hereto have caused this Fifth Amendment to be executed on or as of the day and year above written.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:7%;"></td>
     <td style="width:36.92%;"></td>
     <td style="width:6.54%;"></td>
     <td style="width:7%;"></td>
     <td style="width:42.54%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x201c;Landlord&#x201d;:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x201c;Tenant&#x201d;:</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td colspan="2" style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td colspan="2" style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">ACCURIDE INTERNATIONAL INC.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">a California Corporation</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">RXSIGHT, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">a Delaware Corporation</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td colspan="2" style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jeffrey A. Dunlap</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Ron Kurtz</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">President &amp;CEO</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4/18/2024</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4/18/2024</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="min-height:1in;"></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;This section left intentionally blank&#x201d;</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Attachment A</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">WORK LETTER EXAMPLE</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Tenant Improvements)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">100 Columbia, Suite 100, Aliso Viejo, CA</font></p><div class="item-list-element-wrapper" style="text-indent:18pt;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.385%;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TENANT IMPROVEMENTS</font></div></div><p style="margin-left:36pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The tenant improvement work (&#x201c;Tenant Improvements&#x201d;) shall consist of the work required to complete certain improvements to the Premises based on a working floor drawing attached as Exhibit B.  Tenant shall contract with a general contractor, identified as J.S. Shafer &amp; Associates, Inc. to construct the Tenant Improvements.  The Tenant Improvements work shall be undertaken and prosecuted in accordance with the following requirements:</font></p><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">It is understood that except as provided below, the Tenant Improvements shall only include actual improvements to the Premises approved by Landlord identified in Attachments A and B and shall exclude (but not by way of limitation) Tenant&#x2019;s furniture, trade fixtures, partitions, equipment and signage improvements, if any.  Further, the Tenant Improvements shall incorporate Landlord&#x2019;s building standard materials and specifications (&#x201c;Standards&#x201d;).  No deviations from the Standards may be requested by Tenant with respect to doors and frames, finish hardware, entry graphics, the ceiling system, light fixtures and switches, mechanical systems, life and safety systems, and/or window coverings; provided that Landlord may, in its sole discretion, authorize in writing one or more of such deviations, in which event, unless Landlord otherwise agrees in its sole discretion, Tenant shall be solely responsible for the cost of replacing same with the applicable Standard item(s) upon the expiration or termination of this Lease.  All other non-standard items (&#x201c;Non-Standard Improvements&#x201d;) shall be subject to the prior approval of Landlord, which may be withheld in Landlord&#x2019;s sole discretion.  Landlord shall in no event be required to approve any Non-Standard Improvement if Landlord determines that such improvements (i) is of a lesser quality than the corresponding Standard, (ii) fails to conform to applicable governmental requirements, (iii) requires building services beyond the level Landlord has agreed to provide Tenant under this Lease, or (iv) would have an adverse aesthetic impact from the exterior of the Premises.</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Tenant shall use a licensed general contractor (Identified as J.S. Shafer &amp; Associates) and that contractor&#x2019;s selected subcontractors to construct the Premises. </font></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The TI Contractor and each of its subcontractors shall comply with Landlord&#x2019;s requirements as generally imposed on third party contractors, including without limitation all insurance coverage requirements and the obligation to furnish appropriate certificates of insurance to Landlord, prior to commencement of construction or the Tenant Improvements work.</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">D.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A construction schedule shall be provided to Landlord and Tenant prior to commencement of the construction of the Tenant Improvements work, and weekly updates shall be supplied </font></div></div></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="min-height:1in;"></div><p style="margin-left:180pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Work Letter (Continued)</font></p><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">E.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Tenant Improvements work shall be prosecuted at all times in accordance with all state, federal and local laws, regulations and ordinance, including without limitation all OSHA and other safety laws, the Americans with Disabilities Act (&#x201c;ADA&#x201d;) and all applicable governmental permit and code requirements.</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.5in;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">F.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Tenant hereby designates Richard Drinkward, Telephone No. (949) 521-7833, as its representative, agent and attorney-in-fact for the purpose of receiving notices, approving submittals and issuing requests for Changes and Landlord shall be entitled to rely upon authorizations and directives of such persons as if given directly by Tenant.  Tenant may amend the designation of its construction representative(s) at any time upon delivery of written notice to Landlord.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;This section left intentionally blank&#x201d;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="min-height:1in;"></div><div class="item-list-element-wrapper" style="text-indent:18pt;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.385%;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">COST OF TENANT IMPROVEMENTS </font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:92.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:24%;"></td>
     <td style="width:42.66%;"></td>
     <td style="width:33.34%;"></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Tenant Improvement-CV-2A</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Attachment C</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">J. S. Shafer &amp; Associates, Inc.</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">100 Columbia, Suite 100</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Schedule of Values</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Aliso Viejo, CA 92656</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Job No. 2362</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">blank</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">08/29/16</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:92.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:8%;"></td>
     <td style="width:41.304%;"></td>
     <td style="width:8.696%;"></td>
     <td style="width:13.043%;"></td>
     <td style="width:16.957%;"></td>
     <td style="width:12%;"></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">CSI</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Item Description</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Count</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unit</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unit</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Item Values</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">01030</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">General Conditions</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">70,048.80</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">01000</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Building Permit Fees</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,500.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,500.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">01027</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Electrical Engineering</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,000.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,000.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">01028</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Mechanical Engineer</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,000.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,000.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">01032</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Printing &amp; copying</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">01523</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Scissor / boom lifts-rentals</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,200.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,200.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">01560</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dispose 4-ft flourescent tubes removed</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">496.32</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">496.32</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">01566</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Debris disposal-dumpsters</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">800.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,400.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">02070</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Demo-walls 254' @ 9.5'</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,420</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,840.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">02070</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Demo-additional per 09/14 plan-130 In.ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,260</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,520.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">02070</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Demo wall cladding of X-frame, remove nailer</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Man hours</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39.48</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">236.88</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">02071</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Demo-acoustic ceilings</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,384</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.75</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,038.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">02072</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Demo-existing 2x4 flourescent fixtures</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,053.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">02073</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Demo-existing carpet, vct-break rm, wall base</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,493</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.45</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,821.85</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">02074</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Demo sheet vinyl &amp; cove base-rest rooms</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">475</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">475.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">02075</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Demo existing toilet partitions</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">200.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">200.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">02076</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Demo &amp; abandon existing plumbing drains</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Man hours</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">47.53</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">570.36</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">02080</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Conc cut, demo &amp; dispose - sink installs</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">780.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">02081</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Conc cut, demo-undergound elect &amp; piping</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">182.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">03030</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Replace concrete-sink install</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,080.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">03031</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Replace concrete-underground elect &amp;piping</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">252.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">03034</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Conc slab crack-grind open &amp; fill w/ Sika</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">280</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.35</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">658.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">06200</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Install mid-span support-Chem Lab ceiling</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">488.15</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">488.15</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">06400</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cabinetry-relocate/modify existing</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,000.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,000.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">06410</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cabinetry-new Saron counter top</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">28</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">48.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,344.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">07210</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Insulation-R19 faced-Existing @ mezz-repair</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,638.25</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,638.25</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">07211</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Insulation-R11</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,098.25</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,098.25</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">07212</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Insulation-R-30 at roof of CV-2A only</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,650.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,650.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">07215</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Insulation-R13-in partition walls</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,360</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.15</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,864.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">07216</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">R-19 insulation in 6&#34; walls-Chem Lab</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,080</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.45</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,566.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">07217</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">R-30 insulation in ceiling of Chem Lab</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">900</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.85</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,665.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">07700</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Roof repair work</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,000.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">08331</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Repair 2 roll-up doors at Warehouse</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,208.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,416.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">08500</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Metal window frame &amp; install-5-0x4-0 ea</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">392.20</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,353.20</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">08501</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Window w/ Pyran fire safety glass-1-hr rating</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">08801</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Door-stain birch-frame-side lite-8 ft-hrdwre-ins</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">950.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,800.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">08802</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Doors-6-0x8-0, stain grade, hardware, install</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,100.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,400.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">08803</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Install doors saved for re-use</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">150.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,100.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">08804</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Door-3-0x8-0, stain grade, hardware, installed</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">800.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,200.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">08805</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Replace door access hardware to match CV1</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">130.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,860.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">08806</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Kick plates-stainless-installed</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">44.57</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">623.98</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">08807</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Door closers-installed</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">155.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,240.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09104</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Frame &amp; drywall - H=10-ft, per 9/14 plan</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">28,600.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">28,600.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09105</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Frame &amp; drywall-ceiling Chem Lab-9/14 plan</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">900</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.12</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,008.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09107</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Drywall-recessed boxes for lights 1-hr</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">95.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,520.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09108</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Frame &amp; drywall-combo fire/smoke dampers</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">250.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,750.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09109</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Drywall furring &amp; details at A-frame exposed</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">975.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">975.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09110</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Drywall-cut patch-finish-T24 outlets</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">375.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,375.00</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1 of 3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">Cost of Tenant Improvements (Continued)</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="min-height:1in;"></div><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:92.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:24%;"></td>
     <td style="width:42.66%;"></td>
     <td style="width:33.34%;"></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Tenant Improvement-CV-2A</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Attachment C</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">J. S. Shafer &amp; Associates, Inc.</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">100 Columbia, Suite 100</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Schedule of Values</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Aliso Viejo, CA 92656</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Job No. 2362</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">blank</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">08/29/16</font></p></td>
    </tr>
   </table><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:92.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:8%;"></td>
     <td style="width:41.304%;"></td>
     <td style="width:8.696%;"></td>
     <td style="width:13.043%;"></td>
     <td style="width:16.957%;"></td>
     <td style="width:12%;"></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">CSI</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Item Description</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Count</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unit</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unit</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Item Values</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09115</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Backing supports-2 rows-in walls-Rm 154</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Ln. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.50</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">330.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09512</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">T-bar grid-new-office area-standard tile</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,564</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.74</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,589.36</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09513</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">T-bar &amp; Gridstone-148,148,150,153,154,155</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,000</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.65</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,300.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09514</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Replace ceiling tile w/ matching CV-1 tile</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,976</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.56</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,642.56</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09515</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Install hard washable ceiling tile in Rest Rms</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">500</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.65</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,325.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09666</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Vinyl ESD flooring - Rm 153 Hardware Dev</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">580</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.92</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,593.60</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09675</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sheet vinyl-Rm 154 - Upgraded material</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">900</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.34</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,406.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09676</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sheet vinyl-Rest Rooms-Coved-Upgrade mtl</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">500</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.20</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,100.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09677</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">VCT flooring - NIC - by others</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09678</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Carpet tile - NIC - by others</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09678</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Vinyl-rubber wall base - NIC - by others</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09910</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finish new &amp; existing doors-stain-clear coat</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">75.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,175.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09966</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Vinyl ESD floor-buff &amp; polish-ESD procedure</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">575.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">575.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09970</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">FRP-replace in rest rooms</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,100.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,100.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09990</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Painting-interior-walls-all except Rm 154</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,324</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.88</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16,125.12</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09991</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Painting-interior-Rm 152-Epoxy</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,080</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.70</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,836.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09992</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Painting-ceiling of Rm 152-Epoxy</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">900</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sq. Ft.</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.97</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,773.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09995</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Paint west stair shaft &amp; drywall repair</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">09996</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Detail painting-A frame exposed</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">400.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">400.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10400</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Signage-code required only</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">420.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">420.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10520</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Fire extinguisher cabinets</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">262.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,048.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10600</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Toilet partitions-new-stainless</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,017.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,017.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10800</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Toilet accessories-new</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,887.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,887.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11000</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Assist CV installations of equipment-Allow</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">CrewHours</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90.51</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,620.40</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12512</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Louver blinds-installed</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">76</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">131.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,956.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12526</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Remove &amp; replace window films</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15310</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nitrogen-extend existing &amp; 5 points of service</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,500.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,500.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15315</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Compressed air-extend exist-10 points svc</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,500.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,500.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15316</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Clean water-extend to sinks in labs</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,800.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,800.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15401</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">New condensate piping</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,000.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,000.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15405</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dig trenches &amp; backfill-sink drains, electrical</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,000.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,000.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15449</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Underground sewer pipe explore &amp; video</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15450</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Plumbing per plans P-1 &amp; P-2 dated 7/20/16</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,500.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,500.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15451</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Install CV's sink &amp;disposer-ice mkrCoffee Bar</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,500.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,500.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15455</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Replace toilets, lavs, urinals-install hands free</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,629.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,629.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15456</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Repair trap primers-R/Rs</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,400.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,400.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15620</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Hvac-air balance &amp; report-per unit</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,995.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,995.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15650</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Hvac-pads for new compressors</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,500.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,000.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15800</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Hvac-Rm 154-Chem Lab-negative press-16x</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">30,000.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">30,000.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15801</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Hvac-Rm 128-Optics Lab-positive pressure</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,000.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,000.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15802</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Hvac-Balance of areas - 5 existing machines</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,000.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,000.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15803</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Install 2 Labconco exhaust fans &amp; systems</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25,000.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25,000.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15865</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Combo fire &amp; smoke dampers-Rm 154 1-hr</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">650.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,550.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15883</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Install HEPA filter units, HEPA units NIC</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">800.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,800.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15900</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Fire sprinklers-adjust head locations</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,644.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,644.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16400</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Electricl-demo safe-off</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,000.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,000.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16401</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Electrical-distributed power outlets &amp; data</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31,055.35</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31,055.35</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16408</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Electrical-add 2-120-208 panels w/ feeders</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,471.65</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,471.65</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2 of 3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;text-align:left;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">Cost of Tenant Improvements (Continued)</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="min-height:1in;"></div><p style="margin-left:54pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:92.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:24%;"></td>
     <td style="width:42.66%;"></td>
     <td style="width:33.34%;"></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Tenant Improvement-CV-2A</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Attachment C</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">J. S. Shafer &amp; Associates, Inc.</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">100 Columbia, Suite 100</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Schedule of Values</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Aliso Viejo, CA 92656</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Job No. 2362</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">blank</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">08/29/16</font></p></td>
    </tr>
   </table><p style="margin-left:54pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="margin-left:54pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:92.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:8%;"></td>
     <td style="width:41.304%;"></td>
     <td style="width:8.696%;"></td>
     <td style="width:13.043%;"></td>
     <td style="width:16.957%;"></td>
     <td style="width:12%;"></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">CSI</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Item Description</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Count</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unit</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unit</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Item Values</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16413</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Emergency power-175 amp transfer switch</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,532.60</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,532.60</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16414</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Emer power-panel, xfmr,disconnect, feeders</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,737.55</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,737.55</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16415</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Install grounding buss in CV-2A IT room</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">455.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">455.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16416</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Power to 2 new hvac units-H-8 &amp; H-25</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,863.85</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,863.85</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16417</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Power to 2 Labconco exhaust hoods &amp; fans</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,747.17</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,747.17</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16474</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Replace deteriorated seal-tite-roof hvac units</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,876.98</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,876.98</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16475</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Install power/data/video in conc floor-Rm 130</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Assembly</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,593.83</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,593.83</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16476</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Install power &amp; data in floor box</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">887.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">887.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16511</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Light fixtures-Exit</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">125.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,125.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16512</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Light fixtures-2x4 LED</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">105</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Each</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">131.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,755.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16514</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Install 2x4 LED fixtures on Emer circuit</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">211.27</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,859.21</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16515</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Install 2x4 LED fixtures</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">98</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">270.20</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26,479.60</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16600</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Install overhead quad outlets on flex cords</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">270.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,620.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16650</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Install power to HEPA filter units</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">300.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,800.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16720</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Fire alarm system-B occupancy</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,983.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,983.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16721</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Fire alarm system 1-hr conditions &amp; ducts</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,704.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,704.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16723</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Fire alarm system-conduit install</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Allowance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,500.00</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,500.00</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15930</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title 24 contol zones-lighting only</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23,478.85</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23,478.85</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16931</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">T-24 power outlets &amp; controls</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lot</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,467.35</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,467.35</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">667,921.07</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17100</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Contractors Contingency</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.00%</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,358.42</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17200</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Contractors Overhead &amp; Profit</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.00%</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54,502.36</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17300</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Contractor's Insurance</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.50%</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,036.73</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td colspan="2" style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Cost Per Agreement and Plans</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">746,818.58</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:3.6pt;vertical-align:top;"><p style="margin-left:3.6pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="margin-left:54pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3 of 3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font></p></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-right:auto;padding-right:1in;"><div style="min-height:1in;"></div><p style="margin-left:54pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="margin-left:54pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img77340192_0.jpg" alt="img77340192_0.jpg" style="width:417px;height:710px;">&#160;</p><p style="margin-left:128.15pt;text-indent:-18pt;padding-left:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">_________________________________________________________</font></p><div class="item-list-element-wrapper" style="margin-left:0.75in;display:flex;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11.5pt;font-family:Times New Roman;min-width:4.347629490628745%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Yellow highlighted area to be put back to its original configuration</font></div></div><p style="margin-left:54pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At the termination of the lease</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:1in;width:6.5in;margin-top:auto;margin-right:auto;padding-right:1in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font></p></div>
   <hr style="page-break-after:always;"></div>
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>rxst-ex10_5.htm
<DESCRIPTION>100-150 COLUMBIA SIXTH AMENDMENT
<TEXT>
<html>
 <head>
  <title>EX-10.5</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="min-height:0.5in;"></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 10.5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SIXTH AMENDMENT</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">	THIS Amendment (hereinafter referred to as the &#x201c;Sixth Amendment&#x201d;), dated the 3</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;min-width:fit-content;">rd</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  day of June 2024, is entered into by ACCURIDE INTERNATIONAL INC., a California corporation (hereinafter referred to as &#x201c;Landlord&#x201d;) and RXSIGHT, Inc., a Delaware corporation, (hereinafter referred to as &#x201c;Tenant&#x201d;).  The parties agree as follows:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">		</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">A.	Identification of Lease</font><font style="color:#000000;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">.  Reference is made to that certain Commercial Lease Agreement dated August 31</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.705pt;font-family:Times New Roman;min-width:fit-content;">st</font><font style="color:#000000;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">, 2015 (the &#x201c;Original Lease&#x201d;), as amended by that certain </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">First Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;"> to the Lease dated November 23</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.705pt;font-family:Times New Roman;min-width:fit-content;">rd</font><font style="color:#000000;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">, 2015, as amended by that certain </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">Second Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;"> to the Lease dated December 22</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.705pt;font-family:Times New Roman;min-width:fit-content;">nd</font><font style="color:#000000;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;"> , 2015 , as amended by that certain </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">Third Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;"> to the Lease dated January 18</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.705pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">, 2016, as amended by that certain </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">Fourth Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;"> to the Lease dated November 12</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.705pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">, 2016,  as amended by that certain </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">Fifth Amendment </font><font style="color:#000000;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">to the Lease dated April 18, 2024,</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;">(The Original Lease, as so amended, is herein collectively referred to as the &#x201c;Lease&#x201d;) for certain premises containing approximately 21,498 rentable square feet located at 100 Columbia Suite 200, Aliso Viejo, CA and 20,608 rentable square feet located at 100 Columbia Suite 100, Aliso Viejo Ca as more particularly described in the Lease as the Premises.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">		</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">B.	Context of Sixth Amendment.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  The parties have agreed to the following adjustments to the Fifth Amendment to the Lease, Section 4(ii) and 4(iii) and to adjust the Original Lease, Section 18, </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:0.12986111111111115in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;margin-right:0.07013888888888889in;min-width:0.37013888888888885in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:5.021929601400237%;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 4(ii.) of the Fifth Amendment shall be replaced by:  In the event Tenant&#x2019;s total cash and cash equivalents and short-term investments fall below $40,000,000, Tenant shall notify Landlord within ten (10) business days.</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.12986111111111115in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;margin-right:0.07013888888888889in;min-width:0.37013888888888885in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:5.021929601400237%;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 4(iii.) of the Fifth Amendment shall be replaced by: In the event Tenant&#x2019;s total cash and cash equivalents and short-term investments fall below $30,000,000 for any five (5) business day period, Tenant shall notify Landlord within two (2) business days and provide Landlord with an Irrevocable Standby Letter of Credit (ISLC) in the amount of $773,661.81 within thirty (30) calendar days. Tenant shall conform to the format issued under the ISLC requirements (Attachment F, under the Original Lease).</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.12986111111111115in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;margin-right:0.07013888888888889in;min-width:0.37013888888888885in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:5.021929601400237%;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 18, &#34;Notices&#34; of the Original Lease shall be replaced by: </font></div></div><p style="margin-left:9.35pt;text-indent:26.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07013888888888889in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">RxSight, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="margin-left:9.35pt;text-indent:26.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07013888888888889in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">100 Columbia, Suite 120</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="margin-left:9.35pt;text-indent:26.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07013888888888889in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Aliso Viejo, CA 92656</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="margin-left:9.35pt;text-indent:26.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07013888888888889in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Tel: (949) 521-7830</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">  </font></p><p style="margin-left:36pt;text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">G.	Miscellaneous</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Any term used in this Sixth Amendment, which is defined in the Lease, shall have the same meaning herein, unless the context indicates that another meaning is intended.  The Lease is intended to be and is supplemented and amended by the provisions of this Sixth Amendment, and hereafter the Lease shall be considered and construed together.  All of the terms, provisions, conditions, and covenants of the Lease, as modified by this Sixth Amendment, shall be and remain in full force and effect.</font></p><p style="margin-left:36pt;text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="margin-left:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#34;Intentionally Blank&#34;</font></p><p style="margin-left:36pt;text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
   <hr style="page-break-after:always;"></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="min-height:0.5in;"></div><p style="text-indent:72pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">	IN WITNESS WHEREOF, the parties hereto have caused this Sixth Amendment to be executed on or as of the day and year above written.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:0.07500000000000001in;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:6.54%;"></td>
     <td style="width:37.38%;"></td>
     <td style="width:6.54%;"></td>
     <td style="width:6.54%;"></td>
     <td style="width:43%;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td colspan="2" style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x201c;Landlord&#x201d;:</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x201c;Tenant&#x201d;:</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td colspan="2" style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">ACCURIDE INTERNATIONAL INC.</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">a California Corporation</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">RXSIGHT, Inc.</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">a Delaware Corporation</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td colspan="2" style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jeffrey A. Dunlap</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shelley Thunen</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Financial Officer</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6/3/2024</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
   <hr style="page-break-after:always;"></div>
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>7
<FILENAME>rxst-ex10_6.htm
<DESCRIPTION>SUBLEASE CANCEL
<TEXT>
<html>
 <head>
  <title>EX-10.6</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.92in;width:6.66in;margin-right:auto;padding-right:0.92in;"><div style="padding-top:0.14in;min-height:0.97in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="margin-left:1pt;font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Exhibit 10.6</font></p><p style="font-size:10pt;margin-top:1.7pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.944444444444445E-4in;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:1.7pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.944444444444445E-4in;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:14pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Amendment # 3 to the Sublease Agreement</font></p><p style="margin-left:5.95pt;text-indent:36pt;font-size:10pt;margin-top:9.4pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.08611111111111111in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">THIS 3</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:'Calibri',sans-serif;min-width:fit-content;">rd</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> AMENDMENT TO THE SUBLEASE AGREEMENT </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(hereinafter referred to as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;) is made and entered into effective August 1, 2024 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Amendment Effective Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;), by and between RxSight, Inc., a Delaware corporation (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">RxSight</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;), and Compass Bible Church (&#x201c;Sublessee&#x201d;, and together with RxSight, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;).</font></p><p style="margin-left:6pt;text-indent:35.95pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, the Parties entered into that certain Sublease Agreement dated effective as of April 4, 2022, as amended from time to time (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201d;), and</font></p><p style="margin-left:41.95pt;font-size:10pt;margin-top:6.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, the Parties desire to amend the Agreement in the manner reflected herein, and</font></p><p style="margin-left:41.95pt;font-size:10pt;margin-top:5.9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, the Parties to the Agreement have approved this Amendment in the manner reflected herein,</font></p><p style="margin-left:5.95pt;text-indent:36pt;font-size:10pt;margin-top:6.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.004166666666666667in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">NOW THEREFORE</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, in consideration of the premises and mutual covenants and conditions herein, the Parties, intending to be legally bound, hereby agree as follows:</font></p><div class="item-list-element-wrapper" style="margin-left:0.8298611111111112in;display:flex;margin-top:6.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:4.288325336988806%;display:inline-flex;justify-content:flex-start;">a.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The term of the Agreement shall end on August 31, 2024 (&#x201c;Expiration Date&#x201d;).</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.8298611111111112in;display:flex;margin-top:5.9pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:4.288325336988806%;display:inline-flex;justify-content:flex-start;">b.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Sublessee shall pay rent for the entire month of August 2024.</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.8298611111111112in;display:flex;margin-top:6.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:0.1298611111111111in;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:4.288325336988806%;display:inline-flex;justify-content:flex-start;">c.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Sublessee may vacate the Premises and terminate the Agreement prior to the Expiration Date so long as it is mutually agreed to by the Parties. Upon mutual agreement of an early termination, RxSight agrees to prorate the rent for August through the final date of Sublessee&#x2019;s occupancy and return any rental difference for the month of August.</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.32986111111111116in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:0.20972222222222223in;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:3.949624922406809%;display:inline-flex;justify-content:flex-start;">2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">This Amendment may be executed in one or more facsimile, electronic, or original counterparts, each of which shall be deemed an original and both of which together shall constitute the same instrument.</font></div></div><div class="item-list-element-wrapper" style="margin-left:0.32986111111111116in;display:flex;margin-top:5.95pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:0.10972222222222222in;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Calibri;min-width:3.949624922406809%;display:inline-flex;justify-content:flex-start;">3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">All terms and provisions of the Agreement not amended hereby, either expressly or by necessary implication, shall remain in full force and effect. From and after the Amendment Effective Date, all references to the term &#x201c;Agreement&#x201d; in this Amendment or the original Agreement shall include the terms contained in this Amendment.</font></div></div><p style="margin-left:5.95pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">IN WITNESS WHEREOF, the Parties hereto have executed this Amendment to the Agreement effective as of the Amendment Effective Date.</font></p><p style="margin-left:5.95pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:7%;"></td>
     <td style="width:36.92%;"></td>
     <td style="width:6.54%;"></td>
     <td style="width:7%;"></td>
     <td style="width:42.54%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="text-indent:5.95pt;vertical-align:top;"><p style="margin-left:5.95pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">RxSight, Inc.</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="text-indent:5.95pt;vertical-align:top;"><p style="margin-left:5.95pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">Compass Bible Church</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td colspan="2" style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
     <td style="vertical-align:top;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/Shelley Thunen</font></p></td>
     <td style="vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Rick Talcott</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
     <td style="vertical-align:top;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shelley Thunen</font></p></td>
     <td style="vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Rick Talcott</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
     <td style="vertical-align:top;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Financial Officer</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
     <td style="vertical-align:top;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">CFO</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</font></p></td>
     <td style="vertical-align:top;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8/1/2024</font></p></td>
     <td style="vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</font></p></td>
     <td style="vertical-align:top;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8/1/2024</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.92in;width:6.66in;margin-top:auto;margin-right:auto;padding-right:0.92in;"><div style="flex-direction:column;display:flex;padding-bottom:0.7in;min-height:0.83in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>8
<FILENAME>rxst-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 31.1</font></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">I, Ron Kurtz, M.D., certify that:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:95.84%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">I have reviewed this quarterly report on Form 10-Q of RxSight, Inc.;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:95.84%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:95.84%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:95.84%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The registrant&#x2019;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">a)</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">b)</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">c)</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">d)</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:95.84%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The registrant&#x2019;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">a)</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">b)</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:45.67%;"></td>
     <td style="width:5.063%;"></td>
     <td style="width:3.054%;"></td>
     <td style="width:46.213%;"></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date: August 5, 2024</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Ron Kurtz, M.D.</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Ron Kurtz, M.D.</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Chief Executive Officer and President</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>9
<FILENAME>rxst-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 31.2</font></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">I, Shelley Thunen, certify that:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:95.84%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">I have reviewed this quarterly report on Form 10-Q of RxSight, Inc.;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:95.84%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:95.84%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:95.84%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The registrant&#x2019;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">a)</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">b)</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">c)</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">d)</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:95.84%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The registrant&#x2019;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">a)</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">b)</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:45.67%;"></td>
     <td style="width:5.063%;"></td>
     <td style="width:3.054%;"></td>
     <td style="width:46.213%;"></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date: August 5, 2024</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Shelley Thunen</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Shelley Thunen</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Co-President and Chief Financial Officer</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Principal Financial Officer)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>10
<FILENAME>rxst-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 32.1</font></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the Quarterly Report of RxSight, Inc. (the &#x201c;Company&#x201d;) on Form 10-Q for the quarterly period ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof  (the &#x201c;Report&#x201d;), I, Ron Kurtz, M.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4%;"></td>
     <td style="width:5%;"></td>
     <td style="width:91%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:45.46%;"></td>
     <td style="width:5.04%;"></td>
     <td style="width:3.04%;"></td>
     <td style="width:46.46%;"></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date: August 5, 2024</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Ron Kurtz, M.D.</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Ron Kurtz, M.D.</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Chief Executive Officer and President</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>11
<FILENAME>rxst-ex32_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
 <head>
  <title>EX-32.2</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-right:auto;padding-right:0.5in;"><div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 32.2</font></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the Quarterly Report of RxSight, Inc. (the &#x201c;Company&#x201d;) on Form 10-Q for the quarterly period ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I, Shelley Thunen, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.16%;"></td>
     <td style="width:5.14%;"></td>
     <td style="width:90.7%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.</font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></p></td>
    </tr>
   </table><p style="text-indent:-24.5pt;padding-left:24.5pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:45.46%;"></td>
     <td style="width:5.04%;"></td>
     <td style="width:3.04%;"></td>
     <td style="width:46.46%;"></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date: August 5, 2024</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Shelley Thunen</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Shelley Thunen</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Co-President and Chief Financial Officer</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Principal Financial Officer)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div class="fixed-width-container" style="margin-left:auto;padding-left:0.5in;width:7.5in;margin-top:auto;margin-right:auto;padding-right:0.5in;"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img74569629_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img74569629_0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  O )8# 2(  A$! Q$!_\0
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%@H __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img74569629_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img74569629_1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  K %0# 2(  A$! Q$!_\0
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M[OQQ\3WF.][?7+>SB8@96$:792A,^@>>5OJ[>M:TXI\TGT7ZI?J93;T2ZO\
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MQ^4!TVM\Q^8[AZJ:P-3@S^TKX,6VDF>S\9QA&"&*3P)KB3$D$C;$;/>W 8\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img74569629_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img74569629_2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  K #@# 2(  A$! Q$!_\0
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M:EOOBA8[8(M#\(ZV$4!KZ36KK3C*W<_9Q:7&P>WFM]:R/^&3O@A_T1OX?_\
MA+V/_P :H_X9.^"'_1&_A_\ ^$O8_P#QJM8U.56:NOZ[&<H7=T[,U/[:^*O_
M $)W@[_PK+O_ .5E']M?%7_H3?!W_A67?_RLK+_X9.^"'_1&_A__ .$O8_\
MQJC_ (9.^"'_ $1OX?\ _A+V/_QJJ]I'^1?C_F3[.7\[_#_(]-T][J2QMGO8
M8;>]:-3/#;RF6-),#<JN54LH.0&*J2.<#I5BO*O^&3O@A_T1OX?_ /A+V/\
M\:H_X9.^"'_1&_A__P"$O8__ !JL#8]5HKRK_AD[X(?]$;^'_P#X2]C_ /&J
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img74569629_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img74569629_3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  O )8# 2(  A$! Q$!_\0
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%@H __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img74569629_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img74569629_4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  O )8# 2(  A$! Q$!_\0
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%@H __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>img74569629_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img74569629_5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  O )8# 2(  A$! Q$!_\0
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%@H __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>img74569629_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img74569629_6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  O )8# 2(  A$! Q$!_\0
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%@H __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>img74569629_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img74569629_7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0+T17AI9@  34T *@    @ ! $[  (
M   .   !2H=I  0    !   !6)R=  $    <   "T.H<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M57!E;F1E<B!+=6UA<@  !9 #  (    4   "II $  (    4   "NI*1  (
M   #-SD  )*2  (    #-SD  .H<  <   $,   !F@     <Z@    $
M
M
M
M
M
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M!9HKB=!\<:WJ>G2SS>"=8E9+VZ@#6\MD% BN)(P#ON<[@$ 8]"P8KE<5I?\
M"4:O_P!")X@_[_Z?_P#)5 '245S?_"4:O_T(GB#_ +_Z?_\ )5'_  E&K_\
M0B>(/^_^G_\ R50!TE%<W_PE&K_]")X@_P"_^G__ "51_P )1J__ $(GB#_O
M_I__ ,E4 =)17-_\)1J__0B>(/\ O_I__P E4?\ "4:O_P!")X@_[_Z?_P#)
M5 '245S?_"4:O_T(GB#_ +_Z?_\ )5'_  E&K_\ 0B>(/^_^G_\ R50!TE%<
MW_PE&K_]")X@_P"_^G__ "51_P )1J__ $(GB#_O_I__ ,E4 =)17-_\)1J_
M_0B>(/\ O_I__P E4?\ "4:O_P!")X@_[_Z?_P#)5 '245S?_"4:O_T(GB#_
M +_Z?_\ )5'_  E&K_\ 0B>(/^_^G_\ R50!TE%<W_PE&K_]")X@_P"_^G__
M "51_P )1J__ $(GB#_O_I__ ,E4 =)17-_\)1J__0B>(/\ O_I__P E4?\
M"4:O_P!")X@_[_Z?_P#)5 '245S?_"4:O_T(GB#_ +_Z?_\ )5'_  E&K_\
M0B>(/^_^G_\ R50!TE%<W_PE&K_]")X@_P"_^G__ "545MXMU>>UBE/@37LN
M@;Y9[#'(][D']* .IHKF_P#A*-7_ .A$\0?]_P#3_P#Y*H_X2C5_^A$\0?\
M?_3_ /Y*H Z2BN;_ .$HU?\ Z$3Q!_W_ -/_ /DJC_A*-7_Z$3Q!_P!_]/\
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M -/_ /DJC_A*-7_Z$3Q!_P!_]/\ _DJ@#I**YO\ X2C5_P#H1/$'_?\ T_\
M^2J/^$HU?_H1/$'_ '_T_P#^2J .DHKF_P#A*-7_ .A$\0?]_P#3_P#Y*H_X
M2C5_^A$\0?\ ?_3_ /Y*H Z2BN;_ .$HU?\ Z$3Q!_W_ -/_ /DJC_A*-7_Z
M$3Q!_P!_]/\ _DJ@#I**Y:W\6ZO-&S'P)KW#LORSV'9B.]R/2I?^$HU?_H1/
M$'_?_3__ )*H Z2BN;_X2C5_^A$\0?\ ?_3_ /Y*H_X2C5_^A$\0?]_]/_\
MDJ@#I**YO_A*-7_Z$3Q!_P!_]/\ _DJC_A*-7_Z$3Q!_W_T__P"2J .DHKF_
M^$HU?_H1/$'_ '_T_P#^2J/^$HU?_H1/$'_?_3__ )*H Z2BN;_X2C5_^A$\
M0?\ ?_3_ /Y*H_X2C5_^A$\0?]_]/_\ DJ@#I**YO_A*-7_Z$3Q!_P!_]/\
M_DJC_A*-7_Z$3Q!_W_T__P"2J .DHKF_^$HU?_H1/$'_ '_T_P#^2J/^$HU?
M_H1/$'_?_3__ )*H Z2BN;_X2C5_^A$\0?\ ?_3_ /Y*H_X2C5_^A$\0?]_]
M/_\ DJ@#I**YO_A*-7_Z$3Q!_P!_]/\ _DJC_A*-7_Z$3Q!_W_T__P"2J .D
MHKF_^$HU?_H1/$'_ '_T_P#^2J/^$HU?_H1/$'_?_3__ )*H Z2BN;_X2C5_
M^A$\0?\ ?_3_ /Y*H_X2C5_^A$\0?]_]/_\ DJ@#I**YO_A*-7_Z$3Q!_P!_
M]/\ _DJF#Q7JYG=/^$$U_P"50?\ 7V&><_\ 3U[4 =/17-_\)1J__0B>(/\
MO_I__P E4?\ "4:O_P!")X@_[_Z?_P#)5 '245S?_"4:O_T(GB#_ +_Z?_\
M)5'_  E&K_\ 0B>(/^_^G_\ R50!TE%<W_PE&K_]")X@_P"_^G__ "51_P )
M1J__ $(GB#_O_I__ ,E4 =)17-_\)1J__0B>(/\ O_I__P E4?\ "4:O_P!"
M)X@_[_Z?_P#)5 '245S?_"4:O_T(GB#_ +_Z?_\ )5'_  E&K_\ 0B>(/^_^
MG_\ R50!TE%<W_PE&K_]")X@_P"_^G__ "51_P )1J__ $(GB#_O_I__ ,E4
M =)17-_\)1J__0B>(/\ O_I__P E4?\ "4:O_P!")X@_[_Z?_P#)5 '245S?
M_"4:O_T(GB#_ +_Z?_\ )5'_  E&K_\ 0B>(/^_^G_\ R50!TE%<W_PE&K_]
M")X@_P"_^G__ "51_P )1J__ $(GB#_O_I__ ,E4 =)17-_\)1J__0B>(/\
MO_I__P E4?\ "4:O_P!")X@_[_Z?_P#)5 '245S?_"4:O_T(GB#_ +_Z?_\
M)5'_  E&K_\ 0B>(/^_^G_\ R50!TE%<LWBW5Q=)%_P@FO89&;_7V&>"H_Y^
M<=_7^N)?^$HU?_H1/$'_ '_T_P#^2J .DHKF_P#A*-7_ .A$\0?]_P#3_P#Y
M*H_X2C5_^A$\0?\ ?_3_ /Y*H Z2BN;_ .$HU?\ Z$3Q!_W_ -/_ /DJC_A*
M-7_Z$3Q!_P!_]/\ _DJ@#I**YO\ X2C5_P#H1/$'_?\ T_\ ^2J/^$HU?_H1
M/$'_ '_T_P#^2J .DHKF_P#A*-7_ .A$\0?]_P#3_P#Y*H_X2C5_^A$\0?\
M?_3_ /Y*H Z2BN;_ .$HU?\ Z$3Q!_W_ -/_ /DJC_A*-7_Z$3Q!_P!_]/\
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M1J__ $(GB#_O_I__ ,E4?\)1J_\ T(GB#_O_ *?_ /)5 '245S?_  E&K_\
M0B>(/^_^G_\ R51_PE&K_P#0B>(/^_\ I_\ \E4 =)17-_\ "4:O_P!")X@_
M[_Z?_P#)5'_"4:O_ -")X@_[_P"G_P#R50!TE%<W_P )1J__ $(GB#_O_I__
M ,E4?\)1J_\ T(GB#_O_ *?_ /)5 '245S?_  E&K_\ 0B>(/^_^G_\ R51_
MPE&K_P#0B>(/^_\ I_\ \E4 =)17-_\ "4:O_P!")X@_[_Z?_P#)5'_"4:O_
M -")X@_[_P"G_P#R50!TE%<W_P )1J__ $(GB#_O_I__ ,E4?\)1J_\ T(GB
M#_O_ *?_ /)5 '245S?_  E&K_\ 0B>(/^_^G_\ R51_PE&K_P#0B>(/^_\
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M1_PN'P[_ ,^]_P#]\1__ !='US#_ ,Z#^Q\?_P ^F=]17 _\+A\._P#/O?\
M_?$?_P 72K\7_#S,%%O?Y)Q]R/\ ^+H^N8?^=!_9&/\ ^?3.]HJ"RNX[^PM[
MN$,([B)94#=0&&1G\ZGKI3NKH\QIQ=F%%%%,1S?@/_D7;K_L,ZK_ .G"XKI*
MYOP'_P B[=?]AG5?_3A<5TE !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %<WX\_P"1=M?^PSI7_IPMZZ2N;\>?\B[:_P#8
M9TK_ -.%O0!TE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<WX
M\_Y%VU_[#.E?^G"WKI*YOQY_R+MK_P!AG2O_ $X6] '24444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '-_$;_ ))9XK_[ UY_
MZ(>NDKF_B-_R2SQ7_P!@:\_]$/724 <]X]_Y$+5_^O<_S%?-]?2'CW_D0M7_
M .O<_P Q7S?7S6;_ ,6/I^I^D\(_[I4_Q?H@HHHKQC[(**** "BBB@ HHHH
M**** "GP_P"OC_WA_.F4^'_7Q_[P_G36XGL?3?AK_D4])_Z\H?\ T 5IUF>&
MO^13TG_KRA_] %:=?=4_@7H?AF(_C3]7^844459@<WX#_P"1=NO^PSJO_IPN
M*Z2N;\!_\B[=?]AG5?\ TX7%=)0 4444 %%%% !1110 4444 %%%% !1110
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MH **** "BBB@ I\/^OC_ -X?SIE/A_U\?^\/YTUN)['TWX:_Y%/2?^O*'_T
M5IUF>&O^13TG_KRA_P#0!6G7W5/X%Z'X9B/XT_5_F%%%%68'-^ _^1=NO^PS
MJO\ Z<+BNDKF_ ?_ "+MU_V&=5_].%Q724 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6Y^=N<#W/2M>BBM$K(YJE3VDKVM]_P"K84444S,**** "BBB@ HHHH ****
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M .1=NO\ L,ZK_P"G"XKI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?]G^*7TZ5L0Z@FT G_EHN2OZ;A^(J#XG:'_9/C@W,:8M]0(G4CIOSAQ^?/\
MP*JNK6.GV5O<K<:)?^'[R$;K25Y'D6=@?NDD8!QD@@XXKF?M,]Q/%]HFDEVL
M,;W+8Y]ZJI4Y*"H2UL[I]O*S5S*AA_:XUX^D[)JS3MKV::;7;OL?2WAK_D4]
M)_Z\H?\ T 5IUF>&O^13TG_KRA_] %:=?5T_@7H?E6(_C3]7^844459@<WX#
M_P"1=NO^PSJO_IPN*Z2N;\!_\B[=?]AG5?\ TX7%=)0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M  GFD?\ /GX@_P#"<U#_ .,4?\)YI'_/GX@_\)S4/_C% '245S?_  GFD?\
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M^AR\/_\ @T@_^*KI** .;_X6-X(_Z'+P_P#^#2#_ .*H_P"%C>"/^AR\/_\
M@T@_^*KI** .;_X6-X(_Z'+P_P#^#2#_ .*H_P"%C>"/^AR\/_\ @T@_^*KI
M** .;_X6-X(_Z'+P_P#^#2#_ .*H_P"%C>"/^AR\/_\ @T@_^*KI** .;_X6
M-X(_Z'+P_P#^#2#_ .*H_P"%C>"/^AR\/_\ @T@_^*KI** .;_X6-X(_Z'+P
M_P#^#2#_ .*H_P"%C>"/^AR\/_\ @T@_^*KI** .;_X6-X(_Z'+P_P#^#2#_
M .*H_P"%C>"/^AR\/_\ @T@_^*KI** .;_X6-X(_Z'+P_P#^#2#_ .*H_P"%
MC>"/^AR\/_\ @T@_^*KI** .;_X6-X(_Z'+P_P#^#2#_ .*H_P"%C>"/^AR\
M/_\ @T@_^*KI** .;_X6-X(_Z'+P_P#^#2#_ .*H_P"%C>"/^AR\/_\ @T@_
M^*KI** .;_X6-X(_Z'+P_P#^#2#_ .*H_P"%C>"/^AR\/_\ @T@_^*KI** .
M;_X6-X(_Z'+P_P#^#2#_ .*H_P"%C>"/^AR\/_\ @T@_^*KI** .;_X6-X(_
MZ'+P_P#^#2#_ .*H_P"%C>"/^AR\/_\ @T@_^*KI** .;_X6-X(_Z'+P_P#^
M#2#_ .*H_P"%C>"/^AR\/_\ @T@_^*KI** .;_X6-X(_Z'+P_P#^#2#_ .*H
M_P"%C>"/^AR\/_\ @T@_^*KI** .;_X6-X(_Z'+P_P#^#2#_ .*JO??$[P;;
M6;S6_BK0+B1<8C&JP@D9&?XCVYKK** /,="^-^A:O+<_:;K1K"&*41H\VLQA
MI/E9MVUE7CA!D$\L?[M;>B_%/PKJ&DPW6I^(_#VGSRKN^SC68I"@(R-Q.W#>
MHQQ79T4 <W_PL;P1_P!#EX?_ /!I!_\ %4?\+&\$?]#EX?\ _!I!_P#%5TE%
M '-_\+&\$?\ 0Y>'_P#P:0?_ !5'_"QO!'_0Y>'_ /P:0?\ Q5=)10!S?_"Q
MO!'_ $.7A_\ \&D'_P 51_PL;P1_T.7A_P#\&D'_ ,57244 <W_PL;P1_P!#
MEX?_ /!I!_\ %4?\+&\$?]#EX?\ _!I!_P#%5TE% '-_\+&\$?\ 0Y>'_P#P
M:0?_ !5'_"QO!'_0Y>'_ /P:0?\ Q5=)10!S?_"QO!'_ $.7A_\ \&D'_P 5
M1_PL;P1_T.7A_P#\&D'_ ,57244 <W_PL;P1_P!#EX?_ /!I!_\ %4?\+&\$
M?]#EX?\ _!I!_P#%5TE% '-_\+&\$?\ 0Y>'_P#P:0?_ !5'_"QO!'_0Y>'_
M /P:0?\ Q5=)10!S?_"QO!'_ $.7A_\ \&D'_P 51_PL;P1_T.7A_P#\&D'_
M ,57244 <W_PL;P1_P!#EX?_ /!I!_\ %4?\+&\$?]#EX?\ _!I!_P#%5TE%
M '-_\+&\$?\ 0Y>'_P#P:0?_ !5'_"QO!'_0Y>'_ /P:0?\ Q5=)10!S?_"Q
MO!'_ $.7A_\ \&D'_P 51_PL;P1_T.7A_P#\&D'_ ,57244 <W_PL;P1_P!#
MEX?_ /!I!_\ %4?\+&\$?]#EX?\ _!I!_P#%5TE% '-_\+&\$?\ 0Y>'_P#P
M:0?_ !5'_"QO!'_0Y>'_ /P:0?\ Q5=)10!S?_"QO!'_ $.7A_\ \&D'_P 5
M1_PL;P1_T.7A_P#\&D'_ ,57244 <W_PL;P1_P!#EX?_ /!I!_\ %4?\+&\$
M?]#EX?\ _!I!_P#%5TE% '-_\+&\$?\ 0Y>'_P#P:0?_ !5'_"QO!'_0Y>'_
M /P:0?\ Q5=)10!S?_"QO!'_ $.7A_\ \&D'_P 57/>)/'W@Z;7O"<D/BO0Y
M$M]6DDF9-1A81J;&Z4,Q#<#<RC)[L!WKT6N6\3V\*^+/!]R(U\YM7=&DQR5%
MA>$#/IDG\Z .IHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N;\>
M?\B[:_\ 89TK_P!.%O725S?CS_D7;7_L,Z5_Z<+>@#I**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F_B-_R2SQ7_P!@:\_]
M$/725S?Q&_Y)9XK_ .P->?\ HAZZ2@"KJ<%U=:5=0:=>?8;N6%T@NO*$OD.0
M0K[#PV#@X/!Q7F<=QXK%TNCWNL>(+R[>Z*G4%\,Q+:[ QP&!.-N<'<.<#KUK
MU8D $G@#J:\D^('BT^(-)N['PW<P7D,$BD3Z/XKMK25U*?-O+ A5&X\9.2F>
M.*GJ.UT<_IFD:[;^(DU&_@U2X^Q.S)%%X(LX7=]Q4.DN\X.%'(Q\N.]7M,TN
M2;591>Z;?R7%K:3/#</X,MHU6<(&20-RQ8<A5&-QZ\4Z>_CU73Y8VU&]TNTC
MNI_)NX/&$"K=>=N$:Y!/WE4,BGIDX/!K.75+B_\ $?GIJ]]:6JQ+ ''CNV:W
MS&J#<8P"=YP<GUR>_ E=6_K^OZZ#W=W_ %V_7\A^@Z'J-U8WNHW-GJ;&ZN$=
MK:X\%6=LRD*Y#LI.7V_,,Y)^8  YYKQ:9)>QEX]&U*VN99)XUN'\!6H<JI7&
M=QP4(D&. 3Y;9QCG8&IS:LVH6$6HW36.FM+-!>0^,H/-O]P,:J54$(A?Y1O(
MPQ]>*J6^K2WTMM(C7(\^)U:SB\=POLV2C:2O0L>A*D@#CK1>]NW_  /^ +HV
M6_%,.J,;%'L]9G2$#*+X0M;H*1&2I!W84*0G3."H'TB@TF6XDB06%U$)G12;
MCP1$4PQP=P4X ]3VZD=:(I1;>%K*U>^O<1K=S7LTGC*%#:S'8\2-(#AU8_*#
MC"9).<YK,TRZNI=)6TU"]U*R1#(0TGCFUF_>'?L!8 $ LRI@=B."1DOU_K^O
MZW%T3_K^OZZ%BTTB:'PY;7*Z+J:-;7D86&/P1:)(CR*?WJQYXVX3<PY! X(Z
M1ZOHU_<?8]2^Q:Q.MS=J&,G@NQEFCC#8*2'*D*<_>QD<GI6Q))=26EU/?7-Z
MEAIV9XKD>+(=LCG;F D*"$"QEP6)/+?A"T^M13:CJ/F:@U]=,K16=SXKMXXX
MX9599'B"KA=A3:/?)!R#3UZ?U_7Y>0M]_P"OZ_/S+XTFY>80FPU,WT<ZR1W<
MGABTV+A4,8R,#Y,  YR"OM5*\T:[7^SY["SU2"98$AO)3X0M)&O"95+$]"@.
MW[HX P>2*SKVZU"TL +<ZH'WED9O'D*,V SY)/!!/RG@\+Z YO)-?&8V\&LW
M5\&D=R#XN@)>,,P ^Z&Y.!CH,C/2DM-5ZCWT?]?UT_#<S-:T:>R\87\4.BZ@
MUI=7!1&M? UI)!$N2 OF;MS@D9WD=QTKM?!\GB.]O#:-JVM65I#Q'!>>'(K5
M8T1578KC*D$@D>QQVKE].NK^-IEL]:NC;+%#9RO=>,H'^S ."T@"H</M"CWW
MXKMO!?B6TL8(]%O+ZU6"*9[>RNKS7H;NXO3O.P\8)++R!U'3%.*MHOZ_K\?O
M%+O_ %_7Y6]#O****!A1110!S?@/_D7;K_L,ZK_Z<+BNDKF_ ?\ R+MU_P!A
MG5?_ $X7%=)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5S?PY_Y)9X4_P"P-9_^B$KI*YOX<_\ )+/"G_8&L_\ T0E '25S=C_R5/7?
M^P-IO_H^^KI*YNQ_Y*GKO_8&TW_T??4 =)1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7-^*/^1B\&_P#8
M9D_]-]W725S?BC_D8O!O_89D_P#3?=T =)1110 4444 %%%% !1110 4444
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MZE*QG*)]J\*6]@+9MS$3"13G 7:O'UZFO1O^%C>"/^AR\/\ _@T@_P#BJ/\
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MX(Q J,PFG8_/@9RJ#J#ZDCU&15O3KEKS2[6ZD4*\T*2,J] 2H./UH LT444
M%%%% !1110 4444 %%%% !1110 4454N;_RIA;V\+7-R1GRT( 0=F9CT'YDX
M. <4 6Z*HZ??3W-S=P74$<3V[*O[N0N#E0W4J/7TJ]0 4444 %%%% !1110
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M/MNA3:="R@J978R DN"&78 ,;.H8_>7UK>HHH$@HHHH&%%%% !1110 4444
M<W\.?^26>%/^P-9_^B$KI*YOX<_\DL\*?]@:S_\ 1"5TE !1110!S?@/_D7;
MK_L,ZK_Z<+BNDKF_ ?\ R+MU_P!AG5?_ $X7%=)0 4444 %%%% !1110 444
M4 %%%% !6!XT\5P^#/"]UK$]G<W@ACD98X(G<;EC9QO95;RU)7;O(P"PS6_7
M-_$?_DEGBO\ [ UY_P"B7H KW/Q)T*V:)'M]=,LK!8X_^$?OE9^>2 81G Y.
M.PJEX;^)^FZQH[7DUMJL@:[N8XGL]!OI(WB2>1(SN6)ADHJEAGALC (P+WC_
M $E-5T2VCDT9M62&X\TPQMAU 1N5Y )/W1_O=NHQ?ASXPTYO#T]NUGJT5PNJ
M:B\D2Z5=2+$6O)GV&18RA8!AD!C0#T.A_P"$\TC_ )\_$'_A.:A_\8H_X3S2
M/^?/Q!_X3FH?_&*MQ^*M/E3<MOJP&2/FT:[4\''0Q4]O$EBN,P:GR,\:5='_
M -IT 4?^$\TC_GS\0?\ A.:A_P#&*/\ A/-(_P"?/Q!_X3FH?_&*MIXJT]RP
M%OJPVMM.[1KL?EF+D<]13SXDL0H)@U/YNF-*NO\ XWQ0!1_X3S2/^?/Q!_X3
MFH?_ !BN?\ ^--+M?AOX:MY;77&>'2;5&,6@7TB$B%0=KK"58>A!(/4&NIG\
M5Z?!;RRFWU,^6A8@Z5<CH/4Q\?6L/X?:_9P?##PNCPZ@2FD6J'9IMPXR(4Z$
M(01[C@]J -/_ (3S2/\ GS\0?^$YJ'_QBLW2M?T^;QUK&J.\UI:RZ=8VR?;K
M:2UD:2.6Z9OW<JJ^,3)\V-IR0"2K8W9?%.GPV[S/;ZL53&0FCW;-SZ*(LG\!
M7,W^KQ7FMS75O9ZHT4D$6W.E7(88+_>4Q[E/L0/7I0!UP\0:202+^'"XR=W
MJ(>*M"-PT U6V,J@$IOY -<N;AAC_0M1Y_ZA\_\ \155M9MEU)-/D2\M[J5@
MD7VC3YT5V/3:S* W7G!X]J .T'B;12VT:G;%O02"D_X2C0\X_M6U_P"_@JA_
MPC-Y_P!!&#_P%/\ \73&\+7LD+(VHV_S C(M&_\ CE)WMH-;ZDS^/?"R;?\
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M'0[%X_+'YT 6*YW5/^2@>'_^O6\_]HUT5<[JG_)0/#__ %ZWG_M&@#HJ***
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M]*6D7[H^E+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMK_V&=*_].%O725S?CS_ )%VU_[#.E?^G"WH Z2BBB@ HHHH **** "BBB@
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MQO!'_0Y>'_\ P:0?_%5K?V/;?\]+S_P.F_\ BZ/['MO^>EY_X'3?_%T 9/\
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MHH **** "BBB@ HHHH **** .;^(W_)+/%?_ &!KS_T0]=)7-_$;_DEGBO\
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MU<[JG_)0/#__ %ZWG_M&NBKG=4_Y*!X?_P"O6\_]I4 =%1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH XSPS_R4+6/^P%I7_H=W79UQGAG_ )*%K'_8"TK_ -#NZ[.@#@/B!O\
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M4 %%%% !7-^//^1=M?\ L,Z5_P"G"WKI*YOQY_R+MK_V&=*_].%O0!TE%%%
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M 4444 %%%% !1110 4444 %9'B;_ ) LO^Z__HMZUZR/$W_(%E_W7_\ 1;T
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M%%% '-_$;_DEGBO_ + UY_Z(>NDKF_B-_P DL\5_]@:\_P#1#UTE '-^//\
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M*U*** "BBB@ HHHH **** .;^'/_ "2SPI_V!K/_ -$)725S?PY_Y)9X4_[
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MG\L#\* +%<[JG_)0/#__ %ZWG_M&NBKF]60-\0O#I.<K;7A&&(_YY#GUZ]Z
M.DHHHH CGGCMHO,F)"Y X4L22<#@<]34/]HP_P!RX_\  :3_ .)IFJZ39ZWI
M[66I1M) S*Q5)&C.0<CYE((Y'K7+77@#P]'JUA"EO=A)?,WC^T;CG"Y'_+2@
M#K/[0A_N7'_@-)_\31_:$/\ <N/_  &D_P#B:\UE\(:.OAI[D1W?FC0?M8;[
M?/\ ZW9G=C?CKVZ>U6[KP7HD=Y>(D5V%CU&UA4?VA<<(_E[A]_ON//6@#O\
M^T(?[EQ_X#2?_$TCWT#HRE;H!A@XMY0?S"\5P%KX+T22^LXWBNRLFHW4+#^T
M+@91!)M'W^V!SUK=\&^%='M="T[4$M6DN;FQB,K3SR3 DJ&.%=B!SZ 4 :*6
M6F1H$C.JJHZ!9KL ?K6?-JEOH&JK-+_;$EI*&01I;W=VQ;"G.P*S =?FQC)Q
MGFNC_LVQ_P"?*W_[]+_A6.UA9R>)E@DM('A$;L(VC!4'"<XZ9H 9_P )YI'_
M #Z>(/\ PG-0_P#C%'_">:1_SZ>(/_"<U#_XQ6M_8FE?] RS_P# =?\ "C^Q
M-*_Z!EG_ . Z_P"% &3_ ,)YI'_/IX@_\)S4/_C%'_">:1_SZ>(/_"<U#_XQ
M6M_8FE?] RS_ / =?\*/[$TK_H&6?_@.O^% &3_PGFD?\^GB#_PG-0_^,5>T
M3Q+IWB&2ZCTW[8'M"JS+=V$]J5+#(&)47/ [9QD9ZBK']B:5_P! RS_\!U_P
MKG/"]M!:^//$J6L$<*[X>(T"C[@]/J: .QHQ6;KCS-:K;VC8GD;( _NCDU?M
MYTN;=)HS\KC/T]OK0!@3>.-(@NI[=K?6I'@E:*0PZ#>RIN4X.'6$JP]P2#U%
M-_X3S2/^?/Q!_P"$YJ'_ ,8JGX1L;2^E\0R7MK#<.NMW**TL8<A?EX!/;DUT
M7]B:5_T#+/\ \!U_PH R?^$\TC_GS\0?^$YJ'_QBC_A/-(_Y\_$'_A.:A_\
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MRC<W^R/[J#LH_4DD@'.:%JUII9U!(M=N/$$>^);<^>L\CR,K9C4KQVS[#))
MYK9T#Q(NKRSV5[;'3]5M3^_LW?<0.S*W&Y3D<CU]P3<U32(-31'),%W"=UO=
M1@>9"WJ#W'8@\$$@USFCZKI<$[ZOXBU&U35V7[-+D;%M@&QY2\G'S=3DY/L
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M[V0%!MQUSEAQUH ]8HKD?^$XU#_H0O%'_?-G_P#)%'_"<:A_T(7BC_OFS_\
MDB@#KJ*XR?X@7ML@:3P!XL(8X'EP6KG\EG/IUJ#_ (67<_\ 1/O&7_@#!_\
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MX^3&?DLKI3GWGC;^3BNL-<;I"8^(4C[F.ZTN!M)X&'AZ?G0!V5%%% !1110
MR:0Q6\D@7<44L%'?':N(TK7X/$GCS0;ZWC:/&CZE'(C?PN)K'< >X!.,^U=M
M<!VMI1'G>4.W:<'./6O._"D>M1>--%C\11/%<KINJ! [*Q9/-L/F)7N6W'GG
M)H Z3Q1_R,7@W_L,R?\ IONZZ2N;\4?\C%X-_P"PS)_Z;[NNDH **** "BBB
M@ HHHH **** "N;\>?\ (NVO_89TK_TX6]=)7-^//^1=M?\ L,Z5_P"G"WH
MZ2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ KF_B-_R2SQ7_ -@:\_\ 1#UTE<W\1O\
MDEGBO_L#7G_HAZ .DKF_ ?\ R+MU_P!AG5?_ $X7%=)7-^ _^1=NO^PSJO\
MZ<+B@#I**** "BBB@ KF_AS_ ,DL\*?]@:S_ /1"5TE<W\.?^26>%/\ L#6?
M_HA* .DJO;D?:+O";<2C)S][Y%Y_I^%6*@@W>?<[G##S!M .=HV+Q[<Y/XT
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M)?M(SSR".&&%#))(Q/\ "HY.,_Y)%4-2U74+R\TN'PU=V8CO(9IC--&7!"%
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M HHHH **** "BBB@ KF_B-_R2SQ7_P!@:\_]$/725S?Q&_Y)9XK_ .P->?\
MHAZ .DKF_ ?_ "+MU_V&=5_].%Q725S?@/\ Y%VZ_P"PSJO_ *<+B@#I****
M "BBB@ KF_AS_P DL\*?]@:S_P#1"5TE<W\.?^26>%/^P-9_^B$H Z2J]OL^
MT7>P-GS1OSZ[%Z?ABK%0P!Q/<EU !D&PXQN&Q>??G(_"@":N=U3_ )*!X?\
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M44 %%%% !1110 5S?Q&_Y)9XK_[ UY_Z(>NDKF_B-_R2SQ7_ -@:\_\ 1#T
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M+PX")M4;F);:3GL1TYKT2;X2^!6U*74YM% E>Z%[*/M<RPM,,G>8M_E\9/\
M#CD^M:$?@WPI8W&IS"QMX_\ A(&VWD<DS&*[8@_\LRVS<1D_* 3S5.S37?\
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M *+-<?#X9N]2:\:U@5EFN9F>=]3N8/OR,P*QQDK]TJ>W7ZUV'BK_ )$[6?\
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M:S8-=ZA<WJ!L RV/D!#O3OM&<X_2NRK$U.VEBFLF>]GF'VA?E=4 Z^R@UMT
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MC ^'VJND63,,9W8O6('MSB@#O:K:E_R"KO\ ZX/_ .@FK-5M2_Y!5W_UP?\
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M_P#C='_"-7__ $$M0_\ !FW_ ,;H W/[3L/^?VW_ ._J_P"-']IV'_/[;_\
M?U?\:PCX;O@"3J>H #J3J;?_ !NH&TPP R2ZW>%44NP35=S$#DX&P9_.@#5U
M.\MKB6R6"XBE87"DA'!(&1Z5LUQ'P^MYM1T*Z?6+RZN[BTUF^A#/=R$8CNI
MHQGD#  R.@ Z#%=O0 4444 %%%% !1110 5D>)O^0++_ +K_ /HMZUZR/$W_
M "!9?]U__1;T :R_='TI:1?NCZ4M !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %</>?\E?G_[ UG_Z6M7<5P]Y_P E?G_[
M UG_ .EK4 =S5;4O^05=_P#7!_\ T$U9JMJ7_(*N_P#K@_\ Z": /-_$3L^H
M1V*QHQO;^2+,D7FHHW3L<I_%P#QVZ]JV/ )N+G[<LLYC>W*VY,$:JC[))5R
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M>A?]@;4O_1]C0 >*/^1B\&_]AF3_ --]W725S?BC_D8O!O\ V&9/_3?=UTE
M!1110 4444 %%%% !1110 5S?CS_ )%VU_[#.E?^G"WKI*YOQY_R+MK_ -AG
M2O\ TX6] '24444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% '-_$;_DEGBO_L#7G_HAZZ2N;^(W_)+/%?\ V!KS_P!$/724 ?,&
MB?\ )[4__7U<?^DCU]/U\P:)_P GM3_]?5Q_Z2/7T_0 4444 %%%% !1110
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MG:S_ ->$_P#Z+-,\,L&TUV4@J9 01W^1:?XJX\'ZSC_GQF_]%FF>&%"::ZH
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M&CV6NZ;)8ZC$)(GZ'^)&[,I[$5@:AX<FLO"DR_OM=U#=!O>;;OFC256\L9X
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M2SQ7_P!@:\_]$/724 ?,&B?\GM3_ /7U<?\ I(]?3]?,&B?\GM3_ /7U<?\
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M1<*BC@  =!4$G_(6M_\ KA+_ .A)0!:HHHH **** "N;OO\ DJ>A?]@;4O\
MT?8UT$__ ![R?.8_E/S@?=]ZX30;N>]\9^'9+F^AOV71]3C6>)<;U6>Q 9OF
M/S$#=V^]TH V_%'_ ",7@W_L,R?^F^[KI*\XD,H\<Z+&=26ZB7Q%,5MP%S 3
M97I()!SZ<'IBO1Z "BBB@ HHHH **** "BBB@ KF_'G_ "+MK_V&=*_].%O7
M25S?CS_D7;7_ +#.E?\ IPMZ .DHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** .;^(W_)+/%?_8&O/_1#UTE<W\1O^26>*_\
ML#7G_HAZZ2@#Y@T3_D]J?_KZN/\ TD>OI^OF#1/^3VI_^OJX_P#21Z^GZ "B
MBB@ HHK*3Q+I<FIBP2>0SM,T"YMY CNH8LJOMVD@*V<'@C!YH U:*YIOB#X:
M34(;-[Z59)]FQS9SB(EEW*#+LV D=B0>E2VWCC0+JUO+I+FXCM[$H)YI[*>%
M%WXVX9T ;(93QG ()X.:-PV.@HKGI/'?AF*_ALI=6A2XF.(T96&X[G7KC'6-
MA^7J,R>&?&>A^,(99O#MU-=P1]9C:311MR1\KNH#<@_=)Q1N!NU0UNVEO-'F
M@@7<[;<#('\0)Y-7ZH:XLC:+<B$,6V\A>I7//Z9I#6Y3.CZ8L F:\E$6<;S=
M';GIUSZU#XK@2V^'&NQ1%F1=,N<%FW$_NV[U<%YHATH1^;;?9=O^J)'_ *#U
MS^M9&L+(OPGU@2A@?[+NMH;J%\M]OZ8JB3R_]D__ )%#7O\ K_3_ -%BO?*\
M#_9/_P"10U[_ *_T_P#18KWRD,**** .;\!_\B[=?]AG5?\ TX7%=)7-^ _^
M1=NO^PSJO_IPN*Z2@ HHHH **** "BBB@ HHHH **** "N#^(NB/_P (KXLU
M5IEV#0KL*GS;L_9Y 1G=C'0XQUYZ\UWE<W\1O^26>*_^P->?^B'H Z2N;\!_
M\B[=?]AG5?\ TX7%=)7-^ _^1=NO^PSJO_IPN* .DHHHH **** ,GQ5_R)VL
M_P#7C-_Z+-<5=:Q/H?A:^U%EN)A86DUPP2\\HS>4C'H(\ D*!GM7:^*O^1.U
MG_KPG_\ 19KSO6?^)MX'U>RL&@EFO+"ZA@S=PJ'9T<+R7XR2.30!ZEI[,^F6
MK.Q9FA0EB<DG:.:L55TPYTFTQ_SP3_T$5:H **** "BBB@ HHHH **** "BB
MB@ K%OP!X@M\#JT1/OS)6U6#K3M#J0F4J#&B.NY@,X+],D GD<4 :#7%Q=SO
M%9$111G:\[+DD^BC^IX]C4>GO.NL7UO-=27"1I$R>8%!&=V?N@>@JY91K%8P
MH@P-@./KS68;L6'B"^>9/EECBV'S$7.-V?O,/6@#0U/_ )!5U_UQ;^548KN4
MZHBF\9I&G>-[3"X2, [6QC<.BG)./G^F"[U:*YL;B&),NT3?\MXN.V3\_3)%
M2_VY;_W?_(\/_P 70!S'PC_Y$VZ_[#&H?^E4E;/CO4KO1_A_KNHZ;-Y%W:Z=
M<30R[0VQUB9E.""#R!UK%\ B7PYX<GL]1B432:C>7 $<\3#9)<.R'[W=2#^/
M/.15KQM<-KG@37=,L(=US=Z=<0PJTT0#.T3!1G?W) H Z8Q->VL+//+$&4,Z
MQ$#=D=,XR/P(J>&&.WA6*% B+T44VU!%G"",$1J"#]*EH **** "BBB@ K(\
M3?\ (%E_W7_]%O6O61XF_P"0++_NO_Z+>@#67[H^E+2+]T?2EH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K@M4_Y*U+_
M -@JP_\ 2\UWM<'J,7F_&!_WC*%TBS8JN,-_IK8!R/7GC% '>U1UO_D :A_U
MZR?^@FKU4=;_ .0!J'_7K)_Z": .=\)7,2^)-;M68B:2>615P>56>0$YZ<%E
M_.NPKS?1KUK/Q_?%8U;<MYEI&*HO^D \D*<5W$%[,+R&&6:VG$Z%U\@$%1ZX
MR<KVSQSCKG@ T*SXY!87TD$QVPW#[X&/"AC]Y/J3EAZ[CCI6A39(TFC:.9%D
M1A@JPR#^% &#JO\ R-EE_P!>I_\ 2B"LG4_+_MH;]VXWK;,'H?*;K^&:Z*XT
MRTMF2XB1A*)(XU+2,P53*A( )P!D#@>E<_J(<ZPWEXV_:V\S(Z#RST_''3_&
M@#>\,_\ ("3_ *[S_P#HYZNW7_'S9?\ 7<_^BWJEX9&-!0?]-I__ $<]7;K_
M (^;+_KN?_1;T 6:*Y;Q2JR^+/"$,JAXI+^<.C#*MBTF(R._(!K7D1]* FB=
MWLP?WL<C%C&/[ZD\X'<>G3&,$ TJ*S\2:G-)^]>*SC8H!$Q5I6!P3N'( (QQ
M@G![=<S28H[?QYK<,"+'&+"R8(HP,E[C)^IP.?:@#HZ**@O;H6=H\Y0OMP H
M.,DD #)Z<F@ NKZVL@ANI1'O.%R"?J?8#J3T'>I)IH[>!YIW5(T7<S,> *X*
MZN7OV>]O9BBD JRL4VCJ".X Z@=<\GG 5NDV>K>*"D%Q<F'1+=B&V*5DE8'[
MJD'Y<=#C[IR%P>(P"\RWGC;5!Y<LUIH=JY60I\K7+@XV@]1@@Y(QMZ#YLE.P
MM[>&TMH[>VB2*&)0D<:+A54#  '846]O#:6\=O:Q)##$H2..-0JJHX  '05)
M0 AJK)_R%K?_ *X2_P#H25:-59/^0M;_ /7"7_T)* +5%%% !1110 V1!+&R
M-T8$'C/\ZXNQT9-#^(>A6J7$MR3H^HLTLJH&8^;8+_"H'11VXZ= *[:N:O2#
M\5-#P<XT;4<^W[ZQH RM3T9M/\:^'+MY@YN]=D( W<#[#>D9RQ]<< #BNZKF
M_%'_ ",7@W_L,R?^F^[KI* "BBB@ HHHH **** "BBB@ KF_'G_(NVO_ &&=
M*_\ 3A;UTE<WX\_Y%VU_[#.E?^G"WH Z2BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH YOXC?\DL\5_\ 8&O/_1#UTE<W\1O^
M26>*_P#L#7G_ *(>NDH ^8-$_P"3VI_^OJX_])'KZ8NX&N(-J2F)@<AQV-?,
M^B?\GM3_ /7U<?\ I(]?26K-&M@QF=U3/(CZM[4 5+?6S'));W:-+)'QYD"[
M@W^!K5BE$T*R*& 89 88-9-OJEI96YA6UD@E7&V K\SYZ']*U8'>6W1Y8_+=
MADIZ4 25Q6J?#6'4=:;48/$VOZ<?-,\<%G-"(H792'9 T3$%LL3SR6-8?B'5
MM<M?$^J3PW%Q!I]MJ=K ;S[9B&T1HXF;?#L.Y26()R,;^< 9J*]\=:CJNEZH
MDFHZ?I<=G<Q1QW*R20)=1^8P,OG8;R8FV[ X#88-S@C)TO\ UT_S&TUH7I?@
MQ83X\[Q1X@D4)LVL;0J1Y9BP1]GP?D)'/UZ@&M&+X;-!8R6<?C#7_L\K1N\9
MCL2&,:HJ=;;L(T'OCG.37+V7CO4+.*U9-1B\B2-XS?7\XN+6W'G[1*9%*"5
M/E#DKGC)%6M,\:^)+YI-0BN=->UF6WAVK%(RAY'E021_/]WY58@YSZBC[-_D
M3S+FMU$D_9\\.3>3YNLZPS0,3&Y2SW*"NW;N^SYVX)PN< \@ \UT7@[X:VW@
MB=3I/B#6);7+L]E<&W,3EB3SMA##!;(VL/RXJ'3?$LVH?!E]1758;G5HM$\^
M>: @,DIA+ D G!R#^(/TK/O_ !UXAT^6[D$>GO9QW#VD7F02!T*PI(9G</AE
M&YL@*.%ZU37*VNW_  P77+%]]#TJHKGS_L[?9/+\[^'S<[?QQS6+X6\0Q:S9
M!)-6TW4;KYV$NGJR1S1AMH=59FXSQD,PST)K7OW,=C*ZW"VQ49\UEW!?P[U+
M&M3);3M2#F86FC-(#NR(6#$_7UJ#Q)>#4/ACK=R$V%]+N<J>Q$; _P J([V6
MXM991XB58XQ\Y-F%(ST[YYJ/75@7X5:R+59!%_9=SM\P88_NVY/UZTP/+/V3
M_P#D4->_Z_T_]%BO?*\#_9/_ .10U[_K_3_T6*]\I %%%% '-^ _^1=NO^PS
MJO\ Z<+BNDKF_ ?_ "+MU_V&=5_].%Q724 %%%% !1110 4444 %%%% !111
M0 5S?Q&_Y)9XK_[ UY_Z(>NDKF_B-_R2SQ7_ -@:\_\ 1#T =)7-^ _^1=NO
M^PSJO_IPN*Z2N;\!_P#(NW7_ &&=5_\ 3A<4 =)1110 4444 9/BK_D3M9_Z
M\)__ $6:J:%IUK=6+M/%O*L%7YB !L7@#/O5OQ5_R)NL_P#7A/\ ^BS4?A9G
M;26:1-CEU++G.T^6G&>] &PB+%&L<:A44!5 [ 4ZBB@ HHHH **** "BBB@
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M_?2@_A0!/]KU?_GRD_[]1_\ Q^H;Q]5O+&>V:SE59HVC)$47&1C_ )[UN44
M<;8:+J>GWU]?0Q2_:[H2!)#;QXBWN7.%^T8/)'7^Z*ECM?$T.[R9VCWG<VW3
M[<;CZG]_5KQ-XL/A[4K"T6T2Y-W'/*29]C*(DW85=I+DYZ<<9/;%<YHOQ5DU
M^&PETO2[.5+EU$O_ !,')AW.5 XA(W ;2RL5(+ <T;CM8Z.T;Q)#,6NGEN4V
MD;#:0I@\<Y$_U_.KOVO5_P#GRD_[]1__ !^N5TOXBZ[=ZC':ZCX#U:QW70@+
MA9)%5"H;S=WE!=HZ'YLYX /.-^^NH[HZ/<:@;RS@NLPM&LLL!29@"@<J5/56
M49X)8>HH\Q%EY]3FVK-8S% ZN0D<0)VL#U\X^E<])8ZEK%Y]NM8Y881<&5$:
MWC<\IMY/GCUSTKJ#H=KCB?4 ?7^T)^/_ !^K&G6$6F6*6MNTC(G1I7+L?J3U
MH Q--CUS3K%;983(%=VW&VC'WG+?\_'O46H2>*6O;&>TME>.*4^="T$:@J01
MO!\\G*Y/'0Y^E=3FC- ',3:=JVJ>)=$O+Q!#!IDTLY_<JN\M"\8'$K?W\].U
M=-(BRQM'(H96!#*1P0:7-&: *^G6GV#2[6S\PR^1$L9D/5\#&3]>M8UQ9:I:
M>*[W4;%!)#=VEO%CRE8JT;2D]94[2#UKH<T9H Q?M6N_\^O_ )+1_P#R1574
M)]8>U"W-OMB,L>X^0@_C7N)F_D:Z3-0W5LEY;F&4NJEE;*,5((((P1[B@#R_
M6I(I=!1%F^95+#RY"K K&Q!X.>" ?PKTA=&LXT5(?M$,:@*L<5U(B(!P %5@
M /85P7Q%MY(M3\,62WMY]GN]<MK>=#<,1(CQ7.Y3SR/E'Y5Z7F@"E_9%O_SU
MO/\ P-F_^*H_LBW_ .>MY_X&S?\ Q57<T9H I'2+;_GI>?\ @;-_\55632;?
M^U8!YEY_J9/^7V;^\G^U6O563_D+6_\ UPE_]"2@"/\ LBV_YZ7G_@;-_P#%
MT?V1;?\ /2\_\#9O_BZO44 4?[(MO^>EY_X&S?\ Q=']D6W_ #TO/_ V;_XN
MKU% %'^R+;_GI>?^!LW_ ,77-RZ3:V?Q;T:>W\U9)-(U!I&:9W,F);-1G<3G
M@_H/2NRKF[[_ )*GH7_8&U+_ -'V- !XH_Y&+P;_ -AF3_TWW==)7-^*/^1B
M\&_]AF3_ --]W724 %%%% !1110 4444 %%%% !7-^//^1=M?^PSI7_IPMZZ
M2N;\>?\ (NVO_89TK_TX6] '24444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% '-_$;_DEGBO\ [ UY_P"B'KI*YOXC?\DL\5_]
M@:\_]$/724 ?,&B?\GM3_P#7U<?^DCU](ZM!-/:*+>/S'60-MSC/!KYNT3_D
M]J?_ *^KC_TD>OI>]DN8K5FLHA++V4G% &9OO5U)KU]-Y\H1C,B\8))_G6O;
MRF:W21EVEAD@'./QKFFE%UJ%M%J=S+EV/F0.IC4#!Q]>?>NGBCCBB5(5"HHP
MH'0"@!U07MU'8V%Q=S!C'!&TC!!DD*,G ]>*YSQ)XAUW3-<@MM)T*:^LS:RO
M/=+$6$<I!\I0 06!*D-@'&Y<E>^7I'C37M8$-IJW@JY@CGE$%P\RRA"A"@MM
M:+&,LV58@;5)W'@$U>P]$]2S=^*=$\0:+%_:6GZE!;&(7-PQE$,EAAV4%VCD
M#J^Y&&$)(Q@XIVE>//!]E9-8V,L]M!9.ENL36DVXLR[@-NTON^\"& ;<#D=,
M\SK&M:OI?V0-\-8=6AAFDL_+M[+9Y>WYGF4D,!$P)P".2#S5[PIJ-IK>AM?S
M^!;&QU'[+]KLXQ:?\?)"]B8P%.=N,,W#+SG(#TLV@MJD_P"OZU-F'XA^%%U6
M)8#<"74(_,%Q]@E57"I*V&)4$$+$Y"GDCE0><=)HVLV'B#1K;5=(G^T65TF^
M&78R;ATSA@".G<5YAK6K7UH(H]/^'MKK-PL!"7ZZ++%''_#Y7E,I;!1I!D/C
MKD8.#=\-^-/%@TZQLC\/4LY'MC,RH9K6&)RZ#85\A@I)D+$ L<*Q/(Q1W_KN
M+KI_6W^9ZA6;K\;RZ).D4;2.=N%1<D_,.U8?A7Q;K6N:Y=V&J^&+K2X(8_,C
MO)0X21MV/+PR#D @Y!(/. ,$#<\02/%H<[Q,RL-N"IP?O"D^C!/6QDS2QW&N
M)=SZ3?/$D(4*;8_?!ZX^E6/%DWVCX<Z]*(Y(MVF7/R2KM8?NVZBK0U>\Q_R!
M[K\UJKXLE>?X<Z[))"T+-IESF-^H_=M1T$>1_LG_ /(H:]_U_I_Z+%>^5X'^
MR?\ \BAKW_7^G_HL5[Y0,**** .;\!_\B[=?]AG5?_3A<5TE<WX#_P"1=NO^
MPSJO_IPN*Z2@ HHHH **** "BBB@ HHHH **** "N;^(W_)+/%?_ &!KS_T0
M]=)7-_$;_DEGBO\ [ UY_P"B'H Z2N;\!_\ (NW7_89U7_TX7%=)7-^ _P#D
M7;K_ +#.J_\ IPN* .DHHHH **** ,GQ5_R)VL_]>$__ *+--\-?\@^3_KH/
M_0%IWBK_ )$[6>_^@S_^BS4?A==FELFYFVN!N8Y)_=IUH VJ*** "BBB@ HH
MHH **** "BBB@ HHHH *R-8\266A1M+J*RI;K-# TRJ&4/*X1!@'/5AVK7KD
M/&@#:8X(R#K6C@@_]?UO0!URL)(PRG*L,@UQVI^*=&T/4IM/GL/$;20D9>UL
M;R:-L@'(= 5/7GGKD5TNF2[;<6<I_?VP",#U8#@/]#U_3M5B'_63_P#73^@H
M \ZU7Q[HL;V6HF/Q%;6VGL\UP9M)OQA ,DL3'MV@ YR>*UV^*.C*,MIGB,#U
M.@W?_P ;J_\ $;_DEGBO_L#7G_HAZFUK5;.6SEMHY',GF; ?*8(S*1E0^-I(
MYX!['T.#R#S+2Z_:NBLB[E90RL)HB"",@_?[CFE_MVW_ .>9_P"_T7_Q=4_!
MO_(NP_[D7_HF.M^@#,_MVWR!Y9R2 /WT7)/_  .K5K?V]W9PW$<BA)HU=0S#
M(!&>:L,BNI5U#*>H(SFLY_#FB22,\FC:>[L<LS6J$D^N<4 :"R(^=C*V.N#F
MG5BZ9IMA#K4]QIEC;VL,49@W01*GFL2"W0<@;0,^NX=JVJ "BBB@ K(\3?\
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M0 4444 %%%% !1110!S?Q&_Y)9XK_P"P->?^B'KI*YOXC?\ )+/%?_8&O/\
MT0]=)0!\P:)_R>U/_P!?5Q_Z2/7TU<?:/*_T3R_,_P"FN<?I7S+HG_)[4_\
MU]7'_I(]?2FI,ZV3>7=+:D\>8PZ4 9.HW5^&6UFBL+N5^D"HS''J<]/K6U8Q
M-#8PQR(L;*H!5"2![#-8%FWV)6$.K6.YCEG9,LQ]SFNAMG,EK&[2)*2N2Z#
M;Z4 2T444 %%%% !1110 51UEX8](G>YB\Y !\FXC<<C'(]\5>JGJJP/I<RW
M>_R2/F* DCG@C\:!K<I2WVI-<0V4"VRW7E&64MN**,X %4O$=X;_ .&.N3LF
MQCIET&7/0B-@?Y5$E]:6\5Q)_:-S]IF"J;A[8_*H[ =/QI^O"W7X5ZR+(LT/
M]EW.UF&"W[MLD_C3)/*_V3_^10U[_K_3_P!%BO?*\#_9/_Y%#7O^O]/_ $6*
M]\I#"BBB@#F_ ?\ R+MU_P!AG5?_ $X7%=)7-^ _^1=NO^PSJO\ Z<+BNDH
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M/_1#UTE<W\1O^26>*_\ L#7G_HAZ .DKF_ ?_(NW7_89U7_TX7%=)7-^ _\
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M[J?X2,X] 1WF:S=>/_$GE^J_S%&P="EX-_Y%V'_<B_\ 1,=;]8'@W_D78?\
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MKR*Y^&6O:EJ.I:UIVI6EC+JQ28*7>01@,7"%2NTC<V3@ YR003QZ\>1S6?\
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MB2:=HJQ7Q%G(QLQ\X,S@-\N>/FK;M"K64)C78AC4JN<X&.E $U%%% !1110
M4444 %5]0%N=/F%[CR-AWY]*L53U6U>]TN:"+&]@"N>A(.<?I28UN9!CO1I(
MG74+PVI&/*%LOG!.G7/ISGTI/$@ME^&&LBQY@_LJXV'V\IOUJZ-:G\O8=)O?
M/Z;?+^3/^]TQ[UG:]:267PNUN&;'F?V9=,P7H"8W./UJB3RO]D__ )%#7O\
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M3?\ T??5/'_R4&?_ +!<?_HUZ -VBBB@#,UNPBOTM4N=.3488YM[PNB,/N,
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M *+NJ]%KR'Q5-<2Z[X-:YD>3/B2V'S^T4^/XCZGM7KU !1110 55D_Y"UO\
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MKP/]D_\ Y%#7O^O]/_18KWRD 4444 <WX#_Y%VZ_[#.J_P#IPN*Z2N;\!_\
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MEMYBC5"P&,X&,X[4Z::.WA:69@J+U-+--';PM+,P5%ZFL9$GUFZ\R3=%!&<
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MZ5H-JMSKFIV>FV[N(UEO+A849B"0H+$#. 3CV-9/_"QO!'_0Y>'_ /P:0?\
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M#+H>HO'(ARK*9K$@@^E $OBC_D8O!O\ V&9/_3?=UTE<WXH_Y&+P;_V&9/\
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M\P:)_P GM3_]?5Q_Z2/7T_0 4444 %%%% !1110 4444 %4]52WDTN87KM'
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M\1O^26>*_P#L#7G_ *(>@#I*YOP'_P B[=?]AG5?_3A<5TE<WX#_ .1=NO\
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MTSX-W+"R_P#'M+TV,3F@#T./_5)_NBG4V/\ U2?[HIU !1110 4444 %%%%
M!1110 5D>)O^0++_ +K_ /HMZUZR/$W_ "!9?]U__1;T :R_='TID\\=O"TL
MS;47J<9_ #N?:H;Z]&GZ>UPT;R;0 %09)).!^IK%L+6\U.X>6\F?87W,%;"Q
MG&-J>_8MVY ^8D@ LHL^LW6Z3=%;QL1@'!4]" 1U;L6'W>@YRPV8XTBC6.)0
MB*,*JC  HCC2*-8XE"(HPJJ, "G4 %%%8FN:Z++=;6A#7&!O;&1%GIQW8]E_
M^MD 37==%D&M;1O](P-[XW>5GIQW8]E_^L#@PZ7C6;33KDK#>7UK/=KN@$N$
MB>)6#OO!+$SJ> 1][GUVM#T,Q,+W4 3,3N2-SDH3U9CW<_IT%1WW_)4]"_[
MVI?^C[&@#/UG0KO2M-;4+2^A66U=)1BV(W8894D/T(X/UKJO+O\ _GYMO_ =
MO_BZJ>)HI)_#5['!&TDC(,(BDD\CH!4SW-Q>#R[**2%&X:XE3;M'^RIY)^H
M[\XP0#%70;G4[J[O)KZ$B2<JBM;D[ @"8&7X&5)_&I/^$3D_Y^[?_P !#_\
M%UT,$$=M;I#"NV.-0JC/05)0!@6^A:M:0"&VUWRXU+$*+12!EB>Y)[U(=*UP
MXQXB8<Y_X\X_R_SZ5MT4 <PGA*?#&;4(II&9G9WM>6))/9O>G?\ ")R?\_=O
M_P" A_\ BZZ6B@#FO^$3D_Y^[?\ \!#_ /%T?\(G)_S]V_\ X"'_ .+KI:*
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M+_Z$E %JBBB@ HHHH *YN^_Y*GH7_8&U+_T?8UTE<W??\E3T+_L#:E_Z/L:
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M,ZK_ .G"XKI* "BBB@ HHHH **** "BBB@ HHHH *YOXC?\ )+/%?_8&O/\
MT0]=)7-_$;_DEGBO_L#7G_HAZ .DKF_ ?_(NW7_89U7_ -.%Q725S?@/_D7;
MK_L,ZK_Z<+B@#I**** "BBB@#)\5?\B=K/\ UXS?^BS4?A:-8=):.,81'55'
MH!&E2>*N?!VL_P#7C/\ ^BS4?A=Q)I;. P#.#AA@C]VG4=J -JBBB@ HHHH
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MH_EZU?K)M-0L)+N>ZFO;??N,<>95X0=QSWZT#+5A/?S!OM]G'; ?=(FW%OP
MP/S-7*K1ZI83W2VL-];27#HTBQ),I=E4@,P&<X!903VW#UJS0 4444 %%%%
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M 4444 %%%% !1110 5S?Q&_Y)9XK_P"P->?^B'KI*YOXC?\ )+/%?_8&O/\
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M ,A4 ==17(_V]XQ_Z%K2/_!K=_\ R%1_;WC'_H6M(_\ !K=__(5 '745R/\
M;WC'_H6M(_\ !K=__(5']O>,?^A:TC_P:W?_ ,A4 ==28%<E_;WC'_H6M(_\
M&MW_ /(5']O>,?\ H6M(_P#!K=__ "%0 :T/^+L>&/\ L&:C_P"C+.NNKS6]
MO_$,_CK2KNZTW2;>]MM.O!:V8O[IOM(:6UWDN;0;0H Z!B2PX R1N?V]XQ_Z
M%K2/_!K=_P#R%0!UU%<C_;WC'_H6M(_\&MW_ /(5(=?\8JI)\-Z. !DG^U;O
M_P"0J .OHK+\/ZAJ.I6$DVK65K9S+,T:I:7;7",HP-VYHXR#G/&.@'/.!J4
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M!:HHHH **** "N;OO^2IZ%_V!M2_]'V-=)7-WW_)4]"_[ VI?^C[&@ \4?\
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MX3P3XEU./P_<"+P7KLZMJVI/N26R4 M?3DJ0UR#E2=IXQD'!(P3Z+7-^ _\
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M_P#)_P#^2:3^P_B=D_\ $Q\.8[<ZA_\ )%>DT4 >;'0_B=@XU#PX3VR=0_\
MDB@:'\3L<ZCX<S];_P#^2*])HH \V_L/XG9&-1\.>_.H?_)%+_8?Q-_Z"/AS
M_P G_P#Y)KTBB@#S;^P_B=WU'PY^>H?_ "12_P!A_$W_ *"/AS\[_P#^2*](
MHH \V&A_$['.H^',_74/_DBJU[X5^)-[;RPM?^& )UV2.8KMVQA@ -\S?WV]
M*]2HH \O_P"$;^):!?\ 3_##*#R%LY]V/;,H!_,5KW=CK$)A2.T$<TL@$+B9
M#M< N#R",?+6Q#'X@N/-N++6+4#[1*H@NK'>%57("@HZGH!R<_2K%M#K4VJ0
M/JL5@MO;JS+);S.69R-H&PK@#!/.X]>G>@-B+2M7U6_CGC%C:F6SE^SSLUTR
MAI JEB,1GCYJS]?&NWM]:V/V>W%O-&[-'#.')*XY.^,#'...YJ70=2M;6_UZ
M&27=.=4<B",;Y"#''SM'./?I6W9V\KW3WUXNR5UV1Q9!\E.N,C^(GDXXX YQ
MDG1/R7Y"[^K_ #.9&DZX% %K'@?[-O\ _$5-#:>)+<$0)Y0/4(8!G\DKKJ*!
MG*[/%?\ ?D_[[@_^(HV>*_[\G_?<'_Q%=510!RNSQ7_?D_[[@_\ B*-GBO\
MOR?]]P?_ !%=510!RNSQ7_?D_P"^X/\ XBGQ+XL6=&#1LHSN6X=-K<' ^1<]
M<5T]% &(9/$_.V#2SUQF23WQV_W?S/IS5N1XL>?*_9TCVX"VSKUR>3O4]MO3
MW^M=+10!RNSQ7_?D_P"^X/\ XBHKNR\27UC<6=V'D@N(FBD7S(AE6&#R%!Z5
MU]% '*^7XJ QODQ_OP__ !%'AO3X)[^\ENI!+=V%QY,D/)\F4QI)DL0-S%)$
M.1D#=@<YKJJYOPO_ ,C%XR_[#,?_ *;[2@#I**** "BBB@ KF[[_ )*GH7_8
M&U+_ -'V-=)7-WW_ "5/0O\ L#:E_P"C[&@#I**** "BBB@ HHHH **** "E
M%)0* %KS32=(O-4L,8F ^S1Q,EM<1CY2I(8[XSR0QX'3%>ED\5RW@<YL2X^Z
M]M;LI]1LH T_#\4L-M=)<1>3)]J9BFX-@$ CD=>"*GU1A/%_9Z<R70*,!_!'
MT=CZ<<#W(]Z>]K<>=*8+I8DF8,V(LN#M X)..W<&I;:TBM=Q3<TDG,DCG+.?
M<_TZ#M0!,:*#10 4444 %%%% !1110!R.M?\E8\+_P#8,U'_ -&6===7(ZU_
MR5CPO_V#-1_]&6===0 5'<?\>LO^X?Y5)4=Q_P >LO\ N'^5 &?X?_Y!K?\
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MH **** "BBB@ KF_B-_R2SQ7_P!@:\_]$/725S?Q&_Y)9XK_ .P->?\ HAZ
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MBO?"MWDN5\VSN[>6(#^]EWC;'_ <U8N/$=G9[/MT5W;!NK26SE5^K $?K]:
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MO_V#-1_]&6===7(ZU_R5CPO_ -@S4?\ T99UUK<J<>E)[ <)?^.O%%NFZQ\
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MH **** "BBB@ HHHH **** "BBB@#F_B-_R2SQ7_ -@:\_\ 1#UTE<W\1O\
MDEGBO_L#7G_HAZZ2@#Y@T3_D]J?_ *^KC_TD>OI^OF#1/^3VI_\ KZN/_21Z
M^GZ "BBB@ HHHH **** "BBB@ HHHH *Q/&O_(@^(/\ L&7/_HIJVZQ/&O\
MR(/B#_L&7/\ Z*:@#Q[]D_\ Y%#7O^O]/_18KWRO _V3_P#D4->_Z_T_]%BO
M?* "BBB@#F_ ?_(NW7_89U7_ -.%Q725S?@/_D7;K_L,ZK_Z<+BNDH ****
M"BBB@ HHHH **** "BBB@ KF_B-_R2SQ7_V!KS_T0]=)7-_$;_DEGBO_ + U
MY_Z(>@#9NM-M[RZ@N)C-OM\E D[HIY!^95(#<J.H/?U-8W@/_D7;K_L,ZK_Z
M<+BNDKF_ ?\ R+MU_P!AG5?_ $X7% '24444 %%%% !7-_#G_DEGA3_L#6?_
M *(2NDKF_AS_ ,DL\*?]@:S_ /1"4 =)1110 4444 %%%% !1110!!=65K?1
M^7>VT-RG]V:,./R-9_\ PBFA+;^3;Z5:VJ 8'V2,0$?0I@BM>B@#"L_"L6G1
M^7IVJZM!&/N*]XT^WG/67>3R>^?RIKZ+KT$>;#Q5-++N)_XF5E#,F/3;$(C_
M ./5OT4 9Y;688E CL;R3^)][VX_!<2?SINB:?/86L_VM]TUQ<23L!(75-QX
M4$@$@#';UK2HH **** "BBB@ HHHH **** "BBB@ HHHH **** "N;\+_P#(
MQ>,O^PS'_P"F^TKI*YOPO_R,7C+_ +#,?_IOM* .DHHHH **** "N;OO^2IZ
M%_V!M2_]'V-=)7-WW_)4]"_[ VI?^C[&@#I**** "BBB@ HHHH **** "BBB
M@!#]T_2N6\"?\@>#_KRMO_0#74G[I^E>5Z5K&JZ5X7-W;6P\R*Q3#+=+L8)'
MN7*,A.?FYP1G]:.MAV/5:*I:7JD6J0.\221M&^QTD7!!P#_6KM!*=U<****!
MA1110 4444 %%%(3@$T; <EK7_)6/"__ &#-1_\ 1EG775Y3=:YXFOO%FB:T
M^BZ/ UK83C[.=5N')6=XB"66T.,?9R,<YSU&.=L>,O%#3>7'X=T9CL9P?[9N
M%R%4D];,>E '=T5%;-.]K$UY''%<% 98XI"Z(V.0K$*6 /0D#/H.E2T %4[N
MP,\RW%M.]M<J-HD0 AAG.UE/##\B,G!&35RB@#SWQ'I]Y:^)O#-S?S0RO=>(
MHB#"A0?+8W*_=)..GJ:]"KD?''_(9\%?]C /_2.YKKJ (+Z-YM/N(HQN=XF5
M1GJ2*A-S=>:"+*81XY7$>2?KO_I5VB@"O8H\=KB5"C-([[20< N2.GL:L45F
MZUK$6E6DG/\ I+0R20H8W8,47/.T' Z4 <9\2?\ D8_!_P#V,5E_Z+NJ]%KR
MCQAJ,M_KG@YKGR=Q\26HS"LH  BN,<.@_O'O^%>KT %%%% !563_ )"UO_UP
ME_\ 0DJU563_ )"UO_UPE_\ 0DH M4444 %%%% !7-WW_)4]"_[ VI?^C[&N
MDKF[[_DJ>A?]@;4O_1]C0 >*/^1B\&_]AF3_ --]W725S?BC_D8O!O\ V&9/
M_3?=UTE !1110 4444 %%%% !1110 5S?CS_ )%VU_[#.E?^G"WKI*YOQY_R
M+MK_ -AG2O\ TX6] '24444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% '-_$;_DEGBO_L#7G_HAZZ2N;^(W_)+/%?\ V!KS_P!$
M/724 >&)\-/%&D?M"7/C]+!+_3!-)(EM:W$8N) \)C&!(57@MDY8< XR< ^G
M_P#"4:O_ -")X@_[_P"G_P#R56KJ]Y>6EM&-,M8+J\FD\N&*XG,,9."QW.$<
MCY5;HIR<#C.1E?;O&_\ T+WA_P#\'T__ ,AT '_"4:O_ -")X@_[_P"G_P#R
M51_PE&K_ /0B>(/^_P#I_P#\E5#<:OXTMS"'\.Z"?.D$:XUV;@D$\_Z)[5-]
MN\;_ /0O>'__  ?3_P#R'0 ?\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_
M +_Z?_\ )5'V[QO_ -"]X?\ _!]/_P#(=0C5_&AO3:_\([H.\1B3/]NS8P21
M_P ^GM0!-_PE&K_]")X@_P"_^G__ "51_P )1J__ $(GB#_O_I__ ,E4?;O&
M_P#T+WA__P 'T_\ \AT?;O&__0O>'_\ P?3_ /R'0 ?\)1J__0B>(/\ O_I_
M_P E4?\ "4:O_P!")X@_[_Z?_P#)5'V[QO\ ]"]X?_\ !]/_ /(='V[QO_T+
MWA__ ,'T_P#\AT '_"4:O_T(GB#_ +_Z?_\ )5'_  E&K_\ 0B>(/^_^G_\
MR51]N\;_ /0O>'__  ?3_P#R'1]N\;_]"]X?_P#!]/\ _(= !_PE&K_]")X@
M_P"_^G__ "56=XAUC7-6\,:IIUMX&UU9KRSE@C:2XL H9T*@G%R3C)]*T?MW
MC?\ Z%[P_P#^#Z?_ .0ZAN]7\:V=G-<R^'=!*0QM(P77ILD 9./]$H Y+X!^
M -=\ >&=1MO$D4,,]Y<),D<<HD*#8 0Q'&0?0D>]>KU%;-.]I$UW''%<% 98
MXI"Z*V.0K$*6 /0D#/H.E2T %%%% '-^ _\ D7;K_L,ZK_Z<+BNDKF_ ?_(N
MW7_89U7_ -.%Q724 %%%% !1110 4444 %%%% !1110 5Q_Q7O+BS^%OB#[-
MIT]\LVG7,,I@= 8$:!_WK!F&5!QD+EL'(!Q7844 <P_BK6=F8O >O,<CAKFP
M QGG_EY/;/\ ]:N?\"^*-2;PU*]OX+UZ>.35-1D#+)9)C=>S,5*O<*P9<[3Q
MU!QD8)]'HH YO_A*-7_Z$3Q!_P!_]/\ _DJC_A*-7_Z$3Q!_W_T__P"2JZ2B
M@#F_^$HU?_H1/$'_ '_T_P#^2J/^$HU?_H1/$'_?_3__ )*KI** .;_X2C5_
M^A$\0?\ ?_3_ /Y*KG_ /B/5(/AOX:BB\&:Y<I'I-JJS136(20"%0&7=<AL'
MJ,@'U KT2N;^'/\ R2SPI_V!K/\ ]$)0 ?\ "4:O_P!")X@_[_Z?_P#)5'_"
M4:O_ -")X@_[_P"G_P#R57244 <W_P )1J__ $(GB#_O_I__ ,E4?\)1J_\
MT(GB#_O_ *?_ /)5=)10!S?_  E&K_\ 0B>(/^_^G_\ R51_PE&K_P#0B>(/
M^_\ I_\ \E5TE% '-_\ "4:O_P!")X@_[_Z?_P#)5'_"4:O_ -")X@_[_P"G
M_P#R57244 <W_P )1J__ $(GB#_O_I__ ,E4?\)1J_\ T(GB#_O_ *?_ /)5
M=)10!S?_  E&K_\ 0B>(/^_^G_\ R51_PE&K_P#0B>(/^_\ I_\ \E5TE% '
M-_\ "4:O_P!")X@_[_Z?_P#)5'_"4:O_ -")X@_[_P"G_P#R57244 <W_P )
M1J__ $(GB#_O_I__ ,E4?\)1J_\ T(GB#_O_ *?_ /)5=)10!S?_  E&K_\
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M2F35HV9$FL<Q'[#:C:V;D#. &^7(PPYSD#T2N;\+_P#(Q>,O^PS'_P"F^TH
M/^$HU?\ Z$3Q!_W_ -/_ /DJC_A*-7_Z$3Q!_P!_]/\ _DJNDHH YO\ X2C5
M_P#H1/$'_?\ T_\ ^2J/^$HU?_H1/$'_ '_T_P#^2JZ2B@#F_P#A*-7_ .A$
M\0?]_P#3_P#Y*KG[SQ'JA^)&C2GP9KBNNDWZB$S6.]P9K,EA_I.W V@')!^8
M8!YQZ)7-WW_)4]"_[ VI?^C[&@ _X2C5_P#H1/$'_?\ T_\ ^2J/^$HU?_H1
M/$'_ '_T_P#^2JZ2B@#F_P#A*-7_ .A$\0?]_P#3_P#Y*H_X2C5_^A$\0?\
M?_3_ /Y*KI** .;_ .$HU?\ Z$3Q!_W_ -/_ /DJC_A*-7_Z$3Q!_P!_]/\
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M'KI* .;_ .$HU?\ Z$3Q!_W_ -/_ /DJC_A*-7_Z$3Q!_P!_]/\ _DJNDHH
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M$CU=B@>XLMTKM972A% N" ?FSEB!A3WP#Z1110 4444 %%%% !1110 4444
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MHH **** "BBB@ HHHH **** .;^(W_)+/%?_ &!KS_T0]=)7-_$;_DEGBO\
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M ((9_P#Y,H^W>-_^A>\/_P#@^G_^0Z/MWC?_ *%[P_\ ^#Z?_P"0Z #X<_\
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MZ7Q7H9MX])OXWE&I0[%9IK,JI.[ )",0.^T^AH Z#_A/-(_Y\_$'_A.:A_\
M&*/^$\TC_GS\0?\ A.:A_P#&*/\ A8W@C_H<O#__ (-(/_BJ/^%C>"/^AR\/
M_P#@T@_^*H /^$\TC_GS\0?^$YJ'_P 8H_X3S2/^?/Q!_P"$YJ'_ ,8H_P"%
MC>"/^AR\/_\ @T@_^*H_X6-X(_Z'+P__ .#2#_XJ@ _X3S2/^?/Q!_X3FH?_
M !BC_A/-(_Y\_$'_ (3FH?\ QBC_ (6-X(_Z'+P__P"#2#_XJC_A8W@C_H<O
M#_\ X-(/_BJ #_A/-(_Y\_$'_A.:A_\ &*/^$\TC_GS\0?\ A.:A_P#&*/\
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M1\KK"58>A!(/4&@#H/\ A*-7_P"A$\0?]_\ 3_\ Y*H_X2C5_P#H1/$'_?\
MT_\ ^2J/^$\TC_GS\0?^$YJ'_P 8H_X3S2/^?/Q!_P"$YJ'_ ,8H /\ A*-7
M_P"A$\0?]_\ 3_\ Y*H_X2C5_P#H1/$'_?\ T_\ ^2J/^$\TC_GS\0?^$YJ'
M_P 8H_X3S2/^?/Q!_P"$YJ'_ ,8H /\ A*-7_P"A$\0?]_\ 3_\ Y*H_X2C5
M_P#H1/$'_?\ T_\ ^2J/^$\TC_GS\0?^$YJ'_P 8H_X3S2/^?/Q!_P"$YJ'_
M ,8H /\ A*-7_P"A$\0?]_\ 3_\ Y*H_X2C5_P#H1/$'_?\ T_\ ^2J/^$\T
MC_GS\0?^$YJ'_P 8H_X3S2/^?/Q!_P"$YJ'_ ,8H /\ A*-7_P"A$\0?]_\
M3_\ Y*H_X2C5_P#H1/$'_?\ T_\ ^2J/^$\TC_GS\0?^$YJ'_P 8H_X3S2/^
M?/Q!_P"$YJ'_ ,8H /\ A*-7_P"A$\0?]_\ 3_\ Y*H_X2C5_P#H1/$'_?\
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M ,E4?\)YI'_/GX@_\)S4/_C%'_">:1_SY^(/_"<U#_XQ0 ?\)1J__0B>(/\
MO_I__P E4?\ "4:O_P!")X@_[_Z?_P#)5'_">:1_SY^(/_"<U#_XQ1_PGFD?
M\^?B#_PG-0_^,4 '_"4:O_T(GB#_ +_Z?_\ )5'_  E&K_\ 0B>(/^_^G_\
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MC_GS\0?^$YJ'_P 8H_X3S2/^?/Q!_P"$YJ'_ ,8H /\ A*-7_P"A$\0?]_\
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MS$$KG[3TR.E;?_">:1_SY^(/_"<U#_XQ1_PGFD?\^?B#_P )S4/_ (Q0 ?\
M"4:O_P!")X@_[_Z?_P#)5'_"4:O_ -")X@_[_P"G_P#R51_PGFD?\^?B#_PG
M-0_^,4?\)YI'_/GX@_\ "<U#_P",4 '_  E&K_\ 0B>(/^_^G_\ R51_PE&K
M_P#0B>(/^_\ I_\ \E4?\)YI'_/GX@_\)S4/_C%'_">:1_SY^(/_  G-0_\
MC% !_P )1J__ $(GB#_O_I__ ,E4?\)1J_\ T(GB#_O_ *?_ /)5'_">:1_S
MY^(/_"<U#_XQ1_PGFD?\^?B#_P )S4/_ (Q0 ?\ "4:O_P!")X@_[_Z?_P#)
M5'_"4:O_ -")X@_[_P"G_P#R51_PGFD?\^?B#_PG-0_^,4?\)YI'_/GX@_\
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M0#U#_A*-7_Z$3Q!_W_T__P"2JSKGQ)X@?7K%H?!>MQ0)%*94,M@SR@[0 /\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M .A[\0?]^-/_ /D6C_A%]7_Z'OQ!_P!^-/\ _D6C[#XW_P"AA\/_ /@AG_\
MDRC[#XW_ .AA\/\ _@AG_P#DR@ _X1?5_P#H>_$'_?C3_P#Y%H_X1?5_^A[\
M0?\ ?C3_ /Y%H^P^-_\ H8?#_P#X(9__ ),H^P^-_P#H8?#_ /X(9_\ Y,H
M/AS_ ,DL\*?]@:S_ /1"5TE<W\.?^26>%/\ L#6?_HA*Z2@ HHHH YOP'_R+
MMU_V&=5_].%Q725S?@/_ )%VZ_[#.J_^G"XKI* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YOQY_R+MK_P!AG2O_ $X6
M]=)7-^//^1=M?^PSI7_IPMZ .DHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** .;^(W_)+/%?_ &!KS_T0]=)7-_$;_DEGBO\
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MD?9_L'DI]E^R[?*\K:-FS;QMVXQCC&,59H **** .;\!_P#(NW7_ &&=5_\
M3A<5TE<WX#_Y%VZ_[#.J_P#IPN*Z2@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "N;\>?\B[:_]AG2O_3A;UTE<WX\_P"1
M=M?^PSI7_IPMZ .DHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** .;^(W_ "2SQ7_V!KS_ -$/725S?Q&_Y)9XK_[ UY_Z(>ND
MH YOQY_R+MK_ -AG2O\ TX6]5_$VI^,[>[N$\*Z);744=N&BDN70"6;/W?\
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MG_8&L_\ T0E=)0 4444 <WX#_P"1=NO^PSJO_IPN*Z2N;\!_\B[=?]AG5?\
MTX7%=)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_"4:O_T(GB#_ +_Z?_\ )5'_  E&K_\ 0B>(/^_^G_\ R50!K>=JG_/C:_\
M@6W_ ,;I1-JFX;K*U SR1=-_\;K(_P"$HU?_ *$3Q!_W_P!/_P#DJC_A*-7_
M .A$\0?]_P#3_P#Y*H L^"M/NM(\ ^']-U"+R;NSTRV@GCW!MCI$JL,@D'!!
MY!Q6W5'1=5@UW0-/U>S21+?4+6.ZB64 .JNH8!@"1G!YP35Z@ HHHH YOP'_
M ,B[=?\ 89U7_P!.%Q725S?@/_D7;K_L,ZK_ .G"XKI* "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3,J(@+,[' 4#J<]JRIE*Z9'&5(=]04JA'+ 7&[@>FT$_09H UJ*** "BBB@
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M *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\
M^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3
M*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\
MZ&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^
M"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3*
M .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L
M/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'
MP_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?
M_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/
MC?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P
M_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_
M .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DH
MKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_
M *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\
M^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3
M*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\
MZ&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^
M"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3*
M .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L
M/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'
MP_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?
M_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/
MC?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P
M_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_
M .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DH
MKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_
M *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\
M^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3
M*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\
MZ&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^
M"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3*
M .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L
M/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'
MP_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?
M_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/
MC?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P
M_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_
M .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DH
MKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_
M *&'P_\ ^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\
M^"&?_P"3*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3
M*/L/C?\ Z&'P_P#^"&?_ .3* .DHKF_L/C?_ *&'P_\ ^"&?_P"3*/L/C?\
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M /@AG_\ DRC[#XW_ .AA\/\ _@AG_P#DR@#I**YO[#XW_P"AA\/_ /@AG_\
MDRC[#XW_ .AA\/\ _@AG_P#DR@#I**YO[#XW_P"AA\/_ /@AG_\ DRC[#XW_
M .AA\/\ _@AG_P#DR@#I**YO[#XW_P"AA\/_ /@AG_\ DRC[#XW_ .AA\/\
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ME%<W_P (OJ__ $/?B#_OQI__ ,BT?\(OJ_\ T/?B#_OQI_\ \BT =)17-_\
M"+ZO_P!#WX@_[\:?_P#(M'_"+ZO_ -#WX@_[\:?_ /(M '245S?_  B^K_\
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MY!Z$5SG_  B^K_\ 0]^(/^_&G_\ R+4<'A+5H+>.)?'6O (H4!;>P X_[=:
M.HHKF_\ A%]7_P"A[\0?]^-/_P#D6C_A%]7_ .A[\0?]^-/_ /D6@#I**YO_
M (1?5_\ H>_$'_?C3_\ Y%H_X1?5_P#H>_$'_?C3_P#Y%H Z2BN;_P"$7U?_
M *'OQ!_WXT__ .1:/^$7U?\ Z'OQ!_WXT_\ ^1: .DHKF_\ A%]7_P"A[\0?
M]^-/_P#D6C_A%]7_ .A[\0?]^-/_ /D6@#I**YO_ (1?5_\ H>_$'_?C3_\
MY%H_X1?5_P#H>_$'_?C3_P#Y%H Z2BN;_P"$7U?_ *'OQ!_WXT__ .1:/^$7
MU?\ Z'OQ!_WXT_\ ^1: .DHKF_\ A%]7_P"A[\0?]^-/_P#D6C_A%]7_ .A[
M\0?]^-/_ /D6@#I**YO_ (1?5_\ H>_$'_?C3_\ Y%H_X1?5_P#H>_$'_?C3
M_P#Y%H Z2BN;_P"$7U?_ *'OQ!_WXT__ .1:/^$7U?\ Z'OQ!_WXT_\ ^1:
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M_P"1:/\ A%]7_P"A[\0?]^-/_P#D6@#I**YO_A%]7_Z'OQ!_WXT__P"1:/\
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M2BN;_P"$7U?_ *'OQ!_WXT__ .1:/^$7U?\ Z'OQ!_WXT_\ ^1: .DHKF_\
MA%]7_P"A[\0?]^-/_P#D6C_A%]7_ .A[\0?]^-/_ /D6@#I**YO_ (1?5_\
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M):M))$Q\=:\3&VX9M[#C@CC_ $7WI+16!ZG445S?_"+ZO_T/?B#_ +\:?_\
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M#WX@_P"_&G__ "+1_P (OJ__ $/?B#_OQI__ ,BT =)17-_\(OJ__0]^(/\
MOQI__P BT?\ "+ZO_P!#WX@_[\:?_P#(M '245S?_"+ZO_T/?B#_ +\:?_\
M(M'_  B^K_\ 0]^(/^_&G_\ R+0!TE%<W_PB^K_]#WX@_P"_&G__ "+1_P (
MOJ__ $/?B#_OQI__ ,BT 'Q&_P"26>*_^P->?^B'KI*XGQ'X'UO5_"NJZ;!X
MVUB:6\LIH$CNHK)8G+H5 <I;!@ISR5.<9QS76Z?:S65A';W-_<:A*F=US<K&
M)'R2>1&JKQG'"C@=SS0!B>//^1=M?^PSI7_IPMZZ2LW7]%C\0:0UA+=7%I^^
MAG2>VV>9&\4J2H1O5E^\B\$$8K-_X1?5_P#H>_$'_?C3_P#Y%H Z2BN;_P"$
M7U?_ *'OQ!_WXT__ .1:/^$7U?\ Z'OQ!_WXT_\ ^1: .DHKF_\ A%]7_P"A
M[\0?]^-/_P#D6C_A%]7_ .A[\0?]^-/_ /D6@#I**YO_ (1?5_\ H>_$'_?C
M3_\ Y%H_X1?5_P#H>_$'_?C3_P#Y%H Z2BN;_P"$7U?_ *'OQ!_WXT__ .1:
M/^$7U?\ Z'OQ!_WXT_\ ^1: .DHKF_\ A%]7_P"A[\0?]^-/_P#D6C_A%]7_
M .A[\0?]^-/_ /D6@#I**YO_ (1?5_\ H>_$'_?C3_\ Y%H_X1?5_P#H>_$'
M_?C3_P#Y%H /AS_R2SPI_P!@:S_]$)7251T72H-"T#3](LVD>WT^UCM8FE(+
MLJ*%!8@ 9P.< 5>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
0* "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>img75493150_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img75493150_0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0+T17AI9@  34T *@    @ ! $[  (
M   .   !2H=I  0    !   !6)R=  $    <   "T.H<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M57!E;F1E<B!+=6UA<@  !9 #  (    4   "II $  (    4   "NI*1  (
M   #-#   )*2  (    #-#   .H<  <   $,   !F@     <Z@    $
M
M
M
M
M
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\  $0@
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<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>img75493150_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img75493150_1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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ME)6CL],9-SA&1U>6I$A89H6EP\34XBF$EV=WIM7R_\0 ' $!  ,  P$!
M          $" P0%!@<(_\0 /A$!  $# P(#!0,*!@$%      $" Q$2(3$$
M!08B01,4,D)1!U)A%18C,T-3<7*!D1<D-&*AT:(E-8+2X?_:  P# 0 "$0,1
M #\ ^J:(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B"@=3:WX<_>7
M4ZF<]T9=(YPC=O:<X)/R/;R5PB B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@
M(B("(B B(@(B("(B B(@H,K6MW/.T?55;AG"CH\5-/V34%;HB^"X17&C9'*R
M>HI7"EJ6/;D.CE&6XSO;X]O>-_H 3EMDOL-YI!.(Y!^( _P*,]4O91$1H(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B(-?M5:)OM'Q<KM;W1[[E9*Z)C:*GR]PH.A3&)S&@G
M:UI>Z1XVAN2\Y4F<,#++I6*KGIY8G2?<>,/'XA9>^!LC'QR11O:00&D=N_FN
M8X6P,<R!C&#[H'8!%=,.U$1%A$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1=77&-W3>  '$D8P._GG\%VH"(B B(@(B("(B B(@(
MB("(B B(@(N-P7* B(@(B("(B B(@(B("(B B(@(B("(B BXW!<H"(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("+K\7S78@(B("(B B(@(B("(B B(@(B("(B B(
M@(B("(B B(@(B("(B O,KKY;+6:5MRK8Z5U<\14S93ATLA\HVCS<[Y =SZ97
MIK$]9\+M"\08Z6+66F:&[-HY3-"VJCZC6//F=A\+@?5K@6GU!08SH+C'IG6#
M;XZHOMAAAMNJ7V&AFAO#9&5993Q3QX<[:'2N9)DL;GL-P+F^)9E:M;:3OG3-
MEU+:Z\2,9)FFK8I,1OCZK'G:X^%S/$#ZCOY=UKUP)X9< -92\3(H>%^EJJDL
MW$.OLDD518[=)%#)%3TL<E.QC*=H;%U.^UQ>XN[ND<[LI&;RE<N!ZG6X(:.E
MZU5-7>_MT<_0GFEZDQAZC3TVO=V<UNUKFC:6[?"@SBX<0]%6IU(VZ:OM%)[?
MU/8S/71L%3TVES^ED^/#6O)QGX'?)>C0ZBLUTZYM=SIJP4LAAF=!,R0,EQGI
MG!^/!SA1RWE-Y;8C4"'@1H5D567=:!MFA; _<(L@Q!NSL:>(M[>!P+FX<7%U
MI<.37E;N=-34M3P$T,QE(WIQ]"R4T1+.GT\.+&#=X?4Y.?5!*U'=Z"XQLFH*
MJ.HC>7!KXGM<TEI<#W!^;2,^65<&H ?L+7]W!K3CLXG)[?/ !*B'4G*%P!UA
M7_:.I- 4]7(*9E)&P5U7%#!"R1TD;(88Y6Q1;7.\V,!/JO"'(9RP#$G\G]PZ
MH]H:QYU5=NI VI9)'4MBE]HWQLE9*\/C86L=VR/5!/+JV!C6O?(6-?Y%S' >
M>/4?[]OF%2ZNC;GP2'&1W;MR[.-HSC<3WQC/E]1F"OYB/+,:2FH9-"W":*E(
M.9M375YGQ$8AULU/O=C"6LW9V-):W:TD&J'D>X 4=9]HVZQZFI*B5H94NIM<
M7N%]5AP+7S2MJNI*]@'A)=WPW/PLV!.[)VO (R//.?3'S_W]1G"X$Y<<-WGZ
MX/R_>H/')#R[,HG6UFE;W[$\2B2D.KKQT)^K^GZL?M.V3JX;OW [NG'G.QN.
MJ;D>Y?JFM=<*JRZIFG+H"'G7-[;@0QR0PX JOZN":6%GZL;G-& ]V0G05<3G
M]*-Q>_."&M)Q^/T^OEW""IR0T%VXM#L$$8^F3VS],Y[%0_>>3W@=J*I-;?;;
MJVMJ'4WL<D\VN[\Z:>'SVRR&LWR=]O=Q)]W%^HW%I9.2[@58JRTW:AMFJ([G
M8X>C058UK>M\(/Q=FU36X?XM[0T-?U)=P.]V0FU]5"QKGND[,QN\)R,G [81
ME5"]SVMF;F/XN_P^?^P_N*@JAY(. E"^BJXK?JMM=1 _TR+6MZAFF]YUF[Y&
M50>=D_OF=_!)XFX*]:KY3.%-;6BY3UNOGUK/@K).(=_EG9VD^![ZPNC_ $K_
M ('#T02T+C3D@;_BD,;,$$.Q\3@0?(>I]/+S[+M$[3D#)+0-X[>$_(_7\%"6
MGN3CA1IG/V7=^(<,1N+;D*:/B#>F1Q2"+I-:TLJ6G:QOD3XCY.<6^%5VWD\X
M7V9U#'9M3\4+?26ZA]@I:*EXDWZ*GA9^LP"JW,=]&N#?H@F@50<2&N)(..WK
MZ?L[@CO\OP5;97.:'=)P)P=N6YP?7S4,LY2.',73Z>K^*7]%(-%NXCWP^Q^.
M4^[_ *5W]W,^'Q9]W@>9<YUA2\F7#V!^RJXB<7:VC$#*;V&;B-=V4^QO]F*=
MCL_Z2"=75$;21W);W<!W('S[>BI]JC#'R.<6AF=V1W;VSD_+MW_[>RB&HY4]
M 5]#4VVZZNXGW""K.Z1E7Q(OLK/[@C-5LV_L5$/*QI2-]PGJ.(G%FKGKZB:I
M;++Q)O<?LKI2260,BJ&1,:UV'-RQWR\D$Q-F+L_'VW9&T_=.#Z?N^?HAJ&MP
M2'AKAV=L.,YQC\<J#&<H]GIZ"@IZ+C9QDAJJ$U/]+DUQ5U4DPF@Z1WMJ>I%X
M/C9[OPN732<IE? ^MD=S/<<6"NAZ1B9JIDC(3U.IN9U8'8=OP?[ONOT/ND$Z
MNK1'*R&4.C,LAC87X <1GR_=V]3^PX"OA+0]Q<S<\L\32,8&23\A@9[^7D>_
M90=#RO7LTSJ2JYD>+0:RKJW0RT]_,<OL4V,4TKBUW4+-D>R8;96[7>+WDF^W
M_FG:CJ*6EAK^;CCJY]&RF$#J>]T$&Q\,>P%VRB!FR.[NKOZA\4F]_C03[[2T
M .<' .. 2WS\AY>8[D#![Y]%5U<$@Y!!P<X'^_F/WJ!_YNG$/V:M?_.HXGFX
M72F#*NH,EOZ39NC,S?!![+TX(]TP?TV!O>)GC[+JJ>574C355-KYI.,D-9)3
M[(I9[U2RQMD\'BZ9I<8]TWU]2@GSJOW!HC<>Y!.6X;CRSW]?3'\%0:QC=N0[
M+@2UH&22#C ^O^'KA0K4<M.JJMM)U.:KC+":&21\/1KK2 _=Y";_ (/]_M].
MIN7G4?*UJ&AK7S1<S'%B6".JHJFGCJ;E33DF"#HO;-U(#U!)\;L;=[OCWH)Y
M]O@P'%S@PQ]3J;3LQW/9WD>S2>V>W?R(78:@-)#FN&&EV2,# ]>_^X]<9"@6
MBY6M46Z\4MQIN:?C'-!''*VIAJ[Q2U!J'.,):<OIBV+#H 3TVM[/E9\$KVE)
MRL:BJ#5=7FEXS4_5JFS1^QWJECVQLZG3C[TKNS>M)G_.9;U-_3BV!.[:QCW[
M(VO>2<=@/D3G^!'[O0@JYZHP#M/<X&,>7S_!:\R<KNM649M=)S7\8"33.H>O
M45UOD/L[W->YV11B3K-D#G1S=3>T%K"71MV)4<MW%>&B=3V'F_XFTLE<WIW!
M];#;:P!G2QFD)IFR4SM_?](_]Z"?C61-_2.##DC#G#RR!GS\CD'\%6V8.!<#
MX0<;AW'\/+]J@BX\M&K:YQF_G1<7>H9H)<,K[?3-S&&,W?T>BC[EC3X?T9/Q
MLD2[< ^,U934M)1<W.NVL-/+'<#56BT/,SW8VF+I4L71QW_6]$$[>TQ9 +\%
MP!';L<@GL?(]@?+Y+AU7"QG4=)AGA\6#M\7EW\O_ %(^:@L<OW%=UPWR<VG$
M/V&GJ&/HVBVV,U#(Q!(S$DIH,3'?*X^-I& WU5%HY>^+%MTX=,U'-QQ#JJ<T
MQCZSK9:#4F5_M74=UI*5\F'=:GP=V]O0=A_O/ $\]=F[9N[X+B/4#YX\_E^\
M+AM0UP#ONN\CD$')PWR/KGM_T*!!P-YAFFLJ&\Y>J1.:GK6^/\T[,*:"/W6(
MY8^ANE&&S?"Z/](S]1W4YK^#W-"][HK5S<OAIX\FF]HT+;9G=VR?I<;=^UQC
MQLZ?8']H3W[1'\^^_86Y&1XL9Q\E3[7&<N:26@X<XX&,#)R#@]A]% 5#P?YI
M:;VD2\W K-\<(A]HT+0LC8]K\O/3B>P]Q_;7#N%?-C2FKHZ+F@M572U9@,=3
M7Z,A-71ECJ8/Z?2E9$[='%4YRP>*H^@*"?A5,+0X;B#)TNPSXMV.^/(>O?T5
M?M<0#W'(:PX<3]T_(CSR>V/Q"U[J>$7-A5FN#>;"W4HF>64Q.@*.H--'T(F[
MH<RLZ;^JV0XDZXP1W]!VQ<+^;2BKY7TW,Y8KC25+9&#VW0\3):)S^IMDA<V<
M[@SW'NGY$F'^./MD)Z]K\MT,@R [MAQQC/D"<_+MGO\ 3NJC5-#-[FN'?N"/
M)OZWRQCO_#S[*$9.%W-).QDU5S,Z>?/!%,UD--H!M/2S.='M;U6.K9'$ ^/P
MN'B^GA5M0<+^;VCI2'\TFF*J4NE>6UO#ULA[R[V-ZL%9!V#<,^#X?KXD$\>T
M8(#HY&DG!!;Y=LD_@/+([9[*H2DY\+A@D=QCR\S^'U4 ?R><X<M;6UU1Q^T%
MB>G@924K="/Z-'.^?=43M=[7U7/9"3#'F3:YI\36.\2X?PWYPJY]2Z7F3T5:
MA(!#&*3AX:CP,^&4F2N;ASOO1X+1Z.*"?G5+6]W9:"&["<#?GT&?7\4$Y)[1
M2%OH[;V/_3\_W?49@1W#;F_K*SQ\P6A+124=5')3-H-#S2.JHFQ[7B;J5V&&
M1W<AI=CT*O\ ^33FLZ%2QW,9H0S3',<PX:3#H_H_A;]JX^Y)_P"BO^FT)J%7
M&0XC/ASYX&>^!C/H3Y'R^JI]OI\AKI TD>$$@%SO5H'JX9';ZA0@=%<W\ HA
M'QWT#5].H@;4]?0\[-U/&_+GC;7'WL@^/R:W^K#%T2:1YTXK>:VGXO<+*BYO
MJ3.V@GTA7-I(6.DD<Z$SMKNI,P->P#P,=[MG<>/>$]NGC:6M,@.\.(P,^7FJ
MNHWOB0''R[]_E^/T4(RZ=YQ?89(HN*'"$3GV?IN&B+BQHS^F_P#8F?@_J^WB
M^]M5%1IWG4IABW<4^#E5F'J^_P!%7*#W_P#FO!<G>#_C/B_L()Q%5$2 TEV7
M8SZ>7GW\QY#M\PCJJ)N2"'!N2XAPPT X)/?MZ_ZI4$U,/.O351F%5P/KXIWR
M$Q.H[M324S1%+T0).I*)O>F$NRR/PB7'=P#53+SN?Y/2T7!'?'3[75SZN[@5
M$FV+RIA'[@;NO_7R'!B_5.X)W-1$&&3)VCS=C Q\\GMCURJNID-(C<=PSCL"
M.WJ"H!MLW//2'VBZ6C@3<3[=%)[/3W"[T7]&Z6)6]9T$WO=_D_IXQYM]%13U
M//;&9#56'@/,PS[FQ0W:\P'I=//=_L[O%U?[/P_7L@GYU5"'!@=N<0"&CN<$
MGOC]A_<5R:F$9.3V.#X3V[X_Q!_8,^2A"IN/.9&XU%'IW@SL>QPCHGWJZ@TQ
MVR;<U/LQ$PRZ'/N(^T;_ /.-Z7DQZBYWZ"[5%-5<.N#5ZHY##TW4VJ+E1/ >
M][';@^FE V=2&5V/..-[6;W/:V(-A3.P.+2U_;MG;VSGR_W^85M%<(IF/EC#
MG,8YS-PP07-+@X9!P""T@[L8/8X/91M:KES(NJ2+SP_X:0TI,1'LNK:^1_BD
M]Y\5M:/!$1C_ #CHL'I"3,<1\O%PY@*7@K-1Z0X>Z'I[I'JG4T9AJKO+!14\
MYNUT=4Q.BBIWF%L%08X(^F^?J-8_=TP&O(;7=>,;B_+ WS+OPR?X(Z=H.T-<
M20X@#'<#S/?ZX'[5KS3ZHYV:FLAIY.%7">EA,\Q?4'4U=)%TA'+&P$&D#]SJ
MGIR@AI#X26N,+_&E!JSG4EM[8;EPMX63UYN1DZD6IZR*A%%%* 1O=322=9[,
M/C=LVM;[QP+O<H-B#( W?@X^?TSY_P#2J34,W%H!./U>_IGR'?\ W_!0$_7'
M.<^D^RV\$>&S+G[-%-[8[6U5[)U'R2[H>F*+J;V1QLW>/:73Q['/#93'<V_4
M_-Y%35%/<N%O">X5\/5,<T6L:ZD@J,.'2V1&@E/PEF=[F]Y&>>TH)S%5 7,;
MU!XVEX.>V/#Z_P"D%4)"02(G_A@#/<_/\/XJ";9KWFUK ZKJN 6@*%G3A#**
MJXAU JR1\>9&6LMP=_;_ )&7]9N+*/BIS>4[8Y)^5[2TS)IF0>[X@LAV%T[V
M;CBD?D"/HDX[Y#\9[(-@^LTNV $D>>/3_?\ Z#\E3[2S.TAP=^KV)],^7RW#
M*A+\^^:>:.X4U3R_:.IJQD$3K?/'KV2>FEJ'S0L(DS0,D:QC))GN(83F$1@$
M2]1MH=<\WE%&'OX$</KE*^>D@VT.MY6Y#>KUY<R4+? =D73]1UH\AWCVA/9D
M:/7Y^H]%RUX=Y!P_$$?XK7^;BGS:0,WP\KFGZSS[4_$J#Y]OTE&WS\H_U_O]
M)<2<9N:*EJ1#5<H)JZ?VKH>UVS7MOFBQC9U,3QQ2;.IVSMSTO'C=X$&P!FC:
M0'.P3Y9[>H'K]2/WKALP<7C8\;#C)&,]L]E %/QKYAV5-)#=>3_4$?MM5[.#
M1ZMM$XA.W?O>7RMVMRV8Y \A",;W&-BT<:N82>KIOS@Y-]1T\$T\S#/2ZGLU
M1*RG:_;&XM?.P;RWNX;L?JER"?\ K-\/A?XO[)[=\=UR9,.:W8[Q>N.P_%0
MWCSQOGIZ2H@Y4-7R/JGUL?LHOUHCFIY(*EL4;)0^=H]Y&)IM[7.C\$30XMD<
M^/WJKC5Q-H^J9^5KB)T6S])M1%<[%*S9_G<,N)?L_!N[^R@F!LH<<;2,YQG
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MX/O8^/;]WT5_2<U'#*LMOVI#8^)+HMTK,1\-]03#='YMWQT;H_GCQ8['OV.
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M[!:),@[>_EY=_+NKMG!'@^SX>%ND/\J97?\ >*D_RAGP2?H_C;Z.^+ZJUIN
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MVK(ZU*&DNZ&P1@!TLG=I\?DMG$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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MY?Q7+XYH)]CW M^A5-4I5L/])ZSP<?Q7H4<$D\$<,3FM9)Y%Q[C\5T5'L_\
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M(B("(B B(@(B("(B B(@(B("XP%RB B(@(B("(B B(@(B("(B B(@(B("(B
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MQCO[1PJMT1^)I5 @IZR3+M[6?)4U2KB7;2#V;K^\8[JRY;D_<^7XKF%XFZF
M6=/SW=L_@NXVZ$??/[US%3CI]2IEC(B_2!A[N_!7BF,L:[U,43LWUB_1,_NA
M%S'^C;_="+V</R_/*I$1$"(B B(@(B("(B B(@(B("(B B(@(B("(B J.IV[
MM<#GR\S_  5:\FZQW.:W5,5IEI(JM\&V(U4+I8!)_:C#FG'X.009R+P1Q\M-
MBABI#;H&WG4+Q3;V QQF]5V 71.+<_@2%L2M;^0BWBU<K>F+,!13BWW74$3C
M2OW0 MO-=W9ZN'RSC]BV00$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$&O7)A5V;^0NGHK#>(KO26S4^IZ'VNFAZ;)6
MLO\ 6.B<UA/;,3VO\.>WU[+850;RLSVQ_#6ZVVW"F<*+7>M(9FTD1A$3_P Y
M+@0WIM&8RV)T9 /H0%.2 B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@UEA,;/
MRATC9ZR=M1/P;B:RFP2RH$=]E(D)\F%F!V^]US^JMF"#E:^15$[>?)]$*I@C
M=PAC?*T,&^5_VR_8XG[NW,O8=CO[_"%L*B(C B(B703AI_!:8ZU@@;K6[&+?
M_ELTGB^6[_K^);GR-PTGZ+3S7%,8M:W-I+7.DF>X!OF-TO8%==W+]6]W]G\Z
M>LKS],,=E<UGDTJJ6J9B9T;32B7I[2XM<.WP>O[_ /I54<#JJF]I80&[]F'>
M>5L)PAT/I>ZZ H*BZ6VDK)]\T;WF(=RQ[F_^XE=7T_2U7JL/>]\[O;[%9INU
MQKS5C9KG%32NAZ&X;>KOS@YQ^Y=<3FGT'^LW_:MQ&<.="QM+WZ>MXP"<>S1Y
M[>?HNAG"SA[&<#25&>^,]/Z97*_)-?U>9G[0>DHWFS,Q_%J*RCG:SJ%HQ\L]
MU348]DCCVY>/C;D9*V^_DKX?;\?FK;=O_D[/]BNOS!TB7]9U@M^_Y]%N%3\D
M7?JM_B'TO[J?[M.*9OOHV%N,;M[,@D[?/RRJ/9GU%/45-.,MC?L:,'.5MI6\
M&]!7.H%7)8132C>,PGI@[OP6$:GY>G5,,T5FU!*SJR=3^EMZF/\ 5PJ7.VW(
M^%V/1^/.BO5Z:XT?QW:YR4T!C\1<7_-=TIC=3]%C2#]?)>OJ;1.HM*^T.O5+
MT64_Q/&2T_AV7AL9(]G4:/"/-<&JB;?QP]OTU^SU5OVUJJ)ARYSG-]F'E_!<
M&WSD]1F.E^!Q^_&%W",.B):0YP8YY(\L-\UM-:N"F@*K35/1_9]0*">-KQ$9
MCO =Y9*UZ3I:^HU9]'0][\2V>Q8]I&<YQ_1J>Z%KJC8'>'^X[_8JC10OF<R$
M.=CR:",O_#NMQ!P8X;.CR-,4N[Y^/_:J*?@[PY@K8ZF&Q,ZL/Z+)=C]O9<S\
MD7?J\_/VC]'/%-S^\-/H7#Y[_P"[W73,Q^SJ9:QGZSCV6Y\/"7A_3?HM,TO[
M=W^Q)^$>@:FF]CETO2]/Z.[J/R+7]Y%/VD=)3Q9G^[3;;'%1>\E8T8W9.?AW
M;=V,9QE=D(:S](QSS\F=RMNJ[@WHFKE]LDM3&U'1]FZ@QCIYWYQY+'+_ ,N^
MFI*,_8=1)056.SAW:KU=JK^67)Z?[0.AO3IO4S$_ANUBF:1^C&/Q54U#%31R
M;R9'Q>99W_Q60ZGTG<M*W9UFN[&,FZ?6C<TG9*S.-S20,^+M@X/TQW6/SR&/
MK= %_M'Z+^W^"ZN[:JM_&]GTW46^KM^TM59AU&CIVW20DGI'X!ZA54NZ2HGB
MJ+E4$2^6V)O;^*MWMG=7QM!'O/(^@_%('D5'6)[?Q5',I\R]CB8:CK1D2#^S
MV/\ '"LF-Q'W(W_-=P8]LG3J:B*8_/):/X!6LKR7=,99)^H[S_V?Q5**IJJP
MN[!3U<D;I(HG$-W8 !<7;?EC*[(0TOV,F@!W[,F9GG^]2OP+X=0:ZIZ^XWVV
M/AHZ:5D-.^EJ7,R[[^1CT]5*1Y:M!M9X)+ENZG4R:YZ[.CM==5.7CNX^.>B[
M?U$]-5&9CEJ^?9<5% QPDFC^$-\A^U=;VMK?=D@/^?HLWXP\/8>'VH8Z.V#;
M;[C&]\(=\.6[<M+O/<=PQ^!4?,ZS(\ C?\UQ;EJ;5>*GHNV=PM]QZ:GJ[,^6
M5U,U\+L.C<1OV;AY97>RG>V+K-(Q]/-=;9*HMZ$A88NKO[>>%>P1FDII(:HA
MSH_/;W!_!<1RJKE<.F'J_><"N88(>I&7EQ9]\?-=>XQ>??\ !=\1872-#QB/
MS=Z'\%M'+.]IBF6^L?Z-O]T(D?Z-O]T(O90_,,\JD1$0(B("(B B(@(B("(B
M B(@(B("(B B(@(B("Z7;6^8*[E8UU;'1TSZR>&I,48R>E3R2O/X,8"\_N0:
M\?D_:FHFY2M&33MGWU-3>G/ZV\NW.O-9DDO+NQW ^:V56K?Y.FIT]+R@:$I]
M/4[8Z.F%QBDA!=N9,VY5.\'<XN!^_M.'8/EZ+:/<$'*(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B"!.5&M9<N&ETFZ.
M]L>NM8>(B2-LH?J*O<UY;*W>'9/3VN+B-@S])[4 <G%;5U/!ZLCN<]RFK:+6
M.KH+A6UE *.6JJ?MNL<^8Q![@TDNP0WL)&O:/+*G] 1$0$1$!$1 1$0$1$!$
M1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$
M1 1$0$1$!$1!0^01]R"?P5:X(!\PN4&N4$$,?Y0&LJ) 3-+P@I1$T/;X>G>9
M]^1G(SU8\?W79Q@9V-6ME.^G/Y0RNHW6NFZ_\CM+(RKQX@#>IP01]<=O[CO+
M SLF@+@KE$'3)\!&?1:=ZFE'YSWFX3Y,_P!J5&Q@\Q'U?"/Q6XCSV/X+3;5T
MT4FM+TV,.$D=RJ&.R/#ELO===W/:V]SX!Q7UM>?H\:.>.&+I;QCJ]3]BV=X'
MNI#P^IFTS)F!LU2_WK"SSE>?7\5J_444#G]-A(/S/DMJN#FR;A];7.$F'ME>
M0^4O_K'>I ^2XW:MZZL^CT'CV(CH*(C[SLXF:Z=H&QPW.*B-1)47&*G#.W9K
MG;2[S\E&HYDZQM-)*S3H<^/S8*@Y/O-O;M\E[W,?NCTK9I(7L+/M6&)VXX)C
MV./[\M6O$#FL='5P@[OOAWKX?^MW6O6=7=LW-%,[.M\)^'.D[ET'M;\9G5A,
M\7,A<-GBT_ 7>Y\GG';X_P#L7-!S(5_VG[-<M/0&D_6C?D_QPH3IF3L_30O;
M^.%US3 U729D0_Q7 ]_O_5ZRGP;VFK;V7_+:&W<?]&5<>^MJ9J8?*2,#_ E2
M#;+O;;W11W"UU#:JGE9O:^,@@A:.BH<)]CI#*W^VP+(M(\0]1:6K(&VVI=';
MHI,FG!^Y\A]5S>G[GJ^-Y_NOV?6J;>OHJ_-^.[;V[:?MM]HY*.X4L3Q)YDMW
M?XK4/B+I2MT3J2JM;XV>QU,74HRPD]8_JMR/B_WRMM=-WVEO]LCN=!(9(GM#
ML]L@^K3CU'JL2XQZ/I=3:0J:N.!@N%MIC4T;SY1R#Y$=US.KZ>+]&JEY7PUW
MF]V3KO87IG3]):DU;WTENJ_92-\L4C(B?(%WEE;Y4<8@H8Z=OE'$Q@'U 6@\
MQ>^WL<YI&\ X/F/#NP?P\OQ6_<>1L8.^1W_<N'VFB:=>7H?M(FF*['K&_P#S
MI_[0Q?\ F,CM&H:VTTVF3/#12R025+*EN\N8<'#3@$9[=SYKQF<TERF=1P1Z
M4@$[OTC'5)R/P\*B/B$#3:WU!%[J>D^T*CQ](-^)_4]#Z2> _7Z=UY,#XR)(
M&@M>?@G/Q!<:[W"NB[51$[0[WMO@WME_I+=VNWO53F=TV_SG;QNQ^;L./#XO
M:#CQ>7W5S2<SEZF^.P4K/[TA'_0H-%3'MZ&#TO=_CX?-(F2UTO1#@QWU\EA[
M]?\ J[.OP?V>/V38#3',A4U-<^VWO3\4$4?FXO\ /Q>G^C_%3+9=2674MMAN
MELJ6S0S;<#(W-<6[MK@/(K2A@DAD87/;+*/C<[R*RGA!JR71^JX6NK)317V5
MU/5TY.6O>9&M8_N?"<.'DN?T?7UU5Z:Y>9[_ ."[$=-5U?03IF/1L1Q6T!2:
MVTC5TSHV-KF/]HI:@9W13 8!S\L>''[?-:A-!IJB>E=&8WQ3.@FZCF@4SFNV
MG'?RRM]6-V0,9@$?>SZK3'BW8#:=;7*GVTVV>L<^G;%%GKEXZH:[.,'';Y9_
M>K=SLTS&J>'&^SOKZHO7.AKG.(S#&W1N%)(]M/(Z4NPPM [#];\%YIBD=)TV
M$ _,^2O:B)]NFD8RKE<V)O1./\W]/JK<.#(\$'?\PNB?6;:T;&-F'-E+_GA7
M$<C*JEDEGADZ; P]!H&3N] ?G\U0)ZH_U7\%G'"33$VK-=4M&ZC=+24<SJBJ
M '9T)8Z-F,^?C:3WQV^O95L6ZJ[V(</NG6QV_I*NJJXALYPJTDS2>BZ*WME)
MFJ":B64>LSOC[?+Y+(Z>^4%=<*JS03YK*1D;YHL'+ _RR?+]RNVR0T["W;TH
MJ=N[)[ #&5KOH77(GXUU-5.^L^SKJY])$>J'01.9^C(>#XFR?<)[GU 7L:KU
M-B*8GU?GZST-WO574]1.\Q3J_P#QGO'G2$NI]'QU$,(=+9I&W!A[[G ;MS1]
M3X?W+5BMC;0U4])+XG0>;F=VN_NK?.:,U-/+!/"#$?"X.'FWZ+3;BM8?S9UQ
M<[?):JN*C>^G;;)"UNV<=#QD$'RW?/"ZGNMNJKSTO=?9WW7V54]MKG^#$B7"
M3I^9^8\EV4=8(GQQTVZ(_?)\0/[UVT[1%'3]>-Y?4_"0/+\5;S4DC8Y US&/
MC\RX^?X+I=,/JD>?EWQ1F/\ 3$.^'X?[7DKNEN4L,T=OFM[ S[Y^:M&[MVUQ
M!/N_^;YJY,DU7))( R0Q1]0]/Y?(9]5:.6-^B-,M\H_T;?[H1(_T;?[H1>RA
M^89Y5(B(@1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0%;OIM\88?"<>)S7N!_
M>"#_ !5PN#Y(-:N0=I_FC:!?4556R62.X25 K7MZL<[J^I$@#@!X-^0W :=O
M?.>RV36K_P"3AZYY,N'3:IS99##<9B]DK=Y:;G5$;PTC!],9.""'8(*V@16F
M9FG*M$1%A$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$
M1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$
M1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$
M1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$
M1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$
M1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$
M1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$
M1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$
M1 1$0$1$&O'))%5/Y?+?6W6XFZUKK[J=T]?+(2^ID&H+@72O<1WW.:'$X^)S
MSCQ%;#J!.3(5L/ &VTU;3QQSPZCU4)8X8I&,)^WKAX0)&-(;XA\0![>2GK<$
M'*(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B
M("(B B(@(B("(B B(@(B("(B B(@(B("(B#7.B8)N?JXRAK1(SA);R[Q=^D;
MU6;"/VL'^L[Z+8Q:W,J;=1<_]7!4QV]E36\(Z3H2.JA[0XLO%4Y[!%YN#@_/
M;..F[]NR* B+@^2#I<,@_@M+;]G\[]0F<]-WVQ7=W_V979_])*W3!W#LM+-3
MEU/JG4,(C?/)]K5QR\8&Y[WN:WOZD.'T^JZ[NGZM[O[/X_SE?\N7FS3!C,'N
M_P"86U7!D-;P]M($C7[H7XVGYR.Q_B%J.V<2Q]3OC?LQZY6VW!:&"+0%H9 7
M';&]OB_LR=UQ.T53KK=_]H'^AM_S,6YGXZ.71=H%9)U!]KP^1Q_52_):[4L@
M=-( "(XS@D^1^H6QW,BV6JT;;A#1,E,->RI<,@>[;%)DC.._T6N4;XV4[  >
MC[-TW_K&3Y_@J]R_7N9X#C/;-_O.GP5'Z:XN'X*VFD+(^X)?\PKP2QR-W1Q4
MX/ZI)S_@K=T7O.F[!/S]%U>7NHVX5!CG=.-GB?)Y.'D/Q79!/"WS8[]P2GEC
MIHY!$';S\!=Z*AS1!\??\$B<*51%7*:>7/553%?:W2HE<^AG:ZJIVN/C:\GW
M@/X>8QGLMA9J:.KI9*:5H='*-CA\V_):?<)*N:V:ZL]QI/TE15QQ&-WGAXVR
M?\WR^JW(:-HPO1]NKF[:\SXAXXZ2CI.ZQ-J,1,9_JT9UM0-T]<[_ $-8P,%'
M77(,#1GP;O=X_P!'LMVZ%Y-'',[.7@;?GY+4WF+M[:#7EZ-,60Q244%2X-\1
M).[?Y^IVE;;11$01,;C$8[_N4]/&F[71'#E>*[T]1T/17:MYJIS/_BTAXCQR
M?RCZB?0M+VLN%2'0'X1GN_/XO\0^OR6/R2GIX8"R7]5W8KW]7UU3=-4WFLD@
M,-76W:>FD9%CQ31R=.1C,XW'/?([$>OHK#V%]77>VSQ%AVYP2//]7\5T5^FJ
MKJ)Q3R^J]GN46^@LTW*HS%&^[SZJ"5GDYO[U>L/3J>LSL/XJWJ-C8^L^IC+?
MIG/[L95Q%3335%/21Y-14_#%L=N'X]EEIJ^CL*[MO1G5']W$CY=NW<.HO3TU
M:77R_6ZE@RVI%=$Z-A\\1O8YOEGT:?X*NBTAJ"ZWCHT%%+*W?LST9 ,_M:MB
M.$'""'1TDVH+BV.HNU4P;R<F.)_]@D9Q^P+F=%TER].J=GF?$7B'I.AZ6?9S
M$USZ>B66@.8W_I6I/'-AI^)=171R-=2U-(R.4 ..Z8#!<[MX'8^65M)J&]TE
M@M-9>*]SHJ:CA?-*[MV:WS6E&H[W7WZ^W'44M/69D,DLM.Z7PQ2/^#/T'KC^
M*['N5RGV7LWA?L_Z.N[UESJ.*<8>6U_M$<XD.7R^1_VKDTY?3>T@MV_(^:Z(
MA*R/J%CL?+U7<PEHDIC(W$7GW[?L7GWV>?)PIJ*B1OPM"V1Y<M)^PVRKU)-(
M^9MQ,;*9SP6.]FC#MA(^9+L]LK7ZGHW5]124M!&ZLEK9>DQL+22T[]F3G';*
MW3TO8A8=/4%CAA 90P-IV%WCRQOP^>._S7;=LL?I-=3YY]H'<]/2T=/3/FJG
M?^#%..&K(],:!K)6S&">X.-#1O\ ,.F=N<YO;O\  QX';S:?):D0U,_6BK36
MU/ME(8W4]2<.?OC^ G<7-[?W5+_,)KV*_P"H)>'EOZ CH"R2HK6@E\,YP[IL
M! !&R6(;OG,?D5$KHV0ODC=W?%YM'FJ]RO17=BF.(<GP3VZGINV53=I\UZ=O
MY6[VC=41:NTS07N"-[(ZV)LF'@!P!]" 2,_M40\S=EKQ8:?4M*YCZ*GW0W*G
MF.S=$1L#F''AP>_X*GEHUC+61W#24HDE93LCJ:65K#TQ$'['-W'[P/IY?53'
MJ;3L.I;-<+#<&L=3UT9B?M['9M^H/?<NTJT]3T^(?.YFKPSWO'I37_XM('U\
MU3$V6GVNZ.WP^K=WEE=;I'U'3Z_I\>WU5$U'54]ODHKJSV2Z"84]8R+R#V/V
MD-S@]_ 1D#M(SYD"JEF8)9(G,<3'YD#L?P7FKENJBO$OO?3W:*Z*:HG.?5V5
M!,%9UOTD?R9W*O*9PJ7U4;<P'J=BSU9\OQ733Q>ZZ[,=+]=WDNT@Q4T<K!@C
MX_JJQR79B:9RWTC_ $;?[H1(_P!&W^Z$7LH?E^>52(B($1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$5O-+)#%U&P22N_49C=_$@?Q0:R?DYH#_,YX=U1LU-
M;WU<=PJ7-8WSD=<*@-E[_=D ! [ -(#=K0UK=H%K;^3[]GCY0N&$=)6/JP+?
M/&=W;QQU+XW ?V&D.(]3V.%LGM*(B(B,*D1$2(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@UYY)ZJIJ>7^W^V6RMH:@ZAU
M-+4T55N=/ 77ZO.V20EW4</7:2/JM@R<+7/D2J*"?EJL'L-<VKAANVHA#414
M_L]/,TWRM(DC 8UA[?(>:V+<E7E*O*[$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1!QN"Y5.TJI 1$
M0$1$!$1 1$0:^6XU#^>2]4DLL#Z:/A?;7-CEA9UP]USKFES7[=Q9MC;\3B<R
M>7RV#6OEJ=CGFU!35+?>'A7:?9I6'N(VW:X@AV?(DO'EGX 5L&@+@^2Y7!\D
M@ETM[!:7<0JF:LUQJ%DX;+_PA/%GX1MC=M:SMZ9^]Y_1;HCX5I9J>.2KU9?Y
M6,.7WFL#"[MN'5=XA]/"5UW<][;WGV??ZVO^5CL$+A[PXZ?5WX]<+;3@4XR<
M,[1.?/WQ^OZ5W^Q:MU-*8'Y:YKV?)OFMI.!,T<O#"TRQL<UF:@8([^&>0'^*
MX7:/UE;O?M G_(V_YF,\RU524FF[#[91.G9+>Q&0UY&#T)G;_P#FGMY=UKJZ
M&2.CVS.;&?[1_P!BV'YGG1#3%K,C"?\ A'$>!Y/]GG;D_3Q!:ZTSGA_O3U&?
M*;M_M3N7Z]SO /\ [;/\<DEM;##]H!^7_(%<%P?'AN=_S/DKBG#GTLG4F861
M^8SY_@K,'I^8)_!=4]S1ORN:N)T;ML;'//\ 95%2WJ1]0$8^1\UW&HJ*.X=R
MQS/EGNNJ6&1DF7N:UGR)1&&6<-6M=KJQ3 '?'6,>1Z8;YK<;/I]%I]PCDC.M
M;3OC>[%2W.T X:YNX/\ [N/-;A#OY+T7:_+9S+XUX_F)[A13ZZ6HG,RR>36U
MWZ;FG_@>'R/_ "JVXI\%@'T6I?,@X#7-[CI2-T5HA:[=\_>=OXM_U@MKH'ED
M#),Y#AV6EC];7+B^(:9I[;T.?N?_ %>*_1&FYGSR2:>H7/E=N?*(6ETO?()/
MJ0<=W9SZJN31&F'NR_3]O/BZN.AVZG[O)0I>N9'4-!?;I;*:P4@@H*BHI829
M"#OA<YI)[>3BT[?GZX7ER\R>KIP VSVZD],Q0%YS^UP_?Y)5UMFW<JS'"MKP
MSWR_:IJHSB8^]Z)^&D=*U$CZEM@MAJ&>;_91_@KN'2]BII63Q6>BZS.PD,8W
M!0#0\RVIZ(1B^VRBJ@/CZ!QG\,X4U:,UY8M:49JK15[BT[)(GD"1C_U2 3W_
M (?57L]19ZBK%$.O[EVCNW;*-74:HI_C+(!30,.[9'&X/W=L KSKSJ^Q:>@-
M5>KI24L(;O\ $_OC\%3JO3DNH;,^UT]QFI7GRFC.'!:F:[TGK"QT[*C6,LU5
M5RA]/&][B=SF^H'E@^G_ $*W57IZ>C53"W8>SVN[W=%=[$_BR;C1Q:FUG,-,
MV)[WV<M;),68$DT@/=CFYSL_C]%%I?44\DQFJ'ECNGC;_6[?/?\ ]F5U]-E0
M^.:5SNK)Y.'A>/Q>._\ !=M7+'+\(/[5YKJ;]5ZYFI]N[7VNQV>Q'36XYYE9
MMJ:MSMS(MS-^SL/57 ;1%E6-LH>6;P2!W'[U0RN,%')#3,S)%+O)=Y8^B[:N
M+>ZC;!YU,+6D?4MW#_?YK**9JX=I75$3YN$H<OVEJRY:Q;>FU[VTENA83E@
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MGUG4>YV:[]W:*.?Q2U=K#?-(\"7V6V6>JGNUYIW-K13Q.);+,.[AD#L,JTX
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M< "?(=G>OU\UZ2QK5MZ%HTY>+B^5E.ZCH*J;J5%,^:([&;]Q8S!D: #G'?\
MB@C7E%IS#RI\)6_93+7)^9%HPQK\D_T:+,G@QATO9[AYASL'<05-ZA'D[MM#
M:^5?A+247@A=H^SU989A)B66DCED=G)/BD<]V/(;B!V 4W("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("IVE5*A\@C[D$
M_@@UM_)]P5$G*!PWGK:2*"HJ:.IEFZ7PRM?63O$AR!W>' G]JV26OO(74NJ^
M3_AA-)L ;9S3C!^Y'/)&WR]=H&?JM@]I0C94B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B J6M(
M;Z952("(B B(@(B((0LD<+><'66:QGM,G#C33HH-W>5ANEXZKF_\GEN/^74W
MJ$].3T53S;Z\?[#(*BGX?:5CAG=&<,!K[T^1K78QM=[D'OYQ_138@(B(* '>
MO="T_JA5HD;(Q]'&$PN4482XVA-H7**1&/'>@XQW+AU54W BY6F@U7+41"*I
MN4;GPMI^KF4'#2=Q9D#MC/J/-:0<$.&>A[KRU\8X^8:\ZMO47"?BOJ"NN%RM
MMZF96&IH*.**6HC<YS"XN$LTHSASG/(&7$ _2@PN,F]TKNWH.P6KE^Y%]*:A
MX4:_X3UO$/4T=%Q"UU/KNOJJ4PPR1U,QA<^(,#-CHPZ(N:TC&[8?NJ,#2M^C
M]:Z*X%:$I:GBSK*IXE<8/9;O+8*>XRR-^QWF3V&&(%P>V25TD<CG.E:[>U[,
M>$J1>7RGL-MX7\7]-<Q5]UI;[%PIO=+?V10:@GAJJ>=XJH)(A)'*T/#IX7L:
M'.#,D;G-[K;3C!R:\,>+.F=,V9HGTW<=%Q4U)8KM:MK*FFI8-@CIW$CQQX8!
MCL1VP<Y)P6O_ ">FAKGPQU]HFY:ON5QO_$.Y4]9==47"".>K$$%>VK93QL :
MR./+"7-8!N=(_..Q3 U:I- <8*7@1P\JH=:ZSDU5Q:U)'>;!9CJ"I8:&V4]'
M6B"-M0][<=4UU,XAV!@,R1Y+8CE%H&\1^7WB[PD==[Q;M8?:%UTY?KA6USYZ
MBFKIJ/HA[';CM$8R!C!RPGS4Y<6^6W2?$ZS:2HJ.NK=-W#0E93U&GKC;'[)K
M?$QK(WPQDY:&OCC8.[78+0G+YP TIR[Z9O-CME[J;G6WZYU-\O-SK7 35$DI
M),DI\AAK3WSYN=Z=TP- X>/>LSP2X+:-OVHKC!?N&5\O-;K>"6K?35=6RSR.
M;!;S* 2YLD4LT!<<#,+R2/#NG2Z\_P!Q9ANVG=(_R"45HU3K;[$K--V^ZWX%
MK[?<6SQQS2O#&['F6*%K6]R.L\2;"P@RG:^27AS0\3>*.N[C6U5?%Q2MM7;*
MNU.:UD- *P-]JD@<<ECY.A&_(\BT?JMQB&GN1&MMM\TQJ2]<:[QJ2OT7<M+O
MM$TEOAI>C;;2Z;%$]L9.\2"1CNJ2,EC,Y8' Z8@R\'4G-!5\<N1'BYK^]:=N
M&CKM87UVEYVT=>]Q;5CH-AJ&3 ,< UU0S?D#:62>C5!.GM=:HYCKUP\X::MU
MU?\ 3FF^'>A?MNWT5)/*)]15E!1])\M54@9#96;W#/8Q^T,)#GM<-H]#\@]E
MT?P6XE\#1Q5U%<+#K^YMN=/*R*..2TSM#2\LRYW7W2PLWA^W<QH;\0,CO3XH
M<E%AX@6+A?9J+BC>;36<-+=-:7W>...:NNM-)3Q1/ZTKB QVYC9,[7CXACNL
M\-<TM?M-_E/^+A@I+GJ#A'I6OM]1025.ZUW:HW"8M.P>(/&T. SW\G#'TR2R
M<['-3=JK0UZ_D\X<04&OK3=[O1T$UTJQ*R&UAQJ!O##MD ;NVD=\^FUVW(I_
MR9>BJZ6*FK>*^J/96B=K'4]-3-FVF5KFCJ,B R&MC'PXSNQE9SI_D<T38YN&
M==4ZFN53!P\M=^M>#&T?:]-=(IXWMF!=F,1,JI3&&@EN7[B[*83FE%F@>>WC
M'2Q:2UCQ4T%I^+1^MG:DJK?]EU$C:YD5LA.V-K'NV;Y*D"F8U[V9W-<[:%::
M0_*/:ZNE3-3W3A992Z:P5]PH317"?$=5!32SM9-OB\#).F [U8?3U4LZ6Y!>
M&UBL^C;))K/5592Z2EO(8]URDA=64MSVF:GV,QTF;&QM/3+7/.YSB3V6 VW\
MFUI#8ZY47'743Z>O94M$U-% YCH):>:/SD>_J#:_+OU@/1,(S2EKE?YD>(W&
MO5.JM*Z\T!;-/U-DL]AO=-+;*UM9!-2W.&::$O<2UP<YD<?AV]L.S@;28A_*
M!ZVXR:=UCH?3EDU+>M,:!N4=1=+M==-N++O-54N=L;SW:V!H?2DD9WY<'!NT
M ^3Q(Y).,UDL5JH>&O$JIK*O4-QT98;_ %EMHXZ22V6RV4SX77$>]::G:][/
M=@>,%O4W=,D3KS#\KM^XJZUT?Q9T#Q.FT9K;0U'50LN$5&*AE82&R0QS1%[8
M^F)=SW,+?&),'  4L<-=>4CF8XO6G4=CX4:BO=-Q+N.NK_7NHZN]U]325]JI
MZ2VQU+F3N]FDZK7?#$&M;M>'AV1(TLAW4G.?Q6XB<5Y^,F@M2ZET9:_S>?;;
M;97WMM=2P5!@D K7T3X_9^IN?"=ACR1W&5/]O_)U\0K%1:.N&E>8*#3VL[14
M72MN6I*.Q?TA\E6VG#:: -D:YT36BM[F5K]M1\/EMQ[1?Y-?BEI>:YUT^O\
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M[W >(OE?%@]P(V9\UHX>*G%C1_%^X<1->:GO@UAHC54PN-!07"0T,;8ZIX-
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MDH/T]<*]O-MKNV-M$Y@'#[3#C5F3LQS;C>]K1ZDO$DVW(_\ !^^,@J<$!$1
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M)2T5.W;#!&UK6L8P>@:&X"*/91<;O0]C\E3U8_UP@K14&4 ..UWA&?+S\_\
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M8;'%$[<R%C#5$1L'W2S#F?=(03J*N,LW^//;PB,EPSCT ^HS\LY*J%0UTHA
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M\N^@N)55?=,<HM-'?[%>)&T5YM,])":BI='+#5R;HV@/#8Y"&Y#]P=(X#+'
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MRT-QJJZC.DK2^,U,S97 .IHGAKBUH\3#AH^6,*7]I05(B("(B B(@(B("(B
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MD:7,DD =X6%@<X$]B&.QE6L^M](TT%153ZHM+*>DJ7TE3,:V,,@G9'U'QO\
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M#.!^_P#W*J%+X&1^#:SX1M&&^G8>G;/_ *CLJ#5M#-^U_P ?3QM]=^S\//\
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MZ;AGT.,C^*"W]B=TVL,[G.!RZ0]B>^<8&/P_CY]UVF)^QD>.P[$[R#]/(?\
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M[<+]7W2HXA62:_LH;33-FGMM-3T\,]4)6N>SJ/:R<8#2>[7$D  D-D&Q[7/
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M'9V6^%852\^G*Y6UEDHJ?B;2[K[#'-%))$Z**EWROB:VJ>\!M,[=$\XD+?"
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M/#?F&?M,G,#9&F7J]?IZ'A&=WZ+&ZH/Z+[OS^]N4N&I:W;N8YN7!AW$-VDG
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MSN:#M=Z;O(D=U/J@;DGN=#<N5'A346QD%/%'IBBI##"[>W?"#$]_XN>TN/\
M:[*>5%8(B*01$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1!"=HN$3.<#6=#NHV2OX<
MZ9GPYQ$KXH[I>@]P[8(;O9GO]]OGWQ-BA'30H:_FPXA5,U/&:R@T#I:EB</C
M$+[C?7R-_!P9!GZM:IN0$1$!8A7\)^'=WU([5]YT-8*Z]%\4K;A4VZ&6I8^-
MH8W;(YFX -:!YK+T0:#:^YL.%?#'C1JKA7I?ELTO/6Z=H9:.@JZ:6AIA7ULK
M!'%1!C8R-LO6;&YI.1AS2-V&'!;7SU\/;M=[E!5<LVE([-27NCIY(Y&P/K9:
M&JG=3O<V!C'#VAI&3&YS3AC_ #P =^ZSA3PTK[H^^5N@]-/NU36,N'M3J"(S
M>TL&&RAQ'Z1H:T%WW@,'LM)N/G-EPNX%\:-4<.[QRSZ6NMMTM44MQIKF*"EB
M>^::W.JFEK9&$;FU$T(,S7M(WR8!VDH+GB'QUX#:%XVZIX2:FY4+%,+;>:2U
MW74$$%.2RDN<;)XICF#J/ ;))[D$;7 -:UY\L?TES=<&-1NK[[8^4?2C(M-T
MIK)6@T0E=''(_I.B:V!K(RR-DH(< 26_*-9;JKC-3:;XAUFJ^(G*1I)]YJ]7
M45M?>67!D\\-ZBL3*N$2O]E#G!M))M8YI<6R12LVY:'N\GBEQ-X#:#IXZB+D
MMT9<*>OX=V_5MYC@@AII(FUSJEHHI&LICN.:=V97;?CSY!V0\:Q\T/+M=K;K
M"US\I-@@H=#Z0J=16EMPFIZB>Y0-N$093,]P]\>^KGJ#N#I TAQ^\[:U=SH<
M!VLIM&R<HUKN5'9Y*6I;335-%#34M364D<\XC8Z,C=&^1K00WN&[V8VMQ:ZD
MYFN#ND;Y5Z!N/(?I^"*FTY!0TF*FB!GHJNCCK64371T[@USF51SM>YK7AYW=
M\JZUAS'<K5IUK;+/JKD[MO4K(--76"NM\%"2RBGHXZIDPV; \P3.$0&<.#'E
MQ:UN"7TPE3A'S.\.M?<,]94&I^!M/HSAY2Z.J;U<(Z&M;6QU]'E]+44XBAB8
M'/V,#=[7DEV!Z$F&--<T7*%):[;<[ARLUENKHZ"G@HX;?3,D9'!!&X4D<@,K
M7-<UV&%^W<26G)!RNBAYO^"4-G:7<E5MI_MV"LH+E3TE;1P1= 5CIA!TG;&/
M+GN$A:'#QY:>RS:3C1RZZUO%)?;[REO?)KLPV^!]#/2RUCVU,HHPU].QP:R8
M1LC+6-<3\1[.11=<&^,/+#Q7UIHGA!2<LT%FI]3372.WNJ9HING+!1NFJB[O
MO(,;2W)/?Y+QK7SC\K^N+):JN[<N550LI=/3U5 9J5@&V@I:B2GIHMGC.6CP
MDM<![2TD[27#,++Q'X%<)]$<.^,FB>7Y@?K'4UPL=OFI9HXZJV5;9:FD8PE[
MR6YAAD#L9SCO],9OO-KRR:B&E['<N6FINM+14<]%2LECHX8:""<R4SAXWY=&
M^G@+]XR Q@;YY06V@>-_*%JN_4.FCRY3VJENU#4:BBF>X/@GAIHO;V.<P/VO
M>Z:D[,/A+F@8.5BIXS<G$.G;3J_47)O=;-9+O>3+3U7M49$-7%4Q/D 9'.)&
M&)L\T@@+1&UT;&,'O&E98.(O+/?['K.X5G*'?F1<+:0U=PC+AT(/;ZN.*1L4
ML<N'AT,AJ2WL V%X;@E8EIOB7R=W"I90:6Y-7U3[99[Q7-H+C5MD@I8]S(S&
MR(R3-:^<=)WZ.,QG:X.<7C >GQ#YH>"%UGL&BM=\G%=<Z#2L3]-6JFK[U#*+
M?'LIZ=\38R]S6X#H8W/W%V8PX$[ 3XMVYDN3ZEU75VS7W*%9*.LL5;16"&:.
MOAJX)(63,I-IVQC?''2E[@)&'<6F+R<Z06EDXM<LVJ[Q3:>'(Q;C*RLHI98Y
M;X'T=(Z62EI970N:#%N:)&"3(C$CHI2\DQN(S#7/&3EGX"<5]7\+Z'E19?(K
M)7T;*J]5%8*B6KJ&LIJC>X5H=*&1S/;EX>YI<QTF29"47TP\KB;S'\IFG=5:
MPT;/RDV2N-GU-<;/7.I:ZGI7U-3#5-C-1,&,&=YZCP'/<\&.,!H+^UK>.*O(
M)IO7-5H"'EBI7P,U-4VRX5514/AC;T8XI!)T7C=)O>9QT , QMW8ZG:TK.;?
M@!JNLJ[]=.1NQ37:RW-MU=4.KZ-M=/6OK@_<)1%D^^+7.CE?C!:-I#5>-YIN
M66_ZBN6M=;<F]DDJ;W64%-=ZR..FK*IP'M$M3.T%H;CW=(WN8W2&5VXO$?<I
M&W"5N&%NY2>(_$_2W":+E]TPQUQT"WB%UG5@KXZ2:KDC9-;Q$,CV@-DD+L9/
M39&X9'E$>IN./*#H35UTMHY,Y918[S7V:AN)>V"FK9*:L%.^2GC<02YS>_8$
ML[_K.S1:.9WE?H=6::U/9>2;[-O;98JFBKJ.LI8H:>0/<0XNB\1:'; UQ9A[
M2!@#PK*9>*G+?J;B58=(:\Y,V6VKUAJVDI1<?;::017.X-CFCG;&-CW"0RMZ
MC@UK3YGS&2^F'1=^)/)KP1U9I?4-'P*U+:[C+8[%J>-E!<9J>1D;:VNI"7TQ
MF;[2^.1C6[9(W-<US1(8P"5;7GBER9:\@X9<*M7<MO$ LIXHJ;1]#[=%2OAF
MNM0"^!_3K8VM=NZ$HEG=\)#\AV.ISQQXO<G<>IM3<#]=<N^J-0T>FKS36:2M
MI;SNRZ&*JD%09):F.3?"ZYUIQ([#W3$N?EK /5T])R#U-VTWQ'LO#_4,VH=$
M:8N7$3[*AN]?,VR2VU\-28#U91'_ )0XMB:'^SN-..X;*!(48)JVX<A>FI&V
MW5?+;Q?@DH::>HCM51J9T@8^.J-',UO0NDCNJVHH'9C+@[W)DV8:TGU[UJ[E
M UU:M4ZFT[RL\1H?;ZCQR6LMHZ)ETZ#Y8WNABJ'1T[W=,/R^%[08XY^AG>YN
M.ZUXI<AE^U#?+EJ+@7Q,-PU!/+*+I31T</LCY+O-52O@J)9XW4KII'R;R\Q!
ML0Z<;FA[W22-Q&X7<B?+I;=$WJ_<+]?WK^4":6[66AMM^?*RGA8R!QBD<:Z.
M&2)K*QC6NWR$M<\!Y:["-&'Z<XI<D.B;G9[[3\&.,E/<M#34NK35U-?3/J*^
MJ@#J:GWM96F-V1.7/BBV F-NYCF%P=F]WN'*U0\J5?\ G-R^\1Z;1'#;B3*R
M[V859]OM%V>QQ]H-0*AHJ*:&2OVL=U?%F N#@7$Q/8>(/(.ZUT596\O/&N**
MYVR.T7*BI]0R20]6DFBG(<[[1BD\,A W;6#():QI!<,ATOQ[Y"K=PUU1H[^3
M#BE6:(UK)0C4#KG<))YZZMHXA/#+&P5IJ.I)+$QO4BV,,@;OV,:W<9I0Y8.+
M/*QPDXA1:'TGPYXG:&J]9W"GTF^35S8#2,N=O$[FMD/M,CX)YGUI8=C0PR21
MAK6N,CG877<0>1^'5=\I=1\$N*UC9!=M;15C)HHW4,M]JJ9]+=J6&2"JD:RI
MEA;#!&QKHH&>!S7-/C2JU9R8:>XEW3B*SECXL5VJ=*1/U[?Z"LE=-):9)Q2S
MOND].^N=&^9\=?%,_#G.C;39,<8C>\7MTKN275.F]*<1:GAIQ+O%1Q8U+JJ>
MCLL;C/4RW:Y8I*V*>%LY@IGNCG;+ YSVN#(A(,8R0L."/\R"Z55\I]$Z)XP6
M>PTNG*ZGU/4W:[5D%$^SP6V6.OFJJ>"H?.]LD9B81TF1]:FB; 6.!#L2I:C\
MGY98)+9>^&'&>"CUA9:.EM]TJF2AE1;1(V6">E=$YC>GFG;M>6NE(ZC',!=(
M%Z5!JWDHX56>[Z7GX-<R.E[7>+=<+A-;)YZNGBJ[76XH>F^%E8!+3EV3'URX
MD@ESW'#593ZCY ;;:]+5VM^#O':ML]500V>R#4-15.I*"@=--%-)"8ZO9'&R
M1C@6!WA<S?$P/!>X.+5>?R>=;8*2B9:N.-+]EAEPH[7++7R$P>-\L$,+Y9*9
MS>JTO<.Q)G&UQR<=EHN7Y.)M5J]M@J.+5+07>2"(V40S.AG9#=8ZP5%(V5IV
MQM<YSB'2->(8IW;-^7FJXZ%_)[7:TZ=U79+!Q=DBUDZ\5CK;89G5E9:Z.FE<
MR:JJJ9KY71TK0Y[PY^]SVQ@EK\$+ITAPSY&>(>J]/Z-LW%+B_9!J=[HZ."Z1
M&.*>IZ[HW0F3870RXFIC%(X", 1>)\I<"7TPS+2/#[D?XP\0M,:0X;<:N+5!
M=M025U;9Z*E9-2-BGA!K)8F55;1&7J,#7N#^N\X8-SSF/=MIPLY/>'_"'7=)
MQ%TWJS6%?>:;3TFFY)+S<8ZMM13.K'U6^3,0?U-[PW+7-;L8T;=V7K"F_DZ>
M#%NO]HU/H[5O$31UQM%+'2LGL-_]G=-(*=\4M6\F-SA42QRN8][7-!V,[?%N
MVMVE%%2(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("B[F,H;A4<!N($
M-LCI99V:6N<L#*J=\4&YM+)@2AC27Q_K1GPN'A(&<J45'/'^&LN' [B#;K;M
M94U6E[O3Q22.#6,<:63NX^8'X H/+Y8(H)^6WA?44@J(&5.CK/4MZM3)/('2
M4D4C@7R$N(W'];R4M*)^5IKARR<)80W#VZ%L61D'N*&(%N1VR#V*EA 1$0$1
M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1
M$!$1 1$0%&?'#AOJ7BIPPU!H'2NM(](U]^IS0&[&W^WB.F>YHG;T'21M=OAZ
MD7<Y:)"6D%28NK']AR#4+D"X9P<**#B7HREABKG6/4M#9*BX55+&RY2RP6FA
MF?#*^)NSV>&:JF,+=\A:V9_<$>/:VGT_0T<K*BEIH6R11,@8X,P>DS=L87')
M.-[^YSC>[&-Q43<$ZFA_/_CI56ZNIGT7Y^4\9%.]K8(IF:<L_4P6]G/WDAX)
M&"T@_6;D&*U/#/0U7304=5HRQ5%-3-<R"">ABDCA'C[1M<TM8#O=V P-SL#N
M2K:HX/<+Z^E]DN/#;3%3'LC;B>V0RX#/A;W9Y-[;?^A9FB"/+CR_\%[O7,N-
MSX2Z)J9XGM>R273U(Y^YK0&'<8]PVCRP<^F<'"Z(^6_@)!<1=H.!_#QE9OW=
M8:7H0_RV[MXBW;MG@\_)24B")9>5'ENGI#0R<!.';*<[/=QZ9HF^4C9'=VQ
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MJFOHZX<T&OFOIZDRO)MUD##&>KV;%'0,CZGC9XY!(.TGA\0VS=M*XZ800T>
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MO._JM@>F%SX?D@U_L?"#FKMU;2UUXYN*.]-BZ75I*CA_110NV_'AT4K)>_\
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MM)H_25,_> &.<9[J_+<'N,/B'<#NU_R&9^4+Z<]AHN;CB#"R%_M-QT#I.J.
M,;F5U\:<GYD"/']TJ:$!$1 76)03C:X=\=\?+*[%"/-%QQOO +A8>(MBTI'?
M305])!7F:7I04]%(_$M07G [8 ^>7#&4$=\TO.5JS@7Q!H= :*X7MU6^?34N
MHJVHDJY(/96%\C6 [8W%I B>XAP!V^63V6L7$3C[PNXO7P:NOW*A9=47RNT;
M#45%S;=7M?)(ZBD]I:QK6ECG0"5SNL!O#&QX.6M#<F//!7-U-JCB1;.7K3WM
M55I\6"JJJJ\@MJ:JEWO$4A;!CIL]I>UT)(.W!<YJM>&]'PDU=;N']?I3E*T;
M:*#5K-4NI6U6KJR:686H11U#W!L?B9(ULD?3=N'D'%J#MXF<P/"#7.@]":WU
M9P&N-YK>*^J+A>+C0T6L31OL]WM-/%:X6/JHVL)BDI)L[ \,CZDCL/<XE991
M\;='Z.UA5\!-0<O4U'<KKHTZ)GHZ_5D=50245!!5_95"^?:7.DJ&5LL4I)W,
M>[[VT.,9U/\ -:X>Z7L^IM1\GM#!'<=)1:CHXJC6,CQ+%<HI&;8FD[!-)[+&
M6!P:YF'EFW85;6O67*34\%>+ERT[R[:EI:&@CT3->V3:B<*MU94U$G3F$IZD
MD$C*B,L>Z/<^<%IV!IR@\O1EXY>KSJ'2^A*?E&K_ &W6\=QMMKN\^LI1.R"N
MJI::**H> YSHXXH6L: Z5K6'L,KWK%QXY:N+6HM%\(]2<J\UM^T:^QZ'L]8[
M4(D93VRFJ"Z-S96CQ%DL>._CE;(\B0AVT8U2ZNY3[W;*NCIN5"YU4=@L\-M;
M65NKY8ZP4^UT\?1$6=TD@)>_O&X!S=@=DA9=2<1>4G05?8-9,Y9KC07*WW-]
M31RPWV29T$UGHXQ28<Y^WQO=(QI+<>[>XG. 35X]UU?ROZMU!=;&>4+4==IW
MA]>:VLK[]0ZJEB-#;7WAPGK/9VN8]\;GMZG2QX6=MX])(I-5\L' SA5IKBA<
MN 599K]K:]MO6G;)4W&2:X1T]-<&ST]2Z1^XTE+O?%(8QN;B5@[Y[1-IGC_P
M$T1;M:QV;E>N\=-Q)IZRV:D U@:B?V2K:\RPT[7-'3ZFX.;EXQYY"S37?-GP
M$U+Q"I]?:KY8[K=[G0:;BT]"UU[IGTPI*HM+Z?:P%I+'U!C!&#C/R;@R==7S
M.<OMTTEIS3-9PEN=P;IC55\U6*5MS+>F'OK97U&]HR6O;5.D&!V:T^1 !Z:B
M3E!M.FM!ZMUMPHO-CM6L+7=!874-0^"6"@MU1NBJ)&,.1)52US@TGPX[8 [K
MS6:TY/N#>H[M9K[P<O$=XT[;KG8JR2GK/:Z:D?+;6'I=1CB']7JS0A_PM=@$
M@=UEO';5? C4&D.&MDO'"Z^U$=MX?Z=KH)Z6Z-9);K=7;H6T<YW?$64I R!E
M[F=\GMIIAIIA8\.^,W#.JX!7_3]9P3U%<X=66N"SZG#+N7@%M8RVT[L2$ECL
MU%*\XSASI0>S<F.+K<>7'5%FM.F;/P+XE6JZMM]175LVEM0TU(V:6"F,-7'(
M7-+'QOAI6SYVC9U X=%KGDY/:N(?*KI*U56IK?P>U[/9FPVFDNPI:IO1,L=U
M@JZ>4[Y6CO/31GT(:7[MVX@6$FF.52Z:2&NK?PKXC:BH;7=M.:5AHAJ=D<<U
M9<(9;B^C?*US?"'UD5/,[S!8"W;C)S,4L]X+:(Y:^9[C17UU?P"O.D;YJBWN
MXB>W4NJ:ETE8QEXEI7>T1M(%-,^5KG2Q ES2WPN=EQ-%;S"<OW,/Q O7!K5W
M"S4%)%JSB"R:.[17SI.==*6.GML-2PQQ@Q!T=-3D-W%CG8)<"7;8ZX8:SY9;
M;J_1M3P^Y5=1S7>BI:[6-'4U&I*Q[HI**>M#J>H:(7]:*-U"R8&,RADM0&OR
M[K;I#O%_Y3N"O&?3\%^X8U/VQK%M+Q4EN;ZF4MLEZZ=154L3'[07MED?.W9(
MYC!AA>&C!0^;"$Z'B#R<ZB?JY[.5/7,%VN+9:-EF@U=(^.JJ'!@J9,@E[71,
M;/*'O;(<S3=NXV21K/BART4=RU9I33W+%?9[CJ?1=BI;C3U=W?9Z6"@BHC51
MTH=(T/9TS21,#@W=*6/=G8W>_P "Q\3.6?BIJ6[7BMY5ZJJN]5<[SK"YTM5K
MOHV^:61M/-53O>Z3:Z?JN$4< C8'1D$-]Z0VVU)QWY==>0LKM5<L]UJ[UJ-M
MOM5;-/K!L4U/]F"""+V:M;'O8V2(R,FZ9;U V+=W)=$-,/9OUWY7KYP,T_KG
M07+->:.WVK7IT/2AER,-=_2* 7%TXEWF:=K'MC 8XAIC)+7!>S?Z7EOX0U5A
MLE]X%7NHUAJ71M=>;U427^4NL]G='*UE53/J,QRU3:9TS6;&MVF#)+<G=C%\
MUSRS:EEN5PNW*S+20WN\W6QT]=%JJH9!35%%1TH,]/#&#L>&RM8TAN]F\>'&
M6C)+CQ)X*5'"2/6]3RMU-[T%PJN+IJ&OK];@W$MFK86U3)&O.^</;+"UU-)N
M8YI<'..4*ME.N;ERB\2=-<1>(5PX<<6;7-;-14E[K;Q;I,U=7/<Z^2B#*>;#
MH61;6LF$=06.)>UK0Y>'9*GDKN'#R\WBS4G%R2+A_-#J:^U,CZ:.]:CCN<[Z
M)UGJ)Z<AI@W/I8GM;)@LDD#0'.<Y9_Q_X&<+.$VB--4M3P:X@V:#B0TZ8O-%
MIK4E!.ZA@IJW[4BA=+5'$U06TTQB>US?=Q/C<\G#CB7"FU\J7$K4D7!G37#S
MC;:7ZXMECL%/75/V-32TT$+GW-DTK62.=U)!12NDEZ9<Z)VW:P['.?)E&F&,
M4%#R:W.PZ[XH4-ZXXZ=H-%UNG7PTD%?;V75]76BJAV4;Y9I!.Z1WO9"YSW,?
M!/)&YH<6L[W<5N4?55@T;9M?:GYBKK3Z3O-UCH*W4D=MK:AE-500PN8^0F8N
M@B;!'M9'X7D2[HW;F@93:]$\LU\MO&3AO9;)Q'H&:4=7ZFO]TNM?;*ZZNI;!
M6-W6FB,IFV4^[J;)9)-SC$S<YX#FMPV\1\ENL;1K37]OX6<=J#3S'6W4,K[)
M;;32QVJ*9TS71THCF!%'4.E E80'-,$8RW>,EGCRTG*/INCBL5RO7,U2TMNC
MIKW]C7RGL<])6Q@"6&+:"&31NZL3C'G8&E^\-)<![.H^(?(1Q8U!57.X\*^+
MFF:FNKF72IEL%/04%LAHZ>WQ0STH@=.8_97;))G/,#'N=*\=0-+F.R[B#H_E
M0T-Q0UQH/B!5<:8)[8+1I*IN[Y;=6TEI=6N-10UK9GO?/)TH*9D#9'@N9'OC
MZ>Y^5%-AT[R6P6>Y&K',1=**:LJ+2^EN%;;VQ3/9&]U/<!2QF.=[&"1DC6O#
M8V[7AV_:01HAGNHK3R^VG6D-/?;!S86_4U7!6V6^Z@N-YHV7+4(,4,KJ&YNJ
MIA#T6TGL99&=@?%-&TYD8,7SM,\F-ZU-J?4=UTQQNTQ1W2PW756G:>6KI*>D
MI)J)M5-6QVWV69XB$3:9\;8Y2:=IA<WX71[[B+4O+WS&<3+!5U3.-VD[M>=0
MBH=6TM7I^F'VI=*>DI7;6N+I*B-HH(NS(I'Y,[@UH9WL[3'RN6+7.HN7]VL>
M-6I*Z]U=YX96N;4M+072DT[>+C5>SUUQCVNB+"9YF,#F %VZIVAW6>BM5,0\
MJ_5'*97:-T[!6:=YC9;)6Z=I=,T<M-5VRX=&J]I;<'3;I9I(X:IY,L9<1&WI
MMJV-C!!+/+CHN6&'1EJO][=S3VO2;G/J+%[9:[6ZE?3MJ1[1#$Z($Y,LLKP2
M\.8 QQ&U@,GMZLX9<HNC+OQ"TSQ(XM\8=:W3A?;*%M3%8V4=+!)[0:2CEEI'
M18;+)!/4XZ<LK=HW1;)S%(Y]JW37*1?;E#PAAXF\P4WV1?:*VZ;KI8Z2:SV^
MKFJ9*8U5.QP,+X*BIJFS2%K&O\FL<QI<UPTP[6WGDYTII^Q\+;!K+BQI[4-J
MKI[A!>9Z.EJ;A6TU?%)#5VYSZ:01/CZ9:YSG EW1?TW$R87O:=?RB<-;?PUX
MW:.XJ\1K$R#5=9=-.W"73\T]3J&C8]D5;0/=\,S1[^,RD-+&SN!:X-:6^_HV
M_P#)GP>U1Q*L.J=:ZYUGJ^BJ/S/N-WNMMII*BW]<34E3-;\,8US61](2DMDD
M/3;M8\/VG I;YRSZZX/<+>",7&K7NDZ;04UQJGW2IT$9'!M5*\,$O3<_V8[:
MB1K-FX8.7]VA$:I;M<(N?;@WQ@UY9^'%AIM2TUXO8JWTPK+5TX>G -X>YX<X
M!LC1(&$9RZ*1KMI&#LN3A?.;@3S <J_!^[7OB18=-ZTI[+66>WZ4I*^NT?%&
M(I*"DJ)I(S5QR;9:FN<"YS UA?- -YQM<W=/@YQTT3QTLEPU!H:*\MH[96"A
MG=<K9+1DS=&.4M:) "[:V5@./(]D5KVX2.B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B HLYG*NMM?+KQ3NE$Z /I-&7J>,R1[\.;1RGYA2FHHYIXGR
M\L_%BG:0'2:'OP!/D/Z!+YH*.5RW4ULY;N%%#34O0@_,VT/$1>7%LCJ2.1W<
M]\;LX4M*.>7TQ3<".&VQ[71C1]F=&YI[%IH8NX^BD9 1$0$1$!$1 1$0$1$!
M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0%B.L
M^)^B>'-NBN_$'6=ATQ13U+*.*HO-?%0QR3/:YS8VOF+6N<6QO<&@Y(8[ R,+
M+E&7'#AUJCB7PRO>@M(ZGMNF:Z\M93"Z5-GBN;(J9TS7SAU--X)2]@<S!</C
M+@6N#2T-*I>;_3O![CSJ'06A:O2T]FUQQ8MUTNVJ*Z\LJJ(VNIH+='4L@G;)
M@2,D;42[I'L;#MVM8_N!N+3<V7+-5TPJH./W#PLZ8E<UVIZ!CV-+-_B8Z4.'
M@W.QCR8[Y=XAY'N"E%P3?Q8T[<&4+;]2:HM]IK*VWNEZ<M+%9;=511,&&EC6
MRW*=WENS,02X-!6R]5H'2]6UT4^G[9)%+(:B1CZ9I:9MA9OQC/P.>W&<8>4&
M'LYH.7&244[./_#ITS@TB-NJ*%SB'-W,\I2/$T;A\V]_+NN!S1<N>SJGCYPZ
M;%MWA[M5T !;L8_/>7/PR-/EG'XC.9WK0&D-14WL6H-+V:Z4WOQT*RWPRQXF
M<'3>%[2W+W>)W;Q.\U8W'A+PVNUQ;=;IP]TW6U;:OVX3U%M@DD-1TS%U2]T9
M=OZ6&;LYV99G:2"'D6WF(X#WB;HVCC/H:M\_%3:BHY6_<Q\,A\^HW'[5<0\=
M^#%3_DG%G1T_=K?!?J3XG=78WO)YN]GGQ\^D_P#5..^Z\$>$&H&$:BX6:/NS
MLM(-;8Z67X<;?./^RW]R\V3ENX!/[#@CH(?HQX=.40[LQM=^B^)N!C\ @]%G
M&GA/5#=3\3M)EO4@BR+W2NR^9[(XF^&0G+GR1M;^L7MQG(5;N,O"9M?66L\3
M=*^UV^/K5</VQ3!\$>S?O>W?EK=GBW$;<>J\1W+)R^EGLXX#\.33[W.,;M,4
M+@02UQ!W0G.Y\<;B?/+&_JA4-Y6N7$-;&> ?#@L8!MSI>B^+9LW$]+)=M[9)
M)P@RF+B=P[J/\FUWI^;^B^W^"YP'^BXSU_B_1X[[_+'?..Z[&\1-"Q4GM\NM
MK :793R]<7*'I[)_T+]V[&U_W3][TRL2CY6N6^']!R^<-(O']W2U#\/GG/2\
M\]_Q[^?==3N5'EG?4>TOY=.%Y=O+N^E*#S)[OQT=NXX'IGZH,N_E6X:>V?9W
M\H&FO:_\Q]L4W4_U>IE7U%J[3ERM]-=[?J"WU-!6Q]:FJX:ECX9XO\XR0':Y
MG]H'"P?^:GRSXV_S>N&>W&,?FC;_ /'HY_BK0\H7*_BH#>7KAR#40F%SQIJD
M#MOXMC!'XM(=V\T&;P\2-"U%QH[3!JZS25=Q<YE'"RX0.?4.;U-X8T/W.V])
MV>V/W''9'K_1LNH?S3CU9:77H1=8VX5T7M/3[>/I;M^WQ#Q8V_587%RJ<M\$
M3H8^ /#N1KQ*U_M&G*.8EKYNKM!?$7!@>2YL8(8SL&@ -VTQ<I?+'!"VECY=
M^&?0#?A.E*$C=X?%^BSN\/Q9R@S^EU99ZWH>RW6@F-4)74W2J62==L<@C<6%
MI(<-Y#?H2 <$@*XJK]::*NI+757&GBK:_=[)3/E:V:?8W=)L83N=L;XG8'8*
M-ZKE.Y;*VBJ+?/P"X=LIZDDOB@TY21 DLV[LMC!#\9:'MPX G!&3FRIN3/E9
MHC.:7E_T$&U&S?&ZQ4[FG9'L;V<TAN!W\(&7>,[G=T$L/NE-$"9JAL8$C8LN
M>/B<X-:.WJ2YF!YG>T8R<(R[T4D\E.V8;X#MG&1[EQ +6N^I#@1C.1W'91%#
MR7<KL(Q'P&T4T>R4U'M%M! ;3NE,3N_]9[^4/E[22 @/<X!H;3)R3<JCIHZJ
M'@+HVEGAFFGC?36YL.'R[=^[9C< 6Y8#^C/>/8>Z"777JA%8;<V>-]6(^M[.
MV5G5,0?L=(&9SL:?,X^@R>R[X*V&H&8Y&GNYGQ#XVDAS?/S:1@J'8.2[E>IK
M\-0P\"=&BJ$D,K ;>SH0NB9L88J?'1B['>0QC6E_C(+_ !KJ/)+RO9S%P<M%
M/[Y\^:>IJ(?&Y^]SO \=R[S^B"9V5]*_X:AGF\9W#S:=KOW'L?D>QP>R.JPP
M[9#LP,G+@?E\C]6_ZP4-CDJY81&(QP>L6?'F?,W7[P]$>]ZF_M%X!XNP^':N
MJCY*N7RW'_@_3-_IOZ3#5^ZUG>X_?1=/IO\ #5CX>E'V\CTX\_ W 3:)@X M
M[AWP>7C[>G_:N>LSQ>+X/B\)[*$V\EO+XSV[H:9O]-]I?Y7[-K.]P^T>YZ7O
M-E6-_@\/BS\_-77\S_@=_2?Z!K#^E_I?^[V_?P_IB"7Q5-(SAWH/ASWS@^7R
M/8I[2 TO<TM:UVUQ=@ =\>><*':/D_X+T%#]F4#==45"=Q-'3<1=11P9=)U'
M>!M:&_%]%1!R><'::KJ+E#5<0!<*I\SGUK>(VH&5 ZKLOP]M8",^OZWWLH)D
M=5L:S>6O\PW ;DYS@C ^7K].ZX;5[@UV'@/)V$>+=VSVQGT[A0Y3<HG"^B?U
MZ.]<1HJC+"9QQ'OY<2UNP.P:O&1$>D/U6=F[3W79+RF\._971V[5'$>VU+JA
MM6:V#7UYDJ'3%T9E<]TU2]LG4;!$QP>T@-:0W;DH)?;5A_P;W=L^1!QZ^$]^
MV1GMZCU[*H541PWJ-$C@"(RX!_?R['YJ&;SRC<.[Y+[55ZJXF-J09G"2+B'>
MF>\?+'*R7'M'Q1/BC=&/(=.,'<&,VW<O*MH&I%;#7ZNXH5E+7=/,%1Q)U!(V
M'9W;L+JPN\_/Q()<=4L80'G;GY]O0G_ $_L*"?I$-E!W.=L:/UOJ/HHFBY7]
M$M[U.LN*=6<_%+Q-U#&?TKW_ -56-^[*YGX #ZKI=RIZ&?54]6[7G%LNIGS.
M8#Q.U 00[]&#FK_J_N_/[^]!,!J(P =_G]#V[9_[/Q[>:ZS6PX>YKPX1!QD(
M(PPMQEKCG /?U/H5$;.5C1=.VV^Q:XXH0NME1[6W_P!6#=Y!,_9LVR=2=^6?
M]';X?"NFGY4M-4]*(F\5^+TE3'"R."LEU_='S0D=;<]N9MI+NMWW-=^C9\D$
M9?E);O=Z7EW@M-KU-56>.^ZCM]KJ>DU_5JJ<[Y9(8^F-P($(D+MPQ'%*[)QW
M^>=QJK!HRQWJXW.[75^FZ'3FH;!I"Z50JQ!55>&[/9WMJ3#"_<\,+!))TG9P
MQP:XCZMWWE;L=ZIJBGCXI<4:!\S9L5-/K*LDG897!SV1OJ#*Z*,.8S#6G&,M
MQM+@[Q[CR4\.J_JTXUUQ)BH?;S<J.A.K*B:GH)W%SGN@9+O+'/=+,YS\]1QD
M=XN_8F*ICAJ'Q#K>,G!?E"BX&4'#O5+=!U]%;:BZ:^NU33Q26^AN<[ZBLIGT
M@!FB=#U!"3(6[3(X' ,)DZN7G@):>87B/J"ETYQ<O+N'O#'5K);7!OJZI]TH
MZR3[0.^2I<U[>I+&UTF]K@7RSN:1U,+<YW*D9H9Z6IYB>-,E-4S22R0G5+<.
M!<YS(R_H]38SJ2MQN&]KFLDWMBA;';VGE#MVF*ISM$\<.*>FJ(U4M7]GT%WI
M9*=SGRMDVD5--*YK6B.)@VN&6MP[=DJ_E0G83[L[6N=C(R,8R#@C\?HN/:X]
MS6[AX@2#N;WQY@=^^/7T"A0<L%Z+:C=S0<:-U73P4E1B[T&#%%!TO=_T+W,C
MOC=+'B0N[[U73<ONO*.K@=3\TG%1E/2P"E@'6M+WMB!CV&3J6]_7E&U^99,O
M?D;R_NJ":VS,<UKP?"YVT'(P?P^:Y,H&[+3X6[CW';^/90?)RY:W=24U$SFQ
MXQ""DDB= WVJT=1H;\0DF^S^I/G_ (PE73N7769]J_\ 6L>,O],CV3>_L8R?
MFS_@SW/_ )O:@F%M;$Z*.;<0V0M R.X+L8!'H<D#'S(57M,6US^H UIP7'L/
M3U_;_BH6/+UKR*6"H@YK.*D\T%/'2!]9%8Y0(A,R0D 6YHZIZ;1U7[S@GLKB
M3@?Q08X-H>:GB%%$V0/!EMFGY9O$93)XS;0/Z[MX?ZMOU03"^H:QQ:_PX;NR
M2/GC_<^7U7(J(G1B82LZ9;NW[AM ^I\E#=/P'XBT()HN:OB>YQ?-./:H+',.
MLZ#I,=WMWPCX^G^CW?=5%=P0XJ%YEM7-5KV&66JZTLM39-/3/Z?1V>$"W-;U
M-WW]N-GAVY\:":FU$3MNPD[QD8'^/R_:NHU'P;8I7;S@ ,QCU[YQCMD_L(\^
MRB&KX2<8ZLO YH-8TX-1O9TK/8_#%[SPN_H'C^*/Y#PE6;^#W':,TOLG-CJ3
MW9S5^T:5LC_:_>R.\6RF9M\!AC[?=C?ZO:Z(/'Y/H::DTGKYLM15U=3+Q2U@
M^KJI@T035(NL[72P,!(CC#&QD^0ZKI1^J7;"B5V=NPYQGS'T^OU6H?+APKXK
MU6A+K1T?,?J&S34>NM5T-9);=,V2G^T)8[O.Q\YCFI)0'/,;Y=P)&9]NW;&T
M&2Y."7, XL<SFXOP<P%H)TK:.[CU?>D='!?[T=OT?NV^%)WY$WNJ6,<UDAV%
MS#(-W;L,9_=D?O\ Q7<90&%^#V\QV[*":S@]S)R[]O-M640,<#6>PZ*MC<.9
MU=V>L)?BZC,_\DS^WU./Y(>9O?<S_.ZEV5/^0C\Q;9FB_#]?]J"=@<^GGY=P
MNGVJ+ )<X;L8RPCS_9V^OR]<*#&\)>:=K:?_ -:NMN8^EU!_)Y1^+'Q8/6[9
M]%S1\+N:^#V05?-'9*P0$^T;] P,]K#O9MV[%1X=O2J-F/\ QAV[=MCZ83J)
M=S=S6N.#AV6X(^N#CLN3+&-WC'@^+Z?C\E =)PAYK*2DI(7\UMCJZB""9DM5
M5<.H"^>1WZ)SFQU;![OT^?JKN/AES7C9U.:;3Y]G_0XX=L][_P O_3?%_P";
MZ:";Q,"USFAQ#7[,X\SY=OV]ER)<C+02>_A'GV\_HH'JN$?-15TU5!_.MLT)
MK9NK*8^'4/N6=+;T8,UGA9O\>7]23/WU>NX9\T#W;7<Q^DWP_P!!]U/PY$GZ
M YD[BO;^G_K/U?ZGH()G]J:9#&QKG> O! &"/3'X]\'R[?49&H?U7Q-9(XQ_
M%@=AVR//SSY=E!<W#/FQCCJ33\R&C>ITX&TV_ASV;)'T]TSL5WQR;9-X VCJ
M.V!G;;?5FA>:B>9KZ?CQHF%L_6$@;H2?-,'QU.WI_P#"/O-DDM/C=CPT[?4R
M"0)G-4P$#((R 3N;AN3AN>_KZ+L#R?0YV[O+MC\?+^*ARCT=S24M%644_'+0
ME:^L,YCJY-!53)*/>WP;&BZ8?M=Y;B.R3:6YJ@SV>EXN\,ZAG3+.M4:$K63Y
MZ6W.6W0M^+OY>2"8?:(L@=9@W EIW#Q >>/P]5W;C^H[^'R_W"AZ737-,35F
M+BIPW'7@$D6=&UHZ,P_JQ_PCY.R<R^?RC5,FG^:MWP<3.%7[=$W/_-Y_]F_^
M=_YOU[()A=/&T[2?$/NCN[]P_>AE =MZ;SYC..V?E_OV4&"V\Y,#1$W57!BJ
M=[T^T/M%VA'>3P>Y;5.':+^WV=].ZO*:T\W[&>_XA<(B_P!GE=X=(7+'7_JH
M_P#OC^C^;OB^32@F;VB(=G/ QYY].^.Y3VF//KCSSD8VXSN\_+T_%0K34'..
M^M?'6:MX-FD@GW13LT]=#)4Q;?O1FLQ [=\GRC"Z_LOG+Q[/^>G![9[3_E/Y
MNW/J^S9\MOMFWJ[?OYQG[J":151%[8VO#G/;N :0>W^_^!5QU&@!SCM!_6[*
M!I[7SEW&W5<\FI>$EJN+8JN.AA@M]QJJ=KWRQ]&9[W21N#A$9\M#2-Q;C()(
MN+C_ #T*>N#;2[@M<*7$0,U4VZTDQQ\?@9U6_AXOQ03@)6G&.^?D1V_']O96
M=;=*6W4SJZNE$%+'&99*B5P9''&&ESGO+B-K6M:22<84)];G9J:)_6MW!"FK
M/ZLBJNM0P>\SW)B8?T?@\OB\?E[I:_<XO,+Q?X5<,;WPZXI5_"FJNG$#3USM
MU/;K*^Y,K8Z>9DL+YP'-+=O2R\%[F%TH<UN6L<YH;RT^H[/571UII[K2RU;(
MH:A]+'*U\S8I2\1R%C27!CC%( \C:2QPSEK@/3ZS=S6EKAO\B<#/GZ>?R]/4
M+0OE0X#\T>A67?C35NT1?M0:YM=DB#[_ 'NJ,K+?2T.UL3WPT[F,<YYA=N87
MC9&WMN[K85E?SFMH+="_2/!BIJV"7[2F&H[I!%49,FSI1>P/,7;HYWND^_\
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M]/[0IR[;"_M,WX9G;(CY_?=V;ZN/89/97#*V)SVQEVV1S=^PD9#< D]CW R
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M/S]%W("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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MF-NG ^HKY;O?[YIFEH;/73-A%1/7S439G1B9D%/'(:1F7!IV]1O;N<0_55G
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MHED;%#/#'"\1%Y<6$1M>&D=_>O&0TX&P"(-;K7^3XY7[/I+4.C:+1-4^BU)
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M+!>%$L;^&.BM[W2.&GJ(ASXI(2[;3QAV(7 $?@1E9T@(B("(B B(@(B("(B
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M(UCK'JF2J;/(UYU'<LDRAK01YG(;^Q36@(B("(B B(@(B("(B B(@(B("(B
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M6R@ X<3"\!N2S>$ZHM>;ESR\#+574=-6PZZB@JG3.DK)=%72&&GAB8=\SA)
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M[NS[@\F?=PK"AY'.7*WFE;3Z/NT<-)314D=/%JBZ10;(_A>8F3M9N_8I]1!
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M:;:;Q=[[;Z"B:=CYZFJCCC8[<6;2XG;G<'#SQX2M0'<CU@,L1/*QP?, +S#
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MBZ?@[;7>7S'Q;D$RMJ62.VQN+SXO(?JG!_CV5>\AF]X+1\CC_?ZJ&(N6(0T
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M*#[>U0*2JAF=*TPOO]Q>R0.> 2',+'#< X;AN .5L,@(B("(B B(@(B("(B
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M:;K*ZZZ?H:VX4XIJJII(JBI;#(Q[8YG1-+V!S26N^+LYI+>Q[^6??P$$:UW
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M&5EP.K=8&6K:8F15DS]17!\DL>P[F N=\+@T@>APIZ0$1$!$1 1$0$1$!$1
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MEI(8X0Z0!TCY',C878D.XEP)'WG#L,8S:U1NJJ"CK*APEF=!%(^4 9=(0-Q
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M].Z@[DEINARQZ'I*:.E;30T]7' ZF>YPZ?M4^,[@._<?/U1&F,Y3VB(B1$1
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M-IHQD'\?FLW6#<+))&<,-)OJ;C#5[;#1OEJH:81PU#>BSQA@)#6X],Y^BSE
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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MXU=!#.RBXAZ,K&5DK8W-HFMU#0YGWN(V-Z3IF;FY\+W#X2X@)T1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 6O'.Q1?:' JLMS8[=(+EJ72E%BX/;%
M21@ZAH073O+7;8,_&=C\>>".RV'6O'.HR>KX&U$,#;6QD^I]+QE]TI^I2$&_
MV]@9,TX+F%S@7M( <P.&4MC8=%P' ^2Y0$1$!$1 1$0$1$!$1 1$0$1$!$1
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M=4O9@EC\8)<<CP=P._?Y'/X#\,\NJ6,#R_<T,)#LCY#/^'?_ +>R"Z16OM+
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M:+#P^N.B?R>%ATGKC0U=INLFU189*VSU4YDJ&P5.J:1XB8UX<Z/+7C$9C'O
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M." .K!*62C_24"\B_6BY2.%LM3%+"]^G82T3U(G<8]SBT@M)PW:1AO\ 5C#
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M/HMD=I0C94B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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M)EF/Z+GX//MY_1>?2\0N:>BMT4=SY>;%55,0BZTE%JIL4;O\[LB,;L_V<O\
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MX]\ZBA=TC =H: 6Y!P7@^9< !W/KCU\L*LT>'M+2=K -N7DXQC [_@._G_#
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M$D1(R-#6+_TPB4JJ'.5*XSGEFX2S5-KJZ4?F39VXEV$^"DB8T^!SLB0>-O\
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M0QLD,D;&!Y9LWD9<&X^$?JCLWR[=O)5>S>\$G?._=G>>WG_M_B5 N$1$!$1
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M/ F+R<^F0QH^JR!6%5:X;A ^GJFA[-VYF#@YR' _ZP/["@NQ/&YQ:T[G!H>
M/4'R(78L<TW+6F&KM%1 [=:ZKV(2[F[G0AC7QN\^YVO&?P.,K(T!6M3$'TSJ
M64>!T>TEOGE72I\+ADCM]4%2(B B(@Q7B#!65FA]045OK/8JR:U5+(IQ&'N8
MXQ'N1Y+B@B>WB%J"3<,&SVKL//M-6Y5>NI9*;1=YGCIY9F"@F:VG@PQSW&/
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M8F.! 8X.#'8RX-+<O:"I\4)\SU3$WAI9K?/<Q13737NBZ2DFZD3)&S?G';Y
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M.%I#0T;=D>T.:<$?Z([*Y72R1KFAT><%K7#\"NY 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$00SP2IJN/B'QT=+4EQ/$.GSW^X=-V5S1^(;(T?Z 4S*$N#5;
MNXU<P%O&0R+5UFJ ?3+].6L'ZYQ$/3Y*;4!$1!0]0%R1U=)/RE\,)Z=U,V-M
MDIJ8^SNW 2QO,;L]OC+VEKO0'U4^N[J ^1ZA@AY2^%K:6GB@;+IRGJ"R+P9F
MD<Y\KR?G)([<1Z$G"B)\N1/Z(BD$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 4&\ST;).'NGYG30"BI-?:*GJ)"QQ=T?SBM[,,<T^#NYIR<
MG#'#&3N;.2A'FEM-+<M"::J:FC@<^V<0]$U-)(:>-\M'4OU%00B6%SVN#7;)
MI&[F@G#GM.6O<$$W(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@+7?F
M[K6LL'"UAFI*85'%O2&ULSRWVD?:49V,P/BQA_BP,,<,[MK7;$+7;FPCVZ9X
M?AM940/EXKZ.B8(=A$H-TA;LFWYWMVO+\X<=^P^B#8E$1 1$0$1$!$1 1$0$
M1$!$1 1$0$1$!$1 1$0$1$!$1!YE? [V"62FZ4<CHMK'/8Z1K/EEH<TN_P!9
MJB[E'CJ8^53A#%<7,,DFB[.? <@,=21N:#]0W /U_>I9GJ(&P'J!P8TAKR1@
M-[XR2>V,J).4:"II^5WA%N<Q@DT39]FTEV ZDC<S.0/)N ?J@F94?>V^JK71
M4Q321XA<UK_F2@U[Y(*ELG*7PM%3#3,,FG(V-CCK&5# &NV@%S''WCA@N;YQ
M./3+6$;%L4.RU[Y%;M'J#E(X55C'R 1:>AHR' Y(IWOIV>;CX"(C@>N0<-[A
M;"I.\YD$7&X+E 1$0$1$!$1 1$0$1$!$1 1%T&4 X.1^(QZX001R4UUTN?*G
MPIEO4$L<\6F*.G$=0Z,/VQ 1PGP'&-@9V^+!&YH?EJGY:]\C]R;=N4WA@\/O
M$@_-Z"C_ .%NB^;?"YT;^S#CI!S2&#.\1M8),/SC81)WY!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 6
M$\57R#ACJYC7AK66&O ?)@CO2R8WM>,.'SRLV4:<P$TK. O$>5CC3N.E;L(Y
MI6.F$9%)+B0LC#GD?1K7._LH+7E;<#RS\(Y/0Z$L+_V?9\/^T*55%/*R,\LG
M")@(R-!V%N?K]GP?["I60$1$'S5Y\+5<:SFYL-=TX9K;3\.8A.R+4E)::GIM
MN<KI2#(XOV,8-[CMQM;(X9$<A;!EKDXB0Z!XHZ#M/#NR5=/Q=EMM/4RTUR;4
MW&C=3R-8Z$4D$>V:5C1)O\,+QN$Y9LB?GZ,VZFML?/)?G?8Q?<APIM3:>L=D
MED O%QZT))& )7B!Y/<YC.?10IS$\:.9RFY@_P"1O06K=,Z%MEPTK77BQR7#
MV:26KJ:>4/-54R3-=%%&]\,K6QM<[$9W/ <]H8&L6D;5KJCU)IV[QS:3H(.'
M\L>I+.S4-ZCCFJ#23/A-+$YL3'"-SGR2'KB)@ +G MB>6YL^P:PUIRU6KAY9
M>(NF+WQ"XA<2J+5MOL=G%/3NI(C%#+.(NF=C)('%E1*(R]L;6D.'QY\:OYT.
M<.CLEZ]NXJZ4T[7::M=PN$K[I8(6U=XF,@?'3,(!B=/"!TVM8Q@+&DD/<0Y;
M>\1M8UVI^.?*?>A4/HJ6]27ZZ36QDC9(7ROT])(R0S8:2(Q(]K1AH=OR=F A
M5Y6MMBY9^9G@MQ4O/$[AYPJMU\=HC53[?I:FJZB%\FH+-70U ?.7]2+IR012
M0@[0T.?+, 0R-S'4T7+_ ,P_"V]WW7\_+O9^(5VXT6&YT5_T[UX&TMFN]161
MU1;.]CY6&G>\NV=.1H9AKG30GQ#Z=/MT4CFF1H>&N+ANP=IV[>W;MD%V?[[O
MGVX=;V/&7!HV@EC6^3"0/7'<9'RQ\P4'R2OO*?S6:?LVNM(:=TV^O@DMU!:K
ME5[&F*]0Q41KF-IW&/>X0U5&V$Y+,R21M'BEE:/IAP$L-STEP2X=:)OE"**Y
MV'2EEM=PI2[>*:H@HHVOBSZD%I&5(+:=[7!S?#Y=@\D#N"<=O7O^X?,KF.F<
MSPF0[&@;!DDCM@@D^?XGN@N$1$!$1 1$0%YU9=(*6DFKZIYI::"-TSY9_=M:
MP-W%SB>S1C/Q8QCOA8YQ!XH:=X<62&[W?VVMGKJG[/MEMML/7J[E7&)\L=+
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M[ ?1,5$9>8_O#R&1D_[/4=\>10S@2-C,;LN!/F.V,?7Z@* ':[YO(]25<+^
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ML\!\R[PH-@.JW#G;7X;_ &3W_ (96@M!#O%Y>$_Q^7[5 K.-G,,^XMA')YJ
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M00_[0LBXK/93<-=7U<QJ6PPV&MZH@A;-,Y@IW$M:UY+'OP"/$T@Y6/\ *O\
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M$Y[CM\NW\?/NJA11B4RAF#)^DP\X=^(QW\A_'YG-TB"W;3%GE@^?G]3D_O\
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M:R>E]HU]4L$5-)UPV+_)7^(XC$9'@_I# &0"-[6;*^SN\&7]P<N/?)/S\_\
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M<NW%,SVV:HJ(2=,.+XZB"GCA$SVQ]$5)DAE.X0$@N8^*+J8&=H!3_'N !?\
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M0.S1CBZ\">#M]M,%CO?"C1MPM]++43TU'56*DFAI9*C].Z)CXRUI?][#1O\
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M]P<,EV>[L.R2 L^J.6G@175457<>$&CZSH=5L,%3:89J>%LFW.R%[2QI\';
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M@C/F)TUJ34&E&<0N$<#OS]T;<:>MMLHI&/?51PO+:F@F<YH?T96/E:\1.SD
M@A8O7<N7+WS!_G-Q7JZ"LFN7$_2]):;G VXM;)2-@$<C>FP_H:N%P@:X.PT&
M(!S0'/W39H*UU5'0W&*JJJN647BYR/=+)N(ZE5,]H8/N#8Z/'X_M6&:CY1N
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M()*J>.UU@Z+9JIE-&2QT0>=TLC6C )[$^2S?16L[)Q$M!O-G<XQF62DJZ:H
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MOQ_DDGOE.7UTD]_N\C7.DC:\"42[7,@_HL+"YS7/W]-NS.4'TR%;&Z0PC)E
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MG@;J"EO/.K6W.W3.IZ*KX9R53;6Z6=XH2:VC!B;([$1C:_KN:"UL@:]N6-
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MP/B>PL>U_P"+7.'KZ*$>3>\UIX4R\,+Q515%\X5W"30USEA8!!OI&M="8AG
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M1$!$1 1$0$1$!$1 4"<Z IH>5/BS)46RCK&/TU6PXJ@=H)CZ;9/Q8\[P?ND
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MQY^><MQ\]PPM8*W\F1R>SQ;:?AI5Q32]1DU1^<-Q=*8WQR1[073.^%LKL?/
MW;E54_DT.4J6L%UH^'UPH:X01MAF@U+<=]+4QYZ=6Q[I2\SLSV<3M.QN6H-G
M+??[+=J!MTM=SIJRD=Y34TK9H_\ 682W^*[FU4;I.EN#7=\ N;DX\^V<]EJU
M=/R8G*17'=;M)WZT'Y4>HZYS/]2:5[?X))^3%Y2FU&^W:3OMOIO>_P!#I=15
MC8?>?%YO+OP\2#:.*X4L\LT$%1'+)3G$K6.#C&[]5V/(_BJA4%S=S8I#VSW
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M3IVQ-;'EK>F6 -Q(QFD? ?(W#1$69 B(@(B("(B B(@(B("(B B(@(B("(B
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M;F/<9'[ 6@8!^JP#4]YM%5K#0U3%4L;-47.I;2O=ELDL1M\[I"R(@.(.QGB
M[9C SO4B] .#A( ?'O;]%9OL5"^9TS:6"-Q+G[V1AK]Y;M+MPP0=H:,@AW@;
MW[(,!,0K*W29I[CU!#J^Z=<M/9KA'<=[>_?(<0S\#D94H*,Z*5]+5VB3I4]2
MVLU=<@YP<6EI9%7 .QCXFMB:WZC)/=28C.@1$1H(B("(B B(@*W]E:]CFR-
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MYDII9*; #@.V(MN?7:'>9. V(1$0$1$!$1 1$0$1$!$1 6/:ON3[-IJ[W?\
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MQ\C]J=OQ\)_@I61GJE6K:I?@9#2[^ZKE=;8^F/=X_:C1V(B("(N-P0:O</\
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M-FE+WM:-2W09<YP!=Y-\R>X(\P5-:U\Y/9FU7"BZ7MEDBMWVQK75E6*.%S7
M-=>ZO(RU@[AP<T_L'PAK6AL&B(@@?E$J67'@]-=VTTM.RXZQU?5=*L@?3U'3
M.HKD=DL4A)8\>K"[+?(J>%"/*I;I;5PHJ+74U3GRT&M-8T0J1!TFO#-17(;H
MVN>\AG;MN<XCU)4W("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(BX/D@
MIRH"YX;@+9RE<5GRT['OFT[44K0]KG]ICTP3M!.#\7XJ?!YE:]\\=;3T'*EQ
M/DGD?&W\WZB,-9.V-W4>X.9C=@9'W6_$?U4IWY*=^6Q"+@>2Y0$1$!$1 1$0
M$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0
M$1$!$1 1$0$1$!$1 1$0$1$$&\!*5]'Q,X]FKO(K9:C7],&O>-L@8=/VE[8_
M[K!(&#Z#T4Y*%^#1I'<6./-.RE/M=/K>WSN^1:_3=GVX/EGW;C^T*:$!$1 4
M(\H,]&>5GA.*6YS5,;]'VKWDLI>\2>S1LDC\O-DO@QY9"FA\C(V.D?(UK6?$
M2>S?Q4(<EXHYN4_A-]G6_P!D;^:M"WL,YDZ+-\G?T?(#)]<H)U1$0$1$!$1
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M#I'@8&]^2YQ;M\1)\CM63.MX<_JEYWCR/8@]P02,?=.0!\G'U.5=;2B%2(B
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MN,@ZH/4?&?>?&-YDR/%V$;,*U?;Z>>7I1W[5K74K/LZ(N$N&NZ6_JN\'OCC
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MLS+6Z[=.:>1EQO=96-%0 #"[?@@8)W#>"YF?N8SCR69("(B B(@(B(-3^?\
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MACC&RL'%3@35-#',9K.NA<XM]Y@Z<N[B0W9N )8<C=CPL\\G&LWY'QT!Y?\
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M3QB,MT?9-[87 QL H(N^3C(_#/HNKFD;NY:.+)< \?F+?G=SM[>P2_)7/+S
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MIDJ6TLD3#40AI>&[V@EN'##O(_-:GTW*7QEL=QU976(:=@=;HIH=+N-?(7W
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M3/WO][+_ ,9X&^+PQ^]?[L>'R[*3]XR!\_(KJ=*UKMA>-V<808);N ?">TF
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M'PY_P5PR[6R1NZ.OIW#Z2M_VH+M%YPO=H+2_[5I,#S]Z%7)<::#_ "F5L/\
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M]Q$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 7&X+E6[ZJ%AVN<=V<;0,DG!.
M!YG /E\D$-<;6/K.(' >E>1# .(-47,:<'+-.7O:W=Y8=M(<,Y^65KK^1YE8
MSEPU)3LJY:F0:VE<YKO-K3:;<6D]_([2!]5/G'"CAK.+/ >,W)S8F:SN0-'N
M;TG3_F_=)(YL9^.)T6 /+WCMV,C="'Y(W3]53\MUVU=544M$-2ZCFGI"2-LM
M)!34U,'MP?\ .03-_%A0;U(B("(B B(@(B("(B B(@(B((#Y-IJ:KX&4M?2U
M,K8JW4^JJAG4P)&C[?KNSN^W/[%/B@/DR<Z/@7#**EAII=5:J,&VE%/L9]O5
MW9P)/KGR_>I\04N:3Y*$>3V*WP\$(Z>SSBJH(]7:PCIIFG]) W4ERV/_ &@!
M3@M>>1^CAM?+A8K=%%4M$-ZU+"(JD!LI#+[<.YVEPSEWS0;#(B(('Y031Q<%
MHHK75%U(=4:P;3NE_23,.H[CL>''#L=QYM4ZK7GD9DFJ.66P35(I8I);SJ-\
MC*1Q;#&\7VN#^GV:[9N^??Z>BV'VE*MA4B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B M=.>^Z?8?)_Q1FJ:22O9):&T;6O[;3-/' )/P83U/KCR6Q6
MX+6S\H&*VNY/.)U/334U,[V&F87U3S&WIFJA+\''F6':/[?;MYH-E$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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M76&\-ZF7%K=L<0=(\9W;6D,#WD,(3JB(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@B7FG\/*]Q=)]= 7[_VWS_\ 6"R/A*.GPJTA3,A<R.'3MM88
MR00P>RQY;N!.2/ID+'>:KORN\6O_ ( +_P#^F$J][A%4S5G"[1]7<JBDK*FH
ML-OFFJ*&/W#Y'4T>XQ!F6AGR+7$(,[4=<=)Z:U<$.(%QJ;JRWQQZ7N0-6X'9
M!_19/>  Y]?GZ*15&7,$ZS5' O7U->:%U;:JG3-R@K!&^-K&0^RRY<72.:,?
MM06?*TW/+%PB:TAP&@K"W<WN"?L^#]OHI94.\J]QBKN6;A-4EIR-&6B)S]S6
M'='2Q1D;8W.&2?(9R/(@'LIB0>;<8:FIHZJEI ()I(MC)&D8:?KCO_!1!R@0
MQMY7^$K9-/RVYAT?:G[)&1M)D]FB)EPUQ[S.]]GSR<O:R3LI:NDM::&JCH7P
M12&,N;)/"9HXL-SXXP6GR] 2HNY274]1RO\ "::B9+*TZ%LH(?*<[Q21DM[_
M '-V=H\FM\+6M;X4$T(B("(B B(@(B("(B B(@**^8A[(^7[B;4LK6L,.D+N
M#,*<3MBQ22]^F[X_P)*E/<%&?,<^:#EYXFR4U6ZB?'HV\R,E$8<8MM'(20T]
MC^U(&IG&Z[&/\G-9)8*.MKZB'2NC*J!^U\L%3MEM;&-G!8X3Q%U0"V(@=;IR
MGLYNY;^K0SC5IXP_DY:"Q'V6@-3IG1,+@&20QMDGK+>S>^CW;8,N8T;6@DD2
M[@-Q6^FTJ]9ZY<KE$5 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 5#N_DJU3M*"I$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$&L7.?6.@=P&JZ$L+Z7B_97YE.-@=17!@+F_%YD=@
M"3Y $]EY7";3.WG4XBWVAHJ6GI[/HBQQRTG3>9*.:IJ*EQA#R<%I]FDE[?KQ
M@X<QS6W?/3:*&_VS@MI^YT#JREN_%FT4-3$R65CA#+1U_5(?'(QV T.)[[<
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MI(FUMR9#%5;7RTT0JY1&PG<[=M\LDY..ZD!%A$1 1$0$1$!$1 1$0$1$!$1
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M=ES' Y!';Y]\K8A:\<E\LLW *)T[XFUK=4:I94=*'$,,QO\ 7$LA8!@1M/<
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M1$!$1 1$0$1$!$1 1$0% O'RK=:N)' &1D,\!GX@31O>TRR1L:^P71AB+&.
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MC'<*O<%XE/+56:F9'<J^>ODEJNB'")K<%_PY[^07H17"DGI1703"6G/E(SQ
M]\>G=!!VIJ2VW'BWK"HBINI7LT+-0.C +'X!Z@;U#V&_K/!<<>3<^04*7.JI
MH^3?C\V_5U/3355[X@PM92P2.E@J77*Y.CWS-!W1OEC;AXCA;^U3QK*2WTNK
M=<SWNRON5.W2-0^2FA?(WVFC<W9)"]S6;FOD,$H:6@XV>8R,P>9K)-R6\;Y+
M7::2.EJ9-?2VR6!II9IJ/VRX/I'S-E<'%O5<]H:>WF.GV=A5MP7&TO"6ON%W
MT+27*YSFHGJJFOFDF-,:9X#JJ7&&^0/[5G:P+@Y2FV\/*"CD,+C!/5P!\)\#
M_P"E2>)I+CEOX]^Q[+.NJ,9+7#\1_O\ [_5!6BZS*,%P8\@''ECUQZ_O_!=B
M B(@(B("(B B(@(B("(B B(@+$]2\+M!:QJJ2MU5HZQ7:JH61QT]166Z&62)
MK)!(&L<YI+!N:#@?598B"/ZC@)P8JII)ZCA'H>1\L70D<[3]*=\6<[""S&,]
M\JBGY?\ @G12^T4?!_1$+Q-),.E8:6,%\A872D-C&9/ T;OB\([J0T08!:>
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M'IF01T]5[L/W88WM[R/?]??97.D9))M):.WD=GP]AD=_A\\_]G0VUM9)O9@
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ML96P2#>R5KH^Q$@(+""&D$$?,.&$%VB(@(B("(B B(@(B("(B B(@(B("(B
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M!NDN, :.P/C.\;/3?V);YHI7,Z<MB474QQD[CM^*[47$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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M!T1*R-QR#OD:X!@Q@GS(\U.U/725#=WV?41@M+@7.C.<'&/"X]SY_)!=JDO
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MHO6GX&T\D J6RN-ZH<0-A!W/)'BV@$X![9[(B8B8Q+94 #R"Y7&>^%RB1$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!<8"Y1! '+!6,K-1<=J@00P11<4ZZ$N8?"
M=EJM@,F?+Q?$?[7[U/ZUUY7&T4VJ>/4\$C3,>*MTAZ@^(-9;;8UW?XL@_7_8
MMBD!:R?E#7/BY1]:U#8WX?7V$Y8-K@/MJA[D]^W[/1;-K5'\I'47R'E7NLE
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M(@+7_C+J>6DX\\ =#"&G#*[4EYN(J!,T21F#3MQ8TM9G.W$\V06N;V9XAE;
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M6ECX]N8QCT^;\W"WW3@G=+?9G7:JI^(D(I('/+'23BTW$Q1[V>+:7AKO+OL
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MA[7-=<KG('#RQ[=.?_<A_%94@@.Z5%([G8TW&V"7VR/AA?GR2& ACHW76V;
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M*9H.GI*FK?3XN,L)KI"7F!]PJ7,\_P"Q@K8]%*)\N5:(B+B(B B(@(B("(B
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M<C.E^8B\V_6UGN\%AU93QMHZNLJ:)M725E&QD[FLEICAKWF:5A+R0=@<W]7
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M2&FC#0Z)P<1+4Q2=\8Z;?,]D&W*(B B(@(B("(B B(@(B("(B B(@(B("(B
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MGTQ?UAH>^D2"4L>"*"7ON /^"N^7ND@I> 7#BAIZ66."CTC:(V05&'/8111
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MK5346BZS1NK--SW31T#=/0,FDHJ2+4MP,=!<(S!!!,\%I>YGLD1R=I+6OE!
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M#=K?[*?+D2QS)/TMJC@]K*BH;O#4WW3UOK-26Z.W5D3JRDK:!TCHY&8),?\
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MD_KK]*R3B5=S=H;PQ\?0NI93OJ8Z<D=X"\E[,@9#R/(!!.:(B B(@(B("(B
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M%?,=HS@O#K[5MVBU7!9(C4UMPF>X"KN]13/C(;*T])H:US8PXMR/);N<"N4
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M'B%KBFL5W-E%_#:R-[(S1E\K-^_&,[H).WGV02KM*MG3M+@UK7-!:7N<<!K
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M^8]^^'S_ ,@E5WR_4Q@X%\.Z:2TR4#H=(V>(T<[^J^F/LD7NG$_$1\RK+FH
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M+F"OAE[?Z;6K:I:G_E)JB.+EHJ:2H8XFNU+8XFO &R/%>QQ<\^C=K2.P/?\
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M/<[=-3=.V0.H]07&GN-$]@K8J.V4>R,;\%V9)6#IO#F;&/..P!QROX7<,O\
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M1TX+6B6H;J.W&*,.>0W)/;N4$V;@N50._DJT!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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M'> ,"3+<'</)V?7.>S6YR@HH[W;;E0072V5D-;1U+!+%/32-E8]A&0YI:2'
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MPN4^K77FPT_?-6_R4Z'H+]5VV#4?$BW07,T=4^G=-;Z>@N%8:<O:"7C?1L>
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MTS:XZ*T#;;Z5M,P14@_XL =OH/(>B[HM$Z9I:2HMM+I^VMHJFD]BE@Z# R6
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M;MZ7*GPE$M5UA^9]M.Z)V[L(&X& 7=F AN/4^;6^2"=5:3S.9"^5E/+.Z/\
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M^P45 [5NMK/;7VFSVZ]V^S7LTM+?9;=&UD%360],QRR8:W)#6^)C7_%DK:_
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M6Z&TW<PT--7:Z*1X^0=$T_\ N062+$>&$@DX6Z2> 0!8[>_!\\"",K+D!$1
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M4^LM1<8]/7FNL$5PIZRHH8#J"W0MIH3%.>H=M)#,[L (WR,Z;3&7#Z+("(B
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M1([E7X2-D?/%([1=F.'4SH3D4L6YN' =SGMZ.'<9'=32H+Y/?;G\K/"0W5T
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M&]]S2]6.1[>K&:02,R(P!N8-YD9LWX>6<CF[X5%L$XL_$KV6H:][:G^3B_\
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M*$1$!>#>W=.XV*(/ =)<._?S]Q,[_!I7O+'[W3P?:UAD<_\ 1UY/G_[RU/\
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M #@;.W88&/+LNEW!3A9*-TW#G2KG]O.RTK@WQAV6!T9VC(SM';/?S\2SE$&
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MGK)V1-EHIF G.<[-O^*^X'!YLD7";1+:S:*N/3=N8[8<MS[+'G!0G?EG"(B
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M)S;X08(SEGZ/YD;OXKWUX6F7;M-V@NR'FWP^)X+9?T?ZI&5[J#AK0U<HB#C
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MOZE;0-;X6.\1J8P'>-KO(]\_$/-I:[NLC7@ZFCD9;Z=T.WW=PH2<GT-7'O\
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M+3S5!CB:"]XC&=C02 7.] 2,_,+TU9"JCE,P$C'F"0@]R UX\@?^S*"+.4O
MY8N$8B>US!H73^7-/;/V=%N_YV5,"AOE)AAI^5?A*R)KS#^8]D/B^+/L$6[_
M +%,B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B H+YH+Y[!I72=N,
M)JFW/B7HJD+\MC%)&+Y25/4)<1N&:8,[9.XXQYJ=%!'--)<X=*:,@IJ.>KBD
MXF:*CJ'1/8P43/MVB/7D!R91U#&W QXI8G?<=D)W1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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M7,,C0^.>+!:\.)C.#@R!P;%HB("(B B(@(B("(B B(@(B("(B B(@(B("(B
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MWXF_VOWK97=\VG/R]5K5^4+;')R<<0H*R)CHQ!;@8GRF,2%M?3$M:_#^[OA
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MK0][9G1X>7,P]^?BRK[DE@JK5;^*]EN#X3):.(=1;Y6]4/<V2EL]JB>#MR"
MYA([^$8\_0-ID1$!$1 1$0$1$!$1 1$0$1$!$76R9CW%@/B \3<C+?H<(.Q%
M;^T,VM<'@[R WTSGRP3V/[%7[1%D#)[C=G'AQ^/E_%!VHNHU#&D[@0&@EQ/D
M,#/^'^"[4!4;7?,*M$!$1 1$0$1$!%1U&Y+<]VD _3*&3#F@L=AV>_H/Q*#C
M<,-/GN_@M&>3ZLT=/QDJV6345KJI[5I".G8'5$AJY*>.@L$;I&N>TEU*UT.Q
MLF_<7/=EH&"=Q-=W"HM6CKW=;>]K:FFM]9)$7' #F,<[/_-*A+0/*[PDX"ZX
MTG?-!,K:*OE=+9HS<+K)*Y]#['(]T#<GQX%'2O+CWVTP;OVDM4Q.!LFBZ14Y
M#2(9"'=VD8(/[<X58D& 2"-WED=RH%:L9+>Z5CP]Y!D[/&[<",DX[C'8N=CM
MW  /97R(+5E&YH;EV7AFPR9\9[Y/?'J?W>BJZ$I;T]^UO]@X^7T_']ZN$1&F
M%H*(,#&Q,8T,[-!)=M;N& /V>7R.,=E=HB)%:FB9A@:.T;^J 'EN7_7Z=_)7
M2(-*OR@% VNX=<4?M"VT593T^B:%AE>2)(YG5-9(V3:!Y-=%%ZGX@MS8*F&H
MC;)$X[7-W>(;2!]0>X6D_P"4 K:N'2FL[8^L@;:*C0L/5A<2)I9!)6D%\F,@
M>",>ISN6XEJK;G<;7;ZJ]6P6^JJX=M10$]4L=\NH,=A^'J@]Q$1 1$0$1$!$
M1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0%CU1#*_5U'*RJ&PVVK#8R>[]T
MM-@C^YM/G_G1CUQD*QNJG>-8TC&QNZ+[94N,O;;!LEA[#UR_>?3^H/R[A5H:
M1LVB-.S-!#3:Z1W?SQT6_P"U9$L:X?C&@M.QM(=MM5&T.'D\=&/Q#Z+)4!$1
M 1$0$1$!$1 1$0$1$!$1 1$0%B=Q8YFM;+)[1*&R4%=FG.,22[Z7;GTR&B8_
MZ3UEBQ6Z2R.UCI^D%%-)'[/73FJ:&EK)FF*/:XYR,MEE/E]Q!V</Y&S:(TXZ
M,$M-MIGY],&)N/\ TH+)EC'#M\)T+ISV ;J<6BDV_K?HF@?X%9.@(B("(B L
M2UQ)5"R!M/!(]XNMJ:Z.([7['UL'4\CCX7'U]"LM6-ZS=*RP5QI)GTM1M$S)
MF .(,9!#CGT! SZ_(%!UZ:!=>]3%HQU+K"\Y_P#(*/\ ZJRA8UIUT3;UJ8!X
MRRY19'K_ )#3+)4!$1 1%QN"#E$1 1$04[2FTJI$!4X*J7!\D'SIYM-=6[3N
MK>9C2&J[K4PR:JT/IF"P24UL$L<$D9K<TT\FYK6ETTYD$KBQC&N<XNW,#7?1
M&$NV8=W=\U\_.:#1UDN5_P":;4.HM-6ZMN%OT?I&:QW"JAA>^B=-[=!UH71N
MWQR![ 7.=M>YH#<=,M+OH.T >2M5$0M5$0J6H/#'BEPCT-K+C72<0N)NE=/7
M"HXD5,W1N-V@AGZ/V90=%[PYWP;XW"'>UQ#O"QV[L-OEC]=H;3%QDK)ZZP6V
MJEN&UU69Z2-WM#PP1A\GAR\A@#1D]@,# 554,T_-/RRNLU7<H^-FAY(*2<PS
M.%Z:QL$F&33!CG8+OAWM.,&3$0.[PKT*;F/X&1?:8J>.^B*>HC:*>.MEU#29
MDD:P]04S'2$RX>TC '<^65*QT3IR2G-'/8+9)3=-U,V!U,QS&4Q$8Z0!;W;[
MJ/#3X6[6@9#&XA3EAX7Z7/""DM^I-&Z=N%PH-1:G=&YU'"^*%S;[6M:(G>/I
M !K0W8YVT>2*Z88#S3<=N!MUY:.*EBM'$33-YG?IRMI6VV@O]*R=M5)OBI]F
MR1FZ)LL9<8AEQ9@X).U;1:+M\M#I*Q44XZ<E-;X*;:2TX<R-K3C#6X'A/D&^
MG8>G1+PFX:3?I>'>F7YF]I)-JI^TV".I\'=V'.[E9280X,<6@.C^''D$6C9V
MHB("(B B(@(B("(B O&OPD^RJQ[K@:/?$\Q5##@P'IGQY]<>>",+V5BFOZJY
MC15Z9:30_:<MMJXZ5M7/TH>L8G; YQ&0/#W.$&&\IP:.5[@]L>UW3T'86G;\
M_L^)2ZHDY3::"EY7^$@BW8_,2PN[_P#D$2EM!C&N:*LNFD[M04--UZR>V54=
M-3^[)DG,?@:.H"S/XC'?\5AO*R72\L7")V&M)T)87@-.!@4$!:WR\NX6:ZUJ
MGT>C[U58HVOBH)Y=E=4F"GP(NXDE:'.8P>KF@D?(K".5,'^:_P (MI#L:#L3
M?#\_L^ ?]!02VK">EIZFDFIZQID@,;V/W^9_6*OU9SCVNDFIV.\3PY@(!P,Y
MQGL@B/E*NE)7\L/".*EN$%46Z'LL;^DYI]ZRD@;(/#ZL>"#Z'/?YJ:%"/*#7
MQU_*QPGJ6U=/,T:.M%*74\1CPZ.GCCZ7=SC[M[71%WF2TD;0IN0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1$0$1$!$1 1%P?)!3E07S2Q1U.E-%U;FT4D=/Q.T;*
MQ]4_) =>J2/="/-S\O(QY;'O.>RG,>94"<VCKI'HG2-)1/#):_B7I*'VDTC9
MQ39O,#FO?N</"'!@.W!PXM\G$A3N4[I_1<#R7* B(@(B("(B B(@(B("(B B
M(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B
M(@(B("(B B(@@GE5A?'I?6X%3#,?Y3]: 1QNRZCS>:KPO'J2-K_[LC#YD@3L
MH'Y3H*:'2VOIX;0*23^4[6@E<U^1,?MFH&\_7:UC?P8%/"3OR"TL_*>W.BGX
M(:;M4-PHI;DW6-MJ74SZAC'F/I5/?:#E;IK3?\J"VM@Y?K#54<T8ECUK;7'<
MSLZ/I5/@[=\?M0?,+5KJAEDN\;3[SV*9F?3/27W7X:4<-#H'3=-0PU;6MM5*
M,U<O4GC'29ALCC\3L$?N7PXU#$UNF[W+-$XF*WS5!QCX>EY#ZK[C<-(98.'6
MEH)ZJ:MEALU&TRR8:^7W,?C=W^)!EZ(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B"-]7:8N5+=9-2::%0VKG#3,(.F/ UCF!X)8<.#7 ;OCV^'.T
M- Z:/B9+24;H:TT<L]N89*TPNZ+8V0R;*J1P.[9&T]P]VUI'JLD.JJ:2IJJ?
M[.N[74Q?M:VE[RR,QN+>^01N9@.P';V[=V5Y\O$'2X:X.%P:8J;[0E8()'/C
M8PR%^YK02W:8SDM!+\C;O0>-7:^N5XI'VRBI_L\U=7+:HG=.0N<'L>R*4''N
M#OC><#J$!N2,N:#ZNF]*W9VH!J6\W".=D#6MHH74P#X&O+R27YR]X$CV[SWV
MO=\W;KB76UBBN;H*E]1$ZGJ32P_T6202M,37$M+&D@%TC 0_: 8C@> E>A2Z
MPHZNYTE V.=OM;Y8XFOA=&20-[/BQYQASQ]&D'#O"0R9:1_E49FP\$M#ROK8
MH=G$"@D>9R#M8*.O\@[ )!+3XB!X!ZK=Q:6?E/)*EW!32,D%5-#&_7%%\#&=
M@:"K8.IO!R.H]K?%M\1:WNYS0X-TT1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1
M$!$1 1$0% 5SL]SI^=735W-7&^AJ>&5_I1'&X"9DL5RM3GNE[Y>UPGBV8VEI
M#_FI]6O%R8QG/;9705^Z1_"6YMFIBS!BC^V+<&R[@=VYV7C.,>Y'?L<!L.B(
M@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B NDRCN0PG:<.\ACZ]RNY:F\
MZO,7Q@X%VRRR<-[%IBKBO_5HHY:Q]2ZN@E9$9'/CIV].*1H;CMU0_O\ #AKM
MH9WS6U$(TIH6F92S3F7B=HQC>E)*R. MOM(#)(U@(=&#B/$F&;Y8R#O#&F=U
MI[QLXZ:%XMZ<T?0\,M2V2\&DXB:1J+G;JAIH[PRC;>:)L3Z>CJXVR!KI9:=I
ME/39LD(&[?WW!W!!RH2YL!(S@W$Z.GIY',U?I!PAK9NA3N>-1VW;'))TY QA
M\B3'(WSR'>LVJ$^:*FK*CA90T=,V-LSM::.8UE4TOIWDZDMH'4![;?[(*";$
M1$&LGY0ME-2<H&MZB=KVQT\UFD:V,M+3+]L4A:-KR&X+B/-WE^Y;-8"UD_*'
M1-KN4#6]/#/18'V15.-0^-L;HX;K2RY D<UI!#"//&2/3NMG$!$1 1$0$1$!
M$1 1$0$1$!0;S34USJ>'5E925$=%2G7>B_;9&QC>6.U'0-+6NSW<)"'=V@?5
M3DM>^=AMP?R_W**RUIH+C/J+2L=%5EP;%'*+_0N;(][L,C /?<\AOEW2-N!:
M\50+CQ+X"T[8ZN@-?K"IN'@F@C>UK=/W+=3!K2-[7"-H>1N(:[82QKF@S=J3
MJ36YH>XQ8KZ/O$>Y_I42@OBI6U]NXI< 8Z*.29C-85](8(*84KFM%AN+'M$)
ME86QQ^-S1TY&M86.Z@!'4GC4NV.V->[R]OHO+_RJ)&>J7N(B(T%Y5[>&6.L<
M1G^C2G#AO_JS\\+U5YE[ ;::W=W;[/+Y?\F4'38J<TEFH:-L+&2-IXM[8Y'.
M;\&.SG#)7LKSK;TQ;J6.D&Z 01;6Y\A^*]% 1$0$1$!$1 1$0>%J9@;;=[B(
M![;1NZOQ?^%1GX5[JQS6DS:.QF=U2RD=[70L%0[Q $U47HLC0$1$!>/:IFQ4
M3WX<&QRS..1M_KI/GC_M],KV%CFFVU5/98HJ^F=35.Z0.C+FEP!>]S7=G.P,
M$$#.6^7T0=&GA2U;KVUDHEQ<I:>;:(F8 8QIC\&2&]O7#^ZRI>%:*FGG-Q,<
MKR65DL9W3&3#]K78'C?CL1X1M]?"O=0$1$&/U$$OYWVVH .R*V54+O"?B=+3
MX/EY>$_P60+P*B(#4U(W:W_(YGYVM\NK%_97OH"(B B(@(B("(B O#TY/5R6
MYAK'1/D%1.V1T9+AN$LF6^7F,?A\B5[B\&Q;JBVF4%TF)IHR#W=X)I&]([\]
MV'MN]<?+N@]Y$1 6/T+W_GA=F/&6_9]'_P#):E9 O"I'L.J[K$ 0\6^AR3Y>
M*6IP@YJ9)SJ>C;L'1%%5-W?4R08_P/\ !>XO(G/_  S2TG3=M]EF?N_\[%V7
MKH"(B#P;^)8J6E--4&+^GT@SL#LM-1&7,[_K#U\QZ+VWKR-01N=14I&/\NI'
M?LZT:]=Z"M$1 1$0$1$!$1 6/4\L<VH:Z#J#I14E)+OZI]9)O[7_ !;?XK(5
MCE'#,-9W*9SAB2W4>#O?_G:G[N<(,C1$0%CM[BC%UT]&"[_+Y1_]JS_]59$L
M?O?_ 'ZT[_[4)O\ TUJ4%6J ):"E#QW-PH#V^8JH\KWEX.IYF,HH/"3T[A1D
MXQY>TQEQ_8WQ'Z?->\@(B(*'=_)>-I>I%=IFUUC(7TXJ:."1C, . =$,9]%[
M)[>:\72#*EFE+$RIZ9F9;Z8/+"2TD1#.,A![J(B B(@UCXWW""BYF.$5+7WE
ML+*[3&JXJ>F:Q\F^<.M<I>_Q 2MC9$90UV?@[^BNN4N-E!7<;.A)(Z-O%*M?
MNE:V.20?9-LS)(V%K6!Q=W=AG;/=8[S'WFML_,'PJN%OEK8/8](ZQD,4,A9[
M6Z5UKA/4#7B1HC#VU#\M=@1]@7 EOK\EUQU#=&<6JW4U;%47:X:]^UI)J>$Q
MQ&*HLMKEB8TXQD,=W;YM(.<^H;.HB("(B B(@(B("(B B(@(B("T#DYW^/%]
MM>LN)^D[%H"3AOI#5C]/U$=TZPO(A;-TA))$V8 %SL;=L9R-WEL?MW[W!?,/
M4M=;-0<;>(',I;= :6O>E],ZVMM/74=:]L=8:B "F%;"&[7 %U)'+AQ=NRUP
M!#)-P9K:^>WC;7U]_O%+9=,R6&W172:IE;8:^86,1-#Z$5=0VHVCV@;S[QL0
M:(W["\8SVP?E N+%OUC:8K]I/3LNEGOAJ+]44=NK&55)2BGW5,C![0]HZ3O/
M>&X^1\U";.*NJ=)\&-::8L6D-*4W#_6%]NEOO-9505\CX65+63>R>VL=L\,,
MSF-#M[V%Q>T CI+)F45-P0LWYP73AG25NN+C:ZMM%5WJ6N=1U-/5UK**2.J@
MD='NIS!+$< $=1[1OQW1;3^+?GE]XC7;BSPBT]Q+NE%#3R:D%37QLI]SFBF?
M42BE!#@'9Z'2+NV,^1([J31(TAI&2'>1 SGZKYOZ2XU<S?"EE!RWZ/TSI*HK
MM!53K;(YU-7U]0ZCIR9F1LQ,QSVR11,+3C/3.2&GLMX^#>H-:ZNX8Z;U/Q)M
M5+:=2W.WLGK**DHIX!2R.^X&5'C:1_: _<BJ0$1$!$1 1$0$1$$><4N)EDX9
M:.J-07%@K*J7J4%EM,3))9[O<6M<Z&CA8QA=),\L<-H![@YP 2,19K/FI%%2
M7 \'-!.J)(JB6JM[-9U)>UK=O2VS>Q[<G=W!;Z%8A!>6\4>*>H>)5\M]75Z3
MX&U]RH=-T%#%U:JXW:.G$5=*Z%SW!\U.6NBI@&-_3$[W=3M@IY_]063@S9]:
MZKX7T#M?7.^5ULGT7%>3330TU*Z9CJI[98G2Q8?'&W:]C3F1A[ D@)?GXCZ]
M-ZIN''&K0U%I^W<0'RV6R72QWA]; :GV26>9DKY88NENC9(8\CQ=-[0-V ;K
M^1'B6[V"6?F*U/6S6VY2U\$M99K3))"Z3JL=T^E2MV'HSRL![CN/"H,NO'EW
M,]6VOA15Z#J=&-UM-<9^'.KIJZ&JJ77:QNAJXJIU.Q@,'2<1(27N;NCDARX2
ME;*<%^*M!Q5TA7519-'>-.W6ITKJ&CGV;Z>[T;PV>++';#NW->QP.'->T^J#
M$9[)S5Z&H626+4^DN*#J#K;8+W1BS7:M#OT8=5TSC3LZ?KBG]Y_861:0X[6V
M[ZHI.'NM[!7Z2U?7S53*2@K ^6EN$<'Z2:AK&M$<C#YAKMDI'BZ8;XE*?L;"
MUD3@',B'A#L$'\1A>#K+AYI?B!8)-+:QM$%UM-06&HI:ASG!Y;W'BSN!!SW!
MR?(G'9![3:^%\44H=VJ'[(@2!U/D6Y['(!</4@*]4"<-;GJ#A%JRW\!=85$]
M;9ZJ@W:,OU6]LE761T[(&2TE9("W-0PU#2PAHZD<4A[%N#._7;D M<"X.(&.
MY ]4'8B(@(B("(B#2_\ *!ML\O"[BO/6F".N@T+0FG+W=@?;Y0YOXD.=CLMR
MVQ/: ULKL>NXY/["M*^?.OZ.F>)%B9444=1=="4E/3QU<#9>H]M572DCS(<6
MQY[CT[X[+=.*ICG:V2'+XW-#VO;C!!0=R(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B K;VAGB[_  ?%CN1VSC [YQZ851E:"[<X -!<2?D//]RU
M<J;+PKYCM15'&/BQ)9:CAOIIDMATI#<J^"*DGK(KB^.NN1>"!LEEI:"*$.D<
MX-A>=H%0,AM$)V%N\/&W .?Q\NWGW]/FL>N+;HW5%LKH*9KZ06ZIAKJALC-[
M7[XG0X9G)#MDP&/UNZB^+ETY9JB\3VNET19Y[M1]?VFWQU$Q;#UP#(7TW6V#
M<' _#W&=GDK'AC6VGA)K631E-J:*IX?ZSE@DT!)'*VHIH+E_2#76ME1N<YW:
M!E0S<1GW[1W800ES3COS7L%EL=13RXMM#%0@M&_M%'M<3CY]%V/Q;Y=\93O'
MR*ZFTY:7;6QL'AV[!C'GG_$KNP$'#7!WDJE:.D,#L/!Q^L/)7(D:7[!YXR@J
M1$0$1$!$1 1$0$1$!$1 1$0%C-;'6,UC9NB]PA=15\4K3\)+GT[@\?VO ?\
M7<LF7B5;Z@ZDMO3C#H&4]5O<#W&>GM0>?PV/4X=:;D: QK[+1/:8_(@PM(Q^
M\+*UC.A:6&WZ)L-%%N;!36VG$._SZ;6-VY^N LF0$1$!$1 6/:L##:9BYN>I
M+"QIS\+WR,8R3\&%P)'J LA6.:O;))9GFF@?*634P<&$$B U$1E?Y^36 N_
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M '.._HM9N=]XA6?,%:Z&3F@X2N?2B2LK])ZU@!:P335)ABMTL,4+,_&V3Q#
M#LCL1YKT>4>6QT=ZXZ:9ME5'//;N),E4Y@IS"[WEJMS<X.W.98IV ^1+#@D8
M)#9E$1 1$0$1$!$1 1$0$1$!$1!;RU+(8^HYKB/D!W6C=DX?TO' 5/,#IWE;
ML3*O4\E56N;<.(ESHV5-?;JV.FHWOIH(A![P"I)PPAP!#B1*3+O.^'>_Q8V_
M):U<DMNFO_)MH^W2UMQH6W"VUU'&]LL?M$,3ZRI8PB2/ WM;@!P/W&GSW9##
M;AP.O]QX357"FOY8+(_3M1J-U_DMD_$ZK@;+75%4Y\I+X8FNV,;,7L9OVET;
M#MSW7I\0M&:KXOU%RBU5RWZ7NU9762.U2LCXBSBII*8SBHC="UD#6#=+#'*U
M[70O/3&2!W6I/$O@YJO1'#>FX73:-UQ76>S<3+]4TUZIXY):B=@IHVPW"3HA
MC\%H+C4 %O9V"T@@9'P$'$^GYN])ZOEX6:TNU;7,?1WFX5- \M@M<U)'&RHD
MJ9F!KQ$QL4C!D/<R21K6N):'%-$)VX-\ ^!>K]9:QM$O#74>@M9<.[I]EU?L
M>N;A6.=37&DCECGZ@FVN=-')AP<P2$^)SB[+EMQIK25-I:R4-CH[G<ZV.@@-
M.V>Z5DE=4RCT=+/,72O=^+E"7!V6TU',=S#4\D]$*^*\6'KT[&ELS:?[$IA&
M)#V!:725!&-V-PR1V"V+1<1$0$1$!$1 1$0:\ZSW<%>,MEUY9B7V#BIJ*"Q:
MKI"UTD<%QDI8Z:UUL78=$.%.RFD(?M<9HB(W.!<+'77)'P>U_I:\VBN%71Z@
MNM]N5_CU%3$LN-++6UOM4C&EP+7,[-A#7,(Z30/C]XINU=H"QZYL$NF-21R3
M4$ABD:V*0QNCEBE9-#*TCN'1R,8YA^Z6CS6%5/+=IBLJC-4Z\XGR0>T>U"D_
M/Z[-BW?J9$V[9]-R"#=0<OUDY?M9VS5V@+_J>^:EU%6S:<T)8;K)3SVW3UQN
M+GSUE? QL8>UE-14[WXRXF"&2(N=U1MV,X6\'],\*+!':-/TTDE9.&S7>Y3/
MS4WBM<YSYZRJ.-LDTCWO>YV!DN(&UNT#&K-PKX><(A+Q+ONI+W<ZFPV^2.2_
MZNOTU<**G#,RRMEJ'.;"7XPYS&DX);V!*\WB%SB<&M#T%LK*#5UJU5+=KE]F
M0TNG;Q;ZF9K_ &>HGZCP^H8UK,4SV>>[>^-NWQ=@GA%JQ+^4-X-004\\VGM5
MCVDP-:UIMKR'31NDC:2VL+<N#2&]_$<;=WFKT\^G#$;1^8VMR]PW!K8;<[MN
MV9#A6%I\?A[$]Q\NZ"4>./#:7B7H"OT];:Z*BOD#X+I8+C/'UF4-UI7MFHYW
M1N#FN:)HV;QM\4;I&8PXKNX,<3:/C!PTTSQ'IH*>G;J*VP5LE)'6=?V*K<WW
MM*Y^ 0^-S7,>,##VN;WQWBW^?)PP=,Z(:+UK,&;>I(VFH@UF\$QYW50)WM:2
M, X\.[:7L#N>3CB+9=;\/M4?9=IJ:6BMNN]2MC=41AKJF.NN4EQ@DVL& T1W
M")GA+MK@2<#N@V3W!4F5@P<YW>6.ZX) \\^6?)8CKS6[M$Z=J+^:(58CJ:2D
M$'4$089ZF.#>^09+6,,K'O)'9F2 2,(+NV<0-+W>Y4UHH;FQ]76MN3Z>/_.M
MH*ME)5$$=O!-+&W_ $VK)MP6HFB[Q?M)ZNT9K&Z--P?>+IJNS3TE(P,BI&5F
MIZ*![HG'!(ZKHGDG'NXR!GXUMP#EVW_I"#L1=63D-^9[=PF26[F8>#^J0@TG
MY^81%HO7FHIZK88M$.@ACCI&O=,9):BGEC=,7>$$5+LQ#N#!& [=(&K<VVT]
M0VAI>L6QR11,8^.(Y9D>>,@'"TQY]ZN"V<.^+5PI8WNJ)=$VIDE+%'[Z"*6X
M5-,:AH=ANTMD@,G8$,I1D^#"W7;/'B-[3ALGD/V9_P $'>BHZK?#X7^+R\)_
MBN0_+G-V.\/KCL?P05(J=P^1_<5UMJHWG$;7NQV/A(]2/7ZC^(/EW0=R+C/T
M5/4\.>F[/?PX[G'\$%:*G</EV\\^BXZHQNP<;=R"M%1U/^+?YX\OKC_M56[P
M[MI\LX0<HJ=Q_4<F]GZP05(J.J",AC\?48^7S_W[)U6>(Y[,\R@K1=;9=PR(
MWY!(([9[''S]?-5;\=W M_$A!4BZ^O'XN_PC\3^[S]1^\*O</D?W(.45)>P>
M;@J!41EQ;GR&<_/S_P!A0=J*CJ#;G8[TR,=QE'31L+6O<&[O+/9!6BIW']4I
MO9^L$%2*G>S]8)O\>S8[RSNQV_!!@G&'1NK-:<+=4:-T/JDZ?OMZH9:>CNIS
MFFDD[%W8$@8^62M5^/NDF<=.2'3T7!SAE71U=ANEOD;H^G$K)J"NIJJ6DN-#
M*9-CI'0EU6R1SF^](,AW-=E;Q%S'CLX+7G4%LU=P3XK56MM%:4O.H]%\09I9
M]26JU00NJ;==FPP-BKHF2/9EDK(I!,P-^,]0DEQ"#2;5/!_C17<8-8V#A[PQ
MU73:CBU!J6L=?IYVQBILU6QT-,\3=P34"&OP,#S;MZ66YECA;:]<VKEBX9\
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M2PH8Y1KC32\L'"@15#9S#HNPPR=+Q;'^P19!Q\O53.@(B("(B B(@(B("(B
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M4D!+@&[IPUR\,LE*2]K<WFU^9^=? /\ I"A?B524%MXD\ ;E?B^FK_SKKZ&
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MD0-C>81TZ5HSN'D3YI5M5@;GSR:K?4N=%16N-H,C0Y\\@+_"WID>#T<Z;=]
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M@TYL<O3.QQ9?6E_CQM\G-(&<XD<@V61$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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M'48T/:Z/J&)V \-R$\1ES?C[_@NU<8"Y0:Z\[]RIJ#EWO==7QQ2TD=]TQ(6
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M#+U3)A[XG-<0T-FO0/"^'2%1/J/4NH7Z@U;<-K:^_5-*VFEE:T.V01,:2((
M7.<(\N&YY/GA99>]'V'4MOGM6H;72W&BJ,!]/41->P#U(R,[B?%GT< 1@]U"
M-COU^Y?M96/AOKK74-QT-=+9.VTZBO4L=-54UQC?"/9)Y06PN#XM\K'/8TN?
MX @U-_*S4,=?KG0M#:265K=.7.2=L;3M=$ZII&1[OHTL>1@$C![%;;W[F?X8
MZCIM=:;;HC6FI[?IF>X:>U-)2Z?DGHJ=\4>*F*1^6AP#9/$&[LM\LJ /RA_#
M2:_\9>!]^?6FGHM47RGT%42MHB]M)[34QR,G86N(<X[IF[3C+FCS'=29^3YM
M,=ET]QJLU)5U-3!:N,^HZ"DDJW[Y&PQ,I8FG/D'8#LX SE!D>@-,S:JM\<7"
M[F;EDX>QTT#:2RVBDIG7"@#\/AW5SFR2C<?UXA[OL,_&IUTSI"PZ/TU;M'Z9
MLL-%9;/3PT=%2Q$-8R%C-@  ] T _4Y_%8?K;@C8M2WB#66GY7:8U?12.GI;
MY; V.8R&/I[9X]O3J6%O8]5KL#LW'FNWA?Q-K-7T]XTGJVBH[3KG2L<$>HK7
M1U(D93=>+J0SQ.=C="]N[:XX.8W@@8P@@ZFXMZ)X'\3.:/BMKQURAL=AO^D_
M:G4]/U,]>T4$#-C<@G#W-SG'8]L^2]SB=KW0&J-0::U#472Z\,];VVMEMFGK
MSJ/3\L<-4R?8:FDQ(YD<S'QQLR7/#&O:"'>J@'G/IY8.#G.E< 8FLDU-HF#P
M1D2;F4UCR<Y\O>=OVKZ!WW3-HU58ZS3>IK52W&W72D=17"FG!=%41.86O:YI
M\QW^>?JIS(C3AMPSU4-1,U[Q0X@4NLKK1F1UF@H+>RAM]KCE:]@D@C#WN?,8
M9.F9B1[LANW)>XZ]?E28XZ;0F@ZF*#;65&HZFG;MF+G.:ZW53W-VD9:S<T%T
M@^%HP?B\,O:L95<K%%5\1;-<;S<^'+:BG9<]-P0FJ^Q&3RM;[50@8D,0FD,D
ML9+MS'$C :,QK^5$LTMVY8J;7]HK::>/2%]H+L:B*7+W4U4V6B#F/ PXDU<6
MT_#YDAV H&2<'N-G#72G!/AGPLUHV^WVXR<*K-J.LIV:=FKXVVR6 0[9.E$0
M"2V0;3W(A?\ 0'W]":;U/6VRMIN7OBY8K;I"DN1-';*W3\E=+;'F(=>B<[VB
M(Q;3)%(QC]KHWY:YL@"< M'V/AWQ=U1PVMEV-:=,\+]"6BIGF86&;V=][B$I
M8!M!>SI/<T$C+SWR"I"U[P-T]JF674^GPW3VMH89!0:BMQ=3U#9"X2!D^P^_
M@=(UKGQ/RQP&"$'N\/.'MAX::;H](:?EFFI8)*F<2U<IEFF=43&>9SI, /<Z
M1SOH&AH P,+732M?/5_E-M;TTD18RGX94+807L]^P5<3]S<'R#I'9S@X]%.N
M@N(-5<+K4</]=LI;=K"U4[:RH@#L1UU+AH-=3Y[&-LCNF_:7;)#M=C<W.O>C
M*"TU7Y43B)(8X_;Z3AS12,=M=[M[WTS'.'IGIX;CR]4&YZ(B#&-=Z!LW$32%
MXT1J)A=;;]22T%<(NSGP2@"3&<X<6C =Y@]QW476_A3QRTM;Z716C.+]MCT]
M0]Z:[WNTRW2^QQF25WL[Y9)PR4-8]D;9G8=L!;M!P]3PJ>FWY(,3X=<-[-PR
MT;;-#:=EJ'4%J8_I25,AEFDE<XO=+(\]W.+W.<<^KL>0"TJ_)C<8^&MKX?,X
M72WM\6I;Y?[A<H(9A(]E1&Z"+IMC>6C<YT5.7AORAF^7??\ ,S<X:TN);N:!
MCQ?@OEQR&0TU3P^TQ/52TL553<9HY+73;'>USU7V%4B2)YVX@@$&]S=I<"8Y
M,@=1!]&^%\1BX:Z6C($<C+%01E[/4BGC!['MA9@L8X?-#N'^FPSM_P $4?G_
M ,C&LG0$6&WOBYPUTS;M07?4>M[/:J+2D\%-?)ZRJ9$RW23-A=$V<N(Z9>*B
M';NQG>,+SKEQ^X+6:LOM%=^*.F:%^F*>BJ[RZJN44,=!%5O:RF=*][@UH>Y[
M ._;>S.-[=P2&K3V/+ TL8WT\#B"T8]#_OW[^?98R.*W#]VIK+HT:JH#>]1T
M;KC:J$2@R5=(T9Z[,=C&1Y.S]//LLQ01V_E[X&O<7OX,Z$FS)[1B33]*X];]
M<$L.W\ %;/X5<)-%5E#JBT\+-+TMQBKZ6.&LH[1315$$T\C:=KV2-8,; \ ^
MI:T>K0I-6+ZSBJI+32PT$6Z3[6MDFPN .P5\)D=W[=FG.,Y[=AGL@\ZDONHY
M[S?J"FHMKJ*OI60-J'L\4;XHI)-NUWUG:,_>V^F2/<FFOX),<D)$75#\4Y\6
M6;F8][_H_CY=NZYI9F5MQN$3*:$.HY6,DE$OB<_8V1O;;_: _!7OL4,>WHP-
M\_%EY_6W?+OW06--67:"H]@J:5SH WM.' O)PX[?/SPS/X.;Z]A87:GNMPM]
M5;ZRGAC;[IT#G,'=[)'N'D?E'%_'Z+TJJGJ>L6MIX!!OZP]Z[=U,N/R\LB-W
MG^L/+S[*R&1I;LIH9>C^BZDCO[/GV/\ :_@@ONO'_G.WZV#M\\>?EYKMZK/K
M_O\ [5XGV0S/4^SJ3J?K9[YQN^+9O_2?VO+O]%7'!4M^*AA]/*KD^[\'W?WH
M/5,K1WVOP"1G:?,?[^?DJMQQG:<_JY&?\5C0TK;OT!L5!T/9I*3]*[=T7>3,
M;?XYRO3J:&G8[VAE-NE^39#A!Z0>W=L+@'^>TGNNDU3!((^Y+B ",8).[_JG
M]X6/16RIH6AE%I9[8Q_5Q7'HQ_\ H;,,_@K6EM]5%5P5L&EY-[Q'#3@W#M%"
MW=F23Y.]]+Y;OAC_ -$,K=4AH+C'*</Z9VL)(/X#OCR[_4?5<LJ8WN#6NR3]
M/3Y_7S'E\PH"YII*FS\$I+;01UUGBK;K9[/#+132-Q%/5LB%,XT[FNZ<Y?[-
MC)8WKM.!@XU2TYH.76_$_B!1<)^42USG15%;;146#4FN9Z66DK8Y:A\SH'1.
MD9)'4-CIFA[G-&:;Y$E/ER/I.ZK:QH?(XM'KD^7^WOV[9[JKVJ,",O):)3AI
M<,#X=WG_ +]U\_APBX[3FV5=)R*Z4L[2;B:N-_$N:HKR)9MS.M*R6,.Z@R[O
M(_=+XG=$>%7U!P?X[0RDU_)EI\U%4,LK*7BO6QR ]#&)LR%TGO>_9[?#]4'E
M\P<-QC/.!4MT_1M=+7:"=!5/R7S"**E)<YK7,#Q%N.T&0.)+>_B;GZ''XL87
MRPUYP3XJ:-T7Q1U=QAX',T[17VMTQ4RW&UZJ==K33-HZZ-LTU5025#IJL&*0
M.+7AWA;)MZ9/?ZFQ[FLP\@N^:(B,.U$1$B@WE*T_)HS@%IFPUNJ;)J)\$]SE
M?>+-7&KHZT27"J>)F2C(:"-I<W/@=F/S"FF6<10>T.#BWSP!W6OO(W8J?3'+
M%HZQVNNHZFCM[[JRFFHI(S%/";E4F*8;< AT?CQCQ?$<.0;%HB("(B B(@(B
M("(B B(@+ >-%=3T_!W6KZNNI:02:<N;!+5/Z<8+J:3&21^]9[N"C_C52R5/
M!O6]"'P-=)IRYO9*^G$D;/Z-)C+'$CL@\CE:J:>;EGX3313,=&S1-B8YP/9K
MA0Q @_4'LI544\K],V7ENX6RRRU+WU>CK-4R.EJI)I-\E)%([$CR7XW>7?R4
MK[2@P+C75LMO![6U76331Q0:<N<IDI8-\K-M)*2YK ?&?[)P,KR.5D_^LS<)
M9?3\P;!^/^01+W>+@9_)9K)D[961BR5O4Z4NUY88),^+OZ?Q7A\K+2.6#A(P
M^9T'86_M]@B02JL9UK--!I&]50+896VVH+)W D0R")^U[PP%V!GOM!^@*R98
M+Q<K*FT\*M97.AI:DU5%IRYSTOLS6B?J1T\A:QFXC+CCMG ^9[H/ Y5&2,Y8
M>$<3R"\:&L7<>7^01*52,J+N5HXY:N$N?_=$L+OV>P1*4]I2=^2=^52(B B(
M@(B("(B B(@(B("(B B(@(B("(B B(@(B(. <J!.:J[S06[AQ:C3.(N7%/2E
M.'&,NVMCN#*HO. =H+:< $^N0IZ'FM;^;V@944_!R9M9543J7C!I5S'4\N&S
MXGDRR7U>UPD< /UR''"(F<-DD1$2(B("(B B(@(B("(B B(@(B("(B B(@(B
M("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@+I
MEE;%\0)_!=RH?'O\T$+<KKJ>;A_?*NEDIG15VOM:2Q2P[LSQ_G'<NQ#@-I_#
M*FQ0WROR3R<.[U,[;L=Q!UMTX=H;TF#4ER[#'JID0%IK^4XWU' O3-/3CJ.?
MKRWR@M(P&-IJMQ)^GA+?Q(].ZW*6FOY3B6GI^#.DFU%2:?\ [N*$^ $@[J*N
M:&]AY9\7XA!\X-3.)LEVQ&_WMOFZ7;R]UZK[=\-6@<.M+CVFFKF"S419/2LV
M0RM-/'AS&^K2.X^B^'NH:^9]DN&-ONK?-G_T)?;CA!3VFW<)M&V^P/EDMM#8
M+=34CYVELACCIHXV[@?7:._GW09PK*HI(JR%]/60&>&8.$D4@W-[?)7JP/46
MK[F*V>WV22/JT[X(7;LX=*_SB!&?']$%IJVFM-ONDMU-X9'-/!LGM\>P-F!_
MK' Y_P T_P#<K/1VHM3U=-75=)-#<6$P], O>1M;"Q_P@^; ]W]X_+NO9LFB
M"YHGO+YJF;HNIA(^5VYT8V_VO,X?_P"B.68NH]S6L+FEN ' L!S\/S_NH,09
MJ+64M8RDDL;*4^T^S221$S,/O*<[P7;3MV25 SCSC/;L%G"M2WN,[NX<T-P-
MQ ]?\?\ 65T@*G=XMNT_CZ*I>)JF_G36F[CJ)\9EBME'-6RQL ,CF11N>X-!
M(!<0TXR0,X[A![ E#FAS 79]!YC\4;)N#2UCL.]2,8_$'NM'M-?E*+AJ73E)
M?[?RR:]KHIBUL\]JS5PAY\@)8X2PD_B/-3)R]\W>@^8![M/VFWW&R:HHZ:2J
MK[#<@X3QQ-D$3RUY\RUSF9;@. >WMW03TZ.9Q[EF/KD_+_\ :_@J"(!L+I/C
M.6]\9[[^W^_DJ15L+G-PX;>P+@ ''+A@9]<M_B%I;Q5_*9Z.X=:XO>E+#PAU
M9JNETQ>);)>[Q32QP4M/61.+961@EV0QK2"7%GBP/J@W2>UOCEGE<PXRUQ#?
M=CZ.PJ'4L31O=F1Q(# [&/B\_KW_ '#X<>2U0X@?E!=,Z=Y?:;CKH30E;J6&
MHU4=*RVJIK!0U5-.&22;IW,CE#'F)D<H9@G;/'Y.W-;L)PWU[0<0^&^FM?4,
M,5/2:BM]-4=(R[XX7S-;M8'G <0]P:<9!(P,GS#+71TTK7.=$P-R6AVW&T@X
MP?VJIL$1,AV#;/\ $-N3_!8GQ8US4</.&&K=?QT+:N33%AN%YC@>=K9G4]/)
M, 3^$9./J/V1]RK\P%^YD>$T?$BZZ+H-.F6[U-MCIH[I[2US(0&.E/A86G>7
M^Y< X-82>^,A.1W%VTQY^O;'^"I;#( QID+@,;MV"3CR[X46\Q?,;H;EJT)'
MKO7;J]U)/6Q6^""BINK43SO#G!K&.+0<-8YQ[]@/F0#)[:ECF"5N[9G!=C ;
M]3^WM_V=T!D3-L>V,@ YRYQR.^>P/?\ P[(8H=P;CSW=P3@?//\ T*.^8'C-
M;N7W@_?.+=XL=3=:&P>RAU%2S".5_6J8J9F'N[=GS,)_L@^9P#[?#/73.(_#
M?2?$*@MSJ&GU/:J*[QTSRTN9#4P-F (!SN ?M(&?$TCN/$0ROV9^?TG<CS'[
M<C!SV\NWT5PK)E?%(7"-LCBUF\@,^N,#YG.1],'.%6VKC>1M)(.>^,8Q]#W^
M7IZA!=(NKVAF'N )##@G'JNU 1$08W-H'3-0RL@ELU.8*\/%5%N=LEWME#W%
MOHY_6EWN'B?U';BY=;.'.D8::.CI[)!'#$]\L36N<#%*[^M8?23^W\7U7LBY
M0.(#';PZ0PM+'-<#(';7-['S!SGY;79\EQ#=J.>6>&*9KG4KS',&N:[INV[P
MUV"=I+"UXSCPO:?4(/'9H"SP>T.I6OCDE$C8W.D>]D#79PQD1/3#6[C@8QCM
MC"P*E]HT9J:W,C,SZ6G%):)Y7UL0CJ(9NL&O<7N $P/0>6G#BWNP.+WALK"Y
MTI8)#,P-)V!V]NW?ZLSG&X8/;/H5%ETK([YK:VQV2.%L%774A%89'8F,+Y)2
MTEI>Q[BRCC#7.#7-:YXSN?M03$M)ORJ+WQ<"]'1](DR\0;=M(<WM_0JX_/\
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MHKK3&ZMDIR^X  -F+!)B*4]/L]N\=B=IWCL3MP"1[A[>:"M$1 1$0$1$!$1
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MSG;EV&EP\AN'TS_CY?5!W(NLSQB01D^)P) QG('FN'5#6#NQ^=P;C;ZD=O\
M9GRR@[45!>02-COD.X[_ (=_]\%.JPN+0X$M\P#DC]B"M%U"=A#2 2'=NWBQ
MVSWPN1/&3M\6>WW3Z^2#L1$0$1$!$1 5.TJI$!$1 1$0$1$!$1!B^MH'56F+
ME;H3&'50$$<DYW,8^5^W<YIQAH)SZG&<!66IV.?JS2$C*KHS,KZF=T#F-]]
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MNIG1.#&NQV$D;,Y03KPWX=Z8M5?J2Q5MMM%?/;+A1UTKZAO5E%5[+$>H&/\
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M'@$3:F]6JKHZ62J;[H5$D+C$[&<Y;)L<'=B'#+?+"YU9QCX>Z)O-KTYJ*_\
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MKJ>D$,'3DX76660N:[JN#;K=-K0=NP ;SD.<UWC9@'Q;0GM$1 1$0$1$!$1
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MJI8:"VP0TU)2@-IH8F!D<#&L#&L:T=L8RO07&X(.41$!4[2JE:BI:=G9WO"
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M1PQ5L;HP"7R11R2&-AR,;B"?EW&9;15;"D8=A?&W([D ]L^@^OD.Y_5"N41
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M;GQ.('J,X'RUZ<;HO@WI?25=-537JKHGWF\1U9$CYJVLG-36.>?D9ZM^#Y[
MW.?)!X?##B1S%\1>%-/Q)CT3HCVO4%IM=XTU107>H$1AK V8BKD+0YCHHW $
M,:\2N& 6CNLB=J+F/AT :M_#S1U9K1MXZ7V=37N447L.W_*.K)$UV[=WV[<?
M54\J%6+QRS\([E)"8I3HNRQO<6ANYS:*)N=H[8/FWY _L4N^S!S-CY'.!&#G
M![?+./)!!7&#BEQYX9<*7\0K=PVTY52V&V72[:EIG7EX9104FV2/H.+,REU.
MR0D$-\1;Z$D339KG-<+91U]72R4LE13QSNCD !9O&0QV"<.'J/+/JHGYM):V
MFY6.*;J25XF.D+N ' 3$EU.\=, CQ EP:,_=*F0-=C> UVX[G9/D1Y80=Z(B
M NKKL\7A?X?[)P?P*MZJNCHX9IZALC60,=(_#<]A\L>9/H!D_M6L?$?C;S$W
M3CUJ+A/P.L6CZ6DTKIJGNE==-5"J,$E5-('-AB$3V XC<,[BT^:#:'JG&0QQ
M\.[R'[OQ7+*B*0;HB7M_6:,C]_\ O]5JB+C^4,I;G)TF\&+FV.>:G=;NK6,<
M:5TCY(9LF7S<UA@ _:<8=BB]:RY\M/NK+O>'\OUIL0<T,NEUN5S$$6T]W.;E
MK0)NQCP3L^]DH,RU[1W+1W,MPWUM:)JUMLU]#5Z/OD,,;)65<E+#/<+7,X%I
M<WI8N3B]I&0YH=V :MAEH=JK6O,7J/5>B;M?N+'+M346D]1_;?M5IN<S2(!2
MU%)6N_I$A&YD-;4$=]LCV,=AH8YLFX#.+?"YYVCB-ID'<&8-VI\[CY#&_P!4
M&1=-Y]T^?+.IAH8!@,Q\!'X>O^"Q#1E;:ZS4>LY:"MI*S&H/9W^S$>[E9043
M9(IL'O('=\''8KS-9:OX0ZQTS>=&UW%*P445WH)J"=]#J&".HAZL?3<^-[7[
M@]K3X>WFL!Y1>%FF.#%OXD:+T%J+[=L7YVNK8JV>L]MJC536ZAZS9Y?)SMWH
M#\]VU!,7#<,FX>Z6EB:88S9Z MB;\+0(HUEJQ;AL6GA]I0M:6-^Q:/L[S_11
MK*4!$1 1$0%B>M:&BJ+53FNZXW7FW39BD+<R1U<1:#\VG :1ZM65[@L3X@O?
M#8J:3!(-]LT8 \_'<X&D_AAR#P^$;8MNK(H [I?G+529?YXFAAF_@)6#\6N^
M0)DE1IP9K:>MM=^GIVO:3J&ICE#Q@M>(HFAI'SP&*2T!$1!A,7&/A?)I>Z:V
M?KVPP6"S5D]!7W*IN$,%+33Q3&%[))7N#&'J#:-Q&=S<=G-)Z:+CCP;N=$ZZ
M6KBOH^NH65'LLE537VDDACEVEVQSQ)M#L-)VYSZXQW7S=TSR\<R=%R^W+@KJ
M#A5I^.ULU?%JRKDGU52_\*U$4T,+K;[N4A\KS%ETL@V9/<![6,9SQDY8^/'$
MKB+J+7=JY7[+IVBN0@M[=.VZ_6Z6:&.FBE=[8]S71P,$I],;MV 2']T33B7T
MINW&'A98:*"YWOB/IBWT=53Q54%15WBF@CEBDQTG-+WC(?N\)\C\U<6_BCPZ
MN\EOBM&NK!7R7=V+<REN4$SJT9>"Z$,<2\ Q3 X\NE)^J5\H+URF<T-QJ;#4
MV[E^GDNUMM]N-"RJN-N;2TM/"'%@J7NE:QDL8VY:&ND['N5N!P#Y/;;H+F-U
M/Q#KK?<_LC1)@IN'5//(P4D$-;2%]>Z-K6@C^D5%0.[<MW#'D<D-QS/&!GOG
MR Q@DXR!^*X9.V0%T;7/'F",8/<CL?V*!=2<1N/>IM8W*V\![5HF>P6.KIK3
M6UFIA5Q2NKV2R^W=..$AYBBC$#&O<!OE<X-W-&Y>??;OSWVV@N%UM.G>"]Z?
M$T&CMM/67.*68D1@-Z\NR/)>']R ,%O?N4&QZUVX.].;FKYB88^HR2#\TB8W
MR'X/LR4-<PCNP$AP]>[7_K*8-%Z^LFO=,TVJ["ZJ%'433TKXZB!T4U-402OA
MJ(9F'O&^*6*6-X=Y.80,]LPIP2J#4<WW,C/-35,<O3T?1Q]2![&R,CH:IP+"
MX#<-SY/$/#C;W] &R> J-PR!TW9]>X[?CW74^JA8U\CI0&,&XO/9N.^>_D<8
M.5'/&#C#0\-K%-!36R:^ZKJ*>62SZ?H*>>KJ*N;!$+GQP,=)%3F0LC=.]K8V
MO>P.<-S20@#GMN4^L!IK@[8;_P#94E%J*Q:EU-5&<T\<-%)=(:2CB>=I#C)/
M()0 ]N!09)&1G<T #R"T_P"*?"C3^E^!.H+WQ9AJ[K>-=ZKTE+K%S:EP#8G7
MF@:RC@.'&.GIV/>UC&DG(<6N:7+<% 1$0%!O*-J77>J^7W25[XF4%1:]45/M
M;+I1265UM=3315LS#$:0@&/#&AI.,'(<,Y4Y* ^3#4>N-6<L&A+SQ#K[A/J(
MT,D-<;AO-9+)#52Q-Z[GY<YQ9$T%Q[N[DH)\1$0$1$!$1 1$0$1$!$1!;]=I
M8YS2';7%N 1G(\_/LHXYA\'E\XD"*"J:QFD+QAE+'ND=_1)>S0['?\2%CG-A
MK/7>@>!&H]8\+[W:K)?J T\M+7UYC=2!OM474#@XX<^2-IBC8,NDFEC8!EV5
M >@.;.R\1.7VOX7<6ZR^6SB%J#0EWE-7>[*;;3:@F%/*USJ%X8P2M;YG !P@
MV:Y998G<N_#&6CQT9-$6$PDN!RWV"+#NQ/9289VA@D.X-+=P+AM_9W\OVJ-^
M6_VC^;]PSJ:JBIJ>:?1MCZD%.P-CB)HHAM9_9!/;Z+ >=?BEQ!X+\%QK7AWJ
MJR6B[_;-OM\$-TMYJ65KYWAG3A =[HXWO[AWAC?CO@$)!Y@9V1\!^)#JJN]D
M8-*7<.D;((.D?8WG)?GL[!SV[=BK3E<E:WEKX3&,=8-T)8HW&,@X+:"+/;S6
MMFE>:2EXV\MNKN$FOJ^LMG%*X<.M2SW1]19Y*6B>8VU%.71N<&-<\1!DFT=]
MASZ. V9Y;99KGRZ\+J^J#1/5Z)LKY7#MC=0Q'LTY'JB/FPE)1[QWJ_8N"'$&
MI?;Q4^RZ7NC_ &9V-M2122XC_!WD/Q]%((\E'G'&U0WC@KK^RON$ENCKM*W:
MG=4M()IM]+(#+_H>B)67+%&:;EMX3Q/86N9H>PA[?5O] B\U**B_EGGEK>77
MA;62AHDJM$6)T@![ F@C/92@@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB B(@X!RM=>;X5!_D193Q,<]W%_3N"]I(9AM2<G!'H%L0.Q6N7.'<G6]_ X]
M1L?M/&'3T;R6/=XGLJ0UHV@^9]3V^9"*U0V01$181$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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M#!##4QP-AI?:99WL:(L5<QZ;7$.+/[(SKWI3A;Q:X0:\N&E=1,NM%I&W<2M
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M:@EL(<\;7#:6R"4%NS&6G!*T^0;"ZBTA9]6V6X:?U-;X+C;KM$8*NFF[M,9
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M-&2<#)&2#CMW4:,XD\0-97_3<O"/1U/5Z-N<M'<*[5%WE='35%MEB;(UU'$
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M(#>*1I;(7.RX"1T)+F@GR^[O<W8):_\ -S-5Q:-T;:J'3\-PBK>(>C*65T@
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M#:(PZIJS:YX9;A&]SSTRX/D(A VC<X!V'%JV2Y8'!_+5PE$0Z?\ W#V'Z_\
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M:IL[]-:(?%5540HN)FC9A R"1S*L.O=*P,E<&[6-:7AP<XAN]D;<[GL#IY4
M\UA;)HG1T+61B6;B/HLQSROCZD#OMRB/4B,A(>_!+>S7C!(Q@*?D!$1 1$0$
M1$!$1 1$0$1$!:U\WTD,L?!FFCMEGKZF7BMI\Q4];(TO$&^1LLL/C;EXC<_S
M+OC*V3/DM:^;^XST%%PHF96M;30<3K+-72$2-#XXXZAQW/C[!A+"#G<<N:T
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MYV,_508I)8(9Q5Q3Z<MO2,@?X:@Y(\'ITO\ BF?Q775Z/L]S,T==H^PU4,[
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MMLEKDJY&0.<:60QF2G!+OT),,>6^H&#VR'>Y)3F&"GIH=.53HJ?&T!T#<!H
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M))&N?([<2_.#YNW3+M*#G 7*(@(B("(B B(@(B("(B BIWLV[]PV_-5("(B
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MH3)OVNIP78W1O_?U ]_GYMC^9Q<4%QM]6^&CNUCK&.=+":F>:BD'7F8QTY.
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MZKDH-<\#JT-D<UW$-U,&L9XB9=/WF,QX..SBX9=]T9=Y=U.*"A:Q\Z%5+U^
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M(K!MTI7!A$AQ(-S3CLYN0 0?4$N:!C.21C*KDKHH1NF<&-+V1L<YS0'N<[:
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MBQ<M8<.:B&6UW2JFL--!+9ZM\M/'15+C2QAYB?NJ&22%NT%T9& <K8QLKG'
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MOC>RKAXE\"*^G?6B-NNJV.2&%L;0XOT[>2Q[@]C20T"5SL/:-KGY:]VPLG1
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MG]H.'[J2IRO9DRX>%>)>XWRW.PSQD!L5>\N!\_%2SXQ_K!>X@K1$0$1$!$1
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MMEC&77>B_P#AAG^U=CF5>WP-IMW4]6'&S_:NH17$NW2&E(^0:?\ B_\ JO\
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M>\=?H_H9//VC9N\O+[V?U?W*AMR,L_VRVBO   _HQC9C^K]-W_&_\Q_R&0R
MU+,L;D%TA\#01EP^8[^2Y=*YF Z-X);D# /?]7\5CU89S9HY:07>D-8(8HW0
MR,?-"R3R(ZNX;F_>_AE=E*R6DM_L+;Q>ICTNGUIK?AX./C]W$SN@]YTL;!E\
MK&?WCM_Q7)<6]G8!/H2%CL[J5D_LT-?>&/\ UFM>(_T>_P#2%A9Y?7S7:VCB
ML] *":[WVI&.\PCDFD_>R,H/:Z[<[0<D'#^X\'GW/?Z%=Y>T>;@L4I63R55)
M4F]W@1T]/TY!)1OC,TGN_$0]@_S#O_17?-7<U<QDG2]MO!/S%O!'W_\ BO\
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MUWYKV4S[UP&=/5QTL<?%RU;II"0SPV^Y;&9 )W/<6L'H7. ) [@-B$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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M2:?L%KJ'F*ND.]],&1R3'<7^T&:+MCR<_(_ '/D<9L@(B("(B B(@(B("(B
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M)\4$I/A+9#&9&N&/)QA8/4@ 8PN^T7Z@N@VT\[3*#(U\6X%T;XR ]IP2"07
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MY1!Q@+CIM^2J1!3TV_)<X"Y1!Q@+'K##3V\W"W13QO9'7SSX;G+/:9.L6G(
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MI(X-37415$Q<ZEI,EW_*U*R->'0L?^<=QG+'!LE-2@9:?1\[CZ?)P7N("(B
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M7WJEI_9M0EH="?SNLU0-_;WC?LW;Y9[=AE2@C.@1$1H(B("(B B(@*G:54B
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M,?7%.<_+!4@H"(B B(@(B("(B B(@(B("(B B(@(B("LJZW&NHIJ'VF6$2C
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MDCP'P-MU<Z2$2@Y;U-D8VEP:[<-P(!P*=^6\2+@>2(.41$!$1 1$0$1$!$1
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MYN5/JU^XW66G''/E[U ^1S'T^JKO11M+GDL,VGZ\Y ]1_1F-(/S/J[*V!0%
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MB("B;FG!=RR<88AYR:!O[!^/L%2I942<TLCART<6WMB>_P#[A=0'#,$Y%!4
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M=^"VN*#B30<KNN=4:@IFRMM555:RM+OLTU+&LD?)&9HPU[F;Q(YN[#3L&YI
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M^O;;K#5&K:+A9HR/5$U!0P:@!XE1&&AHJ&>9P=+BF#XV1"KJR\N8?$6=B"
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M+G9!['Q'OZK(]X^16/Z2>V?3-NJ70311S4T53TYBX/8]PWNW;W'MGR[G"R'
M0<HB(/'IGQ,NEP+<.>X1.FP1X!LP-W[CY?JGZ9]A>'26^D-UN3^E%B;I=4=)
MF9#MSXNW?L#^U[OHO<0<!P/DK5M;2NJ/9!51]?&>EGQX_N^:N6M(\UT"DC#N
MT$([?'][/^/\4'/MU+U.CUF]3]3/B_U?/^"[MX^171[%'U,])FW&,=O/\,?]
M*N,!!QO'R*ZO:H_U7?P7=@+KZ+?D$':B(@\RYME=9ZF.B<'/?!+M<3V&1GNJ
MK3(QUNI?98W1P&'LR4;9/W?]JZ[VV1]FKX8G=&0T\H86^0]VKBB#:FDIZES<
M.,>W#O%_OY(+U$1 7@6V.6FJ;E)50F-LE:U[,O:?B:S#>Q."7^A^ZX?L]]8G
M9:.EH?ME],RK>Z>Y2S5!>7/ZTO3C(QV.&M9&R(8_5(^+L@]*"C!U'6UG3?\
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MEP7STT344W!C3?$*'6_#Z\T5SUCHAEIL=#213U[&PB.M9[PM:]D+90ZGP7Q
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M\B'>+9V<WXOU?/S40\V5QH(^6/BU]H5<$#'Z*OT+&RR-!?(Z@F:QC>_=Q>,
M>I('GV0298J.>VZ?MUNKJM]=+34443ZA[@.J6,VE[B.V7>J]M>5:V,HZ*&D8
MZ(10MZ1,-.Z$ _,,.>WUSA7CJJ($-WY+GEC<#S< 3@'\&E!$?-K1Q57*]Q;;
M(_N-#WMW<AWP4<KC\6?+'=2/IR6XOL-MGN5O;1U;:2)KJ=KP6A_3^$$?)0CS
M8\3=$NX3<6^$8U%3QZM/"V^Z@%M?D/=0BFJ83('8V.S)$]K@'$@CN/53/I-M
M9%IBST];0MBK&VZ!DL!EW[?  8R[^R2,G'X909*HEYJLGE>XO ><?#^_D_\
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M(^D;_D,YHO,;8:"-U/)'1TXEHY-]-)TQNAR"T[3CU:]_^L5Z: B(@(B("(B
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M$1$&E7%/5<MCYK=:WBDKJNH-)H:Q6GW<W3%-6S5%VEI_ T$R;7F,M=\373M
M..ZD+D%CJF<INB67226HJO:+T^HFJ',D>Z5]WK"]K]N?%XS_ -.5A;](4>I.
M<?C#;=0VR6FM%UTKI:&6M=)%!'(YTTP;4MD8]SMV8I86]5N2Z,1_HSE<\BW%
M'AYI#E3TM:=4ZBM]%>:&>[372E@=(Z6-YK:J?J"(-ZA!BPX8;]//L@V%U;H"
M2^UT5RLUV-LJJMD4%>Z6WMJXJNEA;,Y@='(W;'(V6H<0>Q+<M(QC;T:7X96F
MUOCO&HZ.V7*_2T3K;47&"CZ$;Z=[Y7"&.$O<R$'K.+AY.<]WZP#<"U#Q>H-<
MWVQ6?A_Q'EIK1=+O/8Y+C:K<*D2UL(;-5QM<Z-PIBR*.0=1^X'VDN&6QN>WT
M]1\:+/P7KOLSBWJ-]:;KU*K3M50VT]2KIV/C9+$X19:96DPS.?F%LIJ'-CC]
MR4&01\O7":CXCV;B=:-+MMVHK,][H*BC=)'%MDIY(71=']$V-S9"]P8&9DC8
MX[B,*3!#L(V-: >[@, 9_6 QYJ"^'?'36O%74EM;I?AC66[2O4JF7BZW6OI^
MK&6QN?3]""&23/5ZD;G%SFA@#F=\!ZF\U; XQ^;VMW%NYH.>^&]SYG#OIV/=
M!W"G8).L/B/S.5UBE<)/0M.[(W.QWP3X?(Y.5SUVYQW/AW=AWQG'P_%_!>%6
MZ\TM;K[3Z8KK[24]WJVF2"AEF:R>2$;BZ8,)#ND UV9,;<C:"7>%![)H,RN>
M'NQDD-,A(SCL0/)I'H1^)[]T^SH2]Y,+ )3O>YKMKG/\L]AGN"1Y^0 7GLU?
MIR6\.T[3WJDFNS-Y?;V3--2QK!&Y[G19W!K6S0N)(\I8\9WMST5VO-)6S3<F
ML*[4%##9(F%[J\SL,.-X8 ' ^)Q<0T-&7%V&XW$ A[!H(Y)'/FC$@>'-(<[=
MAI#00,CR(;W7+:1YD$KYG-=@@[3Y]P1W^F"/J#W7C2Z[TI#:Z^]2WZB%#:I)
M(KA.*ACFTCF,$A;+@G:_8Z-P8?'B1OA^7LFHV-DDF:861^;I"T#]^4'+J0G:
M\',@QDEQ&X]QDXQG&2<>6<>6 N/8R96S9([;7-#SMP/+ ^?U_P!@Q:V^]V^[
M0FIM-;%6P[WQB2G>'L<]CBV1H<.QVN&T^@/;S!"M:G66F*2DK*ZIOM%'#;VR
MOJ7.F:#$V,D/)&<X!!'XH/3;0L;,^81Q[Y6!CI=HWAHSM8.W=K=SL9S\1^97
M M[6O)R'9/4W. !W]P3V'JTD9SV'DJ);K10.V3U+(W!T3'M<0"QTCMC ?J7=
MAC_#NJHJT#J%P+FQ-R]PP T^>TYP0<$'OVQZH.\1O#<F)F[RP'=NW<=\?/Z+
MN1$!$1 1$06[Z8$ AH<6DO&3M!=C SCTPK&DT_04=;57&GHJ:*JK^F*N=C,/
MJ&L+MC7D8SM#L G/;L1A>LB B(@(B("(B#C 5H*V$ES=Y#FNV%N.^[Y?LR,G
MR^JO%KAQJUMQ/M-)JVDX?Q:ANE6^>WV^W4U)IZ;-+'5,ACFJXZD@,<^,;WL)
M(#7>;7A!+VLZR 4]+%3,I:F5MTMKWL+MSF!U9'&'[6Y=D-#BTXQECLD85U61
M3-UY:ZUV!3LM5P8\DXVN=+1[0?QVG]RU8N-VTA<+QHMVA=75MPDGU;:1#%3V
M^HS=(O;HG5$M15@D/;''4329?EP$L.2"[ VGN55'/>Z2UMI:&:2J@FJ)&3S%
MK^DSI@!H /?>Z//T*,GN^VP98"\ O<YH&X=BWXO7T[Y_!4^VQ8D=N[1OV$Y'
MGC/S_P!_/R[KRZ2FN[C(:ME!CJ2.8&M)P#+(X>8\W,=&'?7=Y^9X^QG^S2L^
MQK1U'R;QX1@C._O[O_.=_+Z_%W1J]T3Q'R?W^7JNEE7&\9:,]L=GL^/_ #?G
M\7\/JO-;;YP[K&RVOJ_\H<?_ "-4&WS0_P"24% /%-)XL_I'? [R_?\ P0>L
M:J$;/>M)D&6 'N\?V?G^SZ+GVJ#_ #C?CV>8\UC+K1>8ZRODIK38@*S_ ,(.
M1*[M)^E:(\2_##YD?I)/\VW?Z3&7 ?':K=^DW]IG^7^IYH/5=40@[9'$.^6#
ME>%K!KY=-W6.([W/I^P>TR,.'8QM[>?KW_>JVT-RJ6=:>RVCVCY]4D?OZ652
M:.MFZ$<=DM/3$GO@^0]V;?(>Z[G<@L[';*REUOJB9U3(Z&O90OC:7?H0(Y&N
MV_7=W64F5F,AP=WQV</GC_'M^*L#35#:F2JCH:3?)&UCB97?=W8^[_:_Q72(
MB:/^BT$(>';@'RN ^/?Z#]9!ZKWB,9>['[,J@5,3BUK9&E[V=0-W#.S];'R7
MET=##OZ?V-# ?GD.'\6+QJF]VFV5%:^2U]"YT=L@K9&2/+FQB:1\<<)V9R2^
M-[>P(R/-!F(J&=A)[MQ^ZXC/\.RX$C#Y2L_U@O%@BJ;3;>C;;*"1_5R2EP_U
ML$_P5Q+30Q^5I:?_ #A_V(+]M0UVWOC?\&2/%VSV4?ZRJ+S!5ZLJ*2D9(:72
MI=3RQD.JI9_?X8(_+#<G'AP2_OY!9)3QUK/9]]C']%Z?2]X>W5?B3T^XWS_A
ME=QLT+J9U$^VDQNIO9"PR$@PX'NS)\9'Q=_/N@N[9'-26NGAJ&$F&*.-Q:01
MV8&EWX9_;]%>"H8[X'M=^#A^S]_HL>IZ>LHX#%2:6=$>N9A_3G$9=\3^X\_D
MWR_!=U8TO\]-.E\OBJ8V?#\'D_\ >@]ULH< <8_6!(\/X]_\$W=L]\=L''S7
MCT0J*.CHJ*EL0BAC #8^H7=+]I[N_;A6['S/J?8A8*_V3W?O_;(]G;?_ &\_
M<'^NWR[X#(#(P><C54Z4#X6EWX$?])7FU,<SA[NVU7^M%_UUTU]N96##J&[Q
M_P#DU=T/_2) @]@SQM#G/<&M9YN)&$W?%AKCM^GG^"\,P30=""FH*V6!_P ?
M6K)-P_YQ5M-=&B&":[4=10-DF9 =M23XGN:UGEZ.+AC]OD@R'K#.WOO !+/4
M9_@NW>?\V[T^7K^WT6-LIZ FHL$<MS>:1L!>YMPE+_%NP [=G[G?\0KCVZHZ
M=3+^;U9BFZ_;<W,FSX=GB[[O3./V(/9WDE@:"X/\G =A^*>U0_-WGCX3\L_X
M=UY<$3::1U#%;:KI_=<9SC_'LN6O+NPIZCSS^D]=FS_#O^*#U][/UA^]-[/U
MA^]>3)6QQ]3%MKG]/SVL:<_AXEU/N5#&[:8JT_A3/_M_3_BS^\?-!@U[J(:V
MU5,D$HB,&LK8R0L.\;Q7TA+6?JEP=EWGXWRCS<I.;4,>"6->2/3:<^0/_2%X
M%1;;550S0R6Q\(]LBKW^SM#-T["PA_GW.8Q^SZ]UQ6SPU,HJ'OO4+P)<-BIY
M2/ V5OZH\S-EOSV,\L(,A$S3)TL]_P#U'_6"J+\?=/GC^.%CL,T4ESZ8JKN#
MB3SBD \&[/W/_>D8_P"2;\EV.KJ5U/[3_P *[>CU\>QRYQNW8^'S^B#(=[/U
MA^]<DD?=)7FQ]&3R$@_$?]JM?:X6UWL#C<"?\YT_!^_.?X(/8#R3VC=M\]^1
MC_'*XZA\?NG^#\._X=UCM3J*V4-/<J^:ZR.9:)V4E7"QI<(ZA[8W,B^KB)H_
M+MXNY'=7-3<&TNW?)5.]MGEIX]K1X7,CD>2>_8$1D#'J1^P/=+P%P)F'R#O]
M4JWIY2[X@59M?50L@?)<)W]?X0(F]OQ[H/6R?U2H5UWRXV?5.KZC55CU'?=/
MS7V..CU+%0USFQW6CCA=$(RPY:Q[FB)KI -VUC!]5*6V"&I91R7"5TTGDP>8
M_%6,%=;2[)K:LCP]_9Y,^+&/N_V&?Q0<Z,T;8=!Z4L^C-(4+:.TV.CBHZ6)O
M<AL;6M&XD#<7;27.\R22>Y*R S1G8'GQ/QAOKW7C4ESA_K[[++__  Q;_@%;
M1W" 6]T+[W.6T;&/DK>B.FX#SP_R09)D_/\ @53AVQONSN=YGMX?Q7AR7-CC
MAE[E'O>A_DQ^/P]O+^T._EYKLJKI2T=.ZIJ*^1K99_9Y!MR0[J=/(QZ9_A^Y
M![FX_P";=_#_ &KC>[_-._A_M7D27&G<'EEQD'3ZF00?N>:N9'/C\ZF<_@!_
MM0>AD?,+J$S!L#\L=)Y-<._\%:=4YB:9F RNVM[^NTN_P:5Y]/=*>@HQ2U>H
MV324Y>U\SPW+BQNYWKZ>7[$&0;A\URO-AEE$?4=DCY>JJ=4/DG-/&"' >9\O
MN_\ 6'[B@O\ (^:IZK/[7^J5YTUSIZ>GDJ*F81-CZF0_L3L\\+H]MBW[/S@;
MGY[6X_Q0>R'AS=P\EP9 /,8_$A>)27VVS[)&W2E#)!D S-S]WZ_V@NFENE+%
M2^UUFKZ"L@_7>QC1_ H,A$C3\_BV_M3J_P!AWGCR^N%X_P!KT,59]G.N$!J>
MKOZ0?WQX?V?>"N/;I/\ QNF_>?U?P_6_@@O0[)P#V_6]%6),Y\#NQQY?7"L(
M&3QMZ$A!B^F<JFHK*EG3VSP=OC[GOX?3M^M_!!Z)EPX-V..<^GR4>6'53*VN
MT>VF[BYVVNG)JF&.9T<<E.-H![!V^1O8D>$'U[+-::JG$>)JJG<_P>3CC^UZ
M+$:&CEMUWTS;35LGFBM%;4.?$T!U0YIIMVW(. 3,XX_LL_8&?JPJZ]]/1OJZ
M>BJ:QS6AS(80T22?1O4+1G\2%?J/>.5ZN^EN"VOM366I$=QM6E;O<:69_<Q3
MQ4CWL+?ID(/E]I;C!Q:TEHG0.O:6_P ]-8I-3WRX68&J,L-15O=LDH98'>&9
ML3)FM9EHVN:_I[ TE7O#?6&MM 7WAKPOU_==2VO\T^(K;Y<I[Y-64\L%OJH!
M4/IZD.+2]IE+9&[@!U' GL5M-8N7?@/;>!N@N)&L.*&HK)9+%:+9J*EN-/?.
ME0QSRTT>*@;V%OC=L?GU(;GU+HXU3J3DHI*^T:JU-KCB973:XL[KQ25\\$E8
M^LHPYU/$]KC"]T3G&C'3!$?9[=VT[@T,OY8N/6DZ?F*XPT^J>(#.IKS5E)2:
M+IY*DRQW*"G94-=)3@9#&.VMW$X'DMX#.UKBQY#7=]K21EWX!:!<)J+DUXC\
M3[?P_P"&NO>*<>JK;[1=86S-JJ$TT+F[GRO?-3-W'$K-I?EQZK/%W6P'*5==
M5UMEXEZ=U3JB_7A^D.(MWT]155[F9457LL387P.+P!D.9.QX^A]$&PJQG4KC
M*ZT0!S8I75^6]1P <>C,=H^N&D_@LF4?\2I(8FV2I,5*ZK?=7^P-J9'M:ZHD
MH*B-@)8UQ \62?3!]<(+?@<REBX:T+HJ'[,;-4UX$ D);"YU7+X6Y]5)"P?A
M=0NH]'BWSO$II:^X4^?0N963M+_QRT_P6<("(B J7-)\E4B"ES2?)5(B B(@
M(B(*6M(\U4B(-(.._"725MXGZ5X^P7W4=->KMQ/LEGCM5PNTM9;!-+50TIJ(
MJ9LH#7.930N\>W: W'P, W?6IG,+3T4KN'=('7<^U\;;+<6U-&PMIF/IZR&)
M\50YSP[#I-T;=H<"_![,R];9H*6M(\UJYRB&W_R%:?=8[5#9+:ZLODMLI(G/
MB#BVZUL<CICN/5DZ;(Y0X]LD]@<+:5:J\E4@I^72P3T$>^"2LNM6R>H>V>*G
MAGO%7U6AP)&YHBD<1Y;G-:"<G 3;.X3151%2&]6CE?%*YI#]C(L33'MV)>]@
M_P#-C'DL0X@Z;U!K$6>BT3Q,NND^E4U%945=IAIZY[[<ZGDC>P-DBE87ND=3
MO#RWJ F3#_$LKJF04T;ZX"IEIF-HX"^H+F@Q2/.Z,%H(RYY9O] #Y^A;G]2*
MXWZVMII(2Z3I1N!8^:/.]S>Y/3.R' [>O;RR9-2^9+@OQ#LG!2#\X>/.K;Y#
M]JV&WW"S31TM6]]?67*FCWT72CC<)8!4"2.,AS7.C8>P\*GR]<L6I-16_P"R
M:[FHXQQ4?38S9355F@/AW^L5M:?ZP_ZK/U&8PGG IC5<$+E!1/K&T]NUEI.$
M3TDC&5=/$+K1Q]5LTQW1R R/:V7!+7,;Z!SF[6M:1YHM35,H&=RYZZ-5O'-1
MQ5Z'MOM?QVKKXZ6WI]3V'&W=W^%7 Y<-8^U=8\UW%_9\O^Y_/_MJ4X=,+G:4
M70Q2<!=?45'2T\'--Q0+Z6&.)AGI]/U PSX6G?:SDC_.'WASW<O-MG+GQ%@(
MJ+KS8\3JBK%4ZH$L$-HA #W9DBP:)WNR/*/X(S^C#%/.TKG 00)4\OG%.N94
MT5;S?<4315G>9L%%8J>8GJ[O=S1V\/@\';W9'B\7EX%>57!/BX"XVOFKUY3F
M:JZM1U;189>I%TMN&9MXZ4F[OO&1C[JFWIA.F$$&?R'<:8&TL-OYO]?PP1!@
ME9+8=.REV/BV.-N!;]/-=5%P,X^L;/\ :/.1JR9S?\C-/I'3\(@_'-&[<IXZ
M856 @@6OX)<;Y+B:FS<V>K:2 U'E/IRR3S"#+W'#C2=,2[I"W>(\=(!NW/B5
M+^ G':HL=70U7.'J]U?/%-'%/%IJRPT\/4;MR(64P?X?-OO5/38VCT7.TH(&
MH^"/'>E]D@/.!K1])#2=&2(Z<L/4,O\ G!+[%G;_ &,9_MK N8'@YQ:LG+=Q
M0K;QS.:YOXIM*7BKEI3:;+!'61"CG?+3RN92"41O)P-D@<QN0"0MM>F%$7-O
M$]W*[Q><RIDA$>AKZ3T_7^@2H/'KN#W'FJN%744/-KJ^AI'4^R.D?IFP2@2]
M/;NZII/AW9.W'[5T.X'\Q+:.M,7.!>OM"HCW1S.T?:.D)]D+<R1]+#X_<GP-
M+'>\?XE.%!%5QT$<%<:=TP'C,,>V,_@TJ^P$&B7-;RFZDU3PCU=Q%XG\>*O4
M=YTCIFKKZ6K_ #6MU ^2"EI97RT3Y8 V1T4TFXN878:7NV86><GVK>:#6EUU
M+)S"LN5LDL;*>W0VR72D5OHJQWBVUU/4YZKW>X.\.C:P;V;&,\A)7-[;&7'E
M:XLTU5N>S\R+Q-X3M/5CI9'L&!^NX8*ETTIEW-ZSF@C /9Q /F/$#V[#^*"[
M43<U(_\ 68>,@_\ Z?W_ /\ ;?4J65$?-:YYY8.,6R-V9-!7Z,#Y'[.J#D_3
MN@S+1$%!1:4L%/:I[J*5MOIX81<VO]L>QL7A%07C>) !XG. 65+QZ"2ICH:6
M>Y5E)+4NC;++) PQQ32;,.Z;7$EH\L9<5[" B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B H9XVU$D'$K@5"^FFV/U[6$3  L#CIR\AK#WSD[\CMC#7
M9([9F90MQRIJ^37G B.V5#8)8^($SS*\[B81IV\F1F,>;HNH ?1VW\0$THB(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B#7GD9<^IY9],7%U/$)ZRXWNMJCZ
MND?=JTO/X[EL,M?>1J:*7EOLDE)EU.R\:CC8<8\#;Y7;>Q_L]EL#N"#E:3?E
M5VR-X(Z&>TCOK^D_'/V9<R/X[?W+=E:5?E2W-J>#FA(8B)'/X@4^U@\SLM=S
MW>?RP4'S1U3!35FF[O#7![3[.[\/#YK[^1SMDB;,UCMKF->.V<@_0+X$ZT$7
MYOW*:KE;$V6GDVYSD;O)?>NC-2RC@EN$D4M2R-K99HR6,D/J6@9R,H/2447J
MEI]6:Y%#7ODEIBP4/N2#!@.G>1DD')Z.UW;XL8R.ZE=0W2S-CXF4K65L%/3Q
M5TU3-&'>$O<:V!H'T#W1N/UE9YY. RW4.B;:RF==;;!'3U4+C4O))+'-:TDL
MQC&,$?ZC5SPU==_L*6FND#J<4U6! "X/=TW,:\ ]_D\#\<KT+W?;?]AUK^NW
M_)ZEK6[FESBV)QP!G)RUI</I^Y>!PNFI[38ZRCJI,2-K7R>.</W-Z<)&._HQ
MS"?Q""145@^YT\3V1RES#)+T02/#NV[OB\L8^OGV\U?H"(B B(@(B("(B B(
M@(B("(B B(@(B("\ZOFK_8Y304]//4$>"*H>619^K@UQ_@O15/3;\D$.\/J6
MQW?4U=>RZ85;8VUHAJJ?V2HAZTCGQ.EA;@EKF-B(<>V&;#XMS1+!H9-_4;-C
ML (R 6  8 _#S_UC_9VQ;I*XSZ4O!TW<K4:"FH&.BI9V5+6QOIXB8:=\HC/=
MSJ>G<YQD# SH2,QM8TB5GSQLC,CI6!H\SN&/+/\ AW_!!UU%&*J%]-4 /AD;
MM=&?+^[V [**135&F]5QT<HO;*2F]GHZ1\DD?1JXYGT$#GF;S:[JF,D -)+9
M=OGETHU=YH*&A?<IZAOLL;=[I&>( ?L[J,;5MU)JB.8Y$;GU#X7M>0Z(QSP&
M2#9)M>&%SHP&&+X#,_>SJ1A&27UH]^4_ML3.'FB[Q)/5=236$5"R/VN7V<2&
MW7!S,PYZ>\@.'4V]M_?R"WA6DGY41LE3PCT'2QMD:)M<PN8WHO)>UUKN ,7A
M:=I=O\W8(VNQY(U;MHB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@*#N
M"X8WC3Q]F]B:7OU7:HW5&"-T3=.6QS(_U/"9'G.<G><XP,SBH+X'7!];Q7X]
MR4X!_P"[F@:7D@.PW3UI8YN,[NQ:<';M/?:YWH$$6"P4'"+FROS)K?42VZZW
MEUYI:NH$O0=]IR2RSNC;"XF7;(^JB8'@MP[R&U3QRY6:AL>AKYPKKV4CJ32E
MTJ[%'2=/!%*\AV7#ON$CI)'#/FTM[#.%%'.Y8[UHB]V#F'TW015;Z>G?I>^1
MR-<P-C?U76ZKD>PAS6Q53I698X'^EMR, D9/R[\2Z?B/?X-=55J;:M3W6@=;
M-2T!>PM-5!#"YL\49=U#!MC<UH+,[G2M>YFQF_>?TE.6,1ABW)#4VNIF]LL\
M]-5BXZ0M315TU,^F8Z.(R8'2>3EWO"?"\C'[EE^I^"6CN9GB[0<0.(%IFO.E
MM(,J+;:+37F.2@JZILY]IGZ):0]DK=@.\X/0C^N, Y%*F&JX?:8TS7T$PIZ;
M3A=(VHD,8? RH?$U\L3ML<@VL<T@"0M>"';5N);:&"WT=-;[="V*EI6LB9%$
M/"R-K?  3\L@Y\SZ^JB[5B<P6ZY7SJ1SAM)!:1XV^37GPC<1C/8#RSCY_2Z1
M%BV$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$&NG%FU.N7-KP)K.B7,H+-K*M
MG+@X!D1IZ"#<_M@8-0!A^1ASCYM .Q:UZXF4=^FYJ.#C;#=Z*D]DTYJB:NAK
M:6:8STK:BS,>&B.5@$OC&Q[\@9/A>>RV%0%K3QJH>IS6<M]R,=06Q5FK:>1F
M6EC"^S$@EF<']&1V:?B^+NT2;*[@M9^-$C'\X'+C"R.E+HV:TD!$_CC>+="&
MO$>,O=ME([_YU_?Q#<&S*(B""N-UTEI>)W JEI?8JNNDUM62QQOJ6-=TAI^[
MQSOS\0;%&\G(:0YV&N+"1F=5KCQ_I]O'OEXW13='\ZKJR:2"E=)+U76.I:SQ
MM81M[N+B?&T R@M;"]S=CD!$1 1$0$1$!$1 1$0$1$!:P\?(11\U?+E?)Z6,
MLIZC5E/+,Y[VNAB?:F%[BYTC8R,,WNW!WACR.[,'9Y:I<P-'3W+F5X%4-5'!
M)% -8=/[2JF,BJ&NMCHY8X(I"]KY(V-\1GB+.G*\M<<NP'115U!:_P H)3VZ
M+:Z)_"$4ID]C?U"?M4O;-)-G9(S%.\=3#6M<]C'G<X-6Q5WH8A=++)]E49EI
MGSRQU!<.I2Y86GI#9@D]09&69 .=V,& J!U+/^4&EJI[D[VD\&:80P.$IC>)
M+]4&7#R_L6N9&6LV;GY\+F-86'8RZ1.?<K-@M_RR7>/FSH2=O]8-_<@KI=14
ME7#13LI;A&RM[M,U%+$8?=[_ 'H<T&+MV\6._95NO] V"KJ":C91_'_1Y/'X
M-_N^WO.WZF5>.I/CV.VEX^/ +FG&/4=^WSRN74H+',[8D_2=SW[8[=^W;Y80
M6TEUAC/2+7&H+))! ',ZA#//UQ_%>#JZ3[3L]/' R9ACO%N)ZD+P/=5\&[R!
M\]IQ_P!"R;V?+?&XEVPLSD9[^??"\+5L38+=0O8" ;O0;L/=WS4QY]?GA$5L
MF1$1(B(@(B("(B B(@QR_4[62V^J;003^QU#IQ&Z0[P&P3C,7;!?XO(D=L]\
MX5Y^<MEZ7M'VG3]#VOV#K=5O3]HZW0Z6[.-_5]WM^+=X<9[*TN9?%5V:*,>X
M=6/V1_V#22]G'S^+/S7L^QMW;NV-FW;WQY8Q\L?L0>:-1T\5)[5)3U3G=;H]
M!L?OL]7I[NG\6W[WE\/?Z*Z9>K2]\+&W2ES4_H/?-][_ '._B_9E=_LF6[2W
MZ[NJ[=G&//S\OJJQ#*&@;NY\_$>W;_?RP@QC45U==-&W4T])4TU3-:'U$=/4
M-#9&%\3CTG8)'4&TY:"<+*QW\ECVL*8U6D+NWW<)EM]2YA^$L<Z)PSD=PX9^
M(?7LL@C>#\P@Q'1^IK55Z2L<C)Y,5%!3"'?$XF5SJ7J[8\ =0[ X^#/PN'FU
MV/8?J>U,F@@,LI-0XQL?T7;.H)&L,9>1M$F7_HR=^&O[>%V+72E"V@TK9:8R
M-D=#14S>HQY<'[8@.HXX[]@#^(:/3*]DT+72MG<UCI6L+ \CN!V.?+&<M:?+
MT'R""W^VJ79OV5/Z;H8]G?\ %U-F?+&,^OR1EZHI'[1(0-H.\@;,G?EN[RR-
MASW]6_,*[]E.,=3MG=CO\6<Y\_FNAMJ@8>H((^IN=+_INSGOC'WG^GWC\SD/
M/LT)BN-]GP??5$6T[3WQ2Q>7;O\ LRO?6-V+WEPOT$E++$?:HFETD(8)?Z-%
MXFDMR]N3C)W#((\P0,D0$1$!$1 1$0$1$'E7JH?1VJMK6,#S2TLLC(Q\!Q'G
M!7<RK#6[BQ^-VWR_M[/\>_X*PU;O@TI>&P8WBWU!R?+M$5[/0;OSM&/^W/\
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MV P._B[#XD'<:RGZIA$S2\ $CR\S@>?S/;\52+A3G9[QOOOT'B;[[MGP]_\
M'"HJ;+2U<;HZ@.>T]([<[>\<G4;W'?XEWMHFC?[Q_O?TGO']_P"[XO#^Q!XT
MCHFZFHF>T1$.H*F0-+C]Z2'Q;-^".SO%LR,_$,NW9$L<J8HF:KMC7U!+S;ZE
MX!F=GP2P9=TMVW[XR[:2,C+AD9R- 1$0$1$!$1 1$0%Y%MJ6S0R2T[NLUE1.
M"&]B2)B' ;L>1:>_E\B5ZZQO3U/3S4E2^!_3VU=3$-QZA'2JI/4_=_5;Y,'P
MX0>\9HANR\>#X_[/XJILP=\+''\,?[5;FV4YV=CX/+O\/;'A_4_T<+BFM@I?
MT=3*?Q*"[W>I:1^.%Y3S&;[2U(>T_P!!F&,]\=2+OCY*[GMWM'Z2IE_85YQH
MH_SK@K1^GBMTD)=N\V.E81V\L^$H*;M35,EZLDT;XQ%33323 N\1'2</"WS<
M?$/)>QU>V[!QGS[>6,[OP7D72GGDO5IEC=3AD76#PZ+QGW7W'9\"O&VAP[NK
M9L[]_8^G6ZFW^[]S^Z@] 2,+=X<-N,[L]ET=?^R[Z]OKC]O[,H*("IZXE=LQ
MCI?=_%645C<SV/=7U!%&[)^ ^T>ZZ?O/!W_6\.WQ?1!1>J:2XVBKHHJ6.=U3
M3R0"*4$1N<YF!WQY?7Y+V5BU_MKG:<KZ?KRS12,+HXXX@>G'V]TTL83M^O<K
M*4!$1 1$0:5UK([SS:<<9A"VB^S=!6NAJGQTA,M93&G?/*]K@2)"#)$QDFT/
M:Z-FUKF@A\A\A\E%7\JNC:ZEH74,$WVG3LCFQ(\-CN=5&T/)\W9'X8[*)+CI
MZ74'-CQMIXXV4DD6EK524)BJFP^WMGAB=45$I#""T1@0$OW$QP, D87[E+/(
M%54M;RAZ$FHI(VPO978,(V$9N%02_&7=R3E7FF%*:IGE(FJM 7TWBHO=@@TS
M7QU$])/]FW&A+&120.>\3QS1Y+)G/<"7F-S@6L(<"P!8U'RWV?6%)=ZSBH^D
MJ[W>K<^S33VB$0P04/7?((X62A_3+RYKI,>%Y:T$$-RZ<6QB,> ?O0QCT "H
MNUVX;<%[OIV[5/#S5M@IKGI&VMDJ[!>()NE4L)E8UE-5%I;U)VQMZ9D'A<SP
M$!OA4C1\&+-:XZ%FE;Y?[0Z@?"!*+O/5/FA;U-T;_:#)Y]5_?N?)9][, [<V
M.('R\O3'^WU7=M*"-[?HCB;8VMCMO$NGN$#8RT,O-K$\V=N<]>)\3C[S^SY?
M5:B7RBX:R\1^(N@]=Z-U1J/BC>-<MJ[5[-/+3U8MV!/'[-5 N;#2"%AB+QV
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M]3V_5%EI+];=[J6L@$[2XMW,S]UP#CAP_=]5[>X+C5>5LY1$4@B(@(B("(B
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MV$C/F6[AN[.;N.[WMS?D4%:(B B(@(B("(B L?TO!#'0U79Q/VA7Y_TJJ59
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MHRM<0TU,I=']=A.W/J?/"TJV9T-CT1%FT$1$!$1 1$0$1$!$1 1$0$1$!$1
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M%/&X+7GGD;<I^4'B@+9T"_["FD?UB7GV;J-=, /UNF< >6>V?5!L'O9$-SW
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MAE'\"@@/3/+H^_Z)CUW^;W "SV;45@%TKR_AT\EK*BF#B\O=4C8 1DAVYK,
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M&TU%/77BX0S.CK!0/E9#)'3#86AQ=*U[BYS=K&N(). @\FICTK=N/D?%^X<
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MD=_(GN/H0LH6&\-HG#2KHY*B6=]-<[G3,FG.][F1W"=K2[Z^'_!9CN"#E$1
M1$0$1$!$1 1$0$1$$06FK(K;'0-HFT=32ZWO8J8CCW =!<9V2NQD#J1SPNSY
M>\'KV4ND=U$-!2MEO&D;Q)<)*BH9JV]T[9G@Y$3X[D/9_KL,,0R[<?=@*8$9
MT3D1$1HBOF/93R\NW$QM=5S4E#)HJ\B>>EA]HD@'L4H<]K,C>6M\AG!/F1YK
M(^&5RM%\X>Z5N^G#(+)662BGH&D DTSZ>-\1=M) .WL<$]_FL:YF8Z5_+7Q5
M]H%1+!^9-],PADVRD>P2YV.?G;VS\UE6@/9SP\T]%2TC*"E;:J...F;G$#1#
M&&Q-P!D =LCL@RQ$1 1$0$1$!$1 1$0$1$!:Y\_#KPWE&XE?F]*R&L^R&ROS
M*QH, J(G5)\8/E$U_IZCR]-B]P6N7/U7W6T\H'$ZKL\,DD_V=# 0QS![B2IA
MCF9EP/;I;R>WKVR4C;@3_2U\D]+'45%#4TDD@S[/,&NE'X['.;_%7ZZ1"]K'
M,$AVGX0.Q'[5W(-=N?=CXN3_ (G21%I_X&<TA[ [&Z2-I</[6"['R+L^8"V)
M6N_/M50Q<H7$^25KMAM+&X [Y?/$UO[S_P!JV'W!!RH-YS33CE2XM2U-P-O)
MTG<O>"-LI($#L18)QEX)9GS&\D9P%.2@?G3DI*?E2XJON3ZD0'3M6![T,(E<
MT=+R!\/4(!^@/F@F2V5U+<:""MMU7%5Q5 RVI@>V1GX]CC]R]16SX>J&B6-K
MI&CL2<@?PQ_!7* B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B H1XR$
M1\9. $9?"Z,ZPNI:=HZ@:-.79V ?1@(;GZM:IN6O/&MLAYCN7BN+7B'[;U#"
M&N<-F)+'5'.WX@0(\?#AN]^2/4-AD1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1
M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1
M$!$7&X(-?>0][3RI:"<+G%7-;35A-5&W:QW].J?(+8-:Y<@<E/+RD:#GI:=L
M-+*;D]D36G]&ZX5.T8(SY8/X+8U 6B'Y421S-.\,MK@9?MJO+< XW?9\^V3R
M^($X_P!-W[=[UHO^5#=<H=+\-KA35D?3BO\ 50N!9XBXTKWDCTPUD,H/U<W&
M<D@/G?KBLZ]BJ'.94..QKWM86Y(<[:/3YK[[%O;MA? '6!K*>S5<\9C;+[/#
M\9./TOX+] " B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B+I#RX;A
MWSW;Y>+MGL@Q:DL6F=,5%1<Z.UT]%+6,#ZE\+"T2-:7/P3Y8^,D9PXO<[&3A
M6E'Q0I:Z7I"RUM*&0MFE?4!@:!W+VC:X^*-H+GCTP6C+O"L7CE?KF_.BIC(Y
MP!)J^C[P4?4D=$=VSI;I#@Q-\Q"=\F\%9[3Z#L%+ *=EOC>QP<V;<\_TAICZ
M9$W^=!8 T-=EK&AH:!L;@/%M'$R-_1;?:&GH!,PN,L<XVQN\)+'!^UX<UKPY
MWA( ([]V@YL*AN2'$-VX#LN'A<1G:<'SP0?P(6.W70EIN;9GFBI(JB9T0=/'
M!$).DPM/3!,9P"&EI.,AI.W;VVXCI6X/TK>I].5D+F-K^DXSU$@=$VJ$=/%[
M,'N.,N:V,-C_ %HWC>>HP,"65H%^5---0V#AE<HZ.C-<;W7Q"9U5$V9U+- S
MJQMB=[QP+VTVY[26L$<?;Q-V[^K1#\J-7"#27"NEI8ZJ2KJ]53RM$;XVM$?L
M,QD+BYA=D%[",$ ;3EKO#M#>]$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!:]\N'2KM<\=M02Q6UU7+Q(-O-3!3N;(8(;+;&Q1[WDR9:'NQWZ9)<6-
M8U^%L(H"Y=KA>:O6/',W2:;J1<2'X?):9;>T0-L]K$>&RO=X0QC<N!S+GK ,
M;,&M"CFEX*U7%/1]->].49J-5Z0G?<K- V=S&59+6A]&?&UC3,Z.-H<_>(RQ
MIQC+3JSP@XNP\3[Y;M/Z[K6'3YN#*RX.NP,\44%+&\36T0N[,<:LB,QAKB(G
MD'X5N+S*<49^"?!34VN;:RB=<J&!D5NIZIKC'-55$K8F;FC)D(+MY&>^"7;1
MW4"\%^4"Q7?AG17[4MYFMNH+OMF!H&B"'81O:V2G;MC#FU<D\S9(@PN9,QNY
MXPM:9SRPJF8X2#Q?UQ9.*URH^%NB^(5SML4%335]VO%KJH60.;'+&^*D;4/A
ME8\^\$CC$6/!:P=3=EJDW@7I.]:(X9T=FO\ #1MNI?55-=)1ESHG323.>S9N
M:UY#6%K!EH.(VK!^&G+0S0=W95:HUI^<0IW23TL53;8:<R'>V3+W;WND<TAS
MG8+0YSG'RD?F3Y.+/#*..4S<0]-#H.;%,&W6$NC+MN,NW_VV>0]0J35F,4M:
M:<<RS7(SA,@+P]-ZOTYK&W?:^EKW0W:B+^F*BAJHZB/=@.V[HW$9VEKL>>'#
M\%[9<,A4JS'":=U2(BE(B(@(B("(B B(@(B("(B B(@(B("(B#7;4=FT]<.<
M_2=3<:)U=4TO#S4#Y&5)8^GI?^$;8R-S&$DQ2/$DX<\@;V.V@D!P.Q*@>]W.
M.KYO=!TE**D246@=5R32.AG$$T;J^R-:QD@]V9 ^*0OCRY[0(R]K=\2GA 4#
MZJG@JN;GAU2&69E71:(U7554+"_!II:ZT1Q MVN#\N#LAI:1M+MVWPF>%K[Q
M!IKK_.XX0U=N8^6$Z=U=]H/8V#/L8-H+72&7)Z;9^@ (=LG4DC=MZ77<@V"1
M$0:T<9*1M1SB<M\U-%32TT%)K-TGM!CRW^ATG>$O\1D#@QVUA!V![NX:5LNM
M7^.MTJK?S<\NDL+)ZB::FU7 ZE@C>[<U]/0-E>_;&\=-@()[L((!S@%KMH$!
M$1 1$0$1$!$1 1$0$1$!:R\<J/4]9S0\%8K%(UT,FFM9,N;)IG,@GI7LM<(9
M)TV.<6MJ9*:0=V=Q\8P =FEK?QAHIZWF7X3MHKPV.GBTOK%EPHY63D5U,)+4
M'4Y>UP#!N<U^^7='F+X4'/#V74,_-KQ-J+C=J:*"FT;IJFEH:=_M$X>ZLO+Z
M<.(>YM.]L+9?=-!$C)HI2(GO<Q375R2MU3;(VPDTXIJLN<'-[>.'OC.<9('E
MYE0QPVA@J.:[BI7,A8*C\T-(R]=UO$0+99[L]^S&#4-< UID(#PYK6$.V94O
MW*>IBU;9H:2&G%1,*WVB5[6[A2-'?:<^?6-(,$8QN[^0,YD90)6GR'J1YCT\
MSY^GDN0\EN>F[S(QV]#C/GZ^:\ 1:H8][C46X[H*9H\$I]X))#/][L"TLZ?J
MT@YW#"K>S5)E.RHMS8^A*P#;+GJ=3W1^+RZ?Q>N[RR% ]SJ-W;/7_H^?X>BQ
MG5=/6U--;F4MN$SHKI2REA([M;(,GS;W#,N\^Q;WW %KKY\]_P#:WRQQ4/3C
MJ,'+W;C3]+R'A^+J_LV^N>RL;I4W&*CM%16TU/%6-KX&NB9*Z6 ND)C>T.<T
M.R&O>1X?/"#*41$!$1 1$0$1$!$1!CESBF?J*R/94;(F&H#H]@\0:T#&?/S
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M7?JE*=^1L.B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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MET0>S87N_'*[$08]JD V4%M/%_E]&,'_ ,JB^BR%8]K-_2L0+6EW]/H_A_\
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M08CV[NQ[?,)*11?0\Q/"ZXT3ZBCOAEJ&4K*MU&P-?(&NIS.X;FN,66,:X/\
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MW8(/11>1%J.S3U$E-!<8'R1R/A+1(T'J,V;F $@Y]XSZ>(=^X5;K];6F,>U
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M[5$-0^XF>KDI)J@.-UM,72D(D=EM^J6S'Y8<WZ]@C*=^6<:0D9+?-<%CP?\
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M3MDQ^!7EZ,IJ:G=H.*A=FWQZ,FCC8?7<ZW!A!\\ -.?Q"EDE%$10U$1$!$1
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M(BV8E+/TD>#NV14 \9ZB@CX^<O5(^&;VB74U^DC<UH-.UC;#6B0%WGU"Y["
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M2):=L?GG$S'^48SNC@+&=8:2L^IK)-:[M3O,4KNI')$\MGIY?#B2*3S81@C
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M6%]$1!\W%UR\(^H:'?ZI^F9,44V:JWC3CNE$3'K&^119W !Q^TL/((SN./\
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M-520[:"H<]\,.\G$?HT[@LC0$1$!>)IASI;29)\;O;ZSX?\ RJ1>VO#TL?\
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M<=.U=KGMWM<3NQC\>USMVYK?"6NR?+L?/L<*]U'/#36.Y5569(H8Z6:5Y#G
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M'GZ_+"#*FU#'$ >9\O$T^F?G]"/V%8W=I#3:ELE6RXL;2U39Z @R#+RYK'M
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M2EK?:JV*Z%T%,]E-3A],T1M,?1+<2[#&YL@G9$ ^IGM)V2/$,N&>78 O/?L
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M/C>T>7GZ^GJJ^H=^S:<GR\D'C7VD=4V^K,5N?52#X(BR-[GO8=['#J^'(?\
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M^Z=X7453Q0I+EIW6E7J^&[T7!J_22U4-16UT[6['TS0&NCJXV%[2[;TA[O:
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M?P^U+H&ROMFH.)%SU?,7M,<U?0T=*88F@[86^RPQ-+ YSCES7..>Y4@("(B
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M3MCP;0)#&2"YN[;(0,L >.Y\+F^1.!)UMYU.$]VH^%-301WR7^66KJZ/3/\
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M<71.ZK)FF)P#_#NV[7L<[98^:(B<JD7 \ERB1$1 1$0$1$!$1 1$0$1$!$1
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M.L(Y9]'7IM!+TIJBWS!DH]#LQW#L@*FWQ!NN[U4$C%1;*")H]06R53B3]#U
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MW<DEM@GB8[)'A(IG'(SXF-]#D"8RV,1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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M$!$1 1$0$1$!$1 1$0$1$!:PZZ$$W.?I:LI6"CFBX;762HGI-AJ*EL=UH"V
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MDU68H6:N&Z-T.7%CK37ATNX$NRQO4R,>(O;^H@WA1$0$1$!$1 1$0$1$!$1
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M1R<Z6G;=#;71U%/PUO+ZFJ]DB:'0ONEK,;&S-)DD(<V7P'#6]1SFEY+@W8%
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M?QQ]/P&3V0=NX+E6XJ8MVQV6NV[MI&3C&<]O]_+YC+VVGQV<22\LP!WR//\
MW_9Y]D'>#E"<*U=60QASI'[6LW;G$8#<#)S\NW?N@K8',ZC'[F$,<' =B''
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M\/Q05HNML['#(!\]OE]2/^A5!Q/W2/Q05(B("(B B(@(B("(B B(@(B("(B
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MSC*[6:)YPYZVJCJ=;<&7451.*A[SI6XNEE+'!PC+'UKFM;)M:PX)Z8[MW/\
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M \UU2<;N(C:<.O7+=Q;8\/W.@LSZ(ME=(Z$AQE-9$YNW$@>T-PWONP 6@G*
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ME456C_SA_P"&[I235,T?M+(P#'!/*(X]T@'?#\@Y:/78&:JCP2QXPUN]YS\
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MMM<MG%565OV5+J6KEM77J>IU7^QN?TLCJOV#&UG;#5*2IVE!"5NY4M+VRO\
M;X^(_$NI_HL])TJG5U8YF)89(M^ X>)HFE>T_K.!] KUG+39X#<S2\4>*;37
MVW[+C,FM:V?V2/JQR[X.JY_3FS$UO5.Y^TD9[J8D00W'RS6:.U5%G?Q3XHU$
M%574=?))4:OJGSB2GQX1)G(CD_K(_)W;X53+RQ6)UGH['1\3N)]#3T51558D
M@UA6=>>:8LPZ:5SB7B/I,Z8\FY?\6XJ9D00[7\N%LN>F].:>JN*'$J%^FHZE
MD5PI-5U5/65QFD;(XU4S"'R;7-&WOV"[-5<N-NU7</;Y>*W$NV T%'0F&V:F
ME@9_1CEDG8'Q._K/\Y]_*ES:54@AZ[<M=FN6J:K5K.)W$VEJ:NHBJGTM-JZJ
MCI!+'"(HWB ES/#@/QC:7 %S7+QX^5&WTVI;SK"@XQ\3J.\Z@,<5=60WV-SC
M31F0Q4X;+ \=-@D<T?>PXG=N <IY5.TH-?IN5"HJZ.EI+AQ_XH5G1G]ID?->
M& NEZ3XMXVQCOL<&_LSYKU?YL[F0-AAXV\4O! ZFB+]1-=THS V(D>X\1\#'
M]_O94VX"XVE! =5RE45=9JFP5W''BO54590.M<T<M^A)-*]C6SLW>SY][L;O
M/GY[=JQC4_Y-SE<U+145+'I*Y69U"UK!+:KQ/!),QH #7NR<C +2<9+?P;MV
MCVE5(-0&_DM>5]T[*BIBU7.Z*<SQ"2]/Q".B(PUFUK<!I:UX/<EP[Y5N?R5O
M+,+9/:HZS671G :[J7DR -SDM#',+,$]SX>WIM6XZ(-,HOR5G+A3M(@O&NVD
MM<UH^WLLARQX\+3'M(RX$C !/<]O"J)/R57+I)45$S+]KVD;.\EL-+?A'%$W
MP[0UG2].G%Z_<;\N^YVTIM*#2\?DI>7""JI9J.]:XB9!$ZG>#>FN)AV@,8S,
M7@V.W/!'?)/S&VXI?R7/ "V4DC+7J77454^GGA$CKS[LNDW#J.C:P!SMI:TD
M^?3:?B\2W(VE<X"#2D_DM.#E337)]RU]KJ6X5QW1U%/<HZ=L#G0QQRD,;'@]
M3I@OS\6&9^!N.FH_)5<"264E#JW6M/;(Z>1K:0W",[9]^Z*1KA&"UK._NQV/
MJMW,!4],(-,)_P E=P$-9]H4FMN(T,[7=6!TE[9+T9/#Y$Q;W#P1^;ON?4KN
MM7Y,GAE04E933\6^)#W5L>R1T-R@B'GGN!#XN^#XB>[&'SW;MR\!,!!I-2?D
MMN#L-'!3GB)Q$<\0R1S&.\111N+O+#&P?!_8SCZKD_DR-(TA@HK%S$<9:"U[
MII9Z4:C\+G.>Q[6@,C9X06G.3\C\7B6ZS(]OGA.F$&C;_P E];XVN^S^9CB;
M ^9[1.36[A)#LVNC/B[]_%EV[NKAGY,JAMU95.L',MQ1M]%4RU%>^""Y"%\M
MP><MJ)I(P#*<AN<@9Z;5N]@)@(-!9OR65QJ8YJ:IYL^(<M-/2FC=$X..(B&M
M<T$S$X+&1M+?)PC9NW85R[\FGQ K*AE9<N=#B-)51QU#&SM?.9 96G[[JDR?
M$YQ?X_>;W_!E;XX"8"#1"D_)M\0:1S6?SS->PQ15K*Z(TU*62[^A+ \OE=.Z
M1Y=%/*W.X##WC;XCA7?DY>.%=#4]?G\XGSRU5N=0S"H?52QS!XQ(R0/K"YT;
MOEGMZ+>U\>[RPN=I0:+R_D\N.\TL)E_*$\6)XXJISRVIFJY<P$/ 9WK?TF'#
MWGE\FA=$OY/KCZ#T9.>/6%SHIV>SU5)6TM8(YJ8,?BG<T5YC=%N?WC<PL+20
M1@N:[?# 5/3"#0F#\FQQ'K.M<;WS./%SK'/EJ3#IIKX>J]Q>^1F9VO;E[G=@
M[&.R\R'\FGQ<DIXO:^:>-@>&RU-$W2I? ^I>UK9I0[VIO?:-H.T.<UC6.=M[
M+Z%X"XZ;?D@^>\/Y-CC)3T5/9H.:HBW[&R%KM.G-).2][^FQM0UDC-\C\=HW
M8>>_SI?^3=XVW"[W"EK.8VU4-JW1/HZZ&PRSUE06!HQ-'UHPP':7';*[<XNW
M;MQQ]">F%5@(/EMQZY*^)/"O@]J[BCK?F&&I66RG%;70R6*4=<"<=-@<ZI=N
M#Y@V:<O:2<8]XMS(=/<W]'(?_5I\,JN2N@8^H]ITK6].AJ!"UCFT^RJ]_&YY
M+SOV',8P/>GIV_/G5/H^43B;*)98W_8[F;F1MD.Z1[8]NW.,X>#YX[9[*>J:
MWLI8&4\#GL9#VC]Z7$_CE!"<EFYR8J2KEAUQP@J:QU/$RDC?IRYPPPR;O>DE
MM8XN&WX>V<CO@+NIK+SD,_3\1>$#OZ3*_MI&Y?HF_HQ_WQ\W^O\ F_3JJ<.F
MWY+CIA!!8LW.I[O/$7@V<=%C_P#N2NO=G]:1_P )?%\O\0J)K/SH1C%-K;@M
M)_1RW(TM=(")3+C/:O?VZ?C^>_P^7B4[],+GIM^2#7_V7GIQN_.+@3O_ /:+
M>,?U?_O5]'_\WZJZEI.=@5TS:>_\%?97SQ.;.ZUW;J=(8WCI>T;<]NWC]>ZG
M;IM^2XZ800%)3<\I>'QZAX'#%/G!M%WP:CJN_P#>CX.DV+Z[I).V&M+KHCG5
M;2T>7<$_:9/\J[7;93^Z^YZS^]^?2\/U[*=.FWY+A\>[RP@@3VCG>BIPV4\$
M3,!LRW[7QNVP^]_#<:GW7R$7O.[MO1&.>5U(X5$O SVD03/C+6W@M]I/4V-.
M3GI^)F3Y_%V\EL"86'XAE<=%OR""#@.=,4&=W!7VL3RNZ1%VZ72;^C&[SR_U
M\.(_3JKRYKISTM9'_P !<%W/?6[:?95W3'0[^.;W?A'U;GT6P_3"Z_9R[XW?
M$S8['R^000;([G8<[PTG!'I8QTS47??XI._O-N?!']/>._S0[K4+FPX"<8;-
M67;FXU?;>%]HO&GGV?J2V-UPFJ+I)!701TDDD55&&M)<8&.9D[F1-;O\(7TS
MZ85C7V6ANE,Z@N5'3UM*XQET-3&)6/+2'-RUP(\+FM</J/VH-0N7GF7YG^8W
M2%ZO^D])<++57Z?NCK#7FZ5-V8&5436.J9!$8,D-ZC=L(ER/)[F9&95IJCG/
MC-+UM.\$R^+M+(V[77!W^>QGLW@V?WCU/7I*8[=IZAM@F]AHZ:DZ]3)5/$#
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M B(@(B("(B B(@+135VE:6EY+M17*@LYGI-#\0M3WB*@EA$L--;HM45\=4\
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M1Z@$^7F5-2AKEE<QO#>OC]JZK9=<:W:)7]S,W\YKF&]P@F5$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 6NE)5M'/U<F%@+9.$%%+[0'C:UHO57L!&?-V\X_N.\NV=BMP6O
M5!/3?S[[NQSY14/X3VUL$>/=O:+S6]3OM[%FUF,^>]_R0;#(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B#6_GWI:6HY3>(L=9-(6>P4Q#&S&-IV5<(VEP\F.+@''R'JMBH'.</$M=^
M?2"&HY5]:4\^[V9IM4\XP&AL$=UI73/VN+1X6 GS(_LN]=C0 /((.41$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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MX*"=N<.:6G=MP<>>W/HJ.2[T1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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M_P"4#IZRIY2]7T]%6"CJJBNL4$<[NVUS[W0M!.,]N_HMD$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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MMEKLE4YK]*M=!6.DA9[=/4O;(74[O:VU<+F@-&&9:1G*V%9^3:Y?H_8B+OQ
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M3E?5.K#?E$147$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0% 6E;I1U?-]Q#H!-&VIAT/I9T;([H=S&LK;ON#Z4N&/TC<8
M:>SP<@3-)GU03I*YT5RYJ>*=#$8R^@T7H^AK'N !$KZJ]S=L$D>":/X@WOCT
MP"$[(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B H3TK<:2HYKN)C8:F-\]'H;1]--AV',E]NOSMN#X
M<[9(SY_?;ZG"FQ09I"@JZ+FMXDU#;O*^"NT1H^KECF?U/_#+W'[D[O!$&L)+
M/$=[R[/?#PG-$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1
M$!$1 1$0$1$!$1 1$0$1$!$1 1$0%!')[2ST7!"CIZVXLJ9Z?5.KVSS1,V1U
M+FZAN(=(&Y=V+NX[J=U!7)W1PV_@910P2-$<6J-6Q,=NW!S/SBN).2?GA!.J
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B H MDG3YW=54?V52ETO"^R2>V!WO&_\+7-H81C
M.'%V7>+^JC['/@G]0+IN:>3G'X@1RV6(-9H'3+*>NW.R1[?>'.;G&W)=)(,9
MS[D?)Q:$](B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B#7CGPWGE?U'' P5,@O&F_ 3W/\ P]0K8=:Z
M\]T\;.5S4CYI'P,;=M.NDEC!+XVMOU#N=CS./ID_+*V&CW-^,@_@@[$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 4 <1!+4<V_!(1WR.D-/8-8RRTSFY?7MV6IO3[##'@N$F#@;6G
MOGLI_4":U-OI^:KA4^1]*:EVD=81QR3$@DB>RNS'M:>J_:]W8X&))'9RT1N"
M>T1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!=,A<YF&=G?-=RXP$$"\B\DTW*
M1PPFFV=0V9N=OEGJR94\@@!:_P#(:VII^4/A>VKC+2;*'CN#X#+(6N['R((/
MS^8![*?U%?QBM$12,(XL<.;/Q@X;:BX8:C)AM6I:":@GFA/CC#OA<W^T#W_'
MU6#47+_K6F%+[1S'<1Z@TM-TY ^2BS42?K'W7P?V/XKVN9;B;>.#7 ;6O$FP
MTT,MPL5MEJJ=DQ\'5+@UF?H"\97G3Z0YH7T5$8^*V@Q6Q_Y2XZ4FV._N_P!)
MS_ (*'<%.(T.!1\QNM&#VH./5@I)L,,YE [Q_5K#_9"Z*G@9Q/-8:VW<RFK8
MG^Q>R=&IHZ2>#K?YS8&-[KU:W2O,9.,4/%'1M%[QCO!I>5W8>?G4JVDT]S1P
M,_H^NN'-4_J;LRV"IA[?Z,SNZ#JK>$_&AS=M)S-W.FD'?+M.4!'Z?J^K/]#^
MZO#O?+IQ*OVL],:XN''BL==M*4]PI*.<::M^!#6MB;.W;C[S8(@'>8V_)Q7O
M3,YMZ:/K4]=PFJ9L8Z#J:Y4\7^L'O/\ !85J[B7S,:=XEZ%X;";A94UVMH[M
M- )8;C&RF%#3P2$ F3,SM[G'& =O?L,H4[LMJ>&',/4R?T/F2JJ$NJIGY.E[
M?-F(NEV#NT>31!G_ $OIGL;PMX[MK*R9W,G6"DDJ.O')^;%NZPB]W[OJ8QCP
MO^[ZA4S47-N:Q\L-VX1B**FV4P-ON>1)[SN[WWEV@^9[/^0STTU!S?QTE#13
MWKA)5RQ11,J:Z2BN3'/</C(A$FWOZ>((*:?A7S(4U::EO--UH_=9AETA1[1W
M][Y._<O3'#GCZWN_F*P/?>>D:3[WP^3O16<E/SE%M2UERX/8?UNCF"Z>'/P9
M\7IZKNJ7\V\'3]B/"63J>76-T&/QP2@O*7AOQWC'](YB97_AI:D/_N2Z:'AW
MQ]92"*;F B,F9.XTG28\4NX?>_5[?BN^2;FFC\_Y+C^!N'^Q=#I>:W[E+PR_
M:*[_ &(,>OO!CCI7:BM>J1S!VP7:PTU;%25CM(0;VPU)B=+&6];L":=F/[AS
MY+K'#_F_J*B.KFYE=(TD$G2Q2P:"Z@;CI[]SC69=G;)CR\QY>G5>M><UEHXA
MV/0='8>%-9+?*.ZW2.J?75]-LI:1]&SQ-Z3SN+JDC#=WQ1^C';O1FJ^=V9\G
MLNG>!\+#\ GO=WGQ^/\ 16H//IN#7-/-0S25_-]6P5D^&T_LNBK.UD79_BD+
MHWF:3M3#>-C/!+[O#VF+KI^"G-1#234[N=*J]HBW]&J9P_M8?@^1E:[(DQY]
MMOTRJC!S\2OAW5' *%C#EVZ.^3DG_79Z>'^][S^PKJHI^=N2J8^*IX&B'VC$
M@=2W8NZ'F,>/XFCW9'D_L_+![E!1)P/YAY'-?5<WMV+2*1^':-M#<3122O>3
MB)OA>71@_02?KC;;MY>^/K7U$AYQM3@";VEK_P V[7@R![W-;+X/>1$2.W1>
M!GE@-7HS4O/+3FFZ%_X&56:?;4[K3>*?WOS9BI?V_'!75[)SR=@;SP.+J?I;
M9#;[QFIP8]^6];$&=LF,=3S'U0=U/P<YB6;^IS?WJ1OLL432S1UH.)&G#I,=
M+S*2\)N9ZFHG.MO-?%453#(('7'0]"]OB\()Z3X^V/'V^]_8]VNZX6OG+?7[
M:/4W!M])[1$\S.L]VAF,0;XQM;5.&=WD-V,>:M64_.U04-)3MEX)WB6*GV2N
MD%VH,R_#D;.KVV_MS^]!ULX>\V5)5.#>830=5:X3":>6LT.X^7C?NCCK6>98
MV,8D_1S2N[2!CETC2'.G&XL9Q@X8U3A7S/VU6C*MY]CEVDQ]JYOZ,N?TV>O1
MA#YW[GKW8]0\W5+$9:OA?PNNHQC%-K.XT4G_ *&^V3,_YZ\JFU=S@RSFCN'
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MUVD](44U(?LJN9+2271O2ZCJH-P(CB66(0[G$24SW.#7#"V'=3@E[0&!DGQ
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MU76TSY(&5CFQPPT8(8UHVO>TPAW;IT;VAONW ?2P4[MFW#&'(.6=L8/;SSZ
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M_>61/U!2M?(&G'@R\;\GX=N=X[LW!!,"*)/YV7*_G'\XSAF1OV;OSLH,9_\
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MCS _#S]#^XJK<X=W-(0=R*V]ICVO>78$>=V>P[#/GY>7?S]5RZ=C-FY[1O\
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M [Q 9[>OIE3<@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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MG';VD$?M&& MWDOP0 Y%*JIAMBB(BXB(@(B("(B B(@(B("(B B(@(B("(B
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M>D0:D<6^5VY:+X::DU%PEXA\;+[J.GM4_P!DV,\1KET9971]-F 9?N-\N_F
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M $UQ_%<_RL\TO_WJ5G__ )C4W_ZJIK=.USW2PAY<S <TM(('SV^?\%W"9Y(
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MIH:*[:[HHJII8]L.MKKL&8W1[A&Z<L!VR2_=\W_1NWL;RE\(6[/>ZW\'P_\
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M5UGZM+J%ER!9/;6B67W4.UD8#,QN<03U&;@QQ+01-,3RW81$1(B(@(B("(B
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M-:-Y:&X0>=4?E!.5>DB=4U7$>KBIV%X=4.TS=ND-KMF0_P!FVN#GY8TM)#W
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MF12=>%M5"V9K)<. ?APQV#NP &.Z",1S?\K!I&5HYB^'&R1NZ-GYS475</\
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M#BYX'3_2 D>#MG!_[,H+I%;]<8SD8\L[FXW?J^?FNQL['QME9DAS=P[8[?\
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M$0$1$'& J7Q[O+"K1!Q@*GIA5H@Z]A^85+(2WSPNY$%/3;\EQTPJT04=,*H
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M?HI\VE5((%FY5KK.?'S2<< /I?J#_P#4?HW_ %3_ )R7?S6<K5UKAXN:7CC
M?^*OM /_ -"4\JG:4$+2\O.L'UM=4LYI^+[8+F,55,:FT%K/^0/V?F#_ ,WM
M7F4_+'J^%@I).:[C%-3;^N3)76XS]9C]T+NI['G:T?%%^B?ZL4^;2N<!!#,W
M!+B4Z\BY1<T7$<1"F$.PTUCSU-D@ZF/L[I9RYG]7Z%6%KY>.(=K)QS7\4JH&
MK;5D5+;3)G;T]L?>A^$]&//X._SDN^=<!,!!!$'+OQ'I:7H4O-=Q*8_KMJMT
MM/:IAU6,VM'>D'NG><D7P.^X(U1'P,XT^4O-9JLCV::/_O%:3[Z6+:7_ .3_
M *-KN[8O^>IZP%3TP@^;W&S1G,OQ*U]?.!M5JOB!=^&^G;]IZFN%REMT,,->
M^NGI345$?0BC=414\E9(_P!FR^*)M-&2?  =R> _ .CX#::_,RR:QNETL5,"
M;?25U+1@T;Y)9IJA[9(H(W/=*^;Q%Y=X8VANWNI0;1!DIEC8QA=C(![ CU Q
MYX^6/(9RKK 0<HB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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M-MJ>FV., R.@C+JC+!W=,3UC][<3N)/=2W??M062X.LU514=?[,_H5=7'))
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M0Y_!5!V3C![*$9XN<=H$U&_@[O QT)'W41_ZP[_P5T?YUL-752N=PL,4GZ(
MW#(_'PH)C#\[?"?%_!<8_P!\*(Y&\U9ZFQ_"L?HMF3<.V/CSX?7T_P"A<YYI
MO_9?PH_^&[E_\K0=FH"&\T.@'RD,;'H#6 <YS@!_WPTYW_#L?W*6-X[?7S^G
MXK5>^5/,S#S!Z&F?;.&%3=QHC5>&BMN$%.*<7"R[^_2>[=VIL#;CO+W&&[LK
M-SYY)O9NEIC@DW_QK-ZN_P#S/Z+_ (X03Z'9;N+2.V<'S7&\^+$3SM./3O\
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M2'_E"YJ,SMZL?!]KVQ;CG:Z]'#O+R]T,_P!\HB9Q#9=$1$B(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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MU@V0.!'8U=C.[R\O=G]X^:"9=H57A^2ZA41DEN</&? 2,^>!Z^I\E5O;EH)
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MJJOI9J>.H?Y0N+"W>-N/Q4?\I+9(^5_A#U"#OT+87#'R]@B02\B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@I (*UQE
M.S\H/ UM WQ\')I7U/WL-O4>V/\ #Q.6R"USCO#).>R:G-#4M:.%719-)$8F
M%[;R[=&US\;W'PXV;AV.2$)C+8Q$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M6*Z_ZS= ZC#9:DM;::R020XZKL1.PUN,>(X./V=UE2P_B9=39>'NI[\V5M,:
M"S5=4R9IW>)L,FT;2.__ &H,)Y1KK3W'E;X2NIV2=M%6:C(< ")8J1D<@\_1
MS#^(QC/DIF42<K-+'%RS<(V-PY@T/8#^KEPH83O[?>SN)^>>ZEM 1$0:\<]L
M%34\KVH*>FNKK=43733C6UH8"8G_ &U18<X>BR0<#]9^T556>837O6EJ.I%W
MH>DV/]5T/LW3!_Y-L:Q?GX9!+RM:H9(7-AENFGGOD'8 "]4/E^Y;%8""(8^#
M?$1M+TG\Q>M#+^M[+;_^._\ >?\ XX?^A,^2L?Y%^*T,=<*+F7U9&ZN]L_2V
MNWS"#J?H.EF(;.EZ>>5-F J>F$$.OX2<;'>7,O</_L5M_P#U5'5\X=\5/YR'
M#:CKN/57)6LT=JZ8UE-8*&-^WVRTM,8:6.&W,\!__AF^6XK:C:5#&IF4])S7
M\-"),"HT5K".,$^;O;+"_M],-*#K9PAX\QT7LTW-3=WR=O??FI:]WA?EOW/E
MYKODX5\>35221\R]8(JCXVG3-%[K_DU,CL.3:4$,_P EO,-OS_.BFV>/M^9U
MN]?+T7?!PTX^^RF*JYC&=3WO>FTE21#Q?!YN=Y*7ESM*")?Y.N.__P!\7_\
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M:Z0W+26L*7;'&YW<5%C<79QAK1TSW)'<C .4$VX"8"X#P1NQV7!D ;N#7'Z
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M50V@::B6G::GI/8SWD;VR1#<>[HWL< 3AV5AO*I6LJ>6+A)4]&6!OYD608F
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M:$F(^T1VJ\S.[-\?N75#1\7E[SR\UL'TPCX]WEA!KKT_R@'LV?M/E\]I\_\
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M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$'&X+E4*M
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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MO'P[OV?-:4\_]12PZSX1MGI2PN=?FFH<XAL9]EB<,CR.3'GMGX?JW<&[*(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@+@KE$$5<R50\<O7$]U/4U%.]FC+
MV6S0QN,L1]BD(>QH&7 ?V03V7'+'(S^;;PH<UC@S\R;"QC7#:0?8(O/.%=\P
M?M3N!?$AU/04U7(S2EVV4U2TOAF)H9?!, 02PGL=K@>ZZ.6DP'EXX836QO\
M1YM&6)\31V(;[!%YYRAC?*45RB("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B"G:54B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B M;80X_E#*AS(9 W^1VG<]Y8=IS>I>
MP/EE;([@M:V1U+/RA+Z@1W'I3\&V!HW?T8$7I_8CRR YO^M]#@-E41$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!>1?&5]18*UEOAI9*J:GDB8RI<6PO<YN!O(
M!./P![+UUXFH;W2:=TU<KY<F2MIK5235M1L +A'%&7NP,]S@=OJ@C[E2;(.5
M_@[MC/N] V%AP1W/L$'EW^BEQ0_RFT[8N6#A+MIV4^=#V(CI2%V?Z!%\PI@0
M$1$&NW/HV.7E,U]017'V*6:&WQME<?$)'W"F#&?WG$[1]?DO?N/!SC!=&NBK
M>8Z[[#+"]IIK'24KVAK]SO%&!YA8WSYU-/3\KFM*B;V5D GL^:BIDV11R"[T
MNQ[CCR:_![9_Z%L;@((<BX6\=&]/?S+5IQ%L?C2MO[G_ %5VNX:\>FQX@YC
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MXF:*X3SBBN5#2R6<UM3,(*"&1KWW&!^S'6:[J.B:\%[72$$EH:&[V[V[=Q<
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M)Y]\3@H8T_._^=9KR!M6=C= :2!!8[?X;C?AG.=IP7=^W?+?/!R$SHB("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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M4^NV6(:9.FKS6V>H@JZ\21L?311R[G2AH ;MD&[MV(/GV*#S+G6\0-3Z8K=
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MBA+2C*N/FNXC&:MZT4FB-'B%O3VF)HK;YB,8^/Q-E<2>XRX=P/ $VHB("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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MUK)S%<W-]X-\5-(<%-"<.X]7ZIU+%%6/IY[RRVMIJ:6LCIH0S=$YCW3/$[&
MN!8Z,D[FD$ADM/QSXSU-T9057*KK*B9,V-S)WW>WN:R)[6ES0(I78+=I!.<@
MD8^G X_\3NE130<J^N#-65#6&-U72AM.#V<Y[L^%K0T=SZ]E"-W_ "@7$/2^
MGM:4FNN OV%KW2ESHZ6"RFY1STTU')(UL[FS#:#X8I"TX#7;X\'N0/:L7.'Q
M\M?&.AX*\3N7&GLNH-46FY7C3<$&I(9Y:AM/32SPTT[&/<P2/;#)$7[P=[=^
MS:@EFGX\\46Q4IEY8M:1NEDB@?F>E):TM&'D!Q. XG/;M@^:[J+F0U@UV+[R
MX\1:5O\ [R4<=:?^:YJ@9G/)S"V#5>F^$.M^7.V4O$+4=534\5OI]11ENR5T
M<CRZ,;@TLA,SW9D\(V$XR<;TLB>&[3AO]T_[ $$%U/-?3TE/!43\OO'$B>F]
MI#8M%2S%O]AW3>[#_IY?5=4G-]9X_:L\ >/)]E@ZIQP[KO>2_P"99V[N_MG$
M7]M3R^G+V-8'ENT[A@D?L[8[(8"?O.\(\/BQD_7M_#R^B""7\WVG(ZGV9W!3
MC@YWSCX=W"4?\QA73%SB:;<YCJC@KQPIH'DM$\W#VX  B*20^ -,GE&6_#V)
M;GL=PGT0#=N=(]Q_8/\ #"MWT#G]5YEW/=MVY P"TEPR<9\R?7MZ8/=!!K^<
M+3+(VR?R*\;W!G3-4!P\N&:1KX]X=)X.X ['9O[_ +UW#FYTT*V.CJ>#O&VE
M9[[VBH?PXNDD5+TY7Q^,Q1/)W!AD;L#\L<TG!\(G$4SFN.UYVYW-';PX& T#
M'88_Q5!H 7%SI'N ^%F\@-QG&,8QV)'X800?-S@:/92FJI>$G&NLQT?!!PVN
MQ=[R/?ZP@>$=CW\_+/FNVMYP.&]JMOVG>=&<5+:WITYZ=7P\O$4G6FZF(,&G
MQO;TCN.=@R,./I.'1) +CXO7;D#RP?X+J9;XXW9W%XW..'!OPG/A[#X1N.!]
M4$-5O-EHN@@J'R\->,#JBG^*ECX<7ATA]WU.QZ&SR[?%Y_O5,'.%P>]D-QNU
M)KNS40<V'VJY:%O$,/M7O.I2[_9BWK1])VYF>^1L+^^)L$ 9$^.-K&E_GD%P
M\L>7X!4>Q@G+WDN+2TO& [UQW ]-QQ\LH(2J.<[@E;Q(;S%K^U=!NZH%=P]O
MT70/NO"[-)Y^^9Y9\Q^LS<EYTN ,&_KWO4S/!!+#G1MX/M$4WZ*2+%*=[78?
MY=_=29 VE3:^C:\M+L'IG?'W(P[ZX\_^T_-=;* ,+',BA86O+P.[MIP?+/\
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M=(^4FTG.S^UY*IFJM.25OV:R_P!N=6_^+"KCZO\ JYR@])M+&T>!C6'Z=_\
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MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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M)I]5/B B+C<$'*(B B(@(BX)P,H.41$!$1 1<$X&5R@(B("(B B(@(B("(B
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M8VP.S^BV1"AV,_M]CO\ 3:@G 549[;O%C.W'?.2,?+.1CS^7S"K]JCR\;7^
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M?R9<W\L8SS1Z0I7]:63W/#3>-KOA;XKB.P[H)]Z[/F?O?=/W3@_[^OIE<&H
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MF8&];IC])@,WGRVA!L4)V.#BT$AOF1W_ ,%2:E@<&O:6Y&026X/S]?3OG\%
M#]><Y$M/)5R< -"0P0U,LSZ-FM9YZF6!GN^BW-)''N<_WS9"\ Q> Q!WB5O+
MKGG6I8^LW@5PVN\E-2AV(-95%/[5-'GJ=$OI"-DG5BZ1?M+>G)N_2-V!L3U#
MM#ND_)&2.W;MGOWQ]$ZHSMVD'ZD#_?Y*#I]7<V5/7"I/!3AE)2TW6-3"S7-5
MU9-SLLZ4AM@SAOQ;F#)^2\%_$+G6HYJ2H;R_Z&N$$_LYJ(:?5K8'T?NY#4]5
M[FN^.4Q[.F'[&AQ=U#V(;&^TQ]\AXP[;@M(SWQV^?[%7U8_UQ^]:\,UUS@T=
MSIZ2EY>^'UT@CMS!-74NMG4T+JF)LH?"W?1F1N7.9L;L+6@29E=O&V\LW%3F
M_N=944]=RKZ2L\$'E5UO$MKHI/[H@H)'_O:$$\]=FTN] -WF/A^?X?[%S[1#
MNV[QG.//Z9_P6O5)Q'YQVT]+65?+7I0RU%22^DCUQ[R"G+I -Y-)TQ*-S"7-
M>0\!WAC796<8.;FGCJ#3<I5BK3%%%-"8.(\8%3O;NV1E]"W#F_ [?M =WR6>
M-!L%U8O\XW]ZXZPW8VG\<CYX^:@.7BWS<1MJ'CE1TT\4_2^'B9%[S=^DVYHO
MZO[^<9^YO5%QXL<W=+3YH^4ZR5]3ZPT_$>G$6-O^=DI6N^+^SY(-@>HP#)./
MQ[?XJCVF+=MW?(_L.<'\.Q[J"!QDYF8G24M;R>W.>6,=JBVZUM$L+_[IG?$[
M][0K"3CES.L):WDQO61.6'_NVLO^3MV=67O+\?B=TX_A/WG-0;$"5CG;1ZD@
M'ZCS"I%1$2!NP27 9]<'!_BM?)N./,3%7T]"WE U-))53S1"1NJK3TFPLZNQ
MSB9,L><-W9&T_P!6Z3UMX^/_ #(ROGSR6:B=[-!3U,9.KK1'D2 N+/>2-RYK
M,-(;N'5\/P^-!L;U!NV[79_Z/FN1(T^1\SC]O^X*UWI..G,)$)'7#DSU/2/C
MIX7>XU+9I<U!,G4 ]_\ HQFGVGS]]+N#>GW[*7CIQRK:NHICR>:EI*BGD+7S
M5.I+0V)V_J='8X5!,@.V'?L!QNDQNP-P;![^^ QQ'?N,8_W_ -BIZ[,@?/R.
M1W\OK]5KW<N._'^UTC:EG)EJQU/B#V=C-1VB28#I1R3!S(YW$;,5#68)ZCHH
MP[I]3(]"JXY<;(368Y1=8GJ3]"W@7^Q?TKL_QR_TWW3?"WN<GOY()VZ@W.;M
M.6_4>7S5/M,9(P<@_"01AWGY=_HH-JN83B134-)5LY3^*K35W"&B9&^:S%^R
M3^M>&UQZ);]XR[(A_G"NBIYB>*T==86T_*7Q)]FNVPU&:JSO?3!^TC(96G9@
M$D[RWS/JUX:$\F=N6M#'DNSZ8\B ?/\ %5;SAV(W$M\AV[_@H KN8WB4*/-F
MY1>+4]0-^V&H?:8&'M/T@9&U[W#)@\1VG;N9GXV!_91<R7$*JU'7V.7E'XM0
M1T0\-2YEH#//;X3]H=.7Y^ZD?V03V90!G:X^7D/GY(9"';1&X]\9&/EGY_L6
MO=QYF];T5=&Z#E+XQSTLE-!4;F4%":@;S(7QEGM6W>&&!P&_#>I*U^Q[-CN#
MS5ZL965%!_-.XR.D@]J)D;:*+I.Z;>I'A_M>#N9V_O\ @^+L@V'R?U2N5 ,W
M-5?:6+KUG*MQPCC^<=CH*E_^4^S_ *."M?)\7C^']'[SX/$NV#FCN\GZ?E@X
MWP?7[$H9O5S?ZFL?]]I;^YWP>-!/*HZK"X-!S]1Y!0#4<V-RIGQP/Y6..CJB
M3&(HK%02@9\LR,K3'_>\7@_K-BL6\V>HY;A3TM#RI<:S 0P3&2Q43##NB+V]
M/^E^+NTL=G;TWX;)L/9!L>J3(P.VEP!4#CFHN)N<%I_FN\<^L_\ RB3\W:3H
MTGN^K[R7VO8?=]_=E_B]W^D\"M*;FPO[0&W;E3XWT[L4IW-T_2RMQ/'U&_HZ
MMW=C?C;\3'> M#_ @V%5!EC'F\>GE]?)0%_.W&T'^;3QYR3&,?F<,C.-_P#7
M?U>^//ZV_P!WU-DFRWM_-3J*M='3U'*EQN@J)*H4W1;I^E;@%^8GF22J;'LV
M?$=V6_+'=!L0BU[DYO#3]/VOEBX^P]1^P?\ <:V7!^O3G<KBCYM:*L+ .7KC
MM"7TXE]]H2=N)#U V ^+](7,8,_ WK,<Y[6ME=&$^(M>*;G&H*JD@GCY<>/0
MG?2S5=12'0\G5I&Q[O!(>IL,KMIVQ1N?(>V6A<TO.38ZN5\,? +CJ"R*6;+M
M!5."QD<C]P[_ 'A&0P>;R0&[N^ V&100SFRL[Z3K_P A_&H3^TBF]D.AJGJ^
M+]&_/P;'9'?=EF1U S(S:GG&TN8.O!P5XWU'NB[;3\/:^5W6Z3)1!AK3XS'(
M' _!@'Q9P"&P** JGF_TU$&&EX)\=*P/GZ'N>&MT&#\SOC;V^JK9S@Z#FK10
MTO#_ (LU3SO =3: ND[3T\";X(3^CD(C=\W%NW<US7$)Z103:N;W05UDZ3=
M<4Z8NP^$S:&N&)X <231[8SN:P]L#QR.\,+97=E80<Y^B9WP$<)>,[*>HHHJ
MMM2[A_<.D'O#,4Y(9GJB201'MLW@^,M\:#8/:54H"J.=C@127PV"KN&K::HA
M,HK'U.C+O!'0]./>>N9*9O3R.PR//Y+F'G<Y>YY*)C-1:E8VY,J):2271EZB
MCGB@BEDGD8Y]( X1MIY]^.[>D\D -)03XBU]BYYN7<OIX*N]ZJI*FIIS4MI9
MM%7DU 8/BS$RE<\8^>-OR)5S'SQ<M4MV-A;K*\_:7N_Z(=)W?K>/R\'LN[\>
MR">46O\ 1\]'+57L$]-K&]&F(@?[0[2=W8SIS?HI?%3 ])WI+C9\W!5_SY>6
M'K^S_P HM3OVB3_UWKGC8?@?_D_PR?U9\I/N;D$^HM?8N?+E2ED8U_%=E.R3
MH8GJ;-<((/??HO?20"/Q?WOQPDG/;RP14(NCN)$_LFSJ]46*X_HNG%)U-O0W
M;<3PCRSEX[=B0&P2* _Y]/*C[5[+_+/9\[]G4Z<W2:>GO\<FS9'V_7+>ZJDY
MY>5..IJZ4\:+*74&?:'ALO3;CSQ)LV/Q][:3L^_M03P'Y#3L=XOX?BJE!HYU
MN5U]+4UK>.>DFPP4D-=N?5EN(I&.>, C+G-V[7L:"Z-[F,>&O>UIZX>=[E3G
MBI)V<;].]&NDDC@E,CPQQCCWR'=MP T?$3C'KA!.R*$8>=#E;J&SR0\<-+&&
MF@AJ9IWU@CA9'+\!ZC\-+C^H"7CU"]!G-KRR/  X]Z$$A89.B;Y3];8-^YW3
MW;\-Z;]W;P[3NP@EY%$</-ARVU$E-%#QOT:7UK0:=CKO"QTA/P-#7.#@7X/3
MR!U,'9NP<&<UO+;/4Q4E)QZT%52SEHC]GU%22-.Z-[VY<V0M;D1.^(C!VYQN
M;D)<1130\TW+?7R>SP\==#15&6#V>IOM-3S>/&SW<CVN\6X8[>OT..Z#F;Y=
M*J U%+QZX>3M$76]UJ>B>=GS\,I_VH)011U_.%X$E[(QQGT+OD^!GYQT0<[R
M\@9<_>;^\+JHN8W@)4BEZ?&G1!=6TT-9 QU_I62.AEV]-_3<\/ =N&,C)024
MBC=_,3P'B<QDO&;0[#*QLL>=14?C8[X'#WG8.]"<97;_ "]\&O:Z:B_E6TD9
MJM@DA:V^4KMP):T=P\C)<X ?/OC(:X@)#18'_+EP8V.D_E<T7L9[/O=]OTF&
M]?\ 0Y]Y]_[OZWIE5R\:>$\,DD,G$_2K98Y)83&Z]4S7%\0]X!N>/A/9WH#Y
MX09RBP./CCP>EF; WBGI,/+MA!O5-X7],R;3X_U&//R\#N_978XN<+34^Q#B
M1ICVCI]7I?:T&_IYQOV[L[<]L_/MY]D&8HL2AXG\/YZB&D9KFPB:IK):"",W
M. .EJ(G-;+$UN[)>Q[FL<S&X.([=P36.)G#TO?$==:?#V,ZI'VG!GI_K_'\/
MU094BQB+B%HJ>I=1PZPLSYF-A>6"X0YVS8Z)QN\GY;M/WMPQGOCOI]::8JY'
MP4NH;?++&]L+XVU3-S97$-;$<GXR7- ;Y^-OZS<AD"X)(^Z5C,?$?0<Y(@UG
M8Y2&0R^[N$+O=S?H7Y#L8?D;?ULC&<A7L.J;6]P:ZY41R8V]IV_$]VUC<9SE
MSBT >9+@//(0>TB\R:^VJE:YU;<::FV.C8\2S,&UTCS&P'OYEX<T?,M.$FOE
MJIY9H9KC3,=31>T3[I6M$46,[W$G#1COW].Z#TT5G+700YZLC6X:9.[A^C'F
M_&<[0J'7"%A(DF#,':=S@/O!O^);]?$WYH+]%91U\4DIA8?>-^)A<T.;Y>8S
MGU;_ *P50JV.DV /P3@/QX2?+_$$?L_!!=KC<%T"HB<TR-F86M^)P<,#\2JR
M_;\32W\<(.U%9FJ<'],M?D9SW';'G]3YCRSYCZXJ%7$6-D#CL<XMW8[ C.<^
MHQ@^?E@Y07.X+E6YJ8\O \6QN\X<WR[_ %^A_<5SU1X1WRYVT ]B3^!^@)_8
M4'>BM351MSO.W ).>^ #@^7U[8\U2ZNA;G#G.['&UI.2,Y ^HP>WGV*"\16O
MM<??OVV[VDD /;\P?+\4-4T.PYKP,M&XM^?EV\_IY(+I%;MG8X;@\#N1W..X
M\QW]5PZH:UVWS)) \0[D>GGYG!Q^!07**W$\;MX9(UQB.'@'X>P/?]ARG7[A
MFUV_ <YO;+ <]SZ>A_<@N$5M[2S>(\X<<_AV\^_EV]?P7!JHPUKFNW!^ W'W
MLC/;]@S_ (9072+I+RTX(.<9QC/[%5U?E&\]\>6/3/J@[$5N)V%Q:'Y(&XX'
MD,D?]!_<5P:AH."?7'F/+MXOP[A!<HN@2Y<&8=X@2"&DC'XCLNL5D9:7[AM#
M=V=PQCY^?EV)_84%VBMO: !N(>&X!<XM(#<_//\ N/7"J]MIPTES\.;G<SS<
M, $C \\9'EE!WKC<%;"I!>V,-.7' (P1Y9/D>V/K^S*K=.P': 2_ .SL'=\X
M\\?(_N*#O16OMD)CZC9,X );C#AD9[@XV]N_?"Y-3'G:UV\X#L-(<<'/R_NG
M]Q07*XW!= F!9O![?B/EGS\O)<NGB9\;PW\4'>BMO:&[]@)/AWY R,9P/W^G
MS7(G:3VSC<&YQVW9QC/EV/;\>WGV07"XW!4]3)PUCSY]\8_Q74*ACG;6@DDN
M &1WV]G$=_0]OQ_>@N$5OU?%M<US3YXQGUQZ9_W*KZ[0[:6.S\A@_+Y?B@[4
M71U0!EY+?"7'/ICS\ODJ'54;1N<7 9(.6$$8&2<8SY(+G<%RK;VJ/T:X^(-S
MV [^O?T_Q],KL]H;W\)PT9<=S<-/R/?S0=J+H,IRX!KB6Y[8QG'R)[*CVIA<
MP,\>[U:YN !YD]_3(^O<?5!=(K=T[6-+I"6-#]F7# S_ +%P:E@#R7#P>?<?
M+/\ AW_!!<KC<%:^ULQY.SU.GM[9\\$_ACO^'U[+NWCQ]CX#@]P@[-P7*MQ4
MP%Y9U69&/O#U\E4VI8XO :1L/?)'E^MY^7^PH.Y%TA[R_88W#P[LDC_:NS>/
M%_9\^X05(J#-&&;WNV#^WV_Q7(=D9P1^/9!4BHZK<$X/A^+)';MGNN!*#M'3
M>"X9P6^2#L14[QAW;X?3LJ&SAWPL?][S&/(X]4':BI+_ "PPG/G@CP_BJ3-&
M"T;AEQP!D(.Q%2V2-PRQ[7 ^6#YH'Y^ZX#N@J1=9GB&/&W!]<CM]3^WM^*&4
MMW$QN ;@Y)&,?O\ 3S0=B*CJ#;D-)/?L,?\ J%R7X<UNT^+U] @J1=?6BV[C
M(T X\S\_+]ZY+R-Q,;O#\L=_P05HNOK1XW D]R/+Y'!3KMRX;79:0/+\._\
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MM(<UP/?T*#LT!P?T!PN%Z9H'3=-9(]1726\7&*E<]L3ZR08?*QF=L9< ,AH
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MA>ZB#&ZCA_I"JK:FX5&D[--55+^K+424<1EFD'D9';/$!@8W9QM'R&*F</\
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MR9W9=OVGWM$[_..W?K8&-JG' 3 00/+P'XN,DJZBBYK]<-D%?'6VX36>T/$
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M"F_H.;M<UC,_>:3V]/7&?0*DT;3Z,'AQV!_8//X?[/D@@QG-M;Y.S.7WCN7
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M_#D>/I=]4T(]Y^I^E^+Z+H'-1RXB/K2\<M#PQ]&2HW2WZE8=C-F3M+]W]8W
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M"TE.]\<^E[15,+YIY!/0Q/;UY'M>^5P<,ESW,#G'S<0,DX&.N+A/PY@=_1]
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MQ75>J?R?G#&X7[26KJ;A-:;SIP4YNMLJ-/4PK0)(Q+ 60=/JU 9&YKCTQ(6
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M]S]R[(Y.;*-_O(N$TS/=>4EQC/9OC^Z?O>7T02^)@<[F/:!W)<,!1WQ]B$_
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M_I8_LNOZD'_*MZ&Z/_3 0;#(H+;SM<J\D\E/2\;-.U3X!4NF%+.9]G0V;AX
M=Q<Z6..,-R99'AD8<[PJVCYY^55]-45;^,]HACI9HH'B>.>*0R/CBDP(WL#_
M  ]>)C_#X)'=-^UX+0$^HM?:7GTY2:V&":DXTVJ45'P,;35._P \=V]/=Y^'
MR^+P_%V5Q_/CY5O89;C_ "TV3I0D%[,3=8,):!+T=G4Z7O(_>;=GB^+L<!/2
M* W\]?*6SI[>.-@FZKMC?9Q+-WQG^K8?3O\ W?%\/=51<\O*C-4T$#.-E@Z5
MQ>(X:LO?[*UQQCJ3;=D6?%@R%H]V_P#5*">D4*,YS.5F6IIZ.#CQH^>>J;&Z
M&."XLE<[J/V-'@S@Y\1![AGC/@\2Z*3G7Y69*[[.EXWZ7IIC2LK&NK:QM)$^
M%['/8YDDVQC]P8[ :2<@?,9"<D4&2\['*U%1FM9QIT].UM$^XN9#.9'M@;&U
MY<0!V[/;@'!)S^J['?#SF\K50V26/CMI 0QSPTIG?<8V0]66F]HC'4<0SO'Z
MDX#_ '9(D\"";$4-7'F_Y:J1U0QO&;34XI >L^EJQ.P8>]AVNCR),.BD!V;L
M;"3@=U0SG%Y6WPNG_G!Z#:UM/'4X-^I]Q8_=AH;NW=0;'!T6.HW'B:,MR$T(
MH;IN;_E@J:RKHF\P&@XGT3GMG?/?:>*)NWI]^HYP9AW5;M.</P[;G:[%Q!S8
M<M=1;3=H>.FB7P,A$TK&WJG,\&6.=LE@#NK'(-I;TWL#M^&8W>%!+B*,W\R?
M+VRG]J/';AX8]W3W?G308ZGZF>KC=],KAO,MR\N:R3^7?AX(Y&&2-YU108?&
M!DO'O?A![$GU029N"Y4>Q\P/ V82FGXP:*FZ#XXINGJ"C/3DD?TXV.]YV<Y_
MA ^:Y''C@RYG49Q<T:YO?Q"_TFWM#UQXNICO"#(._P (+O($@)!11_#Q[X(3
MM$D/&/0[V%W3W-U%1.'4_4[2?%]%15\?N"-!+'%7<7M%TPG;*^%\NH*-C91'
MGJ%N9>X9@[CY#!SY' 2&BPN7C'PHAIQ5R<3=*B Y]Z;S3!HQNSW+_P"Q)_J.
M]0N:_B[PSM3:Z2Z:_P!.4D=MQ[4^>\4L8BS&)!OS("W+7#XL?/RP4&9HL/H>
M+7"ZZ4WMMKXD:7K:?I]7K4]XIY(^G^OO:_;C]J[)>*/#:!CWS\0=.1B,PM?F
MZ09:9OT(.'>;_NCS=Z9098BPB#C'PKJJS[/I.)NE)ZGJ=+I1WNE<_=UC!C;U
M,YZK)(\>>]CF_$,+NDXR<)(GQ1NXG:4WS]?HM%ZILR=#]/M\??I_?_5]<(,Q
M18T-?:/<S?%JNT2 [3X:^'R=$)FGXO(PGJCYL\0\/==<O$C0T%NI+O4:NLT5
M!6F%D-4ZX0=%\DVSHQM>'X>]_4;M#2=V>V<C(92BQNFX@Z%K;;]L46M+'44'
M_C45?$Z']#U_C#MOZ'WGG\/B\NZ]!EZHV.]Y4,+22W<U[7>(':6X!SD.+6^7
MF]H\R@]1<;@O(J-3V2EHGW*INE+%212&*2=\[!&R02",L<[. X2$,(/<.(!7
MH"IB?N$)ZI9\081V_><(+A%Y[;M1.\;:AAAZ/M'6#F[-GS\\X^N,>F<]E6RX
M022-B#O$Z)LV,CLUV<$D''W7=_+MY]QD+U=8J(B6#=^D.&GYG&<?N[JV;71O
M+Q$\R%AP=GB_5/I]'M/X'/DL2U;KZ/2]_P!*6F2C?5MU7J&2PC)P(!';JZM?
M)GR!#:1P/S;@#+NR#.D5E[:S?L+P#@._2-SM)\)QG.#AQ'T:?P53JK;DB-Q;
MNV!V6@$YQVR?G@?B0@NT5N)XRYS1(WP#+SD8;^*X-2P'!/KCS'EC.?PP@N45
MG[6T/9&7$&4;F8[AP\/?MGMEP&5V"8.:'-#B#\FGMWQW'^_D@N$5DRM8]YC<
M\QN#BW;)X22"1Z_/&1\P00JFU;7YPU^6EH(QWR1G&//./]OEW070.1E<JR-<
MP^)K'-8-VY[BT-;M.#DD^AR.V?+ZC-?M+=Q;M?EO<Y:1@?/OYC\$%TBLV5;7
MG:'@.PS+2\9&[R]?^P^F56VJ@?TMD[7==NZ/!^,8SV_9W07**Q%:YQ:&QO)<
M2TX<WPD#N#W\\]L?/Z=UWB9A>6"1IQCOGMZ^O["@[T5NV;=@.!83Y-=C/EGT
M\OVKL$T;H^HS+F_0(.Q%TNE8QNY\K6M_6)P/W^2"I:7;1%-]#L.#_L_;A!W(
MK?K=V#:X[W.:#CL,9[D_L7#97N#2W)#CC.>W_;^S*"Y16KJD-+&NCD#I,X&P
M]L>>?P_CZ9576.6AS"W.0<D=L=^_?U'?_'""X16OM0_4DR&[CX">WTQY_LS]
M52:Z(8 R2/CQ@AG?!R?+L?/!.$%XBLG7"!I>'.(Z>"[Z N(_Q:[_ %3],\OK
M&1$=638"6MR[M@N=M:#Z@DD8SYY07B+I%5$YH?'N>T^3F#(/R[CMCZ^7SPN#
M(6@E[2T ;B3CZ_+_ '[A!WHNCVR#<&]1NXDC <,C SGS\L$?ZP^:J]HBV[RX
M!H^(DCP?C\D':BM15,..SNYPWR[]R/V>7KC_ !7/M#-^S</+=G(QCRS^_L@N
M45NZ=C&,<]X:9/A:>SB<9QCS)^GFNN2NAB[RDL8/BD=@,;WQ@N\LY[8\_H@O
M$5L*AIW8R2T@8 SG)P/W_P#;Y*I\NQNYP=C<&]FD^N$'>BMS,P.+2XY']D_[
M_A\_14MJHW@EAWD'&&D./<9![?,>2"Z16_5?MW.B>WL'8.,X/GZ^GK_TJOVF
M/MW&#YNW# ^6>_J@[45L9]H<Z1CVAI(!(!W#Y@#)(7:9@&!^QV#Y_3_?Z(.Q
M%:&LB;\3P!Y DC!]1CYY'?/R!SA5F<!VS!)^F/\ ?T/[B@[]P3<%TB9A<6CX
MF@%P[9;^/[BN!4L)QCOD#XF^1\G>?D?WH+A%;NJ&,QN<0'/V AI(W9QCMY=_
MFJ65)>SJ=)X:1D.RT@C.,Y!/IW_!!=(K8U  W'L#G!+F]_EZ^OHN/:F-_2>#
MQE@W$=\>9['R_P /5!=+C<%29 ,=CW\_I^*I;(QPR#VR!W[>?E^*#M1=9F8'
M;"?%G&/7\?P^J&9C6[W^ 8SXNWXH.Q%09#OV=-Y^O;"I%3&X!S3EI[-=D8=V
M[8/J@[4769<-W;'$[=VT8W?AA.LS=M\61C[A]<8]/K_C\B@[$5JZKB8?$_#?
M"-Q'8$Y['Y'MZ_,+M]HA(!9(UX<1W:X'SQ@_Q'[P@[475[3#@'>.YQ]?/'^*
MJ;)N.-A'[1_T']B"M%0)6.;N;XAW\N_DN'3-:<%KO,#(&?\ U'S[H.Q%U>T1
M]QD[@<%OF0?P_C^"JZC?+ODM+L>O[OVC]Z"M%3O&6@YR[T7&\[-W3=G]7ME!
M6BIWMV;\.Q_=.?W>:=1NSJ=\8SY=_P!R"I%090T%SVN: ,DGT_<N.LS:7=QC
MS!&#CYX/X']R#L14=3S\#_#]%PV=KG.:&O[>NWL1@'(_?_B@[$77UF_JN/RP
M/,=N_P#%<]:/L-X[X_CY(*T76R8/<Y@C>-OJ1@'N1_T?N(5)J8FN+7' 'J2,
M>G_60=R*GJ,W;=PRJD!$1 1<$D?=*IZG]AWK_!!6B(@(B("(B B(@(BX#B?N
ME!RB(@(N"XC[I7* B(@(B("(B B(@(B("(B B(@(B("(B BZ^NW(P"0[NTC&
M",>?^ _:%V("(B BX!R,KE 1$0$1$!$1 1$0$1$!$1 1$0$1<;@@Y1$0$1$!
M$7&X(.41$!$1 1$0$1$!$1 1$0$1$!$7 .1E!RB(@(N-P3<$'*(N-P0<HB("
M(B B(@(BXW!!RB(@(B("(B B+C<$'*(B B(@(B("(B B(@(B("(B B(@+Y0<
M%H>;3CM3TVH]&\ZL=CM4NJJ^S16VZW,/KH8F13R-F,>0:AP$48; #WP]W9K2
MY?5]?+/E&Y'^ ?,_P*IN(VM;CJ1]=->;G!*RBJA3MI(8YRUL#'.B+IHRQD1R
MTM'C>WXFES@DRV7'CQPLUORN<.]7\=JK73=37[5!NMWM58YT=THVLBFIXJA\
MQD;5-8Z0D.:UI8WW4??QG='B5Q*TQPMT?<]=ZNJY:6SVEF^HFCB=*>YVM #<
M]R\A@SCQ$>G=:4\;]/:'Y9N,/)K8+G64T&F-"_G#:I+E=WL9"6&DHHA42$D-
MC=U9!*#GPN:2,X ,B<P7%7AWS3\OO$CAIR]<0;#JK6,EB%[I[90E]3/)34E3
M#,=L3!N+Y#AL;=O=\K < D@(2X:W3\H)S)T%QXUZ&XE5&B[-<(*Y^F[5,RBC
MI&LAJW-91F(Q/>#L8YO7>UQRT]L=UG_+3SG:GN=LXF:$YB-26>R:HX8T;IJF
MX34\4$3FTXZ%1+(6O+)'BK,1S'%C,\3=NYVT>)R5<VW#C1W"*X:&UWIPZ/K]
M$POEFCBJ):FIO566U$D[O9GLWQ59= \RPY\4I<X-:"&F)*>LU;S3\0>8GCKP
MNT1J9]KI-,LMEIH.D::IN4PZ FBC;&W<^5PI97R1M>YX,E/'M+@UI#.>!NJ?
MRDW,7HVJXGZ&XM6'3&FZB*L^SH;U:J,MJYVSY,<6VF<[H1X=3B4N .PD9QE=
M^D.>KC-=>7GBKI/4],V#BUP^LM15P7R 0="XTT=0V"IJQ"Y@C;+3&1KG1EHW
MM=&<>,9D/D1YE^$=NX$T&BM><4+7I^Z:,J39W4FH[A1T$H8P!K.G'MB<6]GL
M=U ]_4;*2[LTG6S2E'3ZHL/.+S(TUKGL>@=16B[T5EJ[M;V,;6U;JN0PMAAD
MC!R964[2[[DE2T$/?'E@2-8N(OY2O5G"6KXT::XTZ"EL-'0SW"6GJ+72&K$4
M+2^0%D5.]K7!FU^'/'AD8?GC:ODTX_7WF-X$6GB5J*ST]LNC)9+75LI9G/AJ
MJFG:.I.,M!C9)G<V,!W3SC<_T^?M'RE7ZZ\H]@YE]+3U-3<(M/U%RNEBF!=)
M)2-E,6^&> Y<TT<;-\+AWV!Y= [W2WIY%>)7!OB/P1C;P;T-#H>UV2XST-59
MF5?M;HZA[8Y14&4^.?J;VN;-*-[BT@9 !(13S&\;N9^AYOK+P"X!Z]T];67N
MS0U=/2W>V1N@CG(J99@^4L)[14!<-H=_E1^FW&+%S'\X?"#B52Z YHZFS2S7
MJP5,ULEI+=1-;3U_3/LDC9V/VO<Z=DD3V%G8.81N!R*>,^CZCB%^4NL>E]*Z
MPO\ HFY?FG2U$M\LSF15,E1'%6EX9U0YL@=%B/+@[X9/U'$9?<.2S3/!FU\3
M./VM]=WWB9J&BT==[@Z6YTL0WW$0U$DL\; UQ!Z(@AC:Z1P86O<._3Z821^3
M[XM<3N,O!FYZKXKWX76_1:CK*0XH!2=%D<%/B$M;EN YSCD9'=>USG\P$_ ?
M@]47?35Q?!J^[S,MNFH=D$LDE2X@&1K)6NZD;&D.>X X!&>_90O^3+USH_1/
M+C56S6&N+?03#55PB@%VND4,FWI4F6QB4M=(UN\9=C\,Y&8_YDM8Z_YHN;.W
M\*N#-7;M0T'#^T?;UK=02NAB]H<R%[WSU9)8\%WL\;)(R6>]\6>Z#8?E'YE-
M5\9> FH]0ZWIZ6FU?H2X5]KNKY*8TT4T\$39(ZB1CL=/+' N'IY>?90YR)<]
MVK.*&K&\...^H(9;YJ*CIZS34T%OA@IY'Q[C44[RT[C4.9B1@P<M:?)Y8UT4
M:)J>+/*WQGUII;B]8ZB.3BWHRNJ:T0FED94W!G5%$]]43T8G%YG@']JKW/R&
MLVXMH+@;JO5_)=I[C3I&FK&ZKX<:MKZ\FW4SY:JOB;)3M;4,+&E_5I98PYG8
M;6LF>W#7'>&Z/+[S%\1>(G-UQIX2:DN='+IC2DKV6"+V81S1F.9L4OC/=V"[
MOD>2V^7S=_)ZZA9K3F7XL\2(ZFUTYOEHBKIJ"DJ 09YZMSI9(879/3!@V22.
M< UTD8[YR/I$@(BX/D@B3F4C-PY;>*E%14L=7+-HJ^L$,OH7T,N&]\. [_+/
MDO:X&7*&NX+\/ZF"*1OM&E;8]K#M) -+'M)+26C/IW7F\RQ,7+AQ3D+@!%HN
M]O(>,MPV@ESV['^*BO@?PGXJW'@SPSN<',=K*AMK-(VPOM@M=H?X7TE-B)KG
MTCB6-V/PZ3?)XOC\T/FPV@-1&"X%X&WSSV^?[_(_N*UTYZ]&ZSX@\O5YTUHS
MAR-67>6MIIH:<5O1GIVP3"9T],"6.EEZ<9Q&Q[22<#.'+(/Y#.,$)NKJ+FMU
MI$:SO1&6SV>;V+X_+-(-WZ1WG\FKJHN"W%N"6G?=.:+6E9!!3-ADGBM%NBJ'
MS.$#9'M/1=& 71;VM,3RWJ2M+O$@^=MMX5<79I;MQM_F\7Z\V?15[AJJW3FH
M(3-=[L16!LK&M8R3>8WM#G^$8C:UPSM"SO6XXE<S'%2UZ<X:<OM\X9:9XG55
M9#7Z@K:0M?>**$LGDJ;C3[FC$,DLI8QSMKW.#&/=Z;PW'A-Q<FGB=!S-:DIJ
M;+I8BZRVM\HFV[:<&5L :X-<?%EGO1AIQYJWFX.\:*FU1TM?S2ZC^U=[RV>'
M3EH@A#=[']/H]$Y/;&X/S@D!P/B1;7+0[0=#Q'Y<N->A[)J_A3Q-U+9N#=WU
M#46::T6.:H=6T==#-1OEI6O=LC@>]L$NUSVM:YX:''>W=:ZDNULXE\7N)W&'
M5G"3F'MEGO5UL?0I+3I.)SHHV0LIZB.X,D:XO;)!#&Z/:2&F1N[>7-SOO3<'
M^.=MH'TL'-3J.JJ QK!4U6G;0Y['LE<[>YHIV[VEG2;M)!RYTF_)PNI_"'CY
MU#%0\U]^@C#ML$$VDK/*YD)WX:7")A):U].-P#?>1EQ\#]C"J7-.W9MST[;;
MM%:ZNVT]1;X:ME+6TYI9J42,W"&5H&&.;Y.  VD>J]HU,8\P[.2,8[_%MS^T
M^7S4(OX/\;X<B/FOU 8H9(Y@U^F;>Y[FQ.W[7.8QN_.2'C&7#T5D_@SS+O:)
M'<WU?UA! S_URK9MZFW^D.\OON^']1GA&3XT%YQIN]%2<8^ C*N6GA$VK[D^
M.>H>V-S7LT[=F=(;L9W>T-!QGQ,8//RGA:C:PT-K[2W,ER^'4?&&\:IIY;IJ
M&G=%66RWTK3)]C3O:_\ HD$668#AL=N['XB<N6W*#6SG8YA[MR\\+J.YZ2I[
M?6:JO]8+5:8;@S>UPZ;WSRNVO:0&-:,N^'+V?/MF/+!QNK./7!:S<2J[3]+:
MKG6SU5)<+935 D]CF@J9*=[20>V71ES<XRTM/;.%IOS,:AO_ !>YW*33%LX:
M:BUY8.%5#3MJ++:9HW&KJJB-E5.^;>6B*,-FI8G-<1^C<T9,N&7G(EK:KX4<
M>N(7+?J?1-9IF?5%PJM06NUM?[4VS2-!WTDKVD[F/I13/CF[QO +@XEQP'T>
M6N?"5\K^</C[)%,SH?9VD&3QBG=D2^QU!SU,[2-KF^GS^1QL8M9^"E+ SF\Y
MCJR&/^E=;20F#HV9=&+.=KF/QNP7/<!D^;)/+/<-F$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$%.TIM*J1!Q@+C:54B"G:5S@+E$%'3"=,*M$'& F N40<8"
MIZ85:(*.F%5@+E$'& J-A^878B#C 5/3"K1!Q@)@+E$%.TKG 7*(.,!,!<H@
MI,;3\0RFTJI$'& F N40<8"8"Y1!3TV_)4B%GW@"NQ$'5T6_((R$,:WL-WWC
M\UVH@I,;3\0RN.F%6B"CIC;Y#=\U&W'ZWFHX#<1Z9NV!U5I:[M&V,%[2ZEEV
MGY=OP4F+ N-]8^W\&M?W%D7M!I],71SH_5VVED. $'D<KTGM'+;PCJ)&'>[0
MM@?EOEWH(E*BB[EC8*7EPX5Q0G--'HNR%CC_ )OV"+:/Q\E** B(@U^YU9[3
M#R^W"6[T[I;=1:GTM)51->0XQ-OU 7@>I.W)Q]"M@5KGSP4$5PX!/K7NV2VS
M4^F*VBE+O Z4WJBC#W#R<-LC_"?7"V,0$1$!$1 1$0$1$!05JSDBY8==WF\Z
MDU?PFMERNNH9W55RJG5-4Q\\KSN<\[9?GY?(=AV4ZH@\33.D[+H[3]MTMINV
MP4%IL]-%24-)%V9#%&W:P#M^KY_]*]M$04[2H!XI\D7 ?C#KN3B)K"T7;[7K
M# RYFENLL<%UIXV;&T]1"<Q]/'<],,<3YN6P"IVE!&_#;EWX.\(+I77GAMP]
ML]AKKA##33U-+&0^2./X02>[?3=M(WX&[.&XDI$0%'_%7@;PYXUVNBLO$?3D
M5TI+?5BMI@9I(W12[@206%OQ-+V'^RYWZQ4@(@U5N'Y-+E:KJJFJ*73=ZM<<
M#GN$%!?*B.$!T_5V!CB[:/N>';X>R\[_ .9B<NQ="9;EK:00.RT.ON,C#_"<
M1_#E^?\ 0:MNT0:?N_)A\OKI('.O^NW""&2',E]+WRA[WNR\EF"6AX:WP]VL
M;OWK8#@WP6TGP*T+1\.M"/KA9;?-4SP1UM29WYGG?,]I<1\.Y^!^ ^N[/MI5
M2 B(@(B("(B B(@+2#F\CD;Q\H"XMV2Z3I(P ?7VNJ\_]=_\%N^M'^<"3?Q^
MML(^*+2M#(?EAU;5@?Q:4&\"(B B*G>/D4%2(B B(@(B("(B B(@(B("(B B
M(@(B("(B#$=>:!IM>V.GL%=<:FCBIKO;;O%-2=,/9+0UL%9#ALC'L_24\8=E
MN<%V"W=VR-U"XN#Q.[>#@N=@ES>_;L 6^9\B/17.TJI!;>QY)WN:X.&'#;C?
MV^]CL?W*AM"6R-=DN;NR\%_F-I'?MX_N^?R!\QWO$06AH6.C;&]H(: SXL98
M!C!P/+UQ\U6:=Q S@^8.3YC.?0#S]?3YY5PB"V=1DS=9LNUV-OKC'["/I_N&
MX-I&L=OC8QC\8+O,NQY9.,G]ZN40=/1[9Z;<[MVW/ASY?)4.HJ=XVNIH@''+
ML?,#:,=OU>Q^G;N%<H@MGTG4WAP:!D;0#].__2/H/)!3R C#R!DGL_MDY],?
MVC_JM5RB"AD9C8V-A&&C [*U^S(=V[+SZ'<\N+VX'8DY./",C/?'?*O406HI
M' LR6O >XN[8!!#LC '?.6Y]"1E4.MP,AFW[WX) >>P=Z'MW\O#^&?F<WJ(+
M-M"YNYKG"0%^X%^"0#V+<8QY9&?/!QZ*KV1H?N,3)!W[OQZCOVQ]7?ZSOFKI
M$%D^A,C9&N.!(7 M#O-N .YQDDAH[^8R<'R54=OBB8(V8# <[0,=_P#<G/SR
M<^9S=H@M?9"6=/<UK0_>,-!\\Y:<CZGO]?W\FDW-CC>6O8QFPAS<GRP<'TR/
M/M^Y7*(+44K]K6N+,G()[9:".^.V.YSGL//Z(*)@W.,<9=(,2#;AKSC&3ZG]
MI*ND0><^T4[G,G;30QS1PF*)S0WW(.TX82TX&8XSCR.P''95"V^]DFSL?*YN
M]T;MF6M!PWL,^N,^?8?(!7Z(+*"VT]-"RF@IXHHXQX TG .,9QY^7;S\NWDN
M&6J$"0N)S)EOH1MW.(&",8\7R]!\@KY$%I+;J64QE]/$[9)O[M'SSZ@^N#^/
M?S5M'8J&*221E%3!TD;('DLSOA9NVL/;^W)YY^-WZW;U$0>'^9^GQ-/4?8]$
M^6LBDBJY'P,<Z=KW;G!^1X@7=\.RT>@752:'TW0"F-#8K=3FC=&:40TT48I=
MH>UHBVL&T-$T^!C^ND_7*R%$'D4^F[=13,GMU+34KHXVQL$4(#6A@<(\#T#1
M))V;C.]WS5A4<.M&5?M[*K25FECN51[56,?1QN%9-@-$DP+</<&C:'.#G =F
MD#LLF1!CK]"::DJJVIELEOD=<O\ *W.IF;Y_ Z,;W%I<[$4DC!DG#7EHVCLJ
M!P^TF;<;*_3=I^S?<-]A%'$*?;"P-B]WMQX0UC0/(-8UH\(P<E1!B\G#?14I
MKGG2ME#[G*^:M(MT!]H<_?O,@+")"[JOR7 D[W9/=6MQX0<,+O<7W6Z\.=+U
M=7).:A\\]IIWR22.:YKGO<69<XM=C))/U69(@C;^;AP(,>#P>T9U#++.7_8L
M!/4E_2/W;=P+OQ[?L5PW@!P5%=670\)M&FLN,4D%94&Q4W5J8Y';G-D?LW.&
M[OW)4@H@CAO+MP,B#/9N#FA83#,R>#9IRCQ#(QV]CA[OL6R>,8QW75#RU< :
M>;K1<$]!AV  3IVBW#:YKF^+I;O-N?/Y?(8DQ$$8GECY=C3>R'@1P\+.KUO%
MIBA=X_U_%$>ZY/+5P%;!74T?!K0X9<W%U;FP4A-07.!>9"8SO)P.Y[C P1AN
M)-1!%5OY6N7BU0>RT'!'0D4&9#TVZ?I<>.5DI\V'X9(V.9^ITXPW:&A*+E:Y
M=+97,N5OX"\.H:J+IF&<:9HC)#TPT-VOZ6[R;GS'?OYY*E5$$2NY3.68U7MQ
MX!Z =-TNCAVGJ0QXSG=LZ>W?_;QN^JXH^4OEEH7SN@Y?N&^*GJ=3=I6A=V?\
M0&8C@'Y?#]%+:((D;RF\M#:9M"[EZX;2T[7;@U^F:0D R/DQET9.-SWG&<8<
M1C"[W\KG+F^J?5G@!PT,DOZ<G2M%[[^\.GZ>F=RE1$$,2\G7*_,\.EY?.'KV
M]&>GQ]@TS?!*6!WE'Y@-\'^;[-9M"[J;E#Y9J-_5@X#:"ZAI):)SWV&G>Y\+
M\9#B6Y?G'<GQ=SXN[MTPH@B&3E$Y7YGB23E[X=^7Z(:<I1%Y[OT88&^??R5K
M6\G'++=*1]+<N!>AY1)/)4N=]BP!^]\DLCO$UH.-T\F!\L#R  FA$$*6ODRY
M7K3UGTO 70G4J)6SN,]CIJG:X,C;M:)F.:UONFX:UK6C)(:'=U:57(QRDUU#
M14-3P"TB&T/Z.6.B#9Y/^6F!ZD__ )QSE.R((#AY#N4:GJA61<"=-;Q4>TX,
M3]N_K=7;MW8Z>?!TOT?3]ULZ?@51Y%N5#H0TPX*6'I15#:D,][C>/:.V=V>G
M_2Y_=?H^[/#[N/9/2(-=ZK\GYR@5O6;+P+L$393_ .#OG@R,M."(GM^1;_<+
MF^3WYZ>)W+OIB]7'A];++P[@N%EH]:NN^H:&KK))(&THMUUZ<@;(2,,K*B(M
M#6Y:]X<-H\:V.5L^EWMV8: #EN'$8[8R<>?X'MV""&-2\FG+WJV]"]W_ $$:
MJ00&F,7VO6QTYC+]P]PR41Y:1D=OB>YWQ>)>3/R#\J\M%#10<*J>D;!1^R1&
MENE;#@=3J;W[)1UI-VWWLFZ3$<7?P-QL,B#78<@G+ VI9*-!5'194>V-IS>J
M_ILJ?\^SW^8Y/JPM']E6-/\ DZ.4JCM_V=2\-IXXNMU=GV]<C'MZ_5V=,U&S
M'W/A^%;+H@UWGY"^7"KJ))J_2MXJVO+7LZNI[F)(I1+-*9FRMG$@>738QNVX
M8WMV7,_(/RQ3U$U?)HF]/KJAVY]7+K&]2S;]^[J![ZLN$G]O.[ZK8=$&O Y$
M>7N%M%#;K3JNW0V\@TC*/7%ZB92,+P^2&&,5.R-DA=-O+0TYFD(PXAS5+R,<
M$Z&.IAHJO6M-#-4S54%-3ZLKXJ>D,M%[&YL<+)!$X] EIEE9),X'#I'-\*V'
M1! 7\S+ARQ_4HM9\3J%T=++1TKJ?7UVWT4#A&(X89'3E[(X]DFUK7-&)7M<'
M-(#>^EY-^%5O-5#:]0<3*"CK(2V6DI>)-_BAZY/^4;15Y=+V'=SG#M\*G9$&
MNAY+;$!2LCX[\;0R*I955#3KJIV53Q*99.M'MV2=1WA<0&NV_"YJ[8>3.R0!
M[8^8#CT0YFUF[B+6GI'I]/+?EX?7YK89$&OO\T"G#7L',;QVW24K*-T_Y]3=
M4,!W/+?!@/DD\;G^;?@CV1^!=;>3JC$'1=S"<;B\DDU'YZ/Z^_IPQ=7J]+?N
MZ< ;C./>/=\9WK89$&OC>4JJ8VFISS,<<Y:.C.8*>35S,Q^#'>84W6F_\Z]Z
MYK>4F[5L/3_G9<?8"?6+4U)_^IK8#:54@UWJN3^NJJ[[6EYKN8-U7^K'K&&"
M#_T&.E$7_,5S/RLZEJ658?S:\<X7U_\ E!BO5O\ #_R/]"]S_H84_JG:4$ 4
MW*UJ)C88JCFCXS.ACIV1EHO5*93)XMSNM[+U,>(>OHJ*/E7U'#1R.GYI^,SK
MA4V_V&JE9>:4Q2G_ #K8Y*9XA=_R6Q;!X"8"#7<<KVMA0/H/YUO%L_H-DQKZ
M7>-D_5?_ %'WO@'ZK?GY*Z@Y;-=$/EJ^;#BT)YC3F0TSK3&W,<?3)&:%WF._
MU/Q]13YTPG3""!:+EIUK17&X547-;Q<;#7ODGP*BU/?"^0^-L8EH'QQL.21T
MV,V^BLZ?EEXHB[>V5?-[Q.?1OZ)? (K;U08JGK,Z<IIL1Y'NW[6#J,\#][>R
MV(P$P$$ 4?+SQ7HZV&Z_SON)U15TPB#&2TEG-/)XGF??%[%@[^H[9^IMCSU.
MFW'93<OW%:(4K'<VO$1C9-WVHYELLCY)P:=D;NB^6A>8=TL;93V?@$L;CXU/
M/3"=,(->(^ O,72FE@HN<_5+:2*HAZK)]*V>>5]*W]*SK/@+S*[[LI.(_P!5
MZYJ."O-"^M I.<2X040BA:1^9-H<\.;U-_3S%A@/N,;S)Y.^F=ANF$Z800"S
M@WS,"LZ[N;NX=/H,;M;HVV#,O6DD<?@\L=%@_LB7R+F[>E_!'FD+J69G.=7!
MS,>T1G05G+/_ #1V9C_TMZV$Z856 @U\_D>YI<O/\[K]'3[*8_F+0]I-P.Z3
MQ^,8CC'^G-^LSIT_R-\T7Z+^=R.G[3U,_F'0;NET=F/C_2;_ ![_ "S]U;!]
M,)TP@@2DX.\ST5P=5U'-L'4\U3++)1P:$H(X883\$$&7N<QH^;W2.^JMZ'A#
MS5AU')=.;B-S 89:VFI="T,>YX8&OCAE<\[(R[Q#<QSL^H6PN J>F$$ -X5<
MUL ;T>:ZTU!!\7MW#RG?G(VC]%51?"/&/[?<^'PKOFX7<V#O:G4_-)IZ$RR4
MCXO_ %743L"%OCSFK\YG=W_J_P!7L4\]-OR7. @U_FX6<V-9'AO-)IRC?[GO
M%PXA?\/Z7SJQ^E^]\ON[55%PRYN*(]6GYE=)ULG4+L5V@0 06;?ZBLC^$^2G
MQD>WSPJL!!!=#P^YL8'CVWC]H.M8'1S^]T!.P]1DNXL]U<F>!S>Q/GE7$.CN
M:@FGFDXX:!.<"JIOS!JNF0[I]3:[[3SX<2;>P^(9PILP%2V-H]$$'4VB^;*A
M=22?RY</K@RC$,<E/-H"H@%6QLF79D;<7&([.PVM<,_O7'YC\W(IZ>D''3AU
ME_6ZU5^8%1U*;/P=%OVCM?CUW%O[5.?3;\ES@(($.AN;X!H9QWT$!-43,J!'
MHF=G2A=-(]DL&:YVU[&NC8(Y.HW .YTGK75:(YNYZX"GXY\-Z2F_S\>@:QTG
MG)_5&Z;?6/[WWG_(9G;IA.F$$#7#0_-R[VAULXY<.F.-/$872:!J!MJ&]3JE
MN+@>FV7$.[/4(WR[0W W=U=HGFXE89Z7CIP[;*9H9?9V: JHXMK?TC-SKG([
M;)][MV^[A3ITV_)<=,(()_-3G)HG6Q]-Q8X3W!G4_IT%3HVXP-A;N!W1.9<7
M&9WT?L'KE4P:=YS*"B%'%Q2X47-\'<5=PTC<&S51^'+A!7L9#X?U0[NIZP%Q
MTV_)! 46F^=0UU-45/$OA#[-&7F6D;I2XECMTNX8)KLG:S 'EW_>NG\W.>!K
M?:#Q+X-32].7^CR:3N/2ZCJK,1W>V[O=0^-O;N[W;L_Y0M@NF$Z800&:7GG;
M6TT;M0<#'4OL\3:F<VJ\=3J_UI9%[3M(_5RX'YX5I54O/DV6JBI;MP%J8V4\
M38)ZF@O3'5$CMG4WQ-F+86LP_&US^IX<B+NMAWQ[O+"YZ;?D@U]?1\\+Z'$=
MSX'Q5NSK;G4=VE@ZO4V]+89 ['3]YUMV=WN^GCWJYMS>>."M++E4\"749/6Z
MM+1W:.7<&;G1;'/<WWDGN^KNS&WWACF/NEL#TV_)4/A:[R0:^01<^;8MD\O
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MDG2;OCV[L ''IU)<?+>[YKJETM8JBFBM]18[=)1Q9#('4[#&SOGLPMV]SW.
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MS<LRXY^$8SC.-WX>N?DH6=RA</9 WVC6W%&?,LLE2'\0+N!6-EDZDC)-D[<
MN_4VX]%>U?*IPZK'X-^XA00[_:NC%KZ] "LW[O:=_M/5ZV/#OWYV]L();;60
MN<&!YW'TQ]2/\01^[YC-1G#1ND!8 S>\NQX!]5"]-RBZ IG6QC-:\2S26SRH
MOSXN?L\WO!)XV];<?$/UO+;^I'LXFY0>&]39ZFQ5>J^)-33U=5[742U&N[I-
M+.?\W*7S$2,^C]R":8ZALCW1CL]CBQS21D'S'KZCN/I\E2*D.[,?N.XMQD [
ML$X[^N/3ZY\E%)Y8M'=&A8-:\21)0LDQ+^?=WWRS/CZ?6?\ TCNYK<X'EE6%
M'RG:2HI34LXD<43*:6&C)CUM<(,P11M:R/W<@["3JR@_$Q\\NTAI:UH31U7;
M=VQV-N1D!O?]7OZJF.I;*XLC!<6]G 8.WN1W[_,%0]6\K5IK*WVAG&OC-2T_
M1Z7LD&NZX1Y_7WEQEW?Z:Z).5:QU-12R5?%GBY-'3CQM=K^Z#K'?"X;MLK>W
MN/\ XX]!-'M<.P2"0;2 <GMV.,'O^(_>%V=1N?TC,?/(4)Q<JE!32-J:7CIQ
ME94""HIS*_6D\YVR]/N&2M='EO3&WP>I3^;!5^U]?^<GQMZ'_BOYS0]/_6]G
MZO\ \<037U1Z$.[X[$?/'^_^WLJ34QAKGEQPSSPTGY?+\0H=I^6JIIOT?,)Q
M?/XWRF_5V?\ BW^;\/X^/])XU33<N-ZM\K)*/F,XN2XN$5<X5=ZII\]/K;&>
M.E=[L=89B^"3ILZ@>@F(UD39!$]Q;D$@N&!V\QGZ9&?V_(X25D;1N826XR2W
MN<9QY#N>_; &<J"F<L-^H&4QM7,OQAZD55!)(:N]4LVZ-DNYX[TOF]O8_M_7
MDWWU!RYZHM9JW4/,EQ.C;75'M53"Z>WNBDF?)U)G-!I-T(<XG#8G, 'D@FW<
M>_8^'S[?[Y72*MI (#L..&9P.IY_#GS[-)_#NH?DY=M4.]AV<SO%P>P_^]EK
M]_\ W_Z"DG+[JV-S30<R'$R,1F$QB:HH)<]*6&4&0FD]X7.A(=OSX)'Q_H_
M@F$5D3@',RYAQXVD$=_+L#G^"KZS0"7-< /,D=OIW]?]\X4*4W OBA1T5)1Q
M<T&O!TJ::*5\M);*AQD=T]A$DE*9<#8_=X_%D8V*C^0CBQ('03\VG$,TKNCX
M&VNQ]7L?>YF]AZGB^[L,?3_MH)J=5L9((B'[CD^7H/7\/K^SS(![3,SJ=($E
M^,X /^/DH1'!#C!!0>Q4G-5K1KO9PWKR6>T32&=TL3I),RTK_ UL;Q''\372
M/)D=D!O(X*<:HZ@U47-KK'>>D,'3ECZ?A^+P>R>OXH)J]H:/C\'B:WN0>Y(
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M+@XG)SYNSF7";ELX)<#)*RIX5\.K78*BXQB&LFIW2&2:-KG.:QSG$^'+OA
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M,Y<N*KNM(875C(J!D.POP3O]K#MPCPX.V[O"!NR@@_C_ *FX^Z>XK<N]VO\
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MT>$D$^O=H]!V5TB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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MVNX%\3G-Q_.;UQGVCJ8Z%)MZ?ZOZ/=_SE.'3"=,((EI.#O$>C_\ NAM6U/\
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MW="4"/3]M@=F,^7M=5)U!^LSQ.;EN3N[8]5O&M%^:>*L;S!;JP1N,5@MKZ/
M:2R'VFJ\)&WQCJ-/9^[L#^"#>A$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1
M$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0%HES.UM1
M6\QU<)V-:+=:;91Q=OBAW33Y_'=+*/V#]F]JT8YIIZ27F!J#2LDWQV2VMF\!
M][)OJO@_6\+H_P!Q_:&\Z(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@+0_F+IJBEYA;X
M!,9/;(K:Z#%02:>/ILCPWM[L]0GMW[.!\LXWP6AO,-!*.8&Z5#K924[*JFMT
MC'4TYE]J]RV,3S=LQ.Q[3#M\NG'%)YN 0;Y(B("(B B(@(B("(B B(@(B("(
MB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB B(@(B("+H9(6C+@7 =LCR_CY_L7>@(B("(B B(@(B("(B B(@(B("(B B(
M@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(
M@(B("(B B(@(B("(B B(@+Y^\=8*:#F0UDQM+[R>IMO6?'*6=0_9U,TO<!V)
MV>''888P>F5] E\_N.+Q+S,ZRA[[HJNVQGY9^SJ1W^#@@^@*(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B#PK-IN:SUMSKA>KE5_:4_M70JJ@21T[L?!$-O@8O
M=1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0
M$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!?/KC8\
M-YHM<YS_ -\+;_[:Z%?05?/;C<X'FBUSC_V86W_VUT*#Z$HB("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B OGOQLC/\Z+7/<?]\+;_ .VNA7T(7SWXU;G<T6N<'_V)VUG[
M?LNA0?0A$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0%\^.,W?FBUQ_[5;:_]GV70KZ#K
MY\<9?_HHM<_^U.VL_;]ET*#Z#HB("(B B(@(B("(B B(@(B("(B B(@IWCY%
M5+C 7* J=X^152XP$'*XW!<JG:4#>/D4WCY%<X"8"#C>/D54N,!<H"(B B(@
M+C<%RJ=I05+C<%RJ=I05(B("XW!<JG:4'.X)N"XVE-I0<[@FX+C:4VE!SN"Y
M5.TJI 7&X+E4[2@YW!-P7&TIM*"I$5&UWS""M<;@N53M*"I$5&UWS""M%1M=
M\PFUWS""M%1M=\PFUWS""M%1M=\PFUWS""M%1M=\PFUWS""M%1M=\PJT!%1M
M=\PFUWS""M%1M=\PFUWS""M%U9*JVN^805HN-P7* BXW!-P0<HN-P3<$'*(N
M-P0<HN-P3<$'*+C<%QO'R*"I%3O'R*J0$5.\?(IO'R*"I%3O'R*;Q\B@J1<;
M@N&R!WD"@J14[Q\BF\?(H*D7&X)N"#E%QN";@@Y1<;@FX(.47&X)N"#E%QN"
M;@@Y1<;@FX(.47&X)N"#E%P' ^2;@@Y1<;@FX(.47&X)N"#E%QN";@@Y1<;@
MFX(.41$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M 1$0$1$!$1 1$0%\^.,?BYI]<Q#S^V+;^'_>FA=_@OH.OGQQ<(EYJ]<2Q[BT
MWBVG):1C_@FA9ZCY_P $'T'1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!
M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!
M$1 1$0$1$!$1 1$0$1$'& N41!3M*J1$%.TIM*J1!3M*;2JD0%3M*J1!3M*;
M2JD04[2N<!<H@XP%RB(.,!,!<H@XP$P%RB"G:5RUH:N40<8"8"Y1!3M*;2JD
M04[2FTJI$%.TIM*J1!3M*;2JD04[2FTJI$%.TIM*J1!3M*;2JD04M:1YIM*J
M1!3M*;2JD04[2FTJI$%.TIM*J1!3M*;2JD0=?B^:[%0JT'5DKM7& N4!=62N
MU<8""CQ?-<9*J56 @Y1$0=62NU<8"Y0=49<WX^_X+M7& N4!=62NU<8"#KR4
MR5V8"8"#E<;@N50@YWCY%-X^17. F @XWCY%-X^17. F @XWCY%-X^17. F
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6 $3NN7>OVQ0]_P +50X0?0=$1!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>img75493150_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img75493150_2.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M!082,3)"$R(4%3,U05$'%R,T0U-QD5)A<J'P%B2")6*!1&.QT=+_V@ , P$
M A$#$0 _ /JF
M
M
M
M
M
M
M
M
M
M
M                   I8O85
M
M
M
M
M
M
M
M
M
M
M
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MU'UR'N4/&N$<3Q/E/#&*J35H)=Y<.>V\R?2A7G0HT^19'^\C 9  \ L88=^
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M^ #L .J<E"M)G);Z%[:R0>KXGU?_ $0$^@VEGXE%R7H4Y]$CU6T]^_T>7K^
M#M .LJ0A!:#D(U;FGN7F\VC[](XBDI<6236LC274E*BOS,^Y$?[)I^_L [P#
MI'+9,[+>27(E&6Y8R2>JRSL?E/0=OWB\GB)1,&M6O[2N=D]^Q_=_>2 [0"S=
M3]HL*3'4_P"')TMTOH7Y@.8!;K(-9 +@%B'$K\HZRWV&]IIZ0:%.O6:/5Y_I
M6^ZW(!W %FLOF[GJ%=9 +@%FZG[18TZR[R:?U;7)5CO^(#F 6ZR%-3?U_P#:
M 7@+=9!K(!< MUD*;J?M 7@+=9!K(!< MUD&L@%P"W60:R 7 +=9"AN)3YC
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M9!K(!< MUD&L@%P"S=3]HKK(!< MUD*(62^P"\!8MQ*/,*ZR 7 +=9!K(!<
MMUD&L@%P"W60:R 7 /).N4Y59/#I5.)X]EA$Q<4I)>(V%*4E"]NVJQJ0I-^W
M(QZFL@%P"W60INI^T!> LW4_:*ZR 7 +=9!K(!< MUD&L@%P"W60:R 7 +=9
M"FZG[0%X"W60:R 7 +=9!K(!< LW4_:*ZR 7  MUD N !;K(!< MUD&L@%P"
MS=3]HKK(!< LW4_:"W$H\P"\!;K(-9 +@%FZG[1760"X!;K(-9 +@%NL@UD
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M5UD N 6ZR%-U/V@+P%NL@UD N 6ZR#60"X!;K(-9 +@%ES]Q760"X!;K(-9
M+@%NLA0W$I\Q@+P%NLA2Y^X"\!9NI^T5UD N 67/W%=9 +@%NL@UD N 6ZR#
M60"X!;K(-9 +@%NL@UD N 6:R1R48KK(!< MUD&L@%P"W60N  %FZG[0N?N
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M,'/F^3EYBFHO<5UD*:D^Q WBHO 67/W"Y^X-7@
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M.UNI9$X7W7F/#R6FZ:AEE]NSJM2V&22VMS6ZM6HRU:M"KW;9-/&UP5\*$/\
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MS-2ZW!9K#;DF3OD^2]:(TB:K=ON:B:.YFRR:-EQ8331*-1-I)1WN=N?.U_\
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M*WC43ETM:=@30@SU&A-R];??_O/\14TI,K&DC*]^P#7:+PC8=BE$T9LYPM'
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MHDE:ZC.YF?VF?J.QMMW,]";G8SY=[<R 0G+R8Q\Y6SQ-2N)K-".\\CPR(O\
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MQ^6[<V?#9>.GA+=<XP^+E(5 !5ZD
M    'D56EQ*M295)EQFGF9L1;+K+J$JW$+*RTJ0?29&7(R/D?J(HX0I;$WAD
MRD<COQ7+8*HQ*\/()TM2(K3;A&9$762TV6GLE9*2=])&):FS(M.ICLMZ1X&.
MTTMYQQ]>G:0COWO8A$/!W5G:IPJ92RUTZ;#,L(4R,EF6RE#VAB*VT3A)3J(V
M5Z"<;47,VW&E'S,P$Y
M
M                                                     +$+)?8!
M>                                    *$1%V(5
M
M                   !2Q>PJ
M
M"EB,R,R*Y=A4
M                        4L7L*@                     "!<_DQ9N/
M,B*<^PELUYC*F=:W&RNU0JFHU'I3S/6I*2^LHTI/I4HA/0U\S_7B%6860JJ2
MVEC5F(M;T@C-3K;14:JF\T39=.DVE.&MS7I3H+DY8;!@
M              *6+V%0 !2Q>P6+V%0 !2Q>PJ     I8O8+%["H
MI8O8+%["H    "EB]@L7L*@           I8O8"(B[$*@ I8O85   4L7L*@
M I8O8#(C[D*@ "A$1=B%0 4L7L%B]A4 &OG')XIKAOK[T!3!R3K>&B9*01*:
M)PJ]!LI9'R-)';N-@K%[#7CCIC(F\-6)8:$$^M^K8;231=!F7R]!Y:AL0
M .,^_P"X0GQ,FZ=#P^VVXI*55<M1$=B.S3EKB;#_ .P0?Q*.::?AYNY_$J#N
MG[#)IVQCQL5[";W.[=,]K64!N06-.DGCM[7'5W"C$;+7Q%/>0SYF7W#L2&F%
MELH?42O<C'6DD3!I5'(EFGL?M]P^6?T/;I1R7/P*$F?(E&I\OJ&OL?WD.-'7
M#UIY'[EW%82R7*6W*Z4.VUI]%6[7+U'-*T+EF;"2;:B>5"2LEW[R+N&92M:3
MR<*W2=;\,YU_8KF.,EK(R>)1Z4]BOR(6+?2VK4HN?N*7.VFYV]AT\ARW/W''
M(=-6O0HT[C^E=CMJ+V/W%SBR7-UHY-_5+M^ HXE-][26F][6Y7]P<YK$I6UW
M4?XBQ1F[V,Q>DS5YCO\ >.-*TM=R(<NG(ZI*_(1%]Q#C)*D>8S/[P1U^4<2'
MY*O,R1_>0QN=7+J1]4OP%DAA!=D)_ 7+;VSWC\OMZ"U2E.?2/\0(5JYFVKJU
M&7/W]18YRF[GZOZOI^ JE2FNZC_$<>LC[@0%F:24RDS)2NYEW,<[G7Y.7W"P
MTD9ZC(K^XYFV%:=F_5[^H$ZK6UI]B%T0T2BV7D$A7N16,";(D[)%U>_J*)AN
ML+BR%K49*[W/O]X./%JX_P!*3#U+9NKW,KF.JMMSZZOQ'>4ZZXG23BM/M?D+
M#;OW'9"M74,B,MDRNKW]1V'%(+LDOP'&LB(]1$5_<7K;-'FY_>.'?%7YK6W"
M2G2YU)]CYD+$QG&E*4:CNKS'?F8Y22E"MY22-/L9<A<IW=/>(ST^WH-.&KAT
M&*$R22VDI(E>Y%S%'U*+LHR_>*27Y#)ZF&M9^]K@H[!$2D[+9:5>Y<C'$2UD
MK42U$?O?F.;6E6IM!$2WO(HNY?<8Z:3-A.ZX9F[_ %9]OP!)R*C,L>1]3O\
M:.XIMN&K4:E7][\Q<2$%")LD$3C/G41<S^\Q1MVZE/&?2]Y"]"^X16I<3WPI
MS4KE8A;O9Q3,19M^AJ/?*]O?X9\QL>1%;L-9.%F*M.*<1ONW0EYB-H(N1%H-
MZ]O^N&S9=A]=@?N\'\[[XTRVU><@  \I\R
M          #IOL1),9R)/C-*8>2I#C2T$:%I5YB,CY&1^I'W$'\(-1KL[ACR
MO55:(=.<9PA28T=HI:)"9,1,5I,>03B;*0;J"2M:306E1*;3KTH<7,58A(K,
M&93IKLAI#[;C)(CO.L.J(T%?0XVI+B5$?9;:DF7H8BK@_F5:H<+>4ZJM2? N
M_F91T$WNZDG&3$:0VX?VN((E:?0!-X
M
M                                                         +%K
M)'<7@    .,B)/E(B^X<@I8O8!4
M
M
M
M
M                                                     0+Q HE.
M9@Y#N0Z@W#>/,)_4F2OX2F?D*K$HS)/NV2TH]"4\5[7$]#7WB"8IZLPLAI,8
MT(JQ9@O+CJ:MXA<4J/4ER;*;,E;1Z&MP[[?-O<)5B&P0
M
M                  UUXY6GI7#+7(Q2D1EOUK#26WG&UK2TOY=@\U:#(U)_
MLV&Q0UXXU</IQ7P\U/"Y0RD-5S$&%X4AN0Z372Y78*"NI=R25S^G<N8V'
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MN
M
M                           %#2E7F21_>0J  +-*O<Q1:B1\0SZ1=K(6
MF1*+2HB,O8P'(
M
M
M
M
M                                          " <_*:A&9&0E;1MM3&
M<Q'XJ)3S2#<1'D46J$\R2SYD3I-ME8N1:4^R"*?AK[Q+PJA*Q-D<W 9BN._R
MI1WC1(02OT9%+J:GC*_TB3<DGZ7Y=QL$
M
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M=>Q*\I$7W WT^?G]XL>,V?4R%[_+5;]=Y/L^X%YAD1JU&1&?OZC@)2B[*/\
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M%9S9U$1>:W:_OYW/[HV8]1]?@?N\'\^;Z^^KR\  >2^5
M                    !X]175"@NIIJH+DXFCV"?4IMM+ECYKT$KD([X3%L
M?S8,HS9?-RV!:"5S.]B* U8AFN*6US<+5=E'B73>@/,)\-K)XE;9\B)+C:[^
MNG<)7/S([B.N#N0T[PJ91K3MJ,\$T<C4R5O+%:2??G=/97\+@)L
M
M
M                    !YZIA([QWN_M^Q<=^Q>P6(^Y"H
M
M
M
M
M
M                #7CB>:2QCG(2HG540I"<RX\53KTA2&5)<I51U-&D[MFM
MQ*32D].LE*+0I)F-AQ O$$J,C&621+I<V7_W3&6C1#0I*C4=(K&A=C5S)HSW
M5G]0C67L)Z
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MFL;).&HB)A@F#7S6KI4E)&7_ +BP3P
M
M
M
M
M
M
M
M                                 U_XCV:?$QMD-4YK4Y\CS-:8-N,1
M+^<HU2;0Z;2NBR7"9,UVU(2IS29:C(]@! /$XQ$+%60J9"B:9_E6ANDOM\1%
M*J6VG]XGX
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MF 3H
M
M
M
M
M
M
M
M       UZXH&*;+K^0;-;\0VU_*S3EDII1I/Q)4JI*:+E] UD25>Y<AL*(!X
MFHS4RNY',./26FRS6@/$IHDF>M%,J3J4\_12B)/W'83\
M
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MJ3\[]#RD-BR[#ZK!?=X/Y\WR]]7G(  /)?,@
M            \"O/.M46HO-R"9=:8>)!*AKE$7PKV-E!ZW[VUZ$&2CM:_<1[
MPG1VHG"[DXT3QN)7@:AES.]R7!:65_N+D)96E-B:;(DJ25B,N5B$0<(TAV7P
MPY3E(I3T14/!M$CI-TTW6IN$TU?E]P"9P
M
M
M                                                        6ZR%
MPLL7L O
M
M
M
M                                           &NG%,TAVN9$1G-DE_
MRL4Q1I=2[(/_ )-J24JT,&E=S(N2[Z&U$2UD:$KOL6-<^)V-$FXOR&IC549B
MNJS4@5(C=F>'3H9ID_46I)<S424M)1?XBG-!D:3,;&
M
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MMG"M%651Q%(TO%<HO,VTE_67&R9=A]5@ON\'\^;X^^KSD  'DOF@
M      6ZR%+G[@+P                   >;)2\N.I$5[P[I%]-)NJM]R3)
M1_B(OX38,:'PO91I9C--E^9-$<LA!%U*@M*4?+U,^9GZF)%Q'5CHE%FU9R+.
MGJI\=V:J)"CJ>?D$VCFTVV1W-2C\I>IV$>\))+_FO91[JC5_F-0?,=_^8- )
M?
M
M
M                        !2Q>PJ
M
M
M
M
M        -<N+F$U4JUD' <DJ;;9S@HSZUDHR,W&84UU*3][V+\!L:(!XB8L*
M=BK)!NHN/MLEF?$F:FR9^<;I534CYTCZ34VVE2O-9=D+(3\
M
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M%"7VMU'!:,S^^_/[P$N@
M
M
M
M
M
M
M
M                      ->^)TJ;(Q;D-$J#53DI<S3BRF_ Q%N$3C=,J)M
MJ<T&702]M:C/Z*5J\MR&P@@GB.DN0,5Y#25/+9W,S&(BS0HTFK>HM409';N1
MF9B=@
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MX#V$'\Z;Y>^+W^=KG+L*BA=A4>2^=H
M      "W60A/A+;4WPP92[$.:DBP?1DGOR3=ZBBM$H^Z^A7T2[)+E9 D_$3,
MB=1),)4E45,R.ZSN-+>2XVM1=)I-E3;QGWY-J2OV,8'PFD1<+^3MB(KX"H!G
M]OZ R?\ B EL
M
M                  6:5>YB\
M       <++Z7RZ1S#B0A"/(A*?N*PY0
M
M
M
M
M                                         $ <3[,J3B'(PH;C2R3F
MM"4>HB<TF5*J?/J[&7V"?QKMQ0OS48DR1<@T&57%(S/C*\'&>::?N5'J2U'\
M4DHZ6R-SFXCM8;$@
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M1KZ"Y+9C1$J;]?UI\U>O,S/]YC8\N9<Q]5@?N\'\^;XTIZZO.0  >2^:
M                                !TWUNL15R8T9*GU6-1$7-7WB*.$I
M[Q'"]E$XV2FB3@:@)(EG]6"TD_Q21']YW$N.N,,L;CSYI;;\RS5;\3$-<(+<
MU7"[E,U4VGW%'@ZE'\=M+9V.(T;9<O309)^[D FP
M
M
M                             %+%["H            "RY^XO%+%[ *@
M
M
M
M
M                                                       "#.(>
MKIHF+,D)IN4YK=S+:82<M6WR>HE4;41&=^LS66GU["<QK9Q9NN-5G(<V(C<I
MXLV:8YX<TF76FF3S)1F2%GT\C(]%_N&R8
M
M       UUXXZI7:+PS5NM88:DJJE.K6&I5.**E*ED^BO0=LFO<S^T;%" .-:
MEG6N'RL4:-)<;>J-?PLP2FG-IQI:Z]!TJ)PK&1EZ'>Y"?P   !QF('XGEK5!
MP]%;6HE'(=^$1VO\(_I?O$\'_P!@@?B<,EP</,(Y*\2Z_P OJ(:/47W=:?P(
M>-BO83>]W8][V4$?T8M*NWL))X>6'OY3KDZLFU4F5=-^D[/-^G_C"$:DA3BM
MI9ZFOZP^9_B)0X<B6G,$FG%&I14A_F9W/FZU?_ OP(>BP'WB#]?WL]T7FS3W
M8R^PQI#BV/)_.^KI-YR0T[47GT.:S2DD.F:S(D>R2,[?>-WGNW[C&CF)YLJ=
MB*JS5MFM::K+;2I7,R22]HDD?M]@]CM:OV>3X/Z.OOEUYRS,DI9(S)2?*9=R
M^X4-1&K>,B-/L?87H;,U:CYG[GW'&XV9%I+M[#T-'[)E1PI2\U^L7^)CM[;D
M52E&I5WO(=^9?<.HHENS-)+5I]K\AV$K6YIUJ-6GM<[V!USYNRAAM1JFJDK-
MQ1&2FS4=C(RL=R^TN7W#;3)R>S4<M</2(RV=)14H(F5FHK(+09%?[1J*P1.*
MWR+E[#:[(0S5E=0"4=^3Q<_;<<Y?P(>UV37SY/S;Z1;?^UMU_P"YP9^T^"YE
ME4WIIR$%%<9ED;"S(S=W.QV^C<SN781KPX1R+'<N38N=/=*_W.MV$K9V*4C+
M*LI4D[*89)5_93I:OP$5\-3NK&E3CF=S3 .U_2[C=QYM_P"]P?/;*E7_ $SB
M:?S_ /RV*FNJ:@*5<S49=QH@F-U*3#*\=Z2Z:%%Z&7:PWUTI?3H,B-/L?81\
MG(S+5V*B"C#KT=I@S41MRGD'<^YW)7,=XS"UQ--'K]T]X+6P)3E.%:YY-3W6
M5&K>.YI]O0<K:9[*4I2^VDD^4NUON&UO\AF7ADI/R7R=\I&^JQ?<+_Y#\LC\
MU%9/_P :8]?ZKN/LZ_2%L^</95:C+CF\G2?,O;T':3%E[;Q,D]*?1\\AMDSV
M_N]AMDUDOE\VK<.@E;VY?X#W:;A#"U,<>E1*2PTJ8?6:&4I-7WV+F.O5-S^-
MX]_Z1K$:?8VT3Y*Y32H571CG$2-N4IHSAQCYDRE16.09>BEERM]'L)QE26(D
M=^3)=T,,-74HS[?:$IQB.R3[CK*&4),EJ<]2]2N(,S>S>BR(\W"%"</>6C]+
M=0HR2EKV0?HK[A["M;>!MOB*0Q^]&-XZ4S0[CG$DS$&/*W.LI45=1=99,S,R
M<;;+2VL_>Y-ME]RAC<I"'5;Q(+3[6Y#M*4IVUE'R[<^W;_<7X$.L2TH3I41&
M7L?8?.7;GBW/$?O. PT<)AK=JG93A&.9RD?TAQ/97D,OWC,<I,'?GAC*FPS>
M4F-"<\5,Y\B)ESX-R_:<Y?:CEV&'?TLU*[FKN?O]XV(X;,.(@TBIXF<80HZL
M\B.THR+DS'Z#/_543AW^D9I^P7V=8\6YJ]%O?C_5FS)UI7*<^2<R4ALCN1=1
MZCY=S]_X$--LU,3GB7'U5J$-U3D>*A,".O49W0R;IK67VF?<QLWFGB9.$,"5
MBM*>.,\W%-$9R^KXZRTI(D^Y&9#3-Y2DI-XC.,Z>J[?G(]5]7+[;G?WN/9[5
MN96O#H^,^CO9M9W+V/K\/+']7/3C0R9N.I)2#*QDHKD96M;\!N%E-BY.+\'0
MJHZM7B-.S(+5S2OW^\:9,*4I*4FH[,^<K\C^\3=PW8F\+6:EAN6\I'B5^(BQ
M^Y*T;A.'?UO8K?</#V3=\_A/HM_MF>D8&F(I3SPYO?XJ,)KJ&$8^+Z>R7B:'
M(;2^HDV4J*XHMPC/U3<T';[%#7-E$=1%J?,]GS7/O]XWJQ'16,0T>HT.6PVJ
M/.AO1E:TD9*-?:Y'WM<_Q,:(J9:C2I$&3*0VN',<BO'L$6HVW-L[^_,7VK;R
MKXCPOH\VA6]AIX&M=8>:/\U"4I:$NK4:G$^5LSN1?<0Y-PY2=,8S)/L]S+^(
MML115/$7Q'O(KU+[C!39K+:5S5[GW'IGZ4GSA50I,O$:5F9D:8A&1]C+XHV*
M-7.PUOX4DI*K8L><E+5:/33(S6>DC3XC49(]+VY_<0V.<Y**P^JP/L(/Y\WS
M]]7O\[78  'DOFJ                                     \>K1(<^C
MRH<R2I,5UEQMUY*]LVT&W<W",NQI[D?H(NX2&YKG##E(N>A6K\R**X1F9WT)
MBM&R7]K18C$IU&-%J$"1$=5'?:6R;,C?(E-;2RLNY%8CY"/.%4S=X8LG%&=S
M7@"@K,S]5'3X]S^_F?XF ED
M
M
M                 !9<_<!>
M
M
M
M
M                              -?.*!J#*Q/D9'J3S++*,UJ>LE&XHOB
M)I524A/^LHB3;U(;!C6KBI5*+&N0CGB'GX+6:$%E<1+;+BUR%09Q-.741V)"
M6WE&?<C41_:C94
M                                                :[<<KSL7ATJT
MTYA-^'Q!A9:5I1J;,RKT"QK(BN7^K]@V)&O?&U-E4CATJE8I;:G95/KV&G&2
M:ZU*65?@V1S]/L&P-S]P%X  #C/_ +!!O$PIIF'A]_;3N[SZ--OHFUS+[N1?
M@0G(_P#L$&<3KJX]*I#K<5#JTONZ5*21F7PC[&/&Q7L)O>[L>][* 24HDZ"4
M>GVOR$G\/*[Y@$^:B)XZ0Z6GTNEUO>Y??;2(N<Z_+R^X2/PZDO\ E1(S4?\
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MS&HAV::6CX9Q&MI/49]1(Y*^LKM8!,P
M
M
M                        +$<^XO%+$78@%0
M
M
M
M
M                                           !K]Q.DXYB#) OEEFG
MF6:M.41NM$O7_DZHDF/]BG.VKT&P(UZXJ6E+K>0R?!.J+^5JFJ,M2>1_)]2Y
MG_O&PH
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MUZ2-7>Q:%6^\QL2[YB^\>_P/L(/Q??+WU>_SMH[   \E\U0
M                       'D5.G-U.%)IJI,QE,MGPZCAO*8?:U<E.)=29*
M2HN^HCY6$1<'D%=,X6\IV%'H7^:5)D%J=0[T/1VG+722/3_A8G!PB,K&1'<K
M?N$&\%ST&3PI93%3:G-GH3A2FI4\X^M:B=2TDG6[K.^AMPU)0GMH;21<B(@$
M[
M
M    +=9"X>:S+/QQP%1WS4225N6/1H,STES^E[CT@
M
M
M
M
M
M                                      :Z<5C)+KF0BT4\GB+-ZDER
M=T6+P%3O_=]2^D-BQKIQ01$3,39!QGT_ +-:$X3O,W#?:I=2-LM!HTZ;D9GV
MMZ#8L
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MV;;Y&1?=;LMPNLPG
M
M                   !0B))6(B+UY"H
M
M
M
M
M
M                              #7OBO6W%J.1;ZB*S>;U(27+MKASVT_
M@;A#80:W<7C;?C,BGYKTG:9S@H1Z8I$HG#4S-2R1ZNY:E(-7W$?H0V1
M
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MKE :4KM[JN1^X"8P
M
M
M
M
M
M
M
M                  &MG%[#)Z7D(DV%FDLX*"9EMH.Q%&FK3KY=/62?+ZV&
MR8UCXT#FD]D:FD1E[Z,Y<.V7X<G4)+:DWY&XBQ<SN=QLS<_<!>
M
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MS"S-9=V_-W1];Z0P:'C2EX<S$+&>&H"J32VT^'=AJ039+3HT;!H1RM<S<O\
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MLHV6C4UUF?972:NSGH G8
M
M
M
M
M
M
M
M                       !K7QD2&8K.3'C4M^&<S?PYOI<3NK1_2+&V9WT
MGN&V1VMT:R[&8V1&M?&2TDYN0JS25SSGPX1G;F9;4K_>?XF-E 2S7@  J
M
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MNI<;/!](?W"/GNN1&E.)O]BNG^ ";@
M
M
M
M
M
M
M
M                                &M'&%,A(J61+4N0N.X[G!03C&;1K
M0M1,2B+479'6XDO?D0V4&M'&(A4@\DVBF/L-N9R8<)PD.&1+)M4@])V.QZE$
MFY'W.Q<UV2K9<$EX  *@
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ML[#E5RPD1(JI,*B1T$E4TULK4I;II[JW33N?-DIOJ'KU+BEXD\A<2N3\U)%
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MB(B(B(B[$78&*Z4^P:4^PJ     II+V"Q"H
M                /)J4B8S39$J*@FG4M7(GWDM$1^^NRT%^ C/A*B1(W"UE
M(B/%::3^8="=LA!)+6J$TI2N7J:N9GW,^8DV9XE#2D06D//-I^&V_*6T;GWK
M3K5;[TF(NX2(U01PO91E4GVS/\R*,1[:K%I**TIKM^QR5[@)F
M
M
M
M
M
M
M
M                                                    :T<8S##T
M7)E]^0<78SGPJEDK7-Q1O.M:+?:1FK5]4S]+C90:X\8#$ H&3Z7G([*49OX6
MVDN.&W8]\VK-Z>_)1ES]#,ALA8O8!4
M
M  !K3^4#<>;X1\P_#)4^XJ/#;:02M!I=54(R4J2LNRB5SOZ'ZH[C9,R(RL97
M(QK'^440V?!UCA3TQ3"67*4\IHGT-:R15(IFWK61_P!X;. DO  !4
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M:41>I*+D?WV'H
M           \Z<VXJ&^EDV"6BVG>*[:;=N78A$G",Z^YPN926CDO_,FC%_1W
M&O\ FK1&749^4O7Z?T;$)C>CL2&3COL-N-*[H6DC2?[C$6\*2$-\+N4FA!)_
MS!H)\BMS\ T=_P 0$M@
M
M
M
M                "W60"X!;K(-9 +@%NLA<
M
M
M
M                                 #73B\:>.!E+(;GL1$(S8PN2TO1B
M<\2I<HVTMV/3I43JVW=1<[,J+Z5CV+&M_&6_5V(V3ITK9VI.<6%6:D3O,CBD
M\XHM)']+>)FWVV&R
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M7LI79M+\,[^9-':T&[KNV49HD+_\8FR_L,!-8
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M
M                 -=^,$FUTW*9'@2?->;V$B0HUZ32?C2<,R_NE]]B]AL0
M-:^,UDWX639LP3?-O.;"!K43NWL%XLC-P_KE8R;T?Z35]$;(W/W 7@
M
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MF7&RWQ!)3CBB3Z92S=><>J**<Q-;B+:VER$DV6XM*$N(/?6G<,C*YW#P=_@
MP_6\$,T'(K,5YB)4),NFU13;OAJNZW/T:WU/O$F0DWFS+XVG0DS)7]6,D5@K
M@%CX@P'EQ*RYQS3W\QSC5VG.2*K)F14N*<7&2J89RWFD*5T)61$M)EMDK01F
M0\*LXX_)_5!%&K)8!S4-;M/F8@AKI3TLCIK2ZA(==CI1XC:;LY&?^$@M&THO
M4>OBO%? %B3+_"N<&)LN,?,079;V"*(I,N<N:ZU&_2#;LF6MM;>XZX6M2S5=
M5O,@S;#Q,*XSX%ZKB[+^LX7R7S'J#$2M2ZC3XU5F;<*"B4A2_$DPY)-IQ&[&
M::TK4C4@R,]PM.N3L=8\X2<I<-85X?,1X+Q]$P_,I#^,:2J(N035-B5%J<R[
MI=;?)2'$HG26MM&I-U).U[&,3A4?@4PSC[#F7U2RLQW@/%*I$:A0$527+C.%
M&J%/6Z<A:?$&V:",_#.'\Z2W$%;29"_&N<7!/G!-H,3,C*C,"5/DT9_"4)EY
MI:%$A$QIE4(ULRBW'4O]G.Y)OSY@.A3WN!G'V9.$,(X1P/F/&F4)J'@ZBS*:
MLXD%4$WG%$\LW';.I-3QO+W$[B]M)DC624+Y,;U/@FJ^*\3M8VPCFOB>J8*J
M!8)D3D3'#.(B EU2VXY,/-FB/K<<(R2@CNG6:$6W!PIQY^3CK&8DG'$[#F-\
M-XXJ.(H\=4J0NHL2_E!Y]W5);-,@T$AM6XMTR+5U(65U6'-F/7. NDXYQ?3*
MU$S%CS)V*ZHC$TNERGD1_E5U:TR7EV=U:2*98EMD22)""(N3EPQ>A5'@EI56
MI[]"7Q'HCY?L1ZI3HL;QIQXZ%22/X:"/<;VGIG5S;U7_ %ERUYPSE7P48LRZ
M>FT[%^:A47$T?$N)'EN5F2X_)307MIY;B7]1MJ0B26VEW29MG\2Z^8Z[^'_R
M=V!,1+H<+&.,D3JW4TX85)HV(JE(829+BRU.$MAPTE&4N1$(W%%I5L+TET+,
M\TP;D7PGXBKN#\J,$XHQXR_4\+53&U!4Q4GBM2*PA#$M3SQIU$I2D-V2X9\T
M)[F7(HCNB5G\GQE_G-^=] EXN6Y0IDJHJ;>8>G4.8B8SX=1)9<,UFEBRE$5N
M1FL_B'HV^*F9#\!-9K;6!Z+CC&N(9>&GGH-7723=<1-547GTLO..QV=&EC<)
MO6P1(TH:2>X2#%*W@[@"HN,UX(<K^9K%9H573AM#$":^\;C["G&S0?2I)I2Y
M%>)2OVB^W1[L#+S@8RJJ^&,?)S,QT495+@UB*<HGWHYLL5#2W(DI4Q=*#?93
MT]!:8IEV,$W3K^ N!^G+Q/E-B//2JNU1",/TZ:^JG).5 =H)JC.HCNG&T-[O
M@EDZ2-76RMSL1WQF+A?@OH52@XIIW&;B6@/O5%B=,=\(;#4E<:0IUM$/=C&F
M.2#49I(G%Z/AW[$,YQY3. 7&RZ&[5<3U&F5/$59JV)VY<"C/L5+$")\R2:V'
M5^'N\AN2\HV.9J03,?1JN,,@X=X&\$XAPI49O$1BYJ%@Z9)J!X5Q11W993";
M?D(,^49!)3J8T6+6BS+9:>P#K8(H7Y/_  Y4<)YAR\<YGXGB+?65,IN(J:N3
M#J*74F2VU(:B-DIMMQZW7\-2FRL:VDDH=7$% _)P2Z!B">SG5CN!3)U3>Q$J
MG8=H)LH@MOJ6MB$S>GK3'90:'S;02V]*B,EF9Z1ST;"'Y/BCX=P\Y5LV\WU4
MBG[5>1+J5)EH2X2WUI2F2^Q3B7J)U+JKD=KHMKY#VXF%?R?-#AXIHC^8F9E4
M>JE)DY:3H4BC5)4MR8BH*E6:2B$1*FH=0SM(5TI2AHE(,K@/49PUP0T3%N$<
MW,4XNS.Q?(JD7$+,-^K,N2V:RW#9DKFS'VT,D\:4(>4PAU"6VCV&3))DV:QC
M67N5'!)CC#TJFX'QOG>_#@0JA5)\J-&EDF(F*R\ZMAQ+D<S-QIE26]"2TN.;
M!%N+,S&>YFQ>#3$&4>1=9KF.<Q:?A.+1JOAS#,NE4Y1OR5;3+#RIRVXZDHD$
MJ(ZNYD@EN%(49&A*].5\*^).#3+R/*PUE35J]5ZS4:54L1-2ZU1Y":J]"1HW
MXC#Y,-J>4G<3\)HUN%I/IZ.085E3F7P4Y=3XN)\MY>8<>BT^1&QZN(_'EN0*
M<>V="7(4EXC=6E3<]MU:D&Y<FVE(Z2-L8IESD=P-8UR]Q/-H6/LT%80RQ-[%
M$F)49YPFXY.FX=V.A"7%K0RZV3AN:[F@KCHT&@_DWOS0D--8\S35&I&&VEID
MR950CN.,^/2V4B,WMMW?WU$W9ILD:65'MV0LSR'+S!O!S5L"9H4US$68CV7U
M8H":O4)=:-4**B'$E-(0E"U:5KEE)CK6VI2-Q1.K0:34:S<*9/-=RX_)^H<P
MSC<L?Y@TRB22IN+V'''7Y,)]E3DLFXKBT,K4RDG(RTO)):%EI;*^HM;>#XKR
MKX!H.&,94^3F/G)1(F#'(L"K(>BH2;]2DO2D+=\-+CD^E2E0OC$1MI-*VD^9
M1CV<6TK\F[5J55X98CS;HK4)V*OP<8YR7*(TIU:D(C,RFU(:0LY2'-)$LE$2
M33;XE[\14W\F_58>((M;XB<VIJ:F;;V[)B3C4PY%4LTI;4[3C,B-+CC>EW4U
MI69VUF:@&YG\^GAY.NJPRC$U<=K1^"V:<QAFI.OK\2RAYKH3'^DVXDRY]7T1
MVYO&APYTVMRX4O-&G.PF6E&W4X3BY<!:VEME)(GV4J2:VO$1=1'R+=Z;Z7M&
MJ%$PEP*UG&,"AT;B#S#G5)V1AVC4QA4II]MY:X#46)9AV$;*%H;6PI\WB2ZT
MZ@T*)')M<E99\&^16<&2_C\&9OX[Q'@W$L&IHI"Y$E#3,%<MQM$AQ+2HZ'#V
ME1+-M.ZD)U&1$1GN@:-O\'8TH6/,,PL9X6F'-I%6CMS(4C0XR;C"D:T*)#J$
MGS+[!DXQ? >&8.!L%X?P;3MU<+#U*C4MEUXS-Q;3#*&T'<^?.PR@$P
M                                 '5?89F,KC/,H<:<+2MM:2-*B]C(
M^1B#N#20Y+X6,HW$LREI_,ZGM*=E+8=59#+2322HZC1IL1DVFVLDD1.:7"6D
M2[B)2FJ),W(\UYM,=Y2V(3YLR7DD5S)IPG&S0KV,E%;W(1=PE)8:X6\I7(LA
M<PSP92G;O3EO64J(TIQ!FHS^;66FW9%K)MY $W@
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M]A&1?@0Y=2?85UD X"822]PD$2K&6JW.QG<_X\QS&1&9&97,NWV!J3[!J3[
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M&KU.D2_ES#N,*S0F:E%Q#48JYT2F51;45QV.W()MM:5L$9&DKK2A.JY.*&[
MU[X3J92:/@C&$*(Y(2T>9F,T,I?,W"(T5F6@R:OYB-"5']+F2[WTF-A
M
M             :Q\8\23+A9,N1EQTLQ<Z,*.N)=*SE_$.)^&:N=[N(/I)7PT
MK_5ZE)V9&O'%XY3$80P-*=I\F;(BYFX053FD-I-Y4DJHT=DK7S(S03B;D?91
MEV,;$V+V 5
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M@]8JM.QMF=Q0M8PP/AI_Y#?I3. *I2CE394=]+33CS-G5)2;1K)1W([:5+[
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M+\FBUMEQV%N,+:=0AMW:=)25$1D27"L?I8KIOR,229^:4F=S21G]PJ
M                                    .E+-;<1:XJ2-\['R[F?VB&N#
M=#+?"]E,U%I:H!?FA3'#81H.YFP1*=-1?UAV<T^G(A+M18J"V)"*2\W&EN-7
M1(>:4\A)V_JR<0K\#(0QP62*?,X3\IYL*,IA*<-085O +C)W&D[;J]"NY*<0
MXO=\KNI+A=*D$03X
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M /"/Z'\U]GF_8$Q)80E6I*$DHBTW(N=O8-"-&WH3I^K;D AN=Q.X @P_E%=
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M\0]3?4;%N2?-]XF@HI)0;:4D23,S-)%R.YW/\3YBNPEHK-()!?LE;L5B_AR
M0FCC3X<7(L>06/)EI&WI_P W*G]/M_S<<RN,+(Q#IQU8GJY*L\>X>%JL:+-?
M/N7\+\RU]-WR)^DI(FHF$I0EM*$DA%M*2+DFW:Q>EAQG'-2="BNGV/L AACB
M]X?I,WY+3F5&;GE46:;X.5!EQ7S><9WFU;;C*5[6W\0W=.WHYZK<AU_YY_#J
MJ$=43F$@X2"0:7"@RM4C4;N@F4[-W=6PKR\K+3[D)O-DC[EZ$7[O87DPP1:2
M9;(BT\M)?1\OX>GL A5SB_X<6/%&YFO3"V?%;I&W(O\ HWSVCH]/2WG^B*QN
M,#APD5 Z:>;%-:DFG5IEM/QD$C:WK:G&TEJV_P!^KX?GZ1,QLDHR-17M>U_M
M[CE-*5>9)'SOS+U 0Q!XO.'>HEM0LUZ0M=V>;C;R/G7-IOZ']9YOZLO/I(=9
M?&'PXKF_)S>;--\5XKP^C;?T[A-;JTZM%M.CD2OK?:)O-HC/4:2,_<R!+;:4
MZ$H22=))L1<K%V+[@$.?SM^'(IQTO^6.C>+W"8)NZ].LSZ>K1;[^?WC@1QB\
M-*X\>H%G)A[:D--O(3NKW%)7OVLU;<_YH]]#Z*?K%>:280GRH274:^1%YC[G
M]XXDQ&4+)Q#*$J2E*"422(R25[%?V+4=OO/W 10_Q4</[*DDG-[#[B'#=V_"
MO^),B8<L[JV]7?TO^X47Q:\.C=<_-Q6<>%/%_P!;X\MC_KM.U_MB7$QFDZM+
M2"U7U627.YW._P!_J+C;;5YFTG]Y /FMQI8^P;G+6<&5K*^NX7JE*I=*GLU-
M^0EN)57#4XVRAE*'4H>6R:52.A"23YG/)U#"<OI.'6\SLOZ[F!1,I8^",+0V
MH:]=89B1G/#MZU3M*-SQ4HW^KF2-U?PW-/S@^KQQVU*4I3:3-:22HS25S(KV
M(_LYG^)CBC1664$VRRAM">R4I(B+G?M]_,!\J,W:17<-8I;?P?Q#9=9O&_AF
MHX2*-/<IU,<H:3LB*AQE+B&6F6UI2;3BEH,GR+VN-KLCL<<*61&",-X:A9DX
M'EU]Z@M(K.(8-I*ZR^ALC>?.8@E;A*4T\HDK<]4^O?:Q,*.A1+1':2I.JQD@
MB,M2M1_BHKG]O,6HC-MK-Q#:4K,B2:B*QF1=BO[ (?\ YWG#>W'>GRLY*"TW
M')O6AU9M*Z^WPE)W!QR>,3AI@T],^3G1AQF-(*S#ANK6I/)?F3:_ZM0FA,=M
M#BWDMH);EM:B25U6[7/UL.,XZ%*UFVDU'ZF7/U_]"5^)^X"'X_%CPWORCC)S
MNPN1,FA2W7*BEJ/8W=OY]9Z#Z^=M7EY\TCO3.)_AZAL3W%YUX1<338+M5=6S
M5FGK1D&>M2="NLT^J2N9>I&)5<BLO$:764+)5KDI)'>QW+^/,=!K#U'C,MQV
MZ3"2TTEE#:$L()*$L_-$16L1(^B7T?2P"-4\4W#B[$=GEGS@<F&M=E%78MGM
MMO6YMEN778OJ$7[QR*XH>'=H]Y[/'!*$?#*RJ_$Y:MOGR<_TK=_:RA)!T.DG
M);F'2HGB&C6;;NPG6@UE9=E6N6HN1^Y=QP1,)8=@)TP,/TV,7Q>3,1M!?$MN
M=B^E8M7O;F P=CB5X>GXZI!9WX'T)2M:_P#.&(1H2GSD=G>:B_9%7N)/(-DG
MWY.>. XK#3CC#CKV(8;;:%HT:OB&[I+YQ/H,]1AC#S:82&Z#3DIIIK5#(HK9
M%&-7F-OET7];6N.-K"^'6''76*!3FUOK4XZI$5!&XM5M2E&1<S/2FYGWTE[
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MC5M88A(OH*R+V:^B7(O;T 9@YBS#K,@HS^(::ATFS>-!RVR,D_%[EJ_T+_\
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MH*4TJ0\3>XEY#R%D1$9$:&&/K#<@
M                                             &NG&9&\72,HG3+4
MF-G#@]9D?/GX]!7_  ,R_>8V+&MO&*W'^3<H%OUR5"6C-_"*F(B6B650=*85
MV'%?J]*-Q[47FV"3SN-D@
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MXWIS,VJ,XHHV#)$9==0]+4PW,4F2H]B-&.,Y'4I/09&9:M1W&*X1PUP9TO\
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M$7)&DD(U((E@-A@
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M[+N=>:KL<E4[A.S,4HS8.\JI8<C^:QK[U(^R#NGW<Z%:" 39K(7"#JGGCF=
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M&8?YZ[$T]M[2_F_,K?3=/=.VOD6A8"<-2?876+V$'EQD<-BO-FM3"YEV;?\
M5%S_ %?H*_SR>&OQ#\?^4UK5'C[B_P!$E6T>WD\W\0$W:R%-2?80RQQ8\/+]
M0I--8S:H1+K#3;D%2Y"M!H7V-YTRT,JM^K=T+'65Q?\ #0?AR:SZP<ZS(-PR
M=:JK;K9$T6I?Q2.W--DE[JY>8!.&LA34GV$,0^+#AVD2RC-YNT1N24DX)QWI
M"D.[_P /IVEE>WQ4=7[*_J.:>63Q7</J3)2,U:+(L9\HCQO7^$X[]']AI?\
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M-2?80S,XMN&JG29L9S//!;QTMG<E;>((IZ$;;IV3\3K5=@_M^(GW(7)XL.'
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MGB'WV?Y3,7H22D)U-VJL@C2;WG?.Y?.K,UZB4F^E*1L$$]
M
M   &MO&3"@.4K)S>GHA^'SAP<33.QKW5%-.S:5?JS)-U:BMR0:?IV&R0UWXP
M93+.'LN8CYL)3.S4P>P@G7#*ROE5M=R+6GG9)_@KV2-B
M
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M3,,P8>.<4T^OUZ(QHF3X=/5$8=<MR4E@W%F1]K_$YG<RVR/;&7
M                               .&3&;D-[3C:5(^JHKE^ A'@Z0MGA5
MRH:74GJJ7YI4U_>E+LHG%,D>Q?\ T2M+9'ZV(Q.@A+@^9D(X4<I2=.,I1X,H
MY_HB2,MLXK:D)._TB2=E?M&9]P$V@
M                                            #&L:8"P?F5AUW#>.
M\*4:O4^0M+IPZI!:ELZT^51H<2I-RN=CM<KB!>"WPC5(S<HU(C,QJ;2,V<2T
MF-"CH)MB"PTZVWLM(+I;1<ENDE)$1)4E/L-G#YVOZ=AK7P9.14,YSQV*44-Q
M.<6*ERGR<U^.<5(09O)3]$K&EJWH;)I\Q7 ;+:4EV27J?8"(B[$1"H +20A/
M-*$EW[%[G<_XBFTU8D[:;$=R*W8Q> "W;;U[FA.HR(M5N?*]O\3_ !,5(B+L
M1"H *:4_5+M;L"DI45E)(R]C(5 !0TI,R49%<NQBFA!VNDN7;EV%P *&E*NZ
M2/[R#2G5JTE?WMS_ ..9BH *:4\NDN7;EV DI3?2DBOWL0J "AD1\C*X$1%R
M(BY"H +30@S)1I(S(C(CMZ'W+^!"X  4-*3/4:2ORYV%NTT=R-M'/OR+VM_@
M+P 4%$H0CDE"2YF?(O4SN?\ $7  M)MLCN3:2/GZ>YW/\3%=*2[)+\!4 %I(
M0FYI01:CN=B[G[BW88N9[+=SYGTES'( "AI296-)&5K=O04)M!&9DA)&?(^7
M<7  M)"",U$@B-1ZC.W<[6O^'(6DPPFYI906HS4=DES,^Y_O'( "S::UFYMI
MU&5C58KF7M_ A>  +%,M+Y*:0?/5S27?M<5-"#.YH(SY>GL+@ 6$TT2M1-I(
M^][??_O/\3%=MNRBT)Z_-R[\K<_W"X %NA)J)9I+416([<[>W\"%;$1$1$5B
M[$*@ M-"%%I4A)E<E6,O6][_ (\Q4DI3R))%;V(5  %NA%]6A-_>W_'L7X"X
M %#(E$:5$1D?(R,-*>?27/OR[BH *$E*;Z4D5SN=B[F+3::,K&T@^W=)>G87
M@ Q^K5!JBTN=5)"73CQH[TB2AF*X\O02=2U)::U+=49]DHY\_?O'_"@RU_-<
MR>0VTA*5X$H3BDI21$:S@M*-1_::C,[^YW$N&E)F1FDC,CU=O7M<13PHD1<+
MN45B(K8!H%OL_0&@$LZ2OJL5S]0)*2,S))$9]^7<5 !;H01W)";VT]O3V%$M
M-)N26D%J5J.R2YJ]_O%X +3;09:30DR,C*UO0_0#0@U$HTD9I[';F0N !0R(
M^Y=A0D(*UDD5BL7+T%+G[B\!0TI5YDD=COS(4)MLC-1(3<[7.W>W87  M-ML
MTFDVTF1EI,K<C+V#;1]1/?5V]?<7  H:4G<C27/OR%-""L1)+D=RY>HN !:3
M;9*UDA.HKE>W/GW_ ,"_ -MLSN:$^GI[=A< "W0BVG0FW>UOMN*FE*O,DCY&
M7,O05 !2Q6M;D!)2GLDB^XA4 %I-H)6HD))5C*]N?,[F*$PR2=!,H)//EI*W
M,[G^)\Q> #3'BNX?\MZ%B>/Q;UO%>(WJO0L48-4W%E5!LZ5"CLUFGM*4TUM:
MVRTK<6=EV,W%'](AN4I*5%922,K6L9"!N,J'39>1-0B5Y$YZ!)Q'A>//73DD
MF2J(=>IQ/:+\M5KV^\3Y8O8!Q;+-E%M(LJ^HM)<[][_>*&PP9H,V6SV[:;I+
MIMVM[#FL7L%B]@%-".7273VY=AQG'0I9N*;2:S3H-1D5S3[7]OL', "TFVR[
M(27._;U]Q;I3IT:2TVM:W*PY!2Q>P :4GW21_N TI/NDC_<*@ X280DTFE"2
M-"=*;$72GER+V+D7X$+C0A230I)&D[W(RY<^XY!2Q>P#C4VVI6I2$F9>IES%
M=""3H)):;WM;EWN+[%[!8O8!9H,BL7O?]XL.*R:TNFR@UHU:5:2NG5YK'Z7]
M1S@ ZA16B<WB:1N%SU:2O]+U_P!97]X_<QRG';4:U&VDS<(B69I+J(NU_<<M
MB]A4!U5QT+22%H2I*3(R(RN1&1D9'^XR(_O(ARH::;MMMH38K%I(BL7M_$_Q
M')8O8+%[ .NS'-J]_4[G]IWO?\1RDE)))!)(DD5B(BY$0Y!2Q>P#KI9)'E*U
MC,^7N?<Q=9?UE?B.:Q>P6+V 0GC151/BIRM9BR-+9X.Q?XM#B4_$:*30K)27
MUB=-I7W&KZHF0F4H(B4DC(K&5R]NWX""\=KICO%KE3"DQW9;[.$<7R&S:(U?
M)QF_1VT/.DG]6:%/-]>I&I:3M<KB?#(C[D1@.(H[9$22;38K6*Q<K=OP%VUR
MM8K$.0 '6;93?5I*YGJO;U]Q:J*TM*D*:2:56)1&DK';M?[AVB(B[$%B]@'#
MMH/NA//[/W?]IB_:NK69%J]_47V+V(5 =8F$E:R"*Q$7(O0N9?@!LD?=)'R-
M/,O0^Y?O'8L7L%B]@'6*.A)D:4)(R5J(R+L=K7^^W+[@\*5B+05BM;EVL=R_
MCS'9L7L*@.J<4E%922,N9\R]^_XW,5-E*O,DCYDKF7J78QV12Q>P#7OC/DNQ
M>%C-9UBDMRE,X9FI0J4LVC;841:G2/IZVS+4VB^I2FBYW4)]-NYDH^9ES(_8
M0KQHTQ%5X5<V4J>9:-.$*F^DWBY&IIDW$H_M&M""3]JN0FM#R%1MYKK*U^X
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M"Y%R$#\9Z)2L@)KU,;;7.1B3"JZ>9M(=U/\ R]!LHD*[]_*)_ 7@
M
M       #6_A&6@L-YGOI.[QYLXO7):-UH_#*\<X?/9)7/1;DNZM1]^PV-N?N
M->.#MY#U)S1,IY2#+-C&""8V='AOT_5M:OI^;7J_TFGZ(V''<^LGHO  '
M
M           -<.+J'4)-&RMJ$2K,Q(L#-?""I;;S&M<I*ZDVV39=![*B6<=S
M66@]*5HO9=CV/$!\54.?)P_@.4Q(BI;B9H8.DNI<96M3C)56,A24I3;2HG%(
M5U7Y)^PK3X
M                                            -<^.I,E_A-S-)$Y<
M+_(JC2LF'%]"'6UJ;/0:;)7;0?V'92'?FSV(/;-.DT$9>UN0@?CBA+J/"7FL
MPRI1;- <D'8_H,J)Q1?<9-G<A.C2#:*R5*=^\[@.P   "W60N&&8[S,P=EO
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M0[F?V^=9=9A-
M                             L&KO!,PVAW/M\R8W$YV8I;)>M6HD$IE
M9)OWMJ<<5;W6H_4QM$-:^#(Y:4YV1I3+!K;SIQ625,.6,V5N-+2IVW=9>2Y\
MR(B+L"6;9<  %0
M               %ES]P%X         /#K:9DBARVHU2E19*X[K3;\5DG'4.
M*1=*B1917+N,"X4O_@7<H_\ Y :!_P"T#0D"K/3FZ1*>AT]4F2RRZXPR3NT;
MKR2Z&]2OK=M0COA.,T\+V3A*,SO@&@7OZ_Y/: 2Z         "EB]A4  6:5
M>YB\                      :^\9Z'2R&E25PV991<3X5=:AO./)9<3\O0
M+$_M&3EON/E8O8;!#7_C,73DY$N/5-HGHA8FPLE;:G%H29%7H'(W$$LDE_;(
MR&P                                      ((Q:N+_ #L\ -JG66[@
M/%2%,1V?C.$<ZB%NOK21FVWT%H5\.SC=B795A.X@W%CS#'%EELZ1-I<?P-BQ
M+BR8LI:43*(I)&?<R(TK,B[$9I,3D                     UYXWWFD\(^
M9[\M#*FSH+MS>G%%;6M1I)!FJRSOJ)"D)+J6K;;(RU&8V!;;;:1MM(2A)?12
M5B&O/'I49--X0\T)\>GHJ#BJ.;!M++EM/.(94JQ_52I2OWC8JQ>P"H
M                                                     -=>-.!"
MD9)?*,R(ZN13L683F-E'?-IQ"E5^"W=+ET:34D[7NG2?5>Y7&PX@/C892_PY
MU>&STK?KN&V$&7(R4==@IY?ZIV^[D)\&=@O  &@
M                                                    UOX1CFG0
MLS&45)U3?\K&+VXS!QT&<(OE!PC:4>OK^)=W5['I&QHU]X17%_FECPGF&FI"
M,T<7-O(C2ENDXZJINFM-C/HTJNFWU4:OI&-A+%[!<%0
M                                                          !K
M1Q@,F\G*9]Y5.999S7PI^D2U:))J.>P>W'21=6JZ3,CL1;1FJZ2&RXU_XKY.
M&489R\15F&U2Y6:6"4TEU5S4B4BM1EG<SYW\,<@N_=2O<;
M
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M(4['25M9ZM*'%JOW,D_JE#9<^X,CR5(5%"["H-
M              !81H).DDD1=K6Y"$>#\V4\+V5"HT6&PD\%4HS\*>LB449O
MZI%S4?=)]9'R69JYC)<=X/S3Q!68T["F<,C"M*;B[;L-BC19+JWMTCWMYXE%
MITV+1MVM?J0(?X2L(9R,Y39/U>9G<W4<)M84BNR,/N8=C;SL5^/K@QTS4*09
M*896PG43=U[2S41&X6V&U@
M                                      L&MG!PQ3BB9P2($:$IR1G!
MBDWW(Q:5.F4DK:C]3L7^'IUC96Q>PUEX,7F),?.,T5*>XA.;^*FTL/N,.MI7
MXO7J;-"2<)-OZPS ;-@
M                      I8O85           !X5?@U&;1)E-I%253)LF*\
MU#E)CI?\(Z;>E#QMJZ5DA5CT=E&(PX2&&XO#!E$F(Y,<TX*HZ2\2;OF7&;-1
MEN&9Z",E:"[:#02+)L)F<:0M*4)0FR;&16[6[?@(;X09Y5+A?RGEKI\R(HL'
MTB,;3[26[[,1I@UV3]%6DEE^S;T(!-0
M       @[BL3;*Z%,4[+0ZSC+"*R>BHUNMH/$4#DENRMSEZ&AR_U#["<1 7%
M^;[>3K=0BT:35G8^*L)24TE*4%\IJ+$$#1#,W"/;UF9$1E:RM)<R,T+GT
M                                  $'8M)P^+++%PI#C),X*Q@2$FLU
ME+/Q5$^'^QR-*]7[))$XB!\8/2HG%IEB:&I[S,O"&+XBO!MI-F&DI-'<UOF?
M/09MLHLG]8I!=E*$\                     ->..F.B?PB9GH<*6\?R"MW
MX2C;.Z5I45SNCHU(NHO5-[\AL(@S/N8A/C*?=8X5<V=AIDR+!U6027%J25E1
M74*L2?9!F8EV%&9CQ4-1I4G89(R42WEOJ5_XQ9FL_P 0'I
M                                              UWXVE5./P^U=ZG
MKAMNLUJ@/)E2G%M-L22K,$F3T[;A+3JYJ+MZ^HV'L7L-<N/)XXG"]B-]$[P^
MFL8=-$ILD)./>NP;J(U$:3M]WIS&QP
M                                               -:^#..IBB9OJ?
M-B3*=S?Q;)<)I!MI-PY6FQIT$HN2;<U.\K=?ZM&R@UNX/D$BGYM*337HB3SA
MQ>ZTI^RBD_IBD&MNY\RW$+1<K<VEEZ&9[(@
M                                                    UXXN"CEA
MC+M<HF%26<VL'N0]U9IZ_E1H[IUWL>A;I7+T*W;D-AQ O%1-HD;!^ "EOHWG
M<S<%_)[R]2U-N?*\=1FD_4S82^GGZ+]SYST
M
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MIP]56\/4U%%IR)K:GDQ82-)H8LNY*))D1D9]C(C$NZ$&K4:2U=KVY^O^\_Q
MT(/NDNUNWH#$8U/(O*C$%;Q)B2H9>TM=2QC#=I5=FN1C.14(#L=AM;+CEM9)
MVX["=-[72KE<S,>LUE#ENS4<+U-C!E*9D8'@'"PZ:&+'2HZFTMFTU;RH-"$)
MTE8M*"*UB(9QH3]4OP^VX;;>O7H3J(K7MSM[ +@
M              !J_DI9GC#XE&T/Q6VR+!CJB0DTF1'!D%9Q7HLUI4KE]%Q(
MV?L-:<EJD[,XK.(V"X33+<%6$6$,H<^,Y>G+<W33K\WQ-!*T%<F4D2UDFS>R
MX)P   4                                    !QW1>^DKWO>WJ(5X/
MHZH?"ME&E,,T&6#J8HB-W<YJC-*([_M^?]F]A+4UV=X9:HC<=]PDEI:4ZMHC
M/^V@E*+^Z(HX2([S/##E.3VPPE6":,M"([&T24+BM&@OG%W4?<S^D?FY@)K
M
M                :X\'$IV31<W?&LOJ)O-_%["-9F>ZT4ZQ*._>Q<ON(;'#
M6S@TE[T+.5A+LO\ 1LYL7,*WUJ.RO$-N?#OV;YGR+ES,!LF
M
M   /,FN/.T][P<I+:W&G"2^D^EIPB.RC,_0C$:\)Q$?"YDX9D1ZL"4%)W]4E
M3VK%]PSO$YT9VA36<2NQ(U/DQS3+.8^A+"$F79PU*(R+[A@G":6GA;R;(^?^
M8U!_^=[0"70                                   !K[QH+<I^2D:O1
M*7&FU.BXOPI4829#RFV_$-UZ$DM5N6E6O0?_ $E_HW&P0@7B^536,I8B<0J4
MFC+QEA)$Y+>\I;D?Y=A$X@U-&2TF9&9%I$]
M             A#'-48IG%AE+'7"==^6,(8QIS;K1<V?C461K4??39A2/[3J
M?<3>(2Q/4FOYV. 8+#D5R3"P%BI<EDW%;K33DZB&A:6^ZKJ84E-O-I<M;;.\
MV@                    ->..V1.9X1LT"ID^9%=<HJF#5%=:;4I"GFVW$7
M<OJ):%*0I'F6E9H29*4DRV$0I+A'8BY]Q /')XAOA-S/*'%1(=.@NMZ%%JLW
MJ(W5V]R1U7^P3Z1$GRD1?< Y
M                        0!QL,R?YO-4CP'U1W7:[A=AM;:R0I"CKT'L>
MM%C^XR$_B .->HHH_#G6:BZV>F)B##2[K<4G495Z#Y3YJO\ <)\N?N O
M
M            &M/!ZFG28.<28L=24OYP8N*3NMF?B'-\DF:C/YU.A*/+8B+2
MWW:4-EAKKPA-R&Z+FXIYMZ\C-W&!)U-HYI\>Y;1]8N7TAL4
M
M    #7SBU=J2<*8'5 EM-/GF=A!34209I*8X56:43&M.K39:2=U?5;T^HV#&
MOW%RV@J#EFDD))+F;&$"65N2B^4&N_OV+\"$_7/W 7@
M
M               -8>+O*+!CV1>;>.7)-9@5%O"57DH>7B.:AEU7AC/9-OQ&
MP;*B;;;)G3HNHRMS$S89RPPMA"L3L445JI(J-1+XRY57F3&R_P!1U9D(ZXVJ
M>]4^%7-2#\E(J!IPY.D)87)0W9ME!.J?NM)E\*VYI['M$6I&H3YI3SY%S[_:
M J   "!>(>([+QID.;RH[ELRF5GTDD[E1:J=RZ^]TI/EZI+V$]"#>(2(<S'&
M1:%+V?\ NE)=)U2=SDBA59>WI_;)"BU?1N8"<@
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MWU+Z5]R^J7*R $W
M                                -=N$F*XQ2<S7GJPS/5,S;Q>]=#1(
M5"(JBXP32S[K5J8O_8>079)#8D:[<'[26J+F>3C),[N;V,'4F9Z_$'\JNIW2
M+Z'ET:?]'J^D V)
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M',
M #7_ (U$UMOA\J*<.U!4"KN8@PLB$\ATVS9<.OP>9N$=R2)]&O7'2N(?#/B)
MN:S(<AIJV&C>\.HVW#1\O0>E!EV5]PV%&=@O  &@
M                                                     UPX-'JL
MNFYP-S(*&V$9OXO3'D;M_%->+OO:?H?$4ZU;_0ZOI#8\:]<)$<I%%S/<7&BH
M4K-C%]M,<TFH_E!PKN<^H[>_V#8*Y^X"\
M                                                 0+Q6*8;PM@<
MI$FG*<3F7@_P\>2X29#KIUJ+9$<]Q!*>T:U:3Y;27C]"$[B!>+-5+AX:R\4\
MAOQ*\UL%MP2,B,]TZJR2E)]E;1O<_:XGRQ>P"H
M
M          "">-)I"^$[-G>?=;+\UIW]$5S(MH[)^Y78R]2$Y-J;<^*VYJ+[
M%7(0MQB,4MWA5S<;J#VTU^9U6=UF=OBMQ'-M)?\ C$H+[U"8(L<HT(FRZ5>Z
M[(_\T!W0   0=GC4W*;F)D@ZBE39:OS^>;+PS:%62YAZKLF7-?9*G]9_LM.G
M]$A.(A+/)4Q./\C?DHB-Y68CYF3G,S;+#];-\B^TT7(OLY=@$V@
M                                           -;\DEQ#XHN(\TQ6BF
M(J6%W%N;"B4IM=$;2E!N7TF1&E9D5OI&?TTVV0&MF2\-;/%AQ'/^!)A^3(PH
M^3R7=9OLE3#22;_043C;Y6O?3I5H02R6YLF
M                Z<E:&(AKD)-3:2L1-D>HONL(QX4T(1PP91ZDD?\ F+0B
MYEZ> :Y"47DJ:ZV4ZE")N%!Z2YPO91G)9\.?YCT(K&>KD4!K2?[P$Q
M
M           -<.#MV:U1,VSD' /7F]C!;6PHR-"?E!1?']EZR6?+Z.CT&QXU
MMX.$$S1LW[+:2;V<.+W[I=,C(O&_3^K8R)/+T(@&R0
M                      LN?N+Q2Q>P"H
M      #Q*TNI(I+RZ7+CQYZFG$L//PU/-I>]#4T2T+<+EY4*)2B\ID, X3B+
M^:YDV=O_ $Q:$7[OD]KE_ OP$@U-Y^/!E.>$=J+RV'+166VM3A?523BDH5W[
M*6(^X3O_ (%[)PO_ -0J ?[_ )/9 2T
M       (7XFBE%EO3#9,]3./\%&IHH]R>_SCIIGI*_/U5_L^XF@0EQ.TQFHY
M<4R(J*:4ECO!+1NM+-#NE6)*;KVG&S2II17\Y6/D)M
M                   ! .*&F(_%]ES57J?)E2Y^!\40FD-QVS*,IB91G-]2
M[;B-2'5MD:C/YTBZ-Q=Y^$(5V-5?YVV"Y;<APJ:O+W$R&TEMV6^BIT8[&6UN
M:?B(Y[IH.Q62W91N3>                     UYXYXK2^%+,9^1 ISY0Z,
MX_&*<RB033R?*M!*(R)TO2W(O<3_ !R6E.TXLS5[F=S$%\;Y(3PG9HI2TEPO
MS?>38RN5M9%;[O03'3)U0FQ8LB319<&1(8W7H\E2-QI?U%&VM:"_U%K >P
M                                                         " >
M-31(R%ETUPVUN2\3868::4LRW5'7Z=V5] ^9_B)[$#\:$9^=P^56'&5):DOX
M@PLAM<9*3>2XJO0"2HB/EJ+E8^_(3P,[!>  -H
M                                                   #6;@QA3F(
M&<\NJ1U,,3LZ<7JBJ6>XF3'*7H,R3V06MMQ-O=*E?3,SV6&N/!I.>FPLXVY$
M]3Z8><F+6&CV]&VGQI*V_P!OJ6M.KV21>@V0L7L$Q4
M                                                          :W
M<8U'FS:;E!4(#S*$T;.'"$J63MCW&52SC)2C]HEOMN?81*^T;(C77B^\+\@9
M>N2:8[*7'S5P@MEMJ0;:T'\H-EN)072\KF:-M5T_2&P]S]P%X
M
M                     ""^,=M?\U#-LV:.W55%A&I*-IQ162C8NN18_5LB
MWK>IIMW$YD1$5B(B+[!"?& I#/"KFW)9LG_,ZL$>[^U$<0GO['8R^XA,4.0U
M,89DQGC<8>:NE1'W^T!VP   0+GI47H>9F14Y^7"C0TYA2(:FY4@FKRW</U1
MMDM1D?Q%&I9(3V6:VB+S&)Z$(Y]T]Z;C/(UA*8:D%F.M[2^V1IZ:#6%D=CY:
MR2E5C[DLT&7,B 3<
M         UMR26I'%'Q*MM0XQI75,+$J02S):_\ (S:5(-!\K-I2@R]#UG[C
M9(:\9&G,5Q+\2+6TV3!5K#O(G+.ZSH,6YGZZ>VG^%AL)<_<!>
M                            "PE)+L1$(>X3)427PQY3*C3&I%L#T)@R
M8D$O2IN!'2HN1%S(_-['V[B3*X[(8I,IV(Y):6VRX>^RA+KC)ES(]M7)9B->
M$YE+O"[E(EQ)+(\$4%5E%?GX%H[_ 'W(C_< F(
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MIR3U)UW):=&V71;J0OU)5PV# 6ZR%-U/V@+P'%K9_KO]H7ZR 7 +=9!K(!<
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M5*2DOA&35M2E'=XE(M;EN;1E/FL@%P"RY^X7/W 7@   "RY^X7/W 7@ MUD
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M%=9 +@%ES]Q760"X!;K(4N?N O 6ZR#60"X!;K(7  "RY^X7/W 7@+=9"X
M!;K(!<              ++G[B\       $ \([5Z+F8I;:"MFOB\T_!4@[_*
MKO.ZG7-?]I)-)]-NZ5..3\-<N#=<TZ7F\;K:FV$9QXPVENW^(SX[5J3]FI2T
MW_9&QH                          MUD N 6ZR%P  MUD&L@%P
M                                   " N+6+$7AC+J0Z[M/1<U<'NQT
M$=M;GRHRWHM_T:EG_J%[">AK_P 7+2'L.8 2Q):8J!YFX553W7VC?:3(54&T
MINVDB4=D&I7,T$1GYR]=@ %X
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M&9<^P"?
M&M61+4&-Q.<1K31*D3_EC#CS^IM"%(:51FME)'_5E;E;J3;G<;)#7/)**9\3
M_$G*-B+9^HX4N[X99.N&W1VS.[E]+EK].DBT'>_<;'6+V 5
M                          !XM0IRI4*1!)UR$E^,;27&+&XRHRYF@UD;
M9=_81SPE.$]PNY2&A6[; ]![%H_Y@T)0F.O-,R/!K:4^EK4AMSI01^ZU"&^#
M:J0*WPJY12:9.8DL-81ID=:H<KQ+9OL,);=;-=B,EH<:6VI'9"B6WSTD8"=
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M<6T6,V;:'=NVLI"RW#*RB3Y/99C84R(S(S(KEV/V%#;0HK*0DRY=R]CN7X&
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M9&?(D<]3GI]%))[I4IRD[!^<+G3 SI;B?I3BOB8:C+(FS-TD,\U)\NXSH/\
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MN)+;'ES.%S&<FGU")\O9/RI$UXI#12,IXI(N@M+*W&SE64XVH[$HRN:.GOS
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M(V)V5K4Q,R-:-R0UJ4G)]HG#;):SVOZ=MZM#SR=6F]I#Q=B(1KBW("G4'.[
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MJZB]CYES <O\LV46K5_*QA'3_P#5N+;Z7[?["OP,%9P95-RO O9HX21+,U_
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M-VVSD8;A.FFR4I*VIL[=+1%]Q6[ )(=Q5AQE_8?Q#3D'?L<MLOI:?K7\W3_
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M\>747V_:-B@
M                                            !"_%W&9>X4LV4+6P
MRVG!58D6616W417'$%8^5S61%]XF>Q7O;F(2XPX+<_A3S;2N 4M2<$59[F[H
MMMQG5;O^IY]/TO*)K1=)649_O 7@   U_P _J7%Q#CW(^A5*EU X3&8RJH4Q
MEUG9;?A46J2F25N*-2;NH<*Z$>5E9&:+M:M@!!O$+)ETS%61TNGMZI'\IS,>
MRST_"<HE7;</I]FG'#^Y("<@
M                &M61\"<WQ9<2E0=I\,V9%1PJ@I6\=U*;HK9[>CW1N(ZO
MI:R^KRV5&NN2;D'^<SQ#LI1^DE5<-$9DXHOA)H48R1H\MR-5_P#QG[(V*
M                          6ZR%P          #R:I$14J8[3I2%-^)2:
M5((F5J<^PDNDI"O]8A%/"0R;'#!E"EN ;"5X,H[Q_"2@EK.&P>LR1JYKU*69
MGS,S,S[B5:Q)8AT:9,DE(<CMQW5O)CW-Q22+LC18]7VES$=\*:$?S8<FNDN>
M ,/J[>I4^,1']]N0"6P                                       !3
M2GER+EV^P5 !"G"U+3(RIER7%L.*=QEC62ER,XM3!$>(ZEV4?.W<36(6X5U1
MTY4OE$<87%>QGC(XKC)DIM3"L25)2#*W*QI$T@ A?AB8ALY<U2!#COM,1<>8
MT;:4X=MQ!8DJ=B3]<B_:$T"(>&92',N:@:Y"UFK'&-[ZE&>K_.BI=_?V 2\
M                          @7A3;=:P-C*++F2I:F<S<7IU2M-S3\MR>1
M&7<K_P"UR["=G"-2=M*C(_<C$"\*"8B</8^3$AK9>+-+&92%J*1MNN_+$NRD
M[R4D9$WMI^#J9N@^K<W4I"?@               !9<_<7BEB]A4
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MPQL C3J);"&%KO8E&YSY\[<B]2ZOW_O$5\4JT?S:,UHLB*LB/ ]?)"5$FW5
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M%[!8O85 !2Q>P6+V%0 4L7L*@ "EB]@L7L*@       "G;L%B]A4 %+%["H
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M+O%51K!(\'&H\UQQ3A72:-ERY';G:Q\QC/"F1%PPY16(B_S&H7_M R E4
M                                       !K3QI,3W*;D^XU3F74,YP
M84<D.J7\S>0I*'4)^G9U31&GV4I7T;C98:V\7AT)ND91ORYCD:9_+#A(J,6S
MKW7SF*):46Y)(XBY9FH[=*#+N9$-D@
M
M   !K_QLJ;7PEYM(=J"XZ/S=DEK;D(C'8R,R*ZB[+5T&7TR,R*UQ/J.??F(%
MXWI5/B\*&::JG#ERFG\,2HY-LMI<+?6>AE=E>B75H4?V$7L)VCI6GSJ,_O,!
MS@   @#B82;6,,AW(U;*DNEF>PHW34L]2/D>J:F="?1Q)+;U'R3K4?J8G\0A
MGVVVUCK(V8W(6RM.8JFR4PKGI5A^KD:;^QER,O8!-X
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M*3D1[A@RF<9;>;26"*$9[QF17\ US+7?\0$Q
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MK=*HD^H\Q\;(;;UW*,V6()Q$R97Y*O=V_?2JP"=
M                                                    %+%["H
M\6I52ET6CR:C5*E%@4^,TMV3*DK2TRPV@B(]:U$26RM[EVN(^X42V^&#*&__
M *H5!/\ ^U\?_>8SS$Z)C^':JU J4>GSW(3R&)#[!/-QG%-]*EH.Y+01\U$?
M(Q@7"BE2>%W*0UJ-1E@"@=S_ /6!K_<0"7
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MB[_>![9VN@CL=RN7K:P#3K-[A>R\AXYR4I;M4QS/I\[%CT"7'DXOJLA,M#=
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MJE7(785%"["HFF
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M=2S9PI#6VZDEDZ1RNQ$?)9=^2N7<;(@
M
M    #7WCBJ3$#A1S,??BM/G^;S\9*%;9))UXR;2KXA&6E*]*C+V+[!/K:30G
M;4HS/W$!<;SLQCA&S1E4^3':-6'7OC.1RD%MJ-"72)"[D2UMFHDG:Z5GJ[B=
M(^M##/Z6F2M+70\H[)</W.W(P'>   !">?;;LK&N1^N'&>068BS,I!D2="L/
MUA)\C^E99:?761";!KSQ6+II5W(9=1-?/-BFH(T-:S-9TRI&B_[)'S,!L,
M                                                   UJR-?CJXK
MN)5E,5>M$_"RI+ARG="DJHK6CX)HVTJY&1FE>I17UI024:]E1K9D?-0OBIXF
M*:@DZX-0PK)216Z"=HR?VSM?:/N2/WC9,
M             !X=9\6NBS/DPHZ9:H[FT<A:DL)/[T\R_<(_X3S/^:_DX5SL
M> * 9_:?R;'/_M,274I)QH4B2MTV-+#AD:S[&78^0BSA)1(;X5,HMV2;YE@6
MB&E24D1DV<-K2G^TE!$D_M(!,@
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M3'%.+BP\Q,9L0E.14,ZV"K,GJ(DE91;BEEJ19/3:Q6 3\
M
M ,:Q?$<FX;J\5$"1)<D093:&6)ZH;SYFWR;1)29*CZC[+(RT]_08;PMD1<,6
M4I$5B_,6@%^[Y/8_WF/>S/;HB\M,8M8OIZI.'#H<Q=480YM.KC>'7OI-:3NE
M6GJ):>=^9'V,8GPG,-L<,.4A-/S';X(H1W><4OK7 9OW^BGT+L5N0"90
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M7H;,HJ<.0WG&'''"-"6C4XE1H(B21\UJ58?2JQ7O;F J
M
M-;^$=F6[1\UI3]38F+D9O8N)MIMO05/24[;VC(BLI6XSNZ^_Q+WOTC9 :X<'
MT\ZA3<XR.EQHBHN;V+6TNMRE.>*,I>G><2?S1V+1I3]%O7W6-CP
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MQ26I3IU%IO4W>^E5GE'<OHDM-[J29;%@
M
M     " >-AZI%PEYJN4^@N561^;\PMAM24FELRTK?N??;;N[;UMIYB:H$.!2
M(K=.IL53;,4M*6VBTI(O:Q<A$?&0ZS_-3S84_&7);_-"IJTE$.05S8<)*K$?
MT3(E:O*FVI1&DK";[$1F9%W 5   ! 7$V[5XF(,A/D0F5RE9K4]I6\5VCCG2
MZF3YV/EJVB<-)^B]!ES(A/HU^XFXTUZM9'LTJBMU*069L=PF%SUQD))NC55U
M;NXD[_")HUZ?I;>FW589 ; @ #0
M                !K7D@Q";XJ^)68@C\>]4<)1WOBJ+4TW1464E/E(KK>[<
M[I5]4ALH-;<D#J7\Z7B--UZHKBKD849C-O-+:90I-'(UFT9)N=SM?]PV2
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MR4J)3C#9X@J#FEQY+BTNJLLN:;=_7S@)W
M07PN5MFH81QI&1%FH.DYDXUC&I;2DE(;77)DDG&BN>XG](2DEIY\K>@G00+P
MITBF4S#>.ID!^0X[4\S\9RY#3R[DVZ5<EL$EHO1&B,A5B]36?H0">@
M
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M^([ L)B&X^<14M:\.1C.+NIL:"<-=S.]D[AG]$?26Y^XT7@
M
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MB+AIRE216+\QJ"5O2W@&@$J@
M      -;>,:%!D4G)Z=,J4J(]3<X<(O0D,(,TOO*EFR;*R[)3M//<ST=24?<
M-DAKYQ>29*<+9<_)SSC"W\T\(15/FLR-O_*C7=/T^?H8V#
M
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MMYM.AMR2^24NI-MX]-K.O/)YD1"=0
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M-.)P=C!IZBH@M'F3C7;=)9+.<CY=F_'5ZMF2B-JR[\HZ3[+18)T
M
M       &%YCQ)51RWQ1"T,7.CSVVS5LFR:C9<3S)]IQJUO1UIULOI)<*Y#'.
M%CEPO92__(#0/_G>T,@S5H-/Q-E=B:AU2B,5>/+HTIMR&X:74/$;*[)ZRLO[
ME<ACO"LK7PP9.6[+R_H!G]OZ!'_WF ED
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MFT+2VJRS,B2I[[!])1M
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MTDI&T=TFI1+1;F?<K<^PPKA.UN\,&4AN+4L_S'H/-1W_ .8- )?
M                                  :[\7I;E$RT.5-I[;[>;&$2A(?C
M+<\0[\H-+T-&APMMS2A?4LG$:-SH)1H<;V(&M_&'):;P]EO"<\2;E8S6P?3U
M.-.+:4T1U!"C(GFC2M)Z266HC+S$-D
M
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MYE6<<PP^Q$J#-3HTNF2$.NHUMJ-J4AMW29>Z.8DT
M                    !9K(NQ").%!@F.%W*1E*229X(H2CL7=1P6C,_OOS
M$IOJ,HFHC,C]_419PG(67"]E(TZXHW/S&H1ZC.YV5 :L EX
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MJQPJ4ZD4W+VLQJ13RB)1CK&9[I,DDY)IQ#4$$:C(OB60V@KEV)"2]" 3D
M                        @#A=IZ(^&,:3&3F-N2,S<8(<2]--V,:BKDY)
M+9;W%DRA1'8VS)LS=-P^QMF)_$"<*40FLO<0O-[WBIN8N+WIIR9/B'"=*NSF
M?B:?A,GMMMEM,D2>ROUB@$]@
M                                       #$\:56'3<*5J?4V5/PF*<
M_(EM%!=GF;)-GR)AA"EOFK^J1U*N>DQB7"F1%POY16+RX%H1%]A> 9Y?P+\!
M*$I#:D&AY"5H41I-*BN1D?<A%?">Z^KABRE\0RZV98'H1?%;2C_F#7HD!+H
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M8;0
M                   !KGP;/+D4;-EM1&;;>;^+S1<[D1_*&L^7]M:R_P!7
M[!L8-=>#UMM%!S+-#1DZO-W&/B2)XS-!_*CUN7[T?N5J]1L4$P
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M]DX?U\#4$C^TOD]H!+8
M #7OBW\9^;^6RF*>VZRC-C"#3[AH(S::.I-IUE[=>TG_ %K#80:\\5SLAC"N
M");<^<M;68N$&V8##[+<><\NN0U(2[N%K5I)&I)-N%UJ(UW0D;!W/W 7@
M
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MB-.ZV;*4$\AW7\0E&GK<T99EYF?BAO'&'.*JI,5N3E]EG#I>#:C-0[N(;0U
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MN6ZMDWC2:^=[&7N2)G <1-MEV;3YM?;Z7O\ >+]ML[W;3S[\N_*W^ K8O85
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MB+!%'0DDO-+Y-Q&FS(M"N741$9?15TJN97 38
M                    UZX+&HT7(IBDPI+4CY/Q7BMG=0\MXR(J_-41*<5S
M<-1=UJTF=RZ1L IHE>9)'>_<AKWP,T67A_ANHV&9U1B3UP*WB>&\]'?5(8=4
MW7)K9FRKNIJ]^:N8V) >3.HE/J:-JI4^++1=9Z7VDN%=2#0KD9'W0I23]TF9
M=C$<<-<U$C V((Y\]C'V-DJ(^?+\Y*D)<L7L()X26Y1Y85287RB2:AC/%TI#
M=382B5'2>()]VG$Z4J-=R49J6:CUFLKZ220"=P
M    $$\*T-3.6%;ES:;X9R=C[&;Q,O*1NM_YP3&B2\M"E$ZZ6DDZ];G8BUV(
MA.P@3A*FL3,&XN;8DR'EQ<Q\7MO)?0M*TJ569+B2T+0A+:]*VS4E'29W6?4I
M0">P
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M+1K]B65_XB[QT'_PI'T_UWU._J"K6#\IO;^8_F*_J*Z?D:SUN9?Y9@^G[B_
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ML\6AOF6E)E]*&6B:*Q$0#E
M                                      &MO",B/*HV9M3\$J+(J.:F
M)WIC;K2$K0ZF3LH26DMM5X[4="MK42E)<5K6:S,;)#67@P;;:H^;+K]*527I
M.;^*W%EO*<.6X<HDF\FZ$'IZ=&E2/U6KU&S0
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MIUI#JFEZ=:4&2C21V/3?5[#%>%4R/AAR<-'+7@"@K.WJ?@(]S^_F8"60
M                                      &NO%NN/\@97&\E3AJS7P>A
MM6F.HVW"J;1:CUJ(R,B)979)2KJ).C0IQ:-AQ!7%I!@2L.Y<O2UDER-FKA!Z
M/?Z;ORJTC3_<<</_ %1.]B]@%0
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M4IW@HK;'BI;A))<AW01:W5$E-UJNH])7/D0]H
M     !K+D4Z<SB:XCX#QJ1)8K6'75(:5J;)/R,TEI-EZ#U&@M6G;T).UUN=R
MV:&LF2[$HN+?B0:>:6B/+8P>[&,DLD2TG3Y*#,B(N:R-LR^)<]!-ER(B(;-@
M                                        /$K3K,:G5!^1">>CG&-3
M^VPX^MQ-K:4M(ZEJM]41MPE:BX7LHTJC)9+\QZ+TI*Q?T)HBY?M)ZOO$PDI)
M=BM<0[PGJ4]PO92+(E15?F/0B^*>OD4!HDGS]R 3*
M                        @WA->4]DPTMZ-"2X_BW%YJ3",U1D'^<=1YMJ
M+41E<B[K]"YB<A 7!_4)<_)%;T^/HJ'YUXP^4&HTI,A++OYP3EJ;2M-M=]1Z
M5?Q$^@ A'A6C0V\K934&"Y!2UC/&&AA>A*XM\15$B2HD=)6(DEH3TV(A-P@7
MA%HL?#>4CV%(,6<B%1<88NIL5V0T@CE--XBJ7.Q>7L9<R1S 3T
M                 A/AB=J*L(XI9FT^1$:8S$QJ4+<-&F0P>()]W6]/,DZS
M4G2KKUI-5]#B1--S]Q!?"@TQ^:V/3CMSFR5FAC,G4O)+2:_EB25V_9&G3R+Z
M1+/U,!.X
M                      LN?N+P'D5-#\FCRD4QQAQ]QAQ+*I*24V3AM].L
MBY&CW(1YPJIU<,&39*YZLOJ!JOZ_Y/C]_P"(S'&T"95\&UVF18)RYDFF2XD=
M@W=!K<6U8D:O?]H8?PK&9<,&3=O_ (7U _\ G?& 2R
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MRQ547T.J2GJ1I6[9J_JIHFK^II'5R@9?C\8_$&N4WMHDTK!,B-Z:D^&G(/\
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MU6UD N
M                      &L?!/";CPLZB2TA.[G/B\G+)(M=I+1%?WY<ON&
MS@UPX.)4&13LYFF&'4+C9P8O9DGS+6OQFNZ?MTK07^J7L0V,N?N O
M                !T9M/B38JX,R(R_&<*RV76R4A1>QI/D8[PX5N$CS<_O
M17PL=7##DX:N9JR^H%[^O^3X_P#O,2T(DX3WT2>&'*)U)%I+ M!(B+L1> :Y
M?P+\!+8#P*_345FA2Z&^X2&)L=UEPC)IQ1-FV970E1&E7?Z0P+A042^%_)JQ
M6_[G]!_]H(PRC-&9#@Y?8KJ%1.(VS"HDN4_XMY331H0TX9[BD=24<NZ>KD,:
MX5DI3PP91:2(M.!:$16]"\ U_N+\ $L@
M              ((XJH2IN$,&+.*R^B'F5@Q<AQ;RD*9)5<AL[C1]TKU/I*Y
M<])K*]C,3N(#XM5S4X6P U&IRY;;^:.#DRT[YH3';^5XO4HNSB=6E.@^5UDK
MZ%Q/@
M                                       @SC%D2&^%+-LSC%,(\'UD
MK+L1%JC.W/\ \67XV$PTN%#IU):A4^(S%CL(VVF66R0AM/U4I+D1?80B/C+D
MO0^%+-MY4/Q:OS0JK>V2;V2J.XDE_P"I?6?L1&)<IR73I\1*EJ?NPV:GKZ=1
MGZZ0'I    UVXI6XAU_(5-0>;2T6:].3J:<4E1_Y+J9-%<O0U'U>Z;D?(;$C
M7'BPEI@UK(0B>0VE6;U(;,C8U\E4^IIL7MJ+E^R0#8X
M                                   !K?DQ'-OBSXB'7E5)>Y^:,MK6
M1'%0RJE.-D3-^:5:FG=6FU]2!L@-8\FW5KXQ>(EQFONRXK$3".JGFG24!?@'
M[*2HUZ+*VU&=BYGW];[.
M /(GO5=J&Z[2&8TB0R1[<>2XMA#I_M.:%K27]E"A%7"9">C<,.4[,BH.RT?F
M51'2==TW)*XS2M'9/2@NE!]]/>YB6W5:&5-MOM-N(:NG<3=#)V]5%:WXB&>#
MJ@PJ#PN950XJ8I$YA6F2R)E+B;N/1VWU<G%GUG>YEVOU>7D G<
M                                !K;P SWZUPGX2JCK)L%*J.(W'FW+
M[B2.M3BL?KJ]S&R0@KA%VW<DTK3\F7_._%[9-TD[0]2<0U(OT?5:[>DBTEZ)
M(C[B=0 0]PROO+RVK+RW6?#?GWC9<=;9ZB4S^<E2Y\A,(@OA+;V<H)),*@*)
M6-<8*3X%5XI(_.2=RCGW-CF?,_M 3H                          *6+V
M$+\,ZG#P1BRY*5HS%QKMWN=O\X)YV*Z/?GRU\Q,US]Q"'"M)=JF6-8J+L=4/
MQ^.<9OFRLMN0T2L1S]1/)5<B6DO8!.0
M                                           "EB]A4  >/5YU/HM.
M?JTM:_#P(SCCJD-FM1(07,D)+Z7W"+N$YZ<7#!E&4B.ZG3@BALIW20@R;**R
ME"NA:_,CJ+WL6K1V$GUM[PU,E&NI_)RFX[KBIA)1IC]_B:5$9*Y^AW$:\)KK
M$KA?RC\.E\D_F-0DF3AG>R8#2#+GZ7O8!,@
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MQ7O;F.YBH  X
M                         !K!P:1JA3SSW1.D(<U9UXCD-&A7)"'$QG-)
M<^5C,S/]D_>XV<&N/""]3WF\Y%,L1(Y0<W,3L.J9,S0M9N,.N&:G+J,S4OK]
MEDHBY)2-D+%[ *@                       \&NQ*I.H53ATRJI@SY<5UJ
M%,6C6EEY36E#QE?L2N>D>\.L]\(C-E!*-1W/UN8"*.$QR*[PP91%#6DT?F-0
M+DD[<R@,H7^!W_>)@$/\)4>.QPOY1DRPVV7YC4,^E)%YH+1J[>Y\S]S$P /.
MJ4*+.B2:9-CM2&9[:V7&G4$M"VU$9*0HCY&DR,R,CY'<1MPGF:N%_)W5SO@*
M@&=_4_D]D9S6XE5J%&F0J75TPJG*BN-0I3C>XEAU36E+QMD:%6)7/21]Q@_"
M>1?S8,HOLP+0B+["\ T ED
M    ! W%7'D2,-X%7'<C-DWF?@]Q9/N-(4O_ "S&21-FX1ZEWOR;TKT7.YI)
M33D\B >*8Z2>&\!+FOKC/JS/P8Y34/J?(I,CY7B(-!$E5B/94XK0Z2B^&I6C
M4DG$3\
M                                        (&XRVY:.%+-DX5<:I*RP
MK4C.2\39DIG9/=CV<29:GFM3!?3NKI,E6,3>ER(\SXE"TN-K(B0M'H7V&0A_
MBP8=D<+^;B$OO-+_ #(K):F=*5$2(3JS3\2_)22(E?LERYD)?AQX\1E,>*PV
MRTGRH;224E]Q%R =L   &N?%I49%-KF0<EIG<,\X:2T:.Z=MV#4D*5;W2FZK
M^AD-C!KQQ7-)D5K(-M%B/^5ZF)O^RBGU(C+\+D V'
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M;(G(+'N--,F0LU.ITUZ<A1K)7PR6:B69[1$W<SY7,[A.0
M           ZDI\HL94A9*=:279!'K$#\)N(_EW">-81R8RETG,K&4=!-H-#
MA(567WU%(3:S:S-ZW.YFFQ][B?TH2CDA))^XK" >$WPJL,9AMM,3D'_*EB]3
MART)23CORO)/6Q;NDK)1S_6LO'VL V"
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M9LUAEOJ6FVHW3:.]W.2CT]A]"VE-.GNLO&M/V*N0[F.8  <
M
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M49K(VS_,>A%8CMR*"U8_W_Q 3"
M         @?BK>>@X8P1L,)0<[,[![#QZ-9I;*M1W25?TLMM*OQ3],[SP('X
MH(<:1@?"<@GR1)IF9.#%Q653G&=Q9U^GI-MS0?66A>O2X2BOH7HW$MJ3/
M
M                                AKBS8</A@S;4:R+_ #'KA]*TEV@.
MV^AZ"5H3Y/PFGV)+4DG$(6TZCRK;7:ROMY",.+%TT\,.;1>(::)6!JXV1N'^
MM5"=2@N?N?(9UA"B1\.8<IE"C.J7'IE.8A(<,]6M#:;:M2;)O^X!D@  "TNX
MUUXNG519V1TB(=WD9P4)*2(^=G&I1._^34K]QG[C8HNXU@XQINSB'(&)$==;
MER,WJ%*:(H:W$.-$E]I]"W"Z4GM/D:;\[-J_<<RY-H0  =
M                                    -;<K78[O&)GJQ$J<9S9I.$52
MV$Q4FZB0N-+-!;EKDC90?(^1J>69;9J,W-DAKOEE%4SQ>9[NKH35/-^E8+),
MELR/Q[>S4"W%D78]1.,\_1ML_0AL0
M          \^>TN1#?)E2B>-HS96T>I2%&1E=)GV/GZ").$68B3PQ92FZ;ER
MP11F"/PCC-VD1&B0?49\C+L?TOHV$KUFIT^E4U^I3YC#,:.TMU;C[Y--DE/>
MZCYV$;<)A2VN&#*3QCS3A_F-0;;?MX!H!+H
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MQKWPG46?1J%F3*J,VJ+;JN;6,)K2).I+3;)U)ULD,WYDW=HUD96(W'%V\QF
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MSVG832T7-9K/I--N:S-7WG?N/)RD(V\K,(QW^C31822+V(F6R(O^P9GK(^Y
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M:K)2?V\A%W"4W;AARE;*1)>1^8U$<UKL9ZS@-71_J^A )F
M                             0#Q3NT6-A# C4TX")2LT<%L4MJ41DZE
M_P"6X]TQK<D.>'0\5^7P]WZW.?A!_%1&HKF75)G5EEM3%+Q]@N4LUK42"0>(
M*<@UK0GDX6E2DZ3(^1B<
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M/($YMCP  4H
M URRF:3_ #R^()UN:XZ2J5@G62EF9,J\/4"VD^Q64VNQ<KK,_4;&C73*AAV/
MQ<9ZF\JFIWZ9@Q?Z$O4J_AY_])OV?N1EH[[*8QWTFE*=BP
M                          '5>:C26%QI$=IUEU"FUMK02DJ2KNDR/D9'
MZD(0X-8T.-PLY4*@.59QM6&:>=IQ/-N$>UJVRW22>VE2C0T?931-D1K21+$L
MXDJRZ+A^I5>*RE_P,5Q\FW9"&"<-"+Z#=7TM<_I*$><*3S<KADRD6;#R5IP)
M0(]W8YI.Z8#5^Q\BN1?@0"8P
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M9^/\;:V=TD_HSJ=.C>YI7M:.H3CLI*]D)ZN_+N+"AL)42TL-DI/,C)!7+O\
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M>,UPN92):9;;+\R:,NR6R+J.*US^\_?Z7T; )J
M                     0MQ+T]Z3@:B)9G2&]G,'!+ZDI<,BT?G)36]/?M;
MK^_F)I$*<3;M09R[I;D.,\:E9@8+0>VEM1J3^<=-,O,XGD:[)M[GIL2>H36
M
M                                 (FXJS6GA?S;4Q=2OS!KYD?J?Z [
MS&8X#DKG8-P]43IB8:Y=*BNJC)7JV4J:19)'Z$5SL7WC >*N-.7PPYLLQWY*
M%%@FN&1,IL9DF*\HT]25]T]/[1=ML9_@=<=>#Z(N- <C,'2X_AXZTV4ADFF[
M)67UB] &3@  +2/F-<>+TXSLC)&),IK\M+^<.'R;2VZ:"2ZVF0Z2_3I0;5[>
MID-C1K=Q;K:9G9';3!+_ .[#0&T'K5="B9FJ+G]6UR]K';L#)TT;*   T
M                                              !KQE?#>B<7V>3S
MKJDHG43!;S6IY#Q*3IJ:=)$@BV2U)4>A=U76:[Z5I(MAQKYEM/;3Q=YUPSJZ
MI;S.',')V=&DXR".JJVR49?$YN(7_:?-/8AL!<_<!>
M                     #PZ['HJZ--+$C4-R N(;,HIUCCN-VZTK2N]TF7<
MC([_ &B*>#R++C<+^5+<U^&MU[!](E(-B,3>EE<1K3R*W58_-Y;>@FA49MPU
M&3:>LC)7(NHC[D?N(5X-=;'"GE,F9.>E*_-.G/:W5D9DDVB4@KJ<<(M*2TD6
MLC(B\C?D0$Z                                           (#X/\
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M[A5IQTW#>/9.]%)R=F7C.4M+"=M2"^6)#9;E_,LB:0K46A.VMGE>YGL"
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M,^22[GS/\1U5S(R5V.6CXCNE/Q2MTHUG;]Q<_L%4SH:BT'+:OVZ7B4?EU?\
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M:?%5";+"5*6:+:2W51K./\CM9Q9J42?0U7 3L
M                    B;B3-)Y>T@C27_?_ (%_CBFF"61!W%@S5I>4,=RB
MR'DRBQC@]<=*"2DS46(:::3ZC3S)7,OM]A.(
M
M          B3BK0G^:_FVO26K\P<0'>W/G =O^(SG!Z%1<*T6/X^9-,H<='B
MI1D;[Y$T5G%F5R-2K%<S[^HPCBK_ /@7<V__ ) *_P#^T#HRK+Z&J-@+#,2+
M#.*S&I$-!QS=WEILRBS>I7>WUK@,O   6#6SC*F^"F9"FFMN0E/9SX=9*R#7
MX@E)E$;7[-R,R-7MR&RMB]AKKQ<K@,/Y-JGQW'27F]AI"=!<R-1R"1;["5S5
M^S>_($YMBP  4H
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M%741V,R.YM>5L_AIZ.H!.@
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MI]F'X)'YN14;&\3Y&I!$1O7]#4I.YI_5[FE7E$_@
M                    *6+V'S>S,FSF^&3C#.J_*+9'F9/:82MQIQ2DJ.E)
M;(KF:K*2LE']1!D3>DR,A](AK7B+@/X<\25[%>(\180F2'\75==7GMM524S'
M>D.)09FIIE1)4?B$*?N9>9YPKZ%&V8>A5<V>(R+/DMX?X19E1A-QD.0#<QK2
MF%&O4E*D/H):DM$5G5IVUOD:%L&K;6I2&Z)SNXB7C/3P<XG(DLI<=(L943J=
M4ZE*FV;/\R)*C5J7H+I<^J6KL3^#C(>K5695ZCAVKN2ZT:CF*/%%5-2];"F5
MFLSD]1J1M$?NMM"^Z2,6'P99!M+:./AS$B"8A/4PR3B^M&?AG$(UM_TJUR\/
M#TJ[EX9BQEM(TA:QG5Q!MR62F\'>)FF2T$\J-C.A.+2>HR7H0J4@E$2"6K4M
M:+J22>W6.&-G?Q-;3R9?!M56EW>)FV.*.I*C(^A&HGO,OL7U5<E:$_$%S7!=
MD;$J/RI$I&*6)<N.]$D26<:UA;LF(\MQQ<=:U2C4E!.NFX2FS29+5>^E3A*Y
M*9P6Y(T<TE0V\:TF*508FM0X6,JM':0;+6TRE*$2221(\Z5D1.I/F2B,!1_.
M?B07 :?A\'=;.4<C:=0_C6D,H0VF^XM"B6HU=NC6A&KKOHLC7<YG7Q %XIV-
MP@XIE+9>,V4'BZCM*<21*;4>A<A/2:F^1]C)Q*R(SZ1?+X.LA:E">IU=PAB*
MHQ7X[4)R/,Q?5IK:T(/<:NEV49&MHR)+;A]2"L23(N0X'."KA_<G)J<C#.(U
M3$S&IY2$8PK3#A28Z$MQ'M2)9'N,MH2AI=[MH26FQD [43.C/]QV.Q-X3,3L
MJ<FQFY+OYUT#9BQ5(N\YJ\5K6ZDSZ6]&E?UVQU8N=^?U0PW#JD/A!Q:Q,E1B
M>5%G8JI$;;=<<TMH,U2#<*S74>XV@]?3HOS'-(X+^'V:TEF3A+$9-H<0HDEC
M"K6(TM;:E6\3W<1R=/NM?6JY_$'5_F;9)VF+F0<9.R*HK3594C%U5W*F;D;9
M-$E:9-WC))E92S.WS9+TW(!ZBL\,Z/%DTGA!S -C<D7<*O8>\I<V%_\ *&FS
MG/5U_#]-P<B<[\U/$+CEPFYD:VFT);_RK0C2MX]OIU?*-K)UN:E?L#K/\*V7
M52F2'6<19FQ$RVD,&EC'U;3M,I:-M#:27(,DMI/XJ3+F:RL?3\,41PE8!*E-
M4S\\,UW$L1UP?B9@U=LR87&V5\DODT9J5\<STW-PSOT_# =IK/'-U4=MY[A.
MS!2EUTR<-NJT-2D%XK:+I7-3^JL[]_3V^*/.JO$)FQ#DOE#X2LQW4L$:E:ZC
M1BNVV3*G;:)J^HD//F7]8IA"$]3EVZN<)^7KTUR;,Q=F1,>?8-I3QXUJJ'-1
MM+9*3=ITCW4M?!(N2%MD5R<7S'J,<,^7D!Q1MU_-):G5$:C7F;B"ZC)!V/\
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M\98.54X6!*R_3\-TV*<W=;D5%QA$@XB$REQCAQE&VMHU=;25.N703071LV,
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M.J:>_P"3S\_XCT)9J+,NC-$AXDHH-3TGH3ME\:#V5YO0983>DB))$1)[$7H
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M#8)5N9IU$2E%H</;(ST7&P(
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MBU7^S2A9?<9@-E@
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MU-F>S'P=224X<Q,G5(1';2ZFY*5S;=2X@_J*1I38BL G$
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M%VGI#$<UML2:EM:WK?,ZD-K_ +W,8/C2L5F%CW!LJ%AR8_5I;%4BHC%*CZ/
M[!.N+>5;X:C>9AH2:-?):R]P2S2[=!<R27N!F@^Z2/MZ>W81RUC'-=V9MO90
M&W$OZ5UCQ'S6KRVT>?I^<''^?V:G_P ).9_]F8GKY?I>GZSV^CK!5)A$1=B(
MK\Q;J3R+27+M]@C=&8.8[T,WF,EZVW()TD^'D56(GDCYWJ0M?^I_6>NV./\
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MY<QL)XVFMS:M2ID!AE3Q1UD_(K]#C-.*<0A1J2?BFT*3MKLAI:E(<-1W[_\
M([QIO.,D]GE ;A.QG&G8K-4>4I2R4TI"D2/"ZR-9H6Y?Z)*-'S9FD!M_K(4-
M23[D--9.0_''.@(I58XC&S2VZR:I\:HFPX9)-Q*B,F8C1\TK94?VLJ^L.5>3
M7&@F-,4SG?3XLQU3#39HQ!+DM.(+JD*,EPCV#U&\DC01<B;+HL5@W#-SF7,Q
MAM-?:5FSB-@GCN6'Z&=B/WE5+_$:[*R?XQ];IR<^(/ATRRGON1JPXT32E?T@
MOB05EH1^J8UH07TR,>;PI3L>8KS,S0IN.LQ*I4:Q3H=/I#TMMYHS:?B53$,!
MQ36EE#;:5*82ZC4WS61)5R+06LMZ\3<\E)+L0:D^P\>1094A*-^NU)1M]S0^
ME@C^_0@AU&Z;-1$4TO$=2-;L4VDK/1<G.OXI?#^<[=';EY!C61ZD^P;J?M&/
M-T*<@KJQ-53ZK6-:/;_H_P!WW_W1:>'IY.27?SFJAMNO[R6MQ!(0A3>V:27M
MZB(N:R*_)7/[0'G96R')N%%/*<=01SYZ5)?OND12G2*Y*ZT_<LS,9KK(1?EQ
MAVHNX/CD[7JTA3,F<39*=;<4XPF9(2VL[M\UNHLLS[D=AE'R%,<5,<*NUI)3
MSZ"W[%&*SOS71RYJ,^NY<F_1)-@(\K*JJKBUP6J5"C1XJ<O\4$T\4I:GY)?*
M% W"6C;T-D@S*QI<7JU<]&GEA7%]\D4NH9=XPKT+Q%/I4O$R9D<VR3XIA6%Z
MLM2/$+N;1FE"B/0VN^L_1M5_7G4*1ASBZP15I-<FU-=6P!B>,UXV7J4SLS:0
MM+3+*4(3KLLKF?Q'",]9GM(%.("GU:OYH9.T9*XZJ7-JN)&Y4=]2%DXZK#\]
M#+VT;2T.)TN.)5K+01.&2DN:TV")_P DU*==X;\0%-DH>=1CF;N+;=69F9QH
M5S,^_-=S_LG[#>0:*_D@I3LGA@K3KD=+2EXSEI4I):34GP$'K,_4^W,;U
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M!^-";X3LIE4JD2*?&/#49:FY#IK<4\H[N+._T7%_$3]5)DD!L
M                                 @3B\G'2\GX]8^43B)IF,<'S2?)!
M+\.15Z#\1*36DG+?548GL0YQ+J@NY;4>%,61E*QY@N*2%G<GKXEIR3)1?2Z3
M,^8F,
M                                       15Q2.&GAJS:,C,O\ ,*OJ
M_P#R!T>SE!*8F9782E1W+,O4.GK3^D^*N?AF[&E\_G#[=1][>@\/BJ6EKAAS
M<49%?\Q:Z5__ )0=&5Y;K6>7F%7&5G))5'AW>OIO\)OGI"G0,M   !KQQ>OH
M9B91N'YEYP82)L_5.J2:3L?I=)J(_L49>HV'&M?&(4ER-E Q&C^(;=SAPJA1
M7TFTV3CB];:_4]1$5S" V4
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M:S:;9U:WW%I46CZ*C/42CZE>9>E=T#8T)@
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MJ$/H^\DCDPF_+?Q%C2,MQ@]JOLDC:Y';Y,A+^(9<S/6LD\_H$1=@&<
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M,^>V2R6E!=B1H(N1$ V"
M   0WQ*Q4'E_1W7HB34SC[!+K2K(M'TXCII&YJ5V*UR^[D)D$*\54:(_E=!3
M5J5'J,%W&6#&)4-QE+B7VE8DINIM:3(R4D^=TF5C$U
M
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MYCB")3#3:+?IJN5OH$);
M 6ZR$'<'=-F4GA4RFBS*K4*DI>#Z9+)^>LG5$3[*74-D:?U2$.;;?J3;:==S
M(3%)3,<CJ;AOHCND7ZPC=L7W$9*/\1"?!8^<OA6RG?.?XA)8:AI21:4\D-6V
MOFD=2.U[:N5E..FE3K@3Z
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M,!4          :T_E#7&H_")BUY]*#;:GT U$]R(_P#+4+O8;+#6_CU<IO\
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M1:]77]M_U3O]P_8[\!XDH:3)M==I[2C3(<,CEI5\)@TI>7YOH:F]1_1-7/N
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M'<,B/N0:4WOI+\!USF0T,:U3V]'US<3_ (C@14(CCUFI[:CU[.T3J;Z[JO\
MOZ5]/[/V ,1RHG3*I@EJ;*@^ DJJ-22Y"<ZB:M.DEMW^[E?V&>V+V&"Y;38[
MF$%.RYL4GE5&J.J5O%MGJGR=)=_)[%V&9*>:1WEI[WYK+^S_ (_Q 0MBZ<Y$
MXJ\LVFG(QG-PABY+QOODDR,I%",DLV+J61)OI.Q:5N+[$1'Y'$PXS%QAE#4)
MV(XD&C1,0UHIS4J*3T8S_-BK+3(>4KH2AI#;Q&@TGK0Z9ES;3;U,2F],XL<
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MR
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M?U] [$3,_/YZ(3[_  N3$/<NC\\:=Z^7U]/I^WT=P!-1D1WN7?N+=9>PB/\
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MQ!/!D3!\*64JH=,7"8+"<%-ED1+-1(+6KWTN*^*1>W(!/(
M                            #7_A0;5_)SB>>5>BUA$[,#%\IIZ*QLQF
M6_EJ9<FEIMNMFO<<U*69_%-&LTH3;8 0=PF1F(&650@HA,1GTXWQHEYN+'4T
MRIQ.(9R3-%SMITDDD^Q$1<K"<0 0!P@5295,H9$F=/IE5DIQ7B]+LNCHTQ9J
ME5^<LWXY&XJS*RMM]:[%R-8G\0;PN^&>P%B&:RYJ1,S!QK-;4U*)Y#R?EV:C
M<)1$1H+]GE_$!.0  #7[A,=0]A/'D1,PY3K.:6+TRK0W(R&WOE=]S2A2C/<*
MRF^LCY*-2/,VHSV!&OW"8Q66\#XU*LR&'&G,Q\7+;A)=;6U ;^6I5VVE(2E6
MWK)2[.(2YJ<6KRJ21; C)@  -                 !JYPMMQ:A#S,:6HCCN
MYF8NH<G0V:]9%5)"B8/;=4;9$;KZ[FVV5I!'Z$:]HQJUPH4^AMT['\0Y$F?,
M3F5C1VNKDOMZ7I9U#:(T-))"32J,BW:R5$\0#T>! \0IX3,OD5J4J1+BQ7(K
M3SAMV..E]S:3T^0D-$3)(5=2;=5^XV1&MWY/@DHX/LN4(?7)-N'(2@]*VR)L
MY;IH06HSYH2:4'S[I47N-D[%[#)BH  T          ?.3@VR)P'Q68.J>??$
MNIS,7%]8EHB).K3-"(33!NJO&9CJ;V6736H]HVVR/96JVE9WS/A/WLI>+W-_
MA9PE5ZS+P)1:;"K5/CU*6J0=-DNL175QXJS-)):64PS]#(F4V))W6O(,7_D^
M*-&QC5,6</N;&+\EV:TRAZHTG";[T:#*E(U;:TLH>:0BVM5FK:.H].W<Q)W#
MAPP8%X=Z5554Q3E6Q?7WUO8EQ//==7-JKIOK>-2C<<<-)))XB*RKK4:5N&IP
MU* 3T                             #23.*54<\.-*/PVXIQA7X67]-P
M(BL5*C4Z6J(=3EKEK2IIUV.I*EM/,FVA;3QDDD)6:";5\4>!CK+O W [FQE'
MBK)K%DZC87QQBDL(U7!$NM&[ ?8J"4;E083)-9M*CJ9B&XX1%N$4=*EH(W%.
M3=Q%<*<'.^JT7,#!.*967V96'9K1Q,70(FI_PY)41M/-DXWO((EI,B4=KI4C
MYMU9*Q'+?@NKT+.[^6WB$S7EYMURBLI9PVB924Q8\!=VWO$H92X;;;J'5/[:
M4E9)*0I-E(+;#;H                       '78,SBDHSN=NYCL#C))$6D
MB(B]B <@  #5OC7SAQ3@&AY<X"P7BIC#]>S/Q=%PL[-<:D:H\%]*V9#[+J#2
MEIU"WF#)1N$I/-2-1IN4<9C\'L3(7+NL9WY59N8Z@9@X5IDS$53KLJK/3U5X
MV6'I#T=V,ZLT*2^\:75)41DHVB)6G5K&Q_$#D3A#B'RUJ.6^,XY%%?44N)-0
MA*I-,F(2:&)31&5KEJ69]C-"E(/D=AK@YPC\8&9.&\/99Y\\3$.M8+;<95B%
MBE17HE3D16XZVD1_%)3^E$:T-N+-SNM2E'K-*+AM?E!C:9F-E5@_,>9$1'=Q
M10X%3>B-NZDL./L(6M)*_949D,\&-X4PAAC!&'8>$\)T9FDTBDMI9BPF&DH2
MA"?*E)%R(B]"+V&2                            #6O\H'#D5'A5Q93T
M340EU*?A^"3ZU62RERLP26I7[C,;*#6KCTC0JOPR8@HLI27TU.KX=C>',R(E
MJ.M05F1JM]7OZZ>?<(:CR*'+GU+C4PY4DI:9H*LI*DQ!4@B2ZEQJM04O,.)+
MFA;)N,MZ%W-)I5S-5S&U)&@BL22(O:PTAF5K$KW%SA:LY-P\.U&LR<N*I2TJ
MKU3<B0C:C3H"ULLICMO*0X1D9);-LM"'369N:=HIWE5?BV=B&Q#P7E3$D[C9
M[KN(ZD^R32O/S*"@S4W]NC7Z;8"9]23YF1>XH6T\5C0E16,N97Y'W$#$_P ;
M.WX'Y%R<W-EY7RB59J>W=36EHMCPM^ASXBOB?$3TEM!XOC2CQ%(.AY13'7U)
M)A3-4J*#C:6>;CGP?BDM\O*FVA)\]R_0'K88F,O\4^9R$.-*.)@;!["R)=M"
MO'X@<ZSMTG99'ROT\^XF0S0KS)(^Q\R]N9#12KYY9SY6\2>**=/PA@_&&):W
M2<,TYR%A^;*8?2VV_79*4(:-AY;[Q1TN/+-"")"$$W\55G!WX_%5Q4)I$IZL
MY+(@36(\A9MM8=KLEAF0VZTI)..(9UN)TIDDK:06@M%[@-VE)966E;:5%>]C
M*_/_ (,7*-"O,DCM[D-,)7%-Q9L^)<9X=$+0V>DG#IE:VR4C:W$65$0YSWRT
MJV_U2[;EA<KBQXEV6]U?#;4W4.^+-EYRDUF,36B+K;WT^$<VKN=/._U>_P 0
M!N66RDS-+9$9WO9/N=S_ (B*.&UTW<O:L\X1MD>.,;E92M?_ *=%3$-_SIN(
MF6=5)[ALJ-*33HZ9AHDM50DOF@^J.B0B M.IX^A*C)&UTJ/<NYL^)PN8VXH,
M;Y+P\8Y98>RM.@XCKN(JQ$=JM;J$=]"I5<G.N)4VW%67SRC)OU))Z5H,^8#=
M@U).UTERYE]@M4EEN_PT]1W/D7,[6_PY?<((74>-A-0E_P";F3/@6K[/^5JI
MK7;W/9Y:O7^J]-T5;JG&<_*2N1@_**.AD]N21UVJ+):/A?&;_1K>DCX=M7S7
M7S4 G<M!6LDNDK%R[",N(Q,U_A\S,;@.-IF)PC620XLMI*3."[SNJ]ABJ*UQ
MBTUM3M1P1E=5UH*7=,#$4^*IHS;;\.2$O15(>,C0[JUK1\\B^@FU+<\O,B5Q
M-8BRDQC2:_EUE?!;JM+GQS2O%\DSAQ'&7$_%W:>3*U6Y:E*0BW<@&=\,<=MG
MARRNC,(TDC ]!2E+A7(B\ URL)0^']0NUNWI[#0C);BVS*@93Y;4[!V0U1Q9
M0(=%I--54J:=6DD\AMCPYFAPX!)/0MAS<MKT&VXD[F6X><1N,'/PTE'G\*&(
MS>*Y>(B1*ZIOI\_2=)]?H@-P+HN9Z2N8I='U2]/3V[#31/&7G='DQW)7#;6I
M5/E_*$EI<2%7&U1X3+;9LNK6[332\:[GI-):3OU$CEKNB\9N<#T2/44\.]3<
M@RY#+:);+%>6R>X[M))M9TRSIFX9&FQ$9^0T6^( D'BJIK=5Q/D+!6\IIO\
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M:/\ ODIOTD]0F$
M                                                13Q2_P#P-.;2
M?3\P<0<O3^@.CW,G&R3D_@E*2(R5A^G&HFNHC,XS9F?5]O,>)Q2__ U9M?\
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M$$S<<0I6HS,RYFDU]P.Q]6@
M  >1/>JS426[2&HLJ0P1DU'D.+;0X?[3B6UJ3Z^5"Q'?"DYO<,64CE^K\QJ"
M5_6Q0&K"4G$*;(C:(UV[$?.PAKA!K$:H\*^4CZ)$19%@RD1K0Y!.EN-16FE%
M=)%99*(R6GLA?1S,K@)N
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M(B(K$1%V(5                               !9M-<OAHY6,N1<K=O\
M$P)EDBL32"+EV27H=R_CS%X                         +$<^XO%B %X
M "FE-R/27+MR["TVFC7N&T@UV,M6DKV.U^?[B_ A>
M             -:N.^7'@<.U;J$E#<IJEUG#DMZ,\P;FMOY8C)(FU)YDO6G7
MRUG9O3HLJPV5&L7Y0>2] X4L0UAV.B7#IU6H#T^GJ3N'(:*LP3-DM/K>W/N
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M)6LFD:K6O;G;V$QC3=!KJT&B9BFI.F;#T8S92RV9&>X27>1?.EJ38_)TE\-
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MOZVN)\&N? ;#G4KA%RP9J2VC<.BIDDM!:[,NN+=0@S[W0BS9^QI^P<#8P
M                                       !$7$Q=G+JE&PDE&K'."K_
M &_YRTT2Z((XMI-0B9.MU.F368LF+BO":VE33T1D.E7Z::5/F7-*2M?NBPG<
M
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MM>CQF7DQ\<T(U$V@ERKG*;N=E<OG3-/]@[=@/PWW$ <:%$OXA'TCD H
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MT;JLOWBU$@KV3/@ZKG['NM7_ +*@5I[-]4P  2
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MR\827(#TA#QTI15N4R49"$\DI4EDW3-5[K><5Y;$-@PN
M     -2^%: T\K,VF%\FT]Z3FUB^J1Y++R')CTCQSK2GU-.D:4*:(F&;DA:3
M(RY:K&-M!K#PHLII\',U=/4;DNH9LXSDN,FXAIMQ;=16T:S-LN1]<="C7J46
MC4E(#M< 91$\'66AQV6;G2'5+-HFUW6J0[N7-I:NHU>9)GN$96<2E=TELH-;
MN DI"^$3+-O0[&3\CD1$\DE'_273Y7_4F@B)L[WT'8SU<QLB%P
M
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M*"J7 7K-<&.K=+2N[23U%SY'[]S_ !,1SPSH6SPZ96(E+4A\L#T)M]!'Y%^
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M;=5K<26MQ9.K-"+(*VX:2ZVU(/;TDI([DDB.UNPH;;:B41H29+*RKEYB^WW
M:H)XB.)%PU3E<!F*36:V&ML\34\RT*.2E:BNFW);*2+W2XA:]"5-DOH5'B2S
M[K5$G0J?P09ATNH.Q'SI4TY4 RBOO(4VV\1*6C2LM\M1%SL;GN8V]-ED^1M(
M/E;REVM;_ $M-(OI;26H]1V+N=[W_$!J3P,P<0X&RXQ11,78#FT&JP*^QO4Z
M+3'67$&BB4]M)V,]+RW"9^A\,C(NUALNYB.:F=X!.%JP:CBNR">TM;=TGTHO
MN>8QXV#%-(K6/5-I<1KKB3<L\;FV::9"O8O0[G?2,X-IH^[:3ZM7;Z7O]X#&
MF<2R_&DF319[+:YYP4'MD\2_G/B='S2>A!W7RZB][BQ>+I3<*+/*@5$X[SVA
MU9MEK0SX7?WM/[M&GZW(958O85 857Y]7;H\UB)@URMJVW&_ K)ME#I:VD&1
MFXK0HM"W%V-1<D:/,-%>&G'F>^2F3I-T7A'Q9C2/5%46<S)5/C1T.M'1X,99
M%J):U&2H[VTE#9-FVMLC7K49K^B[QJ;26T6K[#YC$LFF].46!R<0EIS\W:;=
M)<N?A6^0#6E_B7XAUO2$,\!V+&Y:4^)IKOC(^EUUR,:&W75*;03*B9)M*FTN
M:]3ILWZ%7]"7Q%\2T0GE1> '$2D-*W(AN8BIR=1MJ-MPW3;)9),V.23*_46G
MR?$&W)(07,DD7[A6Q>Q -2F>)KB)0\Y-F<#.*TI3N2'T1:_'5(3':<:0W<E-
MH)]6IQPR:;-:B2FXC//7%F?&:.),JGZGPMXHPG1<!YD4RMU-SQT64Y(;;D)0
MWX9*++<(TOF729=;GND?0&Q>Q#"LT6K8>C-)AMNMN5ZA)6E22,C+Y5C<C+]Y
M_B ['YU+.I(@EA_$)/N1MQ]*H9DW&2A;>LC=OMK69/<MI2_FU6/I'=DUQZ#!
M749M*J.VAB[K33>ZX9_#\FC^VOM]4_89 24EV27/[!30BY*TE<N1';L \1NM
M*;29OTFJ(/X!6<:)P^O_ *+5Y?I#C>KBVO![5*JB_$ND1WC._"3NH1=?3R+2
M9JY^QC("2DNR2+OZ>XH3;:=1I0DM9W58O,=K7/WY$7X -(^,IO%]5S0RQJ^&
M,L<5UY%";DU&4Q3(IN+DQV*]0I9(1MFHT*<3!/OH,MUOZRADT;BJQ>U4)41/
M!-F:T;,9R0PSM4\IKD5+B6DD;!O(,S)2$?"2:U[2$N^4B4-AJDVHLW,/N$9D
MD\/5GE[GXFFC+B;,NW+O_'N U81Q8XBBRH?B."O//P[R4F^N+0H4A3;J+:6C
M;2_I(BU-V4>BUU_U:[]3^=IB,E[D_@HSD8V&".>9T.*O8/D9:#W>OD_*[?61
M]=>WMB3:"[(27[OO_P!Y_B**885;4R@])6*Z2Y%[ -3?YWF-=ZQ\%.<Q26HS
M;RW"I36DW#V=]%[_ $=:K?7T(UZ+JV\9X/:CC"-FMF;6JYEWB&BQ*Y37*ZPB
M?3CCK(G,15Z2TV6HSZC;G$7W-J]ANSMMZ31H3I.YF5N1W[_C<_Q&*4^G1V<Q
MZS/-9:7J-3&$%[*0],N9?;\?^)@/2>KKFM&W2*B:3/J/PSO(MQM-_+]5:U?Z
MICKMXE,C4<F!56"(^RX+CIG\5QK]4E1%S0A?]E9'V&2FE)]TD?[@TI^J7/[
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MW&->^!>.N%PG99H<2V=J,:B3&0I!:#><-1'N.'U7YJ]C,[ -BP
M                                $'\6$=51RCC4Z-!:FR)&+\(-(:DH
M(VS,\1TV^X:N1H/U(^1B<!!W%WNO9'OM+9NE6*,(Z2)\F]V^(J=R)9K02+]B
M/<+OW$X@
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M:U9/SWH.>N4C:62<;+'=%BZ5%<BURFK<OV/3V] 'VR:;VTZ?3V'(
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M7!CLX)J+\^[$<F9Y^+A-^&-1DYI(G7$NW:<+FEM'8G&S*T]F^L@  )
M                               \V43[D53<5XX[A%RUD;ID7W),E'^(
MB'A(?JY<,&5!5.:T9+PA1VVR;BFC2T4-LB5S<7S+EU<D]OAH[";U)2HM*DD9
M>QD(7X18SU/X6LI&CD+EG^95'=(S/2>A49I1)+[$$9%]H":0
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MDVTJ,U%<;%C)@  -
M                          %CB5*\JC+[C%&D*1YC,_WCD
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MG]PV#&NO "T3?!]E@ELR<(J/RTEHM=YT^WW@-B@
M                     $*\5<1B9D^3+D(YS4C%^$"5%)ZY2"/$=-Y75R2)
MJ$*\4S&]E1&CD]&;.3C#"!)<F1TNL\\1TWYQM5B/]XFH
M
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M)OY"[#$.%+@UP+Q24/%U3G5][#LW#%4:@I:@T>"^3C;D<G$O'K1^VOI_8+V
M?6&F8OPS5:E\DTW$],FSD(6XJ-'F-NK-*5(2M=DG<B2I:4_O'O#4CAAX!L,<
M-&9LS-&CXVFU>7,P\=#7'=IS,9+>I<=:I!$GL9JCJ49>IJ,^9F-MP
M?*3\IB6YQ54I@OFE9?4TE(^B9?*%2/F7WC@_)HL'#XL*NI1^,4[@&HMH-HM%
MFRGTPM?X<KB_\I:Z3'%?2B5SWLOJ:I%R[-^/J7(OVAR?DSY<)[B=JJVZ:ZAY
M& :BQKWCY-%.IJM2T7Z.JZ>D%:>S?5L  $@
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MBH9I8TE1D.NLFELOE>2T9-);(E)+X;ETN&:]PW#OH-!-[!!<
M         :H<+$^OL-9K5-FHU:K-1LS,9PX](2E*#2LIZI!-1E.&AM%W9$GY
MY9H4X\W9;9:AM>-4.%^GQJG S4@S:8P_3ZAFEC:FO&]*=0F6TNI-MJ0XTV1(
M<,]3Y$H[V+3:VM>D,UX,E_\ O*66,;9<C/1Z!&BK8=:2VYNLZVUH,CY7,T*2
M:NY\U>HGH:]\!\=MO@_RQ;;;2XDZ.?)*201W==OR_>-A N
M
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M._R/^NZ?UKGL-A1KYP#K2KA"RP))$7^1_3_I7!HV#
M                        0MQ2M(EY4I@')=C&_C/!;3KL8_BMWQ)3>LB/
MD1<Q-(@#C%;F3\E'Z33VB-ZH8GPK$:>4>EIEU5?@Z5*41+61$=O*A9ERZ!/X
M
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MB3%XK*PEN.^MMW $PG'2;3I:O/A<E+\R"O?DGU^U*KE:>S?6(  $@
M                             1QF!BS,K#E0BIP7E8QBNF.QWG*B_P#G
M(S3WXKI6VVD-O)-*M=_-N(TB)N%+$N;QY/Y'TAS*:FEAN9A"EHF5O\Y$D]#:
M;I]H[_A=KXNZ34<M*'"-)24_5=).Q<UJ5*AOM-U"7"=6DR:>CM,FZT=N[9K)
M;97_ &R,1YPLO+E\,>4TIX]#S^!J$=K\[^ 9_P!W\ $L
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M)Z&3   :
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MK\9(NRZKJ,DGJNE%^I*2.Q=B 949DCO?\2#4U\WN<_OYCP7<&T5W_FQ_K?\
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M3&KYKYU/GMJ]N]@'HD323N3:2/D7(O;M_B*ZD^P\S\X*%_ZD$?3^M]'S_A_
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MY*F*4J,HS,R/HD.MJ+_5M8!L4
M        @CBW:@OY1QV:U*6Q3W,980*4G5;Q#)U^!J(R\_+ZJ#)7+N)W&N_&
M]196(N'"MX>B*C$[5*UAB(V<O^CI4NO02+>-OF1<_0;$
M
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MG4K_ (CD_)E(G-\4]80I]DV"P)-223^<M\H4T[?=<S_$P5I[-]6@  2
M                               !;K(05P=2Y4KA4RE>><DO*1A6FMI4
M\IA2[)90E*2-I2N@DD9)O\4DE9Q*7"6DYFG,ONPEDQ*E1G'"+2\PIHW$_:1.
M$;?\!#G!PP]&X4\I$NRDOF>#J:_T.MN7U,-*)-TMHYH+I,OHGTJ4XHC< 3H
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M7WG**E391W%+(F]Q9MI+5V42+$K]HOL&Q 7'0
M                                                  #B9:VDZ;<O
M8<H                                      #7/CGD1&>&W$<R?'<D1
MF*MAOQ+3;2G%N)378)*)*4.$OF7I?F-C!K;QZM*E<+&*FERBIYJJ.'#7(?6;
M;36JMP=1DM/45O\ $!CV#:'1Z#QE4.+ >4M,W+6LRGD)=61)4=4IC!N6Y$25
M[/-'T%EI)#9E<]KR)HCN3:;W,[V]3[C2[&)9G'Q?X<:RIJ-!7C)O+JL(GEB=
MM[Y,*C-UF.TRMM$32LICB]1*^B22;3MDI!F<JU.-QQ-&:J=7<DI1;#2^ND5A
MGXIN6>:Z)"^@D<TN>>_T GH)\+;*UD)+25BY=B]OX$%FK&6A-E%8^7<A *&N
M.I4V6T=2R/\ #ME\!_Y-K!+7\'^KW]'SW[?E%SL;CA4@GDXCR.)>ZS\ J15M
M&V6YOEO^+OJZ&]/POUJ_ZHMP-?LZGWZ'QG19N4."OE7$K$*E?HE.*/#2JH2J
M=BA>\XX\I#:W28)#Y[A*U(96@C)2ML\T77,W/%2)-*X0ZX9SW%2B:DR:0S$:
M)ULE+4]ID:G=LW'%[1MFM6DDW&+X@RQXD\T>)*KUIO%N :#C; 6&L.38=3I)
MRW8]WGJNDF-I]"]!/-KE)6:B<LVMK18U*&:.Y(<<+QPIR^)F S.@I:4;2F&]
MA]\G#=NI+49LE%S-G:/HT'JMJ!1UX]6SEJ"H9-<)55BQW6),1Y4F;1$/-LM2
MG3:8(TOZB02%&DUZ-I)*LA2[EN<3#^<D5U=4F\'=;WUQW5/I8J.'GCE2%*^$
MI%WEF@DFI9FUY/AQS/1I7?T8>4''E'\2_%XFJ6F5)?9DO+E08DDEZ6C2II+7
M@4(82:DLF9(M<U.?2U.NT7D]Q]IJ'BU\4E"*[+/Z/\AQM+RDK+7J,HOP;$9*
MN@E[AEMJ3H-*VB;H-.YP,E/9:X/*V:JJBJTY4?Y;IC"5&MMK;?2^B3K8CN'%
M5J)1F:#D)T$O0>[DGY-!Q#O [EV:TDK459U7*]_\K33YCRCR8XY$I\"?$=3D
MTMJ7,7*=V&_'.Q3:VXY)7X+1J)!65R[]?SO4/%X9\*<2>!<B*#A#)JJY9G0Z
M/B+$-*4C$<*H+<CM1ZO,9LEYA1)D:E-J,W#:83S/D=^8;J&:#2:325E7N5N1
MBIN(,K&5_P!P@0FN.G])+Y0R.^*[JBWA5;X;7LOK\PM7$XX4N.*.JY(]+I[)
M?)U7^.6AQ5E_I'PNI+"+IW.1N.:>>T GTS0:=)I(R[6,N0PC-Z:4#*C&DV,T
MB0<7#]1>\,Z=DFE,5RZ>?H(X\1QS1T?$I^2-0/5W:D5B*?)KYOFVY^N_6]M'
MZL8AFS)XTG,O,9E7Z=D<U1$4&8J6DI54?>\)X5SQ%TK2E-_:_(!"'"M5JW3,
M@LM:+"X3*]BMANG.N.ULHT!YNH/.N2WH3;:EO&I#/Q^MY[2ELE:%D9'82 FL
M5-QB12YO!OC60B52R@(C>&A*3!9BL'H4A3KSB3<<-YU!FAQ=R2PCXBB4;F.Y
M!Y/<7--R2R]:RIS.I]!PY)HL*5$8F+8E.P6)+!S'5+0]3E*4\IUPFR+=LR5R
M+<N6U("\L/R@!FCP?$!1&FE2ISLEE117GFVUFTN,3#RZ38DDX4E*B<;/2C02
M==B%.*A<>75L28JIKL2I3^"+'++Z9#T-"42X$Y27]%C^;?6?A]O4G?VR1=/F
M^(D7MNU>H/3H,[@PQA*=D27:B3JE4=2TSS:4:W$OON)26XTXMY1O$E2G75-J
M2FQMCU_Y+./5@DE3N(BDEX:6T]&*73HBMU@FW"6U(VZ:6HS6EM1J;M<W5GK^
M&C78SE[^4 C38S19UTF7#=?0AY9.042([".ISJ^1=M:W%?#O:Z$'J0A9W$Q"
M.)JW7:]Q-9;M2,MZQE_652\'$5/F+96\U$1)J;AN/.,N*2X2V6WFR2O0]O/N
MHTW21CZ3%M.VNE*M*M17+L?N/G;FOE=Q.8<QGEICK,+%>!\0XGJ&-*#1(Y37
MB3'0XRJ>[$T[4*/8D[TKJ+K*Z;(69%KV1WN-U,\F"/)%#"GV")\UU<E\CL^W
MMVT7TGJ0K7<S+FCOH[K2E1L$:&#,C-E!F5S(])<KF1G_ !(C^\A=J278BYC7
MU55XXG(AO1,,9*1WT[UV'JU5EHLGR7<\+J._VH0+D/<=%^='R0+E(_\ 2S5O
M7YASG%[?7;[G]%QL<#8"Q7([=NPT%XDJC6:;^4"P%.P_@"NXGDIR^F,SZ;1H
M;+[ST5]R7%+<4[\(FD/R4+,W"4VFZS4D]:;3\U4N-N.5YV'\DY'-GYJMU9GR
MM6<\T4_G'_+_ %:>^X->L7X.XF,:<9E-E4JOX*P_CN@Y;KF%,A(=7#<B+G/,
MH:/?CNF>XZJ0NWH@D*\Q$ S&;47W6&8DC@_Q]M;28RVETBFR$U"&A26TZR2]
MR-M!(=+5HU/J2KRH*W6>K2Y+S3=,X/\ ,=F Y&D-17OD6$M]I23,F#4I<A!D
ME"'U*0?SFZV1-N*))FYE+. N/9Q9*G9QX90HG7R_19$5-D=6CYRB'R19JQ>N
MM[KYMVN3EQ^4 T$3F<V#U$X;*G2-4;I.UG[?Y(^F7)/]7Z[@#"GZB\F?,9H_
M!YCEFIUI#%64;N&X!-.%IC1WF7MEY+"D:/$FI@U77=K5INH=JFE#J%,J>$_Y
MAF*ODVHMNPY#DF)265MPG&W6=!/D[K0I""::)+9K62E/*OR2;F3,Y8<?4:GG
M'_EQH3SMF.M;\,U,Z.^DSHEW;^NKS>FT.->!./QT]2,V\*:F3-#5G(O-NZ=+
MQ_Y)[N;;ET>FZDNZ"= <7Y..L%.RSQ3%E3G7YA5FD&3<C4P\4?\ -:BI:/;,
MS,B,F[%S[%]@V[(FR,U$A)&?,SM_Q[$-%N&C#G$3E!+S-R\P+EQE_4X5'K=-
MHYR9&)93!-3"P_3$MJ2YL+<D1FV=I:FS0VLC?-+6K2=IT=Q+QD0BER9>565$
M]QDC-B-3<:5#<<^;O?=@H3ZG^/W:PG;=3]HI\/MH3SOZ>_<0;1\7<6+TE+=5
MR?P$S'-N,RJ0>,9).;JFKOO$V4!:-!+Z2;):U$I!D1K0X3C?G4'&/&HE)RL3
MY,9:O%\8_!Q,73&'N7S/6<1QG]6YJ+7SUM7T74 RJHM[F2>,$I[*?Q(2B]R\
M?*Y'^)_B)9/;/N@O7T]^XT Q-F/Q?4K%]>RCJ%.REAT.H3I9OHCOU&7)B-S9
M<-QULWCE,$I32ZU%+<4VP@T&9D6E.V-UTQL=^!VOE^C'*OI\1\C2-N^YK^:\
M3JMM]/SGF_N G!E-T6TZ2M[!J3WL0Q!+68BVZ6LZC1B7LE\HI\&\7Q$M64;7
MQ>:3>^M]'ZXN*-CUI&A6(*0Z9<]URF.G?_5;>+_@OOT%&6FI)F1FDC,NP^>;
M->5A3CGXCEP<N*Y73D0\/F\]2L.*JCC2U4=!-M;B7B)!/*-1&E;:M97([#=]
MR-CIQQ"(6(J1MJBM,DIVFO+/>3KU/]+I%I.Q=)G;MU=M>IT7A5S-GYGYM8XP
MAFXG!M<Q)5(<2:S ;DR&GG?DR.Z^X:DRFWF4+><)Q+:5$I-B3?:Z@'K+S=Q&
MF,MZG<-.::9Y1X!-^*P^:6WT(^&ZR]I39:RCGNMK^(9NK4@_FTMCB1F'MS*=
M+9X=,UH[T*43Y+309#L5*&Y3<ALM*"(R+432^>V=U/KT:;$/21PR<1TJ2;#_
M !9UMB"]'5%>3HF[B62=DGN?TA%G-/A2(^Z;.)4MQ*4DOG5PZ\3TE<J<KBN<
MCNN1WHZ(Z:2]MQD+VS)@G/$H4M+;N[:1\^:$LEK[D \J'F;7HD128'#_ )I)
M-:WDJ2]1UH,TD9)8<-#BC69H2M:E'>ZC01\[#!\ZLQ*]6LM:A%K66>.($"J3
M:?,<JU4H[L:.TX]48"T+D);2LVRM#/4E1'JW4VM<22UPV<4#%/0_#XIJFY/C
MGX>*U+AR%,KC)>/0;I-R")2C8W"Y_24CK'%,X1LZ\10U4C%_$<C$-/4[&J#;
M=5H4MYO=9>4XVE:2J=E$9)03ERL>DM"V[$ DOA"?I;_#!E?\GNOZ3P[$)PG3
M,]IY!$E]LB/LVV[NI079"4ME;D0]G.?"S6(D8)C25_Y-@XQAOS4_2=034E#*
M2+U(Y#C*5>Z268\?A\PMB["62V \+.8BI<CY/H\2&XKY--EQ2=NSCAH2X@C4
M:KD1VN9?$7NJYCT\QUX@3.PG$K-3@-QYU?\ #L-PV'C><<.-)T()R]VS-HEF
M:SV]M9H-*[BF1<87P+2%.Y(SX;SQRG:=C7%+!J4M-R5\JRN?;D?4?/[3&R>L
MAJ3P,R,35?)E^;!JD,X<K'&(W'(TBGN,RDI547W.MPG=:UW4I=W$(/0:$=D?
M$V*D4_'BW"<+$5'(B/EII4@B^;<+L4HOI*0?^K]J=N8ZN96E>'&$J@,R-VMT
M9"V'$$I*D*JL9*W#2?(S2CJOZ#-2(B(B(K6[?8(YQ&G&/R4E,RJ4!"TU.,K4
MIEYLTLF\TIM'4;G4:RT\]&JW+:^A[B"S 6<<T5*BO$?-3I0GD)/_ %">67K]
M?_$] 97K(4-23[I(QBJ58^29MQUT*2V1V-:MYLR/G<KD:^WOZ_50.NAK,UB1
M#*74L-2&2(SG.MQ9#*R,O*3+9NFA6OMU+1H]=T!F5T?5(8;6SFGF'AQ)0EO0
M'H53CR%J8-26U'X93?/[4I<*_LI7N8[L96,G8T1<KY+C2B21S2:)UU%^@ST$
MLT:.2GO,1]D#'JA&QFYBK"^X_0&DML2534D;Z4.J,D$9M-D=KH)*"(W+VUG;
MN D32SM[6TC1VTVY?@"MA964VD[V[I(^QW+\#&-PTXU4HD2CIJ;1VG/(X?Z2
M>YO%?=\A:V=)>FE7UBV^!"LP2B2M7YOG-:4?AS,WMJ0JSGPUE?X7E8ZDZSYK
MZ.8#+=:?8-9>PQ9Y>8ASST?F^4'XW*SV^5S^!R[?VAU=&:9N.I)[#AEW2C:D
MVZM[46O5?E>/8RY\GNGFC0'#@UU2Z[BU]U,5KQ%?)MLVI)/G*M3HJ;.%:[2N
MF^A/+2@E]E#.#VS5J-!7][<Q&=+<Q?(JF,_DF73'I3%=90TS+>ULM:8,%2DD
MMM>MLC-*E:5H-5U&KRG894<C%Y3I;)?)GAV66U-*,U=;Y[MV3/\ ?'ZO7JZ0
M&1'MFHEF@C4GL=N9 2$%:R"*W;EV_P"+F,7U9B?U5![W\TC^J_L_UO\ LBZ6
MG,!,N.U$70E0UDHWG5&^3S)D73H1<TNW]=2T?O 9/N(M:PPO+)9JP52I#;;*
M$O1CT):J*9I:;F:+/-D2%7N?D(NX[L0\<M./LSCH,E!%=*FDOL&7SGJ9N?5;
M_O+^JG7C6 &\6LX0AQ[P)$9B,11&7T.QY)-I2VE#;QF9EK;4;]U%YK-%K,R6
MX829N(^T+HY=)<NWV#'EKQAXQAM+=,-A7F>)#GMVTW_UO]CO\0<-15C=!H.+
M&I/,SZ3E.\[-.:?H>KQQ[_LFON R8MM-]*$EJ,S.Q=S&'9A1VI.'(S2'UI-R
MKTA*GFU&VLTG4X]RN7.QW/[[G[CLNHS ,]2':(1>/U:?C?T3?O[^;9_=N<_+
M\,8KF"C,&;A>,W%:P\ZKY0IJOCD\DCD(E-Z"+GY#D(;_ -50"4B4T79)%S,^
MWJ8:FC.YI*_O;_CV+\!B[OY[)62T1J22"4HE,^+=N9I;=2GK-'9:CCG:W1UG
M\0=>,O,5Z#>2U0XT];+I$XUXAUHG%ZR:/:6E)Z4V8U<_5SR ,QU)O?25_<4U
M-D>V5M0Q,GL?^-ZJ?22@D_ZS'B<-.W?OH_KN7]GD6L7RY.-]P_#TNDJ5L/*O
MXIXOT@MK9+R>0]3FK^RCZRM <%16TG-W#R"0DE_F]62U$7,R\53?]YC,;HL:
M=)6.]RMWN(NJDC%;&9U%2TU19$MVG5=QM;N\T2829=-29<C791I/5JY)OZ#*
M52,<G-T'3:0PSXC3K.:\Y^C[5[\T(ZMWE_9 91J3[%[ANI^T8BZYCY=/(D0*
M64XWE'M^,>)FR7=22UDC5S3RU=K<]NWPP0>8?C2:VJ$<%+^^E\U/F\\QIU;:
MF].EI6KEJ2M96/YL J:5Q\=X?TQR2PJ-4F-9%V4LV'"M^Y+O]T=["JE+H\>0
MJ[6LY"E7/7J,WC,S/[S,_P 1Y*)]6?K-'I^)&X<)Y.Z]'DQ7R-,MY+>E3>VX
MV:DW0XXK3?5T]QWL&.+:PS#=0VVE$AUQV.1.^5AU\S:4K]HVUI/3[D20&2G&
M;4224T@R2K6FZ2Y*O>Y?;<50VVVG0VVE*;WLDK%>]QQD^M701-^:W)STO_CI
MYBJE)09F:E:/G=>LK6]ON 7DTFQDV1((SN9)*UQC>8$),G ^(HC*20X]1Y:$
M*25C(MDR(B/VYG^(R;<078>#BY]IO#%7D(4:_P#)<IXBU)T:4M\RU>Q\OL =
MJDM-*I,9:FD&IR,WK,TE=5VDWO[^5/X%[#T3CMF=S;1>][Z2^W_>?XG[CQL.
M&9X>I_B5.MK;B,N/[ETF2B(B-/,^1=*BM_O'K[R#NJZ[?1+45E:>]N?XW 6^
M$21*(D)LJQJ*W>W:_P"!?@.5+))4:TI(E*(B,R+F9%V_Q/\ $6&XZ1&3B33J
M-1$>HN7/I_$7..:3/=,T(^N:B(@&$9@[K\"C15ID*)6(*8MWI0HB),A+J3<[
MZ4;B4()22N2B3Z$,W)EDE*432"-?F/25U??[C!<RH27H^&'TN(;:BXCILDG%
M/[>@MPD<])_$Y*)%CO\ .:OHC/-:+[=^H!1+3:5:DMI)7/F1<^?<<+49N.E*
M&&DMI0G0DD)L24^Q6[$.767]>V+]2?8!P[1=/+R>7]G[O88@3D LT3C*8=5*
M.D$X;E^C;)ZY)^XC,CMZ&:/K*&:ZD^PP*S:<WEKDS%I2_AIK8:WCNK;DKUFI
M'E1;<21\NKG>^CD&:E$92:3)E!&@K)LDNDN7;V\J?P+V%Y(,RLV>DKF?+ES,
M[G_$#<--UFE39?MJ38B+OZ@3R25K)YDFO>Y *-M$?<B_XM_N+\!R;)6MI*WW
M"A.,%V=+\15+K#GE=_B P;!S)IKF-$FZVZZ]B#XZFR+XA^ B&V?+R&322:/[
M4W'E9\YBS,G<F\;YHTJ!'DRL.4634&(KNHFE2$(Z"NDKZ2,BU%ZVYZ+7'>RZ
MAMP:YF*W(VU)/$Q[R]E"#<W($-9:C^ETN$7/T(1?QSYA4O W#GBB#66JFI6,
MX,O"<%^%".04>7,AR2;6[\1%D*<:(B=.R4FI'(&0U2EFWFK@#(O!LC'68U0=
MA4M,IMG4V2W7'GG5:22EM-S/DI:CMY6VS5V1R@#*S\H;E3C_ !9&P;BS#E:P
MA4Z[)@4VD',B+D,SWY+AH:92I"+-F1[=TJMJWND^D>A6<9L9ZX(P5Q(X#H=0
MK.$H<?$#\S#E590U(2R<>1 54$-LN:W)"2;?:2@C7KCS))HL[M)$'T;AEP;'
M1B#!N2[C6*\79C8?)TZY4(LSP&#V536S?;C&1EX=UM+RCCMNN*E-.,()PC96
MM2#6[=4QA/A9UT'+E-.IJZ;6<-5:JJD*>6<I+T.33VDM$CRDBTXE:BU\TF9Z
M/I]_*&GQJ3E1@FDPV$)CPL.TQEO2DB)"28:(DD1=B(B*Q%[$-:<?9^T3"G&W
M@G*]W".,9M6@T.3AE^:[38_^46*J]37(LMA:G$$XPTN%+0\X;=DJ)U!$9V,;
M.Y6.,*RQPB\AP]#5 @ZM?3?]&;[@,L)MLBL3:2*Q%V]"[?@*DW8K$16,K?N%
M=Q'M_ <*GEF75H3S/NY;N?1V]P')MMD22)M-D>4K=ON&%9F1X$BD0T3YB(R$
M5^D/(<4T2S)U%0BK0DC]+K2DOP&8I=0OM)0?/W_UO\!B&93D8Z%#U/$V18@H
M9V/J(U?*,8R.WWK2=_<B!DV9J;;6>I3:3.Y'<R]N9?@*>'1JU;:;ZM=[%?5:
MU_OMR!YUAOYUTD?OL.360-<1QHY]X[?TOH%]+S?CZ^XHU#880EMEAMM";Z4I
M21$7._(B^WF+MQC^M+\1R:R 8//B,*S7H#QL-FY\A5A>K25]7B:>5[^]DI+]
MQ>PRA%'IC:-MNG1DIOJTI9217Z>?;]A']U/L0\&H&G^4:C/V^8HU3)1_8;T$
MS&4FMI'F<_%0U+-8F!!29J3"8(U(2V9DV7-"?*GMV+T+T%3@Q34I1QFC4JVH
M]!7.W:_W#FU)]A;NL_-;W/[^8Q5Q(@1&R4EN*RDE^8DMD6K[_<8Q&ID%_,RJ
M5!Z$PMUNC4Y+;BFR-22\1)58C/F1:DD?WD1^@R_60P^"XVWF1625)6:#H-,-
M+)J,U$:)$XE';[=22_<7L REV%&42KQVCU^:Z"Y\[\_W\_O'&J#'6O<7';4O
MZQH(S[:>_P!W+[AV]9"FI/L ZDNG0Y[1L3HC,ALTJ0:'6R6DTJ[E8R['ZD(<
MXQ#@,<*F;+DV*P\2,(5)"2<;)1$X;*DH65_I$I*#(^Y&DC]"$W:B$ \;[,23
MPHYHH>G28^K#LAPRCZ3,W")*DHY^BEJ0DR]26?N8$&*\-&8>)LR\\\U*GBO"
M;U!K=(PGA&E38;L5UG6\E^LN.K0AU"5Z5;I6[E^T8VK$*X,<IJ>*+-!VGDTI
M;V#,'.O&5NMWQ=>+49^I[:$<SYV21>A"79E0B0HWC93QH1]X#M$HO<1_FW 0
M]0Z,\W(4GP^*:$^JRK$:?E..DR^ZSA%]Q$,LH%4B5^DQ:Q <64:6P2V2<OJ)
M)E]*Y^88GG(>SA.$XCIOBO"[?+ETJKL%)E]QER/[ 9/19EB3:<:YM:4)+_/!
MCL7_ ,8*0)&$:97F9XVS;N?_ *>#/_S@I DL&@                   *6+
MV$&\%#,6/PFY3(AQVF$JPS%6:6T$DC4I!J4?+U-1FHS]3,S$XZR&OW HFI)X
M1LKRJ[S29*:(G2IL]2"94M>RDO34EO;2?[25?: V# !;K(!KSP).JG<)V7RG
M?C)3%F0R7Y"-#4Z2VE>GT-2"N9^HV%&NW <VXGA,RZ1*=N]\G.K)"GD/K)"I
M+IINM)<UZ#LH^^HSN-B0%XULX!9/BN$C+F2]%>@+;AS6G$/&:]2D3)!*>Y^C
MIEO%[$9$-DQK7^3_ 'W9_!YEHN?(6M;E.E-+-9FHS),N26T9GWT$5M7K8!LH
M                                           @'C1DO0<@YTZ)-3'?
M9Q)A5Z.\<5M_2LJ]!L>TKI6DOVN0GX0%QHP*;.R$J-/J]*>J%/DU["K4J*UN
M&Y,:^7H5V4Z%$M*COYB/U$]7/W 7@
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M3L@VT8#FNH(U-&R\HY\$E*,[:E&9$R5S^LOW,%:>S?54  $@
M                        6$:"M9)%;MR["#N#!##W"WE.HJ;(AJ_-2 K:
MD-H;69;+9D[H3TV7<G"7YE72I5U*4)AG(D.05Z94F$MPB)+S*F3<3]Q.$;?\
M!'/"L9*X7LI5&1'_ )A4)?[S@-7/[SY@)9
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MG"T%6AQ[<6>EDDFY?GR69$O3]'D7H)V               !;K(-9 +@
M                         %NL@UD N
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M!V#RBZ/U:2EX@,B47WW/]XF;0D^1I+T]!J3ASB6R'IF?F,\8GF/2'*-6LO\
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M[6LT)TZ22G3T-N$;1779/,QF:ID$^;SS:?3YPR[HUG_#F.<W8K9ZC4@C]_\
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M25NMZU\VR.URMYA"G&;3I58X3LU8].EV>3A6;*2G2E>XEA"WC))>NI+:B+[
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M\\");W"E@!3Z[FIF=J^(A=_\H2+&9I(KZK7/WL-B+%[ *C6O\G\B0C@VRO\
M&K9<O3)/S)?JO%2#;3R^D2.1_M7&R@UQ_)_1VXG!MEAI;0T94N0ODG1U*ENF
MH^J_,S,S,_4S ;'                                           (#
MXS$4=>0DL\125QJ7^<V%$RW#09K1'.OT[6I"4]E$1G8^Y<Q/(@OC':J,G(BI
ML4:2S'FOXAPLB*Y(\C;AU^#S5?Z/(A.>DS]1G8.0  :
M
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M6<;;)#BS(F]QU>IPCU+3?R<A]*#0A1&2D)._,[EW%-IKOMI[$GMZ%>Q?Q/\
M$!J!P?Y09C8 S^XD\6XRP?*I%)QABEFHT"2I]+B:@RE^>XI]LKG:Y2&CLJW-
M1?4(4P'D7F-A[\HGF%G;5J(;^#:_A7P=)JZ5LK6B8E-,2MM24$1H5I;DDE2[
M])*YVO?<';;^HG\/O_WG^($V@K$2$E8B(N78B[ /G=P=Y$\4W#!G=(P<>7\*
M=EW7I+U*J&)),]+CAPX7BG(#[;3;NJ.:C>2@VU-FE1+(BV](W$S_ ,,5K&N1
M68V#<*4IV?6L088JE,@QW%);;5)?AN--I(W326DE&1^U^8DS::O?;3WOV^__
M 'G^)BJ6FT$1);21)YD1%V_XN ^9V"^&O/:C?D^,S<KY>7DIS&%=QC"K4*E*
M?0;DI@ETAQ;Q+W.@BV'N5^6CL)@SQR-S=JW KA?)7"N'?E7&=*AT%JH17YJ7
M22J-MKDFB1(<)!?$(TWU]+9FE/3UC<\]A1&E1D9*Y&1GW'%KCM%I<639ILI9
MD9DDSM;FK[B(!H?6LB,[I'Y-/#N3S>$'IN-D2(+TZAKDM)=V%5DI9,*4?01H
M0IG4?[!C6C.[!^)<!Y8Y$X1S P_4:76HE Q,BM0)*BZ&/E=M32DF799H/5?O
M\T?H0^PJ7$N*<23A*,OG"(R/3Z=KG;RGR&M_%+P=T?B;K5&K\[,>M82ET.)+
M@-N06&7F93#SC*R,TN<D*2I"4W[JL7L0#5FN9=<;V?\ ES@#+"NX3A0,)-DW
M.A8A\83ZI+;D5M139QMN*6X:4NR-+9;>XMQ!JN:!*.)N'C,C!/$]PV/8/PC,
MQ+@_+?#:*-5ZT^RTRT6EAZ.TMU)<R4C<):33KT'8SOW&\;$.)$89CPXS1-,)
M2AI"4$26TI*R221=B(N16'82EE"C6AI"5&1),R38[%V(!I)QW\-N86,:]A7B
M R9IC-4Q/A!EB!*I#D=<LYK;$YN1#-MKR+V7E/N+U>9)FGW$4YL43BIXX*]A
M#!U7R2D9;8?C.R6)=4GPW7$,QGXB$+<-:UIWR5K?VVD-D:#)&M?2J_TJ(F$+
M4;J=!N]RNDB]3M[^BC_>8*2TLR>6TTIPDF9*U<NJWK:]N1<_L :!?E#\@\1O
MT'++%&56$ZE7ZK0R5AB7#H\)2I4N'X9;D52E-7TDAQES3?E=_GW'9SUX5<84
M7ALR,;RWR\:J^,,H)5-E^$AZE&I+R+U-11G30U(W):6'5H<).ILW$IVRUZM]
M]+/4>TCJOJZ2YW[W^^Q?@.=3;:K:FTGI,C*Y=C(!\M,5/\9>=2Z#1,-<(L3+
M9<UZ5(<GL4MF.W/G,,.%JDO/$9QHYH-"6];9K=4DK.%8K9/7,E\W(W&5PUU*
M3@FKUIK"&!\/0*[6RIFN#$D->/W4;R+(*VHS(B7RNV9[O(?2,VFCO=M)W[\N
MXM-E)FHS25UV)7+O]X#0CBHRPS+K_'WDCCNAY<RZEA:G?)4>34([:4H;>*HO
MNOJ<674:6F2)SGWW%)^D=^A^41R.SDQQF?@;%N7."*QBNFG3B@S68KYDJ MF
M6VM#R",^@U$_;4FSOPE=5B'T'-*5&1FDCMVN787$A)&9DDB,^_+N ^>&;&2'
M$/DQQ/R<VLF\N(./J7C YC[E-6G1&C[SS3CL:6:G/*J4:)*'"Z&UDY<M-Q7#
M64W&;G'Q#X(S(S/PU1L!83H#U.>=ATPVW%%#B+<D)C;9+4HEJD,:5*O=M$A)
M)\H^AQ(01&DD)L=[E;O?O_B*V+V :B<'>5&/L!9E\16),=4"JTZ%BW,&=+H!
MR7NB1#5)ENH>9;+RZCDH.YD5S,OJ<H3A<+V>%5X5^(W!4^CU";B;$N9#E:IC
M$V$Q$F5^+'FQ))ON*;^"X;R2>TME\-+J;:K=OI,2$DHUDDB4JUSMS,4)IHB-
M)-I(C,U&5B[GW/\ ?<P'R]D-_E I.6% Q#AK#>,<+NY83*528U"B0DQRKD5#
MBT;ST<G5KDI8(H[2FB1MNI<4\E5B.V-YCY8\2?$OG#1',6\-51R]G3:TU2JW
MBF!&7J\(V47]--XW5I-;,=);.U9HW5O'JNTJ_P!9MIKG\-/-))/EW25[%]W,
M_P 1=I3:VDK7OV]0'R=_*.P"5Q/TG](7-D0<NH#"I;RC)Y*SGS+J<V]+:%&:
M&^Q(/XQ'I.W+E_)DM)3Q95=;A$:G,N)AMJ,N:?\ *D(N7MR6DON(A;^4R62.
M+NC*1TJ++Z$=RY'<JI-(=C\FDLCXK9F\DD6R\J,?ERZBJ%-67\ 5_#?5@  $
M@                                    =>0<5IDGI#A(0S],SM;]XB;
MA/.0UPOY2;JVWK8%H/D+EMG :T%_:+U$C5PIOR+-.(FG*?0TYL%.,RBFLNQO
M6*Y)O[",.#U@V>%7*3] \.9X,H[GSNNY'$:,G?LU%U:?HD>D!-0
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M[<E67>(W841F8N62V7:Q'T&_ITK5OFI1N.$M"]O0X@K:%((@WL
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MC"U-;G$ZI1K4HF&R6:S[FLR\QGS-5S/F)8
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MG[\N0QZ@XG75\6U_#CE"?@O44T-'*6Z9I>:<U&TI";]C2ER_[2!F1&@NR2_
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MJ*YB;"Q.M-LN/*47R_!\A(,K?N$]@
M
M  "+>(Z.ROAVS.BNRT1FWL(5=.XMY3"4WB.ES7?40Y^'5R*]D#EJ<=EM##V#
MZ1I;2DB3;P;7*W85X@WB:X?<RG8YZ-G"%8^<+M:(Z.IPS)(^&O*=3Q&V?YDT
M,SU'H.YP&K]O6X)]Z50  4?.K\J:RXC'.4DHEG;Y.Q&5[^B':9?\1JCE*I+6
M>V4R+>'2C,&@J=3YM:O%-)N?N>KG?WYC;G\J.1*QEE&E1$9?)V*>1]OG:1_O
M/\1J-E<I*,[LLE-I)DVL;T)UHR+:-Q2:@UICGKO=:OK=S ?<,
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MSXH5)PSC&I,TFJTN=AN=N.4R)\IM.O,RS0XLD.-LH4DG4=*BN=N9B=6_R?6
MZS3\3*S!S'QCCG$U;I?R13:_B2I',F4%/49.0U*N9*/42[D97)"DEM[CNKS*
M[^3CPIB6B5:/7,Y,8S*Y4XD2+#K,UQ#KM.5'?U(-"BT*</:/PW4?S7+DKF \
M/,/CJS*PKEWB+&.&<(4&9\GYOJP%!*4F0VV]1_DXI:']1.ZCD&CXFOR:#O\
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M#\&]59J'"ME,[$:-'^:,"*1_**91690VTH[I<7WM=+7F:+X:M"^@!/8
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M8CTRH.EIDK.N2U;C!(/23=W4H,K(N\EWHU$1G/@
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MRG6R=)9(7)<NZI)$2;),S+I3[$)9L7<-*;WTE?[@%0
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M:CI?K,UEK0NF0T//FIHD$9MQM1J4Z:EGI92O4E:WA]#M+-K;:;?=]_\ O/\
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MW2^A]3G_ &NCDH8CALYK-9P93YDAIUM["TIUY2/UCZ#I]W#]RZE<_P!H_<2
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MR] ^*T\EM>VJY><F[=AL$
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M7\F+K/BQQ"X:C-!X F<K\O\ E2$"M/9OJV  "0
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MTM$2>E.WH(M!]U(L9\Q/0.@
M                                    %+$78A46(2KU4?X@+P
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MX36_3)CT=),RE1W262EDE#+CB+^?4A*M S)/'] (DE(X9L]V]1N&1GA0BO\
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M;?Q+4AZU^?\ SIT!L8
M @#C.22<@YAJIT>89XIPL?AI$Q,=IY1U^G="WE$9-:KGUD73W$^7/W$$\8R*
MK(R-FQJ.^VU4)>)L+Q(KCBVTI:=<K]-)!J4M)H0DO761W$X,-.IB$A:U&NWF
M,[F [(
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M[W4U^)#5/+%::7F[E?+>23Z"QY0-YR3R*&15",9.D@N2E7,^??F ^X8
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M:7N>DI\%9$OW(E\OAV+D"M/9OK*  "0
M       /.J4"+48CE,EQFGV7RLZTX@E(67LI)\C_ 'B)>$.,U#X8<J41C437
MYE45Q%XJ&;ZXK9J49)27F/G?L??6OSB69TU,"$_,>8>=;91JLTTLW#1;L7.Y
MJ$3\([,QGA>RD;=DJ=M@FE*/XJ7#ZHS2D<TMEY2Y?9V,W#ZP$U
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M?2WB<N9IV%,H6RCGZI:6A/WD7V";0
M                                           ' R\3D;>+U*XYQQ):
M)*="4D2?8BY .4                                    !K5Q_2),/A
M0Q9,@IT24U/#CA:?AGK^6H/5U>OV]QLJ-<./F*F5PJ8MAIE)C>(J>'F$OJ?6
MT23568*2/6@]16,[W >%3\3T*E<6F!)#]);P_3JSE=5FH,V2PEM4Z4<VD+-E
M9(,T*6EI#9D16L2S^LBVR*\1T-$DF#K,8W#OT'+;(R[*[:K=C3^Y2?<QJ.[A
MZF9H<6]#P?FGA6EXOI,#+:JS%MUFF,R(+E6558#+ZFV%I4AA26V-GJ4:M+?E
MLHMR?G.&;A^<5X,\D, >"_\ !OS9A;78R\NBW8UEV_6)^J0#/TXCP\YNH9Q%
M3UJ1\Y:6V9M_?U<AP)Q?A@S_ .^:D]M?].;\NG5K\WET=7\1@+7"]PW-+>>:
MR&P UOVW=&&(1:R;<U%J^%SU%R._<N0[7\V+APOJ_F_9;7V?#W_-2!\UIT:/
MFO+IZ;=K<NP#4K.RMTV3QAOU5.*:\S IE.H,*0_AY#+\VE.O1JXXUL="R):C
MD)=,W$&ZE#KO+0I!#SH-=X>:=(H5-AY]YZD<<H3,>2U2FWF4NMN$\EQ:? .%
MN-DVIHF[<R,T$AQ'4)KP9E#D54>)',_"D3)_!?R53<(84BR*<O"L=$9MYR16
M"426C;)*R4TB,DU6LI+5B.R2$TEP_9'%>V3&!2U*2H[8<A\S21DD_F^Y$9V]
MKF TV;KF1SRX$VG\3/$7)-IPY<1Z'1D*-TVF+*=-*Z5J<0VADVR0MLR0J.A2
MR3J:<5PU?$&0CTAJ//XK.(^=,<FHBH0_17([T93+#Q)<0;E+:)#C27=9D7Q4
M'S21#<*5PU\/DO5NY$9>+UI4A6K#$$[I5JU$?PNQZUW]]:O<QS1N'#(&&@VX
MF1F7S"#)9&EO#$))66G0OD37TD])^Y<CY -0V\89"R95;IL#BES^A5&FO/0Y
M"$TIYM#KIM(2DU$Q3R0E);:$\MNR4)0>A!$0E'\GE4*;A3A"P%!Q--B4B?-?
MJ[[[,V:EO4[\J2KI;)2[EZ<C$YHR R0;BH@MY-8&3&;,E(9+#L,D),D;9&2=
MNQ='3_9Y=A#V0O#_ ,/N.<"5"O8BR3R^KKR\;8S0U,GX;A277(R<15%+):W&
MS4:22E))*]B(B(NP#8M6(J,VGX]6BM];2.<QN^IU>AE'F[K7T)+Z2N17/F.1
M&(:&Z\TVS68:W'O*@GR/5]Q".%\,W#PN2<A[(W [CQS7:CH518QM')<9V'#T
MFW:RBY**W,^HRN.<N%WAP;D(EQ^'_+9I;?D4C"D!)I^XR:Y ,[B8EP_/22Z9
MB&!-(]?S$MMPN74OF2O0OP(8+Q"5BEQ\A<Q)CU57%87AFH-+?8DI2LEN1%);
M2VI1&E*C-96L7>PZ$OA5X<WHJ(ZL@<"["4/M>&C8?AM-7>*RSTI;(K6Y:K:K
M##^(#A^R1I6269%1I&1V!VY;.%JG*9=70HA$V_'A/&RZ7P^2R4E!DHN9&E)^
MA -5^'I^'A[*? S6*>(K-G!4VBQRFJH<#"DFHQX#6^\1*2\<1Y!KT'T&1:-H
MR;6VXG=)67,S,NCCO1F^+?/.2W II.J-67TEU!1T.Z5GH33/(37PE-GR(NHN
MGX8G?*+AFX?\293X!Q'6,EL)NSY>%:,\ZY)H\7Q"TE'0X;*[(L:#-2MU/9S4
M>J]QE<KA&X;Y<9IIW)#"96=)^[<!,=]\[6TO.MD1K18S+949H^SV#66K5C*4
MTOH1Q3Y_,0W(WR3(=DX44X;D-3)FIIMQ=,2O2UJ-9N.W4=SVC4^>L<U)Q%@J
M(Q)JE1XGN(*96WXC$25&@X+<<5)V6S)M),N4Q]E;R2@O*6^A=UGN&;AV(;0*
MX9>'%UQ+AY#9=FJ.LE:SPY$U%9&R7/;]&NWVCC1PK\-[*9<A.0N =,M)-+*1
M0HKR&4DA39):0ILR05EK*R;%UJ^L8#2S9I%1XD,'SJ;B3'U:I,7&F&:8BLXM
M:9C2RF&FJ.>'5X=AM_:2EM#2$OI(S4I:5&A!)6/I')JD."SOS*C&;;+]:X\E
M#9ZCY=S,:G9_Y%Y089K>2[&#,H,%4?Y5S6I<>;X2@1H)2644^H/FT[L,&;J>
M@C(E%I-TDFI2$EREF%P@<,=/=ASHO#]E^R_ W#:)O#["?-YM=D?'T_0UD>GT
ML F'Q+7_ (8S_P ?O!R6RS\]+91]_+_M$*)X,N%5OFKAZP,?Z0S*ZJ0UYT'9
M'T?*?JSY%?3(QSS.$'A<FKDD_P /&7GZ4QX9Z^'8Y$;?Q?)9'P%=1_%19?)'
M/I38)5<J^BN1Z.9*)Q^,]((C3TD;9LD:-5_-\4:+<3#"&^.B@5/$>)<1X6H,
MG+ABCU"NX;4^4R*MV745-MI4VA:DFM24FA24*L:2,[6(QLLYPD<,:YJ9AY!8
M(,VY9OI3\@L&PB[2$J,F=.DKDTDCY><B7:]A%,+(C))/&'5\(HRDPBW32RMI
ML@J1$IS+$(UNU.I-O+<BI03*B5<B-9I-9<K ,$G5W+N93Z+29G&1FNQ!1&==
M:0G!IPV32APBUK-ZGF9M'H0PVWUD;A)VR.VV1>(\!26Y,)KB[S8I[=9CM/U%
MN7@<EI;;2I3MW'6Z:AM"U/./J=62].LEM=R(;11.%OAV:\4:<D\$.*E(VUF]
M1X\G0F]]*=Q!V*_.Q>HXHG"UPYQ7S4SD;@O5JU&IRB-/D9D;ID9FM)WYN+Y_
M8GZK>G<ZC6UBO8(JTQI,#BVS=FR"33FWT1LO)$QIQ#B5[9)2U3#(B<;<<))%
MV4M6O<-1WZ,7$.5L6@529&XILW,1KE1DN%&J6#T.ID.MN.I2W(0NDF2R<>,R
M-*]"DIY&M!#::%PP<.M/VC:R'P$1QFD:#?HD9W1I.Z?,@_*?,C]#[#K%PK<-
MT<CV\C<&JU;QG_D5L^;JM2_H^IF9E_5F9Z;#!$G !@LL(82QNW,A3V*H5:H\
M"4S(8)IYO:PY2%*:Y)0?0ZXZG5])*"[F-M#>09?/_.>709*L-1,J>&?(;%^-
M<Z4UW!2*DY QZQ&;D+D32,THH]+?)G=W-=FWWG>?J1(7Y2(2<UP6\,;9?!RJ
MB,F_V.',EQR:_LZ'BT_N 3EJ1_7_ ,2"[BCU)5T^W(0@YP<\-2O+E52R_1O#
M_P!*D_-_7^>\W^D\_P!HM;X.N&YN3O\ \ES']'V-GQDO3M_7T[MMS]KS?: Z
MF-*K.3PQYHX@P1/>146*?C213IS&E3JI27)ALNMFJY+L:4I(_8B(NPA"G9WY
MQT29%.I8<S-J<>G,>'<B078B'Y#[3CS<A;VMMQ"B:-YJ^AQN^E-]5B&Q."<*
M8:R^R,J^%L/T!$>AT96(X\*G1S2PE+'CI7P$WY$=C,M1"2"P=A4M-L,THM),
MDG]";Y$RHE-6Z?H&E)I^J9$96L!!J"G/C,AB5(HS&!LUG91?Y-9*14(!/1WT
M^)\.A;1EJ>6LE(N:3):]*=PTV(=!C/7.VJ3'*.U0,0/1JF4OY&?2VVW+;0>B
M*W'>-+B[V7*84A\SU$M)ZC<4I*2W2DX8P_,4M<N@TY]3AW6;D5"C4?N=RY@6
M&,/I4E::#3B4B^DRBHNF[1,G;ER^$E+?]@B3V*P%SS\FE[&?F8AT1,"H8!S7
MJ-0*HJH:)D*9#B))TXL<TI)/7\9UE1&DDZUD[ON)2THB2/*1Q)UQIZI')DXR
MH4ZI59IQYNJ2(D>+&F281>%C-;EC2R[O;A:]QQ26V^9&EQ9[PMX-PPU?:PW2
MT7))'IAME<DM$TGT]&B)LO9)$GMR&,X+B,1,18T\-&3(4]7VMU26R2;=XD11
MV/N176;A_MJ>/OW#32EY[YN18+<^/4,=U2*@F#?;34X2K'&/:W5R%JLVSONL
MK4BVXXVE1NFI'(9$_GIB:G2$QZ?AO'+L&;(\+'@U"LQ]3YMR8Z4Q6G6%J,KL
MQU;KBG.2G5F5^O=W,_,C"%YZOS4H]ZJ:CGGX%K]+U%8]WI^)<N1ZKBGYBX1\
M>NJ_FI1_&N)T+D^!:W5)N1V->FYE<B.U^Y$)<%1HN]F[F^S&J=-I]6QG(HKK
M\67#E/5IA,II:EWTJ6;F[MFVZR2DZMI*DJYCW$<0N+$P9,ZGTC&[D,XD)MK>
MK$-U;+-G$.27-*B6:T&RHT*3TN:/C$K66YN&]EU@J13G*/(P=1'8#LER8Y%7
M3F5,KD.*U+=-!ITFM2N9JM<SYF8[+F#L,NSHU3=PY2US(2S<C2%1&S=969F9
MJ0JUTG<S.Y'ZF*C2?#F<68T2C4RDX9HV/)U,)+*'#CRF7VVD^$2_I;EFX274
MJ;4T]J;66VA:4+T'ND?H9?9FUK,O%.'\)YCX5Q%$@ODB/%>EU5#I0I$5J2G>
MEM$1+4M:C?-MPCTJ-+9F7(ALM@##&'U98X2B5BB0I:(-#ATY1SX[<M3+26FT
MK+=21I6DU,I4;GD,RU7L1"F;%)I\B5@JH/-&E<;$T=9(:=-M3JW&9*=LU(,C
M,M3A';M<B,&3Z$:<"LZ5"R!;5B11P:B[BS$29,%^0T?@GCJLM2F4Z?FT),M6
MA741FM7-*DD6QT:MTN<>U%J$:0K_ $#Y+^K[?VT_B0UVX+J;$FY+KCS\,[,V
M%B?%$2:J1$0;KKJ:O+4:=PRNKD\ZC69]]7,3VY@K"KIZG<,4E9^ZH31^W[/[
M*?[I>P->5F!4()8?9??GLMQHU8IJI"K^3;J$8SY^A)/S*]!ZWYWX?[?+D'YO
M?_I;?EW-OW[;GP_OY=QC^8E!HK^'FXLR'&V)%1IT5Y"FTFEQERH1M;2BM8T.
M?32?)7J1CU?Y/<%?^J=0O)M_\GL^31MZ?+VT=-OJ\NP#M.XUPE'=VI&*:4AS
M1OZ3F-D>G3J[:NVGG_$<C.*\-2F'Y#5=AFPP:R4LI!<MOYSU]/4<+V!\'R'O
M$2,)T9UW1MZUP&E*TZ-&FYI[:>FWMR["QO+G ++"XK6!L/H9<W-;::8P25;G
MSERTV/5Z^_J ["L5T!KXC^(:<A/5_P \:^@?7Z_1^D,1K=0I;^8N&ZJUB)+1
ML-U:EZ#-*B.2IMAQ3&GT4E$9;FKL6DRO\5(]YW+; ;R=+V",/N%T\E4UDRZ?
M+W3Z>GL/$EX-P.QC7#\5C#%';=53JDLU(@M$HV22RTM!F2?*>]S+L=SOW'<:
M#.REL:].ZFQ&N_Q>KHZ3Y?>*/3X+/S\I".=N;UOHZ_?V' Y0*4J9\H(I<0I7
M5\<F$[G4=U=5K\SYG[BKV'*%(_I%$@._VXR%?1T^I>W+[N0X'(=1@$6ZY+2@
MFW-@[O<M7VV/O]X1*M3*@DU0*E%E$1),S9?)??R]C]1UX>&Z#3B4FGT2!%)2
M]Q1,QD(NKZQV+O\ :.JY@O#2OF\.4Q/D[0VR\GD]/H^GMZ ,;PS5J#!K^+4.
M5V*EQ[$;4=:'YRU;DI4.*A*$$H^@[D70CE<9>UB7#[[&\BNP#395S*2GZ/G]
M?083A[!6%)]?KTB=ABD2W:56T.05G";>5$64*,I)M&M)Z#)7,M-N8R-&6N F
MT;;>!\/I1U])4Q@BZ_/RT_2]??U >NNMTIEAMU=5C[;O)I9NI^)T:N_W"U&(
M:$Z_MLUV MW;N2"DI/\ ?:X\U>7>!W&FH[F"Z$IICYI!TYDTM].GI+3RY<N7
MIR%K66^!&7O$,X(H#;MK:TTUDE6]KDD!Z!XBHB:@=,568124(0\J/XI&[I6H
MTI/3WMJZ>]O08MEM7$NY>T*J56:F*^Y"7)44IU)*-DE76\:U&9F1)/5JO;G<
M=][*7*YQ"FRRVPMH4A+:D_(T>QH2O6E)EH[$KJ(O0^?<>1EM@W#T;!,)I>":
M' LY(D2*?!:2]':F+-:7]HU%R3RT%:UD]/8!FR*BQ<W7IT9+'SI+WR\O^X<Z
M)49?),A7=?TR^ATG_'^(ZBL*8:6UL+P[3%-:=&@XC9IT^UK=A0L-4%/EH< O
M-VC(^D=U>GJ?,_<!VWY\2,>X],2E-T%S61%UJT%_$8;FA46$8:A/>);-!XBP
M^9DHR^;<JL8D*M['SL?WW\HR![!F&)):9&':6Z73R7#;472K4GN7H?,O8^8Q
M/,G!>%I= CPIE"IQ-O5:EH)345"3TKJ;6M-R+LK>=O[[J[^8[F3TY,V*O4PG
MGXY5&,;K"]M3)OEK)U2=9([V['R%Y5BG+85(*H-DPWS7(2XE39>0_-V[++T'
ME%@/!3;SBE8=@FB4Z3QL'%1MFX2=)+TVMJ(N5^]N0XX.7V#J<]+7#P_"8>?[
M.MQD)67(BY*(K]DI+[DE[ UD7C8_]:7SNQW+S?C_ .C%2D1E%ME+:,_L<Y_X
MW&+'E;EXKM@2E%U[G]%;+J^MV[_:+E9<9?F]NIPC2D_%^C";+EM]O+V]?O >
M5/D(/-_#RRFZO\V:N1:G$[97ETY1'8CYFLB.Q^A-J&;M5!B27P7R/FX72I/T
M%Z#[_:(Y_,S!U*Q]1(M-H\2&CY)K*TQF(Z4.6<DQ=2B4DBLVDI"NCL6Z?+I&
M4OX%PO*CL,3Z#$DICWTN/+UJ<N>I6HSYJNKF=_4=Y#(/&Q-W;\:WJT:].XF^
MGZ_W"GC(M]?C6-.J_P Z5OJV_'^(\-&!\'G&\-\A0]'A/!:MA.YL_4W;:_W:
MARKP5AQ2325"9(MC;(B(B*][W^^_.XX'1GU60C&% @038=CO1Z@4PS(C,B:V
M=))]KGWM[#JX4KN'8E.DTOY=(_ RY++KLE[:/=\0X9H1?T0KI(B[%R()\:/#
MS#P^VQ&;:246HJLA))*UXY;EB^TS1I^W4/7PU\GJI")L>$Q#1)?D/Z3;2GXB
MGG%*4>GEJ,^9GW,^?<!<C&>'G-\D5B.WL'U&YJY=>CU^T:P<?=>P?5LN<)PI
MN)*0I+F+X\79=EI-G==IM2::-5CO8UK0?WI+U(;6NT.DR->_2XCFYY];"3U=
M6KG<N?/G]_,8CF%%ITPJ!'GTU#CLK$$!#"O"MK-MQDG)!*2:RY&2$+;(RYD:
MC+U,!JCACC-R-P7A>B85G0L6Q':;0DT]Y!UYEP[I622-M#<Q:TI4LG4H5="T
M)0TDD$T=D9._QU9#U!F3"DT;'+++CDB*M!SXJ7&E$AM2[&50L5T'J3;MW(;7
ML86H,92%QJ'3VE-'=!HBH2:3^'S*Q<OF6?\ JD?5*UB\(X9=AN4YS#E+7$=6
M3CC"H;9MK42"1J-.FQGI(DW]BMV :OGQWY)N+B(<I6,FES:6BJL-'5*=<V'#
M,R):F9ZME7P%<W=)?%3U<Q;#X^,D?D_Y1:@XX>1LM*VDR::M?1Y>TLN:_3Z_
MTALPO+S CB=#F"J"I.TEFQTUDRVTVTH\OE+25B[%8O86SLN<!5-6NI8'H$M5
MK7?IC+AV]N:3 :!97YC8.JW&_2L=PY\UJBU]51;8?J3[#[Z5%1X:+N(;<6EA
MN["T:DV*RF2[.-V^@/YY8=;>>C2\00&)#"75K0J0A%DM+6VXOJ/RI-L]7U?4
M8-6<$IAYI8(K%%@Q8D.-&J<*HHB0VB-Z*MELDM+Y?,$<:+VYW::+Z1B154.E
MKE+GKIL53KK/AUK-E)J4S<U;9G:YINI1V[749^HID+',1T-IC=>Q#$0V4KP^
MLWT%\;7IV^_UNG1YO0<+>,L+.J=:8Q+35J:/XI^.;Z/*KW]G"_@/6<IL)UGP
M[L-A;6YO:%-I-.YKUZ[=M6KJOWOS[BR/3H;2G%M1&4*>YN&ELB-?(BY^_)*2
MY^A%["8ZY8@I"K.%5H.EQ&XG])1\UHU:_-[>OMS[#0"OYM8;R=X[,98MKM6J
MF(8M0P73Z0@V)T5IQ*7G&7E&RDS82XDF6OG4:E>NLNP^@94>FDE*2IT8B2UL
M)+938F].G07+RVY6[6Y".8F"\-5C-/%JJK@VAOD[3Z:VDWJ>THWD;TA^SMTG
MJ^/K<LKEJ2RKS<P$7/\ '-D2;4AUZ-B]MFFN.1G9"7VB;:46CFK]*NY\XGL2
MQXDKCRR'D15PWJ=C3PQZ-R6W*A)2F[?P[N-RR4=T?%Z?N^P;/KR\P0ZZMYS!
ME#6XXLW%K53F34I9VNHST\SZ4\_V2]AW9&&</R40FYM"ITA%.-!PTNQ4+*,:
M2LDVR,NBQ=K6L U:/CKR1@R7WS5C%YVGMO27U2WH+1)3N-H<NVN0DSLJVG2W
MR]!B&;_$1E3FME_4\O<-5RM1SQ&RB+'C5ZJP2@OI1*CJ-;BEON/(2M+B2+4:
M"MR&Y4? N#8CL9^)A&BLNPT&W&6W :2IE)J)1I09)Z2N1'8O4KCG<PCAQXS-
M[#U-69MH9/5$;.[:#2:$]O*DT(L78M*;=B 0GP<U^E'D12]5>I[Y'7,1.$?B
M4IL1UN<I*/-Z)YFKZ7<3HNMTUM^+'5-9)Z7\TC>+XG]GZW\!AN5=(ATC";=/
M8@L0&$5&J/)BDRA"&VE5"2I#!:>1;*3TZ2Y6^\9<>%,-&_+DGAVF&]4/Z6X<
M1O5(_P"D.UU_ON Q_$U?I;T*&AF1%E&=8I[6RA\E&ZHY3"DZ5>IHW$KY=)=O
MN[&$&&69V*&"=W%-5TR1J.^DEQXSEB]BYD+*M2VX"*<Q1(U.BE ?;CLMK0;>
MB.;B#4A!H;.R+H09I\IFE-U)M<<5+<GPZI5RA48C;=GN/N2M9=;B66"(C3R[
M)5IY=DQS+SG<!''&#)5%R:BDB&J0LL:X4)AI+"'27:OP5D5E%;L5ATN%Q^FO
M<.65DAW"$B6;^$*(Q(>1 LE3JX#32EJU=1I4VTR@UEK2I!HM9LS,6<6E"QMC
M#+J%0J+A=<B='QCAJ5!=1/0VDDHJK9FM?N7PTGI_TR#_ %:A&.&\(\<^%L#T
MG"]#8IK$'#4)%/IT!V?!7-<CPV(Q136X:-*E/.-K)9FXCNY?1=NP_#;5QE4I
M]PM_"SZ#\0EI2"@6ZT$:4E;ZJ".VYY#(S(O,D5:118DMIB+AR0MMEEXFU^ (
M]LF'66E$7(M/-M"TVYK2W=/D2-9W6OR@SD[X:Z8F-XDCW]ZG$OP?ZPMO1HU%
M?X77R^G<<NS^4'1X1+98<23L$G'['#+1**2X9$71Y?#MM%[:E 4;.1E4F,K3
M3</S$+T$WJ9A&P>DB01)OT<B*W+[QJG1I2:S^4ZGSGJ)(CN4W*!LX[ST="%O
MZJJW\5PUE=M5G'$WZ%:4Z-/(T#OP$?E"7DD_5W</1I7RAJ_17H#D?P?Q?53>
MK5\)/_7-_P!4J_5RAR^XAZ?Q-LYQ9P1($NIU/+Z=AJ+!:EQDDA+,V!):2LVF
MB_6/2]:RW+7*P#<5Q9M1S4SUV+D(5P6^VNNTVM4NG%-GKPZR2V(Z]>XA?AM*
M7'5="5,V7?E=6\?1R$HJJ5:1*)A%%M&+=^.4INW3\WTV_6?[(P# %-@1IV#)
M-,A1XGRM@UY^H$VV6]+</P&A;RBY.*3N.6-5S+6KZQ@DSQ-0Q";LN,=((S:)
M.Q*WK,/W+I-7JW8[:M!+'.[/KK5]JBZ]!_%^-?7\+5\'ZW7\/KV_K#W-"/J)
M]?3W[BI)25B))<NW+L"K'7:KB9O<WL*/+VH^ZCPLQI6XY]0]>@<)5#$[DS:_
M-9!,DPRYX@I:+;JG'"<9TGZH)".KLO7RT6&3;39$DB;3TG=/+L?V"IH29ZC2
M1G[V 11'K&)FLR)LIG+R6XJ11J<FJ&=4B7BDAV:M&SU?$NM;B>O1Y1WX>.LR
M%?HTS)>M,OZ3<,VJM!=9V_0R>6ZGXG^CV]/[8]>E;B<Q\0LI82;35%I;C3GJ
MM9R:EJ1]R;%8O2XS+2GV+O?]X"-'L=9C+7MT_);$#B#)[KDU2GM>1W27D>5\
MXCJ3]46P\P\?.1(2I64%:C293NG9.='6AKX6]9;FO7JL6C3HT:N6L28:$&G2
M:2,O:W($H0DS-*2(U=S(NX".W,PL7^F4&)BYE\Y)A)_6[-NA]?KU_P!GF&&:
MQ7&D%'?P55&-=6>5+4;T<]C>+>N:M?Q="S\.>WJ.US["1=)%V(AAV#I#JCJI
MK88C*.KS+DRX;E^QI/GZN%\3[/* [;-4Q0[,E,/84>0TSS9<*4U\3_CZ/O\
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MK,R[&-=N )$=/!QE><=PUWI#G5JY\Y+M_P"[V+V ;&
M                         (,XN)<R+DTM^AN,+JI8MPIX1,GDVMXZ_ TI
M._(T<BN7;ES$YC7_ (U6U.9#RYC++2Y<3$>%CBK7';=-ETZ]!(U*2OIMV&P
M
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MKE*Q&:6OI)/=INJW]OD7V#5S)V&;F=>5Q.EMDG'- ,B+E8RGM6_P+\ 'VZ
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MY1NK:=CI_,NAQR)Y";W3$90GR^BK$:?9-C.Q@)L
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M4@DQ3)U)E8G$F2=9%RV9                %ES]P%X    LN?N+P
M     %NL@%P"W60N  %NL@UD N 6ZR#60"X %NL@%P        LN?N O
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M9M:]AOR^FGF?+MS&8#!\HWHDO*?!+\-IQ$9[#M.-IMV^I+7A6[)_M=OP&<
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M!'&-*\#D?,F(=;95^<^%.I;JFS_Y>IWJGGZG^(G2Y^X"\
M
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M^1<^_(%:=#[A:R%P\V%/1/A^*:CR4M?4=9<9<_\ *:3'I D
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MJ;36HJ6FF\ 5$XY+232W=<^!KTI3TJML_3)'\ 5['U@  !(
M                       'AU>)47:9+@T]QCQ4B.YLG(;4;9'8B+=2VI*C
M+G;H,A%W"!2*=2.%O*6- :<CZL&4B8>I2E&3S[#;KQ?V3<,[%VT\BY"6*C*B
MT^#(=?\ #):;9,UDZHVDF1][WOW$;\)3K[O#!E(M]DFU?F+04\BMR* U8OW
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MAVYD1=8J^J4HX^VBVH^JP[NE)'>Q7%0' X2R[*/\1QM)J!?.[)_N':,B/N0
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MB+4M24)(S/F>DO8!EXLN?N+Q2Q>P"HLTJ]S%X     ++G[B\4L7L J
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MANK4E^1)C(37L.*5);B(E+:25>@W<)A=TO:;$>A1=5B[C8<
M
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MJ932:K')MXL%4=JS96/:1$;;;7R]3;))W]A-@
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M2S5;]]QKS^3[-9\&^6)JC(9O25K/2DDW4I]U2E?>:C,S/U,[@-C@
M                                  $$<9#<QS(Q]+$=E]Y.(\*DVV^Y
MI:W/E^G6-PSY&DOM$[C7WC98C3.'6K1I!16XK]>PLE]4Q:DM)3\O0+D9ES]"
M$_W/W 7@
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M:.73T:GJ=J#>-L./1HN]LG*=^5&NC4N^CL7X /N6
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MLG48 J*IK;Z"4DD>.AHLB_E5K<)=_J]/;D"M/9OK&  "0
M                     .K(0A^.IM_I0I-C7?N0ASA ATF/PO93G28K++2L
M%4A"D-L*92;OA4*<591\U*=4LS/N9J,_43)(<93$-<I*21;F1]A"G!XI!\*F
M5!DRRSHP;2R,FX*HY$@F&[.%KTG=1=9K\JSZT\@$Z
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M&G#%/B'J8-HC..@HYD2.VG4GDKZ165]HGH
M                                                !QM-FWW'(
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MX,LN*]@J@8YEYDML0ZI1HDQ)G0*8VVAQ\F3-;FI*CVSU(LDUZTZSLYS'KQ>
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MSQ7"/ECX9Z.M@J=++2PA:4GHE.(.VI".RB/TY=CW#^* V7
M                             :_\:Y35\.]833J4=0ENU["RH\,WC3XE
MSY>@_#N?E(3Z2B&O_&G'=?X=ZY$AS8T.2[7<.JC2I&\VRS(.N02;<=-![NRE
MPR4M39DHD$=A-5+*KE%BHJKS*IZVOTLHO)HG/K(2Y=1)_>,[![(  T
M
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MDEZL$T1P^7TE0FE*/[S4=S/U/F F,
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M9B5'$^4N;6&8]#S'R[>CQJ[X!S=A3FG4:F);1G<VDO)ZMM?47/GWT!L2
M                         "W60INI^T:P9Z\4N.<'9ITKAXR1RS=Q?F)7
M:8NJD_4'E1*/3XVAU+;[CIWUD;K1)TI61&?3KW%:3ZF!>(;./!>:M.R1XG,-
MX8B53$AME1,189>DG3Y!K):6T.MO_-J6ZTMM.ES6:UM?#TF;A!M:
M               "W60N%EB]@%X  "W60IK)?))B*N(7.VG</N4M8S2JL%^J
MG!\.Q$I;)[4BH3'GFV6VVB5<S,S<U:"*^E*N_,06[Q,<6N6E+DYD9]\/U"I^
M7L0T>*?H=44]58+#CS2$25L$XM+J4(<<4MM%E=!&9HL W, >31*U"Q!0X5<I
MU0:D1:C':FQ7VCZ'&'4ZFUE[D:#N/6            %ES]Q>
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M54<G;.)<:022)WFHDFM3BC*^A2%$6XV>W!F@S(S21V[7%+-<_AIY]^7?G?\
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M\,3ID'!CQLC<NX[,9ME#>%*4TEM,=31)3X5HM)(5=1%R(K7]!(A[9E8T)/\
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M93F\/M5AO%- G-HW%O(6IJK,.:5$ML[DC2R=OI:#/L1-KCO+W*CCZRZPKA7
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M$HS]1LE8KWMS]QK?P &X]PBY>*=80T9Q);>RJ6MRR2G22).H_0BY$0-;)@
M                                        ->N-N'37>'BJ0)D1]R-+
MKV&F5M,/^'W2^78*=LEG\W<N6KER&P26FDI)"6TDDDZ2(BY$GV^X:V\?\A4'
MA0QA*3'-S:J- U,LILMX_EJ#9M/VJOR5W3<;*@
M
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M5<$U:FQ$F>KQ2VYM/?,R+Z!Z4N_W/L!3X/JZ0J*%V%03
M                    !Y%9\?\ (LE<&,EV2IFZ&E2E,IO_ -*GJ+[R$6<(
M\J>KA7RD*5$4TY^9E(9MJ3?IC-(0?3]9/6?LG[;B3*_'JTVCS8='K+E)G28K
MS46:B.AQ4-TRTI>,G+MK)!V/2964(RX2:5!I_"[E&BGPH\8BP71G+,MI01+=
MB-..JY%W6YU*]37WN0":P
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MM^;31J4LVTFI:22H[<U)*]B/W(KG^)BY+323U):01^Y)(!>
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MEADYA#+^K26ILZBX?I],GK:>6\VF0Q&;:>0V2NR"-"M*2M:YV1W$H@
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M_K?]7_'_ (N.D>'*$I_Q2J) -[I^(<9&KIOIYVORU*M[:C]Q?\ATG_U%1/\
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M*1(K:64M.&X24E6)A$1**Q\B+E]EB!G>V.+L*BA=A4&@
M                       -:^/V3(@<*F*I\5)(?8G4,D*)Q+9H2=9@WLXM
MLT-E8N:ED:"^D1C90:\<<:&G>&3%95*4XRWXFC+;7$/K*5\J0BC\S^CO6O\
MLC8<
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MLYBZ=&2A6-</O292TJ;3':*?&W%K.Y<RN?,_<2S'VZ  %0
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M?$UX6/1I=01*P?48:RC:3*"SXF"[N/7,NC2VRWM(W%7,@/PWU=
M                             !YTU;S,&4Y'AI6XSS:1IY*,CN7\1#_!
MS6E5SA8RHD$3&AO"=,BEM/[A_ CI:*]D%WVCO^',3=J3[=A!O!USX7\I4QY3
M\A)X3I:M4J)X91O;%W")&A!FDCU$A6W9:4;AK<->X83J
M                       #Q:VFG%2)*ZC(7%A-M.)D2&WULK;09=2VW$'K
M29>AD96'Q-PA+A3\D</Y?5G!&"(C#2FY<JOQ\/:,2K)$AQY3V]K0MU:4NF1%
MI,R)MM/<R='W&<80ZDT.H2M*DFDR45R-)]R^XQ\G:-@C&F,\L(.4V!>!7%=.
M=P?B"83M73CQCQD>I,.1F)S32Y!)W8Q=#9;;B4?#:4E7PUK ;V<'3]1?R-8^
M5$3FI)8HQ4F24DG$OFZJOU UJ63JC=2JY\S=,E>Z2.PGP0EPL,S8^5T^-4&9
M9/1<:8Q90MUTG#U?G'4BN@SN9^UU";0 0YPTO/R<LJIO-K866.<:W;6M*]N^
M)*BHFSM=)I))D5TG:W83&(!X1HL2-E1..BM4<\.-8UQ@[AM-))*(S4'Y>G$A
M*5$K0I!GN;9MD39M&@[7 3\   @/A3@PXF",65F&P]'^6\Q,9U&0VX1DXDRK
MDMDG%)4VAQ)VCD6E9J/I]#Z$3X(1X7(TF-@;$+[\N4LI68.,Y28\AXEKAJ.N
MS2)A)$9\K)4Y8_5VXFX)@                    -8>&5^,N!C9ING*?7%S
M.QK(=(T[BUI15%DE3"$]*KI-"-:NK62U7[C9M9F78QKIPP1:DU1,7H7,6ZP_
MF1C&8HG8!L-H=36721X=U/-]!K2M>I;AJ^*MORMD1!D?""MO^:YE-L2VG[8-
MHZ"-IY3G(HK233S<5Y2*UKW+MH1Y!-8U_P""VHE4>%/*AQ=;C54CPM$;\1"=
M29$A!:"8LDBZVB(F7/IDXFQFH^H;               "EB]A4
M        %EB]A>*6+V 5         !2Q>PJ
M .-I"D>8S/\ >.0<:%$Y\0CZ0'(   "AD1]R%0
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M-_W#.Q'&6RUO8TS60M:E$UBYA+9&=]!?(-).Q>W,S/\ >8D<$X   *
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MRTND:C>=,Z].N:B4A!&9^X=F8V
M          :X\>,=R=PO8OBO'I0Y-H9L)N9;JTU>$I"#5]!*CZ#5]'S#8X:W
M\?":>[PFYC,3ZD_!:E0XD0Y+3*GS/>FQFB+0CZYF2/V?,-C6TJ3YE&?WF O
M
M                                8_BUHI6%*O'<13EDY$=:44[^C&DV
M^9*_9]Q@/">\^]POY2'(:T'^8U *WV?)\?\ WF,SQG5447"5;K:DR93$.FO2
ME,L1"DZB2V=MM!Z2>,R^BI?/D0P_A1UEPP92&ZM2C_,:@]SO_P P: 2V   ^
M>OY4I#A8QR:6V1+:.-B1*DEYS*]-.U^_VC4/"E$AUG&F!J3,A1ZC#FXLHC,V
M$PT2CE-*EM&XP@U?.FZ9$9*5Y;#<+\I^B0K%N426'62D)C8CTK*V\7_)O8NP
MTUPY*D%CW :E2'$RXV,*#=Q2CCH_I\8OH6]#/\0'W.    %A+;7Y7+_<H7@
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MTG2TXK5K1\4T-=[&X/PWUK   H
M  #CT&(3X/6Y"^%;*54FKLU!9X-I:-:6B29-DRV26>7/4TGX9J]5%J/F)M6L
MD=Q"G!]X)7"OE,J*XQ(26#Z9SB+41$?A6U.%8[<R7R,!-P
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M\$$ANI<(.4SS<"/"4>&(D0T1$$5S;/:4Y8R+J7I4M9][J49<SY[!
M
M       .)E!-H)HS'*+$+2OF1 +P
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M*+Y9HZK*(C*Y5",9'^(RJY# T&1F9=S[F.-;6XDT.%J2?<CYD.;60IN(]OX
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MB+D7H780!P3DXKALI*9;BEN(Q!B3<4Y<C4?R].YF:[W ; @
M                             -;^/E+R.$K'\MNLRH!06H4EQ;;9&9DB
M9&69';[.XV0&O/'8U&5PD9BQ9+Q(1.IQ1D*MR)U<AHFE+_9+E>_H0V&
M
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MD@G5'MFI24+3MCZ%[35R5MHN1&1'8NQVN7\"_ A:24DK622)1^MN?K_O/\3
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MG37\5^.V^\LMR_)1F:R+Z-S(K )R
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M-4C2E):=/D1<BYD9=DG=)=(V"">@
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M:7,3L:",^W^1:9V$A# \ODJ3BK,4E&9_YT,]_P#ZBTT9X#B   "@
M         UIX!H,N#PLX3DNQ&F79DBLRW&8>I4<G'*K*5I92IQ9--G>^E/3S
MOJ[WV6&N/ ,Q36>%#"#$)4=31/U9*4LK-:>54E)+S?:0#8X  !K[P;<\A($A
MRMRJJMO$&)#>FU FB?D+^7IMWGTM%;>.W.W(3^("X(&7XW#=0&7HK"9"*MB1
M&AIPEH)/R[-Y$KVL)_(BL,GUBHUQX##*1PQ8>>-$IA#M7Q&XA+Z'4/)2=:G'
M\0G#-PE_](9F-CAKUP+>*3PT8=.:QID.5K$BG4G] _EV<0T;"@
M                                -</R@#T*-P@YA*GLO.0'F:<R_M>=
M#3E0CH<41^ED*-5_O&QXURX[U0D\(N:"I54*.W\CDHKIW"-2I+>UR_;41(+\
M$Z1L5<_<!>
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M2;^A:=:N9(Y,$GU(@5['UF  !(
M  'FRB?<BJ;BO''<(N6LC=,B^Y)DH_Q$,\(EF^&7*9^;5HTYP\)4J,4B'$-E
MI+.PVAE@R-Q=E-W0VX?TW4K5H;3=M$[J2E1:5)(R]C(0AP@,*:X6<I]--AQ2
M_,VEI)$59$7.*V9'J*W4N]U'W)9GY_.83@
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MAJ(:'$I/4:;F26;.\[I39L_HEV0I2;+$_A<
M                                                 '&@TK^(7E'(
M+&S0:;(21%[$ O                                     :V?E!%FKA
M#QQN5 XAE(HQD^36K3:JPCOI^\;)C7/C^U_S4<7*0HTFJ30B,R.W>LPK_P
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M"<RU$DQ$8MJI,ODGI-Q:/$V4HRZ#,ROZ_:.EC3AAP%0,!8GDX1G8\:J\:B5
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M9K:8KJ6K1?SDJ),EM[GKXC<+5N\^?/:3?RD)\UM\N7;F7+L!;96LA):>W+L
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MTR!B2K3HC4C%RCDU:H/2W(YIES4J,W7%&M?4A2CYGS,S^^3#Q7,*H'3E80Q
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M=O-0GHF66*I, XY28U$G/$3A?#UI8<62C+M<E$1W]^8RS:*QIMR.]R][]_Q
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M+Z5M?N-PVB_UA/:.?<!>
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M(VS;W"22R)++1%UK,Q]&R0@K$22+29J+EV,[W/\ B?XBB=MNYZ$W/OR^V_\
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M,*07%%&B&TRITVB<<N1WNYN.*-9_3<2M9<@$\@
M                    (4X85R7<M)]W6'T'C?&S;"VCLVH_SCJ7:W+1R[%K
M+\!-8A+A7?I[66-2IU-2B.W3L<8T9."GJ./;$50,FE&78[*0K[E%Z":]9 +A
M"_#,AI."<1/1GE.$YF+C4G"U>2V()Z227L6GJ^\[B9M9"">%>8Q5LOL1(8TZ
MF<Q<8[S;"VR-1G7IRKJ4V17/2M)=6GD1%V 3P ZDA]++:C=<6@[*-)DLKF1=
M2K7Y6(BM<QUHM2BS''O!3FG=L]+A-NDX:%)6:#0=E&1'K;=0?[23+N7,(=X6
MY%2=PGC-FHQ([4=G,K&C<)+3A*6^15R6N[GJ2R63A\_HZ/03L-?>%$DE1\?(
M9I<N$I.:F,75N.M-$F49U62>M*D\S3I-*=:^JZ33Y":6K8(9,  !H
M          -6N%:;(FHQY37J.WL0<VL7252W*23*5*54Y!JVG"ZI+J5FE&^7
M(FUDW:Z.6THUBX::=B<H>/G7CC08TK,?&\JE2&V')"G+5=Y!R3,WC)LT.DMK
M;)LM2#(^RG-(>OP1OM/\)F5TE56E2VRPXPDCF.-&>E)*2;1&1<F6^R"[DV22
M5S*PV&&N? R[0T<)V6"*=2R@-'0DH(DH26N4:UK?=(DW^>6E3Q'YC-5UI0LS
M0-C N
M                   #C:;VR'(.NQNFDS?,TG[7 =@
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MZY?D]JA,BX SJK-2D>-EJS?Q+*>5"C..D\Z3<8W#9:3UJ)1]DG]@G6AT;'=
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MF>RR4AQV=B.)/=4HS-MM1TB"QH+T+IC:O_&)^P2@#B   "@
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M,U+QB&#I!D2V201[NZ1LG?<19)O;25%SNA2RT+U&1[$Z5>Y@+P
M
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MVUIF(.5$(V4E;H+433FKW0H@5I[-]:@  2
M          !8M9([C7O@9AM4WA&RF8CTWY+:.A(D)81350TK4XM2]W;4ZX9J
M=-PW->Y9[6;A(:UDVWL&;>KS<_O$"<&<=5-X3<IF&*A G-?FU!7NQ(Z&DDEU
M!*)LT(41;B-Q"%K\RW$J6I*%'I 3^
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MAI5AYA.VRHE(-A)&EI9V^FXVE#JS[DMQ5^=Q/@7
M                                                   !9NI^T!>*
M&DE<E$1_>*:R%P                                      UNX^HL!_
MA*QZS(<80B2=-/6Y&)U.I50C$D]!EW)?47L?/N-D1KOQS-SWN&'%C,"I-1)2
ME4Q&ZXSK22#J,8C6967S25U$?H?,!$TC&L/+?BKP%BK.3'U#I]/9PA7:/3JA
M*G)BLNL(* X9Z3-1H6E27DNG(V36M"U(LE*6RFF1QJ\*4:%XV1GUA1,;9;5<
MYY[O6C47PTEK\G5_Q<1O#81-XNLM/%8=>I\>?@6M324JH(>9ER5.1&C3L&1F
M@D-I*SMR6ZVZ:5WLHG-L8U,A0_Z)"88Y)+X;9)\J=">Q>B>DO8N78!##G&;P
ML1"-IW/K":E^(>C?!JK;Y[B7-M1_#-72:^I/['472*'QG<,:/FL[<..I::8D
M*V'5O_HZ^E+MT$KHU]*W.R#Z5Z5<Q.*8S2+Z&D)N=SLDBN=[_P"/,==ZG0Y&
MKQ$1EW6DT*UMDJZ3.YD=R[7YV]P&J5,XK>'6'Q 8PQ1)S?H/R9/P!AXX<A$D
M[2419E9<?YE:RDE+9/M=/5:US$AGQG<+\<T(FYZ83<2MQYIM;%0-=G&4&MW7
MH3Y+<TN>5?T13#<JG'Q>8WBSHD$JPY@3#+U,297D$PF95D2%F?[*G&DKY\RV
MBYZR(IN.(R:%-FR@T+3I4G25E%:UC+U*W+[@$+S.,?ABB;K2L]\+)4PYLK,Y
MQ&9+TH4?IY4H6DU.>5-^KU'4;XY>%1R3'A%G=0-<O;V^;ESUMZRU=/1R]Q-L
MJC0)1K4Y!CK-Q*D+-323U)4DDJ(^7,C2E)'[DDB]!RIA1T.OO(CMI<DVWED@
MB4[8K%J/Z5BY<_0!"T/C6X5)\>/):S^P83,Q_P ,VI<]*+K^JHS,M!_:?+[1
M&W#_ ,4.0.%,)52@8ESHH,63/QABZK0FG9*G$G 56ISZ7B>21DM&@]U2S<6G
M1U&HT]0VKDT2FR&78[].BN-2&?#O-K92:7&K6T*(RL:;'V/D(0X39E-Q!EIB
M$XE6C5F$>/,8);DI6EY$EDZ[-6E?01-K->HG#-!*2K5RLDTD0=Q'&;PS&6L\
MZL,DJY'X;Q=Y%C=V5?"TZN3G^SU^45_GG<+[4EV._G=AV,IL^TIY3.]R_5ZD
M_$_U!-?AT7U;:;\^=O?O^(.4^(ZM#CL1E:V_(I39&:?N/T 12CBOX9GGWH[^
M?6!HZHZM*_%5^-%LK7HT];B;G?U[#'L;\1O#5B;!%8H+'$'A)D\04V9#:=@U
MV*M]LW6%)T(3N$E+Y$LM+:K*-1HNGD8FI[#E#D+6Z_18+BW(W@EJ7&09JCWU
M;1F9<T7YZ>U_08WBNCX;H^#L2OIPPTU"DTF<NI-02*.Y+3H?4XV2T6-*U*<6
M9+[W6H^YF A/ATXB<A,-</.5=!Q%GG@*F52'@ZA4^3%F5V&VJ,^BF-GLOH4X
M1LKZ5=*S2=T*3<2,[Q7<-+9[J^(7+G3<_P#TYXA=M:5?K/=L[#S^%/"E*@\,
M&5C<FD4HE/X'H:73;BMH-9'$2X9+-1=76ZXOG])Q9]U'>6E8<HJBTKH\$RY<
MCCH]#,R]/0U*/_6/W!DT;?SK>&6026VN('+YQ3SB&VB:Q/$ZG5^1!67ROZD?
M;U%&^*[A@>01GQ'9:H->V:B<Q=3TZ;]7H]RY"38E!I< Y9P:7$C^/<4]+VF$
MH\0XKS+<L76H_4SN9BQK#M#8U;%%@MZ[:M,9!:K%8KV+GRY UJ?Q/<17#SB:
M@X'52,_\!3OD3,C"U4GM1*_&E.$RU4&C6>VTXHR:2A:U+6=R02.9'Z3&?%QP
MP-KBI:XC,O5HDI6IM)XBBJU)07,B5N<E?VC&&<6+=*I="RHID*"Y#VLR<*QZ
M>TW2S5$B6FH)6M9(LT6T:D)LMOFKD?<;")HE*2S*CIID0FIRE+E()E.E]2O,
M:RM91GZWO<!%9<6'#-XQ<)?$'@!"VVF5?&Q+%:WMWJ;-!FOKN7?3Y/I?9VWN
M*OAM9)F07$'E^IETK-&C$<):%]_I$X9^A_\ 5J]A)#5"I##J'V*5#;<;*R%H
M822DE:UB,BY<N0LB8<H< VC@T6#'-CYK:C(1M^?RV+E\Z[V_K%_6.X16[Q=\
M-J#I[K.?6 U)JY$<0CK3)ZB4O0C41'\+XAZ%;FG2?(^?,1G.SWR(=XP<-XEC
MYQ8*71V\M:S&=G%B=@XB'552GZ&?-MDZ>A?1JU&3?;I(;*G@O"RTM)1AFE$3
M&\;1%";LC>1H=T\N6M'2JWF+D=R$*RZ?%9XW* VS3T))[*>KLN)2PTE*TIJD
M#0V=E<S+XMDVTEK7;S+TAFG\ZKAG2=U<0F7'Q/)_G-#_ /;@ZCW%MPQ1R7O<
M067W./XYHV\315ZV/+J^<[WOTB4CH%&/3>D0CT^7]'1R^[D*,8?HD7;\+1H+
M.US;VXZ$Z.=^5BY<^8"*G>*SAJ:D*BJX@,#$_'FLPW8I8CAF\E:G-I*#3N7.
MR^:E%]$N=R';5Q8<,+>UJXALNOC]O\[*?\+^U\;D))5ARA+:B,+HD!3<!6N*
M@XR#3'5[ME;H/[2L.8Z135;NJG13WOG;LIZ_[7+G^\!J=DUFME+3N)+B$Q%)
MSDP(Q#J55P^U$2NKQTD[LT9E!F3IN:%M$HW4DE!$:5H?U7L1B;D\2O#THC;:
MSVP M3BT-IMBB"H]Q?9)6=[?:(IRDR]P+5^(/B!AU/ ]&E1(F)\.R6H+]*C+
MC,OG1H[QN)-2#LZ;KJW#M8M3A*[K68G9K*;+1DTJ9RZPPV:4);2::1'*R$^5
M)61V+T+T >+_ #C^'],9V>K/K+KP;1<WSQ/!TE]Z]VQ?@$KB.X>H/Q*CG_EU
M')OS:\406R_?=T>R>4V5YR5S3RWPL<ASSN_(\?6K[U:+F+F,I,J8R5)C9983
M:)7F)%%C)(_OL@!HQF]G;D57,^:+*IN=E/4TB4WB2G'1YIE&??-JFMQ(SYFH
MF5&:F)#ZE.*V4D3).J3<Q]$B2DNR2+MZ>W80$[@;+:J988\Q35\'T*2[*=Q1
M$G3T4UAN6Y&9ERV5H4_IN:B2UI2H^Q=A)M1_E1--Z5/PRVHB^:>AR'DG_P",
M2Z2O]@=S&8?#(B(D)L7;EV&)9DMOR<N,6,TY#K[ZZ/-2RVRE-UFMD])%?D??
M\+B^8G'ZU3$TUVDI/XO@3>0[Z\TZ^?.WO^[1;K$>Y[UC,+#>2^/,123P^2Z/
MA:?*=<9-Y*KHBZEFT=[H--WC*][69/WMP)BA'$DQ67FR227V"25B[IMV';W4
M_:-'L Y\<<F9M$F5'*O*7*V73:9,.DL2)E3E1U-2&M&ZEQAP]S05^RC0Y]HR
M>;B'\I$X7B(V!,HF%Q9^ZAIJL27&9D?9VMDR4WK26]\;<-QM=BTZ.E5T]!MT
M1H3V21?<&I)F1F17+L8U B9@?E*W%*.3D=E&V;B6XZ?\XWB(G>N[Q6<7T\B^
M'YOM'<7CK\HZN*EU&2V3Q/3(S;R$_G/)_0G?AW0]SLON?)NQ=^OMK"><?1S?
MJ6#UM0#>4UB%IU)H<4@TGX.4DU$:4+MTF97/05C\XSDD(+LDOP&B6),Z>*&C
MYHY.8+SVPIEKA9S%>*9"8"H%0E35M.,1%QT&_')9;J''9C1IT.6UDVE>@S,Q
MM[+1F2HS.F/T33O[OQC>66UMVVKIL?FY[GF_8 9C=%R5I*Y7L=NPQ7%*&'*O
MA6.\^I"D5=;C9)58W'$PI*S2?N5K\A1Q.8#L28RAVB(EJZH#Q$\3=B[DMN^H
M^Y=6JW['(M?7E$^4W#:J^B"=05/-#*HYJTHF*B23>-.Y>Q:$+)/K8S+L Y(Z
MH1YD5%C=TOQZ)"2I'KMJ>DZ%?89;;O/]HO<7U'%#%"5-J6(8RJ92H[[#3%2-
MU#OB-Y22,B2DC6@MS2W;Z7(T]B&&U3";%(ST<S?DXRJ3,<\*,X;D45J1JC.2
M'9Z%1GS:\IOJ/<91RL1*5>US&30VZM6:C*J%'Q8VW"BU;;?C/4HTFMIMHT.Q
MT+4M"KFZLG2=+FE9:3W" =W&\;%L_"]1@8#K=/IN(-I"84JH152H\9WS:G4)
M-"C2:>7)78<4=_&T:?0&UP*(ZP[3GFZPIF2\AQJ2@F3045.E2%M$?B$F;BVS
M(S:[W,=+".6;&$<23:M2<3UY='D0V846@.RTJI<)ELK$N.C1J):B[GKYCQ,5
MX6RFS)Q14,-5ZJ.O5=F129<N&S-?C[AP752XR%I(]*TI<6I:R*_2:$KY6 9M
M#Q/0)]>EX9IM8@.U>EL,O2(:)!*?8:=/H6X@RUZ%:.DR.R[>G(R\S$V)589K
M%'B'(IYM5-]]IV,K6<R2:6'7$MQ6$E8S,R.ZE&7K]@P@X6&\99R89QRS%-BM
M4V@U%PB9EK9\52Y"THCNOMDCXIIVUV:>MMF^I2=2DFD9ACS'=.R\PG4<7UN(
MXRQ#T(-JZ-1.JLEM)=?5=2F[^R%**]B,@'FP<T&J7AW!$C,2DRJ/6L:2&(B8
M4:+)>3$FNL[R&'E$@]@R(B2>OIU%8>MCFJ8XI[=(;P?A:%64RJ[ 8J*)+R&4
MM07'-4F2V:UD6IE'61%K-:N22(^W!CZ'B'$=#13*94I]"6EYF9(FP'VD/,)8
M=W5-F@R6E;:S9)"_72XHBO<R')E]"A81R\P[2:C-B,O/,,O27B6:$.S7UI6X
MXC49\E/N]*?=1$7(!VRC8WJ%/;-QVFTVJQZB2[,LJEL>";DG9LC7H+=<C\E+
M^@I1V&(OS,:8^3BK#E#DLT5FB8DI4*+5:?,-YUZ,TY&DS6%EMI-I6SN1R5=S
MYXS[$8]S,*CT+,VD5[*%W$=5ILE^!%=D2:8^34IEMUUTFS:<(NE:O"2",R.Y
M6/[![M;FX<H+,:LUFHLTYAJ2B.RXZ\I+;C\AU#*4N>BEJ6M"2,^?69%W,!U%
M82ITO#U3PE(F5%ZESVG4)0TZB+L1G2ML,.,$E:$I(^2RYE]?D/(S.P]1\3TB
M-AVMLT-3DJ8EAA%9IY369;:DN-O,I1K2>IR*[)9)1GTFZ9\[];$C-!HN$(-&
MQ;F;/IY2I;#+%974FXDJ0YKWM*7;:"UDERY())FV9)&7SYE(I5,E5.I:(T.$
MA<J2ZZ1:6M";&9VY\DE]'T*WV#L>4U%C+QI/D/88:;D_)<5M-;4TUKEI4[)-
M4(U?.DEOX;F@RT$J0DTZCU#NXD:J\JCS(N&JFS KC<=V/ E28RI+3#ZV_AK<
M:2LE+)/*]SY\QU'\/X73A/\ ,1;KJ*5/BJIB&'9SFZZVM"S<2EPSW=>V3A][
M])_:(YP?F;1L.Y:XIS=QKG#2:Y@1W$$R50:RPUK*#3G7&V/"+T(NM34U4AI)
MD2_ADV7<AP)8HU5@U2-(DTUXEMLS9$1:DD9%N,/.(<3SYZB4A5S['<S*][CP
MZYBJH4K%N',,,X4J<VGU]$XI5890A;%/?CFTII$A/L[K<22R^DT2.[B3+JS:
MC2J?7IU?<IDU$MQV!1)#[JT*)39O-[!I02[$1.2[JY(,B-1J(RVM77I$LL*X
M&A4*C4:+0)D0I5#PZQ69;KC;O@BD-1G'G$F:S:7'C)>U&9JT+^L ]#"#<S!F
M%\%82QAC%VJU@HD>DJJ<HC;>K$YN,M3KJFU&:D+<3'>=(M1D765^17]NLTZ5
M4J9/CPY)P9;K"DPIVVEY4=PTDHE)1V425)2JWJ:2]2N,/Q/1JCF5E]B!6$\8
M-QHV*\-*;PW4HS!-N0)DAE\DS&W-6Y=12&K%R-.TOMK,>UA_"TJ@4Z/A>'5/
M#T2'3(M*HY(2X],B&RA:3<7*>4K>5HVM)K1?4E6LW+F ZT-$'+;"=+ID&F*E
ML05,Q)+\5IB,TRV:;ORU(21);39*G5I27<S(A[E&K] QE0X=5HM0A5*F56$U
M*BNMH);<B(\GH<(KVT*29]RMW&,X Q/AW-G*N-6*'B2?6*55(<JG'4I5/7"D
MR=I3D=U[94V@T&:R,R+07+MW&,89R&PWEYF$O&F6E"HT1B90Z3AI;"G'4-LT
MN.X\JR"2=G5:51TIU=[+)2[& RZG4^93J_2(*IDRMN^"J)OUJ7*;)YE!R8[B
MF32VA!&2S424FGD@FB(NXPG*[,_*NAY2X-@TFH185.<PE\K--0TF\EB$PPWX
MA:C;)2=1+6M/[;A6L9C(L.SL"PJU@BEX6D4]$&31:@S2&6$N+:5'0]$6HV7O
M+I+27)97<TD:;:%7\O .4&7M0R)H66E0HK,O#RFHLV3'8>>T.S3DE--]+B#)
M5SE_'U%](_J<AV,ERLK%*Q-AE^JT?%U2Q'!D5*H.QILZ(N,I"5RW7$,M-N-H
M,TL$M+*%&79!6[6%SF(\509\N15:;1SH<.J]-074TM%'IA0DK<EK)1&2U(EE
M(9-!;?P]*NY#O3\13'8?C\..Q&(U.GG%K#M:;DPVVHC7](=9UH2A6@NRR+;5
M;S#L4RBX6*@N1Z?2XKU'K;CTIU"4$I$I4QQ3SJE)/S)<-RYDKZ/+L.!AV6.4
MZ,&US&^*)M6GUYS&%;77&E29BWD$@SUL(LHS;)3:CVFEH22BCQX;2C/92:NS
MA[%F'\U3E3\%9G5!+C)41Z;$0CPZX!$M%00VMEUO6TJ1%<)IXEWZ4Z2VUI69
MY-ADJ,BM8K*EPUQIA51!U)U;#C:9<OP,<T.H-9V<LQL)-:.GI-OFIM0Z4V/#
MHLC%DC!%)I3V-I4 I[L-QXF%5!Y+2FHKDA2-9I;5L$V2]!J22;%V(@'6P\JF
M4_,G%+3N.ZA4*S5(E.D)H4JH$Y%IL9")*&O#M%Y#=>8F*<<.ZU&R23.S:+>=
M6<O<K<:8]K[6)HS58J\["C%%K-,6:EH12)#SZDW9,NG><8>2:DGJ/P[=K6(>
ME1H]'QLFEXJK^!GJ;6Z<Y$FMHGLZI,5Y<<ST:B.RC:*9)9/2:DDK</V&15.;
M1J*Q/K]1EQ8L2&T;TJ29$C;;:2;YDZKS&1$I2R(NUU&?>P#"$XZRHCXYQTN3
MBD_EW"U'@EB"-)=4A$*$EMZ4S*0VHM!$HI#NMYLN9H2E7S9$7L5NKTNK8OPW
M3XALR)=.J!5!PU64I+#L&<TVMM1\DFM;2TZ2/LE6HBU<[FEX=1CFH)DTR*Q4
M9\&#3'Y[KK)_*#A%-?*GEI5J4XR@W'U)4C3MR+IN1J)'F4ZH4S>P]&@89<HS
MB*NZF5!DLDG:>>ANR74M*+DZDG)):G&S4@C0NW8QJ3M8.KE,HT)Z!4)C*9:Y
M6(*LPSX@]11FZBYNJ4M1Z;H-]E*D_04JQC(<.5"@8FI=.Q7AV:Q/IU8A-2X\
MME!EXAEU*G4K0?)1$K6H])VM<^17$3LU?#5;RVQ,Z[@./C1RB8JJE#J5)3#;
M>=;UUDW'5*2^24J2AOPTH[>;:(^:B*TTRDI@T[<9:<<89193,5I*E&5K607L
M1<K%Z#&P8)A;"3>598FKM:S0JL^@RVEU%QO$M1;6S1%$IQ<G:D*TK;C:5LD3
M2CT-$R6DRUJ&9T^L4:M-.O4V; J$5,AZ(X;+Y.))UMS:<;7:]UDI)D9'S)73
M]HP'*W-)K/7 T;$D++BOT^F8BHS54:CXD8:;:EL2ENH2SJ;6ZDBVF34I.GFA
M]HSYK,AVZ!3Z'EG@"IXBH^67R/.?B/8CJ^'\-Q6GW9%2V=<B-'0@FT/2%&TM
MM)I)).*+4NYJ,S*,NP_1(^':<FEQY\Z>WXI^2;LQ]3SQ$Z\XZ9:E'>R5=)>Q
M$0Q&@8GR\Q7F1B5BA8NESJ_@AA-$K%-\0\F)%1*2U(2I;)6:=6:462X1&LCW
MD7\Q%Y.5..<3XH<H$K$$M^ YB"-7:FQ">H4F+(>AIJC:8;JC>2?AC3%>C787
MU*5(4?ZLS&64_ 5/<IKU+Q+'*M*?KA8@>E/QT-J=DM3/$1362>9G'VXZ&E'<
M[1F^9$1 .?"5+P91:AB16$*= A2YE7<GU]J*E*5N5-Z/'4:G?I;QQSC&?H9*
M3SYE;NR<4T!ANMRCK<%+-#<VZP9/MJ*&O90\I+Y%S:64=;3A$OD;;B%>525%
M'6#<(86EX_K6-:GEO3853EU^1+IM;3/1,?FN-1$PC=3RU-F31/H-KRI5N*1K
MW3,_9RQ/!./*"]FG3,!_(B\<1&4S4U.G>%ESHC+KR(3DAI16/4E:UI)17)#J
M$GR21 /-QP[3HM=E53#%?H%.G8>EPZUC9AZFJJ$J326H[[C25-HZR?2HENL&
M1G8VKDA9)VSR!W-2B(SL:R52Q)56BPN[B=V2;1E':CE):CI;2OLMPW#4HR[I
M+3]<AS4'#S-(Q7B%-/PI"B4ZH>'K!32DF[*G5!6HI!.MJZD$T3$#38['N':V
MD=F._AFJ8Y-28+ZJU0*3M%(5!>;;1%FNM*6EIW1MNFM4%!F32U&DV4W[D \U
MFJ48\VY=$@4.$=8;PS$E5V>IQ2'(<-<IU$&.2=&E:75MU0S-+EVC83J(R<1;
M@JE0Q[B"B8?PU'D0L%8IK5/7/FQUL?*GR=MM-DXB.Z>AIY;<AYKJ65E)2KX9
M^E8%;PMB?-JL8=.CTYZL8&9I<M<LE(*1'>DQYB$-FBVM+:8[D@T.:C0HY#Z"
MTJ0HSRFNU>!AVCS\1560J-3Z9%>G3'%,FZE+176M1;?4O2E*NDB,U73W 8UF
M(QAG#S\'.3$M2:I[6"HL]^?-:A+?65-7'U2F")O4LDJ<9C2.DC5JC(3V48Y3
M)F4W$P=6,8U*I3Y=2F5B-,BD3!H:AU9E?A5J;LG;:W(\52#ZWFTK)1FI2S/D
MQOA.'C1-.IM6P[\HQ'9<C?>\:N,]3&G(#S9O(-//=,G29T$=K.:[W2._3H>'
M\-3F,%4>&<),@IE63&CQE+9UJE)=DKU'R+4[*2HT\C,EKT>56D.[B+#%$Q72
MCH>)J=&J+$E)H-I]M);9*2I"S29%R625K*Y6.RC+L9C$:4[*W7\*XI8CXF6=
M39I-0F)IB(R3(J6Q(<>E)69(<4M;1G9DEI23C">6A8X:MC3%DO'V':'@##*Y
M]#CZZEB.>LT$VN$['E%%\*>Y9UUR2TVI1GS2R5SYNHU<>8^'\"9A1Y67V-:0
MY*\30JJZW#9>6W,.*E2([ZHQD>K4>MHC7RMN)L?6H:EFE!V%#><9>>B,N.1G
M#>94ILC-M9I-)J2?H>E2BN7.RC+U,8]C'%,;!M,^6)=,J,N/)JE-IR$Q4$^H
MGIDN/&9=)*CY()QY"E&7E)*U^YC",:9[4;!M+P=BKY%K4_#.)ZC&;=J\74XS
M!B28TA]F2\E.M1,$IME*W%:$))VYJLVIL2!7)ITQB-);@3YDDY4>.E,2.:W"
M;=E,MJ78S(MILC0MP^^VA9ES&*N"G-.5!^JJJDNGU:(532]#90V2TPR82V@]
M2N>MQ$AIU9'W)5D\E-J,^Q7JJ]0X9U)5,DS4*E1X^S!:2MP]YYMDEF1]TH-Q
M:S]DI,QB[C%>PW@ZH?R9X,B1IQU243,"H2=AIQ;\];C\W66L]HS>DOI:MU$:
M2+;'0BS9.&:-F%)CYA^.D463)DD]B$TLP:*M44IILO/FE*UQ2W[FHKDVR1-I
MLII1GJ3VSQ+19^943#T%Y*YD>GU(I#:VU)2>DZ<XHTJ[=I;'WZC^J/0PBX;M
M=QOS/IKS))^PODN"?(>3M5M&;49508C+I[E*J2HFR6ISSTPC-1GZZS?+VT$@
MO0<M+@U27B;$:J55UP4MUDC>9\,D]:CID:QJ47>VI'?ZI>P#".,1"'<D7U&V
M3R6,3X5,T>4O^7X(Z7"G4Z^YPWY82(]-;F.JPZP1R'Y*]1I05DK,CYV<^BGL
M@O;R#N\0&7>)L:Y2.X.JF-=)3JS0#3.9I]E)-FKQ7$G8G.YZ2Y_8(\H?!CFC
M1FET6E<9^9,.B0T);H\*%'C->"0DK)(U*):'"+4]8DI;MJ3_ %2+=Z9*MG/$
M5I!71 B$5R*Q/J[GHT?A]+]PN:563FZ%TV$U3]CE**9^D7_L$UI+M]<:V*X0
M,SW9<U"^-S.9+;A'X11.12V-=]TG%DUI>U:DZ=)-Z-)6[#FJO"7G6ZE3%#XV
M\UHT>4FT@I:84A]1;6GX3A-(-KJY\K<^?<3&P:9F($Z7"I+)&6X91/$-DKDL
MR*RK>B207_COV1JXI^H*_*=45F='@,VR4VR_32(]*JHM:EM<KNJ):#+2KZ%U
M]Q[:.$3-YN<B0?&CG"<8R9+9WXF[R=0:[NFWIYE>_+GWZRNV+,O^&&L8+SXH
M>9.+<Z\18ZQ,K"M5I\*54HL=!QFRDL$2F+D9H,DRG;:MSM?RGM@-KM1"#<LZ
MO,J686'#5!;9:_,!E9I2G212#=CJ=25OHDEQ!)+L1%8A+,>!6&_$F_6G7]WJ
M;^ E&A'L7[0B+"L:KTS,.D38+,59JP6RV4,IQ:3-)-F^VP9%SZO")2L^Q:AW
ME03II:U:]M.KO>W,7ZR'C^.K?B]KY%_1_P#PCQ3?_FV' U/K[BTI=I#+9&^;
M1GXP[;?Q.KYO]A'][\>!@W%43:>&#-TR0DM6!*Z@^7<O .\ON&%\*A4=7#%E
M31JC47I!.X/IJ$MM37U&E*F-Q*"6O19)-I-)%Z)-!>4DJ5F^>%,Q9BG)?,'"
M]+PZRY/J.&JI!C1GYB#1+4Y$=;(C,RLFYGT]K_2T#7W+8_R@>5F5>&<OJ;E)
MEG4F\*TJ#36I3U>6VX_';9)*#VR;0EE;:$DA9KOK/M8!MDY+I'4EV:5GG"L3
M^HKN);;49E;Z.DB,_P!O[1V/E:AHF:CJ\?5LZ.<D[Z/K]N_VC6V9C?\ *&1U
M/JBY'Y5R/#I>B,-1L0O&I2B-LR?U+-/0H[_#Y*+Z5QZ$K-_C8@5 W9?"-0I<
M20ZTTRU"QRUO13,^9ON*9TN(4?\ 5D1(^E<!L%X2DMIBQVYKB":64E1%(66H
MK:.?/GSMW]2&F6>\B+3^,O!L1BJP&'ZE'PBJEQHZ#29DU79BWS4H_-K;<69&
MDTF9+4GK([.2)5,RN.QQ9RJ9PQ8%CMFZTULRL=(=<)*3NX1+0RB]S[>O[ C/
M&6'>(W'V=^ <Q,P<DJ?A>- JM$IB3IE7C520C8G(EK6^\M*%)0:B=2W8^=UW
M^>2 WQ(T)*R4D17,^7N?<4LUWVT][]O6UO\  :ZR<;\8L2LSI3.3."I%'CU!
MU@FV\4/+E2H*77%H?;-;:&T*-I2"M:^HOLT-PAB/-7C_ /YPDS">%L.41R8W
M18<LZ*9*70([#CKI;_CEZ%K<5L.%;S*VG-*"L=PSO-^;38W%EB*1.=ANN0L@
MJR_)C);/K;^5&N3JNY%WT$7:[MNYWF[A?2M'#7E*TM1FK\QZ#S,^?] :$%YB
M19M6XGZW2JK.BT:J5+AWJ3%3DI<7X6&X=00A*T*[FTAQY]1J\Q$2/8A.G#(^
MA7#;E,]RL>!Z#_[0-#OL()1$?Y^MKD9(YB,-+-*EX1J^@R.QDKPCEC(9-*Q)
M3H<@RE2?#L,I4IR2X9%')1&9*;-R]M96/I[\N_<>#G*1O9/XY)@B29X8J1%N
M%Z'%<]QRDZM)6E>=&(307)G"U$-3I'R5N2ZE;I_U%?B8D41CA*&@LU:W+1,<
M><=PEAQ"EK6:E*2W*JEEF9]S5J.Y_:)(?>888-;[^ALOIFK_ +1A!>(YSQD1
MV,&07WVT++\[L*M))1$=EJKT%"3^\E'<C]#&>HFQG5$RR[J,_4C_ +7_ * H
M8+G4RU(P7#0XRA22Q3AIPKE<M:*Y"4@_ON1'?W!L^A=EZA#&*LRC3(6Z;V)V
M#(S/5M?Y%IO)5^PD01O@=R*>+,QFDLLMJ+$K3;YHL1N$JB4Y6M[MSN9)N5^6
MGW,20!   !0             !Y-8K]'PO2I5:Q+6HM-IL)&X_.FR$,,,M_66
MXNR2_>/6$79[QX\W)S&K4O+N;C-B31)>_AUAQYF15$I;.\5I;)*<)P['I4VE
M2OJ)48#,,,8UPGC6(]4\'8II%=BL/*C+?ILQN0T3B?.B[:E%J(1#P7%%7P]4
MM4.FNPVCQ%BK3'==-QPC^7ZC=!K/U_:N-#^%K-G,+*1& ,'938W5B6KXAQ+*
M5B;*J50SC2:89ZRE279SB=9+)""=-2C0AJR26VK4/H'PIHCPLG?#QV4,1&\6
MXO:2E:2(DH+$=2(DD2>1$1>G8=Y"5JQ7J5AJEOUS$57A4VEQ65294V9*0S'C
MMEU*6MU:DD2"+U/D1=^0ZF&<980QG3I%2PGBZE5R,T\N.[(I4Y$IM#B4I4:+
MMJ41*)"D*,N_41^HP/BBA52?PZYGPX,-F<_(PA5&RC*0ZK?_ $1TW&DDT9.&
MI2;DDB/S6'STX4\=)R>G98X>R&S[I>-WLP:U0V,4X-C4F=> U(2A,V9RN27X
MR23=\]M+C;"]U"DMI27 WUX0G&OY$$>$\03:<78P-LG3,W21^<=2Y+.ZKJ$Y
MB'>&)IR/E=.1(,]Q..,:[BG3TJ498GJ17.W<3$ "!>#)R-*R&BR(:8S;3^*,
M5OH*(LUMDE=?J-B(RL=B$]#7_@KD/U#AZI,R=#:@/.UW$SCC#<XI;<99UVHW
M0A\BLZ2?2Y=K -@                                           &N
MW'9#KDWA!S-9PLIA#K5')QPW^9'#:>:<D]_7PZ9%OVM(V&N?N-?..A*'.$C-
M)!UM<%*L.+6;B4&9J4:^EO[G3^&9=B([=C&P8SL%X  T
M
M              >/6H'RO2)=/;FSH2Y3#L;?8=4VXQN%\XE1&1DI/H9'<A'W
M"ERX8<F[?2P!0%']I^ C\_XG^(DF?))B+(6KK)I@S4R?K_K"->%/_P"!;R:/
MU_,##O\ \[XX"6@  'SM_*N-J36<FS*8ZE@T8C8-)+,EFK;@K([][V;47W&?
MN-*(_P JMSJ1%BPW7W(U5II1VG)!LFJ0J4TE):TGZ*(C+V,KC>+\JK&;<J.4
M3I-IW$2*\:5VYD9LQB.Q_=R&D<7] J%%EGR:C5REU$T^FXW+:,TV^_F ^\8
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MD_(T25Q645Z6>EVGX8JZ(B#:78G"..DC+GR1I)Q5CV_,C[ 'UK
M                              $"<&<>)_-1RF53JO.J"58;IZ]ZH&HU
MFM2"6XB^A!DAM:G6VB[$VE!]1D0G1+[2DZMSX?UE'I&OW!&A!<)V5JF:)%@,
M(PXP9-$\TM-B7=4@MM)$1K/XUK7)1Z5&:BW##8@
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M_B0#G                               6+<2CS"W6S_7?[0#E
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M2^U=MWNA1V$DZR 7 +=9"FZG[0%X"W60N
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M%\N7)I=*_*#4EZ7)D,^(0]@>F.R(^M)&VIILED2#=90IS;4@TWN:;<U@-O\
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M=<ESWVEU)>,,8I>6PKX*G#Q'4;FBVHB1]4NW+D G$
M                       !!7&L;#7";FREQI"DHPU+<2DTD9$LD:B5]Y*+
M5?WYB<A /&R^;'"GFVZZDG4GAV3'-)LN.6-9&1'9*B^N7/Z-B-6HOAB=XS[[
M\,GG&-#MO( [0
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M&T-E8G32X?(R[=B:V[K^DY?N8#.@  %"2DN9$1>@H;;9E8T),C(RM;T/N0N
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M"K\J+XBCUC=\'%:>\2UJBO>'<-?S37-MRZ?B?"TW^(H!]>0
M                          =21$9EM[4IE#R#^BXDE%^!B'N$9$8N&#*@
MF8Z(J?S/HW+09W-$5I)WNA/TN?WG<32(!X(Z-(H/"5E- FU<YSAX<C2B?6X>
MM*7B\0VT:B/RMH6EK3V+21>EAE.@; @ #0
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M/W&PPUOX!U-.<(V6;R)J'TNTYU2-+ZG+-HE.$22U^B2Y&79/T1L@%Q0
M        ?-K(3)VN<=^#<39^9T9G9@TJ+7:L_3,.4>@5U,>-3*0U((SBN&V@
MDND?-DU+:O9LW574X26Y-X4<6X\RUXBL=\(^(JX5=P]2(LG%%!FS*B<ZH1X2
MY<9IJ+)?\NHVY"'R0?627FR[&1%V)?"!G#DQ7:X_P=YA4;!V&\6I-;]#GT]4
MA%(F$P6F6RXX;BE;BFDM*(T703AJ3W/1)'"]PT/Y&1ZWB7&F-)V.<P,6FPNL
MUZ<XI;RVV2TE';<69K4VCETJ.QV+D V(
M !IOQ%XLQYG!Q'8;X1\$9@SL!TMJA_GIBG$%$K#D2LJ82M;+4&-8_A]:4K<O
M?X;B%ER0I+F-X@H.;G!KF;E7-H^;N.,RL*9DXI8P77X>.:XF<N"[(>0J$Y&-
M1IVW4L)D[BDGI<4A-T=:=N2.)?AYQIBK&V&^(+(B85/S4PFVQ3X\>;+D(I=4
MI:)"G%1I9-**QI4^M=^9J2IQ&EPS0XWY.$N'G/C,O-7#F;O%3BVB^"P7(:DT
M'!6$RDE25SFVT*8JCZGWEZGFUOR"-NUTJC,:'%HU)<#;H
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M=-9GH_-N6ZB,Y=!$ZTE2V'R-/.S+B&W;>I,J*QZAL!8O8!4
M
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MIN]OAND3O,N9$21Z$&FXEAS(6]M*;WW2E(9*R4I4AW25BY<C.-;VZP&;@
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MX?J[*RW_ (CC))9/4D[W7\0VU=7HE0'8^O0
M              +!K_P0HA1^%3*[P<.3&(L/QTD3K#K?6=D.'9Q"3TJ<+4GT
M4FQILFQ">WR4M.TVHTJ]R.P@O@KDG*X5<K'DNP'TGA6$S^A&9)U-V1Z^I*ON
M>R[D7(93H$^  #:                                        #7GA
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M-(TU$I2W,W,8*>:3(6XF(LZBHC;02N22,K+L5BNZH^YF-C0N
M        "TS._<:F<),2!-+-J5&@QXU3:SEQ9%=?F,'>034Q;R'&6R<TN&VX
M^E*E)L9Z5)/J0DQMD-3^#9:F:KG5$BPYFI6;N*U$I]I#3#RCDMW-EU/4K2C8
M)S5YE$6D[H<OJ3*> V'%IG")EA&B57Y0:^1M12%-:;.K?<<4P2?9I2EM7]=L
MC&Q0UJX$7$EPG9<I15W:JMNFR$)F)94PBS<EU)$2%MH,B1?0GHZTEK/69W/9
M49<5             %I(0F^E"2N=SL7<_P#@B%=*>9Z2Y_8*@
M                    M)MLC,R;21GS,[?=_N+\"#;1]1//EV%P
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MOYMTI*3-RYJ/F=N?-LS_ !',EJ.U(.?\LNDTXWK4G6UI,^FRCY6,^HN?W?8
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M4MZ/)AQ\;XT-@VWB=6MDL15+0OEW4?OW,@$W@
M                   (=XM&T/\ "WFVWH0I/YD5U6F06HKE!=,CL?L=C+[1
M++*EE$)3FIL_<U:S$.\9#*WN%3-A*74)5^9]7=ZW5)NA,5Q2D]/.QIY&7J1V
M,3&PDF4Z2(B+V+D [
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M3%1WZ>DY#YH:9D1W5HOTFVVZW=)E[<SY=N8#[M1HZX<9,=+BG-HNIU2KJ/\
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MP+\GW4EP.,;#2#DHM4J%6(:4D\OGTI?M;MV8_P!E7U4:RM/9OL&  "0
M                               .-QLU<TG8_<:]\"2DN<(>67AS*414
M;29^32K><);?V[=M&KZ5M0V(&O' K$K5.X1<KFJU!8C/GA]M2FS2I!$TIPS8
M*QF?4;)EJ]348#8<                                          !!
M/"VN6]@"OO/0F8DAW,#&.^PW+4Z:/\OSR.ZE'WU&:?AV*]U=S-(G8:Y<(,^>
MYE[BZ/69C3U8CYB8MCU-N/$DMQ&I:JP^:VXRWU)WT$2M1*3VW#;\[:TGL: "
M!N%QPF,(XXU27.>9^-5$3L9+9)/Y;DE=.G^D=1EU%])>CNBXGD:]\)#$U.%\
MQ)DTY+*GLU\7NM(>TN$E/RJZV9))'(BU)<+[S4KUN V$   :W<'5.5#IV<4I
M$Y2_E;-S%\M*222D1R3+)@KG](SV"7S]%C9$:Q<&$5J-AG-.!!.&Q&@9O8MC
M1&&()MHBME),DH4DK$I1%8ON/3YN8V=                     6#53A%EM
MRY69S$>3)?7"S;Q@RXVY$?0RR2IZU%UFG;6LM:5D?,RW%)]5:-K;%[#5'A*:
M@/R,Y%+5,>=3FIB=\W&UFM@E'4'=LVTK/;)\CAMFHB3;J0?=1@G-[OY/V&<#
M@WRQC'#\,9TU]:D[FO42I3ZMR_[967H^C?3Z#9(:V_D_F%L<'66!.PE,J53G
MWRU/Z[D[+==)W_6)6O3]$CTC9(9-2@  -
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MC-7Y]8W5<SYW_.BI\P$P
M   (CXL3,^%K.-*#,K8%KR2MZ%\GN\A)\)M<>$EN0M2UM>92CN9_O$4<5R5K
MX8,VTLRFU$>#*VI1K5?4@X3O3TVZE&6DOL$H4RHL5ZGLU2FR27#FM-O,*)NR
MM)E](E /4
M                                          !#?"8RS#X8,IF6W)!H
M_,ZC.FM_2HR<7$;4I-R]E&:?X"9!!7!;";IO"GE-#3#5#4>%*8_MJD[YFMQE
M*E'JOV.Y+)'T-1)Y:2L$Z@  /G_^5+@1_P#N3RED\IU50JC&T<QPF=1Q6^Z;
MV,_ML-$*PF.<"*G3%LEZ(AXM2NM).M:R5[D?K?N-_?RIST5-(RGC;3AR%8GE
MNDOGIVT07#4G[C-39V_9+V(:"3'%I1%CN+4HU3XI'<[W)QTK$?X%^ #[V@
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MDTYQ@8-5,;GN.?(]7:C&VDMIM1,WZB+EHT<K=M7V@/L"
M                        -=>!&,</A(RQ*6Y&<DG1$.;D5A;;9MFM9M7)
M1GU$WMD:O*HTK4DB2=AL1K(:]<",6,QPEY9(I<!B+$*AM*-"&T(43^I2G5V1
M;SJ4I5C+41J/4:C,P&PX
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ML(/.3&!DZ36DWR\:LMTS-M&H^6W<C<*R;:^1MM[(
M +3,[]QJMPB,'\HYJS&YOB/^Z]C"&ME453IQU%,4ZE!+29;9FEQY>M5[[Z4^
MEAM0-4^%U94Q6:_B:VS!?CYI8SJ*E.S4NQV6R=(U;K;;EG$HW&5F2]*D64DM
M U)[/Y/V4I7"#EN4BC?)KD>/4(ZHI+W2ULSI"#/5[JVS61_;8;+#5O\ )]5B
MA5+A&R^<H4*7'33D/P7]Z&ZPF7(;D.F\^G<3\1"G77'"-/+</;\R32-I!BH
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MGZWU^D8'FUES@*F8 G2*7@:C0/!S(LE)P:3&29?I3)N6Z2\VA-_?25^PDO\
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MI@B'6%X>J,6)(BX;B-O-*4PXA&A:4$:;>EC%S^ L&GF>B@)<JQ3&J.5<FO\
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M^1 .<
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MB7Q<826EV,ZXW1*NX2W$I=0DC;9+::6OK2>TM1V3Z$KZSF@=CZ^@
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MPO2<*0YID-):ZCF2%FJR2[ZCU7[WY]QLJ"@
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M@0N  %B%DOL+QQD1)\I$7W .0
M !KKQU.3HO"3FA(:.*O71=2CD*;).@W4%V<29:[>4^YKMI-L[&-BAK;Q_DEO
MA$S"5)4V\33$*0X6XIG4RBH1EFDS3ZVN7VW" A&7FI2Z!GWD?B>G0:I/PU1<
M.UQJ4=*I"I4]E+Z"41NM,76;.Q#9?N39GI5?S.IML"7&!ENZ?Z)@[-29R:5\
M#+^L_/.?-,<V/,LO*KYI?HH154X?@N,G(^F.4LH\EZBU:8YJ4;SQ(9AK:0:7
M6W=LD*2;9Z2):%$VE1);66A&Z!MW[E?M_#L*3$$QN+'",N;\GN9=9O,NZW$2
M$HR]JCJHB"<TDM:&V%.'R^HE8Z)<7^$'(2JO$RQSAF0RV7O$1\OJILZ%M..'
MU*9M9*$()RW92N7,3]X=&HE[:=1)-)';G8^Y?<*FPE7)22/D:>9>A]R^[D0F
M-+'^)C!M"XJ*WCJ12,;/45_+NA09K'YIU%N5%FE59JVMR.XVA1E:65M&OLKZ
MAVD4^.W)9AUXY;.-6HJ*<_4HTY6').Q,0RO2:6]*-9&I1*22EMH0=E]7(A$7
M$Y!JLWBRH#E&HIUJ?X3"\2) FO&BF*)Z56S/QS1$I;Q:6G33\,R9(B-'6XE
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MN*C0JR$?^Q#)^BMN?C(C,C,KF78=).RLG34IE+B7-QY1$73TZ==U?LE:_MR
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M71KZ33[F,\@4-BE.+-+\IU3LLI9ZEF9JTLH85?GSOS7_ &KGW$>X\R-IV/\
M$D&N2L<9B4*I4QE+2'J%B%V(PXLB6A"U,6V#4A#ZB,]'43AEUZ3 >:7$M5+Q
M;\-6<^J6Z26?\CP[)(_G-9>,_5^M_-^KUC%L;YW8JQI@.;2J=PQYR-*Q!!4Q
M&)^GPH\AAQQS;;2XE,S>BFDB)PG33I074JZAD4;AA1#EHG.Y]9WRMU\O%M/X
MS?4AWEY22VV6T7[36U]XQ7$_#ZBC8KP+26N(+-UQ-=J2X4F._C!Z\R.Q393I
M;9MD6E:'F&7KHTF9:R]3 90[Q/X@:ITRM*X8\Y?DVGREL+65'A'(=2VWK<6F
M/XLG=.KI+HLOZ(FMNHMR(^^AF7IZ_P!65^C_ -"]!$$3AI@0Y_RE_+9G&\N^
MC;<QF^I.GO:QE_Q_M#+)=431*)B&G%&F.1<-1X\4GSDJWW";CDYN&N]S5VYW
MN!-U,99P3<&XE5A^/E/F#B0V8^\N91Z<PY#:1[&IV0@U*Y?:,91Q+U8I+;!<
M-.<UY6HV+4>'STI:6O7^E_!MNZ4[FG6I"]O7S'>S8R;IN*7*ABQ[,_,O#*H=
M)>9VL.UYV'%*QK63Z6;:=^Q6UVT\BY#$,+<-4K$&!*'.JV>V;Z:O.I,1R=-C
M8R?:7(7=IXE))-FT'JW229$7)]PE[ED;8<&(.(:L3*S0*TQPWYS)ETBHK6[&
M3AQC<.._"6C<,TR5(MNKCEMJ<0JY'_5.:,OI'%'0JI68-&=ROS4@HGOQ(B)]
M0PC)BQ6G9*]MDUJ<)*R29]ST=(ZA<+$2/JDPL[LZ69)E'*YXQ=E(LTJ[=VI!
M*1S,S-7+F=[CFI7#?-@JBE5^('->KPX)1UNPIM:8\))-@[F;JO#[O69779SN
M5R 3$FI(_JG_ .C[W;]7];^U^SW' JL+3)VR@/6/>]_U7;^\.5<264;04F22
MM6O>NW?YS5VM;R\ONY#&LT)=:I&!ZS5L.3)T>I1&4R$/ILX:20ZA2K)5\/FG
M41E;M<!D:ZFM!$V<&<9Z7U7)A7D1Z=_,KZ(QUMAVGXSK>(Y3+RZ=.IM-I;>B
M^LI+#TLS+W_7IZ_L+GR'N38J6(<N2@I#K[#+BVDFLSUK3KTG]IE8K'Z6(8I1
M9^):B_A5J1-J"">PVN5-=W(ADJ091DHW$$GFLS6Z?P[-73YNP#*%U]LG/#^'
MJ7?38H:[_.[-]SR>;K_L\QW45(W$]<9U![VGU+ENZ/\ S>H<:Z/+D*UJJD]O
MJ,[)>27ZO;^I[=7]KF+W:6^[X8RGOEX:3O<G3^*CZJN?,OO 456&40/%'3*I
MI_J]A>[^%_\ M%5U^ 7ZF;_[!O?^@"YNEK2O<5-E*5\+F9E?X?\ Z%Z^XNB-
M26E:77W%G^THS^O_ .B_ @&'Y7;E*P=3J0>')^'Y-I$@H$S<DG":<?<625NZ
MEI4JW^D%JLW\%$\VPFL+2;\AV$E:6EOI;D,[>I*C;U6+XS?4?+DKF.YAIRI3
M'ZDERKU!Q,:I.PS);;&DB)E"2+MVU&:_L49I[<A>QA&GL4\Z1$:E);(EDE;K
M:7U/:K:D/;E]>K;.ZE<E7Y+*X"V5FI@R(9;V(6B^.PCX;2E_#>^:>[?,GZN^
M4OK$*,9EX1<C)G?*KC1HV?$MN(,E,DLK]:.Z=!]*K>7Z5QVXN"8$%W;:9;0T
M5SNEM)?5OSM?GS]?K^Z-NUW N'7Y?CWZ:;DI%];RF&S<7=6L[J,KG<!C]7QA
M0\4PTTZBN523.8?@U)4%AC]()M%0:)?)7+I6V9J]D]A[>+\?4[!E%F5ZIP*R
MZS%2EXVHT!UQ;AJ6VVAM!$GS&IUOD7LKV,>?B/#D;#E-K>,Z;+DQZRS0Y#3+
MJ[*;0E"#4E:FDV0=E<SY#U*SA<Z_2Y%/=K57B(EJ)QMQAY*5QE$V>E3)K0>E
M25J2HM=[*21ES($D>1^)JE%+EPZYEAFM1_ QSFR9+^#9RHR"W&D[:7&VUI<5
MI?)5B+LTL_0(W%1@!<2.Y5,,9G0)3\8I"8KF *QN&>[M)1=$=:-1KYI+7S3W
M'(CA^Q-#TNQ>(_-(UHYD_*E0'UI/MR)47:]3^CZCK(R,S1@JDKA<5&8CA.&:
MFRE4^DR4I-QW69E^B(OI3<BT:;=_+\,%7=G\3>"J3$8J$[".9;#2GVXLE;V!
M*O\ HCBUV(W$DQS3]J-?H/3H>)X6+,6PL94R%4V*(Q1U0EORX;\%Y4A<I"TH
M-A]"7.6PK]SI>XQYO(K-&*<)Q?%)F))=:GI?-3D&DJ9T$U8D[1P[)(E$1EJU
M<[EYC2ZWD>%*!B/!4VB85K>.:EBR9+5/J%1J531%0X^HE,DRG2VE!-6^&DB0
MCNE1\NX#/OS@I_\ 53O_ &$?_P#0 ^5V=5OC>:W]%<_K-OW^OS_L_B/-PG49
M=>H$>J+J,F[ZWGB/:(NA+JR27W&1%^ ]%=/E*BDVFNRR4UYE%MW/X>GGR^MS
M^\!2-784@OT9N<1_Z6(__P!J1>JJ&RSO.Q7TLV\Q,.NK/_52FXJ_$JKL+0U6
MG$N6OO%'3?\ NC%\;S:Q17*;-C5);"G*W3V%K\,2R4P_()I3%]'=5RZK]/+M
MRUAT<!R$4@JU'=IE08O6YTAK12W4FXRX^9I6>A2]Q*UF:B<1;4GFI"++OF2\
M0T\BD?"F_H_?]$>^IK^I[#A?ILEU!28E=E,,DT\I2=#;JC4?(CNLC/HM^\<_
MA)!S5&=4D:5\U1]MKJY6YG;GRY .;Y2A_67_ .PS@X45=I\B\.J0F\?>+<BN
M_-_6YH\W[/<4.'4OTG_+3O6=F_AM]/PM/+E];XG\!R.1)B_UY\I&J]SM;_CE
M_#O\0!C>*$G6L&5NF,093[DZFR;M/1]1N+6UR;42FS:M\5LK'RYJ^HL>G3JS
M'GQT6I]00EC;2HG67>=VVCMS3?\ 7%]^A7L=O"J$BNTO&E%HIU&2Y&JS,E3S
MSS;!)0I@F3(B21?K$FY_92EP^1F0RUV$XX2B^4'[/%8OALGZ?V1WD.E(K<B-
M&,XU,D/+V-VR65L]>VZO3U<_,SIM_I$_ON;Q% 6LTI14"(SOU1GSO\-M7+I^
MJZV7]HE%YB,>AX9ZVKY1DZ;WMMMVOWO\V.BQ3SBKTQ)M52?+YQ9O>I>J[_\
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MRD^)3=325X@J)D39%S25^?Q+_P" "<@
M             $1\6+;"^%[-HWV4.:,!5\TZDD=C\ [S*XDR&Z^J-'7(8**^
MLNIB^OG[:A&?%@I/\U_-RY%_WBUXOW> =$J,I-I!,7YEV =@
M
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M!U]EV)4WT,R$[_AEMPW5MFHE762$$HT)*_)3I6[@?AOL<  !0
M                         '&M*5EI6DE%[&5QK?P&TV@0N$/+3Y&5#<0J
MGDZIYAPS,WRD.DXDU'SUI4:D:>US-/EY#9%?+L-:?R?\]FK\'^5\F!4(KZ?D
MR0THRC-QRW6Y3J'4DVTE)'I6DRU6ZR3J4:E*-PPV9
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MB84HX<)Z*E?AS024-/N-MMD9ES4VUMLFKZ1I4>M?<;,!/10
M                    :Y\7T5M>$< 5ZHU67'@8;S1PE4I[Z)#3#"&?E)IJ
M\G7W;2IU)FDN>LFUG9!+(]B2<078OX"-\^LN8.:V3&,\NYD9^65;H\F&V3#:
M#6E_;NTM*5=)+2LD&D^Y&16YCI\/.8]6S5R8PECFO()-6GPELU@DQSCI:J+#
MQLRT(;NHDH0\R\E*C78R2D_I@)7
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M .27[ )+LU_5I]3[>_<"VR6:R01*,B(SMS,BO8OXG^(CW^561K_]]QCK3_\
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MO/8'Q&AZ(E"6<PL;--$1$1.-G7YRC69>O49E<!,X
M                      ""N,N?.@<*V;3D>AR)[WYH51K88>-'0MEQ"GS4
M1^5MN[BD]E$6D^XFAHUKB[DDU(7[N'H/\4B,>*]*?YKN<16*Q8"KQD7L?R>Z
M?^(E=IK;3I/M[ .0
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MEVO'4:NH2RX9FEQ*F-U).DN^Z1=RTVL?,!]?0
M                6=^XU\X(L0P,5\*V64ZFU:/4UQL/1H+GQ$K-"XQ;6RO2
M1[9MF6W8[JTEU&:N8G]9FWW,:]<#K-:7PBY7'78CC+R:*V9(<0A>F.K6EDRZ
MS+DTI)$1\R+I4FY -C
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M@LF,X'$1<N<Q:15YCD=R6NF(E&U4$,$HD:UQ722^V5U-\S27-7VE<).
M                         '&1$GRD1?<.04L7L J
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M70:#N1?\G>=PK[:?*GZ:^8]%6,>*AR"^^QD9@2,\[\PEW,"2LV_^E+Y,Z?\
M4U@)B7MJU:$D6OS6+S<K<_?D(;KC4G^=_@=2D+..67>*=-WSTW^4Z(1V1V[+
M21^O;V+5XT?'W%B\B-+F\/6&&5N$N2B.G'AD;&EO^C.+*-H<=<.^GIT([&LS
M^(,)J6(^(?\ G(82KBLGL%'7"P!7FVJ,>/7];;2JI3-Y;SYT_26G;C:-+?7K
M=NM>A(#;>Z.?27,[GR[G[_P(#VS.YH29]^W_ ![%^ @]K%O%L<",ZK);+OQ"
MI)NK9+'DSYI5]#*U'3.E3>MO4XC<2O97I(MQ-K9.-^+6+,)E7#W@J0QXK;WX
MV8;ROA;NG5I73T?JN?OJ^@ G(B:26E+:2+V(O^/<P^'<ST%=16/EW+_@S$ T
MK,;BXJ#!,O\ #CA2GR'.ER1+QZK;;<N:#,FT0UJT)65[$?6GR]QZU/QWQ/SB
M,IF0N#XUN=W,>/(;YMM'YFZ>M?=;GT/H ,9R25KXK^)%U:SU?*>%F=1JYDA%
M'84A%_:[JSMVNLC^FL;'W01$DDE8NQ6[#23+K&6=U(XA\^JQ0<@%5F76)6&G
M)\;\[(L;Y.>:H^ULDZM)H=,C2TYJ01:4/:E74G;$V.YF<3""C;/#+$7N_P!)
M(\=1=R+\73Y=G0OX?Q/G/V0$W6:LHMM-E<U%;O\ >+M9" 59N<41MZ"X23N4
M<G#7^?<$FS>UVV4*TZU<OI+0@<O\K7$BV4K>X3)SIJD[<+PV.*:K>:VM6Z[K
M-&UUV;THU^J_* R&H)DT_*[,&2J"HI23Q%)2UOGIMJ>T%?T)967]AF9]Q)D)
M"#AQ30A*>1=B^RW^ @W#4[&]<X=L=_G]@Z%0*NXG$A*@L5%-4+2MR2I):FR+
MD1+2BWU4D7:PF5C$.'EK3&C5N ;J=31-IE(Y*3Y^6KT_@ \#-V8S&R^K)J2F
M\AMN,1VYZEN:"_VN?WC.";;*Y$A)7*QV+N0C#-W%>$J5@JOJKM7@1X]-8BU&
MH/REJ-J$PN1I2_R0>K2IM1DGU,COWY^LK/#)M!;9YOX)U'L=Z_%O\8_@_3_6
M?0^MZ7 9UI3?5I*Y>MA30@SU&DK^]AA2<X,J%JEMIS/PKJI^OQ/^78_Z-I[[
MO7T^8N_V#D_E;RJ3XB^:&$_T?YV]=C]'+Z?7T@,Q2VVF^E"2U'J.Q=S]_O&$
MXK(BQS@=5BOXF:=_7G$<N.9>;&6J)90E9BX;W^^Q\KQMSZ">VY;NLOQ(8OBG
M&.%JKB_ #M*Q13Y*&JS-C/+BSFW$DLJ;+<6A>B]DI)HS49*L@R*]P$LFE*K:
MDD=CN5R]1%N8%.B0<+XVJ)M..*:98J3[;$8MU_P[25$@CW+N*4AG2>KTY<R&
M<IQ/0-SPIUN#OD22V/%M[O4G4CZ5N:.K[>XP+$3,29AO',RD2&92JG"\0E4=
MAM:EGL&6M)I46MNQF6H^?,P&?U]MM= G,/H2EI45U*D+3N),ML^1D?<AY^!R
M<7@O#RG5JUG2XKAN$HWDZC:*ZM:NHS^TQUL2XMH+.'ZTJ!6:>Z_&@5!9(1*;
M58V$&3ER)96TKZ5?5['I'@8#S/RQ:P)0Y)YBT!YJ'2(I+?<K,4U&6TBQJ4E9
M)]?;U 2?I3J-6DKF5C.W.PL0A#=R0DDW,U'8K7,^YC&J'F1E[B4O\V<P,/5<
MVMC5X.J,O_/?-7T*/YSZ'UOHW'"C,; RW)[2<=T3<IL)-4FJ^4&=,:&9.).0
MKJLAHE1WCUG=/PG.KI5I#+M*=6K25[6O;G88'FTR\K+C$2][:65.6G1;45C/
MJ3W^F1$1?5^P>])QAAV,S'E/8FI##,TOT9YV8UMN_P#1]5W/W6&(9O8FH3>5
M6)I;>)8"5'3DFRXQ+9;6HW?F+*4K2>[;HY=5^G4 D2=U0Y.GU9,_X&,$PO,;
MDU["S["I9)>PENJ)Y2CU)6Y'VM5^ZTW5<^_5]HS-R2PI1PE2DM2GDN:6E*2H
M[%?T[?33R^X810)U/8FX/=J-7;B/R,/.,1HKBS^(9^&-1W]339FW]I?N8"2"
M2DKV217.Y\O4#2E7F(C^\=5J?%<:\2Q+86RXC=2O=Y:??[AQ_*47>\,4N/N-
MDG4T;Q;G5Y/7U =XTI/NDC_<*:$WU:2O[V'$3S*^@G47]B=YCB.5&2UK.:R3
M?US>^S3W^\!A&6RI#98H3+5);6SB2H);.223-+1;9I))E^K)-B(^]K"0"::)
M&V3:21]6W+\!'.$:GA^E/XJ9>?@PGRQ._=&_M:I!PFI"KW7YC8^*:>1:.KR]
M0RK\[L+G'*>6)J?X)M6TM_QC>WK5IM=>JU^MNQ?Z5'N0#W=MNRDZ$V7?45N]
M^]Q6Q=[#I*JU,0QOG/8T;>Y??+YOZW?^(Z;V(*5&1+\95H3*HNZ;FJ5I2@D(
MUJ-9_J[$LKW[%:WH \W,1]<7 .(Y40UJ45)EF1M'J.Y,N<[F,H0E)I-)I*QW
MY6Y"/\SJ_3OY+\8U.!)B5!N+19KC:4R=;"W"BFXE#AH,M)&E9<B5S3S[C+EU
MBG,*63U0803-]Q1O$DDF:4JL=SYW)9&5O<@'JF1'W(C#2DCN22O:W;T'!XAC
M_P +1_?3]'N.NW4HRK(3-C.F>HOAO%W(S)7<_2Q_W5 .V3:$\DH27;L7MV'B
M3YLB/B:EQ&V"6Q/9E*>4?,DFWM&V?\1[>ZS_ .$)_O$,:GOPW,34-::PEM6F
M5LQFU:DS")M'K]'3K2?X +L!J8E83I4B.T3,5]C=0RX74E"KZ2MZ$5S&4##L
M ;'YJ0D0J@BIMI6^W&?7R<0P3B]I"B5SNDB(C^[[!E6X?]87X'[_ /%O<!S:
M4_5+M;MZ>PPO'SD1B#265M+-3U?AFDR+F2M[7<OW7&5(DH=C[\=YM:7$ZTJU
M=.GZW?RC LSZE&CTZASILPBC)Q)3$(<;4KFI4C;2:30I/.YV4D]9'SNCF$!(
MVV@NR$\S(^WJ78";;2G2EM)$5N1%RY=AQKD,M^9\OQ(<3<A#I;K+I+2XA+J=
M+GH?EM?T,!VB2DDZ225B*UK<K!8O86)<U]G$']PZ_CXFP3WB6]+NBQ[I?3[
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M'P14T1OA+;I+Q(4CI-)DU;E;MV&-X]<T,XW\.>KP^$"/9^CR*;;EV]!F%57
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MW)+7(NDN7(R >^
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M2J4>-\/G3]U^<WH;<9)M&V<<U\W5*['8BU)3Z&5RY@)&
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M ;?F8?3X&(ZZEE^>IDB6XZTTI1K4=U)<,DZNEQ"D]-P&QP
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M8NDBZD$9H,SYWN-D;%[!<45              %ES]PN?N O
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M0X,N$VNU"FOU?API\-^$3B(B&8JTM2FD-7U.I8<,G%*2]:[^HU+;+U(AT9/
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M;'&,VGWW9GB7)#B:_,(EOJM<U:"1S[Z-!^ID G0
M                     !#/%T[+9X6\VWH[1FZ6"*ZSH+^J5%<2M7[D<Q*L
M*.Q$A(8AMI-E*";2;-E62DK$GGZ$78O01MQ6J2GA?S;6HB,_S Q 5S[V. [<
M2C&;VF_#.=7W\R =D
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MT:25Z&8QIC$%<Q!78:X-(F*B/O&3IHD*;2W&2A"T/<C+J43I=/J"J20
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M;4(KX$G'&^,;+V.])4HU4ZNLJU/(.ZR@DJ_;F=TD=_<B!6G0^QX  )
M                               P3$.5>6>,:VW7<98!H=>FH22&)%3I
MK,HF=)K,]!.)/3VOR];'Z"#^"W .6U7R-ROS&AX*HGRJS1&-JK.TN%&FN$P3
MC#*G5-((U&AHC1K.ZRO]KM]JK%RY%R.Y" >"RCPZ-PHY5QZ93783;N'(DUUA
M:DKO,?/=>=,T^BWG7'-/T4]("?P
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M9@,KAU^93C\7J8-A<@D/NM,NJ2OF2G&D-N&KZ9K,RM<3T
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ME)FI)D?(^8D74GV'@XCJ<.AT.IUJMR'TP(,9Z2^XA!WV4M]1(T]1*YG:W/V
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ME)&M269C6X]H0@MTT:MQ!<]!$T-X*@EE<&4RERQFP=S(^?.__'[QXF6["(>
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MI"9#[\1MQQY*$$6DM3AG;EZ?>)-$2\*B2/ABR;49$9JR_H&H_4_\GQNXEH
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M.7]?M]G^3Y'^XOP$I1[H3I,^1?P <X
M
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MR>,G+OPIQ4E'@UYYS>21G;PAH^%?LO4M/,N>C<+L9@K3H?9(  $@
M                            6ZR&O' W'AP>$_*YJFE')DJ ATRC;A$3
MRW5&XFSCA]1*->JWP]>O0EM!$V4^RY#L*&<E3!O.)^@V0@O@J?B/<*N5LFF2
M77FSPK ,UIB$UJ=2DB=+2;:"OK(T$=NI)$O6X?68;
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MBY>L<2\&>W,SGQAEL]2&V99S(^'*%/8D$K<-,8T//2W"ZD=:_A]"OAIU_.C
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MPGEK)Q*VF%$CYNZS/<Y6Y^_+D.*(N:MN._(A(2ZZ6MU+4E:M#UO*6O3T_9_
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MM8FCOVUPJJW9_9_H+OF]_+Y1S?G) _J9O_L&]_Z /30DC[D1\K?N'61+(_\
MFS_\041]BQ+D^#C>:TXXTS+P@1*<<49DU_3>R#[#UZWB^DQL/U2J3(56)N/!
ME/.$=.=\B->HKZ=-K%VU^PZ6-8]03$QQ,43*FG<+$TA"N9:T^.U&9']'K3^
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MW,0MPTNRU8*KJ9DEMPOY1<;DV37.S?YR3RTK_:U+(_[-@$U
M                              (DXL2+^:_G)_\ (#7R_P#M>]_O,9SA
M)3OYL4HG':DMPH+"S.HV\5I-OEXBW9SZQESN7,8/Q7__  ,&<W_X/J^?_P!K
MY'^X2-3ID293XTR&_%>8D%=MZ.^EUHR,K="R*RNW<R >H
M
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M>OH?J./!M<EUBEONRM6N.YX8S,S,]26R,S^^XR?2DK627+MR[ JJ
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MAX'YT\^,O+N/U[#<>N[B[GU6@.VO[@/L0
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M;D0N                %+%["H  II3RZ2Y=N785 !32G5JTE?WMS%0
M    4L1=B%0     4[]Q4  4TIM;25ON%0 4,B/N0J         LVFC031MI
MT%8B38K<NW(#::,M)MIMJU6M]*][_??F+P <2V$.MJ:=0E:%%I4E17(R]C(=
M>#!C4Z,U#BQVF(["22TTV@DH;278DI+D1?<.Z.-M"D^<S/[P%^E.G1I+27I;
MD*@     "EB+L0J  *6+V%0 4L1]R"Q>PJ     I8C[D*@  *6+V%0
M     !KWQV;Q\)68[;<=+[TFF-QR;45RU+=;27+[%'<;"#6K\H"U.E<(68BH
M]6:I*VJ?%D)DN/K95N,RX[QH)2#N6M*%(*WJJWJ$!#F.,6XEB<3^3%2RZP-
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M\.+CZ@X:HE6;8F5J/+H<(D2:RPE;CY-MN+-?RBI3;9DVXMV(\9)LTVX,X=S
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M/<W*$%<+JZQ+P1BEBO,0V8R,Q<:HIQQGU/;\=6()AK6J_E63SDAO^R23$Z@
M@OA.J$*K99UFLTQM:XM0QOC"43BHQQU24JQ!-TNFDT(TKT$25%:]T\Q.@@KA
M2G2YN6548JS4=-:AXYQ<BIM07''8S4M>(YSCB&EN-H4X@C.VXM"56]K\@G4
M                                         !$7%D9JX7LY-)VO@"OE
MR_\ J>]_O,213H34.)%B-/RB)HK*\4XIU]7WN*,S_B(TXLO$GPOYNE%6RA1X
M&KQ&;A<C24%[47/W]!+B5-+\KE_N,!R
M
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M$M)?S.Q@YN(2DG'".LR"U.$795B(K.:7+6Z>VO8 9,  !H
M   -3^&:DSZ?"S3>B1W&5XKS-QGIGMK:)]1)GOMLDA1%KC$TMIU)$^A5EOZD
MZD*L-K;G[C5WAB8IDRFYF1HU*894]F=C:-4%.RI#B'S<K"TF:F35H+6V26ST
M]C)"O4P&7<%Z'XO"EE,VY$<BJ_-6 K:D/[IVV;DO45^2BZR3]$NGD)W&NW K
M/@S^$;*XJ=,A$E.'VF3.G$>V3K?0Y<UE?<)9&:R[&N^GHY#8D)Z
M
M                                             #6[C\C(F<*..&W&
MVY+2#IC[D=6E)*2BHQEF1FI:"L97&R(UXX_"67"!F0W'3J<=I[!)3_\ +37H
M AZ?B/"=+XG\A9&):S H+:,)5=,1F4ZV;;3BHD1M+*I&K0\LT-DI#SA(2M!1
MR22CN0VOA9RY3U%M4B!FAA)]"O*XBNQEMGU*1RLNW=!_ON-4'V\1XNXG<DJ%
MF5A"%+I9TC$4O9J$!M]LYSZR>6AHG&S(D(;92X6G61:VRU\T;>RJ^&;AZDPT
MP)60^73L5/E8<PO!4V74:N23:MYE*/[U&?J!Q4>XO-K+EN8EA68N&TFZT;UE
M5:.6VDM%S,M?8MUFY^FXBWG*W*UFUEC+F'3X69.%W9A$NS":LPMRZ=6OX9+O
MRT'_ !&+N<,/#I.==D.9#8&2I]+*'#*@1"-:&U$I"3^'S(R2DE$?<DD1WL+%
M<,?#A)5O3,BL"SE&]*+5)PS#</XSID[S4V?+4I5O9)F1<C,!%%+S=RDD<95<
MQ/%S3PZJF'E93&&Y+=9973E);JTQ3QN+)6TE;9+;TV5V</W,3Q!SIRCJ1ROD
M[-7!TE,$W?%[=>C+..3:-;VY9?P]!>:_E+OI$'1\G,E9/%5B3"U1REPC(B*R
M_P /OPVI-%1(:AK\?4D6)M23;1K\.S>UK[!?7,2O,X7^'.HI<:?R RW2IW;W
M#_-6!=>VG2W?X7/27)/L7(AW(9$K.'*A$C0>9V$]S<V=!UZ+:^WN]M??;ZK=
M]//MS'(]FKEBU&5)=S)PVEI;>\E:JNP1$G[++O;[AX9\-?#X;WB#R(R\-W5K
MW#PO!U:MS=O?:O?<Z[_6Y]^8I$X:^'B!+3/@Y"Y=1Y24;:7VL+04.$GZI*)J
M]OL' ]TLV,L7/$-IS+POJA_TNU7CW8Y?2Z^G]]Q#/#?FCEIA_#V**-5<<8?I
ME1>S(QD3S$JHL,.J=57);B=+:EW,U-+0=^UB$C,\,W#LV4=!Y"9<ZXG]'5^:
MT&[7]@]KI_<(EX<<A,DJCA'%-1J63V$:@X[C[&+45R?0HSRF8C5:EQR0@UMF
M:6B)K2316(B*UK )[+-;+)9,F686&K/:+?Y:C_259%K+YW7T\N_8=61G1D_#
M_I.;.$VCW%EUUN,GR^8N:_0>'%X8>'6"E#;>0>7+BFR22#/"L$S225:DV^%R
MLKJ+V/GW';C\.7#]3_Z!D7E[&YK/X.&(2.:_.?)KU]?<![#6:V6BU'':S*PT
M^]H6\26ZM'-9I2YMKY&NUB<Z+^A]/<KCCQ)BRDO87JLVCUZCJ?:A687+G-IC
MK6Z7P#-PE:=+OT>75Z6&/2N&3APGZ3=R-P(C82M!VPU#*Z5HT*2?P^QHZ3+U
M3R[#&,<\-'#52\+5^M_S?,$/*9H,Q@XT*@--+41-FHVFR80D]P[62;9)<([V
M47H';X9,885B\-F5\:5BJAL/T_ U#*6TNH-M^'M3V=>LKW;M9SOVT_8)/+&^
M$#4ZK\ZZ2:665R%&4]NQ-I))K6=C\A:T]7I<0%P[\/.1N(,A,JL38ER6P).J
M[V#*(X[/<P[#6^X:Z>A+EW#;-1I4:UF9&=C)1J/J,Q(I\*?#"VE2$</V7:4I
M)1.$G"T$B62K:M7PN=]*;^]B]@)Z,Y=QSA!B2J O%-*\01(,F?E!O<^(:=OI
MU7NO6G3[W*PK^>^#S58\5TGHB>/,_'ME^C]7QO-\WT*ZCZ>7<8.?"?PSJ9*.
M>0&6QM$:C)!X4@:;JMJY;7KI3?WTE[#@7PL\,?/_ -YURZZI%U?YIP.9\^?S
M7[2O[Q^Y@,+XLZI0*KAK+GP\MJ<AO-3!2G'([Z74Q4KJ+:DN**UB0I/(E>I'
MZ"=W,68<81ID8HI*';^4YC1?JMWMJ_J_B?V.KL-6N)?AVR:P_0\#KPGD)ES3
MF9>8F%J?6)$&B189_)K]399=:-*&RW4+<=0A31W2I*[F1Z.4SO<*?#/(>\4_
MP[98N'[KPC3S/O\ :T SZ'BK#=2C1Y<+$U.D1J@HF8;C,QM;;Z[?JUDJ[A_<
M8N<Q;AE)'O8EIC?PW7.<ULOAMG\57F[(^D?T?48$KA9X;5M$POA\RT4WKW&D
M'A.!I;5]9);7(_M(<KG"WPV/V-7#WEH9DV;17PG \A]T_-=OL 98O,'!"'F&
M%XXHFJ87PB*H,JU';Z'/G^\1'5\6T*3Q5X+JC.)*'(@JRZQ(IA4263KRS74*
M,Z:EJ2K231LMDML[V-*7E'8DD0R?^:[PVPG(KD3A[RT863UM3>$X"3M[7)H0
M_5L@,@6>+C#.&:=DSA!R%,P%7)56IA4"*B S:HTXF9"&"9T+>->ZA2S+5MFD
MC/38!LU3\=X*K=.^4Z+C>C3H1K0R4N%/9>;)2O(6M)FFYBAXTPJFF-UE6+*.
MF"XX2"D^/;-DW"+<4DG-5CZ"U?8GJ[#$?YL/#=V_F^9:^="_^].!YD^4_FNY
M>A^@\QCA2X:HC2&E\/& G$-N/O(2K#L-\DN.GN+41+:Y&1EH2?<BY%8@$HJK
MM%+SUJ(7-'Z\B\W4CU]2_$><K'N#T&RT>+:)=Z5X1)G4V2,W=G>T6OY]OXFC
MOHZNW(8B]PP<.+FBV0.6_P /1J_S5@<]!61^J^B7(O;T'7>X5N&IUQ#Y</.6
M?P^:/\TH'3SOR^%RY@,%R7=A4_B.XD:M*=-E!5?#*#D+=-#"$?(D=2"/F1<E
M*TG;W+]H;#G5(1DSIE,_&1N)^,7S?U_N&F^6G##D!BC/+/B@XER<HTFC0:]1
MDQ8SC"416+TAI]PFT)61)TKENJ.Q=*)+:2L1J(2V?!-PI]'_ '!:!\-K81\%
M?2W]0OB<D_9V%)<R>B:V)\25'-YF:RMIU.XA;3Q'\.UM5S^WU%6I[+[33K$U
MM:7[&TXDTFEXK:NCG[>XA1C@LX7(S!0V\C<,.LIA_)Q()DUD3&K=T=:_/N<]
M=KZ.F^GD.*)P7<,L5IF(SDM0VXC:G8I,I4^39I63A*6^G=L\9DNR#5<T$IO3
M;;3:8RB.IR1E+C)$-N/=;N(T-.OM:V'$^+E<C0@]1IYGR^TQ)$-MM4..1H2>
MM!(5<O,DKV(_<A#F$\)T'!_#_BS#F#\/M0(A.XI=9I\:*J-IUSII);23=B29
M<D%;V)0D>%C+"[-'AJ>Q-3&C:8;-1G-:49W;OSZN?W@,I2A"?*DB^X@)""/4
M2$D9D17MZ%V_Q,>/^=N&#CD\6)*;I=T:3\:WRU]O4<;F,<*L7:7B6FZFV]]5
MYK?EU:>]^VKI_@ Q_$\O7CS!<,HTG:<.H.DX3+JB0:6#1=Q5]!><O.1\RY<Q
MGFVV16)";?=]EO\ #D(>QYF/A:@XRP#4JKBNCT^G3US]R5-FMLH0A4="DJ)Q
M2[$2C4S9-M)FM)ZBU(U9#_+SDCX ZD]G3@9$;J_2/SDADUT]1EKW+<B[\@$@
M:$=])?A^\5TE>]BN(]//?)@G3C.YN820]T65\MQB3\3YO]9ZZRM^X<:L_,EC
MCNR8^<6#I*6(^ZOPU<BO62M24DODYVUF2?\ 73VN D5*$(\B$I^XK?\ '<Q@
MU!AI9S*Q6TF4MZ+(IU(=V5*,T,.WE)-"4]D]+;:K%ZJN.M+S\R2A*M.SEP1'
MT.;2MS$4-%G.GX9W<YJZT\NW,AX.#,S<N\38WQ?^:V-J+46(S=,0MZ!.8>2I
MZRRNE;:E*6=MM.E5T_#_ -(L!,&A'U"[W[>O8"0@E&HDD1GW.W,_^+%^ \K\
MY:%R_P OT[XGE_2$_P#H0M1B6CNGK9KL!2-O>N3S9D2>KGY_V5?W%_98.KC5
M"',&UHGDDV2J9+)1%RN6V?<>9A&9*GUJLRE(UP)#D61#?*Z'%I7&:.SA>OF3
MW]27]HNQAB?"[V%*PRYB*EFHZ5*_YZT?9L]9]_05H\V+'Q#5&)-2@(D)8AD2
M$I,K$3:S+V]2=_U$D78@&8FVV?(T)/MZ>QW+\#%=*;F>DKGWY=QY+>(J(X[L
M-5J&MTB1=DGT&X>KR_2MS_B+#Q-0VS=<.N0-+3FTY>4DR0YU]/;D?0K^Z?L=
MP]!YI1Q=MLS2HB(DF7*PQG*WJRTP>:N=J%"45_0]A'/^)CTZQB&F4ZG39LBL
M0H;,1EPWI+\IMMJ*9=C=6I1DG]Y&,%RJS,R_7E=A$W,=8<CNG0870NILE8O#
MMJ^O]6Q_Q&I9I5-MM1DHVTF9=C,OO_WG^)BI)216))6+TL,4/,[+VVC^4+#)
MJV4R/^5&/FE>1SDOR'];L8Y86/L&5 H?R?C2B2/E%4CPFW/0OQ9-'\79L?7H
M]=.K2,59,24D9F1%<^XPC'JC:AT9*68II?KU/96E]:BTW>N>WI[NW]5<AVT9
MH9=N%(=CX]H4I+&WJ)FI,+M?[ECQ,9XQP^DJ=3X&(Z:VI-;A1YZDU:.TN,VV
MYNJ;=2J^HC2A2-!=1FK[P$C&A"N:D)/MW+V.Y?@8;;9W,VT\S)1\NY\N?\"_
M =)RIQ&GF8RIK6\^[I2C5S/[ ;J<(R_IK9;C:'DW5]%?;]P#MV+V(1=6XZB/
M$>P:G%JQMA\UZCN=DJI1&1_9I,U??S$@2:S2XUT2*S&:43!R.IYM/P?ZWG]'
M[>PP.IR$1V<4O2+Z&<7T8U+9:61GI*FD9F9'[%;[@2S2?H1IT:"T^UN0KI3I
MTZ2M[6Y#RRKU*66M-8@6UO%REI/YKSE_J_2^KZBB<141Q&\54B[-OG_%-[?_
M )UP5>E8M6JQ7[7]?^.9C$\'*2[B;&Z4V+8Q U>WVTN$?^)G^(]R)7*-*5H8
MK,)U;A=.W)2O\+<AB.$:I"BUS,21(J4%MB+7T>(>*0DB;TTJ#J-Q1G9NWV]@
M&?)CL),C2RV5BL5DER[?[B_ O87V+V[CQD8EH2V8;R<00-FIN(\ YXA%I>KJ
M(FSU=?+V'(_B&BQ750Y^(*?'?-DY)-KD(0X3';<L:O+^UV >B;;:E$LT)-23
MU$9ES([6O^'(>?6VF2HLY"FD&DXKJ3(TE:VV?(6JQ)A]OOB&F^3=YR4?-I[J
M\W\1Y-6Q-1)5"J,R)B&(MENG.2G)#<J.M$=O0LMT]1[=NE9]9F@]I?U3N'9P
M"I3N"L.*<4:S.D0S,U'>Y[+9W&1;;=S/0FY\CY=^_P#O/\1B.7$YF9E_A:6<
ME!I?H<.06TI)%9++9G:WIS&5F\TGS24_O4D!R6+V(8W-;/\ E#I#AG=/R/4N
M7I\]"'LIG1UL^(*2G9=)&A9+3]+L/'>5'D8LI,F.^:_\G32O>_(W8M_\"_ !
MT,I7/%Y8X44Z>LW*/$-9JYZKM<[W[W&8[:-6O0G58RO;GSM?_ OP(8EERIAK
M F&VXC9$2J;$2I#*DFEKX7H1]B^X9+XV-_X6W_'_ '@.<B(K6+L5B^PAA..'
M8Y5K!"Y#+JG/E^R=!GR,X$JY\O:XR],Z$MK=3,:T^^M(P?'-6HS-3PI)D8B@
MP$QJZ31[\@FKR'8;[;:"MW69O)Z.Q\O8P&?[31JUFVG5[VY^G^XOP(76+M8N
M]QBS69.7SYJ-C'M!5L'\4DU6.>GHU==U<N7M_@.R>-L+(5.)6*:(2:1_RA_E
M)J\;DY\YSZ/F7/-;RK^H8#W]M'+H3T]N784-EE7F:0?E+FDO0[E^!]AY<:OT
MN<LVH-3C2G2(CV693:G+F1J+LJUC1S+W+F8[RGVD)VS<Z[?-FX5_QN Q.GR5
M_P J>(H1M'K*@4A>[;IZI-1T_A89@;;9D9&VDR/OR[\K?X<A'%!Q)1JAFSBR
M+!K$"0FGT.BM2U,24.I8<2_4EK0X1&>U8B+O_P!@D),EA?PTR$&K[#_]&-2<
MALLF1)-I%DI-!%I+DD[7+[N1<OL&'Y@QU3<"8@B,I4I,BGNQFR3=1(<6WH)5
MF]5B1<EERY'S&4*GQD>:2W]+Z:?H^;\!BV8,LW\!8I0S)BN285-DFLDR"9T'
MM:R-9JOM<O>_(8.2F,$YCZOR3DGRIU.3L&L]*5$]+43MNW4DFBO^P9>@S 8C
M$:BM9B5A;DA""51:8@VEMH3=).SK%JMS+FKEZ7/W&1IFQUNZ4RDVMY/7Z/K?
M]M/XD-'<-MM5M2$GI/45R['[_P 3%FT6K7I+5;3>W.WL+$R&5^62@_WG_O%G
MBH?S?R@B_P#TB;_5_P ?XC%6+91+\5EEA.6\5E*H-.,S/N9G%;.]_P!Y_B8S
M'O8S].PPC*=YIK*/!YRM*"+#U.WR-9]%HS=_[OJ,Q6ZV@U*>?:0TYY5;EC_<
M [!D1E8RN1BPF&$N$ZEELEDDTDHDE<B,[F5_8SYAK;_KR_$AU6ZG3W_)/8/;
M<VE:7;?%^J Q_,34F@0[J-O_ "]1OVK_ .5(UAE8PW,Q]B+AB+)D3-IM=?H=
MC2FW>J1OO/F,O2ZE?E>;/]W_ *,!RI2E)62DB+["#2FUM)<BMV]!P;Y^(VMU
MOM\W;KO]]["UR8PT3KBI"32TWNGU)Y)Y_P .0"/,:S(YIS A)03<EC".\IQP
MN@T*\=I(_<B.Y_B,NQ?%B2<*UB/*,B95 ?)2C]2VS_WW&$9E/1UT;,1M#3;U
M01@ZRTJ3J0I)>--DE(/J/G?5S';S(Q#B;">76,<25+#%.J<*B4*=4RB%4'$J
M=2S'W/#FK1W/0KJ^T!E^%WFI&%Z2ZE):3@,G:W+YH>QT'W21\K=O0:586XVL
M4PL/LTN3DE(E.TFDQ62EP*NI4><]X1MYY""3&LE26U;G+69(4@^RC(>I'XXL
M5J3ID9+[1^*;:N]7WD_#4C<<5RA?JVN?VJ"=,IY#<$]L^Z$GV]/;L*ZDD=R(
MAIJQQZ5Z4B+X3)<D/RV-MM#F(7^<G3JV$7@]1W^'J/JW.G18=I''AB-,Q,*;
MD%4M,M[P\1R'4Y#^M7^E_0T;7^IK ;%9C--2BPX3C:5DG$4-2=17L=W#N7V\
MB_ 9JK1IT.)(R[6,KC2B'Q>XYQ_C3 &!2RKIU*J]9KY$VF96W6DO>&N<O;;=
MAH5\-)J2>DUZ5:RYK)!KVZ:GXM=)HI&&8B3=+XAM5 U-H_UEMH7_ + #W?AV
MTZ$V]K#5++;B@A8ZJ.74'#F&:]4'JS0:X\W,<CM,0:K+AN--RO#+<6:R3O(6
M2=>@M#C1=EE;8U,[&&F*K\VZ<>NWB/\ *Z_T?5YOU'78:(<+%-GQ(O!TRU4D
MN(BTS,%R0ZI9F<I6M/PR/U^(O5;V;4 WS^6Y>O;_ #;JF_JTZKHV]>B]_G/*
M#N()39OG^;%8,DM(472UZW[?$[^_W#W]*=.C26FUK6Y6%#0A5]2$GJ*QW+N
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ME5@K+F9+\7(PW0*?29+[9O*;<>88::6:-PS/2I9&:2Y:4\BY"0P
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MER(BY@)F                                           0YQ;QT/\
M"]FV1MI/_,>NGS+V@.V$F4J J' BQVFWR)MDB6<E\W735]12E'<S_:N(ZXLU
M$7"_FY8O_3&KW_M Z,PP,_59^#J#5JU#654ETR*Y*<=:0TZE:VB6M)H1J(K*
MY6[?@ RP
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M2ZUPI92I?BNLJ_-&F]*VT-]FTF@[)^MR,OK>O<!.P
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M!<
M                ' WK0G:4LS5[F8YQ98KWMS]P%X
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M:<_V^8#TP
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MX>=N!7BK562S,PU.2W#\,C8A&EYHW#962++6K0DUI-S26T5O,(RX#)JF^+O
MZ7JD:BD1:RQU-7\2LXSAF?[!F;:C_>8E#\I_&I#^<.7:RDO2*@G#M0*=%..;
M:&(Q2&3:=9<,B)U2U&M+B=Q>@F6^3>L]R+>!8G&N,C!"'EJ92N)6%*(U&O4Y
MX5SH/W/XCG7^R"F6C[%$*BA=A4$P
M    =";)@PXCKTYUAF,TW=2G5FVDOO,_\1#O!U.:G\*F4KC/,BP92VS(F%QR
MU-,MH6?5R.QW,U>5SS)+2=A-3C##K*H[K+:VEE92%)(TF7L9=A!G!@M<KA.R
MF>:8IEBPM3RU0VEI:TI:(C49'SWKI^)Z*<N9';F GH
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M9;?UN74:E?$/8L9,  !H
M                              "EB]A4
M              !KMQ]R_#<(N8AH6:%+BPV6S([&A:I\="3+V,E+29'Z&1#8
MD:Y\>,6/*X2,PGI2S;3%8A3N9\C6S-C/)1]QJ216" B&D8(BX:XP<EE4R5!9
M8J%"KU488>6:),9"XS27&&EI^&Z:%.,F=RN:$*Z+#>8TI,K&DK7O:WK>]_Q&
MC6+JM0\-\2'#IF,W&KN(V).&,10H;-&ITAX]349%Y*6-)+LZ;CJ$I[I0AH]%
MB^'+4;C/PM(U>/R9SMIS91R>TNY?U$W=9MH5X<R;0HR=-3J$W\EU(Z^L@&QV
ME-]6DK^]AQFEHU$HVTF:>9';F0U\:XO:>\5TY%YYMD27'#(L 3'NIOI4Q=K5
MU7YW'*KBYP_%5N3\G<ZXD=J44=;KN7M04W:_Q'-2$+/2WZ_6_5ZP'4H;,*H\
M=.-:HW'J3)T;+*BTM:G8>F,]NU&<^;B7[]DDVE!6+S;G;0=]BR-!%I))$1>E
MAI UQ(9:T/BJQ!C_ !'@?'5%=G9>4AA*:KA9Z-,8)$^H/.;J'-+J6STQT(4A
M*VU*2=U7:4)!;X^LHTLI<5A3,)+;C+<@B_-Y;JS)[J3Y%\BMV ;/$I)=B(6F
M;)K)PT$:B(R)5N=O8:UO\>>1L2H^#V\7'&(]/B%T&0A.LF]9HTNDEW59*K=/
M5U=])CJP./W)67&DSYE'QS B,/M,J??PX^;.I>FQ[C9++3U_['V\PV=M'_JD
M^4D^4NQ=B^X05PIL'%P;C*0[ DLRY.9.,U3WE.+6W+<36Y+>ZR@W#)I!)2AO
M21%U-+.UU&9XLUQZ9,O^*DJBXM89AF;;SCE!D.$VM"6E/(<2V7PE-MR-Q9'<
M[M.((]:4(7A'#_Q14FBX.Q"ZC)G-F5'FXTQ146Y]+PH]-8=9D5*;+0]K:):$
MZ4JC,N)1JL\NY%TO&@-V=MN^K0F]B*]O0A00&WQ8TL_#:LD\[#WY7@7O\PJC
M\ ]S1N+Z.2=/5=&KN*EQ9T@U2=62.=>E!\K8"J-R+;;/ZG[:_P"X8">K-&:C
M-M-U6N=N]NUQX&*ISM-PM5YS*RWH4*0^T9MI=T[;1\E)Y)]^7VB*'>+/"48O
MC989R-&ZCIW\NZJU9[^IZF?-^U\U^V.M7.(3+S'6%JG0I&$,PR8K5+D$EF1E
MK6WFU-.-&1+=)$51&V9GV5H,_8![_"C+:G<,64Y)D,RB_,:@LKVI!.%J3!:)
M5^1<[\C_ &N7;F)A,T&9*-)&9=CMV&F^0?%GEKA;(C+;#-9@XLFU"E85HL6>
MJ)AR6MAI::<V;IH42"-TT(.RMK6:E?-H6)!E\:N1<**Y,15,7K2<4GV4HP;6
M2UM:U(UI<>CI;2>XEQ%W=/6C1W(!L-9J]]"?4NWOW%;HOJTE?WM_Q[$-=Y/'
M)D3%J#U-FS,71I#*W6F4?FA5%>+=0O0:4?HW+G]?0.5[C5R19,T%+Q<\I;S:
M8Q-X4J/Q2,[='P>KIZNH!U.+RH0SH>6=$<.&IFIYM80BN^.</XB4STR%$T7/
M4HR9-%C[I)SZ@V.,TWO8K^XTCS\XD<H\R:-@"-2',5_*M,S)PO5F(:\'35//
MDQ4FS6:$&T9D6E3JBVC-Y>T;=K*,Q-!<3^"III<AX5S;9)3+CCZ7,N*VCPQ-
MNMH,E:XW4>E3BOA:^E"_UA(2L3T3F>V9DHT$9ER(S(-;=K6Y>UA"D+BDP9*+
M](P%FS35-/.I5XK+NLV^$UNK\C*[W1R3^T.)_B<PN9L)1@;-))R4[J+9>5@C
M(R;;=0Q;8\SB%N%J]%(5VTD FXBCEV:3Y23Y2\I7L7W<S_$Q M2J]&=XX,/4
MDGTE5(N5M;>D)5JU*CN56E[*DEY;$;4BQD=SNJ_EYW(XJL).PH52_DMSF2B7
M8E,?R>UC?A&G63N\G:L>V9=1(W+\M.Y8]$;8@S^P93.)["6)JRUC^F0F<$8K
MIQ0I^#)L13DAJ;3'E24[D="W$N-L*,SN;;>AGFV:U -Q-2?8A2S=B+0FQ&1D
M5O4NPU[=XV<F%Q*C)0]B=/R5 8J,C_->H]"7FFGFFSLSS4HG#09%S2:%WL+'
M^-G)J(?Z7^>,4HT:+)?W\,2T;6ZAQQ+:[H/<4;1$OX.O4171J[ -B3;;,[FV
MF]K=O3G_ +S_ !%B4LH.Z&TIY:>16Y>PUW:XY<CWJE,BIG8I\/$C>(\9^;$X
MF)/-"="4:-YI>MPD?$0CJ^SOPN\=61;3<&9,;QA&:E,E),WL.36E-QOA?'6@
MT>3XY?;\)SZJ-8=S(Z;2)V?7$+%:AF_46,545#D\T6(TE089-,V_T2DR#-7K
MN%8;"71;3I*WL-(LO>*/)G!V>.>U;J>(9AM5FI4*93U0\.U.8Z\RW18VK<;;
M9U-*296^(:35^X2O'XV\BI$R-3BK>(XTNH(WH,9W"M30[+^*ZSMMZV+$K4A"
M[&?E7?UY=R&PQ&@N9)(A=I3WL7N->F.-W(%PR\95\4QBV'Y1ZL*5-RS3;VS;
MX+"N:E=:?V>8[G\]3A[\'\H_G=7]KR[GYFUJVKVT^%[_ +/F' R"/)\#E#C5
MUQ1OHCR<4OF5]):/&2EV^ZQF,DB8;Q*S"-IW'-1:6F,TT1I896AA>UI-23=)
M3JS-7/XIJ.XBJ+F%0\8Y YM5&CF_-32%XG8+Q+"XJI+BFW9"$(2HD&:3:>:3
M?U42QL(WS(B/F1=@&/1Z!7FY9S'<:3U)-EJ[)QV=)&GS';3Z^HXU4+$3-/-A
M6-9[CI1GFO$/1F+DZKYMZR";Y-^J>RO493J29WL5^P71?5I*_N U>XA>&.HY
MSXPRX0SG-B.B3,(O394:?"A,N2VG3*/=Q+B&R0TKX5KJN?Q5>YW\Y_@SS#?@
ME#7QL9VJDIL:7_'L&A)D39D>UHU?/H6HN?S1FUZ*6Y/>(?DTLP\(MK-U3ZBJ
M1L&3J]M-FVC42RO8SN1&F_:Q6&= -1&."7&\:M)JS_&-G,])3(A.(>7*BK6:
M(Y+W"U*:N6I<A\D%V)"T)43I-D.XWP<9N-^((^.'.'K+;1UQ.2=[7;YOD6GE
M8K>_E^&-K-22[$7L&LO8!J>7!AFB[X/Q_&]G0Z3,AZ2K;F-L:NVPV>A/E3]-
M/9ST)L=CAOR F9,XHS"HU)S,JLZJ5%%*DR94RFQ6SD.JBR;N7)-W5'(>-9J6
M9G\-+?E(K;3_  _J)[D?;V[#!,/NQ#S-Q?'\3%U?)](-U))/=O\ I/SI^4OW
M /9^1JXJ63A8QFZ-Y\R3X9BUC;TI+R]D*Y_:8X8U-K\>&2).*IZE?!/6<5E!
M]+EU>9)^=/*WT2^H,I,T*[I(^Q\R]NP:D^Q (VQ=1Z]$PS7Y<G'$Q5-5!GR'
M6'8WZ2VTMI9Z4N-V61HY$5D<DE;SEN#LM4ZN/XDJ7R96'(K#K$,UH3'2XMJS
M;MK:^9'TH[?6,NY[@]G,'X>7V)2/M\D3;_O9<N+*$I#E=K3S"4REJ*(2E^4S
M+:]3% E4/%BH>AK&LF.Y\$]_PC"_*[=WIM^L3R+ZHNDT;%?/3C20G]&>;Y0F
M/.KRO>7Z'U?49.1$1W(B(Q12$*\R$GS)7,O4NQ_>)C%:[ABKU6EU"ER,13R1
M*B/Q]QIEE)FE;1I(KZ;ZB49F1^YC4K)7A%SBP[EYAIW '%?B;"K%5I=-J4N!
M%P]"?:*3X%AK4HGB,M.VVAO096NA*OH*ONT\EM,4U)0DN>KD7TO?[QC.5Y-I
MRPPBE*$DGY"A*L1<KDRW8P$"O<*W$<T1-T_CLQTTHFCYOT2 X=S/F?,A9%X8
M>)*F>&B4CCIQNN,R1DXFH89ILYX[N<[N.H,SY&[^#?U2&U5T7U:2O:U_L#4G
MV(!JW!X;.)N&<GPW'-B_XK'AF]W"E,D6_P!(6M')7VE_?&%8DX6\WX%8R[QA
MF/Q2UC&2<*8KAS&H%5PW'886^](0RM"-E9.*U*66A"CT)05D:2&[)FA7=)']
MXPS'3K+<*C-//O,%)KM/;\[3>KX[9D@R61W)1D71YC]^0#T&Z1BM'FQ:9_I6
M[SA-_,?U/W_M=QPP*)BR.E#=1QB_,4WL&HVX+2+Z&M+O_6*YE]4QE.I/L7:P
MH6V1FHD)N?<[=P&/-4[%Z4[:L3MF?UCIA?\ MP8?+8ER(M?2_/CNS/SHHSMC
M9)+"72^33(M/SGH7J)3UE["*ZPZ<HL5)(S,HV-Z"1_=>DK_\TS+[C,!DWR3C
MSQFY^=[.V?ZCP".7/ZWI_P!G[8[3-%Q0WY\6F?S?>(D_*WI5W]U<QD=BMIL5
MO8-2?8@&*NTK$2SW&L7S=.R]%L49CZ;EMWM\ZT1<C\A\_AC5ZK<,^=6+LT,P
M<?8.X@W,#5ARMKC07(>&VI?Z([!HZM+QK7S,RI\<OAV+X2CU:5&T-R[H[:2[
M6_<,5P>:/E[&_25BK[-N7_QK@@<=&OK?#AQC(F+G0^/RK*==)[3O9?TI3!:B
M:TV:,[<M"[<N6KE:RMWNKX>.+=Y&B9QVUMPS>:LI&!:6QR;^U!]E>OOZC9\U
M).UR([=@NBYGI*Y\^P#6%WAVXP)"2*5Q]5A5OZK+JD,?^988MF+PL\4>,,'8
MCPOB?C4E5.AUME2:C"F9?4],=R.EHMULS943QZK(,B:-/S:^^L;C$32?*A)?
M<0Z=1>;8A/273)G;:<61N6Z3(N1\O_<@(YR;P[B>G9+X"IK-4B1GX.%:7&<3
MX53MU)BQR.^ISGY5_P!XQGRX6(5%TU2(1WO_ $57]7;^L^MS'EY>]6 \.DHV
MTN'2(AZ4.F\979;^FKF?M^\92 \7P^-?_4C0_P#V!=_]NCH-E4V<14J-4)42
M2HV);MV8:FN@C;,D\W%\B-:.7[)>PRFZ/JE^ QJ<I2L;4AQMQ1(^1ZER([%=
M3L+2?[N8#Q,OH>(6<%4BGQZW2W&8L9+$=Q%,>;ULH:T(5\[ZGS_]&/872L=J
MJ&^C$],*%\$_#?)B]=T^;J\1Z\[_ '%[*W.IE-.54LL<*RFW5+UTB&9J>/=,
MSVBYF96N=QFNDB[$0#'&XF*TN;:L0QC,R\WR6YK_ !WMO_9$+<4.2-<SJI.!
M\.Q,S586JU*QC$K5,JD2E^+=1)BPI+B+H6Y;3<WG"^TFR]"&Q9=QAV-S4=9P
MD:%&3:*\:'4D=B6GP,D[&7J5_0&2J@"L<-_%Y.@RVX''?5ENS66MU#>"Z=$0
M9M_4=:-2H^KUV[7%DOADXH:C!1%G\=6+&'7*3X%[P^&(9$VZK;)3S3J";45B
M0CJ+XI:G/B=2K[9:D]K"FE-R5I*Y7L=NU^X-:FP\A./-MA]M/&[362842(#2
M\O8$A.@NRUN+,UF8N:X?N.5*XY_S[D$E,AUTV3RXIUC0K<T*-5^9IU(LUY2T
ME[#:]2&%FHUM(4:DZ5&:;W3[']@J2$D@FR21)(B(DVY$0#5+(7)C-+*?,#$M
M"DYK0<3&UANAGXR=A\R>D*.=67)*5H1((E$;TE3I.F9J,GM/T%;FP'R7C=B)
MH+%<*2Y=I6IZ*37S;FH_+_6)Y+^K]$6TM24YIXB4LKG^;]'*Y\_^=5,9@1$7
M8K <V$+CYH>"TQJS1'5[,4R6<=R]TH-3SG?]8LK$GZ)#H8R9Q.SA*O.U+$+,
M>!%H<I;K[,=;;Z72*Q/;I.6,B2AU6DF^ZTGZ"14DTDK);21=^1#&L=I/\QZX
M2("Y3GR<^E+*64.J>(VN9&A72HC[6/D \Q2*^6/ZPBFSH#!G1Z9<W:<X]^NF
M_5=(>SX7&O\ ZL-+_P#L4Y_[>'0@,-GF=7Y%N::/24DCV/=GW_\ /*_W$,O&
MI/#13L7)*RJW33YW_H+G]7I_KOK<QP;6*FTD3\^&HMDD?!8)OXB3L@^>OI7_
M +(R'0P?=E']TA5.VFVE!%8K%8NQ>PQ5H;DKPM\66'<NZ?(P7Q1TK"<6MT2D
MOG$8P9'>)M;<%F,IQ3CJU*0^EAM"-2>E1I)5A(4O(SC>8J$5FF\:[*:>V1;D
MN3@6G.R%V;;25T&C2?7=7SG<[C8+*TT?R8X//25_D&FGV_T#9#,;%>]BO[@<
MVIZ<DN.J/X31QG4YS;WC<,\OJ=U']"_5^L]?JBQS)+CL:C&^SQIPI$[P["]I
M[ 5.;9\07SY;B4:M'U1MB2DEV21 1H).DDD1=K>@#2+,_ALXIL3?FI,S$XB:
M!C.#AW%5%Q W&E8+CPEHD-/I1NI*,M1O)1N^17FY^Z;;A1(.)F_GZO$5\9WO
M%4?2KR_K/0>7F4EA&&T.+=-E2*Q1R2M)V-)?*$;D0R^Q'W(N]_W@,?1$QH6K
M7B"EGK\O^27.G_RHZ]6CXQ3!E+HM1@/R7&'EMD^TZT27U-$E@NDU=&HKJ+]X
MRK2GETER[<NPMU)O>W/W 1M7*H[1:AC6HID$N5#PFQ,0@VM32R;.<9+,NQZC
M[I^P>QB:E8?9P-6$5&B4^?3_ ),=-V%(82Y'=90P:3;5<EW3INFQWY&9=AXN
M-Y*HO\H+AN*VT8194E-^1:?':K$,DQL<5O E;*>P[(BIISZ7T$9M+6DVN9)T
MVM?V!.#S<+Y>X%1A>DL+P1062536VU,G3F5W2;173JT\R.W,OL'J'EO@-1$E
M6"* 9$5B(Z:SR+;V[>7^KZ/[/+MR'-@LU(P7A\E7:O3HMR,]5[M$,@UD"C&9
MF7&!*A&3"GX)H$F.E&VEEZFLK02.^DDFFUOL%KN6F 'VX[2\#8>4B(HU,).F
M,&31F5KH+3TG;ER]!E&LA3MV 1)F'EC@EEW"<FC88H]+>B8JI\A*X<)IE3J=
M9$X1FA)7)1$1'[EW$K'"CF2R..T9.:M?075J[W][^HP3,7:+\V&G4K^)B.(:
M3*8EE223N.)46JYV-:4D:"[IY=BL) W4_: \EVF-/1U)9;7!>..EM#[#2#<0
MDNQ$3C9ME]UOW#5O(7A@Q)@67E1BNJ8_K5;I^#:+4RI%)=BQF$TMZ?M*=;4H
MBW9#:DF\1)4HR;TMZ2*Q#;FS1*)1-INDK$=N9%[",\*+9G8=P;AYB=/-4NA+
MN\T\MI"F4-MM&L['S79Q*DGW(RN0"0DR)/K2W?WJ0+4327VAS"[_ *I/KW%S
M=,8;[N&?[QX%8E38]8H=%9E.H:J+CT=YU#ADZE11G%$=BY=VS/[^8#U')R+;
MIP5FO<)>BWKN:-5O?3U#MHFOJ\S(XG(2UG$4F8Z1M'UF2SZOO]Q1RE/*F^.1
M.?(OZDG#)'X=@&*UZ),D8OPW6/D*:::=)D[RF#(MG<B:CO8^NZRTC*_E%/C_
M  /AG]7FW+'H\]K?A_N'"W C-J;(W9I^&MW6HR([-?AY2_%SW,=M$3HV3F.F
MKOYS >=+K<F&9D=,FRR49D9LL*0?S3KWO[(0C^TJWJ/3\2OD?ARY'<OL.UAC
MT>4F1BJH4Y-8D[=/AQ92RTL[5G3>];7_ %-_W$/7*GO(TWJ#Y[/FNX?/[P%4
M35R#(UQ9K9D?+H(K==O^/L'@RG);V,J)63I[YQ$46>A^0;3EFWE/0S;1IORO
MI</_ %"]A[;D1U40FRK,PEF1GO$EOGJ/EU;>GEZ<AW'(25\TR%IO[*^V_P#B
M ZWCK3?#E#5M<^NQ_P"CM_YZ_P"X+X\]MXOBQ'6S^X==VGRUZ=-?G)VG]Y5B
M05T?5/X?;[!YV"ZC*KE)DR9$EVZ:I5(A&;AW+9FOL$1?<EJY ,EW4?5(8;F!
MB"'2L"8EGU)#Q1(M*EN234=])%'<6MN_I8B\W^X9 N XHK)K4@N=^6U_5Z?;
MWY_>,.S2I-+FY;XN@XAK4I-'ET:HE.6DE.GX5;,A+I+)',VR2M)6;LYTI*_L
M$/9;8TPCF5QGU7&V7>+(%9H1Y34UI4B,I2E;A5F8I*;*Y^4W"^PE)(;5"$,L
M<BLH<H\P)U3RZP:U1G5T2)$4IN4\LE,*E+--TN.'R(T),N7<E^YWF\!8(RSQ
ME4Z/@^*N:LVF6\4890M:F=RZW*W";1?EY5*Z%>R3OV$GV+V$:9YGM995AQ57
M8@K)<=3"G6]9*=*0V;*"(_IK-*$I/OJ5[A 68&4S_*UF6PAY2U-KI*TW5?2:
MXA$1E[<B(ON(A)XC/!D6!&S1S%D-W*29TE3Z2*VK3%Z-/V=*N0DP9,  !H
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M"HY+Q!.D-D;2BU-6;<(C)>GF GL
M         !"?&)+4QPIYM.E4SC$>#JRWO;6N^J*XG:T_MWT:OHWU":S(CY&0
M@CC'ID^O\*F;$-FKS:4MO!]2GJ>AN(-:FV63><:-1_JG$(6RYZFVI1IYB;VW
MB>:;<3(;/7\VMM6I*O\ > [(
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MG2L7[K%^ #[_ ("RY^XO
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M&]Z&V:2UM-DA3&GU6WMK94KNI2%*/FHQ/8
M
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MO]_/[QC&5I)5ECA!=R494*&9*Y+,CV&R^C;TY<@'@,YWTU\YNC!F.[4\NO\
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MTNQI]OFO,/!I+3A9N8LTKA;:L/4-.T5]TB*34B7=7>QE;3]WH,_(B(K%R+[
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M*MN^$O!C]>KR[O+XEO2VV+D88QX[*W)69+R6_JQ*>PC]9J^F2_H\AF>LO87
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MEEQ)G]))6/\ 'U >J
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MJ1?03YM$:B_LWO\ 8/<
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MD]).P:I'?*(PF03AJ8TZGM)<HY*,W#<*Z4N&:EJ2CD ^Q
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M_<(U7.NY25&K^*<<<DXUQ>;+ZV%1NERNS5I-4=9:XY*OJ)I[4I-[7ZDD-@0
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M-E>BHN3%OE14J3XIE3:B9-UPVT=1F>DD+222Y7(B-*$I(FRV*
M
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M(A0T)5YDD=_<@&*.8S?\!\HIPO7=O;9=-HH[6YMO>55M?=//4GN7L.:9BI,
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M40_@)Y7\M^:>]N)84F@DPO;MKU17347;G8S/[A, [F   X
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MQ$AD:8S:";Y)06@K)+E8B+V 9
M                                                           I
M8KD=BY=AKKP%I>;X3<OBF5!^:919:FWMQ2U.-+GR%-),[W-24D1']@V+&N_
MI#D1.$?+..M$5MUJF+4@F(ZV4+9\2[I7H,]6XIH[F9\S49F8#8@  !HI^5#C
M5->'LL5)@.%2V\2RTN2=_I5(.&LVF31ZFM'BE$OZ)Q[\M0T%K3QPJ2_+29I.
M[+<8R.QMKW+77^Q;T[#Z#_E/53&,O<NWC21TUO%_AW(]NM3[E.FI;7J]B9*5
M?]K2/G/BA:SHM79-:C,XY$;%^Y$[RZ@'WO0A#;:66T)0VE))2A)6(B(K$1%[
M#G'G4Z1+DQ8CL^/X20\P3CT>^K0OE=.K\1Z(
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MZC)G^$O'K)G!)K4F29P73,T&>C0=^?Q;\P'V5
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M:N7.W/D(7K-3CKXO\$TI499OGEOBA]Q[0>E3*ZG1-M!G[IVW;E^VGW =>/Q
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MD9ZR/]PHU1/RDD"7*CLXQR5K##3_ (IF3-B3V'%\K;!H922;=N?^V)B>&G*
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M-J069F-DF@O*TGY?G=*2].?I]H";@
M           $,<8%/8J/"WFW&>:0X:<%5ETM:2.RFH3KA*Y^I6Y&)0ITA3M.
MB/J<-SX+2S><(V+EM\UZ3[?V?01OQ6/,-<,6;DA;J6D_F+B#FZ?JJGO(3W]#
M.PS7!LE%1PO2:E':4TB3!9=:;-YU9VVBZ=;B$K7R_6*ZCO\ : RH
M
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M..M"4WX1*FD)0@BY)25B(=D
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M7Y+$B03U1J4=.@[V??IDA)*+[$H(E*_$!]G@
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M+"@,TA/AWM]O<BD3!D6FRDHNWJ(EDBZ5)/Z1BM-*:),(S/X.\HG<K\64W .
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M(<DX7Q^S+?3^AYJXQ;BD;RC(DG5GU&17[74XLS(O52C]3$^!/0
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MA*C0>I)F5['[E]HO)IHK6;05BL7(N1>P"\
M   &BF?I8AX<^*ZF<59X-K>+\&U7!4RE5>-0J0B3(H"(1-R$24K6M"&VU$HF
MS4K06@G2L:S;U>1C#.1?&MG5E9A_(;#-?GY<Y?8ZI^)J]CB51G6::])B)0XW
M$CJ591WWU)62BUFIU"].TG>&^\F(R^TMAYE#C3J5)6A22-*B5YB,CY&1^ON"
M83:%.K0TE*GU:G3))$:STDFZO<]*4ES]$D7H [8
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M0L.K4YI\F%52,9*2K;3XCF6G3KU*OZ:D?;U?:,5>D;31F1FV@[=KD7V?[B_
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M?P+V$Q""N%.5KRSK5,.!X<J=CO&D8T[NM&K\X)Z[)/SJ.SA>="#_ & $Z@
M-?N$ARE%A;&4>ERW))1<S,8L*-R2XZ:5G59*K]9_4VK_ +:G#[J.^P(@3A02
M\O"N/3>I1,Z,T,8J0HG+;I_+,E5S]SU=/,3V$] &OW!^<!W!6.I]-F2'EU',
MS&$M_4ZI^,EPZU*Z8R[Z5-&VEM5DD1:U.'W,Q/US]Q W"6I3F&<P4.*-24YJ
M8Q0DC.Y$GY5D'8OLOZ )\
M    0EQ=4:)6>&'-J)4G)#;7YH59_6TM1*TLQG'$E?V-SE;U1R["2<%U2;7<
M+T:KSX$B%-J%-C393#RDDZAQ;?-"]/(N?MZD8PSBF62>%_-O3R(L#5TBM_ZX
M.C.,-0X\##L&G,4V-$:B1F&$QF7C=;C$A!?")9\U$CZWJ ]\
M
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MM(>;63ZGR6E?E^(KJ,>N
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MV3(5%"["H)@                                    X'E[7Q3/I&NW
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M:>S'=HE2BR&]R0\\:_$,OMK?.01FLB6RI:$="U-GS;2-JQ-2"XA44+L*@T
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MJYF9<S\W+FA V4&O' 6^F3PAY8.H3L$5%2QI(]74AQQ!G]]R&PX7%
M                                        4,B/N0J
M             +$<^XO%+$78@%0   4-*3,C-)';MR%0
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MV6F?=3A;JCW.@_C.&G;)*6Q[M$X,,ZH= <HC^?.#H"9D-41CP6 R=*+KW2^
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MANF4J-%K4]+!0)#,^HOR7&&UQE(6:VY:#4H[&3NFQF2EFC%*)D9$Q*F9.G\
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MMD*M]YB21%V%67RSOQW)<CH:-VD4$FC+F<IHESK/F?T3U&^U;V:0?TB$H@
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MUXX.5.JHV;!*<4>G-[&)%<^Q?*#G(OW@-AP
M                 $,\6L=B1PR9M-3'W&&RP96W"6B0XT9FB XI'D/R&?2H
MNQER.XR_+>+,AY;X2B56:F9-CT:$TZ^W)7(W7$,H0:B</2I=U&9W5SYF,>XJ
M4I+A?S;LDO\ O!KY=O0X#MQD&6-8J>(,O<-8CJJFG)=6I428XZRRMA"B<CH5
MK)E>E;.H_H*N:3^T!G
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MI*_I;T'J#&\(E+3A*BLOUMNKO(AQVW9Y(LF2HFRUNI+U)7<AD@
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MUJ0[\LFXV9GI;/Y*D]B] 'V1
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M)Q'&E4JG828@XE8=IQIJ$C$,"/';:WYCCA[*'65-FRF3S5XM*S<LLB5Y'X?
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M>-C1EQ4
M                    !8VE2?,HS^\Q>+$&9]S 7@
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M7+L9]S^_F?XBFI/L0UA5^49X0DN--KS;E)6XC4T189J_Q$WMK_HIE:Z%)O\
M6N.O'_*/<)#SW+-PDH<2I?Q*#4TZ%<MMI*/#ZWG#Y=+>HCTK]TW#.^*0J>C!
M>$/%')6;F96"MDVE'TN_+L+FY;Z.@EES^D:/L$V&V@]1&A)ZBLKEW^\:1YP\
M8_#;F5@2-#RWS#>Q+7:9C7"E1BTVGTVHKD.:*U">4I+!H:4_9M#JTM*,T:T(
M(BN2!.$GBZRA@$^Y.9S BI8/KW\N,2(Y;FUZP?K]/]KI[@)L)MLCN3:;V(KV
M]"[$*71WTE[B"G.,;)M@I9NN8WU0G_#/'_)]B*S:O+I<+P-VU;G1I.ZM?3W'
M.7%EE44LX)1\=DMUYQ"$JP#7379MK>=Z/";ED)Z5='0KD8";;HN1Z2N1W+EV
M/_@S&OV-*>V7&#E7,,T0Y#^#<6&AR/(..[4D$_2[QGR4W9QM!.&Z39&1DX1N
M=!)43GH4WBYRFK4N/%I3&.G9BTZSBG@&O*<T;>NUFXBDZK"+,6\5&54/.7*G
M-6K5ROX:PO.P=BR+XBJ84J3*9:WGJ6ZVE!.1TFM1E$<7\,E&>EM/ZT@&X9H0
M9W-";V,KV]#]!?H1<E:2N7K8:QN_E'>#1N,F0K-YTDO%K:M0JIK6GZY)\/<D
M_:=A>[^4:X-H[ST9[.AKQ#;?B'4-T:IK0A&C5YBC6+HZ@&S)MH/NA/KZ>_<6
MFA!G<T$?[AK(Y^4EX-$,O2DYRFI++>Z9EANKZ=N_FOX:W[Q2/^45X-Y&HV\[
MXA;<I;*B<I=3+K2DEJ2GX'61'SOS*W2 [&1]/;1Q><2KEVC>F'@];BDE9:+4
MMQ)6/1]9"C[]S,QLII3<SL7/O]HT<RGXH>'.E<0N<^.'<R6ETS$L?#TJ&\="
MD%O-Q8<A#RT*;9NXBZ%'U=C,]/<Q,D'CJX7*COFUFQ%1L>8GJ54&+>;^M93]
M1S^[]@#8*Q7O8K]KBRQ:M5BU=K^H@ N.+AHLVU_*1(U.)-YN]!JET^16A?Z/
MWLXGE["Y7')PN(+]-S9:I_5IM-I,^(O7KT7TO,ETW 9*^]4BP!F:=/@%2ID=
MZJJA-)Y*,RCGH>2HN9*6NZ[WN1F9]Q),!#:8L5EUM!NFUK,V4V;O:QG8N0C#
M 6,</YJY78HJV%Y+]0CNRZS 2M[<86^9*<T$27"0:"-M2#].1%["0L(3$S<,
M4J4OX2I$",X2"Y$1K;(^WV@/ R_DJEU#&+CKZ'31B-YHM3RC\.CPT<M*+^4M
M*4+L5BNLS]1GFE7N8P/ ")Q5S'>\AAHEXFU&24D5VU4R"9$=NZAGFZG[0%NP
MFQIT)LKN5NXXVV4I).M)*T'=-ROI^[V'/K(4U)/N0#JNMMHAJ-#:4FOS6*VJ
M]S._OW/\3&.96-$UEKA/ES*B02(_L\,CD,ED]<+IY#&\IUZLKL)&L[G\@4X[
MGS_YJV RLFS(K%R%=!WO?F*ZR#60#KG';/5=M)ZK:N7>W:XPW,N,B9AZ)!LR
MLOEVC7)QPVB^%48SB2Y>]ON[#.=2?88IF"9IH\)3'4HZ]2+_ /L>R7_H@&1^
M%:O?:3?5K\OTK:;_ 'VY?=R',3*4JUI21*TDFY%SM[?<+M2?85UD Z_AT:R<
MT%J2=R5;F1VM_AR'&=/BF9F<5HS-.@^@N:;WMV[7YV]QV]2?8-2?8!@DN(7\
MK= G:FB,\.U=@_B*W#5XJ!ST^7T+\!FB8Z$ZM*"+7YK%YN5N?OR&*U*83.;%
M A$JR7Z#5EDDNUT2J=<[?^-(9CJ3[ +5,(42DJ0DR7YB,O-]_N.+P[=R5MIN
M78[?=_Z"7X%[#L:R%-2?8!U_"M$5B:3;3H\OT?;[OL&-89(I%>QIOEN;%=9;
M:U\]"?DZ$O2F_8M9FJQ>IF?<9:,2P@;)U[''Q+E\OL^OK\EP02S9*U3(++F\
MS"CMN?72TDC]?4OO/\3 J9!2UX=,)@FNKH)M.GJ5J5R^T^9^Y\QV=9!K(%7G
MNT>F'%\"=-BG&U:]G93HU>^FUKCP\>MM0\!XFELMI;6Y29;BU((B-2MH[&9E
MW/OS&5FI)]R&/XZ0A[ ^(&E((T_)DQ)I,KE;:7R_@0"N&4*B87H[1*UM-T]D
MDKC_ #9))LNQK,U6MV'O:#OJ]?<>#@51JP?0UKD-.NN4N(;BF3^&H]HKF@BY
M=[]AD&L@%NWTZ;=/MZ"A-$2M1)(C][<Q?K(-9 ,0Q2R3E9P81()24UIPW2[[
M5J?-41E[641%_ 904*&DM*8C)%[$V0QC%CJ6*WA,DD22<KKR%D7+47R9-58_
M<K\_OYC+=2?8!UFZ;3F6MAFGQFV^OH2TDD]?FY6]?7W'!4,-T&K+W*K0Z?,5
M]:1&0X?^T1CT-2?8-U/V@.O\F0>W@H__ %2?>_\ CS&$T2BT9C,;$Y,4F&V[
M)@4>6^M+""4Z_NR?BJ,BZE_M'S&?ZR&(4A))S/Q&1D7_ "/2/_9LW_<7X ,F
M.G4]2=*H$<R]C:3;_ =>#1*52V?#TRF1(C7/H892VGGWY)(B'H:D^P:D^P#K
M^%:U(5M)NWY#T\T\K<O;ER%W@(E[^%9OIT?-EY;WM]U^?WCFU)]A760# <),
MIFR<6,S8+4A/R\\C2XDC+2J.V22L?H1J4BW;F:O49VEA*/*A)?<0PS KLB6]
MB:8ZR2$KK\@F=)6UDA#32.WMMF2OWC-M9 .#P4+_ ,$9\A-_-EY2[)^[[!;X
M1F]]E%ST\])?1\OX>GL.QN(]OX A:5]B 1YG!0Z0]E?C&J2Z1#9F1Z%4G&9*
MF$+=:5X5SJ2NUR/[2&81:53U,1W'X$=R0;-S=4TDUF=BYW,KCQ,R517,O,6)
MD+W&T46H[C%])++9<*QG]W(>_2&W&($5B0ZI;K,9II:E&9J-5N9F?N X6\,T
M-+#48J+ )EA:7&F_#(TMJ21$E22M8C(DI(C+MI+V'*5$I!2&IQ4N&3C'S2]A
M.I';RG;EY4]OJE[#T=9"FI-K6*WL \LL-T%+/ATT2 377T%&1IZUZU\K6ZE]
M1^Y\SYC#<:8?HCM3P=$>H=)4U4*XMN0TY$;4F:E-.F&E*B,K6(D)78_JDD2-
MJ3[# \=Q'3KF"-LV"-S$RM1$1=1'3IUR/W^O]_,!D$S"6':E#33IF'Z;(B)=
MWTL.Q&UMDYSZR296U=2N??J/W':1A^DMRWI[=*AHE2-.\^EA)..:5:TZE6N=
ME=17['S[CTBY=N0;J?M >%+P3A"?$\!.PI1Y,7^H>@M+;_NFFPY96%,-S694
M>;AZFR&IR%MRD.Q&UI?2M6I:5D9641JZC([W/GW'L:D^P:D^P"-HE(IC.:TJ
M!'CP&H[6&HT9$-#B$FA*)3NFS%O(6H[*([EJ/ZR;9[(I<&62RE0F'B<\Y.-D
MK5Y>]RY^1']U/L0Q2/*6>:DRE;LN_P AQ)6G6UX?G*=(STD6[N<SYWV_L&;Z
MD^P#JE!CI/4F.V1]?,D%],[K_$^9^XI%I\2$5H<1E@C]&FR1_@0[>I/L&I/L
M \M[#E"D/0Y#]$@..T]6N(XN,@U1U>[9F5T']I6&"X$PEA6=$J3CN$*,TMBM
MU*.HTP&DZFTR'6D),B+F1L*2BW:Y7$G:D^PQ' [Q'#JZG$DWKK\PK\B(_C:?
M\2T?VB]@'<EX%PC-3"0_A2CN)INSX,EP6E%&V=6SMW3T:-:]-K:=:K6N8X?Y
M,<NM:'/S!PYK;\BODIBZ>C1R/1RZ>G[N7891N(+L7\ U)]@'ALX#P7'T>'P?
M1&MOR:*>RG3UZ^5D\NOJ^_GW'"]A7#$*GK;CX;I;2(R4OLI1#;23;B4:$K21
M%TJ)'21ES(N789'K(=*I-F]3Y3*#LIUAW29=RY<O\0&$X$P-@B;EWAZ(O!]$
MDQUTJ(H[T]I)*4;+=S\O<QD\;!N%(6[X/#%)8W]>[M0FT[FI.A6JR>=T])W[
MER[#R\J%*DY7816XLY"5T"GF;BN1*,XS9WT_Q&7ZD^P#PV<)8=9?5)_-^F[R
MMR[GA6]1[B];ESM?J7U*]SYGS%7L&X4D-;,C#%)=;Z>A<)M2>D[IY&GT/F7L
M/;U)/N0:D^P".,<8+P>U2X;S&$Z/$<1B.DNI<:@M(42_E"/8[DGNJYW/UN)!
M.%&->X<9HUZM>K05]7O?W^T83F;+=A4:FK)&]KQ/0T&R9>BI\=*>K[#Z_P!U
MAGES]P'GQ:)2H+TJ1"ID2.[.=)Z4MIE*%/N%V6LR*ZE?:=S&C&3D&#6I7"^^
MS3:=/IQ8HS%>8?E0[N,L(=J1QT(2J^E1&:#-'G^&GGT*OON- \D44<JOPLH)
MB0W,<Q/F:VAI])JM&)ZHFL^2-)*W$1R29Z#)&LBY&9 -\'*;">2M#L-E:7->
MLE-D9*UE95^7.Y<C]Q@V-\'8;K>)\&G5Z' =:8K$EXDNPM92''*?,0M*B/S7
M05S([WL5[B1=2?88=BQJ.YB3!!.F1::V^LB[=7R7**_WV,_Q 62<GLL*B;BI
MF6V%KNIT.&JCQSUIL96/HYE92BM[*/W%6\FLJV694=G+/"B&IVGQ2$T:,27]
M.K3K+195MQ=KW\ZO<QF9J2?<KBNL@&)JRKRX?DE-?R^PTY(2G03JZ2P:R21)
M*VHT7M9""^Y*?8APGDQE$I*D*RJP>:5&1J(Z'%L9E<B,^C[3_$9EK(-9 (IP
MKE=EKAC,S$C^&L#T:DN/4*EF[X*GM,,+,GIMC-M"2(S*Q=R]"]A()83PTD]2
M<.TLC]RAM_5T^WMR^[D/&I:C/-'$)&9F14"D&1?_ "S4O]Q?@,MN?N"<,_B\
MO\U,-_\ JO4S_P!A&_\ <.)>$<-NZ;X>IG3V_1&^71HY<OJ]/W<NP]K60IK(
MNQ H\E.&,/-:O\@T[J\WZ*WS^_D,5RZPMAWY)ER',/TU3ORS6.M41LU<ZC),
M^=K]QGYFD^XQ; BF6Z%*LLT'\L5>^X?_ ,<)/L-2>HYA:@.O>(=H5/6[]=45
M!J_&PZ%9PG1'J#.I\2C06E/PRC)T1D)LIMO]'M8OU9^3ZOI89-K(>=5E2D4^
M0Y$=:;D[3AQW'/FT.[9V4O\ 9*PQ5CD%<QW&ZH$JGJ2MS#[#KLHW#^(X;KI*
M;-ORF2=7*_\ 6?8,V$?4E9U/%U,G+)U*E8;)Z4RDS.,:Y#K>T?VF6V_^YQ7U
MC$@@+!'&?D14K)O&#C4QZ/(B4U4Z.[&<^(W*CGOM&D[W(];;9$??F))L7L(H
MXBV'I>26+&HCJS<7';(U,'J58W6TG];Z%C >Q1-2,V\6NK4:DKI5'0G5?DYN
MS>DB^K8T<_<E"0!&.&I$I_.S'L=39O-,T.@MM\].A)NU(S27V7]A)P
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M.2WI-K-_%Y-%]<O%WY^_.XX8V*
M         1-Q8)4KA@S<)!F7^8M=+E[> =&;8,I,2C83I-%A%$>BQX3+##C"
M")I;26B)"[%RYD1##^*-24<->;:UD2D?F-7N1\R_H#HR#*A+;66>$4-$2&BH
M%/\ AVU<O#-GYOWF S,
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MN-<F5.-LMD9H/OH_@,J&/81*4WABA+D.MOK5 C$I:2YF9M%<[^M[%^ R$
M             6;J?M 7@+=9!K(!< MUD*;J?M 7@+=9!K(!< LW4_:*ZR 7
M +-U/VBNL@%P                ^;WY2UB--S'R[C)5(=0FGU=E#$V*^W':
M5N07#5'6:-IY3F[H/2HK$V1'V$.<(4*HIXNLM)!+886MZKI.0\V:]6BE2;W2
MAQ'?[A-7Y3\I",Q,K'$HNS+H]<)D_%+*]G8:W5;7E9-)&T1.(ZU[BB5\VD0;
MP;K2GC(RG::(D*4_7E&:2YF7R5)Y\N_]KR?8 ^Q@
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MT\VHC03C[#SC#BTE_5K4P:T?LK28S+RTJSO9^785%"["HX:
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MIGG/BD[[NI*KO(6>E5]:N_TT([F-GS[@R/)4A44+L*@T
M%@U0X09#2:GF^\ELWU)SGQ8B-H-3B6FC\,XXM!*1N)2:S.Y$>V;BC/5=21MC
M8O8:?\(K+4Z9G4S'=N^G.O$TAR*E"KH;6Y&UN:E.?#+]8DTFA6HKESZ 3FR?
M\GLB0WP=Y=;AOI43$_3=A2#))U.0:"ZS[:+$?UBMIMR(;-#6;\GXU3D<'>7B
MHRXLV+X><9/QDN(;ZY\G<,MP]7+UN-EKG[@HO
M                                                  !THB'&R^*Z
MH^9GS,S\Q\AW1QH2D^Z2]/3V[ .0
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ME+4T@U**RC-)7,OM%GB4*U&3BM1)N:241FV9F:>?IW([^VDQV#5I+XKS:?X
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M_(+#.)(+%1DQ8U9DXF. N0AV<MU23,XSA&;>EY)JW/(RV?F-+:YNCYD9XK1
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MWL*34FQ:'AZM1X94Q[%=3<46S=Y2DFL]/FZMN_/E?[D7^GN>A\BUC_U99_\
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M\Z5+2>JZ5;B7E'Q$.EK9XO:PB3\#I+!E**-R\W3MZ^O_ *3I 3SK(46LD=Q
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M>VHSBM]1)ORO^(,[TDEV%10NPJ#0
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MR\J3=;P50:R_5&*L_/I<60<Z,2C1(4IHKNZ2(M.KU+[+#,0
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MI]>H;$F(SA/$13MY4"4HDN*9,EJ2DU5!)FZ9MG=MKX=[V*9>1NN  "8
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M!7,-X1Q?BMY$E#-:FQ*9&=4VYI=3"8L:FN>T:%+=4@]LDENMO(/FDC&Z8Q3
MF"\-8!P52L%85B)ATBCLI;BH0YK+1<SUFKZ9K,S,S/N:C,QE%S]Q*Y55@.<=
M/76,H,9TYR*B6A^A3F'6$(W%K1LK-:4:;'K-)$2;=E6]1X/"[/J-4X>,NI53
MD%4I+M A$\]L%'T6;L9:+<M!IT?M:-7TA++T9MPC3MIL??EW[_[S_$>;2*/
MI%*@4JE;C-.IS2666"4;I&VDK)22UW58B(B+GV*W8![
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MT'],E$9*39)H26RP)P   4                 &I/#(BI3\29N0W\/H0_\
MROURJ$E4!+D=!(:C(CK9>6LR2ZM#1*69%J2;Z^ENS6K;8:F\(KK?C\U*:J=4
M:@;&;6(%,IJ[RW9332&8RT+:.19TFR2^PPHG%&=['^LY!Z7Y.%C8X-,OG"E.
M.I=:J3Z75QD,D25U"29$2$\B(ALZ-9_R=+SZN$'+IM]M*5,QJ@@[:>Q5"38N
ME:^0V8!D%Q"HH785!H
M                            .-"3+N9CD%B%I67(!>
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M1DDI!+MR4[V]'%GY301;-?#,]6A-_>WW?[B_ 5-Q!]R_@ T<R_X<2C\0N<.
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MB?$1$6S@*L.GXIN/UN--<OAW<Z'%=/6O^X.?+@VE9?854A"2O189<B_T+?\
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MK;A])H,M W0R_P 3/LX$PA'<PO76$2*13=PFV6W&FC=9(S)Q1K-1Z5%MJO\
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M8>=EEM.9;84G0DIT/4&(M*4ER/6RT:?P21%]Q$,OT(,[F@OP_P"/8@'@KQ/
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M<+_'^(V0L7L-?>%*;#J$_.\XK3R=C-6KQU[USNI$2%>]_O,%&P8
M                                 "+.)UB.]PWYL,OKT-.8'KJ7%WYH
M+P#M^?I[CNY#'*_D3R]:J5/3!DIPO34G&8<NVFT5OD1ER'2XFC9:X:\V5R$(
M6VC!%=-Q*B(R5^@.]R]1V\@2<1D3E^VY!5"-&$J0E3"G][8441O4@U_3-/JK
MZ0U/O20  ,4
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MT0#P@5,I'%UE(9E(.03]6+3H27(Z5):47W)3U /L2
M                     -8/R;Q1RX*\N2::0@V45",O2DBNI%3E(,S^V]S^
M\;/C6/\ )T4YVF\&>6D1PS>4N%-E+49Z36\]49+JB/[2,P$QYD9@X=RPP+7,
MP<6..(I=#B.ORC:+2M7-));0:M/6XI2$I(O,I1:?MTMH?%SQ,YD[YT_"$*FQ
M%S6FB@8;IBYTB,AYMTDIF2)-V4D9IZ=33&XINQ6)0E;\HH4N3P]MQ"K\>CH_
M.BD*DQ9$O9*JM(?4;<8E&1W4;K;;UDV69,$5^8[_  )P*8>3]37"DP'*F]7Y
M*:@XQNJ6G2E@VTN+4>A2DQU-'9LB:LM)&3BM;KM*=&:<_/R8'2,[<],DV\.8
M.S?.FTYAZO>&1,=PP2HSM,2IA:V8JH#Z&F29:=(S>4EPDW7R<\.]JW&I-835
MJ9&J\!+RF9S:)"&WDFVX25\R[F9$:2[I]/OY#"\X\ 8%S&P1,I.9,TX-)A.G
M-^4TR#AKAN(;4E,A#RNEM26G5)-2B-*KF5K#4^N8R2Y0<'Y891*Q!"PK34*E
MTQ462ZBK5><S)4;KKQMFT:U.K4A]+9&25KD(<7H+3M/:)RKX?-O]K(5,B,R,
MR([=A@^5Z\1IP!AXL2.3ES44YDGC?:,I1GM7)$DEN.*WTD5G3U<W+V.PSD3>
M0                                 -:."UZB+I6<3-')Y$MG.7&#=14
MX?0J6<O46S]9.P<;O]+4-EQKAP>-TPJ3FPU!,R6_G'B]4UI<);.I[QRR\ZC,
MGRTI2>XFR;(V[:D+OL> L&L'!<F4B-G8N1(02GLZ<4J94F(ALU-$XW;FGFLB
M)-]2NJZ31V2D;/C6#@F9I1)SS*GD^A3N>&*W)I.&=CD[C)]/[.@DE_:($LVT
M0  *M8.#/Q#:<[YS[JW_ !V<V)MAY:S5N)2XTA)*+Z!)))-E]B2,;/C63@P2
M24YX-E;6G.C%6Z=N:R6\T:;^]BZ/W7&S8)P   4                 &HG"
M5#<I]3SPJTY^:F/ SGQ1(1';;6I%W4Q#)SI-:G5J2=D-(\ZGE=%U%M[=C4CA
M25,8D9Y*AQJ<N<SFYB1,5Q-/^>W#:>22%K6@GE*5M)-.XV@M"2U<B >W^3T0
M^C@YR]>?J;DE;D>H2E*4V;5S<J$EPV^N_))GH+V(K=ALR-;/R><XI_!MEY(C
M.*?(V*CS<^%_Z4)/L-E;%[ *@
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M?$2TTAR/+D26664,-)231-H@D:$D5D[YV(K<]Z@
M:Z<'+"FZ/F\XXH]<C.'%YDHSY\INV7/]PV+&NW!O$D,4?-QZ0ZM:)6<6,'V2
M4HS)"/'Z;)]BU(4=B]3,P&Q(  #6;@K8CG!SN=-T]Q[.C%^\B_)NSS2"(B].
MA"%?ZWVC9D:T\&331.9ZZ6DDI6<V)#6>GDHS**?_ )FV1_M$H;)W/W!."\:P
M\'S\F;)SYFHGO]>;V(F#9V$DA*V2C()1$5UFI2"3KY\_H);Y$-F[G[C67@O4
MI<S/Q!/&I9YSXC.^XA1_,POJ$7N8*-G0
M              $6\245J=P\9H03<T,R<&UQ#RW#OI(X+I>HLX9NGAZRO;-G
M8-.":$E+1$:B(B@M6+4:$_\ 'L*\3$=N5PWYHQ'UFAM_!%<)UPCL:/T!WG<5
MX:R=9X=,KU.1DQU+P=1B<;,B;)NT%OD1)Y%:PU+O2F  ,5
M
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MAV6::2UE]A6/1ZQ)J<!%&B%3YT@E&]-CDRUI=<OS)2N1F1\SN,Q!(
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M3AW"DNI.1:U(BJ*0IB,AM1FZDRGK41F;"ML]'ZTK]P&Z8"W60N
M ?-;\JI4'SS R>I['0VF!7G7]+K9&MHW("32I)%K,M2$G8S05T%]15X*X-'X
M<;C#RD?D)90VP]B!A;KZF6E&HZ7)T'<U&9F8G/\ *D+JK&/<L&ZJEKPDF)B-
MNG;3"R<LDZ:I:5F2KKYDLTDDV[&:+=B$"<'*I#/%9E2WXV$P7RE42D$Y*2P2
MU> E)(D$9'SN2RT^<U&A)&VFP#[3
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M6.H.L)BSY< I,1PGG+-K4\V6E#*^R'+:3]%$-A3[CQUX\E2%10NPJ#H
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M;3*FC0I+<2&6^:T)([N7NI)F>@SY6&RX,C31<0J*%V%0:
M  -1>$BL46MO9T.T6K,5.FS<XL0-.)W'9:FC>1&L:=)%\-;AWM;0E*E?%^&D
M;=#4WA'J;DK$><T5UUI3;>;F)FI"'62:2M6U&2DV22JU[;!7<O?=5I67- #V
M?R=R7$<(&!FV83L):'JNDV'V4-+015681$M".E!<B\OL-F1K!^3Z6EOA3PA3
M(\@Y*($JL0TR%JN4I3=4E$Z^TD_B((S,[(=2A:;]5^Y[/@
M
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M4<-*D-,_ :=B2#;6?N;F[J 9KK+V 8PXQF X?14Z*DO$FKE"=_HQ_P#C?/\
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M68:DZF$V,B_-^MZO,VOD9=_2W=2"ZQU^**$E[!^$)#;:5G&S(P6I1DTM5O\
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M#:*G>962RZ(+5RL1%[=@$M
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MZ@           /FO^5;:8+&N3IEM$N5$Q":S-2OAFV=,VC2?IUD6KW25C["
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MI>II"TJC$3EKJZM-ALA8AUTM$D]22L=K7+V]AV1-4
M              :U<'D1N'$SE0AW0ES.3%4LU^&=:-PCD-F:DFLSU\[IUHLG
MTL-E+$-:>#%2G8&<#A'4%H5F]BG;3*;-I)?I)*NT1H3RTFCO]-*S]QLN L&M
MO!O-)UO.QE*S+9SEQ0A+.J^@MQHR(E'W)5]?[)KT<B38;)#63@PEF^>=T?PS
M;!EG/BHC-*2)LS)UHS^SFE1$?NLGC] 2;/   JULX/$N+:SF=WCDDYF]B#=E
M%T(DNDB,@S21+4:"0:"9_:V]?TC&R UTX5&#CUS/=LI#DC1F[5G"=<<6HV]=
M/IRE((U(0>E!KTV+I21&2%K2E*U[&V+V 5                    &J'#K+
MKM/Q1G&S$IK%1D0\VJZZ_&A264*4TJ-"<)YO62$$O;?:2OK(R<.RKDM:QM>-
M4^%FFR&<39U.R)\5YO\ ECKC,;0;JDH4N)&<>->ZX?,FR-/[*T'I^&JP#UN
M1NFEPG82;@H9*&N;7&VVHYMFTA)5B;9M.V1-V21%U$758OL&RPUG_)],U&+P
ME8(9GQB1)2]626M,-4*Q)JLTT78-"%%?O;1SO<;*W/W 7@             #
MINR3:4E.LC<._0:B(^Q=KF1&>HT%_K?:.0GT*;0LI"-"[$VI!ZM?^\!V
M                           '7<=9;+XL@T\_K6_9_P ?XCEW4_: O
M                    !8@S/N8O%B %X    L6XE'F'5.6VETT.24)-QHWT
M$9]>E-M9Z?8M2/[P#N@+-U/VB\                           %@A;BY5
M)A\+>;+U,B)DO?FA5FS;39)$@XSB5+Y>J4]1'Z&5R$UV+V$)<8LR;"X5LUGZ
M8V<EQW"U1CO*MK-IAUK:>5TV\K*W%_9IOZ (+@4^L)XF\BJNW5Y$NB3"T4Y2
MS0MMO_-ZHNDVFSBR3TFX6HO9TOI%?=^Y^XT*QIA"JU_,'ATI]/K<S"]/F/NQ
MZ9.I1DS(HT>/AYY1MDVKD;SA$\TM;K1MMIB+29'<VU3LCAEKJ'8BSXH,^E-P
MN6S\N0=MX[^1:O![BO[1J_UP&P&LA3<1[?P$%N\.N,%>7BMSJ+X'A>4FD?\
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M'TE )Z,T&6DTD9>QD,0P"SIH4ME7G*LU@[^O549*D_@?,1Z[QG<*C;\.([Q
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M/IO^\QL&-;.#Z#5(<W/)4^0X\])SAKTA.\A+?0<:#H+I]$$1-E[VN V3
M                                       1OQ .(CY$YB/*-E:&L(U<
MU-N.J:;5:(YW<+F7L.OPW&XKA[RP4;BGC/!-".ZU&HS,X;=SYCL9_I2K(S,-
MI[Q"T?FE5B-+3*GG%%X1PNEHCNL_L,^]OO'7X86%1>&S*:.XLU.-X'H1.*,^
M9_H#7<_7G<!*
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MT[_B-?.!]QQ'&1E*A;BC(Y-8.QGZ_(T_G_Y4@4I3R/M"  "8
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M;J_F*=!6M!)?<;M9Y:"2A"4)2IM+SBEC9H
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MFYMN08+B5Z7#-9$LE:R1?IOI(O0;,'W!D>2I"HH785!H
M U=X;)A5#&6;[;M&)2UYMU5#VW^CMH>9@QB0I2;(W730AI=BW$V5JUZAL\M1
M(^(9](U&X77GFZOG>]*HM1<2UFO6)33\B/+E+<B$Q$-+K).)-I2EH<;)LFB,
MUH4@TZDH2M0>I^3@;(N"W+YM1$1?Y6(R-.FROE6;J1U7.[?UO72-IAK/^3N9
M=9X/\',*CO1VB>K9,-.-I;6TU\L3-M*B3](BM?\ ]R-F <0Z,UX  .P
M    'S;RJRUJGY12HXOS0SNS)KL?!U-JKV&Z'A;#-37&IZSCFRM<AW=0O<-:
MEQG"4DB/45O*@FRE7ADG9FY)<0V)N%3,?,J;CJGM851C2@5.9()V3 CE4'(A
M1WC4@EZG$K9<4=]"#38CLH>+.X,L]<D,?5?$?!-FS3L,X?Q/$,Y] Q";L[PK
MS>@R=BF^AU+ZE7.ZG%H,C,]2W-1;<G\,7#7B;*_%^,<Y\WL1T^OYH8_J+QSY
M=+;4<&GP=9FU#B+>N^I)(0Q?=,R2EEIM&K:W' V:
M         !IEQ*XFSAS:XC,.<(>7V-_S!HT_#;.-<08FICBT5<X3<YUGPL5T
MC(F]3C4<S6GJ,G/5LG$N>#BJ-F3P1XIP?CBI\2.+L<Y?XBKD##.+:?C28B:Y
M">=)S3/B2%V4PV71J;\I$ES6I1Z-N2.)_APQKC7&V%.('([$A4;-/"KC5-8<
MFR=NG3Z8I2S7&DD3:S03:W'5W(NI+CK?-2VC:PF3PO<17$'F%0L1<76+J C!
MV&8[<Z)A# \R>S%DU,G'%[LDW%FHW&C5H);:]2BTDG;^+J#=D
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M9"Y9X?RKPW*D2(=$*6I#\I1DIPWY"GWC,R]W73M?Z/(26
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MQ7$IYI2&\:FQ,2EM5G73JE6NXV6Y9A')7PSW%<^_;7] @
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MSQ6\^N2HLU:B@E*,R,DE3J:1%]Q$7;[+ )[
M                  13Q'PRJ'#MF93WH$=<>1A*K-/HE2%M-I;5%=2M>XE"
MUD9)ZO)]HY>&A;CW#=E<^]=+JL#T,U%?U\ T.UQ#4P\09#9ET!!:E5+"59A)
M*WJY =+_ +1U>&5Y,_AMRHFJ3MKD8'H1Z>UC\ T?_: E$
M
M                  $0\-+))RZK.M)'JS QN9W+N9XHJ9'_  $O"&^&9Z:K
M+W$27V#(F<P,;;7IK_SDJ*O_ #C,OW )D   :9?E2VE+R%PTXA1DVSCBFFI)
M'R/X4GT'S,Q$V?R%5TN]9?)[W)7,OFA]-_RHMD</5&D7Z6,;TC47H=R>1S_>
MX0^9N(>="J[I_.^&>+;/M;:[6!2V^XN4<R1)REP7.J"+O2*!3E:6_=49LS_B
M,V&"9*;1Y/8$)@I*658<IIL$^9FZEOPK7)9GSU#.+G[@FO
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MC,1E$>(RVRTCDEMM))2G[B+D0[8H1$78A4
M    !K?P;\H><Y?6SGQ5?[?C-C8T:S<&JY6C.Y4I]A2"SGQ2:2:.Q$B[1VY?
M2]?[//N-F[%[ G!:-9N"F*EA6>DI#+B&9>=&)%D2VT((S-$5#IV3R/XK:[G[
MW&S=B]AK7P;JI+DO/<Z1O^'1G+B32EY1F2'R3&*0E)'V0;Z7%D1?6,_<%&RH
M  #6+@VC:9&=L3Y;DU947-VMQY$V0VTEUUTXD$U&Z39$V;B5='PR)%N6@ALY
M8AK5P?MLMU#/R\CQ-\XZXLC\BB(X\*S>G[#Z35],RU<[W&RP
M        #C,B46E1$9>QC5WA5;97B'.1]YF5(D,YO5YI#S\YV2TE"X\)"3+4
ME#9&E#K3;:;:DM)4VE2R2I;FTMB]AJ5PFN15YF9^NUC$:*E459FSFVFKJ5'B
MQTQTI9,C/DITFV#:67>[)&?F >S^3D\<?!O@E<_6<WQ5>6\:SNI:CK4ZYF?<
MS/[1LT-;/R>S[\OA,PC+)M3).3:YLM.F>XELJS-TI7ZZOK#9,&07$*BA=A4&
M@         *&E)\S21_N%#0@TDDTE8K6*W(K=A<
M          "U+3:%*6AM*5+MJ,BL9V[7%-ILBTDVFU[VMZWO?\1>
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M:B^[D(*X6\0X7H]7SR<:QO3)K,S-&J5%+I26>AE<* @U)L9:T-K+:OV.Q'[
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M<AJ5^3+84YA'%SE1.\_9P\V;=M!FV5)942_O4I:TF?KH+V ;94K E!I4),>
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M>?F#GU@_+'%U(PAB&C8MF2\0QG)45VC8>EU1*&&E$EQ2RCI<66A3J"5T<MQ
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M)CB]R,J#:EIJ6)T(/NM[!%;TGZ^7PWN SDLN8WB5K7B#%1H=38DGB.7I)/\
M5D6YYOVN_P!HZZLMZ6J7XOY>Q6;GB=S;559&G3="K6U>7NK[S-'E^&,28XML
MFG*>55)W&)LEL6_S)K>HMYRQ%I\)?I]?L'FGQH\/JZI-I%.Q+B"HU*"VN0[3
MX>$JJ[-)*5H97\$H^YR4XCZ/^ "1HF6WA$16X^+L5)-HW=9NUB1(-1*W--S<
M4=]O6G3[Z2U[EA!=)X,LDL5UK%M9JJL1O3)V+)=4=?169+;C;Q,;*[+66H[K
M6L[^N@K+<))K<D5_BHRH1+\$N-CDII[QFQ^8%=-V[#EC^%X35U?1&(8!XDLK
ML.N5F%46\;QWJG79U1CLN8'K"W4H<-M5E[,92;:G'#YGZ& I(X">'Q\KE#Q.
M1VC)Z,22CY,=;?SBSY'Y/[/+L.)K@"R/91)9;J>,41Y+:FC:34S(V4*\R4N;
M>M*3]2(QE+W&)DI BJDU>=BJEDRA3JO&8,K/PFD^=2[1_3W]![>7'$7E)FMB
M96&\#8GG2YYT]=0;0_0IT,WXR5H;6ZAQ]E!/)2IUDNCRZBU& CIS@'R5.KNU
M%N?BYM#L:&T_'177-MY<?792TDFRU*Y:CYF=O**2> ;)E4)^!'J^-8)RVW"4
M\SB):EK?69F3MW$F9NI.YIOR*YVL-H-MO4:M";GW.W,_^+F.)+C:2(DH25NU
MB[ (HR0P6JF9,8!I,JM5]GY+PW2R4VIY3>R;<)M&T9$DB6GOT]AGKF'W%ZM-
M:K);NU:SY].W^_EJ]??U'D90$3^5F")"T()2J!3UF35E(U'&;,SN97[^HS3H
ML1:2L5K<NP#P6\.NH[UNLJ^]\_ZS<]_]3[N787?(!ZMWY8J=O$[NGQ*_)L[.
MGOVO\3^US[\Q[MT?5+\ U)M:W(!#V=^7,#&F6<O"-5Q)B=B/5*O0$-O0Y"$2
MH[C%2BK;4PMQ!H)1K2E6HR[E?OVCJ;^3^R2J;-0@/S,7I8J:33,050(DO%J)
M2206CX9(41&5B*YD)YS*T-8:B+TEJ5B"A&H[<S/Y4BES_<,LLUJ-6VFZK7.W
M,[=OP _DUH@\ >0\.:=75^<\BHV=_25UM]!EJ\OPVR2GEZ<N0X2X#<FY!(8F
MU3&4MAA2UHWZF:'6%>Y.$BZC]CN-G5*:4G2I)&7L9<@-;9F1F7,NQV[ -:)7
M KE35*>['F8DQGI>A(IZ_P!.:,UL(*R#5=KFHT<E'](^XZ<'A+R]R_QI@&OX
M5Q9B&,Y2JZ3[13ZHDR=8:H\II+:+-]9FDR(R5] GC[D0VB(D%Y4D7,SY%[G<
MQB>*W'BK6#295)TG772=)E*%%;Y-FF1.W\I:M/E^GH+L9C4L\G=:H%1*QJQ3
M67OF;\FD=:>Z_)Y3]4=@_-1W_P!66N_T?9_I9>;ZW;S?:,@5MKY+0E7WE<5W
M$>WV]ABKR445"#W3JM1-/L<A=OFMOW_U_OY]QU8=,F1-!'B*I/&TEF,K=-!W
M)OZ9W;\R_4_I>EAD%T6MI*WW!K+V :P9A<+N%LW<_&\6XDKF(VJA1,%Q:.<M
MN0QJ?0[-DO,K-.UM&IHVW#/D>HW$?U9[GFL?D]<F(TN<ZG%6-'&Y4XJ@<9<^
M,IO=+LC5X;<_=JU?:-@Z>49.9U>)"R)U-!IG07H12)Q%_N&6W27(BL0,@U9<
M_)[Y2K9GP2Q=C/:J9+2^9+II<E^8OZ#]+U]_4<-4_)Y9055N8U4,48J\+)-2
M_"MJA$T2E)TF>HHE[F7(_LY#:SHL9:2ZN_+N*DI*2LDB(B]"!K5B-P$970Y#
MDN3B[&3[\F23FZDH#2]!1]LT:F8I'8[+5;UUFGU,AG.0&73F6N%JOA6F8AJD
MIEC%55DN%**,HW-Z6;Y$X;;1$>MM>KX=M).$G1T\IM232#NAM*3Y]BMW.Y_Q
MYC"LMDK>@U=4N^HZ_5DG?U(I3A$7[B >A P]58$/P#F+*O(,S^>>VU+MT>NV
M9^Y?<9EYNL=IO#\Y!=6)JH?/U4C^JT_4]^?W\^X]LB:+D2$_A_Q[$*ZR]@&,
M-X=K2')+JL>U12'=K1T1K(T^:WPO4>=BZCU!NC7;Q)5TJ=GPB29''(RURFNW
MPN6GT]AF]BM:Q6]AX&+G&"HT4Y#V@CJ%.YWMWE- DBC-]F32,Q\DGGJM4JLI
MS,!_2DFV5:=>'*NVH[-ME8DDA:_]9P_0M'=XG5-M9?T&8_468L:)C[!,J8^X
M=D.1TXA@7/V3UDDS/V27[LBS'PU!KM=R]<J++BUT'%*JC%4F:MA1O_)=0;N1
MI41Z3W;&@M?09EHL-6Z#ES2LZ<(YGUS&.=>9TNCP<4XC9FTV/,BS8#-+I54>
M\(Q'AR67B4K;02VWR+7NLI3?H)L%73_)\^&5Q+<7I,J)#CF-T*45]:G$_*%8
M7N']$DJ)PK:1OTD?-K\DO4:E6*_G-4*D;&^\UA99(:(MJ^B<9F1%R+JN1_;U
M=SN/I(D'<^:X  '              "EB]A4 '&:$&=S01G8BO8:V\(+DIU_.
MYQ;C,E2,X,1((F_H%HC*)OE]IW)7J1I5YE*2-E;%[#6K@X\$[#S@ET=J(FGK
MS8Q)M'&69K=T[25WOW^/OZ?V4MD7(B ;+   -<^$QUQZMY]FZM:S_E@JQ=1F
M?),"FI+\%%R]DV]!L2(!X5VHJ*YGX39D1?RLU(^7O\ETRYC8"Q>P"HUQX3W:
MO(KN?!U!3,C1F_5T?#+39'@Z:3=K>S5C5^U<^XV.&OG"PJ.Y6\^29:0FV;54
M\J2*^JGTTU?B?,_<!L&
M  P'.F0<#*/'-39=-IR)AJI/-KMK)%HCMG#3]/\ LG?L/'X6B(^&O*0S(CTX
M!H!E]A^ :'NYG/*BY9XEGLPG9BXU(G/(80R@UZ?#.=*$KT)5]RNXQWA:<D%P
MP92J-JROS&H)<RYV\ U[Z $M@
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M^:])Y+>-Q1?HK?TC/F,]L7L"2H
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MH]2C ;0@  *$1$5B*Q!8O85
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M7SA:13FJ[GTW$-&A6;=369%ZK73J;K.WJ9.&HK@-@P
M                        & YQ0UU;*/',%,E+93,,5)"R,]"D:XKFD]9=
MK>_I8>3PM)4WPU92)-1V_,>@^O\ ZP-#(,SDF>7.)G7HE)E):I4Q:6:F6J&X
M1,N<I)&1W;]R[#&^%DEJX8<HU*49J/ U"YF?_K T E@
M
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M4>Q__*C0D0
M!\X/RL[9GBC)=\^91V<3W_N4TQKCP>%4F>*[*=Z+,CI2J=+0:B8)YTR33).I
M.I!%W:YVW+^R'!LA^5K9<=Q)DTAM1D2BQ(2B(^Y;4'O^!?@-?^#^0[$XK\KZ
MJPRDR359L8FS2G<(WJ3-2KS+1V21%]UC\OP@4IR?9PNPJ*%V%03
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MX?:?A#.;+5RL>)>6]562I3TFGP(ADM,5Y+SAH^-X+DUIZ7%]B,[YI_-(3_\
M%(9\?T?9_P"_QWS>_P WYOM&O_$MG#'_ )4<J,0Y,9A1:H^U0:R4=6&83=8G
MTQF;-I+;K[S-W27\!;VE*VT=32_N+QI''A@R!)DMSN*+,2-+CRG()P)&7%/<
M7K06T;NVAI"[;_3W\_1WY@JVH?X5*))-3IYZ9WM$[Y21F!/21?<6KD.!7"^P
MF<<[^7O/!M'?P_YZO+9M?ZIEN7_?_P"@C5M7'G@-,F-#E\5V83;CU2.,E+V
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M0S3/S-_$F4V6=8QS@G!:<:U.B/L%.I$>I-,+CL&J[SRE*(].E'/2=_3[1$?
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MN!8\EFA8IS)FU> B8TXF2M3U-IYR3<(R(VU>))TS2=S02>?:X#9X
M                                  !A>:A)1E;BY;,E+2U8?FI0YM:R
M(MARW1[>EACG"F32>&'*0FWC=+\QJ%S-5_\ F#0RW'4Z%"P979M64['A-TV5
MXI\_/'1M'Z)YK[F8P[A092QPOY1D22+_ #&H78K?\P: 2V
M
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M4T(,R4:$F:>9';MZ?]I_B+@ 4)*2(B(B(BY%84-"#,C-";I.Y<NQVM_AR%P
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MF9\M/F*X"<S0A1W4A)F7J9?;?_$<9LLJ0EI32#0FVE)I*Q6[6+[+$.84L7L
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M;IN$M-R6E*T_#&]MBM:W(6[3=S/;3<^1\ON_W%^ "\
M                        !A6:,I<'+;%4M:TPS*D3%&O45R/97S(S6CGV
M]1C_  L__ TY2I]/S!H!V^WP#0RC,N$=5RVQ/23,VW)U&FL-F7(TJ6RY8R^T
M8CPJ2$2.&'*22D[)_,6@IY?LP&K@);
M
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MK5S[_P#9Z@.<!P*>4@NM*^17/0DU<O\ =]G<6G(;(M!/:E:=17]4_6Y%V_@
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MBDRGBT"IQ:1)=K#^FH//(6LHA,.I?;(G"<;W'T-O-$5N2EIT;9_% ?:T
M                                   %@UG_ "=<>-%X/,'QH4AMYI$V
MO(2M$<FTDGY9F\B078OL&R;CK+3&^^[H2T5U'>WXC6[\GO,;D\)N"Y$9Y1,/
MR*XM*S6:^]9G<[_\%[+7W ;,@
M                                         -8>#M]:YF?25UA4QU><
M->)9G)6\;?Z/$;0R1N$DR0A"$-I272G0E"%*21#9NY^XUHX-*:4"?G[9I23D
M9UXBDIU/;ER6Q"-1\_<S-)?5+ER ;-
M                                               (!X+4+C</<"+*
M^4#DL5_%+#BI*22\I7R]/YF1<K\^XGX0=PC1HD+)(H<(I)ML8LQ<V9/.+-ZQ
M8BJ)%JU(0K7R+NA!_=8!.(
M                                      ULXP$:JKD(F1"1*06<%'49
M%'4[8R@SS)5DGW(S,R&R8UUXJ67Y-;R&2W&D+TYNTU1DPI*+::?4N9W]$6_U
MK#8H
M                            8MC:!1JEA&MP<03WJ?2Y,&2S+EMO)0I#
M2DV6O4LC0DR3<KK([?B,/X5C/^;!DYS/GE_0#/[3\!'Y_P 3&>5AHG:?+:=I
M#LY,B.MM+#3QMNO)5YDZS-.B_*Y7&!<*W_P,&3?_ .#Z@?\ SOC ):
M
M          $14!AL^*;';^A/+ &$2+EZJJ>(+_CZB71"M";EJXJL<OD^90VL
MO\+-'')*MPU'4*]I/<W-/(T+]#,K]T65N34
M                                                    #$<P5/?R
M?XG=-Y;;C5)EK0XUTJ0HFG+&1K[']HQ+A990WPSY2MMH2E'Y@T$])%8KG :N
M=ADF:\-51RQQ=3?$.I7*H$U@S;<-M;:O#.'J)9<R/[1CW"J9JX8<HU*.Y_F+
M0BN?MX!H!+
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M>9S=VJ/;-6HT),S+3>W.WL*FPRI*T*90:7#NHC25E'[G[]B 7@
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MTJ)7+]PY+G[CA1>
M                     +!J_P &;+AS,[EJF17U,YRX@0>Q')HK;<5#A&22
M^E8EG[F5SOYQM%8O8:V\(=->I-7S\)!FI+V<5;DD6@^1.1H2[<G%EZG]M^Z$
M'T -DP
M                      &OO!8ZY*X>:9)J;JWW7L38K==D.&9+<?/$%2-3
MBE%WO[C8(:]\$]0HM4X<Z34<-)?9HTVO8G73;DG=)@Z[45-DYI22$J)%K\BZ
MN_,!L(
M                      ->>*6-2YV*,@X582ZIH\T8<C6W>^ZS3*DIM-_M
M=-LC_9)9=KC88:[<6+TB-7\A%Q6+G_+!1R(R]27 J:7/P09G^\;$@
M
M                #SZB^4:F2Y5[&EEQ5R[\KV$9<)IFKA>R;U&9_P"8% [_
M /U/9_W$)"K#VQ3IINPYDE:6#UL16TK6Y<N>TA72H_O$?<)W+A?R9M_\+^@?
M^T$?_>8"7
M                         !$M!T%Q29AJ))7_ #!P<J]O7Y0Q)S$M"$L/
M2Y_\[3,**=,D:#P!A2\HUIV.4^N6Y=^ZW?\ JC^L)M
M                                                           !
M@N<$M<#*S&TY$9$GPN'Z@^AN01;3CA,.=)F7/[!XO"WI+AIRD2E)$7YCT'D7
M;^@-#+,>J:AX&Q'*=:)[;I,Q3C2$\E_"<O<O6XPWA;,_YL>3JKG<\"T"Y^_Z
M Q_O,!+0
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M:5M&X[K?L@[)Z4]0RZN\>51P97TY?8QR1KK./YU!IE1AX;B3FI;ZJQ->=;1
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M:5P$:FFS/:4@]#KCG426V^L;"FVV=S-M)ZDZ3Y=R]ONYG^(&A!GJ-"3.UKV
M0%-Q?QC/D7R=DYEBP9L-NGN8WFO65?K8Z::7Q%W3I67PV]+NI1V(=F%C/BZ7
M483$S(W+Y#*7WVYRRQ]),MI.UMO(_P F?2U.6+UT]6@3J:4GW21_N#2D^Y%[
M@(#P#GAFS,S4IF5F<&3M*P6[7:+4*A2JE&Q>U/3.>A/0VY#+;&RA1?TPEI4H
M]6EM5D=Q/HA#'E.;J'%;E,;J$J\%A+&$E.KGK(WZ,T9'^YZW[S]Q-X
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M=?)Q-N2 Z<*=&J,)N?#F-R8\A!/,.-'R6FU^5NX[@X4
M                                               :V\(4R7-J&?4B
M0VHC1G-6XR+MK*[+<>$DC[_5Y%]A>PV2&LW"*F"S6L^F*8](>;_E>K*S*0K7
M\1<2"M]OFLR(M:EDG^Q?D1;: V9
M                                            0?PMR9TK*.3+J;R%
M/NXLQB])-"'$)4M6(*D:C23FDT(O>Q.(3;V$X"".#^GT:F9),0,-M&FD1,58
MMCT]"92WB:BMXBJ26OB*NIT[$7-1F9_XA.X
M                                                   U[XI#C*K^
M0I2JKX)K^5JG+\1MDOXI4^I$VSI_TBOA:OHWN-A!KGQ:.M1ZMD(Z92''/Y8:
M.@D,J5YE1)Q*,_V2(S_$;&
M                                              #IRTH7'=*22T,N
M,_$43QHT<O0[E;[Q&'"=_P# OY-_9@&@?_.]G_<0D.N0FYE.FPE0"GE)8<23
M"W=)/'8[(U?0_M>@C'A)D-R^%[)U]IJ0R18(HB22M"RNHH32%=S\AGU)]-/,
M@$S
M                   "(<.18O\ .ES#=\,UK_,#"'5H*_.?B"_/]Q?@)>$*
M81DJ?XK,STE/-\F<'X0:-)-Z/#EXNN'M'VU]1FYJY])Z>PFL
M
M     &"9M5"%2LK\;U*;+=IT.%A^HNR933)N.-)3&69NI27-9HYGI]3&/\+2
MC?X:LI=2#L6!Z$22)EQG290&=7)1]NVD9-FJ52?RSQ7!I<&3.F.T>:RTW'6E
MMXEK9<))I,S(B/F5ACW"ZEE7#5E+MH2O_,>@<S+V@-6_ !*P
M
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MF&^;NACI<CG^K.ZAT%9A\6)1?$O\-.&9<E1N&TB+CAM*TF16+6E3.@^1V^<
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M(;63+K4MLFC=Z"D1MM23<UDZ]?R$0V)/N.YN8\E2%10NPJ.'0
M                                                 -9N#E)M2\_4
MN.&2_P"62O+(U/(>.RHT)25])%8KF9Z?2YC9D:S\(4IURMY],S6HS+QYM5)9
M,L&M)[2XL)++II<NK6I%E*7Y5'S27L&S
M                                                 " N$)4.+DP<
M&'.14&8.+,5L*GLLDAJ4XFOSU;K:2Z5MJ\Y;:U%ST^Y"?1!/"'$13,D6(**(
M[1O#8IQ7';@/OE)=B-HQ'44HCK=):R<-OR&9+7>U[G>X"=@
M
M  !K?Q7GX2O9#22FG%7_ "M4N-:YK29.09VIDROYU\M*_H^A_6V0&N/%TRE5
M;R#T)(KYQ4=7(O4H$ZQC8X
M                                              >#7=3=&E&I;S:S
MCNDER&T3SIIT>9#6A>OG]#0OF?8Q'W"DA"N%_)LE)(R_,"@'8R_^-<<O\#/\
M1G.+&C/"M609MDI<-YSX9.DE2MOO\$R=7_J&1V^T81PGJ2YPP91+[$G M 07
MV:8#)'_@ ET
M                           0_AQQMWBBS"-LB2;.!\'DHRY'_3\0*_\
M-(B^X3 (!PQ'K$'BZS%=DFJ3%DX)PJ3*C6;2F"5-K9)1MIZ'DGMO*W%];9J2
MA"5)/E/P
M                         ,7QLS%D83JS4^-)=;5 >*S+27U'\/F:&E72
MH^_F(8)PHPS@<,.4D<I#IK_,>BN;:W#6K6<1I:D:O4D^0B]"Y#.\;QITC!M>
M9I[[<24Y2Y1,NO'H0ES:,B4O3]$AA7"=%8C\+^4B8SIJ(\$4-9\_4X+1F?WF
M9F9@)=
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MJ*RO>>!K_F*A@^+?)9F4Y(3JPYC-;:32DTK61T@M*O0BTDM7+U/[QL
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M2TJ(_AD1&KK2MD]R;$+-37+I+EVY=AR
M                                    -:^%,_\ +V>SD.0\XT>;=:7J
MD,OI-3G@X2%()3I'K2EQIPBT&HM)IT[:;-C90:O\(L=A=6S[>@DP<-><%<<5
M%:0ZI:I1QXJGB<<6>@S,]-DMD2$V*ZW &T
M                                                   MUD(9X4XJ
MX&4<BFRIKKSL/&>,([K[CAFM:T8DJ)&:E'S,^0F6Q>PU[X,)$VHY((K,VF56
MG2:SBW%<Z;!JZS>D1WEU^::D.:M.ARQI0:20V6O6HT749F&PX
M
M     U[XJ5NIQ-D(EN*ETOY6Z8BRBN6@Z94KK^]-B,C]+#80:Z\2\>-4,8Y#
MJ?DRU.-9GPOA1Y3C)<J945]DGS*Z6E*(^Z"4D]"757V*
M
M        'F5%EYR#+:B["''B-"#=1=&JQEUEZI^P1OPFI2CA=R=(TESP%03/
MEW,Z>S<QG&*66G</U)#U613&O"/-N3S<091/AW-Q9.D;:R2=CZB,B_$81PK<
MN&#)NW_POZ ?_P!KX_\ O,!+0
M                                         A'#;<Y?%9F%,-^4WX/
M&%XZ(ED$AY*IU;4F09DYS,E(6DB/1R,Q-PARB-U)7%3CA26V/ G@/"NHC(M>
MXFHU\T*^XSN8F,
M                               'CUNGTZL4.= F/;<27&>CR%K5HLTH
MK+.YV[%R$8<)#LE?"[E,Y,C.05E@JA-[:D)\A16TH79/;<38_LOZ#.L<Q55?
M"-<ISLHH)/TV4PF0MM"]DE-_.J)ZR-*>YWY<N:B&(\*:25POY2+6@D*/ % (
MS(K&1> : 2V
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M/XN<H#<R?QI@XZ?2L4DZO&#":<M]IUB)I\&;+KC$M6MHS6UJUH1\4K$-Q@
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M[B:J\
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MUD*;J?M 7@+=9!K(!< MUD&L@%P"S=3]HKK(!< LW4_:&ZG[0%X"W60:R 7
M+-3?U_\ :%=9 +@%NL@UD N 6;J?M%=9 +@%NLA1;B4>8!=8O80!P;T^L47(
MB-3*R]3?E"GXEQ5$E*@H=\(IUJOU)#AMDZ9N(:-RZB)9FLB/J,Q/NIOZ_P#M
M#7K@M)_^;M27%4V- <>Q!B9Q41HW]$)9UR?\!!ODEU2D+Z;NZ5*N?,!L0 MU
MD&L@%P"W60INI^T!> MUD*+<2CS +P%NL@UD N 6ZR#60"X!;K(4W4_: O 6
MZR#60"X!;K(-9 +@%B'$K\HKK(!< MUD&L@%PMUD&LAIWQJ\9V)L@*U1,O\
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M'U<R]2YI^\!V@%NL@UD N 6ZR#60"X!8A9+["NL@%P"W60:R 7 +=9!K(!<
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M)L9"/>$Q#C?#)E(PY&:94G!-'+;:E+=(K16BL2E<^7*_U3+2G4FP":  6ZR
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M];):5KT6U*423(M=SV+_ $%";=9 +@
M                                             !A>9%#^7LM\2X>:
M@>)74J)/AICH=V/$FZRLMLE%;1KY=7T1CW"T1'PTY2I,B,OS&H)6^SP#0R'-
M5Z,UEAB^1)1)4TU0*DMTF3,G30EES439ES)7U3+MZ#&^%4S<X8<HU$?/\QJ%
MS_\ E!H!+
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M)]TE^ 6+V!54
M              !!W$UFOC+)S+F3F+0ZUAJ! H\>8N:NL4B?-2Y))-HK2?"+
M)2$FYR4I5R._/0-)N&_(G-_B KU3XE"/+IU3U?J]5A4#$D&=,I+-8>2TE<A,
M-#W22DI1\ZLWDJ8;5ITDV2?I[-I-.J45R%4:?&E1W2)*V7FDK0HB.Y$:3*QV
M/G]XUYX/G9$BFYO-O..*9CYNXK:C-+:=),-LI1K2E!+,R62C6;GPR(OBFGT
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M/F.&7^>\WS?^$G_D_P":YHZ3^+R5T\QL":$&K6:"U$5KVYV#0B]]";^]OO\
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MAWLO_)_7S^\7JS/XKDPE.EPO8<>D[#3GAD9CZW-U3K:5-*)=/22;(-2M:3-
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MAQJ749E,PM,V79$:&A:EDC1O&EU2E*1T=)J,W-!F,S1QI9!N1H\@JCB_2O\
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M*W8K%_ !V0
M                         !AV9BY[.6^+'*4T;DM%%J+D=+G42G4LN:$\
M_0S&-<+!$GAIRE2DK%^8- .Q>_@&AF>.T,2,(UUF7)7%853):52$+-*F4FT9
M*<(^Y&DC.QEV&&\+/_P-64O_ ,@- _\ :!H!*H
M
M          #Q*]A'#F)8K$*O8?IM3C1G=]AF9$;>0TYH4C6E*R,DJT.+3<N=
MEJ+L9B#LA,N,K*Y1\3XCE8$PK.JD+'^*D'4'Z>RY)CO,UJ18S6I&II2=IHB-
M)]FFW/,HS&Q@AGAGBH:P1B5QAQDER<QL;./D5BL7YQ3D6.WTM"&SN?U@$S
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M'8G9H<4$$Y>QPP4RHDP;VSX;';'Q-/S?GBH\_P#L?2N)TTI^J7(K=A4!!O\
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M5_M&V@UNSC3);XQ>'EN%)=;0Y3L:J?))G9UM,6$DFN7E+4M!W]TD-D0
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M:6DD:BLH])<R$YSI13@<P"W60:R!JX!;K(7
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ML\ XA6>MYO<;3J.'^L29FDO5/,K&.TUQC9&2#Z)V-N]^6!*[_6[7_@GU^?\
M9^SD G>Q>PIK(00UQK</C_Q$8HQ!IY?^F97/3S_\R]/^+#KM<:>1&DO%UG%3
M7QMKKP-7$'N(=VG4?T;SH7S4CN@CY\@&P%B]A40+_/4X?]?/%-<TZ=?_ 'GU
MN^CXG+^B^;X+G]U?U# N-'(@I*8\BLXK0IYGQ<:V!*^6^S]=O]#^*W^V7(!/
M&LA<((8XS,@Y9? Q#B@_)\U@2NJ\Z-9=X?L*/<;'#\U&\0=9Q;;X?_IAU[Z?
M;_F8"=M9"X0&7&CD":3=.M8OTM1R=4X>!*]8TF?5TE#\Q6'*7&5DDDC0Z]C=
M,GPS+^S^8M<-SXB#7HTE#TZDEW 3N++G[B"#XT^'QLB9?Q57X:B-Q%YN#JTS
MT([JZXJ?Q%#XV>&U%-?J$W'E1C1X_F6]ARJ-*_NG'N GC4GV%UB]A *.-GAU
M<EHIWYYU4WY7S+985K-U_#O\)7A?B_NL.U_//X>UHTJQI6(SOU9.%*LS_P"=
M% 3I8O84UD("1QP\-;D;Q!8YJFG=T_\ >Q5O_I?_ (]A>?&KPVE&^44YB2SC
M^%5-O^;U3MLD?4JWA]5S]$]_L 3SJ3[ ('+C3X<SD*CGCZ82FY7@GB_-ZI]3
M^W?2C]'[>NKL+FN-_AH=\N.JC^_#=3_^EP$\6+V%1!)\:_#,DMT\S%:72Z?\
MCS^7_D1R(XQ^'YU)I8Q;5UN[^UI_-JJ^?WML>4!-^I/L+K%[""2XS>&\R)Q&
M8<U:S8W#26'JFOI^Y,?S?Q%_\\[A]_\ 5WJG_P RM5^OH_\ !_<!.@""T<:7
M#FYX?3CZ;^D>7_-RI_\ TN+U\:'#DWYL?S?_ )G*G_\ 2X"<18(,5QH\.T>T
M:?F!-CO6YD]ARI-.%_JJCV%J^,WAY([?GO,M?O\ (]0_K-K_ ,'_ -8!/ "$
M?YX_#;XCP_\ *46IKS%\F3__ &US%(O&7PTR[$QG!1WMH^M1(?3]%"OJ?4<2
MK\ $V"NLA#3_ !;<.$0K/YN45HFMG5>0I1]7E_\ YAUW.,+AO9+XV;M(26\V
MFVA[LMS:(O)_6<_[/V )MUD&LA"*N,_A@*/XG^5VEZ6O-\)_^/PQ:7&7PR%R
M_EDHWQ%+0GH?/K3HUF71Y2W$_8 G#60I<_<0I-XQN&JF-ZI^;]'0LBMLH;>4
MX?7HOMDWK[CI%QK\,R429*\X*8281FE]LX[YJ4DKZ5)+1Z@)X[=A760A1'&-
MPT+DJCEG-ATU(9\4BSR^MK]Y<U"R)QA\-50Y1<W*,]N+8:29*?0>ZXC425='
M19%E*+]7W7H 3?8O86ZD^PA%'&APT.O>%+.&C$_LMR-&V_Y3[_0'"_QJ\,D>
MG_*+F:,$HU[:MI_7;9UWTZ+_ +/]K[0$Z7/W%QI29W-)&=K=O00(YQS<)C3\
MF-(SSP^A^'YT:G"_N]/7^ZXY&^-CA769'_+EAEA)K4C5*F*91J+J66I1=TE]
MM@')AEJL,\4^9+=1=C/TY_!>$BB&AU>ZW:76DH;6WHT'=92#U:^^COJ+;G'4
MGV'S;SJXS*K3,^*W5.'3'."?D_$5&PW09&*L0,R4T^GN0I=3=?;6=B)22346
MS4_8T)(MHBW+J1]",-8FI6+*%3,44.44NF52.W,B24DI"765D1DHTJ(C2?/R
MF ]\
M                    8#G% C5?*3&=)FU9VGM3\/5&&[**0EE<5*HSFIQ*
MT<TFGO<O:_H/)X65$?#5E+R+_O&H)?N\ T/5SL>@Q<F\=R)B7/"?F[4E24M.
M(;4XV<5W425*(T$HR];?B//X9DI1PW96$A))).!J%:Q6M^@- )/
M
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M%V%O/.GL$\M32STGMMF>C09GN0
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M1$.035
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M.W;[A4DI2=TI(ON(<@I8O8!9H2:M9I+5[VYC@\(FRBT)LN^KEWOWN.U8O85
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M4VTI(K%8K$*V+V 5
M                                &'YC)6_ESB=GQ3,/51)A%)D'T,K5
M'=U*7?Z)7(8WPP&9<-64VE1N:L#T&YF=[_H#0[N?-)>Q%D;F/0HUER)^%:I&
M1XFZ&S4N*X1'R]O<=+A<L?#5E+H+27YCT'M_ZX- )4
M
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M59$H^ZMFG%='UCLI17/W/W&Q(
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MWOR+UY_[S_$QD]-%5;%["H .
M
M
M
M
M
M
M
M           &%YIOOHRPQ<ZU'*4M-!J!IC'9)'9ESU_@,?X6^7#7E);_ -4>
M@_\ M T/?S6J"*;ECBFIG!.:S&H=0><@J<TG*2B,Z9M:C\M[<U#P.%K_ .!K
MRE_^0>@_^T#0"5
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MX!,H:-7B32W37R:<47S96C(<U+O\RVGZ1C8X
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ME/2G%&MYU1GS4:GC/29\TI.UQ(0MT(M;0FW/E;W[BX35
M
M
M
M
M
M
M
M                                  1[F\Y!;RIQS)J!EL)PY4SD.E3O
M%J2SX5S5J8*QO$7/X)W-?88_PKN._P V'*=;JVF5?F30D$:75+(VR@-:5]>F
MQF,ASM@?*^3N.Z/$2A+SV'*E';W2NVE2HKFDR(^7+E;V&-<)\Y,_A?RE6U%D
M,-%@ZD1M,E.A>VS%;9U&9?6,M:?L,!,P
M
M    "QQ*E>51E]QB#.%5MQK#.83RW%&TO-+&#[2;\DI*K2$J(B]"-:%F?VJ,
M_4Q.PAGAGBQV\ 8D/=.\K,#&ZKW[_P"<=1+_  08"9@   8MCZHU*EX&Q'5*
M,IAN;%ILJ3&.47PT+0T9W41\M(RD8IF' 9JF7^):6^UXSQM)G1#3HW-1+966
MDR(NW8!A_"BRVSPMY2(2VE*2P%056(K%<X#5S$LZR&IO#M3>)IW(G*1>%L<8
M 8P_^9=%7M3\.37)1LG%0;+)K1*)M1[*VB4M!%U)4,^I>'^+AIPOE?,_+J1N
M132Z36&9B&HLM+NI.V7BMQQ)IL1ZG/\ 4 3L+=9"#&J?QEQY<US\Z,IYB#\.
M<".Y2JC'1R;TOZW"D.+/JYET"K<CC23#VU4S)@Y.YJW_ !M5V]KVVMK5J_>
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M9_Y4J/0[U]*TFS_9$-\6U3XBBX>,=Q\P,+9;(HJD0(S:8E1GR535.SV4(O\
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MQ3]"QB2":9-6T>BG'K>_JD=#B=P[EJ4:+7,S&QXTU=Q?FKB+BPR0D9J914_
M#AP<4E"-RO,U4Y#[D1@UL(4R@M#Y):2N]^IDEI29&2VSW*
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MTVVDDI0A)62E)%R(B+L1=A7PC-EIV46<\Y:2ZN=^?OS':L7L J
M
M
M
M
M
M
M
M                                           P[,NF*K67>*J2AV4I
M4FCS":7').Z1K962=LCZ5&78KC&>%5U]WAIRE-YDFS_,:@ER*W_,&AEN8C;<
MC!.)(\E"2952)>I1E_HG!BO"VI2N&O*74HS_ ,PJ ?,_7P#0"5
M
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M"J!ID++&$:0VE/SK!TQ*C-7N6\RP=C^E8^]ALN
M                   \F?&CU"!+B2I;S;+I:7C:DN1EM_:VZV9+3V]#&O7Y
M.U<A_@WR[.2RLB*-.46M[Q!DCY0DFV5T_2+E?UY?AL7-G^ @*EN,/.M$G59L
MC->BW;WU#7?@&ILNC\'F646<VWO?)3\HUQ2)U"DR);SB%'MMINLT'9:/.A1F
ME9FKK ;,      "EB]A4
M
M
M
M
M
M
M
M               &,8\*=^9E99IR8[DSY-E^'3*-O9<>)HR0AQ+A&1H,SYD9
M&5NXP[A8,_YL.4:K\_S%H17^SP#0RW'56I]'P/6:E.D3VX+%-DNONQ(:WWT-
M):YJ0VE/4=N?,O\ T6%<)QO?S6\I6WDJ0M.!Z%W5N_\ ,VO5("8
M
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M67GF9^*R9<4@E-(25'<):$F?9TUD@TH+GI;>YV0=]D@
M                       %"(B[$-9?R>##,;@[R\CPI#DII+$M.XI#J?B>
M.?W;:DH,DDX:B25K$A)$78;,7/W&KGY-9"5<%&7%TD?Z-4D\R^B53E6+[N9_
MB8#:8
M
M
M
M
M
M
M
M       !A>9,>.]@'$S4ZEG5695%F-.4Y"S:<F-J866QKY+2:RY:K\OW#'N%
MG2?#5E+TE_WCT'T_]8&C&;XI>HT7"]6D5YAEZEH@ONSFGD$MLVR;-2TJ2?(R
M-)G<C[W& \)AF7#!E(IQ1J/\QJ%S/_UP: 2X
M
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ML2I.S5E1I"%&3;2"<0DT$1F=]/:Y=C&ZH
M             "P:P?DY'%'P:9>,K889T_*;9$A1E=M-4E$E7^M_&XVAL7L-
M9N >=4Y/"[A1#\."S38+U08A38=2;E)F,-RW2<>4:&6$-D;YR$I2A*TZ&T+U
MW4 V:
M
M
M
M
M
M
M
M        >!B$J0=!J*L0-$_2SB+3.:./OH?:-)D:3:LK5<N1E8[D,#X3D&GA
M>R=)7.^ J 9W]3^3V1(=;34)=$E,TRJ)@S'XKK<66I&I+:S;Z75)^P^=A'G"
MHZ1\,&3:VB-2?Y/Z#<OM^3X__HP$M@
M
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M]2:;XD.'B(=5=*1*KM??9A$ETTO(109J3<4OYM)H-Q"23:ZMY:B^:69[%
M                                       UF_)_PWZ7PD8(IC\PIDF)
M(JS<F2H[)6MNJ2=9H,OH:B))%V(B(O2PV66LB&L/Y.+P#?!MEZ_!C.,QGU5E
M^.A?-:&5U::M*5'ZF16 ;0@
M
M
M
M
M
M
M
M                         .H\]'CQWY$AM"4MGK6=NYV[_P" B#A"IZJ7
MPHY2-KF/R%E@>CRM3CAF9;D1IS;Y_13R01>B2(A+-4B'4:;,BJ,T;[-B^SD(
MIX1):)W"]E(\E-D_F-1F3+:61:D1&DJ/OW,RN8"9P
M
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M?P%NXXBI-'PM75H97;KZ1WG<Q>)%KYOAKA.?_CS&_P#I83-V[ 24I\J2+[B
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M,<'> 6GU1U.+>K!NJ8(B;:,ZI-49$1<BTJZ?LL0#9P
M
M
M
M
M
M
M
M                                            !X\]3LBF2VH515#=
M=C.K;?6@W#1J\KA$?M]413P@%1RX8,I6*/;:_,JD+N2UJ,EJBM*>\WLNY%[>
M@E"M29T2G2Y<>I0:<;<9UQN3,:-YB/I*^X\>XBY$7T=:"[]0C?A.=AO\+V4R
MJ>MAU/YD41HR:6:DDM,!K4=C]=R_/W 3,
M
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M.ZM6XHY+O;H^ O2M9Z]G;0
M   &NO O';@\+V'6'(\2"RFK8C045"$M-I(J[.(D^I6MZ#8H:S\ #<6#PJX6
MB09"W(S-0KR$2'>AQU!5F<G<<0DK$9GSZ3MR\P#9@
M                                                         6ZR
M%PX]!CD
M
M
M
M
M
M                                                   &-5ZGQIU*
ME(?H\&I)98-;#$I9I949D5SNEM9D7NHB6HO01MP@DPGA6RD2VETR9PE3-6XT
MI@]7AB2=R,S^F7[S+5]HFKX9GJT%<[<[>W80'P0U:AUCA/RHG4.,]'9=PU%B
M+2[&VUJDQT;,A7/Z&\T\:/13:DV*W(!L
M
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MHGOJ[>ON(/XID5)6 ,.S(E62S&;S"P64XD(-2]HZ_!3I3;5U:E(/[TD)PUD
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MH=<22C(S)?\ 6&;2DH2HS2@Y[
M      !K)^3\T?S4\'+=IOR0M51KZRB$X1-Q4KK<Y:6DZ.@S(EIL1EZ%[$-F
MQJ_^3T88_FIX0J*&T/R)LNL29LU*$H5*=^59/Q'-*EFM5O6[G]L!M
M
M
M
M
M
M
M
M                                                         \V7
M-;8A^)=;=-?U(Q*>,OW%W$7<)SVYPP92J1+\098(H5C)HDF7Z UWMJ$E5:(U
M4H,N+-FO-,.L;+VQ)<C+;5[MO(,EI/[2.XB[A#FSI?"ME--G0386>#Z,RELW
M37\),9I#2_WHLI0":@
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MU=FG+98CR:1,8-LMB:M39D^["Z5MFLS\IEMGN;2BTD(+LA)>O;[;_P"(N
M                                      !K1^3Y4Y*X2, 3I3I2WZ@=
M7F/+;+0TA;E3DK4@D%RLE1Z2*W*PV7&LWY/20<WA&P'4"53TE,.IOM,PFUH0
ME)U629Z24XOE?OS[@-F0
M
M
M
M
M
M
M
M                      '7?4HHIJ)1D=N]^8AWA%BQT\+F4O@7#41X'HWS
MIW[Q&M7X=B_ 2S,>?;IZELLO2'2:N2&TI)9G_95TB(>$)YQ[A=RB6ZI"R/!-
M*1K*$N.5RC-%HTKOS^B:OUOG3TV(!-X
M
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MB*=BNIQ4O4RCIB$N&G#E2*03CC;9(,R^%8COKT%IL23-&SX
M                            -8^ !^D%PE9<0</SX\],"F/-2S:C)8<8
MD;[JWF5I)5FC2X:D&H[[AGN%9)C9P:S?D]7*>O@VRT307DR&'*;*-R0OIUR/
M&/$Z2D^IDNZ?W -F0
M                                            !9<_<!>
M
M
M
M
M
M
M                        \V=&*H1'(RGW+NIZ4(6;9E]A*+F(BX0G9RN&
M#)QR24HEG@:DE=Y;)W2B*TELOAJYEI.Z2Y]/SFE?,2U58K,RG/P'),A!*:6@
MU1U)0ZV7UTJ/DDR]#$6<(CY2N%_*-24R&R3@JCH+=6JY*3$;0HRO]$RL:2[6
M 30
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MARLMK<-;K2"MJ6Q;UZ3]AMD
M    #6G@$AR8O"'EF4N-":3\E/R")ALFBLY,==)747G,N:U>J^>MSYP;(.*4
M791_B->>!??/A(RQ>2V]&O1>:945#%S-QPU.$2&T%I4?Q267-1'<UN&>LPV,
M
M                           4L7L*@
M
M
M
M
M
M
M       / Q*U3G<.3VZI#<E4\XK_ (F.AE;IN-%YT)2DRZC^CZ^PCSA)?=D<
M,&49R6M/^8M#38S]$P6DI_%/5^\236ZO%I5*?J<R*IUB,V4@T$XT@R(OVG%)
M;_VA$_!](B2>%G*=<2M1YIE@^EHULJ-5C3&;2I'-:^M'E-/T3+22$%T$$X@
M
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MVV%(B+L1$-?.!.)*A\(.5\::;Q+10VUIUDGDSO.&TK][>D_P ;"
M
M
M
M
M
M
M
M                                                      /*JR)A
M0)+E/81XY3"TLFIS225Z#TZU?5N(NX45,KX7\IVH[;YI1@BAI,G"6@OZ T1E
MUI3>YEIY=_-]HS+,.92XN$ZTW7'&(U-.G26GS=FJ8(T*38RUI(UH5:^DT(6?
MMZ#%N%!9+X7LG#7U7P#0#._._P#DYHO\ $N@
M
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M.4B9,YJ6XUAF(A!LOJ<)!VY)(UN&9+2D]!I^B=T$ALOA@)_
M
M
M
M
M
M
M
M                                         '2*42%;:UJ,S(]M1'J)
M?[R*U_V?P'(A]/Q"):EZ/G+J*Z.7X$ [(#H-3FWEK::?)3B7":,D]R5I2KW,
MO(LE#O@   #R*F[(12I!D^S ?2TLV7Y1)VFU%Y34DEV.W+[K"-^$];I\+V4>
M_'*,:<#4%*2MJY> :&;8T3//!]812:(NKRW:>\J-!1**.J8\;:[,DZ;B"1J.
MW5N%I[\K$,/X4S,N&')OF?5@"@&?VGX"/S_B8"60
M
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M<GU$:,R6K$DUV\#*YH^'R\GF^*C^ZY]5S3W7^+7(&.1&O,0G#;=TKVZ1,/\
M=R: 3,&I/L(5_G@\./B/#EFK3M73R\-*]?)]#^\.@UQK\+RI,2&[G!"C.RR9
MV6I<:0P9&KRZE.(3_K7/[P$]:R%-2?80 CC:X578*ZC_ "[89*&VEAQU:JA9
M9MO..MMJ2@BU'UL*-7]6E25+TI,K]YGC1X5WOF>('!";1]\MRJH\GOS/FK_1
M^<![.<1F68N1QD=KY@3+_P#S+5P2V-3\Q\Z\H\W<QLB,.Y;9DT#%-0/'JJT3
M5&Q$LEM1V*+4#4IUR(:M"KO((X[NE+R"<:,MLG5)VP
M                       6" >!Z>=3X2LKY\1^F22+#\9@E09#BVRV36V:
M-3G42DFC2I'E2LEH3T)2)^&OG ]3$0>$K+!@I3M3;5AUF23CBKF6XG<VN?T4
MWVR+L22(BUIZAE.@;#  #0
M
M
M
M
M
M
M
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M1&1)^U)=R^P1CPB/O2.&#*8E(2DDX(HR4Z=/8HC1%:RU<K )E
M
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M7^8M9PWA>JN4JJ5V!1F78+4M+KB4)09ODM1.*9=/4HBM=!C;W4GV'R&QC4<
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MJ>-HN=FUN(GX0WG0G;S"R,EHN2TX_F601\N>&ZX1B9
M                       %@@7@ND.*X4,L&Y4N)),\.Q_BPH*H[))21&2-
M%U%J2DTH6[Y75H6XFQ.)$[/.I8(W%GTB">#)2#X6,I#8IB(1+PO!6;;49V.5
MTMMI4HR6A/-5S<,_UIF:TFM)ZCRG0)]  &T
M
M
M
M
M
M
M
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M4D5B_,:@\O\ ZWQ_]Y_B E8
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M?(;1CS6:)3HTZ14X].C-3)BDKD2$,I2Z\I*-"36HBNHR21)*Y\B*W8>D
M                                     XUH0X6EQ!*+V,KB ."N"[!X
M4\K66ZC&FM?FU =)<=];A))U)+0W=5[*21H0HOU:DK(K";YLJ8S&-R,V[(?,
MKICMDWN*Y?1W%H2?^L8AG@O:@M<*>5+-)ISK$$\/075;CA*4I]23<><(R6NY
M*?-1E]B@$]
M
M
M
M
M
M
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M@)A
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MG$
M
M
M
M
M
M
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MC4:C,_S!H!W,_7P#0"6P
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MPOQL7JAN0*/0:0JN.4\G#-%/?B+4_P"'W.[J8RK)W.F]N=@$5O<>DN?255;
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M1:N9\NXJ "A)2GRI(ON(6DTVGFEM)6Y<B_X]B_ 7@ M-ML[W;2=^_+OZBX
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M4,IXM02PI1X7ITDU&WHLRXC=;*^VBYD1E?E;]MPK+6$^@
M
M
M
M
M
M
M
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MD/*X1IC<KA=RC4EJ2@OS(HC9DN_F3%;:4?/Z!F6I)=K'<@$U
M
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M^.//*J9XX5H&:F)6ZUAW%DU%$2S"IK31Q)TA+91G%*;TV1KVDGZ=;GN8#Z=
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M/+E.1EI;^0ZF:VR6VE1ZE&=DM7TNF:6U="E**?P
M                   '7?2I23;;4:5'SN1V,:_<#KLP^$G*\Y5;I\\T4-E*
M)$..INS)&>TV:+%\5MDR:6KL:D&X7)7/8:Q7O;G[B!."27*F\)&5SLQYY;A8
M:C-D;J7$GMI024%=PS/22"21'Y#(B-!$@T)()^
M
M
M
M
M
M         6ZR%P
M
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M_HA%W"1%7&X7LHV_$RW5(P11R2I?.Q*BM&7[BY6]"21$ F8
M
M                    $"\/<R=-QCG:X\J*M*<RW&5,P")#:330J0CF6M17
MMU._Z4S$]"%<CEPW<<9XO,QVV4EF0T9$I)(ZBPY1"<5T\KJ4E9G[F9W[F FH
M   '7?;6M.TA1DKW([&.P*6*][<P&NO 5'5 X7,&P)%C=C/U@E&SR;M\JS;<
MBY>G^ V(&N' &ZJ1PHX4FZE:Y4ZNK4B^M+:OEB;T$2+$1%VM]@V1L7L J
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M><H]6;C>A\EK*Q%])73R(;!
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M *I/6Y9'4.W*XJN'B*])CGG;A)1P-[?=.IM*03C25FZR>GNZE#:E$TGJ/OI
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MXCKMU2(XN1_E:.90S,GB;6DS39*7.OVZ%M'RMYR/U(!Z8#A6I1ER0LOO,_\
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MNI^T!> MUD&L@%P"Q"R7V%=9 +@%NL@UD N 6ZR#60"X!;K(-9 +@%NL@UD
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M;%Z6+D0V#&M_ >J9_-IP[(EP%1EOU;$;BV%/;ILK^6IID@DIZ2(O8AL@$]
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M6*O3^(3%&'(53;*C5#!RY\YE#1:G9L:<TRA]T_U>DI4E1)+1J-YWD>DA]20
M            !K]Q#I87BG(TI#JHK*<TF-*D'H/4=(J:21=.KD;AZ3+LH^DR
MTF:AL"-<.+QBEN5K(9%4FO,-GG%2%DZV^EOXB(%26TDS5]$UD2;#8\
M                                  !Q.:"+6LB-/VC7K@=T%PBY9.'(
M^43^1].MF2W*)7Q329;B";1RL:33;6FQI49J2LSV&<(C+29$9>PU]X'9#DOA
M,RN?6B.EQO#K3*E1XRVV[-+4BUCOUI2DM9_K%%<CY<@V!)E)=D)+U[?=_N+\
M"'5^389:;0V>@K)^&7(O8N0[XI8O8!U$TJGH>\0B!&2[]<FDDKS:N_?OS^_F
M+EQT.%I<;2HK&5C*_(RL?\.0[0I8O8!UO#HO?0F^K7V^EVO]_P!HJE@T))">
M22[$7(B'8L7L*@.%$=#9F;;:4&JU])$5[=@3'0@B2EM)$E.@B(BY)]ON', #
MA\.WU_#1\3S])=7W^XZBJ- 5-:J2H$<Y;"'6VI!M)W&TN&1N)2JUR)1I2:B+
MN:2OV(>B #IJA1U/%(5';-TKD3AH+45[7Y]^>E/]TO8<R8Y)*R;$7V?\?80Y
M;%["H#A\.@E:B;3J][%?O?\ QYBPXVI25J*ZD&9I,RYD=K<OW<AV0 =<X4=7
M-4=H[>Z"]C+_  ,R^XS%$P8R-.F,T6G3IL@N6GDFWW>GL.R #K%!C)=4^F,T
M3B].I9(+4>GRW/[/3V%K%,@Q4-M184=E#7S:6VDI)'W$78=L '37"CNKW'([
M:UZ33J4@C.QE:U_:P\^1A##<OPYRL.TQ[PB6DQ]R(VK9)I6IHD7+I)"N:;=C
MYE8>W8O85 >#^8F"_E%57_-"B>/5YI7R>SO']Z].K^(X6,O\%,[ML'T0MZ44
MYVU/9ZY)&T9/*Z>;A''CGK/G\%OGT)MD@ ,=CX$P8RTB.UA"BH:;\-H0FGM$
ME/AOZ/8M-BVOH?4^C8>9#R=RJI[49BF9983B-0S(XR&*+&;2R9(-!:")!:>E
M2D\O11EV,9H1$78@[=@&-'EY@110DJP303*FZ/!$=-9_1M!61M]/1I+D6FUO
M06GEQ@$Z.C#QX&P^=*;42D0?DQGPZ3V]NY-Z=)'MD2.WE*W;D,GL7L%B]@'@
M1\$80B2H$Z)A2CLR:43A0'FX+25Q"<^<)I1)NWJ^EIM?U%\S!N&*@G3/PU2Y
M)&K79Z&VLM7P^?,N_P %K_JT?5*WN6+V%0'B*P9A-:HBE87I!G C>"B&<%HS
MCQ].G9;Y="+<M)6*W*PZLO+S!$^HRJO.P90Y$^:22DRG:<RMY\DJ0I)+6:=2
MK&VV97/D:$GZ$,E !B,O*O+6>N<Y.R[PS(74_P"FJ=I$=9RNO7\4S1U]?5U7
MY\^XYX>7.!:=$7 I^":#%C.H<;6RS364-J0OSI-))L9*]2]?49-8O85 8PU@
M+!Q,^&+"5&)GP[$/;\ UIV&=S9:MIMH1O/:4]D[J[$6H[^0>0N1AR433R7P)
MXANVA[\W(>M-BL5E;=RL0STB(NQ!8O8!AA92Y9I?:DIRZPN3S"$MM.%2(^IM
M"=O2E)Z+D1;+-B+MM(^J5N)62F4:_/E5@]7Z&=/YT.*?Z+J-6QY/F[J4>CRW
M49VYC.+%["H",U<.F0I*:4SDA@!!L&M31IPU"(VS7YS3\/D:O6W?U'H3,ELI
MZC4/EFH97X2E2C=\1OO42,MS=VMG7J-%]6U\._?1T]N0SNQ%V(+%:UN0"/8'
M#_D=24;=.R9P+%1NL/Z6<.PT%N,?,KL3?F;^@?=/I86KX>\BW"TKR5P&HO%*
MGV/#D,_TE164]\W\X9<C7W/W$B=^XJ C7^;MD7JC*_D4P'>'_1S_ #;AW9_L
M?#Z?W#LN9!Y)/)4EW)S ZR5YB5AZ(9'\7=Y_#_K.O^UU=^8D$ $?'D7DRJ3,
MGJRCP6;E0T^+6= B:I&E"T)W#V[KLEQQ)7O8EJ+L9CA8X=<A8N^4;)# #/BG
M4/O[>&H2=UU'D6JS?4I/H9\R]!(UBM:Q6]A4!'DCA^R-GKW:GDQ@26OZS^'(
M;A^=2^YM_6<6K[UJ/N9CF8R+R:BFZ<7*+!;)OZ]W;H$1.YK5J7JLWSU*ZCOW
M/F8ST & Q\B<F(L]=5BY0X*9FN:-<EO#\1+JM"=*+K)NYZ2Y%SY%R(%9$Y,+
MG3*FO*'!2IE1DHF3)!T"(;LF0@[H=<5MW6LCYDHS,R]QGP ,.HN4V6&&TZ<.
MY;X6I9>T*CQV"^C]1!?U:/[B?8@H63N4V%_&_FUE=A&D_*2%MS? T2,QXE*_
M.ES0@M9*]25>_J,PL7L*@,)/)K*A5/B4E65^$C@T_P#HD8Z)&VH_;YM&BR/*
MGL1>4O8>I"P'@^FG)53L)T:*<QQMV2;,!I&\M'D4NR>HT^AGS+T&1  \C\W:
M'X3Y/^18/A32ZG8\,C;LX9FX6FUK*-2C5[ZCOW%',,4-ZHIJ[U$@+G(3H3*5
M&0;Q)^)R)=KV^,[Z_K%_6._KV+V%0'C)PQA]$[Y430:<4WPQ0_$%%1N^'_JM
M=KZ.9]-[<^PZ!9>X-2F6A.$**2:AK\614]JTC4EQ*MSIZ[D\\1WO<G5E]([Y
M/8O85 > W@O"6YN_FM2-?BG9NKP+5_$._.O7T^=?TE=U>IF+',"8/E09E+E8
M3HST*HR539D=R TIJ3(4K4IYQ)ILM9GS-1D9F?.XR$B(NQ"H#'*O@'!E?<W:
M]A"BU)?UI=/:>/U]5)/ZRO[Q^X[)X3P\<Q51.@4XY2W&W5/^%;W#6W\VHU6O
M=/H?IZ#V@ 8[^8N#=<US\T:+KJ2M4U7@&KR3T:+N'IZST]/5?ER[#A3@#!B(
M4>G(PA1$Q(G]'8*GM$VS\3=Z$Z;)^)U\OI=7?F,GL7L%B]@&&/Y399RI:ZA*
MRZPN]*<C>"6^Y2(ZG%1[6V34:+FBW+3V^P75+*/+"J3/E&I9;X6ERN7QWZ/'
M<<Y$T1=2D&?(F&"^YEOZB;9C8O85 8>UE1EBR[OLY<X7;<U[FM-'CDK7ITZK
MDCO;E?VY#L0LML!TZGRZ33\#T"+!J']+C,TQE#4CG?XB"39?/GS(QD]B]A4!
MA_\ )/ECX'Y+_DXPOX+7N>'^1X^UK^+U:-%K_I#_ #M^N<^NJ_#+R9RHGKFN
M3LK\)25U)"FIJGJ)&6<E"O,EPS1UD?J2KW&:V+V%0$6(X<>'AM]#)9&8%W$$
MSH5^;4/6G:T[-E[=RT;73SY6*UAVY?#MD%/B)@3LCLOY$9'E9=PS"6V73IY)
M-JWEZ?NY=A(YD1E8RY!8O8!%)\..0QU3Y0=R*P4M_P $Y$U'08FR2'-W>22-
M%K.>,DZ^75J7>]SO<SPP\.T(OAY!9<N?%W^>%8/SES/7\UYKF?/OS$J:4_5+
MU/L*@(K_ )N>0-UR'<CL J)Q3$<DGAF$=D,IV&D6V_FT(*Z4]D^EAV'N'7(6
M<I:IN2& 9!N(VUF[AJ$O4CETG=OF72GE^R7L)+)*2(B))6+MR[ 1$78@$8HX
M9>'=LHI-Y!Y<I*%;PUL*P2V+*U%H^%TV5SY>O,<CO#=P_P I4)4[(O+V0=.9
M1&AF[AB$OPS*#4:6V[M="2-:S))6(C6KW,26 "+F^&'AR:0XVUP_Y;H2\2R<
M2G"D B62].N_PN=]"+W[Z4^Q"Y7#;D"2=+.1F7R"NH[)PQ"(NI"D*_5>J5K2
M?V*,NQF)/ !$3?"SPWI1H_D,P*]I?-YK?PW#D%%69D9H;);1[:+\]*;%<=Y/
M#-P[HC>#1D'ERF/KW-HL*P21JZNK3M6O\1?/]M7N8DXTD9&1D1D?([^HJ A[
M^:IPQI:B,'D#EZ:VTZ6U2,+PG3<LC06X9M&:K)Z2N?(N0[K'#5P^0CNUD3EZ
MH[VO^;$&_G+_ $7LE/\ =+V$IV*][<PTI]B 0\QPM<.D2)&@1\A<#ML4E+2H
MCJ:#$):3;<2M-G-&LNIE*E\^LU&9WN8[B.%_AI0>]_(+@ R\/X2RL,0K;']5
M\UY/V>PE3;1JUZ$ZO>W,5L5K6 1(_P *_#/)4X](R%P Z2K$^3F&(2MVVFVJ
M[75;2GO]4O8=8N#_ (5TU%4Q/#OEN3JBZB+#T30?WL[>W_ 3)8C(R,N_<-*;
M:;%;V 0LUPG\-Z9#CW\WS "]:NEJ5AV.\BVX[S)*DF1<WG%=BZ3;3R)M-N=S
MA.X:GC5'=X>\!+)R-X3=/#T(S)OEUW-N^OI3U=^DO83#H1JU:$W][<_^.9BN
ME-B+27+MR[ (>=X3>&21$2V?#KEZ2F_7\VX3"E=NYH;_ &4_W2]A8CA-X9&W
MM19 X (C<M_R'&L7-!V,MOW1?_65_6KO,AI29&1I([]^7<4-"#[H2=SOV]?^
M"+\ $11>%3AJA3%U"!D/@.,XY%V%L,T.,AE1=^<<D;9JOZVO<6M\*/"^R2C1
MP]9>.-2NZ585@FEOMV+:Y>5/]TO82_MMEV;3YM7;U]_O%2(B*Q$1$ B!OA0X
M7F8OAV^'G+M"46)QQ.%8)*5MD:>H]KGJ2I1'[DHR]1UG>$?AJ6J&LLA<!MG!
M,]LXU"9:.QM*:3KTI^/9"U$6N]EF:RL?,IH,B,C(R*Q]Q;M-E<R;3U6OR[V
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M#O"3E'N(=9DXYBH.1O2=O'%8/>1K2[9[=E'T[C=K%]'EV' 7!YDB1VBTC%T
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MBED:&]5U:".US-7:[:)W6VVX5EH2HKD?,K\R.Y'^XR(Q72FY'I*Y%8N78O\
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MCR\OF^9<D[8N8RGXKT>?BTIJOG.^7D;WY?\ .Q+F*,68:P/1I6(<4UZ'2:9
M9-Z3*D24MM-)(DI21Z^1$9K+]]A&CO%[PQHA,3BSYP83$A!OQKU1K6^G<VNA
MO5N.EN$9F2?3[ 'DKRUXLMR#):XG:.9Q=2I;1X%9)F8EQTE;B"*4MQ.VE3J4
MI(R)9):2?.[@Y6LH^+!,,VOYV5.)PS:ZCR^CJ/I;;2KF<KE=25F?VJ,>UA#B
M@X>L?XNA8,P=F]ABLURIL+FQH,.I(<>6TAE+BS+2>DU$ATSV[Z]"'5]FEZ)5
MF5&%2*;*JM8FL18L-#CSLAT]"&VT]U+,^7N8"!FLJ.+ BF-JXPZ:32G7I;3I
MY<1KQR4YK2UK.5I6T2>5K:R+]8.2'ECQ8I-3E1XJ:2;CD9EHD-8!:T$^3>EY
M9?'^LEI1*\I:G_AE=&WV6^.+A'DDVX6?F$S)1W:_2E])VU=7+ER&78[X@\FL
MM8% JF.,QJ'1XF(FUNTAY<S64]IO0IQ3!I(]TB)37;ZX#"(F5O%?%<BOKXL:
M<\Z@B<<:E9>QE(DNF;O3I1*0I#-E)/3?7=)'N:?AHO3E=Q9125'3Q5T5XCVC
M\7)R[0IR^ZXH^2)B&O*I!'T_1(>C0N,/A>KU9BX7H><V')=7J509I4>$B4I+
MSLQU>AMNQ%8U&?TKC-GLV<MX4G%L-_&M/;D8"CMRL36<,ODAMUE;K:Y!?13M
M-J45[\B 1RG _%7#J$14;/K"=1BI-V+-.I8(T$6Y(=>)Q),RR+=:;./'0>O0
M:26:T..<QS?FYQCQ4R76\S,KIBVRW&6',+5".T:_ZDW/&+5M_%/XGF^ W]=>
MB9*56:1B&EPJ_1:@S4*748R)<66THE,+84G6A9*]C*QW'B2,S\M8E?JV&7\P
ML,LU?#=.75:O"=JS!2($1*4FJ5(9-6IIHB4VK<7I39=[V 1W)PYQC,SR*/FC
MEK*C&[\ZYA:8T6ESO\)$I1_"^B6[9?TEH'')P]QFJC:TYI93%+CF\=OS*J!M
MRNVPAS_*?PD'J7K6GJ+06G6).P=F%@;']+?K>!,847$L)J6N*])IE29FM-2$
M(2HVC-DU$3I(4A1HY&6K[12A9C8"Q75*U0\*8[H%;J.'E;%8B4VI1Y#],<)2
MDDA]M*C4T=T.<G+>1?L=@C6/$XPCFRF2Q)E"J&Y473;7\G5,WFX9NZ6U:3?M
MN$EMQQ;6NUW=M+C9-$ZYQ1:9QK1"3%J./,F)23J/ATR58?JC+JH5OG]!2]*I
M'^B3I;_;&:NY_P"1<6IRJ-.SJP(BH0'U1)D+\XH9.L2$D=VEH-S4VOH5=!\^
M1_:,MHM9AUZE0:U1ZG#GTZIQ6Y<.7$6F0U(86C4VZAQL]+K:TGK2HK$:3Y$1
M@(=3&XTTRC-5?R:4E*4])4JK\S5YF[>(M8OZSS<_)VUV0(/&JQ*WJQB;)]40
MF-S;;IE3UE(VM-BL_P!#.KG96ZN]^OJ3MR3C7-[*O+J4S'S S(PQAMZ2G6Q'
MK-68@J<2:]!K+=4FZ;^O8<&'L[,H<55=NB89S4P;5:FZYI3$A5Z,_)<_LM(6
MI7X (_.%QR.$3<>OY(1S+=YO4FL/=OF>TA'^L.Q3V.+YUR"](Q'E4RQ,V5S(
MQT.IO.07"=92^RAU,LDNEH*2M*E$CJ-"/*6L2AA3'&$,;1'*G@S&E$Q'"8>7
M&=D4F8U*2T\GJ4TI3:E661&FZ.2O4Q[$F5$IC$B7/ELQ8T=&MUUQ:4I0@B\R
MU*_?S,!"K%(XR&8<=J9CS*53BV'C?5&P[4KQ]/S)H-R>>]^UKT7]5C@GX=XR
M9R)3-,S0RXAH<COM-2$X9E.*2\MQ!M+:2N7R)M*G"-3AN)5M(^&O=/;EK"N-
M<'XUHL?$F$,34JNTQXW":J%)GMR8BS1WLXTI3=^?E-7^ \S!>;^4^9,^92\
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MUE;7MGN=%_$/%8VHV(^6V6<B3J,S5^=U2:;T$XVK;LJFGU;2W$[I=.I)<K]
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M-9 +@%NL@UD N 6ZR#60"X!9NI^T5UD N 6ZR%P  MUD*7/W 7@+=9!K(!<
M"RY^X"\ %NL@%P"W60:R 7 +=9"X  6ZR%+G[@+P%NL@UD N 67/W"Y^X"\!
M;K(4N?N O 6ZR%+G[@+P%FZG[1760"X!;K(-9 +@   !;K(-9 +@ 6ZR 7 +
M=9!K(!< MUD&L@%P +=9 +@%NLA<  +=9!K(!< LW4_:*ZR 7  MUD N 6ZR
M#60"X!;K(-9 +@%NLA<         MUD&L@%P    MUD+@
M                 %NL@%P      "$>,2*Y.X6<VF&#4ZK\SZL\>D]'0B,M
M:D_=9LR/W$W",\_,$8GS,R;QQESA5^GLUC%% J%(B/S5J3&;.0PIKXJDH6I/
M)T_*CL ^4N;.8V0&;.!6<#90\%[U#QI58U+ATV6S+03Z6W%MH0E#+*R<DZTF
M:"4Y?69[BNH9IQ.4.E9*Y]9(X<S>P1'QQ1,#Y3TVF52G,F:(]2>:.7'6;;ZB
M(TN(=-AULC)!<B,]LUE;;_BZX/2XC<#0*IA]%(HN:E&7$.%B!LGHZ76T.(-^
M*ZZTA3JF4VW6+F:R<;2G6@E.FJ*\5<)O&95\TLM\\H6*LNI.+,&87B8?EJKE
M2G+8J$AI<A*ER&HT4C4EUJ2HW"W5V<=<L>A*0&'\*N:7#)C3/K"E#R[X,U8=
MG5)Z9+BXG?D.3? -)BO+-]>I"DEJ=)QC2;GPR4DTVY$-;L@L?9)X0RTFO9X\
M-,[,6H/5],EZJQZBZV4:*ZGYI2#65G"E]))\[FM:E&9LDESZ4TYG\HFK$<6/
MBQ'#J[AA;R&JB45-;5*5&-RR]HE<E.[7.RNG4/.X%.&G&_#AA/&U,Q_)HBZG
MB#$:ZBT=*)1MDPEIIM!6-MOI):%F1=B0I)]!J4 T]Q0>53V-N#3%&566<_+F
M%B7'LFK3:0I;B]%0^4:7#=1O*Y+)2X6E1)))FA:34A!&0^L$^4U&8D/.="F&
M7'M3ODL7N-6.,7ATSBS?QYEAF)E#,P@=3ROE3:NS"Q')?;:>F&_$>C:$,((U
MI4N*XVO6X@CN@_09%@NF<=M6Q BFYU3LD&\(RHLMF>]A%JJ/5-HS8=)A;*)R
M515_&-&I+B5%I3S([<@^:^4>8O#E2\FJ5AO,#A@Q'F%5DL2TU&KQZ[)0P[&(
MG'%*;-BQH4T3C+-U(L9H,R7R$H\0N*L XHX2\K,"9)9=U# $+.G&,RKRZ.BI
MDF,XJ$XFG+;DK>62=/B'8"TMJ3M$F,E1J;T)<+87)?)S\H1D#ECA[*C!,[A[
MFT>@1WG&Y-9*MJ?4X\ZZZI*EMZ",B-Q*"NVCDHB)-D#ULW.%W/#BMR7FX9S_
M '<!4C,?#==<EX7J&%B?539$4HJ=+3[KYG);9=?<=0\22)5XS"R0YMEN%.*C
MUL;?D\>%:K92G@-W"WR*Y26'5IQ,A\SGQI"FT+=F25*^$]J)ELUDLC;3J7H)
MJYC$\1<(V2E.X:\4YI8KK$?,O%AX:G8A:QY4IKYO5!*8SZJ:^DR>-"4(CG';
M(BZ%);N22,N6+8GP+^4\QQEO(R)K4S ;%/1#32Y^*4U!Y,VL,N%I4:E+U$2"
M2\R3VII#BR9>T&O7\38O#_#=.P%PDS.&K!N*SG5%.#ZM1(E7J=V6W9LQIY6L
MR0A>U')Y\S)*#6:$(2@]RP)M?. WAZX?<=\-&%<V,Q,KZ3+Q$=0F3Y=8FDLC
M?<A3G_#K)3BR2MHD$T1DDB;6I"MPE'<:O81RJQ+F3P)XCS0ILJ1)GY=8SD3"
MCJ2DW8C"J;3S<DQI3.IQLD(5&=<6HS234-6DFKCZ6<&>2&.,@LB:;EECR709
ME4I4N=)0_27G7&7$O27GDW4ZA"N6[?\ >(RX..#S%62N1N/<G,YJG2ZF6+W7
M8BT8?D//L)@/06HSBR)YM!:U7<U?#N>@O/R 1%Q?\1N),XN'+*?+++U.&9%>
MSKF0Z?58\>JM3VH#YFR2("S46HE^)>9U7+X9Q7$.&K49C"^(_!W#_D'Q.8;P
MIB7(9>+,(TC*> @H-'M'E/OE4Y#?RA(4RIM+CI,,.:EJ*SBE)UZ;I-N;.';@
M,QCEEQ#/8ZQ]5:!5L)X6*6>#O"25+J2C<=-$=R=\!MHE-1C6HT-$39N.H.W2
M0S?-_)CB51Q41^(#AX9RQ2V>"6L./)Q=)F)0XX<UY]UY+41!*6LDF@DK6Y:S
MA\N8"+>"[$/";F'GJ;^4_#GB;!]:I%)DUNDU2L5!]3:VEG'8?)I"WUH/JF+,
MD']#2YYG-+>:?E6<;8OPMPTLTK"<R3'3B/$,6CU,D]*GH/AY;JVR7<N2G&&2
M47J@UD96,Q(F4Z^.V=BND/YVT;)6#@YQE_Y4BT%5255FC2PM*2;4M2V"N[M_
M3^;)1><9+Q.\.F&^)K*JH9:8IDOPK2"JM'FL&9>!F-)6E#ID7F2I#CC;B;<T
M.J-%EEN (O7^3NR+F9*'EI'P\JD5RH4V"P]B=N(VJI-S8Z=9R%ZG%D1.+NEU
MEI1:DN*0E9(2VIO5[BFP70<D*'PQ9>U+%+V8],PQ#KL]4QUXF$XCC/2H#B8D
M9W=4:$FTHT()EQ1DE""+DHB$RR,O/RFTO!*N'YVNY8+I)8:53SQWXB4<WFAQ
MHXVO4MS?T]&_X3FWU[F]R'5Q9P'YP43"^0\?*BLT"HXBRQ<76ZRYBRH3'XTZ
MK$Y35H0V:$FI#*2B.MI25B2VRP7F4;@"*,O<V.!*=FY@NBX,X4<7T;$LK&=)
MIM'ESI)M-L22G$12C2J2X2U,GW2;:S/L9H$G8N;IBLU_R@4M;BGGXN7M,82T
MV^O0XD\.2#5J;OH-2=)6.UR^)VN8E*1,_*:^%\6C"W#B_*LM)DOY8-PR2JZ2
MMKT>8C,NN_["!Q3.'',B=CKBEF17F*=3<V<-1*+AU4AYK9GSCH[S"Y+IH):X
MZ&W7S;TI1U7-77ZA+O"7\F'POY3.0&D;;F!**2TH*Q&LH;9.(.W+42S,OWC1
M?,>1+;XNN+J;7MB$L\H*T<=$>1OM-M_)E-;94LW&T+W74)0:F='0:S)"W$GK
M$U9?X<_*)Y'9;4? F'<O,F<5TO#5-BQ8#$*HSX\QQ:7FB6;SDI26U.&A;CJM
MLB;Z%$BQI0VO'*UPQ\3$K-G/3-)O"]!>7F-E:]1XK":RXXU(KCT:&V^PV3IH
M=0T:XKB6%/&DD(4U?;3K:;" N$7/&K\+N-L.,XIDK:RVQ_3"4_&BS$?)L"2W
M,3#>JQF2=2MLH>EZ^@]#K9J)1&6GR:AF35<K8_%Y7,-X@0AS'^/6\.PI,>0P
MDBBR9U7?7)2I23U*..AU"%-V-"GTJ*VFXV\PSP8XMQ1P-T/(?'3AT/&^&)%5
MK="7%GVBQ*LIZ:J(;CJ6UFMA2)ADNVMS2ZOGK01E%>0_ IG+5\ILU\(YO4=K
M!E<Q!'H\_#C[%3:DHC56,<TW3=:96ZE:%[R&W+D9*8D&E):B,%.*CHXHX5.!
MW)S*;"=&XGL33J#C/&D;Q[M7@3)LW>E--:9)LN)9<;0Q>:A1&HC-9D7-S2J\
MX?DXZ7A_#V <4TW!W$*C,G#;%9:9@,-4V1!12%J8:=6@D2#-V[JG#,[&;)J0
MK29*-Q"8B3EWQD8?;P%DEB[(+)K,.?AUV9$P7B2NPWY$*AP8_AM3TIMHM*4+
M2ME#*2(G=474I+FV;A[$\$>269>0V6%?IN9?R*=;Q'B>17#CT76J*PTY'CQT
MDE2&R,M115*LG42;M'WN";6_CQAY?5+C)RXCYKI-G!#.&HJJVYO*0LXZJD\9
M$DT?%;1=G2XHC;,B7;7TI(1,VSP^U+BNRFPYP/4B94'G*B[4I<EZ0:&S;09/
MN,L'*1N(2VPB0DTOI,C-37U%7V_STX>LT\R.,K++-)G"='K&7N&X3,.I09LY
MN3^N?<6[X1XB2E3:UL*U-K69FRV?,T)0-KV,+T&GN*=@4.!&6O5J4S&0@SU$
M@E7,B]2;;(_["?8@&EWY+&32D82S9@8<@L-06L>27F-J2LS4E3#"=M39^309
M*ZK=6HOJ#*ORD&.(5%X?9F7Y5".=7QQ485).,1EO(@I=UO2#M;0@B:L:EZD&
M:S:,KJ$3<.62G'?PZ3L90<.Y6Y5SU8AKSLZJ5>I5F495=)D6R4=#*M4=AK6Z
MLR?;-U6IQ-CN@B]ZL<*_$=Q0YOTG$W%12,*X4POA^AG'AHP?4E',F/KOK:)U
M>M2"792U'?H;VD)-2MQP!COY/O,&+E5FABOA\FNT2%2Z^PNO4ETYK"WJA56]
MEB0RR^EXTO)4VDGT(21+,MQ1GS,QK?D)CC$G#AB1G/NF4B8]AF)B21AC$T&+
MM&].CN&_)6T39$AHY#3:$O(-Q:"-1(07FL-KLU^!W$65^8F7F:'"'A&6JLX?
MGSJA4D3,2&A"4+Y,LH3(U*)!MN/QM)&1&T2-S4HB,9)PO\)F+Z3DKFGDEGKA
MMBC4S%E:*<R]0IS#T<DG'8L_'6I.ZF0RZPFRG4&G6TVLD+,UN.AC65"8^*_R
MG^)<?TVLNO0*IEW'KD6[*F"*&N/3$-I5<^9*WTN&?8EM&6FY#Z"#Y]<&W")G
M=D=Q%U3%&-*-3'L+LT:=2F:G#J:%.2EJFQELNN-HTFITTM*4YJ;017U%UW0/
MH*    -6N-7&,3+R+D_C&L/H8IU.S2IIR9""4:V6%P9R7S(TZEW2C79M!:G+
MI;38[#+Y/&1P^19;\6;C*I1Y4=UN.IE_#M587J-RWE7'27_'[AXG%S%F2ZWD
M)'ATXYBD9P4641$[HTM(C33<7]S:")6GZ5OL&Q11&24I1,MDI:B4H])749=C
M/W,@$%(XU>'%4$ZF68<U4%J=\GR)98=J6RW(.^AA:_#V2Z?+I+J^P05Q&U3A
M&XCZG JCV===PYB:F0%PX]:IE(J#S269!NDVR^E;&P2"D-JU-NJ2K2RXD]!V
M<1N5B6MT["F'*QBRJ)4<2B07)TKPT?4I3##9NK4E!>=6CDE//J[#60ORC.2S
MV5N'\W*5A?&-5IE9K<VC)B,1(I2F/"H0XXZI*GM&GXL?2WN:OBE]4! M0R_X
M+8$2GS\H.+#%F!*W'1(IM5K++E16].AR=1)AS&U$R31-&AI7+1J2TXIQ!FDG
M&^_@_ / [EQAS&^%TYK5NH?GW E-0I<G"<]QNFL-FVIDXR$1B)QY#BFW3-&E
M"R2E)MV(3/EU^44RJQQC3!>7D7+W&E)K6,9;<=HI4>GG&;6LW#YN-R#,^IM1
M\D%S,_I=!SK0^(7(C%.)&,'X6S8P75*^Z\Y C4V-7HSDI3K>K=;)E*E+(BVN
M?3Z /GY2\O<@*-%Q73L)<>N.:'%JZIYU]EZ@RD-R3T$T^;J7&DE\)K42^723
MB-6DD$)(R,=RJR6QUA]RG\:&)ZY1:=&D+3AIK#C[-.>W"3'1?;:4@T(4X@KF
MLUDIMHM=B,2EA_\ *(Y-8OQJ>#\*43%-30[B2C88;J$> EN*Y*G*<0E1J-9&
MVA"D-I4I7F)7P]8Z68GY0G+;+G$E=B3LJ<P)=+P[B![#2Z]$IL<H"ZFC<>FL
MM/NOHU.(;;49-D5U*N78""3_ .>SPS)1IEYF*C&Z5DF]1Y[1]7;NR.%KCBX6
MW_":,W(!^(^8M$G?%Y?1^#U_O&2Y 9U0.(+*&@9JT*E3J7#KQRT,Q9FDGFD,
MR78Y+4I!&A1J-"%)TVY*$IICMI)!);21-^0B273]WL USX:<9X)QIF;GE7L#
MUUFJ4ZHXKI$M+C#ADE1*H%/^(GD2E7-"RTJ]6U\N1WV,<=98+=<=L7W\A >2
M^(*?.SOSWH<2=#\;'Q33)10W$*1)-!T"E-J78R(]F[9$E9&M-^HBL:#5[W$N
M[FRUDGBJ-DA0SFXZELE&H^X^24LDZZ2'Y"/B(ZVF%/.H([GN);)*%V) #YH\
M0V+\09M9VYA<1V7<%Z9AO+BK4--)KKM08?BQCB2-J&Y&:4M:EMN2T/NMH8;4
M2TO.&LOB$/JWE=F!2\T,N\-YATB27A<04J-4=*'4NDV;J+J;NGE="S4E1EZH
M_#33([\FEAJ'DM2*'G"O$[.)I>N168$#$*BICSJ'9)1FG&4]"S2TZWJ58^LE
M&VLK]<E< V \^,G\O\1Y59W4!J&U1ZVI6'I,&<M]F4T\VA;J6$'?0T3B3=]$
M:Y#J=*"38PVGJ4.),BNPJA%9DQGT*;=9>02T+0KS)4D^1D?J1B)>#R9*J/"M
ME*]+8-AS\SJ1&-'8M#<5""5[:5(2E1?V_M$LU:HL4VF2JF^1*1&9<D*(_JH[
MB(N#VH0*CPLY2O0I4>9IP;2XA[4@G#NRPTT9<B*VDR(E?4L1<P$W@
M
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M+L-C1K'QD1Y\J9D+%@NJ<F%G%0'R90X;)FAJ-.<7=1Z^1EW(;.
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MEGE,E]T[R4-8JJ;?A?A.EUWA.$?4<8^E?U_0S<1L*3:$G=*$D=[\B]?^#/\
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M3+MD;FM7*:@M1Z&]*>_7^,_[;=U'H3=964=NY?:&VW<ST)ZCU'R[G[_?R+\
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M3?D9^IU&)W.*TKNR@^G1S27E]ON%44^(VG2W%90GD=DMD1<DZ2_V>G[N78!
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M2E$>N1E^E^Z5^W^'N+/Y<,F_#>-_E<P7X.WS_P"<$31Y=5]>[;R]7W<QYO\
M-\R+-!(3DO@,D)?LDBP["TD6]O6+X?\ 7?$_Z3G]H[G\WS(?Q/C?Y$\ ^(_K
M?S;A:_)H\VW?R]/W<NP"P\],F%O/LIS?P@\;#FS(VL01%;![6[==G"V^@C<Y
M_1*_;D/1>SCREC%9_-3!R#_;KL9'^*QYJL@LD9BU.5#)O \E:U[BE/8>B+,U
M7OJ,S;[W]1R1^'W(F!_R;DK@.)_T&'(;?^#9 *-9\Y)NV<:SAP>N.XT3A.%7
MX>V3=E]1*W+_ *M7,<LG/+)R&P;TO-K![9=:>JN1$=24ZS*YN6N1?;8<,?('
M(]DTJ:R:P*A"6ME*4X=AD1-\^@B)OR]2N7;J/W'+%R*R9A(VZ?E%@J*CPRH6
MEF@1$%X=2=*F;$WY#+D:>QERL [,3-S*NH+_ $+-+"TDK=V:Y%7YK6[*^TOQ
M3[F+49P94.'*:3FIA;5#YRS^68WZ.?2JRNOIY.)[^EAX\GAVR+EZDKR:P.GQ
M"-H[8:C%H,KV,NCIM=SG]J?LOV&>'G(=M3*CR4P%=G^C'^;</X'(BZ/A]/)*
M2Y?5+V >RG-7+-7;,G"AZW+)M66#Y>WG[CC_ )8<I-_:_E4PGN?4^6HW_H8\
MLN'+A^3ITY%9>EI.Z;88@\C]R^&+OYO&0OB?&?R)8!W/K?FU"O\ CM@/23FY
ME<Y\SF;A9?.W*LQC\R])?2]^0[R<?X*=2:&,:41;O78O'-<]'?Z0\%K(#)!G
MYG)K S?;RX=AEV5J+LWZ'S^_F.!KASR%9>\2SDC@!M75S3AJ$1]7F[-^OK[@
M/21G#E.^;26\TL+_ !7-MLRK4;K<3U*077SY=_L[#VUXLPTW!^47\2TU$7<V
M?$>+036O3J\]]-]',84GAPR"23!MY(X.3X1UAYK31(I:7(O)A9='F(N1'W(O
M8>?+X6>'6>]XA_)/"A&;%_\ D=NY*T:-7E^<T=.KS6Y=@$DEB&D+8^54U^GG
M LOXY2$;/3>_Q-5O15^7HKV(=56-,)(J!T\\7TGQ/PB**=0:W3W=6CIOJZM*
M]/UM)V[# V^&K(%N;NEDYA:[9K,T?):-JSA--G=FQH.Z6R]/.E:[76HSYSX8
MN'12/!*R&P$;-O,=$C7^E_H_](O^^KW,!G[%>I<N6<*/5X;TA+FSMM2$J5K^
M)>Z$G=/S+G?^K<]COB^7F9M!Q_A61BR,^B"TS5:K3%M/2TJ(O!S789N:KD6E
M1L$X7[+GN8Z>%<A<FL 0)-(PAE-AJFQ:DXTN6RU2XZ4/FG0V:G$I399Z>HS/
MN=S[C%,N\C<*.9=U#"68V75-G;F*<2/LQ9T1EQ*X3F(I<V 1F:3N@T+CND7:
M]B7U%I 32JHTQ%VSJ3-_^G*_4?+U_ >>UC'#+_\ 1\34=?S1<IS9_.'\+Z7T
M_H_7]!&,/A&X8(L/PA9 8&4VM#$<CD4)EUS0W?;5NJ0:R6=^I6JY^IF.S!X3
M^&J(3.UP_P"7Z#CLDP1IP['+<;+LH_A\W"^L=U<^X#/G,>X)8C-S7\9T9N(X
M=VGU5%LD+\JN2]5CY+3R]C(75''6$:51_EVI8PHT&GN-M/)FR9[*&"2[;9/6
MHR19?T>KGZ7$>,<*G#>AUM\\D,'NR&38VGY%&;DK0;.DDDE;B3,N31$NWSA%
MU7'.QPL\-\5,1L\B<".HCQ7(C*5X8C+(VG"+<-PC;ZE*MU&?,_4!F1YD8#2I
MR1^?]$4PP:2>M48UF;\BU]5^H^UNY_8.)O,S+]\W(Z<94!QUMUY!LMU2,;C1
ML)0XZ1D3AE=M"DN+]$IL:K%8ACBN&_( Y:*@G(_ Y2FWVG$/EAN&3B6VVMIM
M)*V[DE+?0DO1/27+D.JSPO<.D:8X\SD/@=K>@II4B.B@0TQWXQ+2X1+03>E1
M$IHC*Y=R 2!$Q1AJ8_:G5^FR'#-=TLRFG5F97-9<E>A-V^RWV"L;%&%9JDM0
M\24R4I,0I1-L3&EV8_KB,C\O[5["+D<)7#1'E'LY#X&2^4=N*<E%&CD\IJSI
M7U[>HE+)Q1+=OK7U:C/2D=A_A*X:I4G><X>\O$N%+;EG;#D;9-16N>WHTW/F
M1\N=^8"6US8";ZYD?G8CO;T'7A56DU,FS@3&)).)WBT.DKI,UE<N?/J2I/XD
M(@5P;\**_"F?#K@!1LQ]AG_-V/U(Y=;GP^IS]I5U?:#W!APL.0$4YS(/",B,
MA+Z&]RG-K<2B1(-]Q).J/61$XI2D\[-I4:6B21F0"4&L7X5?I\^:SB6D+B4V
M0[3Y3WC6MJ,^U\XR\K5I0XGZ25$2D^I"LK%>&XDAR)+KE,3)9)MTR7(;2;2'
M%I0VHRN=E+-9:?KG8B[V$9L<'_"_'90VUP^X%2VV\EY-L/L$\2D/;B$$YHU$
MV:[ZDWTFGH.[72.:E\(?#!0WXDNEY%8,COPVTLQG54-I2V3(R42T&:;I=(TI
M,G2ZKD7/D E-%6HK,#Y234H:(.VE\I6Z@F;+,^>OM8SY_O' WBG#+AF;->IB
MS1-^3EGXMHS.47ZH^KYS]GS?8(@I7!7PGT<R7$X><%N)))(M/IB99:2)JQ6D
M)5R+:;Y?V_ZQW5Z\?A*X9HZI<AO(+ *%28OAI"$8>CZ2*W9LM'27]FP"56JM
M37C>\-/B+-HB([/).WW^P[!I941$24\E:BYER/W[]^9B$&.#OA?9BKBL<.^!
M&HZGF9"U(H[)/J<;-O2@U$F^GH5K;\B[\R/6L=:?P4<*$]>E7#Y@]!'RO&IQ
M,\U;>KRI+MM(^[4[[N:@G)JH4]Y?Z/)CN+M:Y.I,QV-;9E8S*Q^FHO\ >(1D
M<('#3(J*IZ,A,&LO%H(SCTEN*R1H4VXGH;,D\UM-ZN7-"U(.Y+=)74C<&'"I
M&FQ5'P[8.<3&C;2"72&U)3\Y9+A&1DZL]QSK5<^EKGR;L$[;O/;WVM7OI_\
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M;?;5^D\]7K?O]HYG^"/AW62%,8/JB2BNM2F-BOU$[&W;X:KR/CI5SNE=R/U
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MB2JI(S7SCZ$FUH_/:H7;25^G9)6A9)].1DLN^YRUA/6ZG[1:;J4^9]LOO_\
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M7#5!PEC2+B)[PM<D5.>:8;3R-3)+B(:4E:GB-*U:%MZ[&C4G<&U0
M                                 *6*][<Q4
M                                       4L7L*@
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M_'N+@ 6[;=M.VFWM8-""[(3WU=O7W%P *&1&1D9=^XIH01J,DE=7FY=_O%P
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MXB\ %NA',M">KD?+N&A%]6DK][V%P +20DK6216Y%R["I)21$1)(B3VY=A4
M%ALLF2B-I!DJY&1I+G>][_B?XF.JJ PE3CB6&R4\5G3))767[7O^\=T
M   6Z$:B5H3<BTD=N=O85TI([D1"H +30@TF@T)-*KW*W([]Q<  *:4][$*;
M;9=D)_ 7  I8O8O<4)""/422(_>PN !32FYJTE<^YV[BB4(1?0A*;][%:XN
M!0DI+LDN]^WJ%B+L1>XJ "PVFCO=I'49&?27,R["ZQ=K%[BH *:4]])?@*:$
MVMI+\!< "TT(,C(TD9'WN0N  %NA!*U$DKWO>W,5,B,K&5R,5 !;MMZB7MIU
M%V.W,5L1G<R+D*@ M-"#[H([G?M]EO\  %-MJOJ0D[][E]EO\!< "W;;L2="
M;$6DBMZ>WW ;:#5K-"35[VYBX %FTT1:2;1;3IM8NWM]PO  %NA'U$^GI[=@
MT(Y=)=/;EV%P *&E)F2C21F78[ :4F5C21E>_;U%0 4TIO?25_N%0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                   '"M2F^ZC_ !',
M
M
M
M
M
M
M
M                                                         "S6
M2.2C%=9 +@
M
M
M         4-*5>9)']Y"H
M
M
M
M
M
M
M
M                                              /$Q'2I-?HU3H<>
MI3Z<N:P[$1-AK)+L?<;^=0J]TJ29\C([D=K#N0H:J=!CPWIKL@VRLIY]9ZU?
M>?J.XMIMQ*D.-I4E9&2B45R,C*QD8N2E*"LA))+V(K *@
M
M          "RY^X7/W%UB]@L7L MN?N%S]Q=8O8+%[ +=*O<PN?N+Q2Q>P"W
M2KW,-*O<Q> "S2KW,-*O<Q> "S2KW,-*O<Q> "RY^X7/W%UB]@L7L MTJ]S%
MX  "S2KW,7@ LTJ]S#2KW,7@ LTJ]S#2KW,7@ LTJ]S#2KW,7@ LTJ]S#2KW
M,7@ LTJ]S#2KW,7@ LTJ]S#2KW,7@ LTJ]S#2KW,7@ LTJ]S#2KW,7@ LN?N
M%S]Q=8O8+%[ +=*O<Q>  +-*O<PTJ]S%X +-*O<PTJ]S%X +-*O<PTJ]S%X
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MV(6:# 7:R#60K8O8A9H,!=K(-9"W08:# 7:R#60MT&&@P%VL@UD+=!B^Q>Q
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MD N !;K(!< MUD&L@%P"W60:R 7  MUD N
M
M
M
M
M
M
M                                     4L7L*@     "EB]@ !4
M
M                                          4L7L*@         I8O
M8  +%[!8O8  +%[!8O8  +%["H      LN?N  +P     !2Q>PLVOL(  -K[
M"%]B]@ !9M?80;7V$  &U]A!M?80  ;7V$&U]A  "FT7U2_ -HOJE^   KM?
M80IM%]4OP  ')8B[$%B]@ !44L7L  %B]A9H,  7V+V(+%[  "Q:/8Q?8O8
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M?US_ !#0Y_6*_$  ++^N?XA9?US_ !  ')I5[F..R_KG^(  Y-*O<PTJ]S
M"Y^X:5>Y@ !I5[F..R_KG^(  Y-*O<Q;<_<P  N?N87/W,  77/W%C:E'W4?
MX@ "_2KW,5UD  *7/W%=9  !K(-9  "S<,7ZR  #60:R  %FX8;Q>P  ;Q>P
M;Q>P  ;Q>P;Q>P  ;Q>POUD  +-XO8-XO8  -XO8/$(]@ !9XHO8/%%[  "_
M>+V#>+V  %^LA9O%[  !O%["[=3]H  MWB]@WB]@  WB]@WB]@  W#%^L@ !
M9O%[!O%[  !N&+]9  !K(-9  !K(-9  "X
*          ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>img76416671_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img76416671_0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0+X17AI9@  34T *@    @ ! $[  (
M   /   !2H=I  0    !   !6IR=  $    >   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M4')I;65A=7@L($UI:V4    %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,S-   DI(  @    ,S-   ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M UNC<;6,>0/7/-1&+Q)M7%U9;@WS'[.?G'H/FX[5NX%&!0/E?<P?L_B8@_\
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MZ** "DQ2T4 %%%% !1110 48HHH **** "BBB@ HHHH **** "BBB@ HHHH
2**** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>img77340192_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img77340192_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ,V >0# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *Y]_P#D=X_^O8UT%<^__([Q_P#7L:UI?:]#AQW_
M "[_ ,:_4Z"BBBLCN"BBB@ HHHH **** "BBB@ HHHH R?$W_(N7G^Z/_0A2
MZ#_QZ/\ ]L__ $3'2>)O^1<O/]T?^A"ET'_CT?\ [9_^B8ZU_P"77S_0Y(?[
M[+_!_P"W(U:***R.L**** "BBB@ HHHH **** "BBB@ HHHH **** *MGJ-O
M?M,(&),+[&R,<U:IB0Q1,[1QHA<Y8JH&X^]/I*_42OU"BBBF,**** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "N6\2R;;K&]@6CQL!P&&1S[XKJ:Y
MKQ&2&?$,9.P#S"!N ST'>@#I:*** "BBB@ HHHH **** "BBB@ HHHH ****
M ,GQ-_R+EY_NC_T(4N@_\>C_ /;/_P!$QTGB;_D7+S_='_H0I=!_X]'_ .V?
M_HF.M?\ EU\_T.2'^^R_P?\ MR-6BBBLCK"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?UJY150H<LK\S?JRZ>&Y)<W/)^K"BBBMSI"BBB@ HHHH **** ,GQ*"?#MX
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG]8_Y#UC_P
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MBBB@ HHHH **** ,[7%#Z9Y;#*23P(P]5:5 1^1-5'\'Z%(Q9['))S_KI/\
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MWM;Z&[%Q/))"A10PC P1CG:H)X'>M:BBJG4E-WDR:5&%)6@K!137D5,9/)Z
M#)-*K%ADJ5]CBH-!:*** "BBB@ HHHH **** ,_6?^/&/_KZM_\ T<E67#0S
M&15+(_WP.H/J/7CM[56UG_CQC_Z^K?\ ]')5ALSRM'DK$G#8."QZX^F,?7/Y
M@T56FCFUZT\MU8K;S;@#RN6CZCM6E6<\:1ZY9+&BJOV>?A1@?>CK1J([O^NB
M,86YIV[_ *(****LU"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+S_='_H0I=!_X]'_ .V?_HF.M?\ EU\_T.2'^^R_P?\ MR-6BBBLCK"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KDO%_P#K
MX_\ KFO_ *,6NMKDO%_^OC_ZYK_Z,6KI_&O4Y<;_ +M4_P +_(Z>S_X\H/\
MKFO\JFJ&S_X\H/\ KFO\JFI2^)FM'^%'T04445)J%%%% !1110 4444 %%%%
M &3XF_Y%R\_W1_Z$*70?^/1_^V?_ *)CI/$W_(N7G^Z/_0A2Z#_QZ/\ ]L__
M $3'6O\ RZ^?Z')#_?9?X/\ VY&K11161UA1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5R7B_P#U\?\ US7_ -&+76UR7B__
M %\?_7-?_1BU=/XUZG+C?]VJ?X7^1T]G_P >4'_7-?Y5-4-G_P >4'_7-?Y4
M]Y$0@,<9]J4OB9I2:5*+?9#Z*C6XB90RR*58X!]31'/',7"-DH<-P>#C-*S+
M52#LDUJ24444BPHHHH **** "BBB@#)\3?\ (N7G^Z/_ $(4N@_\>C_]L_\
MT3'2>)O^1<O/]T?^A"ET'_CT?_MG_P"B8ZU_Y=?/]#DA_OLO\'_MR-6BBBLC
MK"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD?E0-*[L/HKG/#NJWE_>3QW$A9$0$ [3Z=U KHZ2=U<J<'!V84444R HHHH
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MHHJ3<*Y?Q=_JT^B?^ABNHKE_%W^K3Z)_Z&*NG\<?5&.*_P!VJ_X9?D=%9_\
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M4--+'&"< NP&?SJ#^U-/_P"?ZU_[_+_C0[[L2O-M+5HMT54_M33_ /G^M?\
MO\O^-']J:?\ \_UK_P!_E_QI%>RGV9;HJI_:FG_\_P!:_P#?Y?\ &C^U-/\
M^?ZU_P"_R_XT![*?9ENBJG]J:?\ \_UK_P!_E_QH_M33_P#G^M?^_P O^- >
MRGV9;HJI_:FG_P#/]:_]_E_QH_M33_\ G^M?^_R_XT![*?9ENBJG]J:?_P _
MUK_W^7_&C^U-/_Y_K7_O\O\ C0'LI]F6Z*J'5=. R;^U ]YE_P :MTKJ]B6F
MG9[A1113$12B?/[IH\=PP.?S_P#K40;?F'S>9_%NZU NJ6DDDJ1O)(T3E)/+
MB=MK#J"0.M*+F.6>/8DX;."6@=1CZD8JN26]C%8BBWR\ROZHMT445)L%%%%
M!1110 4444 %%%% !7*^+GY1,?PJ<_\ ;1:ZJN2\7_Z^/_KFO_HQ:NG\:]3F
MQC:PU2W\K_(Z>S_X\H/^N:_RJ:H;/_CR@_ZYK_*IJ4OB9I1_A1]$%%%%2:A1
M110 4444 %%%% !1110!D^)O^1<O/]T?^A"LW2=+L[_[2;FRMY<-$#))&K-C
MR(OE!/(_^O\ E>\02&7PQ=N49"5'RMU'S"H] 5WCND&53?%N8'D_N(N!_C_D
M:M6I_,\^,E+&IK^3]3*UN+PM<:9=) =*22*-G1H71&+A3@#:<GG\/Z<P+/1'
M,8$D"_\ $I\U\S'_ (^/3K][_9_2NSDNDC\  E]D8T\(SXSEB@4*/Q(!/;^7
M*C6K#]SBZV[=$-HW[MO];_=Z?KTK(] -0L?#R3!;8V^S[="A876?W11=W\73
M.<GMZTZ>P\.;91%);AE6Z(/V@G)5OW0'S<\=/7WJ?4M?TN=U2"X^3^T()\A&
M&$6-5)''8@U)-XATLPR1Q7>,I> ?NVY\Q@4'3N!^% &5<6FB#1&DB:W^U"RA
M?_7G=YI8[@!GDXQQVJ>:P\/?VY:P1R0+:M+B1A<$J%\M3UW<?-FEN=;L'\/-
M:1S@RMI\$)78P^=7)(Z>_7I4\VN:4VOV<\=UM@CFWL_EMP/*5<XQGJ#0!TEK
MX8\-RLDUC:03*#_K!*TJ?D2036@VB:23Y46EV.1]YC;H=OZ=:?IVJV>JP-_9
M<OF1H=KR;&7:?^! 9-7/N_N8>"/O-UQ_B: (+>..U'V&UC2)5Y&T !0?;UK$
M\9I$=&DCV*YCC9OFY*GCG/K70.BD"&(?,.2^?N^_UK"\5PE= N]K[_+B.[(Y
MY(Y)]?PJHM)ZF=92E'W=[K\U?\"QX<L+.;P[822VD#R-""S-&"3]3BM/^R]/
M_P"?&U_[\K_A53PQ_P BQIW_ %Q%7;O4+6Q53<S",,0HR"<D_2H=D=,9U).T
M6QO]EZ?_ ,^-K_WY7_"C^R]/_P"?&U_[\K_A4AO+4'!N80?]\4IN[<'!GC'&
M>6%&@<U7NRE>Z)87%LT8MHXN0=T**K?GBJ(\(:<1D37./]Y?_B:W8YX96*QR
MHYQG"L#Q2A60_(05_NFBR-(XFO!<JDT5M/TRVTR$QVZM\W+,S9+'_/I5RJ.G
MZA]N,PV(OEMCY7W>O7@8/%7J9E5Y^=^TW,O6@#%&",@[_P#T$U9_LO3_ /GQ
MM?\ ORO^%5]9_P!7%_P/_P!!-:=:S^"/S//PTI1Q5:S_ )?R*G]EZ?\ \^-K
M_P!^5_PH_LO3_P#GQM?^_*_X5;HK([_:S[LJ?V7I_P#SXVO_ 'Y7_"C^R]/_
M .?&U_[\K_A5NB@/:S[LJ?V7I_\ SXVO_?E?\*/[+T__ )\;7_ORO^%6Z* ]
MK/NRI_9>G_\ /C:_]^5_PH_LO3_^?&U_[\K_ (5;HH#VL^[*G]EZ?_SXVO\
MWY7_  JE=:<3<;+.PTO8$!/G0\YR?0>U;%1R(6*LA =>F>A'H:<79WL9U7.I
M'EYVO1V9S]UH-U>6[6[V^EPHY&9(8R'49SQQ71@8 'I44=RKMLVL&S@X&1^8
MXJ:E*SES629A2PZIR<W)R;LKMWT5[?FPHHHH.@Y?1S>176KFVCW*]](2=@;G
M..[KCI[UJ^=JG_/#_P @K_\ ':I:)=112ZHC"1C]NESLB9\<]\ U9U35([:V
M^TJMY^[ZA8F08/<EEQ_^NM[M+X=/0\>2@^:4JK3N].9+KY^1)YVJ?\\/_(*_
M_':9'=ZC+&LB195AD'R5&?\ R+4&B>)(=6M?.2"X$6!MD",^[\EXKGM8U6:(
MO +N^M1;V.]$BM4?,OS?>WHQ X'3'>IG64(<THJWH;X;!/%5E2HUG>S?Q>:[
M)]^QU?GZI_SQ_P#(*_\ QVF1W>HRQJZ195AD'R5'_M6L";Q FDS64MQ;2$RQ
MX#%-@=B/]T>AI]_-?E=%CC:[MO/CD9T@BC=P0 0/F1N.:N<XQ5VETZ&&&P\\
M15]G&<NOVK[6?1-]^ANI=ZE(&V19VL5/[E>H_P"VM#W>I1[=T6-S;1^Y7D_]
M_:I^%]1+^&8;R_GS([L7=E ).['(  _2M.\N(C'!(K;U$RYV L>_841E=Z1T
M] J453BU*L^9;^]YV];$7G:I_P \/_(*_P#QVCSM4_YX?^05_P#CM9.L>*?[
M,U".#RKG;+@1DQ[<GT *YK:MM04VZ-*ESO(R0;9^/R6ES/\ E7W HTF[.M)>
M?,B/SM4_YX?^05_^.T>=JG_/#_R"O_QVL:]\9Q6VO1Z8+>X,K\HFP@N/7!7-
M=";Z)D^[<J2.UM)Q_P".T*3>T5]P^2CUK2_\"6I7\[5/^>'_ )!7_P".USWB
M-IW8&Y7:X5-HVA>/,7T9OYBND^TK_P ]KS_P%;_XBN>\42K,Z,OF?+&H/F(4
M)_>+V(%7&_,O=Z]C&JJ?L9VJMOE>CDG?1]$=79_\>4'_ %S7^535G0&'RX1<
M,N/)78'/'3G'O5JV8>2QW'RPQV,Q[5SR^)GL4?X4?1$]%(&4L5!&1U&:6I-0
MHHHH **** "BBB@ HHHH PO$-G:P:#=R16T,<BJ,,D8!'([U7T2SAN8[E7MX
MBH:/+L@)P88R0/3DDGZ^IXO^)O\ D7+S_='_ *$*S=)U&SMOM,%S>V]L2T3'
MS)E1B/(B' )]NO\ D;\\O9[]3R_JU'Z[;D7P]EW+&FV%KJ7ANUMY($,4T$1G
M8<%R #C(Y)SU/^1QUCHNGW.AQ3M;_OOLMW*[EFY9&&W'.. ?UKH+C5?!2RM#
MY=@,$AG6SW#\"%Y^M<Q:7NB+H\44JP"Y%M<J[-;[B7+#R^<=<9P>WM6+;>K/
M2C",%RQ5D7AHFD3:GJ4=O"CV\+VJH5F8A=[ . <\YR>O2N@TKPMID;S,=/B8
MF1U4R$R 1[CMX)(SC%8.E3Z)_:FHV=I=Q6UE/Y#I)(Q4?(=S %^<YX__ %5V
M7]MZ0H$,6J6**!RWVA./ISUI% =#TECY4>EV7'#/]G0X_3K5;4]'TJ/3+L0:
M99!T@<[_ "%^7Y3WQUJR=<TE0(HM4L5]6^T)Q^O)JMJ>M:5_95U;V^HV3,T#
M_P#+=3G(/OR30 GAV!88+OR&;?-<NTC,<A<' Q[X%;/W?W,/!'WFZX_Q-86E
M:K86EK):R7]M!*)Y"WFS*"HW'U/6M!=:TK<EO;ZE9EV. ?/4\G\>30!=^[^Y
MA^]_$QYQ[GWK'\5%8_#%_%&-Q\O+'/3D=?>MC[G[F'[W5F/./<^IK'\5%8_"
M]_$@)/EY8^G(Y- %GPQ_R+&G?]<15V\T^UOT"W,0D ((Y(Y'TJEX8_Y%C3O^
MN(K6H:N.,G%W3L5&TNR:,QFW7:?0D?J*<^GVDFW? K;>F>U6:*5D5[2?=D$%
ME;6K,T$*HS?>([_6IZ**9+;;NS!\.1/')?[QC?+N7GJ,FMZLK1OOW'X?S:M6
MDMC?%.]9O^MC,UG_ %<7_ __ $$UIUDZXF^&(;F7!8_*<?PFM&"#R%(\V63)
MSF1LXK>27LX_,\O#I?6*SOK[OY$M%%07DLD%E-+%Y?F(A*^:VU<^Y["L3L)Z
M*Y2'Q5<B!WN5T^)XVPZM<;%QDCAFP/3_ .O5FRUW4]2L9;JPT^RND'$+Q7X*
M2G!_B"G ^[SSG/2@#HJ*BMFF>VC:XC6*8KET5MP4^F>]2T %%%% !44@\R3R
MOX ,M[^@_0U+6)XGO?[*TEM0C@,\_FP6Z1FZ>!"9)5C!9E!P 7SG:3Q35NI,
MW)+W5=_=^C-L  8 P!3)9!%"\A!(12Q Z\5YEJ_B_4;?3Y7CM[!626*)WMM:
MN97C+O&.%:!5)Q*IP6'!KTX#='@D\CJ*ER7,XK^OQ,Z52;FX3C:UGH[[W\EV
M,Y-=M'C=MLP9"P*&,[N#@_RJW;7T%V6$3$E?O C!%1P6<T<H>2[>3D'!R.QS
MQG&/PJV% )( !/7WI*_4ZZGL_LK^ON,#PS_Q]:Y_V$9/Y"M#58//A56#&//.
MUB/Y5G^&?^/K7/\ L(R?R%;+7ENER+=I )6Z+@\URX_"K%X>5!RY;]2(-IW2
MN4M(M$MA(8PP1CD[G+<_B:AU3PY#J=R\_P!LN;9I(?)D$"Q$,O/]]&(/)&1B
MMJH;JZALX?-G8JF<9"EOT%3@<$L+AHT)2<K=67&O*$^>&A#)I=K-&B2"1@B!
M!B5EX'T(J*]T@7<EK)#>W5G);!@CP;&.& !!WJP/058M+ZWOE8V[E@AP<HR\
M_B!5FNUI-6(A4<9<\=S.L=#L+&RBMA!',(QCS)8U+M[D@#G\*LI8VD;AX[6!
M&'1EC (JQ15*4DK7,94:4IN;BKMWO9;E.YTNTO)/,GC9FQC_ %C ?D#BK:*$
M0(HPH&!2T4C0HR:/8S77VEXG,N<Y\UP,_3.*O444!8BN)Q;QAMCN2P4*N,DG
MZD5ROBDR2E97A>(!57#E23^\7T)KHM2CWQP@$AO.7!!([^U<_P")H6BMUWN6
M.4_B)_C'J3711C&Z?4\;,:U51J17PV\NJ?E?\3I+>6..RM_,=4S&N-QQVKE-
M?.B/KA^T2:@;LQ)A8&^5AGC'X]>WK736I$4<3M&Q#0H%95+8XY''2K%LI5&)
M78&8L%]!_GFL9?$SU*/\*/HCS^:3PU]EO;19-0CN+?[P95+ANO'9N^>>E=OH
MK(^C6OE[R@3:"X )QQG X'2K]%2:A1110 4444 %%%% !1110!F^((9+C0KJ
M*)&=V  51DGYA7(VG]NQ3@7%KJ<EJ!@0H[Q\=N0<C%>@45K"IRQY3AQ&#]K5
M]JFD[6VO;6]UJ<?Y\W_0$UK_ ,&$_P#\51Y\W_0$UK_P83__ !5=A11SP_E_
M$/J^*_Y_?^2HX_SYO^@)K7_@PG_^*H\^;_H":U_X,)__ (JNPHHYX?R_B'U?
M%?\ /[_R5''^?-_T!-:_\&$__P 51Y\W_0$UK_P83_\ Q5=A53483/:@"::(
M!@6:%]K8^O\ GI1SP_E_$<<-B6[.M_Y*CF6GN=IV:-K*MCAC?3'!]<9YK&BG
MUJX(,TUT]N)45R6+*#O'6NT&AY&1JNI_^!'_ -:H=/T>P^Q6\HL8))V 8S2H
M'*GUR>GX4>T25DK?,J>7R?ORJJ5K?9^>COI]S-7[G[J+ESRS'M[FL?Q45C\,
M7\: LQCRQ_$<FMC[G[J+ESRS'M[FL?Q5MC\+W\:@LQCRQ_$<FLCK*.B^(K.P
MT6SM95E,D405BH&/YU?_ .$MT_\ YYS_ )+_ (T>'+"SF\.V$DMI \C0@LS1
M@D_4XK3_ ++T_P#Y\;7_ +\K_A6G-#^7\3#V$_\ G\__  &)F?\ "6Z?_P \
MY_R7_&C_ (2W3_\ GG/^2_XUI_V7I_\ SXVO_?E?\*/[+T__ )\;7_ORO^%'
M/#^7\0^KS_Y_/_P&)F?\);I__/.?\E_QH/BVPP<1SD]LA?\ &K=[I%L]L1;P
M6T$F0=_V9&X^A%4?^$<G(XO;7_P7Q4<\?Y?Q-(824E=XBWK%?HF-\-ZBMW<W
M$:QE<(&))[Y/ _/K71UB:)X?;2+J:=KSS_-7&WR]@'.?4UMUC&]M3IKVY])<
MWG:WX&9K/^KB_P"!_P#H)K3K,UG_ %<7_ __ $$UIUO/X(_,\O#_ .]5O^W?
MR"H+R%[FRG@29H'D0J)4ZH2.HJ>F30QW$+PRKNC<%6'J*R.XY.T\/7\VDQ1Q
M>)X[PQQ>1YS6D4@=U^5BQ.23E3G)/.<\UM6^E3Q70E.HR-$"#Y07:,X'H>_/
M7V]*@A\':#;Q"**PVH-V!YK\98L?XO5B:D_X1;1O-\T6A#;2O$K@8/7C- &L
M9$#;2ZY],TV2XAADBCDFC1YF*1*S %V +$*.YP">.P-9J^&-%2;SO[/B,GE^
M4&8EB%XX&3["H9O!^@W#0M+89:&7SHR)7!#[2N>&YX)&#Q0!N457LK*#3[1;
M:V#B)"Q4/(SD9))Y8DXR>!V' X%6* "N=\;H)?#D<;9VMJ6GJ<>]Y#715@^+
MY&BT.(H<$ZC8H>,\-=Q _H30)WMH>>>-=->WNKFUL;9FMWN+=U\EMP78]L#N
M&201M<^F <].?4-%U3^U;-IO)\K:VS&[=V!]!ZUQ/B;Q>--;4=&BLIIUAO(;
M>24F)%5IF1QUEWG D'2,Y(QQR1V.A==1_P"OQ_Z42C%2O%DX6%24)U:L;/1?
MUJ^^^E^QK4444%G,Z7%')+J9;3Q<M]MEPY5#CGI\Q!KE8M+1-6MKUM&M5#:O
M,C39 <X\SY<;L8X_0=:['1&N1)J?DQ1.OVZ7)>0J>OLIJ;^Q[<7AO!H>E+=E
MBQG&!)D]3N\O.?>KJQ<^7;2W7T.3 UJ=!56G).7,M(Z;R6KMJM>[V'JEFYPN
MCHQ] L)_]FJKJNE1:CITMK'I(B,@P6,41X[]'!_6II+M],E_>)!NE8##7).W
MC_<X'%7TGO)$#I#:LK#(9;@D'_QRMI-_+U_X)Y]*G2DFI737:'_VAC:5HT5I
MHLWFQVLBF,M&P@"LO'?D\Y]ZZ&'_ %$?^Z/Y56\IH-'>)\;EA8':<CH:LP_Z
MB/\ W1_*LYNZ^9V86DJ<EI9N*OZCZJ7Z)(L"2*KJ9ERK#(/6K=5KSK;_ /79
M?ZU,/B-\4DZ33_K4/[-L?^?*W_[]+_A7+>)(WAOWCLHI(UCLFG"6UO <L&QE
MC(AXQZ5V#ML7.UF]E'-9UYHUCJT@GN4N5D"&+,=S+"2I.2#L89'UJ92FUH_Q
M-\-3PE.I^\IIZ?RI_F<IX=FNKO4T@>"*Y5K597%Q'$H1B1RNV)21[<_6NFU#
M0H;R%$CAMH2#EBJ,,_BI4U8L-$L=-F\VV6??Y8B!EN9)<*.<#>QP/I5XR 2!
M,-DC.<''YUI4FYZ+8B='#JISQ@E\D9EIIMJL\T4EK;ML1!_JQCH?7-8GBF&*
MWD1(8DC4HI(10 3YB^E;[7<=MJ-P'5SN"8VJ3Z^E8?BXYFC([QK_ .C%JHS?
MM$K]OT/.J8>G'"5)**3]_HN[.GL_^/*#_KFO\JFJ&S_X\H/^N:_RJ:LI?$ST
M*/\ "CZ(****DU"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H(!&#R**
M* (%BEAXB*M'V1SC'T-8VC:P9U2Q%LZNNY%EW J=N,^^>1V_&N@KSRWU&ZTV
M=9;33IKR3SI@%C]]OH">,>F.>M7&*<6^QC4Q,H5(4DE:5_71=#O?]7^ZCY<\
MDGM[FL;Q5MC\,7\:Y9C'EC^(Y-9:^*]81"%\*7VX]6.\Y/\ WQ5/4]<U?4=)
MN+$>%[Z,SK@R$.QZ]<;!4&QU/AC_ )%C3O\ KB*UJS/#L4D'AVPBFC:.180&
M1Q@@^X-7Y9X8 #-*D8)P"[ 9/IS0-*^Q)111D9QGF@0=:A8R0QL57S  2%!Y
M^E344#3L<I%XNO9RPBT"XDVG#;'8X/O\E;NDZA)J5B+B2U:V)8KL8YZ=^@JC
MX>A:&2^+$'?)O&/3)_PK<J(J6[9UXMT8R<*<+>=V9FL_ZN+_ ('_ .@FM.L?
M7;>*9(6=<D;L')';-:L,,<$0CC&$'09)_G73.WLX_,\>@H_6*MGK[OY=[_H/
MHHHK$[ HHHH **** "BBB@ KG_&?_(!A_P"PGI__ *60UT%4]4TNTUBP>RO4
M=X'9'(CE>-@R,'4AD(8$,H.01TH \4\;QS)XO\0R@.T,FLZ4F% PA6.,DG\P
M._T[U[#H774?^OQ_Z5SNN>!M"M]+N;I5U%Y?.CN#YVJW4JO(I4*S*TA#$!5'
M(/ 'I71:%UU'_K\?^E+J=D%_LTGY_P"1K45!>1F6U=!))'G&6C.& SS@U3&C
MY&1J6H_]_P#_ .M6D8Q>[L>56JUH.U.',O5(SM A6XNM9\QY1LU"0*$E9!C@
M]B/6MO[!#_?N/_ F3_XJDL=/@T^.18=Q,CF21W.6=CW-6J'.2T3".'I27-.F
MDWOHG^)S.N>%WU*XBD@E=-G.6N7RQYX.0>.:U[;3(H;6*(F52J@;8[B0*/IS
M5^D;.T[>N.*2E*^Y7U:A_(ON13>TM,F-Y9N>"&N9.?\ QZK*RPJ@VR)M Q]Z
MJ:PW,GF">&%\L<%@.1VIZPR%67[/$"#QQP:TDK[NYRTI.+;A3Y;^5G\RVCK(
MNY&##U%-F@CN$"R!L Y&UBI!^HYJO$MPD\:"-$A .[;CKVJY6;7*]&=5-^U@
MU./D[K1_?T*WV"'^_<?^!,G_ ,51]@A_OW'_ ($R?_%59HHYY=P^JT/Y%]R*
MWV"'^_<?^!,G_P 51]@A_OW'_@3)_P#%59HHYY=P^JT/Y%]R,J\TC3GC>>5-
MTBJ<22S,<?B37)7[LT3!FF8!8\>:<X^<=/;TKO'M+>165X8V#=<J.:Y'Q)9P
MV3JD(8*R*3EB?^6BUT4JBV>[:/(Q^"G?VD$E",972\T^ECKK/_CR@_ZYK_*I
MJAL_^/*#_KFO\JFKGE\3/9H_PH^B"BBBI-0HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "N/\._\A-/^NMQ_[)785QOAYU&J(I8 ^;/P3Z[<?R/Y
M5K!7A+Y'GXF2CB:-W_-^1V5%%%9'H!5'4M)M]45!.9%*,&!0X/%7J*32>C*A
M.4'S1=F9[:/;LA4/*"?XM_(ITFE02D$M(" !D-C/UJ]11RHKVL^Y5M=/ALW9
MXVD9F&"7;/\ ^JK5%%-*Q$I.3NS(T0-ON=Q!Y&,#&!EJUZRM&^_<?A_-JU:2
M-L3_ !69FL_ZN+_@?_H)K3K+UHD0QD#)P^!_P$TOVW5/^@/_ .3*UT<CE"-O
M/JE^9X2Q,*.*J\R>O+M&4NGDG8TZ*S/MNJ?] ?\ \F5H^VZI_P! ?_R96I]C
M+R^]?YG1_:-'M/\ \%S_ /D33HK,^W:I_P! C_R96KUO))+ CRQ>4Y'*;MV/
MQJ90<=7;[TS:CBH5G:*E\XRC^:1+167J&K2V=VL$=IYV[:,^8%Y;.!T_V35N
MPO%O[**Y12HD'0]L'!_E2<&DF^I5.O"I.5.-[QM?1I:[:M6=_(LT52NKJ\BF
MV6]A]H7:"6\X)@\\8/TJ'[;JG_0'_P#)E:I4I-7T^]?YF-3'4H2<6I77:$W^
M*C8TZ*S/MNJ?] ?_ ,F5H^VZI_T!_P#R96G[&7E]Z_S)_M&CVG_X+G_\B-\1
M_P#( NOHO_H0I-"ZZC_U^/\ TJEK=U?RZ/<)/IWDQD+F3SU;'S#L*NZ%UU'_
M *_'_I6<H.+U_-/\CU,-B85L)+E3T?6,H]OYDK_(UJK;FB<I"OF =4Z;?Q_I
M4EQ*(8&D9U0#C<QP!GC-0I?Z?&@5;RVP/^FJ_P"-"BWLCEG6IP=IR2]66E+%
M06 #=P#FEK-?48+F;RH+Z%(U&7D1U)SGH.WUJ)]3AM'4I=&Z1CM*##$'V(K1
M49/8Y:F8T:;?,]%UNORO?\#7J.XD,5M+(N,HA89]A5=+N:5&,=NPXXSW_/%&
MH/-'I%RX59)1"QQDJ#Q^/]:GEL]35UE.$G3[;BHM\Z*WVBW&1G_4-_\ %T[R
M[[_GYM_^_#?_ !=8FCZ]<:O971%H($@5T+[WSN7C@%!_//M6Q%91-$C%[C)4
M$_Z3)_\ %52EI?\ 1&')=J,+O2^LI+_,Y_5->UBSN;R.*+3I(+8QH[/(\<C%
M\?=4 YQGUK4TZ+4HPZO<+R<@RQN_\V%8^M>%KB6[N+BVG5H[AHBRO'))(NW'
M1_-'IW4XKI4L$V#?)/N[XN)!_P"S5G&]W*7RT7]=MSKKJ/+&G06MO>]Z?9=6
MN_-L,=KY)XHO/MSYF>?(;C'_  .I?+OO^?FW_P"_#?\ Q=5IH#;WMLUN&=SN
M&)IW(Z>^?Y59\R^_Y]K?_O\ M_\ $5J[V35OP.&GRJ4XU.:Z?1S:V75";;W_
M )^;;_OPW_Q=+Y=]_P _-O\ ]^&_^+J,K=%]YLK3=_>\XY_] J3S+[_GVM_^
M_P"W_P 12U\OP+7L^O-_Y.1(U\]Q+%Y]N/+"G/D-SG_@=<[XI$JR()G1VV+@
MHA4 >8O8DUT=H93>W1E1$;"<(Q8=#WP*Y_Q?_KX_^N:_^C%JDVJB7H8SA&6$
MJ3N]I[M^:V;.GL_^/*#_ *YK_*IJAL_^/*#_ *YK_*IJRE\3/1H_PH^B"BBB
MI-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N(T[P]?/.FJVT\
M2^9ET&[:PS[E6'Z&NWK/T/\ Y =G_P!<Q5*5DT85L.JUKMKT^7^1C:F^O:=I
MTUVUT=L0!.)XV.,CMY _G4NG-K=]IT%T+DXE0,,S(OZ>0?YU<\5_\BQ?_P#7
M,?S%2>&_^1;T_P#ZXK7!*FY5>7F=K=_,\_V,OKGLO:2MRWWZWL0_9M<_Y^?_
M "83_P",4?9M<_Y^?_)A/_C%;5%:?5O[\OO.OZG_ -/)?>8OV;7/^?G_ ,F$
M_P#C%'V;7/\ GY_\F$_^,5M44?5O[\OO#ZG_ -/)?>84L6N11E_-DDQ_"EQ%
MG]80/UJ'.O\ _/&\_P# BW_^-UT3 ,I!Z&F!RG$G_?78U4:"6\F_FSII480C
M:2<GYRE^C2*.CVMQ;Q,URH5W ^7<&/&>N!COVK2J.*>&;=Y4J2;3AMC X/O4
ME=#5M"E/G]Z]_,S-9_U<7_ __036G69K/^KB_P"!_P#H)K3K2?P1^9Q8?_>J
MW_;OY!11161W!48;RR5;A<\,?Y5)10-,P-5_Y"T/_76#^<E6?#SJGA^U+''#
M?C\QHU:*-); JB@F[C!('7K_ (FM**"*!0L421J.@10 *TG\$?G^9S4*B=>O
M'SA^$;"H#RS#!/;T%/HHK,Z&%%%% '!:]XW@GTZ]@CTC4#"EW]C:Y\RVV!EG
M$1.SS?,V[\#.SN#BNGT+KJ/_ %^/_2O,M77RM#NB3DSZK=%<*>-NKQ Y/3^(
M8Z=Z]-T+KJ/_ %^/_2EU.N#?U:2\_P#(UJ**:^_RV\LJ'P=I89&?>F<AS&CQ
M/<:CJUQY<4QBO9(]L@'W>",'L>:W1#+/+&9(DBBC.X*#DL?Z"L;PMY_VK6?,
M,9'VZ3>5!'S8'3VKI:UE-K1NYS/ TH2?+LW=I6LW]U_Q"J]]$)K"XB9-X:-A
MMQG/%6**S3L[F\X\T7'N9%G#I=H-T-@T<C(%<K:/DCT/RU)LTO\ Z!__ )(M
M_P#$UIT5:FEM?[_^ <LL-.22ERNW>/\ ]L8MV^E06DDIL,;1_P ^A7]67'YU
M%ILNE75N9?L3$YP5:U#X_%%(_6M^BCVCON[>I/U*%KN,;]^7]+F2#:0WD$D%
MI)& &#%+1U[<?PU:DNK>4 ,MT,?W8)1_(5<HH<T][_?_ , <,-.":BXV>MN7
M39+^;R,]I;5A@B]'.>(YA_2I([JWB!"I=<^L$I_F*N44<R>FOW_\ I4*D7S)
MQO\ X?\ [8SHKM%O)Y#'<;7"[3]GDYQG/\-8'BF59Y$9 X 11\Z%#_K%[$"N
MPKDO%_\ KX_^N:_^C%JH2BYK3L88BE5AAJB<DU:3V[W?<Z>S_P"/*#_KFO\
M*IJAL_\ CR@_ZYK_ "J:LY?$SMH_PH^B"BBBI-0HHHH **** "BBB@ HHHH
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M]A_O5)_PF.E_]-?_ !W_ .*I2:N]5]Z.&EG. 5.*=5;(Z"BN?_X3'2_^FO\
MX[_\56CIFKVVK+(UMNQ&0&W8[_0GTI:=U]Z.FAF>#KS5.E43D^A?HHHH.\**
M** "BBB@ HHHH **** "BBB@ HHHH **** "L_0_^0'9_P#7,5H5GZ'_ ,@.
MS_ZYB@"OXK_Y%B__ .N8_F*9X5M_)T"U?SI9/-0/M=LA..B^@I_BO_D6+_\
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MLE),[Y4:D=T8?CO_ )%T?]=E_D:X+2R5U&)@K.1@A5)!/(X!%=[X[_Y%X?\
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M*G@:G.YS;5U9-V^?67D^GD4[6*6"21Y@@+*JJJN6/&?8>M6([>..9Y@O[V0
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M<UI!0.<#<>IQUI:*Q22/1E.4MSF?'7_(O#_KLO\ (UY_IR*^IVZL0$+C);.
M/4^U>@>._P#D71_UV7^1K@M++C48C&</QM.,X.1CBM/KDJ*5-+?];K]#S*>!
MCB,QC)NUFG_X#9H]'TBPBCNA,NIQWABB\M%CQA%S[$UN5R^A6CIJ:2BRG@"P
M%97D4@.Y/49KJ*S1[>,_B[W^[]"GJ=S<VMF7M+<SS%@H7!(&>YQ64MWXBE*[
M]/MC'N&[8PSCOCY^M;=S=06<!FN)!'&.YK._M_2Y)%$5U^\8A0/+;G/X4,=#
MFY/=I\WG9O\ (DN9I3:3 V-WCRVZO'@<>SU'IMQ+' ZK9SRCS#\R%,?JP-6[
MI'%G/@%3Y;9.[.>*KZ6KFV<_>7S#\N<?_KH!23I/1;^?^99^V3?] ZY_[ZB_
M^+IUO=F>0H;::+ SN?:5/T*DU4N=6L;.?R+N?RR!NV;6/7IT%6++5;+4'9+6
M;S&49(VD8'XB@SE3DH<W)IWU+E%9TNE&2^:Y6\GC++@JI]\]?2G)ITB2HPO9
MRH.65V)S^M%WV,^6%OB_ OUS^L?\AZQ_X!_Z,6KMQI#31NBWTZ[R,ACN'TQ5
M#7&*:S9N$+E0AVKC)_>+QR0/SI7MJR9\L5=._P AWB70-/U<V<EY'(S)/&GR
MRLH*EP2" <$9 Z_A6\[!$+'H!FL&\U:2[6..UT^=I4E1U#R1JKX.<!MQ!/TS
M6;/XJU&\4P6VD2QR^84$@?<H9>HSMQ^M-5:LWR24N5;>[*ROOT/+JYK2I-\[
M;716>O=+2U]NIUJP[_FF 9C_  GHOX?UJCI Q<:J!T^V'_T6E<]::AXIOK6.
MYMX=\4@RK;HAG\#6WX<BNELIKB[E5Y;F9I&4)@H1\A&0<'[HZ 52JP3E2N[^
MDELUW2_ TP&:1Q/-#V<XW5TY))/5;:LV:***1W!1110 4444 %%%% !1110
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MA>I_^ __ ->JWA3_ (\+S_K]F_G6]65'^&C/ U*7U:'N=.YE?VY_U"]3_P#
M?_Z](=;RI TO4Q[_ &?_ .O6M2$94CU%:'7[2E_)^)R@O-6  $VIX'_4-3_&
MKVC7][-J,MK=/,RB+S!YT B8'..@/2IH_#FDLG-IR.#^\?K^=7+/2[+3V9K6
M 1LPP3DDX_$TDF=5;$4)0<5'7_"E^*+E%%9NJ:2=2>V<7#1&"42# SG'XC'U
MIN_0X(*+E:3LC2HK.;3KG!*:A*'.!EAD=?3-$VE-)J"7:W<J$*591T(.W@>G
MW?U]J5WV+4(?S?@:-%16\300B-I6E().YNO6H=2D"6H&YUW2("4)!QO&>1TX
MJXKF:1S5ZBI0E/LF4?%?_(LWGT3_ -#6MA?N#Z5ROBH1+HC""6<LSJ&#RN01
MUZ,<=A75+]P?2L.1QQ,GT<8_G(X,+6]KBZNVD8K1WZR?EW%HJM?V:W]G);LY
M0.I&1VX(_K5.UT9K:VBA^WW+"- HPV!QZ"M6W?8]>,8.-W*S]#5J.2".565U
MX<8;!(R/PJHVG2/ B->S"1<_O%Z_KFB'37BFCD>^N9 ASL9N#]:+OL-1BM5(
M@TJ&.WNIH8EVQH"JC.<#>U:Q( R>!698?\A"Y_X%_P"AM6DRAU*L,@C!K:M\
M1YN7.]&[[O\ ,:DL<JEHY%=02"5.1D4YF55W,P ]2:STT.P1G;RB2[%CD^OM
M3X](M(MP56 8@XW8Q],5AJ>DU3Z-_=_P2Z<8YQBJE[9P20&1DRT2LR?,<*<>
ME1+H6GJRD0G*]/F-6[D8LY@.T9_E51O=7,JS4:<N1O9^7ZE#1K2#[!!<;#YK
MQ!6;<>0.G'2M&26*! 9)$C7H-Q %5='_ .0/:_[@JQ<VL%W$8YXPZ>A-75^.
M5N[.? .^&I<STY8_DB3S(\XWKGZTAFB#!3*@8\@;ADU4.CV!##[.!N&"<G-.
M;3+1X5B>,NB] SG_ !K/4[+4^[^[_@EH2(2 '4D]!GK7%R_\EDM_^P4__H8K
MJ[?3;2UE\V&$+)_>R<URDO\ R62W_P"P4_\ Z&*F5]+FM+EO+E[,=:?\E%G_
M .!?^@5VE<7:?\E%G_X%_P"@5VE32V?J:X_XH?X4%%%%:G"%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'GFL
M/CQ8Z^8X_>K\HZ=O>O0ZP[;2K*^O+RYN;=9)DN2JOD@@ #'2MRM:DU))(X<)
MAI49SE*VO;U;[+OY^I@^%/\ CPO/^OV;^=;U8/A3_CPO/^OV;^=79;C4X[Q@
MEE'+;\[2) K=NN?QKDHNU-&N71<L/"W8T:*HQW5\9@DMCM5CPPD! 'OQ3?M6
MH+Q_9^_ISYJK_C^=:\R.WV4O+[T7F3)W*=K>OK]:II>2G6FLF"&,0"7(!!SN
MQZU9MGFDA#3P^4YZINW8_&LY?^1KD_Z\Q_Z'073C?F3Z(UJ***9@%%%% !4%
MW$\UOMCV[PZ, QP#A@>N#Z5/5#6=0DTS33<PP)/*98H4C>0QJ6DD6,98 X W
M9Z'I51OS*Q%2"G!Q>S1D^+$NYM E:2*%$C=7)64L3SCIM'K6UILMS/IT,EY"
M(9V7YD!Z5SOB.7Q%+H%TDFEZ8JD+DIJ,C'[P[& ?SH'BG40H'V/2>G_00G_^
M1JB.'JSKRG&.EDM/67^9Y2K4,)BYNM42YHQ^)I;.7IY'6T5R?_"5:C_SYZ3_
M .#"?_Y&H_X2K4?^?/2?_!A/_P#(U='U6M_*=/\ :F!_Y_1_\"7^9UE%<G_P
ME6H_\^>D_P#@PG_^1J/^$JU'_GSTG_P83_\ R-1]5K?RA_:F!_Y_1_\  E_F
M;-A_R$+G_@7_ *&U:=</:^(=2BNII#9:7A\];^;'WB?^??WJY_PE6H_\^>D_
M^#"?_P"1JTJX>JY743DP.8X.%'EE6BG=_:7?U.LHKD_^$JU'_GSTG_P83_\
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MUKK@@''_ "TJGI^@6C1::IN=5"R6I=@-5N0,C9CI)QU/2NBU/_D%7G_7!_\
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M8FCGNF:+;OD#!^/F& /KQSUJU16Z=DT>5*FI2C)]/\K!1112- HHHH ****
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!GZ7]^_\
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MF#'!(6XPO'4_N/PX]:7M:?<MYGA]]/N9I0MJ;3Q^<ENL/._:3NZ=OQJ#7O\
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M _2N-_X0W4/^>]I_X_1_PANH?\][3_Q^K5*2ZK[_ /@&<\PI2TY:EO\  O\
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MR*QJY1E""C>R26NC^Z[M]YHT5G^=K'_/C8_^!C__ !JCSM8_Y\;'_P #'_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>25
<FILENAME>rxst-20240630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-08-05T11:08:18.0145+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://rxsight.com/20240630" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:rxst="http://rxsight.com/20240630" xmlns:srt="http://fasb.org/srt/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:calc="https://xbrl.org/2023/calculation-1.1" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" namespace="http://xbrl.sec.gov/stpr/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd" namespace="http://xbrl.sec.gov/ecd-sub/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" namespace="http://fasb.org/srt/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2023/calculation-1.1.xsd" namespace="https://xbrl.org/2023/calculation-1.1"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" namespace="http://xbrl.sec.gov/ecd/2024"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" id="Role_StatementCondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails2" id="DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails2">
        <link:definition>100020 - Disclosure - Leases - Schedule of Maturities of Lease Liabilites (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" id="Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>100030 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited" id="StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited">
        <link:definition>100040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income Loss (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" id="StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited">
        <link:definition>100050 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnauditedParenthetical" id="StatementCondensedConsolidatedStatementsOfStockholdersEquityUnauditedParenthetical">
        <link:definition>100060 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1" id="StatementCondensedConsolidatedStatementsOfCashFlows1">
        <link:definition>100070 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical" id="StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical">
        <link:definition>100080 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentation" id="Role_DisclosureOrganizationAndBasisOfPresentation">
        <link:definition>995455 - Disclosure - Organization and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPolicies" id="Role_DisclosureSummaryOfAccountingPolicies">
        <link:definition>995465 - Disclosure - Summary of Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestment" id="Role_DisclosureShortTermInvestment">
        <link:definition>995475 - Disclosure - Short-Term Investment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureInventories" id="Role_DisclosureInventories">
        <link:definition>995485 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>995495 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoan" id="Role_DisclosureTermLoan">
        <link:definition>995505 - Disclosure - Term Loan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiability" id="Role_DisclosureCommonStockWarrantLiability">
        <link:definition>995515 - Disclosure - Common Stock Warrant Liability</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureConvertiblePreferredStockAndStockholdersDeficit" id="Role_DisclosureConvertiblePreferredStockAndStockholdersDeficit">
        <link:definition>995525 - Disclosure - Convertible Preferred Stock and Stockholders&#8217; Deficit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpense" id="Role_DisclosureStockBasedCompensationExpense">
        <link:definition>995535 - Disclosure - Stock-Based Compensation Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquity" id="DisclosureStockholdersEquity">
        <link:definition>995545 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>995555 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeases" id="Role_DisclosureLeases">
        <link:definition>995565 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>995575 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
        <link:definition>995585 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfAccountingPoliciesPolicies">
        <link:definition>995595 - Disclosure - Summary of Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesTables" id="Role_DisclosureSummaryOfAccountingPoliciesTables">
        <link:definition>995605 - Disclosure - Summary of Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentTables" id="Role_DisclosureShortTermInvestmentTables">
        <link:definition>995615 - Disclosure - Short-Term Investment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureInventoriesTables" id="Role_DisclosureInventoriesTables">
        <link:definition>995625 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>995635 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanTables" id="Role_DisclosureTermLoanTables">
        <link:definition>995645 - Disclosure - Term Loan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureConvertiblePreferredStockAndStockholdersDeficitTables" id="Role_DisclosureConvertiblePreferredStockAndStockholdersDeficitTables">
        <link:definition>995655 - Disclosure - Convertible Preferred Stock and Stockholders&#8217; Deficit (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseTables" id="Role_DisclosureStockBasedCompensationExpenseTables">
        <link:definition>995665 - Disclosure - Stock-Based Compensation Expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeasesTables" id="Role_DisclosureLeasesTables">
        <link:definition>995675 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" id="Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails">
        <link:definition>995685 - Disclosure - Organization and Basis of Presentation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails" id="Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails">
        <link:definition>995695 - Disclosure - Summary of Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails" id="Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails">
        <link:definition>995705 - Disclosure - Summary of Accounting Policies - Schedule of Dilutive Securities Excluded from Computation of Income (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails" id="Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails">
        <link:definition>995715 - Disclosure - Summary of Accounting Policies - Schedule of Revenue From Contracts With Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureSummaryOfAccountingPoliciesScheduleOfDeferredRevenueActivityDetails" id="DisclosureSummaryOfAccountingPoliciesScheduleOfDeferredRevenueActivityDetails">
        <link:definition>995725 - Disclosure - Summary of Accounting Policies - Schedule of Deferred Revenue Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails" id="Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails">
        <link:definition>995735 - Disclosure - Short-Term Investment - Schedule of Short-term Investment Available For Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails" id="Role_DisclosureShortTermInvestmentAdditionalInformationDetails">
        <link:definition>995745 - Disclosure - Short-Term Investment - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails" id="DisclosureInventoriesScheduleOfInventoriesDetails">
        <link:definition>995755 - Disclosure - Inventories - Schedule of Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails" id="DisclosureInventoriesAdditionalInformationDetails">
        <link:definition>995765 - Disclosure - Inventories - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails" id="Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails">
        <link:definition>995775 - Disclosure - Fair Value Measurements - Schedule of assets and liabilities measured at fair value on recurring basis and the fair value hierarchy of the valuation techniques (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" id="DisclosureFairValueMeasurementsAdditionalInformationDetails">
        <link:definition>995785 - Disclosure - Fair Value Measurements (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueForWarrantLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails" id="Role_DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueForWarrantLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails">
        <link:definition>995795 - Disclosure - Fair Value Measurements -Schedule of estimated fair value for the warrant liabilities measured using significant unobservable inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" id="Role_DisclosureTermLoanAdditionalInformationDetails">
        <link:definition>995805 - Disclosure - Term Loan - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureTermLoanScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanDetails" id="DisclosureTermLoanScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanDetails">
        <link:definition>995815 - Disclosure - Term Loan - Schedule of Cash Interest Paid and effective interest rate on term loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails" id="Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails">
        <link:definition>995825 - Disclosure - Term Loan - Future Principal Payments Due Under the Term Loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails" id="Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails">
        <link:definition>995835 - Disclosure - Common Stock Warrant Liability - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails" id="DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails">
        <link:definition>995845 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Summary of Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitAdditionalInformationDetails" id="DisclosureConvertiblePreferredStockAndStockholdersDeficitAdditionalInformationDetails">
        <link:definition>995855 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails" id="DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails">
        <link:definition>995865 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Summary of Common Stock Reserved for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails" id="Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails">
        <link:definition>995875 - Disclosure - Stock-Based Compensation Expense - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails" id="Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails">
        <link:definition>995885 - Disclosure - Stock-Based Compensation Expense - Summary of Stock Option Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails" id="DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails">
        <link:definition>995895 - Disclosure - Stock-Based Compensation Expense - Summary of Non-Vested Restricted Stock Unit Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails" id="Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails">
        <link:definition>995905 - Disclosure - Stock-Based Compensation Expense - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails" id="Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails">
        <link:definition>995915 - Disclosure - Stock-Based Compensation Expense - Schedule of Range and Weighted-average Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails" id="DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails">
        <link:definition>995925 - Disclosure - Stock-Based Compensation Expense - Common stock reserved for future issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceParentheticalDetails" id="DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceParentheticalDetails">
        <link:definition>995935 - Disclosure - Stock-Based Compensation Expense - Common stock reserved for future issuance (Parenthetical) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" id="DisclosureStockholdersEquityAdditionalInformationDetails">
        <link:definition>995945 - Disclosure - Stockholders' Equity (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" id="DisclosureLeasesAdditionalInformationDetails">
        <link:definition>995955 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails" id="DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails">
        <link:definition>995965 - Disclosure - Leases - Summary of Lease Balances Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails" id="DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails">
        <link:definition>995975 - Disclosure - Leases - Schedule of Components of Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails" id="DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails">
        <link:definition>995985 - Disclosure - Leases - Schedule of Maturities of Lease Liabilites (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateDetails" id="DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateDetails">
        <link:definition>995995 - Disclosure - Leases - Summary of Weighted Average Remaining Lease Term and Discount Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>996005 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails" id="DisclosureSubsequentEventAdditionalInformationDetails">
        <link:definition>996015 - Disclosure - Subsequent Event (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:href="rxst-20240630.xsd#Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:href="rxst-20240630.xsd#Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited" xlink:href="rxst-20240630.xsd#StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" xlink:href="rxst-20240630.xsd#StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" xlink:type="simple"/>
        <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureShortTermInvestmentAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:href="rxst-20240630.xsd#DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureTermLoanAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails" xlink:href="rxst-20240630.xsd#DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitAdditionalInformationDetails" xlink:href="rxst-20240630.xsd#DisclosureConvertiblePreferredStockAndStockholdersDeficitAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails" xlink:href="rxst-20240630.xsd#DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails" xlink:href="rxst-20240630.xsd#DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails" xlink:href="rxst-20240630.xsd#DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" xlink:href="rxst-20240630.xsd#DisclosureStockholdersEquityAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:href="rxst-20240630.xsd#DisclosureLeasesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails" xlink:href="rxst-20240630.xsd#DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails" xlink:href="rxst-20240630.xsd#DisclosureSubsequentEventAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails2" xlink:href="rxst-20240630.xsd#DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails2" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1" xlink:href="rxst-20240630.xsd#StatementCondensedConsolidatedStatementsOfCashFlows1" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails" xlink:href="rxst-20240630.xsd#DisclosureInventoriesScheduleOfInventoriesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails" xlink:href="rxst-20240630.xsd#DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails" xlink:href="rxst-20240630.xsd#DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="rxst-20240630.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnauditedParenthetical" xlink:href="rxst-20240630.xsd#StatementCondensedConsolidatedStatementsOfStockholdersEquityUnauditedParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:href="rxst-20240630.xsd#StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentation" xlink:href="rxst-20240630.xsd#Role_DisclosureOrganizationAndBasisOfPresentation" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPolicies" xlink:href="rxst-20240630.xsd#Role_DisclosureSummaryOfAccountingPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestment" xlink:href="rxst-20240630.xsd#Role_DisclosureShortTermInvestment" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureInventories" xlink:href="rxst-20240630.xsd#Role_DisclosureInventories" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:href="rxst-20240630.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoan" xlink:href="rxst-20240630.xsd#Role_DisclosureTermLoan" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiability" xlink:href="rxst-20240630.xsd#Role_DisclosureCommonStockWarrantLiability" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureConvertiblePreferredStockAndStockholdersDeficit" xlink:href="rxst-20240630.xsd#Role_DisclosureConvertiblePreferredStockAndStockholdersDeficit" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpense" xlink:href="rxst-20240630.xsd#Role_DisclosureStockBasedCompensationExpense" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquity" xlink:href="rxst-20240630.xsd#DisclosureStockholdersEquity" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:href="rxst-20240630.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeases" xlink:href="rxst-20240630.xsd#Role_DisclosureLeases" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:href="rxst-20240630.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEvents" xlink:href="rxst-20240630.xsd#DisclosureSubsequentEvents" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies" xlink:href="rxst-20240630.xsd#Role_DisclosureSummaryOfAccountingPoliciesPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesTables" xlink:href="rxst-20240630.xsd#Role_DisclosureSummaryOfAccountingPoliciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentTables" xlink:href="rxst-20240630.xsd#Role_DisclosureShortTermInvestmentTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureInventoriesTables" xlink:href="rxst-20240630.xsd#Role_DisclosureInventoriesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:href="rxst-20240630.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanTables" xlink:href="rxst-20240630.xsd#Role_DisclosureTermLoanTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureConvertiblePreferredStockAndStockholdersDeficitTables" xlink:href="rxst-20240630.xsd#Role_DisclosureConvertiblePreferredStockAndStockholdersDeficitTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseTables" xlink:href="rxst-20240630.xsd#Role_DisclosureStockBasedCompensationExpenseTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeasesTables" xlink:href="rxst-20240630.xsd#Role_DisclosureLeasesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureSummaryOfAccountingPoliciesScheduleOfDeferredRevenueActivityDetails" xlink:href="rxst-20240630.xsd#DisclosureSummaryOfAccountingPoliciesScheduleOfDeferredRevenueActivityDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails" xlink:href="rxst-20240630.xsd#DisclosureInventoriesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueForWarrantLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails" xlink:href="rxst-20240630.xsd#Role_DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueForWarrantLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureTermLoanScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanDetails" xlink:href="rxst-20240630.xsd#DisclosureTermLoanScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceParentheticalDetails" xlink:href="rxst-20240630.xsd#DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceParentheticalDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateDetails" xlink:href="rxst-20240630.xsd#DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:label="rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="us-gaap_ConversionOfStockAmountConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForNonCashExercise" xlink:label="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForNonCashExercise"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare" xlink:label="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OfficeBuildingMember" xlink:label="srt_OfficeBuildingMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_DebtFromCashReserves" xlink:label="rxst_DebtFromCashReserves"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueAbstract" xlink:label="us-gaap_DeferredRevenueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CliffordDDownsMember" xlink:label="rxst_CliffordDDownsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount" xlink:label="rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCallDateLatest" xlink:label="us-gaap_DebtInstrumentCallDateLatest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesAvailableForFutureIssuanceUnderTheEquityPlansMember" xlink:label="rxst_SharesAvailableForFutureIssuanceUnderTheEquityPlansMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering" xlink:label="rxst_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RonKurtzMDMember" xlink:label="rxst_RonKurtzMDMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="us-gaap_SeriesHPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis" xlink:label="us-gaap_AwardDateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:label="rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NumberOfWhollyOwnedSubsidiaries" xlink:label="rxst_NumberOfWhollyOwnedSubsidiaries"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AugustFourTwoThousandTwentyThreeMember" xlink:label="rxst_AugustFourTwoThousandTwentyThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockInExchangeForCancellationOfNotesReceivables" xlink:label="rxst_CommonStockInExchangeForCancellationOfNotesReceivables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain" xlink:label="us-gaap_AwardDateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LeaseLiabilitiesNoncurrent" xlink:label="rxst_LeaseLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AccretionToRedemptionValueOfRedeemableStock" xlink:label="rxst_AccretionToRedemptionValueOfRedeemableStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract" xlink:label="rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones" xlink:label="rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_PreferredStockWarrantsMember" xlink:label="rxst_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExpirationOfCommonStockWarrants" xlink:label="rxst_ExpirationOfCommonStockWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesFPreferredStockMember" xlink:label="us-gaap_SeriesFPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LongTermWarrantLiability" xlink:label="rxst_LongTermWarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TermLoanMember" xlink:label="rxst_TermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="us-gaap_FinanceLeasePrincipalPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RedeemableCommonStockReclassifiedShares" xlink:label="rxst_RedeemableCommonStockReclassifiedShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfRedeemableCommonStockToCommonStockOptionsAssumedInNonCashInvestingOrFinancingActivity" xlink:label="rxst_ReclassificationOfRedeemableCommonStockToCommonStockOptionsAssumedInNonCashInvestingOrFinancingActivity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_GainLossFromChangesInFairValueOfPreferredStockWarrants" xlink:label="rxst_GainLossFromChangesInFairValueOfPreferredStockWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_FinanceLeaseObligationsIncurred" xlink:label="rxst_FinanceLeaseObligationsIncurred"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RedeemableStockOptionsMember" xlink:label="rxst_RedeemableStockOptionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TotalLeaseAssets" xlink:label="rxst_TotalLeaseAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueAdditions" xlink:label="us-gaap_DeferredRevenueAdditions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AccretionToRedemptionValueOfRedeemableStockOptions" xlink:label="rxst_AccretionToRedemptionValueOfRedeemableStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockNoParValue" xlink:label="us-gaap_PreferredStockNoParValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares" xlink:label="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EffectiveInterestRateOnBorrowingsTermLoan" xlink:label="rxst_EffectiveInterestRateOnBorrowingsTermLoan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockOfferingCosts" xlink:label="rxst_CommonStockOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RxlalMember" xlink:label="rxst_RxlalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeaseTermOfContract" xlink:label="us-gaap_LessorOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleCommonStockMember" xlink:label="us-gaap_ConvertibleCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="us-gaap_SeriesEPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturingFacilityMember" xlink:label="us-gaap_ManufacturingFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LDDMember" xlink:label="rxst_LDDMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_June2023LsaRepaymentMember" xlink:label="rxst_June2023LsaRepaymentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestmentsAbstract" xlink:label="us-gaap_ShortTermInvestmentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_InvestmentMaturityPeriod" xlink:label="rxst_InvestmentMaturityPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FutureMember" xlink:label="us-gaap_FutureMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_WarrantsIssuedToPurchaseCommonStock" xlink:label="rxst_WarrantsIssuedToPurchaseCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:label="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings" xlink:label="rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtDescription" xlink:label="us-gaap_ShortTermDebtDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare" xlink:label="rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="us-gaap_SeriesDPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:label="rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants" xlink:label="rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockAfterReclassificationOfRedeemableCommonStockShares" xlink:label="rxst_CommonStockAfterReclassificationOfRedeemableCommonStockShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EarningsPerShareTable" xlink:label="rxst_EarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SignificantAccountingPoliciesPolicyTextBlock" xlink:label="rxst_SignificantAccountingPoliciesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AmendedTermLoanMember" xlink:label="rxst_AmendedTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_DeferredOfferingCostsIncludedInAccruedExpenses" xlink:label="rxst_DeferredOfferingCostsIncludedInAccruedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesAvailableForFutureIssuanceUnder2021EsppMember" xlink:label="rxst_SharesAvailableForFutureIssuanceUnder2021EsppMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockTransactionDate" xlink:label="us-gaap_SaleOfStockTransactionDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvotingCommonStockMember" xlink:label="us-gaap_NonvotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:label="us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NonEmployeeDirectorsMember" xlink:label="rxst_NonEmployeeDirectorsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member" xlink:label="rxst_SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansReceivableDescriptionOfVariableRateBasis" xlink:label="us-gaap_LoansReceivableDescriptionOfVariableRateBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount" xlink:label="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ConversionOfNotesReceivablesToTreasuryStockShares" xlink:label="rxst_ConversionOfNotesReceivablesToTreasuryStockShares"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EarningsPerShareLineItems" xlink:label="rxst_EarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_OneTwentyFiveColumbiaLeaseMember" xlink:label="rxst_OneTwentyFiveColumbiaLeaseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SummaryOfLeaseBalancesTableTextBlock" xlink:label="rxst_SummaryOfLeaseBalancesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_OperatingLeaseObligationsIncurred" xlink:label="rxst_OperatingLeaseObligationsIncurred"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NewLoanAndSecurityAgreementMember" xlink:label="rxst_NewLoanAndSecurityAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA" xlink:label="stpr_CA"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares" xlink:label="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings" xlink:label="rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueAbstract" xlink:label="us-gaap_DisaggregationOfRevenueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingSubleaseOptionToTerminate" xlink:label="us-gaap_LesseeOperatingSubleaseOptionToTerminate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions" xlink:label="rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:label="us-gaap_PaymentsForProceedsFromTenantAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestBearingDepositsMember" xlink:label="us-gaap_InterestBearingDepositsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_OfficeManufacturingAndWarehouseFacilityMember" xlink:label="rxst_OfficeManufacturingAndWarehouseFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanTableTextblock" xlink:label="rxst_ScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanTableTextblock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AdditionalNumberOfCommonSharesIssued" xlink:label="rxst_AdditionalNumberOfCommonSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_JulieAndrewsMember" xlink:label="rxst_JulieAndrewsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:label="us-gaap_OperatingLeasesRentExpenseSubleaseRentals1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ServiceWarrantyServiceContractsAndAccessoriesMember" xlink:label="rxst_ServiceWarrantyServiceContractsAndAccessoriesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueRevenueRecognized1" xlink:label="us-gaap_DeferredRevenueRevenueRecognized1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesRedeemedForEmployeeTaxWithholdings" xlink:label="rxst_SharesRedeemedForEmployeeTaxWithholdings"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShelfRegistrationStatementMember" xlink:label="rxst_ShelfRegistrationStatementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:label="us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityDescriptionTextBlock" xlink:label="us-gaap_OptionIndexedToIssuersEquityDescriptionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember" xlink:label="rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfDeferredCost" xlink:label="rxst_ReclassificationOfDeferredCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" xlink:label="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_The2021PlanMember" xlink:label="rxst_The2021PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SeriesGCommonStockMember" xlink:label="rxst_SeriesGCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesGPreferredStockMember" xlink:label="us-gaap_SeriesGPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice" xlink:label="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShortTermInvestmentsPolicyTextBlock" xlink:label="rxst_ShortTermInvestmentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TotalLeaseLiabilities" xlink:label="rxst_TotalLeaseLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPreferredUnitsTextBlock" xlink:label="us-gaap_ScheduleOfPreferredUnitsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_GainLossFromChangesInFairValueOfCommonStockWarrant" xlink:label="rxst_GainLossFromChangesInFairValueOfCommonStockWarrant"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfSharesOfRedeemableCommonStockToCommonStockAssumedInNonCashInvestingOrFinancingActivity" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToCommonStockAssumedInNonCashInvestingOrFinancingActivity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount" xlink:label="rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLoanOriginations1" xlink:label="us-gaap_ProceedsFromLoanOriginations1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AccurideInternationalIncMember" xlink:label="rxst_AccurideInternationalIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NumberOfLeases" xlink:label="rxst_NumberOfLeases"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForWarrantsExercised" xlink:label="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForWarrantsExercised"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RepaymentOfTermLoan" xlink:label="rxst_RepaymentOfTermLoan"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockWarrantMember" xlink:label="rxst_CommonStockWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_BmlManagementLlcMember" xlink:label="rxst_BmlManagementLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LiquidityAndFinancialPositionPolicyTextBlock" xlink:label="rxst_LiquidityAndFinancialPositionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_WeightedAverageDiscountRateAbstract" xlink:label="rxst_WeightedAverageDiscountRateAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_InterestPaidOnTermLoan" xlink:label="rxst_InterestPaidOnTermLoan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtDescription" xlink:label="us-gaap_LongTermDebtDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForFees" xlink:label="us-gaap_PaymentsForFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_PotentialAggregatePaymentsForRegulatoryMilestones" xlink:label="rxst_PotentialAggregatePaymentsForRegulatoryMilestones"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NotesReceivableForRedeemableCommonStockIssuedMember" xlink:label="rxst_NotesReceivableForRedeemableCommonStockIssuedMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember" xlink:label="rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_StockOptionsIssuedAndOutstandingUnderPlansMember" xlink:label="rxst_StockOptionsIssuedAndOutstandingUnderPlansMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_WarrantLiability" xlink:label="rxst_WarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_DebtInstrumentClosingCost" xlink:label="rxst_DebtInstrumentClosingCost"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ConvertiblePreferredStockWarrantLiabilityMember" xlink:label="rxst_ConvertiblePreferredStockWarrantLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SeriesWCommonStockMember" xlink:label="rxst_SeriesWCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" xlink:label="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TwoThousandSixAndTwoThousandFifteenPlansMember" xlink:label="rxst_TwoThousandSixAndTwoThousandFifteenPlansMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_The2015PlanMember" xlink:label="rxst_The2015PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted" xlink:label="rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_WarrantsToPurchaseConvertiblePreferredStock" xlink:label="rxst_WarrantsToPurchaseConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarlyRepaymentOfSeniorDebt" xlink:label="us-gaap_EarlyRepaymentOfSeniorDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_DebtInstrumentFinalPaymentFeeRate" xlink:label="rxst_DebtInstrumentFinalPaymentFeeRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember" xlink:label="rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="us-gaap_CertificatesOfDepositMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AdditionalBorrowingAmount" xlink:label="rxst_AdditionalBorrowingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_WarehouseMember" xlink:label="srt_WarehouseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ConversionOfNotesReceivablesToTreasuryStock" xlink:label="rxst_ConversionOfNotesReceivablesToTreasuryStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation" xlink:label="rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharePurchaseAgreementMember" xlink:label="rxst_SharePurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount" xlink:label="rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EscrowHoldbackOfExercisePriceOfWarrants" xlink:label="rxst_EscrowHoldbackOfExercisePriceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EricWeinbergMember" xlink:label="rxst_EricWeinbergMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperationsCommencedDate1" xlink:label="us-gaap_OperationsCommencedDate1"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_JAndyCorleyMember" xlink:label="rxst_JAndyCorleyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_DeferredRevenue1" xlink:label="rxst_DeferredRevenue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RedeemableCommonStockMember" xlink:label="rxst_RedeemableCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CashInterestPaidPercentagePeriod" xlink:label="rxst_CashInterestPaidPercentagePeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableUnamortizedLoanFeeCost" xlink:label="us-gaap_FinancingReceivableUnamortizedLoanFeeCost"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" xlink:label="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfNotesReceivable" xlink:label="us-gaap_ProceedsFromSaleOfNotesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockWarrantLiabilityMember" xlink:label="rxst_CommonStockWarrantLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IlyaGoldshlegerMember" xlink:label="rxst_IlyaGoldshlegerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AmountOfSettlementOfFractionalShares" xlink:label="rxst_AmountOfSettlementOfFractionalShares"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AccountsReceivablePercentage" xlink:label="rxst_AccountsReceivablePercentage"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_WeightedAverageRemainingLeaseTermAbstract" xlink:label="rxst_WeightedAverageRemainingLeaseTermAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_The2021EsppPlanMember" xlink:label="rxst_The2021EsppPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ExecutiveOfficerMember" xlink:label="srt_ExecutiveOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_InterestPaidOnFinancingLeases" xlink:label="rxst_InterestPaidOnFinancingLeases"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AtmOfferingMember" xlink:label="rxst_AtmOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExecutiveOfficersAndNonEmployeeDirectorsMember" xlink:label="rxst_ExecutiveOfficersAndNonEmployeeDirectorsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_MayThreeTwoThousandTwentyTwoTermLoanMember" xlink:label="rxst_MayThreeTwoThousandTwentyTwoTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued" xlink:label="rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration" xlink:label="rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NotesReceivableForCommonStockIssuedMember" xlink:label="rxst_NotesReceivableForCommonStockIssuedMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExercisePriceOfWarrants" xlink:label="rxst_ExercisePriceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExerciseOfPreferredStockWarrants" xlink:label="rxst_ExerciseOfPreferredStockWarrants"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LeaseLiabilitiesCurrent" xlink:label="rxst_LeaseLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryAdjustments" xlink:label="us-gaap_InventoryAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_GainOnExpirationOfWarrants" xlink:label="rxst_GainOnExpirationOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesReservedForFutureIssuanceTableTextBlock" xlink:label="rxst_SharesReservedForFutureIssuanceTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_OperatingIncomeLoss1" xlink:label="rxst_OperatingIncomeLoss1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_InterestRateOnBorrowingsTermLoan" xlink:label="rxst_InterestRateOnBorrowingsTermLoan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NoCustomerMember" xlink:label="rxst_NoCustomerMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IndustrialCommercialMember" xlink:label="rxst_IndustrialCommercialMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TemporaryEquityNoteReceivablesCommonStockIssued" xlink:label="rxst_TemporaryEquityNoteReceivablesCommonStockIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liability:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate During Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary Of Weighted Average Remaining Lease Term and Discount Rate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Weighted Average Remaining Lease Term And Discount Rate Table [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Weighted Average Remaining Lease Term and Discount Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Amount Converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock to common stock upon initial public offering, net of fractional shares settled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForNonCashExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification From Warrant Liability To Additional Paid-In Capital For Non-Cash exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForNonCashExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification From Warrant Liability To Additional Paid-in capital for non-cash exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForNonCashExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification from warrant liability to additional paid-in capital for non-cash exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock for at-the-market offerings, net of issuance costs, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of common stock in at-the-market offerings, net of issuance costs, Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in at-the-market offerings, net of issuance costs, Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_OfficeBuildingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Office Building [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_OfficeBuildingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Office [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_DebtFromCashReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from Lines of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_DebtFromCashReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt From Cash Reserves</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_DebtFromCashReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt From Cash Reserves</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of unexercised warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive (loss) income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Grant Date Fair Value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant date fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CliffordDDownsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Clifford D. Downs [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CliffordDDownsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Clifford D. Downs [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, shares issued (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level II [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Surrender of common stock in exchange for cancellation of note receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock in exchange for cancellation of notes receivables amount.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock in Exchange for Cancellation of Notes Receivables Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Debt, Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Area of Real Estate Property</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Area of leased space</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 (remainder)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCallDateLatest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repayment Commencement Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCallDateLatest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Call Date, Latest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Leases [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesAvailableForFutureIssuanceUnderTheEquityPlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares available for future issuance under the Equity Plans [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesAvailableForFutureIssuanceUnderTheEquityPlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares available for future issuance under the Equity Plans [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock, Class of Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Stock By Class [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of estimated fair value for the warrant liabilities measured using significant unobservable inputs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion Of Preferred Stock To Common Stock Upon Initial Public Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Of Preferred Stock To Common Stock Upon Initial Public Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock to common stock upon initial public offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Depletion and Amortization, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion and Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RonKurtzMDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ron Kurtz M.D [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RonKurtzMDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Ron Kurtz M.D [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing and Financing Items [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash investing and financing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Benchmark [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stockholders' Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock and Stockholders&#8217; Deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesHPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series H Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesHPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series H Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesHPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series H Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant or Right</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardDateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Date [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due in 2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments Due, Next 12 Months</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial amount of new loans</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign currency translation adjustment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Common stock reserved for future issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Common stock reserved for future issuance [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of Common stock reserved for future issuance [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NumberOfWhollyOwnedSubsidiaries_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of wholly owned subsidiaries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NumberOfWhollyOwnedSubsidiaries_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Wholly Owned Subsidiaries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NumberOfWhollyOwnedSubsidiaries_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of wholly owned subsidiaries.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Options, Forfeited</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AugustFourTwoThousandTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">August Four Two Thousand Twenty Three [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AugustFourTwoThousandTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">August Four Two Thousand Twenty Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in operating assets and liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Shares, Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockInExchangeForCancellationOfNotesReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Surrender of common stock in exchange for cancellation of note receivable, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockInExchangeForCancellationOfNotesReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock in Exchange for Cancellation of Notes Receivables Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockInExchangeForCancellationOfNotesReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock in exchange for cancellation of notes receivables shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Prepaid Expense and Other Assets, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid and other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2029</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardDateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Date [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued for the employee stock purchase plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss before income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Warrant Or Right [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LeaseLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease liabilities noncurrent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LeaseLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Liabilities Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LeaseLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AccretionToRedemptionValueOfRedeemableStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accretion to redemption value of redeemable stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AccretionToRedemptionValueOfRedeemableStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion To Redemption Value Of Redeemable Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AccretionToRedemptionValueOfRedeemableStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accretion to redemption value of redeemable stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease obligations recorded for right-of-use assets abstract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Obligations Recorded For Right Of Use Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease obligations recorded for right-of-use assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MajorCustomersAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer Concentration Risk</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer Concentration Risk [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Potential Aggregate Payments For Sales Based And Operating Milestones</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Potential Aggregate Payments For Sales Based And Operating Milestones</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potential aggregate payments for sales based and operating milestones</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_PreferredStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred stock warrants [Member].</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_PreferredStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_PreferredStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExpirationOfCommonStockWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Expiration of common stock warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExpirationOfCommonStockWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Expiration Of Common Stock Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExpirationOfCommonStockWarrants_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Expiration of common stock warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability Class [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liability Class</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, after Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryRawMaterials_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Inventory, Raw Materials, Gross, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryRawMaterials_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Raw Materials, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryRawMaterials_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Raw materials</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments of debt issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Debt Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payments of debt issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesFPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series F Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesFPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series F Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LongTermWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Long term warrant liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LongTermWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Warrant Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LongTermWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retired Term Loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Basic net income (loss) per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Attributable to common stock, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease extend term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Option to Extend</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeasePrincipalPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Principal Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeasePrincipalPayments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Principal payments on finance lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average discount rate - finance leases (as a percent)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Term loan, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Retained Earnings (Accumulated Deficit), Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Retained Earnings (Accumulated Deficit), Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of Options, Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of Options, Beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RedeemableCommonStockReclassifiedShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable common stock reclassified, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RedeemableCommonStockReclassifiedShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Common Stock, Reclassified, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RedeemableCommonStockReclassifiedShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Redeemable common stock, reclassified, shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Elements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of cash flow information:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares of common stock reserved</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfRedeemableCommonStockToCommonStockOptionsAssumedInNonCashInvestingOrFinancingActivity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification of redeemable common stock to common stock options assumed in non cash investing or financing activity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfRedeemableCommonStockToCommonStockOptionsAssumedInNonCashInvestingOrFinancingActivity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Of Redeemable Common Stock To Common Stock Options Assumed In Non Cash Investing Or Financing Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfRedeemableCommonStockToCommonStockOptionsAssumedInNonCashInvestingOrFinancingActivity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of redeemable common stock options to common stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_GainLossFromChangesInFairValueOfPreferredStockWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gain (Loss) from Changes in fair value of preferred stock warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_GainLossFromChangesInFairValueOfPreferredStockWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain Loss From Changes In Fair Value Of Preferred Stock Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_GainLossFromChangesInFairValueOfPreferredStockWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of preferred stock warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average fair value, forfeited</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Payable term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Term of Contract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Inventory gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Net, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Net, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Net, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_FinanceLeaseObligationsIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_FinanceLeaseObligationsIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance Lease Obligations Incurred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_FinanceLeaseObligationsIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Obligations Incurred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of assets and liabilities measured at fair value on recurring basis and the fair value hierarchy of the valuation techniques</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RedeemableStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Redeemable stock options.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RedeemableStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Stock Options [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RedeemableStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable Stock Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock par value (USD per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock par value per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TotalLeaseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Total lease assets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TotalLeaseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Total Lease Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TotalLeaseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueAdditions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additions during the period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueAdditions_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Consideration earned during the period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueAdditions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consideration earned during the period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel">Temporary Equity, Beginning Balance, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Temporary Equity, Ending Balance, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Temporary Equity, Beginning Balance, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Carrying Value (2) Share Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AccretionToRedemptionValueOfRedeemableStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Value of accretion of redeemable stock options to its redemption value during the period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AccretionToRedemptionValueOfRedeemableStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion To Redemption Value Of Redeemable Stock Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AccretionToRedemptionValueOfRedeemableStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accretion to redemption value of redeemable stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockNoParValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, No Par Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockNoParValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock no par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling, General and Administrative Expenses [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling, General and Administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued for the exercise of stock options and vesting of restricted stock units, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares issued for the exercise of stock options and vesting of restricted stock units, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares issued for the exercise of stock options and vesting of restricted stock units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_EffectiveInterestRateOnBorrowingsTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective interest rate on borrowings term loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_EffectiveInterestRateOnBorrowingsTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Interest Rate On Borrowings Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_EffectiveInterestRateOnBorrowingsTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective interest rate on borrowings term loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock offering costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Offering Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Dilutive Securities Excluded from Computation of Loss Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Borrowing Capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: exit fee and unamortized issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unamortized Debt Issuance Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-Term Investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unvested at December 31, 2023</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RxlalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">LAL [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RxlalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">RxLAL [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RxlalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LAL</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities Noncurrent Operating</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of 4,093,995 shares of redeemable common stock to 4,093,995 shares of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification of shares of redeemable common stock to shares of common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Of Shares Of Redeemable Common Stock To Shares Of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LessorOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sublease agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LessorOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessor, Operating Lease, Term of Contract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock par or stated value per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Receivable [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee Lease Description [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of stock options, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Options, Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of Options, Exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Debt [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future Principal Payments Due Under the Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesEPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series E Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesEPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series E Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ManufacturingFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Facility [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ManufacturingFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Debt [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short Term Debt [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gain (loss)on short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unrealized loss on short-term investments and cash equivalents, net of tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LDDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">LDD Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LDDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">L D D [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LDDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">L D D</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_June2023LsaRepaymentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">June 2023 LSA repayment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_June2023LsaRepaymentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">June 2023 LSA repayment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_June2023LsaRepaymentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">June 2023 LSA repayment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation of Revenue [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disaggregation Of Revenue [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from Lines of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Lines of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Lines of Credit, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Shares Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating cash flows from operating leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allowance for doubtful accounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unvested at June 30, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options, Unvested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued for the employee stock purchase plan, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Short-term Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Options Forfeited</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Liquidation Preference, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liquidation Preference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Stockholders' Equity, Ending Balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Stockholders' Equity, Beginning Balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock outstanding (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Investments [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_InvestmentMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Investment maturity period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_InvestmentMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Maturity Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_InvestmentMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment maturity period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FutureMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Future [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WarrantsIssuedToPurchaseCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrants Issued To Purchase Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WarrantsIssuedToPurchaseCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Issued To Purchase Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WarrantsIssuedToPurchaseCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants issued to purchase common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock par value per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Par Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Benchmark [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due in 2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long-term liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Other than Long-Term Debt, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Liabilities, Other than Long-Term Debt, Noncurrent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock from at-the-market offerings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from issuance of common stock in at-the-market offerings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of common stock in at-the-market offerings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Debt, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Accretion to Redemption Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accretion to redemption value of redeemable stock and stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock for at-the-market offerings, net of issuance costs, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stock for at-the-Market Offerings, Net of Issuance Costs, Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of Common Stock for at-the-Market Offerings, Net of Issuance Costs, Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost of Sales [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of Goods Sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Quarterly Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Quarterly Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average fair value, vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents and restricted cash - end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents and restricted cash - beginning of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less: imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Less: imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesDPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series D Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesDPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series D Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Right-of-use assets obtained in exchange for lease obligations abstract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right Of Use Assets Obtained In Exchange For Lease Obligations [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets obtained in exchange for lease obligations:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Life.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected life (in years), Weighted Average</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cost of Goods and Services Sold, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost of Goods and Services Sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Payment Terms</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total assets at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Assets, Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized Loss, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Loss, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain (Loss), before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain (Loss), before Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Maturities of Lease Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Paper [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial Paper [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Shares Available for Grant, Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Shares Available for Grant, Beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock available for issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shareholder Representative Holdback Of Exercise Price Of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shareholder Representative Holdback Of Exercise Price Of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shareholder representative holdback of exercise price of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockAfterReclassificationOfRedeemableCommonStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock after reclassification of redeemable common stock, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockAfterReclassificationOfRedeemableCommonStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock after Reclassification of Redeemable Common Stock, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockAfterReclassificationOfRedeemableCommonStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock after reclassification of redeemable common stock, shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average period for recognition of expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_EarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Earnings Per Share Table</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_EarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_EarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earnings Per Share [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SignificantAccountingPoliciesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Significant accounting policies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SignificantAccountingPoliciesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies Policy [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SignificantAccountingPoliciesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Accounting Policies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest and Other Income, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest and Other Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and other income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effect of foreign exchange rate on cash, cash equivalents and restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AmendedTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amended Term Loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AmendedTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amended term loan member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_DeferredOfferingCostsIncludedInAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred offering costs included in accrued expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_DeferredOfferingCostsIncludedInAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Offering Costs Included In Accrued Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_DeferredOfferingCostsIncludedInAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred offering costs included in accounts payable and accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Debt [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Short Term Debt [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected life (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Long-Term Debt Instruments [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesAvailableForFutureIssuanceUnder2021EsppMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares available for future issuance under 2021 ESPP [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesAvailableForFutureIssuanceUnder2021EsppMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares available for future issuance under 2021 ESPP [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AOCI Attributable to Parent [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Stock Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payments of deferred offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future minimum lease payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments Due</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Face Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument face amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockTransactionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Transaction Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockTransactionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of stock, date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockTransactionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Date of Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonvotingCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonvoting Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonvotingCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nonvoting Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory held on consignment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NonEmployeeDirectorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-Employee Directors [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NonEmployeeDirectorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non-Employee Directors [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Options, Expired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average discount rate - operating leases (as a percent)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares available for future sale under the at-the-market offering1 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares available for future sale under the at-the-market offering1 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LoansReceivableDescriptionOfVariableRateBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan, Description of Variable Rates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LoansReceivableDescriptionOfVariableRateBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loans Receivable, Description of Variable Rate Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock for at-the-market offerings, net of issuance costs, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of common stock in at-the-market offerings, net of issuance costs, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in at-the-market offerings, net of issuance costs, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee Lease Description [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ConversionOfNotesReceivablesToTreasuryStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of notes receivables to treasury stock, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ConversionOfNotesReceivablesToTreasuryStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of notes receivables to treasury stock, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_EarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Earnings Per Share Line Items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_EarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_EarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income Taxes Paid, Net, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes Paid, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_OneTwentyFiveColumbiaLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">One Twenty Five Columbia Lease [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_OneTwentyFiveColumbiaLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">One Twenty Five Columbia Lease [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SummaryOfLeaseBalancesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary Of Lease Balances.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SummaryOfLeaseBalancesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Lease Balances Table [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SummaryOfLeaseBalancesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Lease Balance Sheet Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">U.S. Treasury Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Debt Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Government Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and Cash Equivalents, at Carrying Value, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and Cash Equivalents, at Carrying Value, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_OperatingLeaseObligationsIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease obligations incurred.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_OperatingLeaseObligationsIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Obligations Incurred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_OperatingLeaseObligationsIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2029</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Component of Lease Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NewLoanAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Loan and Security Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NewLoanAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">New Loan and Security Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryValuationReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Inventory Valuation Reserves, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryValuationReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Inventory Valuation Reserves, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryValuationReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Valuation Reserves</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryValuationReserves_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: reserve for excess and obsolete inventory</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_CA_lbl" xlink:role="http://www.xbrl.org/2003/role/label">CALIFORNIA</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_CA_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">California [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options, Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise of preferred stock warrants, net of shares withheld for exercise price, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exercise of preferred stock warrants, net of shares withheld for exercise price, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Value of shares redeemed for employee tax withholdings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Value of shares redeemed for employee tax withholdings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Value of shares redeemed for employee tax withholdings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation of Revenue [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingSubleaseOptionToTerminate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sublease cancelled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingSubleaseOptionToTerminate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Sublease, Option to Terminate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification of redeemable common stock options to common stock options.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Of Redeemable Common Stock Options To Common Stock Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of redeemable common stock options to common stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Risk-free Interest Rate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Risk Free Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, Weighted Average</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets Finance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Range and Weighted-average Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign currency translation (loss) gain</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForProceedsFromTenantAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for (Proceeds from) Tenant Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForProceedsFromTenantAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases,tenant allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestBearingDepositsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest-Bearing Deposits [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestBearingDepositsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest-Bearing Deposits [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_OfficeManufacturingAndWarehouseFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Structure used in the manufactOffice, Manufacturing and Warehouse Facility.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_OfficeManufacturingAndWarehouseFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Office Manufacturing And Warehouse Facility [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_OfficeManufacturingAndWarehouseFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Office, Manufacturing and Warehouse Facility [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due in 2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanTableTextblock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Cash Interest Paid and Effective Interest Rate On Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanTableTextblock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Cash Interest Paid and effective interest rate on term loan table TextBlock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanTableTextblock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of Cash Interest Paid and effective interest rate on term loan table TextBlock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AdditionalNumberOfCommonSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional number of common shares issued.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AdditionalNumberOfCommonSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Number Of Common Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AdditionalNumberOfCommonSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional common shares sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_JulieAndrewsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Julie Andrews [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_JulieAndrewsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Julie Andrews [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, by Class of Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity By Class Of Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Warrant Or Right [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investing Activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Non-Vested Restricted stock unit Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Revenue from contracts with customers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Revenue from Contract with Customer, Excluding Assessed Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Rent Expense, Sublease Rentals</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Note Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling, General and Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling, general and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Selling, General and Administrative Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Debt, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ServiceWarrantyServiceContractsAndAccessoriesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Service warranty, service contracts, and accessories [Member].</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ServiceWarrantyServiceContractsAndAccessoriesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Service Warranty Service Contracts And Accessories [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ServiceWarrantyServiceContractsAndAccessoriesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Service Warranty Service Contracts And Accessories</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueRevenueRecognized1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recognized during the period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueRevenueRecognized1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue, Revenue Recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueRevenueRecognized1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Revenue recognized during the period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Debt, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesRedeemedForEmployeeTaxWithholdings_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares redeemed for employee tax withholdings, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesRedeemedForEmployeeTaxWithholdings_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares redeemed for employee tax withholdings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesRedeemedForEmployeeTaxWithholdings_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares redeemed for employee tax withholdings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary or Equity Method Investee, Sale of Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities, redeemable common stock, stock options, convertible preferred stock and stockholders' deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShelfRegistrationStatementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shelf Registration Statement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShelfRegistrationStatementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shelf registration statement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShelfRegistrationStatementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shelf registration statement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Noncurrent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anti-dilutive securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Effect of Anti Dilutive Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from sale of shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Consideration Received on Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel">Balance at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel">Balance at beginning of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at beginning of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income Tax Expense (Benefit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowOperatingActivitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowOperatingActivitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Stockholders' Equity Attributable to Parent, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Stockholders' Equity Attributable to Parent, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OptionIndexedToIssuersEquityDescriptionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract Indexed to Issuer's Equity [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OptionIndexedToIssuersEquityDescriptionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Warrant Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Redeemable convertible preferred stock warrant liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Convertible Preferred Stock Warrant Liability [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable convertible preferred stock warrant liability [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfDeferredCost_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification Of Deferred Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfDeferredCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Of Deferred Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfDeferredCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of deferred financing costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted Stock Units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units (RSUs) [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares issued and sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Number of Shares Issued in Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, shares authorized (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Stock-Based Compensation Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected dividend yield.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend Yield</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield, Weighted Average</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total unrecognized expense related to unvested stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leases [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Deferred Revenue Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue, by Arrangement, Disclosure [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_The2021PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The 2021 Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_The2021PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">The 2021 Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_The2021PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Equity Incentive Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SeriesGCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series G Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SeriesGCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series G common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SeriesGCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series G Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk, Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesGPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series G Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesGPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series G Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock to common stock upon initial public offering, net of fractional shares settled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise of preferred stock warrants, net of shares withheld for exercise price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exercise of preferred stock warrants, net of shares withheld for exercise price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShortTermInvestmentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShortTermInvestmentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Short-term investments.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShortTermInvestmentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Investments Policy [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TotalLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Total lease liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TotalLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Total Lease Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TotalLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Short-term Investments Available For Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value by Liability Class [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value by Liability Class</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPreferredUnitsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Preferred Units [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPreferredUnitsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturities of short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale, Maturity and Collection of Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Sale, Maturity and Collection of Short-term Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_GainLossFromChangesInFairValueOfCommonStockWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gain (Loss) from Changes in fair value of common stock warrant.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_GainLossFromChangesInFairValueOfCommonStockWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain Loss From Changes In Fair Value Of Common Stock Warrant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_GainLossFromChangesInFairValueOfCommonStockWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of common stock warrant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToCommonStockAssumedInNonCashInvestingOrFinancingActivity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification of shares of redeemable common stock to common stock, assumed in non cash investing or financing activity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToCommonStockAssumedInNonCashInvestingOrFinancingActivity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Of Shares Of Redeemable Common Stock To Common Stock Assumed In Non Cash Investing Or Financing Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToCommonStockAssumedInNonCashInvestingOrFinancingActivity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of 4,093,995 shares of redeemable common stock to 4,093,995 shares of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value, Options Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Shares Converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable common stock reclassified</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Conversion of preferred stock to common stock upon initial public offering, net of fractional shares settled (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant date fair value, Weighted Average</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on extinguishment of debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss on extinguishment of term loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Extinguishment of Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gain (Loss) on Extinguishment of Debt, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases right-of-use assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of shares, vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares, vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares redeemed for employee tax withholdings, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Redeemed For Employee Tax With Holdings, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares Redeemed For Employee Tax With Holdings, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLoanOriginations1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from Loan Originations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLoanOriginations1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Loan Originations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Diluted net income (loss) per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Attributable to common stock, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Voting Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, voting rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash (used in) provided by investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, Weighted Average</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AccurideInternationalIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accuride International Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AccurideInternationalIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accuride International Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted Average Grant Date Fair Value, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted average fair value, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Awards vesting period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation, Vesting period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NumberOfLeases_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of leases.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NumberOfLeases_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NumberOfLeases_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification from warrant liability to additional paid in capital for warrants exercised.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification from Warrant Liability to Additional Paid In Capital for Warrants Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification from warrant liability to additional paid-in capital for warrants exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RepaymentOfTermLoan_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repayment of term loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RepaymentOfTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayment of term loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RepaymentOfTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Repayment of term loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock warrant.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Stockholders' Equity, Ending Balance, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Stockholders' Equity, Beginning Balance, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Attributable to common stock, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization and Basis of Presentation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_BmlManagementLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">BML Management, LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_BmlManagementLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">BML Management, LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LiquidityAndFinancialPositionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liquidity and Financial Position</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LiquidityAndFinancialPositionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liquidity and Financial Position [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LiquidityAndFinancialPositionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for Liquidity and Financial Position.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense) [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense), net:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WeightedAverageDiscountRateAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Weighted average discount rate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WeightedAverageDiscountRateAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Discount Rate [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WeightedAverageDiscountRateAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average discount rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total Fair Value Less Strike Price of Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less: imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Less: imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity par value (USD per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Noncash Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_InterestPaidOnTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest paid on term loan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_InterestPaidOnTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid On Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_InterestPaidOnTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest on term loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LegalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal proceedings, regulatory matters, legal costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LegalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intrinsic Value of Outstanding Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForFees_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Final payment and other fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForFees_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for Other Fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_PotentialAggregatePaymentsForRegulatoryMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Potential Aggregate Payments For Regulatory Milestones</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_PotentialAggregatePaymentsForRegulatoryMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Potential Aggregate Payments For Regulatory Milestones</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_PotentialAggregatePaymentsForRegulatoryMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potential aggregate payments for regulatory milestones</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Weighted Average Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining lease term - finance leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GrossProfit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gross Profit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GrossProfit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gross profit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of reportable segment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Reportable Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan Maturity Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money market Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average shares outstanding, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Attributable to common stock, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingencies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities Noncurrent Finance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, authorized (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubleaseIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sublease rental income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubleaseIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sublease Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of 4,093,995 shares of redeemable common stock to 4,093,995 shares of common stock, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification of shares of redeemable common stock to shares of common stock in shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Of Shares Of Redeemable Common Stock To Shares Of Common Stock In Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Interest Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance lease cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Finance lease cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level I [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Options Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Remaining Contractual Term (Years), Options outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NotesReceivableForRedeemableCommonStockIssuedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Notes receivable for redeemable common stock issued.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NotesReceivableForRedeemableCommonStockIssuedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Notes Receivable For Redeemable Common Stock Issued [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NotesReceivableForRedeemableCommonStockIssuedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Notes Receivable for Redeemable Common Stock Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Available For Future Issuance Under The 2006 ,2015 And 2021 Plans [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares Available For Future Issuance Under The 2006 ,2015 And 2021 Plans [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_StockOptionsIssuedAndOutstandingUnderPlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options Issued And Outstanding Under Plans [ Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_StockOptionsIssuedAndOutstandingUnderPlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Options Issued And Outstanding Under Plans [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_StockOptionsIssuedAndOutstandingUnderPlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Options Issued And Outstanding Under Plans [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Estimated Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 (remainder)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' deficit:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_DebtInstrumentClosingCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Closing Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_DebtInstrumentClosingCost_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt Instrument Closing Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ConvertiblePreferredStockWarrantLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible preferred stock warrant liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ConvertiblePreferredStockWarrantLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock Warrant Liability [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ConvertiblePreferredStockWarrantLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock warrant liability [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SeriesWCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series W Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SeriesWCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series W common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SeriesWCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series W Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryWriteDown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Write-down</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryWriteDown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provision for excess and obsolete inventory</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Calhoun Vision, Inc. 2015 Equity Incentive Plan and the Calhoun Vision, Inc. 2006 Stock Plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Calhoun Vision Inc2015 Equity Incentive Plan And Calhoun Vision Inc2006 Stock Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">The Calhoun Vision, Inc. 2015 Equity Incentive Plan and the Calhoun Vision, Inc. 2006 Stock Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TwoThousandSixAndTwoThousandFifteenPlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand six , two thousand fifteen and two thousand twenty one plans.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TwoThousandSixAndTwoThousandFifteenPlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Six , Two Thousand Fifteen And Two Thousand Twenty One Plans [Member] [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TwoThousandSixAndTwoThousandFifteenPlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2006 and 2015 Plans [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_The2015PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">The 2015 Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_The2015PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">The 2015 Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_The2015PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The 2015 Plan Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 (remainder)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock sale underwriting discounts and commission deducted.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Sale Underwriting Discounts and Commission Deducted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock sale underwriting discounts and commission deducted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Operating and Nonoperating</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">IPO [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">IPO [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Losses from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LetterOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Letter of Credit [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LetterOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Letter of Credit [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WarrantsToPurchaseConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants To Purchase Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WarrantsToPurchaseConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants To Purchase Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WarrantsToPurchaseConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrants To Purchase Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarlyRepaymentOfSeniorDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of Loan, Partly</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarlyRepaymentOfSeniorDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Early Repayment of Senior Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant or Right</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of Financial Instruments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Remaining Contractual Term (Years), Exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_DebtInstrumentFinalPaymentFeeRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Final Payment Fee Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_DebtInstrumentFinalPaymentFeeRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt Instrument Final Payment Fee Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Debt, Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, and Short-term Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, and Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, cash equivalents, and short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options issued and outstanding under the 2006, 2015 and 2021 plans</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock options issued and outstanding under the 2006, 2015 and 2021 plans[Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock options issued and outstanding under the 2006, 2015 and 2021 plans[Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Certificates of Deposit [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Certificates of Deposit [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Value, Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Value, Issued, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Value, Issued, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AdditionalBorrowingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Borrowing Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AdditionalBorrowingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional borrowing amount.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AdditionalBorrowingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Borrowing Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquisition of property and equipment included in accounts payable and accrued expenses and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capital Expenditures Incurred but Not yet Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock from public offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance Initial Public Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_WarehouseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warehouse [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_WarehouseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warehouse [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ConversionOfNotesReceivablesToTreasuryStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of notes receivables to treasury stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ConversionOfNotesReceivablesToTreasuryStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of notes receivables to treasury stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities and Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accrued Liabilities and Other Liabilities, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unused Term Loan Commitment Fee Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from issuance of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Debt, Net of Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Inventory net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Inventory, Finished Goods, Gross, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Finished Goods, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finished goods</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due in 2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock to common stock upon initial public offering, net of fractional shares settled (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Additional Paid in Capital, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Additional Paid in Capital, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Additional Paid in Capital, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary, Sale of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments for employee taxes related to stock compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for employee taxes related to stock compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments for employee taxes related to stock compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharePurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share Purchase Agreement Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharePurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharePurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued for the employee stock purchase plan, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares issued for the employee stock purchase plan, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares issued for the employee stock purchase plan, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities Current Operating</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_EscrowHoldbackOfExercisePriceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Escrow Holdback Of Exercise Price Of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_EscrowHoldbackOfExercisePriceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Escrow Holdback Of Exercise Price Of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_EscrowHoldbackOfExercisePriceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Escrow holdback of exercise price of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible preferred stock, shares converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate shares of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortization of Debt Issuance Costs and Discounts, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Debt Issuance Costs and Discounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of debt issuance costs and premium</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Revenue from Contracts with Customers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_EricWeinbergMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Eric Weinberg [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_EricWeinbergMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Eric Weinberg [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperationsCommencedDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease commences date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperationsCommencedDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operations Commenced Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_JAndyCorleyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">J. Andy Corley [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_JAndyCorleyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">J. Andy Corley [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_DeferredRevenue1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel">Balance at beginning of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_DeferredRevenue1_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of deferred income and obligation to transfer product and service to customer.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_DeferredRevenue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue1</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_DeferredRevenue1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel">Balance at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration of Credit Risk and Other Risks and Uncertainties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrealized Gain (Loss) on Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrealized Gain (Loss) on Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gain (Loss) on short term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RedeemableCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Redeemable common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RedeemableCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_RedeemableCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intrinsic Value of Vested Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of right-of-use lease assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CashInterestPaidPercentagePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Interest paid, Percentage, Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CashInterestPaidPercentagePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash Interest paid, Percentage, Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CashInterestPaidPercentagePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash interest paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancingReceivableUnamortizedLoanFeeCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan Amendment Fees And Other Closing Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancingReceivableUnamortizedLoanFeeCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financing Receivable, Unamortized Loan Cost (Fee)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued for the exercise of stock options and vesting of restricted stock units, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares issued for the exercise of stock options and vesting of restricted stock units, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares issued for the exercise of stock options and vesting of restricted stock units, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Assets, Noncurrent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaidInKindInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Paid-in-Kind Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaidInKindInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment-in-kind interest income added to principal of notes receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Inventory, Current [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Inventories</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfNotesReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale of Notes Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfNotesReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from notes receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of shares, forfeited</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares, forfeited</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Agencies Short-Term Debt Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Government Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation of Revenue [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disaggregation Of Revenue [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockWarrantLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock warrant liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockWarrantLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Warrant Liability [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_CommonStockWarrantLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock warrant liability [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation and Principles of Consolidation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_IlyaGoldshlegerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ilya Goldshleger [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_IlyaGoldshlegerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Ilya Goldshleger [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AmountOfSettlementOfFractionalShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of settlement of fractional shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AmountOfSettlementOfFractionalShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amount of Settlement of Fractional Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AmountOfSettlementOfFractionalShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fractional shares settled upon conversion of preferred stock to common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AccountsReceivablePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable, percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AccountsReceivablePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accounts receivable, Percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AccountsReceivablePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WeightedAverageRemainingLeaseTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Weighted average remaining lease term.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WeightedAverageRemainingLeaseTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Remaining Lease Term [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_WeightedAverageRemainingLeaseTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weigted average remaining lease term (years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities Current Finance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_The2021EsppPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The 2021 ESPP Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_The2021EsppPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">The 2021 ESPP Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_The2021EsppPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Employee Stock Purchase Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due in 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Remainder of Fiscal Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.001 par value, 900,000,000 shares authorized, 39,617,334 shares issued and outstanding as of June 30, 2024 and 36,139,513 shares issued and outstanding as of December 31, 2023</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Value, Issued, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Value, Issued, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Value, Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Executive Officer [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LinesOfCreditCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate amount of the letter of credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LinesOfCreditCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_InterestPaidOnFinancingLeases_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest paid on financing leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_InterestPaidOnFinancingLeases_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid On Financing Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_InterestPaidOnFinancingLeases_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest on financing leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Right-of-Use Asset, Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance lease cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AtmOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ATM Offering [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AtmOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ATM Offering [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AtmOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ATM Offering [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExecutiveOfficersAndNonEmployeeDirectorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Executive Officers and Non-Employee Directors [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExecutiveOfficersAndNonEmployeeDirectorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Executive Officers and Non-Employee Directors [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_MayThreeTwoThousandTwentyTwoTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">May 2022 Term Loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_MayThreeTwoThousandTwentyTwoTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">May Three Two Thousand Twenty Two Term Loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_MayThreeTwoThousandTwentyTwoTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">May Three Two Thousand Twenty Two Term Loan Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 9)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in notes receivable for redeemable common stock issued.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change In Notes Receivable For Redeemable Common Stock Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in notes receivable for common stock issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average shares, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Attributable to common stock, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Accounting Policies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional Non-Refundable Payment Upon Extension of Expiration.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Non Refundable Payment Upon Extension Of Expiration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional non-refundable payment upon extension of expiration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Receivable, after Allowance for Credit Loss, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease term extended term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Renewal Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Inventories</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Inventories, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Inventories</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NotesReceivableForCommonStockIssuedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Notes receivable for common stock issued.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NotesReceivableForCommonStockIssuedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Notes Receivable For Common Stock Issued [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NotesReceivableForCommonStockIssuedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Notes Receivable for Common Stock Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExercisePriceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise Price Of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExercisePriceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExercisePriceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise price of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExerciseOfPreferredStockWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of preferred stock warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExerciseOfPreferredStockWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise of preferred stock warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExerciseOfPreferredStockWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Of Preferred Stock Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_ExerciseOfPreferredStockWarrants_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercise of preferred stock warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LeaseLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease liabilities current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LeaseLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Liabilities Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_LeaseLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Denominator:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares used in computing net loss per share:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Benchmark [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Inventory Adjustments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Adjustments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories reserves</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation, Terms of Award</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repayment of outstanding debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments of Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">US Treasury Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Rent Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Rent Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Leases, Rent Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_GainOnExpirationOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gain On Expiration Of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_GainOnExpirationOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain On Expiration Of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_GainOnExpirationOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain on expiration of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total Cash Received from the Exercise of Stock Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares reserved for future issuance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Reserved For Future Issuance Table [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_SharesReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Common Stock Reserved for Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Expired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_OperatingIncomeLoss1_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating Income (Loss)1</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_OperatingIncomeLoss1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income Loss1</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_OperatingIncomeLoss1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Losses from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Amortization of discount on short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_InterestRateOnBorrowingsTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest rate on borrowings under the term loan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_InterestRateOnBorrowingsTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Rate On Borrowings Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_InterestRateOnBorrowingsTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest rate on borrowings term loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing Activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted-Average Exercise Price, Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted-Average Exercise Price, Beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NoCustomerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">No Customer [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NoCustomerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">No Customer [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_NoCustomerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">No Customer [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_IndustrialCommercialMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Industrial/Commercial [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_IndustrialCommercialMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Industrial/Commercial [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Temporary Equity, Ending Balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Temporary Equity, Beginning Balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, shares outstanding (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Work in Process, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Work-in-process</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other comprehensive (loss) income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level III [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining lease term - operating leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TemporaryEquityNoteReceivablesCommonStockIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Temporary Equity, Ending Balance, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TemporaryEquityNoteReceivablesCommonStockIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Temporary Equity, Beginning Balance, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TemporaryEquityNoteReceivablesCommonStockIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity note receivables for common stock issued.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TemporaryEquityNoteReceivablesCommonStockIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Note Receivables Common Stock Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="rxst_TemporaryEquityNoteReceivablesCommonStockIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Notes receivable for common stock issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of unexercised warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Notes Payable, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Notes Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from term loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Total liabilities at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Liabilities, Fair Value Disclosure, Total</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:to="rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForNonCashExercise" xlink:to="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForNonCashExercise_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare" xlink:to="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OfficeBuildingMember" xlink:to="srt_OfficeBuildingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_DebtFromCashReserves" xlink:to="rxst_DebtFromCashReserves_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueAbstract" xlink:to="us-gaap_DeferredRevenueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_CliffordDDownsMember" xlink:to="rxst_CliffordDDownsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount" xlink:to="rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfRealEstateProperty" xlink:to="us-gaap_AreaOfRealEstateProperty_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCallDateLatest" xlink:to="us-gaap_DebtInstrumentCallDateLatest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SharesAvailableForFutureIssuanceUnderTheEquityPlansMember" xlink:to="rxst_SharesAvailableForFutureIssuanceUnderTheEquityPlansMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering" xlink:to="rxst_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_RonKurtzMDMember" xlink:to="rxst_RonKurtzMDMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="us-gaap_EmployeeStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesHPreferredStockMember" xlink:to="us-gaap_SeriesHPreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:to="rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_NumberOfWhollyOwnedSubsidiaries" xlink:to="rxst_NumberOfWhollyOwnedSubsidiaries_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_AugustFourTwoThousandTwentyThreeMember" xlink:to="rxst_AugustFourTwoThousandTwentyThreeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_CommonStockInExchangeForCancellationOfNotesReceivables" xlink:to="rxst_CommonStockInExchangeForCancellationOfNotesReceivables_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateDomain" xlink:to="us-gaap_AwardDateDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_LeaseLiabilitiesNoncurrent" xlink:to="rxst_LeaseLiabilitiesNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_AccretionToRedemptionValueOfRedeemableStock" xlink:to="rxst_AccretionToRedemptionValueOfRedeemableStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract" xlink:to="rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones" xlink:to="rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_PreferredStockWarrantsMember" xlink:to="rxst_PreferredStockWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ExpirationOfCommonStockWarrants" xlink:to="rxst_ExpirationOfCommonStockWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesFPreferredStockMember" xlink:to="us-gaap_SeriesFPreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_LongTermWarrantLiability" xlink:to="rxst_LongTermWarrantLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_TermLoanMember" xlink:to="rxst_TermLoanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeasePrincipalPayments" xlink:to="us-gaap_FinanceLeasePrincipalPayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_RedeemableCommonStockReclassifiedShares" xlink:to="rxst_RedeemableCommonStockReclassifiedShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ReclassificationOfRedeemableCommonStockToCommonStockOptionsAssumedInNonCashInvestingOrFinancingActivity" xlink:to="rxst_ReclassificationOfRedeemableCommonStockToCommonStockOptionsAssumedInNonCashInvestingOrFinancingActivity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_GainLossFromChangesInFairValueOfPreferredStockWarrants" xlink:to="rxst_GainLossFromChangesInFairValueOfPreferredStockWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_FinanceLeaseObligationsIncurred" xlink:to="rxst_FinanceLeaseObligationsIncurred_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_RedeemableStockOptionsMember" xlink:to="rxst_RedeemableStockOptionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_TotalLeaseAssets" xlink:to="rxst_TotalLeaseAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueAdditions" xlink:to="us-gaap_DeferredRevenueAdditions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_AccretionToRedemptionValueOfRedeemableStockOptions" xlink:to="rxst_AccretionToRedemptionValueOfRedeemableStockOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockNoParValue" xlink:to="us-gaap_PreferredStockNoParValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares" xlink:to="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_EffectiveInterestRateOnBorrowingsTermLoan" xlink:to="rxst_EffectiveInterestRateOnBorrowingsTermLoan_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_CommonStockOfferingCosts" xlink:to="rxst_CommonStockOfferingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_RxlalMember" xlink:to="rxst_RxlalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock" xlink:to="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LessorOperatingLeaseTermOfContract" xlink:to="us-gaap_LessorOperatingLeaseTermOfContract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleCommonStockMember" xlink:to="us-gaap_ConvertibleCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="srt_NameOfMajorCustomerDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesEPreferredStockMember" xlink:to="us-gaap_SeriesEPreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManufacturingFacilityMember" xlink:to="us-gaap_ManufacturingFacilityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_LDDMember" xlink:to="rxst_LDDMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_June2023LsaRepaymentMember" xlink:to="rxst_June2023LsaRepaymentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestmentsAbstract" xlink:to="us-gaap_ShortTermInvestmentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_InvestmentMaturityPeriod" xlink:to="rxst_InvestmentMaturityPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMember" xlink:to="us-gaap_FutureMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_WarrantsIssuedToPurchaseCommonStock" xlink:to="rxst_WarrantsIssuedToPurchaseCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings" xlink:to="rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtDescription" xlink:to="us-gaap_ShortTermDebtDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare" xlink:to="rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesDPreferredStockMember" xlink:to="us-gaap_SeriesDPreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:to="rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPaymentTerms" xlink:to="us-gaap_DebtInstrumentPaymentTerms_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants" xlink:to="rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_CommonStockAfterReclassificationOfRedeemableCommonStockShares" xlink:to="rxst_CommonStockAfterReclassificationOfRedeemableCommonStockShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_EarningsPerShareTable" xlink:to="rxst_EarningsPerShareTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SignificantAccountingPoliciesPolicyTextBlock" xlink:to="rxst_SignificantAccountingPoliciesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_AmendedTermLoanMember" xlink:to="rxst_AmendedTermLoanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_DeferredOfferingCostsIncludedInAccruedExpenses" xlink:to="rxst_DeferredOfferingCostsIncludedInAccruedExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SharesAvailableForFutureIssuanceUnder2021EsppMember" xlink:to="rxst_SharesAvailableForFutureIssuanceUnder2021EsppMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockTransactionDate" xlink:to="us-gaap_SaleOfStockTransactionDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonvotingCommonStockMember" xlink:to="us-gaap_NonvotingCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:to="us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_NonEmployeeDirectorsMember" xlink:to="rxst_NonEmployeeDirectorsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member" xlink:to="rxst_SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansReceivableDescriptionOfVariableRateBasis" xlink:to="us-gaap_LoansReceivableDescriptionOfVariableRateBasis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount" xlink:to="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ConversionOfNotesReceivablesToTreasuryStockShares" xlink:to="rxst_ConversionOfNotesReceivablesToTreasuryStockShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_EarningsPerShareLineItems" xlink:to="rxst_EarningsPerShareLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_OneTwentyFiveColumbiaLeaseMember" xlink:to="rxst_OneTwentyFiveColumbiaLeaseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SummaryOfLeaseBalancesTableTextBlock" xlink:to="rxst_SummaryOfLeaseBalancesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_OperatingLeaseObligationsIncurred" xlink:to="rxst_OperatingLeaseObligationsIncurred_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_NewLoanAndSecurityAgreementMember" xlink:to="rxst_NewLoanAndSecurityAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_CA" xlink:to="stpr_CA_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares" xlink:to="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings" xlink:to="rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueAbstract" xlink:to="us-gaap_DisaggregationOfRevenueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingSubleaseOptionToTerminate" xlink:to="us-gaap_LesseeOperatingSubleaseOptionToTerminate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions" xlink:to="rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:to="us-gaap_PaymentsForProceedsFromTenantAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestBearingDepositsMember" xlink:to="us-gaap_InterestBearingDepositsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_OfficeManufacturingAndWarehouseFacilityMember" xlink:to="rxst_OfficeManufacturingAndWarehouseFacilityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanTableTextblock" xlink:to="rxst_ScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanTableTextblock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_AdditionalNumberOfCommonSharesIssued" xlink:to="rxst_AdditionalNumberOfCommonSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_JulieAndrewsMember" xlink:to="rxst_JulieAndrewsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:to="us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ServiceWarrantyServiceContractsAndAccessoriesMember" xlink:to="rxst_ServiceWarrantyServiceContractsAndAccessoriesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueRevenueRecognized1" xlink:to="us-gaap_DeferredRevenueRevenueRecognized1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ShortTermDebtTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SharesRedeemedForEmployeeTaxWithholdings" xlink:to="rxst_SharesRedeemedForEmployeeTaxWithholdings_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ShelfRegistrationStatementMember" xlink:to="rxst_ShelfRegistrationStatementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="us-gaap_CashFlowOperatingActivitiesLesseeAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionIndexedToIssuersEquityDescriptionTextBlock" xlink:to="us-gaap_OptionIndexedToIssuersEquityDescriptionTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember" xlink:to="rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ReclassificationOfDeferredCost" xlink:to="rxst_ReclassificationOfDeferredCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" xlink:to="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_The2021PlanMember" xlink:to="rxst_The2021PlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SeriesGCommonStockMember" xlink:to="rxst_SeriesGCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesGPreferredStockMember" xlink:to="us-gaap_SeriesGPreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice" xlink:to="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ShortTermInvestmentsPolicyTextBlock" xlink:to="rxst_ShortTermInvestmentsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_TotalLeaseLiabilities" xlink:to="rxst_TotalLeaseLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPreferredUnitsTextBlock" xlink:to="us-gaap_ScheduleOfPreferredUnitsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_GainLossFromChangesInFairValueOfCommonStockWarrant" xlink:to="rxst_GainLossFromChangesInFairValueOfCommonStockWarrant_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ReclassificationOfSharesOfRedeemableCommonStockToCommonStockAssumedInNonCashInvestingOrFinancingActivity" xlink:to="rxst_ReclassificationOfSharesOfRedeemableCommonStockToCommonStockAssumedInNonCashInvestingOrFinancingActivity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount" xlink:to="rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLoanOriginations1" xlink:to="us-gaap_ProceedsFromLoanOriginations1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_AccurideInternationalIncMember" xlink:to="rxst_AccurideInternationalIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_NumberOfLeases" xlink:to="rxst_NumberOfLeases_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForWarrantsExercised" xlink:to="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForWarrantsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_RepaymentOfTermLoan" xlink:to="rxst_RepaymentOfTermLoan_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_CommonStockWarrantMember" xlink:to="rxst_CommonStockWarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_BmlManagementLlcMember" xlink:to="rxst_BmlManagementLlcMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_LiquidityAndFinancialPositionPolicyTextBlock" xlink:to="rxst_LiquidityAndFinancialPositionPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_WeightedAverageDiscountRateAbstract" xlink:to="rxst_WeightedAverageDiscountRateAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_InterestPaidOnTermLoan" xlink:to="rxst_InterestPaidOnTermLoan_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtDescription" xlink:to="us-gaap_LongTermDebtDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForFees" xlink:to="us-gaap_PaymentsForFees_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_PotentialAggregatePaymentsForRegulatoryMilestones" xlink:to="rxst_PotentialAggregatePaymentsForRegulatoryMilestones_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares" xlink:to="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseInterestExpense" xlink:to="us-gaap_FinanceLeaseInterestExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_NotesReceivableForRedeemableCommonStockIssuedMember" xlink:to="rxst_NotesReceivableForRedeemableCommonStockIssuedMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember" xlink:to="rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_StockOptionsIssuedAndOutstandingUnderPlansMember" xlink:to="rxst_StockOptionsIssuedAndOutstandingUnderPlansMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_WarrantLiability" xlink:to="rxst_WarrantLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_DebtInstrumentClosingCost" xlink:to="rxst_DebtInstrumentClosingCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ConvertiblePreferredStockWarrantLiabilityMember" xlink:to="rxst_ConvertiblePreferredStockWarrantLiabilityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SeriesWCommonStockMember" xlink:to="rxst_SeriesWCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" xlink:to="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_TwoThousandSixAndTwoThousandFifteenPlansMember" xlink:to="rxst_TwoThousandSixAndTwoThousandFifteenPlansMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_The2015PlanMember" xlink:to="rxst_The2015PlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted" xlink:to="rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="us-gaap_LeaseContractualTermDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LetterOfCreditMember" xlink:to="us-gaap_LetterOfCreditMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_WarrantsToPurchaseConvertiblePreferredStock" xlink:to="rxst_WarrantsToPurchaseConvertiblePreferredStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarlyRepaymentOfSeniorDebt" xlink:to="us-gaap_EarlyRepaymentOfSeniorDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_DebtInstrumentFinalPaymentFeeRate" xlink:to="rxst_DebtInstrumentFinalPaymentFeeRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember" xlink:to="rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CertificatesOfDepositMember" xlink:to="us-gaap_CertificatesOfDepositMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_AdditionalBorrowingAmount" xlink:to="rxst_AdditionalBorrowingAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_WarehouseMember" xlink:to="srt_WarehouseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ConversionOfNotesReceivablesToTreasuryStock" xlink:to="rxst_ConversionOfNotesReceivablesToTreasuryStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation" xlink:to="rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SharePurchaseAgreementMember" xlink:to="rxst_SharePurchaseAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount" xlink:to="rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_EscrowHoldbackOfExercisePriceOfWarrants" xlink:to="rxst_EscrowHoldbackOfExercisePriceOfWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_EricWeinbergMember" xlink:to="rxst_EricWeinbergMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperationsCommencedDate1" xlink:to="us-gaap_OperationsCommencedDate1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_JAndyCorleyMember" xlink:to="rxst_JAndyCorleyMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_DeferredRevenue1" xlink:to="rxst_DeferredRevenue1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_RedeemableCommonStockMember" xlink:to="rxst_RedeemableCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_CashInterestPaidPercentagePeriod" xlink:to="rxst_CashInterestPaidPercentagePeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivableUnamortizedLoanFeeCost" xlink:to="us-gaap_FinancingReceivableUnamortizedLoanFeeCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" xlink:to="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaidInKindInterest" xlink:to="us-gaap_PaidInKindInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfNotesReceivable" xlink:to="us-gaap_ProceedsFromSaleOfNotesReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_CommonStockWarrantLiabilityMember" xlink:to="rxst_CommonStockWarrantLiabilityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_IlyaGoldshlegerMember" xlink:to="rxst_IlyaGoldshlegerMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_AmountOfSettlementOfFractionalShares" xlink:to="rxst_AmountOfSettlementOfFractionalShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_AccountsReceivablePercentage" xlink:to="rxst_AccountsReceivablePercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_WeightedAverageRemainingLeaseTermAbstract" xlink:to="rxst_WeightedAverageRemainingLeaseTermAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_The2021EsppPlanMember" xlink:to="rxst_The2021EsppPlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ExecutiveOfficerMember" xlink:to="srt_ExecutiveOfficerMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LinesOfCreditCurrent" xlink:to="us-gaap_LinesOfCreditCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_InterestPaidOnFinancingLeases" xlink:to="rxst_InterestPaidOnFinancingLeases_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_AtmOfferingMember" xlink:to="rxst_AtmOfferingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ExecutiveOfficersAndNonEmployeeDirectorsMember" xlink:to="rxst_ExecutiveOfficersAndNonEmployeeDirectorsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_MayThreeTwoThousandTwentyTwoTermLoanMember" xlink:to="rxst_MayThreeTwoThousandTwentyTwoTermLoanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued" xlink:to="rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration" xlink:to="rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableConvertiblePreferredStockMember" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_NotesReceivableForCommonStockIssuedMember" xlink:to="rxst_NotesReceivableForCommonStockIssuedMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ExercisePriceOfWarrants" xlink:to="rxst_ExercisePriceOfWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_ExerciseOfPreferredStockWarrants" xlink:to="rxst_ExerciseOfPreferredStockWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_LeaseLiabilitiesCurrent" xlink:to="rxst_LeaseLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryAdjustments" xlink:to="us-gaap_InventoryAdjustments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_GainOnExpirationOfWarrants" xlink:to="rxst_GainOnExpirationOfWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_SharesReservedForFutureIssuanceTableTextBlock" xlink:to="rxst_SharesReservedForFutureIssuanceTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_OperatingIncomeLoss1" xlink:to="rxst_OperatingIncomeLoss1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_InterestRateOnBorrowingsTermLoan" xlink:to="rxst_InterestRateOnBorrowingsTermLoan_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_NoCustomerMember" xlink:to="rxst_NoCustomerMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_IndustrialCommercialMember" xlink:to="rxst_IndustrialCommercialMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rxst_TemporaryEquityNoteReceivablesCommonStockIssued" xlink:to="rxst_TemporaryEquityNoteReceivablesCommonStockIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentQuarterlyReport" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="73.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="74.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="75.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="76.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="77.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="78.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LongTermWarrantLiability" xlink:label="rxst_LongTermWarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_WarrantLiability" xlink:label="rxst_WarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LeaseLiabilitiesNoncurrent" xlink:label="rxst_LeaseLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LeaseLiabilitiesCurrent" xlink:label="rxst_LeaseLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:label="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="rxst_LongTermWarrantLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="rxst_WarrantLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="rxst_LeaseLiabilitiesNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="rxst_LeaseLiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebt" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryAdjustments" xlink:label="us-gaap_InventoryAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleCommonStockMember" xlink:label="us-gaap_ConvertibleCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SeriesGCommonStockMember" xlink:label="rxst_SeriesGCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SeriesWCommonStockMember" xlink:label="rxst_SeriesWCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockNoParValue" xlink:label="us-gaap_PreferredStockNoParValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryAdjustments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertibleCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rxst_SeriesGCommonStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rxst_SeriesWCommonStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockNoParValue" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesGPreferredStockMember" xlink:label="us-gaap_SeriesGPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RedeemableCommonStockMember" xlink:label="rxst_RedeemableCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesGPreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rxst_RedeemableCommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestAndOtherIncome" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GrossProfit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RedeemableCommonStockMember" xlink:label="rxst_RedeemableCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TemporaryEquityNoteReceivablesCommonStockIssued" xlink:label="rxst_TemporaryEquityNoteReceivablesCommonStockIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NotesReceivableForRedeemableCommonStockIssuedMember" xlink:label="rxst_NotesReceivableForRedeemableCommonStockIssuedMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NotesReceivableForCommonStockIssuedMember" xlink:label="rxst_NotesReceivableForCommonStockIssuedMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RedeemableStockOptionsMember" xlink:label="rxst_RedeemableStockOptionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" xlink:label="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares" xlink:label="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount" xlink:label="rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesRedeemedForEmployeeTaxWithholdings" xlink:label="rxst_SharesRedeemedForEmployeeTaxWithholdings"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings" xlink:label="rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount" xlink:label="rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount" xlink:label="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare" xlink:label="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare" xlink:label="rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfNotesReceivable" xlink:label="us-gaap_ProceedsFromSaleOfNotesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ConversionOfNotesReceivablesToTreasuryStockShares" xlink:label="rxst_ConversionOfNotesReceivablesToTreasuryStockShares"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockInExchangeForCancellationOfNotesReceivables" xlink:label="rxst_CommonStockInExchangeForCancellationOfNotesReceivables"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount" xlink:label="rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ConversionOfNotesReceivablesToTreasuryStock" xlink:label="rxst_ConversionOfNotesReceivablesToTreasuryStock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice" xlink:label="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares" xlink:label="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="us-gaap_ConversionOfStockAmountConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AccretionToRedemptionValueOfRedeemableStockOptions" xlink:label="rxst_AccretionToRedemptionValueOfRedeemableStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AccretionToRedemptionValueOfRedeemableStock" xlink:label="rxst_AccretionToRedemptionValueOfRedeemableStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued" xlink:label="rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions" xlink:label="rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_41"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TemporaryEquityNoteReceivablesCommonStockIssued" xlink:label="rxst_TemporaryEquityNoteReceivablesCommonStockIssued_42"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_43"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_45"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rxst_RedeemableCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_TemporaryEquityNoteReceivablesCommonStockIssued" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rxst_NotesReceivableForRedeemableCommonStockIssuedMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="rxst_NotesReceivableForCommonStockIssuedMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rxst_RedeemableStockOptionsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_SharesRedeemedForEmployeeTaxWithholdings" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromSaleOfNotesReceivable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ConversionOfNotesReceivablesToTreasuryStockShares" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_CommonStockInExchangeForCancellationOfNotesReceivables" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ConversionOfNotesReceivablesToTreasuryStock" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_AccretionToRedemptionValueOfRedeemableStockOptions" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_AccretionToRedemptionValueOfRedeemableStock" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares" order="38" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions" order="39" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="40" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_41" order="41" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_TemporaryEquityNoteReceivablesCommonStockIssued_42" order="42" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_43" order="43" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44" order="44" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding_45" order="45" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnauditedParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RedeemableCommonStockReclassifiedShares" xlink:label="rxst_RedeemableCommonStockReclassifiedShares"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockAfterReclassificationOfRedeemableCommonStockShares" xlink:label="rxst_CommonStockAfterReclassificationOfRedeemableCommonStockShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AmountOfSettlementOfFractionalShares" xlink:label="rxst_AmountOfSettlementOfFractionalShares"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="rxst_RedeemableCommonStockReclassifiedShares" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="rxst_CommonStockAfterReclassificationOfRedeemableCommonStockShares" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="rxst_AmountOfSettlementOfFractionalShares" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:label="rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract" xlink:label="rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_OperatingLeaseObligationsIncurred" xlink:label="rxst_OperatingLeaseObligationsIncurred"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:label="us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_FinanceLeaseObligationsIncurred" xlink:label="rxst_FinanceLeaseObligationsIncurred"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RepaymentOfTermLoan" xlink:label="rxst_RepaymentOfTermLoan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_InterestPaidOnFinancingLeases" xlink:label="rxst_InterestPaidOnFinancingLeases"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_InterestPaidOnTermLoan" xlink:label="rxst_InterestPaidOnTermLoan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings" xlink:label="rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_DeferredOfferingCostsIncludedInAccruedExpenses" xlink:label="rxst_DeferredOfferingCostsIncludedInAccruedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation" xlink:label="rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForNonCashExercise" xlink:label="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForNonCashExercise"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="us-gaap_FinanceLeasePrincipalPayments"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForWarrantsExercised" xlink:label="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForWarrantsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfSharesOfRedeemableCommonStockToCommonStockAssumedInNonCashInvestingOrFinancingActivity" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToCommonStockAssumedInNonCashInvestingOrFinancingActivity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfRedeemableCommonStockToCommonStockOptionsAssumedInNonCashInvestingOrFinancingActivity" xlink:label="rxst_ReclassificationOfRedeemableCommonStockToCommonStockOptionsAssumedInNonCashInvestingOrFinancingActivity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering" xlink:label="rxst_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfDeferredCost" xlink:label="rxst_ReclassificationOfDeferredCost"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract" xlink:to="rxst_OperatingLeaseObligationsIncurred" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_CashFlowOperatingActivitiesLesseeAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromNotesPayable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract" xlink:to="rxst_FinanceLeaseObligationsIncurred" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_IncomeTaxesPaidNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="rxst_RepaymentOfTermLoan" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="rxst_InterestPaidOnFinancingLeases" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="rxst_InterestPaidOnTermLoan" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="rxst_DeferredOfferingCostsIncludedInAccruedExpenses" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_PaidInKindInterest" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForNonCashExercise" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InventoryWriteDown" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_FinanceLeasePrincipalPayments" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForWarrantsExercised" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="rxst_ReclassificationOfSharesOfRedeemableCommonStockToCommonStockAssumedInNonCashInvestingOrFinancingActivity" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="rxst_ReclassificationOfRedeemableCommonStockToCommonStockOptionsAssumedInNonCashInvestingOrFinancingActivity" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="rxst_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="rxst_ReclassificationOfDeferredCost" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical" xlink:title="presentationLink" xlink:type="extended"/>
        <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="ecd_AllIndividualsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_JAndyCorleyMember" xlink:label="rxst_JAndyCorleyMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RonKurtzMDMember" xlink:label="rxst_RonKurtzMDMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IlyaGoldshlegerMember" xlink:label="rxst_IlyaGoldshlegerMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EricWeinbergMember" xlink:label="rxst_EricWeinbergMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_JulieAndrewsMember" xlink:label="rxst_JulieAndrewsMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="rxst_JAndyCorleyMember" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="rxst_RonKurtzMDMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="rxst_IlyaGoldshlegerMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="rxst_EricWeinbergMember" order="5.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="rxst_JulieAndrewsMember" order="6.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestment" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestmentsAbstract" xlink:label="us-gaap_ShortTermInvestmentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermInvestmentsAbstract" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureInventories" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoan" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiability" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityDescriptionTextBlock" xlink:label="us-gaap_OptionIndexedToIssuersEquityDescriptionTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_OptionIndexedToIssuersEquityDescriptionTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureConvertiblePreferredStockAndStockholdersDeficit" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpense" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeases" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LiquidityAndFinancialPositionPolicyTextBlock" xlink:label="rxst_LiquidityAndFinancialPositionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SignificantAccountingPoliciesPolicyTextBlock" xlink:label="rxst_SignificantAccountingPoliciesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShortTermInvestmentsPolicyTextBlock" xlink:label="rxst_ShortTermInvestmentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="rxst_LiquidityAndFinancialPositionPolicyTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="rxst_SignificantAccountingPoliciesPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="rxst_ShortTermInvestmentsPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ReceivablesPolicyTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" xlink:label="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestmentsAbstract" xlink:label="us-gaap_ShortTermInvestmentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermInvestmentsAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureInventoriesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanTableTextblock" xlink:label="rxst_ScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanTableTextblock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="rxst_ScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanTableTextblock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureConvertiblePreferredStockAndStockholdersDeficitTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPreferredUnitsTextBlock" xlink:label="us-gaap_ScheduleOfPreferredUnitsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesReservedForFutureIssuanceTableTextBlock" xlink:label="rxst_SharesReservedForFutureIssuanceTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfPreferredUnitsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="rxst_SharesReservedForFutureIssuanceTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:label="rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeasesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SummaryOfLeaseBalancesTableTextBlock" xlink:label="rxst_SummaryOfLeaseBalancesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:label="rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="rxst_SummaryOfLeaseBalancesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NumberOfWhollyOwnedSubsidiaries" xlink:label="rxst_NumberOfWhollyOwnedSubsidiaries"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShelfRegistrationStatementMember" xlink:label="rxst_ShelfRegistrationStatementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockTransactionDate" xlink:label="us-gaap_SaleOfStockTransactionDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AdditionalNumberOfCommonSharesIssued" xlink:label="rxst_AdditionalNumberOfCommonSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_OperatingIncomeLoss1" xlink:label="rxst_OperatingIncomeLoss1"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted" xlink:label="rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockOfferingCosts" xlink:label="rxst_CommonStockOfferingCosts"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="rxst_NumberOfWhollyOwnedSubsidiaries" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="rxst_ShelfRegistrationStatementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockTransactionDate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="rxst_AdditionalNumberOfCommonSharesIssued" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="rxst_OperatingIncomeLoss1" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="rxst_CommonStockOfferingCosts" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NoCustomerMember" xlink:label="rxst_NoCustomerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AccountsReceivablePercentage" xlink:label="rxst_AccountsReceivablePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="rxst_NoCustomerMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_AccountsReceivablePercentage" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_MajorCustomersAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_StockOptionsIssuedAndOutstandingUnderPlansMember" xlink:label="rxst_StockOptionsIssuedAndOutstandingUnderPlansMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EarningsPerShareTable" xlink:label="rxst_EarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EarningsPerShareLineItems" xlink:label="rxst_EarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="rxst_StockOptionsIssuedAndOutstandingUnderPlansMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rxst_EarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rxst_EarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="rxst_EarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rxst_EarningsPerShareTable" xlink:to="rxst_EarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LDDMember" xlink:label="rxst_LDDMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueAbstract" xlink:label="us-gaap_DisaggregationOfRevenueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RxlalMember" xlink:label="rxst_RxlalMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ServiceWarrantyServiceContractsAndAccessoriesMember" xlink:label="rxst_ServiceWarrantyServiceContractsAndAccessoriesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="rxst_LDDMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="rxst_RxlalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="rxst_ServiceWarrantyServiceContractsAndAccessoriesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureSummaryOfAccountingPoliciesScheduleOfDeferredRevenueActivityDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueAbstract" xlink:label="us-gaap_DeferredRevenueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_DeferredRevenue1" xlink:label="rxst_DeferredRevenue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueAdditions" xlink:label="us-gaap_DeferredRevenueAdditions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueRevenueRecognized1" xlink:label="us-gaap_DeferredRevenueRevenueRecognized1"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_DeferredRevenue1" xlink:label="rxst_DeferredRevenue1_3"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract" xlink:to="rxst_DeferredRevenue1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract" xlink:to="us-gaap_DeferredRevenueAdditions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract" xlink:to="us-gaap_DeferredRevenueRevenueRecognized1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract" xlink:to="rxst_DeferredRevenue1_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestmentsAbstract" xlink:label="us-gaap_ShortTermInvestmentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermInvestmentsAbstract" xlink:to="us-gaap_ScheduleOfShortTermDebtTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ShortTermDebtLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_InvestmentMaturityPeriod" xlink:label="rxst_InvestmentMaturityPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestmentsAbstract" xlink:label="us-gaap_ShortTermInvestmentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="rxst_InvestmentMaturityPeriod" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermInvestmentsAbstract" xlink:to="us-gaap_ScheduleOfShortTermDebtTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_InvestmentTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ShortTermDebtLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryFinishedGoods" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryRawMaterials" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryWorkInProcess" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryGross" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryValuationReserves" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryNet" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:label="us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ConvertiblePreferredStockWarrantLiabilityMember" xlink:label="rxst_ConvertiblePreferredStockWarrantLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TermLoanMember" xlink:label="rxst_TermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="us-gaap_CertificatesOfDepositMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockWarrantLiabilityMember" xlink:label="rxst_CommonStockWarrantLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestBearingDepositsMember" xlink:label="us-gaap_InterestBearingDepositsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember" xlink:label="rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="rxst_ConvertiblePreferredStockWarrantLiabilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CommercialPaperMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="rxst_TermLoanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CertificatesOfDepositMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="rxst_CommonStockWarrantLiabilityMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_InterestBearingDepositsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="us-gaap_SeriesHPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_WarrantsToPurchaseConvertiblePreferredStock" xlink:label="rxst_WarrantsToPurchaseConvertiblePreferredStock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesHPreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="rxst_WarrantsToPurchaseConvertiblePreferredStock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueForWarrantLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExerciseOfPreferredStockWarrants" xlink:label="rxst_ExerciseOfPreferredStockWarrants"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExpirationOfCommonStockWarrants" xlink:label="rxst_ExpirationOfCommonStockWarrants"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_GainLossFromChangesInFairValueOfCommonStockWarrant" xlink:label="rxst_GainLossFromChangesInFairValueOfCommonStockWarrant"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_GainLossFromChangesInFairValueOfPreferredStockWarrants" xlink:label="rxst_GainLossFromChangesInFairValueOfPreferredStockWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="rxst_ExerciseOfPreferredStockWarrants" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="rxst_ExpirationOfCommonStockWarrants" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="rxst_GainLossFromChangesInFairValueOfCommonStockWarrant" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="rxst_GainLossFromChangesInFairValueOfPreferredStockWarrants" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TermLoanMember" xlink:label="rxst_TermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis" xlink:label="us-gaap_AwardDateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain" xlink:label="us-gaap_AwardDateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AtmOfferingMember" xlink:label="rxst_AtmOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AugustFourTwoThousandTwentyThreeMember" xlink:label="rxst_AugustFourTwoThousandTwentyThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AmendedTermLoanMember" xlink:label="rxst_AmendedTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AdditionalBorrowingAmount" xlink:label="rxst_AdditionalBorrowingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_MayThreeTwoThousandTwentyTwoTermLoanMember" xlink:label="rxst_MayThreeTwoThousandTwentyTwoTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtDescription" xlink:label="us-gaap_LongTermDebtDescription"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NewLoanAndSecurityAgreementMember" xlink:label="rxst_NewLoanAndSecurityAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtDescription" xlink:label="us-gaap_ShortTermDebtDescription"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_InterestRateOnBorrowingsTermLoan" xlink:label="rxst_InterestRateOnBorrowingsTermLoan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableUnamortizedLoanFeeCost" xlink:label="us-gaap_FinancingReceivableUnamortizedLoanFeeCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarlyRepaymentOfSeniorDebt" xlink:label="us-gaap_EarlyRepaymentOfSeniorDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForFees" xlink:label="us-gaap_PaymentsForFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLoanOriginations1" xlink:label="us-gaap_ProceedsFromLoanOriginations1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansReceivableDescriptionOfVariableRateBasis" xlink:label="us-gaap_LoansReceivableDescriptionOfVariableRateBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCallDateLatest" xlink:label="us-gaap_DebtInstrumentCallDateLatest"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_DebtInstrumentFinalPaymentFeeRate" xlink:label="rxst_DebtInstrumentFinalPaymentFeeRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_DebtInstrumentClosingCost" xlink:label="rxst_DebtInstrumentClosingCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EffectiveInterestRateOnBorrowingsTermLoan" xlink:label="rxst_EffectiveInterestRateOnBorrowingsTermLoan"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_DebtFromCashReserves" xlink:label="rxst_DebtFromCashReserves"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="rxst_TermLoanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="rxst_AtmOfferingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateDomain" xlink:to="rxst_AugustFourTwoThousandTwentyThreeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="rxst_AmendedTermLoanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="rxst_AdditionalBorrowingAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="rxst_MayThreeTwoThousandTwentyTwoTermLoanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtDescription" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_AwardDateAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="rxst_NewLoanAndSecurityAgreementMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShortTermDebtDescription" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="rxst_InterestRateOnBorrowingsTermLoan" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_FinancingReceivableUnamortizedLoanFeeCost" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfDebt" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_EarlyRepaymentOfSeniorDebt" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestPaidNet" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentsForFees" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromLoanOriginations1" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LoansReceivableDescriptionOfVariableRateBasis" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCallDateLatest" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="rxst_DebtInstrumentFinalPaymentFeeRate" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="rxst_DebtInstrumentClosingCost" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="rxst_EffectiveInterestRateOnBorrowingsTermLoan" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="rxst_DebtFromCashReserves" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureTermLoanScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CashInterestPaidPercentagePeriod" xlink:label="rxst_CashInterestPaidPercentagePeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="rxst_CashInterestPaidPercentagePeriod" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebt" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvotingCommonStockMember" xlink:label="us-gaap_NonvotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_WarrantsIssuedToPurchaseCommonStock" xlink:label="rxst_WarrantsIssuedToPurchaseCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SeriesWCommonStockMember" xlink:label="rxst_SeriesWCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration" xlink:label="rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharePurchaseAgreementMember" xlink:label="rxst_SharePurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SeriesGCommonStockMember" xlink:label="rxst_SeriesGCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExercisePriceOfWarrants" xlink:label="rxst_ExercisePriceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EscrowHoldbackOfExercisePriceOfWarrants" xlink:label="rxst_EscrowHoldbackOfExercisePriceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants" xlink:label="rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones" xlink:label="rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_PotentialAggregatePaymentsForRegulatoryMilestones" xlink:label="rxst_PotentialAggregatePaymentsForRegulatoryMilestones"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_GainOnExpirationOfWarrants" xlink:label="rxst_GainOnExpirationOfWarrants"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_NonvotingCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_WarrantsIssuedToPurchaseCommonStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="rxst_SeriesWCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="rxst_SharePurchaseAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="rxst_SeriesGCommonStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_ExercisePriceOfWarrants" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_EscrowHoldbackOfExercisePriceOfWarrants" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_PotentialAggregatePaymentsForRegulatoryMilestones" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_GainOnExpirationOfWarrants" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockTransactionDate" xlink:label="us-gaap_SaleOfStockTransactionDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="us-gaap_SeriesDPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="us-gaap_SeriesEPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesFPreferredStockMember" xlink:label="us-gaap_SeriesFPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesGPreferredStockMember" xlink:label="us-gaap_SeriesGPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="us-gaap_SeriesHPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SaleOfStockTransactionDate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesDPreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesEPreferredStockMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesFPreferredStockMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesGPreferredStockMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesHPreferredStockMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockVotingRights" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_PreferredStockWarrantsMember" xlink:label="rxst_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockWarrantMember" xlink:label="rxst_CommonStockWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TwoThousandSixAndTwoThousandFifteenPlansMember" xlink:label="rxst_TwoThousandSixAndTwoThousandFifteenPlansMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="rxst_PreferredStockWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="rxst_CommonStockWarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="rxst_TwoThousandSixAndTwoThousandFifteenPlansMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" xlink:label="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AtmOfferingMember" xlink:label="rxst_AtmOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ExecutiveOfficerMember" xlink:label="srt_ExecutiveOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_The2021PlanMember" xlink:label="rxst_The2021PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NonEmployeeDirectorsMember" xlink:label="rxst_NonEmployeeDirectorsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_The2015PlanMember" xlink:label="rxst_The2015PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExecutiveOfficersAndNonEmployeeDirectorsMember" xlink:label="rxst_ExecutiveOfficersAndNonEmployeeDirectorsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_The2021EsppPlanMember" xlink:label="rxst_The2021EsppPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="rxst_AtmOfferingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ExecutiveOfficerMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_The2021PlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="rxst_NonEmployeeDirectorsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_The2015PlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="rxst_ExecutiveOfficersAndNonEmployeeDirectorsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_The2021EsppPlanMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" xlink:label="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_9"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_9" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" xlink:label="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember" xlink:label="rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FutureMember" xlink:label="us-gaap_FutureMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesAvailableForFutureIssuanceUnderTheEquityPlansMember" xlink:label="rxst_SharesAvailableForFutureIssuanceUnderTheEquityPlansMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_The2021EsppPlanMember" xlink:label="rxst_The2021EsppPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesAvailableForFutureIssuanceUnder2021EsppMember" xlink:label="rxst_SharesAvailableForFutureIssuanceUnder2021EsppMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember" xlink:label="rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member" xlink:label="rxst_SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_FutureMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_SharesAvailableForFutureIssuanceUnderTheEquityPlansMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="rxst_The2021EsppPlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_SharesAvailableForFutureIssuanceUnder2021EsppMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceParentheticalDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NumberOfLeases" xlink:label="rxst_NumberOfLeases"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_BmlManagementLlcMember" xlink:label="rxst_BmlManagementLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_OfficeManufacturingAndWarehouseFacilityMember" xlink:label="rxst_OfficeManufacturingAndWarehouseFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_OneTwentyFiveColumbiaLeaseMember" xlink:label="rxst_OneTwentyFiveColumbiaLeaseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA" xlink:label="stpr_CA"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CliffordDDownsMember" xlink:label="rxst_CliffordDDownsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IndustrialCommercialMember" xlink:label="rxst_IndustrialCommercialMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperationsCommencedDate1" xlink:label="us-gaap_OperationsCommencedDate1"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AccurideInternationalIncMember" xlink:label="rxst_AccurideInternationalIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OfficeBuildingMember" xlink:label="srt_OfficeBuildingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturingFacilityMember" xlink:label="us-gaap_ManufacturingFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_WarehouseMember" xlink:label="srt_WarehouseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:label="us-gaap_PaymentsForProceedsFromTenantAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeaseTermOfContract" xlink:label="us-gaap_LessorOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingSubleaseOptionToTerminate" xlink:label="us-gaap_LesseeOperatingSubleaseOptionToTerminate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:label="us-gaap_OperatingLeasesRentExpenseSubleaseRentals1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="rxst_NumberOfLeases" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="rxst_BmlManagementLlcMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="rxst_OfficeManufacturingAndWarehouseFacilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="rxst_OneTwentyFiveColumbiaLeaseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_CA" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_CounterpartyNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="rxst_CliffordDDownsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="rxst_IndustrialCommercialMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperationsCommencedDate1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="rxst_AccurideInternationalIncMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="srt_OfficeBuildingMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_StatementGeographicalAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ManufacturingFacilityMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_RangeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="srt_WarehouseMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PaymentsForProceedsFromTenantAllowance" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LessorOperatingLeaseTermOfContract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_SubleaseIncome" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingSubleaseOptionToTerminate" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TotalLeaseAssets" xlink:label="rxst_TotalLeaseAssets"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TotalLeaseLiabilities" xlink:label="rxst_TotalLeaseLiabilities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LiabilitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="rxst_TotalLeaseAssets" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="rxst_TotalLeaseLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_FinanceLeaseInterestExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiability" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_WeightedAverageRemainingLeaseTermAbstract" xlink:label="rxst_WeightedAverageRemainingLeaseTermAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_WeightedAverageDiscountRateAbstract" xlink:label="rxst_WeightedAverageDiscountRateAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="rxst_WeightedAverageRemainingLeaseTermAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rxst_WeightedAverageDiscountRateAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rxst_WeightedAverageRemainingLeaseTermAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="rxst_WeightedAverageDiscountRateAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rxst_WeightedAverageDiscountRateAbstract" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="rxst_WeightedAverageRemainingLeaseTermAbstract" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_LetterOfCreditMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LegalFees" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfShortTermDebtTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_LossContingenciesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LinesOfCreditCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_June2023LsaRepaymentMember" xlink:label="rxst_June2023LsaRepaymentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AtmOfferingMember" xlink:label="rxst_AtmOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForFees" xlink:label="us-gaap_PaymentsForFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="rxst_June2023LsaRepaymentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_RepaymentsOfDebt" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="rxst_AtmOfferingMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_InterestPaidNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PaymentsForFees" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LongTermWarrantLiability" xlink:label="rxst_LongTermWarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_WarrantLiability" xlink:label="rxst_WarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LeaseLiabilitiesNoncurrent" xlink:label="rxst_LeaseLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LeaseLiabilitiesCurrent" xlink:label="rxst_LeaseLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:label="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="rxst_LongTermWarrantLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingencies" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="rxst_WarrantLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="rxst_LeaseLiabilitiesNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="rxst_LeaseLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryAdjustments" xlink:label="us-gaap_InventoryAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleCommonStockMember" xlink:label="us-gaap_ConvertibleCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SeriesGCommonStockMember" xlink:label="rxst_SeriesGCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SeriesWCommonStockMember" xlink:label="rxst_SeriesWCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockNoParValue" xlink:label="us-gaap_PreferredStockNoParValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryAdjustments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertibleCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rxst_SeriesGCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rxst_SeriesWCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockNoParValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesGPreferredStockMember" xlink:label="us-gaap_SeriesGPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RedeemableCommonStockMember" xlink:label="rxst_RedeemableCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesGPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rxst_RedeemableCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestAndOtherIncome" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GrossProfit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RedeemableCommonStockMember" xlink:label="rxst_RedeemableCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TemporaryEquityNoteReceivablesCommonStockIssued" xlink:label="rxst_TemporaryEquityNoteReceivablesCommonStockIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NotesReceivableForRedeemableCommonStockIssuedMember" xlink:label="rxst_NotesReceivableForRedeemableCommonStockIssuedMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NotesReceivableForCommonStockIssuedMember" xlink:label="rxst_NotesReceivableForCommonStockIssuedMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RedeemableStockOptionsMember" xlink:label="rxst_RedeemableStockOptionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" xlink:label="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares" xlink:label="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount" xlink:label="rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesRedeemedForEmployeeTaxWithholdings" xlink:label="rxst_SharesRedeemedForEmployeeTaxWithholdings"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings" xlink:label="rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount" xlink:label="rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount" xlink:label="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare" xlink:label="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare" xlink:label="rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfNotesReceivable" xlink:label="us-gaap_ProceedsFromSaleOfNotesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ConversionOfNotesReceivablesToTreasuryStockShares" xlink:label="rxst_ConversionOfNotesReceivablesToTreasuryStockShares"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockInExchangeForCancellationOfNotesReceivables" xlink:label="rxst_CommonStockInExchangeForCancellationOfNotesReceivables"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount" xlink:label="rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ConversionOfNotesReceivablesToTreasuryStock" xlink:label="rxst_ConversionOfNotesReceivablesToTreasuryStock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice" xlink:label="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares" xlink:label="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="us-gaap_ConversionOfStockAmountConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AccretionToRedemptionValueOfRedeemableStockOptions" xlink:label="rxst_AccretionToRedemptionValueOfRedeemableStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AccretionToRedemptionValueOfRedeemableStock" xlink:label="rxst_AccretionToRedemptionValueOfRedeemableStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued" xlink:label="rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares" xlink:label="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions" xlink:label="rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rxst_RedeemableCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_TemporaryEquityNoteReceivablesCommonStockIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rxst_NotesReceivableForRedeemableCommonStockIssuedMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="rxst_NotesReceivableForCommonStockIssuedMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rxst_RedeemableStockOptionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_SharesRedeemedForEmployeeTaxWithholdings" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromSaleOfNotesReceivable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ConversionOfNotesReceivablesToTreasuryStockShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_CommonStockInExchangeForCancellationOfNotesReceivables" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ConversionOfNotesReceivablesToTreasuryStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConversionOfStockAmountConverted1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_AccretionToRedemptionValueOfRedeemableStockOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="33" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_AccretionToRedemptionValueOfRedeemableStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="34" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="35" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="36" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="37" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="38" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="39" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="40" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="ecd_AllIndividualsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_JAndyCorleyMember" xlink:label="rxst_JAndyCorleyMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RonKurtzMDMember" xlink:label="rxst_RonKurtzMDMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IlyaGoldshlegerMember" xlink:label="rxst_IlyaGoldshlegerMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EricWeinbergMember" xlink:label="rxst_EricWeinbergMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_JulieAndrewsMember" xlink:label="rxst_JulieAndrewsMember"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="rxst_JAndyCorleyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="rxst_RonKurtzMDMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="rxst_IlyaGoldshlegerMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="rxst_EricWeinbergMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="rxst_JulieAndrewsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NumberOfWhollyOwnedSubsidiaries" xlink:label="rxst_NumberOfWhollyOwnedSubsidiaries"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShelfRegistrationStatementMember" xlink:label="rxst_ShelfRegistrationStatementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockTransactionDate" xlink:label="us-gaap_SaleOfStockTransactionDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AdditionalNumberOfCommonSharesIssued" xlink:label="rxst_AdditionalNumberOfCommonSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_OperatingIncomeLoss1" xlink:label="rxst_OperatingIncomeLoss1"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted" xlink:label="rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockOfferingCosts" xlink:label="rxst_CommonStockOfferingCosts"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="rxst_NumberOfWhollyOwnedSubsidiaries" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="rxst_ShelfRegistrationStatementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_NumberOfReportableSegments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockTransactionDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="rxst_AdditionalNumberOfCommonSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="rxst_OperatingIncomeLoss1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="rxst_CommonStockOfferingCosts" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NoCustomerMember" xlink:label="rxst_NoCustomerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AccountsReceivablePercentage" xlink:label="rxst_AccountsReceivablePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="rxst_NoCustomerMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="rxst_AccountsReceivablePercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_MajorCustomersAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails">
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EarningsPerShareLineItems" xlink:label="rxst_EarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EarningsPerShareTable" xlink:label="rxst_EarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_StockOptionsIssuedAndOutstandingUnderPlansMember" xlink:label="rxst_StockOptionsIssuedAndOutstandingUnderPlansMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rxst_EarningsPerShareLineItems" xlink:to="rxst_EarningsPerShareTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="rxst_StockOptionsIssuedAndOutstandingUnderPlansMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rxst_EarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rxst_EarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LDDMember" xlink:label="rxst_LDDMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RxlalMember" xlink:label="rxst_RxlalMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ServiceWarrantyServiceContractsAndAccessoriesMember" xlink:label="rxst_ServiceWarrantyServiceContractsAndAccessoriesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="rxst_LDDMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="rxst_RxlalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="rxst_ServiceWarrantyServiceContractsAndAccessoriesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ScheduleOfShortTermDebtTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_InvestmentMaturityPeriod" xlink:label="rxst_InvestmentMaturityPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ScheduleOfShortTermDebtTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="rxst_InvestmentMaturityPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_InvestmentTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ConvertiblePreferredStockWarrantLiabilityMember" xlink:label="rxst_ConvertiblePreferredStockWarrantLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TermLoanMember" xlink:label="rxst_TermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="us-gaap_CertificatesOfDepositMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockWarrantLiabilityMember" xlink:label="rxst_CommonStockWarrantLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestBearingDepositsMember" xlink:label="us-gaap_InterestBearingDepositsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember" xlink:label="rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="rxst_ConvertiblePreferredStockWarrantLiabilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="rxst_TermLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CertificatesOfDepositMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="rxst_CommonStockWarrantLiabilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_InterestBearingDepositsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:label="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="us-gaap_SeriesHPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_WarrantsToPurchaseConvertiblePreferredStock" xlink:label="rxst_WarrantsToPurchaseConvertiblePreferredStock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesHPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="rxst_WarrantsToPurchaseConvertiblePreferredStock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TermLoanMember" xlink:label="rxst_TermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis" xlink:label="us-gaap_AwardDateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain" xlink:label="us-gaap_AwardDateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain" xlink:label="us-gaap_AwardDateDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AtmOfferingMember" xlink:label="rxst_AtmOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AugustFourTwoThousandTwentyThreeMember" xlink:label="rxst_AugustFourTwoThousandTwentyThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AmendedTermLoanMember" xlink:label="rxst_AmendedTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AdditionalBorrowingAmount" xlink:label="rxst_AdditionalBorrowingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_MayThreeTwoThousandTwentyTwoTermLoanMember" xlink:label="rxst_MayThreeTwoThousandTwentyTwoTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtDescription" xlink:label="us-gaap_LongTermDebtDescription"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NewLoanAndSecurityAgreementMember" xlink:label="rxst_NewLoanAndSecurityAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtDescription" xlink:label="us-gaap_ShortTermDebtDescription"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_InterestRateOnBorrowingsTermLoan" xlink:label="rxst_InterestRateOnBorrowingsTermLoan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableUnamortizedLoanFeeCost" xlink:label="us-gaap_FinancingReceivableUnamortizedLoanFeeCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarlyRepaymentOfSeniorDebt" xlink:label="us-gaap_EarlyRepaymentOfSeniorDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForFees" xlink:label="us-gaap_PaymentsForFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLoanOriginations1" xlink:label="us-gaap_ProceedsFromLoanOriginations1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansReceivableDescriptionOfVariableRateBasis" xlink:label="us-gaap_LoansReceivableDescriptionOfVariableRateBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCallDateLatest" xlink:label="us-gaap_DebtInstrumentCallDateLatest"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_DebtInstrumentFinalPaymentFeeRate" xlink:label="rxst_DebtInstrumentFinalPaymentFeeRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_DebtInstrumentClosingCost" xlink:label="rxst_DebtInstrumentClosingCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EffectiveInterestRateOnBorrowingsTermLoan" xlink:label="rxst_EffectiveInterestRateOnBorrowingsTermLoan"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_DebtFromCashReserves" xlink:label="rxst_DebtFromCashReserves"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="rxst_TermLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="rxst_AtmOfferingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AwardDateDomain" xlink:to="rxst_AugustFourTwoThousandTwentyThreeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="rxst_AmendedTermLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="rxst_AdditionalBorrowingAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="rxst_MayThreeTwoThousandTwentyTwoTermLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_AwardDateAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="rxst_NewLoanAndSecurityAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShortTermDebtDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="rxst_InterestRateOnBorrowingsTermLoan" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_FinancingReceivableUnamortizedLoanFeeCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_EarlyRepaymentOfSeniorDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestPaidNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentsForFees" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromLoanOriginations1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LoansReceivableDescriptionOfVariableRateBasis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCallDateLatest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="rxst_DebtInstrumentFinalPaymentFeeRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="rxst_DebtInstrumentClosingCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromLinesOfCredit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="rxst_EffectiveInterestRateOnBorrowingsTermLoan" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="rxst_DebtFromCashReserves" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvotingCommonStockMember" xlink:label="us-gaap_NonvotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_WarrantsIssuedToPurchaseCommonStock" xlink:label="rxst_WarrantsIssuedToPurchaseCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SeriesWCommonStockMember" xlink:label="rxst_SeriesWCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration" xlink:label="rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharePurchaseAgreementMember" xlink:label="rxst_SharePurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SeriesGCommonStockMember" xlink:label="rxst_SeriesGCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExercisePriceOfWarrants" xlink:label="rxst_ExercisePriceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_EscrowHoldbackOfExercisePriceOfWarrants" xlink:label="rxst_EscrowHoldbackOfExercisePriceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants" xlink:label="rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones" xlink:label="rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_PotentialAggregatePaymentsForRegulatoryMilestones" xlink:label="rxst_PotentialAggregatePaymentsForRegulatoryMilestones"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_GainOnExpirationOfWarrants" xlink:label="rxst_GainOnExpirationOfWarrants"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_NonvotingCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_WarrantsIssuedToPurchaseCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="rxst_SeriesWCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="rxst_SharePurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="rxst_SeriesGCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_ExercisePriceOfWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_EscrowHoldbackOfExercisePriceOfWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_PotentialAggregatePaymentsForRegulatoryMilestones" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="rxst_GainOnExpirationOfWarrants" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockTransactionDate" xlink:label="us-gaap_SaleOfStockTransactionDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="us-gaap_SeriesDPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="us-gaap_SeriesEPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesFPreferredStockMember" xlink:label="us-gaap_SeriesFPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesGPreferredStockMember" xlink:label="us-gaap_SeriesGPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="us-gaap_SeriesHPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SaleOfStockTransactionDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesDPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesEPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesFPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesGPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesHPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockVotingRights" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TwoThousandSixAndTwoThousandFifteenPlansMember" xlink:label="rxst_TwoThousandSixAndTwoThousandFifteenPlansMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_PreferredStockWarrantsMember" xlink:label="rxst_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CommonStockWarrantMember" xlink:label="rxst_CommonStockWarrantMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="rxst_TwoThousandSixAndTwoThousandFifteenPlansMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="rxst_PreferredStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="rxst_CommonStockWarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" xlink:label="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AtmOfferingMember" xlink:label="rxst_AtmOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ExecutiveOfficerMember" xlink:label="srt_ExecutiveOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_The2021PlanMember" xlink:label="rxst_The2021PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NonEmployeeDirectorsMember" xlink:label="rxst_NonEmployeeDirectorsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_The2015PlanMember" xlink:label="rxst_The2015PlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ExecutiveOfficersAndNonEmployeeDirectorsMember" xlink:label="rxst_ExecutiveOfficersAndNonEmployeeDirectorsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_The2021EsppPlanMember" xlink:label="rxst_The2021EsppPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="rxst_AtmOfferingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ExecutiveOfficerMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_The2021PlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="rxst_NonEmployeeDirectorsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_The2015PlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="rxst_ExecutiveOfficersAndNonEmployeeDirectorsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_The2021EsppPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" xlink:label="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" xlink:label="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:label="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember" xlink:label="rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FutureMember" xlink:label="us-gaap_FutureMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesAvailableForFutureIssuanceUnderTheEquityPlansMember" xlink:label="rxst_SharesAvailableForFutureIssuanceUnderTheEquityPlansMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_The2021EsppPlanMember" xlink:label="rxst_The2021EsppPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesAvailableForFutureIssuanceUnder2021EsppMember" xlink:label="rxst_SharesAvailableForFutureIssuanceUnder2021EsppMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember" xlink:label="rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member" xlink:label="rxst_SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_FutureMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_SharesAvailableForFutureIssuanceUnderTheEquityPlansMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="rxst_The2021EsppPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_SharesAvailableForFutureIssuanceUnder2021EsppMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="rxst_SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_NumberOfLeases" xlink:label="rxst_NumberOfLeases"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_BmlManagementLlcMember" xlink:label="rxst_BmlManagementLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_OfficeManufacturingAndWarehouseFacilityMember" xlink:label="rxst_OfficeManufacturingAndWarehouseFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_OneTwentyFiveColumbiaLeaseMember" xlink:label="rxst_OneTwentyFiveColumbiaLeaseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA" xlink:label="stpr_CA"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_CliffordDDownsMember" xlink:label="rxst_CliffordDDownsMember"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_IndustrialCommercialMember" xlink:label="rxst_IndustrialCommercialMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperationsCommencedDate1" xlink:label="us-gaap_OperationsCommencedDate1"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AccurideInternationalIncMember" xlink:label="rxst_AccurideInternationalIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OfficeBuildingMember" xlink:label="srt_OfficeBuildingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturingFacilityMember" xlink:label="us-gaap_ManufacturingFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_WarehouseMember" xlink:label="srt_WarehouseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:label="us-gaap_PaymentsForProceedsFromTenantAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeaseTermOfContract" xlink:label="us-gaap_LessorOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingSubleaseOptionToTerminate" xlink:label="us-gaap_LesseeOperatingSubleaseOptionToTerminate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:label="us-gaap_OperatingLeasesRentExpenseSubleaseRentals1"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="rxst_NumberOfLeases" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="rxst_BmlManagementLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="rxst_OfficeManufacturingAndWarehouseFacilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="rxst_OneTwentyFiveColumbiaLeaseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_CA" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="rxst_CliffordDDownsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="rxst_IndustrialCommercialMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LeaseContractualTermAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperationsCommencedDate1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="rxst_AccurideInternationalIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="srt_OfficeBuildingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LeaseExpirationDate1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ManufacturingFacilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="srt_WarehouseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PaymentsForProceedsFromTenantAllowance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LessorOperatingLeaseTermOfContract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_SubleaseIncome" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingSubleaseOptionToTerminate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_FinanceLeaseInterestExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ScheduleOfShortTermDebtTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_LetterOfCreditMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LegalFees" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LinesOfCreditCurrent" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_June2023LsaRepaymentMember" xlink:label="rxst_June2023LsaRepaymentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_AtmOfferingMember" xlink:label="rxst_AtmOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForFees" xlink:label="us-gaap_PaymentsForFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="rxst_June2023LsaRepaymentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_RepaymentsOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="rxst_AtmOfferingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_InterestPaidNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PaymentsForFees" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LeaseLiabilitiesCurrent" xlink:label="rxst_LeaseLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LeaseLiabilitiesNoncurrent" xlink:label="rxst_LeaseLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="rxst_LeaseLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="rxst_LeaseLiabilitiesNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
        </link:definitionLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="rxst_LongTermWarrantLiability" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="rxst_WarrantLiability" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCashNoncurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="rxst_LeaseLiabilitiesNoncurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="rxst_LeaseLiabilitiesCurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermDebt" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="6" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LongTermWarrantLiability" xlink:label="rxst_LongTermWarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_WarrantLiability" xlink:label="rxst_WarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LeaseLiabilitiesNoncurrent" xlink:label="rxst_LeaseLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:label="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_LeaseLiabilitiesCurrent" xlink:label="rxst_LeaseLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiability" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InterestExpense" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InterestAndOtherIncome" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="3" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="rxst_RepaymentOfTermLoan" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromNotesPayable" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="4" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="5" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="6" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_FinanceLeasePrincipalPayments" order="8" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InventoryWriteDown" order="9" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="9" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="10" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="11" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="12" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="13" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="14" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_RepaymentOfTermLoan" xlink:label="rxst_RepaymentOfTermLoan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings" xlink:label="rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation" xlink:label="rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="us-gaap_FinanceLeasePrincipalPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryFinishedGoods" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryRawMaterials" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryValuationReserves" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryWorkInProcess" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="4" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="rxst_TotalLeaseAssets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="rxst_TotalLeaseLiabilities" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="rxst_TotalLeaseAssets" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="rxst_TotalLeaseLiabilities" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="rxst_TotalLeaseLiabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="rxst_TotalLeaseLiabilities" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="3" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TotalLeaseAssets" xlink:label="rxst_TotalLeaseAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="rxst-20240630.xsd#rxst_TotalLeaseLiabilities" xlink:label="rxst_TotalLeaseLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="6" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
        </link:calculationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="rxst_TotalLeaseAssets" name="TotalLeaseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions" name="ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_LongTermWarrantLiability" name="LongTermWarrantLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_The2015PlanMember" name="The2015PlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" name="RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_DebtFromCashReserves" name="DebtFromCashReserves" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_DebtInstrumentFinalPaymentFeeRate" name="DebtInstrumentFinalPaymentFeeRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares" name="ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember" name="StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_NewLoanAndSecurityAgreementMember" name="NewLoanAndSecurityAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount" name="SharesIssuedForTheEmployeeStockPurchasePlanAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="rxst_SeriesGCommonStockMember" name="SeriesGCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_AtmOfferingMember" name="AtmOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_WarrantsToPurchaseConvertiblePreferredStock" name="WarrantsToPurchaseConvertiblePreferredStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="rxst_CliffordDDownsMember" name="CliffordDDownsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract" name="LeaseObligationsRecordedForRightOfUseAssetsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_RxlalMember" name="RxlalMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_ExerciseOfPreferredStockWarrants" name="ExerciseOfPreferredStockWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare" name="IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_JAndyCorleyMember" name="JAndyCorleyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_ShortTermInvestmentsPolicyTextBlock" name="ShortTermInvestmentsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_SignificantAccountingPoliciesPolicyTextBlock" name="SignificantAccountingPoliciesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_DeferredOfferingCostsIncludedInAccruedExpenses" name="DeferredOfferingCostsIncludedInAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_GainLossFromChangesInFairValueOfCommonStockWarrant" name="GainLossFromChangesInFairValueOfCommonStockWarrant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_AdditionalBorrowingAmount" name="AdditionalBorrowingAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_GainOnExpirationOfWarrants" name="GainOnExpirationOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_FinanceLeaseObligationsIncurred" name="FinanceLeaseObligationsIncurred" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_SharesAvailableForFutureIssuanceUnderTheEquityPlansMember" name="SharesAvailableForFutureIssuanceUnderTheEquityPlansMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_MayThreeTwoThousandTwentyTwoTermLoanMember" name="MayThreeTwoThousandTwentyTwoTermLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_SharePurchaseAgreementMember" name="SharePurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_AugustFourTwoThousandTwentyThreeMember" name="AugustFourTwoThousandTwentyThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount" name="IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="rxst_SharesAvailableForFutureIssuanceUnder2021EsppMember" name="SharesAvailableForFutureIssuanceUnder2021EsppMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_TwoThousandSixAndTwoThousandFifteenPlansMember" name="TwoThousandSixAndTwoThousandFifteenPlansMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_PreferredStockWarrantsMember" name="PreferredStockWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_CommonStockOfferingCosts" name="CommonStockOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="rxst_OperatingIncomeLoss1" name="OperatingIncomeLoss1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForNonCashExercise" name="ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForNonCashExercise" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_CommonStockAfterReclassificationOfRedeemableCommonStockShares" name="CommonStockAfterReclassificationOfRedeemableCommonStockShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" name="SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_LDDMember" name="LDDMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_ReclassificationOfRedeemableCommonStockToCommonStockOptionsAssumedInNonCashInvestingOrFinancingActivity" name="ReclassificationOfRedeemableCommonStockToCommonStockOptionsAssumedInNonCashInvestingOrFinancingActivity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_RedeemableStockOptionsMember" name="RedeemableStockOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings" name="ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="rxst_WarrantsIssuedToPurchaseCommonStock" name="WarrantsIssuedToPurchaseCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_ReclassificationOfDeferredCost" name="ReclassificationOfDeferredCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_TemporaryEquityNoteReceivablesCommonStockIssued" name="TemporaryEquityNoteReceivablesCommonStockIssued" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued" name="ChangeInNotesReceivableForRedeemableCommonStockIssued" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_AccurideInternationalIncMember" name="AccurideInternationalIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember" name="SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_IlyaGoldshlegerMember" name="IlyaGoldshlegerMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_NoCustomerMember" name="NoCustomerMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation" name="PaymentsForEmployeeTaxesRelatedToStockCompensation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="rxst_StockOptionsIssuedAndOutstandingUnderPlansMember" name="StockOptionsIssuedAndOutstandingUnderPlansMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForWarrantsExercised" name="ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForWarrantsExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_The2021EsppPlanMember" name="The2021EsppPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_InterestRateOnBorrowingsTermLoan" name="InterestRateOnBorrowingsTermLoan" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_EarningsPerShareTable" name="EarningsPerShareTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_GainLossFromChangesInFairValueOfPreferredStockWarrants" name="GainLossFromChangesInFairValueOfPreferredStockWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_NumberOfLeases" name="NumberOfLeases" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount" name="SharesRedeemedForEmployeeTaxWithHoldingsAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings" name="ValueOfSharesRedeemedForEmployeeTaxWithholdings" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_WeightedAverageDiscountRateAbstract" name="WeightedAverageDiscountRateAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_IndustrialCommercialMember" name="IndustrialCommercialMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_TermLoanMember" name="TermLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_ExpirationOfCommonStockWarrants" name="ExpirationOfCommonStockWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="rxst_AmountOfSettlementOfFractionalShares" name="AmountOfSettlementOfFractionalShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" name="SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_JulieAndrewsMember" name="JulieAndrewsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones" name="PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted" name="CommonStockSaleUnderwritingDiscountsAndCommissionDeducted" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="rxst_NotesReceivableForCommonStockIssuedMember" name="NotesReceivableForCommonStockIssuedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_BmlManagementLlcMember" name="BmlManagementLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_NonEmployeeDirectorsMember" name="NonEmployeeDirectorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_ShelfRegistrationStatementMember" name="ShelfRegistrationStatementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" name="ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_PotentialAggregatePaymentsForRegulatoryMilestones" name="PotentialAggregatePaymentsForRegulatoryMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_TotalLeaseLiabilities" name="TotalLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_RonKurtzMDMember" name="RonKurtzMDMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_AccretionToRedemptionValueOfRedeemableStockOptions" name="AccretionToRedemptionValueOfRedeemableStockOptions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_EffectiveInterestRateOnBorrowingsTermLoan" name="EffectiveInterestRateOnBorrowingsTermLoan" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_ConvertiblePreferredStockWarrantLiabilityMember" name="ConvertiblePreferredStockWarrantLiabilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount" name="CommonStockInExchangeForCancellationOfNotesReceivablesAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_EricWeinbergMember" name="EricWeinbergMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_EscrowHoldbackOfExercisePriceOfWarrants" name="EscrowHoldbackOfExercisePriceOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_SharesReservedForFutureIssuanceTableTextBlock" name="SharesReservedForFutureIssuanceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_LiquidityAndFinancialPositionPolicyTextBlock" name="LiquidityAndFinancialPositionPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_CommonStockInExchangeForCancellationOfNotesReceivables" name="CommonStockInExchangeForCancellationOfNotesReceivables" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_ExercisePriceOfWarrants" name="ExercisePriceOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares" name="SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_OperatingLeaseObligationsIncurred" name="OperatingLeaseObligationsIncurred" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering" name="ConversionOfPreferredStockToCommonStockUponInitialPublicOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_OfficeManufacturingAndWarehouseFacilityMember" name="OfficeManufacturingAndWarehouseFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock" name="ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_AdditionalNumberOfCommonSharesIssued" name="AdditionalNumberOfCommonSharesIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice" name="ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_CommonStockWarrantLiabilityMember" name="CommonStockWarrantLiabilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_DebtInstrumentClosingCost" name="DebtInstrumentClosingCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="rxst_RepaymentOfTermLoan" name="RepaymentOfTermLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_EarningsPerShareLineItems" name="EarningsPerShareLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_AccountsReceivablePercentage" name="AccountsReceivablePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_AccretionToRedemptionValueOfRedeemableStock" name="AccretionToRedemptionValueOfRedeemableStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember" name="RedeemableConvertiblePreferredStockWarrantLiabilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_SummaryOfLeaseBalancesTableTextBlock" name="SummaryOfLeaseBalancesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_InterestPaidOnFinancingLeases" name="InterestPaidOnFinancingLeases" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_ExecutiveOfficersAndNonEmployeeDirectorsMember" name="ExecutiveOfficersAndNonEmployeeDirectorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_OneTwentyFiveColumbiaLeaseMember" name="OneTwentyFiveColumbiaLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_WeightedAverageRemainingLeaseTermAbstract" name="WeightedAverageRemainingLeaseTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_ConversionOfNotesReceivablesToTreasuryStock" name="ConversionOfNotesReceivablesToTreasuryStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_NumberOfWhollyOwnedSubsidiaries" name="NumberOfWhollyOwnedSubsidiaries" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member" name="SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare" name="IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares" name="ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_ConversionOfNotesReceivablesToTreasuryStockShares" name="ConversionOfNotesReceivablesToTreasuryStockShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_LeaseLiabilitiesNoncurrent" name="LeaseLiabilitiesNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration" name="AdditionalNonRefundablePaymentUponExtensionOfExpiration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_CommonStockWarrantMember" name="CommonStockWarrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_June2023LsaRepaymentMember" name="June2023LsaRepaymentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_InterestPaidOnTermLoan" name="InterestPaidOnTermLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_RedeemableCommonStockReclassifiedShares" name="RedeemableCommonStockReclassifiedShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_AmendedTermLoanMember" name="AmendedTermLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_CashInterestPaidPercentagePeriod" name="CashInterestPaidPercentagePeriod" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_ServiceWarrantyServiceContractsAndAccessoriesMember" name="ServiceWarrantyServiceContractsAndAccessoriesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants" name="ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_InvestmentMaturityPeriod" name="InvestmentMaturityPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_ReclassificationOfSharesOfRedeemableCommonStockToCommonStockAssumedInNonCashInvestingOrFinancingActivity" name="ReclassificationOfSharesOfRedeemableCommonStockToCommonStockAssumedInNonCashInvestingOrFinancingActivity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_NotesReceivableForRedeemableCommonStockIssuedMember" name="NotesReceivableForRedeemableCommonStockIssuedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" name="CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_LeaseLiabilitiesCurrent" name="LeaseLiabilitiesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_ScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanTableTextblock" name="ScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanTableTextblock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_DeferredRevenue1" name="DeferredRevenue1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_SharesRedeemedForEmployeeTaxWithholdings" name="SharesRedeemedForEmployeeTaxWithholdings" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="rxst_WarrantLiability" name="WarrantLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="rxst_RedeemableCommonStockMember" name="RedeemableCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_The2021PlanMember" name="The2021PlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="rxst_SeriesWCommonStockMember" name="SeriesWCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948162774944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RxSIGHT, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001111485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3268801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">001-40690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 Columbia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Aliso Viejo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">521-7830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RXST<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,682,804<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948162557744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 24,445<span></span>
</td>
<td class="nump">$ 9,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">208,839<span></span>
</td>
<td class="nump">117,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">25,723<span></span>
</td>
<td class="nump">20,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">19,443<span></span>
</td>
<td class="nump">17,421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">2,773<span></span>
</td>
<td class="nump">3,523<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">281,223<span></span>
</td>
<td class="nump">168,407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,444<span></span>
</td>
<td class="nump">10,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating leases right-of-use assets</a></td>
<td class="nump">10,818<span></span>
</td>
<td class="nump">2,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">711<span></span>
</td>
<td class="nump">711<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">305,499<span></span>
</td>
<td class="nump">182,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">5,095<span></span>
</td>
<td class="nump">3,863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">13,787<span></span>
</td>
<td class="nump">15,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_LeaseLiabilitiesCurrent', window );">Lease liabilities</a></td>
<td class="nump">736<span></span>
</td>
<td class="nump">1,801<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">19,618<span></span>
</td>
<td class="nump">20,903<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_LeaseLiabilitiesNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">10,674<span></span>
</td>
<td class="nump">1,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">30,292<span></span>
</td>
<td class="nump">22,188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 9)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, 900,000,000 shares authorized, 39,617,334 shares issued and outstanding as of June 30, 2024 and 36,139,513 shares issued and outstanding as of December 31, 2023</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">885,104<span></span>
</td>
<td class="nump">754,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(118)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(609,819)<span></span>
</td>
<td class="num">(594,640)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' deficit</a></td>
<td class="nump">275,207<span></span>
</td>
<td class="nump">160,362<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 305,499<span></span>
</td>
<td class="nump">$ 182,550<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_LeaseLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease liabilities current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_LeaseLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_LeaseLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease liabilities noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_LeaseLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948161727408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">900,000,000<span></span>
</td>
<td class="nump">900,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="nump">39,617,334<span></span>
</td>
<td class="nump">36,139,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="nump">39,617,334<span></span>
</td>
<td class="nump">36,139,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948163036064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Income Loss (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 34,887<span></span>
</td>
<td class="nump">$ 20,810<span></span>
</td>
<td class="nump">$ 64,399<span></span>
</td>
<td class="nump">$ 38,299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">10,637<span></span>
</td>
<td class="nump">8,795<span></span>
</td>
<td class="nump">19,464<span></span>
</td>
<td class="nump">15,919<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">24,250<span></span>
</td>
<td class="nump">12,015<span></span>
</td>
<td class="nump">44,935<span></span>
</td>
<td class="nump">22,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">24,292<span></span>
</td>
<td class="nump">18,239<span></span>
</td>
<td class="nump">47,616<span></span>
</td>
<td class="nump">34,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">8,291<span></span>
</td>
<td class="nump">7,401<span></span>
</td>
<td class="nump">16,322<span></span>
</td>
<td class="nump">14,608<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">32,583<span></span>
</td>
<td class="nump">25,640<span></span>
</td>
<td class="nump">63,938<span></span>
</td>
<td class="nump">49,100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(8,333)<span></span>
</td>
<td class="num">(13,625)<span></span>
</td>
<td class="num">(19,003)<span></span>
</td>
<td class="num">(26,720)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense), net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1,568)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(3,075)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest and other income</a></td>
<td class="nump">2,276<span></span>
</td>
<td class="nump">1,777<span></span>
</td>
<td class="nump">3,860<span></span>
</td>
<td class="nump">3,168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(362)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(362)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(6,063)<span></span>
</td>
<td class="num">(13,778)<span></span>
</td>
<td class="num">(15,154)<span></span>
</td>
<td class="num">(26,989)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(6,079)<span></span>
</td>
<td class="num">(13,804)<span></span>
</td>
<td class="num">(15,179)<span></span>
</td>
<td class="num">(27,016)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive (loss) income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss)on short-term investments</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="num">(109)<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation (loss) gain</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive (loss) income</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (6,144)<span></span>
</td>
<td class="num">$ (13,868)<span></span>
</td>
<td class="num">$ (15,292)<span></span>
</td>
<td class="num">$ (26,994)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Attributable to common stock, basic</a></td>
<td class="num">$ (0.16)<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="num">$ (0.82)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Attributable to common stock, diluted</a></td>
<td class="num">$ (0.16)<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="num">$ (0.82)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares used in computing net loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Attributable to common stock, basic</a></td>
<td class="nump">38,455,955<span></span>
</td>
<td class="nump">34,498,265<span></span>
</td>
<td class="nump">37,649,521<span></span>
</td>
<td class="nump">33,075,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Attributable to common stock, diluted</a></td>
<td class="nump">38,455,955<span></span>
</td>
<td class="nump">34,498,265<span></span>
</td>
<td class="nump">37,649,521<span></span>
</td>
<td class="nump">33,075,585<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948163902544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2022</a></td>
<td class="nump">$ 89,902<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 636,001<span></span>
</td>
<td class="num">$ (95)<span></span>
</td>
<td class="num">$ (546,032)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,268,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount', window );">Shares issued for the exercise of stock options and vesting of restricted stock units, Amount</a></td>
<td class="nump">761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares', window );">Shares issued for the exercise of stock options and vesting of restricted stock units, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount', window );">Shares redeemed for employee tax withholdings, Amount</a></td>
<td class="num">(337)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(337)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SharesRedeemedForEmployeeTaxWithholdings', window );">Shares redeemed for employee tax withholdings, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">3,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Amount</a></td>
<td class="nump">53,600<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">53,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount', window );">Issuance of common stock for at-the-market offerings, net of issuance costs, Amount</a></td>
<td class="nump">10,914<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">10,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare', window );">Issuance of common stock for at-the-market offerings, net of issuance costs, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 879,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized loss on short-term investments and cash equivalents, net of tax</a></td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(13,212)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,212)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Ending Balance, Amount at Mar. 31, 2023</a></td>
<td class="nump">145,009<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">704,228<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(559,244)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' Equity, Ending Balance, Shares at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,966,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2022</a></td>
<td class="nump">89,902<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">636,001<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="num">(546,032)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,268,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized loss on short-term investments and cash equivalents, net of tax</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(27,016)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2023</a></td>
<td class="nump">157,188<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">730,274<span></span>
</td>
<td class="num">(73)<span></span>
</td>
<td class="num">(573,048)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,168,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Beginning Balance, Amount at Mar. 31, 2023</a></td>
<td class="nump">145,009<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">704,228<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(559,244)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' Equity, Beginning Balance, Shares at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,966,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount', window );">Shares issued for the exercise of stock options and vesting of restricted stock units, Amount</a></td>
<td class="nump">2,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares', window );">Shares issued for the exercise of stock options and vesting of restricted stock units, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">3,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount', window );">Shares issued for the employee stock purchase plan, Amount</a></td>
<td class="nump">536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued for the employee stock purchase plan, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">834,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount', window );">Issuance of common stock for at-the-market offerings, net of issuance costs, Amount</a></td>
<td class="nump">18,957<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">18,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized loss on short-term investments and cash equivalents, net of tax</a></td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(13,804)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,804)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2023</a></td>
<td class="nump">157,188<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">730,274<span></span>
</td>
<td class="num">(73)<span></span>
</td>
<td class="num">(573,048)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,168,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2023</a></td>
<td class="nump">$ 160,362<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">754,971<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(594,640)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2023</a></td>
<td class="nump">36,139,513<span></span>
</td>
<td class="nump">36,139,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount', window );">Shares issued for the exercise of stock options and vesting of restricted stock units, Amount</a></td>
<td class="nump">$ 10,153<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">10,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares', window );">Shares issued for the exercise of stock options and vesting of restricted stock units, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,061,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount', window );">Shares redeemed for employee tax withholdings, Amount</a></td>
<td class="num">(2,134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SharesRedeemedForEmployeeTaxWithholdings', window );">Shares redeemed for employee tax withholdings, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39,096)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">4,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized loss on short-term investments and cash equivalents, net of tax</a></td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(9,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,100)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Ending Balance, Amount at Mar. 31, 2024</a></td>
<td class="nump">163,929<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">767,685<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(603,740)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' Equity, Ending Balance, Shares at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,161,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2023</a></td>
<td class="nump">$ 160,362<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">754,971<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(594,640)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2023</a></td>
<td class="nump">36,139,513<span></span>
</td>
<td class="nump">36,139,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="nump">1,258,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized loss on short-term investments and cash equivalents, net of tax</a></td>
<td class="num">$ (109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(15,179)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2024</a></td>
<td class="nump">$ 275,207<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">885,104<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="num">(609,819)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2024</a></td>
<td class="nump">39,617,334<span></span>
</td>
<td class="nump">39,617,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Beginning Balance, Amount at Mar. 31, 2024</a></td>
<td class="nump">$ 163,929<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">767,685<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(603,740)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' Equity, Beginning Balance, Shares at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,161,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount', window );">Shares issued for the exercise of stock options and vesting of restricted stock units, Amount</a></td>
<td class="nump">3,103<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">3,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares', window );">Shares issued for the exercise of stock options and vesting of restricted stock units, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">363,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">6,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount', window );">Shares issued for the employee stock purchase plan, Amount</a></td>
<td class="nump">737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued for the employee stock purchase plan, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Amount</a></td>
<td class="nump">107,477<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">107,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,053,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized loss on short-term investments and cash equivalents, net of tax</a></td>
<td class="num">(64)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(6,079)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,079)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2024</a></td>
<td class="nump">$ 275,207<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 885,104<span></span>
</td>
<td class="num">$ (118)<span></span>
</td>
<td class="num">$ (609,819)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2024</a></td>
<td class="nump">39,617,334<span></span>
</td>
<td class="nump">39,617,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in at-the-market offerings, net of issuance costs, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in at-the-market offerings, net of issuance costs, Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued for the employee stock purchase plan, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued for the exercise of stock options and vesting of restricted stock units, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued for the exercise of stock options and vesting of restricted stock units</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Redeemed For Employee Tax With Holdings, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_SharesRedeemedForEmployeeTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares redeemed for employee tax withholdings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_SharesRedeemedForEmployeeTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948162819456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (15,179)<span></span>
</td>
<td class="num">$ (27,016)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,927<span></span>
</td>
<td class="nump">1,944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use lease assets</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance costs and premium</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of discount on short-term investments</a></td>
<td class="num">(3,578)<span></span>
</td>
<td class="num">(2,953)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">10,801<span></span>
</td>
<td class="nump">7,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Provision for excess and obsolete inventory</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(5,441)<span></span>
</td>
<td class="num">(2,338)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(2,189)<span></span>
</td>
<td class="num">(3,124)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and other assets</a></td>
<td class="nump">673<span></span>
</td>
<td class="nump">868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">789<span></span>
</td>
<td class="nump">1,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(1,339)<span></span>
</td>
<td class="num">(2,009)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(13,336)<span></span>
</td>
<td class="num">(25,310)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(3,490)<span></span>
</td>
<td class="num">(2,570)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments', window );">Maturities of short-term investments</a></td>
<td class="nump">119,000<span></span>
</td>
<td class="nump">115,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchases of short-term investments</a></td>
<td class="num">(206,881)<span></span>
</td>
<td class="num">(156,400)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(91,371)<span></span>
</td>
<td class="num">(43,970)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_RepaymentOfTermLoan', window );">Repayment of term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(40,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of common stock from public offering</a></td>
<td class="nump">108,100<span></span>
</td>
<td class="nump">54,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings', window );">Proceeds from issuance of common stock from at-the-market offerings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">30,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">13,993<span></span>
</td>
<td class="nump">3,896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation', window );">Payments for employee taxes related to stock compensation</a></td>
<td class="num">(2,133)<span></span>
</td>
<td class="num">(337)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Principal payments on finance lease liabilities</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of deferred offering costs</a></td>
<td class="num">(377)<span></span>
</td>
<td class="num">(602)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt issuance costs</a></td>
<td class="num">(80)<span></span>
</td>
<td class="num">(1,225)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">119,465<span></span>
</td>
<td class="nump">66,196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign exchange rate on cash, cash equivalents and restricted cash</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">14,754<span></span>
</td>
<td class="num">(3,081)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash - beginning of period</a></td>
<td class="nump">10,402<span></span>
</td>
<td class="nump">12,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash - end of period</a></td>
<td class="nump">25,156<span></span>
</td>
<td class="nump">9,514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">1,128<span></span>
</td>
<td class="nump">1,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_InterestPaidOnFinancingLeases', window );">Cash paid for interest on financing leases</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_InterestPaidOnTermLoan', window );">Cash paid for interest on term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract', window );"><strong>Right-of-use assets obtained in exchange for lease obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease</a></td>
<td class="nump">9,060<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance lease</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract', window );"><strong>Lease obligations recorded for right-of-use assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_OperatingLeaseObligationsIncurred', window );">Operating lease</a></td>
<td class="nump">9,060<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_FinanceLeaseObligationsIncurred', window );">Finance lease</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Acquisition of property and equipment included in accounts payable and accrued expenses and other current liabilities</a></td>
<td class="nump">229<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_DeferredOfferingCostsIncludedInAccruedExpenses', window );">Deferred offering costs included in accounts payable and accrued liabilities</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_ReclassificationOfDeferredCost', window );">Reclassification of deferred financing costs</a></td>
<td class="num">$ (768)<span></span>
</td>
<td class="num">$ (1,075)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_DeferredOfferingCostsIncludedInAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred offering costs included in accrued expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_DeferredOfferingCostsIncludedInAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_FinanceLeaseObligationsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Obligations Incurred</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_FinanceLeaseObligationsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_InterestPaidOnFinancingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest paid on financing leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_InterestPaidOnFinancingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_InterestPaidOnTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest paid on term loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_InterestPaidOnTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease obligations recorded for right-of-use assets abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_OperatingLeaseObligationsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease obligations incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_OperatingLeaseObligationsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for employee taxes related to stock compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of common stock in at-the-market offerings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_ReclassificationOfDeferredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification Of Deferred Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_ReclassificationOfDeferredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_RepaymentOfTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayment of term loan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_RepaymentOfTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-use assets obtained in exchange for lease obligations abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingActivitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales, maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948162203168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (6,079)<span></span>
</td>
<td class="num">$ (9,100)<span></span>
</td>
<td class="num">$ (13,804)<span></span>
</td>
<td class="num">$ (13,212)<span></span>
</td>
<td class="num">$ (15,179)<span></span>
</td>
<td class="num">$ (27,016)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948165277600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Rule 10b5-1 Trading Arrangements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">May 15, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">J. Andy Corley</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, a member of our </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Board of Directors</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">,  entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rule 10b5-1</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> trading arrangement that is intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c) (a &#8220;Rule 10b5-1 Trading Plan&#8221;) for the sale of securities of our common stock. Mr. Corley&#8217;s Rule 10b5-1 Trading Plan, which has a term from August 19, 2024 to May 20, 2025, provides for the sale of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">40,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock at a pre-determined limit price.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">May 21, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Ron Kurtz M.D</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">., </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Chief Executive Officer and President and a member of our Board of Directors</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rule 10b5-1</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Trading Plan for the sale of securities of our common stock. Dr. Kurtz&#8217;s Rule 10b5-1 Trading Plan, which has a term from August 20, 2024 to August 15, 2025, provides for the sale of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">180,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock pursuant to a series of market orders at pre-determined limit prices.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 3, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Ilya Goldshleger</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, Ph.D., </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Co-President and Chief Operating Officer</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rule 10b5-1</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Trading Plan for the sale of securities of our common stock. Dr. Goldshleger&#8217;s Rule 10b5-1 Trading Plan, which has a term from September 16, 2024 to September 15, 2025, provides for the exercise and sale </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of options for</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">295,529</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock pursuant to a series of market orders at pre-determined limit prices</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 7, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Eric Weinberg</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">., </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Co-President and Chief Commercial Officer</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rule 10b5-1</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Trading Plan for the sale of securities of our common stock. Mr. Weinberg&#8217;s Rule 10b5-1 Trading Plan, which has a term from September 9, 2024 to September 9, 2025, provides for the sale of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">100,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock pursuant to a series of market orders at pre-determined limit prices.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 12, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">,  </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Julie Andrews</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">member of our Board of Directors</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rule 10b5-1</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Trading Plan for the sale of securities of our common stock. Ms. Andrews&#8217; Rule 10b5-1 Trading Plan, which has a term from June 14, 2024 to March 20, 2025, provides for the sale of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15,625</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock at a pre-determined limit price.</span></p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=rxst_JAndyCorleyMember', window );">J. Andy Corley [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">J. Andy Corley<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Board of Directors<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">May 15, 2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">274 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=rxst_RonKurtzMDMember', window );">Ron Kurtz M.D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Ron Kurtz M.D<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Chief Executive Officer and President and a member of our Board of Directors<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">May 21, 2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">360 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=rxst_IlyaGoldshlegerMember', window );">Ilya Goldshleger [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Ilya Goldshleger<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Co-President and Chief Operating Officer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">June 3, 2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">364 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">295,529<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=rxst_EricWeinbergMember', window );">Eric Weinberg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Eric Weinberg<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Co-President and Chief Commercial Officer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">June 7, 2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">365 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=rxst_JulieAndrewsMember', window );">Julie Andrews [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Julie Andrews<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">member of our Board of Directors<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">March 12, 2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">279 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">15,625<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=rxst_JAndyCorleyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=rxst_JAndyCorleyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=rxst_RonKurtzMDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=rxst_RonKurtzMDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=rxst_IlyaGoldshlegerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=rxst_IlyaGoldshlegerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=rxst_EricWeinbergMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=rxst_EricWeinbergMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=rxst_JulieAndrewsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=rxst_JulieAndrewsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948164174320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Basis of Presentation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 1 - Organization and Basis of Presentation</span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Description of Business</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RxSight&#174;, Inc. (the &#8220;Company&#8221;) is a Delaware corporation headquartered in Aliso Viejo, California with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> wholly owned subsidiary located in Amsterdam, Netherlands (&#8220;RxSight, B.V.&#8221;).  RxSight, B.V. has a registered branch in the United Kingdom and a wholly owned subsidiary located in Germany (&#8220;RxSight GmbH&#8221;).  The Company is engaged in the research and development, manufacture and sale of light adjustable intraocular lenses used in cataract surgery along with capital equipment used with the lenses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s products, which include the light adjustable lens&#174; (&#8220;LAL&#153;&#8221; and &#8220;LAL+&#153;&#8221;, and collectively the &#8220;LAL&#8221;) and a specially designed machine for delivering light to the eye, the Light Delivery Device (&#8220;LDD&#153;&#8221;), are approved by the United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) primarily for sale in the U.S. and have regulatory approval in the U.S., Europe, Canada and Mexico. The Company began marketing its products in 2019. The LAL is a premium intraocular lens (&#8220;IOL&#8221;) which is partially reimbursable under Medicare. The Company competes with other IOLs in the premium market.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying unaudited condensed consolidated financial statements include the accounts of RxSight, Inc. and its wholly owned subsidiaries, RxSight, B.V. and RxSight GmbH. All significant inter-company balances and transactions have been eliminated in consolidation.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and pursuant to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements. The unaudited interim financial statements reflect all adjustments which, in the opinion of management, are necessary for a fair statement of the results for the periods presented. All such adjustments are of a normal and recurring nature.  The December 31, 2023 balance sheet data was derived from audited financial statements; however, the accompanying notes to the condensed consolidated financial statements do not include all of the annual disclosures required under GAAP and should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2023 Annual Report on Form 10-K filed with the SEC on February 28, 2024. The operating results presented in these unaudited condensed consolidated financial statements are not necessarily indicative of the results that may be expected for any future periods.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Operating Segments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company determined its operating segment on the same basis that it uses to evaluate its performance internally. The Company&#8217;s chief operating decision-maker (&#8220;CODM&#8221;), its Chief Executive Officer, reviews its consolidated operating results for the purpose of allocating resources and evaluating financial performance.  The Company determined that it operates and manages its business (including its non-U.S. subsidiaries) in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> reportable segment: the research and development, manufacture and sale of light adjustable lenses and related capital equipment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Liquidity</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Shelf Registration Statement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On May 8, 2024, the Company filed an automatic shelf registration statement on Form S-3 (&#8220;shelf registration statement&#8221;). The shelf registration statement is effective for three years and permits the Company to sell, from time to time, common stock, preferred stock, debt securities, warrants, and/or units. The shelf registration statement is intended to provide the Company with flexibility to access additional capital.  At the time of filing the shelf registration statement, the Company also filed a prospectus supplement to sell up to an aggregate value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">115.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million dollars of common stock through a public offering (&#8220;Public Offering&#8221;).</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Public Offering</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">May 8, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company entered into an underwriting agreement with BofA Securities, Inc., in which the Company agreed to issue and sell </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,785,714</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company's common stock in a public offering, pursuant to the shelf registration statement. The shares of common stock were sold at a price to the public of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">56.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share. Under the terms of the underwriting agreement, the Company also granted the underwriters an option exercisable for 30 days from the date of the underwriting agreement to purchase up to an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">267,857</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock on the same terms and conditions.  The underwriters' option was exercised in full on May 10, 2024 and the Public Offering (inclusive of the underwriters' option shares) closed on May 13, 2024.  The Company received net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">107.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million from the Public Offering, after deducting underwriters' discounts and commissions of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">6.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and other offering expenses of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024 and December 31, 2023 the Company had cash, cash equivalents and short-term investments of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">233.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">127.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company began generating revenue from its principal operations in 2019. The Company has a limited operating history, and the revenue and income potential of the Company&#8217;s business and market are unproven. The Company has experienced recurring net losses and negative cash flows from operating activities since its inception. For the three months ended June 30, 2024 and 2023, the Company incurred losses from operations of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">13.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. For the six months ended June 30, 2024 and 2023, the Company incurred losses from operations of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;">19.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;">26.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.  Based on the Company&#8217;s anticipated sales growth in relation to the anticipated costs associated with, among other things, its continuing research and development activities and the expansion of its sales and marketing activities, the Company expects to continue to incur net operating losses into the foreseeable future. Successful transition to attaining profitable operations is dependent upon gaining market acceptance of the Company&#8217;s products and achieving a level of revenues adequate to support the Company&#8217;s cost structure.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company believes that existing cash resources will be sufficient to meet projected operating requirements for at least 12 months from the date of issuance of the accompanying condensed consolidated financial statements, however for the near future, the Company expects to continue to incur operating losses and negative cash flows. The Company plans to continue to fund its losses from operations using its cash, cash equivalents and short-term investments as of June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and meet its future capital funding needs through equity or debt financings, other third-party funding, collaborations, strategic alliances and licensing arrangements or a combination of these. If the Company raises additional funds by issuing equity securities, its stockholders may experience dilution. Any future debt financing into which the Company enters may impose additional covenants that restrict operations, including limitations on its ability to incur liens or additional debt, pay dividends, repurchase common stock, make certain investments or engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity raise may contain terms that are not favorable to the Company or its stockholders. If the Company is required to enter into collaborations and other arrangements to address its liquidity needs, it may have to give up certain rights that limit its ability to develop and commercialize product candidates or may have other terms that are not favorable to the Company or its stockholders, which could materially and adversely affect its business and financial prospects. There can be no assurance that the Company will be able to obtain additional financing on acceptable terms, or at all. If the Company is not able to secure adequate additional funding, the Company may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible and/or suspend or curtail planned programs. Any of these actions could materially harm the Company&#8217;s business, results of operations and future prospects.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948265248144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Accounting Policies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 2 - Summary of Accounting Policies</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">preparation of consolidated financial statements in conformity with GAAP requires management to make informed estimates, judgments and assumptions that affect the reported amounts in the condensed consolidated financial statements and disclosures in the accompanying notes as of the date of the accompanying condensed consolidated financial statements. On an on-going basis, management evaluates the most critical estimates and assumptions for continued reasonableness. Actual results may differ materially from the estimates used in the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">preparation </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of the accompanying condensed consolidated financial statements under different assumptions or conditions.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Significant Accounting Policies</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There have been no significant changes to the accounting policies during the three months ended June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, as compared to the significant accounting policies described in Note 2 of the &#8220;Notes to Consolidated Financial Statements&#8221; in the Company&#8217;s audited consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on February 28, 2024.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents consist of investments in money market accounts. The Company considers all highly liquid investments with original maturities of three months or less at the date of purchase that can be liquidated without prior notice or penalty to be cash equivalents.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Short-term Investments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Short-term investments are classified based on the maturity date of the related securities. Based on the nature of the assets, the Company&#8217;s short-term investments, which are government securities, are classified as available-for-sale and are recorded at their estimated fair value as determined by prices for identical or similar securities at the balance sheet date. The Company&#8217;s short-term investments consist of Level 2 financial instruments in the fair value hierarchy. Unrealized gains and losses are recorded as a component of Other Comprehensive Loss within Stockholders&#8217; Equity on the condensed consolidated balance sheets. Realized gains and losses are included as other income (expense) in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss. The cost basis for realized gains and losses on available-for-sale securities is determined on a specific identification basis. Management determines the appropriate classification of its investments at the time of purchase and reevaluates such determination at each balance sheet date. The Company periodically reviews its investments for unrealized losses other than credit losses and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In determining whether the carrying value is recoverable, management considers the following factors:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">whether the investment has been in a continuous loss position for over 12 months; </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the duration to maturity of investments; </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">intention and ability to hold the investment to maturity and if it is not more likely than not that the Company will be required to sell the investment before recovery of the amortized cost basis; </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the credit rating, financial condition and near-term prospects of the issuer; and </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the type of investments made. </span></div></div><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company had an unrealized loss of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">99,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of net unrealized gains related to short-term investments as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk and Other Risks and Uncertainties</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, short-term investments and accounts receivable. The Company&#8217;s policy is to invest cash in institutional money market funds and marketable securities of the U.S. government to limit the amount of credit exposure. The Company currently maintains a portfolio of cash equivalents and short-term investments in money market funds and U.S. treasury bills. A portion of the Company's operating cash is held in accounts in excess of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance limits; however, the Company has established guidelines regarding diversification of its investments and their maturities, which are designed to maintain principal and maximize liquidity. The Company has not experienced material losses on cash equivalents and short-term investments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s products require approval from the FDA and foreign regulatory agencies before commercial sales can commence. There can be no assurance that the Company&#8217;s products will receive any of these required</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">approvals. The denial or delay of such approvals may have a material adverse impact on the Company&#8217;s business and may impact business in the future. In addition, after approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the device approval process.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is subject to risks common to companies in the medical device industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of the Company's products, product liability and the need to obtain additional financing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is subject to the risks related to global lead times, particularly in Europe and Asia, leading to a supply interruption from the Company's suppliers. In addition, the Company is currently experiencing inflation and longer lead times and limited availability in its supply chain for certain components and has continued exposure to price and supply risk related to anticipated purchases of certain commodities, materials and products used in its business.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounts Receivable</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has a diverse customer base and as of June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the Company did not have any customers who individually accounted for greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of accounts receivable. The Company maintains an allowance for credit losses resulting from the inability of its customers, including ambulatory surgery centers, to make required payments. After evaluation of the collectability of accounts receivable, the Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">t record any significant allowance for credit losses as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 or December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p></div><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value of Financial Instruments</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company uses fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures.  Fair value is measured as the price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques that are consistent with the market, income or cost approach are used to measure fair value. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three levels:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 1&#8212;Observable inputs such as unadjusted quoted prices in active markets that are accessible at the measurement date for identical unrestricted assets or liabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 2&#8212;Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability, for substantially the full term of the asset or liability, through correlation with market data. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 3&#8212;One or more significant inputs that are unobservable and supported by little or no market activity and reflect the use of significant management judgment and assumptions. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques and significant management judgment or estimation. These include the Black-Scholes option-pricing model which uses inputs such as expected volatility, risk-free interest rate and expected term to determine fair market valuation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification at each reporting date. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the years presented.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s financial instruments consist principally of cash, cash equivalents, short-term investments, accounts receivable, accounts payable and operating lease liabilities. Cash, cash equivalents, accounts receivable and accounts payable are carried at their estimated fair value because of the short-term nature of these assets and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">liabilities. The Company&#8217;s short-term investments in government securities are carried at fair value, determined based on publicly available quoted market prices for identical securities at the measurement date. The Company believes the fair values of its operating lease liabilities at June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, approximated their carrying values, based on the borrowing rates that were available for loans with similar terms as of such date.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Inventories</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inventories consist of raw materials, work-in-process and finished goods. Raw materials are comprised of chemicals and parts used in the production of the Company's lenses, cartridges, and LDDs. Finished goods are comprised of lenses, cartridges, accessories and LDDs. Inventories are valued at the lower of cost or net realizable value. Cost is computed using standard cost, which approximates actual cost on a first-in, first-out basis. The carrying value of inventories is reviewed for potential impairment whenever indicators suggest that the cost of inventories exceeds the carrying value and management adjusts the inventories to its net realizable value. The cost of finished goods and work-in-process is comprised of raw materials, direct labor, other direct costs and related production overhead to the extent that these costs do not exceed the net realizable value of the goods produced. The Company periodically reviews inventories for potential impairment, estimated losses from obsolescence, material expirations or unmarketable inventories or excess inventories and writes down the cost of inventories to net realizable value at the time such determinations are made. Net realizable value is determined using the estimated selling price, in the ordinary course of business, less estimated costs to complete and dispose.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Leases</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lease right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term, and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized when the Company takes possession of the leased property (&#8220;Commencement Date&#8221;) based on the present value of lease payments over the lease term. The Company estimates the incremental borrowing rate based upon the cost of its own debt financing, current market interest rates and quoted offerings or the rate implicit in the lease. Operating lease right-of-use assets also include any lease payments made at or before lease commencement and exclude any lease incentives received. The lease terms used to calculate the right-of-use asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Rent expense on noncancelable leases containing known future scheduled rent increases is recorded on a straight-line basis over the term of the respective leases beginning on the Commencement Date. The difference between rent expense and rent paid is accounted for as a component of operating lease right-of-use assets on the accompanying condensed consolidated balance sheets. Landlord improvement allowances and other such lease incentives are recorded as property and equipment and as reduction of the right-of-use leased assets and are amortized on a straight-line basis as a reduction to operating lease costs. Leases with an initial term of 12 months or less are expensed as incurred and are not recorded as right-of-use assets on the condensed consolidated balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Net Loss per Share</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average shares of common stock outstanding for the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average shares of common stock and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock and potential dilutive securities outstanding during the period.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common stockholders because their impact under the treasury stock method was anti-dilutive for the periods presented:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:41.74%;"></td>
           <td style="width:1%;"></td>
           <td style="width:12.36%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:11.26%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:11.48%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:12.16%;"></td>
           <td style="width:1%;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock options issued and outstanding under the Calhoun Vision, Inc. 2006 Stock Plan, Calhoun Vision, Inc. 2015 Equity Incentive Plan and the 2021 Equity Incentive Plan</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,618,186</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,821,076</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,843,009</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,409,842</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Restricted stock units issued under the 2021 Equity Incentive Plan</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">666,573</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">773,940</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">544,320</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">671,956</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock issuable in offering period under the 2021 Employee Stock Purchase Plan</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">59,149</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39,568</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">61,085</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45,191</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></div></div><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s revenue is generated from the sale of LALs used in cataract surgery along with a specifically designed machine for delivering light to the eye, the LDD, to adjust the lens post-surgery, as needed. Revenue is recognized from sales of products in the U.S., Canada and Europe. Customers are primarily comprised of ambulatory surgery centers, hospitals, and physician private practices.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company recognizes revenues when promised goods or services are transferred to customers at a transaction price that reflects the consideration to which the Company expects to be entitled in exchange for those goods and services. Specifically, the Company applies the following five steps to recognize revenue: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when, or as, the Company satisfies a performance obligation. The Company applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. At contract inception, the Company assesses the goods promised within each customer contract to determine the individual deliverables in its product offerings as separate performance obligations and assesses whether each promised good or service is distinct. The transaction price is determined based on the consideration expected to be received, based either on the stated value in contractual arrangements or the estimated cash to be collected in non-contracted arrangements. The Company recognizes revenue as the amount of the transaction price that is allocated to the respective performance obligation when, or as, the performance obligation is satisfied, considering whether or not this occurs at a point in time or over time. The Company elected to account for shipping costs as fulfillment costs rather than a promised service and excludes from revenue any taxes collected from customers that are remitted to government authorities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s LDD contracts contain multiple performance obligations bundled for one transaction price, with all obligations generally satisfied within one year. For these bundled arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct, that is, if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company&#8217;s LDD contracts include a combination of the following performance obligations: (i) LDD capital asset and related components, (ii) training and (iii) device service (initial year). Each of these three performance obligations are considered distinct. The LDD capital asset is distinct because the customer can benefit from it together with other resources that are readily available to the customer.  Training on the use of the machine is offered as a distinct activity after installation of the LDD to enhance the customer&#8217;s ability to utilize the machine by having an industry professional provide best practices and customize training to the specific needs of the customer. Each LDD comes with a twelve-month manufacturer&#8217;s warranty (service-type) that includes preventative maintenance, unscheduled service (labor and parts) and software updates. After the first year, service contracts can be purchased separately on a standalone basis. The Company recognizes revenue as performance obligations are satisfied by transferring control of the product or service to a customer. Specifically, revenue for the LDD capital asset is recognized at a point in time at installation.  Revenue for training is also recorded at a point in time, generally 60 days after installation.  Revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">for the device service is recognized ratably over time after installation, generally 12 months. The Company has determined that the transaction price is the invoice price, net of adjustments, if any. The allocation to the separate performance obligations is based upon the relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. The Company estimates the standalone selling price using the market assessment approach considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services, geographies, type of customer and market conditions. The Company regularly reviews and updates standalone selling prices as necessary.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">LALs are generally held at customer sites on consignment. The single performance obligation is satisfied, and revenue from sales is recognized for LALs upon customer notification that the LALs have been implanted in a patient. For the three and six months ended June 30, 2024 and 2023, credits related to returns and rebates on list prices were not significant.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has adopted the practical expedient permitting the direct expensing of costs incurred to obtain contracts where the amortization of such costs would occur over one year or less, and it applied to substantially all the Company&#8217;s contracts. Revenue for service agreements is recognized ratably over the term of each contract.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2024 and 2023, revenue from contracts with customers consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:32.867%;"></td>
           <td style="width:1.259%;"></td>
           <td style="width:1%;"></td>
           <td style="width:16.054%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.259%;"></td>
           <td style="width:1%;"></td>
           <td style="width:11.775%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.259%;"></td>
           <td style="width:1%;"></td>
           <td style="width:13.135%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.259%;"></td>
           <td style="width:1%;"></td>
           <td style="width:13.135%;"></td>
           <td style="width:1%;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">LDD (including training)</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,189</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,720</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,902</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,195</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">LAL</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23,828</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,411</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43,745</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,806</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Service warranty, service contracts, and accessories</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">870</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">679</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,752</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,298</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34,887</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,810</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">64,399</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,299</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the three and six months ended June 30, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company did not have any customers who individually accounted for greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of revenue.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table represents the contract liabilities from sales activity for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">six months ended June 30, 2024 and 2023, respectively (in thousands):</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:51.661%;"></td>
           <td style="width:1.961%;"></td>
           <td style="width:1%;"></td>
           <td style="width:21.769%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.961%;"></td>
           <td style="width:1%;"></td>
           <td style="width:16.686999999999998%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.961%;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="text-indent:40pt;vertical-align:bottom;"><p style="margin-left:40pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at beginning of period</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,888</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,193</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;word-break:break-word;">
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Additions during the period</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,949</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,391</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Revenue recognized during the period</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,707</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,233</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;word-break:break-word;">
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at end of period</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,130</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,351</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></div></div><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has three equity incentive compensation plans: the Calhoun Vision, Inc. 2006 Stock Plan (&#8220;2006 Plan&#8221;); the Calhoun Vision, Inc. 2015 Equity Incentive Plan (&#8220;2015 Plan&#8221;); and the 2021 Equity Incentive Plan (&#8220;2021 Plan&#8221;), which are collectively referred to as the &#8220;Equity Plans.&#8221; The Company also has an employee stock purchase plan, the 2021 Employee Stock Purchase Plan (&#8220;2021 ESPP&#8221;).</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company recognizes compensation expense for equity-based awards on the date of grant to employees, board of directors and consultants based on the estimated grant date fair value of the award's Equity-based payments including stock options, restricted stock units and employee stock plan purchases. The fair value of the option awards are estimated using the Black-Scholes option-pricing model and recognized as an expense in the condensed consolidated statements of operations and comprehensive loss over the requisite service period, which is generally four years. The Company amortizes the stock-based compensation for equity awards with service conditions on a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">straight-line basis over the vesting period of the awards. Forfeitures of unvested stock option awards are recognized as reductions of expense as they occur.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Black-Scholes option-pricing model requires the use of assumptions about a number of variables, such as the fair market value of the Company&#8217;s common stock, expected volatility, expected term, risk-free interest rate, and dividend yield as discussed below:</span></p><p style="margin-left:30.95pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair market value</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;The fair value of common stock is determined by using the closing price per share of common stock as reported on the Nasdaq Global Market.</span></p><p style="margin-left:30.95pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Expected volatility</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;Effective January 1, 2024, the Company based the expected volatility on the historic volatility of its common stock. During the year ended December 31, 2023, the expected volatility was estimated based on the average historical volatilities for comparable publicly traded medical device companies over a period equal to the expected term of the stock option grants. Comparable companies were chosen based on their similar size, stage in the life cycle and area of specialty.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:30.95pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Expected term</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;The Company&#8217;s expected term represents the period that the Company&#8217;s stock-based awards are expected to be outstanding. The Company used the simplified method (based on the mid-point between the vesting date and the end of the contractual term) to determine the expected term.</span></p><p style="margin-left:30.6pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Risk-free interest rate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;The risk-free interest rate used is based on the published U.S. Department of Treasury interest rates in effect at the time of stock option grant for zero coupon U.S. Treasury notes with maturities approximating each grant&#8217;s expected term.</span></p><p style="margin-left:30.6pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Dividend yield</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of zero.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements</span></p></div><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Changes to GAAP are established by the Financial Accounting Standards Board (&#8220;FASB&#8221;) in the form of accounting standards updates (&#8220;ASU&#8221;). There have been no recent accounting pronouncements, changes in accounting pronouncements or recently adopted accounting guidance during the three months ended June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> that are of significance or potential significance to the Company.</span></span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948265250896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investment<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestmentsAbstract', window );"><strong>Short-Term Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Short-Term Investment</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 3 &#8211; Short-Term Investments</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Short-term investments, principally U.S. Treasury bills, are available-for-sale and consisted of the following (in thousands):</span></p><div style="font-size:10pt;font-family:Times New Roman;">
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.94%;"></td>
         <td style="width:2.24%;"></td>
         <td style="width:1%;"></td>
         <td style="width:16.459999999999997%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.24%;"></td>
         <td style="width:1%;"></td>
         <td style="width:22.259999999999998%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.24%;"></td>
         <td style="width:1%;"></td>
         <td style="width:22.619999999999997%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of June 30, 2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amortized Cost</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unrealized Loss, Net</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Estimated Fair Value</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Treasury securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,938</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">99</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,839</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.835%;"></td>
         <td style="width:2.24%;"></td>
         <td style="width:1%;"></td>
         <td style="width:16.397%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.599%;"></td>
         <td style="width:1%;"></td>
         <td style="width:22.156%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.24%;"></td>
         <td style="width:1%;"></td>
         <td style="width:22.535999999999998%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of December 31, 2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amortized Cost</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unrealized Gain, Net</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Estimated Fair Value</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Treasury securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117,480</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117,490</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All available-for-sale securities held as of June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> had a maturity of less than </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">one year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company has classified all marketable securities, regardless of maturity, as short-term investments based upon the Company&#8217;s ability and intent to use any and all of those marketable securities to satisfy the Company&#8217;s liquidity requirements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/940-320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph b<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948165376016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 4 &#8211; Inventories</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inventories consisted of the following (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:57.74%;"></td>
         <td style="width:1.76%;"></td>
         <td style="width:1%;"></td>
         <td style="width:14.200000000000001%;"></td>
         <td style="width:1%;"></td>
         <td style="width:5.16%;"></td>
         <td style="width:1%;"></td>
         <td style="width:14.200000000000001%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.94%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30,</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finished goods</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,327</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,092</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Raw materials</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,313</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,680</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Work-in-process</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,371</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,145</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,011</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,917</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less: reserve for excess and obsolete inventory</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">568</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">496</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19,443</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,421</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At June 30, 2024 and December 31, 2023, finished goods included </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of inventory held on consignment at customer sites, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948265234976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 5 &#8211; Fair Value Measurements</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The table and disclosures for the periods presented below (in thousands) present the Company&#8217;s assets and liabilities measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value. The Company did not have any assets or liabilities measured at fair value on a recurring basis within Level 3 fair value measurements.</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:33.22%;"></td>
         <td style="width:2.18%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.08%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.18%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.08%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.18%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.08%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of June 30, 2024</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level I</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level II</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets:</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Money market securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,986</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,986</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Treasury securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,839</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,839</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total assets at fair value</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,986</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,839</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">227,825</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:33.22%;"></td>
         <td style="width:2.18%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.08%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.18%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.08%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.18%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.08%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of December 31, 2023</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level I</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level II</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets:</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Money market securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,475</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,475</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Treasury securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117,490</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117,490</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total assets at fair value</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,475</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117,490</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">121,965</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948162067568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation Expense</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 6 &#8211; Stock-Based Compensation Expense</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has three equity incentive compensation plans: the 2006 Plan, the 2015 Plan and the 2021 Plan.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">2006 Plan</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The 2006 Plan was originally adopted by the Board and approved by the Company&#8217;s stockholders in 2006. The 2006 Plan was terminated in 2015 in connection with the adoption of the 2015 Plan and as a result no new awards may be issued under the 2006 Plan. However, the 2006 Plan will continue to govern the terms and conditions of the outstanding awards previously granted under the 2006 Plan.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">2015 Plan</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The 2015 Plan was originally adopted by the Board and approved by the Company&#8217;s stockholders in 2015. In July 2021, the 2015 Plan terminated immediately prior to effectiveness of the 2021 Plan with respect to the grant of future awards. However, the 2015 Plan will continue to govern the terms and conditions of the outstanding awards previously granted under the 2015 Plan.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">2021 Plan</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">July 28, 2021, the 2021 Plan was adopted and approved by the Board and stockholders prior to the IPO and became effective on the business day immediately prior to the effective date of the Company&#8217;s IPO registration</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">statement.  </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The 2021 Plan provides for the grant of incentive stock options to employees and any subsidiary corporations&#8217; employees, and for the grant of nonstatutory stock options, stock appreciation rights, restricted stock, restricted stock units (&#8220;RSUs&#8221;), and performance awards to employees, directors, and consultants and subsidiary corporations&#8217; employees and consultants.  The number of shares of the Company&#8217;s common stock originally available for issuance under the 2021 Plan was equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2,420,135</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock plus any shares subject to awards granted under the 2015 Plan and the 2006 Plan that, after the effectiveness of the 2021 Plan, expire or otherwise terminate without having been exercised in full, are tendered to or withheld by the Company for payment of an exercise price or for tax withholding obligations, or are forfeited to or repurchased by the Company due to failure to vest, with the maximum number of shares to be added to the 2021 Plan from the 2015 Plan and 2006 Plan equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4,569,530</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Evergreen provision</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The number of common shares reserved for issuance under the 2021 Plan will be increased automatically on the first day of each fiscal year beginning with the 2022 fiscal year and ending on the ten year anniversary of the date the Board approved the 2021 Plan, by a number equal to the least of: (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">7,260,406</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of our common stock; (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the outstanding shares of our common stock on the last day of the immediately preceding fiscal year; or (iii) such lesser number of shares of our common stock as the administrator may determine. The 2021 Plan is administered by the Board. On January 1, 2024 and 2023, the number of shares available under the 2021 Plan increased by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,445,580</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,130,735</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock, respectively pursuant to this feature.  As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024, the number of shares of the Company&#8217;s common stock available for future issuance under the 2021 Plan was equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">951,817</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">2021 ESPP</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On July 28, 2021, the Board and stockholders adopted and approved the 2021 ESPP. As of June 30, 2024, the number of shares of the Company&#8217;s common stock available for future issuance under the 2021 ESPP was equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">538,942</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The 2021 ESPP provides eligible employees of the Company and its subsidiaries with the opportunity to purchase shares of the Company&#8217;s common stock at a purchase price equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the common stock&#8217;s fair market value on the first trading day or last trading day of each purchase period, whichever is lower. The 2021 ESPP  provides for two six-month purchase periods every twelve months: May 1 through October 31 and November 1 through April 30. The initial purchase period began on November 1, 2021.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Evergreen provision</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The number of common shares reserved for issuance under the 2021 ESPP will be increased automatically on the first day of each fiscal year beginning with the 2022 fiscal year, by a number equal to the least of: (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,452,081</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares; (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the outstanding shares of our common stock on the last day of the immediately preceding fiscal year; or (iii) such other amount as the administrator may determine. The 2021 ESPP is administered by the Board.  No additional shares were reserved for issuance on January 1, 2024 and 2023 pursuant to this feature.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock-Based Compensation Expense</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The purpose of the 2021 Plan and 2021 ESPP is to provide a means by which eligible recipients of stock awards may be given an opportunity to benefit from increases in the value of the common stock in order to retain or procure the services of the employees, members of the Board and consultants and provide them with an incentive to promote the Company&#8217;s success and accomplish corporate goals.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Stock option awards are granted with an exercise price of no less than 100% of estimated fair market value on the date of grant. Time based awards generally vest over </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">four years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> as follows, subject to the optionee&#8217;s continuing service: (i) one fourth of the total number of shares vest and become exercisable on the one-year anniversary and then 1/48th of the total number of shares subject to the option vest and become exercisable on each monthly anniversary thereafter for the remaining three years, or (ii) 1/48th of the total number of shares subject to the option vest and become exercisable each month over four years.</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A summary of the stock option activities related to the Equity Plans for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">six months ended June 30, 2024 is presented below:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:51.15%;"></td>
         <td style="width:1.36%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1%;"></td>
         <td style="width:12.603%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.4%;"></td>
         <td style="width:1%;"></td>
         <td style="width:12.042%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1%;"></td>
         <td style="width:13.443%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of Options</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted<br/>Average<br/>Exercise<br/>Price</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Avg<br/>Remaining<br/>Contractual Life<br/>(Years)</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Options outstanding as of December 31, 2023</span></p></td>
         <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">6,777,404</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">13.02</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.51</span></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Granted</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">799,502</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">55.89</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Exercised</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,258,874</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">10.53</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forfeited</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">62,995</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">16.05</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expired</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">10,236</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.57</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Options outstanding as of June 30, 2024</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">6,244,801</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">18.99</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.78</span></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Exercisable as of June 30, 2024</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">3,623,940</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">13.23</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.45</span></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:18pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the intrinsic value of options vested was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">170.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">121.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, and of all options outstanding was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">257.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">185.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. During the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">six months ended June 30, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the total cash received from the exercise of stock options was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">13.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. The total fair value less strike price of these options was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">50.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.</span></p><div style="font-size:10.5pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A summary of non-vested restricted stock unit activities for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">six months ended June 30, 2024 is as follows:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:61.16%;"></td>
         <td style="width:1.72%;"></td>
         <td style="width:1.2%;"></td>
         <td style="width:1%;"></td>
         <td style="width:15.36%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.68%;"></td>
         <td style="width:1%;"></td>
         <td style="width:14.88%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Average</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Grant Date</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Shares</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair Value</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested at December 31, 2023</span></p></td>
         <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">650,357</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.80</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Granted</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">183,231</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">56.36</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Vested</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">165,567</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">17.99</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forfeited</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">18,033</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.71</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested at June 30, 2024</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">649,988</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">26.68</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Stock-based compensation expense was classified in the accompanying condensed consolidated statements of operations and comprehensive income (loss) as follows (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:37.792%;"></td>
         <td style="width:1.44%;"></td>
         <td style="width:1%;"></td>
         <td style="width:15.697000000000001%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.44%;"></td>
         <td style="width:1%;"></td>
         <td style="width:9.958%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.44%;"></td>
         <td style="width:1%;"></td>
         <td style="width:11.158000000000001%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.44%;"></td>
         <td style="width:1%;"></td>
         <td style="width:11.638%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,395</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,021</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,501</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,823</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,210</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,639</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,410</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,910</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of sales</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">500</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">295</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">890</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">517</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,105</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,955</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,801</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,250</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2,620,861</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2,539,445</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> unvested options, respectively.  As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, total unrecognized expense related to unvested stock options was approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">44.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">22.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. Both amounts are expected to be recognized over a weighted average period of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.5</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.4</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years, respectively.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024, and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, total unrecognized expense related to non-vested restricted stock units was approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. The unrecognized compensation cost is expected to be recognized over a weighted average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.4</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.3</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years, respectively.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the range and weighted-average assumptions, used in the Black-Scholes option pricing model to determine the fair value of stock options:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:23.81%;"></td>
         <td style="width:1.581%;"></td>
         <td style="width:17.467%;"></td>
         <td style="width:1.581%;"></td>
         <td style="width:17.467%;"></td>
         <td style="width:1.581%;"></td>
         <td style="width:17.467%;"></td>
         <td style="width:1.581%;"></td>
         <td style="width:17.467%;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="7" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Range</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Range</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected volatility</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">69.0</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% to </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">72.0</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">71.0</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">64.9</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% to </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">65.7</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">65.1</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Risk-free interest rate</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.9</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% to </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.7</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.4</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% to </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.1</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected life (in years)</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.0</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;years</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.0</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;years</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.0</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;to </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.0</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;years</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.0</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;years</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected dividend yield</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.0</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.0</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.0</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.0</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Grant date fair value</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36.89</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;to $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60.65</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">55.93</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12.91</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;to $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">28.80</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15.26</span></p></td>
        </tr>
       </table></div><p style="text-indent:-18pt;padding-left:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Common Stock</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Each share of common stock is entitled to one vote. Common stock reserved for future issuance consisted of the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.967%;"></td>
         <td style="width:1.16%;"></td>
         <td style="width:1%;"></td>
         <td style="width:13.357%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.16%;"></td>
         <td style="width:1%;"></td>
         <td style="width:13.357%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30, 2024</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock options issued and outstanding under the Equity Plans</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,244,801</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,777,404</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares available for future issuance under the 2021 Plan</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">951,817</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">358,610</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Restricted stock units issued under the 2021 Plan</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">649,988</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">650,357</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares available for future issuance under 2021 ESPP</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">538,942</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">577,847</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total shares of common stock reserved</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,385,548</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,364,218</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948162029040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 7 &#8211; Leases</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has operating and finance leases for facilities and certain equipment. Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheets. Lease expense for operating leases is recognized on a straight-line basis over the lease term.  The Company does not combine lease and non-lease components in the recognition of lease expense.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the Company held </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">four</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> leases for office, manufacturing and warehouse facilities in Aliso Viejo, California. The four leases are for approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">137,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> square feet in the aggregate. For one such operating lease, the lessor provided $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">900,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> in tenant allowances.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 4, 2022, the Company entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">thirty-four-month</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> sublease agreement for a portion of the 5 Columbia Building, in Aliso Viejo, CA. The sublease commencement date was June 13, 2022 and was to expire on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The base rent receivable was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11,410</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per month. On January 4, 2023 the Company entered into a second amendment to the sublease agreement adjusting the base rent receivable to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5,319</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per month. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 1, 2024 the sublease was cancelled.</span></span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">New lease and lease amendments</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 18, 2024, the Company entered into a new lease, and amendments to two existing leases, for three of its facilities comprising the Company&#8217;s headquarters, manufacturing, research and development and administrative offices in Aliso Viejo, California, as described in further detail below.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">125 Columbia</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 18, 2024, the Company entered into a Standard Industrial/Commercial Single-Tenant Lease &#8211; Net (the &#8220;125 Columbia Lease&#8221;) with BML Management, LLC, for an approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">26,825</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> square foot industrial and research and development facility in Aliso Viejo, California.   The 125 Columbia Lease commences on</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> June 1, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and will end on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 31, 2031</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company has two options to extend the term of the 125 Columbia Lease, with each option to extend being for a term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">60</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> months, commencing when the prior term expires. The base rent is initially $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">41,579</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per month, payable on the first day of each month commencing on June 1, 2024, subject to adjustment as set forth in the 125 Columbia Lease.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">5 Columbia</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 18, 2024 and June 3, 2024, the Company entered into Lease Amendment #2 and Lease Amendment #3, respectively to that certain Lease Agreement dated January 10, 2018, as amended on April 5, 2022, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">with Clifford D. Downs, for an approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">19,680</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> square foot industrial facility located at 5 Columbia in Aliso Viejo, California (collectively the &#8220;5 Columbia Amendments&#8221;). Pursuant to the 5 Columbia Amendments, the term of the lease was extended </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">70 </span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">months, beginning on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">April 1, 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and ending on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 31, 2031</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The parties agreed to the base rent rate payable over the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">70</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> month term as set forth in the 5 Columbia Amendments. The base rent is initially $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">30,701</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per month and includes fixed rent escalations beginning on April 1, 2027. The Company has two options to extend the term of the lease, with each option to extend being for a term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">60</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> months, commencing when the prior term expires.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">100 Columbia</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 18, 2024, the Company entered into a Fifth Amendment to that certain Commercial Lease Agreement, dated August 31, 2015, as amended November 23, 2015, December 22, 2015, January 18, 2016, and November 12, 2016, with Accuride International Inc., for an approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">42,106</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> square foot industrial facility located at 100 Columbia in Aliso Viejo, California (the &#8220;April 2024 100 Columbia Amendment&#8221;). Pursuant to the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">April 2024 100 Columbia Amendment, the term of the lease was extended </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">76</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> months, beginning on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">October 1, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and ending on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 31, 2031</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The parties agreed to the base rent rate payable over the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">76</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> month term as set forth in the April 2024 100 Columbia Amendment. The base rent is initially $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">64,843</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per month and includes fixed rent escalations beginning on October 1, 2025.</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The Company has two options to extend the term of the lease at the end of the current term, with each option to extend being for a 5 year term.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The lessor provided $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">50,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> in tenant allowances.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On June 3, 2024, the Company entered into a Sixth Amendment to that certain Commercial Lease Agreement, dated August 31, 2015, as amended April 18, 2024 as amended November 23, 2015, December 22, 2015, January 18, 2016, and November 12, 2016, with Accuride International Inc., for the property located at 100 Columbia in Aliso Viejo, California (the &#8220;June 2024 100 Columbia Amendment&#8221;). The June 2024 100 Columbia Amendment updated certain notification requirements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under these lease agreements, the Company is required to pay approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in future minimum lease payments of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million will be paid in 2024, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million will be paid in 2025, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million will be paid in 2026, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million will be paid in both 2027 and 2028, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million will be paid thereafter.</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the lease balances within the Condensed Consolidated Balance Sheets as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 and December 31, 2023 (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:29.294%;"></td>
         <td style="width:1.64%;"></td>
         <td style="width:35.833%;"></td>
         <td style="width:1.64%;"></td>
         <td style="width:1%;"></td>
         <td style="width:12.977%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.64%;"></td>
         <td style="width:1%;"></td>
         <td style="width:12.977%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30,</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Leases</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Classification</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating leases right-of-use assets</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,818</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,444</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_3e517117-8319-4cc0-8225-94336556f3a7;"><span style="-sec-ix-hidden:F_00e18cde-e7c6-4077-9799-7012c3ad64fb;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Property and equipment, net</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">142</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">156</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease assets</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,960</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,600</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Liabilities</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_0bfe1017-2ed2-4326-a247-db41c8cf4d2b;"><span style="-sec-ix-hidden:F_78fd0571-9a99-465d-8968-e56cfa5898f0;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lease liabilities</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">710</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,764</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_0f7fb7b9-c9ea-4648-8251-fd72d360c669;"><span style="-sec-ix-hidden:F_a8615e7e-3a3b-4497-9d55-86ea65153fd0;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lease liabilities</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">37</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Noncurrent</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_502cbe2a-5432-41d0-85b4-23a20a165bac;"><span style="-sec-ix-hidden:F_8be0e6d4-5a47-411b-9144-c408d3934f9a;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term lease liabilities</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,553</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,093</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_a8cedab2-1fe0-482a-a6c2-28f0caa7a48f;"><span style="-sec-ix-hidden:F_21a43b30-4a3d-4632-a584-149b79b2db2c;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term lease liabilities</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">121</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">118</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease liabilities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,410</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,012</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> For the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2024 and 2023, the components of operating and finance lease expenses were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.965%;"></td>
         <td style="width:1.4%;"></td>
         <td style="width:30.546%;"></td>
         <td style="width:1.52%;"></td>
         <td style="width:1%;"></td>
         <td style="width:6.901%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.3%;"></td>
         <td style="width:1%;"></td>
         <td style="width:7.662000000000001%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.4%;"></td>
         <td style="width:1%;"></td>
         <td style="width:4.481%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.921%;"></td>
         <td style="width:1%;"></td>
         <td style="width:6.901%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Lease Cost</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Classification</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating lease cost</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of sales</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">48</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">61</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">588</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">438</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,027</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">887</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance lease cost</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">63</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance lease cost</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest expense</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Maturities of the Company&#8217;s operating and finance lease liabilities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:42.989%;"></td>
         <td style="width:8.242%;"></td>
         <td style="width:1%;"></td>
         <td style="width:15.143%;"></td>
         <td style="width:1%;"></td>
         <td style="width:11.362%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.264%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Operating</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Finance</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Leases</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Leases</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2024 (remainder)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,004</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2025</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,434</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2026</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,637</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2027</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,782</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2028</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,871</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2029</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,954</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Thereafter</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,308</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease payments</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,990</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">199</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less: imputed interest</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,727</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease liabilities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,263</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">147</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;">&#160;</p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The weighted average remaining lease term and weighted average discount rate used to determine lease liabilities related to the Company&#8217;s operating and finance leases as of June 30, 2024 and December 31, 2023 were:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.311%;"></td>
         <td style="width:1.08%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.484%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.08%;"></td>
         <td style="width:1%;"></td>
         <td style="width:20.044%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30,</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Lease Term and Discount Rate</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average remaining lease term (years)</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating leases</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.58</span></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.69</span></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance leases</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.35</span></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.37</span></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average discount rate</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating leases</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.4</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.4</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance leases</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.4</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.0</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
        </tr>
       </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948265247088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 8 &#8211; Commitments and Contingencies</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Letter of credit</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has a standby letter of credit, expiring September 30, 2024, issued by a financial institution as required security for one operating lease. The aggregate amount of the letter of credit was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 and December 31, 2023.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Legal Matters</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">From time-to-time, the Company may be involved in certain legal proceedings or regulatory matters arising in the ordinary course of business, including without limitation, actions with respect to intellectual property, employment, regulatory, product liability and contractual matters. In connection with these proceedings or matters,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the Company regularly assesses the probability and amount (or range) of possible issues based on the developments in these proceedings or matters. A liability is recorded in the consolidated financial statements if it is determined that it is probable that a loss has been incurred, and that the amount (or range) of the loss can be reasonably estimated. Because of the uncertainties related to any pending proceedings or matters, the Company is currently unable to predict their ultimate outcome and, with respect to any legal proceeding or regulatory matter where no liability has been accrued, to make a reasonable estimate of the possible loss (or range of loss) that could result from an adverse outcome. At June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> legal proceedings, regulatory matters, or other disputes or claims for which a material loss was considered probable or for which the amount (or range) of loss was reasonably estimable. However, regardless of the outcome, legal proceedings, regulatory matters, and other disputes and claims can have an adverse impact on the Company because of legal costs, diversion of management time and resources, and other factors.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948162768944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and pursuant to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements. The unaudited interim financial statements reflect all adjustments which, in the opinion of management, are necessary for a fair statement of the results for the periods presented. All such adjustments are of a normal and recurring nature.  The December 31, 2023 balance sheet data was derived from audited financial statements; however, the accompanying notes to the condensed consolidated financial statements do not include all of the annual disclosures required under GAAP and should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2023 Annual Report on Form 10-K filed with the SEC on February 28, 2024. The operating results presented in these unaudited condensed consolidated financial statements are not necessarily indicative of the results that may be expected for any future periods.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Operating Segments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company determined its operating segment on the same basis that it uses to evaluate its performance internally. The Company&#8217;s chief operating decision-maker (&#8220;CODM&#8221;), its Chief Executive Officer, reviews its consolidated operating results for the purpose of allocating resources and evaluating financial performance.  The Company determined that it operates and manages its business (including its non-U.S. subsidiaries) in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> reportable segment: the research and development, manufacture and sale of light adjustable lenses and related capital equipment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_LiquidityAndFinancialPositionPolicyTextBlock', window );">Liquidity and Financial Position</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Liquidity</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Shelf Registration Statement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On May 8, 2024, the Company filed an automatic shelf registration statement on Form S-3 (&#8220;shelf registration statement&#8221;). The shelf registration statement is effective for three years and permits the Company to sell, from time to time, common stock, preferred stock, debt securities, warrants, and/or units. The shelf registration statement is intended to provide the Company with flexibility to access additional capital.  At the time of filing the shelf registration statement, the Company also filed a prospectus supplement to sell up to an aggregate value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">115.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million dollars of common stock through a public offering (&#8220;Public Offering&#8221;).</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Public Offering</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">May 8, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company entered into an underwriting agreement with BofA Securities, Inc., in which the Company agreed to issue and sell </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,785,714</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company's common stock in a public offering, pursuant to the shelf registration statement. The shares of common stock were sold at a price to the public of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">56.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share. Under the terms of the underwriting agreement, the Company also granted the underwriters an option exercisable for 30 days from the date of the underwriting agreement to purchase up to an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">267,857</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock on the same terms and conditions.  The underwriters' option was exercised in full on May 10, 2024 and the Public Offering (inclusive of the underwriters' option shares) closed on May 13, 2024.  The Company received net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">107.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million from the Public Offering, after deducting underwriters' discounts and commissions of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">6.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and other offering expenses of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024 and December 31, 2023 the Company had cash, cash equivalents and short-term investments of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">233.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">127.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company began generating revenue from its principal operations in 2019. The Company has a limited operating history, and the revenue and income potential of the Company&#8217;s business and market are unproven. The Company has experienced recurring net losses and negative cash flows from operating activities since its inception. For the three months ended June 30, 2024 and 2023, the Company incurred losses from operations of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">13.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. For the six months ended June 30, 2024 and 2023, the Company incurred losses from operations of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;">19.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;">26.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.  Based on the Company&#8217;s anticipated sales growth in relation to the anticipated costs associated with, among other things, its continuing research and development activities and the expansion of its sales and marketing activities, the Company expects to continue to incur net operating losses into the foreseeable future. Successful transition to attaining profitable operations is dependent upon gaining market acceptance of the Company&#8217;s products and achieving a level of revenues adequate to support the Company&#8217;s cost structure.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company believes that existing cash resources will be sufficient to meet projected operating requirements for at least 12 months from the date of issuance of the accompanying condensed consolidated financial statements, however for the near future, the Company expects to continue to incur operating losses and negative cash flows. The Company plans to continue to fund its losses from operations using its cash, cash equivalents and short-term investments as of June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and meet its future capital funding needs through equity or debt financings, other third-party funding, collaborations, strategic alliances and licensing arrangements or a combination of these. If the Company raises additional funds by issuing equity securities, its stockholders may experience dilution. Any future debt financing into which the Company enters may impose additional covenants that restrict operations, including limitations on its ability to incur liens or additional debt, pay dividends, repurchase common stock, make certain investments or engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity raise may contain terms that are not favorable to the Company or its stockholders. If the Company is required to enter into collaborations and other arrangements to address its liquidity needs, it may have to give up certain rights that limit its ability to develop and commercialize product candidates or may have other terms that are not favorable to the Company or its stockholders, which could materially and adversely affect its business and financial prospects. There can be no assurance that the Company will be able to obtain additional financing on acceptable terms, or at all. If the Company is not able to secure adequate additional funding, the Company may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible and/or suspend or curtail planned programs. Any of these actions could materially harm the Company&#8217;s business, results of operations and future prospects.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">preparation of consolidated financial statements in conformity with GAAP requires management to make informed estimates, judgments and assumptions that affect the reported amounts in the condensed consolidated financial statements and disclosures in the accompanying notes as of the date of the accompanying condensed consolidated financial statements. On an on-going basis, management evaluates the most critical estimates and assumptions for continued reasonableness. Actual results may differ materially from the estimates used in the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">preparation </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of the accompanying condensed consolidated financial statements under different assumptions or conditions.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SignificantAccountingPoliciesPolicyTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Significant Accounting Policies</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There have been no significant changes to the accounting policies during the three months ended June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, as compared to the significant accounting policies described in Note 2 of the &#8220;Notes to Consolidated Financial Statements&#8221; in the Company&#8217;s audited consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on February 28, 2024.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents consist of investments in money market accounts. The Company considers all highly liquid investments with original maturities of three months or less at the date of purchase that can be liquidated without prior notice or penalty to be cash equivalents.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_ShortTermInvestmentsPolicyTextBlock', window );">Short-term Investments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Short-term Investments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Short-term investments are classified based on the maturity date of the related securities. Based on the nature of the assets, the Company&#8217;s short-term investments, which are government securities, are classified as available-for-sale and are recorded at their estimated fair value as determined by prices for identical or similar securities at the balance sheet date. The Company&#8217;s short-term investments consist of Level 2 financial instruments in the fair value hierarchy. Unrealized gains and losses are recorded as a component of Other Comprehensive Loss within Stockholders&#8217; Equity on the condensed consolidated balance sheets. Realized gains and losses are included as other income (expense) in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss. The cost basis for realized gains and losses on available-for-sale securities is determined on a specific identification basis. Management determines the appropriate classification of its investments at the time of purchase and reevaluates such determination at each balance sheet date. The Company periodically reviews its investments for unrealized losses other than credit losses and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In determining whether the carrying value is recoverable, management considers the following factors:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">whether the investment has been in a continuous loss position for over 12 months; </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the duration to maturity of investments; </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">intention and ability to hold the investment to maturity and if it is not more likely than not that the Company will be required to sell the investment before recovery of the amortized cost basis; </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the credit rating, financial condition and near-term prospects of the issuer; and </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the type of investments made. </span></div></div><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company had an unrealized loss of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">99,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of net unrealized gains related to short-term investments as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and Other Risks and Uncertainties</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk and Other Risks and Uncertainties</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, short-term investments and accounts receivable. The Company&#8217;s policy is to invest cash in institutional money market funds and marketable securities of the U.S. government to limit the amount of credit exposure. The Company currently maintains a portfolio of cash equivalents and short-term investments in money market funds and U.S. treasury bills. A portion of the Company's operating cash is held in accounts in excess of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance limits; however, the Company has established guidelines regarding diversification of its investments and their maturities, which are designed to maintain principal and maximize liquidity. The Company has not experienced material losses on cash equivalents and short-term investments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s products require approval from the FDA and foreign regulatory agencies before commercial sales can commence. There can be no assurance that the Company&#8217;s products will receive any of these required</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">approvals. The denial or delay of such approvals may have a material adverse impact on the Company&#8217;s business and may impact business in the future. In addition, after approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the device approval process.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is subject to risks common to companies in the medical device industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of the Company's products, product liability and the need to obtain additional financing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is subject to the risks related to global lead times, particularly in Europe and Asia, leading to a supply interruption from the Company's suppliers. In addition, the Company is currently experiencing inflation and longer lead times and limited availability in its supply chain for certain components and has continued exposure to price and supply risk related to anticipated purchases of certain commodities, materials and products used in its business.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounts Receivable</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has a diverse customer base and as of June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the Company did not have any customers who individually accounted for greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of accounts receivable. The Company maintains an allowance for credit losses resulting from the inability of its customers, including ambulatory surgery centers, to make required payments. After evaluation of the collectability of accounts receivable, the Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">t record any significant allowance for credit losses as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 or December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value of Financial Instruments</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company uses fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures.  Fair value is measured as the price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques that are consistent with the market, income or cost approach are used to measure fair value. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three levels:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 1&#8212;Observable inputs such as unadjusted quoted prices in active markets that are accessible at the measurement date for identical unrestricted assets or liabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 2&#8212;Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability, for substantially the full term of the asset or liability, through correlation with market data. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 3&#8212;One or more significant inputs that are unobservable and supported by little or no market activity and reflect the use of significant management judgment and assumptions. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques and significant management judgment or estimation. These include the Black-Scholes option-pricing model which uses inputs such as expected volatility, risk-free interest rate and expected term to determine fair market valuation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification at each reporting date. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the years presented.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s financial instruments consist principally of cash, cash equivalents, short-term investments, accounts receivable, accounts payable and operating lease liabilities. Cash, cash equivalents, accounts receivable and accounts payable are carried at their estimated fair value because of the short-term nature of these assets and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">liabilities. The Company&#8217;s short-term investments in government securities are carried at fair value, determined based on publicly available quoted market prices for identical securities at the measurement date. The Company believes the fair values of its operating lease liabilities at June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, approximated their carrying values, based on the borrowing rates that were available for loans with similar terms as of such date.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Inventories</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inventories consist of raw materials, work-in-process and finished goods. Raw materials are comprised of chemicals and parts used in the production of the Company's lenses, cartridges, and LDDs. Finished goods are comprised of lenses, cartridges, accessories and LDDs. Inventories are valued at the lower of cost or net realizable value. Cost is computed using standard cost, which approximates actual cost on a first-in, first-out basis. The carrying value of inventories is reviewed for potential impairment whenever indicators suggest that the cost of inventories exceeds the carrying value and management adjusts the inventories to its net realizable value. The cost of finished goods and work-in-process is comprised of raw materials, direct labor, other direct costs and related production overhead to the extent that these costs do not exceed the net realizable value of the goods produced. The Company periodically reviews inventories for potential impairment, estimated losses from obsolescence, material expirations or unmarketable inventories or excess inventories and writes down the cost of inventories to net realizable value at the time such determinations are made. Net realizable value is determined using the estimated selling price, in the ordinary course of business, less estimated costs to complete and dispose.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Leases</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lease right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term, and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized when the Company takes possession of the leased property (&#8220;Commencement Date&#8221;) based on the present value of lease payments over the lease term. The Company estimates the incremental borrowing rate based upon the cost of its own debt financing, current market interest rates and quoted offerings or the rate implicit in the lease. Operating lease right-of-use assets also include any lease payments made at or before lease commencement and exclude any lease incentives received. The lease terms used to calculate the right-of-use asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Rent expense on noncancelable leases containing known future scheduled rent increases is recorded on a straight-line basis over the term of the respective leases beginning on the Commencement Date. The difference between rent expense and rent paid is accounted for as a component of operating lease right-of-use assets on the accompanying condensed consolidated balance sheets. Landlord improvement allowances and other such lease incentives are recorded as property and equipment and as reduction of the right-of-use leased assets and are amortized on a straight-line basis as a reduction to operating lease costs. Leases with an initial term of 12 months or less are expensed as incurred and are not recorded as right-of-use assets on the condensed consolidated balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss per Share</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Net Loss per Share</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average shares of common stock outstanding for the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average shares of common stock and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock and potential dilutive securities outstanding during the period.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common stockholders because their impact under the treasury stock method was anti-dilutive for the periods presented:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:41.74%;"></td>
           <td style="width:1%;"></td>
           <td style="width:12.36%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:11.26%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:11.48%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:12.16%;"></td>
           <td style="width:1%;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock options issued and outstanding under the Calhoun Vision, Inc. 2006 Stock Plan, Calhoun Vision, Inc. 2015 Equity Incentive Plan and the 2021 Equity Incentive Plan</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,618,186</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,821,076</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,843,009</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,409,842</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Restricted stock units issued under the 2021 Equity Incentive Plan</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">666,573</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">773,940</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">544,320</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">671,956</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock issuable in offering period under the 2021 Employee Stock Purchase Plan</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">59,149</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39,568</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">61,085</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45,191</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s revenue is generated from the sale of LALs used in cataract surgery along with a specifically designed machine for delivering light to the eye, the LDD, to adjust the lens post-surgery, as needed. Revenue is recognized from sales of products in the U.S., Canada and Europe. Customers are primarily comprised of ambulatory surgery centers, hospitals, and physician private practices.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company recognizes revenues when promised goods or services are transferred to customers at a transaction price that reflects the consideration to which the Company expects to be entitled in exchange for those goods and services. Specifically, the Company applies the following five steps to recognize revenue: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when, or as, the Company satisfies a performance obligation. The Company applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. At contract inception, the Company assesses the goods promised within each customer contract to determine the individual deliverables in its product offerings as separate performance obligations and assesses whether each promised good or service is distinct. The transaction price is determined based on the consideration expected to be received, based either on the stated value in contractual arrangements or the estimated cash to be collected in non-contracted arrangements. The Company recognizes revenue as the amount of the transaction price that is allocated to the respective performance obligation when, or as, the performance obligation is satisfied, considering whether or not this occurs at a point in time or over time. The Company elected to account for shipping costs as fulfillment costs rather than a promised service and excludes from revenue any taxes collected from customers that are remitted to government authorities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s LDD contracts contain multiple performance obligations bundled for one transaction price, with all obligations generally satisfied within one year. For these bundled arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct, that is, if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company&#8217;s LDD contracts include a combination of the following performance obligations: (i) LDD capital asset and related components, (ii) training and (iii) device service (initial year). Each of these three performance obligations are considered distinct. The LDD capital asset is distinct because the customer can benefit from it together with other resources that are readily available to the customer.  Training on the use of the machine is offered as a distinct activity after installation of the LDD to enhance the customer&#8217;s ability to utilize the machine by having an industry professional provide best practices and customize training to the specific needs of the customer. Each LDD comes with a twelve-month manufacturer&#8217;s warranty (service-type) that includes preventative maintenance, unscheduled service (labor and parts) and software updates. After the first year, service contracts can be purchased separately on a standalone basis. The Company recognizes revenue as performance obligations are satisfied by transferring control of the product or service to a customer. Specifically, revenue for the LDD capital asset is recognized at a point in time at installation.  Revenue for training is also recorded at a point in time, generally 60 days after installation.  Revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">for the device service is recognized ratably over time after installation, generally 12 months. The Company has determined that the transaction price is the invoice price, net of adjustments, if any. The allocation to the separate performance obligations is based upon the relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. The Company estimates the standalone selling price using the market assessment approach considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services, geographies, type of customer and market conditions. The Company regularly reviews and updates standalone selling prices as necessary.</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">LALs are generally held at customer sites on consignment. The single performance obligation is satisfied, and revenue from sales is recognized for LALs upon customer notification that the LALs have been implanted in a patient. For the three and six months ended June 30, 2024 and 2023, credits related to returns and rebates on list prices were not significant.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has adopted the practical expedient permitting the direct expensing of costs incurred to obtain contracts where the amortization of such costs would occur over one year or less, and it applied to substantially all the Company&#8217;s contracts. Revenue for service agreements is recognized ratably over the term of each contract.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2024 and 2023, revenue from contracts with customers consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:32.867%;"></td>
           <td style="width:1.259%;"></td>
           <td style="width:1%;"></td>
           <td style="width:16.054%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.259%;"></td>
           <td style="width:1%;"></td>
           <td style="width:11.775%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.259%;"></td>
           <td style="width:1%;"></td>
           <td style="width:13.135%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.259%;"></td>
           <td style="width:1%;"></td>
           <td style="width:13.135%;"></td>
           <td style="width:1%;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">LDD (including training)</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,189</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,720</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,902</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,195</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">LAL</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23,828</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,411</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43,745</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,806</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Service warranty, service contracts, and accessories</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">870</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">679</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,752</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,298</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34,887</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,810</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">64,399</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,299</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the three and six months ended June 30, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company did not have any customers who individually accounted for greater than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of revenue.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table represents the contract liabilities from sales activity for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">six months ended June 30, 2024 and 2023, respectively (in thousands):</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:51.661%;"></td>
           <td style="width:1.961%;"></td>
           <td style="width:1%;"></td>
           <td style="width:21.769%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.961%;"></td>
           <td style="width:1%;"></td>
           <td style="width:16.686999999999998%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.961%;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="text-indent:40pt;vertical-align:bottom;"><p style="margin-left:40pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at beginning of period</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,888</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,193</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;word-break:break-word;">
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Additions during the period</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,949</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,391</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Revenue recognized during the period</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,707</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,233</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;word-break:break-word;">
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at end of period</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,130</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,351</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation Expense</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has three equity incentive compensation plans: the Calhoun Vision, Inc. 2006 Stock Plan (&#8220;2006 Plan&#8221;); the Calhoun Vision, Inc. 2015 Equity Incentive Plan (&#8220;2015 Plan&#8221;); and the 2021 Equity Incentive Plan (&#8220;2021 Plan&#8221;), which are collectively referred to as the &#8220;Equity Plans.&#8221; The Company also has an employee stock purchase plan, the 2021 Employee Stock Purchase Plan (&#8220;2021 ESPP&#8221;).</span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company recognizes compensation expense for equity-based awards on the date of grant to employees, board of directors and consultants based on the estimated grant date fair value of the award's Equity-based payments including stock options, restricted stock units and employee stock plan purchases. The fair value of the option awards are estimated using the Black-Scholes option-pricing model and recognized as an expense in the condensed consolidated statements of operations and comprehensive loss over the requisite service period, which is generally four years. The Company amortizes the stock-based compensation for equity awards with service conditions on a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">straight-line basis over the vesting period of the awards. Forfeitures of unvested stock option awards are recognized as reductions of expense as they occur.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Black-Scholes option-pricing model requires the use of assumptions about a number of variables, such as the fair market value of the Company&#8217;s common stock, expected volatility, expected term, risk-free interest rate, and dividend yield as discussed below:</span></p><p style="margin-left:30.95pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair market value</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;The fair value of common stock is determined by using the closing price per share of common stock as reported on the Nasdaq Global Market.</span></p><p style="margin-left:30.95pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Expected volatility</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;Effective January 1, 2024, the Company based the expected volatility on the historic volatility of its common stock. During the year ended December 31, 2023, the expected volatility was estimated based on the average historical volatilities for comparable publicly traded medical device companies over a period equal to the expected term of the stock option grants. Comparable companies were chosen based on their similar size, stage in the life cycle and area of specialty.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:30.95pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Expected term</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;The Company&#8217;s expected term represents the period that the Company&#8217;s stock-based awards are expected to be outstanding. The Company used the simplified method (based on the mid-point between the vesting date and the end of the contractual term) to determine the expected term.</span></p><p style="margin-left:30.6pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Risk-free interest rate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;The risk-free interest rate used is based on the published U.S. Department of Treasury interest rates in effect at the time of stock option grant for zero coupon U.S. Treasury notes with maturities approximating each grant&#8217;s expected term.</span></p><p style="margin-left:30.6pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Dividend yield</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of zero.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements</span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Changes to GAAP are established by the Financial Accounting Standards Board (&#8220;FASB&#8221;) in the form of accounting standards updates (&#8220;ASU&#8221;). There have been no recent accounting pronouncements, changes in accounting pronouncements or recently adopted accounting guidance during the three months ended June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> that are of significance or potential significance to the Company.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_LiquidityAndFinancialPositionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for Liquidity and Financial Position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_LiquidityAndFinancialPositionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_ShortTermInvestmentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-term investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_ShortTermInvestmentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_SignificantAccountingPoliciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_SignificantAccountingPoliciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948162635888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Dilutive Securities Excluded from Computation of Loss Per Share</a></td>
<td class="text"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common stockholders because their impact under the treasury stock method was anti-dilutive for the periods presented:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:41.74%;"></td>
           <td style="width:1%;"></td>
           <td style="width:12.36%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:11.26%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:11.48%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1%;"></td>
           <td style="width:12.16%;"></td>
           <td style="width:1%;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock options issued and outstanding under the Calhoun Vision, Inc. 2006 Stock Plan, Calhoun Vision, Inc. 2015 Equity Incentive Plan and the 2021 Equity Incentive Plan</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,618,186</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,821,076</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,843,009</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,409,842</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Restricted stock units issued under the 2021 Equity Incentive Plan</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">666,573</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">773,940</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">544,320</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">671,956</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock issuable in offering period under the 2021 Employee Stock Purchase Plan</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">59,149</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39,568</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">61,085</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45,191</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Schedule of Revenue from Contracts with Customers</a></td>
<td class="text"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2024 and 2023, revenue from contracts with customers consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:32.867%;"></td>
           <td style="width:1.259%;"></td>
           <td style="width:1%;"></td>
           <td style="width:16.054%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.259%;"></td>
           <td style="width:1%;"></td>
           <td style="width:11.775%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.259%;"></td>
           <td style="width:1%;"></td>
           <td style="width:13.135%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.259%;"></td>
           <td style="width:1%;"></td>
           <td style="width:13.135%;"></td>
           <td style="width:1%;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">LDD (including training)</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,189</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,720</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,902</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,195</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">LAL</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23,828</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,411</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43,745</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22,806</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Service warranty, service contracts, and accessories</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">870</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">679</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,752</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,298</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34,887</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,810</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">64,399</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38,299</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueByArrangementDisclosureTextBlock', window );">Schedule of Deferred Revenue Activity</a></td>
<td class="text"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table represents the contract liabilities from sales activity for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">six months ended June 30, 2024 and 2023, respectively (in thousands):</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:51.661%;"></td>
           <td style="width:1.961%;"></td>
           <td style="width:1%;"></td>
           <td style="width:21.769%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.961%;"></td>
           <td style="width:1%;"></td>
           <td style="width:16.686999999999998%;"></td>
           <td style="width:1%;"></td>
           <td style="width:1.961%;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="text-indent:40pt;vertical-align:bottom;"><p style="margin-left:40pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
           <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at beginning of period</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,888</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,193</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;word-break:break-word;">
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Additions during the period</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,949</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,391</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Revenue recognized during the period</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,707</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,233</span></p></td>
           <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
           <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;word-break:break-word;">
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Balance at end of period</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,130</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
           <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,351</span></p></td>
           <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueByArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the type of arrangements and the corresponding amounts that comprise the current and noncurrent balance of deferred revenue as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueByArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948164171040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investment (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestmentsAbstract', window );"><strong>Short-Term Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Short-term Investments Available For Sale</a></td>
<td class="text">
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.94%;"></td>
         <td style="width:2.24%;"></td>
         <td style="width:1%;"></td>
         <td style="width:16.459999999999997%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.24%;"></td>
         <td style="width:1%;"></td>
         <td style="width:22.259999999999998%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.24%;"></td>
         <td style="width:1%;"></td>
         <td style="width:22.619999999999997%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of June 30, 2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amortized Cost</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unrealized Loss, Net</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Estimated Fair Value</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Treasury securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,938</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">99</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,839</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.835%;"></td>
         <td style="width:2.24%;"></td>
         <td style="width:1%;"></td>
         <td style="width:16.397%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.599%;"></td>
         <td style="width:1%;"></td>
         <td style="width:22.156%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.24%;"></td>
         <td style="width:1%;"></td>
         <td style="width:22.535999999999998%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of December 31, 2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Amortized Cost</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unrealized Gain, Net</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Estimated Fair Value</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Treasury securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117,480</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117,490</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948288315504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inventories consisted of the following (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:57.74%;"></td>
         <td style="width:1.76%;"></td>
         <td style="width:1%;"></td>
         <td style="width:14.200000000000001%;"></td>
         <td style="width:1%;"></td>
         <td style="width:5.16%;"></td>
         <td style="width:1%;"></td>
         <td style="width:14.200000000000001%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.94%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30,</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finished goods</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,327</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,092</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Raw materials</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,313</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,680</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Work-in-process</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,371</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,145</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,011</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,917</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;word-break:break-word;">
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less: reserve for excess and obsolete inventory</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">568</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">496</span></p></td>
         <td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19,443</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,421</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948162067568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of assets and liabilities measured at fair value on recurring basis and the fair value hierarchy of the valuation techniques</a></td>
<td class="text"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The table and disclosures for the periods presented below (in thousands) present the Company&#8217;s assets and liabilities measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value. The Company did not have any assets or liabilities measured at fair value on a recurring basis within Level 3 fair value measurements.</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:33.22%;"></td>
         <td style="width:2.18%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.08%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.18%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.08%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.18%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.08%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of June 30, 2024</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level I</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level II</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets:</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Money market securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,986</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,986</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Treasury securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,839</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,839</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total assets at fair value</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,986</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,839</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">227,825</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:33.22%;"></td>
         <td style="width:2.18%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.08%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.18%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.08%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.18%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.08%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of December 31, 2023</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level I</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level II</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets:</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Money market securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,475</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,475</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">U.S. Treasury securities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117,490</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117,490</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total assets at fair value</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,475</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">117,490</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">121,965</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948265245968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activities</a></td>
<td class="text"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A summary of the stock option activities related to the Equity Plans for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">six months ended June 30, 2024 is presented below:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:51.15%;"></td>
         <td style="width:1.36%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1%;"></td>
         <td style="width:12.603%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.4%;"></td>
         <td style="width:1%;"></td>
         <td style="width:12.042%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1%;"></td>
         <td style="width:13.443%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of Options</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted<br/>Average<br/>Exercise<br/>Price</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Avg<br/>Remaining<br/>Contractual Life<br/>(Years)</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Options outstanding as of December 31, 2023</span></p></td>
         <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">6,777,404</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">13.02</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.51</span></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Granted</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">799,502</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">55.89</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Exercised</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,258,874</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">10.53</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forfeited</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">62,995</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">16.05</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expired</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">10,236</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.57</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Options outstanding as of June 30, 2024</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">6,244,801</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">18.99</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.78</span></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Exercisable as of June 30, 2024</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">3,623,940</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">13.23</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.45</span></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Non-Vested Restricted stock unit Activities</a></td>
<td class="text"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A summary of non-vested restricted stock unit activities for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">six months ended June 30, 2024 is as follows:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:61.16%;"></td>
         <td style="width:1.72%;"></td>
         <td style="width:1.2%;"></td>
         <td style="width:1%;"></td>
         <td style="width:15.36%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.68%;"></td>
         <td style="width:1%;"></td>
         <td style="width:14.88%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Average</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Grant Date</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Shares</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fair Value</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested at December 31, 2023</span></p></td>
         <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">650,357</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.80</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Granted</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">183,231</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">56.36</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Vested</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">165,567</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">17.99</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forfeited</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">18,033</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.71</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Unvested at June 30, 2024</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">649,988</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">26.68</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Expense</a></td>
<td class="text"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Stock-based compensation expense was classified in the accompanying condensed consolidated statements of operations and comprehensive income (loss) as follows (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:37.792%;"></td>
         <td style="width:1.44%;"></td>
         <td style="width:1%;"></td>
         <td style="width:15.697000000000001%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.44%;"></td>
         <td style="width:1%;"></td>
         <td style="width:9.958%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.44%;"></td>
         <td style="width:1%;"></td>
         <td style="width:11.158000000000001%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.44%;"></td>
         <td style="width:1%;"></td>
         <td style="width:11.638%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,395</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,021</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,501</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,823</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,210</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,639</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,410</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,910</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of sales</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">500</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">295</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">890</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">517</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,105</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,955</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,801</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,250</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Range and Weighted-average Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options</a></td>
<td class="text"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the range and weighted-average assumptions, used in the Black-Scholes option pricing model to determine the fair value of stock options:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:23.81%;"></td>
         <td style="width:1.581%;"></td>
         <td style="width:17.467%;"></td>
         <td style="width:1.581%;"></td>
         <td style="width:17.467%;"></td>
         <td style="width:1.581%;"></td>
         <td style="width:17.467%;"></td>
         <td style="width:1.581%;"></td>
         <td style="width:17.467%;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="7" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Range</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Range</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected volatility</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">69.0</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% to </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">72.0</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">71.0</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">64.9</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% to </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">65.7</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">65.1</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Risk-free interest rate</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.9</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% to </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.7</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.4</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% to </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.1</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected life (in years)</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.0</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;years</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.0</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;years</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.0</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;to </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.0</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;years</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.0</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;years</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected dividend yield</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.0</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.0</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.0</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.0</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Grant date fair value</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36.89</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;to $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">60.65</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">55.93</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12.91</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;to $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">28.80</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15.26</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock', window );">Schedule of Common stock reserved for future issuance</a></td>
<td class="text"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Each share of common stock is entitled to one vote. Common stock reserved for future issuance consisted of the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.967%;"></td>
         <td style="width:1.16%;"></td>
         <td style="width:1%;"></td>
         <td style="width:13.357%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.16%;"></td>
         <td style="width:1%;"></td>
         <td style="width:13.357%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:middle;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30, 2024</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock options issued and outstanding under the Equity Plans</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,244,801</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,777,404</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares available for future issuance under the 2021 Plan</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">951,817</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">358,610</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Restricted stock units issued under the 2021 Plan</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">649,988</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">650,357</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares available for future issuance under 2021 ESPP</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">538,942</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">577,847</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total shares of common stock reserved</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,385,548</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,364,218</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Common stock reserved for future issuance [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948164205184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SummaryOfLeaseBalancesTableTextBlock', window );">Schedule of Lease Balance Sheet Information</a></td>
<td class="text"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the lease balances within the Condensed Consolidated Balance Sheets as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 and December 31, 2023 (in thousands):</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:29.294%;"></td>
         <td style="width:1.64%;"></td>
         <td style="width:35.833%;"></td>
         <td style="width:1.64%;"></td>
         <td style="width:1%;"></td>
         <td style="width:12.977%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.64%;"></td>
         <td style="width:1%;"></td>
         <td style="width:12.977%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30,</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Leases</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Classification</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating leases right-of-use assets</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,818</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,444</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_3e517117-8319-4cc0-8225-94336556f3a7;"><span style="-sec-ix-hidden:F_00e18cde-e7c6-4077-9799-7012c3ad64fb;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Property and equipment, net</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">142</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">156</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease assets</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,960</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,600</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Liabilities</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_0bfe1017-2ed2-4326-a247-db41c8cf4d2b;"><span style="-sec-ix-hidden:F_78fd0571-9a99-465d-8968-e56cfa5898f0;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lease liabilities</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">710</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,764</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_0f7fb7b9-c9ea-4648-8251-fd72d360c669;"><span style="-sec-ix-hidden:F_a8615e7e-3a3b-4497-9d55-86ea65153fd0;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lease liabilities</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">37</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Noncurrent</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_502cbe2a-5432-41d0-85b4-23a20a165bac;"><span style="-sec-ix-hidden:F_8be0e6d4-5a47-411b-9144-c408d3934f9a;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term lease liabilities</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,553</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,093</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_a8cedab2-1fe0-482a-a6c2-28f0caa7a48f;"><span style="-sec-ix-hidden:F_21a43b30-4a3d-4632-a584-149b79b2db2c;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Long-term lease liabilities</span></span></span></span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">121</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">118</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease liabilities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,410</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,012</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Component of Lease Expense</a></td>
<td class="text"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> For the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2024 and 2023, the components of operating and finance lease expenses were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.965%;"></td>
         <td style="width:1.4%;"></td>
         <td style="width:30.546%;"></td>
         <td style="width:1.52%;"></td>
         <td style="width:1%;"></td>
         <td style="width:6.901%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.3%;"></td>
         <td style="width:1%;"></td>
         <td style="width:7.662000000000001%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.4%;"></td>
         <td style="width:1%;"></td>
         <td style="width:4.481%;"></td>
         <td style="width:1%;"></td>
         <td style="width:2.921%;"></td>
         <td style="width:1%;"></td>
         <td style="width:6.901%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Lease Cost</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Classification</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating lease cost</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of sales</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">48</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">61</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">588</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">438</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,027</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">887</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance lease cost</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">63</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Selling, general and administrative</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance lease cost</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest expense</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Lease Liabilities</a></td>
<td class="text"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Maturities of the Company&#8217;s operating and finance lease liabilities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024 were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:42.989%;"></td>
         <td style="width:8.242%;"></td>
         <td style="width:1%;"></td>
         <td style="width:15.143%;"></td>
         <td style="width:1%;"></td>
         <td style="width:11.362%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.264%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Operating</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Finance</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Leases</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Leases</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2024 (remainder)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,004</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2025</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,434</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2026</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,637</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2027</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,782</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2028</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,871</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2029</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,954</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Thereafter</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,308</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#8212;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease payments</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,990</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">199</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less: imputed interest</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,727</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease liabilities</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,263</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">147</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock', window );">Summary of Weighted Average Remaining Lease Term and Discount Rate</a></td>
<td class="text"><p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The weighted average remaining lease term and weighted average discount rate used to determine lease liabilities related to the Company&#8217;s operating and finance leases as of June 30, 2024 and December 31, 2023 were:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.311%;"></td>
         <td style="width:1.08%;"></td>
         <td style="width:1%;"></td>
         <td style="width:18.484%;"></td>
         <td style="width:1%;"></td>
         <td style="width:1.08%;"></td>
         <td style="width:1%;"></td>
         <td style="width:20.044%;"></td>
         <td style="width:1%;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30,</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Lease Term and Discount Rate</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td>
         <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average remaining lease term (years)</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating leases</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.58</span></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.69</span></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance leases</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.35</span></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.37</span></span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted average discount rate</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Operating leases</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.4</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.4</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Finance leases</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.4</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;">&#160;</span></p></td>
         <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.0</span></p></td>
         <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_SummaryOfLeaseBalancesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary Of Lease Balances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_SummaryOfLeaseBalancesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary Of Weighted Average Remaining Lease Term and Discount Rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948169630720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation - Additional Information (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 08, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>Segment </div>
<div>Subsidiary </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_NumberOfWhollyOwnedSubsidiaries', window );">Number of wholly owned subsidiaries | Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segment | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, cash equivalents, and short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 233.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 233.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_OperatingIncomeLoss1', window );">Losses from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 13.6<span></span>
</td>
<td class="nump">$ 19.0<span></span>
</td>
<td class="nump">$ 26.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold | shares</a></td>
<td class="nump">1,785,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockTransactionDate', window );">Sale of stock, date</a></td>
<td class="text">May  08,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (USD per share) | $ / shares</a></td>
<td class="nump">$ 56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_AdditionalNumberOfCommonSharesIssued', window );">Additional common shares sold | shares</a></td>
<td class="nump">267,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds from sale of shares</a></td>
<td class="nump">$ 107.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted', window );">Common stock sale underwriting discounts and commission deducted</a></td>
<td class="nump">6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_CommonStockOfferingCosts', window );">Common Stock Offering Costs</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rxst_ShelfRegistrationStatementMember', window );">Shelf Registration Statement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds from sale of shares</a></td>
<td class="nump">$ 115.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_AdditionalNumberOfCommonSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional number of common shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_AdditionalNumberOfCommonSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_CommonStockOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_CommonStockOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock sale underwriting discounts and commission deducted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_NumberOfWhollyOwnedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of wholly owned subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_NumberOfWhollyOwnedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_OperatingIncomeLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Income (Loss)1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_OperatingIncomeLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockTransactionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the subsidiary or equity investee issued or sold stock, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockTransactionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rxst_ShelfRegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rxst_ShelfRegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948161804624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Accounting Policies - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized gain (Loss) on short term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_AccountsReceivablePercentage', window );">Accounts receivable, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | No Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_AccountsReceivablePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable, Percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_AccountsReceivablePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rxst_NoCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rxst_NoCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948164424640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Accounting Policies - Schedule of Dilutive Securities Excluded from Computation of Income (Loss) Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rxst_StockOptionsIssuedAndOutstandingUnderPlansMember', window );">Stock Options Issued And Outstanding Under Plans [ Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities</a></td>
<td class="nump">5,618,186<span></span>
</td>
<td class="nump">5,821,076<span></span>
</td>
<td class="nump">5,843,009<span></span>
</td>
<td class="nump">3,409,842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities</a></td>
<td class="nump">666,573<span></span>
</td>
<td class="nump">773,940<span></span>
</td>
<td class="nump">544,320<span></span>
</td>
<td class="nump">671,956<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities</a></td>
<td class="nump">59,149<span></span>
</td>
<td class="nump">39,568<span></span>
</td>
<td class="nump">61,085<span></span>
</td>
<td class="nump">45,191<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share Line Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rxst_StockOptionsIssuedAndOutstandingUnderPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rxst_StockOptionsIssuedAndOutstandingUnderPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948163999408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Accounting Policies - Schedule of Revenue From Contracts With Customers (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="nump">$ 34,887<span></span>
</td>
<td class="nump">$ 20,810<span></span>
</td>
<td class="nump">$ 64,399<span></span>
</td>
<td class="nump">$ 38,299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rxst_LDDMember', window );">L D D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="nump">10,189<span></span>
</td>
<td class="nump">7,720<span></span>
</td>
<td class="nump">18,902<span></span>
</td>
<td class="nump">14,195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rxst_RxlalMember', window );">LAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="nump">23,828<span></span>
</td>
<td class="nump">12,411<span></span>
</td>
<td class="nump">43,745<span></span>
</td>
<td class="nump">22,806<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rxst_ServiceWarrantyServiceContractsAndAccessoriesMember', window );">Service Warranty Service Contracts And Accessories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="nump">$ 870<span></span>
</td>
<td class="nump">$ 679<span></span>
</td>
<td class="nump">$ 1,752<span></span>
</td>
<td class="nump">$ 1,298<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rxst_LDDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rxst_LDDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rxst_RxlalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rxst_RxlalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rxst_ServiceWarrantyServiceContractsAndAccessoriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rxst_ServiceWarrantyServiceContractsAndAccessoriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948162033520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Accounting Policies - Schedule of Deferred Revenue Activity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueAbstract', window );"><strong>Deferred Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_DeferredRevenue1', window );">Balance at beginning of period</a></td>
<td class="nump">$ 1,888<span></span>
</td>
<td class="nump">$ 1,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Additions during the period</a></td>
<td class="nump">1,949<span></span>
</td>
<td class="nump">1,391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueRevenueRecognized1', window );">Revenue recognized during the period</a></td>
<td class="num">(1,707)<span></span>
</td>
<td class="num">(1,233)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_DeferredRevenue1', window );">Balance at end of period</a></td>
<td class="nump">$ 2,130<span></span>
</td>
<td class="nump">$ 1,351<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_DeferredRevenue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_DeferredRevenue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueRevenueRecognized1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously reported as deferred or unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueRevenueRecognized1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948287929568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Investment - Schedule of Short-term Investment Available For Sale (Details) - US Treasury Securities [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 208,938<span></span>
</td>
<td class="nump">$ 117,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax', window );">Unrealized Loss, Net</a></td>
<td class="num">(99)<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 208,839<span></span>
</td>
<td class="nump">$ 117,490<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain (loss) in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948171366272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investment - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_InvestmentMaturityPeriod', window );">Investment maturity period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_InvestmentMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment maturity period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_InvestmentMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948164417376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Schedule of Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 11,327<span></span>
</td>
<td class="nump">$ 8,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">5,313<span></span>
</td>
<td class="nump">5,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">3,371<span></span>
</td>
<td class="nump">4,145<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory gross</a></td>
<td class="nump">20,011<span></span>
</td>
<td class="nump">17,917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Less: reserve for excess and obsolete inventory</a></td>
<td class="num">(568)<span></span>
</td>
<td class="num">(496)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory net</a></td>
<td class="nump">$ 19,443<span></span>
</td>
<td class="nump">$ 17,421<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948164565600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment', window );">Inventory held on consignment</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="nump">$ 4.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948163906064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of assets and liabilities measured at fair value on recurring basis and the fair value hierarchy of the valuation techniques (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">$ 227,825<span></span>
</td>
<td class="nump">$ 121,965<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money market Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">18,986<span></span>
</td>
<td class="nump">4,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">U.S. Treasury Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">208,839<span></span>
</td>
<td class="nump">117,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">18,986<span></span>
</td>
<td class="nump">4,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | Money market Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">18,986<span></span>
</td>
<td class="nump">4,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | U.S. Treasury Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">208,839<span></span>
</td>
<td class="nump">117,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | U.S. Treasury Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">$ 208,839<span></span>
</td>
<td class="nump">$ 117,490<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948169997472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">$ 13,993<span></span>
</td>
<td class="nump">$ 3,896<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948162058432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock Warrant Liability - Additional Information (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948164167536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Preferred Stock and Stockholders' Deficit - Summary of Preferred Stock (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Par Value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948165269456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Preferred Stock and Stockholders' Deficit - Summary of Common Stock Reserved for Future Issuance (Details) - shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Conversion of preferred stock</a></td>
<td class="nump">8,385,548<span></span>
</td>
<td class="nump">8,364,218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Conversion of preferred stock</a></td>
<td class="nump">649,988<span></span>
</td>
<td class="nump">650,357<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948165901152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 28, 2021</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 01, 2024</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,617,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,139,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,385,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,364,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward', window );">Stock-Based Compensation, Terms of Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Stock option awards are granted with an exercise price of no less than 100% of estimated fair market value on the date of grant. Time based awards generally vest over four years as follows, subject to the optionee&#8217;s continuing service: (i) one fourth of the total number of shares vest and become exercisable on the one-year anniversary and then 1/48th of the total number of shares subject to the option vest and become exercisable on each monthly anniversary thereafter for the remaining three years, or (ii) 1/48th of the total number of shares subject to the option vest and become exercisable each month over four years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Total unrecognized expense related to unvested stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,993<span></span>
</td>
<td class="nump">$ 3,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember', window );">The Calhoun Vision, Inc. 2015 Equity Incentive Plan and the Calhoun Vision, Inc. 2006 Stock Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Intrinsic Value of Vested Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Intrinsic Value of Outstanding Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 185,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Total Cash Received from the Exercise of Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,300<span></span>
</td>
<td class="nump">3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total Fair Value Less Strike Price of Stock Options Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,500<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options, Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,620,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,539,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Total unrecognized expense related to unvested stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period for recognition of expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rxst_The2021PlanMember', window );">2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common stock available for issuance</a></td>
<td class="nump">2,420,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="nump">7,260,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">951,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,445,580<span></span>
</td>
<td class="nump">1,130,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period for recognition of expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rxst_The2021PlanMember', window );">2021 Equity Incentive Plan | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved</a></td>
<td class="nump">4,569,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rxst_The2021EsppPlanMember', window );">2021 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">538,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved</a></td>
<td class="nump">1,452,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rxst_The2021EsppPlanMember', window );">2021 Employee Stock Purchase Plan | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock-Based Compensation, Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">649,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options, Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">649,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rxst_The2021PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rxst_The2021PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rxst_The2021EsppPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rxst_The2021EsppPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948162486416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense - Summary of Stock Option Activities (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Beginning balance</a></td>
<td class="nump">6,777,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="nump">799,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="num">(1,258,874)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options, Forfeited</a></td>
<td class="num">(62,995)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="num">(10,236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Ending balance</a></td>
<td class="nump">6,244,801<span></span>
</td>
<td class="nump">6,777,404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable</a></td>
<td class="nump">3,623,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Beginning balance</a></td>
<td class="nump">$ 13.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Options Granted</a></td>
<td class="nump">55.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Options Exercised</a></td>
<td class="nump">10.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Options Forfeited</a></td>
<td class="nump">16.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Expired</a></td>
<td class="nump">4.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Ending balance</a></td>
<td class="nump">18.99<span></span>
</td>
<td class="nump">$ 13.02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Exercisable</a></td>
<td class="nump">$ 13.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-Average Remaining Contractual Term (Years), Options outstanding</a></td>
<td class="text">6 years 9 months 10 days<span></span>
</td>
<td class="text">6 years 6 months 3 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-Average Remaining Contractual Term (Years), Exercisable</a></td>
<td class="text">5 years 5 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948162617824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense - Summary of Non-Vested Restricted Stock Unit Activities (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="nump">799,502<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at December 31, 2023</a></td>
<td class="nump">650,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="nump">183,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of shares, vested</a></td>
<td class="num">(165,567)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of shares, forfeited</a></td>
<td class="num">(18,033)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested at June 30, 2024</a></td>
<td class="nump">649,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares</a></td>
<td class="nump">$ 15.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Options Granted | $ / shares</a></td>
<td class="nump">56.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value, vested | $ / shares</a></td>
<td class="nump">17.99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average fair value, forfeited | $ / shares</a></td>
<td class="nump">15.71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value, Ending Balance | $ / shares</a></td>
<td class="nump">$ 26.68<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948166014208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense - Schedule of Stock-Based Compensation Expense (Details) - The Calhoun Vision, Inc. 2015 Equity Incentive Plan and the Calhoun Vision, Inc. 2006 Stock Plan [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 6,105<span></span>
</td>
<td class="nump">$ 3,955<span></span>
</td>
<td class="nump">$ 10,801<span></span>
</td>
<td class="nump">$ 7,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">1,395<span></span>
</td>
<td class="nump">1,021<span></span>
</td>
<td class="nump">2,501<span></span>
</td>
<td class="nump">1,823<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember', window );">Selling, General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">4,210<span></span>
</td>
<td class="nump">2,639<span></span>
</td>
<td class="nump">7,410<span></span>
</td>
<td class="nump">4,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember', window );">Cost of Goods Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
<td class="nump">$ 890<span></span>
</td>
<td class="nump">$ 517<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948166259312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense - Schedule of Range and Weighted-average Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility, Weighted Average</a></td>
<td class="nump">71.00%<span></span>
</td>
<td class="nump">65.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate', window );">Risk-free interest rate, Weighted Average</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife', window );">Expected life (in years), Weighted Average</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield', window );">Expected dividend yield, Weighted Average</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue', window );">Grant date fair value, Weighted Average</a></td>
<td class="nump">$ 55.93<span></span>
</td>
<td class="nump">$ 15.26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, Maximum</a></td>
<td class="nump">72.00%<span></span>
</td>
<td class="nump">65.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, Maximum</a></td>
<td class="nump">4.70%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue', window );">Grant date fair value</a></td>
<td class="nump">$ 60.65<span></span>
</td>
<td class="nump">$ 28.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, Minimum</a></td>
<td class="nump">69.00%<span></span>
</td>
<td class="nump">64.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, Minimum</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue', window );">Grant date fair value</a></td>
<td class="nump">$ 36.89<span></span>
</td>
<td class="nump">$ 12.91<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Grant Date Fair Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected dividend yield.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Risk-free Interest Rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948164562768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stock-Based Compensation Expense - Common stock reserved for future issuance (Details) - shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved</a></td>
<td class="nump">8,385,548<span></span>
</td>
<td class="nump">8,364,218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved</a></td>
<td class="nump">649,988<span></span>
</td>
<td class="nump">650,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember', window );">Stock options issued and outstanding under the 2006, 2015 and 2021 plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved</a></td>
<td class="nump">6,244,801<span></span>
</td>
<td class="nump">6,777,404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember', window );">Shares Available For Future Issuance Under The 2006 ,2015 And 2021 Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved</a></td>
<td class="nump">951,817<span></span>
</td>
<td class="nump">358,610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rxst_The2021EsppPlanMember', window );">The 2021 ESPP Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved</a></td>
<td class="nump">538,942<span></span>
</td>
<td class="nump">577,847<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rxst_The2021EsppPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rxst_The2021EsppPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948164647360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity (Additional Information) (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="nump">39,617,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,139,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="nump">39,617,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,139,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="nump">39,617,334<span></span>
</td>
<td class="nump">37,161,753<span></span>
</td>
<td class="nump">36,139,513<span></span>
</td>
<td class="nump">35,168,041<span></span>
</td>
<td class="nump">33,966,697<span></span>
</td>
<td class="nump">28,268,389<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948166303792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 18, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 04, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>Item</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Sublease agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">34 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Lease Rent Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Future minimum lease payment</a></td>
<td class="nump">$ 10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear', window );">Due in 2024</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Due in 2025</a></td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Due in 2026</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">Due in 2027</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">Due in 2028</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingSubleaseOptionToTerminate', window );">Sublease cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On August 1, 2024 the sublease was cancelled.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1', window );">Operating Leases, Rent Expense, Sublease Rentals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxst_CliffordDDownsMember', window );">Clifford D. Downs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">Apr.  01,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease Payable term</a></td>
<td class="text">70 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Sublease agreement</a></td>
<td class="text">70 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Lease Rent Payable</a></td>
<td class="nump">$ 30,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease term extended term</a></td>
<td class="text">60 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxst_CliffordDDownsMember', window );">Clifford D. Downs [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">Jan. 31,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxst_AccurideInternationalIncMember', window );">Accuride International Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">Oct.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease Payable term</a></td>
<td class="text">76 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromTenantAllowance', window );">Operating leases,tenant allowance</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Sublease agreement</a></td>
<td class="text">76 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Lease Rent Payable</a></td>
<td class="nump">$ 64,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Lease extend term</a></td>
<td class="text"> The Company has two options to extend the term of the lease at the end of the current term, with each option to extend being for a 5 year term.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxst_AccurideInternationalIncMember', window );">Accuride International Inc [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">Jan. 31,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rxst_OfficeManufacturingAndWarehouseFacilityMember', window );">Office, Manufacturing and Warehouse Facility [Member] | California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_NumberOfLeases', window );">Number of leases | Item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of leased space | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromTenantAllowance', window );">Operating leases,tenant allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rxst_IndustrialCommercialMember', window );">Industrial/Commercial [Member] | BML Management, LLC [Member] | One Twenty Five Columbia Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of leased space | ft&#178;</a></td>
<td class="nump">26,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperationsCommencedDate1', window );">Lease commences date</a></td>
<td class="text">Jun.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">Jan. 31,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Sublease agreement</a></td>
<td class="text">60 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Lease Rent Payable</a></td>
<td class="nump">$ 41,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rxst_IndustrialCommercialMember', window );">Industrial/Commercial [Member] | Clifford D. Downs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of leased space | ft&#178;</a></td>
<td class="nump">19,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rxst_IndustrialCommercialMember', window );">Industrial/Commercial [Member] | Accuride International Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of leased space | ft&#178;</a></td>
<td class="nump">42,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_NumberOfLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_NumberOfLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingSubleaseOptionToTerminate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to terminate operating sublease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingSubleaseOptionToTerminate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481418/840-10-55-40<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481418/840-10-55-40<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481418/840-10-55-40<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481418/840-10-55-40<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481418/840-10-55-40<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481418/840-10-55-40<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of sublease rental income recognized during the period that reduces the entity's rent expense incurred under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481418/840-10-55-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseSubleaseRentals1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperationsCommencedDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the operations of the entity commenced, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperationsCommencedDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromTenantAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net cash outflow or inflow from monetary allowance granted by the landlord to a tenant to entice tenant to move into landlords building which will enable the tenant to prepare the leased premises for tenants occupancy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromTenantAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rxst_CliffordDDownsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rxst_CliffordDDownsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rxst_AccurideInternationalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rxst_AccurideInternationalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rxst_OfficeManufacturingAndWarehouseFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rxst_OfficeManufacturingAndWarehouseFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rxst_IndustrialCommercialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rxst_IndustrialCommercialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rxst_BmlManagementLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rxst_BmlManagementLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=rxst_OneTwentyFiveColumbiaLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=rxst_OneTwentyFiveColumbiaLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948163087552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Lease Balances Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating leases right-of-use assets</a></td>
<td class="nump">$ 10,818<span></span>
</td>
<td class="nump">$ 2,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Assets Finance</a></td>
<td class="nump">$ 142<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Property and equipment, net<span></span>
</td>
<td class="text">Property and equipment, net<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_TotalLeaseAssets', window );">Total lease assets</a></td>
<td class="nump">$ 10,960<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Liabilities Current Operating</a></td>
<td class="nump">$ 710<span></span>
</td>
<td class="nump">$ 1,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Lease liabilities<span></span>
</td>
<td class="text">Lease liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Liabilities Current Finance</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Lease liabilities<span></span>
</td>
<td class="text">Lease liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Noncurrent</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Liabilities Noncurrent Operating</a></td>
<td class="nump">$ 10,553<span></span>
</td>
<td class="nump">$ 1,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Long-term lease liabilities<span></span>
</td>
<td class="text">Long-term lease liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Liabilities Noncurrent Finance</a></td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Long-term lease liabilities<span></span>
</td>
<td class="text">Long-term lease liabilities<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_TotalLeaseLiabilities', window );">Total lease liabilities</a></td>
<td class="nump">$ 11,410<span></span>
</td>
<td class="nump">$ 3,012<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_TotalLeaseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total lease assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_TotalLeaseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_TotalLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_TotalLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948165444208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Components of Lease Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Finance lease cost</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Goods Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance lease cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">588<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="nump">1,027<span></span>
</td>
<td class="nump">887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance lease cost</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948161812576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturities of Lease Liabilites (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2024 (remainder)</a></td>
<td class="nump">$ 1,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">2,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">2,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">2,782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">2,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">2,954<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">3,308<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">17,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(6,727)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">11,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2024 (remainder)</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 147<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948163885456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Weighted Average Remaining Lease Term and Discount Rate (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weigted average remaining lease term (years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term - operating leases</a></td>
<td class="text">6 years 6 months 29 days<span></span>
</td>
<td class="text">1 year 8 months 8 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term - finance leases</a></td>
<td class="text">4 years 4 months 6 days<span></span>
</td>
<td class="text">4 years 4 months 13 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxst_WeightedAverageDiscountRateAbstract', window );"><strong>Weighted average discount rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate - operating leases (as a percent)</a></td>
<td class="nump">14.40%<span></span>
</td>
<td class="nump">10.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate - finance leases (as a percent)</a></td>
<td class="nump">14.40%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_WeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_WeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxst_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxst_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948163034528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal proceedings, regulatory matters, legal costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Aggregate amount of the letter of credit</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139948164544448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event (Additional Information) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">$ 13,993<span></span>
</td>
<td class="nump">$ 3,896<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>78
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MNP'B%:_O;0=^E+?CH <)(\_4L U[G!(P8FM3A+-Q(^"P"M)XHNB20<&(7\(
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M5MWEFC/ -@;P_4J"5.]NS$'V_A\7RW\!4$L#!!0    ( .N!!5GB5*%/P (
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M7T'8",(JT)JL"NN1&CJ?*KDCREJC-]NH<E.I,1HF["ZNC,)9ACHS7TB1XIY
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MJ("R!CB_EM+L._8L;*\^\S]02P,$%     @ ZX$%6?]+'O_C!@  VR$  !@
M  !X;"]W;W)K<VAE971S+W-H965T-"YX;6RM6FUOVS80_BN$5PPID,0B]9XE
M!AI;W3*L6]$TZV?%HFVADNB)M)/NUX^49<LF3VR:Z4LL*<\=]=P=CX\H73^Q
M^BM?42K0<UE4_&:T$F)]-1[S^8J6*;]D:UK)_RQ87:9"GM;+,5_7-,T:H[(8
M$\<)QF6:5Z/)=7/M8SVY9AM1Y!7]6".^*<NT_G9+"_9T,\*C_85/^7(EU(7Q
MY'J=+ND]%0_KC[4\&Q^\9'E)*YZS"M5T<3-ZAZ\2$BF#!O%W3I_XT3%25!X9
M^ZI.[K*;D:/NB!9T+I2+5/YLZ906A?(D[^.?UNGH,*8R/#[>>W_?D)=D'E-.
MIZSXDF=B=3.*1BBCBW13B$_LZ3?:$O*5OSDK>/,7/;589X3F&RY8V1K+.RCS
M:O>;/K>!.#*0?F #TAH0W<#K,7!; _>E(WBM@??2$?S6H*$^WG%O C=+13JY
MKMD3JA5:>E,'3?0;:QFOO%*%<B]J^=]<VHG)E%693#O-D#SBK,BS5,B3>R%_
M9#T(CM@"_;6F=:KRRE%:*60IBW*EJF5+T5TU9R5%?S#.T=E#E6ZR7'IXBR[0
MP_T,G;UYB]Z@O$*?5VS#I36_'@MYWVKT\;R]Q]O=/9*>>W31!U:)%4>)O-<,
ML)_9[0.+_5C&ZQ TL@_:+;$Z_'U372+7.4?$(1YP/].7F[L0G?\W>O+JT4^"
MX1XJR&W\>3W^[M."@DG=F06-F>I7VXGK15%X/=X>A\I$$2?"SBEJ9J("SXWC
M4U0"C!B1(]0)/^_ S[/RFS(NU"3@?3QWYO[1J-@)7)VGB8K"V-=H JYB+_ T
MF@#*CW$/3?] T[?2_+56$WA=LT4N():^,2CQB*_E:6JB,'&P3M-$>5[L:J@$
M&)&XD0/3# XT@\;,[:'9MK)JB>CS6C4^?@6Q#6RQ4HOW%5^G<WHSDHV0TWI+
M1Y.??\*!\PO4#89T-AO263*0LY-,A(=,A/:^(<6!S,,Y6M)*YJ1HEI8TDVM<
MSH7*T99"F0FA.HR)5H<F"D?$U?K%S$1Y88 #K0Y-E"O+E<!U&!W81U;VGV0\
MTWJ^:EAG="L5VUJMMQ#ER&P=),8:8Q,4>HX&FID@'+A$"UX"H+S B6#"\8%P
M;"7\F0F98V9,/XAP;$:<^)&K,391Q \\?>4P48$;NY%&V41Y,79Z>@UV.G'E
M6$DWHFA1LW)/7$HH4/\XQO@7D>OJC"$8=@.B]U<0%SN.YB^!<"0(21_O(U&)
M[5U6K&@M55^C#,_:5+\]1Q458+MMW0W4;P?U-AO46S*4M]/$D"XQQ%J0=Y6@
MTJ_83S\P&<2LBD"O1 "#_2#2"Q&"8;T* 9#KA'Y/$7:Z%-N%Z8&K:K'LJ")!
MTBZ@-D*#MHG"81CJK$V4&P6.3AM X:"GR^).K6*[7&U:CGP"I\^JS6YROE++
MBA*P,AHE*EA:@?Q-4:EK.P!R(9N/3OZ[CI+O.3IEW@E8;%>P#?-'NF UW;<>
MD3[#*PPVQ>5%(%6[3AF 83<,C3J'<#[V=>4.X4@01SW:'7>J%ENEVN3NP-<Z
MLP-@_=<IFQ@2Z'0!C*[>(4S80[.3C-BN&?^D0E8PAU-JZC29TC#6^0$P+!\K
M/)TCA/.Q[B^!<"1TCN)ZRK43B#AZP1HZ/]EK.5/DW]K:F%5U_O!".J2WV:#>
MDJ&\G6:G4[/8+F<?JIJF1?XOS= RS:LV,[+O\A6KQ473:_-J*Y>?9A<-S)4I
M.B_T9_TI"#+T'@#"CE&I)JIOTX!T"I?8%>Y[V6WS987FF[JFU?P;DH]N%2\:
MJ;LO5Q4@*  $DJD:?P"C/]1 ;O3&"V#<'NJ=R"56K;9_HGG--&T]6[,Z!4%Z
MFX) &.M"'T"1GO66=%J2V+7DZ39P7UMNG00G++"GUSD$DVW94)0@SC<V !((
M)U?:V.MAW:E*XEK;\GX)0O*!3D[VM*;@$PVQ:M,?;<2#>IL-ZBT9RMMI/CJ]
M2^QZ]YT0=?ZX$>EC(?4/4S.Q5&U8L/G7<_4.*9^#^=EYC8[KP[DTU% +BT]A
MQB1\"2J!AXSZYF&G>XE=]]HCD.7%1H!O36Y;O]^-@?^B&+P$E<!#]L:@T[_$
MOJW[I7DA2+.+=$OK=$EW,Y.CC7JS)9=GU9\WS;Y3]<+Y.^@.\*#>9H-Z2X;R
M=IJY3M(3NZ1_[?P%=F4CS_=CWUA&X?W;B!@R"D*&@1?[1-^R@)!JR\*/>G8M
M2"?[B7UC^/6SV=RV[8L(@.R)"(#LB0B A",R/GI97=)ZV7PEP"7/325V;QT/
M5P]?(KQKWK]KUV_QU10#UV?X*ME]9]"YWWWV\"&MEWG%44$7<BCG,I2W6^^^
M)-B="+9N7I4_,B%8V1RN:)K16@'D_Q>,B?V)&N#P/<?D/U!+ P04    " #K
M@059!]!.\1L-  #)>0  &    'AL+W=O<FMS:&5E=',O<VAE970U+GAM;,U=
M;9.;NA7^*XQ[I[V9B;. D##I9F<2&TW3Z6TS-S?M9V)KUS0V.(!WD_[Z"MMK
M6=)!ALUQDGS(^N7H.4*/CI >'>'KA[+Z5"^%:+POZU51OQHMFV;S\NJJGB_%
M.JM?E!M1R&]NRVJ=-?)M=7=5;RJ1+7:%UJNKT/?9U3K+B]'-]>ZS=]7-=;EM
M5GDAWE5>O5VOL^KK&[$J'UZ-@M'C![_G=\NF_>#JYGJ3W8GWHOFP>5?)=U='
ME$6^%D6=EX57B=M7H]?!2Q[[;8&=Q;]S\5"?O/;:2_E8EI_:-V\7KT9^6R.Q
M$O.FA<CDGWLQ%:M5BR3K\?D .CKZ; N>OGY$Y[N+EQ?S,:O%M%S])U\TRU>C
MR<A;B-MLNVI^+Q_^)@X71%N\>;FJ=_][#P=;?^3-MW53K@^%90W6>;'_FWTY
M-,1)@8!T% @/!<*^!<BA #$*A'%'@>A0(#(*D*X"]%" FAZZ+IH="K!=V^\;
M:]?2LZS);JZK\L&K6FN)UK[8T;4K+1LX+]J>];ZIY+>Y+-?<3,MB(?N)6'CR
M55VN\D76R#?O&_E'=J"F]LI;^:Z<?UJ6JX6HZK]XZ>=MWGSU?OU09-M%+JV?
M>6/OP_N9]^LOS[Q?O+SP_EB6VSHK%O7U52/KV'JZFA_J\V9?G["C/G^43;8"
MBDW=Q:;E>BW[Z:ZB0.F9N_3KA;P.V<^SE?<NRQ=C>0G3;)/#-4G/8,WGV_5V
MM6O%?S5+4<F&7<N@7[;1>"^\?Y0UU"R\/^I,W.;SO-%!KB3O1_+#(_GA#C7J
M0(5X?>Z]$7=Y4>3%G?<F6V7%7#SW7J_+;=%X62.=SU]X)'CNA7X80O3N/;*=
MQW98N[^9)(DO3>]/V;2MPHEN,K--&&&^'^AFJ6TV3JANPP$;&C&?J%IIS4>.
MS4=PFN_],JM$W:OYG![;V\S+>I/-Q:N1[%*UJ.[%Z.;/?PJ8_U<H9O9@5&OE
MD$W()#':&M-KB@G&D< T?J,COY&;WSUM>5UO9=C)N[@GX]D37T0USVO1#HQU
MVP.\<M,.'I+?8N'=B[IIN9=?RK)-E<_;D-W;;8N\J1^#"2(_LOB*F='?I\XJ
M#VS=60^'*:9#C@2FT4F/=-(?0><>%J+369VAL4SM6(X(3<Q1$]-GB@G&D< T
MZMF1>M:'^DHLA)S5[,D7Z\VJ_"J$UV1?Y*2K6;8CN>3:&:',8F%,2&R$J+,N
M0T.TC\<4TR-' M.(BH]$Q9A$=<>>T\W0V(MM#L*($6.DG&'Z3#'!.!*81NGD
M2.GD_"QIW*[^%MY<3H7E/#C;+2K%E_:U@-B;6 U.0G-6-W6Z'1IF?3RFF!XY
M$IC&27+D)'%R\E;> ]NI:7M?F^^73OM[6AMOF^W'53Z77]V*2H;9<Z\036NX
ME2O%ZJ'*=S?$15[/VT%2!F$+(&^JQWOF8T'Y1>V>[R16H]-VBF_PG%BS=X.7
M&81#+?:<33*4/20PC;W 5XMV_^?AKWN0===RZ"A[0#NE42[2VG\&W:AN4U0T
MCH6F=XP3-2=X>L?(FK&<\8[76?5IUR/V--?'#I(_%CX;N(=:G%(5^$D0&9%[
M,#L-7?.>V8%$C-AU7_9@DI#0=)*4ZA*X91=4DAS1Z:S%X.@$A)TX(9%%**;7
M%!6-8Z'IO"NY*'#K11^*2F2K_']R(K0JZ]IK>5^6E21<5&LO+]K%YEYS;8?A
M>58O/?%YF]]G*[$;J \]0$Z#0;IMM6=B!22F-C-#14M[U)]C>=0)5'I0X!:$
M>%F)_*[PYMNJ$L7\J]=465&O]M/9;/'?[9X_D!U;:C$U4;?SP>1@HJ7GJ\^Q
M'.K<*'$G<*L[_Y3!\;:0PZGP?FTU]F<@"[:*,@Y(&%A48"H?,U2T%!6-GV\1
MG0^EN 1G)!=0'$^+1<?&PF]9=53&"<B=K80$$?7]Q.2.63<J$IDW*1LK]J/0
MW(-( ;MQ8O9[P(;2)(RBCB946DAP1@SIU81J<^%\$Z*J(H$MBQ"2,,:2V&QN
M5&4$%8UCH>D<*W$DZ*&.(&_!!;:8 >W!'<R<FW  %+@+!]C9VW"0D6L?+E!R
M1N#6,RZQ$^=V.3A8;(VB8R\.U6^*BL:QT/3=:B5[A&[9X[(3Z-#6'P+SYN*N
MX-") 2I:BHK&L=!TJI60$;J%C%[3N= 6#\9A[ ?,9 U3/9BAHJ6H:!P+36?M
M))_D*0DEW9.^OV\+.0C[W3.6@S\M)FD<3"8FP[8Z04R5&,"*B1_&QN0P!>S&
ML2%(<<B(2KAH M_+0J42A$_)*NF>]9UO0]2<DM!>IA,:L(EO*4&H?E-4-(Z%
MIG.LA(3P3&;)\%G?V<E]:"_1P?71P<ZY/@*PP/418&>MCR ;U_HH5$O^\$Q"
MQ_!9W_E61$W:".W5=<<2"=5OBHK&L=!TFI62$/9*WOA^:5BAO:(/:6+%$6J:
M1R^?*:I/CH6F\ZKDC;!7KL?WR\=RUV=P; /RA[1-0C.R4<4/5#2.A:;W "5^
MA/BI(2&0J9%0,S?$[7AP</;QF:+ZY%AH.C5*40G/*"IP<#ZF8NTC;K.MYDO)
MGK>1-UKGB IF>IB<84H5LSXN4U27' M-3T97Z@AQJR-/H:Q[L'0[&YR);FLK
MU*>^.>]$=9JBHG$L-)U=)8B0;\CL^'XI/^Y:#NX6MH S(5$<F3(TJM<4%8UC
MH>G]0DDNY#LFDW2/X 008B8)-5.?B:W#F+) !Y(Y-+LO>S!)E\C\("<'A7YD
MY@>Q)9DQ,V=$[AH.O;NBHJ5]+H!CN=0I5)(-N5CN!P&4&9,=U-P/5+3T?/4Y
MED.=&R4$$83<#P)F.DS,.<C4[6LP%:BZ#BH:/]\B.A]*L2&XN1]G)6P"Y'Y
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MN1299+,UD-_?EF7S^*;]Z=SCKS??_!]02P,$%     @ ZX$%64W/1SX3"0
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M -ZOA9"'&_4#_<':Z_\!4$L#!!0    ( .N!!5EPS9'JN (  (D)   8
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MX%F144;(RW4Y4C\9J!4*'#&JKY-V2?N1.AO_,FYT'*O!9;71I',P:QM%MV4
M@C8DG@[ZL[.TV0_6K7-?L@GUIZCVK4$R<C>[NJAOR^5WG2K_Q [)AF0[X]9(
ML7FS-WE(!^A"N^;F$KEY2X@>(;6X>@5 U[ RW8RZ,.2X@O?0^0>D)+W$->L
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M(G/9JO,\"9Q-IM_("CA!\@+R9VGK\A8FV_.\?MNY*V$'0I$SQ&/!V')9A\C
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M1D].;JB5UW9I"_(8GB/F \SI'"Z$0/@V^1C5K.+5?![@ UXB2%:_H\C0M;I
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MM0A/L<8]$0CX',"H0)/ #P]#C6M4UI>U\ST"*5,4@*;UIFBVB*C&(5(*CWC
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M7$6)*;HN)? VG<3%:V44&$^M":YA+"[)+658$/5[7<R12\_.@LADS"R-4D[
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M>?J(Q\-,BR_ [PL'VY ON$#X&R$__!]02P,$%     @ ZX$%6?10/<!> P
MO@<  !D   !X;"]W;W)K<VAE971S+W-H965T,3$N>&ULG57?;]LX#'[O7T%X
MAV$#TMB)LS9IDP!I]^-VV(9B77</PQX4FXF%RI(GRLUR?_U1LN-E6!KL[B61
M:'X?/U(B-=T8>T\%HH/OI=(TBPKGJHLXIJS 4E#?5*CYR\K84CC>VG5,E461
M!U"IXF&2G,6ED#J:3X/MQLZGIG9*:KRQ0'59"KN]0F4VLV@0[0P?Y;IPWA#/
MIY58XRVZN^K&\B[N6')9HB9I-%A<S:+%X.)JY/V#PV>)&]I;@\]D:<R]W[S-
M9U'B!:'"S'D&P7\/>(U*>2*6\:WEC+J0'KB_WK&_#KES+DM!>&W4WS)WQ2P:
M1Y#C2M3*?32;/['-YX7GRXRB\ N;QC<=19#5Y$S9@EE!*77S+[ZW==@#C)-'
M ,,6, RZFT!!Y4OAQ'QJS0:L]V8VOPBI!C2+D]H?RJVS_%4RSLUO"V/=Z2>T
M);S5#TB."^ZFL6-J[Q!G+<U50S-\A.8,WAOM"H)7.L?\9WS,DCI=PYVNJ^%1
MPK]JW8<TZ<$P&8Z.\*5=GFG@2_]+G@1?%DMREJ_&UT,Y-Y2CPY2^72ZH$AG.
M(NX'0ON T?SID\%9<GE$\*@3/#K&_OL'<YSF@W$(*3Q],AX.!I?P2!D:L_-F
M^</<@\I*G<E**+6%N_YM'SYQXU-MM["42K&#L CB04@EE@I/>4:<DE!LTCED
MACN7'.9@5N *A)51/ *D7L,SJ=EB:F(_>GYQLB#OPT>.W9&?+$J6)/]A^+4A
M!W>:(ZNP?V>((W_@@?6*G.3&9-MK(2U\%JK&DY]U$F:UE4XBP1],/.Y-TC&O
MGL%D L];TSB=M!)>8H;E$BVD@R C/2+C#4^\_R=C,#COC<:)7R6[[22!A5*'
M:KD'+5#E('XM5JCW+]JA$.S-P\)Y_-:C%!)QY84&P_ M"@LLDL_FVI25T%N&
M$&1*$,F5Y'SXX!EO[]%Y37M2>CR0U\+F@9")=T%Z7AX=O$UA>.905T:'Z]"&
M##?S_)) \)7R,GTN4CN&@#-0D[]-C=6K"7?)L/&@+(\@X22MM@=C*/FMEKF/
M8I%7%H.R_J%VC?=F:HEV'5X.+HZIM6O&:V?M'J=%,Y-_N#<OVWMAUU)S=%PQ
M-.F?OXC -J]%LW&F"A-Z:1S/^[ L^(%%ZQWX^\IP%[<;'Z![LN?_ E!+ P04
M    " #K@059T<KIH/H"  !,!@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q
M,BYX;6R%55UOTS 4?>^ON H(,2DTG_U8:2MMC D00],0\(!X<)/;QL*Q@^VL
MV[_GVLE")VWEI;&O?8[/\?6]7>Z5_FTJ1 MWM9!F%536-HLH,D6%-3-CU:"D
ME:W2-;,TU;O(-!I9Z4&UB-(XGD8UXS)8+WWL6J^7JK6"2[S68-JZ9OK^'(7:
MKX(D> C<\%UE72!:+QNVPZ]HOS77FF;1P%+R&J7A2H+&[2HX2Q;GN=OO-WSG
MN#<'8W!.-DK]=I./Y2J(G2 46%C'P.ASB^]0"$=$,O[TG,%PI ,>CA_8+[UW
M\K)A!M\I\8.7MEH%\P!*W+)6V!NU_X"]GXGC*Y0P_A?VW=XL#:!HC55U#R8%
M-9?=E]WU]W  F,?/ -(>D'K=W4%>Y06S;+W4:@_:[28V-_!6/9K$<>F2\M5J
M6N6$L^N/\A:E59JC64:6"%TX*GKP>0=.GP%/X4I)6QEX+TLL'^,C$C*H21_4
MG*='"3^U<@Q9'$(:I_D1OFQPEWF^[#_N[N&"FT(HTVJ$GV<;8S4]AU]/.>X(
M\Z<)78DL3,,*7 54 P;U+0;K5R^2:?SVB-Q\D)L?8_]?,HZ#ORB+D,.K%_,T
M2=[" =>C<:&HH(S%$M06;(6P58(JD\L=O.:2(JHU3);F9#&B;*#/Q@466&]0
M0Y:$(Y<:EY]L=,DEIY=7PDZITL!+2)(P2V<TF(?Q:3JZ87MZJA8U9\+ ),R2
MC'ZG\WCT@RKU#9=O&JT*- :R,)LED(=)/B'^,$X22&;A:3(;?:;E!?1735HU
MX)V'D$90&Z,$DFT^Y/DU3*9S.*%O?CJ%DQ&).@WS/'/J9F&>)G!F83#FO3BF
M0X?>7 C;Q^ZX+$1+KYR()N.82E$(WU6DB^3C?(C0M?Z34Z$@F;*[]9VD;F:!
MV;ZPZ3C#+9K0^6O0]R=Q/W[J(44'%4ZXG>]C+IFMM%VQ#]&A59YU'>+?]J[/
M7C&]X]* P"U!X_%L$H#N>E<WL:KQ_6*C+(GTPXK:/6JW@=:WBEY:/W$'#'\@
MZ[]02P,$%     @ ZX$%6<MN;_I< P  &P@  !D   !X;"]W;W)K<VAE971S
M+W-H965T,3,N>&ULG5;;;MLX$'WW5PS4H-@"AG7U)8EM()<M-HMF$31M]Z'H
M RV-+2(2J9*47??K.Z0NJP*)B^V+Q<N<,^=0FJ&7!ZF>=(YHX%M9"+WR<F.J
M"]_7:8XETQ-9H:"=K50E,S15.U]7"EGF0&7A1T$P\TO&A;=>NK4'M5[*VA1<
MX(,"79<E4\=K+.1AY85>M_">[W)C%_SULF([?$3SL7I0-/-[EHR7*#27 A1N
M5]Y5>'&=V'@7\(GC00_&8)ULI'RRD[MLY056$!:8&LO Z+''&RP*2T0ROK:<
M7I_2 H?CCOVM\TY>-DSCC2S^Y9G)5]["@PRWK"[,>WGX"UL_4\N7RD*[7S@T
ML7'B05IK(\L63 I*+IHG^]:>PP"P"%X 1"T@<KJ;1$[E+3-LO53R ,I&$YL=
M.*L.3>*XL"_ET2C:Y80SZ[>,*_C$BAKA'IFN%=*)&[WT#9';$#]MB:X;HN@%
MHAG<2V%R#7^*#+.?\3Z)ZI5%G;+KZ"3AW[680!R,(0JBY 1?W#N-'5_\:Z>W
M7*>%M&8U?+[::*/HX_CRG.>&,GF>TA;,A:Y8BBN/*D*CVJ.W?OTJG 67)P0G
MO>#D%/O_>34GB9Z7^8\T"%-X_6H1A>$EO) ,/N0(AFT*!"8RR 8'1PT!#.U6
MJ+C,-#AJ83"#C2UU^(,+VI>U)J!^TVT[R(TL*R:.+O?\4@/3&BF7S5!PMN$%
M-YPRE(V0#)B!K=6W=_IL+5,_2&NEN-C9FN0-EHN,IXQLV1P#0,Y1,97F1Y!;
MMV>7F6L*!M-<\*\U9:L-Y?UNY1^'(L%(JG*#BHH/J7>E^8!ZXLZGB\QX!D(:
MR-G>'M>Q\T4'];NV#MSD=([O<(\%Q,/P<O"6)J,K;;U1R6!?,J,&=->"[^[@
M@S2LH% KZF)$Y8I':B7JB5J_MGD;>6<0+L;GBUGS:427_<+HX^21#"N7^#B$
M=)%1L!@OXO/N.7()^[?[D]L^RUF/HE$T'R^B:>OF%E,L-Z@@#IVC^/<=)>-D
M/NUENMFOW83A?)R<!]WSM)LFPUD/HE$4CL]G4WBN$_B#AEVBVKEK24,J:V&:
MWMVO]C??5=/P_PMOKLU[IG9<:"AP2]!@,I]ZH)JKJ)D86;GVOY&&+A,WS.GV
M1F4#:'\KJ1.T$YN@_S^P_@%02P,$%     @ ZX$%64X .ZZ)#0  I2@  !D
M  !X;"]W;W)K<VAE971S+W-H965T,30N>&ULQ5I9<]M&$G[GKYA2["V["H8
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ME8_XP&!8/QXE)V6@)'O/A0(LFX8L"/*6*/Q%X6)<A7>B0"^8-VTG<:_ (.<
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M /R.H7SBQ1S[X+GTGISUJ8/0Y/1>!M(P1=. NJ;=;PX;XXP7T]^P$:Y---#
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M1[8=6#X,B]L=:L[+Y?=F]54#"+J]@P5E"HT9(=T7)?"!B08+%OKP.OCBH.9
MKRQW?:(WJ:EE5<9JG0[IY/UZA'V#U>=DKPO$Y\-&/<<#),0-'I9X(L/VL]"%
MZ10F5('L@:A:H'JEM&DME8;H2F#HT2$#SUU4V'/!U;>B$J0[M+'A5#KS(1_0
M#5.:'9Q^] H+:< LKL<R5P]^._)_]@H^ZN3.!65BFO9UE*/:J5*O#%MR Q5-
MQ?CHOR(.QP8X@Y )=WMM-L@7$N(!?Z9?-%E)F?-^-) G*. 5K<'0SE:&.^BC
M]V_>H <8 +*_\^#;9.7SL=U*/C)P&>((O=*DM6HN]6U(;V.BE-.DQ ;B$EWC
M7W,N-.Q::UZ@I9TE-6>*;0K$L6.#%E-'B>&FY<*,95XW+: ]EI^P.DR*,GX9
MK"O(/?BI,  5HL1^7.\G!N#SFGO8M;!!JA:J&DV'U0JULZM?J%QIG:Z.^2CN
MW=F#P\WC8#N./#!U MT*F"C$J1R#./S%VW;9(R_68_384;!M*=[C7O:-(NJ[
MT%XB^4S:&[W1'#X? F;6%%5E*X0*[AUB&B.OB^G/.)'0]/ZIE*WY&+Q-3VN.
M%+!X6!NC9.RIFZ#!:]&@V9AB5LF%6='*RVVK*9;#>/E7?SLT3CGSZ']*), 6
M;SSZ73G*)("V043XE4#[U3Y\];B2X:>AU\,2)KY=K5>,S5,5U*0W;G(59BTQ
MJ0':NV8=[%H2J&+3K<"$E9P.C=>2.GCLLSHHP]V(N=GA&7/O48L-B^^OF!K'
MJT7T'_?_'%7+H\X9$F#ELJ4VF*6C-_"\](;,O"CH5G,(0&,)K'L1^RR"]W7Q
MX8TJ,"567CW0)UU2P[I _;P)8LCT=W_J4C%ZR"$G!".1X%!@*0N*N["0 O:G
M4J;&-(VG>F@'D@6P*=C^=FZ2)&A)LKT!3K%Y]<!H4 38>]\[(I5+A=@,Y8#K
M*V"QF;+5A"G0P!Z1;:G9.+B%N,E=V>N&BS6?I';;0(1!##N=P4 B@#)E-(T*
M$X!IWNJ-^A+*X(0/.^H,CMA#"=YW% RPG63(^8'4QS@[J/TU<JJ$R6]-8T.[
MC$V'71=@!-&*N;S62/ZO#VF@"T+FWEGX*^VWJ;0)JV)S#T68\2A+#,<U:;;1
M9&?=O^%J-)T0PG^N9/[!1VIXX7I39+.R*E/,1Q0R8HINO[0S(B4^E4A_::?"
M^;)95U"["P5WTII?D.I!JK_E6E!P'PDG*'2DXM1RJQ\8=!5<NOG"K/*RE*8Y
M.55X6:380'I94F/]T-H_'!.@;#D"GS>]'-9^F7#?,1ABOVJ@0/>!Q<'O : "
M<QG _3@$@SE1\T%^"R?ILCV>[!<Y6Z%"W*P#P#0?:)O]+*+]TXA<\J0=A:QM
M%>(H#0EK;FV,9?2P1AIO$HD>X6F?&-_(R=)0TKO>>=OE4!LE7<912YELH=!Q
M5-2=_P!Y'DB10^K7S4J;'1YMAJ8%%9/C!*,;')HSJ(H/+C*LBO=7QH:$/+53
M4=S0I,!/6$@7M3] !8=.U/FB:[6EU.^HUI9R*8NYHZG()CM*L!IX-3K@"=P(
M<D9(R09#.&/;A**UPXDM\?5K$KEI_=8$31=O\$.3?<DIU53^5YV4/,W#<!_
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MI ED@BZ-/032CLTY9LKF$!/DK=E83:.G ^OQ$_B'L3;")IXLI$*QTBQ!#,O
M61WRAC%"V)]'6]#B;MZBQQ9<4>82WGLB_'ZNL*'?@6%[GLTP@E"V%6A%&2&X
M'ZQUO0LQVPH8!J-X).E@,0$(SXKO)QK>0IYY.HG>HL2V%1A<<SHJ\FLGA4W6
MD^7[D'KB/B@#/$BEMEJQY/EV BDN1 EX-2AJV-.7#BV-%$\G#EQ7R;?D,7:@
M08HB("">E^;<K:5'S>WMIMNX.JH.*]'^-,'V"VHP8W+93BF:M,JI&;Z/-/9^
M8:AT2$QP'F)'N]&:>E*=[Z/3#4H=;AUBAFC.O+JQ@<^HO3,%6%(4Z_2_Z<$=
M1V;Y[Z(GPDU'V) M9;K"[116P'QH(J6LU-Z>4"ZV*UU4WO(CI:A=@<13ECS5
MLKVC(LPM#>33Q@>V]VK !;)O;%?Q1#&7B&K_3>9+%PD58U%"46F<^"'J^M"%
M< )YX2K1:@FVMW5E!T\/"#]JGW)T";T-.S!;C)+!"^9YC@-ZF<CB6-?YG+2F
M<DTNJ2I_2DMOI=C30&<R@'[_:O367YN^\ D!!JI0;LB:#@-+^AO;0/Q^,VS_
MRU*&+:K<EF14^*LH7!J7O/1[-5A;E5)VJ-_GXH9%WZ\+FWZ6DJO&R3FT[!>D
M["<X)67P+\QFUA3VBI+US^V Z^NQ/:[6^"P8>"J'LK!CP'JQ82U])D^ ;2=M
MI/#M27G,S6Z3_DGPJ79'5E[)F([[>D67A@H'=7PB?_%3HHU/P4%],P9Y"><Z
M;M<\3UN&25AUY V [W^W@1,/*^F*U$H5?$F$U"BZ&@[[R#>%33@P1;.5+&]3
M SS.R%)@&JHUJ4K&XJKTOL,"UATU,7LF/1L+WN!]CBSU0D[ #1PK0VZU$. X
M+EO,:V\5/>BFUV%Z/-'OK@*A 4\3H.'L>BX*?^#,>.XT"UI4:P/T+K5H:9$(
M:@JIITTU$(^,XI52#WR+0%9M]?LV1)MR:1!L2?E7^C:<UC9(<\44Y_K(E%B*
M<V)3?JX9-P@ZU$9]/$Q36L.!TJ6\ O=FD4_%$E ->4TSBEW;2K"#YY $[2N)
M#&W9GW\ND(0"V7I.^KT@?48(!;*7_39RG6G5;R)NP(P>QM $<>Z9MFUE^];R
M$W("JJZ!-9NG?V7F O6K]_U9JAZ?\J"8V<4E_' >G\^G^,%%?#F=XP\G\>SR
M]!'<B@B.=S&_ "T5G\QFT<EQ?'YR&LWG\<7T[-&-H%XMJ '+)=8Z:UND>7&.
M.8)+_*Z<TSG\.[^\>/3WZ/@DOK@XQ^]%F,87,P3F["0^OD3HCB_@F<NO)T\T
MU"#ZES7="NG[V3;.?-D**AO;Y5B67]GD"3!KGZNA\04,Z,;P[#'3 QCFT6O)
MS">M7_ZQU%0-L 30YX+^GUT>/[K*5.'MY1WAB<L3)._QY>R17E3O.NZ_\ 1Y
M87H>/:6?YL?'T5,?'JK*\2"9Q[-CXM;X^/1P\L=-2YW=,]T4,TY'/&P0^03D
M(@NWMUP/,9@)^LHE^\*;^5D&FMMJ$W*"[3OT/0#/'YQ:M%5N]#E^HM5M+PZM
M,9IX=,O!(^%R#\A)NK?A$?]M?WR,Q+28@>W7KZ$GP5='UI =<)5FHD-8@Q Z
MFORD$\O(:$*14YQV3MV6LJ\/RSL&P+^]^6"_XW;4P0H(IZ50>*&9Q$=L\B8@
M,S-;+J-C,.F+L\C_%IBPB:'"6G-*MZ/:KN0;[E"9=$5+;<1!0-E%>7DU;G1U
MC2O:#XH ?-<(S00J6\3G%$;C9[[CJ!Y.')/9VT,WHL\.C-AK,!8PY+NN!!U4
M@F3A=^;X SKGV(AR;B-S@*#_\+3L)ACDV)MCG@:#''GDFAH2U"**)JW5>[;Z
MAE,L?HAS68%)1)U6O:2/U'RI;X)B@ZD1<)+C($46MZ@XA:L2^?[R/VPL\O+P
M/D<T9 <M3<ZN"/RIHSXD2^]]@H58]V;<HXFEI8 -AU'),.3S/X"F=IZZ%^CR
MQV8G"ZQP2KQ2FMNDIBAKXYIOV_5^P^/HU_:$7W,QV',9]%6.MF#&4F;.WZ41
M[7+RA"AT"/8&4G=AP%1XSE,/ M"DH7?_O@3507E_JJR[+3A2P3FUKBAGK\"H
M<7/E17C\E#19\D?T#QZ>\R.!-2$MV,.#0OG6?@WG/Y.2YE#/AKX[E!F:Q-/
M6K(Y?_$9.,S^GV38B ?W)'H3MBZ*;;37)1:/;GB7^"T"@?C4\BP%!M!@7]2^
M#9X\SL$*[:B#^Y91T5@P*,H-DJ++E^B5PZ^1*%PWBM^IJPV%_FTC28[]C6YC
MMS+YB"DF^\O@*+DW41AN)WZACGPQ"ZY?Y$MX:Y>Z><8)N7(8M, IU1[5"2R/
M*_N7)H2_9_/*@4>'G?D"S]<"82+4*[,*I6>G?-5023M%+*54[$DX<CK/CCCX
MY_?,JB3,M&N:Z%%:F>BG5/%T3_?3T,'I)S0E<J@EV\/?6-<V%_7TU#DQ&'5-
MT3S"-Q@ :W4FV"]:(]>K_\<L.G]Y1&]6[SY7$4/_:6HL+Z!("6UC%^8OA)"A
M$'90NNMVHR]+0C^:%AMF":R@#.3@/B_Q[#]J8*-B<?LE1)K?VJN,Y&&![ANR
M@J\N&GI+1O%A1T(HFPCMB9=[[TEM0!OBYV"OD!NL/SL\61_G2_6^0J&NRJJ3
MZOKA+J)O6]*VP0.6^-OFV<JR(R%U&)]M\/:6NI%FQR9Z37:H'45Y=?/:&T4I
MX0P67]Z7+S3V=8TFZ@)7-[\&IG3_VR-J/I7_10[!J6)_<//H4Q'-V$YY\IJ&
MR;RG<1HF^9E?\NT3-ET7#+^0&?^V8#?X2_A52H.L](R*XM\D;?+J)7UCUC4%
MN E4X+#'WJ?H("&K/;^:/WX&;[K'7[W<@HP'O;W"*5^%6<*KT\GYZ6,NUM=?
MVFJ+2X)OT;;5AG[$]DA3XP/P]V4%QY!?< -LTR3P7OT_4$L#!!0    ( .N!
M!5DN2G$_( 4  %L,   9    >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;*U7
M;6_;-A#^[E]Q\(JA ;18[R]98B O+=HA!8*XZSX,^T!+M$64$EV2JI/]^MU1
MLA*OCI$!^V)1%._NN;OGCN?SK=)?3<VYA8=&MN9B6EN[.9O-3%GSAIE3M>$M
M?EDIW3"+KWH],QO-6>6$&CD+?3^=-4RTT_FYV[O3\W/562E:?J?!=$W#].,5
MEVI[,0VFNXU[L:XM;<SFYQNVY@MN?]_<:7R;C5HJT?#6"-6"YJN+Z65P=I72
M>7?@B^!;\VP-Y,E2J:_T\K&ZF/H$B$M>6M+ \/&=7W,I21'"^#;HG(XF2?#Y
M>J?]O?,=?5DRPZ^5_$-4MKZ8YE.H^(IUTMZK[0<^^).0OE))XWYAVY_-TBF4
MG;&J&80102/:_LD>AC@\$\C]%P3"02!TN'M##N4-LVQ^KM46-)U&;;1PKCII
M!"=:2LK":OPJ4,[.%WTR0*W@LBQ5UUK1KN%.25$*;N#M9[:4W)R<SRP:(Y%9
M.2B^ZA6'+RA.X9-J;6W@75OQ:E]^AB!'I.$.Z55X5.%O77L*D>]!Z(?Q$7W1
MZ'GD]$4OZ#OD[I^72V,U,N6O0P[W^N+#^JAZSLR&E?QBBN5AN/[.I_.??PI2
M_]<C:.,1;7Q,^WR!U5AUDE.B;H3LB,NPX&6GA27D[QY*V6&@8:55 ]>JV726
M.=ZCP*TR!NZXAD7--#_DVE'CAUW[7'-8*8E532'$>C>6M16M-\IR#"R3\A&J
M'5;SA'7+-0>^!]BBLI+)LI,C:">)WUOL3)(<V* #AAP 9JT62W00N0E60:F:
M!H6P6,JOM9(5UP:6O&2=X:19:! -PK?0(1>U,V:Q@YD.B>^$H.&V5A5LF0&&
MT'\986/;<^?1N% 5@B#_6\1U-OE<:\[W6 [(4>XXNA /A[],B+U$X0C&U63A
M,*@-N6Y &-.A! 9S+ZI/V*^9K)&Z\$50:_3@8UN> G5AZ!7=28:[+YP*$GCW
MK1/VD38H3>@D"3A[I!T1!2\<2;PTR+T@3W&5AX'G9VX51Y[O%Q!YL5_@6SBY
MYUA%HJ3L]>'M6F%'QYX<.6(J35,OR2+(LL@K8A^2./:BT(<T"[PB28>0D49'
M D&466&.B'XN53^8:392/6+"AAAUNJRQFP^.%5X0HP>%EZ0YI.A9GD"<>$$1
MP)'B3<;B35Y=O/?\.V\[OJO3UK4;K EA:[AV_1[9>ZA$CYHX7*+O!_):QU1*
ML$%>-CTO^3YC'1OI"#'2P_OV&<QR'V:Y@TD?C#"49_3,[C6$MY@2K*G.H$YS
M\G]6R^W-#6FG]D&&$)EH<7$";R#PD9T%+C(O0[+@1NX5?DB+&).93&XO;P'=
MR\,<@M"+@P"0O%F<0!AZN8^TPL")DF,CT!H;P:,'9M@98^"Y*+&RY,8H3?TL
MSXB7!01>EH3X&Q;YY U$L9?G&9H.?2\/"$R*%"X(793CF>(8L]*16>GKKP6.
M!: Q>CN*7=+$@[5UB$U'U;ZFX??-5_.A(9J^A0]! BG84LB^W3L*&89C1#^#
M4;7OVNI_X*/9<#?!X:7R;VZ]@C^3*X:%7M+=@5?#6K2MN[56NVZ!#,%TY>X9
M%-'DLJI$WXZKSG65ITL 3Q0Q93LJ@LDNUIJ7:MV*O]'XCP)OB1I^!B=N%481
MG#S'P]MJ#TGH!9$CKQ<EA_O/[-G AX6X=F,ME2,.-/WL-^Z.D_-E/S ^'>_'
M[D],8S0,2+Y"4?\TPSZC^U&V?[%JX\;'I;)8]6Y9X_3/-1W [RN%U_WP0@;&
M_Q/S?P!02P,$%     @ ZX$%61K.Z_.7 @  W04  !D   !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&ULG53?;],P$'[?7W$*"#&I-&G2;>UH([7[ 4,,3>LV
M'A /;G)MK#EVL9UVXZ_G[+2AH*X2O"1WY_N^^R[.W6"E]*,I$"T\E4*:85!8
MNS@-0Y,56#+35@N4=#)3NF267#T/S4(CRSVH%&$<1<=AR;@,TH&/W>ATH"HK
MN,0;#:8J2Z:?QRC4:AAT@DW@EL\+ZP)A.EBP.4[0WB]N-'EAPY+S$J7A2H+&
MV3 8=4['79?O$QXXKLR6#:Z3J5*/SKG*AT'D!*' S#H&1J\EGJ$0CHAD_%AS
M!DU)!]RV-^R7OG?J9<H,GBGQE>>V& :] '*<L4K86[7ZB.M^CAQ?IH3Q3UC5
MN4?= ++*6%6NP:2@Y+)^LZ?U=]@"]*(7 /$:$'O==2&O\IQ9E@ZT6H%VV<3F
M#-^J1Y,X+MVE3*RF4TXXFTX*I>V[.]0E7,DE&DL?W,+;.S85: X'H:4:+C/,
MUGSCFB]^@>\8KI6TA8$+F6/^)SXD;8W >"-P'.\E_%3)-B11"^(H[N[A2YJ&
M$\^7_$O#!KZ-IL9J^D>^[^JYINSNIG1S<VH6+,-A0(-A4"\Q2-^\ZAQ'[_<(
M[C:"N_O8TPG-85X)!#6#6KS]6_QHR;AP-P;TI\*$"=S5Q-XRNYL8&5>5K@";
M*S@8E:2!_\0<SI2Q<"]I%PCO?U;&M. +;9(+8SE-#,4N&=?PP$2%!_?M21ON
M*-M4^AD,9I7FEJ.!UT3<:_63'EEOH=^'PW6HE_0/:@GGF&$Y10U)Q\M(]LCX
M0*OH_V1T.B>M;B]R5K1Q^Q'LNL1P:^1*U'._6 QDJI*VGKXFVNRN43VRO]/K
MQ7?-])Q+ P)G!(W:)T<!Z'J9U(Y5"S_ 4V5I'7BSH/V+VB70^4PINW%<@6:C
MI[\ 4$L#!!0    ( .N!!5EXJ!) N0(  +H%   9    >&PO=V]R:W-H965T
M<R]S:&5E=#(P+GAM;(54R6[;,!"]^RL&:E'$@!*M7FL+R-*@*1H@2-KF4/1
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M!A[HME.T"ZO6C3L7RI+7FVE)S16U"Z#SI5)VMW 7=.TZ^P-02P,$%     @
MZX$%62RHKV1@ P  :P@  !D   !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
MG5;;;MLX$'WW5PS4H&@!P[KXFL0VD,L63=$ 09-V'Q;[0$MCBPA%NB1EU_WZ
M#JG+JH#7;?-BWF;.G#/4<#S?*_UL<D0+WPHAS2+(K=U>A*%)<RR8&:@M2CI9
M*UTP2TN]"<U6(\N\4R'")(HF8<&X#)9SO_>@EW-56L$E/F@P95$P?;A&H?:+
M( Z:C4]\DUNW$2[G6[;!1[2?MP^:5F&+DO$"I>%*@L;U(KB*+ZY'SMX;?.&X
M-YTY."4KI9[=XBY;!)$CA )3ZQ 8#3N\02$<$-'X6F,&;4CGV)TWZ.^\=M*R
M8@9OE/B;9S9?!+, ,ERS4MA/:O\>:SUCAY<J8?PO[&O;*("T-%85M3,Q*+BL
M1O:MSL/O."2U0^)Y5X$\RUMFV7*NU1ZTLR8T-_%2O3>1X])=RJ/5=,K)SR[?
M,:[A"Q,EPCTR4VJDC%L#;Y[82J!Y.P\M17&V85HC7E>(R?\@3N!>29L;^$MF
MF/WL'Q*[EF+24+Q.3@)^*.4 AE$?DB@9G< ;MI*''F_X:\FWW*1".=4&_KE:
M&:OI*_GWF.8*<G0<TE7.A=FR%!<!E89!O<-@^?I5/(DN3Q >M81'I]"7CU2)
M62D0U!J8,4C7PV0&@K,5%]QR(E]4=Y<!L[!V^G9>GR^<M-2:RXW[>'GE:7/L
M6N4<-=-I?G !W)G;9KYH+*:YY%]+-,>2<I+V\:0\$;QUGY8GDG7R3P^,#[Y%
MS55FP/M(2YI6[NF -YSHY*HTY&C>-L?>Y4856R8/KU_-DGAZ:?X\2>QHFKC,
M>,HLOBA?4%J*^]W1/W1)@E7T:EC45,Q(;V&:=Z '\-2QS'@&4EG(V<ZEZ]#H
MHD2]5-:>VYSR^!%W*&#8-2\ZU3_H71FGC2H/V\KK54YWM?/='3PIRP29.E(7
M/:IZ/-#3I)^IE1@7MZ)W!O&L?SZ;@+^>Y++=Z'T>/))@[0,?NBZ-91+-^K/A
M>3/V?,#V=G]2VT8Y:[UHEDS[LV1<J[G%%(L5:AC&7M'PY8I&_=%TW-+TJU^K
MB>-I?W0>->-I-56$L]:)9DG</Y^,X=B#$G8:0(%ZX]N<@525TE:]H-UM.^E5
MU4#^,Z_:\#W3&RX-"%R3:S28C@/056NK%E9M?3M9*4O-R4]S^C> VAG0^5HI
MVRQ<@/;_Q?('4$L#!!0    ( .N!!5DBJT#NC@8  /X0   9    >&PO=V]R
M:W-H965T<R]S:&5E=#(R+GAM;)5867/;-A!^YZ_ J&DGGJ$IWH=K>T9VG!XS
M2366DSQT^@"3D(0Q12@ )-G_OKL 14DVHZHO(HAC#^RWWRYUN1'R2<T9T^1Y
M43?J:C#7>GDQ'*IRSA94>6+)&EB9"KF@&E[E;*B6DM'*'%K4P]#WT^&"\F9P
M?6GFQO+Z4JQTS1LVED2M%@LJ7VY8+397@V"PG;CGL[G&B>'UY9+.V(3I+\NQ
MA+=A)Z7B"]8H+AHBV?1J, HN;G+<;S9\Y6RC]L8$/7D4X@E?_JBN!CX:Q&I6
M:I1 X;%FMZRN41"8\;V5.>A4XL']\5;Z1^,[^/)(%;L5]3=>Z?G5(!^0BDWI
MJM;W8O,[:_U)4%XI:F5^R:;=ZP](N5):+-K#8,&"-_9)G]M[..5 V!X(C=U6
MD;'R ]7T^E**#9&X&Z3AP+AJ3H-QO,&@3+2$50[G]/5$B_+I_ ;\JLBM6$"L
M%377=?>,8T;>/]#'FJFSRZ$&=7AH6+:B;ZSH\ >B4_))-'JNR%U3L>KP_!#,
M[&P-M[;>A$<%_KEJ/!+Y+@G],#XB+^I\CXR\Z$>^SZEDK>]C^@)0TV0D)6UF
MS(S_'CTJ+0$W__0Y;V7'_;(QER[4DI;L:@#)HIA<L\'U+S\%J?_K$<OCSO+X
MF/3KB4TA(J;$!)#\M31!&R'&N>9,]5E\5&:_Q:-MMJ(J/6=$&75BN4LIHP[R
MLZ8:[E$+L^WN^XKK%S*N::,(4(<]RY_)PD*"(20(!)1U 25<$:.X03F/2!<7
MSN?5XI%)5&X]5.2;R3/8T0U&ZYFS707:49HV%6]FA"H\]X&5S,B( J,G(JF;
M99D;^S%Y1X+(\T.2>DG@_ :!1W%94;@)3":)EQ?.W3.3)4>$O">!&R:YFV<Q
M.2.![R61 \0P95R;U31TBR+!I=3S$SBXY-(>\]TP2F$A]I+LB*6'MY&Z81R[
MN1^0(/>* FS,\JTUF)&]AR(W#2.WB'WK&CB;>'%"CB NZ1"7G(JXSZ(Y_\H4
M>GT/#\E+'%I@K!JN_P.%1_6<@,(&U*^M>MFK?@^5IR./XN8:,*<NG"VRG-&:
M2:A,>R@T("' M,PQ[*'(1\HE^4KK%7.^-*U=5/?!+O'=*,DP,H LO\-;D$>
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MRL;]IJ8 %1 @T/BV*HZ!(Q #GT3%:JQ0'YAF$BZ#&9SL,OAU/>WEK^.V/X!
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MJ339^4ZLWE48&+'3X35XKI-Z*39\)PS#T2?&;137$HN>U(^6,_U1L1++D':
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MG=ES/QBGB'D7]GPR[+BH<O(5H"6(;4V3HQ@:U!?%)%%,PGYO2^H$BW2"Q9K
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M:&5E=#,Q+GAM;*V6WV_:,!#'_Q4KJZ9.&LU/$F 0J2VJUFF3JK*N#],>3'*
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MW0+M +B^4\J> M<:W4N8_@%02P,$%     @ ZX$%660E/,H:!   FA<  !D
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MM9.6)3,X4]4WGMMR$IP$D&/!FLI>J\UG[/2\=WR9JHS_PJ;U/8X"R!ICE>C
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MM)T/3*HFU@S7ZF\#<KU ?5\R)@\3;:#Z(S+Y E!+ P04    " #K@059IZ3
M>S4$  "W%0  &0   'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6S%6-MNVS@0
M_15"6RQ:((UNOJ:V@=A2NUEL@"#NY:'H V.-+2$2Z9*TG?S]DI2BV#*C3;8L
M\A*+U,P9SIS)$<G1CK);G@((=%?DA(^=5(CUF>OR10H%YJ=T#42^65)68"&'
M;.7R-0.<:*<B=P//Z[D%SH@S&>FY*S89T8W(,P)7#/%-46!V/X6<[L:.[SQ,
M7&>K5*@)=S):XQ7,07Q97S$Y<FN4)"N \(P2Q& Y=L[]L]@/E8.V^)K!CN\]
M(Y7*#:6W:G"1C!U/K0AR6 @%@>7/%F:0YPI)KN-G!>K4,97C_O,#^D>=O$SF
M!G.8T?Q;EHAT[ P<E, 2;W)Q37=_09505^$M:,[U7[2K;#T'+39<T*)REBLH
M,E+^XKNJ$'L.$L?L$%0.0=.A\X1#6#F$SXW0J1PZSXW0K1QTZFZ9NRY<A 6>
MC!C=(::L)9IZT-77WK)>&5&-,A=,OLVDGYC,!5W<OI_*4B=H1@O9?QQK!N,[
M]0SH/9K+YDPV.2"Z1/]I_C8"@;.<OY..GU- ,YRG=$/0UTRUU@FZ((M3%'A^
M%\4_-YFX5Q- 5+.@JQS+QB$)$D_[>;UR":7Q]TLH;H#]D+&^S"/T]LT[] 9E
M1 :F&RZ1^,@5LD8J4W=1U6-:UB-XHAXANJ1$I!S%)('$X!^U^_=:_%W)34U0
M\$#0-&@%_'M#3E'HG<CD@XYA/;/GNX>F='XM>OR_HQ\4(ZR[-=1XX5/=FF(&
MR-!^YXQAL@*I8 )-[]&^W16^U]/G.\P2]/T?"8DN!!3\AZD[RO@=<WREVF=\
MC1<P=J0L<V!;<"9__N'WO \F:FR"13;!8DM@!R1V:A([;>B3SU3@''&M)#>:
MHL4^E5 JB8F<$K>G<=47<#OI^5YWY&[WBWYL% Z[#:/HV,CW!IY_:!4?6_6#
MKE<;'63?K;/OMF9_+>N)V2+52A?!5GZJUZH_3?FV(KVT&6V"13;!8DM@!W3T
M:CIZKZPH/9LDV@2+;(+%EL .2.S7)/9_DZ*4N-U]'9!JT5 4@Y$7-+0B.C:2
M4M$4% /20'T838(RJ),?M"8_EYOLC*Q.T"<@P&0=E+"<)W*OF''!L-I:F3)O
M!7UI6]H$BVR"Q9; #I@9ULP,7UE;AC9)M D6V02++8$=D.A[CR<D[S>I2P6\
M___>"7RO(2\&JZ 7#AOZ8K#J=YI8L2GBT']BR^+O'1+]UA+,*!?J^/>)TH2C
M.<U-)Z-I.\A+V]$J6F05+;:%=DA'\$A'\,K"4BW %I4VT2*K:+$MM$,J'P^T
M?NM1ZU?$)3PZG72](VTY-@J:^YO(8#08'BF+(9S?;PB+NW<150!;Z1M +E/:
M$%&>\NO9^I;Q7-^M->:G_MG,-\Q'ZE927WP]PI=7FI>8K3+"40Y+&<H[[4L-
M9.4M83D0=*VOP6ZH$+30CRG@!)@RD.^7E(J'@0I0W]5._@502P,$%     @
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M"NY5Z83;"($MX8XD*P22A/ ]31"&5V2'7"TX3(4JA8WV%?!5P]$$9A%1Z J
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MAD>\-L#G*\[58:*OS/5?))/_ 5!+ P04    " #K@0593JJB@14$  !G&@
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M6"O=89/NL/<3U_DA.WQUEMV1;P>NZQUEVVEZ:;8:5]]V1P/;/8H8TC6"A,5
ML%;$HR;B4?^(#T;MN8?J4=^P.^TO#5OCJ@\;TC6"A,5 L%;8MO5SOL7J$W?]
MMGU/\B?"M&_:W9Q+7[5!:7-06@A*BT!I,12M72T'LW,VY.Q,38.J&4C:')06
M@M(B4%H,16O7S,\)/;MS#NB7;R@UML<=1=<RL&73P=%=8*YKJ;]?Z%H.;']H
M>4=O=I&NI>RH[X^"=LM8T](9.O[0'8Z:EM5)-@]FT-4GF'O,5FG!44:64FK=
M!)+!JJ\:U8J@FW)2_8D*0?-R<4UP0IAJ(/<O*14O*VJ>OOFV-/T?4$L#!!0
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MZG?<;GXUF>UOJ( K'BPZJB7'HIFB:^/N_Y_&_9V[)>%J!U\UJ*X<E4:Q:&8
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M.5ZMYI2%\NA%LKKVFFPS#O:-AZJ)8U>"=X5NG*'GE(7R^&6R72B?^ZL&BZ_
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MQOOCK\O;R<%+N.(<X(?TRS=02P,$%     @ ZX$%62BT:!/# 0  B1X  !,
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M_RGKNS&KO_XYVMS32A?U,9^U?Z"GGU!+ 0(4 Q0    ( .N!!5D'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ ZX$%686M6G[O    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ ZX$%69E<G",0!@  G"<  !,
M         ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #K
M@059N/("N-0%  #?'@  &               @($."   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ ZX$%6=!S,9P!!@  Q!@  !@
M         ("!& X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0
M   ( .N!!5GB5*%/P (   8)   8              " @4\4  !X;"]W;W)K
M<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #K@059_TL>_^,&  #;(0
M&               @(%%%P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L!
M A0#%     @ ZX$%60?03O$;#0  R7D  !@              ("!7AX  'AL
M+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( .N!!5E-ST<^$PD
M &0K   8              " @:\K  !X;"]W;W)K<VAE971S+W-H965T-BYX
M;6Q02P$"% ,4    " #K@059<,V1ZK@"  ")"0  &               @('X
M-   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ ZX$%6=^7
M8M#P!@  .R4  !@              ("!YC<  'AL+W=O<FMS:&5E=',O<VAE
M970X+GAM;%!+ 0(4 Q0    ( .N!!5FQ#I'T90X  )\G   8
M  " @0P_  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #K
M@059AB;DZA8@   O9   &0              @(&G30  >&PO=V]R:W-H965T
M<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( .N!!5GT4#W 7@,  +X'   9
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M970Q-2YX;6Q02P$"% ,4    " #K@059T38H[0L%  #Y"P  &0
M    @('-D   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    (
M .N!!5E%^D512"D  /J(   9              " @0^6  !X;"]W;W)K<VAE
M971S+W-H965T,3<N>&UL4$L! A0#%     @ ZX$%62Y*<3\@!0  6PP  !D
M             ("!CK\  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"
M% ,4    " #K@059&L[K\Y<"  #=!0  &0              @('EQ   >&PO
M=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( .N!!5EXJ!) N0(
M +H%   9              " @;/'  !X;"]W;W)K<VAE971S+W-H965T,C N
M>&UL4$L! A0#%     @ ZX$%62RHKV1@ P  :P@  !D              ("!
MH\H  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #K@059
M(JM [HX&  #^$   &0              @($ZS@  >&PO=V]R:W-H965T<R]S
M:&5E=#(R+GAM;%!+ 0(4 Q0    ( .N!!5E7B'PW9P4  +4.   9
M      " @?_4  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%
M  @ ZX$%68X0@W$J!@  [RL  !D              ("!G=H  'AL+W=O<FMS
M:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #K@0597<*,7H,#   X#@
M&0              @('^X   >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+
M 0(4 Q0    ( .N!!5FQG*H3XP,  "@2   9              " @;CD  !X
M;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ ZX$%64-1[('W
M P  HQ0  !D              ("!TN@  'AL+W=O<FMS:&5E=',O<VAE970R
M-RYX;6Q02P$"% ,4    " #K@059S)"QDMP"  #=!P  &0
M@($ [0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( .N!
M!5EJ]3.(I@(  )D&   9              " @1/P  !X;"]W;W)K<VAE971S
M+W-H965T,CDN>&UL4$L! A0#%     @ ZX$%6:T%>6MJ @  Y08  !D
M         ("!\/(  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
M    " #K@059F0UTRN$"   Y"   &0              @(&1]0  >&PO=V]R
M:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( .N!!5FT/I!G-0(  !4%
M   9              " @:GX  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL
M4$L! A0#%     @ ZX$%660E/,H:!   FA<  !D              ("!%?L
M 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #K@059S,.I
M 70"  ##!0  &0              @(%F_P  >&PO=V]R:W-H965T<R]S:&5E
M=#,T+GAM;%!+ 0(4 Q0    ( .N!!5FEYH3S/ (  "T%   9
M  " @1$" 0!X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @
MZX$%67C:?=Z. @  !P<  !D              ("!A 0! 'AL+W=O<FMS:&5E
M=',O<VAE970S-BYX;6Q02P$"% ,4    " #K@059-]L)U:("  #V!P  &0
M            @(%)!P$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4
M Q0    ( .N!!5F'F=,E,@L  /-K   9              " @2(* 0!X;"]W
M;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ ZX$%6<OL5#!C!
MLA,  !D              ("!BQ4! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX
M;6Q02P$"% ,4    " #K@059B=C53[\#  "4#   &0              @($E
M&@$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( .N!!5FG
MI,![-00  +<5   9              " @1L> 0!X;"]W;W)K<VAE971S+W-H
M965T-#$N>&UL4$L! A0#%     @ ZX$%69]%RVB1!   -10  !D
M     ("!AR(! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .N!!5EB*)<$% 0  .H5   9              "
M@3X] 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ ZX$%
M6;;A@OIU P  : T  !D              ("!B4$! 'AL+W=O<FMS:&5E=',O
M<VAE970T."YX;6Q02P$"% ,4    " #K@059 I4JW\("   ^"0  &0
M        @($U10$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0
M   ( .N!!5G$#F9#T@(  *0(   9              " @2Y( 0!X;"]W;W)K
M<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ ZX$%6=) [(5O @  RP4
M !D              ("!-TL! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q0
M2P$"% ,4    " #K@059VB2,!4 #  #*%   #0              @ '=30$
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .N!!5F7BKL<P    !,"   +
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4!08     .P [ !00  "Z6@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>187</ContextCount>
  <ElementCount>318</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>46</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100030 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income Loss (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Income Loss (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100050 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100070 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995455 - Disclosure - Organization and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentation</Role>
      <ShortName>Organization and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995465 - Disclosure - Summary of Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPolicies</Role>
      <ShortName>Summary of Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995475 - Disclosure - Short-Term Investment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestment</Role>
      <ShortName>Short-Term Investment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995485 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureInventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995495 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995535 - Disclosure - Stock-Based Compensation Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpense</Role>
      <ShortName>Stock-Based Compensation Expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995565 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995575 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995595 - Disclosure - Summary of Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995605 - Disclosure - Summary of Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesTables</Role>
      <ShortName>Summary of Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995615 - Disclosure - Short-Term Investment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentTables</Role>
      <ShortName>Short-Term Investment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestment</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995625 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureInventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureInventories</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995635 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurements</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995665 - Disclosure - Stock-Based Compensation Expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseTables</Role>
      <ShortName>Stock-Based Compensation Expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpense</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995675 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeases</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995685 - Disclosure - Organization and Basis of Presentation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails</Role>
      <ShortName>Organization and Basis of Presentation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995695 - Disclosure - Summary of Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995705 - Disclosure - Summary of Accounting Policies - Schedule of Dilutive Securities Excluded from Computation of Income (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails</Role>
      <ShortName>Summary of Accounting Policies - Schedule of Dilutive Securities Excluded from Computation of Income (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995715 - Disclosure - Summary of Accounting Policies - Schedule of Revenue From Contracts With Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails</Role>
      <ShortName>Summary of Accounting Policies - Schedule of Revenue From Contracts With Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995725 - Disclosure - Summary of Accounting Policies - Schedule of Deferred Revenue Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/DisclosureSummaryOfAccountingPoliciesScheduleOfDeferredRevenueActivityDetails</Role>
      <ShortName>Summary of Accounting Policies - Schedule of Deferred Revenue Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995735 - Disclosure - Short-Term Investment - Schedule of Short-term Investment Available For Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails</Role>
      <ShortName>Short-Term Investment - Schedule of Short-term Investment Available For Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995745 - Disclosure - Short-Term Investment - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails</Role>
      <ShortName>Short-Term Investment - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995755 - Disclosure - Inventories - Schedule of Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails</Role>
      <ShortName>Inventories - Schedule of Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995765 - Disclosure - Inventories - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails</Role>
      <ShortName>Inventories - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995775 - Disclosure - Fair Value Measurements - Schedule of assets and liabilities measured at fair value on recurring basis and the fair value hierarchy of the valuation techniques (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of assets and liabilities measured at fair value on recurring basis and the fair value hierarchy of the valuation techniques (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995805 - Disclosure - Term Loan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails</Role>
      <ShortName>Term Loan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995835 - Disclosure - Common Stock Warrant Liability - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails</Role>
      <ShortName>Common Stock Warrant Liability - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995845 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Summary of Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails</Role>
      <ShortName>Convertible Preferred Stock and Stockholders' Deficit - Summary of Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995865 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Summary of Common Stock Reserved for Future Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails</Role>
      <ShortName>Convertible Preferred Stock and Stockholders' Deficit - Summary of Common Stock Reserved for Future Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995875 - Disclosure - Stock-Based Compensation Expense - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation Expense - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995885 - Disclosure - Stock-Based Compensation Expense - Summary of Stock Option Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails</Role>
      <ShortName>Stock-Based Compensation Expense - Summary of Stock Option Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995895 - Disclosure - Stock-Based Compensation Expense - Summary of Non-Vested Restricted Stock Unit Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails</Role>
      <ShortName>Stock-Based Compensation Expense - Summary of Non-Vested Restricted Stock Unit Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995905 - Disclosure - Stock-Based Compensation Expense - Schedule of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation Expense - Schedule of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995915 - Disclosure - Stock-Based Compensation Expense - Schedule of Range and Weighted-average Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails</Role>
      <ShortName>Stock-Based Compensation Expense - Schedule of Range and Weighted-average Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995925 - Disclosure - Stock-Based Compensation Expense - Common stock reserved for future issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails</Role>
      <ShortName>Stock-Based Compensation Expense - Common stock reserved for future issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995945 - Disclosure - Stockholders' Equity (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995955 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995965 - Disclosure - Leases - Summary of Lease Balances Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails</Role>
      <ShortName>Leases - Summary of Lease Balances Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995975 - Disclosure - Leases - Schedule of Components of Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails</Role>
      <ShortName>Leases - Schedule of Components of Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995985 - Disclosure - Leases - Schedule of Maturities of Lease Liabilites (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails</Role>
      <ShortName>Leases - Schedule of Maturities of Lease Liabilites (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995995 - Disclosure - Leases - Summary of Weighted Average Remaining Lease Term and Discount Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateDetails</Role>
      <ShortName>Leases - Summary of Weighted Average Remaining Lease Term and Discount Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="rxst-20240630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Subsequent Event (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails</Role>
      <ShortName>Subsequent Event (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="rxst-20240630.htm">rxst-20240630.htm</File>
    <File>rxst-20240630.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="622">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>85
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "rxst-20240630.htm": {
   "nsprefix": "rxst",
   "nsuri": "http://rxsight.com/20240630",
   "dts": {
    "inline": {
     "local": [
      "rxst-20240630.htm"
     ]
    },
    "schema": {
     "local": [
      "rxst-20240630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 278,
   "keyCustom": 40,
   "axisStandard": 20,
   "axisCustom": 0,
   "memberStandard": 22,
   "memberCustom": 22,
   "hidden": {
    "total": 21,
    "http://fasb.org/us-gaap/2024": 12,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://xbrl.sec.gov/ecd/2024": 5
   },
   "contextCount": 187,
   "entityCount": 1,
   "segmentCount": 46,
   "elementCount": 750,
   "unitCount": 8,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 622,
    "http://xbrl.sec.gov/ecd/2024": 31,
    "http://xbrl.sec.gov/dei/2024": 29
   },
   "report": {
    "R1": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited",
     "longName": "100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical",
     "longName": "100030 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R4": {
     "role": "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited",
     "longName": "100040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income Loss (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Income Loss (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_3c557978-5173-4887-9475-3c1de75ad09d",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_3c557978-5173-4887-9475-3c1de75ad09d",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited",
     "longName": "100050 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_ef35aeef-393e-488b-85fd-95ffed2e764e",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_94635311-ec03-402f-a7d8-37123b9f3f6c",
      "name": "rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1",
     "longName": "100070 - Statement - Condensed Consolidated Statements of Cash Flows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_3c557978-5173-4887-9475-3c1de75ad09d",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_3c557978-5173-4887-9475-3c1de75ad09d",
      "name": "ecd:MtrlTermsOfTrdArrTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_3c557978-5173-4887-9475-3c1de75ad09d",
      "name": "ecd:MtrlTermsOfTrdArrTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentation",
     "longName": "995455 - Disclosure - Organization and Basis of Presentation",
     "shortName": "Organization and Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPolicies",
     "longName": "995465 - Disclosure - Summary of Accounting Policies",
     "shortName": "Summary of Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestment",
     "longName": "995475 - Disclosure - Short-Term Investment",
     "shortName": "Short-Term Investment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureInventories",
     "longName": "995485 - Disclosure - Inventories",
     "shortName": "Inventories",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurements",
     "longName": "995495 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpense",
     "longName": "995535 - Disclosure - Stock-Based Compensation Expense",
     "shortName": "Stock-Based Compensation Expense",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeases",
     "longName": "995565 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies",
     "longName": "995575 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies",
     "longName": "995595 - Disclosure - Summary of Accounting Policies (Policies)",
     "shortName": "Summary of Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesTables",
     "longName": "995605 - Disclosure - Summary of Accounting Policies (Tables)",
     "shortName": "Summary of Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentTables",
     "longName": "995615 - Disclosure - Short-Term Investment (Tables)",
     "shortName": "Short-Term Investment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureInventoriesTables",
     "longName": "995625 - Disclosure - Inventories (Tables)",
     "shortName": "Inventories (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsTables",
     "longName": "995635 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseTables",
     "longName": "995665 - Disclosure - Stock-Based Compensation Expense (Tables)",
     "shortName": "Stock-Based Compensation Expense (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeasesTables",
     "longName": "995675 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "rxst:SummaryOfLeaseBalancesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "rxst:SummaryOfLeaseBalancesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
     "longName": "995685 - Disclosure - Organization and Basis of Presentation - Additional Information (Details)",
     "shortName": "Organization and Basis of Presentation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "rxst:NumberOfWhollyOwnedSubsidiaries",
      "unitRef": "U_Subsidiary",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "rxst:NumberOfWhollyOwnedSubsidiaries",
      "unitRef": "U_Subsidiary",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails",
     "longName": "995695 - Disclosure - Summary of Accounting Policies - Additional Information (Details)",
     "shortName": "Summary of Accounting Policies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:UnrealizedGainLossOnInvestments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "rxst:ShortTermInvestmentsPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:UnrealizedGainLossOnInvestments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "rxst:ShortTermInvestmentsPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails",
     "longName": "995705 - Disclosure - Summary of Accounting Policies - Schedule of Dilutive Securities Excluded from Computation of Income (Loss) Per Share (Details)",
     "shortName": "Summary of Accounting Policies - Schedule of Dilutive Securities Excluded from Computation of Income (Loss) Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_e969fc23-8eb5-4d5d-ace5-3eb8042365bb",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e969fc23-8eb5-4d5d-ace5-3eb8042365bb",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails",
     "longName": "995715 - Disclosure - Summary of Accounting Policies - Schedule of Revenue From Contracts With Customers (Details)",
     "shortName": "Summary of Accounting Policies - Schedule of Revenue From Contracts With Customers (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_3c557978-5173-4887-9475-3c1de75ad09d",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a5ac65aa-cc43-4c9f-a44e-01e67eb807a2",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "unique": true
     }
    },
    "R28": {
     "role": "http://rxsight.com/20240630/taxonomy/role/DisclosureSummaryOfAccountingPoliciesScheduleOfDeferredRevenueActivityDetails",
     "longName": "995725 - Disclosure - Summary of Accounting Policies - Schedule of Deferred Revenue Activity (Details)",
     "shortName": "Summary of Accounting Policies - Schedule of Deferred Revenue Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_6bf98cbd-e518-432a-99cb-1699005a3a9a",
      "name": "rxst:DeferredRevenue1",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredRevenueByArrangementDisclosureTextBlock",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6bf98cbd-e518-432a-99cb-1699005a3a9a",
      "name": "rxst:DeferredRevenue1",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredRevenueByArrangementDisclosureTextBlock",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails",
     "longName": "995735 - Disclosure - Short-Term Investment - Schedule of Short-term Investment Available For Sale (Details)",
     "shortName": "Short-Term Investment - Schedule of Short-term Investment Available For Sale (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_6e1c7f83-49b9-4025-a3c3-dc623355c0cc",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6e1c7f83-49b9-4025-a3c3-dc623355c0cc",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails",
     "longName": "995745 - Disclosure - Short-Term Investment - Additional Information (Details)",
     "shortName": "Short-Term Investment - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_f5781e6f-1600-45ee-a829-0c9af9692565",
      "name": "rxst:InvestmentMaturityPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f5781e6f-1600-45ee-a829-0c9af9692565",
      "name": "rxst:InvestmentMaturityPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails",
     "longName": "995755 - Disclosure - Inventories - Schedule of Inventories (Details)",
     "shortName": "Inventories - Schedule of Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:InventoryFinishedGoods",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:InventoryFinishedGoods",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails",
     "longName": "995765 - Disclosure - Inventories - Additional Information (Details)",
     "shortName": "Inventories - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails",
     "longName": "995775 - Disclosure - Fair Value Measurements - Schedule of assets and liabilities measured at fair value on recurring basis and the fair value hierarchy of the valuation techniques (Details)",
     "shortName": "Fair Value Measurements - Schedule of assets and liabilities measured at fair value on recurring basis and the fair value hierarchy of the valuation techniques (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails",
     "longName": "995805 - Disclosure - Term Loan - Additional Information (Details)",
     "shortName": "Term Loan - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R35": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails",
     "longName": "995835 - Disclosure - Common Stock Warrant Liability - Additional Information (Details)",
     "shortName": "Common Stock Warrant Liability - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R36": {
     "role": "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails",
     "longName": "995845 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Summary of Preferred Stock (Details)",
     "shortName": "Convertible Preferred Stock and Stockholders' Deficit - Summary of Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R37": {
     "role": "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails",
     "longName": "995865 - Disclosure - Convertible Preferred Stock and Stockholders' Deficit - Summary of Common Stock Reserved for Future Issuance (Details)",
     "shortName": "Convertible Preferred Stock and Stockholders' Deficit - Summary of Common Stock Reserved for Future Issuance (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "rxst:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R38": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
     "longName": "995875 - Disclosure - Stock-Based Compensation Expense - Additional Information (Details)",
     "shortName": "Stock-Based Compensation Expense - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails",
     "longName": "995885 - Disclosure - Stock-Based Compensation Expense - Summary of Stock Option Activities (Details)",
     "shortName": "Stock-Based Compensation Expense - Summary of Stock Option Activities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_6bf98cbd-e518-432a-99cb-1699005a3a9a",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails",
     "longName": "995895 - Disclosure - Stock-Based Compensation Expense - Summary of Non-Vested Restricted Stock Unit Activities (Details)",
     "shortName": "Stock-Based Compensation Expense - Summary of Non-Vested Restricted Stock Unit Activities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6f6583f5-ec7a-4082-9b35-96788b1aca0c",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails",
     "longName": "995905 - Disclosure - Stock-Based Compensation Expense - Schedule of Stock-Based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation Expense - Schedule of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_748782be-b4c1-440b-81fc-508b52d9ef24",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_748782be-b4c1-440b-81fc-508b52d9ef24",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails",
     "longName": "995915 - Disclosure - Stock-Based Compensation Expense - Schedule of Range and Weighted-average Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options (Details)",
     "shortName": "Stock-Based Compensation Expense - Schedule of Range and Weighted-average Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
     "longName": "995925 - Disclosure - Stock-Based Compensation Expense - Common stock reserved for future issuance (Details)",
     "shortName": "Stock-Based Compensation Expense - Common stock reserved for future issuance (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "rxst:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e4a673c7-eaa6-4857-856c-50b98038b762",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "rxst:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
     "longName": "995945 - Disclosure - Stockholders' Equity (Additional Information) (Details)",
     "shortName": "Stockholders' Equity (Additional Information) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R45": {
     "role": "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
     "longName": "995955 - Disclosure - Leases - Additional Information (Details)",
     "shortName": "Leases - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_443df5e3-56fa-4ac9-ae8d-93e0566a45d5",
      "name": "us-gaap:LeaseExpirationDate1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_443df5e3-56fa-4ac9-ae8d-93e0566a45d5",
      "name": "us-gaap:LeaseExpirationDate1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails",
     "longName": "995965 - Disclosure - Leases - Summary of Lease Balances Sheet Information (Details)",
     "shortName": "Leases - Summary of Lease Balances Sheet Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "rxst:SummaryOfLeaseBalancesTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails",
     "longName": "995975 - Disclosure - Leases - Schedule of Components of Lease Expense (Details)",
     "shortName": "Leases - Schedule of Components of Lease Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_3c557978-5173-4887-9475-3c1de75ad09d",
      "name": "us-gaap:FinanceLeaseInterestExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_3c557978-5173-4887-9475-3c1de75ad09d",
      "name": "us-gaap:FinanceLeaseInterestExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails",
     "longName": "995985 - Disclosure - Leases - Schedule of Maturities of Lease Liabilites (Details)",
     "shortName": "Leases - Schedule of Maturities of Lease Liabilites (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateDetails",
     "longName": "995995 - Disclosure - Leases - Summary of Weighted Average Remaining Lease Term and Discount Rate (Details)",
     "shortName": "Leases - Summary of Weighted Average Remaining Lease Term and Discount Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "rxst:SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_90e5cd49-e1a4-4b5f-9372-5862dbba9245",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "rxst:SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "longName": "996005 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:LegalFees",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:LegalFees",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
     "longName": "996015 - Disclosure - Subsequent Event (Additional Information) (Details)",
     "shortName": "Subsequent Event (Additional Information) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_0bd63812-92ba-4572-9a40-8db99e7f608b",
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxst-20240630.htm",
      "first": true
     },
     "uniqueAnchor": null
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r851"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1016"
     ]
    },
    "rxst_AccountsReceivablePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "AccountsReceivablePercentage",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, percentage",
        "documentation": "Accounts receivable, Percentage.",
        "label": "Accounts Receivable Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of discount on short-term investments",
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "rxst_AccretionToRedemptionValueOfRedeemableStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "AccretionToRedemptionValueOfRedeemableStock",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion to redemption value of redeemable stock.",
        "label": "Accretion To Redemption Value Of Redeemable Stock",
        "terseLabel": "Accretion to redemption value of redeemable stock"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_AccretionToRedemptionValueOfRedeemableStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "AccretionToRedemptionValueOfRedeemableStockOptions",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of redeemable stock options to its redemption value during the period.",
        "label": "Accretion To Redemption Value Of Redeemable Stock Options",
        "terseLabel": "Accretion to redemption value of redeemable stock options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities and Other Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Accrued Liabilities and Other Liabilities, Total",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of unexercised warrants",
        "label": "AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax",
        "totalLabel": "AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax, Total",
        "documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss",
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r94",
      "r173",
      "r642",
      "r670",
      "r671"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r12",
      "r21",
      "r485",
      "r488",
      "r559",
      "r666",
      "r667",
      "r993",
      "r994",
      "r995",
      "r1004",
      "r1005",
      "r1006",
      "r1007"
     ]
    },
    "rxst_AccurideInternationalIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "AccurideInternationalIncMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accuride International Inc [Member]",
        "documentation": "Accuride International Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "rxst_AdditionalBorrowingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "AdditionalBorrowingAmount",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Borrowing Amount",
        "documentation": "Additional borrowing amount.",
        "label": "Additional Borrowing Amount"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_AdditionalNonRefundablePaymentUponExtensionOfExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "AdditionalNonRefundablePaymentUponExtensionOfExpiration",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Non-Refundable Payment Upon Extension of Expiration.",
        "label": "Additional Non Refundable Payment Upon Extension Of Expiration",
        "terseLabel": "Additional non-refundable payment upon extension of expiration"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_AdditionalNumberOfCommonSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "AdditionalNumberOfCommonSharesIssued",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional number of common shares issued.",
        "label": "Additional Number Of Common Shares Issued",
        "terseLabel": "Additional common shares sold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital",
        "periodEndLabel": "Additional Paid in Capital, Ending Balance",
        "periodStartLabel": "Additional Paid in Capital, Beginning Balance",
        "totalLabel": "Additional Paid in Capital, Total",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r851",
      "r1133"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r685",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1072",
      "r1134"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r408"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r888",
      "r898",
      "r908",
      "r940"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r891",
      "r901",
      "r911",
      "r943"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r902",
      "r912",
      "r936",
      "r944",
      "r948",
      "r956"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r440",
      "r450"
     ]
    },
    "rxst_AmendedTermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "AmendedTermLoanMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amended Term Loan [Member]",
        "documentation": "Amended term loan member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortization of Debt Issuance Costs and Discounts, Total",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt issuance costs and premium",
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r821",
      "r822",
      "r998",
      "r1083"
     ]
    },
    "rxst_AmountOfSettlementOfFractionalShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "AmountOfSettlementOfFractionalShares",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlement of fractional shares.",
        "label": "Amount of Settlement of Fractional Shares",
        "terseLabel": "Fractional shares settled upon conversion of preferred stock to common stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anti-dilutive securities",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Effect of Anti Dilutive Securities",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AreaOfRealEstateProperty",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Area of Real Estate Property",
        "terseLabel": "Area of leased space",
        "documentation": "Area of a real estate property."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r145",
      "r168",
      "r204",
      "r239",
      "r243",
      "r251",
      "r252",
      "r295",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r478",
      "r482",
      "r521",
      "r637",
      "r727",
      "r812",
      "r813",
      "r851",
      "r879",
      "r1037",
      "r1038",
      "r1090"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r176",
      "r204",
      "r295",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r478",
      "r482",
      "r521",
      "r851",
      "r1037",
      "r1038",
      "r1090"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total assets at fair value",
        "totalLabel": "Assets, Fair Value Disclosure, Total",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r498",
      "r839"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_AtmOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "AtmOfferingMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ATM Offering [Member]",
        "label": "ATM Offering [Member]",
        "documentation": "ATM Offering [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_AugustFourTwoThousandTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "AugustFourTwoThousandTwentyThreeMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "August Four Two Thousand Twenty Three [Member]",
        "documentation": "August Four Two Thousand Twenty Three"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r304",
      "r636"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Estimated Fair Value",
        "terseLabel": "Estimated Fair Value",
        "label": "Debt Securities, Available-for-Sale",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r304",
      "r497",
      "r630",
      "r839",
      "r842",
      "r1019",
      "r1076",
      "r1077",
      "r1078"
     ]
    },
    "us-gaap_AwardDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardDateAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Date [Axis]",
        "documentation": "Information by date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069"
     ]
    },
    "us-gaap_AwardDateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardDateDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Date [Domain]",
        "documentation": "Date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r952"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r950"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation and Principles of Consolidation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "rxst_BmlManagementLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "BmlManagementLlcMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BML Management, LLC [Member]",
        "documentation": "BML Management, LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "stpr_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "CA",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "California [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Calhoun Vision, Inc. 2015 Equity Incentive Plan and the Calhoun Vision, Inc. 2006 Stock Plan.",
        "label": "Calhoun Vision Inc2015 Equity Incentive Plan And Calhoun Vision Inc2006 Stock Plan [Member]",
        "terseLabel": "The Calhoun Vision, Inc. 2015 Equity Incentive Plan and the Calhoun Vision, Inc. 2006 Stock Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition of property and equipment included in accounts payable and accrued expenses and other current liabilities",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance",
        "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r166",
      "r801"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash, Cash Equivalents, and Short-term Investments, Total",
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "terseLabel": "Cash, cash equivalents, and short-term investments",
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable."
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash - end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash - beginning of period",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r105",
      "r199"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r105"
     ]
    },
    "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowOperatingActivitiesLesseeAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Operating Activities, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_CashInterestPaidPercentagePeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "CashInterestPaidPercentagePeriod",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureTermLoanScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Interest paid, Percentage, Period",
        "documentation": "Cash Interest paid, Percentage, Period",
        "terseLabel": "Cash interest paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CertificatesOfDepositMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CertificatesOfDepositMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of Deposit [Member]",
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r873",
      "r874",
      "r875",
      "r876"
     ]
    },
    "rxst_ChangeInNotesReceivableForRedeemableCommonStockIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ChangeInNotesReceivableForRedeemableCommonStockIssued",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in notes receivable for redeemable common stock issued.",
        "label": "Change In Notes Receivable For Redeemable Common Stock Issued",
        "terseLabel": "Change in notes receivable for common stock issued"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r170",
      "r171",
      "r172",
      "r204",
      "r225",
      "r226",
      "r233",
      "r235",
      "r241",
      "r242",
      "r295",
      "r331",
      "r333",
      "r334",
      "r335",
      "r338",
      "r339",
      "r370",
      "r371",
      "r374",
      "r377",
      "r385",
      "r521",
      "r677",
      "r678",
      "r679",
      "r680",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r715",
      "r736",
      "r754",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r968",
      "r1000",
      "r1008"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class Of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r171",
      "r172",
      "r241",
      "r370",
      "r371",
      "r372",
      "r374",
      "r377",
      "r383",
      "r385",
      "r677",
      "r678",
      "r679",
      "r680",
      "r823",
      "r968",
      "r1000"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class Of Warrant Or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class Of Warrant Or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "rxst_CliffordDDownsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "CliffordDDownsMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Clifford D. Downs [Member]",
        "documentation": "Clifford D. Downs [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper [Member]",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r330",
      "r873",
      "r874",
      "r875",
      "r876"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 9)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r133",
      "r638",
      "r714"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r321",
      "r322",
      "r785",
      "r1027",
      "r1032"
     ]
    },
    "rxst_CommonStockAfterReclassificationOfRedeemableCommonStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "CommonStockAfterReclassificationOfRedeemableCommonStockShares",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock after reclassification of redeemable common stock, shares",
        "label": "Common Stock after Reclassification of Redeemable Common Stock, Shares",
        "documentation": "Common stock after reclassification of redeemable common stock, shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares of common stock reserved",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Conversion of preferred stock",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "rxst_CommonStockInExchangeForCancellationOfNotesReceivables": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "CommonStockInExchangeForCancellationOfNotesReceivables",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Surrender of common stock in exchange for cancellation of note receivable, Shares",
        "label": "Common Stock in Exchange for Cancellation of Notes Receivables Shares",
        "documentation": "Common stock in exchange for cancellation of notes receivables shares."
       }
      }
     },
     "auth_ref": []
    },
    "rxst_CommonStockInExchangeForCancellationOfNotesReceivablesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "CommonStockInExchangeForCancellationOfNotesReceivablesAmount",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Surrender of common stock in exchange for cancellation of note receivable",
        "documentation": "Common stock in exchange for cancellation of notes receivables amount.",
        "label": "Common Stock in Exchange for Cancellation of Notes Receivables Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock",
        "verboseLabel": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r869",
      "r870",
      "r871",
      "r873",
      "r874",
      "r875",
      "r876",
      "r1004",
      "r1005",
      "r1007",
      "r1072",
      "r1132",
      "r1134"
     ]
    },
    "rxst_CommonStockOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "CommonStockOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock offering costs.",
        "label": "Common Stock Offering Costs",
        "terseLabel": "Common stock offering costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock par value (USD per share)",
        "verboseLabel": "Common stock par value per share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "rxst_CommonStockSaleUnderwritingDiscountsAndCommissionDeducted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "CommonStockSaleUnderwritingDiscountsAndCommissionDeducted",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock sale underwriting discounts and commission deducted.",
        "label": "Common Stock Sale Underwriting Discounts and Commission Deducted",
        "terseLabel": "Common stock sale underwriting discounts and commission deducted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, shares authorized",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r715"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock shares issued",
        "label": "Common Stock, Shares, Issued",
        "totalLabel": "Common Stock, Shares, Issued, Total",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Stockholders' Equity, Ending Balance, Shares",
        "periodStartLabel": "Stockholders' Equity, Beginning Balance, Shares",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock outstanding (in shares)",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r83",
      "r715",
      "r733",
      "r1134",
      "r1135"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.001 par value, 900,000,000 shares authorized, 39,617,334 shares issued and outstanding as of June 30, 2024 and 36,139,513 shares issued and outstanding as of December 31, 2023",
        "label": "Common Stock, Value, Issued",
        "periodEndLabel": "Common Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance",
        "totalLabel": "Common Stock, Value, Issued, Total",
        "verboseLabel": "Common stock, value",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r640",
      "r851"
     ]
    },
    "us-gaap_CommonStockVotingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockVotingRights",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Voting Rights",
        "terseLabel": "Common stock, voting rights",
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "rxst_CommonStockWarrantLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "CommonStockWarrantLiabilityMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock warrant liability.",
        "label": "Common Stock Warrant Liability [Member]",
        "terseLabel": "Common stock warrant liability [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_CommonStockWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "CommonStockWarrantMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock warrant.",
        "label": "Common Stock Warrant [Member]",
        "terseLabel": "Common Stock Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r182",
      "r184",
      "r188",
      "r631",
      "r651",
      "r652"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r62",
      "r63",
      "r256",
      "r784"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r62",
      "r63",
      "r256",
      "r673",
      "r784"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r62",
      "r63",
      "r256",
      "r784",
      "r970"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk and Other Risks and Uncertainties",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r153"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk, Percentage",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r62",
      "r63",
      "r256"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r62",
      "r63",
      "r256",
      "r784"
     ]
    },
    "rxst_ConversionOfNotesReceivablesToTreasuryStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ConversionOfNotesReceivablesToTreasuryStock",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of notes receivables to treasury stock",
        "label": "Conversion of notes receivables to treasury stock"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ConversionOfNotesReceivablesToTreasuryStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ConversionOfNotesReceivablesToTreasuryStockShares",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of notes receivables to treasury stock, Shares",
        "label": "Conversion of notes receivables to treasury stock, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ConversionOfPreferredStockToCommonStockUponInitialPublicOffering",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion Of Preferred Stock To Common Stock Upon Initial Public Offering",
        "label": "Conversion Of Preferred Stock To Common Stock Upon Initial Public Offering",
        "terseLabel": "Conversion of preferred stock to common stock upon initial public offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockAmountConverted1",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Amount Converted",
        "terseLabel": "Conversion of preferred stock to common stock upon initial public offering, net of fractional shares settled",
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33"
     ]
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Redeemable common stock reclassified",
        "verboseLabel": "Conversion of preferred stock to common stock upon initial public offering, net of fractional shares settled (in shares)",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33"
     ]
    },
    "us-gaap_ConvertibleCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleCommonStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Common Stock [Member]",
        "label": "Convertible Common Stock [Member]",
        "documentation": "Common stock securities that may be converted to another form of security."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertiblePreferredStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock",
        "verboseLabel": "Convertible Preferred Stock [Member]",
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r371",
      "r374",
      "r873",
      "r874",
      "r875",
      "r876"
     ]
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible preferred stock, shares converted",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Aggregate shares of common stock",
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r49",
      "r82",
      "r119",
      "r380"
     ]
    },
    "rxst_ConvertiblePreferredStockWarrantLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ConvertiblePreferredStockWarrantLiabilityMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible preferred stock warrant liability.",
        "label": "Convertible Preferred Stock Warrant Liability [Member]",
        "terseLabel": "Convertible preferred stock warrant liability [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "totalLabel": "Cost of Goods and Services Sold, Total",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r98",
      "r598"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Goods Sold",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r206",
      "r207",
      "r344",
      "r372",
      "r560",
      "r580",
      "r635",
      "r803",
      "r805"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r256"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Term Loan",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r201",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r329",
      "r330",
      "r340",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r356",
      "r363",
      "r364",
      "r366",
      "r534"
     ]
    },
    "rxst_DebtFromCashReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "DebtFromCashReserves",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from Lines of Credit",
        "label": "Debt From Cash Reserves",
        "documentation": "Debt From Cash Reserves"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentCallDateLatest": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCallDateLatest",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayment Commencement Date",
        "label": "Debt Instrument, Call Date, Latest",
        "documentation": "Latest date before maturity which the issuer can call the outstanding debt instrument for repayment or conversion to equity, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r49",
      "r141"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial amount of new loans",
        "label": "Long-Term Debt, Gross",
        "totalLabel": "Total",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r132",
      "r367"
     ]
    },
    "rxst_DebtInstrumentClosingCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "DebtInstrumentClosingCost",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument Closing Cost",
        "documentation": "Debt Instrument Closing Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument face amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r534",
      "r535",
      "r819",
      "r820",
      "r849"
     ]
    },
    "rxst_DebtInstrumentFinalPaymentFeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "DebtInstrumentFinalPaymentFeeRate",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument Final Payment Fee Rate",
        "documentation": "Debt Instrument Final Payment Fee Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureTermLoanScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective interest rate",
        "label": "Debt Instrument, Interest Rate During Period",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r359",
      "r1082"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r347",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r365",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r849",
      "r1001",
      "r1082",
      "r1084"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan Maturity Date",
        "label": "Debt Instrument, Maturity Date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r818",
      "r1077",
      "r1078"
     ]
    },
    "us-gaap_DebtInstrumentPaymentTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPaymentTerms",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Payment Terms",
        "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r75"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r49",
      "r52",
      "r65",
      "r118",
      "r120",
      "r208",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r347",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r365",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r849",
      "r1001",
      "r1082",
      "r1084"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized Loss, Net",
        "terseLabel": "Unrealized Loss, Net",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain (Loss), before Tax",
        "totalLabel": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain (Loss), before Tax, Total",
        "documentation": "Amount, before tax, of unrealized gain (loss) in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1020",
      "r1021"
     ]
    },
    "rxst_DeferredOfferingCostsIncludedInAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "DeferredOfferingCostsIncludedInAccruedExpenses",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred offering costs included in accrued expenses",
        "label": "Deferred Offering Costs Included In Accrued Expenses",
        "terseLabel": "Deferred offering costs included in accounts payable and accrued liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodEndLabel": "Balance at end of period",
        "negatedPeriodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Deferred Revenue, Total",
        "terseLabel": "Deferred revenue",
        "label": "Deferred Revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "rxst_DeferredRevenue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "DeferredRevenue1",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSummaryOfAccountingPoliciesScheduleOfDeferredRevenueActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodStartLabel": "Balance at beginning of period",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer.",
        "label": "Deferred Revenue1",
        "negatedPeriodEndLabel": "Balance at end of period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenue [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueAdditions",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSummaryOfAccountingPoliciesScheduleOfDeferredRevenueActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions during the period",
        "negatedLabel": "Consideration earned during the period",
        "terseLabel": "Consideration earned during the period",
        "documentation": "Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueByArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueByArrangementDisclosureTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Revenue Activity",
        "label": "Deferred Revenue, by Arrangement, Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of the type of arrangements and the corresponding amounts that comprise the current and noncurrent balance of deferred revenue as of the balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueRevenueRecognized1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueRevenueRecognized1",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSummaryOfAccountingPoliciesScheduleOfDeferredRevenueActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recognized during the period",
        "label": "Deferred Revenue, Revenue Recognized",
        "negatedLabel": "Revenue recognized during the period",
        "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Depreciation, Depletion and Amortization, Total",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r239",
      "r247",
      "r252",
      "r812",
      "r813"
     ]
    },
    "us-gaap_DisaggregationOfRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation Of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation Of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpense"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation Expense",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r406",
      "r410",
      "r441",
      "r442",
      "r444",
      "r835"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r915"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "us-gaap_EarlyRepaymentOfSeniorDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarlyRepaymentOfSeniorDebt",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment of Loan, Partly",
        "label": "Early Repayment of Senior Debt",
        "documentation": "The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net loss per share:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Earnings Per Share, Basic, Total",
        "verboseLabel": "Basic net income (loss) per share",
        "terseLabel": "Attributable to common stock, basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r223",
      "r225",
      "r233",
      "r234",
      "r235",
      "r238",
      "r473",
      "r476",
      "r494",
      "r495",
      "r632",
      "r653",
      "r808"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Diluted, Total",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted net income (loss) per share",
        "terseLabel": "Attributable to common stock, diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r225",
      "r233",
      "r234",
      "r235",
      "r238",
      "r473",
      "r476",
      "r494",
      "r495",
      "r632",
      "r653",
      "r808"
     ]
    },
    "rxst_EarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "EarningsPerShareLineItems",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share Line Items",
        "label": "Earnings Per Share [Line Items]",
        "terseLabel": "Earnings Per Share [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r35",
      "r237"
     ]
    },
    "rxst_EarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "EarningsPerShareTable",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share Table",
        "label": "Earnings Per Share [Table]",
        "terseLabel": "Earnings Per Share [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents, Total",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of foreign exchange rate on cash, cash equivalents and restricted cash",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "rxst_EffectiveInterestRateOnBorrowingsTermLoan": {
     "xbrltype": "percentItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "EffectiveInterestRateOnBorrowingsTermLoan",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective interest rate on borrowings term loan",
        "label": "Effective Interest Rate On Borrowings Term Loan",
        "documentation": "Effective interest rate on borrowings term loan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average period for recognition of expenses",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized expense related to unvested stock options",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Purchase Plan [Member]",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r965"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r160",
      "r185",
      "r186",
      "r187",
      "r209",
      "r210",
      "r211",
      "r213",
      "r218",
      "r220",
      "r222",
      "r240",
      "r296",
      "r297",
      "r312",
      "r387",
      "r463",
      "r464",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r476",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r493",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r536",
      "r539",
      "r559",
      "r649",
      "r666",
      "r667",
      "r668",
      "r685",
      "r754"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "rxst_EricWeinbergMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "EricWeinbergMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Eric Weinberg [Member]",
        "documentation": "Eric Weinberg [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r888",
      "r898",
      "r908",
      "r940"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r885",
      "r895",
      "r905",
      "r937"
     ]
    },
    "rxst_EscrowHoldbackOfExercisePriceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "EscrowHoldbackOfExercisePriceOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Escrow Holdback Of Exercise Price Of Warrants",
        "label": "Escrow Holdback Of Exercise Price Of Warrants",
        "terseLabel": "Escrow holdback of exercise price of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "srt_ExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ExecutiveOfficerMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "rxst_ExecutiveOfficersAndNonEmployeeDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ExecutiveOfficersAndNonEmployeeDirectorsMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Executive Officers and Non-Employee Directors [Member]",
        "label": "Executive Officers and Non-Employee Directors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ExerciseOfPreferredStockWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ExerciseOfPreferredStockWarrants",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueForWarrantLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of preferred stock warrants",
        "documentation": "Exercise of preferred stock warrants.",
        "label": "Exercise Of Preferred Stock Warrants",
        "negatedLabel": "Exercise of preferred stock warrants"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePrice",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of preferred stock warrants, net of shares withheld for exercise price",
        "label": "Exercise of preferred stock warrants, net of shares withheld for exercise price"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ExerciseOfPreferredStockWarrantsNetOfSharesWithheldForExercisePriceShares",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of preferred stock warrants, net of shares withheld for exercise price, Shares",
        "label": "Exercise of preferred stock warrants, net of shares withheld for exercise price, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ExercisePriceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ExercisePriceOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Of Warrants",
        "label": "Exercise Price Of Warrants",
        "terseLabel": "Exercise price of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ExpirationOfCommonStockWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ExpirationOfCommonStockWarrants",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueForWarrantLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration of common stock warrants.",
        "label": "Expiration Of Common Stock Warrants",
        "negatedLabel": "Expiration of common stock warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r498",
      "r511",
      "r839"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r498",
      "r511",
      "r839"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r512",
      "r840"
     ]
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r512",
      "r840"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r510",
      "r511",
      "r513",
      "r567",
      "r568",
      "r569",
      "r819",
      "r820",
      "r831",
      "r832",
      "r833",
      "r839",
      "r842"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r512"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r506",
      "r508",
      "r509",
      "r510",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r629",
      "r839",
      "r843"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level I [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r399",
      "r404",
      "r498",
      "r511",
      "r567",
      "r831",
      "r832",
      "r833",
      "r839"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level II [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r399",
      "r404",
      "r498",
      "r499",
      "r511",
      "r568",
      "r819",
      "r820",
      "r831",
      "r832",
      "r833",
      "r839"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level III [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r498",
      "r499",
      "r500",
      "r501",
      "r511",
      "r569",
      "r819",
      "r820",
      "r831",
      "r832",
      "r833",
      "r839",
      "r842"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r512"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of estimated fair value for the warrant liabilities measured using significant unobservable inputs",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r507",
      "r512"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueForWarrantLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r512"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r510",
      "r511",
      "r513",
      "r567",
      "r568",
      "r569",
      "r819",
      "r820",
      "r831",
      "r832",
      "r833",
      "r839",
      "r842"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Finance lease cost",
        "negatedLabel": "Finance lease cost",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r549",
      "r850"
     ]
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease liabilities",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r541",
      "r556"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Liabilities Current Finance",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Liabilities Noncurrent Finance",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 (remainder)",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1087"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest",
        "negatedTerseLabel": "Less: imputed interest",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "rxst_FinanceLeaseObligationsIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "FinanceLeaseObligationsIncurred",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease",
        "documentation": "Finance Lease Obligations Incurred",
        "label": "Finance Lease Obligations Incurred"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Principal Payments",
        "negatedLabel": "Principal payments on finance lease liabilities",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r544",
      "r552"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Assets Finance",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r540"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Finance lease cost",
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r549",
      "r850"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate - finance leases (as a percent)",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r555",
      "r850"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term - finance leases",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r554",
      "r850"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r298",
      "r299",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r365",
      "r383",
      "r491",
      "r518",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r650",
      "r816",
      "r839",
      "r840",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r852",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1073",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080"
     ]
    },
    "us-gaap_FinancingReceivableUnamortizedLoanFeeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivableUnamortizedLoanFeeCost",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan Amendment Fees And Other Closing Costs",
        "label": "Financing Receivable, Unamortized Loan Cost (Fee)",
        "documentation": "Amount of unamortized loan commitment, origination, and other costs (fees) on financing receivable recognized as adjustment to yield. Excludes financing receivable covered under loss sharing agreement."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r967",
      "r1018"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r902",
      "r912",
      "r944"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r902",
      "r912",
      "r944"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r902",
      "r912",
      "r944"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r902",
      "r912",
      "r944"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r902",
      "r912",
      "r944"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "us-gaap_FutureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FutureMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Future [Member]",
        "documentation": "Futures contracts are forward-based contracts to make or take delivery of a specified financial instrument, foreign currency, or commodity at a specified future date or during a specified period at as specified price or yield. Futures are standardized contracts traded on an organized exchange."
       }
      }
     },
     "auth_ref": [
      "r720",
      "r724",
      "r729",
      "r743",
      "r749",
      "r768",
      "r869",
      "r870",
      "r871",
      "r1071"
     ]
    },
    "rxst_GainLossFromChangesInFairValueOfCommonStockWarrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "GainLossFromChangesInFairValueOfCommonStockWarrant",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueForWarrantLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) from Changes in fair value of common stock warrant.",
        "label": "Gain Loss From Changes In Fair Value Of Common Stock Warrant",
        "terseLabel": "Change in fair value of common stock warrant"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_GainLossFromChangesInFairValueOfPreferredStockWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "GainLossFromChangesInFairValueOfPreferredStockWarrants",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueForWarrantLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) from Changes in fair value of preferred stock warrants.",
        "label": "Gain Loss From Changes In Fair Value Of Preferred Stock Warrants",
        "terseLabel": "Change in fair value of preferred stock warrants"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_GainOnExpirationOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "GainOnExpirationOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain On Expiration Of Warrants",
        "label": "Gain On Expiration Of Warrants",
        "terseLabel": "Gain on expiration of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on extinguishment of debt",
        "terseLabel": "Loss on extinguishment of term loan",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "totalLabel": "Gain (Loss) on Extinguishment of Debt, Total",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r44",
      "r45"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross Profit",
        "totalLabel": "Gross profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r99",
      "r144",
      "r204",
      "r295",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r521",
      "r810",
      "r812",
      "r1009",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1037"
     ]
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IPOMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IPO [Member]",
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "rxst_IlyaGoldshlegerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "IlyaGoldshlegerMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ilya Goldshleger [Member]",
        "documentation": "Ilya Goldshleger [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r138",
      "r144",
      "r633",
      "r646",
      "r810",
      "r812",
      "r1009",
      "r1011",
      "r1012",
      "r1013",
      "r1014"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "terseLabel": "Income Statement Location",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r319",
      "r320",
      "r503",
      "r507",
      "r512",
      "r663",
      "r665",
      "r739",
      "r797",
      "r841",
      "r1103"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Domain]",
        "terseLabel": "Income Statement Location",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r320",
      "r503",
      "r507",
      "r512",
      "r663",
      "r665",
      "r739",
      "r797",
      "r841",
      "r1103"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r453",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r465",
      "r467",
      "r468",
      "r469",
      "r682",
      "r836"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income Tax Expense (Benefit), Total",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r156",
      "r221",
      "r222",
      "r239",
      "r248",
      "r252",
      "r454",
      "r455",
      "r466",
      "r654",
      "r836"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income Taxes Paid, Net, Total",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r198",
      "r461",
      "r462"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total",
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "totalLabel": "Increase (Decrease) in Inventories, Total",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (Decrease) in Prepaid Expense and Other Assets, Total",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid and other assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r902",
      "r912",
      "r936",
      "r944",
      "r948",
      "r956"
     ]
    },
    "rxst_IndustrialCommercialMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "IndustrialCommercialMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Industrial/Commercial [Member]",
        "documentation": "Industrial/Commercial [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r884",
      "r960"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r884",
      "r960"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r884",
      "r960"
     ]
    },
    "us-gaap_InterestAndOtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestAndOtherIncome",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Interest and Other Income, Total",
        "label": "Interest and Other Income",
        "terseLabel": "Interest and other income",
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestBearingDepositsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestBearingDepositsMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest-Bearing Deposits [Member]",
        "terseLabel": "Interest-Bearing Deposits [Member]",
        "documentation": "Cash on deposit with financial institutions that earns interest, either at a fixed or market rate."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r134"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Interest Expense, Total",
        "label": "Interest Expense, Operating and Nonoperating",
        "negatedLabel": "Interest expense",
        "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r243",
      "r246",
      "r249",
      "r252",
      "r533",
      "r812",
      "r813"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest paid",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r196",
      "r197"
     ]
    },
    "rxst_InterestPaidOnFinancingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "InterestPaidOnFinancingLeases",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest paid on financing leases",
        "label": "Interest Paid On Financing Leases",
        "terseLabel": "Cash paid for interest on financing leases"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_InterestPaidOnTermLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "InterestPaidOnTermLoan",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest paid on term loan.",
        "label": "Interest Paid On Term Loan",
        "terseLabel": "Cash paid for interest on term loan"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_InterestRateOnBorrowingsTermLoan": {
     "xbrltype": "percentItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "InterestRateOnBorrowingsTermLoan",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate on borrowings under the term loan.",
        "label": "Interest Rate On Borrowings Term Loan",
        "terseLabel": "Interest rate on borrowings term loan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryAdjustments",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Inventory Adjustments, Total",
        "label": "Inventory Adjustments",
        "terseLabel": "Inventories reserves",
        "documentation": "Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r989"
     ]
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureInventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Inventory, Finished Goods, Gross, Total",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "us-gaap_InventoryGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryGross",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Gross",
        "totalLabel": "Inventory gross",
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories, net",
        "label": "Inventory, Net",
        "totalLabel": "Inventory net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r802",
      "r851"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r165",
      "r174",
      "r308",
      "r309",
      "r311",
      "r597",
      "r806"
     ]
    },
    "us-gaap_InventoryRawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryRawMaterials",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Inventory, Raw Materials, Gross, Total",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials",
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r987"
     ]
    },
    "us-gaap_InventoryValuationReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryValuationReserves",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Inventory Valuation Reserves, Ending Balance",
        "periodStartLabel": "Inventory Valuation Reserves, Beginning Balance",
        "label": "Inventory Valuation Reserves",
        "negatedLabel": "Less: reserve for excess and obsolete inventory",
        "documentation": "Amount of valuation reserve for inventory."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r989"
     ]
    },
    "us-gaap_InventoryWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWorkInProcess",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work-in-process",
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r986"
     ]
    },
    "us-gaap_InventoryWriteDown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWriteDown",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Write-down",
        "terseLabel": "Provision for excess and obsolete inventory",
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels."
       }
      }
     },
     "auth_ref": [
      "r310"
     ]
    },
    "rxst_InvestmentMaturityPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "InvestmentMaturityPeriod",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment maturity period.",
        "label": "Investment Maturity Period",
        "terseLabel": "Investment maturity period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type",
        "documentation": "Information by type of investments."
       }
      }
     },
     "auth_ref": [
      "r697",
      "r699",
      "r700",
      "r702",
      "r704",
      "r759",
      "r761",
      "r763",
      "r766",
      "r767",
      "r769",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r871"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Domain]",
        "terseLabel": "Investments",
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "auth_ref": [
      "r697",
      "r699",
      "r700",
      "r702",
      "r704",
      "r759",
      "r761",
      "r763",
      "r766",
      "r767",
      "r769",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r871"
     ]
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Short-Term Investment",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r159",
      "r263",
      "r264",
      "r519",
      "r520",
      "r1099"
     ]
    },
    "rxst_IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "IssuanceOfCommonStockForAtTheMarketOfferingsNetOfIssuanceCostsShare",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for at-the-market offerings, net of issuance costs, Shares",
        "label": "Issuance of Common Stock for at-the-Market Offerings, Net of Issuance Costs, Share",
        "documentation": "Issuance of Common Stock for at-the-Market Offerings, Net of Issuance Costs, Share"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for at-the-market offerings, net of issuance costs, Amount",
        "label": "Issuance of common stock in at-the-market offerings, net of issuance costs, Amount",
        "documentation": "Issuance of common stock in at-the-market offerings, net of issuance costs, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for at-the-market offerings, net of issuance costs, Shares",
        "label": "Issuance of common stock in at-the-market offerings, net of issuance costs, Share",
        "documentation": "Issuance of common stock in at-the-market offerings, net of issuance costs, Share"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_JAndyCorleyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "JAndyCorleyMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "J. Andy Corley [Member]",
        "documentation": "J. Andy Corley [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_JulieAndrewsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "JulieAndrewsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Julie Andrews [Member]",
        "documentation": "Julie Andrews [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_June2023LsaRepaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "June2023LsaRepaymentMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2023 LSA repayment",
        "label": "June 2023 LSA repayment [Member]",
        "terseLabel": "June 2023 LSA repayment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_LDDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "LDDMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LDD Member",
        "label": "L D D [Member]",
        "terseLabel": "L D D"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseAndRentalExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseAndRentalExpense",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Rent Payable",
        "label": "Operating Leases, Rent Expense",
        "totalLabel": "Operating Leases, Rent Expense, Total",
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseContractualTermAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseContractualTermAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Contractual Term [Axis]",
        "documentation": "Information by contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r558",
      "r971"
     ]
    },
    "us-gaap_LeaseContractualTermDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseContractualTermDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Contractual Term [Domain]",
        "documentation": "Contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r558",
      "r971"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Component of Lease Expense",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1086"
     ]
    },
    "us-gaap_LeaseExpirationDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseExpirationDate1",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Expiration Date",
        "terseLabel": "Lease expiration date",
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "rxst_LeaseLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "LeaseLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease liabilities current.",
        "label": "Lease Liabilities Current",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_LeaseLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "LeaseLiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease liabilities noncurrent.",
        "label": "Lease Liabilities Noncurrent",
        "terseLabel": "Long-term lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_LeaseObligationsRecordedForRightOfUseAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "LeaseObligationsRecordedForRightOfUseAssetsAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease obligations recorded for right-of-use assets abstract",
        "label": "Lease Obligations Recorded For Right Of Use Assets [Abstract]",
        "terseLabel": "Lease obligations recorded for right-of-use assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LegalFees",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal proceedings, regulatory matters, legal costs",
        "label": "Legal Fees",
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee Lease Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r558"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee Lease Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r558"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Lease Liabilities",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1087"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 (remainder)",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1087"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest",
        "negatedTerseLabel": "Less: imputed interest",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease extend term",
        "label": "Lessee, Operating Lease, Option to Extend",
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease term extended term",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Payable term",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r538"
     ]
    },
    "us-gaap_LesseeOperatingSubleaseOptionToTerminate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingSubleaseOptionToTerminate",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublease cancelled",
        "label": "Lessee, Operating Sublease, Option to Terminate",
        "documentation": "Description of terms and conditions of option to terminate operating sublease."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "us-gaap_LessorOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeaseTermOfContract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublease agreement",
        "label": "Lessor, Operating Lease, Term of Contract",
        "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1088"
     ]
    },
    "us-gaap_LetterOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LetterOfCreditMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of Credit [Member]",
        "label": "Letter of Credit [Member]",
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r71",
      "r72",
      "r73",
      "r77",
      "r78",
      "r79",
      "r80",
      "r204",
      "r295",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r479",
      "r482",
      "r483",
      "r521",
      "r713",
      "r809",
      "r879",
      "r1037",
      "r1090",
      "r1091"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders' equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r135",
      "r644",
      "r851",
      "r1002",
      "r1026",
      "r1081"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, redeemable common stock, stock options, convertible preferred stock and stockholders' deficit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r164",
      "r204",
      "r295",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r479",
      "r482",
      "r483",
      "r521",
      "r851",
      "r1037",
      "r1090",
      "r1091"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure",
        "negatedLabel": "Total liabilities at fair value",
        "totalLabel": "Liabilities, Fair Value Disclosure, Total",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r1074"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liability:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesOtherThanLongtermDebtNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term liabilities",
        "label": "Liabilities, Other than Long-Term Debt, Noncurrent",
        "totalLabel": "Liabilities, Other than Long-Term Debt, Noncurrent, Total",
        "documentation": "Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowing Capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r76"
     ]
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unused Term Loan Commitment Fee Rate",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LinesOfCreditCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LinesOfCreditCurrent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate amount of the letter of credit",
        "label": "Line of Credit, Current",
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r131"
     ]
    },
    "rxst_LiquidityAndFinancialPositionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "LiquidityAndFinancialPositionPolicyTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liquidity and Financial Position",
        "label": "Liquidity and Financial Position [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for Liquidity and Financial Position."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoansReceivableDescriptionOfVariableRateBasis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LoansReceivableDescriptionOfVariableRateBasis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan, Description of Variable Rates",
        "label": "Loans Receivable, Description of Variable Rate Basis",
        "documentation": "Description of reference rate used for variable rate of loan receivable."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt",
        "terseLabel": "Term loan, net",
        "totalLabel": "Term loan, net",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r132",
      "r353",
      "r368",
      "r819",
      "r820",
      "r849",
      "r1101"
     ]
    },
    "us-gaap_LongTermDebtDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtDescription",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan Description",
        "label": "Long-Term Debt, Description",
        "documentation": "Description of long-term debt arrangements, which are debt arrangements that originally require full repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer, and disclosures pertaining to the underlying arrangements, including repayment terms, conversion features, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements. Types of long-term debt arrangements include borrowing under notes payable, bonds payable, debentures, term loans, and other contractual obligations for payment."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r49"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r208",
      "r358"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Long-Term Debt, Maturity, Year Five",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r208",
      "r358"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Long-Term Debt, Maturity, Year Four",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r208",
      "r358"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year Three",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r208",
      "r358"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Long-Term Debt, Maturity, Year Two",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r208",
      "r358"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 (remainder)",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1003"
     ]
    },
    "rxst_LongTermWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "LongTermWarrantLiability",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term warrant liability.",
        "label": "Long Term Warrant Liability",
        "terseLabel": "Long-term warrant liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r1028",
      "r1029",
      "r1030"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r43",
      "r1028",
      "r1029",
      "r1030"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r328",
      "r451",
      "r817",
      "r1033",
      "r1034"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r256",
      "r826",
      "r862",
      "r866",
      "r1042",
      "r1102",
      "r1104",
      "r1105",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131"
     ]
    },
    "us-gaap_ManufacturingFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ManufacturingFacilityMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturing Facility [Member]",
        "terseLabel": "Manufacturing [Member]",
        "documentation": "Structure used in the manufacturing of goods."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r327",
      "r405",
      "r451",
      "r501",
      "r596",
      "r662",
      "r664",
      "r672",
      "r705",
      "r706",
      "r760",
      "r762",
      "r764",
      "r765",
      "r770",
      "r795",
      "r796",
      "r815",
      "r823",
      "r834",
      "r842",
      "r843",
      "r847",
      "r848",
      "r863",
      "r1039",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097"
     ]
    },
    "rxst_MayThreeTwoThousandTwentyTwoTermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "MayThreeTwoThousandTwentyTwoTermLoanMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "May 2022 Term Loan [Member]",
        "label": "May Three Two Thousand Twenty Two Term Loan [Member]",
        "documentation": "May Three Two Thousand Twenty Two Term Loan Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r327",
      "r405",
      "r451",
      "r501",
      "r596",
      "r662",
      "r664",
      "r672",
      "r705",
      "r706",
      "r760",
      "r762",
      "r764",
      "r765",
      "r770",
      "r795",
      "r796",
      "r815",
      "r823",
      "r834",
      "r842",
      "r843",
      "r847",
      "r863",
      "r1039",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market Securities [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]"
       }
      }
     },
     "auth_ref": [
      "r256",
      "r826",
      "r862",
      "r866",
      "r1042",
      "r1102",
      "r1104",
      "r1105",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) provided by investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r107"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "totalLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r107",
      "r139",
      "r162",
      "r180",
      "r183",
      "r187",
      "r204",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r221",
      "r222",
      "r231",
      "r295",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r473",
      "r476",
      "r495",
      "r521",
      "r648",
      "r735",
      "r752",
      "r753",
      "r877",
      "r1037"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Attributable to common stock, diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r224",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r235"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "rxst_NewLoanAndSecurityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "NewLoanAndSecurityAgreementMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Loan and Security Agreement [Member]",
        "documentation": "New Loan and Security Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_NoCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "NoCustomerMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No Customer [Member]",
        "label": "No Customer [Member]",
        "terseLabel": "No Customer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_NonEmployeeDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "NonEmployeeDirectorsMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Employee Directors [Member]",
        "label": "Non-Employee Directors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r902",
      "r912",
      "r936",
      "r944"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r918"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Non-cash investing and financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense), net:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonvotingCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonvotingCommonStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonvoting Common Stock [Member]",
        "terseLabel": "Nonvoting Common Stock [Member]",
        "documentation": "Common stock securities that do not empower a holder to vote on corporate resolutions or the election of directors."
       }
      }
     },
     "auth_ref": []
    },
    "rxst_NotesReceivableForCommonStockIssuedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "NotesReceivableForCommonStockIssuedMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes receivable for common stock issued.",
        "label": "Notes Receivable For Common Stock Issued [Member]",
        "terseLabel": "Notes Receivable for Common Stock Issued"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_NotesReceivableForRedeemableCommonStockIssuedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "NotesReceivableForRedeemableCommonStockIssuedMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes receivable for redeemable common stock issued.",
        "label": "Notes Receivable For Redeemable Common Stock Issued [Member]",
        "terseLabel": "Notes Receivable for Redeemable Common Stock Issued"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_NumberOfLeases": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "NumberOfLeases",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of leases.",
        "label": "Number Of Leases",
        "terseLabel": "Number of leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segment",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r811",
      "r814",
      "r1010"
     ]
    },
    "rxst_NumberOfWhollyOwnedSubsidiaries": {
     "xbrltype": "integerItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "NumberOfWhollyOwnedSubsidiaries",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of wholly owned subsidiaries",
        "label": "Number of Wholly Owned Subsidiaries",
        "documentation": "Number of wholly owned subsidiaries."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OfficeBuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OfficeBuildingMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office Building [Member]",
        "terseLabel": "Office [Member]"
       }
      }
     },
     "auth_ref": [
      "r1136",
      "r1137"
     ]
    },
    "rxst_OfficeManufacturingAndWarehouseFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "OfficeManufacturingAndWarehouseFacilityMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure used in the manufactOffice, Manufacturing and Warehouse Facility.",
        "label": "Office Manufacturing And Warehouse Facility [Member]",
        "terseLabel": "Office, Manufacturing and Warehouse Facility [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_OneTwentyFiveColumbiaLeaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "OneTwentyFiveColumbiaLeaseMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Twenty Five Columbia Lease [Member]",
        "documentation": "One Twenty Five Columbia Lease [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss)",
        "terseLabel": "Losses from operations",
        "totalLabel": "Loss from operations",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r810",
      "r1009",
      "r1011",
      "r1012",
      "r1013",
      "r1014"
     ]
    },
    "rxst_OperatingIncomeLoss1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "OperatingIncomeLoss1",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income (Loss)1",
        "label": "Operating Income Loss1",
        "terseLabel": "Losses from operations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r550",
      "r850"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease liabilities",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Liabilities Current Operating",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Liabilities Noncurrent Operating",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "rxst_OperatingLeaseObligationsIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "OperatingLeaseObligationsIncurred",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease obligations incurred.",
        "label": "Operating Lease Obligations Incurred",
        "terseLabel": "Operating lease"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r545",
      "r552"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating leases right-of-use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r540"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "terseLabel": "Amortization of right-of-use lease assets",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate - operating leases (as a percent)",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r555",
      "r850"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term - operating leases",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r554",
      "r850"
     ]
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future minimum lease payment",
        "label": "Operating Leases, Future Minimum Payments Due",
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r147"
     ]
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 2025",
        "label": "Operating Leases, Future Minimum Payments Due, Next 12 Months",
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r147"
     ]
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 2028",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r147"
     ]
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 2027",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r147"
     ]
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 2026",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r147"
     ]
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Operating Leases, Future Minimum Payments, Due Thereafter",
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r147"
     ]
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 2024",
        "label": "Operating Leases, Future Minimum Payments, Remainder of Fiscal Year",
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeasesRentExpenseSubleaseRentals1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasesRentExpenseSubleaseRentals1",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Leases, Rent Expense, Sublease Rentals",
        "documentation": "The total amount of sublease rental income recognized during the period that reduces the entity's rent expense incurred under operating leases."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_OperationsCommencedDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperationsCommencedDate1",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease commences date",
        "label": "Operations Commenced Date",
        "documentation": "Date the operations of the entity commenced, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OptionIndexedToIssuersEquityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OptionIndexedToIssuersEquityDescriptionTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiability"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract Indexed to Issuer's Equity [Text Block]",
        "terseLabel": "Common Stock Warrant Liability",
        "documentation": "The entire disclosure for freestanding contract indexed to and potentially settled in entity's own stock. Includes, but is not limited to, strike price and number of shares to which contract is indexed, settlement date, and settlement alternatives."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r490"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization and Basis of Presentation",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r127",
      "r674",
      "r675"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other Assets, Noncurrent, Total",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Unrealized gain (loss)on short-term investments",
        "verboseLabel": "Unrealized loss on short-term investments and cash equivalents, net of tax",
        "documentation": "Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r12",
      "r128"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation (loss) gain",
        "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent, Total",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r12",
      "r128"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment",
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r92",
      "r93",
      "r94",
      "r522",
      "r523",
      "r525"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of unexercised warrants",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "totalLabel": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total",
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r178",
      "r179",
      "r649"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other comprehensive (loss) income",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r12",
      "r128",
      "r181",
      "r184",
      "r218"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive (loss) income",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross",
        "terseLabel": "Inventory held on consignment",
        "documentation": "Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r890",
      "r900",
      "r910",
      "r942"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r893",
      "r903",
      "r913",
      "r945"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r893",
      "r903",
      "r913",
      "r945"
     ]
    },
    "us-gaap_PaidInKindInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaidInKindInterest",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Paid-in-Kind Interest",
        "terseLabel": "Payment-in-kind interest income added to principal of notes receivable",
        "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "rxst_PaymentsForEmployeeTaxesRelatedToStockCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "PaymentsForEmployeeTaxesRelatedToStockCompensation",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for employee taxes related to stock compensation",
        "label": "Payments for employee taxes related to stock compensation",
        "documentation": "Payments for employee taxes related to stock compensation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForFees",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Final payment and other fees",
        "label": "Payments for Other Fees",
        "documentation": "Amount of cash outflow for fees classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_PaymentsForProceedsFromTenantAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForProceedsFromTenantAllowance",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for (Proceeds from) Tenant Allowance",
        "terseLabel": "Operating leases,tenant allowance",
        "documentation": "Net cash outflow or inflow from monetary allowance granted by the landlord to a tenant to entice tenant to move into landlords building which will enable the tenant to prepare the leased premises for tenants occupancy."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r102"
     ]
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments of debt issuance costs",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Payments of debt issuance costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Payments of deferred offering costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireShortTermInvestments",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Short-Term Investments",
        "negatedLabel": "Purchases of short-term investments",
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r918"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "rxst_PotentialAggregatePaymentsForRegulatoryMilestones": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "PotentialAggregatePaymentsForRegulatoryMilestones",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential Aggregate Payments For Regulatory Milestones",
        "label": "Potential Aggregate Payments For Regulatory Milestones",
        "terseLabel": "Potential aggregate payments for regulatory milestones"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "PotentialAggregatePaymentsForSalesBasedAndOperatingMilestones",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential Aggregate Payments For Sales Based And Operating Milestones",
        "label": "Potential Aggregate Payments For Sales Based And Operating Milestones",
        "terseLabel": "Potential aggregate payments for sales based and operating milestones"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockLiquidationPreferenceValue",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Liquidation Preference, Value",
        "terseLabel": "Liquidation Preference",
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r374",
      "r386"
     ]
    },
    "us-gaap_PreferredStockNoParValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockNoParValue",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, No Par Value",
        "terseLabel": "Preferred stock no par value",
        "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r1040"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock par value per share",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Par Value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r370"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, shares authorized",
        "terseLabel": "Shares Authorized",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r715"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred shares issued",
        "totalLabel": "Preferred Stock, Shares Issued, Total",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r370"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares Outstanding",
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r715",
      "r733",
      "r1134",
      "r1135"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Value, Issued",
        "totalLabel": "Preferred Stock, Value, Issued, Total",
        "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance",
        "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance",
        "terseLabel": "Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r639",
      "r851"
     ]
    },
    "rxst_PreferredStockWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "PreferredStockWarrantsMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock warrants [Member].",
        "label": "Preferred Stock Warrants [Member]",
        "terseLabel": "Preferred Stock Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from issuance of common stock",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock from public offering",
        "label": "Proceeds from Issuance Initial Public Offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "rxst_ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock from at-the-market offerings",
        "label": "Proceeds from issuance of common stock in at-the-market offerings",
        "documentation": "Proceeds from issuance of common stock in at-the-market offerings"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised, Total",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Total Cash Received from the Exercise of Stock Options",
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r16"
     ]
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from Lines of Credit",
        "label": "Proceeds from Lines of Credit",
        "totalLabel": "Proceeds from Lines of Credit, Total",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r1001"
     ]
    },
    "us-gaap_ProceedsFromLoanOriginations1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromLoanOriginations1",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from Loan Originations",
        "label": "Proceeds from Loan Originations",
        "documentation": "Cash inflow associated with loan origination (the process when securing a mortgage for a piece of real property) or lease origination."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromNotesPayable",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Proceeds from Notes Payable, Total",
        "label": "Proceeds from Notes Payable",
        "terseLabel": "Proceeds from term loan",
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturities of short-term investments",
        "label": "Proceeds from Sale, Maturity and Collection of Short-Term Investments",
        "totalLabel": "Proceeds from Sale, Maturity and Collection of Short-term Investments, Total",
        "documentation": "The cash inflow from sales, maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ProceedsFromSaleOfNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfNotesReceivable",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Sale of Notes Receivable",
        "verboseLabel": "Proceeds from notes receivable",
        "documentation": "The cash inflow associated with the sale of a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "auth_ref": [
      "r253",
      "r598",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r799",
      "r824",
      "r861",
      "r863",
      "r864",
      "r867",
      "r868",
      "r1035",
      "r1036",
      "r1042",
      "r1102",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "auth_ref": [
      "r253",
      "r598",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r799",
      "r824",
      "r861",
      "r863",
      "r864",
      "r867",
      "r868",
      "r1035",
      "r1036",
      "r1042",
      "r1102",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "verboseLabel": "Net loss",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r180",
      "r183",
      "r194",
      "r204",
      "r212",
      "r218",
      "r221",
      "r222",
      "r295",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r473",
      "r476",
      "r477",
      "r480",
      "r481",
      "r495",
      "r521",
      "r633",
      "r647",
      "r684",
      "r735",
      "r752",
      "r753",
      "r837",
      "r838",
      "r878",
      "r995",
      "r1037"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r557"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance",
        "totalLabel": "Property, Plant and Equipment, Net, Total",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r557",
      "r634",
      "r645",
      "r851"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r557"
     ]
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Allowance for doubtful accounts",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r300"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r327",
      "r398",
      "r405",
      "r436",
      "r437",
      "r438",
      "r451",
      "r501",
      "r570",
      "r579",
      "r596",
      "r662",
      "r664",
      "r672",
      "r705",
      "r706",
      "r760",
      "r762",
      "r764",
      "r765",
      "r770",
      "r795",
      "r796",
      "r815",
      "r823",
      "r834",
      "r842",
      "r843",
      "r847",
      "r848",
      "r863",
      "r871",
      "r1031",
      "r1039",
      "r1077",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r327",
      "r398",
      "r405",
      "r436",
      "r437",
      "r438",
      "r451",
      "r501",
      "r570",
      "r579",
      "r596",
      "r662",
      "r664",
      "r672",
      "r705",
      "r706",
      "r760",
      "r762",
      "r764",
      "r765",
      "r770",
      "r795",
      "r796",
      "r815",
      "r823",
      "r834",
      "r842",
      "r843",
      "r847",
      "r848",
      "r863",
      "r871",
      "r1031",
      "r1039",
      "r1077",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097"
     ]
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r262",
      "r1017"
     ]
    },
    "rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForNonCashExercise": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForNonCashExercise",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification From Warrant Liability To Additional Paid-In Capital For Non-Cash exercise",
        "label": "Reclassification From Warrant Liability To Additional Paid-in capital for non-cash exercise",
        "terseLabel": "Reclassification from warrant liability to additional paid-in capital for non-cash exercise"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForWarrantsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ReclassificationFromWarrantLiabilityToAdditionalPaidInCapitalForWarrantsExercised",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification from warrant liability to additional paid in capital for warrants exercised.",
        "label": "Reclassification from Warrant Liability to Additional Paid In Capital for Warrants Exercised",
        "terseLabel": "Reclassification from warrant liability to additional paid-in capital for warrants exercised"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ReclassificationOfDeferredCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ReclassificationOfDeferredCost",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification Of Deferred Cost",
        "label": "Reclassification Of Deferred Cost",
        "terseLabel": "Reclassification of deferred financing costs"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ReclassificationOfRedeemableCommonStockOptionsToCommonStockOptions",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of redeemable common stock options to common stock options.",
        "label": "Reclassification Of Redeemable Common Stock Options To Common Stock Options",
        "terseLabel": "Reclassification of redeemable common stock options to common stock options"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ReclassificationOfRedeemableCommonStockToCommonStockOptionsAssumedInNonCashInvestingOrFinancingActivity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ReclassificationOfRedeemableCommonStockToCommonStockOptionsAssumedInNonCashInvestingOrFinancingActivity",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of redeemable common stock to common stock options assumed in non cash investing or financing activity.",
        "label": "Reclassification Of Redeemable Common Stock To Common Stock Options Assumed In Non Cash Investing Or Financing Activity",
        "terseLabel": "Reclassification of redeemable common stock options to common stock options"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ReclassificationOfSharesOfRedeemableCommonStockToCommonStockAssumedInNonCashInvestingOrFinancingActivity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ReclassificationOfSharesOfRedeemableCommonStockToCommonStockAssumedInNonCashInvestingOrFinancingActivity",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of shares of redeemable common stock to common stock, assumed in non cash investing or financing activity.",
        "label": "Reclassification Of Shares Of Redeemable Common Stock To Common Stock Assumed In Non Cash Investing Or Financing Activity",
        "terseLabel": "Reclassification of 4,093,995 shares of redeemable common stock to 4,093,995 shares of common stock"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of 4,093,995 shares of redeemable common stock to 4,093,995 shares of common stock",
        "documentation": "Reclassification of shares of redeemable common stock to shares of common stock.",
        "label": "Reclassification Of Shares Of Redeemable Common Stock To Shares Of Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ReclassificationOfSharesOfRedeemableCommonStockToSharesOfCommonStockInShares",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of 4,093,995 shares of redeemable common stock to 4,093,995 shares of common stock, shares",
        "documentation": "Reclassification of shares of redeemable common stock to shares of common stock in shares.",
        "label": "Reclassification Of Shares Of Redeemable Common Stock To Shares Of Common Stock In Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r885",
      "r895",
      "r905",
      "r937"
     ]
    },
    "rxst_RedeemableCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "RedeemableCommonStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable common stock.",
        "label": "Redeemable Common Stock [Member]",
        "terseLabel": "Redeemable Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_RedeemableCommonStockReclassifiedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "RedeemableCommonStockReclassifiedShares",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable common stock reclassified, shares",
        "label": "Redeemable Common Stock, Reclassified, Shares",
        "documentation": "Redeemable common stock, reclassified, shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RedeemableConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RedeemableConvertiblePreferredStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Redeemable Convertible Preferred Stock",
        "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer."
       }
      }
     },
     "auth_ref": []
    },
    "rxst_RedeemableConvertiblePreferredStockWarrantLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "RedeemableConvertiblePreferredStockWarrantLiabilityMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable convertible preferred stock warrant liability.",
        "label": "Redeemable Convertible Preferred Stock Warrant Liability [Member]",
        "terseLabel": "Redeemable convertible preferred stock warrant liability [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_RedeemableStockOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "RedeemableStockOptionsMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable stock options.",
        "label": "Redeemable Stock Options [Member]",
        "terseLabel": "Redeemable Stock Options"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_RepaymentOfTermLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "RepaymentOfTermLoan",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of term loan",
        "label": "Repayment of term loan",
        "documentation": "Repayment of term loan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayment of outstanding debt",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r206",
      "r207",
      "r344",
      "r372",
      "r560",
      "r580",
      "r635",
      "r804",
      "r805"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "totalLabel": "Research and Development Expense, Total",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r797",
      "r812",
      "r1098"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r886",
      "r896",
      "r906",
      "r938"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r887",
      "r897",
      "r907",
      "r939"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r894",
      "r904",
      "r914",
      "r946"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r980",
      "r999"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restricted Stock Units",
        "terseLabel": "Restricted Stock Units [Member]",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance",
        "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r121",
      "r643",
      "r669",
      "r671",
      "r681",
      "r716",
      "r851"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r209",
      "r210",
      "r211",
      "r213",
      "r218",
      "r220",
      "r222",
      "r296",
      "r297",
      "r312",
      "r463",
      "r464",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r476",
      "r484",
      "r486",
      "r487",
      "r489",
      "r493",
      "r536",
      "r539",
      "r666",
      "r668",
      "r685",
      "r1134"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue from contracts with customers",
        "terseLabel": "Sales",
        "totalLabel": "Revenue from Contract with Customer, Excluding Assessed Tax, Total",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r143",
      "r239",
      "r244",
      "r245",
      "r250",
      "r252",
      "r253",
      "r254",
      "r256",
      "r396",
      "r397",
      "r598"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r798"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r850"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating lease",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r850"
     ]
    },
    "rxst_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-use assets obtained in exchange for lease obligations abstract",
        "label": "Right Of Use Assets Obtained In Exchange For Lease Obligations [Abstract]",
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations:"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_RonKurtzMDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "RonKurtzMDMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ron Kurtz M.D [Member]",
        "documentation": "Ron Kurtz M.D [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "rxst_RxlalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "RxlalMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LAL [Member]",
        "documentation": "RxLAL [Member]",
        "terseLabel": "LAL"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from sale of shares",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of shares issued and sold",
        "terseLabel": "Number of shares sold",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Common stock par or stated value per share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockTransactionDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockTransactionDate",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Transaction Date",
        "terseLabel": "Sale of stock, date",
        "verboseLabel": "Date of Issuance",
        "documentation": "Date the subsidiary or equity investee issued or sold stock, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r256",
      "r969"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Dilutive Securities Excluded from Computation of Loss Per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Short-term Investments Available For Sale",
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value."
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanTableTextblock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ScheduleOfCashInterestPaidAndEffectiveInterestRateOnTermLoanTableTextblock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash Interest Paid and Effective Interest Rate On Term Loan",
        "label": "Schedule of Cash Interest Paid and effective interest rate on term loan table TextBlock",
        "documentation": "Schedule of Cash Interest Paid and effective interest rate on term loan table TextBlock"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Common stock reserved for future issuance",
        "label": "Schedule of Common stock reserved for future issuance [Table Text Block]",
        "documentation": "Schedule of Common stock reserved for future issuance [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Future Principal Payments Due Under the Term Loan",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Stock-Based Compensation Expense",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Schedule of Revenue from Contracts with Customers",
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of assets and liabilities measured at fair value on recurring basis and the fair value hierarchy of the valuation techniques",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1074",
      "r1075"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureInventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r89",
      "r90",
      "r91"
     ]
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Summary of Non-Vested Restricted stock unit Activities",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "us-gaap_ScheduleOfPreferredUnitsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPreferredUnitsTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureConvertiblePreferredStockAndStockholdersDeficitTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Preferred Units [Table Text Block]",
        "terseLabel": "Summary of Preferred Stock",
        "documentation": "Tabular disclosure of preferred units of master limited partnerships that have priority over limited partner units in areas including liquidation, redemption, conversion, tax status of distribution or sharing in distributions. This schedule ordinarily includes a description of the preferred units that details various rights including redemption, conversion, liquidation, and sharing in distributions; capital contributed by preferred partners; number of preferred units authorized to be issued, issued, and outstanding; aggregate cumulative cash distributions made to the preferred partners; aggregate cumulative net income earned by the preferred partners; capital account balance of the preferred partners."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r409",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activities",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r15",
      "r123"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Range and Weighted-average Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Table]",
        "terseLabel": "Schedule Of Short Term Debt [Table]",
        "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock, Class of Stock [Table]",
        "terseLabel": "Schedule Of Stock By Class [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r116",
      "r118",
      "r120",
      "r121",
      "r170",
      "r171",
      "r172",
      "r241",
      "r370",
      "r371",
      "r372",
      "r374",
      "r377",
      "r383",
      "r385",
      "r677",
      "r678",
      "r679",
      "r680",
      "r823",
      "r968",
      "r1000"
     ]
    },
    "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Sale of Stock [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "auth_ref": [
      "r254",
      "r255",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r698",
      "r701",
      "r703",
      "r761",
      "r763",
      "r767",
      "r771",
      "r783",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r800",
      "r825",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r865",
      "r871",
      "r1042",
      "r1102",
      "r1104",
      "r1105",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative",
        "totalLabel": "Selling, General and Administrative Expense, Total",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesScheduleOfComponentsOfLeaseExpenseDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative",
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Preferred Stock [Member]",
        "documentation": "Series A preferred stock."
       }
      }
     },
     "auth_ref": [
      "r983",
      "r984",
      "r1041"
     ]
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesBPreferredStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B Preferred Stock [Member]",
        "documentation": "Series B preferred stock."
       }
      }
     },
     "auth_ref": [
      "r983",
      "r984",
      "r1041"
     ]
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesCPreferredStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series C Preferred Stock [Member]",
        "terseLabel": "Series C Preferred Stock [Member]",
        "documentation": "Series C preferred stock."
       }
      }
     },
     "auth_ref": [
      "r983",
      "r984",
      "r1041"
     ]
    },
    "us-gaap_SeriesDPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesDPreferredStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series D Preferred Stock [Member]",
        "terseLabel": "Series D Preferred Stock [Member]",
        "documentation": "Series D preferred stock."
       }
      }
     },
     "auth_ref": [
      "r983",
      "r984",
      "r1041"
     ]
    },
    "us-gaap_SeriesEPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesEPreferredStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series E Preferred Stock [Member]",
        "terseLabel": "Series E Preferred Stock [Member]",
        "documentation": "Series E preferred stock."
       }
      }
     },
     "auth_ref": [
      "r983",
      "r984",
      "r1041"
     ]
    },
    "us-gaap_SeriesFPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesFPreferredStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series F Preferred Stock [Member]",
        "terseLabel": "Series F Preferred Stock [Member]",
        "documentation": "Series F preferred stock."
       }
      }
     },
     "auth_ref": [
      "r983",
      "r984",
      "r1041"
     ]
    },
    "rxst_SeriesGCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SeriesGCommonStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series G Common Stock",
        "documentation": "Series G common stock.",
        "label": "Series G Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesGPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesGPreferredStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series G Preferred Stock [Member]",
        "terseLabel": "Series G Preferred Stock [Member]",
        "documentation": "Series G preferred stock."
       }
      }
     },
     "auth_ref": [
      "r983",
      "r984",
      "r1041"
     ]
    },
    "us-gaap_SeriesHPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesHPreferredStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series H Preferred Stock [Member]",
        "terseLabel": "Series H Convertible Preferred Stock",
        "verboseLabel": "Series H Preferred Stock [Member]",
        "documentation": "Series H preferred stock."
       }
      }
     },
     "auth_ref": [
      "r983",
      "r984",
      "r1041"
     ]
    },
    "rxst_SeriesWCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SeriesWCommonStockMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series W Common Stock [Member]",
        "documentation": "Series W common stock.",
        "label": "Series W Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ServiceWarrantyServiceContractsAndAccessoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ServiceWarrantyServiceContractsAndAccessoriesMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfRevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service warranty, service contracts, and accessories [Member].",
        "label": "Service Warranty Service Contracts And Accessories [Member]",
        "terseLabel": "Service Warranty Service Contracts And Accessories"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Awards vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Stock-Based Compensation, Vesting period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average fair value, forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested at December 31, 2023",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r424"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average fair value, vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, Maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, Minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Grant Date Fair Value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Grant Date Fair Value",
        "terseLabel": "Grant date fair value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, Maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, Minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield": {
     "xbrltype": "percentItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected dividend yield.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend Yield",
        "terseLabel": "Expected dividend yield, Weighted Average"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Life.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Life",
        "terseLabel": "Expected life (in years), Weighted Average"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Grant Date Fair Value",
        "terseLabel": "Grant date fair value, Weighted Average"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Risk-free Interest Rate.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate, Weighted Average"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility, Weighted Average",
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r409",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "periodEndLabel": "Shares Available for Grant, Ending balance",
        "periodStartLabel": "Shares Available for Grant, Beginning balance",
        "verboseLabel": "Common stock available for issuance",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Number of Options, Exercisable",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Exercisable",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Number of Options, Expired",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Number of Options, Forfeited",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Number of Options, Granted",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted Average Grant Date Fair Value, Options Granted",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Intrinsic Value of Outstanding Options",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Number of Options, Ending balance",
        "periodStartLabel": "Number of Options, Beginning balance",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r416"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted-Average Exercise Price, Ending balance",
        "periodStartLabel": "Weighted-Average Exercise Price, Beginning balance",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r416"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Intrinsic Value of Vested Options",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum",
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award",
        "terseLabel": "Stock-Based Compensation, Terms of Award",
        "documentation": "Description of terms of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Options Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Exercise Price, Expired",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Options Forfeited",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Options Granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r406",
      "r414",
      "r433",
      "r434",
      "r435",
      "r436",
      "r439",
      "r445",
      "r446",
      "r447",
      "r448"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceParentheticalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock price",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "rxst_SharePurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SharePurchaseAgreementMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Purchase Agreement Member",
        "label": "Share Purchase Agreement [Member]",
        "terseLabel": "Share Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfRangeAndWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life (in years)",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-Average Remaining Contractual Term (Years), Exercisable",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Unvested at June 30, 2024",
        "terseLabel": "Number of Options, Unvested",
        "periodStartLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares",
        "documentation": "Number of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of shares, forfeited",
        "terseLabel": "Number of shares, forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "documentation": "Number of non-vested options forfeited."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Grant Date Fair Value, Beginning Balance",
        "periodEndLabel": "Weighted average fair value, Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-Average Remaining Contractual Term (Years), Options outstanding",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Total Fair Value Less Strike Price of Stock Options Exercised",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfNonvestedRestrictedStockUnitActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of shares, vested",
        "terseLabel": "Number of shares, vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ShareholderRepresentativeHoldbackOfExercisePriceOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholder Representative Holdback Of Exercise Price Of Warrants",
        "label": "Shareholder Representative Holdback Of Exercise Price Of Warrants",
        "terseLabel": "Shareholder representative holdback of exercise price of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_SharesAvailableForFutureIssuanceUnder2021EsppMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SharesAvailableForFutureIssuanceUnder2021EsppMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares available for future issuance under 2021 ESPP [Member]",
        "documentation": "Shares available for future issuance under 2021 ESPP [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Available For Future Issuance Under The 2006 ,2015 And 2021 Plans [Member]",
        "documentation": "Shares Available For Future Issuance Under The 2006 ,2015 And 2021 Plans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_SharesAvailableForFutureIssuanceUnderTheEquityPlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SharesAvailableForFutureIssuanceUnderTheEquityPlansMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares available for future issuance under the Equity Plans [Member]",
        "documentation": "Shares available for future issuance under the Equity Plans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SharesAvailableForFutureSaleUnderTheAtTheMarketOffering1Member",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares available for future sale under the at-the-market offering1 [Member]",
        "documentation": "Shares available for future sale under the at-the-market offering1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_SharesIssuedForTheEmployeeStockPurchasePlanAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SharesIssuedForTheEmployeeStockPurchasePlanAmount",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued for the employee stock purchase plan, Amount",
        "label": "Shares issued for the employee stock purchase plan, Amount",
        "documentation": "Shares issued for the employee stock purchase plan, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued for the exercise of stock options and vesting of restricted stock units, Amount",
        "label": "Shares issued for the exercise of stock options and vesting of restricted stock units, Amount",
        "documentation": "Shares issued for the exercise of stock options and vesting of restricted stock units, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued for the exercise of stock options and vesting of restricted stock units, Shares",
        "label": "Shares issued for the exercise of stock options and vesting of restricted stock units, Shares",
        "documentation": "Shares issued for the exercise of stock options and vesting of restricted stock units"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_SharesRedeemedForEmployeeTaxWithHoldingsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SharesRedeemedForEmployeeTaxWithHoldingsAmount",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares redeemed for employee tax withholdings, Amount",
        "label": "Shares Redeemed For Employee Tax With Holdings, Amount",
        "documentation": "Shares Redeemed For Employee Tax With Holdings, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_SharesRedeemedForEmployeeTaxWithholdings": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SharesRedeemedForEmployeeTaxWithholdings",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares redeemed for employee tax withholdings, Shares",
        "label": "Shares redeemed for employee tax withholdings",
        "documentation": "Shares redeemed for employee tax withholdings"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_SharesReservedForFutureIssuanceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SharesReservedForFutureIssuanceTableTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureConvertiblePreferredStockAndStockholdersDeficitTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares reserved for future issuance.",
        "label": "Shares Reserved For Future Issuance Table [Text Block]",
        "terseLabel": "Summary of Common Stock Reserved for Future Issuance"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ShelfRegistrationStatementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ShelfRegistrationStatementMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shelf Registration Statement [Member]",
        "label": "Shelf registration statement [Member]",
        "documentation": "Shelf registration statement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtDescription",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan, Description",
        "label": "Short-Term Debt, Description",
        "documentation": "Description of borrowing classified as short-term upon issuance. Includes, but is not limited to, description of underlying arrangement, repayment terms, interest rate, collateral provided, restriction on use of asset and activity, and compliance with debt covenant."
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Line Items]",
        "terseLabel": "Short Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r1028",
      "r1029",
      "r1030"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Domain]",
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r1028",
      "r1029",
      "r1030"
     ]
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Short-term Investments, Total",
        "label": "Short-Term Investments",
        "terseLabel": "Short-term investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r137",
      "r990"
     ]
    },
    "us-gaap_ShortTermInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_ShortTermInvestmentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ShortTermInvestmentsPolicyTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Investments",
        "documentation": "Short-term investments.",
        "label": "Short Term Investments Policy [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_SignificantAccountingPoliciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SignificantAccountingPoliciesPolicyTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant accounting policies.",
        "label": "Significant Accounting Policies Policy [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r200"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r170",
      "r171",
      "r172",
      "r204",
      "r225",
      "r226",
      "r233",
      "r235",
      "r241",
      "r242",
      "r295",
      "r331",
      "r333",
      "r334",
      "r335",
      "r338",
      "r339",
      "r370",
      "r371",
      "r374",
      "r377",
      "r385",
      "r521",
      "r677",
      "r678",
      "r679",
      "r680",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r715",
      "r736",
      "r754",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r968",
      "r1000",
      "r1008"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r83",
      "r86",
      "r87",
      "r160",
      "r185",
      "r186",
      "r187",
      "r209",
      "r210",
      "r211",
      "r213",
      "r218",
      "r220",
      "r222",
      "r240",
      "r296",
      "r297",
      "r312",
      "r387",
      "r463",
      "r464",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r476",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r493",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r536",
      "r539",
      "r559",
      "r649",
      "r666",
      "r667",
      "r668",
      "r685",
      "r754"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "auth_ref": [
      "r254",
      "r255",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r698",
      "r701",
      "r703",
      "r761",
      "r763",
      "r767",
      "r771",
      "r783",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r800",
      "r825",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r865",
      "r871",
      "r1042",
      "r1102",
      "r1104",
      "r1105",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r240",
      "r539",
      "r598",
      "r676",
      "r696",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r715",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r734",
      "r737",
      "r738",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r754",
      "r872"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited",
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r240",
      "r257",
      "r539",
      "r598",
      "r676",
      "r696",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r715",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r734",
      "r737",
      "r738",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r754",
      "r872"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r889",
      "r899",
      "r909",
      "r941"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of preferred stock to common stock upon initial public offering, net of fractional shares settled (in shares)",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r49",
      "r83",
      "r86",
      "r121",
      "r357"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued for the employee stock purchase plan, Shares",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r82",
      "r83",
      "r121"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Shares",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r82",
      "r83",
      "r121",
      "r677",
      "r754",
      "r777"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseSummaryOfStockOptionActivitiesDetails",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options, shares",
        "negatedLabel": "Number of Options, Exercised",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r82",
      "r83",
      "r121",
      "r420"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of preferred stock to common stock upon initial public offering, net of fractional shares settled",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r83",
      "r86",
      "r87",
      "r121"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Shares issued for the employee stock purchase plan",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r82",
      "r83",
      "r121"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for public offering, net of underwriting discounts, commissions and offering costs, Amount",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r82",
      "r83",
      "r121",
      "r685",
      "r754",
      "r777",
      "r878"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r83",
      "r86",
      "r87",
      "r121"
     ]
    },
    "rxst_StockOptionsIssuedAndOutstandingUnderPlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "StockOptionsIssuedAndOutstandingUnderPlansMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesScheduleOfDilutiveSecuritiesExcludedFromComputationOfIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options Issued And Outstanding Under Plans [ Member]",
        "label": "Stock Options Issued And Outstanding Under Plans [Member]",
        "documentation": "Stock Options Issued And Outstanding Under Plans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options issued and outstanding under the 2006, 2015 and 2021 plans",
        "label": "Stock options issued and outstanding under the 2006, 2015 and 2021 plans[Member]",
        "documentation": "Stock options issued and outstanding under the 2006, 2015 and 2021 plans[Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent",
        "totalLabel": "Total stockholders' deficit",
        "periodEndLabel": "Stockholders' Equity Attributable to Parent, Ending Balance",
        "periodStartLabel": "Stockholders' Equity Attributable to Parent, Beginning Balance",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r86",
      "r87",
      "r110",
      "r717",
      "r733",
      "r755",
      "r756",
      "r851",
      "r879",
      "r1002",
      "r1026",
      "r1081",
      "r1134"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' deficit:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Stockholders' Equity, Ending Balance, Amount",
        "periodStartLabel": "Stockholders' Equity, Beginning Balance, Amount",
        "totalLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Total",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60",
      "r61",
      "r160",
      "r161",
      "r186",
      "r209",
      "r210",
      "r211",
      "r213",
      "r218",
      "r220",
      "r296",
      "r297",
      "r312",
      "r387",
      "r463",
      "r464",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r476",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r493",
      "r526",
      "r527",
      "r531",
      "r537",
      "r559",
      "r667",
      "r668",
      "r683",
      "r717",
      "r733",
      "r755",
      "r756",
      "r781",
      "r878",
      "r1002",
      "r1026",
      "r1081",
      "r1134"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockholdersEquity",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureConvertiblePreferredStockAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stockholders' Equity",
        "label": "Equity [Text Block]",
        "terseLabel": "Convertible Preferred Stock and Stockholders\u2019 Deficit",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r203",
      "r369",
      "r371",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r382",
      "r384",
      "r387",
      "r492",
      "r757",
      "r758",
      "r782"
     ]
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublease rental income",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r551",
      "r850"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r562"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r562"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r562"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r562"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r562"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r561",
      "r563"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "rxst_SummaryOfLeaseBalancesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SummaryOfLeaseBalancesTableTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Lease Balances.",
        "label": "Summary Of Lease Balances Table [Text Block]",
        "terseLabel": "Schedule of Lease Balance Sheet Information"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Weighted Average Remaining Lease Term and Discount Rate.",
        "label": "Summary Of Weighted Average Remaining Lease Term And Discount Rate Table [Text Block]",
        "terseLabel": "Summary of Weighted Average Remaining Lease Term and Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowElementsAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Accretion to Redemption Value",
        "terseLabel": "Accretion to redemption value of redeemable stock and stock options",
        "documentation": "Value of accretion of temporary equity to its redemption value during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityByClassOfStockTable",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, by Class of Stock [Table]",
        "terseLabel": "Temporary Equity By Class Of Stock [Table]",
        "documentation": "Disclosure of information about equity instrument classified as temporary equity. Includes, but not is limited to, description of share, value, share authorized, issued, and outstanding, redemption price per share, and subscription receivable."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r46"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodStartLabel": "Temporary Equity, Beginning Balance, Amount",
        "periodEndLabel": "Temporary Equity, Ending Balance, Amount",
        "periodStartLabel": "Temporary Equity, Beginning Balance, Amount",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "terseLabel": "Carrying Value (2) Share Capital",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r333",
      "r334",
      "r335",
      "r338",
      "r339",
      "r449",
      "r641"
     ]
    },
    "us-gaap_TemporaryEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityLineItems",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Line Items]",
        "terseLabel": "Temporary Equity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "rxst_TemporaryEquityNoteReceivablesCommonStockIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "TemporaryEquityNoteReceivablesCommonStockIssued",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Temporary Equity, Ending Balance, Amount",
        "periodStartLabel": "Temporary Equity, Beginning Balance, Amount",
        "documentation": "Temporary equity note receivables for common stock issued.",
        "label": "Temporary Equity Note Receivables Common Stock Issued",
        "terseLabel": "Notes receivable for common stock issued"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Temporary equity par value (USD per share)",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r46"
     ]
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesAuthorized",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Temporary equity, shares authorized (in shares)",
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesIssued",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Temporary equity, shares issued (in shares)",
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Temporary Equity, Ending Balance, Shares",
        "periodStartLabel": "Temporary Equity, Beginning Balance, Shares",
        "label": "Temporary Equity, Shares Outstanding",
        "terseLabel": "Temporary equity, shares outstanding (in shares)",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "rxst_TermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "TermLoanMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retired Term Loan [Member]",
        "documentation": "Term loan member.",
        "terseLabel": "Term loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_The2015PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "The2015PlanMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The 2015 Plan",
        "label": "The 2015 Plan [Member]",
        "documentation": "The 2015 Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_The2021EsppPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "The2021EsppPlanMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2021 ESPP Plan [Member]",
        "label": "The 2021 ESPP Plan [Member]",
        "terseLabel": "2021 Employee Stock Purchase Plan"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_The2021PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "The2021PlanMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2021 Plan [Member]",
        "label": "The 2021 Plan [Member]",
        "terseLabel": "2021 Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1015",
      "r1089"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_TotalLeaseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "TotalLeaseAssets",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total lease assets.",
        "label": "Total Lease Assets",
        "totalLabel": "Total lease assets"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_TotalLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "TotalLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfLeaseBalancesSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total lease liabilities.",
        "label": "Total Lease Liabilities",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureStockbasedCompensationExpenseCommonStockReservedForFutureIssuanceDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r365",
      "r383",
      "r491",
      "r518",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r650",
      "r839",
      "r840",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r852",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1073",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r957"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r957"
     ]
    },
    "rxst_TwoThousandSixAndTwoThousandFifteenPlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "TwoThousandSixAndTwoThousandFifteenPlansMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersDeficitSummaryOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand six , two thousand fifteen and two thousand twenty one plans.",
        "label": "Two Thousand Six , Two Thousand Fifteen And Two Thousand Twenty One Plans [Member] [Member]",
        "terseLabel": "2006 and 2015 Plans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentAgenciesShorttermDebtSecuritiesMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Government Agencies Short-Term Debt Securities [Member]",
        "terseLabel": "Government Securities [Member]",
        "documentation": "Debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae) which have maturities of one year or less. Excludes US Treasury securities and debt issued by Government-sponsored Enterprises (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae)."
       }
      }
     },
     "auth_ref": [
      "r873",
      "r874",
      "r875",
      "r876",
      "r1100"
     ]
    },
    "us-gaap_USGovernmentDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentDebtSecuritiesMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisAndFairValueHierarchyOfValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "U.S. Treasury Securities [Member]",
        "label": "US Government Debt Securities [Member]",
        "terseLabel": "Government Securities [Member]",
        "documentation": "Debt securities issued by the United States government."
       }
      }
     },
     "auth_ref": [
      "r1100"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentAdditionalInformationDetails",
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureShortTermInvestmentScheduleOfShortTermInvestmentAvailableForSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Treasury Securities [Member]",
        "terseLabel": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r807",
      "r831",
      "r833",
      "r839",
      "r1100"
     ]
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnamortizedDebtIssuanceExpense",
     "crdr": "debit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureTermLoanFuturePrincipalPaymentsDueUnderTermLoanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: exit fee and unamortized issuance costs",
        "label": "Unamortized Debt Issuance Expense",
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrealizedGainLossOnInvestments",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Unrealized Gain (Loss) on Investments, Total",
        "label": "Unrealized Gain (Loss) on Investments",
        "terseLabel": "Unrealized gain (Loss) on short term investments",
        "documentation": "Amount of unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureSummaryOfAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40",
      "r151",
      "r152",
      "r154",
      "r155"
     ]
    },
    "rxst_ValueOfSharesRedeemedForEmployeeTaxWithholdings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "ValueOfSharesRedeemedForEmployeeTaxWithholdings",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value of shares redeemed for employee tax withholdings",
        "label": "Value of shares redeemed for employee tax withholdings",
        "documentation": "Value of shares redeemed for employee tax withholdings"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r923"
     ]
    },
    "srt_WarehouseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "WarehouseMember",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warehouse [Member]",
        "terseLabel": "Warehouse [Member]"
       }
      }
     },
     "auth_ref": [
      "r1136",
      "r1137"
     ]
    },
    "rxst_WarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "WarrantLiability",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant liability.",
        "label": "Warrant Liability",
        "terseLabel": "Warrant liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Note Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_WarrantsIssuedToPurchaseCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "WarrantsIssuedToPurchaseCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/Role_DisclosureCommonStockWarrantLiabilityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Issued To Purchase Common Stock",
        "label": "Warrants Issued To Purchase Common Stock",
        "terseLabel": "Warrants issued to purchase common stock"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_WarrantsToPurchaseConvertiblePreferredStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "WarrantsToPurchaseConvertiblePreferredStock",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants To Purchase Convertible Preferred Stock",
        "label": "Warrants To Purchase Convertible Preferred Stock",
        "documentation": "Warrants To Purchase Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "rxst_WeightedAverageDiscountRateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "WeightedAverageDiscountRateAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate.",
        "label": "Weighted Average Discount Rate [Abstract]",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average shares, diluted",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Attributable to common stock, diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r235"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average shares used in computing net loss per share:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average shares outstanding, basic",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Attributable to common stock, basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r235"
     ]
    },
    "rxst_WeightedAverageRemainingLeaseTermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://rxsight.com/20240630",
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "presentation": [
      "http://rxsight.com/20240630/taxonomy/role/DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term.",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "terseLabel": "Weigted average remaining lease term (years)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478353/942-405-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "330",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477263/942-210-45-4"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-12A"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/815-40/tableOfContent"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/942-320/tableOfContent"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "470",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Subparagraph": "(Note 3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481418/840-10-55-40"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481501/840-20-50-2"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "b",
   "Publisher": "SEC"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-10"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-2"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-9"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-3"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-12"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5D"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "20",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-3"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481598/310-20-45-1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-3"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/940-320/tableOfContent"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>86
<FILENAME>0000950170-24-090770-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-24-090770-xbrl.zip
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M>^'U;4YS.[8K^8QZ?QC*SV68V,$26O_G9%!&P.(J?GD '>>V2FJ;.HZQS&#
M.C#Q0<<),B*CF4&*1]A#*KT.G;4C;R6[<I"MK?P1;.++^#D.1LTAY=[7$WA:
M?)Q;ZD@RTCF44J*(&Q>S^\T@)VD,+O$H ^FW=+-,28^U\(&BI#5LJ686&28%
M,AX,D:0"['9G)5UWW7&\1:$7HH@.;)Z0& <8-0[I&!4BEOG(*>&1V*YNT"U5
MD5WO)\<Y+CR&M^.C6.7[JGB4G_8Y3OEV8]QTR2A#?4 BTH@X=P$Y#;LEG!6!
M1D88ZRP[/1*3\NF)Y=L=#W?L2+ M?+Q5X'?'..Y:H^!@-/SKI!K_S^\O'R>A
M4NXD"1'@,,)>&4R198$@(CB0L!4<[+BN[=7WRK(0FA &.WAGR[ _?&%/RK$=
MK%1^T?8._PQ5BG&N$9$XA]"K@ P!248C=0$GP83L I1TP+-GJ%4J -Z&:"WB
MQ :D<0!)SPCPC,0F\<ZZ\#OF(FI3&K"D71(<F<@%XIY(9(S,RK,-CGM,9=ST
M7>F MMS:;N7<,D8( JF=0PUHSOP)&C%%*',FL22[$,MT#[1I*VK&"(4MU1XY
M!B0--A]H.4HP9!3UQB7G.5LY+M^9KJ\_1VB4GL.C.$@'\5-9CZ=9/ M&N*_=
M4%>@4MGAIYE)DS_^;K^6QY/C1WEJ841TTCF"$N,$\91S*S$#]4H3*5)@BN4L
MW6X2R8/$B.P=GPQ&IS$^4'3=.C1L(RU3,N4D+D!4T->0#CXB8BGLF+2$T95[
MB[Y;^+?E?#%.4A9Q -(G\)\ G& C]R@1'&-,6H=(NTK_C\3Y<A@' ^#+W^(P
M5F#9#L-N."Z',V3_'&=>F,<9U&.\YCPJ@Z2.P'LTG_5;ZY%-)"H.4CJF3??4
M'L2Q+8<QS.%W4V):C;>8*^. *'#*81@:F: =F+68"D>"I73E3J+-. \R(26P
M^#U269'@V8UH@HHYASXD'Y@.O+,!*X\$0Q][\*.)EDII03F5PN7@1YI3,36*
M#$?F.%CNIKM>P&_8,@\9"=FBV\12#LI1R)GC@<-_<BZ]20&!X!)@E6OK66>C
MRS?$;=*BD]8*ZZ6P%GDP^Q'W)@$\\PB<'*6*3F-E.Z?G9MO[734*$S]^6QW&
MZG/IEW'Z]<O'>>)A%5ACRG&DA 'N4EPARXA%QKH81<*1^,Z=3N6M>@&B<!RK
M$UBDTXLB=5"F-*K"RY>C+\.5AU%P1%J)];8F12.YR&F3N5J(B<@0,!4EYXPG
MCX-2G=5K5AGG<I=!+/[\"TPK'[6?OLX'[>='M+AI?W@R&=?-'613[ 5KJ5',
M:90\48BGF.M\P7\252%PJS!6FRX/'R[/=#V&C'5::P=:9LPUYCC/J7..@MW'
M@L#88NE5YX3DTTB86\-AK</.1)\X2@I[Q$TBR"0J$<&"**JQ9J)SQX+?T)AF
MW_S=5A6@W.GL8R[&E0M\Y<)<H/'&NAY5*PEV[,2F>N>RASL0;!%G,9=Y<AC8
M7!K-"0LD;H)(O[,TI2L0[8\WCM;ERCXZ4I0$#XA3DGU:N7:CPD+&%*+0G3T<
MZXQWM@,GX8XJR9SQN=ZFS]XC#,94BO 1$PF<'T%SZ^H^KLU!N:$ KS2CUBDD
MK <M7(,^[IBT*$9K):?.J=1=1^'1J!J_C]5Q1LM<W?H\J[Z.8S"OWZ8750SS
MQVP AFJ=I&(&8>UR*6'%D$TB(J8EQR88%6GG$O VQWYM<Z.L"5PGF@MT@6J4
MO$!&YL1)IE-B-!*O.ZGO7@S6*8</$ZRSAE,0YZ461A&D4]9>H^5(>\ESXI76
M-EH']DD7M^@&D^3@ZV 5D<Z=V"Q#F5,>)4E2KJ2MD!4<))&R8&IX8;#M;%H/
MF(19D9B&UAV4]1]_/OUS'/JC8UM=R.9OCAP/ .B&D_@FMA)]][O]YZAZ,:G'
MH^-8U4NT\F8T_[8M*^:*>5Z6N_.77KKY4?K 7 ":I58B$G(AY$0-RBD8" ?&
M<!!*8MO9J-%-UI77L=4)-I29@)+*]6R9$\BE&!'&04=LC0)SJ:M;W>'4FA:C
M$SU)TA##0,); LIS:"I01Z2D"@J$B+6Z<];,6A+55J,2>RH2(4&BX'/=5")S
ML2?JD5;46<85!U6Y:\O_'0ZZWX%C3G\'D1['KR;#L#%N.<\T-U$!+_ (-K[4
M%KE<E%Q;EF( 33C0SEDJO6;5(<UJ/0:!9TY[G#2B,J=<!ZZ0(<$BZ;$040L9
M[,HSEU8M;M<1,-6! L4^MT_S@$A.:D DX3FR@7G0I "2$A:&R,XZN1Y)!.R:
MR_"LP=7MN1 T*HL"J"&(<YYR1XX +P@),Y>]#YU3#M<>TK<>2\OSY%/VK2;'
M-.+4&< '[U!T,@@BG>9RY8KD]ZEKM%DGWHJZ)H7 T7M$$LTE4RV8F2:7=\."
M #;&Z$AGM>C-2F!:0["J-RHX;< Z@O5'W.<B_8&'[.J4\+4FN+MEI?L8R0>W
MW"RCB<6$I,O9EKEYDHDY.1W4I]AT$#"=]3@]$CWI28.5"X3E$NJYP%-N!:.1
M-IP@[5+0D7C2X5I"UW8X7#:L&ZI\FQ)H5;_;X219/P:X&GZ"^_]NP1 ;3>KX
MROJFK5(;#H4%K?T61Y\J>W)4^KG++S>=WWFQVQ%#KS4*\IBP?.2J&:< 8 !E
M)E=1LXF#&L-P4''3\W77G?348DB^]T(RF>DDP3.YCQ89R7*]I402 UEC4N=J
MSW;!0EJ',1N)BCA7YR:YNX4)-)<)CHAX^,(QHI7I[&GY]=TM'B*?<WFS[L4L
M*5G'F %EC(-&YI)%+K<P)(Y(PQ7%BG0V^6&3#GY7HUD';+1@DB F9>X^0"72
M^5378^<-CR8(TH6R6*M)U L,=#<2X(DAY.16E4 @6]'DNIKDB0FK[V^X<3B_
M'@4J:*.X$08%87*Q8T\1Z$WY6)N3$#6&_^M8L:$6*ST'HYVS42&*?=9'? #M
MT3'DH@4I1X13LK,'EYW-)UB#.S=8+R)Q 5F?ZQ]XE9MR>0 =ABV/5%HJ.H<W
MWV]'[@_#)*?[V4'.^XQ5[K;;AM%X0YYXMCTJF.5^OF%HIY$[()(W)6,\N&1R
MB5>4A,@155[EHFH:L0A*%3.9[3OG8-B@G,$UB:R0 HG,3<L_<2[=M/NLI31B
M;S%HRIU5C+L6)M>!L_J0M$\R&&2BU#DN.Y=%#0JQE ],>>1!=-;2[$Z&4(M>
MFHAE3)I%I%-2"-1 T(I -T+.4YMX")%W]WQPI5GW4_S-ENC;D_S[>K^N)S$
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M@,$'IP?Q9%2-GQ5I5!W;\2_/2IA''3V0]VC@[& P&H-9U0*G7,_[1G'YTRT
M]/DX/ 0=Z!6209L+][</NP?O]PY>_Z,XV'OW]N!]\>[#P>&'W3?OB_=O"]"9
MWX-B7!!6O#THB/@A_%B\?56\_\M>L:1.+U3IW1?O\V5B&+]RQ1>\#']DW-E(
MA>FN=OBK456,CV+QKSG+%%,_91&'(89OJ5+?>NLU6("!8'%D#C&!/0+65\@1
MPE"PFH3DM,#*M(4%[YKI[$T/I<XAP4Z ;] QO.4H_PS>?HI.HZU0''9C;_YS
M,HP%PULKV@6/<P@N+"'QLBE##"MJ: 2 -H$+X6.,H:U=>%76@%G_@-5]!=_4
MW5C?[+/_%C3?0N5]_"#Q]J!7WSJEOMV#L.ZLP 4.X*P$P 7Q#%@_]V7-V8U,
M,1ZX<JIA_9;LW\H.Z^8HM1,:'.^N!M<R);2Y=.\/=M\<[C>:6J_$/8@2-UZP
MS5R+2]7HN*')\>@J)6)-XRV>J!S-X6-EG0,7BE<ER$^ $1>KG17I=\QZ*5W*
MA4."1CSR@ PF%F&?DZPB9A[S^P+V7A,:D2<SG4LWUAGGX&\L#>X]EP_NN6SY
M_.GL1?1;9TG7L '1SN9N3"AHGDMV6XHTLQ&9B*.B/$3N:#ML<! _-46JAN,<
M!]@J*WQS\M?MX<'7P_W?_O)^J]A_\V*[':NF6R>,=\6('_:^6C\N\DX5HU2<
M[5UAZ^+P)/H<D!:*<EB4X[IX<=2X1WYL'SF^;S4?$#6^*70[@1IWB%EI;6*7
M+>%+T4/MF<:7 XWN:2P+?).UO'RU16OY\LY=>O\%\VBZZ:L^UOB6\+G)+E:,
M\9@H$IIXQ&VPR+$0D6"!R=RKDW#9CGS)J2@5F,--$E@3VMBD352G+T8A7C:1
MZWS'237ZG)_3BD_S.LYX&0?VB\VAJ7>SDC=MR[FGR:K@D,+"@$HA,7+)>I2[
M7%LAM22TI2U_;[_NSZ*CIY4R6U.SK]M+PQ'+$?HY=_/VN]E=B&CKQ*L]Y>5:
MC:1AZ0)L^5'.0BO^.:G*.I2^L>='Z1L2]3[SW%8YVN!!)ULN8UDSY^J3'9;_
MTWS^L57$V" *V-\^V#[<+F8ETJJ?7?7\U_/\7[P9;5^]/-UEP7NZ<VY)G;="
M;B4E!R0FR*H(PMJP[!.A"GFLL Y6>\]L.\B]&T(5ZWKVS^MR&,D**0>TQV*>
M'G@W*V\U7'+U+D1ON"-&(2I33M./%EFN-8K4,I"C.F)][UB0<[OP OY\6[T?
M?5FE%K0[*.M1\5]E_.?H&UNPJA&</RF^QBN(=20\YG:VQB$>I40F"8RD9YH)
M+2B3+>DNL[5OI-K;ZATHH@#Z;;A%KG6O[K:[[K=R7[>NT+;N[+X5,%(OL> ^
M(N(H *-2&-G ,*+"<D>QBDRF5LGBW0CLD\'_5YXTQLL*]5DJA>Q5V0=69&:;
MG#UK)Q6P?7EB!T7\&GU3@!*^!GTFUD]6SP.R+S+=?T.3>XIGF6>.V/_S)TV)
M^JDNQG$03XY&PU@,&^MWJP"*&DRRC[6PP&T 2R'N%#^LYAA-Z2A3C 09P+5<
M;Y(A9Z)$,IE$;5(\!7Q?9,SZR2[,I"4L;&$;S%*^S6J4F!8&^>.*3DX=B8RY
MZ% R-C<A"!@9H\!4\"();4!58O<6AKGUR>!=INHNG9P*2I#2[.$.3I_2\4<S
MI'*8[?D=L<T8^_<;%H:O)["G&8NY:S+CHK!T434P'JL8BI-)54_RP=IX5, =
MC1>#T!_<CUD[R&$KNWZ\<Q]4N=>8OS<6I3^I>O"3*G[C216Y\:*^\T]YQT[
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MZ=+V '!M!?:N \!F6P(/'@*]67 !,X.UKV/XZ.P >#E^K(]B'#\(>KR8O[N
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MR#1U)-]S$.O)X*+CI$>/;Y,PY3UZK!,]V*-$#_;Q7SGOJ@1!7GZ.^<-@_G<
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MI:[/9I57Z4S';_3[Z7][(.R!\#N!< I P#_6^WC2D'U#A9-IU%RF9&"Q,/'
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MU:MV-AE'5_^<QU,W#6,W*4]<_G!:/K!]\;QK]G3[X<]Q_+'N_9_+OTV8N+:
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M* J#%X7@SL;%R$190%E 69B=EIM.TK0=?TS+05\H%B@6@Q>+F/(XC-%<0EE
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M!,81*8TD@8)GFH((DH+C5!8KF@B3A/0LK14N/1O&K8[#=65Y(\(AP@V;E8-
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M7!GB%3!B552$.RL[Z9&(N+C#:28\D+5:S[^XB9N&U+A%\W<W#R<-IZ.F"(=
M_7.;8%^V1IJOGO6%/%LT[6PRCLU=R[YCHO5TA.^%]MJR?O'$2YI= .*D!L$#
M!:.EK:](9-QG[\QM_9*"S\MB"EJ,<A#1,G"!.3 VND"Y$B+0V_KEU>ST=#9=
M#KI;S6P\/%^T"S>MTQF_4#?M\MV;>N;MNU^^5<*@1U31D98;U#+<MU]6F$MX
MCT4%07%O0/%A]L8?$1T[[JX0*&.6)^"Q_!!29K"6:N#)1ZE<K".1ND#')2Z>
MS":%-^V;?YZ/%Y^*,3XYK^!X9].$=[-I_=+Y;#(IE[RMRY_:[VBB\ TT111%
M%$44113M"$6I,HF1$, [PD P+@L8Y@C1!R$$]S**M>-)/I,HN8V0-2_WE(N@
MP&H"0J))Q%FMUF.[.X6B6NF1,ANTH4$H12A%*-U7*-WK8#,C0@5O>479 KHB
M&K!&<I B<VU\3$S)M20<\]I0;2$E*\L]M)C(CF0(,FKJ"F!%[Y\;J!\6I1Y:
M] !S>XC:B-K[C]I"\^B=3Y"<2B"4]N"]%N I(=+H+#192Q&*;'EBE(,QA(.P
M)(+G64*P7(;D*7->[ =J*\)'6FR0743H1NA&Z-Y[Z-XRN'+IO+=$ HE9@V"B
M1H"5!Z),YL8R[S*Y#:[E L>URN U+^ J:[PCA@34,2J,<I0S]]S@^E5,I8J/
M++/#PE0<5OF$E1RK'' S;MOS%.MF;!8GJ4D7:1[&;:K#)]LJ$,WLK&Z\]M;$
MRCK*LNSZ>EG=]?-Q6*1X>4<5 #R'O$^U5$.K1]QV18<CFD@F@),401!=-!83
MQ=*7+!$=O/0IW-984N;D)25@5? @(B/@<ODU*"NS2819(Z\TUORB7;Q<R>_;
MI?C^,IL?GZ0WE[)[F)>J[' EN ?3^(^5L![FWZY%=7G%[U50CRZK/;Y: $*^
ME; LZHJ2?G5\QT@ZXAOBVUWXYJQ7WB0*!<T$B) 2&!4I2&&#4\K[Z-+.X-O!
M:;'^.C/+$>$0X8;-RD$@G'">J%!,-B%\!B%KLS):0[LL:,I#DC&IM31<><<%
M8X'+6%"1)U[O,4"9X<P*RV3(NX]PU8YCB'*(<L-F)?8!&!"S46Y[PTJ4VP$Q
M&^6V-ZP<A%?A9'321@I:Z>)5*._!AZ"@5N^)1%6@9JT%,@]2:JL-2*J+.V*,
M!BNT!!YH3%JZ2&S<#Z^B7UV.GR17B:?.+W.5=5>"=VV*13Q.S]*T78T 31?U
M=4*E<DUP6>7ZUO_\ _O#\(A'@@=(\/XK!O1UD-DHMX-AY2!\'2ID,I%%H%X*
M*-Y- N.%!VI43MX1&4)\3 ;EJFKSX'H(?'L\.XAQ7)_!3=Z[<7P[?>7.Q@LW
M6;I$2^OQU0WC\;?TS_-Q6P@]2O./XY!6,UY^2V'V8;K\E'^XR7GJR %26!XS
M5.A#BQP)'A;!@T4JM,@'Q&R4V]ZP<A 6>;0V$FI<31VD6M@DP:3H@!')F2^O
ME%L[1_4]V0>TR/=/7O#X5,?'IT[/)K-/*36KDU!GY_-P4G9Y<S9Q4]0]_98E
MU#U?.\.K7,UP0U99@&#&@[72@W-:41.\UGRMQ^WWG!CXX@SO*O=]<W#O2EC?
M7 KG\J+WEZ+YODCFHT\_F9%%78)0-G16HOL[(&:CW/:&E8,P03QUAM=VIHJ$
MXOYJ0L$+2T )3FCTW''[J(34?<5W]QD=G=;7Z4TZ1N/>1QCK$RO1_!@0LU%N
M>\-*E-L!,1OEMC>L'(3;(&+V6;IZ_E]8$(8+L)HI""GJ+*/)X0ZWH8,S.^@V
M[&H&# _EK!:U;M?E+,A9KH=R3F?3RZQ738:=G?O).)2W<JIA^%$S38MZ85G'
M-/_7?+QL'AC';:B[N1TM/V#<MO5@6E/["U[=6-YHL9E@WX40%=#]"BA9SK+5
M :15!D0.#AR/ 0C)@>@4BX):4T"=I\[*ZBS?>FRFC(V(Y".IL8\6@M? 63D,
M\-(N4NLUD%C,8:&3 J.8AVBD2$E'QH3>(G@MZ\7NQJ[-C6;LCH78-7!6#@*[
M9$S>2R8A^]JMPZL GN0,C$;-'$U"T;69B9N<8'M*[*)$CX3&4B5$L(&S$G,.
M V(VRFUO6(ER.R!FH]SVAI6#\!AX5#'[F"$G5CR&2&6-=G#(PDE)O50AK'L,
M&YRP>WJ/ =.$>%!N0U'Y?5K(GI0'C,UDUK9-31.>S.8+*"!PVHRG=9+8\K!H
M<VO$6'#M25-/A'XLVW:9)+S,(2[<!6J9?HL;6H?(;)3;P; 2Y79 S$:Y[0TK
M46X'Q&R4V]ZP<C>B,0\0W%L+?\\"_7"U-D\8Z[$YTD@$!V8\!5%/DAH1";"H
M57F+1.79[5@/\RYXP2-8S@P(&3S8F!E8$74R6JE<I\I]&>LY7)RD>6V2-$\G
M:=J./Z:WTS [30<?W7A2!]'GV;PM#O)1"N>UK#:UG_LOO4N+PWSL+NX<7__>
MS=/W%)*WA8_EU;>Z*HE>18J^W#;W[9 ?$6;WB*>[![-H'O6 V2BWO6$EFD>/
M-H]",$X)2B +(NNI!0E.Y&(M,24)BYDHX[M(A:%YM*_F$1Z\VU3B?IG-RS)-
MF[*CRQX-GYK%W$W;R6HBEKO>WJC<]DB2=D^YH5': V:CW/:&E2BW V(VRFUO
M6(ER.R!FH]SVAI48!'IT$(A(YH-E 8S/H=9#$[!UWKE01"E%F31DK75%ESFR
M2T?YU:6??%S=Y-4#'DSC\6>G^:]N//UUUK8'\W$[GGZX65-]%2/J.A#4KP88
MF"9#I$4+"9F-<OO\Y.Z>W**%=*^%E&*,TD@-VA:31] 0P0E'(#/-LK&)R]S)
MB3&TD/;80L*S9YL*7=F;RT-GJ, V%A5?MDR:7S_K"WFV:-K99!R;*X[T6<5]
MFWHT7A^^9*L$/N&]WC*(#X@/B ^(#X@/B ^(#X@/B ^(#X@/B ^(#X@/SX@/
M&(2_OTPA6:D-)<"\D"!4B&!4II!%TEQH$7GDMX/PQ'IE:7!@N(D@."WW2$+!
M&<TCX28QO];H^5U:K*+N-9+>^<F2$=%VBR'SW81=+#Q _$7\W7/\#8JQ9$6
MH&D"0;(%$XT"GACGWA$OXMJ0D$V2H(B_.X6_> !P4S'ZBYLL!^^Y1?,?Y]/4
M<#)J&&$"U5Q'XL5>L"I?<7;N)VF BNYN^G=#U6U;&6G-B' 4F.%%&6E)P&K"
MRBMA"0\Q6+'6U\<RIW5THF@#YT!05YP!$C5(3HM4*F*S6%-&KY83,Y>=G%<C
M]@[/%^W"3>-X^N&10_:X'2FJ1YQO\[#Y5S<,!F(0(7?) /DC0N46H-(1$K--
M!E12!2J=R.!"EN"EL-FJK%GL!"J7('DRFY15;]_\\WR\^%3,^,EY1<H[6W>\
MFTWKE\YGDTFYY&U=_M1V-3);$ 15!%4$5035[8"J=O5<G!! G"9UZB O>&H"
M1*=25$X+LUX13JQ5+GH)Q'L#@@4)UA1XM4XQE[E26J>=!E5CY(@2-%<161%9
MAXNL>QW$-M)30:, &Y0$(;D!KZP&;H7*3&?/A;N-V]K$[&EDD&E2((@O!K3C
M DQ6W!D?0K1W3XM]0MQ^X&$=:@8(WIA]1!1'%.\3BNNHLXLB08$4"L+R $X7
M6*9"4J6\U<FOE8)0SYU,C(!,JECL)!IPP7#(Q0XW(E%O:L1X'U!<$3LR].FR
MF(CDB.2(Y#N+Y-L^^\Y]9-[6))LM%G-T'JPP":BW@A<K.EIKUL+'),D0A85$
MG0#A90;+-0-I%(O>.\N$?&ZL_2K$,BU'C&QSG.JN0NQCAJZ6%Y4WVY6!SY+V
M3=#\<L6^^GT/IOKI2?LN2VWY+)M0>I12XT*8G99O_E0$JIG.%N7&Q:P(E"M2
MN$BQ"GE,TW;U:EG5Y.J?\WCJIF'L)N6)RQ^64V*_V"AQ_+'NCY_+OTV8N+9(
M8!Y?I+AZD.5#N/$TS?]PO0E7:U3WYTMWOIC]=.9B!8+57\@+.9[^M"*"DO'T
MYMHOK[[\?8F67]Z_^M/J \HRUP>Z8N<D74 <S]-2T%^613\_G?X4Q^W9Q'UZ
M6=^]_I#/Q5WCU7I>5D/1\FOMZCW.GZX6=GDCI&DL\GY1.53N?WDM^A=7U5 _
M+^7F7NHO;ZA,K_>7/5,OA_)@L_/R%74IKY>#O"#_?G5#(6+BSMKTLDUG;EY8
M<\?*?*['NB[N^CANQWX\*0C\\NH3KB_[ NN67\GY"R'TO__TAS\_\A)*U(U+
M/I>=W5%WMMSE=TK"UXO.;G[O%3>7$ON"5.;=0NKRSFV8OJKF6]M0R_NWK/T[
M+D_3=SENC_B\YF[EV+\U[\Q W_+2[(9YVIT[\[D0]2GLC =S_L9W=V9E7*G,
MYN>3^><=\B&MH U<+MQ\Z2;_<I_:"IE/IF*_2Z5^N:7O4);WZ<2=X^MMQO[I
M5?DL/Q__:=2Z:0MMFH_S]W)WARW)?ZU8Y(LSUH$-_=O%T=N__NUXU+Q]]^K%
MACIG"X_5/*]5O[Q@.1&F.J(OS\_.TCRX8FD]SVJ\.GSW^LV[HS>OF_+JZ/#7
MMZ\/CLLO1\?EG[^_>7=\U!S^4GX[?/6__G;XZ^LWOQTM#PSKGYHW__OWM\?_
MYRZV[AB%R.\OHO:_OSOX_?7;PN,?[UR76[[.-0!VL%1?VC#T\Q&9CEWAC9?F
M[;19G,S."[3'=M2DBY#*$T[/3WV:-[/<K"J][UZVW=!7:B^B';TE;*,(U<:!
MFS7:_FTG @H/C">L!0*8?B&8O1D(N'T%W?A-6_PBM?E'OR!LXYO5"RWU\WRU
M?2'D,U%-R0O&!_C=YH76#_WJS<]7/CS^M8ZZ:\_U/=E/577V4T/E(S.@O:6O
M;(KZUO_\ V-_^#JQS]TCH#NG]-XDQOBB^7OY[:1MWDQCBE^<N^4;[I'G/]*]
MW5UT)P AZB#J/ QUO@$Z/: 5Z=MO^G"O(GW[0A_N5:1O7^C#O8KT[0M]N%>1
MOGVA#_=J+^C[6F#7[F9@U^[%P@Z NFL(4%N*Z6YW+;J,Z:XZL)5/GH7_?O((
M[AYMF8$(Q&8Z<7^V^T&,XWH"P4V:,S>.,)X.E>7]IFXX&SJ$\]/SR?*DT*S.
MMQTJQ_M-W1#W\U!YW6_J!K.3CV>+Y9G-S^>N_S1 GJ.;CE"Q=:CHOYN^ZHZ.
M#CJ*PN!%X>"T:(L%B@**PN!%(;BS<3$R4190%E 69J?EII,T;<<?4S.9M6@M
MH5B@6,24QV&,YA+* LI"6O8]1%'H:!!E*#3G@(,H;PRB?)U"6C8RX'1Y*(YA
MK]RO$?S5%IY/3^[3C2'9C=YA7ZYJYZUM%6/"A.1 1N]!$$'!>48AL9"L5]H)
M$M:&09#HHA<:J"0$A*L3Y3.UD)GUU@KBB5@;!K'%(9+,C)@R(VZVV0Z\SQL=
M,:M_O;N' 5XAQ,2S VTE+^#%-#B=.=@4M/-",IEL%^"U6WVYMSF_!F$.80YA
M;L=@SE/"*?42M"F6F9!4@A6B6&N"4>\L5R2LCQ]@PBL:$TB?RI66,' \TH)Z
M@B3II-#<[S3,*:Y&A%#$.L2Z763E8+%NKX=FF>+J,I<X1%4'N02GP%@GP.BD
M9;'\I&=K<\!=<9!CBG7J813E1R#EGAR!EEL(R\8%_NP&X\.&9EG9*S3%25@(
MJPBKNP"KU7%F07&@)%D0.F5P21D@W)B4J1#6TMNPFFR*1 0/GJ14L=6!+2XX
M.)*I4DZGY,1^P*H4Q5+E#+$5L;4'/.TAMFX9_8CGUIA8T"_'@GXI\^)JVPQ1
M%B2SQ,:HU]SS<I%TJ> DM[R@GS$>C"Q&I94YI\B25B(]-_I]%?2,'5G2+\Q[
MDGS\U<&9H>?C5TG 9MRVYW5\WFS>+$Y2DR[2/(S;M)PQ4+=[,SNK^ZK]V<__
M?,D(-XW-Q[*1ZX"^<EG=T_-QJ$=K5W?4[?WMLL*=7M>!*29,Z7<<+K8T*\^*
M,G$.A"^:R5E/(2M>;&L2J%/IMC[*+%'*LH3RPQ1K7+ERCY%@'5,Q.*J%#U?Z
M:'[1+EZNY/?M4GQ_F<V/3]*;2]D]S$M%=;@2W(-I_,=*6 _S;]>BNKSB]RJH
M1Y?I_L=5  @^DA;S8HAO V?E0_&M*VHW#67<OR*&48;,1KG=!7)W3V[WVBXQ
M7#N?:KV-H!Y$MAI,$ :"Y]X1Z8J-L>8G"^&,TC*",CJ B%J#E]E#L%9'%9G6
M3F[%+ED=8.W(6=8*\]B(<0-G)=HF V(VRFUO6(ER.R!FH]SVAI6#\"FT=316
MAT#Q6/P#R@-X*ATDDHSSWBI!\UIIK%!<<DHA!;(\-9#!Z6B :\JXMYEGM9U8
M)_H4SYU]P].P7V3?YBFF='J9?TNG9Y/9IY2:A;MH_C5>G-14<]G+F$OKN1CM
MM7[9Z[HYE24CM?(M"2Y!^**]7&06G")4!RTIUVOER!MFZGZ[%/6BO]Y<"OJQ
MN_C/&V+^[1S<P\KAF!@IWB_=A-5P")3H0".S46Z?G]S=DULT<.XU<!B+4GOF
M(1)/0&22P*8LH)@I43L7C')K!_0W3/G=;^#\[=+ ^5[W^V'F#N<:;1W$S)WF
MZ>YA)MHZ/6 VRFUO6(ER.R!FH]SVAI7HHSS:1[$I!.-%!N^4 &&*Y^$X-T"U
M%%HI3JR0':40T4=Y?A\%C^QMG#2LB>PB)6VJ#:M/S]*T=4LY2A?U=4(5M4<B
MM'LJ"DW+'C ;Y;8WK$2Y'1"S46Y[P\K=< FW?99,9N.-RL =)2"8D^ C\6"$
MEIXF*1);ZSCU/8FEJYXK!_&_SMO%:7F4]GAV$..X/H.;O'?C^';Z:C79;>G;
M+<WB5S>LXM_J().V$'J4YA_'(;U/\_$L_I;"[,-T^2G_<)/SU%$Q*!^QGC7W
M0^A#Z$.3!9F]2[2AW*+<HMRBW"(KA^1J% ^#%__" 5'1U.:V%+SG%"2/FMIH
M?>3B,?DA=#7V3U[PY-FF,E9/42X',<YR32*=SNJ'UK:-]0C:V;F?C$-Y*Y<=
M//TP:J9I42\LZYCF_YJ/EST?X[@--4G:CI8?,&[;>O:RJ6TAKVXL;[38 [+O
M0HA*ZWZEY9AQ7E$)U.90Q_\$<#EH2";Z)'@D5*R=B_Z>DV5?]"1>G8Q^?5Y%
M;Z5[5N4.9766;SVVO:,8*4)&966&KG80O(;.RD& 5^*&9A8UV&P%".%=G4GK
MP"?OG30L4.&V"%Y+:_EN[-K<;!Z\R8S8-716#@*[3$A4)F+!>EEPJ/:B,3H2
M(-E090D/4762F'Q2[*K=M1' $, &SDI,4PR(V2BWO6$ERNV F(URVQM6#L)A
MT#&QG)*'Y+@'40?'V> T",T=,]Y9%707Z<4G=A@41FOQI-E6DH1N 8N3!.5I
M_GN9'5RE_-I1LYP1=YDQ'%]] F8"!R!IJ%^^E@FT3'NMP$NA0#!)P$@=01$M
M'57U[+-Z=(_)*X$]S*^6XKI2-M.#Q?%)^OM24 ^OY/1=?7UU_:LJG<MDX9>:
MI[RLC9/=(K6'^>"TW!G<Z]EDXN975S\\>VBT'7'1KX:4:$XCW"'<W3W\,F@M
M@X) 0P)!,P7/70+"A?*$*>;X6L>YIX6[3KO (ZPAK V<E8. -<9SHH1JH,'[
M"E$>'",$"M8I%G5T7H='-]+<(5@C(TLY8AMBV[!9B9F+ 3$;Y;8WK$2Y'1"S
M46Y[P\I!^!(Z!<-I/<MH%:D91PJ&:0)!EG<T<5XZ_^B&ESOF2XBA^Q)X8G%3
M(?I]6LB>E >,S0<WGC8U&7DRFR^@P,-I,YY^3)>G=E<)R!4/ZFG$X-J3IA[-
M_5AV[?*\XF5R<N$N4/_T6]S0;D1FH]P.AI4HMP-B-LIM;UB)<CL@9J/<]H:5
M@XC32*.IILJ"#U34X8D"O$NI1C9H#EQJ1]>F0R<6&#'E2D*Y+O=P!2;%!-H8
MSV/DRLITNS+\<'&2YK6?U#R=I&D[_IC>3L/L-!U\=..)\X73LWE;7-BC%,YK
M#Y[4?FY5M8S='+N+]\4A+D]^L%C,Q_Y\4>\ZGKUW\]19&,<,/H2#L#=T5J*Y
M,B!FH]SVAI6#,%=4,)G&*$ QZT PG\%(2R!&E[R)DGCRJ+02FBO[)2MX_&U3
M^?IE-B_+-&W*_BT[,GQJ%G,W;2>K86ON>C.CLNFW *&1B,Q&N1T,*U%N!\1L
ME-O>L!+E=D#,1KGM#2L'$92Q7(@0<@"K7.W^8!CXZ!@(*X*@S-AH^#9S2)>N
M[*M+3_:X.K*K!SR8QN//;NU?W7CZZZQM#^;C=CS]<+-#T57,IJ/ #!MZ7 :1
M;^BL1(ME0,Q&N>T-*P=AL<@HO:+!@^.>@-"2@\LT07!$"^(ULWIM<DV7:22T
M6'9.7/#LTJ8B5G9B,RF;%!5*OR4$#4%D-LKM8%B)<CL@9J/<]H:5*+<#8C;*
M;6]8B7([(&:CW/:&E;L1,'V X-Y:^'L6Z(>KM7G"<&RFAC/K#>BD. CA"#B?
M(BAA@F%22F/7QM-X5D?7) 99B@B"T01.* -&$ZE2CDD:=3L<^RXM5O'7&E-]
M>."T+:M>7GVK!10?%?SK51CU2T;?Q],?$1CWB*<(C'L$C-;%VD5;0I)9@$C6
M@^%.@.:4I$B2(D%VD:="8'PZ8,0C2YO*R%_<9#ENRRV:O[MY.&DX'36,,(X*
MZ#;!OFR--%\]ZPMYMFC:V60<F[N6?<=$Z^D(WPOUM>WSM,1$%[(#ZB4!X6D
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M]<1Y$#&9;*U5*J_U^N_B$-9]1D>G%9&2*S0_$,:&S4HT/P;$;)3;WK 2Y79
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M@8$((8*-GH-/SE%&I=<JW@ZYOTN+58R]QLV[/GE!^<AL=:K[;N(N'F!% $8
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MW%$!GZ@FVJBDH#PMM-H"RC(IBI1S0;!D!X%K#"E98DEB$V6HR](LWZKC\7!
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M2-^H/+ORMPY^N5 ]VG6='$)JP/S,-J,Q=\6Q P-WZ0*!5KM<XVZ0^AP)U==
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M[Y;&717"ZTL??KSI#*NW.;V/[AIPZ@U$OQ=A6)U&LWNA1VLXBLVZLK+!$!5
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MC?X,M'/*H-]B?A7>T[E6.V^_-^2^ZG5I.P_S\K*S<KUO()S[#'9.:V<S[VK
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M/NNKYY]R([Q/\>K_[K_CO@M$GQSEN&BG8/QQGEXY%LE=LH1WD25\%''87>8
M+_SCSR" HUB30O.%YA]*\ZL1H$+W9T3W14,H5%/.$>T<3TOKD<(UA6N>P#6E
M0$7AFB=H*(_2.;:?/7QXINGKBN#^7 ]G79(_C4;A8><(7^DB[8NU'K0<7\TQ
M/3C%/"\+>Q?T<!QAYIVG7ENGE8Z1(4I80MQ1C%QR&'E!G7*>!,O]9HS%X"A\
MX 9%8CG<(Q(R3%$DM*3!.6LH%UN#:@MV_FOFYITE6O<854_+LWZ5S/%2H% P
M\JC)H&#DBV"DX]R'(# RRCG .^R1D8$C9P.+6"5,?"=I6;IDM'<!14$TXHQ:
M9(QWB$AC,!:666-?%"-U#QM:(/)YF/ UU^'1S/R(7*RE'LH?]G/.>X_C&MAT
MUT<&7SEQ/>FXV^N$DB)$HQ#<:J80XPX$HLXGE8@"(6H4?.\M(6RWA@9PWJ\+
MQMN1#!4]1MB>CW.>/'T7T#K!33U1T-+::L&,1C8 7G'#0?/7H-2S(+FW3C@F
M.@?3GZ7Y[P6TY-[+*9T\?;]RT#JR.,3K4^/_:S3^)X+?KL8C'YL2A3B(A^W^
MJ/+KQ*%=$,JC(NZG)*(]2]@P+) 4!$2T9P0YYR22/CH6E=<"=TX%/<NNR%#P
MR_#]# AV)*-9CRER*.?<0U(/SI>Q"@(7!"X(_#4$#EY)A;E&*AF*N%42@8D3
M48H";">J;1*=@K3/,I+V@<"\1[@H"%Q"**<>0CF6:/5.BFZ\IND7)V1Q0CY)
MODKB=)0A(DYY EDI&'(J8>1!TAJ=*-&D<PS^619.6W5X9UU]>Y@\T;0IE%W@
MZH0W]43ARM/@J:$2<4D)XB* _L*Q0-8&+S0 0W)AI^; +N&*J)XA3\PD+91]
M(G!5HB7/!(:_@5W^IAK')HZO<W68<16_9%N]+= Y<F#:QDELRWZV#%Q\><67
M5WQY+RR\O]UQ7<R[E0$F**762F2Y (W >8VTEO 7D0%[)EDPG8XJS[)=<M=#
MFP?PQPQ]=I9%(77Q#C[A\,%W!=P+N!=P/TEPA\V0E J.5.XAP'&(R'I!$'R;
MJ(V [2[MU-+;%[AS(PNXOR"XEQA0B0&5&%!IN59:KATNLUW$P+3RR 3XAW,3
MD7.&(RM("EQ0K"39J6'V6YSLRD=K>ISO^QC.J755*QA9,+)@Y".=5UH'F7L-
M8(%S.(MEYY6@B!$ 3VU32)'MU+[9(4:J'J?[#KL7C#P%C'Q2O\W3;WCP;O*0
M9I.]*JV5)ZOJH1], WP\7+.^?[OKU8]X[NZ/?FMC-,,8L1P)X%PJI!T H_*1
M,)QHC&HG08#?)Q=QO 33Y3G*#].KJT'NLSX,O\:QOX"-K)OX=R#>\0^YD\6G
M86[PMQ5XY1KPBOOB!/WM9RU?GA0JN'J0-R(3;Z'(VQP5DHBG6B%#5$ \:(:,
MR(=[":42QP0?.BEU3Y'LQT"1O,^/D2)'Z38!8-;A%[[TM[.O[*3RTP9D L!M
M X-IVXDV5[EUY74<W#R@'^=.FQ&!'FB%,!YAA@GBA 3D$H;MQQ$G&SCFK%,$
MZBG-B'ZV]3C[N>-M]ZGF6>VG'J-XR-U)WWVTGQ++]E-YE:IVF:I?H\V+U#9I
MW5LK*LEDHD%:A&D$P% "H ,$$?)<$4F%%3)UDMJ>UXIJ20?OFB9.,E3\K9YU
MOP7@F,\Y_#[\([>U'=?#3]_;IFY*OZH%O>1^Q;-.4UGTA5M>:M.1<M.JJ[8G
M=%-=Y3RE8>YFY>)@]'FCA=7BY[N[$;=;T[YA<+LYU>5\=S*$I4RHURVA9C$,
M$#;?K]SIN&[FC8P#6!5 WVTOK=L;+NHXMB >;A9]MJX7\:]J$OW%L/[7%-XV
MG<![_S</?ZV=<>YR'&+NKUR#%MM,_<7*H]?[.8<Z5,/1I+JPU_,^RK-YP4(]
M=5J?Z\D%K./?(D!UQ58OOUQAUU4,/YW^8(SU*;V_WQ71S^_#I?OX^4\I0RFM
M1$IY]^<W12!X6U>$RSJ$03S'K@COFBR[UAPI3R&7^Q?P=)LD%&@JT+2W?BWG
MBTPSU?27@D8[8YSYLISFE LKW<M*A9<*+Q5>>B8O?1Q-[* PTHNHR%\[.O Z
M5>3=FF[9"?BFJ-#W8%7W-/]I,%7IF'PV4RY$7J9\\E,N1'Y&4RX'KIZ?%/WK
M:!AO*GC?/R/8$#G V\:!2_KLJZP =*#C R=Z- !+$C4V EGF#>+)4^123,C0
MR(RV6 K:.1I +5:8&HPX9? /8PI9*11B@6"3SV*)?%QZ/1]H9H3=D1.VJW,"
MNF?T$P\_'S.U'ZR2VVF(S[+-)XEE;>(:+=M>N/M5;'-1679:K851^+^H0>E(
M''',<P*[S"U3DO""<^)M)X794Y$("1(%GT^)$TF0,]0CK:BSC"M.N"DJRT%!
M[9FQCV+IPG/^WO_0KSZ.V\SDFV+J[O&0\.E4(BL%QQYPS$XF35VTB,M(X)\$
M6)./<R8J5!31PX^=]IG>J."T 6F#\SDK'QQR 625%5S"UYI@C?<L<MI3!.A_
MXWBTHC*_X$GZHZD"5O3L@I<%+U]019>"$$4)\HGF=L.)(!ML0!HS:K4REL5.
MCW2'O7.""10(!J!E42)+'4;.2:,Y88'$?>/E'4T_=$\S4T"S@&8!S0*:^P5-
M#DC#I8O(1(%!:W06&6LI,D&&1 S J>Q4%]$>:^$#14EKBN )< ^3 AE/A$PJ
M2)<5TP*:Q\XK+QCF7SLRWS8 >9K=OWJBN7W.ZH/Q5P[B'XNSI,U07AY]7ST*
M7MPEI?C@/H7:614?C,0[&WQ 3'G0Z[4ER!&&0;FW4@3G(O:=# .G=9**&80U
MR$,.?R*;1$1,2XY-,"K2>)+N^E*)L !F <SS!DS&N9,!)T1C;I/JJ4?."HF(
M\T(1XX(4G8K6@)7$8A91ROW+N7 $:6\P$C@QI@1C,K!SL ,*8A;$+(AY;HC)
M':/2>($4H5G%Y!89S!3R3/)@J3&TBYA/J<NZ=\2DJJ>I*(BY@[K/1X&&M^^^
MM_K@@^=^JA,K=?/.KEC=$0VE%*?:LU9WNA,L=?/NK9O7:3=0"H.4VGG'P;TG
M/\%2I*C4SGLYQBGUOLZ;E0HO%5XJO%1JY[T:%;G4SBNU\TK%I5)QZ>RG7(B\
M3/GDIUR(_(RF7&KG/3_AHM3.*X5H2B&:+6E'@27/*44N>(*XT0XY*AV2UALE
MDXL,=S+;F?$I$.60-B8ACCU'F@N+9 HV&AZ,I"^>=L1[7.T[Z>CUI!.5\ZME
MFT\8RDKIO,+=99M/E;NW%/DE243M)$J4Y-,A#"/-F$7")V'A4Z['T3E10A0%
M'8:@Y$%;X4H:9 0VR#GK?+#,::6*HG(T><^E8%XIF'=DTJ+4,CG?6B:>,99X
MU$AJ"Q(',XIT( P98B+5*3G3+0!E38I&<H&L5 9Q;R)<C@.2G#.>/ Y*E8)Y
M)\DF1;LN>'G>>.D2!67<4&02Y8AS[Y"A4B)AO.4J<2PY[K@2F15!4X8 & GB
MB4AD/#6(")<DHRDX)U^\2 91/6YP <T"F@4T"VCNN5"&,80P%Y$2#D S 0I:
MZBT2A-@4J;."=.(OFFO%6:[%S(3.+0,8LBXPE!@F,H*&R<++5Q8JH'G,L?U2
M,*\4S"O53$HUDY<2:]J+0+4 F03Z/>(A&.2XID@3%X,$V49XIPZL2)(:;SQB
M/'?""8D@$[5&3C"=A$W)QY-,*SBU6B8%+PM>%KQ\I*\9.QVPHLAR$Q'GT0%4
MVH"BIBX8*YGT'=\)MM@JFB02-N,EB3)W/ 6#P!GLD]*<^;/PG13$+(A9$//<
M$%,QB[%U!@F&58[.>62P-(A*+$3PP7FC-Q%3NF2T=P"K(N>0,&J1,=XA(HW!
M6%AFC7UQQ*2D9V31,7=1+V^^AK]-+^.X]O YU-?;OCT*Y+Q]]^YJZ\'L[I@:
MV7C^GW^ H;IQ_>=>8X<-:F!ITBVOS==JSFH4&Z*S8>852Z!>Z-RL-!=#=S(P
M%\&:PZ:CG+@@F2845!)G$1>@VAC+,=+!&1-5DEB[35:[Y:W?TP^CRZLX;&SF
MA3_BP$YB^&'43)H/%W8<O[=-#._MS26L0?,17OK]8.3_^4T5@0.OLK=K/(T/
MH^5[EWUMD_7"X;7;@\L;PWL*&?PVFL1*5FV\G[RM/DQ@/5"[3-7J2E8_?<E_
MK_FZEJNTYB/4BX$<U[(];Y4^7L1V.>SPIKJP336Y&,=8Q7]-Z\E-50^S>*RO
M(U#RRHI=#8 _WL"EL:(8R^H]?.[-/Q+1?JSL,,R_H:3]IG_(8I=[)L'9I?E5
M;^H)C,)O7>[E>ITQN2W7H/H,!#<"W:@>VL'@IK)A= 6@5KF;EG2^']EQ: G)
M7EV-1]>WO\P)MF5M];:!*0!O7\"FQ7$#1-N^H5]UWP6:'@PL ^?L*B!6^"^,
M;AAG>M3G>G+1OJ$=2OYFE.X@;'B4K<:QF0XFU7!4#6':]C,,MJDN[4WE8E4W
MS11>,H6M'*_S2;_Z?T>?(V@DO?7OX=6#02LPZN$T5I-1]0EF/!ZV5^5Q-^V;
MX8)0YX$UBY&-II-F C_5PT^+0<"&7=>C:0-+^FELAY,M(RD,V3+D?&//FB$7
MQ+T_AB2B7_TRK/YS"H_-,F%37JRRYN5E##7\"9=>C>O1.'-#3"GSZ'4<QJ:Y
MY<JY<)DQ+G#D%5R4+\^_MK2?+TW3"2A0<^[H,.!R[B_&@/,W%@:<,>!\#\^4
M 7\?5HN9O_S+9^RH>VLLN>2I+.;F"' 7T]_"P1J[+UDV7_/+^]_;*UST8-?<
M<G$UFC&6FS9UR]$!!.>=C)^ONKTMP*\+QML$G?RN<?Q4-Y-QJZ<>;EFK55H&
M\S%^\8-IB#-#U ]LTP"?MSG)[=WMG1;68;RL7K&:5-#6,+^R(2/,/,V@'LZ+
MH<N^J(>K7-!>//^\4@)]<?OLJWS_-^MF\2!^0:$>S_2@7!!]>CE\&^H&=/V;
M-_G7Y2-N,TWJV0HL4C/@X_],FTF=;A9+T=Z(XC"\=:,O>4US:?>EW^7+V[7"
M[,=0'OXQ]>'O+!#/N=JH4/Z<RPB6F_7.U_)CMB7(/+'JV>H8%KO="IX^SIN[
MX4:#7S9]:(O4HPURF]]_<!_THURL1#\1/QX$"NONR]-;^)T&1?:\/,<1#=AM
M&&D]C>Y(FZ=L.F"?[N"=>[67ONVEP%WY>[X<_W$QOJ6E3W&&B,@FV/<W=O#9
MWC09<5=EXSK)W2'UM@FWHUOO!WF\'[WJJ^M]S/[EY^ET8.--8O:N]ZL#*NP?
MUS3TK(_7 6Y,H_&ZR7OKN6UU\VKFS6I:2_KR:C"ZB7%FSV:_;S-U30V*]_@&
MS-OQU6BF/C=SQ?KVAEY[1^==0[@6%@=4J7S6=O5UO?G';#E$7\^\QRWZP4]@
MK4_&M<_617M5]YLVFMA4W^:!4/SVCP]_;\=$R=OO9D.YBN,VD B379C>JQ/L
M53.-=C2>#QW6,?OL8-RSR3]TXILW PGDC1A.V^87L 1-#L$TVPP3/[J\' T7
M2[/B7KFV]:!5>_.:9I]A.Y-55\&J+1;_-;6#/,&[R.\1M+7SN'.RD2AM(S+"
M8<1%(DB+$)"(&AM'<>2ID["/352>*X,$U7"/RPG[5%/D'=6)<\THIYO!L-M
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M)&TK/6^O> <L-  1.QM)#5M= R]MO"N[]F&+8!5NGS"3\X\-1[VVHZDE)'6
MD-1, 7NAD-2K#1^Q&(EV@B+'L]FMA45&18(42)QD?6!@O7:*;"I"'+,!69O]
MERZ'XQWSR,&SA,0R8!8.;W:3'A>TAS4Y(HDQ)^"C#2)Y'Z/)J@()B!MJ<I(&
M153[I'P0D81.:D84TBOA&/(6" (4#8DT9Q0)+Y/@5.D4.U7]7X.B<4Q4<Z@@
M4IN85=G+T70X>5R4J,7>KT>)0 G(R4WM&4IX_WPZH,W$+? ^VAY6VN[N+6XE
M&%4I>;%5PP#"N1HURZ.$M[[R.6G=DG*V-&=J-<CYRVB'32;H5AF_M6AS=O-5
MG4NOM*ZEF:VY5A'@4\Z(S-F'&U:LB\,(PYLE]BVTE?;,=![7W'[H6AOY@O:H
M07[&..;3@YF)8:2^33>$RS,O@7V[-(Q7TJ(O6RU\^<NMHVTS07HQ<[CJ<J8$
MS>*R\]SRV=I<CN9Y-IU3X%.0*\T\S]SG$B*#NKE8IEK#HHP DX_/2_((&MM2
M'DBPX+7R%D6:^^0PKI'S%$0DYJ!$@785?2<MXRGE@9XL43_F ^V_I_;O@S#A
MAY5S @M6R2FVB^3C!;%M)NOFXP9MED-./!Y6!.-62L9F O([W[C5_%X<'6[?
M #(+!EJYF6DPSWL&5ARWUD%.U:WRZ?_GJFI;R",DEH25&!&C#>+*, 3*M$&4
M8$YC<);)3O* , 9KFT#A8CD7UGB"C',:$44</"HZD7;GV6G_^4=>U.&G]ZT1
M3];T)M1$_R9,Q_D(:1.'!Z&@E/6?K+[<=G7;K&IVN'2%[((9#$:?\Q&8VP3[
MF1<S[T&,*P[*MN1$J]O-('MF,<)%59XC\,$<IR=MH?9."*.EUODA^U$^9#]C
MF39@,:=]>!;JI$G.<_F!B?Z=ZWO?<N<T[GMW:U*WSJ5\W&7EW5G#C+-# XOS
M1.-X"5(L+\.L!E6[M;VY:OK=O@9Y.\(9P]]25?\>LBIG^\O9_G*V_W6>[3?E
M;'\YVU_.]I>S_>5L_\//]M]=1?>))A!W5EMI#2(LYEK5H"]ID@+R6(NDA%?.
MBIU8R/XBAND@S@__=HRAU@[]?79<_5W.(@6=X&/FJ ?4T#U]5]D[T*@O+U?.
M5#5K9OMLO>HV,M?6(UXHWC_-ZL=FC]IM<8+#V6--_64>XL['QV"8:YEAV<MW
ME7W/K>/!13#;WJRPPK*D]E%HL8]08CM:IR!](C:5SLV+2)]U%-/.-<^_@/8E
M9L]_3)_O8BB8TQ>8\KT79-OAL6MR7\.\#"7;^^4]S998&=-S>ICJ'4G+EVUA
M6F9\PC,&]L@_MV'BK\[^4<U9#[8^3XE$;BVGO_2US;6E9]#.0WJ6'L/ZO2Q'
M[7>&+]*ZJ/#/UN7[K_::&/[#C?_]+^]@5<! ;?_^:1[A:C^\SU&NPEE%5A5>
MVP&O5>^N/[5L]<<BMM1^^@$NS-E=.5GS;W6:<=ZW_YV#/M\5WMMIOVYSI_GA
M82V2?YRE\>PF@.8X8Q%S;6J]C4";FO-C]+-L>3;+>V,/HLU5IY38%B_:6+?+
M.H1!7%NW5?^&N-K>U'R?J_H2G16/CI0.WD[RY:?\LEMZ'"&A]97=>4JWQ,PZ
ME3P21%/$@X[()FM0$,0;S+7$/NVB%>23,XSFL+>2S3TS,.])_\?WI&_+GE*J
MQ_'V6D"%20KN'<F4#]0A]RP 4&&E$I4!J93+XQFKD2.4H4 \X4H2&P4_,@!<
M6"USY\#"+]"Z!-8[ZPYS#=H/N2!YSN%MPZKVQQP"&L^:@2[/ON!''7UA?;S]
M5/UK9;*"FR>'FT5?W';L0!E/N6'(\V00]RDB+9E$8#QJ$[2,)G0.=1)*F14^
M(9'R/1;@SPD*IKJ*T87H-"5W%V)W]X.>>S3H+1TU*SZ:?%:!WIE^GO-T=V>)
MR[X@#\CY/2..>9IW9Q%<+MZ=;_[RU]EQED-ATJY6Y06R&E\)+11Q>X;B=N?6
MB6>"JR D,D1AQ&.TR%(B40K>Q$2-CZ3;,>4ESP?.!74+7\TOP]D9L+^.1TWS
M3 >-,J8GBIE1<*]LZ1GB7@R44F4#BDYRQ)5,R/#(4.14)199PCB^".XUCP*^
M0WMFA.AK4R#SW"'SCHR/8C.4=2@Y&,^UTA> OG,[_01 ITRZ",\C44X?=5BL
M7?PMB_3MU\NZ[$7U3309HC%'E+D<7/0<.98(2EQRKJTW-*F=J+[YA-ZLTO:/
MT_&R?LNLZN+J:<<EZ#W3HB<]*G1/J]-+N7A8?/YA*:,%/X]K;\\1/_>=<J&U
ML$Q)I-HCW1XS9*-TR&/I!-&1X-0I(WH0XWZ!?$=CWQ/<%^SDX+-HG2]JWY_
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M'(4/W*!(+$?<B80, PU7:$F#<]90+HZ_T"+EO*<Q.4L/0,'78O@7P_\^;*2
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M,_2H/2KH8)\I)9U!0"@.##_"D)8FH5R( T>NH[:=ID%4VB2"H9D8!1 C=KE
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MA]4&\*UJ#^I\[D(/JF\S@3]R*WE8/"#3K.'_]*\I**W5^X$=/NPDUW$OW+X
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M,DFD8#02DD9<; 0.12J](."2*,&!8'R7$990C[ TDTQY LAL0V-NJ^$VL&1
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M*:H(YQX($K@^)K"* %"#@<$4)1&-71%[;,/P]H7PHD@FQ%>Q &/= V,]""1
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M\H5(0L&4V/"G'98IL-KF?MEBFR8V?#X!$^1:YVIJ@Q/^8,;T'!SG,"].E0A
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M^MS5V=.X!:XSW-0S!:XX\Y.44D4RE0((94R0)'+Q6'T4AZGGNUGH[?O Z(&
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M7I*<VW= ^MCL"T--?:^/;J??L/N 6W,HV9O:J?==K28<!UU_;^-R)QFU6*6
M^R;[;S9 ][2" E$2!W'L$:6PH #U,L)BBD<ZW"2-$BZ28".-,W%5*"0^Y.&%
MT&F8D22(?1*RR)=IRA.?;@3H'HRI_(W?85'IYM>.-S]E/^88I4/E?W\W>KCV
MVGH+<:>PJ1;B]EMP@+'4]P(BHQC@*LR8*1Z@9"RIQWS&DHT::R^!N'X.PE&A
MS;>IH#OJU2\IMV;UZJ5>'5I!<TE<9N7+ZF7"6>0GF2(J9B K1.B2A#*7"$H%
MZ-)4^?[Q5.@/<_4+=//E5A4WZF?H\[K9EY09T< JT!;7[*9>"*[1-&8LY'C"
M$T]K"I<3T)0Y23*A9,3\- DVTBWWKC<?#L]H9,%L-ZW9>J-WTYHC*UTNB<NL
M=.E+%R]-,M?-. G]1!!*W80P-Y9$,BZ2)):Q1_?BE7FJUHS^F"^WU=Z4Y2BP
M)T8LG-E-O10XXZ&;R01 + A 659!1!*6922,I>"IXBR2&Y<1'4)9WB^,61W9
M>I9?5T>.K5"Y)"ZS0J4O5%(OSCSA9\0-4TEHE+F$2SP3'=,PYJ&B =V+!^99
M.O)UK?96PF84,QN[M(!F-_5" $V(+ VXQTA $X Q-XT("^$_(@H]F:6 9_(H
M+N5] YG5DZTO^77U9&;%RB5QF14K*U6&PDB&/(N("CP0$1GW"!.A(/"5EP7,
M"S.V4<O^T'KRC]5\;_E](Q;;JFD6S^RF7@B>>3REU)6*>$GD$QJ$(1:Z$B1B
MF?2R+(U#FAQ+3=XCC@7VDK0=M63K3=Y-2TZL5+DD+K-29>4<C"M\Z<<I2>,
MM626$4;Q!CJ:)6G 8Q N&[?6'5Q+SF_VYTQ.0IN?;/',;NJ%X)ETW80ISD@:
MQAZAR@M(FK"4)(PRQH/4]=314BY>CF.Z.B;YIZHKW'[F>_Y;"V*[:<G6E[P#
MKWVY5K!8&:"$E2V[\]H@R[,=5_H\JR;2.<FG0+B21EY*O-C'.O8^(XE(*.%4
M9H&7A3X31ST7^ Z9>L]*=S *W$-?N3K0>GU6,;?@:<'S4.#)(L_S@\0G/*0I
MH3QEA,=4$#>,:2P0)OVCN,#W )K'U_#/"S&/Z"L?-B#OHM57,UZT-VY,6^JV
M(NJ2;&GK.^J+%S]+DI2GDO@L<@F-9$18E(9$J5AZJ1OYKI#'U,WW5>0N'B6)
M:_U'%LCLIEX&D+$L\5BB4J(D!STY2P/0F%U.(D\E*A!>1J.-BT$/H2?O"\ 2
MFR.RH]Z[J_?;VY/WVSM%[S?*ZS=./IG.9THZ>6ENDK0"QCISK#/G*93SW0LO
M;WQF)DN4)$(*#P18&(  $SYA//%())3/1<8R3QR^=LC?2YDW I 7D.*'KP(>
M?3?!3WN2A-$H]@]=062@?J*GE3^V]?LM*EM4'A J2Y8FBGN*"-]5A+HB(SR-
M Q*[4@;P4;G1X>IL'QB-PT,?4S]3*+:^^_WZ[GNW95OQMV^N\\<^LIVLYGC9
M]6#N3SS:_0]/68V3EX7W7(.3\=@3:49$$,>$>@$ES$T44=SU0L$#/V3Q/F37
M/;;$OKQGWLB/@J-*JC4J.<'PLH5+"Y<6+I\9/@W]C+J11S+&):%!DI(D3!+B
MLU@$B?!C'AY.U=\76-+CNE=.'RE7E'GXP&$B?^[6\)?Y1-6Y@,\ROSG*E+K1
MPC"ARWOZ>ZB+!76W8^_L6.KZG+HN84H"<?LIZ *ACW$UC](LDB).W77B=E,9
M!<SS2>*GG- 0Z#J!-@B3:9*H.(M<EG;$77]M9F\^SR<PP[M/V?]H0TC)=T!#
M_$J9>Z(Z!>&+JB?O2OFA-6U_Y3/U!5?]"_3\EZ(2OWWC*"#^*89PZKGJD])*
M2(=U*[%U(Z)'UFEU*U@7UMG)V'G&-CUP4L&Y;5?/X6;YG+I;O]9@ LB=.+R4
MFT]V_@('%#+ES!OX:58!@. ;>:DV#2YHN^ S\]@,^GY?36#.=SJE+W[;.%6G
MV^G^,@-=IIG&X?![YOQU#@T'[LC1=Y'B8_T[S?';  9:JS<]'EPPG.:W;9$V
M/I]5'=C@,L,0D&'P<5+PNVK>YB"^-:OHN>[8_;9[ ?:JX--&O6G4E.-2=-NM
M)8EI^YNM)OQ-WN0&D=]TC=QKF^N.PW <>-ZW;[_YXT-/>6.7/?K,HP^P,65T
M]V;V,18?EIL^=RP[.DZVL=QV;\HF*S_C[N8#RZXAW&A^'E-\\@WFKS+=?=Y'
MWD'LQ6_Y!4SQ<JBZKR9<\K8?32P^2PP.,HJZ3_+3QHCSI=.E.WO$08-D!W(<
M:-#K]7#J6;'H;NBGC6QH"1V8A :Q9L>5[^<Y9<M'#_)18/GHJ!G6!](FAJDK
MW+?$__,D#]QW=XK7S=-2]@:S*F=KKQPSN&@G>+(3M.1Z)A-\I6JS%WV2:)'I
MTT: ;/[))9W=.\E#JMO#X<Q+>1:'+@DEE832-"4I3WVBW#CPN.?ZW _WGQKW
M:%C<6TGO((T2;^2\1C5S?SP<C</EO2KK:0Z6L"U:7?:F#A&M7"].>"PB(E+&
M"641!^0)07^ADB5Q' O.-FX8B](L82*51(4>PT)]\$XB4N)%2>*Z(0]XPD\
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MP"RT,7;^W^H6Q$RMQ\MK68  ZZ"FQ8G14V>'Z+$V/>V\,?-#L+_F-ZJ/1#E
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MI[/Y0"%^5^2@(_]WKOY1H3U2Y* ;EZ#5FFR%$C3PZPI-P^H6O<WHNLMECD&
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M$M?6$+,\/)#Y6AY^ 0_3D9>$)[WMQTTIO7"GP[N/%A3/G3LN%0O]8,1\>XF
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M^J)JO(WR6G%]/:FJ2\V:LZJ]=7CU!F1S%W.!=XQJE!!=M]?Y=(IM8>O PK*
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M \QWO=_@/O]/[^#F49G^*:RBO#JH5)F.OS\_S<[/A/_Z_?UZOPN\'/BO][O
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M&IP=N4'K[@7#&_\X'!R=W/_NP<D#;G[:5S]@SA[RWK-#]S_K/LI7V#VHMM?
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MTGPB!8II_I:%XG3P*LU=8::+Y6<Z-MNW\Z_P?I!:'(U6;9FZ/DC24L4X.V]
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MQ@VX%@5[-4.-Q<?GX2LZCD3P,LWCK"&ZQ^X7NB_A<?\(6[VH.'-/3S^6B'V
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MEI.H7'@I\U+V@*,5V;L0$A5*>@L3:*#11  3-:9X7<-<"5FF.!T/,@=R T_
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M41PWLX;+TJ3>?M;D6(]FZM1 8=/;S$2YFLE)3,-[^K;H+5L3$\M58$L4*=X
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M9O7%K+Z8U1>S^BY:FS+[P%S*NQ1#8*Z3^4\$ZZ#4,(:ZRJ]-\W$95779,'*
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MT!5B+*45TUA=IVCCPKJ,J8J]@(LOD9Q$H0F&("YM!]!"+!RRO<XH2H6<@%S
MFKL$[?55P0<_=I+E"@(ZL^M*&/CX?E"&YA;P?(IQ@9/<M4:8$62)_ET_D,,]
M^8&Q)=$:20H3!G>BB"9>JA;,?C)2GC7<8]$]%MUCT?NPZ$<>B^ZQZ!Z+[K'H
M'HN^ ZSA6^/<)FF&H;=!\-Z$QZJ6?>MVA O[\EIC@YH3. 532^(S?U<.M0XZ
M(^ +@F>:N9XR!:S$<;0M3DV0T)/->(#;0P(W_Y)^BPZSJ66T+L:4 2,>5A5A
M;IF",&!2-YARB1NB.W?QT!R-1>O<0_6]A#Y80H62K,7!YF0_#0XS1O3 @N$#
MQ,*+@2:4:?@(D&7$-WEQ].+X4'&\L,<ZMJK 0*F+@N,@J6"")5;JQ<Z+W6;P
MITB'7%+Z,6[*2XF7NR29)GE)[$4./LK+H)?!A\K@3[ X6(W05#H99-BXO7AY
M\7JP>,$_BUD:6RI9SJ]B(C5"()Q78E[*'BQE7\%DPS(<0A]UR=:\@'D!>[ :
M,S!S QO1L U;?4/= \N)6FIY88 %OH+5B^-&PB>";IF7J50?4+AO+)A/PH)0
MZ"2::*LNG8VP<@T%RM>/.NBP5G$<!NN98+^?S3]1"*EJ84$)"N64H%+P@']K
MX$3TD]+U)1DC>QU$(Z/+=$>@Q'0>T3WREOHR^.2 UQWWY_EF,6,N'^[%DN9Y
M<1DQ?I,[+*H:L=^V4HJ:QB5)B6+90D!J:PMAUOW=ZK TI2WQI)]:?3]45"U
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MO\O,8,83GB4$ZRU1&BD.--,'TY,<#E\-H;,AM%\IN>-(@O0EO9.D.\3(Z:K
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MM?93;JW]<FVM75MKU];:M;5V;:U=6VL_:FOMWUJCB=]Q',VAA:?6)RYYM&[
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M:9?;=F>AA.')B%O7,( GU44V)F_UU/2\P_Q7L[-7-Q-<NZ6M.:F8R2/W=+R
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M(^R,F3+LZLZMB7Z HN0!!QJ[[=M#'"5C3K3JJE"L%!Q:^!#%C_[W*<)\O=O
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M'=$DI'9A[I"D>8U[35R>XV,("PE4K'(E$/$X'-@Z=.ISHH.O#]$C$7X&31R
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M/A]:1'%9-CLJN9MQ?A"6F]S+IO-G'6N?X [PSR_,39;TBR/-R6,HLI7<"5I
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M4M[&:2<M0#H7,YG"M$G'WTXH_L8^/NYXD&Y[?4L3WA*$QDOL]UKO;3-(SC.
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MJ06)9#E=GS6YW\FM!+')Y5FG"Q.$-"G;D'YE9^3QXJY50.!^S9Q C&3,*I+
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MKA"N)X<BU:+$@FNV1V/C7)U";\4%5PM2%Z 3]ZZ6_B]?E8,237="\A60')O
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M?&#IO/!-(>8+07*8K*0+:-K^,^V/41TS+HIW$CO"#%%'3)D>D'GC7A9OSCV
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M</K@&_9\!)T?I0%Y1ISG'L/)5W6BX,>%L&J_&(\F#715;\%K0Y!\U7M#5LX
ML;&:)V_1?#0&NGNU#68\CM9*T4:@.YF7I*WY[M[.._@<V3YY*D=:8G$C:DO%
M^S(\9C^'XA'-"$55$-<+^H6D-R%<L:A$.9'4X:I#VQ89-V]QSPF1RQ#4?)E<
MQA1%\PXZ,;1%]B.^GO2W8J&GY/=T;:(LO5&\>+8139[%AG-<@H12KC:;UR4
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M PIH>,@35>5O?]C\GW;@ .H;.:\XK#"PCL4Y!M-U8#4)7"**A3(/!5#9I#$
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MRC*5J3X]V5&PJK^2QK9'?_K3'XRUX*\OOGOR9,IGKDNW7[88Y4]$T,Q=+OF
M3C[M2^(_(5/5[P[H^J7LCH9C9^_(;,NF#.^F&\R9@HDAN-CY=,Q)B&;=5NNV
M^N#T/;;!':PA+W"8'_FL^;[<'9KP5-=<;?LV7*4]5COF.@BO0.&.?(^Y2#C[
M676Q/#X5W.(".Y]*\5CC(C:.+W!;Z%&NCO^,1X/8-I(</"7WP[T.[6C:%EH4
MGQQR2<D"SPJJ>LFT6AYH::>M2-05B;HB43\Q).J7*Q)U1:*N2-05B;HB47][
M).H:>_P*L8?S7 Y5493-SX]&/OTPQ$ ;WA'7 * ?MTX-R^<BF<P/O!7Z 8!.
M@1WMA8!'G'E6>MV'P,/I1%-R<G=&278W=IH[( BLTX*.B<6H9EN1:VMQB(5(
M:T2^1N0?LT3YW>'<@T^PV7RGC$=O1L -&F7[1/C,I3N1C>Y9D.GEF\VK4QF_
MIQDN:2SM/8 B[=Q%N[1L/)0R 31G.%:VV5:(_JN=XI2YP"GPZZ6"'X@_C=66
M:WM:M<LBM:70/3T]5'71E8WI<<[3?%H"I*VM1'^18*O/6%ZNX<T:E;LQ'&Z;
M.KUX0\KK^#HH%PS!7H;D)J]'P4[QV(2@NCI5/+0.OZ\3UF\^*\I]U6BUE26D
MBE9,&)F1'M]M3X"]#!W_=&J+8 7I!\Y9'"IH^;#E^SRSQVW:YH'=ZR+X</.9
MIDSB9X,=J@@/RS=HT%NPH3L03H,!.#'WV7_.1A'=PGA! _0G&MW+8]O>XG*'
MZB1= 8"D'86+K01,OF?"2-2)XKCYI!&)%P$,3%LHK+CC%GG/E2EBM;0?P^D(
M>Z2]GN#R1/UY&2^FVTD_[\"W_&V/OZ5+1(09#"ZS].0UBT4Z+-<462:7"'NF
MK6]HW[ENB@5 @C0)T5Z";4C H$MPNZ3EZ(;153T= $K5'I%92D80S/\04\!&
MF[4DJYQ^%&"3?NC.9MG#6Z$\TYT]KO=Z#-X55D/D+^C"YKW)J?$I^9CB@*?D
MJ//*Y]=N;NL6Q]7\O>Y ZHB,/9TCJ9%C.!V77]_OY!#CG\X\,9\6U6 :T_I0
M_/K7D;2! 2#!+/+Z"0_%A6GNJ_GZXJQ-WBZ9MH4W$ZI<);^ -R!GSN1"1B#E
MFC9F.XB>A&?#N]S2E2->MZ?IC@^"<C+X+7;@)C[VQ'3/%&U.&;6H"/E$16PB
MM. )P'>=M"O!NVEZ]@/(<SM2^T-E'Q4\7CY2"!D.8R^K;9=+;Y8M/:&36VED
MWLQPS(Y"D!E8HOJHZ5E[5I&<"BR(J RI7D8<U90K;]D:JY4@+0?C/M&[,!OI
M$!S*Z^$@!-IYL)%H7@Q7]T\XM&U-78[]8,0XPG);$="A#P,LA+>1)/4KJR5_
M\XVK)*=,IR;O&X$L$4CA43-< V/R4QD'YYXN 30F*''&NRT!SJXVWRY-!\4.
M?DY.X0@9L37"Q.!J;2?*IF'Y2R7=*)T%6TP4M#1$.X"%,P^MLQL9UQ#U<L3Q
M<6O&Z(5FBP?K!'>>1O,)GC+MDD5  K,FW[4&$&FIU3\KP,6/(3$"T<#KO+&>
M!TMRT_1-GPZKU3%=+X-*[\;>T^,9((%.R,,2IENM9P1>W=_6BV]*$8EF7"12
MR,5PB'1*9C+PUR8X6(A&>EK.,21EK+H:+:^>_!-A.\@2=90Y E?GEETGBFMC
MMQ VL5(Y$7+=EIUW&-O=VP?2*8P3I6QZ/N9.B("==T"78X(FBI*$O)F$KQAT
MFE_CW(H]%F"MM]9$UW02V?1Y>;8-L^^A29D$+<*C\1Y&$Z^(:&T)GH?-&\Q.
M,(=C[RU25"?0$6Z[U"93"T&X-/K-&:T<PF "%NA#\K1Q-T?8>!!-=D<U@ZV9
M#[Y4_5S4C%2O2^2];*, "M.P_A?3/Y>QE5-GQ"B!T5 F(&0W4.H!BS47#*)8
M=-OC.C+;LV]P3Q",!%M@!/<4"6R4QZYY^?YN7G1^7(<=R1MVQBVM$5+DW[5^
M72>0,@Z@.M>!3ON)1;>;P9/D>&KS"KGD=KZF*QDWH-P$#/^%YD%N6^FJ_JT]
M>DG8+:A0P/&<@L%](]UB]R6869F6SYV-&M"PH@.UQS1R@'(_8-AFO+_H@</D
MN##(.V..F\$DJ,+=>H_.<4!>PM,C<0@?C?K62O;0[39*.OXSC,:ED5@T'JS9
MMV!"[/)H??@$;,D+_H5O',=I3>N H</3U2"AB[,+V:7 J:".DBT(#;>ML*/C
MV]R))ZUW@!0+L_HO;-T4D+*F)L;>:Q]Z$ZD^JW>6_%BKOY2QBZ/<& E9B[M(
MD1]SDJA!BA07/08CW+>-"A E6DR&5N9I87>S.EF8Z'S.Z-/-ND3P0)IRCESU
M>FY*M,P\+2.<;K+9+,>>3C,O?9W',&G7K7!XL&C$KE01-511V[&OSQ<X]%-&
M?Z&2N+^GPA.B"-8V_W[LE5/>A>"SGN49<<3%CEKA4\%N J=+?:8M?%NJY7?M
MW'X?D\W5ID6_A7EC<I9ONF=X(7GJB<D&><?^<.T6;F>\>RM<[IMZORWAM[1L
MS7G?1895OR\I:96MM* K&',%8ZY@S"4PYA]6,.8*QES!F"L8<P5CKK2@'\_Q
M"S[3==M=2PH>4;U&DQX%:+_LRM/(60LXQB$0RZ:.]W8,JZ,A2DWZ_8$E"O:5
M5'4ER"[SKB'M5$TK2Z!XE%B<F!]'E"2D<IK&C=DF*5URB+BH8;_ ??*>L://
MRA"O@J.!FJ9G\ 8+*9K%RH/G)=(LS9U9WBBO]XZ,#'_\8^9EGEJ%NR^'@?1?
M[RZ_9!=X&JSDL]!Z#C%%B-%*&4VB/Y]%H/.0D_<@*NL@^A@N^B+\^IK*WD\T
MCQ]A$Z]>_(7XEHA50]O [P[Z/JNNRJML4[=]A.[E(D!OV3TJU'_^C@#Q[OCP
MZNYWZ#?#^22BN]+.ET2_+(#6I/"#DB G+KR_VCRC=<1E#EZMV#3\9)*(EX(I
MQ_ 9R\E2>>2HJ0.OH.&7'W.W-"7ME[!H=MH:R%IL*R/H;\ (^E2%@AL#JN[+
MDKJF08W0FRX>#;=GM971I ;2>YXI^XO+>$+!U25W,* ),E-179/B.]L&%4AT
M[-2J<9-MQB$<0Z[^ G16N.]Y LY0&-K5YCE9YXJ[W_'_2XKA!M0 (QCV+?IO
M1;C'LVCOWK50*EB3YL>QV8D&=C"B6P)IP%0G.KFOHZYK>/84+; ]+S(),<N%
M8Z5&HGR49+!1M+6=?TXJ&9T]NEBML9VNGH52IXS]6+58;$T=D4C&5&H52@!>
M XC 4&?!CMBP[:=SD+R]#&8Z IWU7?AW$0BWE<%@SR+%9803*DU?NT/]19;>
MU>:-< A.IO&4]U+>]GI/JBAL6+I+@W\!@^97?!A-8AY1"#7;=?HEE;Z%\6Z*
M6)JXA'XRPL*6^IQ[F;2 DPFX<('XMDR*7#27.J1W'3NBYBYPO*(\2HDH77]D
M%R=2Z'!IN&)]]A@<?@1BRE$\?;IZ8V$N2\MRTT<FCV<]+G^3X_(?J4*R6[3,
MV\XS K8ZX%)H@0,3"3C6(/XUW"1:.5PG%2))=Z5%)F3UJ\&MT+!6M(1!R>)+
MD5C*:[G$\AN_AM3"A9M6O3S??:;47CA&O=Q$&*.BPR#*F8ECF\UGF%8[71E;
MR&7(Z *'E< [WLFPB^RS(@"XFJJ 0F\E99(R/^/B/BN<F4Y7^H93^5/@07KJ
MD/!@NR<$H<K<99OGSYZD_"#A\H;XIB.:(+S!+ZQZ7I7AJG,$!"X#@D$ ?XU=
M-!V'!<EP"ZSUR:.^P<2$T_WC#Q-P!.%+5=O!?Y-@*1P=.64_"8Z"[56L*BX?
M;CK0@H$XQ<5-&(:/N1V/GKY:9;5O#R4;=6=%U.*K5H:()9*9GXQ^%H>^[:8(
M$+F0UM*56U'/+0&8R=U8V[XYJ\MR?S<W%I1L07&)%J P,]Q\M);DJZBY)!>I
M[\N4*:J-[,R9+1V7Q[)]R>;AW8='/#66K38.%VR29,.KD.;%0\%V2%S+;URP
M'J(-[%XZJD!S>I&S7\V+(S@78M0['A=CE#SRK9,%:2YX,RXO1SBT5$)B=5HL
MQI_@-3 [W_X@H56]><;.^VM;[YE'="30N(1?_>]A"13$YFB=-AX)(O"IM$7
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M\EH(3:FX=J^;8%[Y]M*J][YZLNN#?S^?JJ2SVCKGM'->MLXT*F!&9_BYZ*A
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MLMI1 @0[$8$L_9!.@1];)WG*B<QC6%Z2A=!Q,V<J["[8@QNG.AE?:'ET@X&
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M2>9Z$7FL*1G(BY!GR"_OY]'&"RD56?8R>8;%5*.H3DN&CI4QEY X]YP6($Q
ML&B[@R2[C$1($M6^*A#G)<EN2E+SD/\G[PH@$L12J$KC)/F<;VY 7C[0]A9[
MC01N#BJ;NMW)&:4%@_>8::\ZS(+B+?!<V8:Z#I% #G;]FO\9CADN J%]4O&]
M;+.8EX#J7[SBLLOOQ.Q.Z"2G)G]*3B,74DHQO2MWYQW_.@*Q1<B5'L'U_5.6
M$LXW7F'ICE>;?Q@\C/$O[[/\P;%0;GYL*R7U!H6"#"[V4#L.@L%BR#*VJBN'
M[<JKS51!]SUN*\CPE,$H+<9.O1Y_L"2&@AT>RH]&#R6LP5[\"\*]\&Q47?$
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M?$FQL&%:1U7L7 ']J%3K+0*705W!=\NV-N1J[G4/I0Z_\44GS/H(LSYN<?C
M*55"X<UBP[6>_2H..E DR&1/P<IM"=YHY9CK.ZAL0=@2RL8W%'YA%!"&) 5)
MO:ND<N<;)\=0F1X040R-K3QW"3M2^R&NDH, ?U")D@0 ^V$DPD%4@ZC>650E
M"TKZTDD>]2BA^'(M@0I04E5=TTCWMM:FCLK-]WZRC/@J/B@F>[HL>V#[A3+;
MQJIF#M@A$0YHYH!F#FCF$T,S+P*:.:"9 YHYH)D#FOGAT<S!J0]._6T@XH:U
M;(]Y2'SX58Y=D\E&)^^-%[]#O^*JP 8-BUE+1&(TI<.G(<C<>?,1G>Z:*"2C
M%P3CQ9E2A31!EQG.O+F >/;K$+D&(;]S.A#+587%JSMND-T8D^ <F 8D_APD
M*-*ZH9H=DGU\*A@-4AFD\G;YE W$PTU'+\I<VM559,B-L'6%V: (2&+0UI2M
MWO]F+;WIC7H/WR6.(I'A&^=4@A@',?X<,4[:+;4^?=#1AQ(E+DA7D*[[\T\/
MMV$1 F6KI1.$Z^E![H+<W6,%&9$+"7:0(4E2%]V+!8ZB)-^2;"_^3(5BCUJ+
M@Z*2N3$1@EK6/$2R(8X_!GK ZZVH=15[;2[8 >A2<36&7=6W^<8]I<I*D/H@
M]7>4>M,^A0WA(!F]K?H#@;I7$;6)[\1 3O52W[4'7DIUG539"M$2"$SN'Y+,
M9P4&ZW07FGZ T6!L\-O_TH6NX&R_]/!AWZM+VRO0"(+,0/_BZ(6D9U[]Z^7W
MAM,4B7'9%W,\8?E5;Z-S#S3H0]"($507YXI:7PF5;G&F2;E=B5X3YL*"L?(:
MYPW[@A!'Y_SXB(25#FH)5IKRG&>$TQ7HN;P!.Y<%MR/@'S./X=F?^K!1]$%L
M)AI._VIB&/8O(V'_I5')>..L3'G)O*D1:\.JG<H:$O]MI8I:0JW,/BQS<>+3
M&R;@XZ_<%KG!Y!U<LJR6TK;T^V+2S!P*D!18K^<+C42DL1M*(UM*FD0:R'#!
MJ5?D>DSLP:\(I+*LNCA9,K,;Y3<@$X &49$&-LW 2().'\!&<EJ3@,_,HGN!
M_2W(+7UE1]GOJD=P4C7&0[3]VZS=&@1VMC=[7ABQW9 "C^' XWKU9F.3UC7=
M(3S] X':@OW$W@'S6)]&Y)Z@C'UQ"#8B=$5:?&A+YVP;'*LD80@':SB097A%
M3OU#9F1-N^7>EY>P[B1A+S?H/5971W6Y;=H@R?R8Y&UMK\6LQ1V&%$S[H*O0
M-L3.W5PBSWY;NP'QG@C&G>8C%MW=STB_EL_4*00D*EJK#W#8$$'R1YMFE!!U
MCV4?@G1[RWRTU'CO&#*$_((H0PS/QO/5>Y\2..JX(CG;$3/F9#=QA4R\O[/<
MO2BK6%KQ#GPM+>&=$!5+W3)_M%56(_L+*]Z"@=I\S82^"T]LKVRZ3'1*7DV*
MY/;(',.?-$THK\ROO8?Z&@WGD8,0 .$AL/E\)BSL0ZBR#WQ@Q/7C@!S9\?&@
MK6@V5&/ZO59ZH_)UR"4%X;L/X1.)0Y*3RKB8N<J(=P6A-V"E::A-VH*91?7;
M-E=!]H+L?5'94^<XCJPA]Q'LNZ,;(O/\KY??QY\7FAE74-+Q(3D91/D!19F"
MX\QP43G.(L/TT(-P6F40E:1E @YH$?*3__P%9^):]YT];I>AP0X/#AX[&"[+
M].&%CJO*WQ0*(G="QT-MH\B?@=WI-MS\C/A2AAJ8*#/VB*Y<&RRF@NJ6\I">
MZI/(^="%O7$)-GZE3GE)%&)@"Y$YO+P,9I)<DAW,PC->*M./;]*)S 'H,$AN
MHDR]48;G!XFYF,_C@RT_4?"7FCC14#QDM=LNY@:16,M0@N "\^>.[C+C1K("
MU&X.:AVW@4;;:IP@EC!7 #,7*@D#.YR>>XR?<$9+I 30*>^@F6^#>5N<4V/W
M%RZZ;?,FN\BU&:C+2^X'G3NY#,3&EFV=7\'B5-L.0T+(+WS)_,+AF-Z.Y/BU
M(%H(2@S0+\^VL%.)^F22"PY%F7^PM!5(J82T/5U-;^B]C!78\UEV!FOB_,SE
M>$S3/*P3(P=?N4-\:$P3G4V95U::'(GE!"6UY\\;Y,%N%$6VW$R\RY"!4\M+
M*AS8 6\QT8=636QSS/Q L=-GJ5[#8RN<1DPZVBS_/:CHG;6ZF\9^('5[0DKV
MMTV6LSA;C?JNQ2R_2:9AL8%*;Z3M?&H'4K1KE7!"EV=($NY96/7\)!W6+FA0
M(M+5&'ZIJ*F8S)F.'CVY:&F^VXDPPX7FS-"<&9HS3ZPY<QF:,T-S9FC.#,V9
MH3DSC)JY9W(0-P':32'AB<89)P0DE#L4>M3D%!/#.E(F2IQ#+JZPSV%.KRBC
M\U;A:'>M+4>:Q)^8+U8RX 9A9A5/N[;Y"S<1NNN0?R)A<BSD>L!\R>'URF16
MO%FD$K'&\$7^)1$"=5<Q)%#NE :UB C<<0JE3<O5M8D(?TJI9"0F!#"D#EDO
MI=()YVR*Q$^",;,[B2_+0 !SV:U3'RG\=]3"=-9@K7 2QKHEZ!0I($O16F_H
M)-!Z8\C#_&[$:NQ-#3<?DT_(8'8\7;!_L;"<PF'FK]89O(<"&5 ?:2#*<1YE
M-\F)3CO.0Y*_7" &%OL%O&'SW<.[-P4>CR]S2]?>3&G4;<_V+/^&K1KY%;.@
M954*RUK!8M?ENC&GV].4>9G@%&WU,<*(&9:[O4A9%6\T,P7;OPDTE"B "9UI
M;L-7TQ_U]L)FK+$'T]H'1BKCM V\6:H_X-!MR>Y4](/99GQ Y/FOX.VX@'60
M8/U#I@DC3O !NKU+3I*8XD-;WEA_-!FL4R*#6GQ@LCQ: ^YF(Y.X_LL,>5'U
MD4NQ=B,LN9D?@O^-[5!ILR!,%599<G7<K*S@:0E6IZ(H,]4ZHRV92IB,%;X.
M/G&G+M"/7L*A1KQBY]<.UGUIB;7M$48%2B>4MHU62G*$]LZ44$7Z_([6\+Z)
M6^1O[6&:=]P 'FQ#RQE'%QHL/JDG'O/ F4JK*0X,<3OPU!T%U8_>R5]N<B=/
ML70ZF?#&>VJ%IQDXM>)&XQU5+2>H1QX$2'R@,Y$DQ+0O\CP^'/#!#-XT+P7U
M11<&ODNMD16^HXA.FQ1$RW:G;]SPZ+$/0JCO#8VWL@.)]MFC[S1"Y(LOZ_.=
M,O)I[F@C5O71Z81&2'9)%O<QXE8PKQ7%N.N\N)$ZGOU877DJ$04L/C(9TTQN
M\Z+&.[2!U-Z3'SA ?&KB+H_JGKG:85:5*YH@#ZM[')FRK46-*Z=1!I"NLX]"
MZL\GFQ[M HPG+C$_E2Z,O1?V&RDLNJ<_?''XB,RK3)1X%OX&</64JK%"'0ZW
M*M<\K^]&3U#K UKFP&**=:IUD94TQ1.+< 5Z5M:/W6TW\0N#<"$<H(*Y '*;
M@P4Q!_ZE8UFW+EM9=8X,3XLR3H?V@P#8" >/25I8]ZT68E8*;I0;!"1?LAU0
M12?RCWE>Q#HOX>3Z,W<+%@X1M1!F^"D#'4'LR?.;"F[@WF+1V9_+9$CT!6KQ
M:_]=W^YS;$:=U>".:3/RBP^-J4E'5QI'$6D<)8*!K L-^I$G.D8K:C^081\.
MEND_=K99H6E4%)]LXS<V&%#DRD!"4"SH.=TF\[7@\_9". \"7M---C'J*L63
MWF0NY6;GI)J4=&J<6+-X%O) SXZC)K8X #JK^0"(9[TKSV9&\,[($<(7[+]A
MO.>?^[M4%KI'E@ =IW/G9LN<%\]SQC5 "R<MIK99KS-$6CYK-UN6H!^=T8@K
M.TN:VF$Z%US!:Q<4FZ6MF>G"?:RCP6@4=Y;-4ENETI1HJ >R+<^QU"0ON!WX
MVG!]#"_) [7#9_C1X(C35%1_K(V?R%4?+]25Y<BB;D6DY: Y6%L<,,@<<ELS
M?O #Y4/7&3PX""Z_V45;(<$<^1"F#7HXGSB$3=I!DIC=A=5T [N,;%L@">DL
M.DXFI=*/7-B*+9CT-DR](/+@21;U0,G1A9L; 6EH=KA'%T;CTFD=W0JEH&GK
M)DMNN+3-AEI,<!NG'/')W9JJ5&;RF[MWAJ)0:% X)"2X^?0M^,>X'_WL!FJ5
ME7NA#YVY0A+850B289>'O2Y>"2N;<MY<_O);'!@4G:4@6PCTDH4R6JEVES"X
ME!T5YU01.FM;V35XQJW98%IVE8+ TJ#(G7/IIAK[^J8S",FS/NCI<'V@Q;0&
M*I@&%_(<W&*:>TF% GY"OF^!T]\%DF;4=G><\*YMW)E#+V:0G2S4@^<E]=#S
M.$E5\UA,Q5/@1!4D^U8^/J+7OI2=IL'!7"'!U)6?@0&7+3/CYKUAS6X*N^"G
MQ4MT8O,)]!M>!%OWS_-RA8QZ(%%;^;Z5(D%HOZW.%<B;D!/ L[R&!RRW<+Y>
MEKWN@*Q73L;AI;Z#-0##R*KQ3;$6F_$SFR'XEYUC#4?H!7Y(Z!/>_'QFV!.B
M2QS<;M6,4\)8CLIJS(NA$I/3Y\:U.6V 9SWQ!N/ Q;W!T >M%@\RM"?$:;"
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M2Z_*X[_>VK#)'O;Y?_[X#C6".7ZFLKVC-F.#BCL 7LCUN9A,9T#!+2KK5F0
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MM%)HWX1J1D2;_RDN31JE["O3G>DMS.512 D];*-&,GNX2/D:WH 7R?'U6 6
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M'1S\O6JU$U1A#\+(>M I<0?+0R\QGZWPC7>I?0]A]XQW<<QK$.">I81'?ZQ
MM^'Y6IW?L(M1OV=XG31->% _']<C:]7I;#6M5;":H)QQ( !%+(+?W-'N.!3/
M$,QA]O0CO*VATA.  Q+Y&[ABATH_ZR!RSVK468Q/0EER8U1SE5"CX2X;9*4N
M7:;+A_;5:+R878@:!$UK))HXG@18"W,K_)300Y'U:^@ZL!_OU3E!'U0*Z@5G
M(F#GLR;\/N=F#805#+F-92^(6K";;J,$FZ%V[L >33-+'6VYK<!L!3%VN2O
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MZ[]C@L1H/!CA9^E2JEJI0M>]MQ]S?66N B'SZ%/CNHZMUZ<9YH)U?S*'*ZQ
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MU0T9NG4]YI T) (%<O28YFRA_2ZS$B2:TB3JNABV,>1#B,H8NU('5WW;Z>#
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MU(?,*#EZ*FS599K *DN)[DO@THCA"+_[XX=W[W\X"=P/ E*XKE;P<*JF^51
MO?EZPIC*+<%FU,155QK390)5PI"A8-*(+-NZ^W0,\AK +&X4KCVO$2F]IL/$
ML,UGG6&;RWO,UJ>A?C820J@CK%YOPK/0W?9 7[@,XJ)].0^BZV+UK"<T&=-9
MD<'6>E)=CQF%P#=P,4)AZ*HXTT+*16E0:;&-X3GH_K8SV#4F39>7>JMN;#SK
M8G!%O8GKZ/'+_9<.Q11*VDZ/85;KGM8;37A1(?!0&.U^ 4&&GH?/54%?)0WG
M K%4N\YE34U_<([_""+5SQ[B4<$]CG)\EM-#LS* K"A#L>6[/[(S6U^]Q.P
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M(&?H+7!=9A,0%^<R))HM%6=!Q#0(GP>1$_FJ5BD3BU]7QQK\S_AZ.\QNQ9\
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M9QDLZ62%6TN*M*KAY%X2[Q=VW7L/9E.\M^<R23FE:PW?L55-2^P/*NEK*\F
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M*!N5,0KZGEBN-S40$6FOTI1%7"1#G-06SAH3(FD_HJ_</'3QLO)3%\1JQ$.
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MVZ7O//3UQ$L:!(G,=K:::]W*E'E&RXOO^(-<L=<GUY:2;_I/M9@-]7((D];
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M=X->R4^]%$R@0""9ROF18 $VA2)NXP"EKY":CH_9(,R68!7$9P$0"+.,!$&
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MA?M7VY,H>D#2 XKX.8=I6K5'\(AUEG@QC"U"1-];2N<8D*%RH*2(\R!!Z8?
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M-8]&C_8>CAF^L8&@)RB2-'I"DRBFHWO3 >E_OF*GYSPE@16]C("$(G#!,[\
MH@RH6K,##LB38LXU,68-"ENR:Q99E!G%?>P-]:U:-B7Z4R),CL*Z$H[5S/_X
M-^LY+;E'*[Z'\1-8F[?[/FS9G<IH>H*H1ZD>"C<:-<$V2T/!_3(0;,B :0GW
M^]D!\&5IU.\*?-G";/0&7Y;&."FZS,46P9"N,(&>-L3_/%0^^#W9"AN'F ZA
M%XOP##"RB#%ZA4CHXD!X$X2R.!\P;1)=>%BL-2!0V&51MG?GS-[=L[Y1V8QM
ML;C1$%RHOB',2JZR8CGQM3<V>2GOU:950!/3U1?[3A_495']'Y(GQ5W-Z%K
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M[[\F^ :(B3@9WO0]1"OF+(*EP,/LY0M]N/>*CCS>DT>Z*B)8)'Q0>R&]8TM
MWF"2#"9@=18OH88WND#TG[/87)&Y, J,7HG:8@5JVQ*(A.&*=.=]X!W_ $[@
M^G+5DI7$GH NPLQG$3T$7H8E<%WWK&FADI5A/VS4M!B+.26?7>5P;I=#ZM(L
M5$L&J2CL:H,$?I_+U0T9EJ+8O+MQX[\'YXTM3"7JE5$NS)%V@L$'YTT3D6R8
M-&M7#\'/GJ_PB0<^%BC:2;+"Z/\.8FT@/<#)HE2,I"4DB6$IHA@@2HG)PV0[
M*G%<D)\BZXZLX5FT\[\F49"M(_2$TEY[$FAY$C$[NW 0#DHGIG5.(+EN$>;4
MKA>$+V&P]:/?PWQ-RO; 8V,=;A8)M1CT<CF27NCV2AA\R]C^13)-U$F+GW.D
M3"[(>KZZ$D5T]WOD&3$",M&)ME;ON%?>&)RRR2LXO%<X+,B/_/P<C4$%$=E8
M6YD PRZ[5',>5Q#T_):,N$4T6L\W%Z$K67!/ #&!D3X8GLK[4\=607WD73D@
M7U%IF@J:$CNC<E,"0+A#<(#S2  PR^P;YEN:,H$<X3- A)3WQ*+\P=@R[L2-
MQBJ;Q0HXANB!(9$3*Y>ER.31F"VC7#3-J?=AA_QT_!+V6K#Y?D4^%!SY*4I\
M#,E34X$/UM>HBW*Q1E\^??E\F6TV /(XB(:-:7I U+N\O[TE0)9V7@N#\,)5
MZ4/FH12RAIG@17^H3464;(,N[*:N95?;?)LBAA'"P]GH61B 2^@JS)9^!%%F
MO2Q_6P3&7,S\3^^&/[8R2X%ZV8E'N_0X[@KO],03W9)W!.F8Q.]9S(+OG7@J
MV\I.O/_UZ<^?/GWV-G[JO0#E$^_73Y]./M'_YR\*?YNODQ0R DZ\'W\]^>7S
M?YS\^.-/_%<6H4Q<'84CWO.)U>9OVQAY/WXZ(2N'M/GQEY//F,C/GW]L1> "
MJXO$6_CC9T+D1]=EK;&YGM <WQ-6LL-U#LI%Y&M8L5U%?AC69-3'6N:LUX_O
MO=&E^-Q:SJR$Z/;E1HO=P0ZNES&1!<#">/F&EML\?$'SU2I<]K3V"F(>HV8/
M?"2,439?412W ?3J N7!%_8U2$R)$,02D/(\I*M#X"OB3X48%4AWH[]\J"%>
MRLJ<QR(3CVH@?0WR<E(F('.M1*(?>;..:_ <E#/N+.$< 5%O'GM%ZN+U@7%4
M2:$EDP3I72)FW.*,Z5[A-6 8PQ@9= @@<B\'RJRQ3B$I)32NO39_QO<*UFWB
M/>NC*"?\XIO'J=EYH_<>?G2P(R];_:US4%9S(#+L)HFY@>,B3-$R3](]PP++
M=7?*:A -!</]?106%='C>^#?I/Y-RO?^&&[K%/6R/5@IC6"%*ZXZ-F#3 6F[
M]K+]R^Q*3T?R.F27E\7 U8$XT=OU3NQ5R1UJ1J2=8WE&R-'XS=^1!;QX31;K
M9)OA(VOQBK?0#OZ USR@@PR ;NWOP*[WA;H.">*(E8-_/.ZB@C'2 T!4>KP/
MCW9"__9>."Y=\UTXIQW:L$2%%(D+W^]0@!'O3IH&T=>6SLB2"WTI$_8^0-*B
M]^OH;N$!F8OT?"DTQPT3)B7.9W$IW_,J2;5HTM2<V3?DFY95#^-**BAYEZ=Z
M*'#FMA@Y(MR&./BD4S',XDJZ+^1N>28H\7%]&O:DH.SK^A6A609C[_%2K O/
M][L(HRU #_5-LE4M[:*R"P]ZX8F2 >WNP)F5-=U*0%,Y-U'%.&9#L.0_&5D.
M41\1'#COBL$KS]/P<9N3_5T*B;6VYN_#ISA<A4NH"ZLF4H3]2WE+Q*4\"H^3
M]_YA$Y1C%$852([M\[.?[M2D$<'LN/9 @1A\ _5C5]LX(-&SU/;PL $\Z1S%
M&<G,NWS;A.E>IN:RU;# *0:34M&O2,^&GCW1-4BFZ'SD4&([$N$68$427K,D
MYK(DWH,@#/C5,5X7:2$-9@RC.0)(7A=H=&G41GX6,%@"  ]"O(@WS(]X%@Z3
M%.;D.NP'W&2.?Y4!S13H03$:*2FH&)!W&>.M224X^EDZF0CUCKT#DY[\>( L
MF1Q&<,M39 8NOB0Z\$0/ELO0C,:NL3B3D>?1,> K^2LW:._@%^FUH$EB.?'\
M%02^G$91\DHV [P06=%$P'87\226'@U#\AX-P/8A\=N05S8%4ND=BM&K'X'!
MM%<Z1)&L0JY[ D>(_^O 6.)N-Q/&*B--[,NNX,I:P9$]5&9-7D?NK;6/E2.!
M./9#8;.(!CD,%YHI,6#Z2-0MW6J#<ABU96[4!V'5FEVQ80_BC;MI:<(>UPXP
M&K=L,K4^"XVCPHZK=31N%2##,LLK/<MCQT\5Y>3G*X;MTS>$62TE#U8:3O@0
MF&%+\K"94(!E.2<;P@E^QK_:Y 1"MN1GZJ L:6 Q#I(YTPZJX6_<$W]H!LN[
M:KZJF%*L[J_>?&FUQLG7I:+:8QUHSZ=T:3E>ER/7/&8>''<-#L2,>)(!$QID
M@4/@H6H-L!C9:?#F5MRX^R)VJ/$+%RA.GL/8QTK\Z.4FQ^:,+;W]G/06D%AL
MR:&,R:*)3Q%U1_'C9K,E)A-1GG2#945:C;X@SI,80(VH#^,NS/XX0_%R_>RG
M?_2"HE/(>D#7$X2M%;W2^IL.,-!\$#X:?& 'P<.$(>:%98>59I&JY?8S63%Z
MGD30FI6J/R]1#1N','ZUEITPI4%!0I2^C+>>BNHC]\]^%)UM,\@0W_N50<N-
M$%(>I^7XT#6E8.R,7REO<=9<WN*L7-X"W#6 ( S_/EWQ"C(*$C4&__TNA:6$
MR<&;4B,QVX* S+F+,%MB/6V;]BY"1BIL%.2LAC8.Q(ER*?-$F?&C0XH$2>"C
M7Q (CR_#:TB&= HP8=<9B4H\,!2J\0?^<+\ )]0VW0U7CH93G*;FS%#\R&MK
M8J:(NGT:!W=@VHHN:9V7_J88( ?7D9THDP%88$NLBIU'.&%$#X(3I:1M+3LC
M/R*(L>\K?L;/XR+\=S"/&A &Y)R"M#6'U' \L57W+GA1*F8!0R026S!DP<>F
MJ[8)'F,P*W#+W0.@7<Z(Z2E\@;VF5UL!]S3#S:(MW/-$LV1UW_IL1SXP"EM'
MK"S"WLF*/WY\5#7Y0GT^\<1X6 TZC_M6;.5O.278J+U,S_:1Z5$)LVHW(UA>
M-!8#RXX4E@58/-F=1WV4K,=13RDJE3MJ<0FNDI0BVG*Q]:M^7+I8F/N!F7<H
ME-F* NB&K+]Q?7RC,BM;%R#6AC$)P44,)5AL(UK>VL9[<WRV#>ET2G#1G3SC
M)6%,;CS)3-83MOV*&QP?"+<$%;;DP5+": ;Q5G'7G1H7=$+5&$O%9QV660=#
M7M:V#*TT9' ,TD&?>!5OJCHEH^Y;\<; %U'RC"!7XG//([AXME":W@>@^L-G
MY_FHO"+9^ DQYT>O/.,Q <0*RB<;EL$VNN8.M541V<42;B4DR6<T=P5K0K<I
M>@ZWS]F,U&/NXY$2G7D?Y.Y^(/8QWB.K14C[//&D7@]<%MI@+;DK$$/ .H.W
M7$:J/I.,FW!\*2A M7=XB//X+$G3Y!4O\8R#.PV%*YP"_#-F\5'TX&U)5030
M> G'$>YM7*UO:%Z%VY7Q"'3!QE!0]D:WQ8_"F.J/-<^@F+>Q-RJDY^''$G[/
MO80!"LYV#_@&GQ6XRJ=+_(BC1:K[Q4SACNBSC'<%6L.'!QHD](.$(5WT:#%@
M:GPQ5//<569'#X7:V\7)]#<I;&PB1;.MGJD$WTVD73HN]7)5D>9G$?49/MJI
MO.&TU.2")8UR*XJ66!*=%)O<\\260ZOMG<0#C-]0>6[T&$ _3$EEE;,=@:\_
MC_PL.WT+]U;Q@8A'J&#Y8SKC1Y0.Q8&2NE^P,7*6W_DVR_'S<9A"VC>)Q^G9
MRE+L-WZN9QW:N-4D2LN#G\4![B\-_0BLJ7!T^U&_2O*"X%\*BH?&2^6I.05/
M(H1(+0HR?\S], ;E_/)M29!!KY)T6*SR:DD4C_<*=DO>+S&UEX(4[$6<6Q2+
MO$,+?DEL^MA<+M#S)DG]='?YKRU$Y/9%FBSKO8*^1SLHE] [&;DJ_;A\RIIJ
ME=-*/;U#938R<5A-QCHTUM3H4\X?8ORQ3"LYJ/-#&+,_CXYT+O(3?D_2/V8Q
M"0G8.\1?$,,O=DR.^(<HP1/O:YJ,'RX_##>*JQ$3^AC&'S>4U.AU+O(U F"+
M38K6 .#W@@IOR@V^(%8+_^T6+.3X(2UA["Z26[\O$AL-NDA@ "3=3XS ^P#Y
M?@#D B-Y9Q+@_C+"MM*MZOD[\<#VF:P\W/V)QP;@E7&.Z1BLO?!F\0:?&M?H
M!44_]E)X@:*H9TJ(GGB$K/>C-15Q0*[4:&!@8S:;66-$5=A*IBM:[YK_"!Z(
M_BY>EB=9,9**OIA::P/";6SF=6$@'D]:3@7#40'.]Y%[CZV5?KS?/F;X=L<G
MP25<1T-!<'.B'J5Z,%Q$!@;L!7:5%#I >2HPGK+>=2ZZOT=.2:'?P^>Y\]OD
M\!DOF57*^CPI;R)!PV738,.-+ 3#8XV4N9'@TS+KV&DC\UW%BIN^CDV=PGSZ
MXH<1@\N[]R-4I'<5Z>A<J>[E"Q?Z(ZC(VQCQ$'9K&1=328$K8^>S$Y+2*&70
MX=..=_P1KXV/T#5^!T-B"G]3,,1G,0H2ZX5'\5ZEI62&#2NR"1)0R G 4@R'
M2,JAL8[T7&%D#XRKJ)&A0^%$/MU4=JQ%=7&X=,;!0(#S8F%9!I/OQX461GYC
M9TD-Q(&NZ$%Y,BQM=RF>0EA="I2%_I$F)YZD$!2$#X0M;5PR@W*2HFG\W%L!
MER_0S8&PIEF+S=/6?E&>IDN%*3]=\F'A?VT8&6OQER7 LFWRCW19L<_AY)5,
M$[S\S748HQG^UTP(,ZEK1>3TEXD'7S^5/%Q*QU"[+YU@$O2Z68P'1-[*<@#V
M!5;UXB>:-J1CLMV7DS))DP5I#M]\U6CC/(T#GC(!;*AIA+((AJ3KQ"J@]8IH
M_37RZJ;F'U;&" 6?=0N@\2,G6*M63ZA6S=%QU^8[)QB$S.X;_QE1'$P=*VJ+
MZ7<D%B#$)Y)*F&"<@R< @Y(043.+I*C@!T5>9O&YOPGQ[88?NS=)#.D#//BW
MLC,'IC^]P(J<?]DP%I_FBS7ZYJ=_P"-_A>#0I9Y7WOX\R?*,1$549-2?Y*1B
MR=+\GWB X1*=;<,(;/;49RCS:6HS_7S"U0F+$E892R7/*C.D:S3IT NH1KQU
M\%V?W>*UX$?_-]R<)X&RPNI;.G%J7C!X^3OT@N)MK39G:.H$&_A.VCYO(WC_
M#&4JU(E@A&Z<$)_0SDE4)^3)2JK[-P*UACF.[X /. MQ WPYI/P_S_PLS!8F
M#6(PXH[L>ICG%)PV<&N2-]LYZ$/ISKS]:S]Q8P7HH*2EHF[:B6WXQ@G&>H9G
MU1V( Y&>_A[>._%-WMK;9YH%]Q7TRPN\Q,6/U2?CN/TYL>ZX(0"4:KP8]$\K
MI8D3P^Z; \D>"[#.ZW(@M>8O.UU/O]W.HW"U2M+@XB)YC;.JPFYLY,0*D=+U
MQ+_^-<1R3I?K'0E>A-R]6D6@]DLGF-1&U-,0#!UG-<V=8$<7JOJENO!:-'>"
MG;U/BGKS>V^J#APMLA%#RLDZ!T4MBA@@3JDT948-EM4CJ <Q)];)=1(_@?<;
M3 @+W)/9-*AOZ003IRGRYZL[Y$>7&;P<;E,(#\YWVO>IH:T3C(",%TS&W_R<
MO8AEK'9\/\?+<.-'L_COR$^OL$9MFJS.A-P009L2VM1Q$D#IK*LP6_H1L*"5
MP][4G!"&ZC@[]Z,(M/AK_/^9P?YD;N\$0[KYR+2.LW9?.,$47 (A!2X[C?'-
M&,- $=Y=*-/4N=#[Q[I0F/X.I=J;;,-3854)TO!BC:BN1P"%#3K\WI2<F/G[
MY1H%VP@QK^;9CJ!I&,U\-<V=8$<HM?761V)N?(B31_ TP.")#HQ_QCW@KXC2
M4[O<Q^AG<A\35B2"[3*?I_=XM/@177[BF=I,OYME[[Q:K'>12 KNPR:)9S&>
M+#^ZW3Y&X9*[_31:<3^"3FR&"[1)T9*N,OSO$47-C ,9S5)_!S=_-_V<WR7Q
M?V_3_-_?+@P'<[F!$W-R@YOXV9HBDU(_B(#L(\_+.EMTZX^=8/7R>1,E.X3(
M3C';(33-G!A^M;[K3A1B-1F_FKYQ@C$BZ'428;4D*Q*26NIYK3]V@U4$)2G_
MJI[@YJ58TWSRRWD1YJ!VS>(@? F#K5\QP!H;.3$31$\4173F*<$8,FXC4V,G
M6"'F0'B5FH:O-'!BR*7')WV@? OC\'G[+/ER6;R_U@W:B8(33$-0!GNG0$#@
M?+7 JRG#MR.H-48C8?-73C!7MI.DZ0X4@HJ-MTU[)Q@R^=GQ>QJ%3S%=6,N=
M-!M8^R'_16W4D(Y'PG+2,,.<R6'9=<$^%KIU0KP"@^@VP<^47>T=;VH[O<Y?
MF!^D1UC+TCA5PTT/8HY$*9T393/"]SUZ^V^D> N,C::?Q9LM:%3X?L=Z9+2;
MO\98T]H^9F$0^J!_52:JH;T3^ZMO7 ->;RL4PH(3-7?&")_0=#/]>CC=/FVS
M_"K9IHO79+%.MIF/S]A7//3=8ITB9'C?M_O,B=51S:\0^A2+Q*][]K?_V@EF
MI=.T*:3"T-0)-@:-7P-;P!5>DW+F&-.>!]WF'?N>?N_O%WXP4!2#$^NLNKMO
M4[3QPX"'XK.JQ%CO),HJ#;!N=TZTH>2$$)JBC.LB!=I^ZP2CPC9@?H&6FC@Q
M[.[1&/A:'B:L Q-R0@3T72C2MQLN;%U31QX-+$V)#&^>DKI$\;(^I:G4UHGY
MD "SY%<WN?T4G\+M-L7W08; ]6XT:7<EY(0(FDZ^&_Q<Q0IQ](*^)7&^UL?K
M=J3A!.-%"@9)&B31)EL\<W-1D?$,K9*4V7(6_AO*+M_P'DS2 +.;[HBS#+QI
M^$O<9T3J0U+MR+R?1^G."7%J[>W&&!!SZ^G52649XXL%A%XU:C<TG9X-4>-R
MD=RA %%%GAQ($/@9(/0,XB:'4O59W/Y;)Q8?/VL6R>GR7]LP1?=04!-T!*E\
MIVX=MOK0"18K;N'Z..6:YM,O3;)MYH]1^$1//@AF2@-B,"W5#=&&,NQ+8W+_
MZS?_?_!SDE40RG3.UVH+-Q8?&U%E59G]X V?3+\(;_%#/H:HJ].GIY0@8O'#
M@"5C9\0R @]=;BG[%N*_YDFL,1[THN: ,)1P!78MFZ)5ZQI/STI1QEUQRO!A
M5KAI:._$_I,2XH1^+:K?:37RN@_<8*GAS7 *:*A]3#8* 2=8%C[1.__U&SXA
MH&29P0BG:>@$"[?"Q$*" 62,FSKU2M/<"79HL-95M]@N;?/ISSUN%2L#-U4U
M)T/#R4U+Y\D+2G4*7^7'Z:7-*ZP;KDCU9S?6NEKUXKHVP]70U@E&+OT4T *S
M6Y1R!U:XU'&A;>@$"[IT+NI=7R27;UB3U'HZF[]R@CDQ0.8JJ@U'-S9V@A59
MQQ ^!7ZI-2DEE0^<8.DTBI(EX%+I_<-L&K0^I59?.L&D/ TEB \96!0?#$M#
MK&HW"DXP+;O%FMQF3@SX#M&BL/R<ED#3+M J7(9:-IJ_<H(YCB%J>J')OSLQ
MX+YA85(941IL-VA0BJF3Z37!PAZNA(!R1%5V7%;M#BV_<V-M;#>;B,R/'P&\
MYE64O%[2/]3>[FV^<X)!:BAFF0=U'&D;.L&"M(I81!]=0,9H9+W;H",1)U@O
M?#7@Y3"=N-56+AP>*O*R[%Z3YD))&&9'(8G.@XKJ#'U99'3.4Y'0>;K,PQ>=
M#<!2OTZLCAN4PSA)X$F @K/=0P;#%R\/-MA2U'CWKZ=?33R1A$08D/#%;!8+
M4W Y"]UH$=^/C!-SO;=^0?-0B^RFC$0W+C#WU:CWTGN@'L?2K9%-[@)EV \
M\,+0'[*J$[NVH1/KK"6^\P 0T4YE@.DL4/"D!,]9;*[NTOB5$\RIZ8VU]E%#
M4R?8$,ZCKRE>/K7N)=+"B4%S_#EX%>=XR\.AMV'HY]K7<TU[)QAJ!;G& \M-
M<<X=:4RO@,A6,RDV9T:CXH**IM'0WHF9;*\ UL*N=*;B!/-%?FM7</X"C;\>
M"V3(#J;? *7@2*:AF<"%:AH[,?O2X^_63^<I">&G0>W<I]9@1#!]-OU,D<I_
MY."I)D-I&S@Q(^72*JPDDT%)T;=U@I$2$+8*)J$K@J#CL#.1Z9==A\AJ=AY4
M%F9W$D[,N$AEPFH_,P77VXYKVD_^C"5565"Z\;$.JO/RF-HX,1.G<1X&8;3%
M&H=4<:B^)%[3-TXPIAJF;F#3&^TQIK9.,'*/2(+/5Q1C]3 "V,3@.8S#C(11
MOR >*U$7J=:!P/2GHIRX?Y40I%M6B8/!*'';<QS\QHS-^*C#W(3+G,W@0QRR
M.GO5$W-8\M.+ZW*U0O!>4-+QY_%9DJ;)*_C$>?A911*MOW1C&_ K@-WO";[N
M8^([-+AX:C^8/+Y128=E_P#;D5(LMK;A]$M/]@<QG-I*]&]M0S<6EAK?6.<U
M-#1U@PWQ>-9?SY=ORV@+.5$DX_1Y@Y5AZNPK1T:V?*(/U8L3PH,-A55+K &$
M^96_)$:U;_X;0)J(X_#<W^!?]"4TNGSO!,,/L4_!ER%0JHC&KXGXJ__""::D
M-,U9#(/$=_@W4HX7'D&LRE)153,.SE$*\6.+U(<@(OJT;XE;.U9?3@AR//_D
M34+DAH(1PL*Z=CZY#G"*1QG 2*\B_ZE\[RL_3G_7W[U%?F2R71:_.;%\#5X2
M?>Y^ZX\<F(-*H Y]A!@#=OC/TA];1/]T)^K$K(.'+$GW\4?7?^4$<Q**,*E'
M66=R-[5U@A'#-F-!E)*=C\6/^=%MDH4TIR"'> B\'*]#/:S*4+2=$)0$*]<"
M8M?<V@EF;E!>1+$87*)% R>&3!WNUQ3_+ENF(4VN,H'8U#1W@AT#*!4]S&6[
M%[>&Z>%B.U-Q@_E]54K96#@*C*ZN@\,66;6N\G@9()5.G! =Q,?CYFO\Z+N
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MS\;[+1X]O)1I=><$S.9A; BG:_NM$XSBT67H7UO0;5Z8K=,\Y<;&TQ]B+5/
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MN)GX(HRVX)-MD_/>D803;-^'3S'!O8OS:M7I>L]3JR^G7]A%),X-9!*LMG%
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MS,>=TF3DI:S?Z+5-IWOU2*5X32\;N<F41^KV>1N!G:L->J'YE.U$93)V[Q#
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M9)QGN&X.N]&8,"([PRKLUR0)2*XZ2E_")<KND\@<4V[\P+F'PU62XEF(*?K
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MG-#5^LZ!6?N97JWU [25C_]TYGS7\L'Z*!K-)BMLB_F^!U&,M^(NA9^#N,6
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MJQUPRZ4/!/"Y>[Q(2.P=P$22\5SQXLO4]1,P1Z"=,S!".?[L;C@0KN>*BX*
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MWF/CLM">4)<6OJ$N"WF=-]]?EPFA45ZLYUHU$M3I^(88Y=V"1_]EX3T9][[
MDV%9.S+!"1![56B-C!94H[<5]TN]1^<3 8SK&6SWY&!]"H[H/TDU$Z1OX07Q
M',HE.MISV'K<\IVSFM_M^2'BLU?AQ\69TM!>$G& P]__V>7'7*1Y/>R[)?H>
M0])*5U>\9%$8!?"TA;=_%.1:S ]I6*8 !$ RS[O4*/:6VTROQ7PX#NCL]FXM
M86 =DUG'@_V @%8))I(Z *G>Z+8[@"2+WI'8@:Y7@.LPL<OG;,+_+<H$E9]
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M([">;7>!D'"I:>C^72'T]V4<-29#8F)H A^?*8CGCU]A]5\K5@RW_PJ@?ZP
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M30&^((X*5Z[L0A:XRE@3@:S]WMALVA/ CDMHM[;[.[2"(/X7"%@I+B\>U@=
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M44A?!;N#Y;VX5MX+>@\7]H(H78(3PFQN>1]NE/>!WL,1OD4PS39%?D 2\I^
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M+LV5QTRW:$G]AAM>K0)?8,VN@<L(;]+F)J@48C#:SV[FD:!"?SN,\BA/-Q/
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MH':U>!P35IW5)W2*O P_F3)(@9';7HPS?7:*G<W.NDT("O.E=G/$1X$SU4<
M=T"R_IC$,&XN>$A+/X]9,&T8)QQH1N^OXB N+E9^;Q4'<4,(8#\OJW+<6;LX
MJ#)RMIPD<Y86!Z7X)I<&E'I>9PWHN*-,I]Y9.S!<<HA5K\/% :EVA%4OW.G@
MG%:E?$+_\^VL5UZGQV.4$^4;J8S7:8*Y'$AVN/A&&$;E.GVOA'W.T/#YD,(<
M[_ ->,EY^66Y7>QEV^O,!7V(DUJ6WM:=J7/3R;):6PQLR'/L8GN-SGJ4<],9
M4IO:FWB:99UC_2!*?LON8!']UR"^ X.R@L/?+2:.93+2,[<5V++4QK!8NSC!
M&6Y*^N97S:4V=4-XE;D4.MF/Z+S7A* ?.R!Q25TY7'Q,YNIT&B%V!BWZ+;(,
M75%X#W6!:AC^(M 9=7MT3A^7F\W^""KR<AXQSEJ/'GD:J1?^7#7D\X'[7+QD
MX(\"C7G[COYG1@IQ0,Y*GNY^_Q0<T7\^PR#)$&L1E?F0Z*CY+?._BP2@O_[U
M(0N>P%OI)T!5OT2M[6F^72H2Z5_,YA8K,%1((AZ V2ICXH-FKB N,I0P6KLT
M??ZA9+:WIPW'0995C(([=TI#JRI\FI"I"&J_]-NY0BK\,AO4ME:G'H51 $^M
M2T5P3.GM74&?:T^F-75EXB(?*V9SS7?])C]N]TA:1%(I^XH?-K)8**W,&_X8
M1.$GP$*OW\K:=&LOR[L4<FRI_5;VB+3.3-Z^(W@,@MG>WA):XG*!:14KJ$@Y
MR^ZSK #A?=(2GR4D;N$0]D@+ICL PNP.:9EX8OBIE=2HK"]*%K$)^[FA+\LK
M3(WW T]Q681-2Z3W=$M9]%6,)4+$-:^SE8*Y6_?8RD2W6-% >C<!S#N +ZGS
M5,0IXD'7&!9SW+@J1P<H"98_]Y/'4W $S&DAKZ,"18H'TD*>9M0E)XH:N(A'
M&16!::!Z+A$A+C]B,'H3.#EUWA2(:& 06$2N+J%=H2-54F3/&J6_S)=IRYXS
M-I0F2,EAB+CG3,T,9"(5F0=:BZ1L^3#PU- *E*\D)F& FRY]F*2_1@CV41+U
MO#5Z'A(C?3A(E,.9.Z5HK"0#V+$J2^,HQ'DEKH(8@_3Y $">?4F"(HQRFRX9
M31U.D7_ L*%]$SWWZ:O;R-ID25UAT5-7KY'ER5:^5E)S[K>U]XP>9+@D,?X_
MMW\4T3NZ_+!FG%\'$)Z03O=;$#.+><CUM>CYWJ0LD=L:3@=[I+4CP8,XZ0H^
MD'P'?D9C%W8 T0FYV0YIC"ZV#--+?I+?#WYWBRQ5<4DN+J(E=W!/>[^9_>BT
M^^0=9*4C-@MO6E.;AQDB%:)+U]O\ &#K3^RS+=%7LX_'0YJ\8O2^(HX>8"&&
M7FR&W];B.W<E'0MIF];2YO/\&X#YZ1&)O#G:9,PGWC#ELKU6N%U<C++C\!A6
M#^M7\!/8 23DH(L5H2IW$5.[Z,X?)7$VM9U)%I_HI8C[E"8[*D"BUO8VN0D7
MP$;Z^^0Z>(MRK&+3]Y?1VI'\4T]8X][NOV2 :!N,1?#[6/33P_:3%)YX3GJM
M)H9)F7[0N4TMAH^75S#'[[_3Q"9++8Y%C"T[1(1!?/\-@@-(LN@=W">[] AP
MT!/:WNW^.?C!YK)*HUB,R4 R?K1#\\2Z,I,Y"IL[J\B-5."LBH9OB'/?_GC#
MIL9:DN[89MBBHK"G"_LD"O5WB&N=YT*P?#X$"693><6FA.=%80"++" /H@2$
MMP'$R8NR%N^Z ?MH%[&9@;"C/:GC3/K"3:*W=<-D*V.J=>)\B ^ 2[8P:1N8
M;3+@[C]M<N?',.KKXMEM!4\LS/\/#E$&X?_[MQP2$T3U1Z3>@A_Y;4S>6_[?
MOV7@]=@BQO[C9/.@%R7Y3V%T;-XF@[A14QB^$P_<]^[>LQ#GO7$T$O\Q0&(?
MQ!E07FI(G#K^_=B)-QJSZ/[SDN>+YCY =3QDY)Y[/(=#_/+3H07&$\M\0)!Z
M?.GFD& #Z#DL:D ,WT8\7S[]77W(&B?9]N$%:?E:D#\SGL,A?6'0W]H\7[WR
M_2#S:C<?3*2O"\$;H>>(J-T4U,=&SQ$07Q;\MTH3R__%M3N#^\KI.0+2UP3_
MC=1S%.2N"\9C['S6KG@M<)Z$/<=$[6)@OBQ[CH+X<A \2IM8_U]=NQVFUB$F
M!$#Z<NB^Z'N^:H7+@.E*,!\(U"U+'1<%SX%0O A4G1X\1T=\0;#](DPL_3]=
MNQO$7A6>PR!]0TBY8W@.AIK1::IKPPX ESQ("'U$/(=)#1@9OQ+/ 9%0-.A^
M*";6_3<'N><$?'+"96MB$][CH+;RJ:2'R>E?3/BR"ZT"W;N![#Z$N3^2Y ,'
MD$<[M"+KX>,#F7:->=<<^; )_[?@QS52FZX)Y-6BTQ"&,(^PRX]T+GE.%_LT
M[F_JY0L(Z!OBV$$16_3/?0;'MQ0&\%3>NXA;;R'!."2OP(\ DOQ!C!7)]G;A
MG'3?N&6/"K67*[M5IG;:%/D!21!_GB]W_BX->FD.0OL,(!)A/XCX$K^M6Q"7
MV;-4X*UZ&('VJP*TE+9N0;LM\BP/DA#I_RKXMKNYD'Q"D7'*]'1A69(<AM?#
MG65P3S&KM3O3%Y\4;A=',EDH'A3)SHXL[E.*9BB?JZ/5W)$%2)YW02>G%L,]
M]9P.3BU"?/9%O=9 ,)\B'>063;>Y>+YTV1H</ .(TQ!$1^PUD2;_'G96ISEU
MM"<05/8/$Q@TQA6GL3B@D>&N> '_WJ B0&-,CFS/??GEV*&T+<MS-)0Y)-WT
MY;D+[RB:&,JWGJ/ IP6!/<YS'[T+**!6"CQ'0'KW:29#SSUK+MC]CC;EN:.!
M?)R7T%)I HF_.XS$-)?!?SF/@$EF^ _G5V^<&?SJ&@2R!EDC8K)S1A2V!=?(
M^IW3FD0&8",H.*<G\"S'1A!P3DX6FIW]<%3D^R@VOR*IN8KP1+^2T'=J/--:
MK6?^GHM/X!TD!<#UK' "!.RO^S7*#]=%EB,J@+<_=G&!3P!VV$7_+V3G]!TS
MDMW\EX(POL<4$D:6YS!Z*7*\3\]IZ=$KJ!6B:W3GX-F\!U&,I[I/81;$X#/8
M%;!T^&\>8206J B;KJ_:S_%>A<F)JF.QV]MC:B!&P[U^  F:6HSNC$UX1+<8
MGE:.-JJ:*(O9R77VT8G5YHX0RZ:"9R>OA_W;TE\?Z$]( JM/;,FQZG!8_C$7
M][,8T%#6O>:?ZWXK:].M8RAK]5T /+.Y,PNX"K)H)SG[LJVUJ7\%6"L!X>8=
MD?(KZ%;>;>E0@CU1'L;Y!?/V4&T,BVZ8&1*K/J1I2"(Z 7R/=B#[G,9L1U)F
M!^>$V;L4HEU(RNC;W:E5'!I-G?PK+LL0&Q1MS<S!9KD4$, =3E1]@]3!."49
M!?F7"+^/YAB")Q "< PD(L>$S:W?S76RC9*2!%=TK[$S%]U-%!<YTT.5U=HU
MWE_-2]9=5744:\O] -,L>X3IGEGDI-W".0XO:6\Q8\5QR-P@:V:P2&A(E<XP
ML(CPD]L?>%)%E!WP38#.!;LHFKB?/:T0Y&=Z:4Q8SVGK)JFR/O!YH/HX]@GO
M/&$1Z;5:6KQ0ZSG4QNLH*=#<SF\D5]CT6!U_=.I!AD@-!BE$W#F )_+>@-/7
M8+-W2DQ=];7+O)7-?=$RC&BR%3NY @E@7QRLUFZ<5YFS:#4ZKG\I"0HN\GJL
MP3'.^,-K>\\>]:SG.3*:W_0&:<I,OH?Y#KWH@:MS("6?DCS'1"Y0@?N*XS0"
M:R27!!%(/PUU(QM[CR\N@^!O"->$9"!ZGVJCP'@*\AR!L:]$;604'UX\#W23
M]>AFO]!X#H %><[0DY#O&Z$BW0F>@#R'0B+FC/O$Y/GR+Q)G^N]5GF-QR9W>
M6'P]Q\#@K<Y^4O,\:%GN7N^\O'F^8@L7N?3+G^_0JES-E'=!SY<_ZCZ2>&OT
M'!:5JVG$,Z7G>0/D&##G9"TB=P#U+7<1Z0(DF,HBD@48?19?1+(!YHOX(I(-
M]![4%Y%=0)NHNXST UQ'AF5D(&#+:LO(/:!N0IA;*/ZP -0:>#__P/M>;J[K
M ,(3)O-C6J![0-Y+67T<^_M3314Q_S3!9T FW)/:QUX80W<VW*!A>EM_IVZ_
M;H]\U2=G@G9LA)C/. ;*?M0X ]P>._Z4YN )[$#TC@',6@A2,_./&L+:)FS"
M,"H%K\<@"N^3Z^ MRH.8>R3Y?31O!H8N.V-WET(J,9<XLD_ F&%<D2NLUQF2
MWIJ+-D3W-@A9)_G4EN@=F0SOI+2WR#S["@=2O4M_<*IM0BFT1=/@]IC:N0PW
MRYC#9W#2_2U&:9^YUY@*@?+]79 0_:X?U:\2+]@8:F/==?A:^2$1ZWT^@-L?
M .ZB#%1R5<7F-DGX&SK*^,5@_X3^ T:[O"*/+TF$-#BBHM+8IN8O.+K^<AR3
MZZ^^8&3])1,@\[L]OL7I">"'#AQD]$_$_#'UB?97>H2)YW^HOCYFYDU?S7,F
M27EKJ^BXJ:L.85<\*8G_IH!8;@ P2LO\S&WJK\\$*W!:?1S7EESNE88U\P:R
MJ#XV=;N>4X9>2";^$A#K^1&_H9*'YR> !,LLRD'E[UXN$BD$Z6MIS>=5(33^
M6?/7375BRPSF!=P=T$P?XR!1NE$%@[AY%IBS9AM^QHWFVO():7T"W\DOBHOM
M]75M:>5>C%Q;O[/FPX='#9(=NC?;%@:DPJ(3]#& O^/':J3VX N3/%S7[7%8
M#D< TC&L2RNE%;'5->H4ZT0LT<1"%8=U[6 2OL'DD2-X$'LLB_5FTQT (7%Q
M^QS$:/]ZQD7&,L7]---M:6K!X;6#3R$YYAF"("O@J66^H%&I^B#:5]'B K<_
M$ $DK\1^BX]"7 ;7#:=&7\JHD9Q8#_MBN&@\>Q1W(:WIGOG96M*U2GX-( R0
MW$\8<$G@1.4%,5&$JUZ/$,GVM!7I&-:]E;*YA;[!+=J!ST18OOF2HU+9K4'X
M,],8+.KGSI)*C-67-.CGFOS1GF Y[]9[PSG5SAB%03RH:V 0 4HS%I)C:N99
MF]T. GR1/:?8#'E\:TPGV(I->S"E,:<1H]A;QX4+<"^SZEH(QDHJ<ARZ2.+T
M8)2A4]P^RX($@%-\6;?\283?^T3)_88JB8X:2+OKR Z[GD7[:%=)\=4K\YXZ
MB>>T_KGU1[J+B89Q'5SK?<(63+6.;WSMU#E5=U(GSI9SVVD8U>_$JFM&4F=3
M>XVJ12X3[^ T+FKI#WD1#YUH,+ISOB=(5'$!!J%H8@_<AD0B10,O"H-1LMN+
MM*!^YM!:LZ(ZG1"4SC,\3Y[%OS?'19-X#HDT5Q2$GG@.@P2''!7:XC(L_N81
M=BZD7AP"Y#D,0C:A&F+D.1Y*$A4M<FD1&;UTA3UY#I;\'2L?">4Y)'*E&A3"
MIA:1(8X?8^4Y!-*GA!6@->M4>4;BP&:=5,](Y-BLD^B-BC6;=6(]Q>BU62?<
M&Q<5MXRL>B,"Z):1:V],F-TRLO"9C\4S@J,S.N;82#TCJ#BG*8P.Z3,"CS-2
MM&+(GQ$PG!&058,$C:#AEO"K)?C0"$YNB<0Z0A>-P.26M*PE\M&(I=PK"9H3
M$&D$'.>D:(F022- .",TCXW'-(**6R+PV/A.(] X(P=K"!4U I SDK!ZO*D1
M/)P1AO5%L1K!R2TQ66,,K!&TG!&6%8)BC0#AC#BL$$IKY&7;%WE7.@#7"$K.
M";X71N8: <DMH7A,:*\16-R2BI4BA8W@X8PH/%E@L1$8G1&8)PTH-@*E6[+V
MR%AC(\BX)5WKB5LV I0S@K6!H&<C@#DC@&N+E#;B9>B<>#ZJDJ;1 GADS1G8
M_>4U??\)[,*RYMU]$D;O45@@M+9)?-)2O:[]D3+8?!>>8\S1/[YMXKCU86J"
M?&8SS<'__XUNU]-U"F-P8A<%&3;2G8(@3?ZG@/F?'V\XE4GZ;72GV8Q/P8<T
M#K-##%X!9$^$WE!WFC08[;Z"*$%#O[*G0FFEFSZ*. )H^R'XSJD:0VEE/:J3
MP\M$9[!A^)33X7)$FHXE#X^BIZ%&TBMF''Q/(T2DETWC,)Z&0,B?9PHW<T V
M@>+BO$_H?[[=1!G&L(!@"U^#)/HSJ/3CJR"+,O*:D"')K/QKXQ)YG^Q3>"1_
MO,&A'W%FKTAO\9*!/PH<'_\N4ZJ7U=Q>JL/NC+AE>VE-[4V<N#T05>13<$3_
MV3*P<*M[2G2TMJC[QRVWNM3Y=]VU *N:WU\/:1R?MM\3$.+MCL(H@,.<EE)=
M](*8P;P%(/K7&3STCV]/V'9$A:[_ZZ33^AC\B([%D3FQ[N_3(T8IU]K]S<U-
MM%_^N*'T4XN=\(K?,MO/D8%>O#_,.CP@WC^!URC+(;G^&]L-6Y,3]K&7E*]B
MH$_@+87DZ>1SF0R/F:&/W<$)*JJFUX[!N$]:Q"%!3\(A7%AHF]X1+8F7U>_@
M0DW.QP!N(3D+Y>OY(X"TRBHJ/74G=VX$_IHLJDFTB(-VXJ7ZN4!'UVF"+@4
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MM-\NQV.:*-\GHDY.T<Q?E6GFK[:7<9_D ((LOP(!9GX5"?#%$7X?W9F!0 C
M$?-A#?+)^,&<<.0:Z;<EZZ;EAQN1D<>#3MR3/I.[YX_8:I;U-H8BL[7+P$@_
MZ&I_FZ%2H<!6[C*2DA%E2J\"5(SD[-">0,6-()L&*T]\Z53)BVVYIR)ESICK
M":J2E.@(K)X0K4029UF3=R=ZCVU4]AP.TQ:B-HHLL^Q<(#3]/M4X[BHK:W-!
M6.5)G,H>:1;IN8!C2F63X)A.0Z@JR-"-_1PE5B/3] 1(2=G%'I)^9&5P3AGN
M;YC+X#DFW#!>B.:"X&2R3?]A:RX ZA1=?ID;.*9$%UD;J\MI:)R[)&@6"9<!
M=.VBX#TDSP7'"55AX<OW7##5>8/\U20X?YWGP16\YL\%R<F.[@7.!R:P_L]Y
M4JW8Q<&/*$]!@*>;V>:*ERP*HP"><,J_[9[0]$!@[:=LXW=R(?M<,\,MO/VC
M(.<R/Z1A&8 ,N+4'54>QM]PS^+C"YW9/DH8B;0'3%<\)5J*C/8>TQRW?^:SY
MW9Z?)69G%7Y<G"D-[1$+P!5D_MF]O+A(\WK86P:-]7 \WMGM[2TA1WH5OA':
MY,%; K.]O0BF<P+=;7X $!>;AN" 5?]W) >@.Q+@++KLC+*;\'^+,A'$)Y C
M_L,L8&#B2]9@,XR5_P QI6Q2M3R[S[("A%_>TJ1LV#8T#2(<U$?2[+E<:0;9
M<_I8(/4WR-A*1&\1RMV]=>:5$S\9N0'E9#RGWRLE$J5)"WD=0\!9BO)\_6QA
MJT,5/.G&:02DGOZ%4D\'"PF*<1F2,0FU5-2]#E9L8%V&2))J1()FQ^9/.6=.
M0R#!.I4O%R-RK<LOH).>-38YN@R1$4)SF[HF?#I2AVZ4CN#YRX<\2NJ:AQ^V
M]5X&Q=H%QTF;.G[#.!=A$AG36:VMUJ0\3XAG*:>UM)<I+TU>ZS2Y.+LHUS++
M:+S8# B;[P$,;]#]S+%#=MO8GRIW@_NM_)JN_6PB+KXM,4[9)C]N]^A*BY)7
M]D$;-M(]B^(5R69W:0&?OZ?/A[3(@B1\_H[XXND9=:07_%'IZ<A]<!?LP.:8
M%@DK\1JSN?T'EU)=P6)WFI 7>8E'%VH?:TOIS89[$NEMK;[<@3\*#.F[N*P:
MJ[5+T^?S069[_Y=@_WIJ^50*$UUUVZVEWJ8J]3;'LFI]O8'#P:A-73G[?,</
M:MO5Y<.J;GHQSV7)K4=BEQ&KJO2&NF?3V'.N4@C3[S@&A"9L"AK/L 8A ["/
M0:DD#%4'] ?AGBKTMGIVZEHY-R#;P8B8)SF'A]9:,^R?P'=B?L3%V8EU_K1Y
M13@>6:Q5LI,]'MNN2"1&F=E<>UG8,I[A"2ECVZ0YY5E-FS24A7WLI8R,DB#9
MH;D\@1V(B,_\ER0X(BAQZ7D\MSL KM.,I5G+][>VQ"?P%IR(MSN.&WMAK630
MS)Y"'<#XU$P'"0L@B5+(F3JG@_4DGH]!%'X"K)GW6UF;[F.U]W<I1 3+$N/Z
MK>Q-%Z8[ ,+L#J:$@6QA](I.(N9WV<^LR7/[6+Q+@R0[<X\6Y\9UPF"$_XCY
M)HGM8=ZP*F-8+)R4(-G_&@(D(]X%NS(VJ]1KFSOA.GA#O^0GUDI5AG!JH5^2
M(@-A/3=L!(F(VP Z2(\ [M!_!:_LXE%CQW/$0EU7BL7/*5(VZDX'1Q9Q'<0Q
MGL\#CL&6,[7WNF@6Q7IF?<3,XHI#(R)X&D(MV<D1N*M981E1[IV^T\$HU-=Q
MFF%&,Y0+!8W=N# 1-\EJ=B)S67;:.[$$[%&$Y&[,%,_69(FET/MIII7;_1[L
M<N(_IJXJR7<V0.$8HNL@.SP!'$ \$ /9[;P-=A#X!;6=W*@^.)Z[X_*-H)-F
M5YK6#YOJ7--Q.^[[B'BR9EZ./=5%SR9[KUK #LN#Q7,0&%Y/YQ5+>LMX#L-H
MCM_VLG$: [5 %)X#3AL,AIO+#)#@.\'T0Y,8WAJ>X,"['G0 ,9LK@^O5U<_@
MV7-[\73I#.\8O%B*AXK3B^0>?*I/2[W*#@ NKU$Z3(P3.]!)>DEUHW$9 <D@
M':Y['8>I^4 $:ZCR2$AX3F.\4^$9 KSK_C((_$B5KL\$PO#)\GSQ$LJ0R ?,
M4P1$PD[7@<SE1>H6!)AJ@.=AS9('7<5[SW-$%$PA3(\_ER'0?3)Z]E// ]@E
MSX.$6Z7G0"@< [9/ILL8F+@A)LS0,V&*95EY2/RRZS(0VNF!;TLV <7?G**)
M$=[$+H.BBSYZAC832_Z[DW0P=+DVL?;_<G+M/.]M$RC\PTD4!N[?)I;^JY-+
M'[B2&U&>W7PQ%OBE&T'"+7/12+=V(\@XJDHK><$; <9-Y8H&C*37O!&4W-([
M9!SKC<#@IJC-=\TW H1;LJ9L!( 1*-P4/7GQ T9@<$OV% 4J&(' 41F4'>Y@
MQ&#MOC3*B)@P@H9;$JEJ3(812-P213D!'UZFGN64\W0R&VV5;;N:ZQ8^X?4.
M=HI>N8K5R7;IK>Z\>"EJ.1W<6@0GH1&[O5M+D*F%1NTQCV4XD!7/Q\)TG]+D
M/<V)X"B7TX_3P5 %IS*G?#N;.BL.5+J;_62HUJK/,< N2_A\%5$!OZVQ=&2(
MZ)[ ODA"?'54VAXN,G"+A8N,6!IO?[Q%,*!D3;IH*-THXR()-4%*Y*SBMG<A
M_>=C +>0$&E(*NX^ DCFS.)\$CV-$/8'!<*FM-4=-OX#P%V4@4<8836MYEBT
M*;&:ZIY1AI2.[_],X_ EV/V.CX#\#"6[FCA*!_15 )_ &]+SL($8JWVC%G'!
M:)K7]9@B/I1'0;QY1>?]%9V/UBL;=L+)KA O"#=)N'T#F$LEKQ\C]-<\3>A1
M_)<-..7JGL KKOZ4PM,%*Z(.HGD5'Y#(MDW.UP2?MCBMO4VF(*?64BJ<475'
M3T(L.$$F0J52",6,PDUT@>%'A*FT"Y78>B+$91:1>G(U17F*Z3P D&">\GJP
MTY"L]3+'4@7#4Y^MK<\B?$F-4\ZWLJ4BHQAM+YDC3*R3P[7 N!SBI)5>E$PY
M<T2%RUAIUB*7HW[TLQ*FZ<3E8!<#,,B:Q5R.\= /RR6V-\]#0Q21NM":YWDL
MB4ZPZ,9!S\-,% 'BV1W]\.9I._(P:F+C\&/\?TO^DMV@R>RB_'-Q/.*B]_MN
M8]ON/<_@^)9"-+$R'G*P=;WW+V9S:V]YO1E=G=I*%,^U1Z+CZHFAY!I 1,]-
ME[[YE>(X/1;LX: A_7@;4,4G;LG.ELGL2IG,Z#WL+>.<CJ"=M8Q==(+3P?)>
M7"OO!;V'"WM!Q'W!"6$VM[P/-\K[0._A"-\BF&:;(C\@N?#/L\C&Y5>#3I;W
MY%9Y3^@]G-J3\B%'83^J#I;WXDYY+^@]'-F+AP@)KB'1H\H?0+(#Y)*6VAE.
M=\O[]$%YG^@]7-%)KI&.>VK2$&[R'$8O18XUC.<4R5=@4)YV_#B6=^Z?RCM'
M[^'("2N9U[;(LSQ(0H2\ LMK]_+62TID'6B_Q,@HXO-XX18X?G#U8)<1D'[>
MEK>Y6'SFGI N5(Z)K&[N-"3^^L-,_ZHOQ2T8Y@S/$5 Y%SQ[R#S>[Z4(@6%+
M\1R!D830,\;,PX-!B@P8IAS/$1A_3PYM0?/PXY B!H8-R7,$+B6&V@@U#\\5
M*4)@&+ \1V \(? L8/-PTY$B"X:]S',$+K ]R!C<YN&9)$4?#*N<YPA<>G]T
MS'HS=SYR.;-0Q<FE$@KUVMJS=N\.("P:/:4R@/&\C7@][+NZ\ JKLMQ=J'VL
M+85; [.W!'I;%[)1<!],]&5UT#GEWTB,(_'[9!Y>1FMOGT6XG*MS__+XA,L6
M7NFG  E.:+G\QEJK>BU);.N1D,L<F$QTYL)HXPG? J!*ZAGB0@Q%CL:L<\"N
M0NK2A512R>Y<V9$Z\6X;VV[[:V9.ZS(U4?%)9!J^@]"]'90W!,0EGDA$UM7I
MW*:*TB)4=":E)'R,@P07EN:NW\BG-.=[:A4(_1S]V. RH<T?[J)]#D"")Y"Q
M,\LICF";?OV*G&%>H )]D-_+!>WP.GB+\B N+6[,2UZL-TJ.8]^2XF_0D.<L
M\^+TR:R$?YVC58>KLADEM[VUS45')H?1+J^F]07I!-G3YR]<_L+OHQGF85I\
M-L3,MJM!R5G%V91!J:<=N S!FHA1R8YB\CYJ$A*H"L:>8RKW:BP41V>$@JR%
M3E:0=1H:?]VVIX6 :G+J7,-&>),GP/$RYUI!SH\TNYH3O?'U$I<#!TR)@A,G
M')XPCL*T*"2I)7J.HLKI8JNC+D=B&'^U'QNY9_NMLE>#KUQT_SS=_L#_"9ST
ME1-R !8#&,BWJJ8X\< N/'".9I"2SZ$7CF\OGEW&'&OV[>DZB)%"G?P6879T
MG^Q^^8^?_U:ZAZ!_X'2)[P!/ %U0PY;_\?<R#@S]SC$':OV N_9W%HE]*O#$
M*R+--N^(46&B0\KI!WQQZ3[XHL_I!3"#>0L\]*\S<.@?WYZC')_/^R2,WJ.P
M"&+*FPN[G=VI?HWRPQ.(">[9(7I[3F\1L>8GZED=,\*\EV>_7F8K4A6SS^V^
M';C,??\2=]1=B3 _;O=(7\3I>9F,=-C(^KW%>4+M-+$^484+UA#A"L[G$^;K
MU+WO_SKIM#XBD?]8')D3Z_[N[N7L]N.XQ;B,XUN<GD"I<FV):LA]=&:W7UV*
M? PJD>%*#)GM_)N]8U^\9%$8!?#4NK)Y;CW,]JMGDK\>P (:OOT!=@76,I'P
M%.T 9-YEC(:Z?3T/ /WQ9[[./&SD J>2R"[*:CVMT!+\X LMG=]7IR\6J7Y*
MD_J^OXD@V*%^',\Z3FL31^CGOTD<H4XC%XZ0)PZW[+KB'0Z9(4E6C4@41S##
M>V^SMS<I_MMKZ*YZPU(Y'@'$)M;@%>'=2JA0RI,E%]1M?Y3YI'] /@-X1-(6
M^6_=B'7&]@\:\C^_H7L)[3+:_"@-?]:-$.T3_@%5JLL97@>IR(4?-/%-_ISB
M/[7.2E.>ZCY!EWV213M>VG![\_%V"UIKFP1B]O<L9M).=P"$V1U,C[6X4#\:
M?4E" )O'.1PE3%T_\;Q%S>*B8?#5>EEV5J/?M$N-+V+J>.$>P/NDY&QW000)
M;7"YJ(G/>0L@+N5.%M5]^S2$'^MK]FVX2 E ,C7]X#2S)DO)GE.D/;1_OTZS
M_%.:_POD3V"7OB8XBZ?$D9[FV_.#MCI\N.PD^1-NQSKP$T_"B??:SM$J;4CW
M2>L95N+E5CB$8W=O2[M7NC_;_9Q8T@UXR3^!?+NOYXAI3T8F8'3T3\SLTEQY
MS'2+EM1O>!MAJ<^!DA&.>:D'HN>A"X(X.\U.@)Z#98@8C3D0.@TW-Z)+Z".(
M 1SEON8))K1@+5.@S"8.2]ZQKV%P% <[IT&0BH.D>>%UTBK/+X!1;<G>4SS#
M,[!F #WO/$\7.8437R>E)]OGS7,$9?,'^)734RA!#+S4ZO/1.3K^KE':W8U1
MIXEY2<X DC4;PIH-04N@K9X015]S'_%%D)'!0S4;9GE@>AZP+LI=-'3T]'S!
M9NPB3 =33]$2R>Q=YU1/%SFUS.YQZ@LW+J.NXNPR7N;N(J%3L\O)0S1=2%VW
M:<\7;/Q"LIE6SF;6&7W\AV/,=ADTPTQ(U9'>\\+"<I)RWRW?\T4[]HHH%0K@
M,N3V^5C+SNAY<6?':+,;7>$RMFX(\Q<G?%,#;\)BTXX1)C6VQ66(':%/]D.%
MYU6O'://RT.*/*\R[>9^<.*+3.#]#]_Q-AR,9 +S7WW'W%S4DA'CHDM^*%;P
M9@8Y&8';I2>$47!/%!1E!'SO+:A3ATT9V07_345*\51&,/3>I"$1JF4$..]5
M;IF ,"/(+5<9I$>=S:\"0%.@O'45;Q 7>T=3 ]E:"H ]\%H*8"T%L)8"<"G]
M3"F8Z3[QS.]8IV[G$X9?BCD)R<SJZ_<#3#/M_)SS)8MI;-'9+$6/FP(VKR6E
M2-)6F6]_ +B+,F8"T1$#>4LK2(_=@PA[$F6FL@1PON0M;$@,C&#I:6,8-MJ7
M/(:-'!@LY1B]=8;?\1:RU@7Z%6 5!H2;=P"#5U!SGT<8,=.U3O5U=^%ERMK4
M*\P$Q!IGX"_,]3JL(JTV"7_!IERU-N!6G8:_@%,N:3OTK38-=P&7O]\M7(JR
M7_<VF27[UG\"V.B#_GZ=)CD,=GD1Q-AS\A<>U!//Q%O8V73%6JRI_*QC9K+F
M?5OSOE'Q7?.^^?N>Q[86.XWSXE)7N>%S/8L 7[=/(M6V[VD4HV&D1SP'N!Q[
MYBW)4I\87 ZP\A9IZJO$&NUB!.G!0\8:Q6)6\.0;>M:8EC'HZWP<62-<3.R
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M?);R#8D>01'G5IW^ )(I#X@EW8!W$*=O>);5(16Y_@E[VKN/08R&>_T $B1
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M=XWPB)QJA%K1&J_EE>#:H.T=YA'(T@6E=G^0Y7LK=:+R.F(?3]E[77=;CE^
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M9$?YIYZ.\Z;WLX+SMS\A-!G(\FWPC_\'4$L#!!0    ( .N!!5ED,X-PE?8
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M 1<]X!\/]T:#[@ZWQO:HGNDNV#I)6V7-*GJIEV6=#5H#'3Z*#W[:G^SM;;4
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M?8'DFQ":/84C',3'/(&N8%@+QD-Q6;T78/>QZV9%ZIOV@>O(5EX:@'JQ4I*
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MJ?&@]+U:&:BY#_8(,3@.=]/7'!AK<^<E->WV^ELS_@ES,O!!*LI%*JVV!F'
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M6FNQ&6I;<T^H0G"0^',^0TW]HR&JQM)=K*WYD?DW%+A^I"S:1JIM/N7\WN6
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MW/>Y/0\Y>4ATLS[235=63>4:FG(]S658=?33Y"G[3\[^X)IQ[(?ARJ/Q68X
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ME>BTQ#P2TA=2@.8 9+7?Q]Q0I^"H\+1FM%05:R[3?S;#1Z*QV^!Z=RE?ND.
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M!@\C(H6<1+7N>(-!%)-7EL.8L&.*>MQ8[LIX ]<EY90=UV5WO3:GE>D#-R>
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M"/VOBPZQ2V5P5S9SF$R<UMSVF?QIMFQ'OP;_5F_1;D$0 ,UE(1 ZJ6@AV:K
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MTT\Z'? X2#G]:NF0KY=6[:I(5$JR8!)-4Y-2ZJYY6:)0;S 9I\ ?,?6<+CA
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MJ_P1UL!@)>5,?N#G7!659XQ/ZV&E$V*M7"54774=1Z!:IRW%_3/UP@RK[DN
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M@BA>/< ,>J/A3=#CCX(">R3DUSP2&6@F]&[3/,BLVF)AA*4?2NESI!7-64M
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M?JX0:6!.''NCN'G09F\ID!XN-;8KZG!XL*.:$:E<S["1&_8\) Q5(-T8DKW
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M^8:[\=LE[-Y+\1F6L_>U=\F2SZ\YN[CHH>;DC<U2\&OG_W7ZQV??+F!O?KZ
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M3$322\(I+6'JC25&WO5RFKPZ2F/.G-!?*?2FP_P<@:7NM[7TG,-2!_#-T(M
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M(<EF164F46\+Q3/$P\.VL)^PA.,)$V4&R3 ?WTB7KMO,:L>9AXX6'UNLYPU
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M5\E.3ZXD^.5F3E(96MQA8NZ-?^S*5G-'S1W/Q!T1TUQ96[<$8.\M^0(H!"\
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M.;&%3PM6RZW=L1F,2VL($<' P=<5+(2O> K LSSEH8U/&Z5Y0GB*IP?P+Y[
MUUBJL,P2L&=M+OF,AP1XH<C P%'8X\,U?D[17NEC5'LX4"NKCA0J 19[Z,7F
MS0J9E7OJ%<4LA2Z&S$683B)6-:[)(KLSNME:33!O;F-H\)>SX?"$O*=9WB>#
MX^/A;Q?#DS>T'_*.8'HU':7LUESG,N$81X3YQR  %G>  ^4$N!,3I_L5/[K
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MAU!O8['?F(SB6$'530NAS7R<"=X_./\($[(R(8I+-LX)R.'C3/-_VX[IN(?
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MW>Z#3.83[Y1CP6SR2Y7',V^NN21R@LL7FVV.CI44_+J4-"Q&JE[V=I1GJG+
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M1LB].A-;*Q"^9,WLKH'W!+%+3<*X'ZT*&U &E %E0!E0!I0!94 94 :4 65
MV7YG8#Q'>A?P % &E %E0!E0!I0!94 94 :4 650H@<"X30-A/-?[M5Z!,(]
M294(&TI$/$>)"'<?^U .?S^_0+]_1!L*0FP,O7YM6-K>7<+K[,,W<'>VX7M@
MTSVWMEF>[UK=;FUK/L_R[M$P3ZK.AEV-YMA3J'O%))8M5?J&6IBKH%!>MWFK
MTG]"QGM(!>1;L:;F\)OIKA0ZVK@NNDS04KVTX5-.RL9SF2><IJ;;W:T-(RQ4
M5U[FW@6G08SO.OM;ZI>U2XJ?HI2SQA)[7F4*LC'ZAJ.<<!#0IX.1U3J":.!V
M.UT03Q#/[8#*1BKGP/6Z+@CFDPFFBB<!001!W#I#=O_ '1PXF[6U3NT#6DO9
M'OE3^K7N%,?R[%JG2]_J#FJ=+HYGV;Y7>U77&G1ZM5>Y3^:]N<U%=6U,"@:\
M=]>ZQU)0CQ=WN=4'?'YZW]8NK9^3TXQ,T0?"@Y0F33I=MWZ"ABR/,YB5M5GY
M(Z;WGI0F+3'W=T;VFI@AX\#S&U7EB[F$[MQS[)5:E+9C>_6>UWVA<OO)_C;Z
M_U96LQS*\K"JO$"3R7@55N.+-@_<-Q>!3H2]"NY\@([JV8;M]ZW^9CT%^KU&
MO]_A9&W?J?RU*K[]M:BU])%LV0RT7%*<6J*7 ]0\2[;2J5G[9>=2<<-JC-NK
MYXUCV:=%%@C3DB%<HV/;5C,5T&[B 3=J<,/MM1XW3F2U^53U03F)Q3N):FVB
MI:P <MR:D\^LD3-M[UFA;]CZ8L9.X@$SZC"CWWK,^&W1.ZO"#"T%!0 # *,@
M6V>\ +AXT-'#YF#!-E'Y55@4JLEAD680L&0&)@8@!CBGWOS2Z^B*&CLH!\S8
MC1D=UVL]9IP'E'.6H@,T8FPJ._-FW$R)["8!QQJ '(7K$@<3+7G!<+4U-G;2
M#L!1 QS=]I^#?Z!<-6KQS7&&QA&3K=\EIZ,L'Q'9^F7*KDBHI>@ A("[JJPB
M->A:S1P/+:8<T*,./>H3H/>=R@]DE%*.0@4B@HPPGR9<<+F6-D>]E:D?8.AJ
M<_2UM3A<PP>+HR%FN'9/ XM#F!3F-8XBCMR._Q?T/VA@=?ZBHZAXAN_6K[=^
MH''^;PM]S#;7TVHY2[B:HD;7Z/N &H :NU%#EE\I.B7)UKW('APX/DHB')N.
M9Z/3V!KKJ34<P[V#JQ* 1".6T!5(7*/C I  D.P$$B3-#UFV7I7SD@4B_V6.
M4SPE1GG@@6),(SVC=.N=EOKAR&\X1A.6:^K6'%A^HQC]?2?<];I6?S/E "1U
M0%)_>KKO5!862<!DRXT !81& DNTU! =P^O[ !M@?BRI *O7T9%NW["]/I@?
M35&C_<D="C7(#>4JP\.]\5>"KL;T)I._Z"@ZCE-?/4 _#-'U 'V@J?_*,>R.
M!P#2%$#:G^FQ"B !3A.2&>@JR(J%1^G4*-Q;(\RUS!'K&_X 0K' &EFQ1GPM
MK1'/Z+N.U=],.X!)'9C4^S3VG4IU&,(GA&3HBL:S:)YR?D44?IC"%LE0RMA4
M2Y/$OX,3 X!$(X9P-+5*A"" 3=(41AIM/?:*2@4C<YLD8S02@))@0=1^UT>'
M[$'('GR$<V1]<T$@$Z0Y;.B0/2A@H[ X\ C'(8L7()*H9L_BAS#%5%,(F9^&
M/=(#$6 2A':M;NNM3B./^;X3WNG9EE?3\12 :3,P;6FJTB8JARP.4)!G!@H7
M$!66E5),Q&G\'0E0RF02HX[B \DFX!9;V:EL/;%N.>&]/A@XC7&D_2'"JSAB
MJMZ"ETS\@XAL(U("2T(37>O[^F#A "X!+CU!3Y*M^9^ 2SMQR6M3<]MM5)Z1
M)!(7(O%)D!)YWY)%HZ.\@$$#P+&J/W4%#L,&DZ8Y=+3?I+D%'851DZY;-6#4
M )8 EFB-)6X'C)#&2-+^V&/E'.,1'J$@Q<%W\S(5Z@RQA,2E7VQ,HPA='Z!S
M^AUK*3]W.&G;4R2YUSS\_(/3M8^TY #+TS)OI=N!'/IFR-%UF^TU]HK*T\)1
MA:8TE+?$B.=)PM+,'$[(%'V6B%)48]%1=B#P& */J_"N?M]RM 20'90#@.P&
M$%\# !GB$8U)EL[,E$0LP!DYF+*0CF?S^&,=A0:0 [KMKM72M?5-78$N[0_
M$$<G#(G%V\]QRF(4L%RR.A+CU%)FZLO$ZH<@&I]\^+J>?#B&Y_L 'HW H^=J
M !ZG,<\C+)/CS3-G@,;BIM \J7(?_P=-R7_^(VR3!%,M:]"#)0(^K+DJ[7I]
MR]72B[63=H"1.AAI?S#6"HPT(G?O1020 I!B'KHZT!<I=M .2%&'%.TO.[^,
M%*9G(ZRJ.HYEZZOA-],]1BR.9EI*#@ ( $B5+6AT.[J>=^PF'B"D#D+:7^1Q
MQ=CPA#I;5'A4!>>UK(3B&1[D#L*IQVJ-8#UCKCRCWX5#C\8 TOYRCV>F,Y!)
MYB6*B!]1]^<?//^H@(]Y]*Z.PJ/R;@%' $>6<43/IB6.T>EV 4>:XDA]$[U]
MIU(YL%9QI,SW4.XLC5%D< ??!6"(1@RQM?E3V^DVNEWH6-(00WH:9("<R<./
M(L *B>7]KJ.00)T2./JHZMAJ>^[A09Y'8Z3H>WH4O)(@X:*419&9)RAD+.7R
M /V?."43ENO99;<^9$(_\-"U5[MCN+:NJ1ZNX3O@K6J('QT-+(W?2(8C="VT
M&+M&XQ1/25G>JBRW:W9,^\8W;42T+')5?^P%.*(++W@#UW(U11&OXVVC'5"D
M#D7:;X7\L\"/ZP/T=9;B&(UI2A#'8Y+-T&6$.3<=<Y*B%$/Q$L 1*%ZBM4MK
M!^4 );NAI*\!E'Q@+#6%Z4%C-*)I,#&542*&'!(4R>?TT3@38!)>BR=IVGH7
MCD;@:*2*J= 61SRC#T<CS9&D_4F%$DFXV37MF[YI&ZC E,L4A\1 $RP !*?B
M)XW;2@&,@'-K<4CB:%M,T3=\0)+F2.*U'DFJBN[%V3K'5R1$8Y8B<9^FY^O0
M10I,D#DO:&N"N+M $X"C#CC:WT1*.;.\NUD@)-11A !' $=*LG>X<UI.N6>X
M@"/-<:3]Q4VJMK;2 $$X" CG<P!!&4-3G 43-/RF99%%%X)]P8^U*!2E*XBX
M1K\+(-(81-I?X.0?-/B.!(YDA!<'[)& $5-KZP/<6  ="U/4MSJ-RE/L.^%=
MU[,&FYOC &[4X4;["YI()Q8*(L9)JCE<0 ,I0(O%J<?6"AYMI]QP?3 TF@'&
MP-'@U./C4AIAF,YD^41DHD]_=6QSG!DH(2D:'#B^M$5B+04(8 3./$JG3=_H
M:GOLL9MX0)(Z)&G_N<<&)#&K8HI5)453:RR!FHI04W%U<^%8S1H&[3WAMF%O
MK_,":%*')AHXLDH$28D\0"<A&K$;,109R1M)1N!(9JEK*3M0YP0\6XN40DWM
M$<?HN&".- :0>N_XOE.YT1QATQ%3!4\.^)1])R@47Y-4R[ST^BT$H(@NO.!J
MFQ7B&%#BY $P,F@]C)1V"!KG:2H]626@D S32)7N/2Z*GB!RDS"NYU$[G)%
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M:*1ETI=K=+I0HAWJ6RUK4ZNGY6YJ8'3Z \NK<<L#CFS!D?8WJ2UPI A%^IM
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MT0RQ;*)I!REH^[$A943/UNB.IA76M](-B%&'&.WO0#C$:2(,#W5L#H !@ &
M 8 !@ & L?O(W$SST8BD*B,=C3 '[ #L .P [ #L:(P= PTZ"WY4?011+%Y=
MI!62&\HSZ:L*&4NY3$\7=P81P2D*&-92<;C0%A#: LY#KG3M"N@:#C2I;0PE
M^D7NFJ-\/"Y!)6&1[%8KOTM2%I P3[5,*@1K!*R1*H)"6R#903G 2 V,]#2P
M2,Z^FFF9FDYCE,K(JU1&7NDH*P 8 !B+_??V2".=:0?0J &-0?M!XRNFLB?R
MI5!C,K5#6!]%95YY&$)N I)D2-\BO4[?\%PHL0CQNLMJP>HW.AC==[J=KN&X
M'6M+S5F DCHHJ=^0[CN5MZ%$(8=KGB3L9J:ES!@V))X#?*R>*3?S1.P]W4;?
M@Z3!QNC1_DKO<_2HJE^Q,=(=/R#E'-!C#3T&C1*_]IYNH]?S #V:HD?[RY8H
M]$#7\LA#!EX)-IC@<58>HH?I3 7WIB017VDI/P CM^;D.(K8-8X#+>,I>AU=
M3T1V4 Y 4@<D[8_%^D $?$0HJ:R18S1.\90@<I,P3D(=)0;  X[2JZ(=VAZD
M[Z <8&.G]K#]9ARS5U2>BV?B2R(^"8FP,_Z=TY2$B,61EGXK0 Q C$IONMHB
MQG;* 3%V(T:G64FTO:+RHT (855((R.G?$)2%. 1C4FF9;@N!%E!HN \9K7K
M:@H9CF'[?0"-9J#1U<#,N& T(AE*L" CHRSFJBNZ2C6/"-<2.<#6 %MCWKC5
M=GJ:0L=.V@$Z=D-'7Q_HP$$@@(*EE"CLT%%4 #$ ,>9%R/M]71%C)^V &#LU
MB&-K@!C'G%.>H>$W1(LVM5B9'#(P5QYP)%-QF:FB:+04'PC-W5"!.277GUBN
M9\7,@6UU&F5Y[3OAGM%U;6N+0 "2[$02M[,EH[)-5'YFN2 !C2*AR;A9HHF>
MP51W:/^E'VSH>M+A>+J6UAT8@PZD S:%#+?]<;AG9,JN2)G 456UNA8JC5VC
M,8V@J!5@A]:>*UV! VJR-YNVCJ=!3?8O-$O9)8E-\082AXN2[ 6,=%#":)PI
M#Q8GZ175,_<+4 22 ==. CKZYG7LHATPI0Y3VI]9/F13<0WG)$28IBO(8CIV
MA2C\*M!1>@!* $I6B.]J#"4[:0<HJ8.2]ONTAA'!,;K&@K4K',D8XC3^SF7!
M]@B/P*L%( (@XAA];4%D)^T (KM!Q+?;7V57OE/\)A09%T""$IK0^%)+20'8
M -A8RY[3&#9VT ZP40<;[7=C?:"7*$M)'$S$ (KCD!$.OH]I%)G2 D%ABFG,
M#40B$F2I)%5+.0)0@1-V@!. DX? B5_?]GK?J?Q#:*_T,F5Y+$@BUR25AHBJ
MDB@>685M7=&0,"W%!U $4(1 H5U D(8(TFE_K-;7*)^.9&Q6(L$CPC%'7TVG
M1(ZOIHM"G)$0]0Y<^Z#9V="^"Q"@"#BX5AFBI_'I^F[B 5'J$*7])R.G15XA
M&G[["U>GZ@68A)3+TNVI20."IM_3(1N/"4&_8N@$ J "H.+HC"D *0^!E/:?
MFIR5B8>9*I[%#13A*_%WGM(81_-,=C3!<<C1."5Z:A" %/!VE:Q@&UUWH"N:
M["0>X*0.3MH? 'RF&A"B3%R#DE0,(^7FV<$91/T":H AXACZ=I?:23L@QV[D
MZ&K0+>33%0Y,B1TC'$D%L2B,PM+,E$<H>4SUW'("CH#U4>5R#P8=31%D)^V
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M:,A4LT]LH/-<W(J<.QR7[]7\W&M&;IM((+&K,W0>3$B81ZJLQS<<Y5LJ>("
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M7[79_@?:P!X$>[ =]F!_K^W!]P<C%LY^^:_W!Y-L&OWR_P%02P,$%     @
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M/ .G":3X,=>PA/<JQ(J@1Z#3C@R/"HM;1-JF#-ZB'VXL$M"@[%6 T=T_,$8
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M1>+H-^B%C%#\#SW%E6!'PT_60<MN]9K%+0HT2XG>-*%+R-12L+=[$9$S'GM
M<I7\SJ,TD8K$JIL22GD\\^!UNNCN&;64?P5?D"Q[NQ?P!:/6G%,56GX2*\)C
M)O>NJK0$"Y2GU5;*BA+'[O"X:]IZK\QU*2_Y++S6H"@J6NP=&0O*/BH)E:1E
M?80J0G:IP3196!G_5WLQ321ETL(2K2:ME 1HNA9AGNNDJK+#J.R:NH!$7"R]
M"8]8!J=L#N=)1&J#IXE2282RBBV4102?Q9YV4?>AFU?=S$.NF)6EQ&=>*IDU
MER3M7NO[F]UA7P5> 5<&;Q;K3EX\<P^=;J^IVQ[UFBG^(D(_UC_S1*X[Z"<B
MD=XSQWRZM[L[+Q[/-!%T$_X/%R&?<@7%,+] 80W_W==W]7D[!#[VSN0CP6 P
M/)^<')\,^I.3T2F<?3P??^R?3F RNB<@WST@'A4:[FOX:(_M@0WCX< @XAYT
MG ;TQ]!_/SJ;#-__\A!5P+QQ#F%T#),_AC#NG[_KGP['UNC37\._H3^8Z)J6
MX]QW5FT8H9_'FS\[(JS[[/^?GR<QX$W,?,63&.9<A:!"!A]R(A%ML81SIL,]
M) &<+\9ZE#7@)/9MV-=B+YXM6H[K=P=)E))X6=S2[DM 7<>)C,!UK \0)-(H
M_5(K39GD"0464T;ASSQF<( SL.6TV@T@&01<8'EMS)CYN>2*HT,DIC!<^"&)
M9PRPUXAGF38<?[0D)8I!R"1#<Z\86'A1VX<^-& <,B'8$B8A&A W8!!R%L Q
MCTGL<R)@% 3<9U*[KE65/C8 RQ0/\"+-999C(@0J@0M6T2/G5;?@%/2%T"15
MZ,UEX4)$SZY2]YC(*8E99HT6VJ*^;P#7LZN!]00QQU;1$C['R1RAF3%O^T<F
M7'(14TM,6<E4L%OSQS)]TW;H; Z=T.*6(,LD5YY)1LN$TG4<VWE>-4!G!$DS
MYF4L)1+'SXI4T^2VV@)9=?^59YA6"*Z67J6@DD(Q6K.3Z;!MNX?/-8A-16^3
MZ=AN^RZ9-X[]ZJH,7LD;MI4)K@%^Y<.9H^?65#+RV3-_+5VPRORK";3C8L+\
M50]^GXAR>&#-C43<R#U "KW&L%QGK*U^ K\,%*Z]PZ+"8H+47,:_(!<8MWR,
M 4+'H3HV2?8EYY)%V"#3G#TN(ZE[L$\P#$IP._OT9<WS%Y&LCF(EV;MO#MI=
M'=]6PE]/=+S0O/9@, ;FLR/]'>D_^=F](_T:BM:.]*^0/H]QS1(1P^35WB7%
M4D/B540@W"QE),LT^3=T-1$"L!FN;G#]@!4I1H.L85H%];H"%5)N5.O5#$KE
MHH@="2Z+3)_9M37'ZJ?SC9A@T.&XNHJ59[7:=B=55S=8R[)MV]Q\XB&C8[?7
MB!G.G3'C8 V9]N&-SNX,+%/B?Y[))(^IM48ZL,&(4PRT;6"7]SAR/.CGLSQ3
MT"GV/#; O=L#T"XJUU"\6WJ;&QKUZZW";+N%_ ]9(CB%RKB5D*UP[U'N@]\&
M8C-K7MOI^W8PW7'?HY[:.S0NHQ%Q2@5[2FC<>%WU4(/EJ?#:VH#M2&YKIO4.
MC:>-QH[D?A1@@\0ZDRSC>F?#;)_<\M)V1W\;WZ^YQPFSK9CG.Q >)0A;1VG[
M9Y(C=Z5(7C=H[.7F7@:ZK>\_S?BP!U8?Q9C?>7;_0\8_XT"XQLB(?\\!\4"P
MA46Y+-[9ZQWZ/(J[E&>I($M/U]9*ZGVSE<?(_\DS?22L@L0TM5A,?]GSY8:=
M0GE!^3-6I$H6"9!//2+F9)F9MP^%>*^IOW!P]%NO:;ZJ\!]02P$"% ,4
M" #K@059URUPN;QA P#!2B@ $0              @ $     <GAS="TR,#(T
M,#8S,"YH=&U02P$"% ,4    " #K@059L+5(*^V+ 0#$Q1< $0
M    @ 'K80, <GAS="TR,#(T,#8S,"YX<V102P$"% ,4    " #K@0599#.#
M<)7V  " ;P@ #P              @ $'[@0 <GAS="UE>#$P7S$N:'1M4$L!
M A0#%     @ ZX$%66TWMGF #0  D+X   \              ( !R>0% ')X
M<W0M97@Q,%\R+FAT;5!+ 0(4 Q0    ( .N!!5FD[*=-R0@  -U=   /
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M   /              "  6%9!@!R>'-T+65X,S)?,2YH=&U02P$"% ,4
M" #K@059"$97;H$%  "Q,   #P              @ '[7@8 <GAS="UE>#,R
<7S(N:'1M4$L%!@     ,  P X (  *ED!@    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>rxst-20240630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rxst="http://rxsight.com/20240630"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rxst-20240630.xsd" xlink:type="simple"/>
    <context id="C_8075f4fa-a67c-485b-862f-ee66abf092dc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="C_83a98163-4754-4205-8811-d48d703e7dce">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_848743db-b358-4cf3-abd3-f3016e7703de">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_859e1bb0-35f3-40e8-afc9-6b5a07eec379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_8658457e-b5f0-4fd7-bb30-dac4f9d122bf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_870c219c-a4a7-4462-846d-85d7110b3380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_8711b3ad-aa2f-4b24-ab3c-bee15606d03d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021EsppPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="C_872467f9-67fd-4871-b993-41838a2b5113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_8869c8c5-5883-4a92-b4bf-6238296536a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-08</startDate>
            <endDate>2024-05-08</endDate>
        </period>
    </context>
    <context id="C_88b8255e-f275-4b86-96c2-52ba7228dcd4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_897a6866-6f1b-4fb5-a915-4273bf3c2aee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:JulieAndrewsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_89a390bf-cf3f-4d6e-9839-74e86626c8d9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_8b1f96bb-fff2-49be-8819-b62edbf4e6d1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_8c085cd2-f882-483a-9365-9c156f7d6bb4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_8de5eb07-df34-4d9b-8ee7-1a3ce4214e1a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_8f9792cd-5e2e-44bd-b8e7-5ba5d2e31334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_9161bac0-099b-4ec0-be0c-82d298abeca3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:RonKurtzMDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_924b61de-5beb-4902-a3d1-1540e5a5473b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_92773448-1606-437d-912e-2e2bd0f53565">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_92a77da4-deaa-41ad-80d7-531024609f4d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_93f8bf54-9e45-4c16-9967-dfadb4c026ed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_94635311-ec03-402f-a7d8-37123b9f3f6c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_9570a28c-b316-4e10-b753-972c9bfbc435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxst:ShelfRegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-08</startDate>
            <endDate>2024-05-08</endDate>
        </period>
    </context>
    <context id="C_95eb6bb1-f341-4f69-9031-18165fd37316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_996a376f-b733-4535-8dce-1a21486a132a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_9b623e0d-4f1d-4db1-ae4c-f10eeef88de2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_9c844e79-68e3-4292-baac-af1e749bfefa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_9ca0479b-010f-4a98-9d8b-2e025b1da223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_9dff912c-7bb1-4372-9d7e-a40dfcd38d40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_9ea266a9-965b-4b22-8258-e30e3b49e49b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxst:The2021EsppPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_a248ded6-40d4-40c0-89fd-1e7502f8ac3f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_a5ac65aa-cc43-4c9f-a44e-01e67eb807a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:LDDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_a73767b4-7596-4747-a31a-9abee5f0e1c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:CliffordDDownsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-18</instant>
        </period>
    </context>
    <context id="C_a9fe9645-a679-4c9e-910d-64434fc0d770">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_aa2973b8-fc17-4fe1-b3e1-f27dd4a7007f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_ab888ba9-e469-447e-bb28-93d500a06c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_b0b9ecf4-f70c-49f1-9f26-10517280835d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:ServiceWarrantyServiceContractsAndAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_b0cbb535-d10a-43e6-a2b0-bb698413d1e0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_b23a28e2-f54d-421e-a468-87056efde586">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_b2763b9c-65fc-4b20-9afe-65016b69e297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_b7832ab7-5ac7-48b8-b36a-eeaa642bb7fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_b88f6739-08be-4673-af5e-386409d97e2e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_ba9d48f2-149a-4fc5-9666-638ff32e1c8d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_bc685971-8f0a-4ea4-8c64-9c188aeabf26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:RxlalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_bc923b7c-f61f-4557-a54a-e7a984c590a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rxst:NoCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_bdb7c2a6-1dd2-4f29-924b-0d330d5760a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_bf0d539d-f732-43b5-bfee-00d8e0a9765f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_c1f69193-9ca1-46d8-825e-767d784caa8b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:RonKurtzMDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_c25f11d6-dc7c-4161-b92c-872ba3474149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_c3849e78-84e7-468a-b497-8a3fed88ad2d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rxst:NoCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_c3b8c0f8-26a4-4d47-91da-6c055e856dac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_c40bec78-b687-45c4-ad3c-00a3ff05916e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_c4552e7a-d149-444f-86ed-06df03b923bb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:LDDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_c4fcf8f2-fb38-42b9-adcb-eb6d516b8469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <instant>2022-04-04</instant>
        </period>
    </context>
    <context id="C_c6550ecc-1f2d-48a5-b93f-4051f05eeb19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_c97db89c-4001-4cdb-bd4d-a54689c81080">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_ca32f3ef-6b1d-45b4-9e16-40beee1bb09f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_cbd133ad-eca3-4208-8941-8bfd8e1c173b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rxst:OfficeManufacturingAndWarehouseFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_cc013c64-8342-45ef-9d49-af4eb130d7ea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_cc563601-0f12-4cea-9637-53f1f309f9f1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:LDDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_ce17e0b5-a12f-49d2-881e-1ca12b318794">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-01</instant>
        </period>
    </context>
    <context id="C_cffab339-4046-4bfa-b82a-1b1694720712">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_d0985361-3665-4b26-8732-c0bc94e9d51c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <instant>2024-04-18</instant>
        </period>
    </context>
    <context id="C_d31c11d4-0dd3-4c7f-afa5-cc439fc19ddc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:LDDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_d8974959-d59e-44c2-b138-8241de80e80a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_d98bbae7-20c2-4ccd-9db3-beaa1215b76d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_dac5e1bd-acd6-4c7d-aacf-a30a4e26a25c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:AccurideInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rxst:IndustrialCommercialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-18</instant>
        </period>
    </context>
    <context id="C_dbf9a77d-f552-43c7-b738-3e4043920c2b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:ServiceWarrantyServiceContractsAndAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_ddfd1e3b-9d8b-446b-abd3-a22e0ca0bfa2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_df8cf6d9-9e68-4550-b7d7-3f23bb4e4d54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_e06ef83e-8ff7-41dd-94cc-bc2af4dde419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxst:StockOptionsIssuedAndOutstandingUnderPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_e16a6e57-fa09-4b23-9d5a-b5b69cb75e2d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:JAndyCorleyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_e17b2aa6-cab6-4346-b87c-a405a33a2764">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:EricWeinbergMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_e18f6da3-90c2-4d9b-8b4e-269b15d12144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_e2c20804-0137-4f36-8ede-788b3dd3695e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_e3efc9bd-860f-444e-a889-ebfd9d131560">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_e4a673c7-eaa6-4857-856c-50b98038b762">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_e56c75b3-caad-43f6-8432-5c6f54278fe0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021EsppPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="C_e648d52d-9f33-406d-b707-f0d436342566">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rxst:OfficeManufacturingAndWarehouseFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_e7d6d427-25c9-4896-bb46-4266c78ddbb2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:ServiceWarrantyServiceContractsAndAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_e95a0f17-9a53-4675-91e9-06e88ee7f46d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:AccurideInternationalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-18</instant>
        </period>
    </context>
    <context id="C_e969fc23-8eb5-4d5d-ace5-3eb8042365bb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxst:StockOptionsIssuedAndOutstandingUnderPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_e9ed04cb-b0ee-40da-929b-a0f166a7eea4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_ebf267e3-249d-4c66-a032-0ae76ee1e173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_ecbfe3e0-15a9-4d92-ac2a-89dac13644c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_eddb3485-0e74-4545-b102-ed16c7ec0a2c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:RxlalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_ef35aeef-393e-488b-85fd-95ffed2e764e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_f1b15466-ecb1-46a7-a2a9-b73c5a09ae08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_f2e112f5-12f8-406a-a985-9a26dca174bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_f4720bce-2db3-4982-a9fd-2cefd4a958ca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f5781e6f-1600-45ee-a829-0c9af9692565">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_f8984806-8a2c-407e-87a3-79fd81817c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_f9980517-1437-4032-bfd8-e4a47703b439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_f9e9e639-bb5c-4c5b-bef2-2b16f5ee280c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_fd5d1c6b-a916-4a4b-8a21-c86da5a58d96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:CliffordDDownsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-18</startDate>
            <endDate>2024-04-18</endDate>
        </period>
    </context>
    <context id="C_05587aab-7a1f-40a3-9a56-c925bb5331b9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_080ee223-a04a-45a8-98a5-9eab7d1606a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_0996adb5-0bb8-42c5-98aa-9a62af36677e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_09b691ca-838d-431d-8501-a873d038e2bf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_09e7c479-5280-4bf3-a282-cb28f4483242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="C_0a0a72f6-5a6d-41e6-92e8-4b90cf7843c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_0abad422-2500-4d9e-b9d3-8c167c8ee9ab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_0bd63812-92ba-4572-9a40-8db99e7f608b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_0c499457-67d8-4be1-bbac-93b1615afe77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:EricWeinbergMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_0f2db67e-f20d-4666-a388-00d0b1a6b9f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:StockOptionsIssuedAndOutstandingUnderThe20062015And2021PlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_101ce506-9642-467b-b38c-f2c003a92905">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_107d2d34-29e5-4238-80a7-75906a0160b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:CliffordDDownsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rxst:IndustrialCommercialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-18</instant>
        </period>
    </context>
    <context id="C_1223a5cf-5ff9-4abd-b52d-c7eebdeb8212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_15d45034-58a3-4d42-bc68-b3740b5e0b2a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_1b3a5e20-5e60-40d8-ac83-f2c584e1b842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_1cc1ee8b-02ae-4c94-beaa-b81200fcda42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:JulieAndrewsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_1e158749-5a3a-428a-9c8c-71d3347c8329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_204a0bf3-73bf-4334-8ffd-365bddaf6a28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="C_23476103-2290-488c-b788-5f19565bb756">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_236410b5-5576-4fb5-8213-e1ee25595cc3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:RxlalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_26af5d92-2265-4e0b-b68d-a926ef38258d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_27166295-b86b-480b-8ace-2e05125185d6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_2790d20b-5e9b-4fbb-aab0-0988eacc2119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_2a070290-4230-4337-a657-3d109387c5bf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_2bacb43d-9328-45cb-9df2-94d7e8766fe6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_2cc166d9-2e7c-4d1e-b33d-918c247c655d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:AccurideInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-18</startDate>
            <endDate>2024-04-18</endDate>
        </period>
    </context>
    <context id="C_2d3d3cc5-4096-4048-9e86-726c8e7126ef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_306d346a-380e-4f34-a95e-850689d48e3f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_32b78179-ee95-441f-9a0f-c5d71aff0dbb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_32b79176-7c08-4e2f-8dd4-4a8b2a419726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:IlyaGoldshlegerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_33a5d823-d771-4f16-9c29-15bf632fdbb6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_35ccf33e-5721-47b9-9631-6b62ea10a50a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_3713ac89-35d4-43e3-9168-1283294925cf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_3861c8c4-bc18-464d-8af7-febf616f8757">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_39cfd17b-899f-40c4-845a-6fdae94d9625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_3b6572ea-8779-41d7-9699-5abd96466e88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="C_3c557978-5173-4887-9475-3c1de75ad09d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_3ccf0dc7-e2f1-4cd5-97cc-45c2be8de24d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_3ce1a97a-19b2-4c6c-aa54-c82451d2825f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_3d547736-7d2f-4ab1-ba32-5440721ad534">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:BmlManagementLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">rxst:OneTwentyFiveColumbiaLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rxst:IndustrialCommercialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-18</instant>
        </period>
    </context>
    <context id="C_3da2657a-3194-4635-a909-ab3fd0a1dd6a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:IlyaGoldshlegerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_3e89f686-064a-4ed5-8601-3e8782699162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_3fde5492-dc3e-412c-b180-b37e6ed47396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:SharesAvailableForFutureIssuanceUnderThe20062015And2021PlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_426cc0de-05ef-4df6-9f8f-d9cfc2eca447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_428789be-eb44-4bee-8e7d-43887c59ba81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_43a01723-f1d7-414d-a915-41d499a7b20c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:RxlalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_443df5e3-56fa-4ac9-ae8d-93e0566a45d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <context id="C_44a8675d-687c-4d77-b5fb-c997d6d277a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_46ae809e-f67b-4a77-b4c5-50a424b655df">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_46db9299-0314-43f1-84b8-70e7b2fcce61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_4b3ce656-4281-4287-90bf-5e25822bf054">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_4c8e9ae1-1e9e-45b8-982a-f941b1e59b4d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rxst:ServiceWarrantyServiceContractsAndAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_4cac1f56-50f3-44b0-afcc-1b3e03ff9aad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_4d46893f-4145-428e-8ad7-90506451e341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021EsppPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_4f93e213-8803-490d-b3f5-c935ceb12ab4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_51a8f883-c93e-441e-8b3a-10e80e0d9a20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_53193d0d-eccf-4650-b5ff-2f01e68f7024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:CliffordDDownsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-18</startDate>
            <endDate>2024-04-18</endDate>
        </period>
    </context>
    <context id="C_5501518b-7c81-4968-a973-df58e4381f69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="C_5517632f-b947-4c40-8db1-42c309a847d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rxst:NoCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_55616c71-0dc0-4231-8880-c2204423fe8a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_55f52d8a-909f-44fb-865e-6571cbcee723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_55feb510-96cb-4d20-af10-c695f8e02985">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_59908af3-c3c5-49c1-9bb8-171ba60eb5f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_5aacfb5c-bd2e-4b8f-915c-d1f78db2a9d7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_5f4a79f9-a984-4624-83b4-b702658dbd28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_5f629c9c-346d-4df1-9e88-b538f5affce5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_5ff8a19a-ef8a-4d06-aaa2-5caaf0edeb10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_628a0a40-4c51-46a8-ae7c-d6e7b44797d1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxst:JAndyCorleyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_6702e775-6fe0-4e23-b7e7-44e40075c069">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxst:StockOptionsIssuedAndOutstandingUnderPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_67e0d5d6-5fee-4a17-ba10-34c977d6903a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_6ade43c7-7714-458d-a02a-e56ad23d0eec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_6bf98cbd-e518-432a-99cb-1699005a3a9a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_6e1c7f83-49b9-4025-a3c3-dc623355c0cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_6f6583f5-ec7a-4082-9b35-96788b1aca0c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_70dadb47-1500-4a1d-8f19-f29b9940b04f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_714e2128-63aa-4240-8ef9-520e2ff63b1a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_71726fb1-fc7b-4769-9509-bbabcda3b877">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_7186a63a-2ded-414c-b053-cba2402cd973">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxst:StockOptionsIssuedAndOutstandingUnderPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_72207dc6-8a88-4a0a-988b-d8bca47ecaaa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_72d61c44-49fd-41dd-ad51-35f48ea85916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_7391a03e-f048-45b1-8c90-50f3375336d3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_7424c8a5-89f5-43f8-895f-fd84c2c2a996">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021EsppPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="C_748782be-b4c1-440b-81fc-508b52d9ef24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:CalhounVisionInc2015EquityIncentivePlanAndCalhounVisionInc2006StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_754f24b7-506d-4d0e-80c0-6352678c3425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rxst:NoCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_755fa8c1-f901-448e-a391-c05a19ebe37b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:AccurideInternationalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-18</startDate>
            <endDate>2024-04-18</endDate>
        </period>
    </context>
    <context id="C_7634a85b-9ef7-4095-a9b2-36e304f09a7e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxst:The2021EsppPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_78dfb1d2-f1e6-40bf-aa34-8f63a8bccd9f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_79f66c27-e4ac-416a-b575-59bf974253cf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxst:BmlManagementLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">rxst:OneTwentyFiveColumbiaLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rxst:IndustrialCommercialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-18</startDate>
            <endDate>2024-04-18</endDate>
        </period>
    </context>
    <context id="C_7e061ea2-e4c5-4f24-a010-06a54d38af8e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxst:The2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="C_7e492a7e-2688-44a6-8a92-202d81383908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_7fd1d14f-2011-4d83-8445-f16b305c1b27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001111485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-08</instant>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Subsidiary">
        <measure>rxst:Subsidiary</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_Segment">
        <measure>rxst:Segment</measure>
    </unit>
    <unit id="U_Item">
        <measure>rxst:Item</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_bb88959c-f356-4068-b027-b3dc5285c04b">false</dei:AmendmentFlag>
    <ecd:TrdArrDuration
      contextRef="C_3da2657a-3194-4635-a909-ab3fd0a1dd6a"
      id="F_2f6eecc9-9f4f-40be-a663-c1c2c4ab2fd5">P364D</ecd:TrdArrDuration>
    <ecd:TrdArrDuration
      contextRef="C_9161bac0-099b-4ec0-be0c-82d298abeca3"
      id="F_23fea469-98dd-41bb-9305-d3fa52a2a388">P360D</ecd:TrdArrDuration>
    <dei:EntityCentralIndexKey
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_570d48e1-9972-46b1-b30e-66ec7ba6108a">0001111485</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_a8d8ba7a-c559-43d9-b3de-4656978882f1">Q2</dei:DocumentFiscalPeriodFocus>
    <ecd:TrdArrDuration
      contextRef="C_e17b2aa6-cab6-4346-b87c-a405a33a2764"
      id="F_d8dc038a-1947-4b2c-a8ff-a7f396403c89">P365D</ecd:TrdArrDuration>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_f0a67186-5427-4468-82c4-65fa1c61c56c">--12-31</dei:CurrentFiscalYearEndDate>
    <ecd:TrdArrDuration
      contextRef="C_e16a6e57-fa09-4b23-9d5a-b5b69cb75e2d"
      id="F_7259b73d-46cd-455b-aa27-086f0efec3bc">P274D</ecd:TrdArrDuration>
    <ecd:TrdArrDuration
      contextRef="C_897a6866-6f1b-4fb5-a915-4273bf3c2aee"
      id="F_48ef4de0-fded-40e6-8c90-fd15c86c12d1">P279D</ecd:TrdArrDuration>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      id="F_33c93a11-4585-4640-99ad-44e5cef73f19"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      id="F_f659414f-436d-4bae-b738-d7b407266e59"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      id="F_3e517117-8319-4cc0-8225-94336556f3a7">http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      id="F_00e18cde-e7c6-4077-9799-7012c3ad64fb">http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      id="F_0bfe1017-2ed2-4326-a247-db41c8cf4d2b">http://rxsight.com/20240630#LeaseLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      id="F_78fd0571-9a99-465d-8968-e56cfa5898f0">http://rxsight.com/20240630#LeaseLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      id="F_0f7fb7b9-c9ea-4648-8251-fd72d360c669">http://rxsight.com/20240630#LeaseLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      id="F_a8615e7e-3a3b-4497-9d55-86ea65153fd0">http://rxsight.com/20240630#LeaseLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      id="F_502cbe2a-5432-41d0-85b4-23a20a165bac">http://rxsight.com/20240630#LeaseLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      id="F_8be0e6d4-5a47-411b-9144-c408d3934f9a">http://rxsight.com/20240630#LeaseLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      id="F_a8cedab2-1fe0-482a-a6c2-28f0caa7a48f">http://rxsight.com/20240630#LeaseLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      id="F_21a43b30-4a3d-4632-a584-149b79b2db2c">http://rxsight.com/20240630#LeaseLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_468542ba-c480-4c3c-8cc4-80ab0b4a2573">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_386fe7b3-7915-4370-8df3-ef5907c40db5">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_0add0e3b-350c-40d7-b113-da81dfb85079">2024-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_c0a03e40-1c6e-4412-992e-799d455ceeed">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_d481d750-11c3-4535-a240-3734d47b708b">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_3ac66bfb-16d8-4e4d-901a-0cf337e03c04">001-40690</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_18baac1f-d84f-44a2-83ae-9e0e724de4b2">RxSIGHT, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_d7334ef2-581c-4ada-b3de-53d3622bf146">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_4c2fa7db-7059-4460-bfac-8675a5686126">94-3268801</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_76640bd1-a7ec-493d-9027-c0708da8cc3a">100 Columbia</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_ec94b197-26f1-44ea-a488-e2a3fac8e085">Aliso Viejo</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_308e14e4-039b-4e66-9f50-6c3835852366">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_2c6054ce-1b2c-4770-ad30-25a4b207e36f">92656</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_78e6fee1-98db-49f3-b9e6-6f9f2af74fd0">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_b1e33beb-f9a9-40d0-997d-9c5f5896c33f">521-7830</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_1567118b-79fa-4d1a-ad2b-a2fe58930340">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_b4182d6c-b792-4461-9172-3b4baf82fcbf">RXST</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_067ebab5-5fc4-4caa-8bea-4630dd5e363f">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_a6ecfd6a-ccde-4490-8e30-9f9493edd5ed">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_646a91fd-5abc-4dd0-9e83-ad276d07a4fe">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_e9b9a1bd-142c-4365-bfad-db96bcac4979">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_8c7ef7c5-f79c-4fd0-afdd-c4ff8c108d2c">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_fd6839ae-902c-4461-8f60-43d9cb5ab9d8">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_e9ae6319-7a8c-46e0-967b-c2e5c2e0c632">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_8075f4fa-a67c-485b-862f-ee66abf092dc"
      decimals="INF"
      id="F_26a17a7a-6a17-4955-8d17-5d6058ff5a4c"
      unitRef="U_shares">39682804</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_7afbff37-8b25-48a5-9f1d-a1b5034c0fbe"
      unitRef="U_USD">24445000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_84f5626f-b97c-42c1-9a5d-239f750bdfad"
      unitRef="U_USD">9692000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_d0a44074-af77-41cf-99a3-1e4e5469bd96"
      unitRef="U_USD">208839000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_9d1f0e72-e9f0-4d4a-ab76-c5d82a22e81e"
      unitRef="U_USD">117490000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_cfadd42f-e313-41a1-a006-f77a9bb1909d"
      unitRef="U_USD">25723000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_1d8675d1-c618-42c0-a8fd-836fe43c8210"
      unitRef="U_USD">20281000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_ec5f9a99-b9d7-4bf0-ae5a-1ff80a575786"
      unitRef="U_USD">19443000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_aa4f1490-270a-4cdd-bd98-3c0cf593617a"
      unitRef="U_USD">17421000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_a74576a5-0899-4de4-bf9a-0f2d60e2d4f6"
      unitRef="U_USD">2773000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_f76ccd57-9647-424f-9d51-4b004bf4b7c0"
      unitRef="U_USD">3523000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_016f2178-8bc8-4634-9837-f99801b1eb63"
      unitRef="U_USD">281223000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_cccfe43e-f80c-44a9-a128-9869191d7e1a"
      unitRef="U_USD">168407000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_06d64d46-e685-479e-9cdb-695281b5d4ad"
      unitRef="U_USD">12444000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_ff95ca1e-cab8-4dad-ba6f-563fe6d13f35"
      unitRef="U_USD">10841000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_87e49d85-8637-4a11-bd19-955476a9049a"
      unitRef="U_USD">10818000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_1a544e37-8184-4d5d-96fc-3847504fc504"
      unitRef="U_USD">2444000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_a2b9608e-fcab-4367-9577-6da40bdbb411"
      unitRef="U_USD">711000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_c5c50abc-3cee-452a-88fe-3c74f4d00128"
      unitRef="U_USD">711000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_34f420b5-794e-406c-bf62-fe373b58b1c9"
      unitRef="U_USD">303000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_88c3aa53-6b99-49ac-b1f6-26de4ff0ac2d"
      unitRef="U_USD">147000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_e9c5c915-df58-46c2-9153-2e22c791d45c"
      unitRef="U_USD">305499000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_937a20b8-64f4-4b8b-a2df-ee9055499475"
      unitRef="U_USD">182550000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_6e41e23b-db67-4455-8010-c2a56cce1fee"
      unitRef="U_USD">5095000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_9801e629-57bd-4958-828c-e814c4c3fcf2"
      unitRef="U_USD">3863000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_0cc236bd-6e61-46db-9189-70ceae37253a"
      unitRef="U_USD">13787000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_514d1a26-7c63-4226-8c66-e1195f3e2226"
      unitRef="U_USD">15239000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <rxst:LeaseLiabilitiesCurrent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_36a15cde-27d5-4f3c-a662-c92b990a298b"
      unitRef="U_USD">736000</rxst:LeaseLiabilitiesCurrent>
    <rxst:LeaseLiabilitiesCurrent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_10256429-af59-4315-b608-515eb4b4cc10"
      unitRef="U_USD">1801000</rxst:LeaseLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_2e15577e-3c05-45ee-8f9f-4c11d52233de"
      unitRef="U_USD">19618000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_d43df426-595b-4b37-951b-79d9279f2e01"
      unitRef="U_USD">20903000</us-gaap:LiabilitiesCurrent>
    <rxst:LeaseLiabilitiesNoncurrent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_8703eeae-a557-4607-a8d5-1d3175708b69"
      unitRef="U_USD">10674000</rxst:LeaseLiabilitiesNoncurrent>
    <rxst:LeaseLiabilitiesNoncurrent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_f6dbe58b-45d0-4fc8-a5e0-c396c03d9c12"
      unitRef="U_USD">1211000</rxst:LeaseLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_602b90df-cbe5-4780-a8b4-3746ed4dec14"
      unitRef="U_USD">0</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_f0a73557-3e43-4001-95f6-edee45eb0446"
      unitRef="U_USD">74000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_309b292a-3d40-402b-aa74-6194382e8164"
      unitRef="U_USD">30292000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_00211713-fc90-44bb-b68f-ffebf5b39eeb"
      unitRef="U_USD">22188000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="3"
      id="F_d7c4b66b-b924-4daa-993c-beb4ef1384e4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="3"
      id="F_331448c0-92b3-4567-9f3c-5ae439eb3c11"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="0"
      id="F_9b8ccba8-b3ab-4ce8-87dc-e2f5c40ddafa"
      unitRef="U_shares">900000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="0"
      id="F_01b7c800-34b0-4a2b-9a16-8e4a270f2e50"
      unitRef="U_shares">900000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="0"
      id="F_0d52a8cf-e87b-47bb-9e53-9b10ea54c355"
      unitRef="U_shares">39617334</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="0"
      id="F_4f94b57e-175f-453e-a04c-46665185903a"
      unitRef="U_shares">39617334</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="0"
      id="F_c607fb56-8a8d-4ad0-b90f-7e537518b78a"
      unitRef="U_shares">36139513</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="0"
      id="F_304cb782-34ad-4a9e-bd48-a0db9fc52695"
      unitRef="U_shares">36139513</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_78895e80-6123-46a4-baae-3967b7982b21"
      unitRef="U_USD">40000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_740b5e99-f532-47ca-b6de-369e900fdcd0"
      unitRef="U_USD">36000</us-gaap:CommonStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="3"
      id="F_d7c18882-058e-429b-975b-5fd7702b0b88"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="3"
      id="F_4121e940-8bf1-4543-bf8d-baad432a2696"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="0"
      id="F_d8d65060-6308-4335-9f07-3a178c71e3a3"
      unitRef="U_shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="0"
      id="F_33b97761-536f-4186-ad18-e1e04798baf3"
      unitRef="U_shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="0"
      id="F_bb7c1543-c2c5-4588-b6fc-62f414cd1151"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="0"
      id="F_f6108473-1f78-4809-b9dd-7da8b078f3a5"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="0"
      id="F_957abbda-5e8e-432b-843f-cb5598dea11e"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="0"
      id="F_b0200075-eda4-4890-9867-5ab6e331e065"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_0ad5ccda-ba3f-4339-915e-89f4a716bd17"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_dfae5745-e227-4f3e-8388-dd9636cc2170"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_0fa8423e-b505-43bf-940b-1a8b0433d94f"
      unitRef="U_USD">885104000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_c3389bf5-4e78-45bc-8873-937ef901f23b"
      unitRef="U_USD">754971000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_21703fc1-b869-4619-b65f-610033efa25a"
      unitRef="U_USD">-118000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_f56d0f42-d7ae-4c9e-9da5-ace4c8386529"
      unitRef="U_USD">-5000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_31d9b910-0136-432c-bd17-6a85bce1d58e"
      unitRef="U_USD">-609819000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_e5ad90fa-1d2e-44d5-9575-99ed55a82789"
      unitRef="U_USD">-594640000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_628c3352-f0cc-4d69-8e62-9474023f6fb2"
      unitRef="U_USD">275207000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_e58166b8-853d-4719-85d6-feafe1b9bacb"
      unitRef="U_USD">160362000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_f565793c-0cd9-46e8-9b40-f953b51ec511"
      unitRef="U_USD">305499000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_4a36e66d-f649-4995-ad8b-dd184045bca9"
      unitRef="U_USD">182550000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_c62e5fe9-2f12-4fd8-a7a9-ae07631c0108"
      unitRef="U_USD">34887000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_7e014ed8-5df7-4039-817c-37fe27ba5524"
      unitRef="U_USD">20810000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_81799486-d33d-4224-bc86-59f440d6ca2f"
      unitRef="U_USD">64399000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_d6aa82b7-6c88-4fa7-9655-c79903ee53a1"
      unitRef="U_USD">38299000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_c22ab69b-7cfc-46dc-931e-2cd220dd2b36"
      unitRef="U_USD">10637000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_86e60b33-4ce9-410d-906b-8b3b5aebfa2a"
      unitRef="U_USD">8795000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_60fc0848-8e8b-4f72-8c66-f75ff16df2ea"
      unitRef="U_USD">19464000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_73030a95-cb4a-4386-97e5-3489f5892e5d"
      unitRef="U_USD">15919000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_5192f2d7-bedd-4055-a042-d707269382e8"
      unitRef="U_USD">24250000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_9cf88bbf-d450-479f-8ead-2cdc381c7aa8"
      unitRef="U_USD">12015000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_1606953b-b711-48e5-ad73-7812f147ceb0"
      unitRef="U_USD">44935000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_03824927-ae8c-4ada-aef7-213718b5e752"
      unitRef="U_USD">22380000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_0e5f313f-2c63-4b8e-bea1-e153643d1e5c"
      unitRef="U_USD">24292000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_53f6e99e-2458-459c-9694-57b6abcc71b1"
      unitRef="U_USD">18239000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_9d1a37c5-619e-4886-93fb-cf317c092a9e"
      unitRef="U_USD">47616000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_e77a7afc-1bf7-4fba-aec9-6ce9f89cb56c"
      unitRef="U_USD">34492000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_a56ef974-f9e7-4cc5-bdb8-cb787b5fb1e8"
      unitRef="U_USD">8291000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_23df147b-b39e-45c9-ac6c-4dcf01b936ab"
      unitRef="U_USD">7401000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_31731d5f-28ad-46c0-8f61-d55ea37afd29"
      unitRef="U_USD">16322000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_8b69965d-0ce1-4eb3-ac05-f9bde94baa03"
      unitRef="U_USD">14608000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_8eb76c45-bc65-4e8e-8edf-b002697551b2"
      unitRef="U_USD">32583000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_a5b731d3-b1c7-484a-897f-926023fe2b63"
      unitRef="U_USD">25640000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_2e79dd5b-edac-43fb-a49b-9273a3afabcd"
      unitRef="U_USD">63938000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_fdb7308c-2075-429b-9eea-6163dbf76003"
      unitRef="U_USD">49100000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_4b490e84-8787-43c5-ad06-ea2a3730c87e"
      unitRef="U_USD">-8333000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_0df53456-15a0-4979-89fc-666f53a52527"
      unitRef="U_USD">-13625000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_4d2a17c7-9495-4c7d-9b87-3c758ab6da0e"
      unitRef="U_USD">-19003000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_63414d11-8a85-443d-b2bc-8a84349ed4ce"
      unitRef="U_USD">-26720000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_b86d9dc6-bf4b-4b2b-8615-850383be745f"
      unitRef="U_USD">6000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_cea92882-671a-445f-bd3b-ebd86e3a5038"
      unitRef="U_USD">1568000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_ec13e22a-c8b8-4134-a76b-520f002c8240"
      unitRef="U_USD">11000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_79e67358-73d0-482b-a697-8719de27f919"
      unitRef="U_USD">3075000</us-gaap:InterestExpense>
    <us-gaap:InterestAndOtherIncome
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_82ec3fdf-5347-47c6-9fe8-2275a25a5ae2"
      unitRef="U_USD">2276000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_61a10fa0-b23b-44f8-ad8f-99e62e44687b"
      unitRef="U_USD">1777000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_4ee2f604-5d26-429f-81fc-84caecc416c9"
      unitRef="U_USD">3860000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_ba209629-2d2b-49d3-8a35-5d9e31cdba54"
      unitRef="U_USD">3168000</us-gaap:InterestAndOtherIncome>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_09515eff-0177-492b-9958-ed0dedf352f4"
      unitRef="U_USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_68b69129-4889-4ebf-b404-f85806c0b7f5"
      unitRef="U_USD">-362000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_c2915fc4-10f2-401d-9ec0-0a0d7f02e568"
      unitRef="U_USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_0f509bb7-6118-4c81-b14c-9d6e78255beb"
      unitRef="U_USD">-362000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_fa138c1b-bf27-4a20-a3d5-2dccc3147672"
      unitRef="U_USD">-6063000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_e1e77f02-c78d-4dcc-ba73-0eee56f19f9f"
      unitRef="U_USD">-13778000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_1fcd902d-66ea-4b1e-abd6-012ee3bc6e01"
      unitRef="U_USD">-15154000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_0089612e-0f23-476f-8176-dca382fe7480"
      unitRef="U_USD">-26989000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_1c65869d-022d-4dd1-bdf7-42477d04c6be"
      unitRef="U_USD">16000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_76dacad5-ed6c-411f-b9ca-3842a5744b35"
      unitRef="U_USD">26000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_9f693330-6a45-4c0a-bfd3-0fc7d9611200"
      unitRef="U_USD">25000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_9c229c43-ae43-4389-a885-7356bcf8f970"
      unitRef="U_USD">27000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_239a8137-bfe8-4ee3-9e1e-75c593208eef"
      unitRef="U_USD">-6079000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_d35f1401-82d4-43db-9323-3fbf316350fe"
      unitRef="U_USD">-13804000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_23f68c84-d999-4634-ab5d-05730ebb660f"
      unitRef="U_USD">-15179000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_c40e0a36-34d6-486b-9c4a-64a8d04d26ed"
      unitRef="U_USD">-27016000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_ba9964d3-8255-4d6a-ace2-bdd0882db550"
      unitRef="U_USD">-64000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_2c75811a-601e-475e-8404-308bd9d19ea5"
      unitRef="U_USD">-65000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_0291a537-163d-4bba-acbf-3921b5fa684e"
      unitRef="U_USD">-109000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_cf433510-82cb-4149-a5d0-0f103f028bbb"
      unitRef="U_USD">19000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_666106a8-f0a2-4ee7-a406-7c251797014c"
      unitRef="U_USD">-1000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_3bdea725-a498-4d58-bcb9-b2417ae1fad5"
      unitRef="U_USD">1000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_65b7ec32-3b55-435b-82a5-04e62f9e7a7c"
      unitRef="U_USD">-4000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_c715ddb6-2d74-47d7-9e25-2d6182f716f0"
      unitRef="U_USD">3000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_ce94f259-ad6c-4d07-8038-284df37454ba"
      unitRef="U_USD">-65000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_c467f7cf-29fe-4ecd-9f17-4f054c175c50"
      unitRef="U_USD">-64000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_e542abc4-2546-4ab1-ba51-640475df6964"
      unitRef="U_USD">-113000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_3ea6e706-a1f9-4b18-bfe7-7d7b1e8fb77f"
      unitRef="U_USD">22000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_66b6bef2-7d2a-431c-8045-043685e23180"
      unitRef="U_USD">-6144000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_9a4aa7e9-df93-4765-8170-47b47e3ab129"
      unitRef="U_USD">-13868000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_4863e397-7f73-4d1b-bd0c-33a39c7a462d"
      unitRef="U_USD">-15292000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_38dfab1f-fd70-44d7-88d3-8cd70d34115f"
      unitRef="U_USD">-26994000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="2"
      id="F_6b82eb60-9721-491c-81a4-89d99fe3cf54"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="2"
      id="F_a8572260-f3e3-4233-968e-d501cf930327"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="2"
      id="F_5e9e0785-a9f0-41d3-831c-8ac1753a50e6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.4</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="2"
      id="F_1a2e4a59-5f96-4bc9-b21f-5426bd090a97"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.4</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="2"
      id="F_edd8b778-2783-45d9-af13-6a6dc3707300"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.4</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="2"
      id="F_94623031-f063-48ed-b115-9b55ff664549"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.4</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="2"
      id="F_dfc59f4c-c93e-422c-bfce-de421cba9700"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="2"
      id="F_4d1143ac-f4a0-48a5-b9dc-62252bb4944e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.82</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="INF"
      id="F_f3aff8aa-5eba-40fa-ba5f-c2913f19b880"
      unitRef="U_shares">38455955</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="INF"
      id="F_72814266-864f-4ef1-af51-85be5fc763b1"
      unitRef="U_shares">38455955</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="INF"
      id="F_575df07c-da96-478e-ab82-d55337d84681"
      unitRef="U_shares">34498265</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="INF"
      id="F_86f847aa-5732-4f18-abb9-dbc7df74a3be"
      unitRef="U_shares">34498265</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="INF"
      id="F_0977c0ca-8aeb-4711-b55f-affc1943654d"
      unitRef="U_shares">37649521</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="INF"
      id="F_6a65eacd-4950-4c31-90ba-69b4ce3259e1"
      unitRef="U_shares">37649521</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="INF"
      id="F_00826041-3635-4146-a1e7-04a64b385862"
      unitRef="U_shares">33075585</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="INF"
      id="F_691d1c76-3a1a-43c5-8960-d62efb90679c"
      unitRef="U_shares">33075585</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_f4720bce-2db3-4982-a9fd-2cefd4a958ca"
      decimals="INF"
      id="F_54f62da2-6278-417b-8ad5-72244e16fef4"
      unitRef="U_shares">36139513</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_f4720bce-2db3-4982-a9fd-2cefd4a958ca"
      decimals="-3"
      id="F_a90e8f8e-e7ff-4338-ba61-4533020cede1"
      unitRef="U_USD">36000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_7e492a7e-2688-44a6-8a92-202d81383908"
      decimals="-3"
      id="F_12dbdd65-cd5c-4629-82b9-15d9edea56ad"
      unitRef="U_USD">754971000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_cc013c64-8342-45ef-9d49-af4eb130d7ea"
      decimals="-3"
      id="F_342cf532-c0e8-4208-b223-a8b5d586b052"
      unitRef="U_USD">-5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_9c844e79-68e3-4292-baac-af1e749bfefa"
      decimals="-3"
      id="F_9e283dc9-3992-44bd-a199-023fd7c08b7f"
      unitRef="U_USD">-594640000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_9fe76340-4747-427a-b85f-121e2effac2e"
      unitRef="U_USD">160362000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares
      contextRef="C_83a98163-4754-4205-8811-d48d703e7dce"
      decimals="INF"
      id="F_31145d93-e120-4388-bb48-cd20751d5fb8"
      unitRef="U_shares">1061336</rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares>
    <rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount
      contextRef="C_83a98163-4754-4205-8811-d48d703e7dce"
      decimals="-3"
      id="F_055850c1-b271-4c51-a315-99048e45b2e4"
      unitRef="U_USD">1000</rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount>
    <rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount
      contextRef="C_ddfd1e3b-9d8b-446b-abd3-a22e0ca0bfa2"
      decimals="-3"
      id="F_10ff395a-e231-4dc4-b553-bdf93bfcacbb"
      unitRef="U_USD">10152000</rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount>
    <rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount
      contextRef="C_27166295-b86b-480b-8ace-2e05125185d6"
      decimals="-3"
      id="F_24b644ff-55e7-486d-b929-ac5b67c0359e"
      unitRef="U_USD">10153000</rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount>
    <rxst:SharesRedeemedForEmployeeTaxWithholdings
      contextRef="C_83a98163-4754-4205-8811-d48d703e7dce"
      decimals="INF"
      id="F_ef1db93a-e9ee-403d-9237-34ddd95b577a"
      unitRef="U_shares">-39096</rxst:SharesRedeemedForEmployeeTaxWithholdings>
    <rxst:SharesRedeemedForEmployeeTaxWithHoldingsAmount
      contextRef="C_ddfd1e3b-9d8b-446b-abd3-a22e0ca0bfa2"
      decimals="-3"
      id="F_64369299-da42-4c2b-8bbe-5e95849ddb80"
      unitRef="U_USD">-2134000</rxst:SharesRedeemedForEmployeeTaxWithHoldingsAmount>
    <rxst:SharesRedeemedForEmployeeTaxWithHoldingsAmount
      contextRef="C_27166295-b86b-480b-8ace-2e05125185d6"
      decimals="-3"
      id="F_ec4abf04-407d-4b32-b90c-1ecc006df166"
      unitRef="U_USD">-2134000</rxst:SharesRedeemedForEmployeeTaxWithHoldingsAmount>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_ddfd1e3b-9d8b-446b-abd3-a22e0ca0bfa2"
      decimals="-3"
      id="F_ec66b23f-ce77-4bfa-9386-3ea8922cdbc9"
      unitRef="U_USD">4696000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_27166295-b86b-480b-8ace-2e05125185d6"
      decimals="-3"
      id="F_b9980b40-ae50-4625-8b02-a937b2adfa61"
      unitRef="U_USD">4696000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_c3b8c0f8-26a4-4d47-91da-6c055e856dac"
      decimals="-3"
      id="F_8c265bcc-5a08-43d6-b928-cdce5f9b36df"
      unitRef="U_USD">-45000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_27166295-b86b-480b-8ace-2e05125185d6"
      decimals="-3"
      id="F_2480a7b2-dee9-4ea9-8f00-4462c0bb3e59"
      unitRef="U_USD">-45000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="C_c3b8c0f8-26a4-4d47-91da-6c055e856dac"
      decimals="-3"
      id="F_9b735bb9-54c2-4066-8665-5576a5576714"
      unitRef="U_USD">-3000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="C_27166295-b86b-480b-8ace-2e05125185d6"
      decimals="-3"
      id="F_caa9e3e0-c0a1-412d-96a0-ba86326ee3d3"
      unitRef="U_USD">-3000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_3ce1a97a-19b2-4c6c-aa54-c82451d2825f"
      decimals="-3"
      id="F_98b68504-b75a-4e49-818e-af0bd29bc5a9"
      unitRef="U_USD">-9100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_27166295-b86b-480b-8ace-2e05125185d6"
      decimals="-3"
      id="F_cc67c202-9edb-412d-80b6-2096d603a951"
      unitRef="U_USD">-9100000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_ecbfe3e0-15a9-4d92-ac2a-89dac13644c1"
      decimals="INF"
      id="F_b0b51fac-0a57-43c1-8759-43c0d23bfba8"
      unitRef="U_shares">37161753</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_ecbfe3e0-15a9-4d92-ac2a-89dac13644c1"
      decimals="-3"
      id="F_2c12293e-3d3e-455f-9917-3ebd56ada892"
      unitRef="U_USD">37000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_bf0d539d-f732-43b5-bfee-00d8e0a9765f"
      decimals="-3"
      id="F_168e20cc-ba02-4235-89fd-dbc4443b5d44"
      unitRef="U_USD">767685000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_32b78179-ee95-441f-9a0f-c5d71aff0dbb"
      decimals="-3"
      id="F_2046cb93-00d2-44d8-9853-54f378bde265"
      unitRef="U_USD">-53000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_4f93e213-8803-490d-b3f5-c935ceb12ab4"
      decimals="-3"
      id="F_473dbabe-ea6e-467b-bb74-b100587f4701"
      unitRef="U_USD">-603740000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_996a376f-b733-4535-8dce-1a21486a132a"
      decimals="-3"
      id="F_35abb905-0df7-424f-996b-068f3892baf0"
      unitRef="U_USD">163929000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares
      contextRef="C_55feb510-96cb-4d20-af10-c695f8e02985"
      decimals="0"
      id="F_ba070524-30ed-407f-9243-852e07cb5bec"
      unitRef="U_shares">363105</rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares>
    <rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount
      contextRef="C_55feb510-96cb-4d20-af10-c695f8e02985"
      decimals="-3"
      id="F_a9b6b8e1-e074-4cee-86d1-549ca66bbdae"
      unitRef="U_USD">1000</rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount>
    <rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount
      contextRef="C_3713ac89-35d4-43e3-9168-1283294925cf"
      decimals="-3"
      id="F_4ab06c43-44bf-452d-916e-42c713ce5de6"
      unitRef="U_USD">3102000</rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount>
    <rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_a5da59d1-767f-46bb-bcc6-78174e16c183"
      unitRef="U_USD">3103000</rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_3713ac89-35d4-43e3-9168-1283294925cf"
      decimals="-3"
      id="F_145e8d2d-1b54-4e1e-8b4b-186feba05ccd"
      unitRef="U_USD">6105000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_d99d018a-3c1e-44b5-8eda-20532beda6a0"
      unitRef="U_USD">6105000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_55feb510-96cb-4d20-af10-c695f8e02985"
      decimals="0"
      id="F_356a4e16-f6f4-428b-995b-aa7618cb7738"
      unitRef="U_shares">38905</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <rxst:SharesIssuedForTheEmployeeStockPurchasePlanAmount
      contextRef="C_3713ac89-35d4-43e3-9168-1283294925cf"
      decimals="-3"
      id="F_b1a8339d-60ce-4701-b490-64301db3a39d"
      unitRef="U_USD">737000</rxst:SharesIssuedForTheEmployeeStockPurchasePlanAmount>
    <rxst:SharesIssuedForTheEmployeeStockPurchasePlanAmount
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_4dfbf5ad-9149-4834-9726-ced7f5d8fc9d"
      unitRef="U_USD">737000</rxst:SharesIssuedForTheEmployeeStockPurchasePlanAmount>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_55feb510-96cb-4d20-af10-c695f8e02985"
      decimals="0"
      id="F_e932f97c-5968-4fca-a3dc-00fc07ed4dfd"
      unitRef="U_shares">2053571</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_55feb510-96cb-4d20-af10-c695f8e02985"
      decimals="-3"
      id="F_e7ad19b7-0d78-47e6-862b-d854ee7d2247"
      unitRef="U_USD">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_3713ac89-35d4-43e3-9168-1283294925cf"
      decimals="-3"
      id="F_5debb525-fb7f-4b6c-b0ff-21d72a1e4614"
      unitRef="U_USD">107475000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_3d6dfbdf-fe2f-4d15-8623-f4a551b56cc4"
      unitRef="U_USD">107477000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_2bacb43d-9328-45cb-9df2-94d7e8766fe6"
      decimals="-3"
      id="F_9fd1d043-28b1-4490-84d0-2d76fd10d6b2"
      unitRef="U_USD">-64000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_cc8a6410-f405-4fc5-a4f3-226502df068b"
      unitRef="U_USD">-64000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="C_2bacb43d-9328-45cb-9df2-94d7e8766fe6"
      decimals="-3"
      id="F_052bc92c-8bfc-4d10-9cc6-46066612580d"
      unitRef="U_USD">-1000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_eddd5857-793d-41cd-a4a0-f272f89e35f4"
      unitRef="U_USD">-1000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_09b691ca-838d-431d-8501-a873d038e2bf"
      decimals="-3"
      id="F_0e957810-2b45-46cd-86f1-f4e73474d3d3"
      unitRef="U_USD">-6079000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_c622e94c-c71e-40f9-8d86-3e233ba0b4d7"
      unitRef="U_USD">-6079000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_92a77da4-deaa-41ad-80d7-531024609f4d"
      decimals="0"
      id="F_c77204a1-283e-4750-9702-474903cdc942"
      unitRef="U_shares">39617334</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_92a77da4-deaa-41ad-80d7-531024609f4d"
      decimals="-3"
      id="F_a00df9e8-6e6e-4a4f-acf5-b549f96f72d2"
      unitRef="U_USD">40000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0996adb5-0bb8-42c5-98aa-9a62af36677e"
      decimals="-3"
      id="F_7a125844-0a70-4b63-b58c-da6ed6a748f4"
      unitRef="U_USD">885104000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_78dfb1d2-f1e6-40bf-aa34-8f63a8bccd9f"
      decimals="-3"
      id="F_85b141d4-9c65-4538-b697-3946f27fb34a"
      unitRef="U_USD">-118000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_1b3a5e20-5e60-40d8-ac83-f2c584e1b842"
      decimals="-3"
      id="F_7d7fad4e-fff1-493c-a7bf-145166b97eb3"
      unitRef="U_USD">-609819000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_e3bd2b9e-4795-4dab-948e-1b9439c6d998"
      unitRef="U_USD">275207000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_70dadb47-1500-4a1d-8f19-f29b9940b04f"
      decimals="0"
      id="F_62248cea-5dbb-4041-ab21-e2ce9b67a40c"
      unitRef="U_shares">28268389</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_70dadb47-1500-4a1d-8f19-f29b9940b04f"
      decimals="-3"
      id="F_6ccde3fa-7953-4027-a7f3-9ec7ab4525e9"
      unitRef="U_USD">28000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_924b61de-5beb-4902-a3d1-1540e5a5473b"
      decimals="-3"
      id="F_b10311b5-7821-4515-944b-4421ba9360c8"
      unitRef="U_USD">636001000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_a248ded6-40d4-40c0-89fd-1e7502f8ac3f"
      decimals="-3"
      id="F_88ce2ae3-d695-4ca6-89a4-87e75b045b22"
      unitRef="U_USD">-95000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_e9ed04cb-b0ee-40da-929b-a0f166a7eea4"
      decimals="-3"
      id="F_b9942c63-10e9-47ef-ae68-0388ef144991"
      unitRef="U_USD">-546032000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_ef35aeef-393e-488b-85fd-95ffed2e764e"
      decimals="-3"
      id="F_0b3988d3-1fd9-4ef3-a39f-d5f16909dd78"
      unitRef="U_USD">89902000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares
      contextRef="C_f2e112f5-12f8-406a-a985-9a26dca174bc"
      decimals="0"
      id="F_b191f6b2-95aa-4bd3-a9b1-f630f10c1a6e"
      unitRef="U_shares">243598</rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares>
    <rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount
      contextRef="C_44a8675d-687c-4d77-b5fb-c997d6d277a5"
      decimals="-3"
      id="F_837abe1d-841b-4f97-8c48-cb3ba05a74b8"
      unitRef="U_USD">761000</rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount>
    <rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount
      contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c"
      decimals="-3"
      id="F_79a1d5fb-63dc-413c-b15a-e0e8abb9641f"
      unitRef="U_USD">761000</rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount>
    <rxst:SharesRedeemedForEmployeeTaxWithholdings
      contextRef="C_f2e112f5-12f8-406a-a985-9a26dca174bc"
      decimals="0"
      id="F_6f5200da-e435-4b3c-ad29-a6017c751372"
      unitRef="U_shares">-24631</rxst:SharesRedeemedForEmployeeTaxWithholdings>
    <rxst:SharesRedeemedForEmployeeTaxWithHoldingsAmount
      contextRef="C_44a8675d-687c-4d77-b5fb-c997d6d277a5"
      decimals="-3"
      id="F_22d57b2b-d0b0-4f0e-9ef4-a17d7aac86a9"
      unitRef="U_USD">-337000</rxst:SharesRedeemedForEmployeeTaxWithHoldingsAmount>
    <rxst:SharesRedeemedForEmployeeTaxWithHoldingsAmount
      contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c"
      decimals="-3"
      id="F_9ecc8b4f-ba64-485d-a338-175476630945"
      unitRef="U_USD">-337000</rxst:SharesRedeemedForEmployeeTaxWithHoldingsAmount>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_44a8675d-687c-4d77-b5fb-c997d6d277a5"
      decimals="-3"
      id="F_85f8b86f-3a10-42a5-bd0b-8475b1e54e21"
      unitRef="U_USD">3295000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c"
      decimals="-3"
      id="F_3a132a5a-06d8-47e1-bb31-53d719d9bd34"
      unitRef="U_USD">3295000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_f2e112f5-12f8-406a-a985-9a26dca174bc"
      decimals="0"
      id="F_a28ab615-19fc-490c-afc7-e8dbe43d014f"
      unitRef="U_shares">4600000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_f2e112f5-12f8-406a-a985-9a26dca174bc"
      decimals="-3"
      id="F_e381f2d7-9f94-44ba-ab2a-bebba582c14a"
      unitRef="U_USD">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_44a8675d-687c-4d77-b5fb-c997d6d277a5"
      decimals="-3"
      id="F_8ce15e09-9b58-415a-87d0-0f816903cd61"
      unitRef="U_USD">53595000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c"
      decimals="-3"
      id="F_7de2feeb-ea3b-439f-9ca7-473a28ba96c7"
      unitRef="U_USD">53600000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare
      contextRef="C_f2e112f5-12f8-406a-a985-9a26dca174bc"
      decimals="0"
      id="F_a2927b76-b546-4250-857d-6075a16cc8b6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">879341</rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsShare>
    <rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount
      contextRef="C_f2e112f5-12f8-406a-a985-9a26dca174bc"
      decimals="-3"
      id="F_b1c775c6-c1ce-41f1-b3ae-0346b0262a39"
      unitRef="U_USD">1000</rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount>
    <rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount
      contextRef="C_44a8675d-687c-4d77-b5fb-c997d6d277a5"
      decimals="-3"
      id="F_23fe1017-1cbb-406b-a200-77562d7dab7c"
      unitRef="U_USD">10913000</rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount>
    <rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount
      contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c"
      decimals="-3"
      id="F_7ec831d8-4960-4391-8270-c57ec70ab5ab"
      unitRef="U_USD">10914000</rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_e2c20804-0137-4f36-8ede-788b3dd3695e"
      decimals="-3"
      id="F_58717169-bc14-4f04-baee-dec1fc357a12"
      unitRef="U_USD">84000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c"
      decimals="-3"
      id="F_6c8f1dd4-629a-42bf-8590-ddaeb8d50b0b"
      unitRef="U_USD">84000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="C_e2c20804-0137-4f36-8ede-788b3dd3695e"
      decimals="-3"
      id="F_9344ccfc-96a6-4282-bda2-494c41289d83"
      unitRef="U_USD">2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c"
      decimals="-3"
      id="F_5d5b61cb-a3b0-4753-af1e-ca0740b7297f"
      unitRef="U_USD">2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_b23a28e2-f54d-421e-a468-87056efde586"
      decimals="-3"
      id="F_f18329b8-7e63-44a0-abed-648c82555897"
      unitRef="U_USD">-13212000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_94635311-ec03-402f-a7d8-37123b9f3f6c"
      decimals="-3"
      id="F_9ad7d6d5-e5f4-4e9b-83a4-7310ed0e60c5"
      unitRef="U_USD">-13212000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_859e1bb0-35f3-40e8-afc9-6b5a07eec379"
      decimals="0"
      id="F_608dacfa-1b50-4b1c-b36d-a9db6a853be4"
      unitRef="U_shares">33966697</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_859e1bb0-35f3-40e8-afc9-6b5a07eec379"
      decimals="-3"
      id="F_ac060396-3928-49b7-a3f0-3c4cca2f5eed"
      unitRef="U_USD">34000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_46db9299-0314-43f1-84b8-70e7b2fcce61"
      decimals="-3"
      id="F_72f4f698-426f-4ad4-ade3-0e067b53bd8e"
      unitRef="U_USD">704228000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_8de5eb07-df34-4d9b-8ee7-1a3ce4214e1a"
      decimals="-3"
      id="F_902a6a1c-9b48-4364-be42-8bf9268e1e55"
      unitRef="U_USD">-9000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_3861c8c4-bc18-464d-8af7-febf616f8757"
      decimals="-3"
      id="F_1f1ec47a-2e88-44e3-807d-b6914ec259fb"
      unitRef="U_USD">-559244000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_d8974959-d59e-44c2-b138-8241de80e80a"
      decimals="-3"
      id="F_b5cc02b4-e602-48b3-9382-3e74645d41a7"
      unitRef="U_USD">145009000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares
      contextRef="C_aa2973b8-fc17-4fe1-b3e1-f27dd4a7007f"
      decimals="0"
      id="F_b9a2c8bc-12a0-4d61-9b22-a198307cd20e"
      unitRef="U_shares">316092</rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsShares>
    <rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount
      contextRef="C_51a8f883-c93e-441e-8b3a-10e80e0d9a20"
      decimals="-3"
      id="F_0c1fe43f-6da3-4e9d-8a37-2b76fa1cd8e0"
      unitRef="U_USD">2599000</rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount>
    <rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_695803c0-0fcf-4f90-99e6-894672b243ea"
      unitRef="U_USD">2599000</rxst:SharesIssuedForTheExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsAmount>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_51a8f883-c93e-441e-8b3a-10e80e0d9a20"
      decimals="-3"
      id="F_da039c26-2578-4510-8c8d-f293631e7237"
      unitRef="U_USD">3955000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_b7631a0d-37b7-4bf4-b805-59320fe53358"
      unitRef="U_USD">3955000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_aa2973b8-fc17-4fe1-b3e1-f27dd4a7007f"
      decimals="0"
      id="F_4aba49dd-f442-4a8a-b503-cb92941533e3"
      unitRef="U_shares">50504</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <rxst:SharesIssuedForTheEmployeeStockPurchasePlanAmount
      contextRef="C_51a8f883-c93e-441e-8b3a-10e80e0d9a20"
      decimals="-3"
      id="F_927cce34-c9c8-4198-b0ab-4de8f99966f4"
      unitRef="U_USD">536000</rxst:SharesIssuedForTheEmployeeStockPurchasePlanAmount>
    <rxst:SharesIssuedForTheEmployeeStockPurchasePlanAmount
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_6c4c6782-421d-47d5-84b6-cbebd4c2c38f"
      unitRef="U_USD">536000</rxst:SharesIssuedForTheEmployeeStockPurchasePlanAmount>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_aa2973b8-fc17-4fe1-b3e1-f27dd4a7007f"
      decimals="0"
      id="F_8c0a49bb-f317-4eea-84a8-54a320fef64a"
      unitRef="U_shares">834748</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount
      contextRef="C_aa2973b8-fc17-4fe1-b3e1-f27dd4a7007f"
      decimals="-3"
      id="F_36491e35-2fd7-4b56-8da4-de6486c6a27d"
      unitRef="U_USD">1000</rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount>
    <rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount
      contextRef="C_51a8f883-c93e-441e-8b3a-10e80e0d9a20"
      decimals="-3"
      id="F_9a57b6c5-afbc-46a0-b1a7-c393741fc949"
      unitRef="U_USD">18956000</rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount>
    <rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_6762c99b-0cba-4e2a-9019-9c149bc0ca69"
      unitRef="U_USD">18957000</rxst:IssuanceOfCommonStockInAtTheMarketOfferingsNetOfIssuanceCostsAmount>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_f9e9e639-bb5c-4c5b-bef2-2b16f5ee280c"
      decimals="-3"
      id="F_cc4a5eb1-ab4b-4140-8368-33c5b65af421"
      unitRef="U_USD">-65000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_5372c1bf-fd19-4fff-8142-222563389818"
      unitRef="U_USD">-65000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="C_f9e9e639-bb5c-4c5b-bef2-2b16f5ee280c"
      decimals="-3"
      id="F_7b68616c-efb1-4607-bc3a-0b170ec738f5"
      unitRef="U_USD">1000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_75035192-8b58-4ad2-bd77-6534384304c4"
      unitRef="U_USD">1000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_d98bbae7-20c2-4ccd-9db3-beaa1215b76d"
      decimals="-3"
      id="F_e78d845d-b3ea-48a1-b0ed-a0f689e6ea8b"
      unitRef="U_USD">-13804000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_175539eb-0c73-477b-a0e4-fcd12340f612"
      unitRef="U_USD">-13804000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_88b8255e-f275-4b86-96c2-52ba7228dcd4"
      decimals="0"
      id="F_08a31b96-699b-407f-8552-67a4e1025aab"
      unitRef="U_shares">35168041</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_88b8255e-f275-4b86-96c2-52ba7228dcd4"
      decimals="-3"
      id="F_fd1dff6d-ba99-4770-92c3-baabe433a123"
      unitRef="U_USD">35000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_080ee223-a04a-45a8-98a5-9eab7d1606a5"
      decimals="-3"
      id="F_34217056-8c79-4896-afe0-aa72cbaa104f"
      unitRef="U_USD">730274000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_93f8bf54-9e45-4c16-9967-dfadb4c026ed"
      decimals="-3"
      id="F_9a5f36bc-7da7-424c-a53d-e97efa859e9d"
      unitRef="U_USD">-73000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_5aacfb5c-bd2e-4b8f-915c-d1f78db2a9d7"
      decimals="-3"
      id="F_6ca7c851-428d-4786-805a-20b5a3285507"
      unitRef="U_USD">-573048000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_4cac1f56-50f3-44b0-afcc-1b3e03ff9aad"
      decimals="-3"
      id="F_88bb0e1f-e833-45da-87c8-474fceb6aab5"
      unitRef="U_USD">157188000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_2f616cc2-e9e1-454b-89f5-9242e580fc01"
      unitRef="U_USD">-15179000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_38026887-85cf-4f08-850c-cdb270437cb1"
      unitRef="U_USD">-27016000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_6ad755b5-7f7b-44cb-980c-3ee5ce89a4fe"
      unitRef="U_USD">1927000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_4e7fa969-d285-409e-8cf4-01deaa7b78d2"
      unitRef="U_USD">1944000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_70b9436c-f092-46ed-9450-ab4b9d52d824"
      unitRef="U_USD">33000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_957ed513-bf81-4333-b652-4564656e8cf5"
      unitRef="U_USD">85000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_a5e500ee-e128-4e83-bf07-68e5effd6edd"
      unitRef="U_USD">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_311b6dc3-53fd-4591-b21d-2eb8729c2665"
      unitRef="U_USD">283000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_a3036dfb-b9f5-48a9-90ad-777f7c414acd"
      unitRef="U_USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_3bcc4784-c82b-4a50-9091-60af80452a4f"
      unitRef="U_USD">-362000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_ffbbcc09-980d-4426-847b-6bb881ac7076"
      unitRef="U_USD">3578000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_75501ab5-9d8c-4371-a40e-12f4b1a775f4"
      unitRef="U_USD">2953000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_14b818fc-6e6b-413b-a46d-17201e259183"
      unitRef="U_USD">10801000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_e4beea6e-9698-4d1e-ad8e-e60bcbb2682d"
      unitRef="U_USD">7250000</us-gaap:ShareBasedCompensation>
    <us-gaap:InventoryWriteDown
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_fd867550-5c7c-4f78-a7fc-7133d96beef5"
      unitRef="U_USD">167000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_57d02b08-8872-4a74-be4b-1f4751b2a4eb"
      unitRef="U_USD">14000</us-gaap:InventoryWriteDown>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_8cb2a630-60eb-4657-8b30-fd56221fcdd5"
      unitRef="U_USD">5441000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_5fe3db23-67d8-46a4-894f-db6e2b93f9e9"
      unitRef="U_USD">2338000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_05420c7c-bc94-4244-8fb8-3f6668cbadaf"
      unitRef="U_USD">2189000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_ad1e7179-f425-4f00-b7f1-ab2f568c94e8"
      unitRef="U_USD">3124000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_7e3a4dc9-187d-4be2-9ffd-eca19b1c913e"
      unitRef="U_USD">-673000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_8d610d2d-07cb-4ad4-9110-a655138a74fa"
      unitRef="U_USD">-868000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_4acd82ec-4fbc-4b14-93ce-30ca89e53e68"
      unitRef="U_USD">789000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_2b266d42-c447-4df8-9a63-a88a5d3968e5"
      unitRef="U_USD">1324000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_3ade0a34-f5b0-4725-bca7-0228ef89937c"
      unitRef="U_USD">-1339000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_46f1707b-4fc3-48d6-9988-8bc4fbf5357f"
      unitRef="U_USD">-2009000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_96a7f645-1362-4711-8b0e-86a104d6971e"
      unitRef="U_USD">-13336000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_e14990e2-30e8-4db2-ba8d-ee8a9e130191"
      unitRef="U_USD">-25310000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_99c8b7a7-8940-4fe2-b3f0-7b0dbb620382"
      unitRef="U_USD">3490000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_0f1ecd23-7c89-4426-a85e-cad5b6bec1ae"
      unitRef="U_USD">2570000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_282a7d69-5391-4e0c-8814-d91b85b4d52d"
      unitRef="U_USD">119000000</us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_17220518-0441-46b1-bb6d-cff0ba35a784"
      unitRef="U_USD">115000000</us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_384837fa-ccaa-4b5f-bd50-3fc5c4694511"
      unitRef="U_USD">206881000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_3b8a647f-7915-4f26-96f0-d0e86f9c6056"
      unitRef="U_USD">156400000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_bd319cd4-c923-4b47-8d26-c9b3f77fb148"
      unitRef="U_USD">-91371000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_8dfffad1-602c-4248-bf6f-be82afc3884b"
      unitRef="U_USD">-43970000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_6e7239b8-c359-4aa3-97e2-f773896f476e"
      unitRef="U_USD">0</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_157c29e9-478b-44aa-8900-8c1d66700be0"
      unitRef="U_USD">20000000</us-gaap:ProceedsFromNotesPayable>
    <rxst:RepaymentOfTermLoan
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_88f033c7-476d-4011-9dfd-9f356a7325e6"
      unitRef="U_USD">0</rxst:RepaymentOfTermLoan>
    <rxst:RepaymentOfTermLoan
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_10dd6bca-920d-4ff7-9baf-0af8fd961b12"
      unitRef="U_USD">40000000</rxst:RepaymentOfTermLoan>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_c8653d95-2077-46d6-bd5f-d52df66780f7"
      unitRef="U_USD">108100000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_7bcaf0cc-6419-4d25-9788-6199d20bbd08"
      unitRef="U_USD">54050000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <rxst:ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_1064cfd4-198d-443d-875a-864fad532c71"
      unitRef="U_USD">0</rxst:ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings>
    <rxst:ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_73b1cd4d-da43-4e9d-bf24-85a00be7f506"
      unitRef="U_USD">30496000</rxst:ProceedsFromIssuanceOfCommonStockInAtTheMarketOfferings>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_e999b4f9-c9ca-4137-985d-8d3de89fadfd"
      unitRef="U_USD">13993000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_ac0f2caa-25b1-46f3-8343-43f798f4d371"
      unitRef="U_USD">3896000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <rxst:PaymentsForEmployeeTaxesRelatedToStockCompensation
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_8746a4b1-2081-4773-8376-07cc5f00fea2"
      unitRef="U_USD">-2133000</rxst:PaymentsForEmployeeTaxesRelatedToStockCompensation>
    <rxst:PaymentsForEmployeeTaxesRelatedToStockCompensation
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_71baa480-7695-4189-92ae-e875ed1ef59a"
      unitRef="U_USD">-337000</rxst:PaymentsForEmployeeTaxesRelatedToStockCompensation>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_72f8fdf4-f1f5-4bc1-a3b5-ed5aa74b2a33"
      unitRef="U_USD">38000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_47f49fd8-8466-40d9-a930-7fc4723681d9"
      unitRef="U_USD">82000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_c00373e0-e31b-4ac1-836b-c1a0e543e73a"
      unitRef="U_USD">377000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_a5315514-a60b-4d4a-ab2a-c273d1ae06f9"
      unitRef="U_USD">602000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_f8e66263-1630-4f93-8c8b-6245030cc726"
      unitRef="U_USD">80000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_bb63392c-0314-4c98-aa39-ad36642f69e3"
      unitRef="U_USD">1225000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_d23852d7-4b82-46aa-a5b2-9cf3482d0e40"
      unitRef="U_USD">119465000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_b430c663-878d-4592-9083-6e28d7376cdc"
      unitRef="U_USD">66196000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_6b040cfd-abdd-4c15-8655-33a8bbaaa711"
      unitRef="U_USD">-4000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_a1c776dd-d6b7-4953-beac-0c5d0e4845f7"
      unitRef="U_USD">3000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_a2bc7f69-ab3e-4b2a-be64-c8238252689b"
      unitRef="U_USD">14754000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_21c8eeda-5547-4e95-b3b8-06635e003425"
      unitRef="U_USD">-3081000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_76b1f6b6-e86a-4ad5-a1a3-8c2fc50cd210"
      unitRef="U_USD">10402000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_ef35aeef-393e-488b-85fd-95ffed2e764e"
      decimals="-3"
      id="F_6c4ed82d-4782-472c-b592-df3ad1779e05"
      unitRef="U_USD">12595000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_b0d6c42d-efde-4333-bef3-17884bc08731"
      unitRef="U_USD">25156000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_4cac1f56-50f3-44b0-afcc-1b3e03ff9aad"
      decimals="-3"
      id="F_ed8c2e8a-4f94-4603-85ca-b340346aa6a6"
      unitRef="U_USD">9514000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OperatingLeasePayments
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_77cfacdc-9852-401e-8477-acdd4a492ee9"
      unitRef="U_USD">1128000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_6b6ef941-ce18-40a3-aeb4-e5fb7996f781"
      unitRef="U_USD">1107000</us-gaap:OperatingLeasePayments>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_71a7bc7d-3ed4-4cf1-bb59-b9ad91227602"
      unitRef="U_USD">24000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_b4ee8f74-2f9d-4b6f-b100-da35b50efd54"
      unitRef="U_USD">12000</us-gaap:IncomeTaxesPaidNet>
    <rxst:InterestPaidOnFinancingLeases
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_d833f75e-36f5-44c3-8fbd-f90b1a2a7d92"
      unitRef="U_USD">11000</rxst:InterestPaidOnFinancingLeases>
    <rxst:InterestPaidOnFinancingLeases
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_6fcd3194-6fc7-4d39-bd35-52613b297dd2"
      unitRef="U_USD">7000</rxst:InterestPaidOnFinancingLeases>
    <rxst:InterestPaidOnTermLoan
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_64e746ee-9971-4ac8-990b-ba3d27530a0b"
      unitRef="U_USD">0</rxst:InterestPaidOnTermLoan>
    <rxst:InterestPaidOnTermLoan
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_e5b894e3-a65f-4d68-8506-201194151dd0"
      unitRef="U_USD">3240000</rxst:InterestPaidOnTermLoan>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_d9982fe6-da74-438d-9c0b-347c9a5f5026"
      unitRef="U_USD">9060000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_4fa2f9b2-88fc-498e-8247-f888012566f1"
      unitRef="U_USD">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_ee243091-da9c-4429-88aa-53091edc5176"
      unitRef="U_USD">19000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_bd032f52-4829-4c07-b450-0d8dd0fde630"
      unitRef="U_USD">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <rxst:OperatingLeaseObligationsIncurred
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_5de748dd-8af1-423c-ac24-10bb35498408"
      unitRef="U_USD">9060000</rxst:OperatingLeaseObligationsIncurred>
    <rxst:OperatingLeaseObligationsIncurred
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_d4a69e3a-8c9a-4399-abe5-de2b10671df4"
      unitRef="U_USD">0</rxst:OperatingLeaseObligationsIncurred>
    <rxst:FinanceLeaseObligationsIncurred
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_2b7da1b4-0e0d-4461-9f96-9432c53df499"
      unitRef="U_USD">19000</rxst:FinanceLeaseObligationsIncurred>
    <rxst:FinanceLeaseObligationsIncurred
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_20fcb84f-48e5-450a-92e4-156d17c4030f"
      unitRef="U_USD">0</rxst:FinanceLeaseObligationsIncurred>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_728cce9f-d4db-4d3f-91ec-6b43adeb973a"
      unitRef="U_USD">229000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_8695dea1-0cd6-44f1-b2eb-2b95b2dcb51d"
      unitRef="U_USD">408000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <rxst:DeferredOfferingCostsIncludedInAccruedExpenses
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_05f5265d-950b-4fec-9f68-e76ab990192c"
      unitRef="U_USD">392000</rxst:DeferredOfferingCostsIncludedInAccruedExpenses>
    <rxst:DeferredOfferingCostsIncludedInAccruedExpenses
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_12d2dc80-526c-4975-a488-8c2177ed4e35"
      unitRef="U_USD">187000</rxst:DeferredOfferingCostsIncludedInAccruedExpenses>
    <rxst:ReclassificationOfDeferredCost
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_d26d13de-f89b-4bd6-80eb-2de4f28ab475"
      unitRef="U_USD">-768000</rxst:ReclassificationOfDeferredCost>
    <rxst:ReclassificationOfDeferredCost
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_ebd1f684-0d02-4346-9d07-b5b80c9d8a27"
      unitRef="U_USD">-1075000</rxst:ReclassificationOfDeferredCost>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_c6e64300-be56-4750-8495-4ca30021a813">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 1 - Organization and Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Description of Business&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;RxSight&#xae;, Inc. (the &#x201c;Company&#x201d;) is a Delaware corporation headquartered in Aliso Viejo, California with &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; wholly owned subsidiary located in Amsterdam, Netherlands (&#x201c;RxSight, B.V.&#x201d;).  RxSight, B.V. has a registered branch in the United Kingdom and a wholly owned subsidiary located in Germany (&#x201c;RxSight GmbH&#x201d;).  The Company is engaged in the research and development, manufacture and sale of light adjustable intraocular lenses used in cataract surgery along with capital equipment used with the lenses.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s products, which include the light adjustable lens&#xae; (&#x201c;LAL&#x99;&#x201d; and &#x201c;LAL+&#x99;&#x201d;, and collectively the &#x201c;LAL&#x201d;) and a specially designed machine for delivering light to the eye, the Light Delivery Device (&#x201c;LDD&#x99;&#x201d;), are approved by the United States (&#x201c;U.S.&#x201d;) Food and Drug Administration (&#x201c;FDA&#x201d;) primarily for sale in the U.S. and have regulatory approval in the U.S., Europe, Canada and Mexico. The Company began marketing its products in 2019. The LAL is a premium intraocular lens (&#x201c;IOL&#x201d;) which is partially reimbursable under Medicare. The Company competes with other IOLs in the premium market.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The accompanying unaudited condensed consolidated financial statements include the accounts of RxSight, Inc. and its wholly owned subsidiaries, RxSight, B.V. and RxSight GmbH. All significant inter-company balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and pursuant to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). Accordingly, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements. The unaudited interim financial statements reflect all adjustments which, in the opinion of management, are necessary for a fair statement of the results for the periods presented. All such adjustments are of a normal and recurring nature.  The December 31, 2023 balance sheet data was derived from audited financial statements; however, the accompanying notes to the condensed consolidated financial statements do not include all of the annual disclosures required under GAAP and should be read in conjunction with the audited consolidated financial statements included in the Company&#x2019;s 2023 Annual Report on Form 10-K filed with the SEC on February 28, 2024. The operating results presented in these unaudited condensed consolidated financial statements are not necessarily indicative of the results that may be expected for any future periods.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Operating Segments&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company determined its operating segment on the same basis that it uses to evaluate its performance internally. The Company&#x2019;s chief operating decision-maker (&#x201c;CODM&#x201d;), its Chief Executive Officer, reviews its consolidated operating results for the purpose of allocating resources and evaluating financial performance.  The Company determined that it operates and manages its business (including its non-U.S. subsidiaries) in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; reportable segment: the research and development, manufacture and sale of light adjustable lenses and related capital equipment.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Liquidity&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Shelf Registration Statement&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On May 8, 2024, the Company filed an automatic shelf registration statement on Form S-3 (&#x201c;shelf registration statement&#x201d;). The shelf registration statement is effective for three years and permits the Company to sell, from time to time, common stock, preferred stock, debt securities, warrants, and/or units. The shelf registration statement is intended to provide the Company with flexibility to access additional capital.  At the time of filing the shelf registration statement, the Company also filed a prospectus supplement to sell up to an aggregate value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;115.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million dollars of common stock through a public offering (&#x201c;Public Offering&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Public Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;May 8, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, the Company entered into an underwriting agreement with BofA Securities, Inc., in which the Company agreed to issue and sell &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,785,714&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of the Company's common stock in a public offering, pursuant to the shelf registration statement. The shares of common stock were sold at a price to the public of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;56.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per share. Under the terms of the underwriting agreement, the Company also granted the underwriters an option exercisable for 30 days from the date of the underwriting agreement to purchase up to an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;267,857&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock on the same terms and conditions.  The underwriters' option was exercised in full on May 10, 2024 and the Public Offering (inclusive of the underwriters' option shares) closed on May 13, 2024.  The Company received net proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;107.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million from the Public Offering, after deducting underwriters' discounts and commissions of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and other offering expenses of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As of June 30, 2024 and December 31, 2023 the Company had cash, cash equivalents and short-term investments of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;233.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;127.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company began generating revenue from its principal operations in 2019. The Company has a limited operating history, and the revenue and income potential of the Company&#x2019;s business and market are unproven. The Company has experienced recurring net losses and negative cash flows from operating activities since its inception. For the three months ended June 30, 2024 and 2023, the Company incurred losses from operations of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;8.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;13.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively. For the six months ended June 30, 2024 and 2023, the Company incurred losses from operations of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;"&gt;19.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;"&gt;26.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively.  Based on the Company&#x2019;s anticipated sales growth in relation to the anticipated costs associated with, among other things, its continuing research and development activities and the expansion of its sales and marketing activities, the Company expects to continue to incur net operating losses into the foreseeable future. Successful transition to attaining profitable operations is dependent upon gaining market acceptance of the Company&#x2019;s products and achieving a level of revenues adequate to support the Company&#x2019;s cost structure.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company believes that existing cash resources will be sufficient to meet projected operating requirements for at least 12 months from the date of issuance of the accompanying condensed consolidated financial statements, however for the near future, the Company expects to continue to incur operating losses and negative cash flows. The Company plans to continue to fund its losses from operations using its cash, cash equivalents and short-term investments as of June 30, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; and meet its future capital funding needs through equity or debt financings, other third-party funding, collaborations, strategic alliances and licensing arrangements or a combination of these. If the Company raises additional funds by issuing equity securities, its stockholders may experience dilution. Any future debt financing into which the Company enters may impose additional covenants that restrict operations, including limitations on its ability to incur liens or additional debt, pay dividends, repurchase common stock, make certain investments or engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity raise may contain terms that are not favorable to the Company or its stockholders. If the Company is required to enter into collaborations and other arrangements to address its liquidity needs, it may have to give up certain rights that limit its ability to develop and commercialize product candidates or may have other terms that are not favorable to the Company or its stockholders, which could materially and adversely affect its business and financial prospects. There can be no assurance that the Company will be able to obtain additional financing on acceptable terms, or at all. If the Company is not able to secure adequate additional funding, the Company may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible and/or suspend or curtail planned programs. Any of these actions could materially harm the Company&#x2019;s business, results of operations and future prospects.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <rxst:NumberOfWhollyOwnedSubsidiaries
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="INF"
      id="F_72ca3af0-d321-47b4-a89f-2f9b0ff2afa6"
      unitRef="U_Subsidiary">1</rxst:NumberOfWhollyOwnedSubsidiaries>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_443141ee-b4d3-403c-a472-d4780c1f40bc">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and pursuant to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). Accordingly, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements. The unaudited interim financial statements reflect all adjustments which, in the opinion of management, are necessary for a fair statement of the results for the periods presented. All such adjustments are of a normal and recurring nature.  The December 31, 2023 balance sheet data was derived from audited financial statements; however, the accompanying notes to the condensed consolidated financial statements do not include all of the annual disclosures required under GAAP and should be read in conjunction with the audited consolidated financial statements included in the Company&#x2019;s 2023 Annual Report on Form 10-K filed with the SEC on February 28, 2024. The operating results presented in these unaudited condensed consolidated financial statements are not necessarily indicative of the results that may be expected for any future periods.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Operating Segments&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company determined its operating segment on the same basis that it uses to evaluate its performance internally. The Company&#x2019;s chief operating decision-maker (&#x201c;CODM&#x201d;), its Chief Executive Officer, reviews its consolidated operating results for the purpose of allocating resources and evaluating financial performance.  The Company determined that it operates and manages its business (including its non-U.S. subsidiaries) in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; reportable segment: the research and development, manufacture and sale of light adjustable lenses and related capital equipment.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="0"
      id="F_44643835-4d9e-472c-a02b-34a8ef834845"
      unitRef="U_Segment">1</us-gaap:NumberOfReportableSegments>
    <rxst:LiquidityAndFinancialPositionPolicyTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_9b1ed617-c6e8-46d2-9620-4ed0d10903f7">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Liquidity&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Shelf Registration Statement&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On May 8, 2024, the Company filed an automatic shelf registration statement on Form S-3 (&#x201c;shelf registration statement&#x201d;). The shelf registration statement is effective for three years and permits the Company to sell, from time to time, common stock, preferred stock, debt securities, warrants, and/or units. The shelf registration statement is intended to provide the Company with flexibility to access additional capital.  At the time of filing the shelf registration statement, the Company also filed a prospectus supplement to sell up to an aggregate value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;115.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million dollars of common stock through a public offering (&#x201c;Public Offering&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Public Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;May 8, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, the Company entered into an underwriting agreement with BofA Securities, Inc., in which the Company agreed to issue and sell &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,785,714&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of the Company's common stock in a public offering, pursuant to the shelf registration statement. The shares of common stock were sold at a price to the public of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;56.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per share. Under the terms of the underwriting agreement, the Company also granted the underwriters an option exercisable for 30 days from the date of the underwriting agreement to purchase up to an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;267,857&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock on the same terms and conditions.  The underwriters' option was exercised in full on May 10, 2024 and the Public Offering (inclusive of the underwriters' option shares) closed on May 13, 2024.  The Company received net proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;107.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million from the Public Offering, after deducting underwriters' discounts and commissions of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and other offering expenses of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As of June 30, 2024 and December 31, 2023 the Company had cash, cash equivalents and short-term investments of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;233.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;127.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company began generating revenue from its principal operations in 2019. The Company has a limited operating history, and the revenue and income potential of the Company&#x2019;s business and market are unproven. The Company has experienced recurring net losses and negative cash flows from operating activities since its inception. For the three months ended June 30, 2024 and 2023, the Company incurred losses from operations of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;8.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;13.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively. For the six months ended June 30, 2024 and 2023, the Company incurred losses from operations of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;"&gt;19.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;"&gt;26.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively.  Based on the Company&#x2019;s anticipated sales growth in relation to the anticipated costs associated with, among other things, its continuing research and development activities and the expansion of its sales and marketing activities, the Company expects to continue to incur net operating losses into the foreseeable future. Successful transition to attaining profitable operations is dependent upon gaining market acceptance of the Company&#x2019;s products and achieving a level of revenues adequate to support the Company&#x2019;s cost structure.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company believes that existing cash resources will be sufficient to meet projected operating requirements for at least 12 months from the date of issuance of the accompanying condensed consolidated financial statements, however for the near future, the Company expects to continue to incur operating losses and negative cash flows. The Company plans to continue to fund its losses from operations using its cash, cash equivalents and short-term investments as of June 30, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; and meet its future capital funding needs through equity or debt financings, other third-party funding, collaborations, strategic alliances and licensing arrangements or a combination of these. If the Company raises additional funds by issuing equity securities, its stockholders may experience dilution. Any future debt financing into which the Company enters may impose additional covenants that restrict operations, including limitations on its ability to incur liens or additional debt, pay dividends, repurchase common stock, make certain investments or engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity raise may contain terms that are not favorable to the Company or its stockholders. If the Company is required to enter into collaborations and other arrangements to address its liquidity needs, it may have to give up certain rights that limit its ability to develop and commercialize product candidates or may have other terms that are not favorable to the Company or its stockholders, which could materially and adversely affect its business and financial prospects. There can be no assurance that the Company will be able to obtain additional financing on acceptable terms, or at all. If the Company is not able to secure adequate additional funding, the Company may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible and/or suspend or curtail planned programs. Any of these actions could materially harm the Company&#x2019;s business, results of operations and future prospects.&lt;/span&gt;&lt;/p&gt;</rxst:LiquidityAndFinancialPositionPolicyTextBlock>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="C_9570a28c-b316-4e10-b753-972c9bfbc435"
      decimals="-5"
      id="F_292e23cb-1873-462a-b78d-331e8102a579"
      unitRef="U_USD">115000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockTransactionDate
      contextRef="C_8869c8c5-5883-4a92-b4bf-6238296536a0"
      id="F_1e6016d2-619a-476e-b3b8-4619af7dad0b">2024-05-08</us-gaap:SaleOfStockTransactionDate>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_8869c8c5-5883-4a92-b4bf-6238296536a0"
      decimals="0"
      id="F_74c013f7-323f-49af-85e5-da708b523c6c"
      unitRef="U_shares">1785714</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_7fd1d14f-2011-4d83-8445-f16b305c1b27"
      decimals="2"
      id="F_4d489139-7c0f-4c1f-b565-b750b5438f8c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">56</us-gaap:CommonStockParOrStatedValuePerShare>
    <rxst:AdditionalNumberOfCommonSharesIssued
      contextRef="C_8869c8c5-5883-4a92-b4bf-6238296536a0"
      decimals="0"
      id="F_39ba392b-8732-4886-a9c4-b12911887316"
      unitRef="U_shares">267857</rxst:AdditionalNumberOfCommonSharesIssued>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="C_8869c8c5-5883-4a92-b4bf-6238296536a0"
      decimals="-5"
      id="F_e79860f0-4d0b-40d9-90e1-1fdd57cfc91e"
      unitRef="U_USD">107500000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <rxst:CommonStockSaleUnderwritingDiscountsAndCommissionDeducted
      contextRef="C_7fd1d14f-2011-4d83-8445-f16b305c1b27"
      decimals="-5"
      id="F_5fe7c5a6-7064-40f9-9d5a-63d09fe9be52"
      unitRef="U_USD">6900000</rxst:CommonStockSaleUnderwritingDiscountsAndCommissionDeducted>
    <rxst:CommonStockOfferingCosts
      contextRef="C_7fd1d14f-2011-4d83-8445-f16b305c1b27"
      decimals="-5"
      id="F_234d28fe-6e11-4094-b48a-5b198af6f82d"
      unitRef="U_USD">600000</rxst:CommonStockOfferingCosts>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-5"
      id="F_00000bf3-b7c5-4cd3-84ad-9319a0274d5e"
      unitRef="U_USD">233200000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-5"
      id="F_ebe4a9c6-22a9-4f53-bf2e-156f9269fbc0"
      unitRef="U_USD">127200000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <rxst:OperatingIncomeLoss1
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-5"
      id="F_100f889c-92b3-43fa-bfb2-eeffd2f3900c"
      unitRef="U_USD">8300000</rxst:OperatingIncomeLoss1>
    <rxst:OperatingIncomeLoss1
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-5"
      id="F_a81c5816-f18a-4519-854d-bbc788b8c290"
      unitRef="U_USD">13600000</rxst:OperatingIncomeLoss1>
    <rxst:OperatingIncomeLoss1
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-5"
      id="F_11ab7eff-ef03-45dd-9eb7-f97b24541e0f"
      unitRef="U_USD">19000000</rxst:OperatingIncomeLoss1>
    <rxst:OperatingIncomeLoss1
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-5"
      id="F_0721bae3-56a9-4344-9687-f4f379bd0640"
      unitRef="U_USD">26700000</rxst:OperatingIncomeLoss1>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_0c273bdd-6e84-4d5e-b6e8-6d6e4d329411">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 2 - Summary of Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;preparation of consolidated financial statements in conformity with GAAP requires management to make informed estimates, judgments and assumptions that affect the reported amounts in the condensed consolidated financial statements and disclosures in the accompanying notes as of the date of the accompanying condensed consolidated financial statements. On an on-going basis, management evaluates the most critical estimates and assumptions for continued reasonableness. Actual results may differ materially from the estimates used in the&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;preparation &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;of the accompanying condensed consolidated financial statements under different assumptions or conditions.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;There have been no significant changes to the accounting policies during the three months ended June 30, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, as compared to the significant accounting policies described in Note 2 of the &#x201c;Notes to Consolidated Financial Statements&#x201d; in the Company&#x2019;s audited consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on February 28, 2024.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Cash equivalents consist of investments in money market accounts. The Company considers all highly liquid investments with original maturities of three months or less at the date of purchase that can be liquidated without prior notice or penalty to be cash equivalents.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Short-term Investments&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Short-term investments are classified based on the maturity date of the related securities. Based on the nature of the assets, the Company&#x2019;s short-term investments, which are government securities, are classified as available-for-sale and are recorded at their estimated fair value as determined by prices for identical or similar securities at the balance sheet date. The Company&#x2019;s short-term investments consist of Level 2 financial instruments in the fair value hierarchy. Unrealized gains and losses are recorded as a component of Other Comprehensive Loss within Stockholders&#x2019; Equity on the condensed consolidated balance sheets. Realized gains and losses are included as other income (expense) in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss. The cost basis for realized gains and losses on available-for-sale securities is determined on a specific identification basis. Management determines the appropriate classification of its investments at the time of purchase and reevaluates such determination at each balance sheet date. The Company periodically reviews its investments for unrealized losses other than credit losses and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In determining whether the carrying value is recoverable, management considers the following factors:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;whether the investment has been in a continuous loss position for over 12 months; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;the duration to maturity of investments; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;intention and ability to hold the investment to maturity and if it is not more likely than not that the Company will be required to sell the investment before recovery of the amortized cost basis; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;the credit rating, financial condition and near-term prospects of the issuer; and &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;the type of investments made. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company had an unrealized loss of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;99,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; of net unrealized gains related to short-term investments as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, short-term investments and accounts receivable. The Company&#x2019;s policy is to invest cash in institutional money market funds and marketable securities of the U.S. government to limit the amount of credit exposure. The Company currently maintains a portfolio of cash equivalents and short-term investments in money market funds and U.S. treasury bills. A portion of the Company's operating cash is held in accounts in excess of the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) insurance limits; however, the Company has established guidelines regarding diversification of its investments and their maturities, which are designed to maintain principal and maximize liquidity. The Company has not experienced material losses on cash equivalents and short-term investments.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s products require approval from the FDA and foreign regulatory agencies before commercial sales can commence. There can be no assurance that the Company&#x2019;s products will receive any of these required&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;approvals. The denial or delay of such approvals may have a material adverse impact on the Company&#x2019;s business and may impact business in the future. In addition, after approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the device approval process.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company is subject to risks common to companies in the medical device industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of the Company's products, product liability and the need to obtain additional financing.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company is subject to the risks related to global lead times, particularly in Europe and Asia, leading to a supply interruption from the Company's suppliers. In addition, the Company is currently experiencing inflation and longer lead times and limited availability in its supply chain for certain components and has continued exposure to price and supply risk related to anticipated purchases of certain commodities, materials and products used in its business.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company has a diverse customer base and as of June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; the Company did not have any customers who individually accounted for greater than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of accounts receivable. The Company maintains an allowance for credit losses resulting from the inability of its customers, including ambulatory surgery centers, to make required payments. After evaluation of the collectability of accounts receivable, the Company did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;t record any significant allowance for credit losses as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;June 30, 2024 or December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company uses fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures.  Fair value is measured as the price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques that are consistent with the market, income or cost approach are used to measure fair value. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three levels:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Level 1&#x2014;Observable inputs such as unadjusted quoted prices in active markets that are accessible at the measurement date for identical unrestricted assets or liabilities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Level 2&#x2014;Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability, for substantially the full term of the asset or liability, through correlation with market data. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Level 3&#x2014;One or more significant inputs that are unobservable and supported by little or no market activity and reflect the use of significant management judgment and assumptions. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques and significant management judgment or estimation. These include the Black-Scholes option-pricing model which uses inputs such as expected volatility, risk-free interest rate and expected term to determine fair market valuation.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification at each reporting date. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the years presented.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s financial instruments consist principally of cash, cash equivalents, short-term investments, accounts receivable, accounts payable and operating lease liabilities. Cash, cash equivalents, accounts receivable and accounts payable are carried at their estimated fair value because of the short-term nature of these assets and&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;liabilities. The Company&#x2019;s short-term investments in government securities are carried at fair value, determined based on publicly available quoted market prices for identical securities at the measurement date. The Company believes the fair values of its operating lease liabilities at June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, approximated their carrying values, based on the borrowing rates that were available for loans with similar terms as of such date.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Inventories&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Inventories consist of raw materials, work-in-process and finished goods. Raw materials are comprised of chemicals and parts used in the production of the Company's lenses, cartridges, and LDDs. Finished goods are comprised of lenses, cartridges, accessories and LDDs. Inventories are valued at the lower of cost or net realizable value. Cost is computed using standard cost, which approximates actual cost on a first-in, first-out basis. The carrying value of inventories is reviewed for potential impairment whenever indicators suggest that the cost of inventories exceeds the carrying value and management adjusts the inventories to its net realizable value. The cost of finished goods and work-in-process is comprised of raw materials, direct labor, other direct costs and related production overhead to the extent that these costs do not exceed the net realizable value of the goods produced. The Company periodically reviews inventories for potential impairment, estimated losses from obsolescence, material expirations or unmarketable inventories or excess inventories and writes down the cost of inventories to net realizable value at the time such determinations are made. Net realizable value is determined using the estimated selling price, in the ordinary course of business, less estimated costs to complete and dispose.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Lease right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term, and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized when the Company takes possession of the leased property (&#x201c;Commencement Date&#x201d;) based on the present value of lease payments over the lease term. The Company estimates the incremental borrowing rate based upon the cost of its own debt financing, current market interest rates and quoted offerings or the rate implicit in the lease. Operating lease right-of-use assets also include any lease payments made at or before lease commencement and exclude any lease incentives received. The lease terms used to calculate the right-of-use asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Rent expense on noncancelable leases containing known future scheduled rent increases is recorded on a straight-line basis over the term of the respective leases beginning on the Commencement Date. The difference between rent expense and rent paid is accounted for as a component of operating lease right-of-use assets on the accompanying condensed consolidated balance sheets. Landlord improvement allowances and other such lease incentives are recorded as property and equipment and as reduction of the right-of-use leased assets and are amortized on a straight-line basis as a reduction to operating lease costs. Leases with an initial term of 12 months or less are expensed as incurred and are not recorded as right-of-use assets on the condensed consolidated balance sheets.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Net Loss per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average shares of common stock outstanding for the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average shares of common stock and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock and potential dilutive securities outstanding during the period.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common stockholders because their impact under the treasury stock method was anti-dilutive for the periods presented:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:41.74%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:12.36%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:11.26%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:11.48%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:12.16%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Stock options issued and outstanding under the Calhoun Vision, Inc. 2006 Stock Plan, Calhoun Vision, Inc. 2015 Equity Incentive Plan and the 2021 Equity Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5,618,186&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5,821,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5,843,009&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3,409,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Restricted stock units issued under the 2021 Equity Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;666,573&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;773,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;544,320&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;671,956&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Stock issuable in offering period under the 2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;59,149&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;39,568&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;61,085&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;45,191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s revenue is generated from the sale of LALs used in cataract surgery along with a specifically designed machine for delivering light to the eye, the LDD, to adjust the lens post-surgery, as needed. Revenue is recognized from sales of products in the U.S., Canada and Europe. Customers are primarily comprised of ambulatory surgery centers, hospitals, and physician private practices.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company recognizes revenues when promised goods or services are transferred to customers at a transaction price that reflects the consideration to which the Company expects to be entitled in exchange for those goods and services. Specifically, the Company applies the following five steps to recognize revenue: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when, or as, the Company satisfies a performance obligation. The Company applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. At contract inception, the Company assesses the goods promised within each customer contract to determine the individual deliverables in its product offerings as separate performance obligations and assesses whether each promised good or service is distinct. The transaction price is determined based on the consideration expected to be received, based either on the stated value in contractual arrangements or the estimated cash to be collected in non-contracted arrangements. The Company recognizes revenue as the amount of the transaction price that is allocated to the respective performance obligation when, or as, the performance obligation is satisfied, considering whether or not this occurs at a point in time or over time. The Company elected to account for shipping costs as fulfillment costs rather than a promised service and excludes from revenue any taxes collected from customers that are remitted to government authorities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s LDD contracts contain multiple performance obligations bundled for one transaction price, with all obligations generally satisfied within one year. For these bundled arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct, that is, if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company&#x2019;s LDD contracts include a combination of the following performance obligations: (i) LDD capital asset and related components, (ii) training and (iii) device service (initial year). Each of these three performance obligations are considered distinct. The LDD capital asset is distinct because the customer can benefit from it together with other resources that are readily available to the customer.  Training on the use of the machine is offered as a distinct activity after installation of the LDD to enhance the customer&#x2019;s ability to utilize the machine by having an industry professional provide best practices and customize training to the specific needs of the customer. Each LDD comes with a twelve-month manufacturer&#x2019;s warranty (service-type) that includes preventative maintenance, unscheduled service (labor and parts) and software updates. After the first year, service contracts can be purchased separately on a standalone basis. The Company recognizes revenue as performance obligations are satisfied by transferring control of the product or service to a customer. Specifically, revenue for the LDD capital asset is recognized at a point in time at installation.  Revenue for training is also recorded at a point in time, generally 60 days after installation.  Revenue&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;for the device service is recognized ratably over time after installation, generally 12 months. The Company has determined that the transaction price is the invoice price, net of adjustments, if any. The allocation to the separate performance obligations is based upon the relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. The Company estimates the standalone selling price using the market assessment approach considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services, geographies, type of customer and market conditions. The Company regularly reviews and updates standalone selling prices as necessary.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;LALs are generally held at customer sites on consignment. The single performance obligation is satisfied, and revenue from sales is recognized for LALs upon customer notification that the LALs have been implanted in a patient. For the three and six months ended June 30, 2024 and 2023, credits related to returns and rebates on list prices were not significant.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company has adopted the practical expedient permitting the direct expensing of costs incurred to obtain contracts where the amortization of such costs would occur over one year or less, and it applied to substantially all the Company&#x2019;s contracts. Revenue for service agreements is recognized ratably over the term of each contract.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;three and six months ended June 30, 2024 and 2023, revenue from contracts with customers consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:32.867%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.259%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:16.054%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.259%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:11.775%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.259%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:13.135%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.259%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:13.135%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;LDD (including training)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;7,720&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18,902&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;14,195&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;LAL&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;23,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;12,411&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;43,745&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;22,806&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Service warranty, service contracts, and accessories&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;870&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;679&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,298&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;34,887&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;20,810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;64,399&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;38,299&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the three and six months ended June 30, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, the Company did not have any customers who individually accounted for greater than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of revenue.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table represents the contract liabilities from sales activity for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;six months ended June 30, 2024 and 2023, respectively (in thousands):&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:51.661%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.961%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:21.769%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.961%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:16.686999999999998%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.961%;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="text-indent:40pt;vertical-align:bottom;"&gt;&lt;p style="margin-left:40pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Balance at beginning of period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,888&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;word-break:break-word;"&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Additions during the period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Revenue recognized during the period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,707&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,233&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;word-break:break-word;"&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Balance at end of period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company has three equity incentive compensation plans: the Calhoun Vision, Inc. 2006 Stock Plan (&#x201c;2006 Plan&#x201d;); the Calhoun Vision, Inc. 2015 Equity Incentive Plan (&#x201c;2015 Plan&#x201d;); and the 2021 Equity Incentive Plan (&#x201c;2021 Plan&#x201d;), which are collectively referred to as the &#x201c;Equity Plans.&#x201d; The Company also has an employee stock purchase plan, the 2021 Employee Stock Purchase Plan (&#x201c;2021 ESPP&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company recognizes compensation expense for equity-based awards on the date of grant to employees, board of directors and consultants based on the estimated grant date fair value of the award's Equity-based payments including stock options, restricted stock units and employee stock plan purchases. The fair value of the option awards are estimated using the Black-Scholes option-pricing model and recognized as an expense in the condensed consolidated statements of operations and comprehensive loss over the requisite service period, which is generally four years. The Company amortizes the stock-based compensation for equity awards with service conditions on a&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;straight-line basis over the vesting period of the awards. Forfeitures of unvested stock option awards are recognized as reductions of expense as they occur.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Black-Scholes option-pricing model requires the use of assumptions about a number of variables, such as the fair market value of the Company&#x2019;s common stock, expected volatility, expected term, risk-free interest rate, and dividend yield as discussed below:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:30.95pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Fair market value&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;The fair value of common stock is determined by using the closing price per share of common stock as reported on the Nasdaq Global Market.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:30.95pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;Effective January 1, 2024, the Company based the expected volatility on the historic volatility of its common stock. During the year ended December 31, 2023, the expected volatility was estimated based on the average historical volatilities for comparable publicly traded medical device companies over a period equal to the expected term of the stock option grants. Comparable companies were chosen based on their similar size, stage in the life cycle and area of specialty.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:30.95pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Expected term&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;The Company&#x2019;s expected term represents the period that the Company&#x2019;s stock-based awards are expected to be outstanding. The Company used the simplified method (based on the mid-point between the vesting date and the end of the contractual term) to determine the expected term.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:30.6pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;The risk-free interest rate used is based on the published U.S. Department of Treasury interest rates in effect at the time of stock option grant for zero coupon U.S. Treasury notes with maturities approximating each grant&#x2019;s expected term.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:30.6pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Dividend yield&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of zero.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Changes to GAAP are established by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) in the form of accounting standards updates (&#x201c;ASU&#x201d;). There have been no recent accounting pronouncements, changes in accounting pronouncements or recently adopted accounting guidance during the three months ended June 30, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; that are of significance or potential significance to the Company.&lt;/span&gt;&lt;/span&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_0f12b5db-257b-46ca-8c29-454af0a93cb2">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;preparation of consolidated financial statements in conformity with GAAP requires management to make informed estimates, judgments and assumptions that affect the reported amounts in the condensed consolidated financial statements and disclosures in the accompanying notes as of the date of the accompanying condensed consolidated financial statements. On an on-going basis, management evaluates the most critical estimates and assumptions for continued reasonableness. Actual results may differ materially from the estimates used in the&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;preparation &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;of the accompanying condensed consolidated financial statements under different assumptions or conditions.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <rxst:SignificantAccountingPoliciesPolicyTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_4a8f0693-6a3a-4926-b348-cbac73ad40e4">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;There have been no significant changes to the accounting policies during the three months ended June 30, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, as compared to the significant accounting policies described in Note 2 of the &#x201c;Notes to Consolidated Financial Statements&#x201d; in the Company&#x2019;s audited consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on February 28, 2024.&lt;/span&gt;&lt;/p&gt;</rxst:SignificantAccountingPoliciesPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_7b76a851-b1e4-4415-8b45-968cb87a21ad">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Cash equivalents consist of investments in money market accounts. The Company considers all highly liquid investments with original maturities of three months or less at the date of purchase that can be liquidated without prior notice or penalty to be cash equivalents.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <rxst:ShortTermInvestmentsPolicyTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_93dce737-a2a9-4380-9aaa-f910cf770991">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Short-term Investments&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Short-term investments are classified based on the maturity date of the related securities. Based on the nature of the assets, the Company&#x2019;s short-term investments, which are government securities, are classified as available-for-sale and are recorded at their estimated fair value as determined by prices for identical or similar securities at the balance sheet date. The Company&#x2019;s short-term investments consist of Level 2 financial instruments in the fair value hierarchy. Unrealized gains and losses are recorded as a component of Other Comprehensive Loss within Stockholders&#x2019; Equity on the condensed consolidated balance sheets. Realized gains and losses are included as other income (expense) in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss. The cost basis for realized gains and losses on available-for-sale securities is determined on a specific identification basis. Management determines the appropriate classification of its investments at the time of purchase and reevaluates such determination at each balance sheet date. The Company periodically reviews its investments for unrealized losses other than credit losses and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In determining whether the carrying value is recoverable, management considers the following factors:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;whether the investment has been in a continuous loss position for over 12 months; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;the duration to maturity of investments; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;intention and ability to hold the investment to maturity and if it is not more likely than not that the Company will be required to sell the investment before recovery of the amortized cost basis; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;the credit rating, financial condition and near-term prospects of the issuer; and &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;the type of investments made. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company had an unrealized loss of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;99,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; of net unrealized gains related to short-term investments as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</rxst:ShortTermInvestmentsPolicyTextBlock>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_3337b1c7-0bab-4bfb-a537-eb3ceefeb0d9"
      unitRef="U_USD">99000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_1223a5cf-5ff9-4abd-b52d-c7eebdeb8212"
      decimals="-3"
      id="F_176bbb39-02e0-4375-ad15-ab46a5cb9822"
      unitRef="U_USD">10000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_1f0a3125-8c5b-4120-a915-8d2559e68a88">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, short-term investments and accounts receivable. The Company&#x2019;s policy is to invest cash in institutional money market funds and marketable securities of the U.S. government to limit the amount of credit exposure. The Company currently maintains a portfolio of cash equivalents and short-term investments in money market funds and U.S. treasury bills. A portion of the Company's operating cash is held in accounts in excess of the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) insurance limits; however, the Company has established guidelines regarding diversification of its investments and their maturities, which are designed to maintain principal and maximize liquidity. The Company has not experienced material losses on cash equivalents and short-term investments.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s products require approval from the FDA and foreign regulatory agencies before commercial sales can commence. There can be no assurance that the Company&#x2019;s products will receive any of these required&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;approvals. The denial or delay of such approvals may have a material adverse impact on the Company&#x2019;s business and may impact business in the future. In addition, after approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the device approval process.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company is subject to risks common to companies in the medical device industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of the Company's products, product liability and the need to obtain additional financing.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company is subject to the risks related to global lead times, particularly in Europe and Asia, leading to a supply interruption from the Company's suppliers. In addition, the Company is currently experiencing inflation and longer lead times and limited availability in its supply chain for certain components and has continued exposure to price and supply risk related to anticipated purchases of certain commodities, materials and products used in its business.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_7d66201c-dc7b-46a7-831e-bff880b806d0">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company has a diverse customer base and as of June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; the Company did not have any customers who individually accounted for greater than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of accounts receivable. The Company maintains an allowance for credit losses resulting from the inability of its customers, including ambulatory surgery centers, to make required payments. After evaluation of the collectability of accounts receivable, the Company did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;t record any significant allowance for credit losses as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;June 30, 2024 or December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <rxst:AccountsReceivablePercentage
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="2"
      id="F_ee1a033b-5318-47f5-a822-c07619c40d97"
      unitRef="U_pure">0.10</rxst:AccountsReceivablePercentage>
    <rxst:AccountsReceivablePercentage
      contextRef="C_1223a5cf-5ff9-4abd-b52d-c7eebdeb8212"
      decimals="2"
      id="F_fa0389be-b9b1-4a20-983b-00696915d165"
      unitRef="U_pure">0.10</rxst:AccountsReceivablePercentage>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_e4c276de-923d-44bb-a755-cdc7ef506c69"
      unitRef="U_USD">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="C_1223a5cf-5ff9-4abd-b52d-c7eebdeb8212"
      decimals="-3"
      id="F_dd215395-ce15-45eb-a695-1b902eea0bad"
      unitRef="U_USD">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_255d278e-286f-4645-b3b4-fe10b60f6184">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company uses fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures.  Fair value is measured as the price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques that are consistent with the market, income or cost approach are used to measure fair value. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three levels:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Level 1&#x2014;Observable inputs such as unadjusted quoted prices in active markets that are accessible at the measurement date for identical unrestricted assets or liabilities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Level 2&#x2014;Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability, for substantially the full term of the asset or liability, through correlation with market data. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Level 3&#x2014;One or more significant inputs that are unobservable and supported by little or no market activity and reflect the use of significant management judgment and assumptions. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques and significant management judgment or estimation. These include the Black-Scholes option-pricing model which uses inputs such as expected volatility, risk-free interest rate and expected term to determine fair market valuation.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification at each reporting date. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the years presented.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s financial instruments consist principally of cash, cash equivalents, short-term investments, accounts receivable, accounts payable and operating lease liabilities. Cash, cash equivalents, accounts receivable and accounts payable are carried at their estimated fair value because of the short-term nature of these assets and&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;liabilities. The Company&#x2019;s short-term investments in government securities are carried at fair value, determined based on publicly available quoted market prices for identical securities at the measurement date. The Company believes the fair values of its operating lease liabilities at June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, approximated their carrying values, based on the borrowing rates that were available for loans with similar terms as of such date.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_cbb9f2ec-8558-4ba0-bf9b-bd646d0891fb">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Inventories&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Inventories consist of raw materials, work-in-process and finished goods. Raw materials are comprised of chemicals and parts used in the production of the Company's lenses, cartridges, and LDDs. Finished goods are comprised of lenses, cartridges, accessories and LDDs. Inventories are valued at the lower of cost or net realizable value. Cost is computed using standard cost, which approximates actual cost on a first-in, first-out basis. The carrying value of inventories is reviewed for potential impairment whenever indicators suggest that the cost of inventories exceeds the carrying value and management adjusts the inventories to its net realizable value. The cost of finished goods and work-in-process is comprised of raw materials, direct labor, other direct costs and related production overhead to the extent that these costs do not exceed the net realizable value of the goods produced. The Company periodically reviews inventories for potential impairment, estimated losses from obsolescence, material expirations or unmarketable inventories or excess inventories and writes down the cost of inventories to net realizable value at the time such determinations are made. Net realizable value is determined using the estimated selling price, in the ordinary course of business, less estimated costs to complete and dispose.&lt;/span&gt;&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_0f42d387-58e9-4805-b03e-338553aa3e3b">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Lease right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term, and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized when the Company takes possession of the leased property (&#x201c;Commencement Date&#x201d;) based on the present value of lease payments over the lease term. The Company estimates the incremental borrowing rate based upon the cost of its own debt financing, current market interest rates and quoted offerings or the rate implicit in the lease. Operating lease right-of-use assets also include any lease payments made at or before lease commencement and exclude any lease incentives received. The lease terms used to calculate the right-of-use asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Rent expense on noncancelable leases containing known future scheduled rent increases is recorded on a straight-line basis over the term of the respective leases beginning on the Commencement Date. The difference between rent expense and rent paid is accounted for as a component of operating lease right-of-use assets on the accompanying condensed consolidated balance sheets. Landlord improvement allowances and other such lease incentives are recorded as property and equipment and as reduction of the right-of-use leased assets and are amortized on a straight-line basis as a reduction to operating lease costs. Leases with an initial term of 12 months or less are expensed as incurred and are not recorded as right-of-use assets on the condensed consolidated balance sheets.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_e987f6e8-2ae5-40c0-be12-afc5431af5b3">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Net Loss per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average shares of common stock outstanding for the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average shares of common stock and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock and potential dilutive securities outstanding during the period.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common stockholders because their impact under the treasury stock method was anti-dilutive for the periods presented:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:41.74%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:12.36%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:11.26%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:11.48%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:12.16%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Stock options issued and outstanding under the Calhoun Vision, Inc. 2006 Stock Plan, Calhoun Vision, Inc. 2015 Equity Incentive Plan and the 2021 Equity Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5,618,186&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5,821,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5,843,009&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3,409,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Restricted stock units issued under the 2021 Equity Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;666,573&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;773,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;544,320&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;671,956&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Stock issuable in offering period under the 2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;59,149&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;39,568&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;61,085&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;45,191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_fc8944f6-d505-46cc-bfae-f61ff857f758">&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common stockholders because their impact under the treasury stock method was anti-dilutive for the periods presented:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:41.74%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:12.36%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:11.26%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:11.48%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:12.16%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Stock options issued and outstanding under the Calhoun Vision, Inc. 2006 Stock Plan, Calhoun Vision, Inc. 2015 Equity Incentive Plan and the 2021 Equity Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5,618,186&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5,821,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5,843,009&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3,409,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Restricted stock units issued under the 2021 Equity Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;666,573&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;773,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;544,320&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;671,956&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Stock issuable in offering period under the 2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;59,149&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;39,568&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;61,085&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;45,191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_e969fc23-8eb5-4d5d-ace5-3eb8042365bb"
      decimals="INF"
      id="F_072d9ada-2a1c-4622-8528-00f20f45fcc1"
      unitRef="U_shares">5618186</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_6702e775-6fe0-4e23-b7e7-44e40075c069"
      decimals="INF"
      id="F_d107ccc4-e67e-4bd9-9901-5a9025867b2b"
      unitRef="U_shares">5821076</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_e06ef83e-8ff7-41dd-94cc-bc2af4dde419"
      decimals="INF"
      id="F_d3bec5b3-9e73-4696-ac90-f1bb3bb400a4"
      unitRef="U_shares">5843009</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_7186a63a-2ded-414c-b053-cba2402cd973"
      decimals="INF"
      id="F_62314761-3e44-4d4e-acb4-be8cb2615beb"
      unitRef="U_shares">3409842</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_5f4a79f9-a984-4624-83b4-b702658dbd28"
      decimals="INF"
      id="F_1201ef1e-b2b2-4883-89c6-b876e093997a"
      unitRef="U_shares">666573</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_8658457e-b5f0-4fd7-bb30-dac4f9d122bf"
      decimals="INF"
      id="F_7eead190-8f3d-496f-969a-440d07ec0ab4"
      unitRef="U_shares">773940</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_05587aab-7a1f-40a3-9a56-c925bb5331b9"
      decimals="INF"
      id="F_afaaf286-3cef-45f2-aa42-dab001d94b89"
      unitRef="U_shares">544320</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_ab888ba9-e469-447e-bb28-93d500a06c72"
      decimals="INF"
      id="F_78d43b01-1750-4724-a3a5-1d11ef2c4705"
      unitRef="U_shares">671956</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_95eb6bb1-f341-4f69-9031-18165fd37316"
      decimals="INF"
      id="F_4eafd2cc-91c5-440d-a6cc-b84975de41ac"
      unitRef="U_shares">59149</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_714e2128-63aa-4240-8ef9-520e2ff63b1a"
      decimals="INF"
      id="F_28ff6d44-0661-4d04-8f14-38bf69b26b36"
      unitRef="U_shares">39568</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_426cc0de-05ef-4df6-9f8f-d9cfc2eca447"
      decimals="INF"
      id="F_eb66c1a2-5d12-429c-b075-4a4ee36d8833"
      unitRef="U_shares">61085</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_6ade43c7-7714-458d-a02a-e56ad23d0eec"
      decimals="INF"
      id="F_2e1f17cb-97cc-4a6e-b893-28631c984c55"
      unitRef="U_shares">45191</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_938a8e55-0085-4138-bccf-aad8c1037f41">&lt;p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s revenue is generated from the sale of LALs used in cataract surgery along with a specifically designed machine for delivering light to the eye, the LDD, to adjust the lens post-surgery, as needed. Revenue is recognized from sales of products in the U.S., Canada and Europe. Customers are primarily comprised of ambulatory surgery centers, hospitals, and physician private practices.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company recognizes revenues when promised goods or services are transferred to customers at a transaction price that reflects the consideration to which the Company expects to be entitled in exchange for those goods and services. Specifically, the Company applies the following five steps to recognize revenue: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when, or as, the Company satisfies a performance obligation. The Company applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. At contract inception, the Company assesses the goods promised within each customer contract to determine the individual deliverables in its product offerings as separate performance obligations and assesses whether each promised good or service is distinct. The transaction price is determined based on the consideration expected to be received, based either on the stated value in contractual arrangements or the estimated cash to be collected in non-contracted arrangements. The Company recognizes revenue as the amount of the transaction price that is allocated to the respective performance obligation when, or as, the performance obligation is satisfied, considering whether or not this occurs at a point in time or over time. The Company elected to account for shipping costs as fulfillment costs rather than a promised service and excludes from revenue any taxes collected from customers that are remitted to government authorities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s LDD contracts contain multiple performance obligations bundled for one transaction price, with all obligations generally satisfied within one year. For these bundled arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct, that is, if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company&#x2019;s LDD contracts include a combination of the following performance obligations: (i) LDD capital asset and related components, (ii) training and (iii) device service (initial year). Each of these three performance obligations are considered distinct. The LDD capital asset is distinct because the customer can benefit from it together with other resources that are readily available to the customer.  Training on the use of the machine is offered as a distinct activity after installation of the LDD to enhance the customer&#x2019;s ability to utilize the machine by having an industry professional provide best practices and customize training to the specific needs of the customer. Each LDD comes with a twelve-month manufacturer&#x2019;s warranty (service-type) that includes preventative maintenance, unscheduled service (labor and parts) and software updates. After the first year, service contracts can be purchased separately on a standalone basis. The Company recognizes revenue as performance obligations are satisfied by transferring control of the product or service to a customer. Specifically, revenue for the LDD capital asset is recognized at a point in time at installation.  Revenue for training is also recorded at a point in time, generally 60 days after installation.  Revenue&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;for the device service is recognized ratably over time after installation, generally 12 months. The Company has determined that the transaction price is the invoice price, net of adjustments, if any. The allocation to the separate performance obligations is based upon the relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. The Company estimates the standalone selling price using the market assessment approach considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services, geographies, type of customer and market conditions. The Company regularly reviews and updates standalone selling prices as necessary.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;LALs are generally held at customer sites on consignment. The single performance obligation is satisfied, and revenue from sales is recognized for LALs upon customer notification that the LALs have been implanted in a patient. For the three and six months ended June 30, 2024 and 2023, credits related to returns and rebates on list prices were not significant.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company has adopted the practical expedient permitting the direct expensing of costs incurred to obtain contracts where the amortization of such costs would occur over one year or less, and it applied to substantially all the Company&#x2019;s contracts. Revenue for service agreements is recognized ratably over the term of each contract.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;three and six months ended June 30, 2024 and 2023, revenue from contracts with customers consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:32.867%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.259%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:16.054%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.259%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:11.775%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.259%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:13.135%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.259%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:13.135%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;LDD (including training)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;7,720&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18,902&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;14,195&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;LAL&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;23,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;12,411&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;43,745&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;22,806&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Service warranty, service contracts, and accessories&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;870&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;679&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,298&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;34,887&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;20,810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;64,399&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;38,299&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the three and six months ended June 30, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, the Company did not have any customers who individually accounted for greater than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of revenue.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table represents the contract liabilities from sales activity for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;six months ended June 30, 2024 and 2023, respectively (in thousands):&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:51.661%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.961%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:21.769%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.961%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:16.686999999999998%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.961%;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="text-indent:40pt;vertical-align:bottom;"&gt;&lt;p style="margin-left:40pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Balance at beginning of period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,888&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;word-break:break-word;"&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Additions during the period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Revenue recognized during the period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,707&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,233&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;word-break:break-word;"&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Balance at end of period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_353ab134-d1e9-4193-bc4d-4daa1ccb2a77">&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;three and six months ended June 30, 2024 and 2023, revenue from contracts with customers consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:32.867%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.259%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:16.054%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.259%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:11.775%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.259%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:13.135%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.259%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:13.135%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;LDD (including training)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;7,720&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18,902&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;14,195&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;LAL&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;23,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;12,411&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;43,745&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;22,806&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Service warranty, service contracts, and accessories&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;870&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;679&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,298&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;34,887&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;20,810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;64,399&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;38,299&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_a5ac65aa-cc43-4c9f-a44e-01e67eb807a2"
      decimals="-3"
      id="F_c21a877a-fca5-4be2-a358-ac8ddee8dbd1"
      unitRef="U_USD">10189000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_c4552e7a-d149-444f-86ed-06df03b923bb"
      decimals="-3"
      id="F_fd3a0136-46e0-4350-9be6-e5cb4807f36c"
      unitRef="U_USD">7720000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_d31c11d4-0dd3-4c7f-afa5-cc439fc19ddc"
      decimals="-3"
      id="F_fe2326e1-0f89-46cb-9ef4-e57caea5adbc"
      unitRef="U_USD">18902000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_cc563601-0f12-4cea-9637-53f1f309f9f1"
      decimals="-3"
      id="F_9bb4229d-8ae0-4005-a8c2-81c57c9dcab0"
      unitRef="U_USD">14195000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_43a01723-f1d7-414d-a915-41d499a7b20c"
      decimals="-3"
      id="F_c2d63a44-e147-45d5-a3e0-3b24ae97ab52"
      unitRef="U_USD">23828000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_236410b5-5576-4fb5-8213-e1ee25595cc3"
      decimals="-3"
      id="F_ef3d01b1-9738-4f38-87b4-a0d997fdf03e"
      unitRef="U_USD">12411000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_bc685971-8f0a-4ea4-8c64-9c188aeabf26"
      decimals="-3"
      id="F_c566960d-9118-4198-9afc-fcfa59137c65"
      unitRef="U_USD">43745000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_eddb3485-0e74-4545-b102-ed16c7ec0a2c"
      decimals="-3"
      id="F_4e7b309c-6c3f-4ac0-b41f-7b7ab88751b9"
      unitRef="U_USD">22806000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_e7d6d427-25c9-4896-bb46-4266c78ddbb2"
      decimals="-3"
      id="F_92f33a83-6028-480d-99ce-342a7256688d"
      unitRef="U_USD">870000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_4c8e9ae1-1e9e-45b8-982a-f941b1e59b4d"
      decimals="-3"
      id="F_177db21f-c9a4-47fe-97f1-6018983c09b0"
      unitRef="U_USD">679000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_dbf9a77d-f552-43c7-b738-3e4043920c2b"
      decimals="-3"
      id="F_f32495e9-33d3-4c8b-83dc-ccdc741bcebe"
      unitRef="U_USD">1752000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_b0b9ecf4-f70c-49f1-9f26-10517280835d"
      decimals="-3"
      id="F_75d09100-e594-4e45-8e46-13ebdee43d34"
      unitRef="U_USD">1298000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_7b50649f-db0b-4b93-bec5-d51483c006f9"
      unitRef="U_USD">34887000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_9f69913a-75ac-4dad-8639-98bc5c679e18"
      unitRef="U_USD">20810000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_a7ca2479-4933-4bb1-9d7a-ace2eb92df6e"
      unitRef="U_USD">64399000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_574c37c3-5d6f-4409-900a-e2df24533864"
      unitRef="U_USD">38299000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_754f24b7-506d-4d0e-80c0-6352678c3425"
      decimals="2"
      id="F_1386d4b6-1ef0-4f3c-b0da-e970a6cd95fd"
      unitRef="U_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_bc923b7c-f61f-4557-a54a-e7a984c590a4"
      decimals="2"
      id="F_f8c9b176-abb1-401a-957e-e458a69d57e9"
      unitRef="U_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_c3849e78-84e7-468a-b497-8a3fed88ad2d"
      decimals="2"
      id="F_7d083e65-289b-404e-ad8c-5b5dcadc56c0"
      unitRef="U_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_5517632f-b947-4c40-8db1-42c309a847d8"
      decimals="2"
      id="F_2642d07d-17ae-4116-b08c-522830fff095"
      unitRef="U_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:DeferredRevenueByArrangementDisclosureTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_bb7c7950-a0fb-4b1f-8da7-937f399f05d5">&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table represents the contract liabilities from sales activity for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;six months ended June 30, 2024 and 2023, respectively (in thousands):&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:51.661%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.961%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:21.769%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.961%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:16.686999999999998%;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;"&gt;&lt;/td&gt;
           &lt;td style="width:1.961%;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="text-indent:40pt;vertical-align:bottom;"&gt;&lt;p style="margin-left:40pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Balance at beginning of period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,888&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;word-break:break-word;"&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Additions during the period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Revenue recognized during the period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,707&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,233&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;word-break:break-word;"&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Balance at end of period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;</us-gaap:DeferredRevenueByArrangementDisclosureTextBlock>
    <rxst:DeferredRevenue1
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_dc04029f-f879-4864-ada0-bda2f1012156"
      unitRef="U_USD">-1888000</rxst:DeferredRevenue1>
    <rxst:DeferredRevenue1
      contextRef="C_ef35aeef-393e-488b-85fd-95ffed2e764e"
      decimals="-3"
      id="F_4945a2f2-c98d-4808-a2c2-39256e20d4d1"
      unitRef="U_USD">-1193000</rxst:DeferredRevenue1>
    <us-gaap:DeferredRevenueAdditions
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_9e3a436a-cdab-483c-a3ba-cee6a01eb8de"
      unitRef="U_USD">1949000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:DeferredRevenueAdditions
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_6b909d52-267d-4b7b-8504-4ac3dace455e"
      unitRef="U_USD">1391000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:DeferredRevenueRevenueRecognized1
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_e6e6af70-8488-4f0d-95ee-ca0618584ccf"
      unitRef="U_USD">1707000</us-gaap:DeferredRevenueRevenueRecognized1>
    <us-gaap:DeferredRevenueRevenueRecognized1
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_4722011c-2491-4b97-8df3-53effbdea67a"
      unitRef="U_USD">1233000</us-gaap:DeferredRevenueRevenueRecognized1>
    <rxst:DeferredRevenue1
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_4d7bba67-1baf-4398-aaee-c09e5db3d134"
      unitRef="U_USD">-2130000</rxst:DeferredRevenue1>
    <rxst:DeferredRevenue1
      contextRef="C_4cac1f56-50f3-44b0-afcc-1b3e03ff9aad"
      decimals="-3"
      id="F_a158ae8e-47ba-4d98-844b-b99970ccb585"
      unitRef="U_USD">-1351000</rxst:DeferredRevenue1>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_ee3978c3-d8e6-46ba-a4f3-7fb63e68f5e3">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company has three equity incentive compensation plans: the Calhoun Vision, Inc. 2006 Stock Plan (&#x201c;2006 Plan&#x201d;); the Calhoun Vision, Inc. 2015 Equity Incentive Plan (&#x201c;2015 Plan&#x201d;); and the 2021 Equity Incentive Plan (&#x201c;2021 Plan&#x201d;), which are collectively referred to as the &#x201c;Equity Plans.&#x201d; The Company also has an employee stock purchase plan, the 2021 Employee Stock Purchase Plan (&#x201c;2021 ESPP&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company recognizes compensation expense for equity-based awards on the date of grant to employees, board of directors and consultants based on the estimated grant date fair value of the award's Equity-based payments including stock options, restricted stock units and employee stock plan purchases. The fair value of the option awards are estimated using the Black-Scholes option-pricing model and recognized as an expense in the condensed consolidated statements of operations and comprehensive loss over the requisite service period, which is generally four years. The Company amortizes the stock-based compensation for equity awards with service conditions on a&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;straight-line basis over the vesting period of the awards. Forfeitures of unvested stock option awards are recognized as reductions of expense as they occur.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Black-Scholes option-pricing model requires the use of assumptions about a number of variables, such as the fair market value of the Company&#x2019;s common stock, expected volatility, expected term, risk-free interest rate, and dividend yield as discussed below:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:30.95pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Fair market value&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;The fair value of common stock is determined by using the closing price per share of common stock as reported on the Nasdaq Global Market.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:30.95pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;Effective January 1, 2024, the Company based the expected volatility on the historic volatility of its common stock. During the year ended December 31, 2023, the expected volatility was estimated based on the average historical volatilities for comparable publicly traded medical device companies over a period equal to the expected term of the stock option grants. Comparable companies were chosen based on their similar size, stage in the life cycle and area of specialty.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:30.95pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Expected term&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;The Company&#x2019;s expected term represents the period that the Company&#x2019;s stock-based awards are expected to be outstanding. The Company used the simplified method (based on the mid-point between the vesting date and the end of the contractual term) to determine the expected term.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:30.6pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;The risk-free interest rate used is based on the published U.S. Department of Treasury interest rates in effect at the time of stock option grant for zero coupon U.S. Treasury notes with maturities approximating each grant&#x2019;s expected term.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:30.6pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Dividend yield&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of zero.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_942eeccf-5a89-4bd0-9209-6406cd30484d">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Changes to GAAP are established by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) in the form of accounting standards updates (&#x201c;ASU&#x201d;). There have been no recent accounting pronouncements, changes in accounting pronouncements or recently adopted accounting guidance during the three months ended June 30, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; that are of significance or potential significance to the Company.&lt;/span&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_e9a4c6b5-0e38-4cd4-af0b-89ab59509e7a">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 3 &#x2013; Short-Term Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Short-term investments, principally U.S. Treasury bills, are available-for-sale and consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:25.94%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.24%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:16.459999999999997%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.24%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:22.259999999999998%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.24%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:22.619999999999997%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;As of June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Unrealized Loss, Net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Estimated Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;U.S. Treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;208,938&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;99&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;208,839&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:25.835%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.24%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:16.397%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.599%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:22.156%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.24%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:22.535999999999998%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;As of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Unrealized Gain, Net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Estimated Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;U.S. Treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;117,480&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;117,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;All available-for-sale securities held as of June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; had a maturity of less than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;. The Company has classified all marketable securities, regardless of maturity, as short-term investments based upon the Company&#x2019;s ability and intent to use any and all of those marketable securities to satisfy the Company&#x2019;s liquidity requirements.&lt;/span&gt;&lt;/p&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_2fa48cc5-9ab5-48d8-892d-38deeb2b720a">
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:25.94%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.24%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:16.459999999999997%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.24%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:22.259999999999998%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.24%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:22.619999999999997%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;As of June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Unrealized Loss, Net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Estimated Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;U.S. Treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;208,938&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;99&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;208,839&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:25.835%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.24%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:16.397%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.599%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:22.156%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.24%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:22.535999999999998%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;As of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Unrealized Gain, Net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Estimated Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;U.S. Treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;117,480&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;117,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_6e1c7f83-49b9-4025-a3c3-dc623355c0cc"
      decimals="-3"
      id="F_3823c18f-a634-4945-9e8b-a40251bd3590"
      unitRef="U_USD">208938000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
      contextRef="C_6e1c7f83-49b9-4025-a3c3-dc623355c0cc"
      decimals="-3"
      id="F_3861f418-502e-49d2-840f-5258ab1a88fd"
      unitRef="U_USD">99000</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_6e1c7f83-49b9-4025-a3c3-dc623355c0cc"
      decimals="-3"
      id="F_93a9565c-34e6-446d-9fc6-87a405715277"
      unitRef="U_USD">208839000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_5ff8a19a-ef8a-4d06-aaa2-5caaf0edeb10"
      decimals="-3"
      id="F_c2206204-1172-45b1-b6d8-fa55cce8a36a"
      unitRef="U_USD">117480000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
      contextRef="C_5ff8a19a-ef8a-4d06-aaa2-5caaf0edeb10"
      decimals="-3"
      id="F_98f3cf4e-74fa-4619-b980-4b3de59ebb67"
      unitRef="U_USD">-10000</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_5ff8a19a-ef8a-4d06-aaa2-5caaf0edeb10"
      decimals="-3"
      id="F_ea89dc15-e19b-409a-bba2-3a8ecf201aa4"
      unitRef="U_USD">117490000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <rxst:InvestmentMaturityPeriod
      contextRef="C_f5781e6f-1600-45ee-a829-0c9af9692565"
      id="F_ae7e114b-b437-4b9d-a3a1-8afccfb13f60">P1Y</rxst:InvestmentMaturityPeriod>
    <rxst:InvestmentMaturityPeriod
      contextRef="C_e18f6da3-90c2-4d9b-8b4e-269b15d12144"
      id="F_222b099c-ba65-4afc-8ec1-1cd8bbee4228">P1Y</rxst:InvestmentMaturityPeriod>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_2ea52163-c108-4bd4-85f4-b3e0e51eea92">&lt;p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 4 &#x2013; Inventories&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Inventories consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:57.74%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.76%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:14.200000000000001%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:5.16%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:14.200000000000001%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.94%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;word-break:break-word;"&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finished goods&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;11,327&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;8,092&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Raw materials&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5,680&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;word-break:break-word;"&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Work-in-process&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3,371&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;20,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;17,917&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;word-break:break-word;"&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Less: reserve for excess and obsolete inventory&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;568&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;496&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;19,443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;17,421&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;At June 30, 2024 and December 31, 2023, finished goods included &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million of inventory held on consignment at customer sites, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_d9acc590-294a-4baa-a4f0-71ba41199b6e">&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Inventories consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:57.74%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.76%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:14.200000000000001%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:5.16%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:14.200000000000001%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.94%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;word-break:break-word;"&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finished goods&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;11,327&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;8,092&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Raw materials&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5,680&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;word-break:break-word;"&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Work-in-process&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3,371&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;20,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;17,917&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;word-break:break-word;"&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Less: reserve for excess and obsolete inventory&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;568&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;496&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#cff0fc;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="background-color:#ffffff;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;19,443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;17,421&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_ab878ee3-213f-4b20-bfb0-c52b7bc1da4c"
      unitRef="U_USD">11327000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_b44cdd50-97bb-4b0c-96d4-bad3e07f01c8"
      unitRef="U_USD">8092000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryRawMaterials
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_e554a837-34b8-489d-a174-b974a8ca113c"
      unitRef="U_USD">5313000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_88a85398-ad9d-494c-98bd-3d64cab5b354"
      unitRef="U_USD">5680000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_c3f09305-651d-4c31-bbb6-6ceb3e7c8502"
      unitRef="U_USD">3371000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_dc767048-7f92-4a76-a9ae-fe553928af5a"
      unitRef="U_USD">4145000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryGross
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_61b8e6de-424f-4353-b7f0-ca7698f2181e"
      unitRef="U_USD">20011000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_c2dc2926-4621-45dd-b405-aadc58decfbd"
      unitRef="U_USD">17917000</us-gaap:InventoryGross>
    <us-gaap:InventoryValuationReserves
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_35222aa6-a456-4bc8-8866-416d0c363d97"
      unitRef="U_USD">568000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_bac62254-75ee-40de-ac51-c62f2ae3d9bf"
      unitRef="U_USD">496000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryNet
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_85ed387c-9d7c-449e-bb94-a51fd4520761"
      unitRef="U_USD">19443000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_388d6108-0506-4638-8852-315ed8afdfe3"
      unitRef="U_USD">17421000</us-gaap:InventoryNet>
    <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-5"
      id="F_e8998300-3aa6-4467-8b2a-7ce130f2ee77"
      unitRef="U_USD">5000000</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment>
    <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-5"
      id="F_c1f1c287-917d-4d83-954c-912260ef954e"
      unitRef="U_USD">4400000</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_108a559c-0301-411d-bf0b-10e0fad40438">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 5 &#x2013; Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The table and disclosures for the periods presented below (in thousands) present the Company&#x2019;s assets and liabilities measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value. The Company did not have any assets or liabilities measured at fair value on a recurring basis within Level 3 fair value measurements.&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:33.22%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.18%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.18%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.18%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;As of June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Level I&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Level II&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Money market securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18,986&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18,986&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;U.S. Treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;208,839&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;208,839&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Total assets at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18,986&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;208,839&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;227,825&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:33.22%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.18%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.18%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.18%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;As of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Level I&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Level II&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Money market securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4,475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4,475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;U.S. Treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;117,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;117,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Total assets at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4,475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;117,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;121,965&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_636f2d6a-02ed-4757-962d-c471625a56fd">&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The table and disclosures for the periods presented below (in thousands) present the Company&#x2019;s assets and liabilities measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value. The Company did not have any assets or liabilities measured at fair value on a recurring basis within Level 3 fair value measurements.&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:33.22%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.18%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.18%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.18%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;As of June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Level I&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Level II&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Money market securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18,986&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18,986&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;U.S. Treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;208,839&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;208,839&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Total assets at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18,986&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;208,839&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;227,825&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:33.22%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.18%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.18%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.18%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;As of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Level I&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Level II&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Money market securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4,475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4,475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;U.S. Treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;117,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;117,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Total assets at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4,475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;117,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;121,965&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_2a070290-4230-4337-a657-3d109387c5bf"
      decimals="-3"
      id="F_061e8095-a3c9-4fc2-bfef-92e398a06523"
      unitRef="U_USD">18986000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c25f11d6-dc7c-4161-b92c-872ba3474149"
      decimals="-3"
      id="F_b32b32e8-a6f4-404d-bf6d-4cf5c5441cad"
      unitRef="U_USD">18986000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c97db89c-4001-4cdb-bd4d-a54689c81080"
      decimals="-3"
      id="F_c6f82bea-46e1-46fd-b1a4-f257e5ec82b4"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_b0cbb535-d10a-43e6-a2b0-bb698413d1e0"
      decimals="-3"
      id="F_b6511721-cf2d-49f1-adad-8032a879a3ec"
      unitRef="U_USD">208839000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_8c085cd2-f882-483a-9365-9c156f7d6bb4"
      decimals="-3"
      id="F_483946be-9e50-40ba-9aa2-9d6df1972167"
      unitRef="U_USD">208839000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_b88f6739-08be-4673-af5e-386409d97e2e"
      decimals="-3"
      id="F_e1cbadcd-37ca-48a1-b130-a2a65dbbe0c3"
      unitRef="U_USD">18986000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_7391a03e-f048-45b1-8c90-50f3375336d3"
      decimals="-3"
      id="F_344b6d0f-2e4f-4c2c-ba56-1bc5719bd651"
      unitRef="U_USD">208839000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_4b3269c5-712a-484a-9037-c364da299251"
      unitRef="U_USD">227825000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_39cfd17b-899f-40c4-845a-6fdae94d9625"
      decimals="-3"
      id="F_4d3fc422-bdc1-498b-b26b-6ac976fbe303"
      unitRef="U_USD">4475000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_71726fb1-fc7b-4769-9509-bbabcda3b877"
      decimals="-3"
      id="F_01f5e8b6-f218-4530-833a-5cf5a5309a3e"
      unitRef="U_USD">4475000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_a9fe9645-a679-4c9e-910d-64434fc0d770"
      decimals="-3"
      id="F_c333f4e8-68a8-4032-8d13-919e28ffb9ec"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_33a5d823-d771-4f16-9c29-15bf632fdbb6"
      decimals="-3"
      id="F_bf25cf92-9f24-44cb-9266-59ca47f40640"
      unitRef="U_USD">117490000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_848743db-b358-4cf3-abd3-f3016e7703de"
      decimals="-3"
      id="F_399113be-75b4-4f71-a2ca-511afe2ba513"
      unitRef="U_USD">117490000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_5f629c9c-346d-4df1-9e88-b538f5affce5"
      decimals="-3"
      id="F_8c5d2853-fa5d-4dd9-b482-81bed611a147"
      unitRef="U_USD">4475000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0a0a72f6-5a6d-41e6-92e8-4b90cf7843c6"
      decimals="-3"
      id="F_c0b8d072-a49e-44eb-81ad-e82bd9a636c0"
      unitRef="U_USD">117490000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_73a00ab9-5307-403c-9069-26055dcdbc98"
      unitRef="U_USD">121965000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_20918c9c-c73f-4b8d-bfcd-3b6d3be11a09">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 6 &#x2013; Stock-Based Compensation Expense&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company has three equity incentive compensation plans: the 2006 Plan, the 2015 Plan and the 2021 Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;2006 Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The 2006 Plan was originally adopted by the Board and approved by the Company&#x2019;s stockholders in 2006. The 2006 Plan was terminated in 2015 in connection with the adoption of the 2015 Plan and as a result no new awards may be issued under the 2006 Plan. However, the 2006 Plan will continue to govern the terms and conditions of the outstanding awards previously granted under the 2006 Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;2015 Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The 2015 Plan was originally adopted by the Board and approved by the Company&#x2019;s stockholders in 2015. In July 2021, the 2015 Plan terminated immediately prior to effectiveness of the 2021 Plan with respect to the grant of future awards. However, the 2015 Plan will continue to govern the terms and conditions of the outstanding awards previously granted under the 2015 Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;2021 Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;July 28, 2021, the 2021 Plan was adopted and approved by the Board and stockholders prior to the IPO and became effective on the business day immediately prior to the effective date of the Company&#x2019;s IPO registration&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;statement.  &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The 2021 Plan provides for the grant of incentive stock options to employees and any subsidiary corporations&#x2019; employees, and for the grant of nonstatutory stock options, stock appreciation rights, restricted stock, restricted stock units (&#x201c;RSUs&#x201d;), and performance awards to employees, directors, and consultants and subsidiary corporations&#x2019; employees and consultants.  The number of shares of the Company&#x2019;s common stock originally available for issuance under the 2021 Plan was equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,420,135&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock plus any shares subject to awards granted under the 2015 Plan and the 2006 Plan that, after the effectiveness of the 2021 Plan, expire or otherwise terminate without having been exercised in full, are tendered to or withheld by the Company for payment of an exercise price or for tax withholding obligations, or are forfeited to or repurchased by the Company due to failure to vest, with the maximum number of shares to be added to the 2021 Plan from the 2015 Plan and 2006 Plan equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4,569,530&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Evergreen provision&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The number of common shares reserved for issuance under the 2021 Plan will be increased automatically on the first day of each fiscal year beginning with the 2022 fiscal year and ending on the ten year anniversary of the date the Board approved the 2021 Plan, by a number equal to the least of: (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;7,260,406&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of our common stock; (ii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of the outstanding shares of our common stock on the last day of the immediately preceding fiscal year; or (iii) such lesser number of shares of our common stock as the administrator may determine. The 2021 Plan is administered by the Board. On January 1, 2024 and 2023, the number of shares available under the 2021 Plan increased by &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,445,580&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,130,735&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock, respectively pursuant to this feature.  As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;June 30, 2024, the number of shares of the Company&#x2019;s common stock available for future issuance under the 2021 Plan was equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;951,817&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;2021 ESPP&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On July 28, 2021, the Board and stockholders adopted and approved the 2021 ESPP. As of June 30, 2024, the number of shares of the Company&#x2019;s common stock available for future issuance under the 2021 ESPP was equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;538,942&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The 2021 ESPP provides eligible employees of the Company and its subsidiaries with the opportunity to purchase shares of the Company&#x2019;s common stock at a purchase price equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of the common stock&#x2019;s fair market value on the first trading day or last trading day of each purchase period, whichever is lower. The 2021 ESPP  provides for two six-month purchase periods every twelve months: May 1 through October 31 and November 1 through April 30. The initial purchase period began on November 1, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Evergreen provision&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The number of common shares reserved for issuance under the 2021 ESPP will be increased automatically on the first day of each fiscal year beginning with the 2022 fiscal year, by a number equal to the least of: (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,452,081&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares; (ii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of the outstanding shares of our common stock on the last day of the immediately preceding fiscal year; or (iii) such other amount as the administrator may determine. The 2021 ESPP is administered by the Board.  No additional shares were reserved for issuance on January 1, 2024 and 2023 pursuant to this feature.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The purpose of the 2021 Plan and 2021 ESPP is to provide a means by which eligible recipients of stock awards may be given an opportunity to benefit from increases in the value of the common stock in order to retain or procure the services of the employees, members of the Board and consultants and provide them with an incentive to promote the Company&#x2019;s success and accomplish corporate goals.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Stock option awards are granted with an exercise price of no less than 100% of estimated fair market value on the date of grant. Time based awards generally vest over &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;four years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; as follows, subject to the optionee&#x2019;s continuing service: (i) one fourth of the total number of shares vest and become exercisable on the one-year anniversary and then 1/48th of the total number of shares subject to the option vest and become exercisable on each monthly anniversary thereafter for the remaining three years, or (ii) 1/48th of the total number of shares subject to the option vest and become exercisable each month over four years.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;A summary of the stock option activities related to the Equity Plans for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;six months ended June 30, 2024 is presented below:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:51.15%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.36%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:12.603%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.4%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:12.042%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:13.443%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Number of Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Weighted Avg&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Options outstanding as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="text-indent:5pt;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6,777,404&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;13.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.51&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;799,502&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;55.89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,258,874&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10.53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;62,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;16.05&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,236&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.57&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Options outstanding as of June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6,244,801&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18.99&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.78&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Exercisable as of June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3,623,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;13.23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5.45&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As of June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; the intrinsic value of options vested was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;170.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;121.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively, and of all options outstanding was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;257.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;185.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively. During the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;six months ended June 30, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, the total cash received from the exercise of stock options was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;13.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively. The total fair value less strike price of these options was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;50.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.5pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;A summary of non-vested restricted stock unit activities for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;six months ended June 30, 2024 is as follows:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:61.16%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.72%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.2%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:15.36%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.68%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:14.88%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Weighted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Number of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Grant Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Unvested at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="text-indent:5pt;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;650,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;15.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;183,231&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;56.36&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;165,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;17.99&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18,033&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;15.71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Unvested at June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;649,988&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;26.68&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Stock-based compensation expense was classified in the accompanying condensed consolidated statements of operations and comprehensive income (loss) as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:37.792%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:15.697000000000001%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:9.958%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:11.158000000000001%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:11.638%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,395&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Selling, general and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4,210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,639&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;7,410&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4,910&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Cost of sales&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;295&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;890&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;517&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6,105&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3,955&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,801&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;7,250&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As of June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,620,861&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,539,445&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; unvested options, respectively.  As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, total unrecognized expense related to unvested stock options was approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;44.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;22.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively. Both amounts are expected to be recognized over a weighted average period of approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.4&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; years, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As of June 30, 2024, and December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, total unrecognized expense related to non-vested restricted stock units was approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;15.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;8.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively. The unrecognized compensation cost is expected to be recognized over a weighted average period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.4&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; years and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; years, respectively.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table presents the range and weighted-average assumptions, used in the Black-Scholes option pricing model to determine the fair value of stock options:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:23.81%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.581%;"&gt;&lt;/td&gt;
         &lt;td style="width:17.467%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.581%;"&gt;&lt;/td&gt;
         &lt;td style="width:17.467%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.581%;"&gt;&lt;/td&gt;
         &lt;td style="width:17.467%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.581%;"&gt;&lt;/td&gt;
         &lt;td style="width:17.467%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="7" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Weighted Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Weighted Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;69.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;72.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;71.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;64.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;65.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;65.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Expected life (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#160;to &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Grant date fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;36.89&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#160;to $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;60.65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;55.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;12.91&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#160;to $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;28.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;15.26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:-18pt;padding-left:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Common Stock&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Each share of common stock is entitled to one vote. Common stock reserved for future issuance consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.967%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.16%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:13.357%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.16%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:13.357%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:middle;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Stock options issued and outstanding under the Equity Plans&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6,244,801&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6,777,404&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Shares available for future issuance under the 2021 Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;951,817&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;358,610&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Restricted stock units issued under the 2021 Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;649,988&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;650,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Shares available for future issuance under 2021 ESPP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;538,942&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;577,847&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Total shares of common stock reserved&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;8,385,548&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;8,364,218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_09e7c479-5280-4bf3-a282-cb28f4483242"
      decimals="INF"
      id="F_fae178ae-95b0-45f1-85dd-5e809b20e4f3"
      unitRef="U_shares">2420135</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_7e061ea2-e4c5-4f24-a010-06a54d38af8e"
      decimals="INF"
      id="F_dda4aa8f-b0ee-47bb-aa61-1d22624e1978"
      unitRef="U_shares">4569530</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_09e7c479-5280-4bf3-a282-cb28f4483242"
      decimals="INF"
      id="F_b08d5327-42a6-450d-8965-783aeb0dbebc"
      unitRef="U_shares">7260406</us-gaap:CommonStockSharesIssued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="C_3b6572ea-8779-41d7-9699-5abd96466e88"
      decimals="2"
      id="F_82b8d2a6-284e-46e2-8808-969a0c7d7b9a"
      unitRef="U_pure">0.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_ce17e0b5-a12f-49d2-881e-1ca12b318794"
      decimals="INF"
      id="F_06dc6fe9-49ba-440b-bc17-4b8f5ae2a106"
      unitRef="U_shares">1445580</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_5501518b-7c81-4968-a973-df58e4381f69"
      decimals="INF"
      id="F_9ff33db1-be0b-48ef-bf5d-c4671ddd39dc"
      unitRef="U_shares">1130735</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_f1b15466-ecb1-46a7-a2a9-b73c5a09ae08"
      decimals="INF"
      id="F_55f72d8b-9b4f-4af7-bf22-f7e9ed8de611"
      unitRef="U_shares">951817</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_4d46893f-4145-428e-8ad7-90506451e341"
      decimals="INF"
      id="F_1bba3837-5e26-428f-b1ec-381f69289812"
      unitRef="U_shares">538942</us-gaap:CommonStockSharesIssued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="C_7424c8a5-89f5-43f8-895f-fd84c2c2a996"
      decimals="2"
      id="F_a8d5d99d-5847-4488-989c-0a90a158cdab"
      unitRef="U_pure">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_8711b3ad-aa2f-4b24-ab3c-bee15606d03d"
      decimals="INF"
      id="F_3ee18b52-b44f-485a-97e1-7d99facd3951"
      unitRef="U_shares">1452081</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="C_e56c75b3-caad-43f6-8432-5c6f54278fe0"
      decimals="2"
      id="F_82ccee98-891d-4929-b0e2-28cf7cd5e1d8"
      unitRef="U_pure">0.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_53dc87ca-e2a8-4348-bc26-804871cd3eca">Stock option awards are granted with an exercise price of no less than 100% of estimated fair market value on the date of grant. Time based awards generally vest over four years as follows, subject to the optionee&#x2019;s continuing service: (i) one fourth of the total number of shares vest and become exercisable on the one-year anniversary and then 1/48th of the total number of shares subject to the option vest and become exercisable on each monthly anniversary thereafter for the remaining three years, or (ii) 1/48th of the total number of shares subject to the option vest and become exercisable each month over four years.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_59908af3-c3c5-49c1-9bb8-171ba60eb5f6"
      id="F_df3f5a60-1989-4793-b249-21042edba366">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_4ba8a6a9-13e7-40ed-81fd-c085f75c7ba5">&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;A summary of the stock option activities related to the Equity Plans for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;six months ended June 30, 2024 is presented below:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:51.15%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.36%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:12.603%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.4%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:12.042%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:13.443%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Number of Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Weighted Avg&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Options outstanding as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="text-indent:5pt;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6,777,404&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;13.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.51&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;799,502&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;55.89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,258,874&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10.53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;62,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;16.05&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,236&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.57&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Options outstanding as of June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6,244,801&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18.99&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.78&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Exercisable as of June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3,623,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;13.23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5.45&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="0"
      id="F_603ab7fc-5182-4d8e-afa9-d51c904860cf"
      unitRef="U_shares">6777404</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="2"
      id="F_7077f26d-7fa6-49a8-b123-d1c14761ae54"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">13.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_1223a5cf-5ff9-4abd-b52d-c7eebdeb8212"
      id="F_579c2493-c4f9-4cfe-8636-20289d86e9d1">P6Y6M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="0"
      id="F_c3547d56-9170-4eea-a216-fdc9ef29ce13"
      unitRef="U_shares">799502</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="2"
      id="F_ed2227ad-eb64-476f-94e3-e427f3e3f00e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">55.89</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="0"
      id="F_f2f91804-23b8-43c4-b3f1-f46448ac92f7"
      unitRef="U_shares">1258874</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="2"
      id="F_7885a376-73e7-4c03-ae6b-c06b518e10f8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">10.53</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="0"
      id="F_a5e70c63-b77b-42ba-a46b-89a9d74cff5c"
      unitRef="U_shares">62995</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="2"
      id="F_dc80197c-356e-4d3e-a58e-f8f283de5b1e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">16.05</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="0"
      id="F_4372ed40-46a5-45d3-8f0c-7c5ba3cedc2b"
      unitRef="U_shares">10236</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="2"
      id="F_58f80331-52dc-4348-a3b6-2d25ae5def1e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.57</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="0"
      id="F_837a7631-ec41-4dd6-b832-fca39b3fcf36"
      unitRef="U_shares">6244801</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="2"
      id="F_2fcfc02d-3a93-4b13-8fd3-63f280622db0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">18.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_38d67ac8-d722-4e56-9120-51be024be880">P6Y9M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="0"
      id="F_2fc46ae0-b6ad-4b08-a1ab-ab7060989ad4"
      unitRef="U_shares">3623940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="2"
      id="F_b56ffbc6-6bbc-422d-bad6-4eb21eb26910"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">13.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_e08c48e2-2636-4532-81ba-c9c38bd4476b">P5Y5M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_cffab339-4046-4bfa-b82a-1b1694720712"
      decimals="-5"
      id="F_423f1e75-c0f3-4938-8f15-fd26ccb3a45f"
      unitRef="U_USD">170100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_1e158749-5a3a-428a-9c8c-71d3347c8329"
      decimals="-5"
      id="F_1752a5f3-c1c2-4107-a19d-41f53cea2c91"
      unitRef="U_USD">121300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_cffab339-4046-4bfa-b82a-1b1694720712"
      decimals="-5"
      id="F_13081e48-d44f-49e4-91a9-18f1703bacf1"
      unitRef="U_USD">257200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_1e158749-5a3a-428a-9c8c-71d3347c8329"
      decimals="-5"
      id="F_7908a9c7-4792-4f5d-9c8d-6bf97c784281"
      unitRef="U_USD">185000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_f9980517-1437-4032-bfd8-e4a47703b439"
      decimals="-5"
      id="F_65aed650-2e8d-450c-b0e8-1a8d0ee972eb"
      unitRef="U_USD">13300000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_b2763b9c-65fc-4b20-9afe-65016b69e297"
      decimals="-5"
      id="F_7e8caaa4-a356-4a85-a56b-42ce6c28a328"
      unitRef="U_USD">3400000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_f9980517-1437-4032-bfd8-e4a47703b439"
      decimals="-5"
      id="F_3bb023dc-7e58-4c9a-b8e4-0d43bc30d477"
      unitRef="U_USD">50500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_b2763b9c-65fc-4b20-9afe-65016b69e297"
      decimals="-5"
      id="F_1e63f5e9-046e-4f93-b2a0-7bfdf436b313"
      unitRef="U_USD">5200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_b5ea7f37-76ab-4ae3-8648-cf28ef25366e">&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;A summary of non-vested restricted stock unit activities for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;six months ended June 30, 2024 is as follows:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:61.16%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.72%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.2%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:15.36%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.68%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:14.88%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Weighted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Number of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Grant Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Unvested at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="text-indent:5pt;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;650,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;15.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;183,231&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;56.36&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;165,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;17.99&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18,033&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;15.71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Unvested at June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;649,988&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;26.68&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_6f6583f5-ec7a-4082-9b35-96788b1aca0c"
      decimals="0"
      id="F_00f23ad4-402a-4d19-ae64-a6181806e676"
      unitRef="U_shares">650357</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_6f6583f5-ec7a-4082-9b35-96788b1aca0c"
      decimals="2"
      id="F_953df739-3cbf-477d-a9ed-10eb0dba2a76"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15.8</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_72d61c44-49fd-41dd-ad51-35f48ea85916"
      decimals="0"
      id="F_315e50f7-c370-4552-b292-c47609f067a0"
      unitRef="U_shares">183231</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_72d61c44-49fd-41dd-ad51-35f48ea85916"
      decimals="2"
      id="F_f84168c9-7d94-4924-9ce6-557ec033c4dd"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">56.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="C_72d61c44-49fd-41dd-ad51-35f48ea85916"
      decimals="0"
      id="F_79dd5519-0e71-4f48-a040-b7c0cc8e38b5"
      unitRef="U_shares">165567</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_72d61c44-49fd-41dd-ad51-35f48ea85916"
      decimals="2"
      id="F_05f7735b-67d7-4341-9a3c-bd12cf896d28"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">17.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="C_72d61c44-49fd-41dd-ad51-35f48ea85916"
      decimals="0"
      id="F_1e76c25c-c5b8-4ac9-98fc-2112f06f63ef"
      unitRef="U_shares">18033</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_72d61c44-49fd-41dd-ad51-35f48ea85916"
      decimals="2"
      id="F_25a24024-f6fe-4378-9087-de222a175657"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="C_0abad422-2500-4d9e-b9d3-8c167c8ee9ab"
      decimals="0"
      id="F_0e24f73e-34af-4266-96ae-7878e745712d"
      unitRef="U_shares">649988</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0abad422-2500-4d9e-b9d3-8c167c8ee9ab"
      decimals="2"
      id="F_bc0c7109-b6c8-4713-8621-5085abdef2ac"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">26.68</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_bde16b79-d09a-44bb-b43a-55243514d2b2">&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Stock-based compensation expense was classified in the accompanying condensed consolidated statements of operations and comprehensive income (loss) as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:37.792%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:15.697000000000001%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:9.958%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:11.158000000000001%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:11.638%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,395&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Selling, general and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4,210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,639&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;7,410&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4,910&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Cost of sales&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;295&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;890&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;517&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6,105&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3,955&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,801&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;7,250&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_8f9792cd-5e2e-44bd-b8e7-5ba5d2e31334"
      decimals="-3"
      id="F_70856c81-5348-4bd5-a549-d6f31a8028b3"
      unitRef="U_USD">1395000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_15d45034-58a3-4d42-bc68-b3740b5e0b2a"
      decimals="-3"
      id="F_4f476979-6e97-4a17-9ed1-9f173693041c"
      unitRef="U_USD">1021000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_2d3d3cc5-4096-4048-9e86-726c8e7126ef"
      decimals="-3"
      id="F_60f2af53-94de-48dd-b347-03c86d075596"
      unitRef="U_USD">2501000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c40bec78-b687-45c4-ad3c-00a3ff05916e"
      decimals="-3"
      id="F_fb759cd6-7be1-4f3a-ab6b-37f1e51c99ca"
      unitRef="U_USD">1823000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_ca32f3ef-6b1d-45b4-9e16-40beee1bb09f"
      decimals="-3"
      id="F_7670973c-f1c5-40cc-b587-aba2446c8b58"
      unitRef="U_USD">4210000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_306d346a-380e-4f34-a95e-850689d48e3f"
      decimals="-3"
      id="F_c5c94d85-4b39-4641-94a6-65168f9c31a0"
      unitRef="U_USD">2639000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_9b623e0d-4f1d-4db1-ae4c-f10eeef88de2"
      decimals="-3"
      id="F_970d35d1-8183-40f0-8c40-81950db69452"
      unitRef="U_USD">7410000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_55f52d8a-909f-44fb-865e-6571cbcee723"
      decimals="-3"
      id="F_f4c06bde-b5da-4bfe-b981-ccc0d18b07e9"
      unitRef="U_USD">4910000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_ebf267e3-249d-4c66-a032-0ae76ee1e173"
      decimals="-3"
      id="F_7bbfb565-da03-4be7-8311-d3daf84c2eed"
      unitRef="U_USD">500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_35ccf33e-5721-47b9-9631-6b62ea10a50a"
      decimals="-3"
      id="F_65afef93-9708-45d2-a765-e2ec7c292cbb"
      unitRef="U_USD">295000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_9dff912c-7bb1-4372-9d7e-a40dfcd38d40"
      decimals="-3"
      id="F_f6a2a938-2a06-4c92-8605-d6cdcb6fdb0f"
      unitRef="U_USD">890000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_872467f9-67fd-4871-b993-41838a2b5113"
      decimals="-3"
      id="F_5939e50a-0b39-462e-9e51-2df4188079e2"
      unitRef="U_USD">517000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_748782be-b4c1-440b-81fc-508b52d9ef24"
      decimals="-3"
      id="F_59ea0e4a-1868-4721-9dd7-6077471299af"
      unitRef="U_USD">6105000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_bdb7c2a6-1dd2-4f29-924b-0d330d5760a5"
      decimals="-3"
      id="F_f2388649-c360-4d17-a59f-c17488381b21"
      unitRef="U_USD">3955000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_f9980517-1437-4032-bfd8-e4a47703b439"
      decimals="-3"
      id="F_80583c23-e3d9-4472-834e-45fde6f44f30"
      unitRef="U_USD">10801000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_b2763b9c-65fc-4b20-9afe-65016b69e297"
      decimals="-3"
      id="F_d4998a01-1586-4e3e-8ccb-16a1c1db8968"
      unitRef="U_USD">7250000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="C_cffab339-4046-4bfa-b82a-1b1694720712"
      decimals="INF"
      id="F_26a12a0b-affc-42b4-8ab4-91b62a936d55"
      unitRef="U_shares">2620861</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="C_1e158749-5a3a-428a-9c8c-71d3347c8329"
      decimals="INF"
      id="F_b098af18-da35-42ab-ad75-c9ed87bdb790"
      unitRef="U_shares">2539445</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_cffab339-4046-4bfa-b82a-1b1694720712"
      decimals="-5"
      id="F_717bf915-1723-47e3-bdf6-4aa080312c44"
      unitRef="U_USD">44100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_1e158749-5a3a-428a-9c8c-71d3347c8329"
      decimals="-5"
      id="F_b1dd1776-cc0a-4d19-876f-5ae5298c6f5a"
      unitRef="U_USD">22700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_f9980517-1437-4032-bfd8-e4a47703b439"
      id="F_65bbe0df-4761-4664-9384-4680e01292bb">P2Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_4b3ce656-4281-4287-90bf-5e25822bf054"
      id="F_18560374-11c6-467e-a0cf-963168ef3751">P2Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-5"
      id="F_c1cd00a2-42b6-4c17-b059-9823e0243f2f"
      unitRef="U_USD">15300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-5"
      id="F_da6a1132-32c1-4c6f-9a1a-d23281b8f691"
      unitRef="U_USD">8300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_72207dc6-8a88-4a0a-988b-d8bca47ecaaa"
      id="F_4a53baad-2264-4e75-999c-b2a60dd8cb14">P2Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_26af5d92-2265-4e0b-b68d-a926ef38258d"
      id="F_b43776b9-dc6b-4713-869f-daf80e48e8ac">P2Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_ed1ee47f-b966-4439-9ed6-c20b6ae3f0ed">&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table presents the range and weighted-average assumptions, used in the Black-Scholes option pricing model to determine the fair value of stock options:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:23.81%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.581%;"&gt;&lt;/td&gt;
         &lt;td style="width:17.467%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.581%;"&gt;&lt;/td&gt;
         &lt;td style="width:17.467%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.581%;"&gt;&lt;/td&gt;
         &lt;td style="width:17.467%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.581%;"&gt;&lt;/td&gt;
         &lt;td style="width:17.467%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="7" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Weighted Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Weighted Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;69.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;72.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;71.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;64.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;65.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;65.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Expected life (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#160;to &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Grant date fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;36.89&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#160;to $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;60.65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;55.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;12.91&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#160;to $&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;28.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;15.26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_ba9d48f2-149a-4fc5-9666-638ff32e1c8d"
      decimals="3"
      id="F_ca767714-5335-427c-a4fc-43d9604d7aaf"
      unitRef="U_pure">0.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_f5781e6f-1600-45ee-a829-0c9af9692565"
      decimals="3"
      id="F_1bc02982-949a-4a15-b8f4-2c9b28d0bb87"
      unitRef="U_pure">0.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="3"
      id="F_3e77aeed-0f1f-43be-a8a6-cd7727a2036b"
      unitRef="U_pure">0.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_55616c71-0dc0-4231-8880-c2204423fe8a"
      decimals="3"
      id="F_145d944c-bb9e-4923-855f-d6c7d808ca4c"
      unitRef="U_pure">0.649</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_3ccf0dc7-e2f1-4cd5-97cc-45c2be8de24d"
      decimals="3"
      id="F_4cdfbfd6-9cf9-4709-b6d2-350c91f17c74"
      unitRef="U_pure">0.657</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="3"
      id="F_cbec10fc-540f-4d1f-9f9c-0148a1b5e8f4"
      unitRef="U_pure">0.651</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_ba9d48f2-149a-4fc5-9666-638ff32e1c8d"
      decimals="3"
      id="F_b0b9d79d-db7a-4799-a130-e04cafd3ab16"
      unitRef="U_pure">0.039</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_f5781e6f-1600-45ee-a829-0c9af9692565"
      decimals="3"
      id="F_f5d4dade-b57d-4f18-b7b5-5e8afef4b55a"
      unitRef="U_pure">0.047</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="3"
      id="F_e1eea515-436d-46f5-8edb-cd1f7be10274"
      unitRef="U_pure">0.042</rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_55616c71-0dc0-4231-8880-c2204423fe8a"
      decimals="3"
      id="F_cb8c5e7b-37c6-4958-aaef-c217e3ddbd0f"
      unitRef="U_pure">0.034</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_3ccf0dc7-e2f1-4cd5-97cc-45c2be8de24d"
      decimals="3"
      id="F_38817c6b-0016-4b9e-8265-c5ec1dbf94aa"
      unitRef="U_pure">0.042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="3"
      id="F_a510e126-0622-498a-af85-db85269d5deb"
      unitRef="U_pure">0.041</rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_ba9d48f2-149a-4fc5-9666-638ff32e1c8d"
      id="F_28e1b1db-dbc3-4d98-8f75-42da72cc6273">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_51e98ba1-017a-47bf-ae73-98a2ed82ebb6">P6Y</rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_55616c71-0dc0-4231-8880-c2204423fe8a"
      id="F_6fa5202a-c136-40c3-aa98-761f8fe43e79">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_3ccf0dc7-e2f1-4cd5-97cc-45c2be8de24d"
      id="F_5c65fb28-733a-469c-bb6e-36deab46c24c">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      id="F_ca7256af-2162-4902-a41e-c2137bac59f2">P6Y</rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="3"
      id="F_850ccd58-d9ce-4d59-b8ff-b914344ced17"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="3"
      id="F_c9bec6ad-ab76-4e6d-b9e7-3011f35855fe"
      unitRef="U_pure">0</rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="3"
      id="F_9260f4ed-cfb2-4671-a7ee-fac3fd238f7c"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="3"
      id="F_ae5d8ac8-4f84-4ec9-946d-d0f1b28dfe33"
      unitRef="U_pure">0</rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendYield>
    <rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue
      contextRef="C_ba9d48f2-149a-4fc5-9666-638ff32e1c8d"
      decimals="2"
      id="F_b048b075-435f-44ba-96fe-57c470dc357a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">36.89</rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue>
    <rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue
      contextRef="C_f5781e6f-1600-45ee-a829-0c9af9692565"
      decimals="2"
      id="F_de23e424-75e5-45e9-81a4-9c4fef2a5dc3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">60.65</rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue>
    <rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="2"
      id="F_71fb0542-0c56-491c-81e3-b5545f836102"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">55.93</rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue>
    <rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue
      contextRef="C_55616c71-0dc0-4231-8880-c2204423fe8a"
      decimals="2"
      id="F_9e5dc522-3833-40a8-ae7c-35d1fd75c166"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">12.91</rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue>
    <rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue
      contextRef="C_3ccf0dc7-e2f1-4cd5-97cc-45c2be8de24d"
      decimals="2"
      id="F_dffdd35f-72a6-43e0-996f-77c283ac1b82"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">28.8</rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantDateFairValue>
    <rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="2"
      id="F_c996e710-cff6-445a-bdc1-fc5e9622dabc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15.26</rxst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue>
    <rxst:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_a5142fd3-f670-4721-b644-e9c568f5f0bb">&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Each share of common stock is entitled to one vote. Common stock reserved for future issuance consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.967%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.16%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:13.357%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.16%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:13.357%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:middle;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;June 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Stock options issued and outstanding under the Equity Plans&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6,244,801&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6,777,404&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Shares available for future issuance under the 2021 Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;951,817&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;358,610&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Restricted stock units issued under the 2021 Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;649,988&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;650,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Shares available for future issuance under 2021 ESPP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;538,942&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;577,847&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Total shares of common stock reserved&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;8,385,548&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;8,364,218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</rxst:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_e4a673c7-eaa6-4857-856c-50b98038b762"
      decimals="0"
      id="F_869b30f7-cfe3-4468-b26d-04a2548ca898"
      unitRef="U_shares">6244801</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0f2db67e-f20d-4666-a388-00d0b1a6b9f6"
      decimals="0"
      id="F_bad76b78-4350-4ce5-8dc3-e8124d724ce2"
      unitRef="U_shares">6777404</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_23476103-2290-488c-b788-5f19565bb756"
      decimals="0"
      id="F_ee6bdd7e-9c69-45ad-a2a1-86eecf202bb9"
      unitRef="U_shares">951817</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_3fde5492-dc3e-412c-b180-b37e6ed47396"
      decimals="0"
      id="F_cf5ed909-383a-41e7-b4e9-7baab78be153"
      unitRef="U_shares">358610</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0abad422-2500-4d9e-b9d3-8c167c8ee9ab"
      decimals="0"
      id="F_08263fec-43a2-4e02-a7cb-392b954bf09e"
      unitRef="U_shares">649988</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_6f6583f5-ec7a-4082-9b35-96788b1aca0c"
      decimals="0"
      id="F_4712b9ec-07ff-4dfb-8612-d4f06da97441"
      unitRef="U_shares">650357</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_9ea266a9-965b-4b22-8258-e30e3b49e49b"
      decimals="0"
      id="F_5f0aab4f-3087-4907-b9a9-087e8c614b1a"
      unitRef="U_shares">538942</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_7634a85b-9ef7-4095-a9b2-36e304f09a7e"
      decimals="0"
      id="F_f3f968a3-9b9e-40d3-a319-d7ef66b7ee09"
      unitRef="U_shares">577847</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="0"
      id="F_5f1a8d7e-817a-4290-b2ca-1934c6059f9a"
      unitRef="U_shares">8385548</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="0"
      id="F_1560a4de-2c55-468d-94a8-7f6975d108bb"
      unitRef="U_shares">8364218</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_ca8ea59f-9b3a-40d6-a50e-612fb5793b93">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 7 &#x2013; Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company has operating and finance leases for facilities and certain equipment. Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheets. Lease expense for operating leases is recognized on a straight-line basis over the lease term.  The Company does not combine lease and non-lease components in the recognition of lease expense.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As of June 30, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; the Company held &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;four&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; leases for office, manufacturing and warehouse facilities in Aliso Viejo, California. The four leases are for approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;137,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; square feet in the aggregate. For one such operating lease, the lessor provided $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;900,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; in tenant allowances.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On April 4, 2022, the Company entered into a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;thirty-four-month&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; sublease agreement for a portion of the 5 Columbia Building, in Aliso Viejo, CA. The sublease commencement date was June 13, 2022 and was to expire on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;March 31, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;. The base rent receivable was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;11,410&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per month. On January 4, 2023 the Company entered into a second amendment to the sublease agreement adjusting the base rent receivable to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5,319&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per month. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On August 1, 2024 the sublease was cancelled.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;New lease and lease amendments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On April 18, 2024, the Company entered into a new lease, and amendments to two existing leases, for three of its facilities comprising the Company&#x2019;s headquarters, manufacturing, research and development and administrative offices in Aliso Viejo, California, as described in further detail below.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;125 Columbia&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On April 18, 2024, the Company entered into a Standard Industrial/Commercial Single-Tenant Lease &#x2013; Net (the &#x201c;125 Columbia Lease&#x201d;) with BML Management, LLC, for an approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;26,825&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; square foot industrial and research and development facility in Aliso Viejo, California.   The 125 Columbia Lease commences on&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; June 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; and will end on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;January 31, 2031&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;. The Company has two options to extend the term of the 125 Columbia Lease, with each option to extend being for a term of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;60&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; months, commencing when the prior term expires. The base rent is initially $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;41,579&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per month, payable on the first day of each month commencing on June 1, 2024, subject to adjustment as set forth in the 125 Columbia Lease.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;5 Columbia&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On April 18, 2024 and June 3, 2024, the Company entered into Lease Amendment #2 and Lease Amendment #3, respectively to that certain Lease Agreement dated January 10, 2018, as amended on April 5, 2022, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;with Clifford D. Downs, for an approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;19,680&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; square foot industrial facility located at 5 Columbia in Aliso Viejo, California (collectively the &#x201c;5 Columbia Amendments&#x201d;). Pursuant to the 5 Columbia Amendments, the term of the lease was extended &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;70 &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;months, beginning on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;April 1, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; and ending on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;January 31, 2031&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;. The parties agreed to the base rent rate payable over the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;70&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; month term as set forth in the 5 Columbia Amendments. The base rent is initially $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;30,701&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per month and includes fixed rent escalations beginning on April 1, 2027. The Company has two options to extend the term of the lease, with each option to extend being for a term of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;60&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; months, commencing when the prior term expires.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;100 Columbia&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On April 18, 2024, the Company entered into a Fifth Amendment to that certain Commercial Lease Agreement, dated August 31, 2015, as amended November 23, 2015, December 22, 2015, January 18, 2016, and November 12, 2016, with Accuride International Inc., for an approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;42,106&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; square foot industrial facility located at 100 Columbia in Aliso Viejo, California (the &#x201c;April 2024 100 Columbia Amendment&#x201d;). Pursuant to the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;April 2024 100 Columbia Amendment, the term of the lease was extended &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;76&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; months, beginning on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;October 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; and ending on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;January 31, 2031&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;. The parties agreed to the base rent rate payable over the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;76&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; month term as set forth in the April 2024 100 Columbia Amendment. The base rent is initially $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;64,843&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per month and includes fixed rent escalations beginning on October 1, 2025.&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; The Company has two options to extend the term of the lease at the end of the current term, with each option to extend being for a 5 year term.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; The lessor provided $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;50,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; in tenant allowances.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On June 3, 2024, the Company entered into a Sixth Amendment to that certain Commercial Lease Agreement, dated August 31, 2015, as amended April 18, 2024 as amended November 23, 2015, December 22, 2015, January 18, 2016, and November 12, 2016, with Accuride International Inc., for the property located at 100 Columbia in Aliso Viejo, California (the &#x201c;June 2024 100 Columbia Amendment&#x201d;). The June 2024 100 Columbia Amendment updated certain notification requirements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Under these lease agreements, the Company is required to pay approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million in future minimum lease payments of which $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million will be paid in 2024, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million will be paid in 2025, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million will be paid in 2026, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million will be paid in both 2027 and 2028, and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million will be paid thereafter.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table presents the lease balances within the Condensed Consolidated Balance Sheets as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;June 30, 2024 and December 31, 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:29.294%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;"&gt;&lt;/td&gt;
         &lt;td style="width:35.833%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:12.977%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:12.977%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Classification&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Operating&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Operating leases right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,818&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,444&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_3e517117-8319-4cc0-8225-94336556f3a7;"&gt;&lt;span style="-sec-ix-hidden:F_00e18cde-e7c6-4077-9799-7012c3ad64fb;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;142&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Total lease assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,960&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Operating&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_0bfe1017-2ed2-4326-a247-db41c8cf4d2b;"&gt;&lt;span style="-sec-ix-hidden:F_78fd0571-9a99-465d-8968-e56cfa5898f0;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;710&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,764&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_0f7fb7b9-c9ea-4648-8251-fd72d360c669;"&gt;&lt;span style="-sec-ix-hidden:F_a8615e7e-3a3b-4497-9d55-86ea65153fd0;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Noncurrent&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Operating&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_502cbe2a-5432-41d0-85b4-23a20a165bac;"&gt;&lt;span style="-sec-ix-hidden:F_8be0e6d4-5a47-411b-9144-c408d3934f9a;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,553&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,093&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_a8cedab2-1fe0-482a-a6c2-28f0caa7a48f;"&gt;&lt;span style="-sec-ix-hidden:F_21a43b30-4a3d-4632-a584-149b79b2db2c;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;121&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;118&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;11,410&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3,012&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; For the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;three and six months ended June 30, 2024 and 2023, the components of operating and finance lease expenses were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:25.965%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.4%;"&gt;&lt;/td&gt;
         &lt;td style="width:30.546%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.52%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:6.901%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.3%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:7.662000000000001%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.4%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:4.481%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.921%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:6.901%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Lease Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Classification&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Cost of sales&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Selling, general and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;588&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;438&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;887&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finance lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;63&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Selling, general and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finance lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Maturities of the Company&#x2019;s operating and finance lease liabilities as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;June 30, 2024 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:42.989%;"&gt;&lt;/td&gt;
         &lt;td style="width:8.242%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:15.143%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:11.362%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.264%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Operating&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Finance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2024 (remainder)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,004&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,434&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,637&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,782&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,871&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;39&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,954&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3,308&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Total lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;17,990&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6,727&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;11,263&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;147&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&#160;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The weighted average remaining lease term and weighted average discount rate used to determine lease liabilities related to the Company&#x2019;s operating and finance leases as of June 30, 2024 and December 31, 2023 were:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:55.311%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.484%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:20.044%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Lease Term and Discount Rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.58&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1.69&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.35&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.37&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Weighted average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;14.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;14.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;14.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <rxst:NumberOfLeases
      contextRef="C_e648d52d-9f33-406d-b707-f0d436342566"
      decimals="INF"
      id="F_4b3b35f1-6705-4a6d-8c9e-a56fbf79654e"
      unitRef="U_Item">4</rxst:NumberOfLeases>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_e648d52d-9f33-406d-b707-f0d436342566"
      decimals="0"
      id="F_9ec26b75-0ae1-446d-84d2-f111751739f4"
      unitRef="U_sqft">137000</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:PaymentsForProceedsFromTenantAllowance
      contextRef="C_cbd133ad-eca3-4208-8941-8bfd8e1c173b"
      decimals="0"
      id="F_e77fb000-b47f-4474-9a8d-dc846cd46ac9"
      unitRef="U_USD">900000</us-gaap:PaymentsForProceedsFromTenantAllowance>
    <us-gaap:LessorOperatingLeaseTermOfContract
      contextRef="C_c4fcf8f2-fb38-42b9-adcb-eb6d516b8469"
      id="F_b4691cd3-a6f6-44a0-9d0d-dcc38941e143">P34M</us-gaap:LessorOperatingLeaseTermOfContract>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_443df5e3-56fa-4ac9-ae8d-93e0566a45d5"
      id="F_36a8f29f-818a-44a1-a188-f96ff73b9d2d">2025-03-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_443df5e3-56fa-4ac9-ae8d-93e0566a45d5"
      decimals="0"
      id="F_6aa21ba2-89d9-4bd3-8eca-8d09dc9c6765"
      unitRef="U_USD">11410</us-gaap:LeaseAndRentalExpense>
    <us-gaap:OperatingLeasesRentExpenseSubleaseRentals1
      contextRef="C_204a0bf3-73bf-4334-8ffd-365bddaf6a28"
      decimals="0"
      id="F_b7716a45-d767-4ec1-86f9-d40a8ba304be"
      unitRef="U_USD">5319</us-gaap:OperatingLeasesRentExpenseSubleaseRentals1>
    <us-gaap:LesseeOperatingSubleaseOptionToTerminate
      contextRef="C_204a0bf3-73bf-4334-8ffd-365bddaf6a28"
      id="F_033c3dc5-2f90-473c-8dbf-a307d9352d2c">On August 1, 2024 the sublease was cancelled.</us-gaap:LesseeOperatingSubleaseOptionToTerminate>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_3d547736-7d2f-4ab1-ba32-5440721ad534"
      decimals="0"
      id="F_12ca8718-2263-419b-b2ea-9aca7120a35b"
      unitRef="U_sqft">26825</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:OperationsCommencedDate1
      contextRef="C_79f66c27-e4ac-416a-b575-59bf974253cf"
      id="F_946655ab-e440-4abe-9ece-bea69acfca9f">2024-06-01</us-gaap:OperationsCommencedDate1>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_79f66c27-e4ac-416a-b575-59bf974253cf"
      id="F_7cf4db5f-c62d-4cea-af3d-5602585324f8">2031-01-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LessorOperatingLeaseTermOfContract
      contextRef="C_3d547736-7d2f-4ab1-ba32-5440721ad534"
      id="F_2cd73cff-0926-41af-8d11-f8dffb550d6b">P60M</us-gaap:LessorOperatingLeaseTermOfContract>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_79f66c27-e4ac-416a-b575-59bf974253cf"
      decimals="0"
      id="F_c9d74e40-b3f9-4e53-ac23-e88ce5f70013"
      unitRef="U_USD">41579</us-gaap:LeaseAndRentalExpense>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_107d2d34-29e5-4238-80a7-75906a0160b4"
      decimals="0"
      id="F_47c9cad1-e450-45bd-a93b-905936e4c2f9"
      unitRef="U_sqft">19680</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LessorOperatingLeaseTermOfContract
      contextRef="C_a73767b4-7596-4747-a31a-9abee5f0e1c3"
      id="F_a2b0fec5-21c2-45e5-893a-c5fc0c5ec6ca">P70M</us-gaap:LessorOperatingLeaseTermOfContract>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_fd5d1c6b-a916-4a4b-8a21-c86da5a58d96"
      id="F_cf841917-3cc6-4b9c-85e1-86a8cbd96e75">2025-04-01</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_53193d0d-eccf-4650-b5ff-2f01e68f7024"
      id="F_369d5770-9813-41d2-b2f5-5cbdfc5295e5">2031-01-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_a73767b4-7596-4747-a31a-9abee5f0e1c3"
      id="F_360188f9-9a77-4df3-8813-67a419eb9b4e">P70M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_fd5d1c6b-a916-4a4b-8a21-c86da5a58d96"
      decimals="0"
      id="F_2ca6c720-0f3b-4dbe-ba6e-74dcf125bc92"
      unitRef="U_USD">30701</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_a73767b4-7596-4747-a31a-9abee5f0e1c3"
      id="F_0c69d2b4-d4ef-4505-88e5-a68063dd9386">P60M</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_dac5e1bd-acd6-4c7d-aacf-a30a4e26a25c"
      decimals="0"
      id="F_2877d9b1-00ef-4f30-ac5d-eb8c4c76bc27"
      unitRef="U_sqft">42106</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LessorOperatingLeaseTermOfContract
      contextRef="C_e95a0f17-9a53-4675-91e9-06e88ee7f46d"
      id="F_c064a79e-5f9e-492b-975b-1cfad4548aa8">P76M</us-gaap:LessorOperatingLeaseTermOfContract>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_755fa8c1-f901-448e-a391-c05a19ebe37b"
      id="F_dc435c9a-31f3-4768-8f29-353467772427">2024-10-01</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_2cc166d9-2e7c-4d1e-b33d-918c247c655d"
      id="F_e620243c-3029-4ec3-9784-d696470c7182">2031-01-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_e95a0f17-9a53-4675-91e9-06e88ee7f46d"
      id="F_9c8bba11-10dd-4b7b-95ac-6659f25dbc41">P76M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_755fa8c1-f901-448e-a391-c05a19ebe37b"
      decimals="0"
      id="F_44668959-966b-4bdb-bdab-a937d101a326"
      unitRef="U_USD">64843</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="C_755fa8c1-f901-448e-a391-c05a19ebe37b"
      id="F_bbf74d80-ae48-4fe3-9414-d478990f9aab"> The Company has two options to extend the term of the lease at the end of the current term, with each option to extend being for a 5 year term.</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:PaymentsForProceedsFromTenantAllowance
      contextRef="C_755fa8c1-f901-448e-a391-c05a19ebe37b"
      decimals="0"
      id="F_6530a97b-5866-452e-a8ab-b7e278522ccf"
      unitRef="U_USD">50000</us-gaap:PaymentsForProceedsFromTenantAllowance>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="C_d0985361-3665-4b26-8732-c0bc94e9d51c"
      decimals="-5"
      id="F_6b0df3c0-f6d8-4616-a14a-70173d9ea874"
      unitRef="U_USD">10800000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
      contextRef="C_d0985361-3665-4b26-8732-c0bc94e9d51c"
      decimals="-5"
      id="F_c8ad058b-11e1-42f2-87e1-728019f4c8ae"
      unitRef="U_USD">200000</us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent
      contextRef="C_d0985361-3665-4b26-8732-c0bc94e9d51c"
      decimals="-5"
      id="F_2de54286-3016-4c79-83b5-6bc6b03519b1"
      unitRef="U_USD">1400000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears
      contextRef="C_d0985361-3665-4b26-8732-c0bc94e9d51c"
      decimals="-5"
      id="F_5c0c3d0f-0cbb-481d-b689-7b807803fec6"
      unitRef="U_USD">1600000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears
      contextRef="C_d0985361-3665-4b26-8732-c0bc94e9d51c"
      decimals="-5"
      id="F_f1d79f31-f00f-4165-99f6-fc4fd014a8a5"
      unitRef="U_USD">1800000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears
      contextRef="C_d0985361-3665-4b26-8732-c0bc94e9d51c"
      decimals="-5"
      id="F_a6eb7584-c690-4c2a-8575-b62cc95c8ecb"
      unitRef="U_USD">1800000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter
      contextRef="C_d0985361-3665-4b26-8732-c0bc94e9d51c"
      decimals="-5"
      id="F_817bec39-87b5-48fe-9081-1a8f089b0ad0"
      unitRef="U_USD">4000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
    <rxst:SummaryOfLeaseBalancesTableTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_8efd21fe-95de-4c3a-a1e8-cf70fe964980">&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table presents the lease balances within the Condensed Consolidated Balance Sheets as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;June 30, 2024 and December 31, 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:29.294%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;"&gt;&lt;/td&gt;
         &lt;td style="width:35.833%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:12.977%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.64%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:12.977%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Classification&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Operating&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Operating leases right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,818&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,444&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_3e517117-8319-4cc0-8225-94336556f3a7;"&gt;&lt;span style="-sec-ix-hidden:F_00e18cde-e7c6-4077-9799-7012c3ad64fb;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;142&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Total lease assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,960&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Operating&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_0bfe1017-2ed2-4326-a247-db41c8cf4d2b;"&gt;&lt;span style="-sec-ix-hidden:F_78fd0571-9a99-465d-8968-e56cfa5898f0;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;710&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,764&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_0f7fb7b9-c9ea-4648-8251-fd72d360c669;"&gt;&lt;span style="-sec-ix-hidden:F_a8615e7e-3a3b-4497-9d55-86ea65153fd0;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Noncurrent&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Operating&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_502cbe2a-5432-41d0-85b4-23a20a165bac;"&gt;&lt;span style="-sec-ix-hidden:F_8be0e6d4-5a47-411b-9144-c408d3934f9a;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10,553&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,093&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_a8cedab2-1fe0-482a-a6c2-28f0caa7a48f;"&gt;&lt;span style="-sec-ix-hidden:F_21a43b30-4a3d-4632-a584-149b79b2db2c;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;121&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;118&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;11,410&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3,012&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</rxst:SummaryOfLeaseBalancesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_8d12057b-b2aa-4f0c-8cc3-ded2eab775d9"
      unitRef="U_USD">10818000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_aaeb33aa-d17e-43b5-b304-45f4e6135c33"
      unitRef="U_USD">2444000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_ee0da4b3-8421-4392-82a3-dfca4d739aaa"
      unitRef="U_USD">142000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_bcf06078-d158-441b-af9a-9798fb5e0564"
      unitRef="U_USD">156000</us-gaap:FinanceLeaseRightOfUseAsset>
    <rxst:TotalLeaseAssets
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_608f8d67-fc2e-4ee0-96ae-cc40c9cdc2a3"
      unitRef="U_USD">10960000</rxst:TotalLeaseAssets>
    <rxst:TotalLeaseAssets
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_70788c75-a57b-46d1-979c-cf5f45cc389c"
      unitRef="U_USD">2600000</rxst:TotalLeaseAssets>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_b0443a72-fc70-4650-9ccb-de68f51e3d99"
      unitRef="U_USD">710000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_1acbdfe9-eb6b-4731-94ae-999b1f4fc269"
      unitRef="U_USD">1764000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_cf1e7a1c-8add-41ef-8ccf-c0b1b1677db9"
      unitRef="U_USD">26000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_7f29b44e-feb4-4f8c-9602-82675b120f51"
      unitRef="U_USD">37000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_df73bb11-6f32-4037-9268-8ad4849adbde"
      unitRef="U_USD">10553000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_b1754a26-2287-4973-a9ec-4e6b93f3e0b1"
      unitRef="U_USD">1093000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_70bea841-4f1f-4f19-8bd7-c59ec67284ff"
      unitRef="U_USD">121000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_a3b26af9-a799-49e5-ae07-892010bf8df8"
      unitRef="U_USD">118000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <rxst:TotalLeaseLiabilities
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_5557ee2f-80a9-4ffd-8565-a1eb412e17ac"
      unitRef="U_USD">11410000</rxst:TotalLeaseLiabilities>
    <rxst:TotalLeaseLiabilities
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="-3"
      id="F_b2ef5658-841d-46c2-89d2-fb995dcc7213"
      unitRef="U_USD">3012000</rxst:TotalLeaseLiabilities>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_092b48c8-9b59-4b4b-9feb-e4bd064dcdb9">&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; For the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;three and six months ended June 30, 2024 and 2023, the components of operating and finance lease expenses were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:25.965%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.4%;"&gt;&lt;/td&gt;
         &lt;td style="width:30.546%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.52%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:6.901%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.3%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:7.662000000000001%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.4%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:4.481%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:2.921%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:6.901%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Lease Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Classification&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Cost of sales&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Selling, general and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;588&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;438&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;887&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finance lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;63&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Selling, general and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finance lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_f8984806-8a2c-407e-87a3-79fd81817c95"
      decimals="-3"
      id="F_fda7a48b-8138-445e-94bc-00b7b7fef87d"
      unitRef="U_USD">3000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_428789be-eb44-4bee-8e7d-43887c59ba81"
      decimals="-3"
      id="F_9bd164d8-1214-4ae3-87bd-b2f2d03cdff2"
      unitRef="U_USD">3000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_870c219c-a4a7-4462-846d-85d7110b3380"
      decimals="-3"
      id="F_be4ff0d2-9c95-4af9-98a8-23631a2419d4"
      unitRef="U_USD">7000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_46ae809e-f67b-4a77-b4c5-50a424b655df"
      decimals="-3"
      id="F_ecc0ea2f-3e90-4a75-b476-ac59f2e6c2b7"
      unitRef="U_USD">7000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_89a390bf-cf3f-4d6e-9839-74e86626c8d9"
      decimals="-3"
      id="F_08bb3bae-5ba7-4042-b61a-18c2508424e5"
      unitRef="U_USD">23000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_8b1f96bb-fff2-49be-8819-b62edbf4e6d1"
      decimals="-3"
      id="F_6b8835b0-4c36-4949-8414-c0097d69fbca"
      unitRef="U_USD">24000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_3e89f686-064a-4ed5-8601-3e8782699162"
      decimals="-3"
      id="F_e754d8b4-5ea4-417a-8a1d-003c45ba4e6b"
      unitRef="U_USD">48000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_101ce506-9642-467b-b38c-f2c003a92905"
      decimals="-3"
      id="F_c089284b-c404-4273-895a-1b2360e715c6"
      unitRef="U_USD">61000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_c6550ecc-1f2d-48a5-b93f-4051f05eeb19"
      decimals="-3"
      id="F_86473ee7-2021-43e8-8270-7cbcfc3ed22d"
      unitRef="U_USD">588000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_67e0d5d6-5fee-4a17-ba10-34c977d6903a"
      decimals="-3"
      id="F_5b5e0900-d0f1-4a01-975b-f3e4661ea73d"
      unitRef="U_USD">438000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_2790d20b-5e9b-4fbb-aab0-0988eacc2119"
      decimals="-3"
      id="F_61cd8750-45c1-4d02-92df-e02f8300289f"
      unitRef="U_USD">1027000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_e3efc9bd-860f-444e-a889-ebfd9d131560"
      decimals="-3"
      id="F_2e1d2796-f115-4dbb-bb89-b936120cd067"
      unitRef="U_USD">887000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_89a390bf-cf3f-4d6e-9839-74e86626c8d9"
      decimals="-3"
      id="F_44da6cd4-6727-458c-97f2-6715487ee7b4"
      unitRef="U_USD">0</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_8b1f96bb-fff2-49be-8819-b62edbf4e6d1"
      decimals="-3"
      id="F_453d9155-d1a0-49e3-8f05-0a1a7574de8a"
      unitRef="U_USD">29000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_3e89f686-064a-4ed5-8601-3e8782699162"
      decimals="-3"
      id="F_d571789a-f2ba-442d-a8db-179a4c2d589f"
      unitRef="U_USD">17000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_101ce506-9642-467b-b38c-f2c003a92905"
      decimals="-3"
      id="F_f9e3fa9e-752f-4c95-aeec-b2a301d747a4"
      unitRef="U_USD">63000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_c6550ecc-1f2d-48a5-b93f-4051f05eeb19"
      decimals="-3"
      id="F_95a863db-394d-4913-8b39-0773dd511da6"
      unitRef="U_USD">8000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_67e0d5d6-5fee-4a17-ba10-34c977d6903a"
      decimals="-3"
      id="F_f3d988c2-5743-4070-8381-6db06e02a103"
      unitRef="U_USD">9000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_2790d20b-5e9b-4fbb-aab0-0988eacc2119"
      decimals="-3"
      id="F_63949c2e-e58a-40a4-8bae-d53281d61e3c"
      unitRef="U_USD">15000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_e3efc9bd-860f-444e-a889-ebfd9d131560"
      decimals="-3"
      id="F_adf5c4a4-590b-419b-9df2-544345841c4e"
      unitRef="U_USD">18000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      decimals="-3"
      id="F_85c28938-4cf3-4313-9ca2-1bdd72b81a11"
      unitRef="U_USD">5000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="C_9ca0479b-010f-4a98-9d8b-2e025b1da223"
      decimals="-3"
      id="F_06ed1df9-1511-4722-b744-d026af433df5"
      unitRef="U_USD">2000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="-3"
      id="F_d689edc2-3b76-4e80-b568-ffb2224e963a"
      unitRef="U_USD">11000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="C_92773448-1606-437d-912e-2e2bd0f53565"
      decimals="-3"
      id="F_7db8df52-a87a-4046-b107-42d670ceff06"
      unitRef="U_USD">7000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_44e37b99-ecb9-4fdf-8d50-1e2afa478388">&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Maturities of the Company&#x2019;s operating and finance lease liabilities as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;June 30, 2024 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:42.989%;"&gt;&lt;/td&gt;
         &lt;td style="width:8.242%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:15.143%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:11.362%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.264%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Operating&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Finance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2024 (remainder)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1,004&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,434&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,637&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,782&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,871&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;39&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;2,954&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;3,308&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Total lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;17,990&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6,727&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;11,263&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;147&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_96973771-ee4d-441f-8749-eb09b69ac931"
      unitRef="U_USD">1004000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_f388b213-d674-45f8-ba10-ed7d41828894"
      unitRef="U_USD">22000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_86f629fe-e784-4c50-9480-c44c8744e221"
      unitRef="U_USD">2434000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_4b7885a8-4c73-4c0a-894a-9fced682b938"
      unitRef="U_USD">46000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_1b9f00fa-529c-4409-807d-d8ac997d7144"
      unitRef="U_USD">2637000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_1a50fd99-8333-4e36-98ff-57dcabea86df"
      unitRef="U_USD">46000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_b17f1c2f-05bd-46f0-ad06-47457a5e4348"
      unitRef="U_USD">2782000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_ccfb3a18-3496-40b6-85b6-c651dfb434d8"
      unitRef="U_USD">46000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_756d5af6-e314-4fa1-8c5c-af61f3815f8e"
      unitRef="U_USD">2871000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_1ab440de-1962-4355-8d5c-68fd1ffb7549"
      unitRef="U_USD">39000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_f0c2d27b-b734-4f8f-84b0-04f9b3a78fdc"
      unitRef="U_USD">2954000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_d0098ea8-b571-4e13-b98b-98488a3b01ef"
      unitRef="U_USD">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_3c0d461b-1726-4328-9c94-a4df31f528c1"
      unitRef="U_USD">3308000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_86112392-a54b-4ab8-a74c-05747c90e529"
      unitRef="U_USD">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_2f99babd-2860-46d6-86b5-ee7d1b0620cd"
      unitRef="U_USD">17990000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_8f9189eb-edab-4fb3-a50a-61e9e3c1f46a"
      unitRef="U_USD">199000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_f699cdc1-e153-4bc2-8a91-6ce2acf8f1c4"
      unitRef="U_USD">6727000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_d8b9ea1e-c20e-40cf-ab73-70dd340ce064"
      unitRef="U_USD">52000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_9fa71cbf-c377-4134-809e-ea015ca32587"
      unitRef="U_USD">11263000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="-3"
      id="F_252f4061-f8ad-439b-9599-287c39c27a54"
      unitRef="U_USD">147000</us-gaap:FinanceLeaseLiability>
    <rxst:SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_d402a400-8edd-42b4-8523-a5144f6dc7b0">&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The weighted average remaining lease term and weighted average discount rate used to determine lease liabilities related to the Company&#x2019;s operating and finance leases as of June 30, 2024 and December 31, 2023 were:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:55.311%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:18.484%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:1.08%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;td style="width:20.044%;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;Lease Term and Discount Rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;6.58&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;1.69&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.35&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;4.37&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Weighted average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;14.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;10.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;14.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;14.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</rxst:SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      id="F_81baf750-5d4d-44bb-bab2-e0731a102a25">P6Y6M29D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      id="F_0179a7c6-cb8a-486a-935d-b4d89777ca88">P1Y8M8D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      id="F_bfddf7dc-30af-4964-94d2-a2c1b4b25447">P4Y4M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      id="F_f5d5bd84-06aa-4ca3-a1b6-44f0203e3997">P4Y4M13D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="3"
      id="F_9949c7aa-c2fd-4c48-aa40-82fc6763ed5f"
      unitRef="U_pure">0.144</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="3"
      id="F_ed5d6b94-e089-44cd-a62e-0b530eeb56d9"
      unitRef="U_pure">0.104</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="C_90e5cd49-e1a4-4b5f-9372-5862dbba9245"
      decimals="3"
      id="F_5a3769e3-4785-4ece-a3e1-e71e04c66c05"
      unitRef="U_pure">0.144</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="C_6bf98cbd-e518-432a-99cb-1699005a3a9a"
      decimals="3"
      id="F_8eaa47e2-f092-4fa5-a9e3-2dfe54c2cdc4"
      unitRef="U_pure">0.14</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      id="F_41c00b32-9cba-4c06-b050-8f3581a6f689">&lt;p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 8 &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Letter of credit&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company has a standby letter of credit, expiring September 30, 2024, issued by a financial institution as required security for one operating lease. The aggregate amount of the letter of credit was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;June 30, 2024 and December 31, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Legal Matters&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;From time-to-time, the Company may be involved in certain legal proceedings or regulatory matters arising in the ordinary course of business, including without limitation, actions with respect to intellectual property, employment, regulatory, product liability and contractual matters. In connection with these proceedings or matters,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;the Company regularly assesses the probability and amount (or range) of possible issues based on the developments in these proceedings or matters. A liability is recorded in the consolidated financial statements if it is determined that it is probable that a loss has been incurred, and that the amount (or range) of the loss can be reasonably estimated. Because of the uncertainties related to any pending proceedings or matters, the Company is currently unable to predict their ultimate outcome and, with respect to any legal proceeding or regulatory matter where no liability has been accrued, to make a reasonable estimate of the possible loss (or range of loss) that could result from an adverse outcome. At June 30, 2024 and December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; legal proceedings, regulatory matters, or other disputes or claims for which a material loss was considered probable or for which the amount (or range) of loss was reasonably estimable. However, regardless of the outcome, legal proceedings, regulatory matters, and other disputes and claims can have an adverse impact on the Company because of legal costs, diversion of management time and resources, and other factors.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LinesOfCreditCurrent
      contextRef="C_b7832ab7-5ac7-48b8-b36a-eeaa642bb7fb"
      decimals="-5"
      id="F_c258bd01-5adc-45e6-9037-41371df259de"
      unitRef="U_USD">200000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="C_df8cf6d9-9e68-4550-b7d7-3f23bb4e4d54"
      decimals="-5"
      id="F_a8b230d9-12fc-4e58-acdb-dbaa48cb8dd1"
      unitRef="U_USD">200000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LegalFees
      contextRef="C_0bd63812-92ba-4572-9a40-8db99e7f608b"
      decimals="0"
      id="F_7faecc7e-0a97-4777-87d4-1d8749b97a12"
      unitRef="U_USD">0</us-gaap:LegalFees>
    <us-gaap:LegalFees
      contextRef="C_1223a5cf-5ff9-4abd-b52d-c7eebdeb8212"
      decimals="0"
      id="F_8eac3d8b-6072-4388-8fbc-44880cbc7a41"
      unitRef="U_USD">0</us-gaap:LegalFees>
    <ecd:MtrlTermsOfTrdArrTextBlock
      contextRef="C_3c557978-5173-4887-9475-3c1de75ad09d"
      id="F_38a565c1-b9b7-4d8c-9d86-ca2b89f36747">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Rule 10b5-1 Trading Arrangements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;May 15, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;J. Andy Corley&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, a member of our &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Board of Directors&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;,  entered into a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Rule 10b5-1&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; trading arrangement that is intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c) (a &#x201c;Rule 10b5-1 Trading Plan&#x201d;) for the sale of securities of our common stock. Mr. Corley&#x2019;s Rule 10b5-1 Trading Plan, which has a term from August 19, 2024 to May 20, 2025, provides for the sale of up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;40,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock at a pre-determined limit price.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;May 21, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Ron Kurtz M.D&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;., &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Chief Executive Officer and President and a member of our Board of Directors&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, entered into a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Rule 10b5-1&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; Trading Plan for the sale of securities of our common stock. Dr. Kurtz&#x2019;s Rule 10b5-1 Trading Plan, which has a term from August 20, 2024 to August 15, 2025, provides for the sale of up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;180,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock pursuant to a series of market orders at pre-determined limit prices.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;June 3, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Ilya Goldshleger&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, Ph.D., &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Co-President and Chief Operating Officer&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, entered into a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Rule 10b5-1&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; Trading Plan for the sale of securities of our common stock. Dr. Goldshleger&#x2019;s Rule 10b5-1 Trading Plan, which has a term from September 16, 2024 to September 15, 2025, provides for the exercise and sale &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;of options for&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;295,529&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock pursuant to a series of market orders at pre-determined limit prices&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;June 7, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Eric Weinberg&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;., &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Co-President and Chief Commercial Officer&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, entered into a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Rule 10b5-1&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; Trading Plan for the sale of securities of our common stock. Mr. Weinberg&#x2019;s Rule 10b5-1 Trading Plan, which has a term from September 9, 2024 to September 9, 2025, provides for the sale of up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;100,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock pursuant to a series of market orders at pre-determined limit prices.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:18pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;March 12, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;,  &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Julie Andrews&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;member of our Board of Directors&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, entered into a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Rule 10b5-1&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; Trading Plan for the sale of securities of our common stock. Ms. Andrews&#x2019; Rule 10b5-1 Trading Plan, which has a term from June 14, 2024 to March 20, 2025, provides for the sale of up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;"&gt;15,625&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock at a pre-determined limit price.&lt;/span&gt;&lt;/p&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate
      contextRef="C_e16a6e57-fa09-4b23-9d5a-b5b69cb75e2d"
      id="F_8adbd0ff-0457-487d-8a3f-c087a060244d">May 15, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName
      contextRef="C_e16a6e57-fa09-4b23-9d5a-b5b69cb75e2d"
      id="F_1cf4e412-5d95-4d8a-b525-465e686c04a5">J. Andy Corley</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle
      contextRef="C_e16a6e57-fa09-4b23-9d5a-b5b69cb75e2d"
      id="F_6b3554c2-0df2-418f-a497-d997b1bd1842">Board of Directors</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_e16a6e57-fa09-4b23-9d5a-b5b69cb75e2d"
      id="F_8f39efd9-7401-4741-9f3b-2095ab9ab26a">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="C_628a0a40-4c51-46a8-ae7c-d6e7b44797d1"
      decimals="0"
      id="F_b466ed0d-aa2f-4008-8113-bbc5b0a4935c"
      unitRef="U_shares">40000</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:TrdArrAdoptionDate
      contextRef="C_9161bac0-099b-4ec0-be0c-82d298abeca3"
      id="F_9b1c7452-966e-44ec-83f2-5608a312d0e2">May 21, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName
      contextRef="C_9161bac0-099b-4ec0-be0c-82d298abeca3"
      id="F_b18f7c28-a5c9-4bae-85d6-09c612e759b1">Ron Kurtz M.D</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle
      contextRef="C_9161bac0-099b-4ec0-be0c-82d298abeca3"
      id="F_f9c68b15-edd3-4806-9416-270a8fd55cd7">Chief Executive Officer and President and a member of our Board of Directors</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_9161bac0-099b-4ec0-be0c-82d298abeca3"
      id="F_4b65e25d-6912-47f3-8493-059715408ff0">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="C_c1f69193-9ca1-46d8-825e-767d784caa8b"
      decimals="0"
      id="F_82b12066-d0d2-4b7c-b76a-e90d6f496c96"
      unitRef="U_shares">180000</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:TrdArrAdoptionDate
      contextRef="C_3da2657a-3194-4635-a909-ab3fd0a1dd6a"
      id="F_2f1922cb-4e4f-4e75-8747-8a3f15fe5d0a">June 3, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName
      contextRef="C_3da2657a-3194-4635-a909-ab3fd0a1dd6a"
      id="F_fb3755a9-368f-4818-821b-c41b867ce1ff">Ilya Goldshleger</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle
      contextRef="C_3da2657a-3194-4635-a909-ab3fd0a1dd6a"
      id="F_ec303f45-ac74-484a-b6cb-76ecac6a00f8">Co-President and Chief Operating Officer</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_3da2657a-3194-4635-a909-ab3fd0a1dd6a"
      id="F_5fa9a443-49b4-4fe5-abba-58d253a3d635">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="C_32b79176-7c08-4e2f-8dd4-4a8b2a419726"
      decimals="0"
      id="F_ef451c23-e726-4880-9f2a-253e6672603a"
      unitRef="U_shares">295529</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:TrdArrAdoptionDate
      contextRef="C_e17b2aa6-cab6-4346-b87c-a405a33a2764"
      id="F_20fa451a-69bf-4861-b6ce-6d63eeed4c13">June 7, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName
      contextRef="C_e17b2aa6-cab6-4346-b87c-a405a33a2764"
      id="F_9477c82b-6e3a-4bb2-bad6-16b2b796107a">Eric Weinberg</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle
      contextRef="C_e17b2aa6-cab6-4346-b87c-a405a33a2764"
      id="F_d61bb82d-5283-4785-9b9d-fc3c6b44bac6">Co-President and Chief Commercial Officer</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_e17b2aa6-cab6-4346-b87c-a405a33a2764"
      id="F_4d84148a-5c3a-4105-8c8f-b9e147f5b3aa">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="C_0c499457-67d8-4be1-bbac-93b1615afe77"
      decimals="0"
      id="F_371f2021-297a-43d5-ba8d-ca8895c33e66"
      unitRef="U_shares">100000</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:TrdArrAdoptionDate
      contextRef="C_897a6866-6f1b-4fb5-a915-4273bf3c2aee"
      id="F_6bb97f57-21c8-4fc8-9355-e56145992f47">March 12, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName
      contextRef="C_897a6866-6f1b-4fb5-a915-4273bf3c2aee"
      id="F_b695cb8b-1ffa-4124-816a-fac34a0b578f">Julie Andrews</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle
      contextRef="C_897a6866-6f1b-4fb5-a915-4273bf3c2aee"
      id="F_f55aead6-0da4-4225-813c-3da8b59ba535">member of our Board of Directors</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_897a6866-6f1b-4fb5-a915-4273bf3c2aee"
      id="F_035e4dd1-b415-44d7-b62e-0a1a6f4e7aef">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="C_1cc1ee8b-02ae-4c94-beaa-b81200fcda42"
      decimals="0"
      id="F_e3195463-1eaf-4b78-af4c-bae8696e1546"
      unitRef="U_shares">15625</ecd:TrdArrSecuritiesAggAvailAmt>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
